,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,type,units,uo_units,value,target
0,16626879.0,[],CHEMBL3821890,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg secretion by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,O=S(=O)(Oc1cc(CSc2ccccn2)[nH]n1)c1ccc(Br)cc1,CHEMBL3817822,Medchemcomm,2016.0,CHEMBL3817899,CHEMBL3817899,,0.0,http://www.openphacts.org/units/Nanomolar,2783923.0,=,1.0,1.0,=,IC50,nM,114930.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,114.93,CHEMBL613497
1,42387.0,[],CHEMBL695512,Antiviral activity against K103N/G190A strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL593,CHEMBL593,5.57,0.0,http://www.openphacts.org/units/Nanomolar,20822.0,=,1.0,1.0,=,IC50,nM,2700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2700.0,CHEMBL378
2,1403427.0,[],CHEMBL834757,Inhibitory concentration against 181C mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1Sc1nc(Nc2ccc(C#N)cc2)c(O)nc1C,CHEMBL1145199,J Med Chem,2005.0,CHEMBL367414,CHEMBL367414,5.30,0.0,http://www.openphacts.org/units/Nanomolar,360761.0,=,1.0,1.0,=,IC50,nM,5012.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.012,CHEMBL378
3,10938662.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1/C=C/C(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@]3(O)[C@@H]2C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]2(C)[C@]3(O)CC[C@@]2(O)C(C)=O)C1,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046557,CHEMBL2046557,4.19,0.0,http://www.openphacts.org/units/Nanomolar,1651440.0,=,1.0,1.0,=,IC50,nM,64040.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,64.04,CHEMBL613497
4,5306730.0,[],CHEMBL1696840,Antiviral activity against HIV1 isolate 71361-1 harboring reverse transcriptase K65R mutant infected in human TZM-b1 cells after 2 hrs by luciferase assays,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,CHEMBL1687731,Antimicrob Agents Chemother,2009.0,CHEMBL483,CHEMBL483,,0.0,http://www.openphacts.org/units/Nanomolar,1337339.0,>,1.0,1.0,>,IC50,nM,30000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,30000.0,CHEMBL378
5,1954141.0,[],CHEMBL891424,Antiviral activity against HIV1 RT 181C mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(Cl)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL234282,CHEMBL234282,7.00,0.0,http://www.openphacts.org/units/Nanomolar,647173.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,100.0,CHEMBL378
6,5126333.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,CN1c2ccc(Cl)cc2N(c2ccccc2)C(=O)c2c1ncn2Cc1ccc(C(=O)O)cc1,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642539,CHEMBL1642539,6.37,0.0,http://www.openphacts.org/units/Nanomolar,1317849.0,=,1.0,1.0,=,IC50,nM,430.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.43,CHEMBL378
7,12717509.0,[],CHEMBL2350955,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBV DNA replication after 72 hrs by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,C=CCc1ccc(O)c(-c2cc(C[C@@H](O)CO)ccc2O)c1,CHEMBL2346656,Bioorg Med Chem Lett,2013.0,CHEMBL2346748,CHEMBL2346748,,0.0,http://www.openphacts.org/units/Nanomolar,1874414.0,>,1.0,1.0,>,IC50,nM,1000000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1000.0,CHEMBL613497
8,1402101.0,[],CHEMBL837470,In vitro inhibitory concentration against HIV V179E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCO)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175692,CHEMBL175692,,0.0,http://www.openphacts.org/units/Nanomolar,360365.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
9,1751285.0,[],CHEMBL854522,Antiviral activity against Measles virus variant in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)c1cc(N)cc(NC(=O)Cc2ccccc2)c1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL209923,CHEMBL209923,,0.0,,532815.0,,1.0,0.0,,IC50,,,CHEMBL613738,Measles virus,Measles virus,11234,IC50,,,,CHEMBL613738
10,1092292.0,[],CHEMBL712251,Inhibition of HIV-1 replication in infected MT-4 human T-lymphoid cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCSC1,CHEMBL1129277,J Med Chem,1996.0,CHEMBL277725,CHEMBL277725,6.88,0.0,http://www.openphacts.org/units/Nanomolar,209990.0,=,1.0,1.0,=,IC50,nM,132.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,132.0,CHEMBL378
11,560084.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1)c1ccccc1SSc1ccccc1C(=O)Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL353646,CHEMBL353646,4.71,0.0,http://www.openphacts.org/units/Nanomolar,334001.0,=,1.0,1.0,=,IC50,nM,19500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,19.5,CHEMBL378
12,622925.0,[],CHEMBL710534,Inhibitory activity against 188L strain of HIV-1 in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,COc1nc(Cc2c(Cl)cccc2Cl)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL71579,CHEMBL71579,5.81,0.0,http://www.openphacts.org/units/Nanomolar,126934.0,=,1.0,1.0,=,IC50,nM,1550.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.55,CHEMBL378
13,1740152.0,[],CHEMBL854478,Inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2CCOCP(=O)(O)O,CHEMBL1138932,J Med Chem,2006.0,CHEMBL484,CHEMBL484,5.89,0.0,http://www.openphacts.org/units/Nanomolar,520776.0,=,1.0,1.0,=,IC50,nM,1300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.3,CHEMBL613497
14,2930426.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cc(Br)cn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL583614,CHEMBL583614,8.10,0.0,http://www.openphacts.org/units/Nanomolar,852896.0,=,1.0,1.0,=,IC50,nM,7.94,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.94,CHEMBL378
15,6200488.0,[],CHEMBL1781474,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 4 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,[O-][N+](CCc1c[nH]c2ccccc12)(CC1CCCCC1)CC1CCCCC1,CHEMBL1777761,Bioorg Med Chem,2011.0,CHEMBL1779170,CHEMBL1779170,,0.0,http://www.openphacts.org/units/Nanomolar,1425126.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
16,658122.0,[],CHEMBL683819,Anti-HIV activity in cell culture assay expressed as IC50 values.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OC[C@H]1OC(O)[C@@](O)(COC(=O)c2cc(O)c(O)c(O)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,CHEMBL1126373,Bioorg Med Chem Lett,1992.0,CHEMBL450816,CHEMBL450816,4.40,0.0,http://www.openphacts.org/units/Nanomolar,60612.0,=,1.0,1.0,=,IC50,nM,40000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,40.0,CHEMBL378
17,673498.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC2=NC(SSC3=C(C#N)C(c4ccc(Br)cc4)C4=C(O)CC(C)(C)CC4=N3)=C(C#N)C(c3ccc(Br)cc3)C2=C(O)C1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL333885,CHEMBL333885,,0.0,,228606.0,=,1.0,0.0,=,IC50,,74.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,74.3,CHEMBL378
18,701695.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccccc1SSc1ccccc1N,CHEMBL1129635,J Med Chem,1996.0,CHEMBL122355,CHEMBL122355,,0.0,,228535.0,=,1.0,0.0,=,IC50,,5.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,5.4,CHEMBL378
19,2048684.0,[],CHEMBL925406,Antiviral activity against Hepatitis B virus infected human HepG2 cells after 9 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2CCOCP(=O)(OCOC(=O)OC1CCCCC1)OCOC(=O)OC1CCCCC1.O=C(O)/C=C/C(=O)O,CHEMBL1140514,Bioorg Med Chem Lett,2007.0,CHEMBL398252,CHEMBL1185212,5.27,0.0,http://www.openphacts.org/units/Nanomolar,679855.0,=,1.0,1.0,=,IC50,nM,5330.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,5.33,CHEMBL613497
20,1249497.0,[],CHEMBL816327,DNA relaxation activity tested by the inhibition of the type 1B topoisomerase of molluscum contagiosum virus (MCV); ND=Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC2(CC(C)(C)c3c(Br)c(OS(=O)(=O)[O-])c(OS(=O)(=O)[O-])c(Br)c32)c2c(Br)c(OS(=O)(=O)[O-])c(OS(=O)(=O)[O-])c(Br)c21.[K+].[K+].[K+].[K+],CHEMBL1133186,J Med Chem,2000.0,CHEMBL292735,CHEMBL1206658,,0.0,http://www.openphacts.org/units/Nanomolar,108745.0,,1.0,0.0,,IC50,nM,,CHEMBL613121,Molluscum contagiosum virus,Molluscum contagiosum virus,10279,IC50,uM,UO_0000065,,CHEMBL613121
21,2649318.0,[],CHEMBL1024326,"Antiviral activity against HIV1 expressed in 293T cells assessed as protection against viral M33 envelope infection in human U87 cells coexpressing CD4, CCR5 receptors after 72 hrs by luciferase reporter gene pseudoviral assay",F,BAO_0000190,BAO_0000218,organism-based format,O=C(C(=O)N1CCN(C(=O)c2ccccc2)CC1)c1c[nH]c2c(-n3ccnn3)ncc(F)c12,CHEMBL1158460,J Med Chem,2009.0,CHEMBL236995,CHEMBL236995,,0.0,http://www.openphacts.org/units/Nanomolar,815605.0,<,1.0,1.0,<,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.0,CHEMBL378
22,613255.0,[],CHEMBL691383,Inhibitory concentration for cytopathicity of HIV-1 (HTLV-IIIB) in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1cc(C(O)(c2ccc(O)c(C(=O)OC)c2)c2ccc(O)c(C(=O)OC)c2)ccc1O,CHEMBL1125737,J Med Chem,1991.0,CHEMBL333146,CHEMBL333146,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,217791.0,>,1.0,1.0,>,IC50,ug.mL-1,78.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,78.0,CHEMBL378
23,24750958.0,[],CHEMBL5121091,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication by Nano-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCC(=O)O[C@@]12C[C@@H](C)[C@@]3(O)[C@H]([C@@H]1C2(C)C)[C@@H](OO)C(CO)=C[C@]1(O)C(=O)C(C)=C[C@@H]31,CHEMBL5120745,J Nat Prod,2021.0,CHEMBL5181689,CHEMBL5181689,,0.0,http://www.openphacts.org/units/Nanomolar,3861266.0,>,1.0,1.0,>,IC50,nM,41.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,41.0,CHEMBL378
24,1243465.0,[],CHEMBL677521,Concentration required to inhibit HIV-1TK-(B2006) induced cytopathicity in E6SM cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCC(=O)NCCCCCCCCCCC(=O)NCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL113937,CHEMBL1205558,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221533.0,=,1.0,1.0,=,IC50,ug.mL-1,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,20.0,CHEMBL378
25,42372.0,[],CHEMBL688337,Antiviral activity against wild-type HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL593,CHEMBL593,6.70,0.0,http://www.openphacts.org/units/Nanomolar,20822.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,200.0,CHEMBL378
26,22480470.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '120.0'}]",CHEMBL4687212,Antiviral activity against HIV-1 NL4-3 infected in human TZM-bl cells infected with supernatants from virus-infected human H9 cells treated with compound for 72 hrs assessed as reduction in luciferase expression measured after 48 hrs by luciferase reporter gene assay based BiCycle assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCc1cn(-c2ccc(NC(=O)Nc3cc(OC4CCOC4)ccc3C)cc2)nn1,CHEMBL4680261,Eur J Med Chem,2020.0,CHEMBL4792698,CHEMBL4792698,5.58,0.0,http://www.openphacts.org/units/Nanomolar,3523698.0,=,1.0,1.0,=,IC50,nM,2600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.6,CHEMBL378
27,24831002.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,NC1CCN(c2ccc3c(=O)c4cccc(F)c4oc3c2)C1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5209207,CHEMBL5209207,,0.0,http://www.openphacts.org/units/Nanomolar,3878114.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
28,7969191.0,[],CHEMBL1930947,"Antiviral activity against LacZ-containing HIV1 in COS7 cells expressing HXB2 Env, R8.91, and pTY-EFnLacZ assessed as reduction of viral vector infection into human HeLa cells expressing CD4 after 2 days using 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside staining",F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2cn(CCc3ccc(OC)c(OC)c3)c3c(=O)oc4cc(OS(=O)(=O)[O-])c(OC)cc4c23)cc1O.[Na+],CHEMBL1926605,Bioorg Med Chem,2011.0,CHEMBL1928865,CHEMBL1962902,,0.0,http://www.openphacts.org/units/Nanomolar,1565979.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
29,15166148.0,[],CHEMBL3404736,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as decrease in viral DNA replication treated for 7 days by real time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(OC(=O)/C=C/c2ccc(F)cc2)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402775,CHEMBL3402775,,0.0,http://www.openphacts.org/units/Nanomolar,2284129.0,>,1.0,1.0,>,IC50,nM,828500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,828.5,CHEMBL613497
30,23153204.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4810870,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 production treated at 48 hrs post-infection and measured on day 4 post-viral infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O,CHEMBL4808236,Bioorg Med Chem Lett,2021.0,CHEMBL116437,CHEMBL116437,5.87,0.0,http://www.openphacts.org/units/Nanomolar,3599012.0,=,1.0,1.0,=,IC50,nM,1360.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1360.0,CHEMBL378
31,1471737.0,[],CHEMBL834619,Inhibitory activity against HIV-1 mutant strain 181C; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1ccc(OC)c(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL187891,CHEMBL187891,,0.0,http://www.openphacts.org/units/Nanomolar,380718.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
32,24830983.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C(=O)c1ccncc1)c1ccc2c(=O)c3cccc(F)c3oc2c1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5173699,CHEMBL5173699,,0.0,http://www.openphacts.org/units/Nanomolar,3878095.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
33,2947383.0,[],CHEMBL1038497,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)COc1ccccc1)[C@@H](OC(=O)COc1ccccc1)C(C)(C)OC(=O)COc1ccccc1)C1=C2C[C@H](OC(=O)COc3ccccc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL574328,CHEMBL574328,,0.0,http://www.openphacts.org/units/Nanomolar,850757.0,>,1.0,1.0,>,IC50,nM,1400000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.4,CHEMBL613497
34,147847.0,[],CHEMBL756132,Compound was tested for the inhibition of LPS-induced TNF-alpha production in human peripheral blood mononuclear cells (PBMC),F,BAO_0000190,BAO_0000218,organism-based format,O=C1NC(=S)c2ccccc21,CHEMBL1146001,J Med Chem,2003.0,CHEMBL146923,CHEMBL146923,,0.0,http://www.openphacts.org/units/Nanomolar,291258.0,>,1.0,1.0,>,IC50,nM,30000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,30.0,CHEMBL378
35,2601777.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,OC[C@@H]1O[C@H](n2cnc3c(O)ncnc32)CC1(F)F,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL473685,CHEMBL473685,4.00,0.0,http://www.openphacts.org/units/Nanomolar,808005.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
36,8041797.0,[],CHEMBL1953242,Antiviral activity against HIV1 harboring VSV glycoprotein-G co-transfected with luciferase gene infected in human TZM-bl cells assessed as inhibition of viral replication after 48 hrs by microplate luminometer based luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1949625,Eur J Med Chem,2012.0,CHEMBL129,CHEMBL129,7.52,0.0,http://www.openphacts.org/units/Nanomolar,1577169.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,30.0,CHEMBL378
37,2030622.0,[],CHEMBL886374,Inhibition of cJun translocation in IL-1-beta-stimulated A549 cells,B,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)N1CC(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)C1,CHEMBL1139954,Bioorg Med Chem Lett,2007.0,CHEMBL246545,CHEMBL246545,5.37,0.0,http://www.openphacts.org/units/Nanomolar,674106.0,=,1.0,1.0,=,IC50,nM,4272.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,nM,UO_0000065,4272.0,CHEMBL4977
38,2009805.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3nccn3)ncc(F)c12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL238265,CHEMBL238265,6.21,0.0,http://www.openphacts.org/units/Nanomolar,668108.0,=,1.0,1.0,=,IC50,nM,620.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,620.0,CHEMBL378
39,24731847.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5115939,Antiviral activity against DENV-NGC-1 infected in human BHK cells incubated for 7 days by CellTiter 96 luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(c1ccc(C(F)(F)F)cc1O)c1[nH]c(Cl)c(Cl)c1-n1c(C(=O)c2ccc(C(F)(F)F)cc2O)cc(Cl)c1Sc1ncccn1,CHEMBL5113415,Eur J Med Chem,2022.0,CHEMBL5177334,CHEMBL5177334,,0.0,,3857947.0,,1.0,0.0,,IC50,,,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,,,,CHEMBL613757
40,14596878.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CCCCn1c(Sc2ccccc2)c(C)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL288728,CHEMBL288728,5.23,0.0,http://www.openphacts.org/units/Nanomolar,2082720.0,=,1.0,1.0,=,IC50,nM,5920.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.92,CHEMBL378
41,337092.0,[],CHEMBL653791,Inhibition of HIV-1 mediated cytotoxicity in CEM (human leukemia) cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@H](CC[C@@H](C)[C@H]1C[C@H](OS(=O)(=O)[O-])[C@H]2[C@@H]3C[C@H](O)C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)OC1OCC(O)C(O)C1O.[Na+],CHEMBL1127706,J Med Chem,1994.0,CHEMBL3138307,CHEMBL3138477,,0.0,http://www.openphacts.org/units/Nanomolar,327173.0,>,1.0,1.0,>,IC50,nM,126000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,126.0,CHEMBL378
42,880694.0,[],CHEMBL685389,Inhibition of HIV replication in H9 cells.,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@]12CCCC[C@@]1(O)[C@@H](Cl)C(=O)C(C(=O)Nc1ccccc1)C2,CHEMBL1128512,J Med Chem,1995.0,CHEMBL320506,CHEMBL320506,5.48,0.0,http://www.openphacts.org/units/Nanomolar,204867.0,=,1.0,1.0,=,IC50,nM,3300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.3,CHEMBL378
43,2292375.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1ccccc1Br,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL293780,CHEMBL293780,,0.0,http://www.openphacts.org/units/Nanomolar,812358.0,=,1.0,1.0,=,IC50,nM,5000345.35,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,2.301,CHEMBL378
44,15690088.0,[],CHEMBL3610404,Antiviral activity against HIV1 BaL infected in CD4/CCR5 expressing human MAGI cells incubated for 48 hrs by beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(Cc2cn[nH]c2C2CCN(Cc3ccccn3)CC2)cc1,CHEMBL3608277,ACS Med Chem Lett,2015.0,CHEMBL3608761,CHEMBL3608761,4.77,0.0,http://www.openphacts.org/units/Nanomolar,2496839.0,=,1.0,1.0,=,IC50,nM,17000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,17.0,CHEMBL378
45,24383453.0,[],CHEMBL5039283,Antiviral activity against HIV 1 BaL(R5) incubated overnight by ELISA analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL5038580,J Med Chem,2022.0,CHEMBL525076,CHEMBL525076,8.80,0.0,http://www.openphacts.org/units/Nanomolar,3777694.0,=,1.0,1.0,=,IC50,nM,1.58,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.58,CHEMBL378
46,10937555.0,[],CHEMBL2051603,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4c(F)c(F)c(F)c(F)c4F)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046582,CHEMBL2046582,5.00,0.0,http://www.openphacts.org/units/Nanomolar,1651465.0,=,1.0,1.0,=,IC50,nM,9900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,9.9,CHEMBL613497
47,1402253.0,[],CHEMBL833792,In vitro inhibitory concentration against HIV-1 Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(CC)CC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175534,CHEMBL175534,5.90,0.0,http://www.openphacts.org/units/Nanomolar,360399.0,=,1.0,1.0,=,IC50,nM,1259.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.259,CHEMBL378
48,1402480.0,[],CHEMBL835252,In vitro inhibitory concentration against HIV K101E and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177666,CHEMBL177666,6.80,0.0,http://www.openphacts.org/units/Nanomolar,360358.0,=,1.0,1.0,=,IC50,nM,158.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.158,CHEMBL378
49,24731878.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5115940,Antiviral activity against ZIKV-SMGC-1 infected in human BHK cells incubated for 7 days by CellTiter 96 luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(c1ccc(C(F)(F)F)cc1O)c1[nH]c(Cl)c(Cl)c1-n1c(C(=O)c2ccc(C(F)(F)F)cc2O)cc(Cl)c1Sc1nc2ccccc2[nH]1,CHEMBL5113415,Eur J Med Chem,2022.0,CHEMBL5188966,CHEMBL5188966,4.84,0.0,http://www.openphacts.org/units/Nanomolar,3857954.0,=,1.0,1.0,=,IC50,nM,14490.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,14.49,CHEMBL4296612
50,1143087.0,[],CHEMBL679241,Concentration required to reduce vaccinia virus-inducted cytopathicity by 50% (E6SM cells),F,BAO_0000190,BAO_0000218,organism-based format,O=C([O-])CCSCCCOC[C@H]1O[C@@](COCCCSCCC(=O)[O-])(O[C@H]2O[C@H](COCCCSCCC(=O)[O-])[C@@H](OCCCSCCC(=O)[O-])[C@H](OCCCSCCC(=O)[O-])[C@H]2OCCCSCCC(=O)[O-])[C@@H](OCCCSCCC(=O)[O-])[C@@H]1OCCCSCCC(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],CHEMBL1130336,J Med Chem,1997.0,CHEMBL3142960,CHEMBL3305994,,0.0,http://www.openphacts.org/units/Nanomolar,225170.0,>,1.0,1.0,>,IC50,nM,237000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,237.0,CHEMBL613493
51,3432542.0,[],CHEMBL1247392,Antiviral activity against HIV1 infected in human CEM cells assessed as protection against virus-induced cytopathic effect after 6 days by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)OC[C@H]1O[C@@H](Sc2nc3sc4c(c3c(=S)[nH]2)CCCC4)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,CHEMBL1240504,Eur J Med Chem,2010.0,CHEMBL1243336,CHEMBL1243336,,0.0,http://www.openphacts.org/units/Nanomolar,954887.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM/L,UO_0000065,100.0,CHEMBL378
52,17720718.0,[],CHEMBL3889300,"Cellular Firefly Luciferase Assay (AP-1): Curcumin is a known inhibitor of the AP-1 activation cascade. Therefore, modification of the structure of curcumin could lead to analogs with enhanced activity. The library consisting of three series of curcumin analogs were used to examine the role of the enone functionality in aryl systems where the spacer is 7-carbons (as in curcumin), 5-carbons or 3-carbons in length. In addition, the importance of aryl ring substituents was assessed. The AP-1 activities of curcumin and analogs were determined by a cellular firefly luciferase assay. This assay utilized a commercially available cell line (Panomics 293-luc cellular assay) developed for screening inhibitors of AP-1. This cell line is stably transfected with a luciferase reporter controlled by an AP-1 dependent promoter. The cell is stimulated with phorbol ester which activates AP-1. AP-1 then binds to one of three promoter regions on the cells DNA leading to the production of a luciferase enzyme. Luciferin is added to the cell lysates and the luciferase enzyme catalyzes a cleavage of luciferin leading to the emission of light.",B,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1cccnc1)/C=C/c1cccnc1,CHEMBL3886177,,2015.0,CHEMBL1971185,CHEMBL1971185,5.39,0.0,http://www.openphacts.org/units/Nanomolar,2849106.0,=,37.0,1.0,=,IC50,nM,4100.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,nM,UO_0000065,4100.0,CHEMBL4977
53,870934.0,[],CHEMBL653610,Inhibitory activity tested against the HIV-1 in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N[C@@H](C)C(=O)O)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL269462,CHEMBL269462,7.04,0.0,http://www.openphacts.org/units/Nanomolar,9064.0,=,1.0,1.0,=,IC50,nM,92.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,92.0,CHEMBL378
54,3284640.0,[],CHEMBL1110057,Antiviral activity against HIV1 3B infected in human HOS cells expressing human CXCR4/CCR5/CD4/pHIV-LTR luciferase assessed as inhibition of viral infection to cells,F,BAO_0000190,BAO_0000218,organism-based format,CN(Cc1ncc2ccccc2c1CCCN)[C@H]1CCCc2cccnc21,CHEMBL1157822,Bioorg Med Chem Lett,2010.0,CHEMBL1096503,CHEMBL1096503,7.92,0.0,http://www.openphacts.org/units/Nanomolar,910423.0,=,1.0,1.0,=,IC50,nM,12.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,12.0,CHEMBL378
55,1470285.0,[],CHEMBL833081,Inhibitory activity against HIV-1 mutant strain 190A,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cc(Cl)cc(Cl)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188941,CHEMBL188941,8.00,0.0,http://www.openphacts.org/units/Nanomolar,380720.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
56,19162202.0,[],CHEMBL4383613,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells after 7 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2ccc3c(c2)[C@@H](N)CC[C@@H]3O)cc1,CHEMBL4382211,Eur J Med Chem,2018.0,CHEMBL4473891,CHEMBL4473891,6.63,0.0,http://www.openphacts.org/units/Nanomolar,3198006.0,=,1.0,1.0,=,IC50,nM,232.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,232.0,CHEMBL378
57,3014053.0,[],CHEMBL1042767,Antiviral activity against HIV1 3B infected in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,CN(Cc1nc2ccccc2n1CCCCN)C1CCCc2cccnc21,CHEMBL1155333,Bioorg Med Chem Lett,2009.0,CHEMBL568233,CHEMBL568233,6.84,0.0,http://www.openphacts.org/units/Nanomolar,854919.0,=,1.0,1.0,=,IC50,nM,144.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.144,CHEMBL378
58,13463744.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1Sc1cccc(Cl)c1,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL55599,CHEMBL55599,5.13,0.0,http://www.openphacts.org/units/Nanomolar,1920861.0,=,1.0,1.0,=,IC50,nM,7413.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.13,CHEMBL378
59,15568203.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(Br)cc1)N1CCN(C(=O)c2cccc(B(O)O)c2)CC1,CHEMBL1201862,,,CHEMBL3560195,CHEMBL3560195,7.54,0.0,http://www.openphacts.org/units/Nanomolar,2474569.0,=,7.0,1.0,=,IC50,nM,28.7,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.0287,CHEMBL3259470
60,3199198.0,[],CHEMBL1104122,Antiviral activity against HIV1 UG/92/029 infected in PBMCs assessed as reverse transcriptase activity after 7 days by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](CN[C@H](CN[C@H](CN[C@H](CNCCC(N)=O)Cc1ccc(O)cc1)Cc1ccc(O)cc1)Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@@H](N)Cc1ccc(O)cc1,CHEMBL1153724,Bioorg Med Chem Lett,2009.0,CHEMBL1075815,CHEMBL1075815,5.35,0.0,http://www.openphacts.org/units/Nanomolar,889158.0,=,1.0,1.0,=,IC50,nM,4500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.5,CHEMBL378
61,3509174.0,[],CHEMBL1261042,Antiviral activity against HIV1 harboring reverse transcriptase V106A mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(F)c1Oc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1Br,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1258364,CHEMBL1258364,8.41,0.0,http://www.openphacts.org/units/Nanomolar,963336.0,=,1.0,1.0,=,IC50,nM,3.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.9,CHEMBL378
62,12651399.0,[],CHEMBL2327723,Antiviral activity against 0.001 MOI bevirimat-resistant Human immunodeficiency virus 1 NL4-3 harboring gag V370A mutant infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCC(=O)N[C@@H](CCC(N)=O)C(=O)OC(C)(C)C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324157,CHEMBL2324157,6.09,0.0,http://www.openphacts.org/units/Nanomolar,1850184.0,=,1.0,1.0,=,IC50,nM,810.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.81,CHEMBL378
63,2930178.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3cc(Br)cn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL573467,CHEMBL573467,8.30,0.0,http://www.openphacts.org/units/Nanomolar,848268.0,=,1.0,1.0,=,IC50,nM,5.01,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.01,CHEMBL378
64,1195875.0,[],CHEMBL880061,Inhibitory activity against LAI strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(Br)cc3Br)n2)cc1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL306169,CHEMBL306169,9.22,0.0,http://www.openphacts.org/units/Nanomolar,127463.0,=,1.0,1.0,=,IC50,nM,0.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0006,CHEMBL378
65,2149837.0,[],CHEMBL935681,Antiviral activity against HIV1 098-T20 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL440443,CHEMBL440443,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708031.0,=,1.0,1.0,=,IC50,ug.mL-1,0.056,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.056,CHEMBL378
66,24823627.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '144.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '6.0'}]",CHEMBL5140688,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in intracellular core HBV DNA level incubated for 6 days by qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3cccc(Cl)c3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5173167,CHEMBL5173167,8.37,0.0,http://www.openphacts.org/units/Nanomolar,3876725.0,=,1.0,1.0,=,IC50,nM,4.3,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0043,CHEMBL613497
67,24788588.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5131691,Antiviral activity against ZIKV-PRVABC59 infected in Neuronal cell line measured after 24 hrs,F,BAO_0000190,BAO_0000218,organism-based format,NCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1,CHEMBL5131375,J Med Chem,2022.0,CHEMBL1650595,CHEMBL1650595,5.70,0.0,http://www.openphacts.org/units/Nanomolar,3869435.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,2.0,CHEMBL4296612
68,13476934.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435877,CHEMBL2435877,,0.0,,1924253.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
69,2719817.0,[],CHEMBL1061801,Antiviral activity against HIV-1 3B infected human MT4 cells assessed as protection against virus-induced cytopathogenicity,F,BAO_0000190,BAO_0000218,organism-based format,CS(=O)(=O)Nc1ccc(NC(=S)Nc2ccc([N+](=O)[O-])cc2)cc1Oc1ccccc1,CHEMBL1153581,Eur J Med Chem,2009.0,CHEMBL562904,CHEMBL562904,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,830033.0,>,1.0,1.0,>,IC50,ug.mL-1,15.17,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,15.17,CHEMBL378
70,10862034.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](OC(=O)c2cc(=O)c3ccccc3o2)CC[C@]2(C)[C@H]3CC=C4[C@@H]5C[C@@](C)(C(=O)OCc6ccc(Br)cc6F)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2023707,CHEMBL2023707,,0.0,http://www.openphacts.org/units/Nanomolar,1639316.0,>,1.0,1.0,>,IC50,nM,1083570.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1083.57,CHEMBL613497
71,1156394.0,[],CHEMBL757806,Cytotoxicity against human peripheral blood mononuclear (PBM) cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2[C@@H]1CS[C@H](CO)O1,CHEMBL1126808,J Med Chem,1993.0,CHEMBL278444,CHEMBL278444,,0.0,http://www.openphacts.org/units/Nanomolar,100965.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
72,16494752.0,[],CHEMBL3772328,Antiviral activity against HIV1 NL4-3 infected in human TZM-bl cells assessed as inhibition of viral replication administered 6 hrs postinfection measured 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(O)c1ccc(Nc2nc(-c3cccnc3)nc3ccccc23)cc1,CHEMBL3769372,J Med Chem,2016.0,CHEMBL3769485,CHEMBL3769485,,0.0,http://www.openphacts.org/units/Nanomolar,2761346.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
73,12531032.0,[],CHEMBL3078221,Antiviral activity against HIV1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(-[n+]2noc([O-])c2CN2CCN(C)CC2)cc1,CHEMBL3044741,Med Chem Res,2013.0,CHEMBL2282182,CHEMBL2282182,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824352.0,>,1.0,1.0,>,IC50,ug.mL-1,12.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,12.9,CHEMBL378
74,1982307.0,[],CHEMBL899339,Antiviral activity against HBV transfected Hep G2.2.15 cells assessed as inhibition of e antigen HBsAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1O)C[C@H]1c3c(cc(OC)c(O)c3-2)CC[N+]1(C)C,CHEMBL1149710,Bioorg Med Chem Lett,2007.0,CHEMBL235429,CHEMBL235429,,0.0,http://www.openphacts.org/units/Nanomolar,661664.0,>,1.0,1.0,>,IC50,nM,3684000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,3.684,CHEMBL613497
75,24830987.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc2c(=O)c3cccc(F)c3oc2c1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5191500,CHEMBL5191500,,0.0,http://www.openphacts.org/units/Nanomolar,3878099.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
76,19261840.0,[],CHEMBL4404361,Antiviral activity against HIV1 subtypeA QF495.23M.ENV.A3,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.58,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,260.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.26,CHEMBL378
77,18849447.0,[],CHEMBL4305534,Inhibition of recombinant N-terminal His-tagged human FER (SH2 domain to C-terminal) expressed in Escherichia coli assessed as decrease in FL-Peptide22 substrate phosphorylation incubated for 90 mins,B,BAO_0000190,BAO_0000019,assay format,Cc1cccc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)c(Br)c3cn[nH]c(=O)c23)c1,CHEMBL4304751,ACS Med Chem Lett,2019.0,CHEMBL4456804,CHEMBL4456804,8.57,0.0,http://www.openphacts.org/units/Nanomolar,3145973.0,=,1.0,1.0,=,IC50,nM,2.7,CHEMBL3982,Homo sapiens,Tyrosine-protein kinase FER,9606,IC50,nM,UO_0000065,2.7,CHEMBL3982
78,919347.0,[],CHEMBL656269,Inhibition of human immunodeficiency virus-1 (HIV-1) induced cytopathicity in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(N)c2nn(C[C@@H](CF)OCP(=O)(O)O)nc2n1,CHEMBL1129435,J Med Chem,1996.0,CHEMBL130509,CHEMBL130509,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251938.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,100.0,CHEMBL378
79,2199520.0,[],CHEMBL952494,Inhibition of HBV promoter in human HepG2(2.2.15) cells by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1NCc2c1cc1ccc3c(c1c2-c1ccc2c(c1)OCO2)OCO3,CHEMBL1156464,Proc Natl Acad Sci U S A,2007.0,CHEMBL367646,CHEMBL367646,7.10,0.0,http://www.openphacts.org/units/Nanomolar,791642.0,=,1.0,1.0,=,IC50,nM,80.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.08,CHEMBL613497
80,2929608.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3ccnc3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL572507,CHEMBL572507,7.30,0.0,http://www.openphacts.org/units/Nanomolar,848285.0,=,1.0,1.0,=,IC50,nM,50.11,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,50.11,CHEMBL378
81,691048.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Nc1cc(Cl)ccc1SSc1ccc(Cl)cc1N,CHEMBL1129635,J Med Chem,1996.0,CHEMBL119940,CHEMBL119940,,0.0,,228636.0,=,1.0,0.0,=,IC50,,12.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,12.1,CHEMBL378
82,24830930.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c2ccc(N3CCCC3)cc2oc2c(F)cccc12,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5184875,CHEMBL5184875,6.68,0.0,http://www.openphacts.org/units/Nanomolar,3878103.0,=,1.0,1.0,=,IC50,nM,210.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.21,CHEMBL613497
83,3084018.0,[],CHEMBL1072584,Antiviral activity against HIV1 infected in human JC53-BL cells after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)nc(C)c1C(=O)N1C[C@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@H]2C1,CHEMBL1153211,Bioorg Med Chem Lett,2010.0,CHEMBL593027,CHEMBL593027,8.70,0.0,http://www.openphacts.org/units/Nanomolar,872814.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
84,2371540.0,[],CHEMBL1035738,Antiviral activity against HIV1 with reverse transcriptase L100I mutant in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4nc(N)ccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL489586,CHEMBL489586,8.74,0.0,http://www.openphacts.org/units/Nanomolar,773548.0,=,1.0,1.0,=,IC50,nM,1.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.8,CHEMBL378
85,15027151.0,[],CHEMBL3367171,Inhibition of AP-1-mediated transcriptional activation in human Jurkat cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cnc(Cl)cn1,CHEMBL3352097,J Med Chem,2014.0,CHEMBL340410,CHEMBL340410,5.40,0.0,http://www.openphacts.org/units/Nanomolar,2265167.0,=,1.0,1.0,=,IC50,nM,4000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,4.0,CHEMBL4977
86,1188800.0,[],CHEMBL698757,Inhibition concentration against influenza A (WSN),F,BAO_0000190,BAO_0000218,organism-based format,O=C1N(CCCCCCOc2ccc(C(F)(F)F)cc2)CCN1c1ccncc1,CHEMBL1135916,J Med Chem,2002.0,CHEMBL296696,CHEMBL296696,,0.0,http://www.openphacts.org/units/Nanomolar,71838.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL613128,unidentified influenza virus,unidentified influenza virus,11309,IC50,uM,UO_0000065,25.0,CHEMBL613128
87,16556871.0,[],CHEMBL3795205,Antiviral activity against CXCR4 using HIV-1 NL4.3 infected in human MT4 cells assessed as reduction of viral replication preincubated for 15 mins with cells followed by viral infection measured after 4 days by MTS/PES method,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(Cc2ccccc2)CCCN(S(=O)(=O)c2ccccc2N)C1.Cl,CHEMBL3792300,J Med Chem,2016.0,CHEMBL3793640,CHEMBL3794631,5.16,0.0,http://www.openphacts.org/units/Nanomolar,2770901.0,=,1.0,1.0,=,IC50,nM,6930.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.93,CHEMBL378
88,1471415.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cccc(C(F)(F)F)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188995,CHEMBL188995,8.00,0.0,http://www.openphacts.org/units/Nanomolar,380836.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
89,10861938.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)C(=O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL493512,CHEMBL493512,,0.0,http://www.openphacts.org/units/Nanomolar,1640519.0,=,1.0,1.0,=,IC50,nM,432540.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,432.54,CHEMBL613497
90,15066684.0,[],CHEMBL3390094,Antiviral activity against HIV1 infected in HEK293T cells by p24 ELISA based phenotypic assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1[nH]c2ccc(Cl)cc2c1C(O)c1ccccc1,CHEMBL3352750,Bioorg Med Chem Lett,2014.0,CHEMBL3325516,CHEMBL3325516,5.94,0.0,http://www.openphacts.org/units/Nanomolar,2270412.0,=,1.0,1.0,=,IC50,nM,1150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.15,CHEMBL378
91,3003248.0,[],CHEMBL1045518,Antiviral activity against HIV1 Ba-L infected in HOS cells assessed as inhibition of viral infection,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(N)(=O)=O)c(C)c1C(=O)N[C@H]1CC[C@](CCN2[C@@H]3CC[C@H]2C[C@@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1,CHEMBL1155363,Bioorg Med Chem Lett,2009.0,CHEMBL571300,CHEMBL571300,5.97,0.0,http://www.openphacts.org/units/Nanomolar,857681.0,=,1.0,1.0,=,IC50,nM,1070.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.07,CHEMBL378
92,2003494.0,[],CHEMBL901904,Antiviral activity against Vaccinia virus-infected Vero cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccccn1)c1cc2nc(-c3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3)[nH]c2cn1,CHEMBL1138288,J Med Chem,2007.0,CHEMBL238906,CHEMBL238906,5.82,0.0,http://www.openphacts.org/units/Nanomolar,666653.0,=,1.0,1.0,=,IC50,nM,1500.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,nM,UO_0000065,1500.0,CHEMBL613493
93,2649350.0,[],CHEMBL1024326,"Antiviral activity against HIV1 expressed in 293T cells assessed as protection against viral M33 envelope infection in human U87 cells coexpressing CD4, CCR5 receptors after 72 hrs by luciferase reporter gene pseudoviral assay",F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(-c2ccn[nH]2)ccc1C(=O)C(=O)N1CCN(C(=O)c2ccccc2)C[C@H]1C,CHEMBL1158460,J Med Chem,2009.0,CHEMBL561022,CHEMBL561022,,0.0,http://www.openphacts.org/units/Nanomolar,816258.0,<,1.0,1.0,<,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.0,CHEMBL378
94,18812958.0,[],CHEMBL4276412,Antiviral activity against darunavir-resistant HIV1 at passage 21 infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL4270667,J Med Chem,2018.0,CHEMBL116,CHEMBL116,,0.0,http://www.openphacts.org/units/Nanomolar,3125925.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
95,3397922.0,[],CHEMBL1217303,Antiviral activity against HIV1 3B infected in human MAGI cells after 40 to 48 hrs assessed as inhibition of viral life cycle,F,BAO_0000190,BAO_0000218,organism-based format,O=C1C(c2ccc(O)c(O)c2)=c2c(c3c(n2CCc2ccc(O)cc2)=C(c2ccc(O)c(O)c2)C(=O)c2cc(O)c(O)cc2-3)-c2cc(O)c(O)cc21,CHEMBL1212851,Bioorg Med Chem,2010.0,CHEMBL1214277,CHEMBL1214277,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,931709.0,>,1.0,1.0,>,IC50,ug.mL-1,25.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,25.0,CHEMBL378
96,3199195.0,[],CHEMBL1104123,Antiviral activity against HIV1 HT/92/599 infected in PBMCs assessed as reverse transcriptase activity after 7 days by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](CN[C@H](CN[C@H](CN[C@H](CNCCC(N)=O)Cc1ccc(O)cc1)Cc1ccc(O)cc1)Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@@H](N)Cc1ccc(O)cc1,CHEMBL1153724,Bioorg Med Chem Lett,2009.0,CHEMBL1075815,CHEMBL1075815,4.90,0.0,http://www.openphacts.org/units/Nanomolar,889158.0,=,1.0,1.0,=,IC50,nM,12700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.7,CHEMBL378
97,18202578.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(C2NC(=O)NC(C)=C2c2nc(-c3ccc(C#N)cc3)cs2)c1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4083554,CHEMBL4083554,6.42,0.0,http://www.openphacts.org/units/Nanomolar,3019962.0,=,1.0,1.0,=,IC50,nM,380.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.38,CHEMBL378
98,16494771.0,[],CHEMBL3772328,Antiviral activity against HIV1 NL4-3 infected in human TZM-bl cells assessed as inhibition of viral replication administered 6 hrs postinfection measured 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1ccc(Nc2nc(-c3ccncc3)nc3ccccc23)cc1,CHEMBL3769372,J Med Chem,2016.0,CHEMBL3770825,CHEMBL3770825,,0.0,http://www.openphacts.org/units/Nanomolar,2761472.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
99,560999.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,NS(=O)(=O)c1ccc(CCNC(=O)c2ccccc2SSc2ccccc2C(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL353498,CHEMBL353498,4.28,0.0,http://www.openphacts.org/units/Nanomolar,334046.0,=,1.0,1.0,=,IC50,nM,52800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,52.8,CHEMBL378
100,6336417.0,[],CHEMBL1821125,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by measuring HBsAg and HBeAg production after 9 days by EIA,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)Nc1ccc(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)OC)cc1,CHEMBL1817553,Bioorg Med Chem,2011.0,CHEMBL1819247,CHEMBL1819247,5.54,0.0,http://www.openphacts.org/units/Nanomolar,1451649.0,=,1.0,1.0,=,IC50,nM,2850.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.85,CHEMBL613497
101,2649343.0,[],CHEMBL1024326,"Antiviral activity against HIV1 expressed in 293T cells assessed as protection against viral M33 envelope infection in human U87 cells coexpressing CD4, CCR5 receptors after 72 hrs by luciferase reporter gene pseudoviral assay",F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(-c2ccc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)cc2)cs1,CHEMBL1158460,J Med Chem,2009.0,CHEMBL550829,CHEMBL550829,5.27,0.0,http://www.openphacts.org/units/Nanomolar,816169.0,=,1.0,1.0,=,IC50,nM,5400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5400.0,CHEMBL378
102,10866464.0,[],CHEMBL2025518,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)c4cccnc4)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2023670,CHEMBL2023670,5.39,0.0,http://www.openphacts.org/units/Nanomolar,1639234.0,=,1.0,1.0,=,IC50,nM,4050.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,4.05,CHEMBL613497
103,16662883.0,[],CHEMBL3832826,AntiDengue activity HCI DV2/Huh7 IC50 (uM),F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1ccc(F)cc1NS(=O)(=O)c1cccc(-c2cnn(Cc3ccccc3)c2)c1,CHEMBL3832761,,,CHEMBL3637931,CHEMBL3637931,5.00,0.0,http://www.openphacts.org/units/Nanomolar,2790167.0,=,34.0,1.0,=,IC50,nM,10000.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,10.0,CHEMBL613757
104,18399214.0,[],CHEMBL4149755,Inhibition of human Pit-2 expressed in HEK293 cells coexpressing tetracyclin assessed as reduction in uptake of 33P-radiolabeled Pi incubated for 20 to 30 mins prior to substrate addition,B,BAO_0000190,BAO_0000219,cell-based format,Cc1[nH]c2c(N3CCO[C@H](CO)C3)c(C#N)c(C(F)(F)F)nc2c1Cl,CHEMBL4145593,ACS Med Chem Lett,2018.0,CHEMBL4175607,CHEMBL4175607,,0.0,http://www.openphacts.org/units/Nanomolar,3053882.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL4295806,Homo sapiens,Sodium-dependent phosphate transporter 2,9606,IC50,uM,UO_0000065,25.0,CHEMBL4295806
105,2413666.0,[],CHEMBL987708,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@H](OC(=O)COC(C)=O)[C@H](C[C@@H](C)[C@]12CC[C@@]3(C)[C@@]1(C[C@H](OC(=O)COC(C)=O)[C@H]1[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@@]13C)O2)OC(=O)COC(C)=O,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL453254,CHEMBL453254,4.29,0.0,http://www.openphacts.org/units/Nanomolar,810807.0,=,1.0,1.0,=,IC50,nM,51000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.051,CHEMBL613497
106,18808326.0,[],CHEMBL4275448,Antiviral activity against Zika virus SMGC infected in BHK cells assessed as inhibition of virus induced cytopathic effect after 8 days by CellTiter-Glo luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2[C@@H]1O[C@H](C[C@@H](N)CC[C@H](N)C(=O)O)[C@@H](O)[C@H]1O,CHEMBL4270631,Eur J Med Chem,2018.0,CHEMBL1214186,CHEMBL1214186,,0.0,http://www.openphacts.org/units/Nanomolar,3125052.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,50.0,CHEMBL4296612
107,595275.0,[],CHEMBL710373,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Oc3c(Cl)cc(F)cc3Cl)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL305805,CHEMBL305805,6.15,0.0,http://www.openphacts.org/units/Nanomolar,126915.0,=,1.0,1.0,=,IC50,nM,706.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.706,CHEMBL378
108,5132806.0,[],CHEMBL1646268,Antiviral activity against HIV1 89.6 infected in human PBMC assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2[nH]c(=O)c(CN(Cc3ccco3)C(=O)c3ccc(Cl)cc3)cc2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645043,CHEMBL1645043,5.21,0.0,http://www.openphacts.org/units/Nanomolar,1321031.0,=,1.0,1.0,=,IC50,nM,6170.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.17,CHEMBL378
109,674963.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)SSCN(N)C(=O)O,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120596,CHEMBL120596,,0.0,,228588.0,>,1.0,0.0,>,IC50,,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,200.0,CHEMBL378
110,2930239.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CN3CCOC(CN(C)C)C3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL584769,CHEMBL584769,,0.0,,848259.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
111,1497622.0,[],CHEMBL874206,Inhibitory concentration that required to Induced a 50% decrease in PBMC+PHA (healthy human's peripheral blood cells) cells survival ,F,BAO_0000190,BAO_0000218,organism-based format,CCc1cc(CC)c(C(=O)CC(SCC(=O)O)C(=O)O)c(CC)c1,CHEMBL1141166,J Med Chem,2005.0,CHEMBL192916,CHEMBL192916,4.70,0.0,http://www.openphacts.org/units/Nanomolar,386652.0,=,1.0,1.0,=,IC50,nM,19920.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,19.92,CHEMBL378
112,14596872.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)c1c(Sc2ccccc2)n(COCc2ccccc2)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL39015,CHEMBL39015,5.07,0.0,http://www.openphacts.org/units/Nanomolar,2082392.0,=,1.0,1.0,=,IC50,nM,8510.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.51,CHEMBL378
113,2414471.0,[],CHEMBL953484,Antiviral activity against HIV1 with reverse transcriptase L100I mutation in human CEM cells assessed as protection against virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCS(N)(=O)=O)[nH]c3ccc(Cl)cc23)c1,CHEMBL1153955,J Med Chem,2009.0,CHEMBL470007,CHEMBL470007,8.92,0.0,http://www.openphacts.org/units/Nanomolar,810749.0,=,1.0,1.0,=,IC50,nM,1.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.2,CHEMBL378
114,24831010.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,OC1(C(F)(F)F)c2ccc(N3CCCC3)cc2Oc2c(Cl)cccc21,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5205914,CHEMBL5205914,,0.0,http://www.openphacts.org/units/Nanomolar,3878122.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
115,613871.0,[],CHEMBL710534,Inhibitory activity against 188L strain of HIV-1 in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)cc(C)c1Oc1nc(N)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL71659,CHEMBL71659,6.92,0.0,http://www.openphacts.org/units/Nanomolar,126911.0,=,1.0,1.0,=,IC50,nM,121.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.121,CHEMBL378
116,10866795.0,[],CHEMBL2027346,Antiviral activity against Human immunodeficiency virus 1 Clade B WITO4160.33 infected in human TZM-bl cells after 2 days by luciferase reporter gene analysis,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOc1c2cc(C(=O)Nc3cc(C(=O)O)cc(C(=O)O)c3)cc1Cc1cc(C(=O)Nc3cc(C(=O)O)cc(C(=O)O)c3)cc(c1OCCCC)Cc1cc(C(=O)Nc3cc(C(=O)O)cc(C(=O)O)c3)cc(c1OCCCC)Cc1cc(C(=O)Nc3cc(C(=O)O)cc(C(=O)O)c3)cc(c1OCCCC)C2,CHEMBL2021873,Bioorg Med Chem Lett,2012.0,CHEMBL1090293,CHEMBL1090293,5.75,0.0,http://www.openphacts.org/units/Nanomolar,1638074.0,=,1.0,1.0,=,IC50,nM,1800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.8,CHEMBL378
117,7924551.0,[],CHEMBL1921362,Antiviral activity against Human immunodeficiency virus 1 Ba-L in human PBL cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CS(=O)(=O)Nc1ccc(Oc2ccc(CN3CCC(N(C(=O)Nc4ccc(C(N)=O)nc4)c4ccccc4)CC3)c(C3CC3)n2)cc1,CHEMBL1914281,Bioorg Med Chem Lett,2011.0,CHEMBL1914525,CHEMBL1914525,8.66,0.0,http://www.openphacts.org/units/Nanomolar,1556600.0,=,1.0,1.0,=,IC50,nM,2.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.2,CHEMBL378
118,3013894.0,[],CHEMBL1045234,Antiviral activity against HIV1 3B infected human HOS cells expressing human CXCR4 and CD4 assessed as inhibition of viral infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCN(Cc1cn2c(N3CCN(C)CC3)cccc2n1)[C@H]1CCCc2cccnc21,CHEMBL1156094,Bioorg Med Chem Lett,2009.0,CHEMBL585016,CHEMBL585016,8.52,0.0,http://www.openphacts.org/units/Nanomolar,860806.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
119,1472427.0,[],CHEMBL826114,Inhibitory activity against HIV-1 mutant strain 138K,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cc(Cl)cc(Cl)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL184294,CHEMBL184294,,0.0,http://www.openphacts.org/units/Nanomolar,380650.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
120,1243461.0,[],CHEMBL709463,Concentration required to inhibit by 50% syncytium formation between MOLT-4 cells and HIV-1(IIIB),F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCC(=O)NCCCCCCCCCCC(=O)NCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL113937,CHEMBL1205558,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221533.0,=,1.0,1.0,=,IC50,ug.mL-1,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,10.0,CHEMBL378
121,18057381.0,[],CHEMBL4012533,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA level,F,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)C1=C(C)NC(c2ncccc2F)=N[C@@H]1c1ccc(F)cc1Cl,CHEMBL4011615,J Med Chem,2017.0,CHEMBL4101893,CHEMBL4101893,6.82,0.0,http://www.openphacts.org/units/Nanomolar,2992841.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.15,CHEMBL613497
122,15027158.0,[],CHEMBL3367171,Inhibition of AP-1-mediated transcriptional activation in human Jurkat cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cnc(Cl)nc1Cl,CHEMBL3352097,J Med Chem,2014.0,CHEMBL340779,CHEMBL340779,6.70,0.0,http://www.openphacts.org/units/Nanomolar,2265160.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.2,CHEMBL4977
123,15158540.0,[],CHEMBL3398830,Inhibition of HBV HBsAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)c1cccc2c1CCOC2=O,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397164,CHEMBL3397164,,0.0,http://www.openphacts.org/units/Nanomolar,2278962.0,>,1.0,1.0,>,IC50,nM,3290000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,3.29,CHEMBL613497
124,6200538.0,[],CHEMBL1781474,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 4 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,c1coc(CN(CCc2c[nH]c3ccccc23)Cc2ccco2)c1,CHEMBL1777761,Bioorg Med Chem,2011.0,CHEMBL1779160,CHEMBL1779160,5.46,0.0,http://www.openphacts.org/units/Nanomolar,1425115.0,=,1.0,1.0,=,IC50,nM,3500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,3.5,CHEMBL613497
125,1403323.0,[],CHEMBL834755,Inhibitory concentration against 100I mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Sc2cn(C)c(=O)c(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL175827,CHEMBL175827,,0.0,http://www.openphacts.org/units/Nanomolar,360628.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
126,2432639.0,[],CHEMBL1027472,Antiviral activity against HIV1 3B infected in human HOG.R5 assessed as inhibition of viral replication by microtiter assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1159344,J Nat Prod,2003.0,CHEMBL269277,CHEMBL269277,4.49,0.0,http://www.openphacts.org/units/Nanomolar,735816.0,=,1.0,1.0,=,IC50,nM,32500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,32.5,CHEMBL378
127,19261936.0,[],CHEMBL4404393,"Antiviral activity against HIV1 subtypeC ZM214M.PL15, SVPC7",F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.62,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,240.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.24,CHEMBL378
128,641358.0,[],CHEMBL683819,Anti-HIV activity in cell culture assay expressed as IC50 values.,F,BAO_0000190,BAO_0000218,organism-based format,O=C1O[C@H]2[C@H](O)[C@@H](OC(=O)c3cc(O)c(O)c4c3[C@@H]3C1=CC(=O)C(O)(O)C3(O)O4)[C@H](OC(=O)c1cc(O)c(O)c(O)c1)O[C@@H]2CO,CHEMBL1126373,Bioorg Med Chem Lett,1992.0,CHEMBL447361,CHEMBL447361,4.16,0.0,http://www.openphacts.org/units/Nanomolar,60643.0,=,1.0,1.0,=,IC50,nM,70000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,70.0,CHEMBL378
129,5229816.0,[],CHEMBL1677713,Antiviral activity against Human immunodeficiency virus 1 3B infected in human H9 cells infected with 12.5 uL of virus stock assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,<,1.0,1.0,<,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
130,15621456.0,[],CHEMBL3584167,Antiviral activity against HIV1 NL4.3-Ren infected in human MT2 cells assessed as inhibition of viral growth measured 48 hrs post infection by luminometry,F,BAO_0000190,BAO_0000218,organism-based format,C=C(CO)[C@@H]1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5[C@H](O)C[C@]43C)[C@@H]12,CHEMBL3580560,J Nat Prod,2015.0,CHEMBL3581940,CHEMBL3581940,5.02,0.0,http://www.openphacts.org/units/Nanomolar,2482778.0,=,1.0,1.0,=,IC50,nM,9500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,9.5,CHEMBL378
131,1411646.0,[],CHEMBL832751,Inhibitory concentration against hepatitis C virus polymerase,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(Br)cc1-c1cccc(C(=O)CC(=O)C(=O)O)c1,CHEMBL1145280,J Med Chem,2005.0,CHEMBL175894,CHEMBL175894,7.00,0.0,http://www.openphacts.org/units/Nanomolar,362377.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,0.1,CHEMBL4620
132,826302.0,[],CHEMBL772932,Inhibition of Hepatitis C virus NS3 protease in vitro.,B,BAO_0000190,BAO_0000357,single protein format,CC(C)C[C@H](NC(=O)[C@H](O)c1ccccc1)C(=O)N[C@@H](CC(F)F)C(=O)C(=O)O,CHEMBL1147550,Bioorg Med Chem Lett,2004.0,CHEMBL69077,CHEMBL69077,5.52,0.0,http://www.openphacts.org/units/Nanomolar,119346.0,=,1.0,1.0,=,IC50,nM,3000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,3.0,CHEMBL4620
133,22980433.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '192.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '8.0'}]",CHEMBL4772774,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in intracellular viral DNA level incubated for 4 days prior to compound washout followed by compound addition and measured after 4 days by fluorogenic probe based RT-qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Cc1nc(-c2ccncc2)sc1C(=O)NCc1ccc(F)cc1,CHEMBL4765395,Eur J Med Chem,2020.0,CHEMBL4784545,CHEMBL4784545,4.39,0.0,http://www.openphacts.org/units/Nanomolar,3568773.0,=,1.0,1.0,=,IC50,nM,40500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol/L,UO_0000065,40.5,CHEMBL613497
134,5247020.0,[],CHEMBL1687411,Antiviral activity against HIV1 Ba-L infected in human PBL cells assessed as reverse transcriptase activity after 7 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CCC(C)(CNS(=O)(=O)c1ccccc1)c1ccccc1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL3084354,CHEMBL3084354,,0.0,,1333589.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
135,3014807.0,[],CHEMBL1050520,Antiviral activity against multidrug-resistant HIV1 isolate JSL infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(c1)OCCC=CCCCCN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]3OCC[C@H]31)S2(=O)=O,CHEMBL1156053,J Med Chem,2009.0,CHEMBL2094013,CHEMBL2094013,7.14,0.0,http://www.openphacts.org/units/Nanomolar,862636.0,=,1.0,1.0,=,IC50,nM,73.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.073,CHEMBL378
136,13861064.0,[],CHEMBL3101351,Antiviral activity against HIV1 NL4.3 infected in human TZM-bl cells expressing CXCR4-tropic incubated for 1 hr prior to infection measured after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C12C=CC(=O)C(O)=C1CC=C(C)C2C/C=C(\C)CO,CHEMBL3098125,Bioorg Med Chem Lett,2014.0,CHEMBL3099061,CHEMBL3099061,4.14,0.0,http://www.openphacts.org/units/Nanomolar,1956064.0,=,1.0,1.0,=,IC50,nM,72443.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.14,CHEMBL378
137,435998.0,[],CHEMBL683810,Antiviral activities against HIV-1 replication in CEM cells and its ability to lower the viral charge supernatants was reported,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)ccc1O,CHEMBL1133718,J Med Chem,2000.0,CHEMBL40170,CHEMBL40170,5.52,0.0,http://www.openphacts.org/units/Nanomolar,61380.0,=,1.0,1.0,=,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.0,CHEMBL378
138,2929482.0,[],CHEMBL1056901,Antiviral activity against HIV1 HXB2 harboring 101E and K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSCc3ccco3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567204,CHEMBL567204,8.40,0.0,http://www.openphacts.org/units/Nanomolar,852794.0,=,1.0,1.0,=,IC50,nM,3.98,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.98,CHEMBL378
139,921594.0,[],CHEMBL677528,Antiviral activity against vaccinia virus (VV) in E6SM cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2nn(CCOCP(=O)(O)O)nc12,CHEMBL1129435,J Med Chem,1996.0,CHEMBL130760,CHEMBL130760,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251948.0,>,1.0,1.0,>,IC50,ug.mL-1,400.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,ug ml-1,UO_0000274,400.0,CHEMBL613493
140,3014831.0,[],CHEMBL1050516,Antiviral activity against multidrug-resistant HIV1 isolate C infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,CHEMBL1156053,J Med Chem,2009.0,CHEMBL729,CHEMBL729,,0.0,http://www.openphacts.org/units/Nanomolar,862429.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
141,18509583.0,[],CHEMBL4191604,Antiviral activity against HIV1 isolate LAV0.04 infected in PHA-stimulated human PBMC assessed as reduction in p24 level after 7 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL4190218,J Nat Prod,2017.0,CHEMBL129,CHEMBL129,7.10,0.0,http://www.openphacts.org/units/Nanomolar,3073113.0,=,1.0,1.0,=,IC50,nM,79.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,79.0,CHEMBL378
142,2099827.0,[],CHEMBL949222,Antiviral activity against HIV1 RU570 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)N(CCCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nc4c2CCN(C(=O)c2ccccc2)C4)C3)c2ccccc2)cc1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL401620,CHEMBL401620,8.30,0.0,http://www.openphacts.org/units/Nanomolar,699406.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.005,CHEMBL378
143,2009791.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-c3nccs3)nccc12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL237859,CHEMBL237859,6.30,0.0,http://www.openphacts.org/units/Nanomolar,668121.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,500.0,CHEMBL378
144,12687178.0,[],CHEMBL2344307,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral surface antigen production,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)O[C@H]1C[C@@H]2C(=CC[C@@H]3[C@@]2(C)C(=O)C[C@]2(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](OC(C)=O)C[C@@]32C)C(C)(C)[C@@H]1OC(=O)CC,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332401,CHEMBL2332401,,0.0,http://www.openphacts.org/units/Nanomolar,1866095.0,>,1.0,1.0,>,IC50,nM,649900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,649.9,CHEMBL613497
145,2681608.0,[],CHEMBL1052429,Antiviral activity against HIV1 CAP244.2.00.D3 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N[C@@H](CC(C)C)[C@H](O)CC(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL137752,CHEMBL137752,5.92,0.0,http://www.openphacts.org/units/Nanomolar,823862.0,=,1.0,1.0,=,IC50,nM,1210.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.21,CHEMBL378
146,5222682.0,[],CHEMBL1675429,Antiviral activity against HIV1 harboring reverse transcriptase Q151M mutant infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL141,CHEMBL141,,0.0,,1332024.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
147,19261746.0,[],CHEMBL4404352,Antiviral activity against HIV1 HXB2 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4463095,CHEMBL4463095,5.96,0.0,http://www.openphacts.org/units/Nanomolar,3216285.0,=,1.0,1.0,=,IC50,nM,1100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.1,CHEMBL378
148,12680670.0,[],CHEMBL2342597,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral replication after 9 days by fluorescence PCR method,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)NCCc3ccc(F)cc3)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333291,CHEMBL2333291,,0.0,http://www.openphacts.org/units/Nanomolar,1867254.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
149,24788559.0,[],CHEMBL5131662,Antiviral activity against TIBO resistant HIV-1 mutant in PBMC,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,CHEMBL5131375,J Med Chem,2022.0,CHEMBL14762,CHEMBL14762,9.44,0.0,http://www.openphacts.org/units/Nanomolar,3869388.0,=,1.0,1.0,=,IC50,nM,0.36,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.36,CHEMBL378
150,18183401.0,[],CHEMBL4040187,Antiviral activity against CXCR4-tropic HIV-1 NL4-3 infected in human PHA-stimulated PBMC assessed as inhibition of viral replication by measuring reduction in p24 antigen production preincubated with cells for 30 mins followed by viral infection measured on day 10 post infection in presence of IL-2 by ELISA,F,BAO_0000190,BAO_0000019,assay format,Nc1ncnc2c1ncn2C[C@@H](CF)OCP(=O)(O)O,CHEMBL4038313,J Med Chem,2017.0,CHEMBL519667,CHEMBL519667,5.92,0.0,http://www.openphacts.org/units/Nanomolar,3016390.0,=,1.0,1.0,=,IC50,nM,1190.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.19,CHEMBL378
151,1199849.0,[],CHEMBL710376,Inhibitory activity against 100I strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1Br,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL439757,CHEMBL439757,8.18,0.0,http://www.openphacts.org/units/Nanomolar,127455.0,=,1.0,1.0,=,IC50,nM,6.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0066,CHEMBL378
152,13463752.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2cccc(N)c2C#N)c1,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL294627,CHEMBL294627,6.37,0.0,http://www.openphacts.org/units/Nanomolar,1920682.0,=,1.0,1.0,=,IC50,nM,426.58,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.37,CHEMBL378
153,15679998.0,[],CHEMBL3606515,Antiviral activity against HIV1 LAI infected in human MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CO[C@H]3OC[C@H](N(C)C(=O)OC(C)(C)C)[C@H]32)cc1,CHEMBL3603748,J Med Chem,2015.0,CHEMBL3605642,CHEMBL3605642,7.43,0.0,http://www.openphacts.org/units/Nanomolar,2495841.0,=,1.0,1.0,=,IC50,nM,37.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,37.0,CHEMBL378
154,10961183.0,[],CHEMBL2061268,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M3 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCNC=C1C(=O)Nc2ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)cc21,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057468,CHEMBL2057468,7.40,0.0,http://www.openphacts.org/units/Nanomolar,1655130.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,40.0,CHEMBL378
155,23274466.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](OCc5cn([C@@H]6CC[C@@]7(C)[C@@H](C6)C[C@H](O)[C@@H]6[C@@H]7CC[C@]7(C)[C@@H]([C@H](C)CCC(=O)NCCS(=O)(=O)O)CC[C@@H]67)nn5)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4869726,CHEMBL4869726,7.92,0.0,http://www.openphacts.org/units/Nanomolar,3621266.0,=,1.0,1.0,=,IC50,nM,12.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,12.0,CHEMBL613497
156,22806659.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@@H](Sc3ccc(OCc4ccccc4)cc3)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4743026,CHEMBL4743026,6.59,0.0,http://www.openphacts.org/units/Nanomolar,3541899.0,=,1.0,1.0,=,IC50,nM,256.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.256,CHEMBL613497
157,18509593.0,[],CHEMBL4191606,Antiviral activity against NRTI-resistant HIV1 isolate 1617-1 infected in PHA-stimulated human PBMC assessed as reduction in p24 level after 7 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(O[C@@H]3O[C@H](C)[C@@H](O)[C@H](O)[C@H]3O)c3c(c(-c4ccc5c(c4)OCO5)c2cc1OC)C(=O)OC3,CHEMBL4190218,J Nat Prod,2017.0,CHEMBL458904,CHEMBL458904,7.21,0.0,http://www.openphacts.org/units/Nanomolar,3073112.0,=,1.0,1.0,=,IC50,nM,61.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,61.0,CHEMBL378
158,16436239.0,[],CHEMBL3755173,Antiviral activity against R5-tropic HIV1 cYTA48P infected in TZM-bl cells by single round assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc2c(c1)OCO2)C(=O)NC1CC2(CCCCC2)NC2(CCCCC2)C1,CHEMBL3751773,Bioorg Med Chem Lett,2016.0,CHEMBL3751929,CHEMBL3751929,5.95,0.0,http://www.openphacts.org/units/Nanomolar,2746198.0,=,1.0,1.0,=,IC50,nM,1130.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.13,CHEMBL378
159,2602217.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCCCC(=O)N[C@@H](CC(C)C)C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL137753,CHEMBL137753,6.34,0.0,http://www.openphacts.org/units/Nanomolar,808040.0,=,1.0,1.0,=,IC50,nM,460.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.46,CHEMBL378
160,682956.0,[],CHEMBL683678,Tested for cytoprotection against production of HIV-1 p24.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(N/N=C\c1ccc(Cl)cc1Cl)c1ccccc1SSc1ccccc1C(=O)N/N=C\c1ccc(Cl)cc1Cl,CHEMBL1129635,J Med Chem,1996.0,CHEMBL420725,CHEMBL420725,,0.0,http://www.openphacts.org/units/Nanomolar,228639.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
161,19288676.0,[],CHEMBL4410544,Antiviral activity against wild type HIV-1 3B infected in wild type human C8166 cells,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)[C@H](C)NP(=O)(OC[C@@H]1C=C[C@H](n2cc(C)c(=O)[nH]c2=O)O1)Oc1cccc(S(F)(F)(F)(F)F)c1,CHEMBL4406893,Bioorg Med Chem Lett,2019.0,CHEMBL4578360,CHEMBL4578360,7.27,0.0,http://www.openphacts.org/units/Nanomolar,3220827.0,=,1.0,1.0,=,IC50,nM,54.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.054,CHEMBL378
162,3198136.0,[],CHEMBL1104124,Antiviral activity against HIV1 97ZA003 infected in PBMCs assessed as reverse transcriptase activity after 7 days by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)CCNC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@@H](N)Cc1ccc(O)cc1,CHEMBL1153724,Bioorg Med Chem Lett,2009.0,CHEMBL1075830,CHEMBL1075830,4.57,0.0,http://www.openphacts.org/units/Nanomolar,889153.0,=,1.0,1.0,=,IC50,nM,27000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,27.0,CHEMBL378
163,3498066.0,[],CHEMBL1259504,Antiviral activity against HIV1 isolate 89.6 infected in human PM1 cells expressing CCR5 assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC1,CHEMBL1255517,Bioorg Med Chem Lett,2010.0,CHEMBL1258620,CHEMBL1258620,,0.0,http://www.openphacts.org/units/Nanomolar,963625.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
164,608331.0,[],CHEMBL691384,Inhibitory concentration for cytopathicity of HIV-1 (HTLV-IIIB) in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C1=CC(=C(c2ccc(O)c(C(=O)O)c2)c2ccc(O)c(C(=O)O)c2)C=CC1=O,CHEMBL1125737,J Med Chem,1991.0,CHEMBL275938,CHEMBL275938,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,217786.0,=,1.0,1.0,=,IC50,ug.mL-1,1.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,1.1,CHEMBL378
165,2263397.0,[],CHEMBL1010846,Antiviral activity against R5 tropic HIV1 BaL infected in human JC53-BL cells expressing CCR5 after 2 days by cell-cell fusion assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC1CN(S(C)(=O)=O)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2,CHEMBL1139267,Bioorg Med Chem Lett,2009.0,CHEMBL479627,CHEMBL479627,7.00,0.0,http://www.openphacts.org/units/Nanomolar,750004.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,100.0,CHEMBL378
166,2694291.0,[],CHEMBL1053927,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV surface antigen,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2nc3c(cc2c(CN(C)C)c1O)CSc1c(C)cc(C)cc1-3,CHEMBL1152943,Bioorg Med Chem,2009.0,CHEMBL564533,CHEMBL564533,4.86,0.0,http://www.openphacts.org/units/Nanomolar,824861.0,=,1.0,1.0,=,IC50,nM,13800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,13.8,CHEMBL613497
167,5222596.0,[],CHEMBL1675304,Antiviral activity against HIV1 infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1.O=S(=O)(O)O,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL1200619,CHEMBL1380,5.21,0.0,http://www.openphacts.org/units/Nanomolar,1332021.0,=,1.0,1.0,=,IC50,nM,6200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.2,CHEMBL378
168,3129690.0,[],CHEMBL1065520,Antiviral activity against HIV1 LAI infected in human CEM-SS cells assessed as inhibition of viral replication by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1csc(-c2nc(COc3c4cc(CC(=O)[O-])cc3Cc3cc(CC(=O)[O-])cc(c3O)Cc3cc(CC(=O)[O-])cc(c3OCc3csc(-c5nc(C)cs5)n3)Cc3cc(CC(=O)[O-])cc(c3O)C4)cs2)n1.[Na+].[Na+].[Na+].[Na+],CHEMBL1157689,Bioorg Med Chem,2010.0,CHEMBL590677,CHEMBL1208390,4.55,0.0,http://www.openphacts.org/units/Nanomolar,880943.0,=,1.0,1.0,=,IC50,nM,28000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,28.0,CHEMBL378
169,2149800.0,[],CHEMBL935679,Antiviral activity against HIV1 3B infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL428147,CHEMBL428147,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708030.0,=,1.0,1.0,=,IC50,ug.mL-1,0.008,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.008,CHEMBL378
170,2929697.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCSCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578367,CHEMBL578367,8.20,0.0,http://www.openphacts.org/units/Nanomolar,852822.0,=,1.0,1.0,=,IC50,nM,6.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.3,CHEMBL378
171,22933317.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCNC(=O)/C=C/c3ccc4c(c3)OCO4)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4740354,CHEMBL4740354,7.77,0.0,http://www.openphacts.org/units/Nanomolar,3560878.0,=,1.0,1.0,=,IC50,nM,17.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.017,CHEMBL378
172,2244600.0,[],CHEMBL1003077,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase V106A/Y181C mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL57,CHEMBL57,,0.0,http://www.openphacts.org/units/Nanomolar,798657.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2000.0,CHEMBL378
173,2149851.0,[],CHEMBL935682,Antiviral activity against HIV1 098-T1249 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL428436,CHEMBL428436,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708036.0,=,1.0,1.0,=,IC50,ug.mL-1,0.024,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.024,CHEMBL378
174,5199542.0,[],CHEMBL1670948,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1nc2ccc(Cl)cc2c(-c2ccccc2Cl)c1CCO,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668634,CHEMBL1668634,5.16,0.0,http://www.openphacts.org/units/Nanomolar,1328418.0,=,1.0,1.0,=,IC50,nM,6900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,6.9,CHEMBL613497
175,574441.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1)c1ccccc1SSc1ccccc1C(=O)Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL353645,CHEMBL353645,4.75,0.0,http://www.openphacts.org/units/Nanomolar,334000.0,=,1.0,1.0,=,IC50,nM,17800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,17.8,CHEMBL378
176,1195877.0,[],CHEMBL710530,Inhibitory activity against 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(Br)cc3Br)n2)cc1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL306169,CHEMBL306169,8.24,0.0,http://www.openphacts.org/units/Nanomolar,127463.0,=,1.0,1.0,=,IC50,nM,5.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0057,CHEMBL378
177,1403436.0,[],CHEMBL834756,Inhibitory concentration against 103N mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(S(=O)(=O)c2nc(Nc3ccc(C#N)cc3)c(=O)n(C)c2C)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL175570,CHEMBL175570,6.50,0.0,http://www.openphacts.org/units/Nanomolar,360772.0,=,1.0,1.0,=,IC50,nM,320.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.32,CHEMBL378
178,18083432.0,[],CHEMBL4018068,Antiviral activity against HIV-1 NL4.3 infected in human TZM-b1 cells pretreated for 1 hr followed by viral infection measured after 2 days by CPRG assay,F,BAO_0000190,BAO_0000219,cell-based format,O=C1/C(=C/c2ccc(-c3cc(C(F)(F)F)ccc3Cl)o2)SC(=S)N1Cc1ccc(F)cc1,CHEMBL4017470,Bioorg Med Chem Lett,2017.0,CHEMBL4081817,CHEMBL4081817,4.76,0.0,http://www.openphacts.org/units/Nanomolar,2998247.0,=,1.0,1.0,=,IC50,nM,17300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,17.3,CHEMBL378
179,6336415.0,[],CHEMBL1821125,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by measuring HBsAg and HBeAg production after 9 days by EIA,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccncc1,CHEMBL1817553,Bioorg Med Chem,2011.0,CHEMBL1819337,CHEMBL1819337,5.27,0.0,http://www.openphacts.org/units/Nanomolar,1451751.0,=,1.0,1.0,=,IC50,nM,5390.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,5.39,CHEMBL613497
180,640214.0,[],CHEMBL696966,Concentration required for reduction of plaque against influenza B,F,BAO_0000190,BAO_0000218,organism-based format,CCCN(CCC)C(=O)[C@@H]1OC(C(=O)O)=C[C@H](N)[C@H]1NC(=O)C(F)(F)F,CHEMBL1134218,Bioorg Med Chem Lett,2001.0,CHEMBL350298,CHEMBL350298,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,313074.0,=,1.0,1.0,=,IC50,ug.mL-1,0.3,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,0.3,CHEMBL613129
181,12723431.0,[],CHEMBL2351032,Antiviral activity against Hepatitis B virus-infected human HepG2(2.2.15) cells assessed as inhibition of HBsAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/C=C/c1ccc2c(c1)OCO2)N1CCCCC1,CHEMBL2346644,Bioorg Med Chem Lett,2013.0,CHEMBL43185,CHEMBL43185,,0.0,http://www.openphacts.org/units/Nanomolar,1875477.0,=,1.0,1.0,=,IC50,nM,150000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.15,CHEMBL613497
182,2719813.0,[],CHEMBL1061801,Antiviral activity against HIV-1 3B infected human MT4 cells assessed as protection against virus-induced cytopathogenicity,F,BAO_0000190,BAO_0000218,organism-based format,CS(=O)(=O)Nc1ccc(NC(=S)NCc2ccccc2)cc1Oc1ccccc1,CHEMBL1153581,Eur J Med Chem,2009.0,CHEMBL561482,CHEMBL561482,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,829986.0,=,1.0,1.0,=,IC50,ug.mL-1,20.15,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,20.15,CHEMBL378
183,15210808.0,[],CHEMBL3421430,Antiviral activity against recombinant Human immunodeficiency virus 1 NL4.3 containing Renilla gene infected in CD3/IL2-activated human MT2 cells assessed as inhibition of virus replication pretreated for 2 hrs followed by viral infection for additional 2 hrs measured after 48 hrs by Renilla-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1[C@H](OC(C)=O)[C@H]2[C@@H](OC(C)=O)[C@](C)(OC(C)=O)C[C@]2(OC(C)=O)C(=O)[C@H](C)/C=C/C(C)(C)C(=O)[C@H](OC(C)=O)[C@H]1OC(C)=O,CHEMBL3414423,J Nat Prod,2014.0,CHEMBL3414610,CHEMBL3414610,8.70,0.0,http://www.openphacts.org/units/Nanomolar,2289945.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
184,2395646.0,[],CHEMBL944654,Antiviral activity against HIV1 LAI infected in human CEM-SS cells assessed as reverse transcriptase activity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(OC(=O)CCCCCNC(=O)[C@@H](N)C(C)C)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)OC(=O)CCCCCNC(=O)[C@H](N)C(C)C.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL1140955,Eur J Med Chem,2008.0,CHEMBL508351,CHEMBL1187551,4.81,0.0,http://www.openphacts.org/units/Nanomolar,728713.0,=,1.0,1.0,=,IC50,nM,15500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,15500.0,CHEMBL378
185,18727038.0,[],CHEMBL4259326,Antiviral activity against HIV1 subtype BC CNE30 pseudovirus assessed as inhibition of viral infection in Ghost (3)X4/R5 cells after 48 hrs by Bright-Glo luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@]1(C)CCC/C=C\CCC[C@@](C)(C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O,CHEMBL4257519,Medchemcomm,2018.0,CHEMBL4277174,CHEMBL4277174,7.14,0.0,http://www.openphacts.org/units/Nanomolar,3111234.0,=,1.0,1.0,=,IC50,nM,71.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,71.7,CHEMBL378
186,10866462.0,[],CHEMBL2025518,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/n4ccnc4)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2023668,CHEMBL2023668,5.13,0.0,http://www.openphacts.org/units/Nanomolar,1639232.0,=,1.0,1.0,=,IC50,nM,7480.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,7.48,CHEMBL613497
187,613872.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)CCOc1nc(Cc2c(Cl)cccc2Cl)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL310247,CHEMBL310247,8.26,0.0,http://www.openphacts.org/units/Nanomolar,126931.0,=,1.0,1.0,=,IC50,nM,5.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0055,CHEMBL378
188,1755805.0,[],CHEMBL864208,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-n2c(C)nnc2SCC(=O)Nc2ccccc2Cl)cc1,CHEMBL1146046,Bioorg Med Chem Lett,2006.0,CHEMBL379311,CHEMBL379311,,0.0,http://www.openphacts.org/units/Nanomolar,545182.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
189,1401673.0,[],CHEMBL835178,In vitro inhibitory concentration against HIV-1 Y181C mutant strain; not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175522,CHEMBL175522,,0.0,http://www.openphacts.org/units/Nanomolar,360264.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
190,2681592.0,[],CHEMBL1064021,Antiviral activity against HIV1 5768.4 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N[C@@H](CC(C)C)[C@H](O)CC(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL137752,CHEMBL137752,6.17,0.0,http://www.openphacts.org/units/Nanomolar,823862.0,=,1.0,1.0,=,IC50,nM,670.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.67,CHEMBL378
191,495629.0,[],CHEMBL694654,Inhibitory concentration against HIV-1 IIIB strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1133473,J Med Chem,2000.0,CHEMBL338047,CHEMBL338047,8.62,0.0,http://www.openphacts.org/units/Nanomolar,245553.0,=,1.0,1.0,=,IC50,nM,2.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.4,CHEMBL378
192,18323329.0,[],CHEMBL4134874,Antiviral activity against VSV-G pseudotyped HIV1 infected in human SupT1 cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(O)c(O)c(O)c2c1COC2,CHEMBL4130477,J Nat Prod,2017.0,CHEMBL4170170,CHEMBL4170170,4.31,0.0,http://www.openphacts.org/units/Nanomolar,3042112.0,=,1.0,1.0,=,IC50,nM,49300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,49.3,CHEMBL378
193,24830953.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(N3CCCC3)cc2Oc2c(Cl)cccc21,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5189564,CHEMBL5189564,5.23,0.0,http://www.openphacts.org/units/Nanomolar,3878126.0,=,1.0,1.0,=,IC50,nM,5860.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,5.86,CHEMBL613497
194,654513.0,[],CHEMBL683819,Anti-HIV activity in cell culture assay expressed as IC50 values.,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CC2C(=O)O[C@H]3C(OC(=O)c4cc(O)c(O)c(O)c4)O[C@@H]4CC(=O)c5cc(O)c(O)c(O)c5-c5c(cc(O)c(O)c5O)C(=O)O[C@H]4[C@@H]3O/C(O)=C3\C=C(O)C(O)C(O)\C3=C\2C(O)=C1O,CHEMBL1126373,Bioorg Med Chem Lett,1992.0,CHEMBL1159558,CHEMBL1159558,4.50,0.0,http://www.openphacts.org/units/Nanomolar,60608.0,=,1.0,1.0,=,IC50,nM,32000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,32.0,CHEMBL378
195,17602940.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(Cc2ccccc2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644875,CHEMBL3644875,6.71,0.0,http://www.openphacts.org/units/Nanomolar,2517995.0,=,37.0,1.0,=,IC50,nM,195.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,195.0,CHEMBL4620
196,1470593.0,[],CHEMBL826114,Inhibitory activity against HIV-1 mutant strain 138K,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL57,CHEMBL57,7.30,0.0,http://www.openphacts.org/units/Nanomolar,380791.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.05,CHEMBL378
197,2395636.0,[],CHEMBL944654,Antiviral activity against HIV1 LAI infected in human CEM-SS cells assessed as reverse transcriptase activity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,CHEMBL1140955,Eur J Med Chem,2008.0,CHEMBL114,CHEMBL114,8.05,0.0,http://www.openphacts.org/units/Nanomolar,728703.0,=,1.0,1.0,=,IC50,nM,9.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,9.0,CHEMBL378
198,2243660.0,[],CHEMBL998762,Growth inhibition of HIV1 3B infected human MOLT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,CHEMBL1156591,Bioorg Med Chem Lett,2008.0,CHEMBL503858,CHEMBL503858,4.40,0.0,http://www.openphacts.org/units/Nanomolar,796398.0,=,1.0,1.0,=,IC50,nM,40000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,40.0,CHEMBL378
199,2432644.0,[],CHEMBL1027472,Antiviral activity against HIV1 3B infected in human HOG.R5 assessed as inhibition of viral replication by microtiter assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(CCC[C@@H](C)[C@H]1CC[C@@]2(C)[C@@H]3CC[C@H]4C(C)(C)C(=O)CC[C@@]45C[C@@]35CC[C@]12C)C(=O)O,CHEMBL1159344,J Nat Prod,2003.0,CHEMBL490332,CHEMBL490332,4.36,0.0,http://www.openphacts.org/units/Nanomolar,735812.0,=,1.0,1.0,=,IC50,nM,43900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,43.9,CHEMBL378
200,2179591.0,[],CHEMBL966469,Antiviral activity against HIV1 3B isolate replication in human H9 cells assessed as decrease in viral p24 level after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,CHEMBL1155638,J Nat Prod,2000.0,CHEMBL211684,CHEMBL211684,4.30,0.0,http://www.openphacts.org/units/Nanomolar,712152.0,=,1.0,1.0,=,IC50,nM,49500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,49.5,CHEMBL378
201,5189389.0,[],CHEMBL1659267,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 6 days by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/c1ccc2c(c1)OCO2)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652528,CHEMBL1652528,,0.0,http://www.openphacts.org/units/Nanomolar,1326903.0,=,1.0,1.0,=,IC50,nM,160000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.16,CHEMBL613497
202,1402037.0,[],CHEMBL837469,In vitro inhibitory concentration against HIV V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCCCO)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL176107,CHEMBL176107,,0.0,http://www.openphacts.org/units/Nanomolar,360364.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
203,22806642.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@@H](Sc3cccc(NCc4ccccc4)c3)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4793790,CHEMBL4793790,6.77,0.0,http://www.openphacts.org/units/Nanomolar,3541916.0,=,1.0,1.0,=,IC50,nM,171.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.171,CHEMBL613497
204,18452580.0,[],CHEMBL4178817,Antiviral activity against Chikungunya virus LR2006 OPY1 infected in human MRC5 cells after 30 mins by indirect immunofluorescence analysis,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,CHEMBL4177563,Bioorg Med Chem,2017.0,CHEMBL1214598,CHEMBL1214598,4.64,0.0,http://www.openphacts.org/units/Nanomolar,3062327.0,=,1.0,1.0,=,IC50,nM,23100.0,CHEMBL4296563,Chikungunya virus,Chikungunya virus,37124,IC50,uM,UO_0000065,23.1,CHEMBL4296563
205,1206550.0,[],CHEMBL710376,Inhibitory activity against 100I strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Sc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70863,CHEMBL70863,7.27,0.0,http://www.openphacts.org/units/Nanomolar,127465.0,=,1.0,1.0,=,IC50,nM,54.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.054,CHEMBL378
206,3596626.0,[],CHEMBL1292012,Antiviral activity against HIV1 BaL in human PBL cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(CNC(=O)N(c2cccc(F)c2)C2CCN(CCC3(c4cccc(F)c4)CCN(C(=O)c4c(Cl)cncc4Cl)CC3)CC2)cc1,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288678,CHEMBL1288678,8.32,0.0,http://www.openphacts.org/units/Nanomolar,973788.0,=,1.0,1.0,=,IC50,nM,4.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.8,CHEMBL378
207,1437856.0,[],CHEMBL834618,Inhibitory activity against HIV-1 mutant strain 103N; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(CNC(C)=O)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL182707,CHEMBL182707,,0.0,http://www.openphacts.org/units/Nanomolar,371574.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
208,3014810.0,[],CHEMBL1050516,Antiviral activity against multidrug-resistant HIV1 isolate C infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,CHEMBL1156053,J Med Chem,2009.0,CHEMBL114,CHEMBL114,7.50,0.0,http://www.openphacts.org/units/Nanomolar,862676.0,=,1.0,1.0,=,IC50,nM,32.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.032,CHEMBL378
209,2149842.0,[],CHEMBL935682,Antiviral activity against HIV1 098-T1249 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL428503,CHEMBL428503,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708045.0,=,1.0,1.0,=,IC50,ug.mL-1,0.147,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.147,CHEMBL378
210,2929564.0,[],CHEMBL1056894,Antiviral activity against HIV1 HXB2 harboring 106A mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSCc3ccco3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567204,CHEMBL567204,8.80,0.0,http://www.openphacts.org/units/Nanomolar,852794.0,=,1.0,1.0,=,IC50,nM,1.58,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.58,CHEMBL378
211,1402362.0,[],CHEMBL837466,In vitro inhibitory concentration against HIV K101E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(-n2cccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL360957,CHEMBL360957,,0.0,http://www.openphacts.org/units/Nanomolar,360357.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
212,594044.0,[],CHEMBL710373,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(C)c(Cc2nc(N)nc(Nc3ccc(C#N)cc3)n2)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL74409,CHEMBL74409,5.23,0.0,http://www.openphacts.org/units/Nanomolar,126942.0,=,1.0,1.0,=,IC50,nM,5860.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.86,CHEMBL378
213,2614804.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1ccccc1F,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL53684,CHEMBL53684,,0.0,http://www.openphacts.org/units/Nanomolar,731989.0,=,1.0,1.0,=,IC50,nM,2999162.52,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,2.523,CHEMBL378
214,14714277.0,[],CHEMBL3293255,Antiviral activity against HIV1 harboring reverse transcriptase K103N/Y181C mutant infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(c1ccc(/C=C/C#N)cc1)c1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL3288565,CHEMBL3288565,,0.0,http://www.openphacts.org/units/Nanomolar,2116123.0,>,1.0,1.0,>,IC50,nM,41414.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,41.414,CHEMBL378
215,167075.0,[],CHEMBL683693,Tested in vitro against human immunodeficiency virus (HIV) infected CEM cells using XTT assay (LAV-BRU strain),F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc2c(ncn2CCOCP(=O)(O)O)c(=O)[nH]1,CHEMBL1126801,J Med Chem,1993.0,CHEMBL223737,CHEMBL223737,6.70,0.0,http://www.openphacts.org/units/Nanomolar,169341.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.2,CHEMBL378
216,3253225.0,[],CHEMBL1108003,Antiviral activity against HIV1 NL4.3 infected in human MT4 cells assessed as inhibition of virus-induced cytopathicity in presence of 10% human serum,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(CNCc2ccc(CN(Cc3nc4ccccc4[nH]3)[C@H]3CCCc4cccnc43)cc2)nc1,CHEMBL1156989,J Med Chem,2010.0,CHEMBL1093137,CHEMBL1093137,7.16,0.0,http://www.openphacts.org/units/Nanomolar,902936.0,=,1.0,1.0,=,IC50,nM,69.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.069,CHEMBL378
217,1401867.0,[],CHEMBL837471,In vitro inhibitory concentration against HIV Y188L mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC=O)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL338936,CHEMBL338936,6.50,0.0,http://www.openphacts.org/units/Nanomolar,360411.0,=,1.0,1.0,=,IC50,nM,316.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.316,CHEMBL378
218,10865206.0,[],CHEMBL2025516,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OP(=O)(Oc4ccccc4)Oc4ccccc4)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024039,CHEMBL2024039,,0.0,http://www.openphacts.org/units/Nanomolar,1639761.0,>,1.0,1.0,>,IC50,nM,1938250.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1938.25,CHEMBL613497
219,3229742.0,[],CHEMBL1113200,Antiviral activity against recombinant HIV1 virus infected in human JC53BL cells after 3 days,F,BAO_0000190,BAO_0000218,organism-based format,CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC1)CC2,CHEMBL1154224,Bioorg Med Chem Lett,2009.0,CHEMBL1078710,CHEMBL1078710,7.28,0.0,http://www.openphacts.org/units/Nanomolar,898386.0,=,1.0,1.0,=,IC50,nM,52.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,52.0,CHEMBL378
220,12651408.0,[],CHEMBL2327723,Antiviral activity against 0.001 MOI bevirimat-resistant Human immunodeficiency virus 1 NL4-3 harboring gag V370A mutant infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCNC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324148,CHEMBL2324148,6.48,0.0,http://www.openphacts.org/units/Nanomolar,1850174.0,=,1.0,1.0,=,IC50,nM,330.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.33,CHEMBL378
221,16556856.0,[],CHEMBL3795205,Antiviral activity against CXCR4 using HIV-1 NL4.3 infected in human MT4 cells assessed as reduction of viral replication preincubated for 15 mins with cells followed by viral infection measured after 4 days by MTS/PES method,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(Cc2ccccc2)CCCN(S(=O)(=O)c2ccc([N+](=O)[O-])cc2)C1.Cl,CHEMBL3792300,J Med Chem,2016.0,CHEMBL3792671,CHEMBL3794616,4.45,0.0,http://www.openphacts.org/units/Nanomolar,2770886.0,=,1.0,1.0,=,IC50,nM,35900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,35.9,CHEMBL378
222,24735315.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5116803,Antiviral activity against CHIKV infected in human Huh-7 cells assessed as inhibition of viral infection by measuring EGFP-positive cells measured 24 hrs post infection by fluorescent microscopic analysis,F,BAO_0000190,BAO_0000218,organism-based format,Oc1c(O)c(O)c2c(=S)cc(-c3ccccc3)oc2c1-c1cccc(F)c1,CHEMBL5113447,Bioorg Med Chem Lett,2022.0,CHEMBL5206850,CHEMBL5206850,5.01,0.0,http://www.openphacts.org/units/Nanomolar,3858566.0,=,1.0,1.0,=,IC50,nM,9700.0,CHEMBL4296563,Chikungunya virus,Chikungunya virus,37124,IC50,uM,UO_0000065,9.7,CHEMBL4296563
223,18988893.0,[],CHEMBL4340644,Antiviral activity against Hepatitis B virus infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathogenic effect by microscopic analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1CNc1ncnc(Cl)c1/C=N/O,CHEMBL4340503,Bioorg Med Chem,2019.0,CHEMBL4538096,CHEMBL4538096,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,3167792.0,=,1.0,1.0,=,IC50,ug.mL-1,0.00249,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ng/ml,UO_0000274,2.49,CHEMBL613497
224,1402486.0,[],CHEMBL837471,In vitro inhibitory concentration against HIV Y188L mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177666,CHEMBL177666,6.60,0.0,http://www.openphacts.org/units/Nanomolar,360358.0,=,1.0,1.0,=,IC50,nM,251.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.251,CHEMBL378
225,1438126.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C(C)C#N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL182580,CHEMBL182580,6.60,0.0,http://www.openphacts.org/units/Nanomolar,371620.0,=,1.0,1.0,=,IC50,nM,250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.25,CHEMBL378
226,693382.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cccc(SS(=O)(=O)c2cccc(C(=O)O)c2)c1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL119983,CHEMBL119983,,0.0,,228546.0,=,1.0,0.0,=,IC50,,129.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,129.0,CHEMBL378
227,5249020.0,[],CHEMBL1685193,Antiviral activity against X4 tropic HIV1 NL4.3 infected in CD4 and CXCR4 expressing human MT4 cells assessed as inhibition of viral cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc(C(C)N(CCCCN)Cc2nc3ccccc3[nH]2)c1,CHEMBL1681661,Bioorg Med Chem Lett,2011.0,CHEMBL1682876,CHEMBL1682876,6.36,0.0,http://www.openphacts.org/units/Nanomolar,1333998.0,=,1.0,1.0,=,IC50,nM,438.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,438.0,CHEMBL378
228,842414.0,[],CHEMBL713546,Compound potency to achieve protection of MT-4 cells from HIV-1 cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(NC(=S)NC(=N)C2(c3c(Cl)cccc3Cl)CC2)cc1,CHEMBL1134808,Bioorg Med Chem Lett,2001.0,CHEMBL304303,CHEMBL304303,5.83,0.0,http://www.openphacts.org/units/Nanomolar,126243.0,=,1.0,1.0,=,IC50,nM,1480.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.48,CHEMBL378
229,13967471.0,[],CHEMBL3135324,Antiviral activity against HIV1 VSVG harboring reverse transcriptase Y181C mutant infected in 293ET cellsassessed as inhibition of viral replication by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1sc(Cl)cc1S(=O)(=O)N1c2cc(Cl)ccc2NC(=O)C1C,CHEMBL3132804,Medchemcomm,2014.0,CHEMBL3133061,CHEMBL3133061,,0.0,http://www.openphacts.org/units/Nanomolar,1974733.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
230,2927904.0,[],CHEMBL1044799,Antiviral activity against HIV1 NL4-3 infected in human TZM-b1 cells assessed as reduction in luciferase activity after 2 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCNC(C)=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1154770,J Med Chem,2009.0,CHEMBL508943,CHEMBL508943,7.42,0.0,http://www.openphacts.org/units/Nanomolar,852836.0,=,1.0,1.0,=,IC50,nM,38.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.038,CHEMBL378
231,18406020.0,[],CHEMBL4150963,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL4145651,J Nat Prod,2018.0,CHEMBL129,CHEMBL129,7.85,0.0,http://www.openphacts.org/units/Nanomolar,3054872.0,=,1.0,1.0,=,IC50,nM,14.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.014,CHEMBL378
232,10961134.0,[],CHEMBL2061266,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M9 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNc1ccccc1)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058320,CHEMBL2058320,7.00,0.0,http://www.openphacts.org/units/Nanomolar,1656260.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,100.0,CHEMBL378
233,18727033.0,[],CHEMBL4259324,Antiviral activity against HIV1 subtype B' CNE11 pseudovirus assessed as inhibition of viral infection in Ghost (3)X4/R5 cells after 48 hrs by Bright-Glo luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O,CHEMBL4257519,Medchemcomm,2018.0,CHEMBL4289957,CHEMBL4289957,8.23,0.0,http://www.openphacts.org/units/Nanomolar,3111237.0,=,1.0,1.0,=,IC50,nM,5.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.9,CHEMBL378
234,12411973.0,[],CHEMBL3061874,Antiviral activity against Hepatitis B virus infected human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 9 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(Cn1cnc2c(Sc3ccc4c(c3)CCO4)nc(N)nc21)OCP(=O)(OCC(F)(F)F)OCC(F)(F)F,CHEMBL3046955,Med Chem Res,2012.0,CHEMBL2237814,CHEMBL2237814,6.21,0.0,http://www.openphacts.org/units/Nanomolar,1798782.0,=,1.0,1.0,=,IC50,nM,610.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol,UO_0000065,0.61,CHEMBL613497
235,18044404.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,CNCC(NC(=O)c1ccc(-c2ccc(C)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4062459,CHEMBL4062459,5.70,0.0,http://www.openphacts.org/units/Nanomolar,2990221.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.0,CHEMBL378
236,12204027.0,[],CHEMBL2211838,Antiviral activity against HIV-1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)C1=NN(C(=O)Nc3ccc(Cl)cc3)C(c3ccncc3)C1C2,CHEMBL2203270,Bioorg Med Chem Lett,2012.0,CHEMBL1910203,CHEMBL1910203,,0.0,http://www.openphacts.org/units/Nanomolar,1759356.0,>,1.0,1.0,>,IC50,nM,4830.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.83,CHEMBL378
237,152107.0,[],CHEMBL698766,Concentration required for 50% inhibition of influenza A/WS/33 by plaque reduction assay; not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCCO[C@@H]1C=C(C(=O)O)C[C@H](N)[C@H]1NC(=O)CC,CHEMBL1130481,Bioorg Med Chem Lett,1997.0,CHEMBL53768,CHEMBL53768,,0.0,http://www.openphacts.org/units/Nanomolar,90740.0,,1.0,0.0,,IC50,nM,,CHEMBL613128,unidentified influenza virus,unidentified influenza virus,11309,IC50,nM,UO_0000065,,CHEMBL613128
238,932311.0,[],CHEMBL716463,Inhibitory concentration required to reduce virus Plaque formation (measles),F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2[C@@H]1C=C[C@@H](O)[C@H]1O,CHEMBL1129081,J Med Chem,1996.0,CHEMBL299961,CHEMBL299961,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,240304.0,=,1.0,1.0,=,IC50,ug.mL-1,0.47,CHEMBL613738,Measles virus,Measles virus,11234,IC50,ug ml-1,UO_0000274,0.47,CHEMBL613738
239,2417967.0,[],CHEMBL1018899,Antiviral activity against HBV in human HepG2(2.2.15) cells assessed as inhibition of viral genome replication after 9 days by Southern blot hybridization,F,BAO_0000190,BAO_0000218,organism-based format,O=C(N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)c1ccccc1,CHEMBL1153412,Bioorg Med Chem,2009.0,CHEMBL515267,CHEMBL515267,4.60,0.0,http://www.openphacts.org/units/Nanomolar,754243.0,=,1.0,1.0,=,IC50,nM,25350.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,25.35,CHEMBL613497
240,149059.0,[],CHEMBL844410,Inhibition of 50% of the integrase-mediated catalysis of the Y-oligo substrate with 95% confidence interval,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C(Cc1ccc(O)c(O)c1)C(Cc1ccc(O)c(O)c1)C(=O)O,CHEMBL1135546,J Med Chem,2002.0,CHEMBL120931,CHEMBL120931,5.56,0.0,http://www.openphacts.org/units/Nanomolar,231555.0,=,1.0,1.0,=,IC50,nM,2780.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.78,CHEMBL378
241,18183407.0,[],CHEMBL4040187,Antiviral activity against CXCR4-tropic HIV-1 NL4-3 infected in human PHA-stimulated PBMC assessed as inhibition of viral replication by measuring reduction in p24 antigen production preincubated with cells for 30 mins followed by viral infection measured on day 10 post infection in presence of IL-2 by ELISA,F,BAO_0000190,BAO_0000019,assay format,CCCCCOC(=O)C[C@H](NP(=O)(CO[C@H](CF)Cn1cnc2c(=O)[nH]c(N)nc21)Oc1ccccc1)C(=O)OCCCCC,CHEMBL4038313,J Med Chem,2017.0,CHEMBL4099787,CHEMBL4099787,7.52,0.0,http://www.openphacts.org/units/Nanomolar,3016402.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.03,CHEMBL378
242,12528700.0,[],CHEMBL3078221,Antiviral activity against HIV1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,[O-]c1on[n+](-c2ccc(Cc3ccc(-[n+]4noc([O-])c4CN4CCN(c5cccc(Cl)c5)CC4)cc3)cc2)c1CN1CCN(c2cccc(Cl)c2)CC1,CHEMBL3044741,Med Chem Res,2013.0,CHEMBL2282179,CHEMBL2282179,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824338.0,>,1.0,1.0,>,IC50,ug.mL-1,13.22,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,13.22,CHEMBL378
243,18202877.0,[],CHEMBL4043730,Antiviral activity against HIV-1 A17 harboring reverse transcriptase K103N/Y181C double mutant infected in human MAGI-CCR5 cells after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2cc3ccccc3n2C)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4061932,CHEMBL4061932,,0.0,http://www.openphacts.org/units/Nanomolar,3019978.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
244,1437999.0,[],CHEMBL833076,Inhibitory activity against HIV-1 mutant strain 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C=O)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL359749,CHEMBL359749,6.92,0.0,http://www.openphacts.org/units/Nanomolar,371610.0,=,1.0,1.0,=,IC50,nM,120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.12,CHEMBL378
245,1740589.0,[],CHEMBL854478,Inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,O=C1c2ccccc2C(=O)N1CCc1nc2cc(F)c(F)cc2n1S(=O)(=O)c1cccc([N+](=O)[O-])c1,CHEMBL1138932,J Med Chem,2006.0,CHEMBL378983,CHEMBL378983,6.85,0.0,http://www.openphacts.org/units/Nanomolar,520766.0,=,1.0,1.0,=,IC50,nM,140.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.14,CHEMBL613497
246,2614782.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1[S+]([O-])c1cccc(Br)c1,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL55998,CHEMBL55998,4.10,0.0,http://www.openphacts.org/units/Nanomolar,731557.0,=,1.0,1.0,=,IC50,nM,79983.43,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.097,CHEMBL378
247,16626874.0,[],CHEMBL3821890,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg secretion by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)Oc2cc(-c3ccccn3)[nH]n2)cc1,CHEMBL3817822,Medchemcomm,2016.0,CHEMBL3818104,CHEMBL3818104,4.63,0.0,http://www.openphacts.org/units/Nanomolar,2783928.0,=,1.0,1.0,=,IC50,nM,23170.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,23.17,CHEMBL613497
248,1198283.0,[],CHEMBL683689,Inhibitory concentration against HIV-1 was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn(C2CC3C(COCN3O)O2)c(=O)[nH]c1=O,CHEMBL1126389,Bioorg Med Chem Lett,1992.0,CHEMBL295826,CHEMBL295826,,0.0,http://www.openphacts.org/units/Nanomolar,79699.0,>,1.0,1.0,>,IC50,nM,210000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,M,UO_0000065,0.00021,CHEMBL378
249,24963891.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5216625,Antiviral activity against NNRTI resistant HIV1 harboring Tyr181Cys mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect measured after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Cc3c(Cl)ccc4[nH]ccc34)n2)cc1,CHEMBL5214932,Eur J Med Chem,2022.0,CHEMBL313405,CHEMBL313405,6.60,0.0,http://www.openphacts.org/units/Nanomolar,3900015.0,=,1.0,1.0,=,IC50,nM,250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.25,CHEMBL378
250,1471848.0,[],CHEMBL833076,Inhibitory activity against HIV-1 mutant strain 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc([N+](=O)[O-])c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188489,CHEMBL188489,7.70,0.0,http://www.openphacts.org/units/Nanomolar,380788.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.02,CHEMBL378
251,1402120.0,[],CHEMBL837465,In vitro inhibitory concentration against HIV G190S mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCCCO)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL367745,CHEMBL367745,,0.0,http://www.openphacts.org/units/Nanomolar,360369.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
252,3596617.0,[],CHEMBL1292012,Antiviral activity against HIV1 BaL in human PBL cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(CNC(=O)N(c2cccc(F)c2)C2CCN(CCC3(c4cccc(F)c4)CCN(C(=O)c4cc(S(=O)(=O)N5CCCC5)c(F)cc4Cl)CC3)CC2)cc1,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288666,CHEMBL1288666,9.22,0.0,http://www.openphacts.org/units/Nanomolar,973776.0,=,1.0,1.0,=,IC50,nM,0.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.6,CHEMBL378
253,2947346.0,[],CHEMBL1038495,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1)[C@@H](OC(=O)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1)C(C)(C)OC(=O)c1cc([N+](=O)[O-])ccc1[N+](=O)[O-])C1=C2C[C@H](OC(=O)c3cc([N+](=O)[O-])cc([N+](=O)[O-])c3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL584793,CHEMBL584793,,0.0,http://www.openphacts.org/units/Nanomolar,850754.0,>,1.0,1.0,>,IC50,nM,990000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.99,CHEMBL613497
254,1421936.0,[],CHEMBL824926,Inhibitory activity against human immunodeficiency virus type 1 (inactive>0.1),F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2ccccc2)n(COCc2ccco2)c(=O)[nH]c1=O,CHEMBL1144258,Bioorg Med Chem Lett,2005.0,CHEMBL178448,CHEMBL178448,,0.0,http://www.openphacts.org/units/Nanomolar,364919.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
255,18044767.0,[],CHEMBL4010414,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype D QD435.100M.ENV.E1,F,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075766,CHEMBL4075766,6.33,0.0,http://www.openphacts.org/units/Nanomolar,2990214.0,=,1.0,1.0,=,IC50,nM,470.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.47,CHEMBL378
256,2099767.0,[],CHEMBL949219,Antiviral activity against HIV1 ASM80 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL271854,CHEMBL271854,8.00,0.0,http://www.openphacts.org/units/Nanomolar,699400.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
257,1051218.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CCc1ccc(NN2C(S)=NC(C)C2c2ccccc2)cc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL38630,CHEMBL38630,,0.0,http://www.openphacts.org/units/Nanomolar,62351.0,>,1.0,1.0,>,IC50,nM,34450.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,34.45,CHEMBL378
258,2371440.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)CCCNc1c2c(nc3ccccc13)CCC2,CHEMBL1140145,J Med Chem,2008.0,CHEMBL501131,CHEMBL501131,4.50,0.0,http://www.openphacts.org/units/Nanomolar,746362.0,=,1.0,1.0,=,IC50,nM,32000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,32.0,CHEMBL613493
259,1298372.0,[],CHEMBL756142,Tested for the inhibition of p24 production in HIV-1 IIIB infected human peripheral blood mononuclear cells (PBMC),F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@@H](C[C@H](O)[C@H](CC1CCCCC1)NC(=O)[C@H](CO)NC(=O)COc1cccc2ccccc12)C(C)C)C(=O)N(C)c1ccccn1,CHEMBL1126785,J Med Chem,1993.0,CHEMBL2304047,CHEMBL2304047,8.62,0.0,http://www.openphacts.org/units/Nanomolar,156155.0,=,1.0,1.0,=,IC50,nM,2.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.4,CHEMBL378
260,1402207.0,[],CHEMBL837464,In vitro inhibitory concentration against HIV G190A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177744,CHEMBL177744,,0.0,http://www.openphacts.org/units/Nanomolar,360400.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
261,2947315.0,[],CHEMBL1038495,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,COCC(=O)OC(C)(C)[C@H](OC(C)=O)[C@H](C[C@@H](C)C1=C2C[C@H](OC(C)=O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)OC(C)=O,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL584797,CHEMBL584797,5.36,0.0,http://www.openphacts.org/units/Nanomolar,850763.0,=,1.0,1.0,=,IC50,nM,4400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.0044,CHEMBL613497
262,619396.0,[],CHEMBL710373,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)c(Oc2ncnc(Nc3ccc(C#N)cc3)n2)c(Br)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL302542,CHEMBL302542,7.80,0.0,http://www.openphacts.org/units/Nanomolar,126919.0,=,1.0,1.0,=,IC50,nM,16.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.016,CHEMBL378
263,3076984.0,[],CHEMBL1067297,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CCCC2=C1C(c1ccccc1Cl)N=C(c1ccccn1)N2,CHEMBL1153099,Bioorg Med Chem Lett,2010.0,CHEMBL610183,CHEMBL610183,,0.0,,877079.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
264,23153196.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4810870,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 production treated at 48 hrs post-infection and measured on day 4 post-viral infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCCCCC(=O)O[C@@]12[C@H](O)[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@H]34)[C@@H]1C2(C)C,CHEMBL4808236,Bioorg Med Chem Lett,2021.0,CHEMBL4865013,CHEMBL4865013,7.87,0.0,http://www.openphacts.org/units/Nanomolar,3599004.0,=,1.0,1.0,=,IC50,nM,13.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,13.5,CHEMBL378
265,799825.0,[],CHEMBL683816,"Inhibitory activity against NNI-resistant HIV-1 strain A17 with Y181C,K103N mutation",F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1133139,Bioorg Med Chem Lett,2000.0,CHEMBL57,CHEMBL57,,0.0,http://www.openphacts.org/units/Nanomolar,111932.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
266,19262024.0,[],CHEMBL4404425,Antiviral activity against multidrug resistant HIV1 12229 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,5.62,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,2400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.4,CHEMBL378
267,2244494.0,[],CHEMBL1002216,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase V106I mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL223228,CHEMBL223228,9.05,0.0,http://www.openphacts.org/units/Nanomolar,798658.0,=,1.0,1.0,=,IC50,nM,0.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.9,CHEMBL378
268,1213161.0,[],CHEMBL710376,Inhibitory activity against 100I strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Cc3c(Cl)cccc3Cl)n2)cc1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL307297,CHEMBL307297,6.40,0.0,http://www.openphacts.org/units/Nanomolar,127432.0,=,1.0,1.0,=,IC50,nM,398.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.398,CHEMBL378
269,2929747.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(COCC3CCCO3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567214,CHEMBL567214,7.40,0.0,http://www.openphacts.org/units/Nanomolar,852932.0,=,1.0,1.0,=,IC50,nM,39.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,39.8,CHEMBL378
270,5199482.0,[],CHEMBL1670944,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,OCCc1c(N2CCOCC2)nc2ccc(Cl)cc2c1-c1ccccc1Cl,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668649,CHEMBL1668649,,0.0,http://www.openphacts.org/units/Nanomolar,1328433.0,=,1.0,1.0,=,IC50,nM,323400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,323.4,CHEMBL613497
271,16544811.0,[],CHEMBL3789812,Antiviral activity against HIV1 virion infected in human TZM-bl cells after 48 hrs by firefly luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Nc2nc(NCC3CCCO3)nc(Nc3ccc(C)cc3)n2)cc1,CHEMBL3784952,Bioorg Med Chem,2016.0,CHEMBL3786003,CHEMBL3786003,,0.0,,2769496.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
272,12687185.0,[],CHEMBL2344307,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral surface antigen production,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@H]1C[C@@H]2C(=CC[C@@H]3[C@@]2(C)C(=O)C[C@]2(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](O)C[C@@]32C)C(C)(C)[C@@H]1OC(C)=O,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332394,CHEMBL2332394,4.65,0.0,http://www.openphacts.org/units/Nanomolar,1866088.0,=,1.0,1.0,=,IC50,nM,22400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,22.4,CHEMBL613497
273,2602193.0,[],CHEMBL1033990,Antiviral activity against Hepatitis B virus,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1/C(Br)=C(\NC(=O)c1ccc([N+](=O)[O-])cc1)C(=O)N1CCCCC1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL316306,CHEMBL316306,5.62,0.0,http://www.openphacts.org/units/Nanomolar,807863.0,=,1.0,1.0,=,IC50,nM,2400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.4,CHEMBL613497
274,1402490.0,[],CHEMBL837462,In vitro inhibitory concentration against HIV E138K mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177666,CHEMBL177666,8.22,0.0,http://www.openphacts.org/units/Nanomolar,360358.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
275,404766.0,[],CHEMBL874634,Inhibition of human peripheral blood mononuclear cell (PBMC)donor C proliferation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCC(=O)CC(=O)N[C@H]1CCOC1=O,CHEMBL1145979,J Med Chem,2003.0,CHEMBL8450,CHEMBL8450,4.19,0.0,http://www.openphacts.org/units/Nanomolar,4334.0,=,1.0,1.0,=,IC50,nM,65000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,65.0,CHEMBL378
276,1437834.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCNC(=O)Nc1cccc(C(=O)c2c(CC)c(C)nc(O)c2N(C)C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL425531,CHEMBL425531,5.70,0.0,http://www.openphacts.org/units/Nanomolar,371467.0,=,1.0,1.0,=,IC50,nM,1990.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.99,CHEMBL378
277,2263403.0,[],CHEMBL1010846,Antiviral activity against R5 tropic HIV1 BaL infected in human JC53-BL cells expressing CCR5 after 2 days by cell-cell fusion assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC1CN(S(=O)(=O)C2CCN(C(C)=O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2,CHEMBL1139267,Bioorg Med Chem Lett,2009.0,CHEMBL454493,CHEMBL454493,8.00,0.0,http://www.openphacts.org/units/Nanomolar,750010.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
278,12680692.0,[],CHEMBL2342597,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral replication after 9 days by fluorescence PCR method,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)Nc3ccccc3)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333692,CHEMBL2333692,,0.0,http://www.openphacts.org/units/Nanomolar,1867768.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
279,18812955.0,[],CHEMBL4276409,Antiviral activity against Atazanavir-resistant HIV1 infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL4270667,J Med Chem,2018.0,CHEMBL116,CHEMBL116,,0.0,http://www.openphacts.org/units/Nanomolar,3125925.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
280,2947396.0,[],CHEMBL1038495,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)CCC1CCCCC1)[C@@H](OC(=O)CCC1CCCCC1)C(C)(C)OC(=O)CCC1CCCCC1)C1=C2C[C@H](OC(=O)CCC3CCCCC3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL584175,CHEMBL584175,,0.0,http://www.openphacts.org/units/Nanomolar,850749.0,>,1.0,1.0,>,IC50,nM,1700000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.7,CHEMBL613497
281,18173482.0,[],CHEMBL4038383,Antiviral activity against VSV pseudotyped HIV1 infected in SupT1 cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CN1C(=O)c2c3c(cc4cccc1c24)C(C)(C)NC3=O,CHEMBL4038266,J Nat Prod,2017.0,CHEMBL4081646,CHEMBL4081646,4.90,0.0,http://www.openphacts.org/units/Nanomolar,3015253.0,=,1.0,1.0,=,IC50,nM,12600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.6,CHEMBL378
282,2602265.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=c1nc(O)ccn1[C@@H]1S[C@H](CO)C=C1F,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL143997,CHEMBL143997,4.00,0.0,http://www.openphacts.org/units/Nanomolar,807421.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
283,503944.0,[],CHEMBL757967,Inhibition of cell growth against HIV-1 infected PBM (Human peripheral blood mononuclear) cells,F,BAO_0000190,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](n2cnc3c(Cl)ncnc32)CS1,CHEMBL1126792,J Med Chem,1993.0,CHEMBL89555,CHEMBL89555,,0.0,http://www.openphacts.org/units/Nanomolar,161279.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
284,1286740.0,[],CHEMBL656278,Inhibition of particle production in de novo infection assay of HIV infected CEM cells.,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(CNC(=O)c2ccc3ccc(C(=O)O)c(O)c3n2)cc(O)c1O,CHEMBL1146726,Bioorg Med Chem Lett,2004.0,CHEMBL80008,CHEMBL80008,4.60,0.0,http://www.openphacts.org/units/Nanomolar,147496.0,=,1.0,1.0,=,IC50,nM,25000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.0,CHEMBL378
285,12680718.0,[],CHEMBL2342598,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(NC(=O)/C=C/c2coc3cc(OC)ccc3c2=O)cc1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333679,CHEMBL2333679,,0.0,http://www.openphacts.org/units/Nanomolar,1867755.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
286,600576.0,[],CHEMBL712878,Concentration required for 50% protection of MT-4 cells against the cytopathic effect of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CSc1ccc2[nH]c(=S)n3c2c1CN(CC=C(C)C)[C@@H](C)C3,CHEMBL1128253,J Med Chem,1995.0,CHEMBL351433,CHEMBL351433,8.30,0.0,http://www.openphacts.org/units/Nanomolar,327826.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.005,CHEMBL378
287,18044388.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(C(CCN(C)C)NC(=O)c2ccc(-c3ccc(F)c(Cl)c3)[nH]2)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4076809,CHEMBL4076809,5.82,0.0,http://www.openphacts.org/units/Nanomolar,2990205.0,=,1.0,1.0,=,IC50,nM,1500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.5,CHEMBL378
288,2188044.0,[],CHEMBL973321,Antiviral activity against HIV1 JRFL in HOS-CD4-CCR5 cells by viral infectivity assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](C)NC(=O)CNC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)NCC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C)C(=O)N[C@H](C)C(=O)O,CHEMBL1156527,Proc Natl Acad Sci U S A,2007.0,CHEMBL525958,CHEMBL525958,,0.0,http://www.openphacts.org/units/Nanomolar,717668.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.0,CHEMBL378
289,2601679.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(F)nc2c1ncn2[C@H]1S[C@@H](CO)C=C1F,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL515100,CHEMBL515100,4.94,0.0,http://www.openphacts.org/units/Nanomolar,807925.0,=,1.0,1.0,=,IC50,nM,11500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,11.5,CHEMBL378
290,2530541.0,[],CHEMBL1011336,Antiviral activity against Rift Valley fever virus infected in african green monkey Vero cells after 6 days by plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1N[C@H]2[C@H](O)[C@H](O)[C@@H](O)C[C@@H]2c2cc3c(cc21)OCO3,CHEMBL1150051,J Nat Prod,1992.0,CHEMBL251056,CHEMBL251056,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,790698.0,=,1.0,1.0,=,IC50,ug.mL-1,0.25,CHEMBL613130,Rift Valley fever virus,Rift Valley fever virus,11588,IC50,ug ml-1,UO_0000274,0.25,CHEMBL613130
291,2091772.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1ccccc1Cl,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL301086,CHEMBL301086,,0.0,http://www.openphacts.org/units/Nanomolar,700514.0,=,1.0,1.0,=,IC50,nM,245470891568.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,2.39,CHEMBL378
292,476313.0,[],CHEMBL752813,Inhibition to hepatitis C virus (HCV) NS3/NS4A serine protease,B,BAO_0000190,BAO_0000357,single protein format,CCC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(F)F)C(=O)C(=O)O)C(C)C,CHEMBL1135212,Bioorg Med Chem Lett,2002.0,CHEMBL350593,CHEMBL350593,4.80,0.0,http://www.openphacts.org/units/Nanomolar,317208.0,=,1.0,1.0,=,IC50,nM,16000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,16.0,CHEMBL4620
293,3077001.0,[],CHEMBL1067297,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(=O)C2=C(C1)NC(c1cccnc1)=NC2c1ccccc1,CHEMBL1153099,Bioorg Med Chem Lett,2010.0,CHEMBL609296,CHEMBL609296,4.65,0.0,http://www.openphacts.org/units/Nanomolar,877110.0,=,1.0,1.0,=,IC50,nM,22400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,22.4,CHEMBL613497
294,6327118.0,[],CHEMBL1821353,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as reduction in HBeAg antigen secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1817662,J Nat Prod,2011.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/Nanomolar,1449980.0,=,1.0,1.0,=,IC50,nM,30260000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,30.26,CHEMBL613497
295,3100391.0,[],CHEMBL1064781,Antiviral activity against HIV1 3B in human MT4 cells assessed as RT activity after 5 days by single passage assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1156918,J Med Chem,2010.0,CHEMBL129,CHEMBL129,7.75,0.0,http://www.openphacts.org/units/Nanomolar,887739.0,=,1.0,1.0,=,IC50,nM,18.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.018,CHEMBL378
296,1219739.0,[],CHEMBL710530,Inhibitory activity against 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C#Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(C)cc(C)cc1C,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL71881,CHEMBL71881,8.21,0.0,http://www.openphacts.org/units/Nanomolar,127453.0,=,1.0,1.0,=,IC50,nM,6.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0062,CHEMBL378
297,1402243.0,[],CHEMBL837470,In vitro inhibitory concentration against HIV V179E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(CC)CC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175534,CHEMBL175534,,0.0,http://www.openphacts.org/units/Nanomolar,360399.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
298,3399374.0,[],CHEMBL1219621,Antiviral activity against R5 tropic HIV1 HXB2 infected in human TZM-bl cells assessed as inhibition of virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,CHEMBL1212937,J Med Chem,2010.0,CHEMBL267345,CHEMBL267345,6.76,0.0,http://www.openphacts.org/units/Nanomolar,933740.0,=,1.0,1.0,=,IC50,nM,175.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.175,CHEMBL378
299,1751262.0,[],CHEMBL854523,Antiviral activity against wild type Measles virus Edmonston in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(CC(=O)Nc2cc([N+](=O)[O-])ccc2O)c1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL211381,CHEMBL211381,,0.0,http://www.openphacts.org/units/Nanomolar,532797.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,100.0,CHEMBL613738
300,593277.0,[],CHEMBL689615,Reduction of viral load in the cell supernatant.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)ccc1O,CHEMBL1135622,J Med Chem,2002.0,CHEMBL59548,CHEMBL59548,4.10,0.0,http://www.openphacts.org/units/Nanomolar,275330.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,80.0,CHEMBL378
301,23165157.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '96.0'}]",CHEMBL4813049,Antiviral activity against Zika virus infected in SF-268 cells assessed as inhibition of viral infection at post entry stage after 96 hrs measured after 1 hr post infection by DAPI staining based fluorescence microscopic analysis,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOC(=O)[C@@]1(C)CC[C@]2(C)CC[C@]3(C)C(=CC(=O)C4[C@@]5(C)Cc6snnc6C(C)(C)C5CC[C@]43C)[C@@H]2C1,CHEMBL4811277,Bioorg Med Chem,2021.0,CHEMBL4854270,CHEMBL4854270,6.37,0.0,http://www.openphacts.org/units/Nanomolar,3601582.0,=,1.0,1.0,=,IC50,nM,430.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,0.43,CHEMBL4296612
302,2930156.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3cccc3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL574164,CHEMBL574164,9.00,0.0,http://www.openphacts.org/units/Nanomolar,848360.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
303,6335947.0,[],CHEMBL1820049,Antiviral activity against wild type Human immunodeficiency virus 1 ERS104pre infected in PHA-stimulated human PBMC assessed as inhibition of p24 Gag protein production,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2C[C@@H]3[C@@H](O)CO[C@@H]3C2)cc1,CHEMBL1817554,J Med Chem,2011.0,CHEMBL1817686,CHEMBL1817686,8.54,0.0,http://www.openphacts.org/units/Nanomolar,1451706.0,=,1.0,1.0,=,IC50,nM,2.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0029,CHEMBL378
304,16422829.0,[],CHEMBL3751454,Antiviral activity against recombinant HIV-1 NL4-3 expressing HIV-1 JR-CSF envelope infected in U87.CD4.CCR5 cells assessed as inhibition of Env mediated cell entry by HIV-1 single round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CC=C(CNC(=O)c4ccccc4)CC3)c12,CHEMBL3745657,Bioorg Med Chem Lett,2016.0,CHEMBL3747479,CHEMBL3747479,6.65,0.0,http://www.openphacts.org/units/Nanomolar,2740457.0,=,1.0,1.0,=,IC50,nM,224.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.224,CHEMBL378
305,2091730.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(Cc2ccccc2)CCCN(S(=O)(=O)c2cccc3c(N(C)C)cccc23)C1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL202316,CHEMBL202316,,0.0,http://www.openphacts.org/units/Nanomolar,700556.0,=,1.0,1.0,=,IC50,nM,104712854805089.84,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,5.02,CHEMBL378
306,3235116.0,[],CHEMBL1106812,Antiviral activity against HIV-1 NL4-3 expressing VSV-G envelope infected in human 293T cells assessed as inhibition of viral replication after 48 hrs by Luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C/C1=C\[C@@H]2[C@H](CC[C@@]3(C)O[C@@H]3[C@H]3[C@@H](O)[C@@H](C)C[C@]3(OC(=O)/C=C/c3ccccc3)C1=O)C2(C)C,CHEMBL1154243,J Nat Prod,2009.0,CHEMBL489265,CHEMBL489265,4.90,0.0,http://www.openphacts.org/units/Nanomolar,898033.0,=,1.0,1.0,=,IC50,nM,12600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.6,CHEMBL378
307,1487143.0,[],CHEMBL833976,Inhibitory concentration against wild type human immunodeficiency virus type 1 was determined by recombinant virus assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCc1c(O)nc2ccc(F)cc2c1OCC1CCC1,CHEMBL1138845,J Med Chem,2004.0,CHEMBL190731,CHEMBL190731,7.20,0.0,http://www.openphacts.org/units/Nanomolar,384150.0,=,1.0,1.0,=,IC50,nM,63.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,63.0,CHEMBL378
308,15748674.0,[],CHEMBL3630970,Antiviral activity against HIV1 3B assessed as inhibition of viral attachment to human MAGI cells,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(C[C@@H]1CN(Cc2ccccc2)CCN1)[C@H]1CCCc2cccnc21,CHEMBL3627700,Bioorg Med Chem Lett,2015.0,CHEMBL3627792,CHEMBL3627792,7.52,0.0,http://www.openphacts.org/units/Nanomolar,2506620.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.03,CHEMBL378
309,1755836.0,[],CHEMBL864208,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(-n2c(C)nnc2SCC(=O)Nc2ccccc2Br)cc1,CHEMBL1146046,Bioorg Med Chem Lett,2006.0,CHEMBL213406,CHEMBL213406,,0.0,http://www.openphacts.org/units/Nanomolar,545151.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
310,24788552.0,[],CHEMBL5131655,Antiviral activity against AZT resistant HIV-1 mutant in monocyte,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,CHEMBL5131375,J Med Chem,2022.0,CHEMBL14762,CHEMBL14762,9.44,0.0,http://www.openphacts.org/units/Nanomolar,3869388.0,=,1.0,1.0,=,IC50,nM,0.36,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.36,CHEMBL378
311,19261719.0,[],CHEMBL4404352,Antiviral activity against HIV1 HXB2 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(Cl)cn2)[nH]c1C(=O)N[C@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4476838,CHEMBL4476838,5.92,0.0,http://www.openphacts.org/units/Nanomolar,3216254.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.2,CHEMBL378
312,2930436.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1c(C)cn(Cc2c(C)[nH]c(=O)c(I)c2Sc2cc(C)cc(C)c2)c1C,CHEMBL1154778,J Med Chem,2009.0,CHEMBL576961,CHEMBL576961,8.00,0.0,http://www.openphacts.org/units/Nanomolar,848286.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
313,22983737.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '144.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '6.0'}]",CHEMBL4773497,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication supplemented with fresh medium containing compound every 2 days for 6 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL4765418,Eur J Med Chem,2020.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/Nanomolar,3569423.0,<,1.0,1.0,<,IC50,nM,100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.1,CHEMBL613497
314,1043695.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,SC1=NC2CCCCC2N1Nc1cccc(Cl)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL288161,CHEMBL288161,,0.0,http://www.openphacts.org/units/Nanomolar,62332.0,>,1.0,1.0,>,IC50,nM,126420.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,126.42,CHEMBL378
315,2681586.0,[],CHEMBL1064015,Antiviral activity against HIV1 Q461.e2 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N[C@@H](CC(C)C)[C@H](O)CC(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL137752,CHEMBL137752,6.51,0.0,http://www.openphacts.org/units/Nanomolar,823862.0,=,1.0,1.0,=,IC50,nM,310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.31,CHEMBL378
316,24830943.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C1CCCN1c1ccc2c(=O)c3cccc(Cl)c3oc2c1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5169771,CHEMBL5169771,4.94,0.0,http://www.openphacts.org/units/Nanomolar,3878116.0,=,1.0,1.0,=,IC50,nM,11500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,11.5,CHEMBL613497
317,1402288.0,[],CHEMBL835251,In vitro inhibitory concentration against HIV F227L and V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NCc2ccccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177491,CHEMBL177491,,0.0,http://www.openphacts.org/units/Nanomolar,360417.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
318,5199544.0,[],CHEMBL1670948,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CS(=O)(=O)OCCc1c(Cl)nc2ccc(Cl)cc2c1-c1ccccc1Cl,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668636,CHEMBL1668636,,0.0,http://www.openphacts.org/units/Nanomolar,1328420.0,>,1.0,1.0,>,IC50,nM,881700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,881.7,CHEMBL613497
319,1056090.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(NN2C(S)=NC(C)C2c2ccccc2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289785,CHEMBL289785,5.19,0.0,http://www.openphacts.org/units/Nanomolar,62325.0,=,1.0,1.0,=,IC50,nM,6500.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,6.5,CHEMBL613499
320,2527522.0,[],CHEMBL1003778,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect albumin after 5 days by MTS method in presence of 40 mg/mL human serum albumin,F,BAO_0000190,BAO_0000218,organism-based format,CCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(C)c1=O,CHEMBL1138484,J Med Chem,2009.0,CHEMBL491336,CHEMBL491336,5.40,0.0,http://www.openphacts.org/units/Nanomolar,735543.0,=,1.0,1.0,=,IC50,nM,4000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4000.0,CHEMBL378
321,15666424.0,[],CHEMBL3602749,Antiviral activity against ENF-resistant HIV1 NL4-3 harboring gp41 N-terminal heptad repeat V38A/N42T double mutant infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL3600303,J Med Chem,2015.0,CHEMBL3600949,CHEMBL3600949,9.22,0.0,http://www.openphacts.org/units/Nanomolar,2492329.0,=,1.0,1.0,=,IC50,nM,0.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.6,CHEMBL378
322,249597.0,[],CHEMBL714981,Inhibition of antiviral activity against moloney murine sarcoma virus(MSV)in CEM cells in cell protection assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2CCOCP(=O)(O)O,CHEMBL1134666,J Med Chem,2001.0,CHEMBL484,CHEMBL484,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,233576.0,=,1.0,1.0,=,IC50,ug.mL-1,2.0,CHEMBL613501,Moloney murine sarcoma virus,Moloney murine sarcoma virus,11809,IC50,ug ml-1,UO_0000274,2.0,CHEMBL613501
323,24830935.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c2ccc(N3CCOCC3)cc2oc2c(F)cccc12,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5204552,CHEMBL5204552,5.68,0.0,http://www.openphacts.org/units/Nanomolar,3878108.0,=,1.0,1.0,=,IC50,nM,2100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.1,CHEMBL613497
324,2149864.0,[],CHEMBL935683,Antiviral activity against HIV1 098-T651 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL427982,CHEMBL427982,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708042.0,>,1.0,1.0,>,IC50,ug.mL-1,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,20.0,CHEMBL378
325,1284897.0,[],CHEMBL691379,Compound was evaluated for anti-retrovirus activity against HIV-1 (D34) Diagen strain; Not active,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(O)c2ncn(CC/C=C/P(=O)(O)O)c2n1,CHEMBL1126681,J Med Chem,1993.0,CHEMBL26888,CHEMBL26888,,0.0,http://www.openphacts.org/units/Nanomolar,40466.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
326,2321218.0,[],CHEMBL1004248,Antiviral activity against HIV1 3B in human H9 cells after 4 days by p24 antigen ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL1150942,J Nat Prod,1998.0,CHEMBL464466,CHEMBL464466,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,760909.0,=,1.0,1.0,=,IC50,ug.mL-1,36.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,36.0,CHEMBL378
327,13940330.0,[],CHEMBL3131385,Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)OCc1cn(Cc2cccc(Cl)c2)nn1)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL3124823,Eur J Med Chem,2014.0,CHEMBL3126763,CHEMBL3126763,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1972616.0,=,1.0,1.0,=,IC50,ug.mL-1,66.67,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,66.67,CHEMBL613129
328,1470291.0,[],CHEMBL832527,Inhibitory activity against HIV-1 double mutants strain 227L and 106A,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cc(Cl)cc(Cl)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188941,CHEMBL188941,7.22,0.0,http://www.openphacts.org/units/Nanomolar,380720.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.06,CHEMBL378
329,19450611.0,[],CHEMBL4433618,Antiviral activity against wild-type HIV1 NL4-3 infected in human TZM-bl cells infected with supernatants from virus-infected human MT2 cells treated with compound for 72 hrs assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay based monocycle assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(-c2ccc(OCc3cccc(C(=O)NCCNC(=O)c4ccc(COc5cccc6sc(N)nc56)cc4)c3)cc2)cs1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4593627,CHEMBL4596380,,0.0,http://www.openphacts.org/units/Nanomolar,3249755.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
330,610169.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(F)nc(Cc3c(Cl)cccc3Cl)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL71042,CHEMBL71042,4.00,0.0,http://www.openphacts.org/units/Nanomolar,126925.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
331,2432638.0,[],CHEMBL1027472,Antiviral activity against HIV1 3B infected in human HOG.R5 assessed as inhibition of viral replication by microtiter assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1159344,J Nat Prod,2003.0,CHEMBL23236,CHEMBL23236,4.86,0.0,http://www.openphacts.org/units/Nanomolar,735817.0,=,1.0,1.0,=,IC50,nM,13800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,13.8,CHEMBL378
332,24823554.0,[],CHEMBL5140686,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBsAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3cc(C)ccc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5185045,CHEMBL5185045,8.46,0.0,http://www.openphacts.org/units/Nanomolar,3876728.0,=,1.0,1.0,=,IC50,nM,3.5,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0035,CHEMBL613497
333,12717516.0,[],CHEMBL2350955,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBV DNA replication after 72 hrs by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,C=CCc1ccc(Oc2ccc(C=O)cc2O)cc1,CHEMBL2346656,Bioorg Med Chem Lett,2013.0,CHEMBL2346745,CHEMBL2346745,,0.0,http://www.openphacts.org/units/Nanomolar,1874407.0,>,1.0,1.0,>,IC50,nM,1000000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1000.0,CHEMBL613497
334,16626883.0,[],CHEMBL3821890,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg secretion by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)Oc2cc(CSc3ccccn3)[nH]n2)cc1,CHEMBL3817822,Medchemcomm,2016.0,CHEMBL3819256,CHEMBL3819256,4.70,0.0,http://www.openphacts.org/units/Nanomolar,2783919.0,=,1.0,1.0,=,IC50,nM,19830.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,19.83,CHEMBL613497
335,2009800.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-c3ncon3)nccc12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL393332,CHEMBL393332,5.91,0.0,http://www.openphacts.org/units/Nanomolar,668113.0,=,1.0,1.0,=,IC50,nM,1240.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1240.0,CHEMBL378
336,1671963.0,[],CHEMBL870621,Antiviral activity against HIV1 Y181C mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(C(F)(F)F)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL275658,CHEMBL275658,8.54,0.0,http://www.openphacts.org/units/Nanomolar,411926.0,=,1.0,1.0,=,IC50,nM,2.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.9,CHEMBL378
337,16580179.0,[],CHEMBL3800939,Antiviral activity against HIV1 BAL infected in human TZM-bl cells assessed as inhibition of viral infection,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1ccc(Cl)cc1-c1oc2ccccc2c(=O)c1O,CHEMBL3797057,Bioorg Med Chem,2016.0,CHEMBL2386689,CHEMBL2386689,4.90,0.0,http://www.openphacts.org/units/Nanomolar,2774369.0,=,1.0,1.0,=,IC50,nM,12600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.6,CHEMBL378
338,2003481.0,[],CHEMBL901910,Antiviral activity against Modoc virus-infected HeLa-H1 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NC1CCCCC1)c1ccc2[nH]c(-c3ccc(NC(=O)C4CCCCC4)cc3)nc2c1,CHEMBL1138288,J Med Chem,2007.0,CHEMBL375891,CHEMBL375891,,0.0,http://www.openphacts.org/units/Nanomolar,666639.0,>,1.0,1.0,>,IC50,nM,600.0,CHEMBL612946,Modoc virus,Modoc virus,64300,IC50,nM,UO_0000065,600.0,CHEMBL612946
339,12627462.0,[],CHEMBL2317015,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)c1ccc(/C=C2\CCC(/C=N/N=C/c3cccnc3)=C2N2CCOCC2)cc1,CHEMBL2311445,Bioorg Med Chem,2013.0,CHEMBL2311893,CHEMBL2311893,,0.0,http://www.openphacts.org/units/Nanomolar,1841391.0,>,1.0,1.0,>,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
340,2368251.0,[],CHEMBL1031562,Antiviral activity against HIV1 infected in human MT4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1140132,J Med Chem,2008.0,CHEMBL57,CHEMBL57,8.00,0.0,http://www.openphacts.org/units/Nanomolar,745219.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
341,2061740.0,[],CHEMBL942899,Inhibition of HIV SF162 in TZM-bl cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,CCC(C)/C=C(C)/C=C\C(O)C(C)(O)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1C(=O)N[C@H](COC)C(=O)NCC(=O)N[C@@H](C)C(=O)N(C)[C@@H]([C@@H](C)O)C(=O)N[C@H]([C@H](OC)c2ccc(O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)cc2)C(=O)N2CC[C@H](Cl)C[C@H]2C(=O)O[C@@H]1C(C)C)[C@@H](C)[C@@H](C)C(N)=O)[C@@H](C)N)[C@@H](C)O,CHEMBL1141334,J Nat Prod,2007.0,CHEMBL429406,CHEMBL429406,6.40,0.0,http://www.openphacts.org/units/Nanomolar,684423.0,=,1.0,1.0,=,IC50,nM,400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.4,CHEMBL378
342,710900.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,O=S(=O)(c1ccc(Br)cc1)S(=O)(=O)c1ccc(Br)cc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120275,CHEMBL120275,,0.0,,228551.0,=,1.0,0.0,=,IC50,,29.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,29.6,CHEMBL378
343,5309044.0,[],CHEMBL1693122,Antiviral activity against HIV1 infected in human PBMC assessed as inhibition of gag gene expression after 5 days post infection by quantitative real time RT-PCR,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1687924,Bioorg Med Chem,2011.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337696.0,=,1.0,1.0,=,IC50,ug.mL-1,0.19,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.19,CHEMBL378
344,8051463.0,[],CHEMBL1959807,Antiviral activity against HIV1 LAL infected in human MT2 cells by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N[C@@H]1CO[C@@H]2C[C@H](OC(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc(OC)cc3)C[C@H]12,CHEMBL1955842,Bioorg Med Chem Lett,2012.0,CHEMBL1958482,CHEMBL1958482,8.80,0.0,http://www.openphacts.org/units/Nanomolar,1583258.0,=,1.0,1.0,=,IC50,nM,1.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.6,CHEMBL378
345,22480471.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '120.0'}]",CHEMBL4687212,Antiviral activity against HIV-1 NL4-3 infected in human TZM-bl cells infected with supernatants from virus-infected human H9 cells treated with compound for 72 hrs assessed as reduction in luciferase expression measured after 48 hrs by luciferase reporter gene assay based BiCycle assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOCc1cn(-c2ccc(NC(=O)Nc3cc(C(C)C)ccc3C)cc2)nn1,CHEMBL4680261,Eur J Med Chem,2020.0,CHEMBL4790390,CHEMBL4790390,5.42,0.0,http://www.openphacts.org/units/Nanomolar,3523694.0,=,1.0,1.0,=,IC50,nM,3800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.8,CHEMBL378
346,553939.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,NS(=O)(=O)c1ccc(CNC(=O)c2ccccc2SSc2ccccc2C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL169630,CHEMBL169630,4.71,0.0,http://www.openphacts.org/units/Nanomolar,334048.0,=,1.0,1.0,=,IC50,nM,19400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,19.4,CHEMBL378
347,10863178.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCCCCCCO)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024639,CHEMBL2024639,4.32,0.0,http://www.openphacts.org/units/Nanomolar,1640535.0,=,1.0,1.0,=,IC50,nM,47680.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,47.68,CHEMBL613497
348,14553716.0,[],CHEMBL3225005,Antiviral activity against HIV1 NL4-3 infected in human MT2 cells after 3 days by human JC53BL cell-based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1c2ncc3c(ccn3Cc3ccc(F)cc3OC(F)F)c2CCN1O,CHEMBL3217509,Medchemcomm,2013.0,CHEMBL3219149,CHEMBL3219149,8.30,0.0,http://www.openphacts.org/units/Nanomolar,2073846.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.0,CHEMBL378
349,1403329.0,[],CHEMBL834755,Inhibitory concentration against 100I mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Oc2cn(Cc3ccccc3)c(=O)c(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL435548,CHEMBL435548,6.20,0.0,http://www.openphacts.org/units/Nanomolar,360637.0,=,1.0,1.0,=,IC50,nM,631.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.631,CHEMBL378
350,1671916.0,[],CHEMBL870624,Antiviral activity against HIV1 K103N mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(Br)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL203313,CHEMBL203313,8.21,0.0,http://www.openphacts.org/units/Nanomolar,411930.0,=,1.0,1.0,=,IC50,nM,6.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.1,CHEMBL378
351,2601558.0,[],CHEMBL1034017,Antiviral activity against Vaccinia virus,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(N)nc(N)nc1OCCOCP(=O)(O)O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL342983,CHEMBL342983,9.07,0.0,http://www.openphacts.org/units/Nanomolar,807385.0,=,1.0,1.0,=,IC50,nM,0.86,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,0.00086,CHEMBL613493
352,2929742.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3cccc3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL574164,CHEMBL574164,7.50,0.0,http://www.openphacts.org/units/Nanomolar,848360.0,=,1.0,1.0,=,IC50,nM,31.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.6,CHEMBL378
353,333685.0,[],CHEMBL697276,In vitro inhibition of HIV-1 plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCCCCC(=O)NCC(COP(=O)([O-])OCC[N+](C)(C)C)OCC,CHEMBL1125666,J Med Chem,1991.0,CHEMBL29094,CHEMBL29094,6.80,0.0,http://www.openphacts.org/units/Nanomolar,43731.0,=,1.0,1.0,=,IC50,nM,160.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.16,CHEMBL378
354,1031668.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(S)n(Nc2cccc(Cl)c2)c1-c1cccc(Br)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL37967,CHEMBL37967,5.76,0.0,http://www.openphacts.org/units/Nanomolar,62314.0,=,1.0,1.0,=,IC50,nM,1750.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,1.75,CHEMBL613499
355,10961163.0,[],CHEMBL2061267,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M10 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCC(C)(C)C)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058323,CHEMBL2058323,7.57,0.0,http://www.openphacts.org/units/Nanomolar,1656263.0,=,1.0,1.0,=,IC50,nM,27.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,27.0,CHEMBL378
356,2099814.0,[],CHEMBL949221,Antiviral activity against HIV1 97-ZA-003 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL272748,CHEMBL272748,7.92,0.0,http://www.openphacts.org/units/Nanomolar,699397.0,=,1.0,1.0,=,IC50,nM,12.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.012,CHEMBL378
357,1194678.0,[],CHEMBL710372,Inhibitory activity against 100I strain and 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70554,CHEMBL70554,,0.0,http://www.openphacts.org/units/Nanomolar,127459.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
358,10938673.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4c(F)c(F)c(F)c(F)c4F)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046582,CHEMBL2046582,4.58,0.0,http://www.openphacts.org/units/Nanomolar,1651465.0,=,1.0,1.0,=,IC50,nM,26300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,26.3,CHEMBL613497
359,2601652.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)ccc1O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL59548,CHEMBL59548,4.10,0.0,http://www.openphacts.org/units/Nanomolar,807390.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,80.0,CHEMBL378
360,12663830.0,[],CHEMBL2330345,Antiviral activity against T20-resistant Human immunodeficiency virus 1 NL4-3 harboring gp41 NHR (36G)V38A/N42D mutation infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CCNC(=O)c1ccc(-n2c(C)ccc2C)cc1OCC(=O)O)[C@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O,CHEMBL2321797,J Med Chem,2013.0,CHEMBL2326371,CHEMBL2326371,6.60,0.0,http://www.openphacts.org/units/Nanomolar,1852840.0,=,1.0,1.0,=,IC50,nM,250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,250.0,CHEMBL378
361,2601738.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C=C(F)[C@H](CO)O2)c(=O)nc1O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL474033,CHEMBL474033,4.00,0.0,http://www.openphacts.org/units/Nanomolar,807652.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
362,709514.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(CCl)Nc1ccc(SSc2ccc(NC(=O)CCl)cc2)cc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL121080,CHEMBL121080,,0.0,,228637.0,=,1.0,0.0,=,IC50,,0.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,0.8,CHEMBL378
363,886859.0,[],CHEMBL683811,Antiviral activity against HIV-1 using antiinfectivity assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc(CO[C@H]2C(=O)Nc3ccc(Cl)cc3[C@@]2(C#CC2CC2)C(F)(F)F)cc1F,CHEMBL1134695,Bioorg Med Chem Lett,2001.0,CHEMBL294720,CHEMBL294720,7.58,0.0,http://www.openphacts.org/units/Nanomolar,100523.0,=,1.0,1.0,=,IC50,nM,26.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,26.0,CHEMBL378
364,2927200.0,[],CHEMBL1041197,Antiviral activity against Dengue virus,F,BAO_0000190,BAO_0000218,organism-based format,CN(CCCNC(=O)c1ccc(O)cc1)CCCNC(=O)c1ccc(O)cc1,CHEMBL1155220,J Med Chem,2009.0,CHEMBL574855,CHEMBL574855,,0.0,http://www.openphacts.org/units/Nanomolar,851395.0,=,1.0,1.0,=,IC50,nM,2000000.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,mM,UO_0000065,2.0,CHEMBL613757
365,1740596.0,[],CHEMBL854478,Inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,O=C1c2ccccc2C(=O)N1CCc1nc2ccccc2n1S(=O)(=O)c1cccc(C(F)(F)F)c1,CHEMBL1138932,J Med Chem,2006.0,CHEMBL209625,CHEMBL209625,4.52,0.0,http://www.openphacts.org/units/Nanomolar,520765.0,=,1.0,1.0,=,IC50,nM,30400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,30.4,CHEMBL613497
366,890349.0,[],CHEMBL683811,Antiviral activity against HIV-1 using antiinfectivity assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1C[C@](C#CC2CC2)(C(F)(F)F)c2cc(Cl)ccc2N1,CHEMBL1134695,Bioorg Med Chem Lett,2001.0,CHEMBL293736,CHEMBL293736,7.85,0.0,http://www.openphacts.org/units/Nanomolar,100520.0,=,1.0,1.0,=,IC50,nM,14.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,14.0,CHEMBL378
367,37577.0,[],CHEMBL695511,Antiviral activity against K103N strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL223228,CHEMBL223228,7.57,0.0,http://www.openphacts.org/units/Nanomolar,20823.0,=,1.0,1.0,=,IC50,nM,27.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,27.0,CHEMBL378
368,16662880.0,[],CHEMBL3832825,AntiDengue activity HCI DV2/A549 IC50 (uM),F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)C(=O)N(CCCCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO)C1CCCCCC1,CHEMBL3832761,,,CHEMBL2348373,CHEMBL2348373,6.22,0.0,http://www.openphacts.org/units/Nanomolar,2790263.0,=,34.0,1.0,=,IC50,nM,600.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,0.6,CHEMBL613757
369,18700310.0,[],CHEMBL4254756,Antiviral activity against HIV1 NL4-3 infected in human TZM-bl cells measured after 2 days by luciferase reporter gene based monocycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c2cc(S(=O)(=O)Nc3ccc4[nH]ncc4c3)ccc2o1,CHEMBL4251639,Eur J Med Chem,2018.0,CHEMBL4288780,CHEMBL4288780,4.51,0.0,http://www.openphacts.org/units/Nanomolar,3105628.0,=,1.0,1.0,=,IC50,nM,30600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,30.6,CHEMBL378
370,15064923.0,[],CHEMBL3366183,Antiviral activity against wild type HIV1 infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CNc2nc(-c3cc(OC)ccc3OC)c(Cc3ccccc3)s2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3329457,CHEMBL3329457,5.21,0.0,http://www.openphacts.org/units/Nanomolar,2248826.0,=,1.0,1.0,=,IC50,nM,6200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.2,CHEMBL378
371,1222250.0,[],CHEMBL710537,Inhibitory activity against 188L strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Nc1nc(Nc2ccc(C#N)cc2)ncc1Cl,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL312764,CHEMBL312764,8.33,0.0,http://www.openphacts.org/units/Nanomolar,127444.0,=,1.0,1.0,=,IC50,nM,4.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0047,CHEMBL378
372,2423351.0,[],CHEMBL1024932,Antiviral activity against Hepatitis B virus infected in human Hep3B cells assessed as surface antigen production,F,BAO_0000190,BAO_0000218,organism-based format,C=CC[C@H]1OC(=O)CCNC(=O)[C@H](C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CCCN2C1=O,CHEMBL1159235,J Nat Prod,1995.0,CHEMBL4524055,CHEMBL4524055,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,761948.0,=,1.0,1.0,=,IC50,ug.mL-1,0.1,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,0.1,CHEMBL613497
373,23274476.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CCC(=O)NCc2cccc(c2)CNC(=O)CC[C@@H](C)[C@H]2CC[C@H]3[C@@H]4[C@@H](O)C[C@@H]5C[C@@H](CC[C@]5(C)[C@H]4CC[C@]23C)NC(=O)CCCC(=O)N[C@@H]2CC[C@@]3(C)[C@@H](C2)C[C@H](O)[C@@H]2[C@@H]3CC[C@]3(C)[C@@H]1CC[C@@H]23,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4873195,CHEMBL4873195,,0.0,,3621276.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
374,1401876.0,[],CHEMBL837465,In vitro inhibitory concentration against HIV G190S mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177563,CHEMBL177563,6.50,0.0,http://www.openphacts.org/units/Nanomolar,360416.0,=,1.0,1.0,=,IC50,nM,316.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.316,CHEMBL378
375,2149844.0,[],CHEMBL935682,Antiviral activity against HIV1 098-T1249 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL437278,CHEMBL437278,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708043.0,=,1.0,1.0,=,IC50,ug.mL-1,0.555,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.555,CHEMBL378
376,8043634.0,[],CHEMBL1953039,Antiviral activity against HIV1 3B infected human TZM-bl cells assessed as inhibition of viral replication by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NC(C(=O)[O-])c1ccc(O)cc1)C(=O)C(O)=C3C(C)C)/C(=C/NC(C(=O)[O-])c1ccc(O)cc1)C(=O)C(O)=C2C(C)C.[Na+].[Na+],CHEMBL1949531,Bioorg Med Chem Lett,2012.0,CHEMBL1949752,CHEMBL1963077,5.87,0.0,http://www.openphacts.org/units/Nanomolar,1576820.0,=,1.0,1.0,=,IC50,nM,1340.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.34,CHEMBL378
377,3276410.0,[],CHEMBL1104905,Antiviral activity against HBV infected in HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion after 8 days by radio immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnsc1/C(Br)=C(/NC(=O)c1ccccc1)C(=O)N1CCOCC1,CHEMBL1157863,Eur J Med Chem,2010.0,CHEMBL1088233,CHEMBL1088233,,0.0,,912504.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
378,609119.0,[],CHEMBL710373,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2ncnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL71728,CHEMBL71728,7.89,0.0,http://www.openphacts.org/units/Nanomolar,126924.0,=,1.0,1.0,=,IC50,nM,13.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.013,CHEMBL378
379,14596901.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(Sc2c(C)c(=O)[nH]c(=O)n2COCCO)cc1,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL117196,CHEMBL117196,5.44,0.0,http://www.openphacts.org/units/Nanomolar,2082743.0,=,1.0,1.0,=,IC50,nM,3600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.6,CHEMBL378
380,1402183.0,[],CHEMBL837471,In vitro inhibitory concentration against HIV Y188L mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL180008,CHEMBL180008,4.90,0.0,http://www.openphacts.org/units/Nanomolar,360390.0,=,1.0,1.0,=,IC50,nM,12590.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.59,CHEMBL378
381,591868.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1cccc(S(=O)(=O)c2cccc(NC(=O)c3ccccc3SC(=O)CCCC[n+]3ccccc3)c2)c1.[Br-],CHEMBL1132203,J Med Chem,1999.0,CHEMBL172036,CHEMBL1181462,,0.0,http://www.openphacts.org/units/Nanomolar,334033.0,=,1.0,1.0,=,IC50,nM,205000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,205.0,CHEMBL378
382,1080457.0,[],CHEMBL709777,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,C=CC(=C)CN1Cc2cccc3nc(O)n(c23)CC1C,CHEMBL1125252,J Med Chem,1991.0,CHEMBL165660,CHEMBL165660,4.15,0.0,http://www.openphacts.org/units/Nanomolar,322347.0,=,1.0,1.0,=,IC50,nM,71000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,71.0,CHEMBL378
383,13876367.0,[],CHEMBL3107507,Antiviral activity against HIV-1 infected in human SupT1 cells assessed as inhibition of viral infectivity after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccccc3)CC2)c2cccc(Cl)c2)CC1,CHEMBL3102803,Eur J Med Chem,2014.0,CHEMBL3104682,CHEMBL3104682,7.14,0.0,http://www.openphacts.org/units/Nanomolar,1959707.0,=,1.0,1.0,=,IC50,nM,73.01,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,73.01,CHEMBL378
384,2601845.0,[],CHEMBL1033990,Antiviral activity against Hepatitis B virus,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(Sc2ccc3ccccc3c2)c2ncn(CCOCP(=O)(OCC(F)(F)F)OCC(F)(F)F)c2n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL106152,CHEMBL106152,7.05,0.0,http://www.openphacts.org/units/Nanomolar,808023.0,=,1.0,1.0,=,IC50,nM,90.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.09,CHEMBL613497
385,3021957.0,[],CHEMBL1040768,Inhibition of HIV1 mediated cell to cell fusion,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Cc1cc(-c2ccc(-c3ccc(CCC(O)O)cc3CC(C)C)cc2C(C)C)ccc1OCC(=O)O,CHEMBL1156072,J Med Chem,2010.0,CHEMBL568403,CHEMBL568403,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,855817.0,=,1.0,1.0,=,IC50,ug.mL-1,15.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,15.0,CHEMBL378
386,19261908.0,[],CHEMBL4404384,Antiviral activity against HIV1 subtypeB 1006_11.C3.1601,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.86,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,139.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.139,CHEMBL378
387,19243765.0,[],CHEMBL4400278,Antiviral activity against Zika virus infected in human A549 cells assessed as reduction in viral titer incubated for 48 hrs by plaque assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CCNc1nc(NC(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)ns1,CHEMBL4396960,Bioorg Med Chem Lett,2019.0,CHEMBL4465951,CHEMBL4465951,9.95,0.0,http://www.openphacts.org/units/Nanomolar,3212392.0,=,1.0,1.0,=,IC50,nM,0.1135,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,pM,UO_0000065,113.5,CHEMBL4296612
388,2602109.0,[],CHEMBL1033990,Antiviral activity against Hepatitis B virus,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ccn2[C@H]1C[C@H](OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)C[C@@H]2O)[C@@H](CO)O1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL1162549,CHEMBL1162549,6.52,0.0,http://www.openphacts.org/units/Nanomolar,806783.0,=,1.0,1.0,=,IC50,nM,300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.3,CHEMBL613497
389,342408.0,[],CHEMBL873617,Inhibition of concanavalin A (con A)-induced proliferation of rat peripheral blood mononuclear cells.,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(C(F)(F)F)nn1-c1ccc(NC(=O)c2ccccc2F)cc1,CHEMBL1133605,J Med Chem,2000.0,CHEMBL101202,CHEMBL101202,6.21,0.0,http://www.openphacts.org/units/Nanomolar,188096.0,=,1.0,1.0,=,IC50,nM,613.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,613.0,CHEMBL378
390,1830885.0,[],CHEMBL918634,Antiviral activity against wild type HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C(C#N)c2ccccc2)nc(SCc2ccc([N+](=O)[O-])cc2)[nH]c1=O,CHEMBL1144474,J Med Chem,2007.0,CHEMBL222245,CHEMBL222245,5.88,0.0,http://www.openphacts.org/units/Nanomolar,629306.0,=,1.0,1.0,=,IC50,nM,1330.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.33,CHEMBL378
391,24830929.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)c1ccc2c(=O)c3cccc(Cl)c3oc2c1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5197583,CHEMBL5197583,5.78,0.0,http://www.openphacts.org/units/Nanomolar,3878102.0,=,1.0,1.0,=,IC50,nM,1650.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.65,CHEMBL613497
392,1202634.0,[],CHEMBL710372,Inhibitory activity against 100I strain and 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2nc(Nc3ccc(C#N)cc3)ncc2Cl)c(C)c1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70271,CHEMBL70271,6.50,0.0,http://www.openphacts.org/units/Nanomolar,127442.0,=,1.0,1.0,=,IC50,nM,319.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.319,CHEMBL378
393,15748675.0,[],CHEMBL3630970,Antiviral activity against HIV1 3B assessed as inhibition of viral attachment to human MAGI cells,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(C[C@H]1CN(C(=O)c2ccccc2)CCN1)[C@H]1CCCc2cccnc21,CHEMBL3627700,Bioorg Med Chem Lett,2015.0,CHEMBL3627793,CHEMBL3627793,7.22,0.0,http://www.openphacts.org/units/Nanomolar,2506621.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.06,CHEMBL378
394,597916.0,[],CHEMBL710373,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2nc(N)nc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL74174,CHEMBL74174,7.43,0.0,http://www.openphacts.org/units/Nanomolar,126898.0,=,1.0,1.0,=,IC50,nM,37.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.037,CHEMBL378
395,1402132.0,[],CHEMBL837469,In vitro inhibitory concentration against HIV V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCCCO)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL367745,CHEMBL367745,,0.0,http://www.openphacts.org/units/Nanomolar,360369.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
396,157563.0,[],CHEMBL844409,Inhibition of 50% of the integrase-mediated catalysis of the Y-oligo substrate,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OC(C(=O)O)C(C(=O)O)C(=O)Oc1ccsc1)c1ccsc1,CHEMBL1135546,J Med Chem,2002.0,CHEMBL123536,CHEMBL123536,,0.0,http://www.openphacts.org/units/Nanomolar,231549.0,>>,1.0,1.0,>>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
397,13463714.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1nc(N)nc2ncn([C@H]3C[C@H](N=[N+]=[N-])[C@@H](CO)O3)c12,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL2430334,CHEMBL2430334,5.05,0.0,http://www.openphacts.org/units/Nanomolar,1920831.0,=,1.0,1.0,=,IC50,nM,8912.51,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.05,CHEMBL378
398,22851144.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4723683,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein expression incubated for 48 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCC(=O)O[C@@]12[C@H](OC(=O)c3ccccc3)[C@@H](C)[C@]3(O)[C@@H]4C=C(C)C(=O)[C@@]4(O)[C@H](O)C(CO)=C[C@H]3[C@@H]1C2(C)C,CHEMBL4715862,J Nat Prod,2020.0,CHEMBL2375488,CHEMBL2375488,7.89,0.0,http://www.openphacts.org/units/Nanomolar,3548049.0,=,1.0,1.0,=,IC50,nM,12.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,12.8,CHEMBL378
399,3188307.0,[],CHEMBL1107773,Antiviral activity against HIV1 NLBal infected JC53BL cells assessed as inhibition of replication by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)C[C@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@H]3C1)CC2,CHEMBL1155421,Bioorg Med Chem Lett,2010.0,CHEMBL1077361,CHEMBL1077361,7.75,0.0,http://www.openphacts.org/units/Nanomolar,896405.0,=,1.0,1.0,=,IC50,nM,18.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,18.0,CHEMBL378
400,24378639.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5037884,Antiviral activity against HIV1 harboring reverse transcriptase E138K mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect incubated for 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NCC(F)(F)F)nc(Nc2ccc(C#N)cc2)n1,CHEMBL5036347,Eur J Med Chem,2021.0,CHEMBL5091520,CHEMBL5091520,7.14,0.0,http://www.openphacts.org/units/Nanomolar,3776743.0,=,1.0,1.0,=,IC50,nM,73.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.073,CHEMBL378
401,14654451.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(C)=O)[C@H](OC(C)=O)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3263013,CHEMBL3263013,4.40,0.0,http://www.openphacts.org/units/Nanomolar,2101896.0,=,1.0,1.0,=,IC50,nM,39600.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,39.6,CHEMBL613497
402,1401627.0,[],CHEMBL837467,In vitro inhibitory concentration against HIV K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Cc2c(C)c(C)[nH]c(=O)c2N(C)C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL367956,CHEMBL367956,6.40,0.0,http://www.openphacts.org/units/Nanomolar,360330.0,=,1.0,1.0,=,IC50,nM,398.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.398,CHEMBL378
403,3267406.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1Cc2cccc3[nH]c(=S)n(c23)C[C@@H]1C,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL46961,CHEMBL46961,7.01,0.0,http://www.openphacts.org/units/Nanomolar,906993.0,=,1.0,1.0,=,IC50,nM,97.72,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.01,CHEMBL378
404,1420531.0,[],CHEMBL833369,Antiviral activity in an in vitro HIV replication assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(CC(C)(CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1,CHEMBL1141903,Bioorg Med Chem Lett,2005.0,CHEMBL179141,CHEMBL179141,7.00,0.0,http://www.openphacts.org/units/Nanomolar,365503.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,100.0,CHEMBL378
405,3363282.0,[],CHEMBL1176970,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral cytoplasmic DNA synthesis after 8 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(Cc1ccccn1)c1nc2ccccc2n1C1CCCCC1,CHEMBL1177679,Bioorg Med Chem,2010.0,CHEMBL1173290,CHEMBL1173290,,0.0,,924647.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
406,2373423.0,[],CHEMBL1023811,Antiviral activity against HIV1 Ba-L in human HOS cells by MTS assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1,CHEMBL1140149,J Med Chem,2008.0,CHEMBL3084492,CHEMBL3084492,6.64,0.0,http://www.openphacts.org/units/Nanomolar,746097.0,=,1.0,1.0,=,IC50,nM,229.09,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.64,CHEMBL378
407,12680681.0,[],CHEMBL2342597,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral replication after 9 days by fluorescence PCR method,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)Nc3cccc(Cl)c3)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333683,CHEMBL2333683,,0.0,http://www.openphacts.org/units/Nanomolar,1867759.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
408,16498283.0,[],CHEMBL3777089,Antiviral activity against HIV1 dual CXCR4/CCR5-tropic strain 89.6 infected in human 293T cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1=NN(c2nc(C(F)(F)F)cs2)C(=O)/C1=N\Nc1ccc2c(S(=O)(=O)O)cc(S(=O)(=O)O)cc2c1,CHEMBL3774382,Bioorg Med Chem,2016.0,CHEMBL3774422,CHEMBL3774422,4.10,0.0,http://www.openphacts.org/units/Nanomolar,2762404.0,=,1.0,1.0,=,IC50,nM,79700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,79.7,CHEMBL378
409,1402578.0,[],CHEMBL837470,In vitro inhibitory concentration against HIV V179E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC(=S)Nc2ccccc2)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177253,CHEMBL177253,,0.0,http://www.openphacts.org/units/Nanomolar,360414.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
410,1755803.0,[],CHEMBL864208,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(SCC(=O)Nc2ccccc2Cl)n1C,CHEMBL1146046,Bioorg Med Chem Lett,2006.0,CHEMBL379344,CHEMBL379344,,0.0,http://www.openphacts.org/units/Nanomolar,545184.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
411,12642501.0,[],CHEMBL2317525,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NCc1ccc(F)cc1)c1cn2ccn(C3CCCCC3)c(=O)c2c(O)c1=O,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314683,CHEMBL2314683,7.92,0.0,http://www.openphacts.org/units/Nanomolar,1844815.0,=,1.0,1.0,=,IC50,nM,12.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,12.0,CHEMBL378
412,8027838.0,[],CHEMBL1948542,Antiviral activity against HIV1 NF-462 expressing wild-type Vpr infected in human 293T cells containing 1 ng of viral p24 antigen after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Oc1cc2c(cc1O)[C@@H]1c3ccc(O)c(O)c3OC[C@]1(O)C2,CHEMBL1944615,Bioorg Med Chem Lett,2012.0,CHEMBL477197,CHEMBL477197,,0.0,http://www.openphacts.org/units/Nanomolar,1573823.0,>,1.0,1.0,>,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
413,2614778.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1[S+]([O-])c1cccc(N)c1C#N,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL293298,CHEMBL293298,,0.0,http://www.openphacts.org/units/Nanomolar,731471.0,=,1.0,1.0,=,IC50,nM,92896638.68,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,1.032,CHEMBL378
414,664423.0,[],CHEMBL683819,Anti-HIV activity in cell culture assay expressed as IC50 values.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1ccc(O)c(O)c1)c1cc(O)c(O)c(O)c1,CHEMBL1126373,Bioorg Med Chem Lett,1992.0,CHEMBL36327,CHEMBL36327,,0.0,http://www.openphacts.org/units/Nanomolar,60626.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.0,CHEMBL378
415,2516321.0,[],CHEMBL975243,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2ccccc2)n(COCCO)c(=O)[nH]c1=O,CHEMBL1138559,Eur J Med Chem,2009.0,CHEMBL31871,CHEMBL31871,5.30,0.0,http://www.openphacts.org/units/Nanomolar,733353.0,=,1.0,1.0,=,IC50,nM,5060.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.06,CHEMBL378
416,2413728.0,[],CHEMBL987710,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/Nanomolar,810808.0,=,1.0,1.0,=,IC50,nM,38000000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,38.0,CHEMBL613497
417,14927148.0,[],CHEMBL3391567,Antiviral activity against NNRTI-resistant HIV-1 LAI harboring reverse transcriptase Y181C mutant infected in human MT4 cells assessed as inhibition of viral replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL3390846,Medchemcomm,2010.0,CHEMBL223228,CHEMBL223228,8.52,0.0,http://www.openphacts.org/units/Nanomolar,2173138.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.0,CHEMBL378
418,1402474.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177666,CHEMBL177666,9.00,0.0,http://www.openphacts.org/units/Nanomolar,360358.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
419,18057383.0,[],CHEMBL4012533,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA level,F,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)C1=C(C)NC(c2c(F)cc(F)cc2F)=N[C@H]1c1ccc(F)cc1Cl,CHEMBL4011615,J Med Chem,2017.0,CHEMBL4102567,CHEMBL4102567,6.55,0.0,http://www.openphacts.org/units/Nanomolar,2992844.0,=,1.0,1.0,=,IC50,nM,280.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.28,CHEMBL613497
420,539369.0,[],CHEMBL769300,Compound was evaluated for 50% inhibition of HBV polymerases (Hepatitis B virus),F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@@H]2C[C@@H](F)[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,CHEMBL1131623,J Med Chem,1998.0,CHEMBL2092833,CHEMBL2092833,6.60,0.0,http://www.openphacts.org/units/Nanomolar,109353.0,=,1.0,1.0,=,IC50,nM,250.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.25,CHEMBL613497
421,2614785.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cccc([S+]([O-])c2cccc(N)c2C#N)c1,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL293553,CHEMBL293553,,0.0,http://www.openphacts.org/units/Nanomolar,731706.0,=,1.0,1.0,=,IC50,nM,14190575.22,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,1.848,CHEMBL378
422,12627457.0,[],CHEMBL2317015,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1cccc(/C=N/NC(=O)c2n[nH]c3c2CCC3)c1O,CHEMBL2311445,Bioorg Med Chem,2013.0,CHEMBL2311872,CHEMBL2311872,,0.0,http://www.openphacts.org/units/Nanomolar,1841366.0,>,1.0,1.0,>,IC50,nM,4000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.0,CHEMBL378
423,2929495.0,[],CHEMBL1056900,Antiviral activity against HIV1 HXB2 harboring 100I and K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSCc3csc(C)n3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567623,CHEMBL567623,6.80,0.0,http://www.openphacts.org/units/Nanomolar,852982.0,=,1.0,1.0,=,IC50,nM,158.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,158.0,CHEMBL378
424,43590.0,[],CHEMBL688336,Antiviral activity against Y188C strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL57,CHEMBL57,5.64,0.0,http://www.openphacts.org/units/Nanomolar,20821.0,=,1.0,1.0,=,IC50,nM,2300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2300.0,CHEMBL378
425,23306081.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL4843118,Antiviral activity against Zika virus H/PF/2013 infected in pre-seeded Huh-7 cells assessed as inhibition of viral replication incubated for 72 hrs by immunodetection based secondary yield reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,CHEMBL4842338,Eur J Med Chem,2021.0,CHEMBL1643,CHEMBL1643,5.36,0.0,http://www.openphacts.org/units/Nanomolar,3627097.0,=,1.0,1.0,=,IC50,nM,4400.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,4.4,CHEMBL4296612
426,3596592.0,[],CHEMBL1292013,Antiviral activity against HIV1 BaL in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(CNC(=O)N(c2cccc(F)c2)C2CCN(CCC3(c4cccc(F)c4)CCN(C(=O)c4cc(S(=O)(=O)N5CCCC5)c(F)cc4F)CC3)CC2)cc1,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288668,CHEMBL1288668,9.05,0.0,http://www.openphacts.org/units/Nanomolar,973778.0,=,1.0,1.0,=,IC50,nM,0.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.9,CHEMBL378
427,18339052.0,[],CHEMBL4138326,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@]23C=C[C@@]2(CC(=O)CC[C@]12C)OO3,CHEMBL4138041,Medchemcomm,2017.0,CHEMBL4168329,CHEMBL4168329,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,3045178.0,=,1.0,1.0,=,IC50,ug.mL-1,1.86,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,1.86,CHEMBL613497
428,2601653.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2ccc(/C=C/c3ccc(O)cc3O)nc2c1O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL36586,CHEMBL36586,4.10,0.0,http://www.openphacts.org/units/Nanomolar,807391.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,80.0,CHEMBL378
429,16662875.0,[],CHEMBL3832824,AntiDengue activity HCI DV1/A549 IC50 (uM),F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)C(=O)N(CCCCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO)C1CCCCCC1,CHEMBL3832761,,,CHEMBL2348373,CHEMBL2348373,7.16,0.0,http://www.openphacts.org/units/Nanomolar,2790263.0,=,34.0,1.0,=,IC50,nM,70.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,0.07,CHEMBL613757
430,2203589.0,[],CHEMBL987023,Antiviral activity against HIV1 3B in human MT4 cells assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCNC(=S)Nc1ccc(-c2n[nH]c(=S)n2C)cc1,CHEMBL1149790,Eur J Med Chem,2008.0,CHEMBL494426,CHEMBL494426,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,765672.0,>,1.0,1.0,>,IC50,ug.mL-1,8.82,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,8.82,CHEMBL378
431,2694326.0,[],CHEMBL1053931,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV surface antigen at < TC50,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2nc3c(cc2c(CN2CCOCC2)c1O)CSc1ccccc1-3,CHEMBL1152943,Bioorg Med Chem,2009.0,CHEMBL560859,CHEMBL560859,,0.0,,824860.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
432,3238683.0,[],CHEMBL1116129,Antiviral activity against Human immunodeficiency virus 1 NL4.3 infected human CEM cells expressing GFP measured up to 8 days postinfection by p24 antigen capture ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C#CCOc1cc(OCCCC)nc2ccccc12,CHEMBL1156233,Bioorg Med Chem,2010.0,CHEMBL1091955,CHEMBL1091955,,0.0,,904795.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
433,10866435.0,[],CHEMBL2025517,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HbeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CN(C)C)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2023667,CHEMBL2023667,,0.0,http://www.openphacts.org/units/Nanomolar,1639231.0,>,1.0,1.0,>,IC50,nM,749300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,749.3,CHEMBL613497
434,2570690.0,[],CHEMBL1000472,Antiviral activity against hepatitis B virus-infected human HepG2.2.15 cells assessed as inhibition of HBV surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@H](OC(=O)CC)[C@H](C[C@@H](C)[C@]12CC[C@@]3(C)[C@@]1(C[C@H](OC(=O)CC)[C@H]1[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@@]13C)O2)OC(=O)CC,CHEMBL1155923,Bioorg Med Chem Lett,2008.0,CHEMBL504405,CHEMBL504405,,0.0,http://www.openphacts.org/units/Nanomolar,769067.0,=,1.0,1.0,=,IC50,nM,160000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.16,CHEMBL613497
435,3234773.0,[],CHEMBL1110484,Antiviral activity against HIV1 NL4-3 co-transfected with VSV glycoprotein plasmid in human 293T cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C(/C)C(=O)OC/C=C/c1cc(OC)c(OC(=O)/C(C)=C\C)c(OC)c1,CHEMBL1153770,J Nat Prod,2009.0,CHEMBL1085911,CHEMBL1085911,5.39,0.0,http://www.openphacts.org/units/Nanomolar,894884.0,=,1.0,1.0,=,IC50,nM,4040.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.04,CHEMBL378
436,3229728.0,[],CHEMBL1113200,Antiviral activity against recombinant HIV1 virus infected in human JC53BL cells after 3 days,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC1N(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2,CHEMBL1154224,Bioorg Med Chem Lett,2009.0,CHEMBL1078072,CHEMBL1078072,,0.0,http://www.openphacts.org/units/Nanomolar,897938.0,>,1.0,1.0,>,IC50,nM,625.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,625.0,CHEMBL378
437,3014830.0,[],CHEMBL1050515,Antiviral activity against multidrug-resistant HIV1 isolate B infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,CHEMBL1156053,J Med Chem,2009.0,CHEMBL729,CHEMBL729,,0.0,http://www.openphacts.org/units/Nanomolar,862429.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
438,5229803.0,[],CHEMBL1676982,Antiviral activity against Human immunodeficiency virus 1 3B infected in human CEM-SS cells infected with 3.13 uL of virus stock assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,6.52,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,=,1.0,1.0,=,IC50,nM,300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.3,CHEMBL378
439,1954153.0,[],CHEMBL891425,Antiviral activity against HIV1 RT 188L mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(CC)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL395522,CHEMBL395522,7.20,0.0,http://www.openphacts.org/units/Nanomolar,647177.0,=,1.0,1.0,=,IC50,nM,63.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,63.1,CHEMBL378
440,5229746.0,[],CHEMBL1676718,Antiviral activity against simian immunodeficiency virus Mac251 infected in phytohemagglutininin and interleukin-2-stimulated PBMC assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,7.22,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,0.06,CHEMBL613499
441,1403548.0,[],CHEMBL834757,Inhibitory concentration against 181C mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Oc2nc(Nc3ccc(Cl)cc3)c(=O)n(C)c2C)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL178054,CHEMBL178054,,0.0,http://www.openphacts.org/units/Nanomolar,360703.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
442,2099829.0,[],CHEMBL949222,Antiviral activity against HIV1 RU570 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)N(CCCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nc4c2CCN(C(=O)C2CCC2)C4)C3)c2ccccc2)cc1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL270578,CHEMBL270578,8.70,0.0,http://www.openphacts.org/units/Nanomolar,699404.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.002,CHEMBL378
443,592855.0,[],CHEMBL710381,Inhibitory activity against 103N strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)CCNc1nc(Cc2c(Cl)cccc2Cl)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL306023,CHEMBL306023,7.68,0.0,http://www.openphacts.org/units/Nanomolar,126902.0,=,1.0,1.0,=,IC50,nM,21.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.021,CHEMBL378
444,6152662.0,[],CHEMBL1763333,Inhibition of c-Jun,B,BAO_0000190,BAO_0000357,single protein format,c1cc(-n2cnc(N3CCOCC3)n2)ccc1Nc1ncc2ccc(-c3cn[nH]c3)cc2n1,CHEMBL1759990,Bioorg Med Chem Lett,2011.0,CHEMBL1761555,CHEMBL1761555,6.92,0.0,http://www.openphacts.org/units/Nanomolar,1413771.0,=,1.0,1.0,=,IC50,nM,120.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.12,CHEMBL4977
445,700232.0,[],CHEMBL802987,Inhibitory activity against sialidase of influenza B,F,BAO_0000190,BAO_0000218,organism-based format,CCC(CC)O[C@@H]1C=C(C(=O)O)[C@@H]2CC[C@@]1(C(=O)O)[C@H]2O,CHEMBL1131952,Bioorg Med Chem Lett,1999.0,CHEMBL155186,CHEMBL155186,,0.0,http://www.openphacts.org/units/Nanomolar,305993.0,>,1.0,1.0,>,IC50,nM,670000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,670.0,CHEMBL613129
446,5132854.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCc1ccc2[nH]c(=O)c(CN(Cc3ccco3)C(=O)c3ccccc3)cc2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645064,CHEMBL1645064,,0.0,http://www.openphacts.org/units/Nanomolar,1321052.0,>,1.0,1.0,>,IC50,nM,13900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,13.9,CHEMBL378
447,1069538.0,[],CHEMBL712251,Inhibition of HIV-1 replication in infected MT-4 human T-lymphoid cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1CO[C@@H]2CCO[C@@H]21,CHEMBL1129277,J Med Chem,1996.0,CHEMBL105753,CHEMBL105753,,0.0,http://www.openphacts.org/units/Nanomolar,209978.0,>,1.0,1.0,>,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3000.0,CHEMBL378
448,15679585.0,[],CHEMBL3607082,Antiviral activity against Tacaribe virus infected in African green monkey Vero 76 cells after 3 days by neutral red dye-based plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncc(F)c2c1ncn2[C@@H]1C=C(CCO)[C@@H](O)[C@H]1O,CHEMBL3603790,Bioorg Med Chem,2015.0,CHEMBL3604362,CHEMBL3604362,,0.0,http://www.openphacts.org/units/Nanomolar,2494264.0,<,1.0,1.0,<,IC50,nM,340.0,CHEMBL613131,Tacaribe virus,Tacaribe virus,11631,IC50,uM,UO_0000065,0.34,CHEMBL613131
449,10961199.0,[],CHEMBL2061269,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M4 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNC1CCC1)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058325,CHEMBL2058325,7.44,0.0,http://www.openphacts.org/units/Nanomolar,1656265.0,=,1.0,1.0,=,IC50,nM,36.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,36.0,CHEMBL378
450,5249075.0,[],CHEMBL1685197,Antiviral activity against X4 tropic HIV1 NL4.3 infected in human PBMC assessed as inhibition of viral cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccnc1CN(CCCCN)[C@@H](C)c1ccccn1,CHEMBL1681661,Bioorg Med Chem Lett,2011.0,CHEMBL1682998,CHEMBL1682998,8.68,0.0,http://www.openphacts.org/units/Nanomolar,1334133.0,=,1.0,1.0,=,IC50,nM,2.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.1,CHEMBL378
451,171419.0,[],CHEMBL656397,Activity against HIV-1 by syncytial plaque assay performed in duplicate using CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,FC(F)(F)c1cccc(Cn2c(Cl)nc3cc(Cl)c(Cl)cc32)c1,CHEMBL1131326,J Med Chem,1998.0,CHEMBL25044,CHEMBL25044,,0.0,http://www.openphacts.org/units/Nanomolar,30673.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
452,15748654.0,[],CHEMBL3630970,Antiviral activity against HIV1 3B assessed as inhibition of viral attachment to human MAGI cells,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(C[C@H]1CN(S(=O)(=O)c2cc3ccccc3s2)CCN1)[C@H]1CCCc2cccnc21,CHEMBL3627700,Bioorg Med Chem Lett,2015.0,CHEMBL3627861,CHEMBL3627861,5.46,0.0,http://www.openphacts.org/units/Nanomolar,2506692.0,=,1.0,1.0,=,IC50,nM,3440.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.44,CHEMBL378
453,1470422.0,[],CHEMBL826114,Inhibitory activity against HIV-1 mutant strain 138K,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL185715,CHEMBL185715,8.52,0.0,http://www.openphacts.org/units/Nanomolar,380721.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
454,1751348.0,[],CHEMBL854523,Antiviral activity against wild type Measles virus Edmonston in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1cccc(NC(=O)Cc2ccccc2)c1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL441539,CHEMBL441539,4.72,0.0,http://www.openphacts.org/units/Nanomolar,532792.0,=,1.0,1.0,=,IC50,nM,19000.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,19.0,CHEMBL613738
455,704292.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cc(Br)cc(SSc2cc(Br)cc(C(=O)O)c2O)c1O,CHEMBL1129635,J Med Chem,1996.0,CHEMBL121491,CHEMBL121491,,0.0,,228622.0,=,1.0,0.0,=,IC50,,122.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,122.4,CHEMBL378
456,2165103.0,[],CHEMBL921437,Antiviral activity against HIV1 with RT K103N/V179E mutation in human MT4 cells in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ccccc34)ccc2Cl)c1,CHEMBL1145601,Bioorg Med Chem Lett,2008.0,CHEMBL402823,CHEMBL402823,7.69,0.0,http://www.openphacts.org/units/Nanomolar,711002.0,=,1.0,1.0,=,IC50,nM,20.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,20.3,CHEMBL378
457,2414476.0,[],CHEMBL953485,Antiviral activity against HIV1 with reverse transcriptase K103N mutation in human CEM cells assessed as protection against virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)C(N)=O)[nH]c3ccc(Cl)cc23)c1,CHEMBL1153955,J Med Chem,2009.0,CHEMBL127012,CHEMBL127012,7.85,0.0,http://www.openphacts.org/units/Nanomolar,810480.0,=,1.0,1.0,=,IC50,nM,14.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,14.0,CHEMBL378
458,1421937.0,[],CHEMBL834672,Inhibitory activity against human immunodeficiency virus type 1,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(Sc2ccccc2)n(COCc2ccco2)c(=O)[nH]c1=O,CHEMBL1144258,Bioorg Med Chem Lett,2005.0,CHEMBL361739,CHEMBL361739,,0.0,http://www.openphacts.org/units/Nanomolar,364920.0,<,1.0,1.0,<,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
459,1487556.0,[],CHEMBL833976,Inhibitory concentration against wild type human immunodeficiency virus type 1 was determined by recombinant virus assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCc1c(O)nc2cc(OC)ccc2c1OCC1CCC1,CHEMBL1138845,J Med Chem,2004.0,CHEMBL427336,CHEMBL427336,,0.0,http://www.openphacts.org/units/Nanomolar,383838.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2000.0,CHEMBL378
460,139054.0,[],CHEMBL692689,Inhibition of HCV NS5B polymerase,B,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1sc(-c2ccccc2)cc1NS(=O)(=O)c1ccc(Cl)cc1,CHEMBL1148275,Bioorg Med Chem Lett,2004.0,CHEMBL165438,CHEMBL165438,5.39,0.0,http://www.openphacts.org/units/Nanomolar,326851.0,=,1.0,1.0,=,IC50,nM,4100.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,4.1,CHEMBL4620
461,2947321.0,[],CHEMBL1038495,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)C(C)(C)O[Si](C)(C)C)C1=C2C[C@H](O[Si](C)(C)C)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL584796,CHEMBL584796,4.70,0.0,http://www.openphacts.org/units/Nanomolar,850762.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.02,CHEMBL613497
462,2927214.0,[],CHEMBL1041197,Antiviral activity against Dengue virus,F,BAO_0000190,BAO_0000218,organism-based format,O[C@H]1[C@H](O)[C@@H](O)CN2CC[C@H](O)[C@H]12,CHEMBL1155220,J Med Chem,2009.0,CHEMBL311226,CHEMBL311226,6.00,0.0,http://www.openphacts.org/units/Nanomolar,851457.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,1.0,CHEMBL613757
463,1471564.0,[],CHEMBL833079,Inhibitory activity against HIV-1 mutant strain 181C,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cccc(Cl)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL187305,CHEMBL187305,7.10,0.0,http://www.openphacts.org/units/Nanomolar,380906.0,=,1.0,1.0,=,IC50,nM,80.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.08,CHEMBL378
464,6216885.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CC(=O)C1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784388,CHEMBL1784388,,0.0,http://www.openphacts.org/units/Nanomolar,1429326.0,<,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.0,CHEMBL378
465,18044770.0,[],CHEMBL4010415,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype D/A MF535.W0M.ENV.C1,F,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075766,CHEMBL4075766,6.44,0.0,http://www.openphacts.org/units/Nanomolar,2990214.0,=,1.0,1.0,=,IC50,nM,360.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.36,CHEMBL378
466,1402502.0,[],CHEMBL834487,In vitro inhibitory concentration value against HIV K103N and Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCOC)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL426046,CHEMBL426046,6.40,0.0,http://www.openphacts.org/units/Nanomolar,360366.0,=,1.0,1.0,=,IC50,nM,398.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.398,CHEMBL378
467,8027854.0,[],CHEMBL1948540,Antiviral activity against HIV1 NL432 infected in human ConA and IL2-stimulated PBMC assessed as inhibition of viral replication by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,Oc1cc2c(cc1O)[C@@H]1c3ccc(O)c(O)c3OC[C@]1(O)C2,CHEMBL1944615,Bioorg Med Chem Lett,2012.0,CHEMBL477197,CHEMBL477197,,0.0,,1573823.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
468,24731842.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5115939,Antiviral activity against DENV-NGC-1 infected in human BHK cells incubated for 7 days by CellTiter 96 luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(c1ccc(C(F)(F)F)cc1O)c1[nH]c(Cl)c(Cl)c1-n1c(C(=O)c2ccc(C(F)(F)F)cc2O)cc(Cl)c1Sc1cccs1,CHEMBL5113415,Eur J Med Chem,2022.0,CHEMBL5191957,CHEMBL5191957,,0.0,,3857942.0,,1.0,0.0,,IC50,,,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,,,,CHEMBL613757
469,1471430.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1ccccc1Cl,CHEMBL1138799,J Med Chem,2004.0,CHEMBL364403,CHEMBL364403,8.22,0.0,http://www.openphacts.org/units/Nanomolar,380883.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
470,1242227.0,[],CHEMBL824446,Concentration required to inhibit Sindbis induced cytopathicity in Vero cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCCCCCCCCCCCC(=O)NCCCCCCCCCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL119862,CHEMBL1205597,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221529.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL613725,Sindbis virus,Sindbis virus,11034,IC50,ug ml-1,UO_0000274,100.0,CHEMBL613725
471,1224908.0,[],CHEMBL710372,Inhibitory activity against 100I strain and 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C=Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(C)cc(C)cc1C,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL307950,CHEMBL307950,,0.0,http://www.openphacts.org/units/Nanomolar,127452.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
472,1223906.0,[],CHEMBL645946,Concentration required to inhibit activator protein-1(AP-1) mediated transcriptional activation in human Jurkat T-cells,B,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)nc(Cl)n1,CHEMBL1133475,J Med Chem,2000.0,CHEMBL340165,CHEMBL340165,,0.0,http://www.openphacts.org/units/Nanomolar,247711.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,10.0,CHEMBL4977
473,2432645.0,[],CHEMBL1027472,Antiviral activity against HIV1 3B infected in human HOG.R5 assessed as inhibition of viral replication by microtiter assay,F,BAO_0000190,BAO_0000218,organism-based format,C/C(=C\CC[C@@H](C)[C@H]1CC[C@@]2(C)[C@@H]3CC[C@H]4C(C)(C)C(=O)CC[C@@]45C[C@@]35CC[C@]12C)C(=O)O,CHEMBL1159344,J Nat Prod,2003.0,CHEMBL490331,CHEMBL490331,4.36,0.0,http://www.openphacts.org/units/Nanomolar,735811.0,=,1.0,1.0,=,IC50,nM,44100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,44.1,CHEMBL378
474,17602958.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(S(=O)(=O)c2ccc(Cl)cc2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644893,CHEMBL3644893,8.70,0.0,http://www.openphacts.org/units/Nanomolar,2518013.0,=,37.0,1.0,=,IC50,nM,2.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,2.0,CHEMBL4620
475,2244612.0,[],CHEMBL1005550,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase V108I/Y181C mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL203420,CHEMBL203420,9.22,0.0,http://www.openphacts.org/units/Nanomolar,798654.0,=,1.0,1.0,=,IC50,nM,0.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.6,CHEMBL378
476,12683860.0,[],CHEMBL2339980,Antiviral activity against Hepatitis B virus transfected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1CN2CC(C)O[Si](CCCNC(=O)CCCC(=O)OCCOCn3cnc4c(=O)[nH]c(N)nc43)(OC[C@@H]2C)O1,CHEMBL2331251,Bioorg Med Chem Lett,2013.0,CHEMBL2333793,CHEMBL2333793,,0.0,http://www.openphacts.org/units/Nanomolar,1867886.0,=,1.0,1.0,=,IC50,nM,485600.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,485.6,CHEMBL613497
477,5189172.0,[],CHEMBL1658799,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O)c1ccco1,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652517,CHEMBL1652517,4.29,0.0,http://www.openphacts.org/units/Nanomolar,1326892.0,=,1.0,1.0,=,IC50,nM,51000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.051,CHEMBL613497
478,164864.0,[],CHEMBL844409,Inhibition of 50% of the integrase-mediated catalysis of the Y-oligo substrate,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)[C@@H](O)[C@H](O)C(=O)O,CHEMBL1135546,J Med Chem,2002.0,CHEMBL1200861,CHEMBL1200861,,0.0,http://www.openphacts.org/units/Nanomolar,231550.0,>>,1.0,1.0,>>,IC50,nM,25000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.0,CHEMBL378
479,947096.0,[],CHEMBL655544,Inhibition of wild type HIV-1-IIIB strain replication in CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)Nc1c(O)ncc(C)c1Sc1cc(C)cc(C)c1,CHEMBL1128194,J Med Chem,1995.0,CHEMBL126931,CHEMBL126931,4.38,0.0,http://www.openphacts.org/units/Nanomolar,276287.0,=,1.0,1.0,=,IC50,nM,41400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,41400.0,CHEMBL378
480,13475428.0,[],CHEMBL2439263,Antiviral activity against Human immunodeficiency virus 1 clade C isolate ETH2220 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435856,CHEMBL2435856,6.76,0.0,http://www.openphacts.org/units/Nanomolar,1924231.0,=,1.0,1.0,=,IC50,nM,173.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,173.9,CHEMBL378
481,23373513.0,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'M', 'standard_value': '1.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'M', 'value': '1.0'}]",CHEMBL4885290,Fer(FER1LGY1) Takeda global kinase panel,B,BAO_0000190,BAO_0000357,single protein format,CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21,CHEMBL4507327,,2021.0,CHEMBL4097778,CHEMBL4097778,,0.0,http://www.openphacts.org/units/Nanomolar,3489319.0,,54.0,1.0,,IC50,nM,1000.0,CHEMBL3982,Homo sapiens,Tyrosine-protein kinase FER,9606,pIC50,,UO_0000065,6.0,CHEMBL3982
482,2602277.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C(=C\c1ccc(O)c(O)c1)/C(=C\c1ccc(O)c(O)c1)C(=O)O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL513047,CHEMBL513047,5.66,0.0,http://www.openphacts.org/units/Nanomolar,807222.0,=,1.0,1.0,=,IC50,nM,2190.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.19,CHEMBL378
483,23284033.0,[],CHEMBL4837921,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)OC[C@H]2CCCNC2)cc1,CHEMBL4837199,Eur J Med Chem,2021.0,CHEMBL4875282,CHEMBL4875282,8.87,0.0,http://www.openphacts.org/units/Nanomolar,3622965.0,=,1.0,1.0,=,IC50,nM,1.35,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.35,CHEMBL378
484,13463720.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,[N-]=[N+]=N[C@H]1C[C@H](n2cnc3nc(N)nc(Oc4ccccc4)c32)O[C@@H]1CO,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL2430340,CHEMBL2430340,4.55,0.0,http://www.openphacts.org/units/Nanomolar,1920837.0,=,1.0,1.0,=,IC50,nM,28183.83,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.55,CHEMBL378
485,43584.0,[],CHEMBL695510,Antiviral activity against K101E strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL57,CHEMBL57,6.28,0.0,http://www.openphacts.org/units/Nanomolar,20821.0,=,1.0,1.0,=,IC50,nM,520.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,520.0,CHEMBL378
486,14653422.0,[],CHEMBL3266817,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)c3ccccc3)[C@H](O)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262999,CHEMBL3262999,,0.0,http://www.openphacts.org/units/Nanomolar,2101882.0,=,1.0,1.0,=,IC50,nM,880000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,880.0,CHEMBL613497
487,12651390.0,[],CHEMBL2327723,Antiviral activity against 0.001 MOI bevirimat-resistant Human immunodeficiency virus 1 NL4-3 harboring gag V370A mutant infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCCNC(=O)[C@H](C)NC(=O)OC(C)(C)C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324132,CHEMBL2324132,5.80,0.0,http://www.openphacts.org/units/Nanomolar,1850156.0,=,1.0,1.0,=,IC50,nM,1580.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.58,CHEMBL378
488,17602988.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(c2ccc(-c3cnc(N)nc3)cc2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644923,CHEMBL3644923,4.80,0.0,http://www.openphacts.org/units/Nanomolar,2518043.0,=,37.0,1.0,=,IC50,nM,16000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,16000.0,CHEMBL4620
489,13475592.0,[],CHEMBL2439261,Antiviral activity against Human immunodeficiency virus 1 clade G isolate BZ163 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435856,CHEMBL2435856,8.19,0.0,http://www.openphacts.org/units/Nanomolar,1924231.0,=,1.0,1.0,=,IC50,nM,6.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.5,CHEMBL378
490,18406017.0,[],CHEMBL4150963,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CO[C@@H]1O[C@@]2(C=C(C)C(=O)O2)C[C@@H]1[C@H]1CC[C@@]2(C)[C@@H]3CC[C@H]4C(C)(C)C(=O)C=C[C@@]45C[C@@]35CC[C@]12C,CHEMBL4145651,J Nat Prod,2018.0,CHEMBL4159649,CHEMBL4159649,,0.0,,3054863.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
491,2517062.0,[],CHEMBL975243,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)nc(SCc2ccc([N+](=O)[O-])cc2)[nH]c1=O,CHEMBL1138559,Eur J Med Chem,2009.0,CHEMBL475364,CHEMBL475364,,0.0,http://www.openphacts.org/units/Nanomolar,732868.0,>,1.0,1.0,>,IC50,nM,248000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,248.0,CHEMBL378
492,5230640.0,[],CHEMBL1680051,Antiviral activity against HIV-1 Bal infected in human MT4 cells after 7 days by RT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1671644,Antimicrob Agents Chemother,2009.0,CHEMBL70663,CHEMBL70663,,0.0,,1331935.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
493,19261766.0,[],CHEMBL4404352,Antiviral activity against HIV1 HXB2 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.57,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,270.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.27,CHEMBL378
494,5137403.0,[],CHEMBL1646839,Antiviral activity against X4 tropic HIV1 infected in human PBMC assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NCc1cocc1N(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21,CHEMBL1641524,Bioorg Med Chem Lett,2011.0,CHEMBL1644082,CHEMBL1644082,8.39,0.0,http://www.openphacts.org/units/Nanomolar,1319756.0,=,1.0,1.0,=,IC50,nM,4.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.1,CHEMBL378
495,22806666.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@@H](Sc3ccc(C)cc3)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4754821,CHEMBL4754821,6.55,0.0,http://www.openphacts.org/units/Nanomolar,3541892.0,=,1.0,1.0,=,IC50,nM,281.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.281,CHEMBL613497
496,18239614.0,[],CHEMBL4052021,Antiviral activity against tipranavir-resistant HIV1 NL4-3 harboring protease L10I/L33I/M36I/M46I/I54V/K55R/I62V/L63P/A71V/G73S/V82T/L90M/I93L mutant infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,CHEMBL4049446,J Med Chem,2017.0,CHEMBL729,CHEMBL729,,0.0,http://www.openphacts.org/units/Nanomolar,3026806.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
497,1248534.0,[],CHEMBL709463,Concentration required to inhibit by 50% syncytium formation between MOLT-4 cells and HIV-1(IIIB),F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCC(=O)NCCCCCCCCCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL118801,CHEMBL1205590,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221516.0,=,1.0,1.0,=,IC50,ug.mL-1,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,50.0,CHEMBL378
498,2997510.0,[],CHEMBL1046975,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)c2ccc(=O)n(-c3ccc(F)cc3)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL571739,CHEMBL571739,,0.0,http://www.openphacts.org/units/Nanomolar,856568.0,>,1.0,1.0,>,IC50,nM,117900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,117.9,CHEMBL613497
499,2997537.0,[],CHEMBL1047854,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV DNA replication after 9 days by PCR,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)c2ccc(=O)n(-c3ccc([N+](=O)[O-])cc3)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL576649,CHEMBL576649,,0.0,,856575.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
500,18775509.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCC1Cc2cc(OCC(N)=O)c(OC)cc2-c2cc(=O)c(C(=O)O)cn21,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4281091,CHEMBL4281091,4.58,0.0,http://www.openphacts.org/units/Nanomolar,3119667.0,=,1.0,1.0,=,IC50,nM,26100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,26.1,CHEMBL613497
501,8027849.0,[],CHEMBL1948540,Antiviral activity against HIV1 NL432 infected in human ConA and IL2-stimulated PBMC assessed as inhibition of viral replication by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)Oc2cc3c(cc2O1)[C@@H]1c2cccc(OCc4ccccc4)c2OC[C@]1(O)C3,CHEMBL1944615,Bioorg Med Chem Lett,2012.0,CHEMBL1945224,CHEMBL1945224,,0.0,,1574224.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
502,16394358.0,[],CHEMBL3744725,Inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC/N=C(\c1ccc(=O)n(CCCCC)c1)c1ccc(OC)cc1O,CHEMBL3739304,Medchemcomm,2015.0,CHEMBL568411,CHEMBL568411,4.52,0.0,http://www.openphacts.org/units/Nanomolar,2738867.0,=,1.0,1.0,=,IC50,nM,30000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,30.0,CHEMBL613497
503,19243774.0,[],CHEMBL4400278,Antiviral activity against Zika virus infected in human A549 cells assessed as reduction in viral titer incubated for 48 hrs by plaque assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CCSc1nnc(NC(=S)Nc2ccc(Br)cc2C(F)(F)F)s1,CHEMBL4396960,Bioorg Med Chem Lett,2019.0,CHEMBL4525531,CHEMBL4525531,7.33,0.0,http://www.openphacts.org/units/Nanomolar,3212401.0,=,1.0,1.0,=,IC50,nM,46.6,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,nM,UO_0000065,46.6,CHEMBL4296612
504,1401625.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Cc2c(C)c(C)[nH]c(=O)c2N(C)C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL367956,CHEMBL367956,8.30,0.0,http://www.openphacts.org/units/Nanomolar,360330.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.005,CHEMBL378
505,8041785.0,[],CHEMBL1953242,Antiviral activity against HIV1 harboring VSV glycoprotein-G co-transfected with luciferase gene infected in human TZM-bl cells assessed as inhibition of viral replication after 48 hrs by microplate luminometer based luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Oc1c(C(=O)NCc2ccc(F)cc2)nc(C(C)(C)NC(=O)c2nnc(C)o2)n(C)c1=O,CHEMBL1949625,Eur J Med Chem,2012.0,CHEMBL1949870,CHEMBL1949870,9.00,0.0,http://www.openphacts.org/units/Nanomolar,1576971.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
506,10866422.0,[],CHEMBL2025517,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HbeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)COCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@]3(O)[C@@H]2C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]2(C)[C@]3(O)CC[C@@]2(O)C(C)=O)C1,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2023666,CHEMBL2023666,4.10,0.0,http://www.openphacts.org/units/Nanomolar,1639230.0,=,1.0,1.0,=,IC50,nM,78620.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,78.62,CHEMBL613497
507,2927203.0,[],CHEMBL1041197,Antiviral activity against Dengue virus,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CCOC(=O)/C=C/c1ccc(O)cc1)Cc1cc(Cl)ccc1O,CHEMBL1155220,J Med Chem,2009.0,CHEMBL582943,CHEMBL582943,4.34,0.0,http://www.openphacts.org/units/Nanomolar,851444.0,=,1.0,1.0,=,IC50,nM,46000.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,46.0,CHEMBL613757
508,18202893.0,[],CHEMBL4043732,Antiviral activity against HIV-1 NL4-3 harboring reverse transcriptase K103N mutant infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL129,CHEMBL129,8.00,0.0,http://www.openphacts.org/units/Nanomolar,3019997.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
509,3253126.0,[],CHEMBL1107997,Antiviral activity against HIV1 NL4.3 infected in human MT4 cells expressing CD4 and CXCR4 assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(CNCc2ccc(CN(Cc3cc4ccccc4[nH]3)C3CCCc4cccnc43)cc2)nc1,CHEMBL1156989,J Med Chem,2010.0,CHEMBL1093455,CHEMBL1093455,5.80,0.0,http://www.openphacts.org/units/Nanomolar,901652.0,=,1.0,1.0,=,IC50,nM,1600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.6,CHEMBL378
510,18940379.0,[],CHEMBL4328847,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)OC(=O)c1cccc(Cn2ccc3ccc(-c4ccc5ccn(Cc6cccc(C(=O)O)c6)c5c4)cc32)c1,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4467904,CHEMBL4467904,6.70,0.0,http://www.openphacts.org/units/Nanomolar,3159814.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.2,CHEMBL378
511,626048.0,[],CHEMBL689615,Reduction of viral load in the cell supernatant.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2ccc(/C=C/c3cc(O)c(O)c(O)c3)nc2c1O,CHEMBL1135622,J Med Chem,2002.0,CHEMBL37869,CHEMBL37869,5.92,0.0,http://www.openphacts.org/units/Nanomolar,275304.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.2,CHEMBL378
512,2003500.0,[],CHEMBL901904,Antiviral activity against Vaccinia virus-infected Vero cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(-c2nc3cc(NC(=O)C4CCCCC4)ccc3[nH]2)cc1)C1CCCCC1,CHEMBL1138288,J Med Chem,2007.0,CHEMBL240389,CHEMBL240389,6.70,0.0,http://www.openphacts.org/units/Nanomolar,666647.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,nM,UO_0000065,200.0,CHEMBL613493
513,5230900.0,[],CHEMBL1678276,Antiviral activity against Human immunodeficiency virus 1 subtype D UG/92/046 infected in phytohemagglutininin and interleukin-2-stimulated PBMC assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL129,CHEMBL129,9.15,0.0,http://www.openphacts.org/units/Nanomolar,1332124.0,=,1.0,1.0,=,IC50,nM,0.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0007,CHEMBL378
514,24788548.0,[],CHEMBL5131651,Antiviral activity against wild-type HIV-1 in T cells,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,CHEMBL5131375,J Med Chem,2022.0,CHEMBL14762,CHEMBL14762,9.44,0.0,http://www.openphacts.org/units/Nanomolar,3869388.0,=,1.0,1.0,=,IC50,nM,0.36,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.36,CHEMBL378
515,3013886.0,[],CHEMBL1045234,Antiviral activity against HIV1 3B infected human HOS cells expressing human CXCR4 and CD4 assessed as inhibition of viral infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(c2cccc3nc(CN(C)[C@H]4CCCc5cccnc54)cn23)CC1,CHEMBL1156094,Bioorg Med Chem Lett,2009.0,CHEMBL570522,CHEMBL570522,8.70,0.0,http://www.openphacts.org/units/Nanomolar,860785.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.002,CHEMBL378
516,2371459.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1C(C(=O)NCc2ccco2)C1C(=O)NCc1ccco1,CHEMBL1140145,J Med Chem,2008.0,CHEMBL492893,CHEMBL492893,,0.0,http://www.openphacts.org/units/Nanomolar,746082.0,=,1.0,1.0,=,IC50,nM,272000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,272.0,CHEMBL613493
517,2009851.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2csc(N)n2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL240049,CHEMBL240049,6.28,0.0,http://www.openphacts.org/units/Nanomolar,668062.0,=,1.0,1.0,=,IC50,nM,520.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,520.0,CHEMBL378
518,611981.0,[],CHEMBL691384,Inhibitory concentration for cytopathicity of HIV-1 (HTLV-IIIB) in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1cc(C(c2ccc(O)c(C(=O)OC)c2)c2ccc(O)c(C(=O)OC)c2)ccc1O,CHEMBL1125737,J Med Chem,1991.0,CHEMBL114154,CHEMBL114154,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,217793.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,100.0,CHEMBL378
519,2713023.0,[],CHEMBL1054012,Antiviral activity against HIV1 LAI in human CEM-SS cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CO[C@H]1CC(=O)N[C@H](c2ccccc2)CO[C@H](OC)CCN(Cc2ccc(CN3CC[C@@H](OC)OC[C@@H](c4ccccc4)NC(=O)C[C@H](OC)OC[C@H]3c3ccccc3)cc2)[C@H](c2ccccc2)CO1,CHEMBL1153004,Eur J Med Chem,2009.0,CHEMBL554366,CHEMBL554366,5.06,0.0,http://www.openphacts.org/units/Nanomolar,826159.0,=,1.0,1.0,=,IC50,nM,8650.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.65,CHEMBL378
520,24831192.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5142784,Antiviral activity against HBV infected in human primary hepatocyte cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBsAg secretion measured after 48 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)[C@H]1CCN(c2ccc3c(=O)c4cccc(Cl)c4oc3c2)C1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5202800,CHEMBL5202800,5.80,0.0,http://www.openphacts.org/units/Nanomolar,3878147.0,=,1.0,1.0,=,IC50,nM,1580.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.58,CHEMBL613497
521,13463741.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(Sc2cccc(N)c2C#N)c1,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL296376,CHEMBL296376,5.21,0.0,http://www.openphacts.org/units/Nanomolar,1920858.0,=,1.0,1.0,=,IC50,nM,6165.95,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.21,CHEMBL378
522,12680704.0,[],CHEMBL2342598,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)NCCc3cccc(F)c3)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333290,CHEMBL2333290,,0.0,http://www.openphacts.org/units/Nanomolar,1867253.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
523,15749735.0,[],CHEMBL3632389,Antiviral activity against HIV-1 LAI infected in MT-2 cells measured after 7 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COCc1coc(CN(C)C(=O)c2cccc(C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc(OC)cc3)c2)n1,CHEMBL3627614,Bioorg Med Chem Lett,2015.0,CHEMBL3627878,CHEMBL3627878,7.60,0.0,http://www.openphacts.org/units/Nanomolar,2506712.0,=,1.0,1.0,=,IC50,nM,25.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,25.0,CHEMBL378
524,2244505.0,[],CHEMBL1003077,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase V106A/Y181C mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL223228,CHEMBL223228,8.70,0.0,http://www.openphacts.org/units/Nanomolar,798658.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
525,15621464.0,[],CHEMBL3584167,Antiviral activity against HIV1 NL4.3-Ren infected in human MT2 cells assessed as inhibition of viral growth measured 48 hrs post infection by luminometry,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(CO)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL3580560,J Nat Prod,2015.0,CHEMBL3581946,CHEMBL3581946,5.16,0.0,http://www.openphacts.org/units/Nanomolar,2482786.0,=,1.0,1.0,=,IC50,nM,6900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.9,CHEMBL378
526,15748655.0,[],CHEMBL3630970,Antiviral activity against HIV1 3B assessed as inhibition of viral attachment to human MAGI cells,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(C[C@H]1CN(S(=O)(=O)c2ccc3ccccc3c2)CCN1)[C@H]1CCCc2cccnc21,CHEMBL3627700,Bioorg Med Chem Lett,2015.0,CHEMBL3627860,CHEMBL3627860,5.34,0.0,http://www.openphacts.org/units/Nanomolar,2506691.0,=,1.0,1.0,=,IC50,nM,4600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.6,CHEMBL378
527,18812981.0,[],CHEMBL4276413,Antiviral activity against darunavir-resistant HIV1 at passage 30 infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,CHEMBL4270667,J Med Chem,2018.0,CHEMBL729,CHEMBL729,,0.0,http://www.openphacts.org/units/Nanomolar,3125924.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
528,593923.0,[],CHEMBL698606,In vitro antiviral activity was evaluated in a plaque reduction assay against influenza B,F,BAO_0000190,BAO_0000218,organism-based format,CCCN(C)C(=O)[C@@H]1OC(C(=O)O)=C[C@H](N)[C@H]1NC(C)=O,CHEMBL1159157,Bioorg Med Chem Lett,1996.0,CHEMBL50254,CHEMBL50254,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,87339.0,=,1.0,1.0,=,IC50,ug.mL-1,16.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,16.0,CHEMBL613129
529,18528875.0,[],CHEMBL4194999,Antiviral activity against HIV1 virions derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL57,CHEMBL57,7.89,0.0,http://www.openphacts.org/units/Nanomolar,3076518.0,=,1.0,1.0,=,IC50,nM,13.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.013,CHEMBL378
530,11014434.0,[],CHEMBL2089834,Antiviral activity against HIV1 in human TZM-bl cells assessed as viral infectivity by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(CO)[C@H](O)CC[C@@]2(C)[C@@H]1C/C=C1/C(=O)OC[C@H]1OC(=O)c1ccc(Cl)nc1Cl,CHEMBL2086289,Eur J Med Chem,2012.0,CHEMBL2088492,CHEMBL2088492,6.08,0.0,http://www.openphacts.org/units/Nanomolar,1675629.0,=,1.0,1.0,=,IC50,nM,831.76,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.08,CHEMBL378
531,335854.0,[],CHEMBL653791,Inhibition of HIV-1 mediated cytotoxicity in CEM (human leukemia) cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C(C)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)[O-])C4C[C@H](OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])C[C@]4(C)[C@H]3CC[C@]12C.[Na+].[Na+].[Na+],CHEMBL1127706,J Med Chem,1994.0,CHEMBL3138004,CHEMBL3138466,4.25,0.0,http://www.openphacts.org/units/Nanomolar,327184.0,=,1.0,1.0,=,IC50,nM,56000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,56.0,CHEMBL378
532,16626943.0,[],CHEMBL3821894,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 48 hrs by SYBR Green based RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)Oc2cc(CSc3ccccn3)[nH]n2)cc1,CHEMBL3817822,Medchemcomm,2016.0,CHEMBL3818752,CHEMBL3818752,4.42,0.0,http://www.openphacts.org/units/Nanomolar,2783924.0,=,1.0,1.0,=,IC50,nM,38140.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,38.14,CHEMBL613497
533,2030610.0,[],CHEMBL886374,Inhibition of cJun translocation in IL-1-beta-stimulated A549 cells,B,BAO_0000190,BAO_0000219,cell-based format,CC1CCN(NC(=O)N2CCC(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)CC2)CC1,CHEMBL1139954,Bioorg Med Chem Lett,2007.0,CHEMBL245935,CHEMBL245935,6.09,0.0,http://www.openphacts.org/units/Nanomolar,674119.0,=,1.0,1.0,=,IC50,nM,807.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,nM,UO_0000065,807.0,CHEMBL4977
534,1402338.0,[],CHEMBL834487,In vitro inhibitory concentration value against HIV K103N and Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N2CCCCC2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175655,CHEMBL175655,,0.0,http://www.openphacts.org/units/Nanomolar,360430.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
535,2009806.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnn3)nccc12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL238115,CHEMBL238115,7.27,0.0,http://www.openphacts.org/units/Nanomolar,668107.0,=,1.0,1.0,=,IC50,nM,54.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,54.0,CHEMBL378
536,14653461.0,[],CHEMBL3267146,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)/C=C/c3cccc(Cl)c3)[C@H](O)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262981,CHEMBL3262981,4.22,0.0,http://www.openphacts.org/units/Nanomolar,2101863.0,=,1.0,1.0,=,IC50,nM,59800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,59.8,CHEMBL613497
537,10938467.0,[],CHEMBL2051603,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(/C=C/C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(O)C(C)=O)C2)cc(OC)c1OC,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046563,CHEMBL2046563,5.61,0.0,http://www.openphacts.org/units/Nanomolar,1651446.0,=,1.0,1.0,=,IC50,nM,2440.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.44,CHEMBL613497
538,12091427.0,[],CHEMBL2168515,Antiviral activity against R5 tropic HIV1 Ba-L infected human PBMC assessed as inhibition of viral replication by p-24 antigen specific ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC2CCOCC2)CC1,CHEMBL2163215,ACS Med Chem Lett,2012.0,CHEMBL2164215,CHEMBL2164215,7.65,0.0,http://www.openphacts.org/units/Nanomolar,1736639.0,=,1.0,1.0,=,IC50,nM,22.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,22.5,CHEMBL378
539,1437984.0,[],CHEMBL834618,Inhibitory activity against HIV-1 mutant strain 103N; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(-c2nccs2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL364116,CHEMBL364116,,0.0,http://www.openphacts.org/units/Nanomolar,371597.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
540,13861112.0,[],CHEMBL3101351,Antiviral activity against HIV1 NL4.3 infected in human TZM-bl cells expressing CXCR4-tropic incubated for 1 hr prior to infection measured after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C12C=CC(=O)C(OC(C)=O)=C1CC=C(C)C2CC=C(C)C,CHEMBL3098125,Bioorg Med Chem Lett,2014.0,CHEMBL3099063,CHEMBL3099063,4.43,0.0,http://www.openphacts.org/units/Nanomolar,1956066.0,=,1.0,1.0,=,IC50,nM,36700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,36.7,CHEMBL378
541,1438438.0,[],CHEMBL834618,Inhibitory activity against HIV-1 mutant strain 103N; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C/c2ccccc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL181761,CHEMBL181761,,0.0,http://www.openphacts.org/units/Nanomolar,371612.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
542,1402138.0,[],CHEMBL837463,In vitro inhibitory concentration against HIV F227C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCOC)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177275,CHEMBL177275,6.10,0.0,http://www.openphacts.org/units/Nanomolar,360374.0,=,1.0,1.0,=,IC50,nM,790.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.79,CHEMBL378
543,19262020.0,[],CHEMBL4404423,Antiviral activity against enfuvirtide-resistant HIV1 9489 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.15,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,710.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.71,CHEMBL378
544,3003256.0,[],CHEMBL1045518,Antiviral activity against HIV1 Ba-L infected in HOS cells assessed as inhibition of viral infection,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1[C@H]1C[C@H]2CC[C@@H](C1)N2CC[C@]1(c2ccccc2)CC[C@H](NC(=O)c2cc(NS(C)(=O)=O)c(Cl)cc2F)CC1,CHEMBL1155363,Bioorg Med Chem Lett,2009.0,CHEMBL577124,CHEMBL577124,5.83,0.0,http://www.openphacts.org/units/Nanomolar,857689.0,=,1.0,1.0,=,IC50,nM,1480.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.48,CHEMBL378
545,672195.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc(S(N)(=O)=O)cc1SSc1cc(S(N)(=O)=O)ccc1N,CHEMBL1129635,J Med Chem,1996.0,CHEMBL332657,CHEMBL332657,,0.0,,228536.0,>,1.0,0.0,>,IC50,,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,200.0,CHEMBL378
546,1471869.0,[],CHEMBL834619,Inhibitory activity against HIV-1 mutant strain 181C; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(N(C)C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188689,CHEMBL188689,,0.0,http://www.openphacts.org/units/Nanomolar,380839.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
547,18044708.0,[],CHEMBL4010417,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype A/G CRF02_AG clone 263,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.22,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.6,CHEMBL378
548,1184057.0,[],CHEMBL710376,Inhibitory activity against 100I strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)cc(C)c1Sc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72652,CHEMBL72652,6.76,0.0,http://www.openphacts.org/units/Nanomolar,127466.0,=,1.0,1.0,=,IC50,nM,174.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.174,CHEMBL378
549,22898293.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731090,Antiviral activity against LPV-resistant HIV1 infected in human MT4 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL729,CHEMBL729,,0.0,http://www.openphacts.org/units/Nanomolar,3554416.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
550,1207882.0,[],CHEMBL880061,Inhibitory activity against LAI strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(Br)c1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL310476,CHEMBL310476,9.15,0.0,http://www.openphacts.org/units/Nanomolar,127458.0,=,1.0,1.0,=,IC50,nM,0.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0007,CHEMBL378
551,407663.0,[],CHEMBL665058,Inhibitory concentration required against Cowpox virus in Vero cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2C[C@H](CO)OP(=O)(O)O,CHEMBL1147452,Bioorg Med Chem Lett,2004.0,CHEMBL326139,CHEMBL326139,,0.0,http://www.openphacts.org/units/Nanomolar,214245.0,>,1.0,1.0,>,IC50,nM,300000.0,CHEMBL612672,Cowpox virus,Cowpox virus,10243,IC50,uM,UO_0000065,300.0,CHEMBL612672
552,1156391.0,[],CHEMBL757806,Cytotoxicity against human peripheral blood mononuclear (PBM) cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(=O)n([C@H]2CS[C@H](CO)O2)cc1Cl,CHEMBL1126808,J Med Chem,1993.0,CHEMBL61181,CHEMBL61181,,0.0,http://www.openphacts.org/units/Nanomolar,100982.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
553,2362935.0,[],CHEMBL1026412,Antiviral activity against HIV1 LAI in human MT2 cells assessed as inhibition of virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)OC2COCCS(=O)(=O)CCOC2)cc1,CHEMBL1140100,J Med Chem,2008.0,CHEMBL449291,CHEMBL449291,,0.0,http://www.openphacts.org/units/Nanomolar,747074.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
554,267955.0,[],CHEMBL706841,Antiviral activity by observing cytopathic effect induced by HIV-1 strain IIIB in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)[C@@H](NCc1ccccc1)C(=O)N[C@H](C(=O)NCc1ccccc1)C(C)C,CHEMBL1127464,J Med Chem,1994.0,CHEMBL322027,CHEMBL322027,5.70,0.0,http://www.openphacts.org/units/Nanomolar,195861.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2000.0,CHEMBL378
555,1401639.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Cc2c(CC(C)C)c(C)[nH]c(=O)c2N(C)C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177978,CHEMBL177978,7.30,0.0,http://www.openphacts.org/units/Nanomolar,360341.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.05,CHEMBL378
556,2321158.0,[],CHEMBL1004248,Antiviral activity against HIV1 3B in human H9 cells after 4 days by p24 antigen ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@]1(C)O,CHEMBL1150942,J Nat Prod,1998.0,CHEMBL486986,CHEMBL486986,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,787819.0,=,1.0,1.0,=,IC50,ug.mL-1,23.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,23.3,CHEMBL378
557,18452387.0,[],CHEMBL4178857,Antiviral activity against Chikungunya virus MY/065/08/FN295485 infected in African green monkey Vero cells assessed as reduction in virus yield after 48 hrs by titration assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)c(O)c(O)c12,CHEMBL4177563,Bioorg Med Chem,2017.0,CHEMBL413552,CHEMBL413552,,0.0,http://www.openphacts.org/units/Nanomolar,3062357.0,=,1.0,1.0,=,IC50,nM,25300000.0,CHEMBL4296563,Chikungunya virus,Chikungunya virus,37124,IC50,mM,UO_0000065,25.3,CHEMBL4296563
558,390540.0,[],CHEMBL693754,Evaluated in vitro for the concentration required to produce 50% inhibition of replication of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CCC(C)C(N)C(=O)OC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)C[C@@H]1N=[N+]=[N-].O=C(O)C(F)(F)F,CHEMBL1124778,J Med Chem,1990.0,CHEMBL1743590,CHEMBL1789165,7.00,0.0,http://www.openphacts.org/units/Nanomolar,58327.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
559,3596622.0,[],CHEMBL1292012,Antiviral activity against HIV1 BaL in human PBL cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(CNC(=O)N(c2cccc(F)c2)C2CCN(CCC3(c4cccc(F)c4)CCN(C(=O)c4c(F)ccc(S(N)(=O)=O)c4F)CC3)CC2)cc1,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288672,CHEMBL1288672,8.70,0.0,http://www.openphacts.org/units/Nanomolar,973782.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
560,15666413.0,[],CHEMBL3602745,Antiviral activity against ENF-resistant HIV1 NL4-3 harboring gp41 N-terminal heptad repeat Q40H mutant infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL3600303,J Med Chem,2015.0,CHEMBL525076,CHEMBL525076,5.84,0.0,http://www.openphacts.org/units/Nanomolar,2492339.0,=,1.0,1.0,=,IC50,nM,1454.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1454.2,CHEMBL378
561,490793.0,[],CHEMBL752813,Inhibition to hepatitis C virus (HCV) NS3/NS4A serine protease,B,BAO_0000190,BAO_0000357,single protein format,CC[C@H](C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(F)F)C(=O)c1nnn[nH]1,CHEMBL1135212,Bioorg Med Chem Lett,2002.0,CHEMBL3348569,CHEMBL3348569,,0.0,http://www.openphacts.org/units/Nanomolar,317183.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,50.0,CHEMBL4620
562,5199520.0,[],CHEMBL1670946,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,OCCc1c(N2CCOCC2)nc2ccc(Cl)cc2c1-c1ccccc1Cl,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668649,CHEMBL1668649,,0.0,http://www.openphacts.org/units/Nanomolar,1328433.0,>,1.0,1.0,>,IC50,nM,1592000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1592.0,CHEMBL613497
563,19256959.0,[],CHEMBL4403203,Antiviral activity against HIV1 3B infected in human C8166 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(CC1(O)C(=O)Nc2ccc(Cl)cc21)c1ccccc1Cl,CHEMBL4402520,Eur J Med Chem,2019.0,CHEMBL4517119,CHEMBL4517119,6.12,0.0,http://www.openphacts.org/units/Nanomolar,3215098.0,=,1.0,1.0,=,IC50,nM,760.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.76,CHEMBL378
564,12663824.0,[],CHEMBL2330349,Antiviral activity against T20-sensitive Human immunodeficiency virus 1 NL4-3 harboring gp41 NHR D36G mutation infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL2321797,J Med Chem,2013.0,CHEMBL2326636,CHEMBL2326636,7.30,0.0,http://www.openphacts.org/units/Nanomolar,1853136.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,50.0,CHEMBL378
565,2238631.0,[],CHEMBL1000357,Antiviral activity against HIV 3B in human MT4 cells assessed as inhibition of viral replication by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CNc1nc(Nc2ccc(C#N)cc2)nc(Oc2ccc3ccccc3c2Cl)n1,CHEMBL1156684,Eur J Med Chem,2008.0,CHEMBL461992,CHEMBL461992,7.93,0.0,http://www.openphacts.org/units/Nanomolar,723383.0,=,1.0,1.0,=,IC50,nM,11.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0118,CHEMBL378
566,24823632.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '144.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '6.0'}]",CHEMBL5140688,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in intracellular core HBV DNA level incubated for 6 days by qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(c1)OCC(COc1cc3c(cc1OC)-c1cc(=O)c(C(=O)O)cn1C(C(C)C)C3)O2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5208401,CHEMBL5208401,7.28,0.0,http://www.openphacts.org/units/Nanomolar,3876730.0,=,1.0,1.0,=,IC50,nM,52.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.052000000000000005,CHEMBL613497
567,18239589.0,[],CHEMBL4052034,Antiviral activity against saquinavir-resistant HIV1 NL4-3 harboring protease L10I/N37D/G48V/I54V/L63P/G73C/I84V/L90M mutant infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL4049446,J Med Chem,2017.0,CHEMBL1323,CHEMBL1323,7.35,0.0,http://www.openphacts.org/units/Nanomolar,3026807.0,=,1.0,1.0,=,IC50,nM,45.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,45.0,CHEMBL378
568,10961197.0,[],CHEMBL2061269,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M4 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCNC=C1C(=O)Nc2ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)cc21,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057471,CHEMBL2057471,7.55,0.0,http://www.openphacts.org/units/Nanomolar,1655133.0,=,1.0,1.0,=,IC50,nM,28.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,28.0,CHEMBL378
569,2614792.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1S(=O)(=O)c1cccc(N)c1C#N,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL55308,CHEMBL55308,,0.0,http://www.openphacts.org/units/Nanomolar,731794.0,=,1.0,1.0,=,IC50,nM,599791.08,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,3.222,CHEMBL378
570,1403320.0,[],CHEMBL834757,Inhibitory concentration against 181C mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1Sc1cn(C)c(=O)c(Nc2ccc(C#N)cc2)n1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL366644,CHEMBL366644,,0.0,http://www.openphacts.org/units/Nanomolar,360622.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
571,2413651.0,[],CHEMBL987708,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)NCC(=O)O[C@@H](C[C@@H](C)C1=C2C[C@H](OC(=O)CNC(C)=O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)[C@@H](OC(=O)CNC(C)=O)C(C)(C)O,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL496689,CHEMBL496689,,0.0,http://www.openphacts.org/units/Nanomolar,810792.0,=,1.0,1.0,=,IC50,nM,290000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.29,CHEMBL613497
572,15568200.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(F)cc1)N1CCN(S(=O)(=O)Cc2ccccc2)CC1,CHEMBL1201862,,,CHEMBL3560082,CHEMBL3560082,7.54,0.0,http://www.openphacts.org/units/Nanomolar,2474390.0,=,7.0,1.0,=,IC50,nM,28.7,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.0287,CHEMBL3259470
573,2527526.0,[],CHEMBL1003778,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect albumin after 5 days by MTS method in presence of 40 mg/mL human serum albumin,F,BAO_0000190,BAO_0000218,organism-based format,Cn1c(=O)c(C(=O)N2CCOCC2)c(O)c2ncc(Cc3ccccc3)cc21,CHEMBL1138484,J Med Chem,2009.0,CHEMBL491520,CHEMBL491520,,0.0,,735622.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
574,1114975.0,[],CHEMBL697278,Compound was tested for binding of HIV-1 to CEM-ss cells; NI = No inhibition,F,BAO_0000190,BAO_0000218,organism-based format,C/C(=C(\CCO)SS/C(CCO)=C(/C)N(C=O)Cc1cnc(C)nc1N)N(C=O)Cc1cnc(C)nc1N,CHEMBL1130070,J Med Chem,1997.0,CHEMBL416503,CHEMBL416503,,0.0,http://www.openphacts.org/units/Nanomolar,103199.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,I50,uM,UO_0000065,,CHEMBL378
575,14596871.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CCOCn1c(Sc2ccccc2)c(C(C)C)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL38711,CHEMBL38711,5.10,0.0,http://www.openphacts.org/units/Nanomolar,2082391.0,=,1.0,1.0,=,IC50,nM,7990.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.99,CHEMBL378
576,24502938.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5053572,Antiviral activity against HIV1 NL4-3 Env-deficient pseudotype virus infected in human U87.CD4.CCR5.CXCR4 cells assessed by reduction in viral infection in early stage measured after 48 hrs by luciferase activity based single-round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C(=O)[C@@H](Cc1ccccc1)NC(=O)Cc1c[nH]c2c(N)cccc12)c1ccccc1,CHEMBL5053482,J Med Chem,2021.0,CHEMBL5081619,CHEMBL5081619,,0.0,,3836464.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
577,1420920.0,[],CHEMBL833369,Antiviral activity in an in vitro HIV replication assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C[C@@](C)(CCN1CCC2C(CCC(=O)N2Cc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1,CHEMBL1141903,Bioorg Med Chem Lett,2005.0,CHEMBL361585,CHEMBL361585,6.48,0.0,http://www.openphacts.org/units/Nanomolar,365517.0,=,1.0,1.0,=,IC50,nM,333.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,333.0,CHEMBL378
578,14658841.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1ccc(C(=O)N2CCN(C(=O)/C=C/c3ccc(OC)cc3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262890,CHEMBL3262890,7.75,0.0,http://www.openphacts.org/units/Nanomolar,2101732.0,=,1.0,1.0,=,IC50,nM,18.0,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,IC50,nM,UO_0000065,18.0,CHEMBL3259471
579,14999584.0,[],CHEMBL3364435,Antiviral activity against HIV1 harboring reverse transcriptase K103N/G190A double mutant infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CNc2nc(-c3ccccc3Cl)c(Cc3ccccc3)s2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3330438,CHEMBL3330438,5.38,0.0,http://www.openphacts.org/units/Nanomolar,2248824.0,=,1.0,1.0,=,IC50,nM,4180.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.18,CHEMBL378
580,3247270.0,[],CHEMBL1116114,Antiviral activity against HIV1 3B infected in human HOS cells expressing human CXCR4/CCR5/CD4 and HIV-LTR-luciferase,F,BAO_0000190,BAO_0000218,organism-based format,CN(Cc1nc2ccccc2n1C[C@H]1CCCN(Cc2cccnc2)C1)[C@H]1CCCc2cccnc21,CHEMBL1156326,Bioorg Med Chem Lett,2010.0,CHEMBL1089170,CHEMBL1089170,7.48,0.0,http://www.openphacts.org/units/Nanomolar,901914.0,=,1.0,1.0,=,IC50,nM,33.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,33.0,CHEMBL378
581,18707045.0,[],CHEMBL4256227,Antiviral activity against HIV1 92HT599 infected in human MT2 cells assessed as reduction in p24 production in absence of serum by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C1=C2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)[C@H]6C[C@@H](C(=O)O)C6(C)C)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(c2nnc(-c3ccc(Cl)cc3)o2)CC1=O,CHEMBL4251729,ACS Med Chem Lett,2018.0,CHEMBL4282250,CHEMBL4282250,,0.0,http://www.openphacts.org/units/Nanomolar,3106951.0,<,1.0,1.0,<,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
582,23274459.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](OCCCCCO[C@@H]5CC[C@@]6(C)[C@@H](C5)C[C@H](O)[C@@H]5[C@@H]6CC[C@]6(C)[C@@H]([C@H](C)CCC(=O)NCCS(=O)(=O)O)CC[C@@H]56)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4878495,CHEMBL4878495,6.03,0.0,http://www.openphacts.org/units/Nanomolar,3621259.0,=,1.0,1.0,=,IC50,nM,935.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,935.0,CHEMBL613497
583,24788932.0,[],CHEMBL5131874,Antiviral activity against DENV,F,BAO_0000190,BAO_0000218,organism-based format,N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N,CHEMBL5131375,J Med Chem,2022.0,CHEMBL34704,CHEMBL34704,4.85,0.0,http://www.openphacts.org/units/Nanomolar,3869453.0,=,1.0,1.0,=,IC50,nM,14200.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,14.2,CHEMBL613757
584,3453348.0,[],CHEMBL1247787,Antiviral activity against HIV1 isolate 05-121786 assessed as inhibition of viral replication after 7 days by scintillation counting,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(c2cccc3nc(CN(C)[C@H]4CCCc5cccnc54)c(CO)n23)CC1,CHEMBL1240366,Antimicrob Agents Chemother,2010.0,CHEMBL1242210,CHEMBL1242210,9.00,0.0,http://www.openphacts.org/units/Nanomolar,953332.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
585,3358080.0,[],CHEMBL1175710,Antiviral activity against HIV1 expressing reverse transcriptase K103N/Y181C double mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccccc3)CC2)ncc1Br,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1170190,CHEMBL1170190,,0.0,http://www.openphacts.org/units/Nanomolar,922873.0,>,1.0,1.0,>,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,100.0,CHEMBL378
586,171007.0,[],CHEMBL847543,Inhibitory activity against vaccinia virus,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1/C=C/I,CHEMBL1136729,J Med Chem,2003.0,CHEMBL223205,CHEMBL223205,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,583.0,=,1.0,1.0,=,IC50,ug.mL-1,2.3,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,ug ml-1,UO_0000274,2.3,CHEMBL613493
587,19262033.0,[],CHEMBL4404430,Antiviral activity against multidrug resistant HIV1 12243 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,5.35,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,4500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.5,CHEMBL378
588,2997420.0,[],CHEMBL1046975,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)c2ccc(=O)n(-c3ccccc3OC)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL572186,CHEMBL572186,4.31,0.0,http://www.openphacts.org/units/Nanomolar,856690.0,=,1.0,1.0,=,IC50,nM,49000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,49.0,CHEMBL613497
589,16498295.0,[],CHEMBL3778316,Antiviral activity against HIV1 NL4-3 infected in human 293T cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2csc(N3N=C(C)/C(=N/Nc4ccc5c(S(=O)(=O)O)cc(S(=O)(=O)O)cc5c4)C3=O)n2)cc1,CHEMBL3774382,Bioorg Med Chem,2016.0,CHEMBL3775274,CHEMBL3775274,5.16,0.0,http://www.openphacts.org/units/Nanomolar,2762403.0,=,1.0,1.0,=,IC50,nM,7000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.0,CHEMBL378
590,2665977.0,[],CHEMBL1061338,Inhibition of TPA-induced AP1 transfected in HEK293 cells assessed as inhibition of beta-lactamase reporter activity treated 1 hr before TPA stimulation measured after 18 hrs by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)=CC(=O)O[C@@H]1[C@H]2C(C)=C[C@H](O)[C@@H](O)[C@]2(C)[C@H]2[C@]3(O)OC[C@@]24[C@@H]1OC(=O)C[C@H]4[C@@H](C)[C@H]3O,CHEMBL1152334,J Nat Prod,2009.0,CHEMBL564009,CHEMBL564009,7.15,0.0,http://www.openphacts.org/units/Nanomolar,818230.0,=,1.0,1.0,=,IC50,nM,71.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.071,CHEMBL4977
591,3315838.0,[],CHEMBL1119774,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,CCO[C@H]1CC[C@H](CN2C[C@H](c3ccccn3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)cc(C#N)nc5C)CC4)CC3)C2=O)CC1,CHEMBL1155507,Bioorg Med Chem Lett,2010.0,CHEMBL1085722,CHEMBL1085722,8.05,0.0,http://www.openphacts.org/units/Nanomolar,915819.0,=,1.0,1.0,=,IC50,nM,9.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,9.0,CHEMBL378
592,3292024.0,[],CHEMBL1108227,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc[n+]([O-])c(C)c1C(=O)N1C[C@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@H]2C1,CHEMBL1157775,Bioorg Med Chem Lett,2010.0,CHEMBL1097170,CHEMBL1097170,7.72,0.0,http://www.openphacts.org/units/Nanomolar,910945.0,=,1.0,1.0,=,IC50,nM,19.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.0,CHEMBL378
593,1671919.0,[],CHEMBL870624,Antiviral activity against HIV1 K103N mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(OC)cc(C(=O)c2cc(Cl)ccc2OCC(=O)Nc2ccc(S(N)(=O)=O)cc2C)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL427200,CHEMBL427200,6.43,0.0,http://www.openphacts.org/units/Nanomolar,411927.0,=,1.0,1.0,=,IC50,nM,370.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,370.0,CHEMBL378
594,1438426.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C\Cc2ccccc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL362584,CHEMBL362584,5.80,0.0,http://www.openphacts.org/units/Nanomolar,371603.0,=,1.0,1.0,=,IC50,nM,1580.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.58,CHEMBL378
595,1037835.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1cccc(C2C(C)N=CN2Nc2cccc(Cl)c2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39815,CHEMBL39815,,0.0,http://www.openphacts.org/units/Nanomolar,62338.0,>,1.0,1.0,>,IC50,nM,33150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,33.15,CHEMBL378
596,18775471.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC1Cc2ccccc2-c2cc(=O)c(C(=O)O)cn21,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4286405,CHEMBL4286405,4.28,0.0,http://www.openphacts.org/units/Nanomolar,3119629.0,=,1.0,1.0,=,IC50,nM,52000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,52.0,CHEMBL613497
597,473470.0,[],CHEMBL756134,Cytotoxic effect in human peripheral blood monocyte cells(PBMC),F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2cc(Nc3ccccc3C(=O)[O-])ccc2s1.[Na+],CHEMBL1125493,J Med Chem,1992.0,CHEMBL92751,CHEMBL1205392,4.05,0.0,http://www.openphacts.org/units/Nanomolar,170446.0,=,1.0,1.0,=,IC50,nM,89600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,89.6,CHEMBL378
598,18479566.0,[],CHEMBL4184680,Antiviral activity against Zika virus infected in human A549 cells preincubated for 5 hrs followed by compound wash measured after 48 hrs by viral plague-forming assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCn1c(=O)[nH]c2nc(-c3ccc(S(=O)(=O)N4CCN(c5ccc(Cl)cc5)CC4)cc3)[nH]c2c1=O,CHEMBL4184095,Bioorg Med Chem Lett,2018.0,CHEMBL483688,CHEMBL483688,7.36,0.0,http://www.openphacts.org/units/Nanomolar,3066997.0,=,1.0,1.0,=,IC50,nM,43.8,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,nM,UO_0000065,43.8,CHEMBL4296612
599,5306758.0,[],CHEMBL1696827,Antiviral activity against X4 tropic HIV1 3B infected in human TZM-b1 cells after 2 hrs by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1687731,Antimicrob Agents Chemother,2009.0,CHEMBL70663,CHEMBL70663,9.28,0.0,http://www.openphacts.org/units/Nanomolar,1337341.0,=,1.0,1.0,=,IC50,nM,0.53,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.53,CHEMBL378
600,828361.0,[],CHEMBL686566,Anti-HIV activity in H9 lymphocytes.,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(c3oc(=O)ccc13)[C@@H](OC(=O)C13CCC(C)(C(=O)O1)C3(C)C)[C@@H](OC(=O)C13CCC(C)(C(=O)O1)C3(C)C)C(C)(C)O2,CHEMBL1132174,J Med Chem,1999.0,CHEMBL313674,CHEMBL313674,,0.0,http://www.openphacts.org/units/Nanomolar,163816.0,>,1.0,1.0,>,IC50,nM,153000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,153.0,CHEMBL378
601,1982297.0,[],CHEMBL899338,Antiviral activity against HBV transfected Hep G2.2.15 cells assessed as inhibition of surface antigen HBsAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C[C@H]2c3cc(O)c(OC)cc3CCN2C)cc1O,CHEMBL1149710,Bioorg Med Chem Lett,2007.0,CHEMBL235212,CHEMBL235212,,0.0,http://www.openphacts.org/units/Nanomolar,661661.0,=,1.0,1.0,=,IC50,nM,2143000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.143,CHEMBL613497
602,926527.0,[],CHEMBL683817,Compound was evaluated for the antiviral activity against human immunodeficiency virus-1(HIV-1),F,BAO_0000190,BAO_0000218,organism-based format,CCc1cn([C@H]2C[C@H](O)[C@@H](CO)S2)c(=O)[nH]c1=O,CHEMBL1129021,Bioorg Med Chem Lett,1996.0,CHEMBL367028,CHEMBL367028,,0.0,http://www.openphacts.org/units/Nanomolar,349475.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
603,1052585.0,[],CHEMBL692262,Compound was tested for inhibition of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2C=C=CCO,CHEMBL1126199,J Med Chem,1992.0,CHEMBL313478,CHEMBL313478,4.85,0.0,http://www.openphacts.org/units/Nanomolar,252796.0,=,1.0,1.0,=,IC50,nM,14000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,14.0,CHEMBL378
604,1471591.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1ccc(N(C)C)cc1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL187513,CHEMBL187513,5.90,0.0,http://www.openphacts.org/units/Nanomolar,381002.0,=,1.0,1.0,=,IC50,nM,1250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.25,CHEMBL378
605,18452450.0,[],CHEMBL4178843,Antiviral activity against Chikungunya virus isolate DRDE-06 infected in African green monkey Vero cells by neutral red dye uptake assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2,CHEMBL4177563,Bioorg Med Chem,2017.0,CHEMBL866,CHEMBL866,7.00,0.0,http://www.openphacts.org/units/Nanomolar,3062348.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL4296563,Chikungunya virus,Chikungunya virus,37124,IC50,uM,UO_0000065,0.1,CHEMBL4296563
606,19262047.0,[],CHEMBL4404437,Antiviral activity against multiple-PI-resistant HIV1 11804 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.29,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,510.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.51,CHEMBL378
607,1982277.0,[],CHEMBL899339,Antiviral activity against HBV transfected Hep G2.2.15 cells assessed as inhibition of e antigen HBsAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)C1=CC(=O)[C@]2([C@@H](Cl)C[C@@]34C(OC)=C(OC)C(=O)C[C@@]23CCN4C)[C@H]1O,CHEMBL1149710,Bioorg Med Chem Lett,2007.0,CHEMBL234980,CHEMBL234980,,0.0,http://www.openphacts.org/units/Nanomolar,661652.0,>,1.0,1.0,>,IC50,nM,2870000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.87,CHEMBL613497
608,1043697.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,SC1=NC2CCCCC2N1Nc1cccc(Cl)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL288161,CHEMBL288161,,0.0,http://www.openphacts.org/units/Nanomolar,62332.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
609,5126309.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,CCN1C(=O)/C(=C\NCCOC)C(=O)Nc2cc(Cl)ccc21,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642305,CHEMBL1642305,6.33,0.0,http://www.openphacts.org/units/Nanomolar,1317595.0,=,1.0,1.0,=,IC50,nM,470.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.47,CHEMBL378
610,1066152.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2c(C)nc(S)n2Nc2cccc(Cl)c2)cc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL290020,CHEMBL290020,,0.0,http://www.openphacts.org/units/Nanomolar,62367.0,>,1.0,1.0,>,IC50,nM,38690.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,38.69,CHEMBL378
611,12204002.0,[],CHEMBL2211838,Antiviral activity against HIV-1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C2C3Cc4cc(OC)c(OC)cc4C3=NN2C(=O)Nc2c(C)cccc2C)cc1,CHEMBL2203270,Bioorg Med Chem Lett,2012.0,CHEMBL1824324,CHEMBL1824324,,0.0,http://www.openphacts.org/units/Nanomolar,1758527.0,>,1.0,1.0,>,IC50,nM,168540.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,168.54,CHEMBL378
612,863181.0,[],CHEMBL713546,Compound potency to achieve protection of MT-4 cells from HIV-1 cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(N/C(S)=N/C(=N)Cc2c(F)cccc2F)cc1,CHEMBL1134808,Bioorg Med Chem Lett,2001.0,CHEMBL308638,CHEMBL308638,8.22,0.0,http://www.openphacts.org/units/Nanomolar,126228.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
613,625362.0,[],CHEMBL710534,Inhibitory activity against 188L strain of HIV-1 in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Cc3ccc(Cl)cc3Cl)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL72343,CHEMBL72343,5.63,0.0,http://www.openphacts.org/units/Nanomolar,126945.0,=,1.0,1.0,=,IC50,nM,2320.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.32,CHEMBL378
614,3188303.0,[],CHEMBL1107773,Antiviral activity against HIV1 NLBal infected JC53BL cells assessed as inhibition of replication by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2,CHEMBL1155421,Bioorg Med Chem Lett,2010.0,CHEMBL1078231,CHEMBL1078231,8.22,0.0,http://www.openphacts.org/units/Nanomolar,896401.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.0,CHEMBL378
615,2930371.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3ccnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL584160,CHEMBL584160,8.70,0.0,http://www.openphacts.org/units/Nanomolar,848339.0,=,1.0,1.0,=,IC50,nM,1.99,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.99,CHEMBL378
616,3267366.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1Cn2c(=O)[nH]c3cccc(c32)CN1Cc1ccco1,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL1099292,CHEMBL1099292,,0.0,http://www.openphacts.org/units/Nanomolar,906524.0,=,1.0,1.0,=,IC50,nM,107151.93,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,3.97,CHEMBL378
617,626670.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1Cc1nc(N)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL74410,CHEMBL74410,6.65,0.0,http://www.openphacts.org/units/Nanomolar,126943.0,=,1.0,1.0,=,IC50,nM,225.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.225,CHEMBL378
618,2032182.0,[],CHEMBL886779,Inhibition of cytoplasmic HBV DNA synthesis in HepG2.2.15 cells after 8 days,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)S(=O)(=O)n1c(N)nc2ccc(NC(=O)c3ccc(F)cc3)cc21,CHEMBL1139980,Eur J Med Chem,2007.0,CHEMBL249976,CHEMBL249976,5.92,0.0,http://www.openphacts.org/units/Nanomolar,674616.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.2,CHEMBL613497
619,1954083.0,[],CHEMBL890376,Antiviral activity against HIV1 LAI assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(Oc2cc(C)cc(C)c2)cc(=O)[nH]c1C,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL231902,CHEMBL231902,6.40,0.0,http://www.openphacts.org/units/Nanomolar,647191.0,=,1.0,1.0,=,IC50,nM,398.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,398.0,CHEMBL378
620,5248974.0,[],CHEMBL1685193,Antiviral activity against X4 tropic HIV1 NL4.3 infected in CD4 and CXCR4 expressing human MT4 cells assessed as inhibition of viral cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)nc(CN(CCCCN)C2CCCc3cccnc32)c1,CHEMBL1681661,Bioorg Med Chem Lett,2011.0,CHEMBL1682858,CHEMBL1682858,7.77,0.0,http://www.openphacts.org/units/Nanomolar,1333980.0,=,1.0,1.0,=,IC50,nM,17.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,17.0,CHEMBL378
621,10866949.0,[],CHEMBL2027390,Antiviral activity against luciferase tagged VSV envelope pseudotyped HIV1 infected in human MT2 cells dosed simultaneously with virus infection measured 48 hrs post-infection by recombinant virus assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)C=C2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5[C@H](O)C[C@@]4(C)[C@]3(C)CC[C@@]2(C)CC1,CHEMBL2021887,Eur J Med Chem,2012.0,CHEMBL2023099,CHEMBL2023099,5.36,0.0,http://www.openphacts.org/units/Nanomolar,1638539.0,=,1.0,1.0,=,IC50,nM,4322.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.322,CHEMBL378
622,10961119.0,[],CHEMBL2061266,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M9 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC=C1C(=O)Nc2ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)cc21,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057464,CHEMBL2057464,7.30,0.0,http://www.openphacts.org/units/Nanomolar,1655126.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,50.0,CHEMBL378
623,834993.0,[],CHEMBL713546,Compound potency to achieve protection of MT-4 cells from HIV-1 cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccccc1NC(=S)NC(=N)Cc1c(Cl)cccc1Cl,CHEMBL1134808,Bioorg Med Chem Lett,2001.0,CHEMBL72280,CHEMBL72280,,0.0,http://www.openphacts.org/units/Nanomolar,126233.0,=,1.0,1.0,=,IC50,nM,631000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,631.0,CHEMBL378
624,5306728.0,[],CHEMBL1696835,"Antiviral activity against HIV1 A17 harboring reverse transcriptase K103N, Y181C mutant infected in human TZM-b1 cells after 2 hrs by luciferase assays",F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1687731,Antimicrob Agents Chemother,2009.0,CHEMBL70663,CHEMBL70663,8.08,0.0,http://www.openphacts.org/units/Nanomolar,1337341.0,=,1.0,1.0,=,IC50,nM,8.34,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.34,CHEMBL378
625,5189158.0,[],CHEMBL1658799,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,N#CCC(=O)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652503,CHEMBL1652503,4.12,0.0,http://www.openphacts.org/units/Nanomolar,1326878.0,=,1.0,1.0,=,IC50,nM,75000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.075,CHEMBL613497
626,2927201.0,[],CHEMBL1041197,Antiviral activity against Dengue virus,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CCCN(CC)C(=O)c1ccc(O)cc1)C(=O)c1ccc(O)cc1,CHEMBL1155220,J Med Chem,2009.0,CHEMBL574190,CHEMBL574190,,0.0,http://www.openphacts.org/units/Nanomolar,851378.0,=,1.0,1.0,=,IC50,nM,2000000.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,mM,UO_0000065,2.0,CHEMBL613757
627,2362908.0,[],CHEMBL1026419,Antiviral activity against multidrug-resistant HIV1/A with protease mutation in phytohemagglutininin-activated PBMC assessed as inhibition of p24G protein production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL1140100,J Med Chem,2008.0,CHEMBL1323,CHEMBL1323,8.52,0.0,http://www.openphacts.org/units/Nanomolar,747151.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.0,CHEMBL378
628,606616.0,[],CHEMBL710381,Inhibitory activity against 103N strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(Cc3c(Cl)cccc3Cl)nc(NO)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL71683,CHEMBL71683,7.89,0.0,http://www.openphacts.org/units/Nanomolar,126901.0,=,1.0,1.0,=,IC50,nM,13.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.013,CHEMBL378
629,2601938.0,[],CHEMBL1034012,Antiviral activity against influenza virus,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc2c(C(=O)c3ccccc3)c(O)n(O)c2c1)NC1CCCCC1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL277284,CHEMBL277284,4.30,0.0,http://www.openphacts.org/units/Nanomolar,807025.0,=,1.0,1.0,=,IC50,nM,50000.0,CHEMBL613128,unidentified influenza virus,unidentified influenza virus,11309,IC50,uM,UO_0000065,50.0,CHEMBL613128
630,1306215.0,[],CHEMBL698607,Inhibitory concentration of compound against formation of Influenza A virus (HK) plaque in plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(C(c2ccccc2)N2CCN(c3ncnc4c3cnn4-c3ccccc3)CC2)cc1,CHEMBL1146731,Bioorg Med Chem Lett,2004.0,CHEMBL84696,CHEMBL84696,,0.0,http://www.openphacts.org/units/Nanomolar,151635.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,25.0,CHEMBL613129
631,12642495.0,[],CHEMBL2317525,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)N1CCN2C(=O)c3c(O)c(=O)c(C(=O)NCc4ccc(F)cc4)cn3CC21,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314689,CHEMBL2314689,8.64,0.0,http://www.openphacts.org/units/Nanomolar,1844821.0,=,1.0,1.0,=,IC50,nM,2.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.3,CHEMBL378
632,1401913.0,[],CHEMBL837466,In vitro inhibitory concentration against HIV K101E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)Nc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL435522,CHEMBL435522,,0.0,http://www.openphacts.org/units/Nanomolar,360379.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
633,2413632.0,[],CHEMBL987708,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/C(=O)O[C@@H](C[C@@H](C)C1=C2C[C@H](OC(=O)/C=C/C)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)[C@@H](OC(=O)/C=C/C)C(C)(C)O,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL442893,CHEMBL442893,,0.0,http://www.openphacts.org/units/Nanomolar,810681.0,>,1.0,1.0,>,IC50,nM,850000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.85,CHEMBL613497
634,19261738.0,[],CHEMBL4404352,Antiviral activity against HIV1 HXB2 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(N)[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cn2)[nH]1)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4528064,CHEMBL4528064,5.77,0.0,http://www.openphacts.org/units/Nanomolar,3216274.0,=,1.0,1.0,=,IC50,nM,1700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.7,CHEMBL378
635,2930243.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL233664,CHEMBL233664,8.50,0.0,http://www.openphacts.org/units/Nanomolar,848384.0,=,1.0,1.0,=,IC50,nM,3.16,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.16,CHEMBL378
636,18320107.0,[],CHEMBL4134181,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA level incubated for 3 days followed by medium replacement measured after 3 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C2CCCN2C(c2nccs2)=NC1c1ccncc1Cl,CHEMBL4130455,ACS Med Chem Lett,2017.0,CHEMBL4176249,CHEMBL4176249,,0.0,http://www.openphacts.org/units/Nanomolar,3041702.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.0,CHEMBL613497
637,18754867.0,[],CHEMBL4265061,Antiviral activity against HIV1 cYTA48P infected in PM1/CCR5 cells by single round assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(NC(=O)c2cc3cc(Cl)ccc3[nH]2)CC(C)(C)N1,CHEMBL4261625,Bioorg Med Chem,2018.0,CHEMBL4293799,CHEMBL4293799,5.44,0.0,http://www.openphacts.org/units/Nanomolar,3116213.0,=,1.0,1.0,=,IC50,nM,3650.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.65,CHEMBL378
638,1671939.0,[],CHEMBL865135,Antiviral activity against HIV1 V106A mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(Br)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL203313,CHEMBL203313,7.89,0.0,http://www.openphacts.org/units/Nanomolar,411930.0,=,1.0,1.0,=,IC50,nM,13.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,13.0,CHEMBL378
639,15139709.0,[],CHEMBL3384587,Antiviral activity against Dengue virus assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL3352310,Eur J Med Chem,2014.0,CHEMBL269277,CHEMBL269277,5.77,0.0,http://www.openphacts.org/units/Nanomolar,2241354.0,=,1.0,1.0,=,IC50,nM,1700.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,1.7,CHEMBL613757
640,1954084.0,[],CHEMBL890376,Antiviral activity against HIV1 LAI assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(/C=C/CO)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL388864,CHEMBL388864,7.20,0.0,http://www.openphacts.org/units/Nanomolar,647190.0,=,1.0,1.0,=,IC50,nM,63.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,63.1,CHEMBL378
641,11014426.0,[],CHEMBL2089834,Antiviral activity against HIV1 in human TZM-bl cells assessed as viral infectivity by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(CO)[C@H](O)CC[C@@]2(C)[C@@H]1C/C=C1/C(=O)OC[C@H]1O,CHEMBL2086289,Eur J Med Chem,2012.0,CHEMBL186141,CHEMBL186141,6.23,0.0,http://www.openphacts.org/units/Nanomolar,1675621.0,=,1.0,1.0,=,IC50,nM,588.84,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.23,CHEMBL378
642,197032.0,[],CHEMBL691754,Concentration required to inhibit HIV replication by 50%,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1,CHEMBL1126179,J Med Chem,1992.0,CHEMBL1460,CHEMBL1460,5.89,0.0,http://www.openphacts.org/units/Nanomolar,137297.0,=,1.0,1.0,=,IC50,nM,1280.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.28,CHEMBL378
643,508986.0,[],CHEMBL694654,Inhibitory concentration against HIV-1 IIIB strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC=O)c1Cc1cc(C)cc(C)c1,CHEMBL1133473,J Med Chem,2000.0,CHEMBL338936,CHEMBL338936,7.58,0.0,http://www.openphacts.org/units/Nanomolar,245543.0,=,1.0,1.0,=,IC50,nM,26.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,26.0,CHEMBL378
644,12687122.0,[],CHEMBL2344305,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral e antigen production,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@H]1C[C@H]2[C@]3(C)C(=O)C[C@]4(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](OC(C)=O)C[C@@]4(C)[C@@H]3C[C@@H](O)[C@@]2(OC(=O)c2cccc(Cl)c2)C(C)(C)[C@@H]1OC(C)=O,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332413,CHEMBL2332413,,0.0,http://www.openphacts.org/units/Nanomolar,1866107.0,=,1.0,1.0,=,IC50,nM,327200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,327.2,CHEMBL613497
645,13475593.0,[],CHEMBL2439260,Antiviral activity against Human immunodeficiency virus 1 clade O isolate I-2478B infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL1201187,CHEMBL1201187,8.19,0.0,http://www.openphacts.org/units/Nanomolar,1924220.0,=,1.0,1.0,=,IC50,nM,6.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.4,CHEMBL378
646,10865208.0,[],CHEMBL2025516,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@]3(O)[C@@H]2C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]2(C)[C@]3(O)CC[C@@]2(OC(=O)COC)C(C)=O)C1,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024041,CHEMBL2024041,,0.0,http://www.openphacts.org/units/Nanomolar,1639763.0,=,1.0,1.0,=,IC50,nM,331070.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,331.07,CHEMBL613497
647,1834527.0,[],CHEMBL909292,Antiviral activity against HIV1 isolate 5512 with V321 and M46L mutation in CBMCs,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,CHEMBL1142192,Antimicrob Agents Chemother,2007.0,CHEMBL115,CHEMBL115,7.35,0.0,http://www.openphacts.org/units/Nanomolar,625900.0,=,1.0,1.0,=,IC50,nM,45.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.045,CHEMBL378
648,3188298.0,[],CHEMBL1107773,Antiviral activity against HIV1 NLBal infected JC53BL cells assessed as inhibition of replication by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)ccnc4C)C[C@@H]3C2)C[C@@H]1C,CHEMBL1155421,Bioorg Med Chem Lett,2010.0,CHEMBL1077351,CHEMBL1077351,,0.0,http://www.openphacts.org/units/Nanomolar,896396.0,>,1.0,1.0,>,IC50,nM,625.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,625.0,CHEMBL378
649,1470303.0,[],CHEMBL833082,Inhibitory activity against HIV-1 mutant strain 190S,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL185715,CHEMBL185715,7.40,0.0,http://www.openphacts.org/units/Nanomolar,380721.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
650,10961145.0,[],CHEMBL2061266,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M9 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)CCN2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057724,CHEMBL2057724,6.72,0.0,http://www.openphacts.org/units/Nanomolar,1655447.0,=,1.0,1.0,=,IC50,nM,190.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,190.0,CHEMBL378
651,18940415.0,[],CHEMBL4328848,Antiviral activity against HIV-1 3B infected in human MAGI-CXCR4 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1ccc(Cn2ccc3ccc(-c4ccc5ccn(Cc6cccc(C(=O)O)c6)c5c4)cc32)c(OC)c1,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4524345,CHEMBL4524345,5.51,0.0,http://www.openphacts.org/units/Nanomolar,3159816.0,=,1.0,1.0,=,IC50,nM,3100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.1,CHEMBL378
652,2276093.0,[],CHEMBL1030793,Inhibition of HIV1 replication in human 293T cells preincubated 15 mins prior to infection measured after 48 hrs postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)CC1C(=O)Nc2ccc(F)cc2N1S(=O)(=O)c1ccsc1C(=O)OC,CHEMBL1153359,Bioorg Med Chem,2009.0,CHEMBL494533,CHEMBL494533,,0.0,http://www.openphacts.org/units/Nanomolar,754448.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
653,2681629.0,[],CHEMBL1051716,Antiviral activity against HIV1 ZM55F.PB28a infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL525076,CHEMBL525076,6.15,0.0,http://www.openphacts.org/units/Nanomolar,823863.0,=,1.0,1.0,=,IC50,nM,710.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.71,CHEMBL378
654,15165595.0,[],CHEMBL3404732,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBsAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(OC(=O)/C=C/c2ccc(F)c(F)c2)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402776,CHEMBL3402776,,0.0,http://www.openphacts.org/units/Nanomolar,2284130.0,=,1.0,1.0,=,IC50,nM,610100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,610.1,CHEMBL613497
655,2373415.0,[],CHEMBL1023811,Antiviral activity against HIV1 Ba-L in human HOS cells by MTS assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1[C@H]1C[C@H]2CC[C@@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)C(C)(C)C)CC1,CHEMBL1140149,J Med Chem,2008.0,CHEMBL3084499,CHEMBL3084499,7.84,0.0,http://www.openphacts.org/units/Nanomolar,746105.0,=,1.0,1.0,=,IC50,nM,14.45,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.84,CHEMBL378
656,24868587.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5152416,Antiviral activity against HBV infected in human HepG2-hNTCP cells assessed as reduction in intracellular HBV RNA incubated for 16 hrs followed by compound washout and measured after 6 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C1N=C(O)S/C1=C\c1ccc(OCc2ccc(-c3ccccc3)cc2)cc1,CHEMBL5150016,J Med Chem,2022.0,CHEMBL3685364,CHEMBL3685364,5.42,0.0,http://www.openphacts.org/units/Nanomolar,3886068.0,=,1.0,1.0,=,IC50,nM,3800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,3.8,CHEMBL613497
657,2602208.0,[],CHEMBL1034002,Antiviral activity against Human parainfluenza virus 3,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1NS(=O)(=O)C(Cl)Cl,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL473893,CHEMBL473893,5.70,0.0,http://www.openphacts.org/units/Nanomolar,807950.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL613126,Human parainfluenza virus 3,Human parainfluenza virus 3,11216,IC50,uM,UO_0000065,2.0,CHEMBL613126
658,15568205.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(Br)cc1)N1CCN(Cc2ccccc2F)CC1,CHEMBL1201862,,,CHEMBL3560274,CHEMBL3560274,7.54,0.0,http://www.openphacts.org/units/Nanomolar,2474709.0,=,7.0,1.0,=,IC50,nM,28.7,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.0287,CHEMBL3259470
659,793899.0,[],CHEMBL736575,Compound was tested for its antagonistic activity against Moloney leukemia virus (MoLV) replication,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCC[S+](C)(=N)[O-],CHEMBL1126537,Bioorg Med Chem Lett,1993.0,CHEMBL1627198,CHEMBL1627198,5.30,0.0,http://www.openphacts.org/units/Nanomolar,78984.0,=,1.0,1.0,=,IC50,nM,5000.0,CHEMBL613500,Moloney murine leukemia virus,Moloney murine leukemia virus,11801,IC50,uM,UO_0000065,5.0,CHEMBL613500
660,2929701.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COCCSCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567837,CHEMBL567837,8.10,0.0,http://www.openphacts.org/units/Nanomolar,852983.0,=,1.0,1.0,=,IC50,nM,7.94,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.94,CHEMBL378
661,1185425.0,[],CHEMBL710530,Inhibitory activity against 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL57,CHEMBL57,5.20,0.0,http://www.openphacts.org/units/Nanomolar,127448.0,=,1.0,1.0,=,IC50,nM,6310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.31,CHEMBL378
662,1750642.0,[],CHEMBL864975,Antiviral activity against HIV1 LAI isolate in human PHA-PBMC cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)O[C@@H]1C[C@@H]2CCO[C@@H]2C1)S(=O)(=O)c1ccc(CO)cc1,CHEMBL1146019,J Med Chem,2006.0,CHEMBL377329,CHEMBL377329,8.74,0.0,http://www.openphacts.org/units/Nanomolar,539996.0,=,1.0,1.0,=,IC50,nM,1.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.8,CHEMBL378
663,467824.0,[],CHEMBL756136,Cytotoxic effect in human peripheral blood monocyte cells (PBMC) Value in the parentheses is %inhibition at 100 uM,F,BAO_0000190,BAO_0000218,organism-based format,O=C([O-])CSc1ccc2nc3ccccc3c(O)c2c1.[Na+],CHEMBL1125493,J Med Chem,1992.0,CHEMBL94060,CHEMBL1205403,,0.0,http://www.openphacts.org/units/Nanomolar,170454.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
664,5229809.0,[],CHEMBL1677603,Antiviral activity against Human immunodeficiency virus 1 3B infected in AA5 cells infected with 1.56 uL of virus stock assessed as expression of p24 antigen after 6 days postinfection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,>,1.0,1.0,>,IC50,nM,53100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,53.1,CHEMBL378
665,560087.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)NS(=O)(=O)c1ccc(NC(=O)c2ccccc2SC(=O)c2ccccc2)cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL368730,CHEMBL368730,4.34,0.0,http://www.openphacts.org/units/Nanomolar,334019.0,=,1.0,1.0,=,IC50,nM,45700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,45.7,CHEMBL378
666,889312.0,[],CHEMBL653610,Inhibitory activity tested against the HIV-1 in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N[C@@H](CC(=O)O)C(=O)O)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL273980,CHEMBL273980,4.75,0.0,http://www.openphacts.org/units/Nanomolar,9076.0,=,1.0,1.0,=,IC50,nM,18000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,18000.0,CHEMBL378
667,10861966.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCC(N)=O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024637,CHEMBL2024637,4.40,0.0,http://www.openphacts.org/units/Nanomolar,1640533.0,=,1.0,1.0,=,IC50,nM,40000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,40.0,CHEMBL613497
668,10961065.0,[],CHEMBL2061264,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing wild type protease infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNC(C)(C)C)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057459,CHEMBL2057459,8.05,0.0,http://www.openphacts.org/units/Nanomolar,1655121.0,=,1.0,1.0,=,IC50,nM,9.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,9.0,CHEMBL378
669,3114025.0,[],CHEMBL1073712,Antiviral activity against HIV1 NL4-3 infected in GFP expressing human CEM cells assessed as inhibition of viral infection measured after 9 days postinfection by microfluorometry,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CC(=O)c1c(O)c(C(=O)CC(C)C)c(O)c(C(c2ccc(O)cc2)c2c(O)c(C(=O)CC(C)C)c(O)c(C(=O)CC(C)C)c2O)c1O,CHEMBL1157554,Bioorg Med Chem,2010.0,CHEMBL601524,CHEMBL601524,,0.0,,888447.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
670,1498105.0,[],CHEMBL833971,Concentration required to inhibit 50% viral production of human immunodeficiency virus type 1 (HIV-1-IIIB),F,BAO_0000190,BAO_0000218,organism-based format,Cc1occc1/C(S)=N/c1ccc(Cl)c(CNOC(C)(C)C)c1,CHEMBL1143567,J Med Chem,2005.0,CHEMBL192832,CHEMBL192832,6.85,0.0,http://www.openphacts.org/units/Nanomolar,388329.0,=,1.0,1.0,=,IC50,nM,142.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.142,CHEMBL378
671,14658798.0,[],CHEMBL3266157,Antagonist activity at recombinant human EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)c3ccc4c(c3)CCO4)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262891,CHEMBL3262891,7.75,0.0,http://www.openphacts.org/units/Nanomolar,2101733.0,=,1.0,1.0,=,IC50,nM,18.0,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,nM,UO_0000065,18.0,CHEMBL3259470
672,3198138.0,[],CHEMBL1104123,Antiviral activity against HIV1 HT/92/599 infected in PBMCs assessed as reverse transcriptase activity after 7 days by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)CCNC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@@H](N)Cc1ccc(O)cc1,CHEMBL1153724,Bioorg Med Chem Lett,2009.0,CHEMBL1075830,CHEMBL1075830,5.06,0.0,http://www.openphacts.org/units/Nanomolar,889153.0,=,1.0,1.0,=,IC50,nM,8800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.8,CHEMBL378
673,1163476.0,[],CHEMBL694658,Inhibitory concentration against HIV-1 LTR polymerase chain reaction product,F,BAO_0000190,BAO_0000218,organism-based format,Cl.Cl.Cn1cc(NC(=O)c2cc(NC(=O)c3cc(NC=O)cn3C)cn2C)cc1C(=O)NCCC(=N)N,CHEMBL1132187,J Med Chem,1999.0,CHEMBL3216873,CHEMBL11252,4.30,0.0,http://www.openphacts.org/units/Nanomolar,289522.0,=,1.0,1.0,=,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
674,3603805.0,[],CHEMBL1291656,Antiviral activity against Hepatitis B virus infected in HepG2.2.15 assessed as inhibition of HBsAg production by EIA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)Cc2nc3c(Cn4ccnc4)c(O)ccc3n2C)cc1,CHEMBL1287795,Bioorg Med Chem Lett,2010.0,CHEMBL1288204,CHEMBL1288204,4.20,0.0,http://www.openphacts.org/units/Nanomolar,973225.0,=,1.0,1.0,=,IC50,nM,62600.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,62.6,CHEMBL613497
675,15668306.0,[],CHEMBL3603050,Antiviral activity against HIV-1 HXB2 assessed as inhibition of viral infection in human TZM-bl cells after 18 hrs by steady-glo luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCC(O)C(CO)NC(=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL3600350,Medchemcomm,2014.0,CHEMBL3601612,CHEMBL3601612,6.46,0.0,http://www.openphacts.org/units/Nanomolar,2493147.0,=,1.0,1.0,=,IC50,nM,350.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,350.0,CHEMBL378
676,18323341.0,[],CHEMBL4134874,Antiviral activity against VSV-G pseudotyped HIV1 infected in human SupT1 cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1O/C(=C\c2ccc(O)cc2)C(O)=C1c1ccc(O)cc1,CHEMBL4130477,J Nat Prod,2017.0,CHEMBL2337339,CHEMBL2337339,,0.0,,3042100.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
677,1472288.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C(\C#N)c2cccnc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL187572,CHEMBL187572,7.22,0.0,http://www.openphacts.org/units/Nanomolar,380956.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.06,CHEMBL378
678,12542814.0,[],CHEMBL3076900,Antiviral activity against Human immunodeficiency virus 1 IIIB infected MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,NNc1nc2ccc([N+](=O)[O-])cc2s1,CHEMBL3046062,Med Chem Res,2013.0,CHEMBL1241373,CHEMBL1241373,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824473.0,>,1.0,1.0,>,IC50,ug.mL-1,12.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,12.8,CHEMBL378
679,18342077.0,[],CHEMBL4139011,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)Nc2c[nH]c(=O)c(-c3cc(C)ccc3C)c2)c(O)c1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL4160642,CHEMBL4160642,4.29,0.0,http://www.openphacts.org/units/Nanomolar,3045883.0,=,1.0,1.0,=,IC50,nM,51530.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,51.53,CHEMBL613497
680,12108668.0,[],CHEMBL2173498,Antiviral activity against HIV1 harboring reverse transcriptase Y188L mutant,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL2169791,J Med Chem,2012.0,CHEMBL72335,CHEMBL72335,7.72,0.0,http://www.openphacts.org/units/Nanomolar,1740558.0,=,1.0,1.0,=,IC50,nM,19.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.0,CHEMBL378
681,1470286.0,[],CHEMBL833082,Inhibitory activity against HIV-1 mutant strain 190S,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cc(Cl)cc(Cl)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188941,CHEMBL188941,8.52,0.0,http://www.openphacts.org/units/Nanomolar,380720.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
682,1402081.0,[],CHEMBL837471,In vitro inhibitory concentration against HIV Y188L mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,COCCCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175693,CHEMBL175693,6.70,0.0,http://www.openphacts.org/units/Nanomolar,360398.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.2,CHEMBL378
683,3003257.0,[],CHEMBL1045518,Antiviral activity against HIV1 Ba-L infected in HOS cells assessed as inhibition of viral infection,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1[C@H]1C[C@H]2CC[C@@H](C1)N2CCC[C@]1(c2ccccc2)CC[C@H](NC(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)CC1,CHEMBL1155363,Bioorg Med Chem Lett,2009.0,CHEMBL577339,CHEMBL577339,6.42,0.0,http://www.openphacts.org/units/Nanomolar,857690.0,=,1.0,1.0,=,IC50,nM,380.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.38,CHEMBL378
684,2570668.0,[],CHEMBL1000470,Antiviral activity against hepatitis B virus-infected human HepG2.2.15 cells assessed as inhibition of HBV e antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)/C=C/c1ccccc1)[C@@H](OC(=O)/C=C/c1ccccc1)C(C)(C)O)C1=C2C[C@H](O/C=C/c3ccccc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1155923,Bioorg Med Chem Lett,2008.0,CHEMBL499135,CHEMBL499135,,0.0,http://www.openphacts.org/units/Nanomolar,768985.0,>,1.0,1.0,>,IC50,nM,1400000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.4,CHEMBL613497
685,18320112.0,[],CHEMBL4134181,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA level incubated for 3 days followed by medium replacement measured after 3 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C1=C2CCCN2C(c2nccs2)=NC1c1ccc(F)cc1Cl,CHEMBL4130455,ACS Med Chem Lett,2017.0,CHEMBL4177334,CHEMBL4177334,6.50,0.0,http://www.openphacts.org/units/Nanomolar,3041707.0,=,1.0,1.0,=,IC50,nM,320.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.32,CHEMBL613497
686,891780.0,[],CHEMBL653610,Inhibitory activity tested against the HIV-1 in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCNC(=O)c3cccc(C(=O)O)c3)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL275533,CHEMBL275533,6.98,0.0,http://www.openphacts.org/units/Nanomolar,9103.0,=,1.0,1.0,=,IC50,nM,105.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,105.0,CHEMBL378
687,2601886.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1O[C@@H](n2c(Cl)c(C=O)c3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL474697,CHEMBL474697,4.70,0.0,http://www.openphacts.org/units/Nanomolar,808019.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
688,15158574.0,[],CHEMBL3398830,Inhibition of HBV HBsAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,O=C1OCCc2c(/C=N/Nc3ccc([N+](=O)[O-])cc3[N+](=O)[O-])cccc21,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397171,CHEMBL3397171,,0.0,http://www.openphacts.org/units/Nanomolar,2278969.0,>,1.0,1.0,>,IC50,nM,1650000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.65,CHEMBL613497
689,2947350.0,[],CHEMBL1038497,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)c1ccc(Cl)cc1Cl)[C@@H](OC(=O)c1ccc(Cl)cc1Cl)C(C)(C)OC(=O)c1ccc(Cl)cc1Cl)C1=C2C[C@H](OC(=O)c3ccc(Cl)cc3Cl)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL584380,CHEMBL584380,,0.0,http://www.openphacts.org/units/Nanomolar,850752.0,>,1.0,1.0,>,IC50,nM,1000000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.0,CHEMBL613497
690,24815379.0,[],CHEMBL5138357,Antiviral activity against HIV-1 harboring Y181C mutant infected in human MT4 cells by MTS assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(C(=O)c2cc(Cl)ccc2OCC(=O)Nc2ccc(S(N)(=O)=O)cc2Cl)c1,CHEMBL5136999,J Med Chem,2022.0,CHEMBL5206840,CHEMBL5206840,8.61,0.0,http://www.openphacts.org/units/Nanomolar,3874916.0,=,1.0,1.0,=,IC50,nM,2.48,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.48,CHEMBL378
691,2009819.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnn3)ccc(F)c12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL235966,CHEMBL235966,6.82,0.0,http://www.openphacts.org/units/Nanomolar,668094.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,150.0,CHEMBL378
692,3467378.0,[],CHEMBL1250743,Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 6 hrs by p24 antigen based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)oc2c3c(ccc12)S[C@H](C)[C@H](OC(=O)[C@]12CC[C@](C)(C(=O)O1)C2(C)C)[C@@H]3OC(=O)[C@]12CC[C@](C)(C(=O)O1)C2(C)C,CHEMBL1250555,Bioorg Med Chem,2010.0,CHEMBL1253536,CHEMBL1253536,4.41,0.0,http://www.openphacts.org/units/Nanomolar,955461.0,=,1.0,1.0,=,IC50,nM,39100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,39.1,CHEMBL378
693,15666360.0,[],CHEMBL3602702,Antiviral activity against wild type HIV1 NL4-3 infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL3600303,J Med Chem,2015.0,CHEMBL3600949,CHEMBL3600949,8.96,0.0,http://www.openphacts.org/units/Nanomolar,2492329.0,=,1.0,1.0,=,IC50,nM,1.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.1,CHEMBL378
694,1253856.0,[],CHEMBL878997,Inhibition of Hepatitis C RNA dependent RNA polymerase Nonstructural protein 5B activity.,B,BAO_0000190,BAO_0000357,single protein format,O=C(O)[C@H](Cc1ccccc1)N(Cc1cccc(Br)c1)C(=O)c1ccc(Cl)cc1,CHEMBL1136248,Bioorg Med Chem Lett,2003.0,CHEMBL26052,CHEMBL26052,4.97,0.0,http://www.openphacts.org/units/Nanomolar,213338.0,=,1.0,1.0,=,IC50,nM,10600.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,10.6,CHEMBL4620
695,1401670.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175522,CHEMBL175522,8.60,0.0,http://www.openphacts.org/units/Nanomolar,360264.0,=,1.0,1.0,=,IC50,nM,2.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0025,CHEMBL378
696,661732.0,[],CHEMBL683819,Anti-HIV activity in cell culture assay expressed as IC50 values.,F,BAO_0000190,BAO_0000218,organism-based format,O=C1OCC2OC(=O)c3cc(O)c(O)c(O)c3-c3c(O)c(O)c(O)c4c3C(=O)OC(C2OC(=O)c2cc(O)c(O)c(O)c2-c2c1cc(O)c(O)c2O)C1OC(=O)c2c-4c(O)c(O)c(O)c2[C@@H]1[C@@]1(O)O[C@@H](CO)[C@@H](O)[C@H]1O,CHEMBL1126373,Bioorg Med Chem Lett,1992.0,CHEMBL611124,CHEMBL611124,4.82,0.0,http://www.openphacts.org/units/Nanomolar,60630.0,=,1.0,1.0,=,IC50,nM,15000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,15.0,CHEMBL378
697,2393052.0,[],CHEMBL941181,Inhibition of HIV1 NL4-3 replication in CD4-CXCR4 expressing human NP2 cells assessed as decrease in p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OCC(=O)N(CC1CCCO1)c1nc(-c2ccc(Br)cc2)cs1)c1ccc([N+](=O)[O-])o1,CHEMBL1140907,J Med Chem,2009.0,CHEMBL522795,CHEMBL522795,4.64,0.0,http://www.openphacts.org/units/Nanomolar,730252.0,=,1.0,1.0,=,IC50,nM,22700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,22.7,CHEMBL378
698,10911768.0,[],CHEMBL2038369,Antiviral activity against wild type HIV1 clade B 94US3393IN clinical isolate infected in PHA-P-stimulated human PBMC assessed as reverse transcriptase activity incubated for 6 hrs followed by incubated in drug-free medium for 6 days by multiround infection assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](F)[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL2034836,J Med Chem,2012.0,CHEMBL105318,CHEMBL105318,8.70,0.0,http://www.openphacts.org/units/Nanomolar,1644913.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
699,17602969.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(c2cccc(-c3ccccc3)c2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644904,CHEMBL3644904,7.89,0.0,http://www.openphacts.org/units/Nanomolar,2518024.0,=,37.0,1.0,=,IC50,nM,13.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,13.0,CHEMBL4620
700,19261957.0,[],CHEMBL4404400,"Antiviral activity against HIV1 subtypeC HIV-25711-2, clone 4",F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.58,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,260.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.26,CHEMBL378
701,22980457.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '192.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '8.0'}]",CHEMBL4772778,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBeAg secretion incubated for 4 days prior to compound washout followed by compound addition and measured after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL4765395,Eur J Med Chem,2020.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/Nanomolar,3568781.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol/L,UO_0000065,100.0,CHEMBL613497
702,1438007.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C(C)=O)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL362435,CHEMBL362435,8.00,0.0,http://www.openphacts.org/units/Nanomolar,371615.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
703,1402278.0,[],CHEMBL837469,In vitro inhibitory concentration against HIV V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCCN(CCCC)c1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL179736,CHEMBL179736,,0.0,http://www.openphacts.org/units/Nanomolar,360413.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
704,12542791.0,[],CHEMBL3076900,Antiviral activity against Human immunodeficiency virus 1 IIIB infected MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Clc1ccc(-c2nnc(-c3cccnc3)n2Nc2nc3ccc(Cl)cc3s2)cc1,CHEMBL3046062,Med Chem Res,2013.0,CHEMBL2282286,CHEMBL2282286,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824496.0,>,1.0,1.0,>,IC50,ug.mL-1,54.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,54.3,CHEMBL378
705,2184029.0,[],CHEMBL951616,Antiviral activity against HIV1 NDK infected in U87.CD4 cells expressing human CXCR4 E288A mutant,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(CNCc2ccc(CN3CCCNCCNCCCNCC3)cc2)nc1,CHEMBL1156482,J Biol Chem,2007.0,CHEMBL477121,CHEMBL477121,,0.0,http://www.openphacts.org/units/Nanomolar,791971.0,>,1.0,1.0,>,IC50,nM,5500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5500.0,CHEMBL378
706,1471994.0,[],CHEMBL834619,Inhibitory activity against HIV-1 mutant strain 181C; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C\c2ccncc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL363979,CHEMBL363979,,0.0,http://www.openphacts.org/units/Nanomolar,380930.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
707,2099778.0,[],CHEMBL949220,Antiviral activity against HIV1 BaL by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C(F)(F)F)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL257000,CHEMBL257000,8.10,0.0,http://www.openphacts.org/units/Nanomolar,699412.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
708,3003249.0,[],CHEMBL1045518,Antiviral activity against HIV1 Ba-L infected in HOS cells assessed as inhibition of viral infection,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1[C@H]1C[C@H]2CC[C@@H](C1)N2CC[C@]1(c2ccccc2)CC[C@@H](NC(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)CC1,CHEMBL1155363,Bioorg Med Chem Lett,2009.0,CHEMBL571212,CHEMBL571212,5.79,0.0,http://www.openphacts.org/units/Nanomolar,857682.0,=,1.0,1.0,=,IC50,nM,1630.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.63,CHEMBL378
709,12642498.0,[],CHEMBL2317525,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NCc1ccc(F)cc1)c1cn2c(c(O)c1=O)C(=O)N1CCOC1C2,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314686,CHEMBL2314686,8.57,0.0,http://www.openphacts.org/units/Nanomolar,1844818.0,=,1.0,1.0,=,IC50,nM,2.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.7,CHEMBL378
710,23274482.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CCC(=O)NCCCCNC(=O)CC[C@@H](C)[C@H]2CC[C@H]3[C@@H]4[C@@H](O)C[C@@H]5CC[C@@H](C[C@]5(C)[C@H]4CC[C@]23C)n2cc(nn2)CO[C@H]2CC[C@H]3C[C@H](O)[C@@H]4[C@H](CC[C@]5(C)[C@@H]1CC[C@@H]45)[C@@]3(C)C2,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4852439,CHEMBL4852439,6.55,0.0,http://www.openphacts.org/units/Nanomolar,3621282.0,=,1.0,1.0,=,IC50,nM,280.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,280.0,CHEMBL613497
711,19261721.0,[],CHEMBL4404352,Antiviral activity against HIV1 HXB2 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cn2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4435092,CHEMBL4435092,6.02,0.0,http://www.openphacts.org/units/Nanomolar,3216256.0,=,1.0,1.0,=,IC50,nM,960.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.96,CHEMBL378
712,499090.0,[],CHEMBL691388,Inhibitory concentration against HIV-1 AZTres.,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC)c1Cc1cc(C)cc(C)c1,CHEMBL1133473,J Med Chem,2000.0,CHEMBL339511,CHEMBL339511,7.12,0.0,http://www.openphacts.org/units/Nanomolar,245559.0,=,1.0,1.0,=,IC50,nM,76.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,76.0,CHEMBL378
713,1402353.0,[],CHEMBL834488,In vitro inhibitory concentration against HIV L100I and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(-n2cccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL360957,CHEMBL360957,,0.0,http://www.openphacts.org/units/Nanomolar,360357.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
714,264860.0,[],CHEMBL690478,In vitro antiviral activity against NNRTI-resistant DLVR-IIIB (L100I) HIV-1 variant,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccccc1NC(C(N)=O)c1c(Cl)cccc1Cl,CHEMBL1131332,J Med Chem,1998.0,CHEMBL283861,CHEMBL283861,5.19,0.0,http://www.openphacts.org/units/Nanomolar,41265.0,=,1.0,1.0,=,IC50,nM,6500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.5,CHEMBL378
715,2009835.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL241763,CHEMBL241763,,0.0,http://www.openphacts.org/units/Nanomolar,668078.0,>,1.0,1.0,>,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,20000.0,CHEMBL378
716,1470717.0,[],CHEMBL833075,Inhibitory activity against HIV-1 mutant strain 101E,F,BAO_0000190,BAO_0000218,organism-based format,CCOCn1c(Cc2ccccc2)c(C(C)C)c(=O)[nH]c1=O,CHEMBL1138799,J Med Chem,2004.0,CHEMBL35033,CHEMBL35033,6.92,0.0,http://www.openphacts.org/units/Nanomolar,380792.0,=,1.0,1.0,=,IC50,nM,120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.12,CHEMBL378
717,400857.0,[],CHEMBL729931,Inhibitory concentration required against Monkeypox virus in Vero cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2C[C@H](O)CO,CHEMBL1147452,Bioorg Med Chem Lett,2004.0,CHEMBL494759,CHEMBL494759,4.27,0.0,http://www.openphacts.org/units/Nanomolar,214240.0,=,1.0,1.0,=,IC50,nM,54000.0,CHEMBL613120,Monkeypox virus,Monkeypox virus,10244,IC50,uM,UO_0000065,54.0,CHEMBL613120
718,1210459.0,[],CHEMBL710372,Inhibitory activity against 100I strain and 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1Cl,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72205,CHEMBL72205,6.86,0.0,http://www.openphacts.org/units/Nanomolar,127443.0,=,1.0,1.0,=,IC50,nM,138.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.138,CHEMBL378
719,3129675.0,[],CHEMBL1065520,Antiviral activity against HIV1 LAI infected in human CEM-SS cells assessed as inhibition of viral replication by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(-c2nc(COc3c4cc(CC(=O)[O-])cc3Cc3cc(CC(=O)[O-])cc(c3O)Cc3cc(CC(=O)[O-])cc(c3OCc3nc(-c5nc(C)c(C(=O)[O-])s5)sc3C(=O)[O-])Cc3cc(CC(=O)[O-])cc(c3O)C4)c(C(=O)[O-])s2)sc1C(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],CHEMBL1157689,Bioorg Med Chem,2010.0,CHEMBL590624,CHEMBL1208388,5.28,0.0,http://www.openphacts.org/units/Nanomolar,880944.0,=,1.0,1.0,=,IC50,nM,5300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.3,CHEMBL378
720,2997404.0,[],CHEMBL1046974,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC/N=C(\c1ccc(=O)n(CCCCC)c1)c1ccc(OC)cc1O,CHEMBL1156796,J Med Chem,2010.0,CHEMBL568411,CHEMBL568411,4.54,0.0,http://www.openphacts.org/units/Nanomolar,856721.0,=,1.0,1.0,=,IC50,nM,29000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,29.0,CHEMBL613497
721,19243767.0,[],CHEMBL4400278,Antiviral activity against Zika virus infected in human A549 cells assessed as reduction in viral titer incubated for 48 hrs by plaque assay,F,BAO_0000190,BAO_0000218,organism-based format,C#CCSc1nsc(NC(=S)Nc2ccc(Cl)c(C(F)(F)F)c2)n1,CHEMBL4396960,Bioorg Med Chem Lett,2019.0,CHEMBL4466830,CHEMBL4466830,7.24,0.0,http://www.openphacts.org/units/Nanomolar,3212394.0,=,1.0,1.0,=,IC50,nM,57.4,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,nM,UO_0000065,57.4,CHEMBL4296612
722,1021222.0,[],CHEMBL756465,Tested for the ability to inhibit the replication of HIV-1 strain HTLV IIIB in human peripheral blood mononuclear cells (PBMC),F,BAO_0000190,BAO_0000218,organism-based format,S=C(NCCc1ccccn1)Nc1nccs1,CHEMBL1134194,Bioorg Med Chem Lett,2001.0,CHEMBL145709,CHEMBL145709,6.00,0.0,http://www.openphacts.org/units/Nanomolar,292659.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
723,14658811.0,[],CHEMBL3266157,Antagonist activity at recombinant human EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(Cl)c(Cl)c1)N1CCN(C(=O)Cc2ccccc2)CC1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262882,CHEMBL3262882,7.62,0.0,http://www.openphacts.org/units/Nanomolar,2101724.0,=,1.0,1.0,=,IC50,nM,23.99,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,pIC50,,UO_0000065,7.62,CHEMBL3259470
724,1471292.0,[],CHEMBL833076,Inhibitory activity against HIV-1 mutant strain 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1ccc(C)cc1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL187832,CHEMBL187832,4.90,0.0,http://www.openphacts.org/units/Nanomolar,380813.0,=,1.0,1.0,=,IC50,nM,12590.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.59,CHEMBL378
725,658448.0,[],CHEMBL713512,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1Cn2c(S)nc3cccc(c32)CN1CC1CC1,CHEMBL1128252,J Med Chem,1995.0,CHEMBL349271,CHEMBL349271,7.22,0.0,http://www.openphacts.org/units/Nanomolar,326374.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.06,CHEMBL378
726,12204033.0,[],CHEMBL2211838,Antiviral activity against HIV-1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)C1=NN(C(=O)Nc3ccc(F)cc3)C(c3ccncc3)C1C2,CHEMBL2203270,Bioorg Med Chem Lett,2012.0,CHEMBL1808361,CHEMBL1808361,,0.0,http://www.openphacts.org/units/Nanomolar,1758562.0,>,1.0,1.0,>,IC50,nM,31940.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,31.94,CHEMBL378
727,18044386.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(C(CCN(C)C)NC(=O)c2ccc(-c3cccc(Cl)c3)[nH]2)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4074344,CHEMBL4074344,4.98,0.0,http://www.openphacts.org/units/Nanomolar,2990203.0,=,1.0,1.0,=,IC50,nM,10400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.4,CHEMBL378
728,6344573.0,[],CHEMBL1825887,Antiviral activity against HIV1 HxB2 infected in human TZM-bl cells assessed as inhibition of virus neutralization after 48 hrs by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1821725,Bioorg Med Chem,2011.0,CHEMBL129,CHEMBL129,7.43,0.0,http://www.openphacts.org/units/Nanomolar,1452388.0,=,1.0,1.0,=,IC50,nM,37.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.037,CHEMBL378
729,24823590.0,[],CHEMBL5140687,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBeAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3cc(Br)ccc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5195944,CHEMBL5195944,,0.0,http://www.openphacts.org/units/Nanomolar,3876726.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.0,CHEMBL613497
730,5229729.0,[],CHEMBL1678268,Antiviral activity against Human immunodeficiency virus 1 ROJO infected in phytohemagglutininin and interleukin-2-stimulated PBMC assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,6.52,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,=,1.0,1.0,=,IC50,nM,300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.3,CHEMBL378
731,1954147.0,[],CHEMBL891425,Antiviral activity against HIV1 RT 188L mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(C(C)C)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL397934,CHEMBL397934,7.50,0.0,http://www.openphacts.org/units/Nanomolar,647184.0,=,1.0,1.0,=,IC50,nM,31.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.6,CHEMBL378
732,1954112.0,[],CHEMBL891425,Antiviral activity against HIV1 RT 188L mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(Br)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL234077,CHEMBL234077,6.20,0.0,http://www.openphacts.org/units/Nanomolar,647172.0,=,1.0,1.0,=,IC50,nM,631.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,631.0,CHEMBL378
733,16394330.0,[],CHEMBL3744526,Inhibition of HBV DNA replication in HepG2.2.15 cells,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)C(=O)c1ccc2c(c1)nc(-c1nccs1)n2C,CHEMBL3739304,Medchemcomm,2015.0,CHEMBL3741663,CHEMBL3741663,5.96,0.0,http://www.openphacts.org/units/Nanomolar,2738858.0,=,1.0,1.0,=,IC50,nM,1100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.1,CHEMBL613497
734,1401878.0,[],CHEMBL834488,In vitro inhibitory concentration against HIV L100I and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177563,CHEMBL177563,6.22,0.0,http://www.openphacts.org/units/Nanomolar,360416.0,=,1.0,1.0,=,IC50,nM,598.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.598,CHEMBL378
735,14542020.0,[],CHEMBL3223532,Antiviral activity against Hepatitis B virus,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@H]2C=C(C(F)(F)F)[C@@H](CO)O2)c(=O)n1,CHEMBL3217414,Medchemcomm,2013.0,CHEMBL3220080,CHEMBL3220080,5.00,0.0,http://www.openphacts.org/units/Nanomolar,2075072.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.0,CHEMBL613497
736,1402406.0,[],CHEMBL837467,In vitro inhibitory concentration against HIV K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)CCOC)c1C(=O)c1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369697,CHEMBL369697,7.70,0.0,http://www.openphacts.org/units/Nanomolar,360426.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.02,CHEMBL378
737,15210766.0,[],CHEMBL3421426,Antiviral activity against Human immunodeficiency virus 1 3b infected in human MT4 cells assessed as inhibition of virus replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1[C@H](OC(C)=O)[C@H]2[C@@H](OC(C)=O)[C@](C)(OC(C)=O)C[C@]2(OC(C)=O)C(=O)[C@H](C)/C=C/C(C)(C)C(=O)[C@H](OC(C)=O)[C@H]1OC(C)=O,CHEMBL3414423,J Nat Prod,2014.0,CHEMBL3414610,CHEMBL3414610,4.43,0.0,http://www.openphacts.org/units/Nanomolar,2289945.0,=,1.0,1.0,=,IC50,nM,37100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,37.1,CHEMBL378
738,2694314.0,[],CHEMBL1053929,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1152943,Bioorg Med Chem,2009.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/Nanomolar,825104.0,=,1.0,1.0,=,IC50,nM,240000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,240.0,CHEMBL613497
739,2371454.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(C)nc(NC(=N)/N=C(\C)c3ccccc3C(=O)O)nc2c1,CHEMBL1140145,J Med Chem,2008.0,CHEMBL492293,CHEMBL492293,4.89,0.0,http://www.openphacts.org/units/Nanomolar,746178.0,=,1.0,1.0,=,IC50,nM,13000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,13.0,CHEMBL613493
740,2594525.0,[],CHEMBL958175,Antiviral activity against X4-tropic HIV1 3B assessed as inhibition of viral attachment,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CN2C(CS/C(=N\C3CCCCC3)NC3CCCCC3)=CSC2=N1,CHEMBL1151747,J Med Chem,2008.0,CHEMBL460491,CHEMBL460491,8.15,0.0,http://www.openphacts.org/units/Nanomolar,727142.0,=,1.0,1.0,=,IC50,nM,7.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.0,CHEMBL378
741,2048688.0,[],CHEMBL925406,Antiviral activity against Hepatitis B virus infected human HepG2 cells after 9 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C.O=C(O)/C=C/C(=O)O,CHEMBL1140514,Bioorg Med Chem Lett,2007.0,CHEMBL1486,CHEMBL1538,5.29,0.0,http://www.openphacts.org/units/Nanomolar,679851.0,=,1.0,1.0,=,IC50,nM,5100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,5.1,CHEMBL613497
742,19139083.0,[],CHEMBL4376259,Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition in virus-induced cytopathic effect incubated for 40 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)O)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL4373726,Bioorg Med Chem Lett,2019.0,CHEMBL1956398,CHEMBL1956398,4.01,0.0,http://www.openphacts.org/units/Nanomolar,3194266.0,=,1.0,1.0,=,IC50,nM,97700.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,97.7,CHEMBL613129
743,18342091.0,[],CHEMBL4139012,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(C(=O)Nc2c[nH]c(=O)c(-c3cccc(C)c3)c2)c1O,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL4169233,CHEMBL4169233,,0.0,http://www.openphacts.org/units/Nanomolar,3045869.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
744,1470416.0,[],CHEMBL833076,Inhibitory activity against HIV-1 mutant strain 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL185715,CHEMBL185715,8.70,0.0,http://www.openphacts.org/units/Nanomolar,380721.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.002,CHEMBL378
745,2214928.0,[],CHEMBL971334,Antiviral activity against HIV1 BaL in CCR5 expressing P4 cells after 2 hrs,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1C[C@@H](n2cc(-c3ccc(C)cc3)nn2)C[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)CC,CHEMBL1150247,J Med Chem,2008.0,CHEMBL526734,CHEMBL526734,6.81,0.0,http://www.openphacts.org/units/Nanomolar,768063.0,=,1.0,1.0,=,IC50,nM,156.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,156.0,CHEMBL378
746,3432539.0,[],CHEMBL1247392,Antiviral activity against HIV1 infected in human CEM cells assessed as protection against virus-induced cytopathic effect after 6 days by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1nn(-c2ccc(Cl)cc2)c2nc3sc4c(c3c(=S)n12)CCCCC4,CHEMBL1240504,Eur J Med Chem,2010.0,CHEMBL1243307,CHEMBL1243307,,0.0,http://www.openphacts.org/units/Nanomolar,954844.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM/L,UO_0000065,100.0,CHEMBL378
747,15606032.0,[],CHEMBL3579360,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C=C/C(=O)O/N=C/c2ccco2)cc1OC,CHEMBL3576819,Eur J Med Chem,2015.0,CHEMBL3577786,CHEMBL3577786,,0.0,http://www.openphacts.org/units/Nanomolar,2480525.0,=,1.0,1.0,=,IC50,nM,201650.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,201.65,CHEMBL613497
748,12680741.0,[],CHEMBL2342599,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)NCc3cccc(F)c3)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333689,CHEMBL2333689,4.08,0.0,http://www.openphacts.org/units/Nanomolar,1867765.0,=,1.0,1.0,=,IC50,nM,83800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,83.8,CHEMBL613497
749,5306741.0,[],CHEMBL1696832,Antiviral activity against X4 tropic HIV1 RF infected in human PBMC assessed as inhibition of p24 antigen production after 2 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1687731,Antimicrob Agents Chemother,2009.0,CHEMBL70663,CHEMBL70663,8.83,0.0,http://www.openphacts.org/units/Nanomolar,1337341.0,=,1.0,1.0,=,IC50,nM,1.48,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.48,CHEMBL378
750,3085618.0,[],CHEMBL1047696,Antiviral activity against HIV1 3B in human MT2 cells assessed as inhibition of cell-cell fusion,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(C)n1-c1ccc(-c2ccccc2)c(C(=O)O)c1,CHEMBL1153143,Bioorg Med Chem Lett,2010.0,CHEMBL595968,CHEMBL595968,4.23,0.0,http://www.openphacts.org/units/Nanomolar,877335.0,=,1.0,1.0,=,IC50,nM,59170.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,59.17,CHEMBL378
751,18044700.0,[],CHEMBL4010443,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype A2/D QG393.60M.ENV.B7,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.37,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,430.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.43,CHEMBL378
752,18940372.0,[],CHEMBL4328847,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cn1ccc2cc(F)c(-c3ccc4ccn(Cc5cc(F)cc(C(=O)O)c5)c4c3)cc21,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4468550,CHEMBL4468550,5.01,0.0,http://www.openphacts.org/units/Nanomolar,3159807.0,=,1.0,1.0,=,IC50,nM,9700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,9.7,CHEMBL378
753,18727039.0,[],CHEMBL4259326,Antiviral activity against HIV1 subtype BC CNE30 pseudovirus assessed as inhibition of viral infection in Ghost (3)X4/R5 cells after 48 hrs by Bright-Glo luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@]1(C)CCC/C=C\CCC[C@](C)(NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O,CHEMBL4257519,Medchemcomm,2018.0,CHEMBL4287830,CHEMBL4287830,7.79,0.0,http://www.openphacts.org/units/Nanomolar,3111235.0,=,1.0,1.0,=,IC50,nM,16.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,16.2,CHEMBL378
754,18775525.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCC1Cc2cc(OCc3ccccc3)c(OC)cc2-c2cc(=O)c(C(=O)N3CCOCC3)cn21,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4281818,CHEMBL4281818,,0.0,http://www.openphacts.org/units/Nanomolar,3119683.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
755,10938603.0,[],CHEMBL2051599,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccc(Cl)c(Cl)c4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046584,CHEMBL2046584,,0.0,http://www.openphacts.org/units/Nanomolar,1651467.0,=,1.0,1.0,=,IC50,nM,949320.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,949.32,CHEMBL613497
756,933985.0,[],CHEMBL755976,Anti-HIV activity against multidrug resistant HIV TM strain by inhibition of HIV p24 antigen expression in peripheral blood mononuclear cells(PBMC),F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C[S+]([O-])c1ccc2ccccc2c1)NS(C)(=O)=O)S(=O)(=O)c1ccc(N)cc1,CHEMBL1144922,J Med Chem,2003.0,CHEMBL299578,CHEMBL299578,7.37,0.0,http://www.openphacts.org/units/Nanomolar,83377.0,=,1.0,1.0,=,IC50,nM,43.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,43.0,CHEMBL378
757,1402596.0,[],CHEMBL837464,In vitro inhibitory concentration against HIV G190A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(NC(=S)NC(=O)c2ccccc2)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177383,CHEMBL177383,,0.0,http://www.openphacts.org/units/Nanomolar,360418.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
758,16498266.0,[],CHEMBL3778315,Antiviral activity against HIV1 CXCR4-tropic strain HxB2 infected in human 293T cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1/C(=N\Nc2cc(S(=O)(=O)O)cc3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)C(c2ccccc2)=NN1c1nc(-c2ccccc2)cs1,CHEMBL3774382,Bioorg Med Chem,2016.0,CHEMBL3775491,CHEMBL3775491,4.53,0.0,http://www.openphacts.org/units/Nanomolar,2762325.0,=,1.0,1.0,=,IC50,nM,29300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,29.3,CHEMBL378
759,15027130.0,[],CHEMBL3367171,Inhibition of AP-1-mediated transcriptional activation in human Jurkat cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)c1cnc(-c2cccs2)nc1NN1C(=O)C=C(C)C1=O,CHEMBL3352097,J Med Chem,2014.0,CHEMBL43549,CHEMBL43549,7.70,0.0,http://www.openphacts.org/units/Nanomolar,2265194.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.02,CHEMBL4977
760,15606364.0,[],CHEMBL3579358,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C=C/C(=O)O/N=C/c2ccco2)cc1OC,CHEMBL3576819,Eur J Med Chem,2015.0,CHEMBL3577786,CHEMBL3577786,,0.0,http://www.openphacts.org/units/Nanomolar,2480525.0,=,1.0,1.0,=,IC50,nM,191260.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,191.26,CHEMBL613497
761,1471425.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1ccc(-c2ccccc2)cc1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188365,CHEMBL188365,5.40,0.0,http://www.openphacts.org/units/Nanomolar,380860.0,=,1.0,1.0,=,IC50,nM,3980.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.98,CHEMBL378
762,1066170.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(NN2C(S)=NC(C)C2c2cccc(C(=O)O)c2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289090,CHEMBL289090,,0.0,http://www.openphacts.org/units/Nanomolar,62353.0,>,1.0,1.0,>,IC50,nM,187130.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,187.13,CHEMBL378
763,1402043.0,[],CHEMBL837463,In vitro inhibitory concentration against HIV F227C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC(C)=O)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL129144,CHEMBL129144,,0.0,http://www.openphacts.org/units/Nanomolar,360368.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
764,59301.0,[],CHEMBL857692,Inhibitory concentration against HCV NS3 protease was determined,B,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)c1cnccn1)[C@@H](C)CC)C(=O)C(=O)N[C@@H](CCCCN)C(=O)O,CHEMBL1136650,Bioorg Med Chem Lett,2003.0,CHEMBL266222,CHEMBL266222,5.11,0.0,http://www.openphacts.org/units/Nanomolar,12746.0,=,1.0,1.0,=,IC50,nM,7700.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,7.7,CHEMBL4620
765,6200536.0,[],CHEMBL1781474,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 4 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc2c(CCN(CC3CC3)CC3CC3)c[nH]c2c1,CHEMBL1777761,Bioorg Med Chem,2011.0,CHEMBL1779156,CHEMBL1779156,5.22,0.0,http://www.openphacts.org/units/Nanomolar,1425111.0,=,1.0,1.0,=,IC50,nM,6000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,6.0,CHEMBL613497
766,1041229.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CSc1nc(C)c(-c2ccccc2)n1Nc1cccc(Cl)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289337,CHEMBL289337,,0.0,http://www.openphacts.org/units/Nanomolar,62312.0,>,1.0,1.0,>,IC50,nM,42110.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,42.11,CHEMBL378
767,581732.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(CCCCBr)Sc1ccccc1C(=O)Nc1ccc(S(=O)(=O)c2ccc([N+](=O)[O-])cc2)cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL353730,CHEMBL353730,4.66,0.0,http://www.openphacts.org/units/Nanomolar,334014.0,=,1.0,1.0,=,IC50,nM,21700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,21.7,CHEMBL378
768,1401916.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCNc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL174339,CHEMBL174339,7.80,0.0,http://www.openphacts.org/units/Nanomolar,360384.0,=,1.0,1.0,=,IC50,nM,16.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.016,CHEMBL378
769,6336443.0,[],CHEMBL1821125,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by measuring HBsAg and HBeAg production after 9 days by EIA,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1817553,Bioorg Med Chem,2011.0,CHEMBL141,CHEMBL141,4.08,0.0,http://www.openphacts.org/units/Nanomolar,1451770.0,=,1.0,1.0,=,IC50,nM,82420.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,82.42,CHEMBL613497
770,1402484.0,[],CHEMBL837467,In vitro inhibitory concentration against HIV K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177666,CHEMBL177666,8.22,0.0,http://www.openphacts.org/units/Nanomolar,360358.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
771,23228449.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '36.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '36.0'}]",CHEMBL4826198,Antiviral activity against Human hepatitis B virus in Huh-7 cells assessed as reduction in intracellular viral DNA level incubated for 36 hrs by qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cncc(C(=O)NCCNc2cc(Nc3ccc(N4CCOCC4)cc3)nc(SC)n2)c1,CHEMBL4825668,J Med Chem,2021.0,CHEMBL4865160,CHEMBL4865160,5.08,0.0,http://www.openphacts.org/units/Nanomolar,3613065.0,=,1.0,1.0,=,IC50,nM,8420.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,8.42,CHEMBL613497
772,5137368.0,[],CHEMBL1646836,Antiviral activity against X4 tropic HIV1 NL4.3 infected in human MT4 cells expressing CD4 and CXCR4 assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CN(Cc2nc3ccccc3[nH]2)C2CCCc3cccnc32)c(CN)c1,CHEMBL1641524,Bioorg Med Chem Lett,2011.0,CHEMBL1644072,CHEMBL1644072,7.75,0.0,http://www.openphacts.org/units/Nanomolar,1319746.0,=,1.0,1.0,=,IC50,nM,18.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.018,CHEMBL378
773,2997413.0,[],CHEMBL1046975,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)c2ccc(=O)n(-c3cc(C)ccc3C)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL567982,CHEMBL567982,4.42,0.0,http://www.openphacts.org/units/Nanomolar,856566.0,=,1.0,1.0,=,IC50,nM,38000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,38.0,CHEMBL613497
774,10861960.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCCCBr)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024634,CHEMBL2024634,,0.0,http://www.openphacts.org/units/Nanomolar,1640530.0,>,1.0,1.0,>,IC50,nM,1392040.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1392.04,CHEMBL613497
775,2099843.0,[],CHEMBL949221,Antiviral activity against HIV1 97-ZA-003 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(ncn2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL403457,CHEMBL403457,,0.0,http://www.openphacts.org/units/Nanomolar,699407.0,>,1.0,1.0,>,IC50,nM,10000000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10000.0,CHEMBL378
776,1672799.0,[],CHEMBL863515,Antiviral activity against HIV1 3B in MT4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(NC(=O)CCN2CCOCC2)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(F)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL201526,CHEMBL201526,8.30,0.0,http://www.openphacts.org/units/Nanomolar,411942.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.0,CHEMBL378
777,12651436.0,[],CHEMBL2327724,Antiviral activity against 0.001 MOI wild type Human immunodeficiency virus 1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCC(=O)N[C@H](C(=O)OC)C(C)C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324138,CHEMBL2324138,8.00,0.0,http://www.openphacts.org/units/Nanomolar,1850164.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
778,2930200.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSC(C)C)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578558,CHEMBL578558,7.90,0.0,http://www.openphacts.org/units/Nanomolar,852863.0,=,1.0,1.0,=,IC50,nM,12.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,12.5,CHEMBL378
779,2602101.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL584,CHEMBL584,7.57,0.0,http://www.openphacts.org/units/Nanomolar,808149.0,=,1.0,1.0,=,IC50,nM,27.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.027,CHEMBL378
780,1740569.0,[],CHEMBL854478,Inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,O=C1c2ccccc2C(=O)N1CCc1nc2cc(F)c(F)cc2n1S(=O)(=O)c1ccccc1[N+](=O)[O-],CHEMBL1138932,J Med Chem,2006.0,CHEMBL209890,CHEMBL209890,6.19,0.0,http://www.openphacts.org/units/Nanomolar,520767.0,=,1.0,1.0,=,IC50,nM,640.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.64,CHEMBL613497
781,2292384.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1S(=O)(=O)c1cccc(N)c1C#N,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL55308,CHEMBL55308,,0.0,http://www.openphacts.org/units/Nanomolar,813490.0,=,1.0,1.0,=,IC50,nM,599791.08,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,3.222,CHEMBL378
782,10861974.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)COC(=O)[C@@]1(C)CC[C@]2(C)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024641,CHEMBL2024641,,0.0,http://www.openphacts.org/units/Nanomolar,1640537.0,>,1.0,1.0,>,IC50,nM,1203300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1203.3,CHEMBL613497
783,12683855.0,[],CHEMBL2339980,Antiviral activity against Hepatitis B virus transfected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL2331251,Bioorg Med Chem Lett,2013.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/Nanomolar,1867885.0,>,1.0,1.0,>,IC50,nM,1000000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1000.0,CHEMBL613497
784,1203883.0,[],CHEMBL710537,Inhibitory activity against 188L strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL223228,CHEMBL223228,6.80,0.0,http://www.openphacts.org/units/Nanomolar,127446.0,=,1.0,1.0,=,IC50,nM,158.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.158,CHEMBL378
785,2681566.0,[],CHEMBL1064020,Antiviral activity against HIV1 HXB2 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCNC(C)=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL508943,CHEMBL508943,7.16,0.0,http://www.openphacts.org/units/Nanomolar,823861.0,=,1.0,1.0,=,IC50,nM,70.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.07,CHEMBL378
786,18564551.0,[],CHEMBL4202340,Antiviral activity against HIV1 infected in human PBMC incubated for 24 hrs in presence of 10% NHS by GFP based single cycle HIV replication assay,F,BAO_0000190,BAO_0000218,organism-based format,C#CC1(CO)CC(n2cc(C)c(=O)[nH]c2=O)CC1O,CHEMBL4196238,J Med Chem,2018.0,CHEMBL4212382,CHEMBL4212382,,0.0,http://www.openphacts.org/units/Nanomolar,3082365.0,>,1.0,1.0,>,IC50,nM,2100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.1,CHEMBL378
787,823777.0,[],CHEMBL772932,Inhibition of Hepatitis C virus NS3 protease in vitro.,B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](O)C(=O)N1C[C@H](OCc2ccccc2)C[C@H]1C(=O)N[C@@H](CC(F)F)C(=O)NCCc1c(F)cc(C(=O)O)cc1F,CHEMBL1147550,Bioorg Med Chem Lett,2004.0,CHEMBL71391,CHEMBL71391,4.57,0.0,http://www.openphacts.org/units/Nanomolar,119351.0,=,1.0,1.0,=,IC50,nM,27000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,27.0,CHEMBL4620
788,1690583.0,[],CHEMBL858237,Inhibition of replication of R5 HIV1 HNK in PMBC,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1.CS(=O)(=O)O,CHEMBL1139007,J Med Chem,2006.0,CHEMBL2105686,CHEMBL2110727,10.06,0.0,http://www.openphacts.org/units/Nanomolar,438963.0,=,1.0,1.0,=,IC50,nM,0.087,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.087,CHEMBL378
789,22933330.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)CC(C)(C)C(=O)O)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](ON6CCN(C(=O)CC(C)(C)C(=O)O)CC6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4777239,CHEMBL4777239,7.85,0.0,http://www.openphacts.org/units/Nanomolar,3560891.0,=,1.0,1.0,=,IC50,nM,14.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.013999999999999999,CHEMBL378
790,3399307.0,[],CHEMBL1219623,Antiviral activity against R5 tropic HIV1 BAL infected in human TZM-bl cells assessed as inhibition of virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)O,CHEMBL1212937,J Med Chem,2010.0,CHEMBL1215925,CHEMBL1215925,,0.0,http://www.openphacts.org/units/Nanomolar,933726.0,=,1.0,1.0,=,IC50,nM,484500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,484.5,CHEMBL378
791,16556855.0,[],CHEMBL3795205,Antiviral activity against CXCR4 using HIV-1 NL4.3 infected in human MT4 cells assessed as reduction of viral replication preincubated for 15 mins with cells followed by viral infection measured after 4 days by MTS/PES method,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(Cc2ccccc2)CCCN(S(=O)(=O)c2ccc3ccccc3c2)C1.Cl,CHEMBL3792300,J Med Chem,2016.0,CHEMBL3793832,CHEMBL3794615,5.87,0.0,http://www.openphacts.org/units/Nanomolar,2770885.0,=,1.0,1.0,=,IC50,nM,1350.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.35,CHEMBL378
792,2930401.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSCc3ccccc3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL565680,CHEMBL565680,8.20,0.0,http://www.openphacts.org/units/Nanomolar,852864.0,=,1.0,1.0,=,IC50,nM,6.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.3,CHEMBL378
793,2292414.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Sc2cccc(N)c2C#N)cc1,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL51912,CHEMBL51912,,0.0,http://www.openphacts.org/units/Nanomolar,813166.0,=,1.0,1.0,=,IC50,nM,115080038.89,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,0.939,CHEMBL378
794,1954165.0,[],CHEMBL891428,Antiviral activity against HIV1 RT 103N/181C mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(OC)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL233662,CHEMBL233662,6.30,0.0,http://www.openphacts.org/units/Nanomolar,647182.0,=,1.0,1.0,=,IC50,nM,501.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,501.0,CHEMBL378
795,3214434.0,[],CHEMBL1110484,Antiviral activity against HIV1 NL4-3 co-transfected with VSV glycoprotein plasmid in human 293T cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=C[C@@H]1OC(=O)/C(=C/CC/C(C)=C/CCC2=CC(=O)OC2)[C@@H]1O,CHEMBL1153770,J Nat Prod,2009.0,CHEMBL1087556,CHEMBL1087556,,0.0,,894837.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
796,22449752.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.5', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.5'}]",CHEMBL4680707,Antiviral activity against HIV1 AD8 infected in dog Cf2Th/CD4-CCR5 cells assessed as inhibition of viral entry incubated for 30 mins prior to infection and measured after 48 hrs post infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(Cc1ccc2c(c1)C[C@H](CNC(=N)N)[C@H]2NC(=O)C(=O)Nc1ccc(Cl)c(F)c1)C(=N)N.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4680075,ACS Med Chem Lett,2016.0,CHEMBL4758519,CHEMBL4802996,5.80,0.0,http://www.openphacts.org/units/Nanomolar,3518673.0,=,1.0,1.0,=,IC50,nM,1600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.6,CHEMBL378
797,18239604.0,[],CHEMBL4052030,Antiviral activity against nelfinavir-resistant HIV1 NL4-3 harboring protease L10F/K20T/D30N/K45I/A71V/V77I mutant infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,CHEMBL4049446,J Med Chem,2017.0,CHEMBL1163,CHEMBL1163,7.77,0.0,http://www.openphacts.org/units/Nanomolar,3026808.0,=,1.0,1.0,=,IC50,nM,17.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,17.0,CHEMBL378
798,1241679.0,[],CHEMBL683624,In vitro integration activity provided by preintegration complexes isolated from HIV-infected cells,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC2(CC(C)(C)c3ccc(O)c(NC(N)=O)c32)c2cc(O)c(NC(N)=O)cc21,CHEMBL1133186,J Med Chem,2000.0,CHEMBL62411,CHEMBL62411,4.10,0.0,http://www.openphacts.org/units/Nanomolar,108756.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,80.0,CHEMBL378
799,1502900.0,[],CHEMBL834971,Inhibitory concentration against hepatitis C virus NS3 protease (IC50 spans 2.5 log units),B,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H](C(=O)N[C@H](C(=O)C1C[C@H](Oc2cccc3cccnc23)C[C@H]1C(=O)CC1(C(=O)O)CC1)C(C)C)C1CCCCC1,CHEMBL1143583,J Med Chem,2005.0,CHEMBL192148,CHEMBL192148,,0.0,http://www.openphacts.org/units/Nanomolar,389179.0,=,1.0,1.0,=,IC50,nM,251188.64,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,Log 1/IC50,,UO_0000065,3.6,CHEMBL4620
800,1520700.0,[],CHEMBL837207,Inhibitory concentration against resistant (A17) human immunodeficiency virus,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(CN2CCN([C@H](C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc(NC=O)cc3)C(C)C)C2=O)cs1,CHEMBL1144377,Bioorg Med Chem Lett,2005.0,CHEMBL380987,CHEMBL380987,5.62,0.0,http://www.openphacts.org/units/Nanomolar,395267.0,=,1.0,1.0,=,IC50,nM,2410.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.41,CHEMBL378
801,6152686.0,[],CHEMBL1763333,Inhibition of c-Jun,B,BAO_0000190,BAO_0000357,single protein format,Cc1c(-c2cnn(C)c2)ccc2cnc(Nc3ccc(-n4cnc(N5CCOCC5)n4)cc3)nc12,CHEMBL1759990,Bioorg Med Chem Lett,2011.0,CHEMBL1761579,CHEMBL1761579,6.80,0.0,http://www.openphacts.org/units/Nanomolar,1413795.0,=,1.0,1.0,=,IC50,nM,160.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.16,CHEMBL4977
802,200006.0,[],CHEMBL815090,Inhibition of HIV-1 (ADA) entry into U-87 (human glioblastoma) cells.,F,BAO_0000190,BAO_0000218,organism-based format,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)c[n+]([O-])cc3C)CC2)CC1,CHEMBL1136595,Bioorg Med Chem Lett,2003.0,CHEMBL161664,CHEMBL161664,9.40,0.0,http://www.openphacts.org/units/Nanomolar,317571.0,=,1.0,1.0,=,IC50,nM,0.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.4,CHEMBL378
803,2930446.0,[],CHEMBL1056901,Antiviral activity against HIV1 HXB2 harboring 101E and K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL223228,CHEMBL223228,6.80,0.0,http://www.openphacts.org/units/Nanomolar,848289.0,=,1.0,1.0,=,IC50,nM,158.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,158.0,CHEMBL378
804,601670.0,[],CHEMBL710534,Inhibitory activity against 188L strain of HIV-1 in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Nc1ncnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL305838,CHEMBL305838,7.30,0.0,http://www.openphacts.org/units/Nanomolar,126921.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.05,CHEMBL378
805,19261970.0,[],CHEMBL4404405,Antiviral activity against HIV1 subtypeD QD435.100M.ENV.B5,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.43,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,370.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.37,CHEMBL378
806,1271078.0,[],CHEMBL691378,Compound was evaluated for anti-retrovirus activity against HIV-1 (D34) Diagen strain,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2OCC/C=C/P(=O)(O)O,CHEMBL1126681,J Med Chem,1993.0,CHEMBL27301,CHEMBL27301,4.99,0.0,http://www.openphacts.org/units/Nanomolar,40481.0,=,1.0,1.0,=,IC50,nM,10200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.2,CHEMBL378
807,14714287.0,[],CHEMBL3293255,Antiviral activity against HIV1 harboring reverse transcriptase K103N/Y181C mutant infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)NC(c1ccnc(Nc2ccc(C#N)cc2)n1)c1ccccc1Cl,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL3288575,CHEMBL3288575,,0.0,http://www.openphacts.org/units/Nanomolar,2116133.0,>,1.0,1.0,>,IC50,nM,35462.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,35.462,CHEMBL378
808,24866696.0,[],CHEMBL5151773,Antiviral activity against DENV NS5/RNA-dependent RNA polymerase,F,BAO_0000190,BAO_0000218,organism-based format,CCCC/C=C/C#CC#CCCCCCCCC(=O)O,CHEMBL5150000,Eur J Med Chem,2021.0,CHEMBL2204412,CHEMBL2204412,5.66,0.0,http://www.openphacts.org/units/Nanomolar,3885521.0,=,1.0,1.0,=,IC50,nM,2200.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,2.2,CHEMBL613757
809,2602135.0,[],CHEMBL1034017,Antiviral activity against Vaccinia virus,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc2c(ncn2COCCO)c(=O)[nH]1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL184,CHEMBL184,6.42,0.0,http://www.openphacts.org/units/Nanomolar,807306.0,=,1.0,1.0,=,IC50,nM,384.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,0.384,CHEMBL613493
810,18239554.0,[],CHEMBL4052026,Antiviral activity against wild type HIV1 NL4-3 infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1C2CO[C@H]3OCC1C3C2)S(=O)(=O)c1ccc(N)cc1,CHEMBL4049446,J Med Chem,2017.0,CHEMBL4088111,CHEMBL4088111,8.48,0.0,http://www.openphacts.org/units/Nanomolar,3026803.0,=,1.0,1.0,=,IC50,nM,3.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.3,CHEMBL378
811,6257663.0,[],CHEMBL1798704,Antiviral activity against HIV1 3B infected in human MT4 cells coinjected with HTLV1 assessed as reduction in virus induced cytopathicity measured 5 days post infection by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C=C[C@]3(CO)C[C@H]23)c(=O)[nH]c1=O,CHEMBL1795267,Bioorg Med Chem,2011.0,CHEMBL606941,CHEMBL606941,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1435346.0,=,1.0,1.0,=,IC50,ug.mL-1,0.033,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.033,CHEMBL378
812,1045229.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=CN(Nc2ccccc2)C1C,CHEMBL1144865,J Med Chem,2003.0,CHEMBL40059,CHEMBL40059,,0.0,http://www.openphacts.org/units/Nanomolar,62348.0,>,1.0,1.0,>,IC50,nM,351420.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,351.42,CHEMBL613499
813,753247.0,[],CHEMBL691758,Inhibition of HIV-cell fusion was determined at 10 uM by using cellular FIGS assay; Inactive,F,BAO_0000190,BAO_0000218,organism-based format,N=C(N)c1cccc(Oc2ccccc2)c1,CHEMBL1146750,Bioorg Med Chem Lett,2004.0,CHEMBL314851,CHEMBL314851,,0.0,http://www.openphacts.org/units/Nanomolar,164111.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
814,18202548.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2ccc(Cl)nc2Cl)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4074355,CHEMBL4074355,6.07,0.0,http://www.openphacts.org/units/Nanomolar,3019986.0,=,1.0,1.0,=,IC50,nM,860.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.86,CHEMBL378
815,1690585.0,[],CHEMBL858238,Inhibition of replication of R5 HIV1 HTN in PMBC,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1.CS(=O)(=O)O,CHEMBL1139007,J Med Chem,2006.0,CHEMBL2105686,CHEMBL2110727,10.05,0.0,http://www.openphacts.org/units/Nanomolar,438963.0,=,1.0,1.0,=,IC50,nM,0.089,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.089,CHEMBL378
816,1402211.0,[],CHEMBL835252,In vitro inhibitory concentration against HIV K101E and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177744,CHEMBL177744,,0.0,http://www.openphacts.org/units/Nanomolar,360400.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
817,10938466.0,[],CHEMBL2051603,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccc(F)c(F)c4F)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046581,CHEMBL2046581,5.55,0.0,http://www.openphacts.org/units/Nanomolar,1651464.0,=,1.0,1.0,=,IC50,nM,2830.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.83,CHEMBL613497
818,2601990.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(C(F)(F)F)c1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL275658,CHEMBL275658,8.40,0.0,http://www.openphacts.org/units/Nanomolar,807582.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.004,CHEMBL378
819,19261763.0,[],CHEMBL4404352,Antiviral activity against HIV1 HXB2 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.46,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,350.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.35,CHEMBL378
820,12067397.0,[],CHEMBL2160773,Antiviral activity against HBV assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nccn1-c1c(O)ccc2c1nc(CNc1ccccc1)n2C,CHEMBL2157888,Bioorg Med Chem,2012.0,CHEMBL2159764,CHEMBL2159764,,0.0,http://www.openphacts.org/units/Nanomolar,1734972.0,=,1.0,1.0,=,IC50,nM,7800000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,7.8,CHEMBL613497
821,1402291.0,[],CHEMBL833792,In vitro inhibitory concentration against HIV-1 Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NCc2ccccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177491,CHEMBL177491,5.00,0.0,http://www.openphacts.org/units/Nanomolar,360417.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
822,24731877.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5115940,Antiviral activity against ZIKV-SMGC-1 infected in human BHK cells incubated for 7 days by CellTiter 96 luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(c1ccc(C(F)(F)F)cc1O)c1[nH]c(Cl)c(Cl)c1-n1c(C(=O)c2ccc(C(F)(F)F)cc2O)cc(Cl)c1SCCc1ccccn1,CHEMBL5113415,Eur J Med Chem,2022.0,CHEMBL5182449,CHEMBL5182449,6.82,0.0,http://www.openphacts.org/units/Nanomolar,3857953.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,0.15,CHEMBL4296612
823,2601951.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)c2c(C(N)=O)[nH]c3ccc(Cl)cc23)cc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL84217,CHEMBL84217,8.52,0.0,http://www.openphacts.org/units/Nanomolar,806778.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
824,2694330.0,[],CHEMBL1053931,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV surface antigen at < TC50,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2nc3c(cc2c(CN2CCN(C)CC2)c1O)CSc1ccc(C)cc1-3,CHEMBL1152943,Bioorg Med Chem,2009.0,CHEMBL561065,CHEMBL561065,,0.0,,824941.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
825,2929729.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cccn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578376,CHEMBL578376,7.50,0.0,http://www.openphacts.org/units/Nanomolar,852984.0,=,1.0,1.0,=,IC50,nM,31.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.6,CHEMBL378
826,24735314.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5116803,Antiviral activity against CHIKV infected in human Huh-7 cells assessed as inhibition of viral infection by measuring EGFP-positive cells measured 24 hrs post infection by fluorescent microscopic analysis,F,BAO_0000190,BAO_0000218,organism-based format,Oc1c(O)c(O)c2c(=S)cc(-c3ccccc3)oc2c1-c1ccc(F)cc1,CHEMBL5113447,Bioorg Med Chem Lett,2022.0,CHEMBL5203342,CHEMBL5203342,5.33,0.0,http://www.openphacts.org/units/Nanomolar,3858565.0,=,1.0,1.0,=,IC50,nM,4700.0,CHEMBL4296563,Chikungunya virus,Chikungunya virus,37124,IC50,uM,UO_0000065,4.7,CHEMBL4296563
827,1403341.0,[],CHEMBL834758,Inhibitory concentration against 188L mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1Sc1nc(Nc2ccc(C#N)cc2)c(=O)n(C)c1C,CHEMBL1145199,J Med Chem,2005.0,CHEMBL180474,CHEMBL180474,,0.0,http://www.openphacts.org/units/Nanomolar,360749.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
828,506275.0,[],CHEMBL752813,Inhibition to hepatitis C virus (HCV) NS3/NS4A serine protease,B,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H](C(=O)[C@H](CCC(=O)O)N[C@@H](CC1CCCCC1)C(=O)N[C@H](C=O)CC(F)F)C(c1ccccc1)c1ccccc1,CHEMBL1135212,Bioorg Med Chem Lett,2002.0,CHEMBL163864,CHEMBL163864,,0.0,http://www.openphacts.org/units/Nanomolar,317191.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,50.0,CHEMBL4620
829,18342096.0,[],CHEMBL4139012,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1ccc(-c2cc(NC(=O)c3ccc(Cl)cc3O)c[nH]c2=O)cc1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL4167090,CHEMBL4167090,4.64,0.0,http://www.openphacts.org/units/Nanomolar,3045874.0,=,1.0,1.0,=,IC50,nM,22800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,22.8,CHEMBL613497
830,1954152.0,[],CHEMBL891425,Antiviral activity against HIV1 RT 188L mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(C2CC2)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL234285,CHEMBL234285,6.80,0.0,http://www.openphacts.org/units/Nanomolar,647178.0,=,1.0,1.0,=,IC50,nM,158.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,158.0,CHEMBL378
831,1049991.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(NN2C=NC(C)C2c2cccc(C(N)=O)c2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289608,CHEMBL289608,,0.0,http://www.openphacts.org/units/Nanomolar,62339.0,>,1.0,1.0,>,IC50,nM,162310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,162.31,CHEMBL378
832,1502788.0,[],CHEMBL834971,Inhibitory concentration against hepatitis C virus NS3 protease (IC50 spans 2.5 log units),B,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H](C(=O)N[C@H](C(=O)C1C[C@H](Oc2cccc(-c3cccc([N+](=O)[O-])c3)c2)C[C@H]1C(=O)CC1(C(=O)O)CC1)C(C)C)C1CCCCC1,CHEMBL1143583,J Med Chem,2005.0,CHEMBL191670,CHEMBL191670,5.20,0.0,http://www.openphacts.org/units/Nanomolar,389118.0,=,1.0,1.0,=,IC50,nM,6309.57,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,Log 1/IC50,,UO_0000065,5.2,CHEMBL4620
833,37578.0,[],CHEMBL695519,Antiviral activity against V106A strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL223228,CHEMBL223228,8.82,0.0,http://www.openphacts.org/units/Nanomolar,20823.0,=,1.0,1.0,=,IC50,nM,1.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.5,CHEMBL378
834,5222611.0,[],CHEMBL1675305,Antiviral activity against HIV1 infected in human MT2 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL853,CHEMBL853,6.89,0.0,http://www.openphacts.org/units/Nanomolar,1332026.0,=,1.0,1.0,=,IC50,nM,130.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.13,CHEMBL378
835,1681481.0,[],CHEMBL866396,Antiviral activity against HIV1 NL4.3 in MT4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(OC)cc2)CCCN(CCC(C)C)CCCN(S(=O)(=O)c2ccc(OC)cc2)C1,CHEMBL1149461,J Med Chem,2006.0,CHEMBL204141,CHEMBL204141,6.20,0.0,http://www.openphacts.org/units/Nanomolar,427690.0,=,1.0,1.0,=,IC50,nM,630.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.63,CHEMBL378
836,10863174.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCCOc6ccccc6)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024635,CHEMBL2024635,4.85,0.0,http://www.openphacts.org/units/Nanomolar,1640531.0,=,1.0,1.0,=,IC50,nM,14170.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,14.17,CHEMBL613497
837,1210454.0,[],CHEMBL880061,Inhibitory activity against LAI strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1Cl,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72205,CHEMBL72205,8.85,0.0,http://www.openphacts.org/units/Nanomolar,127443.0,=,1.0,1.0,=,IC50,nM,1.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0014,CHEMBL378
838,10860670.0,[],CHEMBL2020780,Antiviral against R5 tropic HIV1 Bal infected in human CEMx174 5.25M7 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CCN(C(=O)Cc1ccccc1)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2ccc(C)c(Cl)c2)CC1.Cl,CHEMBL2016501,Bioorg Med Chem Lett,2012.0,CHEMBL2017515,CHEMBL2021730,8.28,0.0,http://www.openphacts.org/units/Nanomolar,1635088.0,=,1.0,1.0,=,IC50,nM,5.23,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.23,CHEMBL378
839,2371542.0,[],CHEMBL1035740,Antiviral activity against HIV1 with reverse transcriptase Y181C mutant in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4nc(N)ccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL489586,CHEMBL489586,8.25,0.0,http://www.openphacts.org/units/Nanomolar,773548.0,=,1.0,1.0,=,IC50,nM,5.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.6,CHEMBL378
840,22933240.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)/C=C/c4ccc(OCOC)cc4)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4797012,CHEMBL4797012,6.70,0.0,http://www.openphacts.org/units/Nanomolar,3560846.0,=,1.0,1.0,=,IC50,nM,199.53,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.7,CHEMBL378
841,8027845.0,[],CHEMBL1948541,Antiviral activity against HIV1 NF-462 expressing wild-type Vpr infected in human 293T cells containing 4 ng of viral p24 antigen after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Oc1cc2c(cc1O)[C@@H]1c3ccc(O)c(O)c3OC[C@]1(O)C2,CHEMBL1944615,Bioorg Med Chem Lett,2012.0,CHEMBL477197,CHEMBL477197,,0.0,http://www.openphacts.org/units/Nanomolar,1573823.0,<,1.0,1.0,<,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
842,2244609.0,[],CHEMBL1005599,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase V106I/Y181C mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(COc1ccc(Cl)cc1C(=O)c1ccccc1)Nc1ccccc1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL296939,CHEMBL296939,5.72,0.0,http://www.openphacts.org/units/Nanomolar,798577.0,=,1.0,1.0,=,IC50,nM,1905.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1905.0,CHEMBL378
843,22753379.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4700293,Antiviral activity against Vaccinia virus Copenhagen infected in African green monkey Vero cells assessed as reduction in cell survival incubated for 4 days by neutral red dye based colorimetric analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@H]2CC=C(CNC(=O)C34CC5CC(CC(C5)C3)C4)[C@@H]1C2,CHEMBL4699424,RSC Med Chem,2020.0,CHEMBL4789170,CHEMBL4789170,5.77,0.0,http://www.openphacts.org/units/Nanomolar,3531597.0,=,1.0,1.0,=,IC50,nM,1700.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,1.7,CHEMBL613493
844,1830875.0,[],CHEMBL918634,Antiviral activity against wild type HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(C(=O)c2ccccc2)nc(SC(C)C)[nH]c1=O,CHEMBL1144474,J Med Chem,2007.0,CHEMBL375856,CHEMBL375856,5.69,0.0,http://www.openphacts.org/units/Nanomolar,629316.0,=,1.0,1.0,=,IC50,nM,2050.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.05,CHEMBL378
845,2601883.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(Cl)n([C@@H]2O[C@H](CN=[N+]=[N-])[C@@H](O)[C@H]2O)c2cc(Cl)c(Cl)cc12,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL475088,CHEMBL475088,4.82,0.0,http://www.openphacts.org/units/Nanomolar,807847.0,=,1.0,1.0,=,IC50,nM,15000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,15.0,CHEMBL378
846,1401708.0,[],CHEMBL837465,In vitro inhibitory concentration against HIV G190S mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,COCCCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL178689,CHEMBL178689,7.50,0.0,http://www.openphacts.org/units/Nanomolar,360393.0,=,1.0,1.0,=,IC50,nM,32.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.032,CHEMBL378
847,925548.0,[],CHEMBL650153,Compound was tested for anti-retroviral activity against moloney murine sarcoma virus (MSV) in murine C3H/3T3 embryo fibroblast cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(N)c2nnn(C[C@@H](CO)OCP(=O)(O)O)c2n1,CHEMBL1129435,J Med Chem,1996.0,CHEMBL129687,CHEMBL129687,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251946.0,=,1.0,1.0,=,IC50,ug.mL-1,1.0,CHEMBL613501,Moloney murine sarcoma virus,Moloney murine sarcoma virus,11809,IC50,ug ml-1,UO_0000274,1.0,CHEMBL613501
848,18057382.0,[],CHEMBL4012533,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA level,F,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)C1=C(C)NC(c2nccs2)=N[C@H]1c1ccc(F)cc1Cl,CHEMBL4011615,J Med Chem,2017.0,CHEMBL3741774,CHEMBL3741774,7.52,0.0,http://www.openphacts.org/units/Nanomolar,2992842.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.03,CHEMBL613497
849,18044542.0,[],CHEMBL4010365,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of p24 antigen production pretreated with virus for 30 mins followed by 4 days incubation with cells by sandwich ELISA based multicycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(C(NC(=O)c2ccc(-c3ccc(Cl)cc3)[nH]2)C2CCCCN2)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4096918,CHEMBL4096918,6.07,0.0,http://www.openphacts.org/units/Nanomolar,2990237.0,=,1.0,1.0,=,IC50,nM,850.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.85,CHEMBL378
850,18044755.0,[],CHEMBL4010409,"Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype C 6055-2, clone 3",F,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075766,CHEMBL4075766,6.66,0.0,http://www.openphacts.org/units/Nanomolar,2990214.0,=,1.0,1.0,=,IC50,nM,220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.22,CHEMBL378
851,19281695.0,[],CHEMBL4409359,Antiviral activity against HIV1 VB59 infected in human TZM-bl cells incubated for 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(cnn2-c2ccc(C(F)(F)F)cc2)c(=O)[nH]1,CHEMBL4406854,Eur J Med Chem,2019.0,CHEMBL4467245,CHEMBL4467245,,0.0,http://www.openphacts.org/units/Nanomolar,3219935.0,>,1.0,1.0,>,IC50,nM,170650.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,170.65,CHEMBL378
852,3247254.0,[],CHEMBL1116114,Antiviral activity against HIV1 3B infected in human HOS cells expressing human CXCR4/CCR5/CD4 and HIV-LTR-luciferase,F,BAO_0000190,BAO_0000218,organism-based format,CN(Cc1nc2ccccc2n1CC1CNC1)C1CCCc2cccnc21,CHEMBL1156326,Bioorg Med Chem Lett,2010.0,CHEMBL1088793,CHEMBL1088793,7.08,0.0,http://www.openphacts.org/units/Nanomolar,902950.0,=,1.0,1.0,=,IC50,nM,84.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,84.0,CHEMBL378
853,2929517.0,[],CHEMBL1056898,Antiviral activity against HIV1 HXB2 harboring 190S mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3ccnc3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL568526,CHEMBL568526,8.66,0.0,http://www.openphacts.org/units/Nanomolar,852832.0,=,1.0,1.0,=,IC50,nM,2.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.2,CHEMBL378
854,2601796.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,OC[C@@H]1O[C@H](n2cnc3c(O)ncnc32)C=C1F,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL515143,CHEMBL515143,4.00,0.0,http://www.openphacts.org/units/Nanomolar,808125.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
855,2371445.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2oc(=O)c3cc(C(=O)NCCN4CCCCC4C)sc3c2c1,CHEMBL1140145,J Med Chem,2008.0,CHEMBL523387,CHEMBL523387,4.60,0.0,http://www.openphacts.org/units/Nanomolar,746357.0,=,1.0,1.0,=,IC50,nM,25000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,25.0,CHEMBL613493
856,645099.0,[],CHEMBL696966,Concentration required for reduction of plaque against influenza B,F,BAO_0000190,BAO_0000218,organism-based format,CCCN(CCc1ccccc1)C(=O)[C@@H]1OC(C(=O)O)=C[C@H](O)[C@H]1NC(C)=O,CHEMBL1134218,Bioorg Med Chem Lett,2001.0,CHEMBL162413,CHEMBL162413,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,313064.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,100.0,CHEMBL613129
857,1401943.0,[],CHEMBL837467,In vitro inhibitory concentration against HIV K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCNc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL424972,CHEMBL424972,5.80,0.0,http://www.openphacts.org/units/Nanomolar,360389.0,=,1.0,1.0,=,IC50,nM,1585.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.585,CHEMBL378
858,10911764.0,[],CHEMBL2038369,Antiviral activity against wild type HIV1 clade B 94US3393IN clinical isolate infected in PHA-P-stimulated human PBMC assessed as reverse transcriptase activity incubated for 6 hrs followed by incubated in drug-free medium for 6 days by multiround infection assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL2034836,J Med Chem,2012.0,CHEMBL141,CHEMBL141,7.06,0.0,http://www.openphacts.org/units/Nanomolar,1644919.0,=,1.0,1.0,=,IC50,nM,87.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,87.3,CHEMBL378
859,12687174.0,[],CHEMBL2344307,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral surface antigen production,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(/C=C/C(=O)O[C@H]2C[C@@H]3C(=CC[C@@H]4[C@@]3(C)C(=O)C[C@]3(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](OC(C)=O)C[C@@]43C)C(C)(C)[C@@H]2OC(=O)/C=C/c2cccc(OC)c2)c1,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332405,CHEMBL2332405,,0.0,http://www.openphacts.org/units/Nanomolar,1866099.0,>,1.0,1.0,>,IC50,nM,718900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,718.9,CHEMBL613497
860,3084544.0,[],CHEMBL1065276,Antiviral activity against HIV1 89.6 laboratory isolate assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC(C)(C)N1,CHEMBL1153139,Bioorg Med Chem Lett,2010.0,CHEMBL254781,CHEMBL254781,5.00,0.0,http://www.openphacts.org/units/Nanomolar,873907.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
861,22898283.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731088,Antiviral activity against HIV1 LAI infected in human MT2 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)C[C@H]1C2CO[C@H]3OC[C@@H]1C3C2)S(=O)(=O)c1ccc2nc(NC3CC3)sc2c1,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL4740468,CHEMBL4740468,8.59,0.0,http://www.openphacts.org/units/Nanomolar,3554414.0,=,1.0,1.0,=,IC50,nM,2.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.6,CHEMBL378
862,19407955.0,[],CHEMBL4426963,Antiviral activity against wild type HIV1 NL4-3 infected in human MT4 cells by p24 assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL4425138,J Med Chem,2016.0,CHEMBL116,CHEMBL116,7.77,0.0,http://www.openphacts.org/units/Nanomolar,3243728.0,=,1.0,1.0,=,IC50,nM,17.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.017,CHEMBL378
863,2320860.0,[],CHEMBL984035,Antiviral activity against HIV1 infected in CEM-SS cells assessed as virus-induced cytopathic effect by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CC(C)(C)C1(CC=C(C)C)C(=O)Nc2ccccc2C1=O,CHEMBL1158254,J Nat Prod,1996.0,CHEMBL511557,CHEMBL511557,4.54,0.0,http://www.openphacts.org/units/Nanomolar,739138.0,=,1.0,1.0,=,IC50,nM,29000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,29.0,CHEMBL378
864,501644.0,[],CHEMBL691389,Inhibitory concentration against HIV-1 Bal/Mono,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC(C)=O)c1Cc1cc(C)cc(C)c1,CHEMBL1133473,J Med Chem,2000.0,CHEMBL129144,CHEMBL129144,6.70,0.0,http://www.openphacts.org/units/Nanomolar,245545.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,200.0,CHEMBL378
865,7843576.0,[],CHEMBL1913152,Antiviral activity against HIV1 Ba-L infected in human HOS cells assessed as reduction of viral replication after 4 days by Steady-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(S(C)(=O)=O)cc2F)ccc1CN1CCC(N2C(=O)N(c3cc(C(N)=O)c(F)cc3F)C[C@H]2c2ccccc2)CC1,CHEMBL1909524,Bioorg Med Chem Lett,2011.0,CHEMBL1909871,CHEMBL1909871,8.28,0.0,http://www.openphacts.org/units/Nanomolar,1542000.0,=,1.0,1.0,=,IC50,nM,5.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.2,CHEMBL378
866,2614805.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1cccc(F)c1,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL58988,CHEMBL58988,,0.0,http://www.openphacts.org/units/Nanomolar,731990.0,=,1.0,1.0,=,IC50,nM,2999162.52,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,2.523,CHEMBL378
867,10937570.0,[],CHEMBL2051603,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccc(F)c(F)c4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046579,CHEMBL2046579,5.33,0.0,http://www.openphacts.org/units/Nanomolar,1651462.0,=,1.0,1.0,=,IC50,nM,4660.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,4.66,CHEMBL613497
868,2602171.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C(\O)c1nnn[nH]1)c1c[nH]c2ccc(F)cc12,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL516201,CHEMBL516201,5.75,0.0,http://www.openphacts.org/units/Nanomolar,807499.0,=,1.0,1.0,=,IC50,nM,1800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.8,CHEMBL378
869,18940423.0,[],CHEMBL4328848,Antiviral activity against HIV-1 3B infected in human MAGI-CXCR4 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)OC(=O)n1ccc2ccc(-c3ccc4ccn(Cc5cccc(C(=O)O)c5)c4c3)cc21,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4440451,CHEMBL4440451,6.00,0.0,http://www.openphacts.org/units/Nanomolar,3159824.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
870,5229732.0,[],CHEMBL1678271,Antiviral activity against Human immunodeficiency virus 1 WEJO infected in phytohemagglutininin and interleukin-2-stimulated PBMC assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,8.00,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
871,10938646.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(/C=C/C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(OC(=O)/C=C/c3cccc(OC)c3)C(C)=O)C2)c1,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046592,CHEMBL2046592,,0.0,http://www.openphacts.org/units/Nanomolar,1651476.0,>,1.0,1.0,>,IC50,nM,1367030.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1367.03,CHEMBL613497
872,1671958.0,[],CHEMBL870621,Antiviral activity against HIV1 Y181C mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)cc(C(=O)c2cc(Cl)ccc2OCC(=O)Nc2ccc(S(N)(=O)=O)cc2C)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL201343,CHEMBL201343,8.48,0.0,http://www.openphacts.org/units/Nanomolar,411931.0,=,1.0,1.0,=,IC50,nM,3.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.3,CHEMBL378
873,10937545.0,[],CHEMBL2051603,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccc(Cl)cc4Cl)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046583,CHEMBL2046583,4.84,0.0,http://www.openphacts.org/units/Nanomolar,1651466.0,=,1.0,1.0,=,IC50,nM,14540.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,14.54,CHEMBL613497
874,24823545.0,[],CHEMBL5140686,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBsAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3cc(F)ccc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5205341,CHEMBL5205341,7.74,0.0,http://www.openphacts.org/units/Nanomolar,3876719.0,=,1.0,1.0,=,IC50,nM,18.4,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0184,CHEMBL613497
875,13933251.0,[],CHEMBL3124237,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV DNA production,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2cc3c(nc2c(CN2CCCCC2)c1O)-c1ccc(F)cc1SC3,CHEMBL3120134,Eur J Med Chem,2014.0,CHEMBL3121583,CHEMBL3121583,,0.0,http://www.openphacts.org/units/Nanomolar,1969538.0,<,1.0,1.0,<,IC50,nM,10000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol/L,UO_0000065,10.0,CHEMBL613497
876,3014829.0,[],CHEMBL1050514,Antiviral activity against wild type HIV1 isolate ERS104pre infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,CHEMBL1156053,J Med Chem,2009.0,CHEMBL729,CHEMBL729,7.47,0.0,http://www.openphacts.org/units/Nanomolar,862429.0,=,1.0,1.0,=,IC50,nM,34.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.034,CHEMBL378
877,512570.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1Sc1cccc(Br)c1,CHEMBL1134494,J Med Chem,2001.0,CHEMBL56465,CHEMBL56465,5.29,0.0,http://www.openphacts.org/units/Nanomolar,94273.0,=,1.0,1.0,=,IC50,nM,5100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.1,CHEMBL378
878,1471432.0,[],CHEMBL833076,Inhibitory activity against HIV-1 mutant strain 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1ccccc1Cl,CHEMBL1138799,J Med Chem,2004.0,CHEMBL364403,CHEMBL364403,6.41,0.0,http://www.openphacts.org/units/Nanomolar,380883.0,=,1.0,1.0,=,IC50,nM,390.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.39,CHEMBL378
879,1472130.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C/c2ccsc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188574,CHEMBL188574,7.00,0.0,http://www.openphacts.org/units/Nanomolar,380697.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
880,239036.0,[],CHEMBL690481,In vitro antiviral activity against NNRTI-resistant IIIB (WT) HIV-1 variant,F,BAO_0000190,BAO_0000218,organism-based format,CC(Sc1nc(N)cc(Cl)n1)c1cc2ccoc2cn1,CHEMBL1131332,J Med Chem,1998.0,CHEMBL280752,CHEMBL280752,8.70,0.0,http://www.openphacts.org/units/Nanomolar,41266.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.002,CHEMBL378
881,2930370.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3ncnc3C)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL573699,CHEMBL573699,8.70,0.0,http://www.openphacts.org/units/Nanomolar,848338.0,=,1.0,1.0,=,IC50,nM,1.99,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.99,CHEMBL378
882,1403424.0,[],CHEMBL837591,Inhibitory concentration against wild-type HIV-1 LAI Virus was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1Sc1nc(Nc2ccc(C#N)cc2)c(O)nc1C,CHEMBL1145199,J Med Chem,2005.0,CHEMBL367414,CHEMBL367414,7.40,0.0,http://www.openphacts.org/units/Nanomolar,360761.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
883,13933236.0,[],CHEMBL3124190,Antiviral activity against Hepatitis B virus assessed as inhibition of Hepatitis B virus DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1oc2nc1C(=O)N[C@@H](C)c1nc(co1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)c1nc-2cs1,CHEMBL3120134,Eur J Med Chem,2014.0,CHEMBL370651,CHEMBL370651,4.12,0.0,http://www.openphacts.org/units/Nanomolar,1969510.0,=,1.0,1.0,=,IC50,nM,76400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol/L,UO_0000065,76.4,CHEMBL613497
884,3198129.0,[],CHEMBL1104127,Antiviral activity against HIV1 BR/93/020 infected in PBMCs assessed as reverse transcriptase activity after 7 days by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)CCNC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@@H](N)Cc1ccc(O)cc1,CHEMBL1153724,Bioorg Med Chem Lett,2009.0,CHEMBL1075830,CHEMBL1075830,5.33,0.0,http://www.openphacts.org/units/Nanomolar,889153.0,=,1.0,1.0,=,IC50,nM,4700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.7,CHEMBL378
885,19261876.0,[],CHEMBL4404373,Antiviral activity against HIV1 subtypeA/G CRF13_cpx clone 258,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.28,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,520.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.52,CHEMBL378
886,1401614.0,[],CHEMBL835252,In vitro inhibitory concentration against HIV K101E and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL366692,CHEMBL366692,7.89,0.0,http://www.openphacts.org/units/Nanomolar,360329.0,=,1.0,1.0,=,IC50,nM,13.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.013,CHEMBL378
887,5132789.0,[],CHEMBL1646267,Antiviral activity against HIV1 BaL infected in human PBMC assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2[nH]c(=O)c(CN(Cc3ccco3)C(=O)c3ccc(Cl)cc3)cc2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645043,CHEMBL1645043,5.38,0.0,http://www.openphacts.org/units/Nanomolar,1321031.0,=,1.0,1.0,=,IC50,nM,4220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.22,CHEMBL378
888,1402054.0,[],CHEMBL837469,In vitro inhibitory concentration against HIV V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC(C)=O)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL129144,CHEMBL129144,,0.0,http://www.openphacts.org/units/Nanomolar,360368.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
889,668344.0,[],CHEMBL696966,Concentration required for reduction of plaque against influenza B,F,BAO_0000190,BAO_0000218,organism-based format,CCCN(CCC)C(=O)[C@@H]1OC(C(=O)O)=C[C@H](N)[C@H]1NC(C)=O,CHEMBL1134218,Bioorg Med Chem Lett,2001.0,CHEMBL295490,CHEMBL295490,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,313062.0,=,1.0,1.0,=,IC50,ug.mL-1,0.7,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,0.7,CHEMBL613129
890,13933292.0,[],CHEMBL3124244,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV surface antigen secretion after 21 days,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1[C@H](OC(=O)CCC(=O)O)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,CHEMBL3120134,Eur J Med Chem,2014.0,CHEMBL361497,CHEMBL361497,5.64,0.0,http://www.openphacts.org/units/Nanomolar,1969549.0,=,1.0,1.0,=,IC50,nM,2300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol/L,UO_0000065,2.3,CHEMBL613497
891,472107.0,[],CHEMBL756134,Cytotoxic effect in human peripheral blood monocyte cells(PBMC),F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2cc3nc4ccccc4c(O)c3cc2s1.Cl,CHEMBL1125493,J Med Chem,1992.0,CHEMBL542907,CHEMBL1191765,4.68,0.0,http://www.openphacts.org/units/Nanomolar,170443.0,=,1.0,1.0,=,IC50,nM,21100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,21.1,CHEMBL378
892,3432866.0,[],CHEMBL1246459,Antiviral activity against R5 tropic HIV1 BaL infected in human CEMx174 5.25M7 cells after 3 days by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1C(=O)N1CCC(C(=O)NN2C(=O)C3C4C=CC(C5CC45)C3C2=O)CC1,CHEMBL1240449,Eur J Med Chem,2010.0,CHEMBL1241833,CHEMBL1241833,,0.0,http://www.openphacts.org/units/Nanomolar,952749.0,>,1.0,1.0,>,IC50,nM,117960.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,117.96,CHEMBL378
893,1438420.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/c1cccc(C(=O)c2c(CC)c(C)nc(O)c2N(C)C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL182725,CHEMBL182725,6.41,0.0,http://www.openphacts.org/units/Nanomolar,371593.0,=,1.0,1.0,=,IC50,nM,390.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.39,CHEMBL378
894,23274458.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](NC(=O)CCCC(=O)N[C@@H]5CC[C@@]6(C)[C@@H](C5)C[C@H](O)[C@@H]5[C@@H]6CC[C@]6(C)[C@@H]([C@H](C)CCC(=O)NCCS(=O)(=O)O)CC[C@@H]56)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4863154,CHEMBL4863154,7.03,0.0,http://www.openphacts.org/units/Nanomolar,3621258.0,=,1.0,1.0,=,IC50,nM,93.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,93.0,CHEMBL613497
895,622922.0,[],CHEMBL710373,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,COc1nc(Cc2c(Cl)cccc2Cl)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL71579,CHEMBL71579,5.94,0.0,http://www.openphacts.org/units/Nanomolar,126934.0,=,1.0,1.0,=,IC50,nM,1150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.15,CHEMBL378
896,5229823.0,[],CHEMBL1678270,Antiviral activity against Human immunodeficiency virus 1 TEKI infected in phytohemagglutininin and interleukin-2-stimulated PBMC assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL129,CHEMBL129,9.00,0.0,http://www.openphacts.org/units/Nanomolar,1332124.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
897,2030629.0,[],CHEMBL886374,Inhibition of cJun translocation in IL-1-beta-stimulated A549 cells,B,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)N1CCC(Nc2ncc(C)c(-c3c[nH]c4ccccc34)n2)CC1,CHEMBL1139954,Bioorg Med Chem Lett,2007.0,CHEMBL245724,CHEMBL245724,5.00,0.0,http://www.openphacts.org/units/Nanomolar,674099.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,nM,UO_0000065,10000.0,CHEMBL4977
898,24831021.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C1CCN(c2cc3oc4c(Cl)cccc4c(=O)c3cn2)C1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5200770,CHEMBL5200770,,0.0,http://www.openphacts.org/units/Nanomolar,3878133.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
899,15690081.0,[],CHEMBL3610403,Antiviral activity against HIV1 3B infected in CD4/CXCR4 expressing human MAGI cells incubated for 48 hrs by beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1cc(CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[nH]n1,CHEMBL3608277,ACS Med Chem Lett,2015.0,CHEMBL3608765,CHEMBL3608765,4.17,0.0,http://www.openphacts.org/units/Nanomolar,2496843.0,=,1.0,1.0,=,IC50,nM,68000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,68.0,CHEMBL378
900,14714263.0,[],CHEMBL3293254,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(O)CNC(c1ccnc(Nc2ccc(C#N)cc2)n1)c1ccccc1Cl,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL3288577,CHEMBL3288577,6.48,0.0,http://www.openphacts.org/units/Nanomolar,2116135.0,=,1.0,1.0,=,IC50,nM,330.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.33,CHEMBL378
901,3221770.0,[],CHEMBL1102828,Antiviral activity against HIV1 carrying reverse transcriptase L1001 mutant infected human MT4 cells by phenoscreen assay in the presence of 40 percent normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,CS(=O)(=O)c1ccc(NC(=O)CSC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,CHEMBL1153798,Bioorg Med Chem Lett,2009.0,CHEMBL1078944,CHEMBL1078944,4.30,0.0,http://www.openphacts.org/units/Nanomolar,898067.0,=,1.0,1.0,=,IC50,nM,50500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,0.0505,CHEMBL378
902,1206556.0,[],CHEMBL880061,Inhibitory activity against LAI strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Nc1nc(Nc2ccc(C#N)cc2)ncc1C#N,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL69890,CHEMBL69890,9.30,0.0,http://www.openphacts.org/units/Nanomolar,127450.0,=,1.0,1.0,=,IC50,nM,0.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0005,CHEMBL378
903,1243032.0,[],CHEMBL683624,In vitro integration activity provided by preintegration complexes isolated from HIV-infected cells,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC2(CC(C)(C)c3cc(C=O)c(O)cc32)c2cc(O)c(C=O)cc21,CHEMBL1133186,J Med Chem,2000.0,CHEMBL417029,CHEMBL417029,4.10,0.0,http://www.openphacts.org/units/Nanomolar,108752.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,80.0,CHEMBL378
904,5199466.0,[],CHEMBL1670944,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)OCCc1c(Cl)nc2ccc(Cl)cc2c1-c1ccccc1Cl,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668633,CHEMBL1668633,,0.0,http://www.openphacts.org/units/Nanomolar,1328417.0,=,1.0,1.0,=,IC50,nM,146800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,146.8,CHEMBL613497
905,17987405.0,[],CHEMBL3999574,Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 40 hrs,F,BAO_0000190,BAO_0000219,cell-based format,C=C(C(=O)OC)[C@@H]1CC[C@H](C)[C@H]2C(=C(C)C(=O)[C@@H]2[C@@H](O)c2cc(F)cc(F)c2)C1,CHEMBL3997818,Bioorg Med Chem Lett,2017.0,CHEMBL4067716,CHEMBL4067716,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,2979923.0,=,1.0,1.0,=,IC50,ug.mL-1,18.52,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,18.52,CHEMBL613129
906,3198132.0,[],CHEMBL1104126,Antiviral activity against HIV1 CMU06 infected in PBMCs assessed as reverse transcriptase activity after 7 days by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](CN[C@H](CN[C@H](CN[C@H](CNCCC(N)=O)Cc1ccc(O)cc1)Cc1ccc(O)cc1)Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@@H](N)Cc1ccc(O)cc1,CHEMBL1153724,Bioorg Med Chem Lett,2009.0,CHEMBL1075825,CHEMBL1075825,4.74,0.0,http://www.openphacts.org/units/Nanomolar,889166.0,=,1.0,1.0,=,IC50,nM,18200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,18.2,CHEMBL378
907,18987181.0,[],CHEMBL4340290,Antiviral activity against HIV NL4-3 infected in human MT4 cells measured on day 3 post-infection by Nano-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC/C=C/C=C/C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(COC(C)=O)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C,CHEMBL4339238,J Nat Prod,2019.0,CHEMBL444960,CHEMBL444960,8.30,0.0,http://www.openphacts.org/units/Nanomolar,3167473.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.0,CHEMBL378
908,1470289.0,[],CHEMBL832525,Inhibitory activity against HIV-1 double mutants strain 101E and 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cc(Cl)cc(Cl)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188941,CHEMBL188941,7.40,0.0,http://www.openphacts.org/units/Nanomolar,380720.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
909,5189200.0,[],CHEMBL1658800,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Clc1ccc2nc3c(c(-c4ccccc4Cl)c2c1)CCS3,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652497,CHEMBL1652497,,0.0,http://www.openphacts.org/units/Nanomolar,1326872.0,>,1.0,1.0,>,IC50,nM,2400000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.4,CHEMBL613497
910,12687125.0,[],CHEMBL2344305,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral e antigen production,F,BAO_0000190,BAO_0000218,organism-based format,COCC(=O)O[C@H]1C[C@H]2[C@]3(C)C(=O)C[C@]4(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](OC(=O)COC)C[C@@]4(C)[C@@H]3C[C@H]3O[C@]32C(C)(C)[C@@H]1OC(=O)COC,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332410,CHEMBL2332410,,0.0,http://www.openphacts.org/units/Nanomolar,1866104.0,=,1.0,1.0,=,IC50,nM,591700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,591.7,CHEMBL613497
911,15679589.0,[],CHEMBL3607086,Antiviral activity against Influenza B virus infected in MDCK cells after 3 days by neutral red dye-based plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncc(F)c2c1ncn2[C@@H]1C=C(CCO)[C@@H](O)[C@H]1O,CHEMBL3603790,Bioorg Med Chem,2015.0,CHEMBL3604362,CHEMBL3604362,6.00,0.0,http://www.openphacts.org/units/Nanomolar,2494264.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,1.0,CHEMBL613129
912,795831.0,[],CHEMBL692690,In vitro inhibition of Hepatitis C polymerase.,B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)N(C)c2cc(-c3ccccc3)sc2C(=O)O)c(C)c1,CHEMBL1137940,Bioorg Med Chem Lett,2004.0,CHEMBL167521,CHEMBL167521,5.30,0.0,http://www.openphacts.org/units/Nanomolar,327695.0,=,1.0,1.0,=,IC50,nM,5000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,5.0,CHEMBL4620
913,15166161.0,[],CHEMBL3404736,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as decrease in viral DNA replication treated for 7 days by real time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(O[C@@H]2O[C@H](COC(=O)/C=C/c3cccc(F)c3)[C@@H](O)[C@H](O)[C@H]2O)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402786,CHEMBL3402786,4.64,0.0,http://www.openphacts.org/units/Nanomolar,2284142.0,=,1.0,1.0,=,IC50,nM,22800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,22.8,CHEMBL613497
914,14596905.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1c(Sc2ccccc2)n(COCCO)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL325458,CHEMBL325458,5.29,0.0,http://www.openphacts.org/units/Nanomolar,2082747.0,=,1.0,1.0,=,IC50,nM,5180.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.18,CHEMBL378
915,2321204.0,[],CHEMBL1004248,Antiviral activity against HIV1 3B in human H9 cells after 4 days by p24 antigen ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CCCC(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL1150942,J Nat Prod,1998.0,CHEMBL320364,CHEMBL320364,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,787872.0,=,1.0,1.0,=,IC50,ug.mL-1,14.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,14.6,CHEMBL378
916,1203880.0,[],CHEMBL710376,Inhibitory activity against 100I strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL223228,CHEMBL223228,7.40,0.0,http://www.openphacts.org/units/Nanomolar,127446.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
917,1677463.0,[],CHEMBL862055,Cytotoxicity against Vaccinia virus,A,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1,CHEMBL1148631,J Med Chem,2006.0,CHEMBL152,CHEMBL152,,0.0,http://www.openphacts.org/units/Nanomolar,420645.0,<,1.0,1.0,<,IC50,nM,317000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,317.0,CHEMBL613493
918,2244499.0,[],CHEMBL1003073,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase Y188C mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL223228,CHEMBL223228,8.92,0.0,http://www.openphacts.org/units/Nanomolar,798658.0,=,1.0,1.0,=,IC50,nM,1.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.2,CHEMBL378
919,592852.0,[],CHEMBL710534,Inhibitory activity against 188L strain of HIV-1 in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Oc3c(Cl)cc(Cl)cc3Cl)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL70374,CHEMBL70374,6.30,0.0,http://www.openphacts.org/units/Nanomolar,126892.0,=,1.0,1.0,=,IC50,nM,502.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.502,CHEMBL378
920,18808319.0,[],CHEMBL4275448,Antiviral activity against Zika virus SMGC infected in BHK cells assessed as inhibition of virus induced cytopathic effect after 8 days by CellTiter-Glo luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)N(CCCO)C[C@H]1O[C@@H](n2cnc3c(NCc4cccc(Cl)c4)ncnc32)[C@H](O)[C@@H]1O,CHEMBL4270631,Eur J Med Chem,2018.0,CHEMBL4290889,CHEMBL4290889,4.56,0.0,http://www.openphacts.org/units/Nanomolar,3125059.0,=,1.0,1.0,=,IC50,nM,27470.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,27.47,CHEMBL4296612
921,630559.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(Cc3c(Cl)cccc3Cl)nc(NN)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL70528,CHEMBL70528,5.23,0.0,http://www.openphacts.org/units/Nanomolar,126937.0,=,1.0,1.0,=,IC50,nM,5830.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.83,CHEMBL378
922,559705.0,[],CHEMBL694651,Inhibitory activity against HIV-1 IIIB to achieve 50% protection of MT-2 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C=C[C@@](C)(CO)O2)c(=O)[nH]c1=O,CHEMBL1136327,Bioorg Med Chem Lett,2003.0,CHEMBL341042,CHEMBL341042,,0.0,http://www.openphacts.org/units/Nanomolar,236171.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
923,1830891.0,[],CHEMBL918634,Antiviral activity against wild type HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C(C#N)c2cccc3ccccc23)nc(SC2CCCC2)[nH]c1=O,CHEMBL1144474,J Med Chem,2007.0,CHEMBL223364,CHEMBL223364,6.75,0.0,http://www.openphacts.org/units/Nanomolar,629300.0,=,1.0,1.0,=,IC50,nM,180.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.18,CHEMBL378
924,1248536.0,[],CHEMBL677520,Concentration required to inhibit HIV-1(KOS) induced cytopathicity in E6SM cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCC(=O)NCCCCCCCCCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL118801,CHEMBL1205590,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221516.0,>,1.0,1.0,>,IC50,ug.mL-1,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,200.0,CHEMBL378
925,1421812.0,[],CHEMBL824926,Inhibitory activity against human immunodeficiency virus type 1 (inactive>0.1),F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(SC2CCCCN2)n(COCNc2ccccc2)c(=O)[nH]c1=O,CHEMBL1144258,Bioorg Med Chem Lett,2005.0,CHEMBL181127,CHEMBL181127,,0.0,http://www.openphacts.org/units/Nanomolar,364877.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
926,12103565.0,[],CHEMBL2175368,Inhibition of wild type HIV1 3B infected in human MT4 cells using cells pre-incubated with compound for 1 hr measured 4 days post viral infection by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1[nH]cc(C(=O)NCc2ccc(F)cc2)c(=O)c1O,CHEMBL2169855,J Med Chem,2012.0,CHEMBL2171670,CHEMBL2171670,8.00,0.0,http://www.openphacts.org/units/Nanomolar,1741651.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
927,1401974.0,[],CHEMBL834487,In vitro inhibitory concentration value against HIV K103N and Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C(C)COC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177709,CHEMBL177709,5.06,0.0,http://www.openphacts.org/units/Nanomolar,360424.0,=,1.0,1.0,=,IC50,nM,8680.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.68,CHEMBL378
928,2681601.0,[],CHEMBL1051712,Antiviral activity against HIV1 Du151.2 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N[C@@H](CC(C)C)[C@H](O)CC(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL137752,CHEMBL137752,6.09,0.0,http://www.openphacts.org/units/Nanomolar,823862.0,=,1.0,1.0,=,IC50,nM,810.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.81,CHEMBL378
929,5189168.0,[],CHEMBL1658799,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O)c1ccccc1,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652513,CHEMBL1652513,4.50,0.0,http://www.openphacts.org/units/Nanomolar,1326888.0,=,1.0,1.0,=,IC50,nM,32000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.032,CHEMBL613497
930,15621469.0,[],CHEMBL3584167,Antiviral activity against HIV1 NL4.3-Ren infected in human MT2 cells assessed as inhibition of viral growth measured 48 hrs post infection by luminometry,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(COC(C)=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL3580560,J Nat Prod,2015.0,CHEMBL1079568,CHEMBL1079568,4.87,0.0,http://www.openphacts.org/units/Nanomolar,2482791.0,=,1.0,1.0,=,IC50,nM,13400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,13.4,CHEMBL378
931,3014067.0,[],CHEMBL1042767,Antiviral activity against HIV1 3B infected in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,CN(Cc1nc2cccc(CNCCc3cnc[nH]3)c2[nH]1)C1CCCc2cccnc21,CHEMBL1155333,Bioorg Med Chem Lett,2009.0,CHEMBL568660,CHEMBL568660,7.39,0.0,http://www.openphacts.org/units/Nanomolar,855077.0,=,1.0,1.0,=,IC50,nM,41.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.041,CHEMBL378
932,1470272.0,[],CHEMBL833079,Inhibitory activity against HIV-1 mutant strain 181C,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL366692,CHEMBL366692,7.22,0.0,http://www.openphacts.org/units/Nanomolar,380699.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.06,CHEMBL378
933,14594150.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2cccc(I)c2)n(COCCO)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL16628,CHEMBL16628,5.30,0.0,http://www.openphacts.org/units/Nanomolar,2082343.0,=,1.0,1.0,=,IC50,nM,5000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.0,CHEMBL378
934,15159569.0,[],CHEMBL3398834,Inhibition of HBV DNA replication in HepG2(2.2.15) cells exposed to fresh medium supplemented with compound every other day for additional 5 days by real-time PCR-fluorescent probing method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OCc1cccc2c1CCOC2=O)c1cc2ccccc2[nH]1,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397183,CHEMBL3397183,4.11,0.0,http://www.openphacts.org/units/Nanomolar,2278983.0,=,1.0,1.0,=,IC50,nM,77000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.077,CHEMBL613497
935,532463.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1Sc1cccc(F)c1,CHEMBL1134494,J Med Chem,2001.0,CHEMBL449041,CHEMBL449041,5.01,0.0,http://www.openphacts.org/units/Nanomolar,94192.0,=,1.0,1.0,=,IC50,nM,9800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,9.8,CHEMBL378
936,5230642.0,[],CHEMBL1680053,Antiviral activity against HIV-1 Bal infected in human monocyte derived macrophages after 7 days by RT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1671644,Antimicrob Agents Chemother,2009.0,CHEMBL70663,CHEMBL70663,8.62,0.0,http://www.openphacts.org/units/Nanomolar,1331935.0,=,1.0,1.0,=,IC50,nM,2.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.4,CHEMBL378
937,15200452.0,[],CHEMBL3413997,Antiviral activity against X4 tropic HIV-1 clone pNL4-3 infected in H9 cells assessed as reduction in p24 antigen after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CCO)c1ccc(/C=C(\C#N)c2nc3ccccc3[nH]2)cc1,CHEMBL3407469,Eur J Med Chem,2015.0,CHEMBL3410123,CHEMBL3410123,5.21,0.0,http://www.openphacts.org/units/Nanomolar,2288853.0,=,1.0,1.0,=,IC50,nM,6110.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.11,CHEMBL378
938,1402286.0,[],CHEMBL835252,In vitro inhibitory concentration against HIV K101E and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NCc2ccccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177491,CHEMBL177491,,0.0,http://www.openphacts.org/units/Nanomolar,360417.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
939,2614758.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1Sc1ccccc1,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL52068,CHEMBL52068,,0.0,http://www.openphacts.org/units/Nanomolar,732655.0,=,1.0,1.0,=,IC50,nM,14588142.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,1.836,CHEMBL378
940,19261859.0,[],CHEMBL4404368,Antiviral activity against HIV1 subtypeA/G CRF02_AG Clone 211,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.42,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,380.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.38,CHEMBL378
941,86455.0,[],CHEMBL808329,The compound was tested in vitro for the inhibitory concentration against influenza B/Mem/89 sialidase from whole virus by MUN assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc(C(=O)O)cc1[N+](=O)[O-],CHEMBL1128587,J Med Chem,1995.0,CHEMBL111082,CHEMBL111082,,0.0,http://www.openphacts.org/units/Nanomolar,206094.0,=,1.0,1.0,=,IC50,nM,5000000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,mM,UO_0000065,5.0,CHEMBL613129
942,1402160.0,[],CHEMBL835252,In vitro inhibitory concentration against HIV K101E and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCOCCN(C)c1c(Cc2cccc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL174536,CHEMBL174536,,0.0,http://www.openphacts.org/units/Nanomolar,360385.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
943,2413720.0,[],CHEMBL987710,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,COCC(=O)O[C@@H](C[C@@H](C)[C@]12CC[C@@]3(C)[C@@]1(C[C@H](OC(=O)COC)[C@H]1[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@@]13C)O2)[C@@H](OC(=O)COC)C(C)(C)O,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL465065,CHEMBL465065,,0.0,http://www.openphacts.org/units/Nanomolar,810800.0,>,1.0,1.0,>,IC50,nM,1100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.1,CHEMBL613497
944,1064946.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(S)n(Nc2cccc(Cl)c2)c1-c1ccc(Br)cc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL38556,CHEMBL38556,,0.0,http://www.openphacts.org/units/Nanomolar,62334.0,>,1.0,1.0,>,IC50,nM,33240.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,33.24,CHEMBL378
945,2601669.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc2c(ncn2C2C=CC(OCP(=O)(O)OP(=O)(O)C(Br)(Br)P(=O)(O)O)C2)c(=O)[nH]1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL23333,CHEMBL23333,,0.0,http://www.openphacts.org/units/Nanomolar,807654.0,=,1.0,1.0,=,IC50,nM,200000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,200.0,CHEMBL378
946,12113555.0,[],CHEMBL2176187,Antiviral activity against HIV-1 clade B Env pseudovirus assessed as geometric mean titer for virus neutralization to infect human TZM-bl cells by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,N=C(N)N[C@H]1Cc2ccccc2[C@@H]1NC(=O)C(=O)Nc1ccc(Cl)c(F)c1.O=CO,CHEMBL2169814,J Med Chem,2012.0,CHEMBL2171086,CHEMBL2219813,5.10,0.0,http://www.openphacts.org/units/Nanomolar,1740955.0,=,1.0,1.0,=,IC50,nM,7900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.9,CHEMBL378
947,3214436.0,[],CHEMBL1110484,Antiviral activity against HIV1 NL4-3 co-transfected with VSV glycoprotein plasmid in human 293T cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=C[C@@H]1C/C(=C\CC/C(C)=C/CCC2=CC(=O)OC2)C(=O)O1,CHEMBL1153770,J Nat Prod,2009.0,CHEMBL1087554,CHEMBL1087554,,0.0,,894835.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
948,1401858.0,[],CHEMBL837471,In vitro inhibitory concentration against HIV Y188L mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(CO)nc(O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL424772,CHEMBL424772,6.20,0.0,http://www.openphacts.org/units/Nanomolar,360403.0,=,1.0,1.0,=,IC50,nM,631.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.631,CHEMBL378
949,612639.0,[],CHEMBL710534,Inhibitory activity against 188L strain of HIV-1 in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Cc2nc(N)nc(Nc3ccc(C#N)cc3)n2)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL70745,CHEMBL70745,,0.0,http://www.openphacts.org/units/Nanomolar,126889.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
950,2292381.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1S(=O)(=O)c1cccc(N)c1C#N,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL54444,CHEMBL54444,,0.0,http://www.openphacts.org/units/Nanomolar,813574.0,=,1.0,1.0,=,IC50,nM,2301441.82,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,2.638,CHEMBL378
951,18683317.0,[],CHEMBL4237101,Antiviral activity against CCR5-dependent HIV1 Ba-L infected in human PM1 cells assessed as reduction in virus infection measured after 5 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1,CHEMBL4229569,J Med Chem,2018.0,CHEMBL4248282,CHEMBL4248282,7.83,0.0,http://www.openphacts.org/units/Nanomolar,3103083.0,=,1.0,1.0,=,IC50,nM,14.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,14.9,CHEMBL378
952,3596627.0,[],CHEMBL1292012,Antiviral activity against HIV1 BaL in human PBL cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(CNC(=O)N(c2cccc(F)c2)C2CCN(CCC3(c4cccc(F)c4)CCN(C(=O)c4ccnc(Cl)c4)CC3)CC2)cc1,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288679,CHEMBL1288679,7.89,0.0,http://www.openphacts.org/units/Nanomolar,973789.0,=,1.0,1.0,=,IC50,nM,13.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,13.0,CHEMBL378
953,17602961.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(S(=O)(=O)c2ccc(OC)cc2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644896,CHEMBL3644896,8.70,0.0,http://www.openphacts.org/units/Nanomolar,2518016.0,=,37.0,1.0,=,IC50,nM,2.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,2.0,CHEMBL4620
954,2670844.0,[],CHEMBL1035389,Antiviral activity against LASV infected in human A549 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(CN2C(=O)CN(C(=O)c3ccc(C)cc3)CC2CCc2ccccc2)cc1,CHEMBL1151924,Bioorg Med Chem Lett,2009.0,CHEMBL550575,CHEMBL550575,5.92,0.0,http://www.openphacts.org/units/Nanomolar,820697.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL615051,Lassa virus,Lassa virus,11620,IC50,uM,UO_0000065,1.2,CHEMBL615051
955,13933223.0,[],CHEMBL3124190,Antiviral activity against Hepatitis B virus assessed as inhibition of Hepatitis B virus DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL3120134,Eur J Med Chem,2014.0,CHEMBL141,CHEMBL141,6.58,0.0,http://www.openphacts.org/units/Nanomolar,1969516.0,=,1.0,1.0,=,IC50,nM,260.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol/L,UO_0000065,0.26,CHEMBL613497
956,5222600.0,[],CHEMBL1675304,Antiviral activity against HIV1 infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL991,CHEMBL991,5.24,0.0,http://www.openphacts.org/units/Nanomolar,1332028.0,=,1.0,1.0,=,IC50,nM,5700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.7,CHEMBL378
957,17987406.0,[],CHEMBL3999574,Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 40 hrs,F,BAO_0000190,BAO_0000219,cell-based format,C=C(C(=O)OC)[C@@H]1CC[C@H](C)[C@H]2C(=C(C)C(=O)[C@@H]2[C@@H](O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)C1,CHEMBL3997818,Bioorg Med Chem Lett,2017.0,CHEMBL4095139,CHEMBL4095139,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,2979924.0,>,1.0,1.0,>,IC50,ug.mL-1,18.52,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,18.52,CHEMBL613129
958,2927892.0,[],CHEMBL1044799,Antiviral activity against HIV1 NL4-3 infected in human TZM-b1 cells assessed as reduction in luciferase activity after 2 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCC(=O)N3CCC[C@H]3C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1154770,J Med Chem,2009.0,CHEMBL584986,CHEMBL584986,4.29,0.0,http://www.openphacts.org/units/Nanomolar,852852.0,=,1.0,1.0,=,IC50,nM,51400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,51.4,CHEMBL378
959,14658856.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(/C=C/C(=O)N2CCN(C(=O)Cc3ccccc3)CC2)cc1F,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262883,CHEMBL3262883,7.34,0.0,http://www.openphacts.org/units/Nanomolar,2101725.0,=,1.0,1.0,=,IC50,nM,45.71,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,pIC50,,UO_0000065,7.34,CHEMBL3259471
960,874447.0,[],CHEMBL710366,Inhibitory activity tested against the HIV-1 in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)NCC(O)CC(=O)O)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL11851,CHEMBL11851,7.48,0.0,http://www.openphacts.org/units/Nanomolar,9098.0,=,1.0,1.0,=,IC50,nM,33.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,33.0,CHEMBL378
961,644158.0,[],CHEMBL713946,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1CCn2c(=S)[nH]c3ccc(Cl)c(c32)C1C,CHEMBL1128252,J Med Chem,1995.0,CHEMBL66155,CHEMBL66155,7.92,0.0,http://www.openphacts.org/units/Nanomolar,326408.0,=,1.0,1.0,=,IC50,nM,12.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.012,CHEMBL378
962,1066157.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=C(S)N(Nc2cccc(Cl)c2)C1c1cccc(C#N)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39683,CHEMBL39683,,0.0,http://www.openphacts.org/units/Nanomolar,62363.0,>=,1.0,1.0,>=,IC50,nM,99400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,99.4,CHEMBL378
963,1401872.0,[],CHEMBL837471,In vitro inhibitory concentration against HIV Y188L mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL339511,CHEMBL339511,5.70,0.0,http://www.openphacts.org/units/Nanomolar,360412.0,=,1.0,1.0,=,IC50,nM,1995.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.995,CHEMBL378
964,22980447.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '192.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '8.0'}]",CHEMBL4772776,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion incubated for 4 days prior to compound washout followed by compound addition and measured after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL4765395,Eur J Med Chem,2020.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/Nanomolar,3568781.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol/L,UO_0000065,100.0,CHEMBL613497
965,2091731.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)N2CCCN(Cc3ccccc3)CCCN(S(=O)(=O)c3ccc(C)cc3)CC(CO)C2)cc1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL269825,CHEMBL269825,,0.0,http://www.openphacts.org/units/Nanomolar,700555.0,=,1.0,1.0,=,IC50,nM,138038426460288.67,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,5.14,CHEMBL378
966,16621493.0,[],CHEMBL3820486,Inhibition of FER (unknown origin) incubated for 1 hr by spectrophotometric analysis,B,BAO_0000190,BAO_0000357,single protein format,CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21,CHEMBL3817824,Bioorg Med Chem,2016.0,CHEMBL3818247,CHEMBL3818247,,0.0,http://www.openphacts.org/units/Nanomolar,2784915.0,>,1.0,1.0,>,IC50,nM,30000.0,CHEMBL3982,Homo sapiens,Tyrosine-protein kinase FER,9606,IC50,nM,UO_0000065,30000.0,CHEMBL3982
967,3221763.0,[],CHEMBL1102831,Antiviral activity against HIV1 carrying reverse transcriptase Y188L mutant infected human MT4 cells by phenoscreen assay in the presence of 40 percent normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,CS(=O)(=O)c1ccc(NC(=O)CSC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,CHEMBL1153798,Bioorg Med Chem Lett,2009.0,CHEMBL1078944,CHEMBL1078944,,0.0,http://www.openphacts.org/units/Nanomolar,898067.0,>,1.0,1.0,>,IC50,nM,250000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,0.25,CHEMBL378
968,1402187.0,[],CHEMBL837462,In vitro inhibitory concentration against HIV E138K mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL180008,CHEMBL180008,,0.0,http://www.openphacts.org/units/Nanomolar,360390.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
969,12642410.0,[],CHEMBL2317522,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay in presence of human serum albumin,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCCCN2C(=O)c3c(O)c(=O)c(C(=O)NCc4ccc(F)cc4)cn3CC12,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314674,CHEMBL2314674,7.50,0.0,http://www.openphacts.org/units/Nanomolar,1844806.0,=,1.0,1.0,=,IC50,nM,31.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.4,CHEMBL378
970,19261931.0,[],CHEMBL4404392,"Antiviral activity against HIV1 subtypeC ZM197M.PB7, SVPC6",F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.51,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.31,CHEMBL378
971,1402606.0,[],CHEMBL837471,In vitro inhibitory concentration against HIV Y188L mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(NC(=S)NC(=O)c2ccccc2)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177383,CHEMBL177383,4.00,0.0,http://www.openphacts.org/units/Nanomolar,360418.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
972,1839863.0,[],CHEMBL916790,Antiviral activity against HIV1 BAL in human MDM cells at 10 uM,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)C(=S)OCC1CN(C(=O)c2cc(OC)c(OC)c(OC)c2)CCN1C(=O)c1cc(OC)c(OC)c(OC)c1,CHEMBL1149263,J Med Chem,2004.0,CHEMBL222925,CHEMBL222925,,0.0,,629990.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
973,8043633.0,[],CHEMBL1953039,Antiviral activity against HIV1 3B infected human TZM-bl cells assessed as inhibition of viral replication by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NC(C(=O)[O-])c1ccc(Cl)cc1)C(=O)C(O)=C3C(C)C)/C(=C/NC(C(=O)[O-])c1ccc(Cl)cc1)C(=O)C(O)=C2C(C)C.[Na+].[Na+],CHEMBL1949531,Bioorg Med Chem Lett,2012.0,CHEMBL1949753,CHEMBL1962862,5.89,0.0,http://www.openphacts.org/units/Nanomolar,1576821.0,=,1.0,1.0,=,IC50,nM,1280.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.28,CHEMBL378
974,3596594.0,[],CHEMBL1292013,Antiviral activity against HIV1 BaL in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(CNC(=O)N(c2cccc(F)c2)C2CCN(CCC3(c4cccc(F)c4)CCN(C(=O)c4cc(S(N)(=O)=O)c(F)cc4Cl)CC3)CC2)cc1,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288670,CHEMBL1288670,8.17,0.0,http://www.openphacts.org/units/Nanomolar,973780.0,=,1.0,1.0,=,IC50,nM,6.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.8,CHEMBL378
975,3407230.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1c(-c2ccccc2)oc2ccc(N)cc2c1=O,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1214817,CHEMBL1214817,,0.0,http://www.openphacts.org/units/Nanomolar,932426.0,=,1.0,1.0,=,IC50,nM,126100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,126.1,CHEMBL378
976,87559.0,[],CHEMBL808329,The compound was tested in vitro for the inhibitory concentration against influenza B/Mem/89 sialidase from whole virus by MUN assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc(C(=O)O)cc1NC(=N)N,CHEMBL1128587,J Med Chem,1995.0,CHEMBL55440,CHEMBL55440,5.00,0.0,http://www.openphacts.org/units/Nanomolar,206086.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,mM,UO_0000065,0.01,CHEMBL613129
977,12463724.0,[],CHEMBL3057688,Antiviral activity against wild type Human immunodeficiency virus 1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1CC(=N)/N=C(\S)Nc1ccc(C#N)cc1,CHEMBL3046335,Med Chem Res,2009.0,CHEMBL415070,CHEMBL415070,,0.0,http://www.openphacts.org/units/Nanomolar,1805835.0,=,1.0,1.0,=,IC50,nM,26001595.63,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,1.585,CHEMBL378
978,14553711.0,[],CHEMBL3225005,Antiviral activity against HIV1 NL4-3 infected in human MT2 cells after 3 days by human JC53BL cell-based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(F)ccc1Cn1ccc2c3c(ncc21)C(=O)N(O)C(C)(C)C3,CHEMBL3217509,Medchemcomm,2013.0,CHEMBL3219144,CHEMBL3219144,8.41,0.0,http://www.openphacts.org/units/Nanomolar,2073841.0,=,1.0,1.0,=,IC50,nM,3.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.9,CHEMBL378
979,2516319.0,[],CHEMBL975243,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Cc2ccccc2Br)nc(SCc2ccc([N+](=O)[O-])cc2)[nH]c1=O,CHEMBL1138559,Eur J Med Chem,2009.0,CHEMBL513393,CHEMBL513393,5.84,0.0,http://www.openphacts.org/units/Nanomolar,734089.0,=,1.0,1.0,=,IC50,nM,1460.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.46,CHEMBL378
980,2929777.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COCC1CCN(Cc2c(C)[nH]c(=O)c(I)c2Sc2cc(C)cc(C)c2)CC1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL574592,CHEMBL574592,6.20,0.0,http://www.openphacts.org/units/Nanomolar,848347.0,=,1.0,1.0,=,IC50,nM,630.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,630.0,CHEMBL378
981,3284636.0,[],CHEMBL1110057,Antiviral activity against HIV1 3B infected in human HOS cells expressing human CXCR4/CCR5/CD4/pHIV-LTR luciferase assessed as inhibition of viral infection to cells,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)CC(=O)NCc1c(CN(C)[C@H]2CCCc3cccnc32)ncc2ccccc12,CHEMBL1157822,Bioorg Med Chem Lett,2010.0,CHEMBL1094864,CHEMBL1094864,7.92,0.0,http://www.openphacts.org/units/Nanomolar,911435.0,=,1.0,1.0,=,IC50,nM,12.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,12.0,CHEMBL378
982,2550834.0,[],CHEMBL980249,Antiviral activity against HIV1 3B assessed as reverse transcriptase activity by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,O[C@]12C=C(c3nccc4c3[nH]c3ccccc34)[C@@H]3CCN(CCCC/C=C\CC1)C[C@@]31C[C@@H]3/C=C\CCCCN3[C@H]12,CHEMBL1142603,J Nat Prod,2006.0,CHEMBL403233,CHEMBL403233,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,786990.0,=,1.0,1.0,=,IC50,ug.mL-1,4.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,4.2,CHEMBL378
983,6152224.0,[],CHEMBL1763053,Antiviral activity against Human immunodeficiency virus 1 BAL infected in human PBMC assessed as inhibition of viral replication by p24 antigen specific ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(=O)c2ccc(Br)cc2)CC1,CHEMBL1759996,Bioorg Med Chem Lett,2011.0,CHEMBL1762310,CHEMBL1762310,4.49,0.0,http://www.openphacts.org/units/Nanomolar,1414761.0,=,1.0,1.0,=,IC50,nM,32600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,32.6,CHEMBL378
984,1174891.0,[],CHEMBL757806,Cytotoxicity against human peripheral blood mononuclear (PBM) cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,O=c1ccn([C@H]2CS[C@H](CO)O2)c(=O)[nH]1,CHEMBL1126808,J Med Chem,1993.0,CHEMBL60768,CHEMBL60768,,0.0,http://www.openphacts.org/units/Nanomolar,100998.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
985,3234790.0,[],CHEMBL1110484,Antiviral activity against HIV1 NL4-3 co-transfected with VSV glycoprotein plasmid in human 293T cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(C)=O)cc1C(=O)CC(C)(C)O,CHEMBL1153770,J Nat Prod,2009.0,CHEMBL1084910,CHEMBL1084910,,0.0,,894864.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
986,2099755.0,[],CHEMBL949219,Antiviral activity against HIV1 ASM80 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C(F)(F)F)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL257000,CHEMBL257000,8.30,0.0,http://www.openphacts.org/units/Nanomolar,699412.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.005,CHEMBL378
987,19261942.0,[],CHEMBL4404395,"Antiviral activity against HIV1 subtypeC ZM53M.PB12, SVPC11",F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.27,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,540.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.54,CHEMBL378
988,1402196.0,[],CHEMBL835251,In vitro inhibitory concentration against HIV F227L and V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369599,CHEMBL369599,,0.0,http://www.openphacts.org/units/Nanomolar,360395.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
989,1982293.0,[],CHEMBL899338,Antiviral activity against HBV transfected Hep G2.2.15 cells assessed as inhibition of surface antigen HBsAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1149710,Bioorg Med Chem Lett,2007.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/Nanomolar,661665.0,=,1.0,1.0,=,IC50,nM,11700000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,11.7,CHEMBL613497
990,2321156.0,[],CHEMBL1004248,Antiviral activity against HIV1 3B in human H9 cells after 4 days by p24 antigen ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CCC(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL1150942,J Nat Prod,1998.0,CHEMBL446073,CHEMBL446073,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,787871.0,=,1.0,1.0,=,IC50,ug.mL-1,6.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,6.5,CHEMBL378
991,3498065.0,[],CHEMBL1259504,Antiviral activity against HIV1 isolate 89.6 infected in human PM1 cells expressing CCR5 assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN1CCC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC1,CHEMBL1255517,Bioorg Med Chem Lett,2010.0,CHEMBL1258619,CHEMBL1258619,,0.0,,963624.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
992,13463759.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc([S+]([O-])c2cccc(N)c2C#N)c1,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL53893,CHEMBL53893,4.53,0.0,http://www.openphacts.org/units/Nanomolar,1920690.0,=,1.0,1.0,=,IC50,nM,29512.09,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.53,CHEMBL378
993,10961186.0,[],CHEMBL2061268,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M3 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNC1CCC1)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058325,CHEMBL2058325,7.51,0.0,http://www.openphacts.org/units/Nanomolar,1656265.0,=,1.0,1.0,=,IC50,nM,31.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.0,CHEMBL378
994,1982310.0,[],CHEMBL899339,Antiviral activity against HBV transfected Hep G2.2.15 cells assessed as inhibition of e antigen HBsAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C[C@H]2c3cc(O)c(OC)cc3CCN2C)cc1O,CHEMBL1149710,Bioorg Med Chem Lett,2007.0,CHEMBL235212,CHEMBL235212,,0.0,http://www.openphacts.org/units/Nanomolar,661661.0,>,1.0,1.0,>,IC50,nM,2994000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.994,CHEMBL613497
995,2602250.0,[],CHEMBL1033985,Antiviral activity against Cowpox virus,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc21)OCOC(=O)C(C)(C)C,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL922,CHEMBL922,4.89,0.0,http://www.openphacts.org/units/Nanomolar,808153.0,=,1.0,1.0,=,IC50,nM,13000.0,CHEMBL612672,Cowpox virus,Cowpox virus,10243,IC50,uM,UO_0000065,13.0,CHEMBL612672
996,1401605.0,[],CHEMBL837466,In vitro inhibitory concentration against HIV K101E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL338047,CHEMBL338047,7.80,0.0,http://www.openphacts.org/units/Nanomolar,360324.0,=,1.0,1.0,=,IC50,nM,16.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.016,CHEMBL378
997,19288671.0,[],CHEMBL4410545,Antiviral activity against HIV-1 3IIB infected in thymidine kinase deficient human C8166 cells,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)[C@H](C)NP(=O)(OC[C@@H]1C=C[C@H](n2cc(C)c(=O)[nH]c2=O)O1)Oc1cccc(S(F)(F)(F)(F)F)c1,CHEMBL4406893,Bioorg Med Chem Lett,2019.0,CHEMBL4578360,CHEMBL4578360,6.47,0.0,http://www.openphacts.org/units/Nanomolar,3220827.0,=,1.0,1.0,=,IC50,nM,335.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.335,CHEMBL378
998,14990578.0,[],CHEMBL3383785,Antiviral activity against HIV1 isolate Hxbc2 pseudotyped virus expressed in human U87 cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CC4CN(C(=O)c5ccccc5)CC4C3)c12,CHEMBL3351851,Bioorg Med Chem Lett,2014.0,CHEMBL3353051,CHEMBL3353051,9.00,0.0,http://www.openphacts.org/units/Nanomolar,2241680.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
999,2649359.0,[],CHEMBL1024326,"Antiviral activity against HIV1 expressed in 293T cells assessed as protection against viral M33 envelope infection in human U87 cells coexpressing CD4, CCR5 receptors after 72 hrs by luciferase reporter gene pseudoviral assay",F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1ccc(-c2cnco2)c(Cl)c1,CHEMBL1158460,J Med Chem,2009.0,CHEMBL551898,CHEMBL551898,,0.0,http://www.openphacts.org/units/Nanomolar,816498.0,<,1.0,1.0,<,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.0,CHEMBL378
1000,10863190.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCc6cc(C(F)(F)F)cc(C(F)(F)F)c6)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022386,CHEMBL2022386,,0.0,http://www.openphacts.org/units/Nanomolar,1637636.0,>,1.0,1.0,>,IC50,nM,425600.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,425.6,CHEMBL613497
1001,2238622.0,[],CHEMBL1000357,Antiviral activity against HIV 3B in human MT4 cells assessed as inhibition of viral replication by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CNc1nc(Nc2ccc(C#N)cc2)nc(Oc2cccc3ccccc23)n1,CHEMBL1156684,Eur J Med Chem,2008.0,CHEMBL454665,CHEMBL454665,6.73,0.0,http://www.openphacts.org/units/Nanomolar,724130.0,=,1.0,1.0,=,IC50,nM,186.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.186,CHEMBL378
1002,1437991.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(-c2cccnc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL361250,CHEMBL361250,5.00,0.0,http://www.openphacts.org/units/Nanomolar,371602.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
1003,291145.0,[],CHEMBL706841,Antiviral activity by observing cytopathic effect induced by HIV-1 strain IIIB in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CCCCN[C@@H](C(=O)N[C@H](C(=O)NCc1ccccc1)C(C)C)[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C,CHEMBL1127464,J Med Chem,1994.0,CHEMBL105002,CHEMBL105002,,0.0,http://www.openphacts.org/units/Nanomolar,195829.0,>,1.0,1.0,>,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3000.0,CHEMBL378
1004,18726964.0,[],CHEMBL4259330,Antiviral activity against HIV-1 subtype B JRFL pseudovirus assessed as inhibition of viral infection in Ghost (3)X4/R5 cells after 48 hrs by Bright-Glo luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@]1(C)CCC/C=C\CCC[C@@](C)(C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O,CHEMBL4257519,Medchemcomm,2018.0,CHEMBL4277174,CHEMBL4277174,8.06,0.0,http://www.openphacts.org/units/Nanomolar,3111234.0,=,1.0,1.0,=,IC50,nM,8.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.7,CHEMBL378
1005,24823572.0,[],CHEMBL5140687,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBeAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCCC1COc3ccccc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5180911,CHEMBL5180911,7.79,0.0,http://www.openphacts.org/units/Nanomolar,3876709.0,=,1.0,1.0,=,IC50,nM,16.4,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0164,CHEMBL613497
1006,1520699.0,[],CHEMBL833990,Inhibitory concentration against wild type human immunodeficiency virus,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(CN2CCN([C@H](C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc(NC=O)cc3)C(C)C)C2=O)cs1,CHEMBL1144377,Bioorg Med Chem Lett,2005.0,CHEMBL380987,CHEMBL380987,6.78,0.0,http://www.openphacts.org/units/Nanomolar,395267.0,=,1.0,1.0,=,IC50,nM,168.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.168,CHEMBL378
1007,2929499.0,[],CHEMBL1056899,Antiviral activity against HIV1 HXB2 harboring 227C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL338047,CHEMBL338047,,0.0,,848385.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1008,2368183.0,[],CHEMBL1031556,Antiviral activity against HIV1 infected in human 293T cells assessed as inhibition of pseudovirus infection,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1NC(=S)NCc1ccco1,CHEMBL1140132,J Med Chem,2008.0,CHEMBL492280,CHEMBL492280,,0.0,http://www.openphacts.org/units/Nanomolar,746335.0,>,1.0,1.0,>,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
1009,2212945.0,[],CHEMBL989682,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion in HepG2.2.15 cells by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1150244,J Nat Prod,2008.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/Nanomolar,767838.0,=,1.0,1.0,=,IC50,nM,11700000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,11.7,CHEMBL613497
1010,1048829.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(NN2C=NC(C)C2c2ccccc2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39904,CHEMBL39904,4.96,0.0,http://www.openphacts.org/units/Nanomolar,62362.0,=,1.0,1.0,=,IC50,nM,10990.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.99,CHEMBL378
1011,2681588.0,[],CHEMBL1064017,Antiviral activity against HIV1 Q259.d2.17 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N[C@@H](CC(C)C)[C@H](O)CC(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL137752,CHEMBL137752,6.60,0.0,http://www.openphacts.org/units/Nanomolar,823862.0,=,1.0,1.0,=,IC50,nM,250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.25,CHEMBL378
1012,12723417.0,[],CHEMBL2351030,Antiviral activity against Hepatitis B virus-infected human HepG2(2.2.15) cells assessed as inhibition of HBeAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/CCCC[C@@H](O)[C@H](O)c1ccc2c(c1)OCO2)N1CCCCC1,CHEMBL2346644,Bioorg Med Chem Lett,2013.0,CHEMBL2347641,CHEMBL2347641,,0.0,http://www.openphacts.org/units/Nanomolar,1875485.0,=,1.0,1.0,=,IC50,nM,110000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.11,CHEMBL613497
1013,1402117.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCCCO)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL367745,CHEMBL367745,8.00,0.0,http://www.openphacts.org/units/Nanomolar,360369.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
1014,2238645.0,[],CHEMBL1000357,Antiviral activity against HIV 3B in human MT4 cells assessed as inhibition of viral replication by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CNc1nc(Nc2ccc(C#N)cc2)nc(Oc2ccc3ccccc3c2)n1,CHEMBL1156684,Eur J Med Chem,2008.0,CHEMBL488702,CHEMBL488702,6.58,0.0,http://www.openphacts.org/units/Nanomolar,722885.0,=,1.0,1.0,=,IC50,nM,260.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.26,CHEMBL378
1015,19261947.0,[],CHEMBL4404397,"Antiviral activity against HIV1 subtypeC CAP210.2.00.E8, SVPC17",F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.94,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,115.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.115,CHEMBL378
1016,2930228.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3ccc(N)n3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL568496,CHEMBL568496,7.40,0.0,http://www.openphacts.org/units/Nanomolar,852869.0,=,1.0,1.0,=,IC50,nM,39.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,39.8,CHEMBL378
1017,1206552.0,[],CHEMBL710533,Inhibitory activity against 181C strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Sc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70863,CHEMBL70863,7.60,0.0,http://www.openphacts.org/units/Nanomolar,127465.0,=,1.0,1.0,=,IC50,nM,25.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.025,CHEMBL378
1018,5306735.0,[],CHEMBL1696837,Antiviral activity against X4 tropic HIV1 NL4.3 infected in human PBMC assessed as inhibition of p24 antigen production after 2 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,CHEMBL1687731,Antimicrob Agents Chemother,2009.0,CHEMBL483,CHEMBL483,5.86,0.0,http://www.openphacts.org/units/Nanomolar,1337339.0,=,1.0,1.0,=,IC50,nM,1395.98,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1395.98,CHEMBL378
1019,1051204.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=C(S)N(Nc2ccccc2Cl)C1c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39115,CHEMBL39115,,0.0,http://www.openphacts.org/units/Nanomolar,62318.0,>,1.0,1.0,>,IC50,nM,161810.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,161.81,CHEMBL378
1020,3104728.0,[],CHEMBL1065873,Antiviral activity against multi drug-resistant HIV1 isolate of subtype JSL in PHA-stimulated human PBMC assessed as inhibition of p24 antigen production,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,CHEMBL1159037,Bioorg Med Chem Lett,2010.0,CHEMBL1163,CHEMBL1163,6.20,0.0,http://www.openphacts.org/units/Nanomolar,883254.0,=,1.0,1.0,=,IC50,nM,635.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.635,CHEMBL378
1021,2263410.0,[],CHEMBL1010846,Antiviral activity against R5 tropic HIV1 BaL infected in human JC53-BL cells expressing CCR5 after 2 days by cell-cell fusion assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC1C(=O)N(C[C@H]2CC[C@H](O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2,CHEMBL1139267,Bioorg Med Chem Lett,2009.0,CHEMBL444667,CHEMBL444667,8.00,0.0,http://www.openphacts.org/units/Nanomolar,750091.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
1022,2694310.0,[],CHEMBL1053929,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)Cc1c(O)c(OC)cc2nc3c(cc12)CSc1cc(F)ccc1-3,CHEMBL1152943,Bioorg Med Chem,2009.0,CHEMBL552200,CHEMBL552200,5.62,0.0,http://www.openphacts.org/units/Nanomolar,825022.0,=,1.0,1.0,=,IC50,nM,2400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.4,CHEMBL613497
1023,19033631.0,[],CHEMBL4350064,Antiviral activity against HIV1 LAI infected in human LC5 cells expressing DsRed1 reporter gene assessed as inhibition of viral infection measured after 48 hrs post infection by reporter gene based luminescence assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Oc1ccc2ccccc2c1-c1cccc2cccnc12,CHEMBL4346738,Bioorg Med Chem,2019.0,CHEMBL4434676,CHEMBL4434676,4.40,0.0,http://www.openphacts.org/units/Nanomolar,3175417.0,=,1.0,1.0,=,IC50,nM,39500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,39.5,CHEMBL378
1024,2099793.0,[],CHEMBL949220,Antiviral activity against HIV1 BaL by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)N(CCCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nc4c2CCN(S(C)(=O)=O)C4)C3)c2ccccc2)cc1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL272580,CHEMBL272580,8.30,0.0,http://www.openphacts.org/units/Nanomolar,699396.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.005,CHEMBL378
1025,1306842.0,[],CHEMBL691378,Compound was evaluated for anti-retrovirus activity against HIV-1 (D34) Diagen strain,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(O)c2ncn(OCC/C=C/P(=O)(O)O)c2n1,CHEMBL1126681,J Med Chem,1993.0,CHEMBL27062,CHEMBL27062,7.00,0.0,http://www.openphacts.org/units/Nanomolar,40467.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
1026,43585.0,[],CHEMBL871983,Antiviral activity against L100I strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL57,CHEMBL57,6.30,0.0,http://www.openphacts.org/units/Nanomolar,20821.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,500.0,CHEMBL378
1027,1013315.0,[],CHEMBL756465,Tested for the ability to inhibit the replication of HIV-1 strain HTLV IIIB in human peripheral blood mononuclear cells (PBMC),F,BAO_0000190,BAO_0000218,organism-based format,S=C(NCCC1=CCCCC1)Nc1nccs1,CHEMBL1134194,Bioorg Med Chem Lett,2001.0,CHEMBL146770,CHEMBL146770,8.15,0.0,http://www.openphacts.org/units/Nanomolar,292663.0,=,1.0,1.0,=,IC50,nM,7.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.007,CHEMBL378
1028,309419.0,[],CHEMBL653803,In vitro inhibition of CEM-SS cell growth by 50 %,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCCC(=O)NCC(COP(=O)([O-])OCC[N+](C)(C)C)OCC,CHEMBL1125666,J Med Chem,1991.0,CHEMBL416753,CHEMBL416753,4.87,0.0,http://www.openphacts.org/units/Nanomolar,43735.0,=,1.0,1.0,=,IC50,nM,13500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,13.5,CHEMBL378
1029,2602013.0,[],CHEMBL1034006,Antiviral activity against influenza B virus,F,BAO_0000190,BAO_0000218,organism-based format,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](N)[C@H]1NC(C)=O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL674,CHEMBL674,7.82,0.0,http://www.openphacts.org/units/Nanomolar,807580.0,=,1.0,1.0,=,IC50,nM,15.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,0.015,CHEMBL613129
1030,2149811.0,[],CHEMBL935680,Antiviral activity against HIV1 098 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL428455,CHEMBL428455,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708038.0,=,1.0,1.0,=,IC50,ug.mL-1,0.021,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.021,CHEMBL378
1031,759763.0,[],CHEMBL691759,Inhibition of HIV-cell fusion was determined by using cellular FIGS assay,F,BAO_0000190,BAO_0000218,organism-based format,Cl.N=C(N)Nc1cccc(Oc2ccccc2)c1,CHEMBL1146750,Bioorg Med Chem Lett,2004.0,CHEMBL553973,CHEMBL1195160,,0.0,http://www.openphacts.org/units/Nanomolar,164103.0,=,1.0,1.0,=,IC50,nM,167000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,167.0,CHEMBL378
1032,1066169.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(NN2C(S)=NC(C)C2c2cccc(C(=O)O)c2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289090,CHEMBL289090,,0.0,http://www.openphacts.org/units/Nanomolar,62353.0,>,1.0,1.0,>,IC50,nM,187130.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,187.13,CHEMBL378
1033,17602943.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(CC(=O)c2ccccc2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644878,CHEMBL3644878,7.68,0.0,http://www.openphacts.org/units/Nanomolar,2517998.0,=,37.0,1.0,=,IC50,nM,21.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,21.0,CHEMBL4620
1034,303578.0,[],CHEMBL824013,Tested for antiviral activity against HBV (Hep AD79),F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(O)c2ncn(C3C=CC(CO)C(O)C3)c2n1,CHEMBL1134101,Bioorg Med Chem Lett,2001.0,CHEMBL289718,CHEMBL289718,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,66194.0,=,1.0,1.0,=,IC50,ug.mL-1,3.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,3.0,CHEMBL613497
1035,1470722.0,[],CHEMBL833081,Inhibitory activity against HIV-1 mutant strain 190A,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL223228,CHEMBL223228,8.00,0.0,http://www.openphacts.org/units/Nanomolar,380816.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
1036,2203565.0,[],CHEMBL987023,Antiviral activity against HIV1 3B in human MT4 cells assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CCNC(=S)Nc1ccc(-c2n[nH]c(=S)n2-c2ccccc2)cc1,CHEMBL1149790,Eur J Med Chem,2008.0,CHEMBL297866,CHEMBL297866,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,765616.0,>,1.0,1.0,>,IC50,ug.mL-1,55.13,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,55.13,CHEMBL378
1037,489743.0,[],CHEMBL683684,In vitro inhibition of recombinant HIV-1 IIIB mutant Y181C,F,BAO_0000190,BAO_0000218,organism-based format,CCN(c1ncccc1NC(C)(C)C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1129647,J Med Chem,1996.0,CHEMBL338979,CHEMBL338979,6.18,0.0,http://www.openphacts.org/units/Nanomolar,236794.0,=,1.0,1.0,=,IC50,nM,660.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.66,CHEMBL378
1038,1402133.0,[],CHEMBL837462,In vitro inhibitory concentration against HIV E138K mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCCCO)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL367745,CHEMBL367745,,0.0,http://www.openphacts.org/units/Nanomolar,360369.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1039,13857135.0,[],CHEMBL3097947,Antiviral activity against enfuvirtide-resistant HIV-1 NL4-3 harboring gp41 (36G)N42T/N43K mutation infected in human MT2 cells assessed as inhibition of p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1cccc(CN2C(=O)/C(=C/c3cc(C)n(-c4ccc(O)c(C(=O)O)c4)c3C)SC2=S)c1,CHEMBL3091377,Bioorg Med Chem,2013.0,CHEMBL3092878,CHEMBL3092878,5.70,0.0,http://www.openphacts.org/units/Nanomolar,1952760.0,=,1.0,1.0,=,IC50,nM,2017.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.017,CHEMBL378
1040,12680743.0,[],CHEMBL2342599,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CNC(=O)/C=C/c2coc3cc(OC)ccc3c2=O)cc1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333687,CHEMBL2333687,4.86,0.0,http://www.openphacts.org/units/Nanomolar,1867763.0,=,1.0,1.0,=,IC50,nM,13970.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,13.97,CHEMBL613497
1041,16422849.0,[],CHEMBL3751457,Antiviral activity against recombinant HIV-1 NL4-3 expressing AMLV envelope infected in U87.CD4.CCR5 cells assessed as inhibition of Env mediated cell entry by HIV-1 single round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CC(CCC(=O)c4ccccc4)C3)c12,CHEMBL3745657,Bioorg Med Chem Lett,2016.0,CHEMBL3746938,CHEMBL3746938,,0.0,,2740454.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1042,2929510.0,[],CHEMBL1056898,Antiviral activity against HIV1 HXB2 harboring 190S mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL57,CHEMBL57,7.36,0.0,http://www.openphacts.org/units/Nanomolar,848288.0,=,1.0,1.0,=,IC50,nM,44.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,44.0,CHEMBL378
1043,10961194.0,[],CHEMBL2061268,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M3 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL1163,CHEMBL1163,6.46,0.0,http://www.openphacts.org/units/Nanomolar,1655449.0,=,1.0,1.0,=,IC50,nM,350.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,350.0,CHEMBL378
1044,821151.0,[],CHEMBL696633,Concentration of compound required to 50% growth inhibition of HIV-1 in CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCSCC(COP(=O)([O-])OCC[N+](C)(C)C)OCC,CHEMBL1125670,J Med Chem,1991.0,CHEMBL286705,CHEMBL286705,,0.0,http://www.openphacts.org/units/Nanomolar,47357.0,=,1.0,1.0,=,IC50,nM,4100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,4.1,CHEMBL378
1045,1954175.0,[],CHEMBL891426,Antiviral activity against HIV1 RT 100I mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(SC)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL233452,CHEMBL233452,7.70,0.0,http://www.openphacts.org/units/Nanomolar,647179.0,=,1.0,1.0,=,IC50,nM,19.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.9,CHEMBL378
1046,5199516.0,[],CHEMBL1670946,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)[Si](CCc1c(N2CCOCC2)nc2ccc(Cl)cc2c1-c1ccccc1Cl)(c1ccccc1)c1ccccc1,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668645,CHEMBL1668645,,0.0,http://www.openphacts.org/units/Nanomolar,1328429.0,>,1.0,1.0,>,IC50,nM,1203100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1203.1,CHEMBL613497
1047,618111.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)c(Oc2nc(N)nc(Nc3ccc(C#N)cc3)n2)c(Br)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL69503,CHEMBL69503,7.77,0.0,http://www.openphacts.org/units/Nanomolar,126913.0,=,1.0,1.0,=,IC50,nM,17.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.017,CHEMBL378
1048,2601794.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1cc(OC[C@H](CO)OCP(=O)(O)O)nc(N)n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL346387,CHEMBL346387,10.85,0.0,http://www.openphacts.org/units/Nanomolar,808011.0,=,1.0,1.0,=,IC50,nM,0.014,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.000014,CHEMBL378
1049,3473986.0,[],CHEMBL1262290,Antiviral activity against PI-resistant Human immunodeficiency virus 1,F,BAO_0000190,BAO_0000218,organism-based format,Cn1c(=O)c(C(=O)NCCO)c(O)c2ncc(Cc3ccc(F)cc3)cc21,CHEMBL1255253,Antimicrob Agents Chemother,2008.0,CHEMBL1256978,CHEMBL1256978,8.70,0.0,http://www.openphacts.org/units/Nanomolar,961177.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
1050,2442782.0,[],CHEMBL987533,Antiviral activity against HIV1 3B infected in human HOG.R5 cells after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1.CS(=O)(=O)O,CHEMBL1148153,J Nat Prod,2004.0,CHEMBL929,CHEMBL593,7.70,0.0,http://www.openphacts.org/units/Nanomolar,789730.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.02,CHEMBL378
1051,2614775.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Sc2cccc(N)c2C#N)cc(C(F)(F)F)c1,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL54970,CHEMBL54970,,0.0,http://www.openphacts.org/units/Nanomolar,731468.0,=,1.0,1.0,=,IC50,nM,5105050.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,2.292,CHEMBL378
1052,1243880.0,[],CHEMBL878997,Inhibition of Hepatitis C RNA dependent RNA polymerase Nonstructural protein 5B activity.,B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(C(=O)N(Cc2cccc(Br)c2)[C@@H](Cc2ccccc2)C(=O)O)c(C)c1,CHEMBL1136248,Bioorg Med Chem Lett,2003.0,CHEMBL323981,CHEMBL323981,5.23,0.0,http://www.openphacts.org/units/Nanomolar,213332.0,=,1.0,1.0,=,IC50,nM,5900.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,5.9,CHEMBL4620
1053,18044761.0,[],CHEMBL4010412,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype D QA013.70I.ENV.M12,F,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075766,CHEMBL4075766,6.62,0.0,http://www.openphacts.org/units/Nanomolar,2990214.0,=,1.0,1.0,=,IC50,nM,240.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.24,CHEMBL378
1054,808648.0,[],CHEMBL683815,Inhibitory activity against NNI-resistant HIV-1 strain A17 with Y181C mutation; ND is not determined.,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](/N=C(\S)Nc1ccccn1)C1CCCCC1,CHEMBL1133139,Bioorg Med Chem Lett,2000.0,CHEMBL305150,CHEMBL305150,,0.0,http://www.openphacts.org/units/Nanomolar,111930.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1055,701705.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,[O-][S+](c1ccc(Cl)cc1)[S+]([O-])c1ccc(Cl)cc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120686,CHEMBL120686,,0.0,,228555.0,=,1.0,0.0,=,IC50,,18.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,18.5,CHEMBL378
1056,5188254.0,[],CHEMBL1664702,Antiviral activity against HIV1 LAI infected in human MT2 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2CCO[C@@H]3OCC[C@@H]32)cc1,CHEMBL1649426,J Med Chem,2011.0,CHEMBL1651154,CHEMBL1651154,7.72,0.0,http://www.openphacts.org/units/Nanomolar,1324305.0,=,1.0,1.0,=,IC50,nM,19.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.019,CHEMBL378
1057,24383447.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.5', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '12.5'}]",CHEMBL5039280,Antiviral activity against HIV 1 25710-2 subtype C assessed as inhibition of viral entry preincubated for 30 min followed by U87-CD4-CRC5 positive cells addition and culture medium replacement after 12 hrs post infection and measured after 48 hrs by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL5038580,J Med Chem,2022.0,CHEMBL525076,CHEMBL525076,7.94,0.0,http://www.openphacts.org/units/Nanomolar,3777694.0,=,1.0,1.0,=,IC50,nM,11.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,11.5,CHEMBL378
1058,3453363.0,[],CHEMBL1247802,Antiviral activity against HIV1 isolate 05-121781 assessed as inhibition of viral replication after 7 days by scintillation counting,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(c2cccc3nc(CN(C)[C@H]4CCCc5cccnc54)c(CO)n23)CC1,CHEMBL1240366,Antimicrob Agents Chemother,2010.0,CHEMBL1242210,CHEMBL1242210,9.00,0.0,http://www.openphacts.org/units/Nanomolar,953332.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
1059,15166112.0,[],CHEMBL3404734,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBeAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(C(=O)Oc2ccc(C(C)=O)cc2)cc(OC)c1OC,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402778,CHEMBL3402778,,0.0,http://www.openphacts.org/units/Nanomolar,2284132.0,>,1.0,1.0,>,IC50,nM,2584700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2584.7,CHEMBL613497
1060,924262.0,[],CHEMBL758490,Anti-HIV activity against multidrug resistant HIV JSL strain by inhibition of HIV p24 antigen expression in peripheral blood mononuclear cells(PBMC),F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1144922,J Med Chem,2003.0,CHEMBL129,CHEMBL129,7.19,0.0,http://www.openphacts.org/units/Nanomolar,83381.0,=,1.0,1.0,=,IC50,nM,64.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,64.0,CHEMBL378
1061,10865186.0,[],CHEMBL2025516,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)COc4ccccc4)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2023664,CHEMBL2023664,4.12,0.0,http://www.openphacts.org/units/Nanomolar,1639228.0,=,1.0,1.0,=,IC50,nM,76660.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,76.66,CHEMBL613497
1062,3084009.0,[],CHEMBL1072584,Antiviral activity against HIV1 infected in human JC53-BL cells after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@H]2C1,CHEMBL1153211,Bioorg Med Chem Lett,2010.0,CHEMBL593195,CHEMBL593195,7.64,0.0,http://www.openphacts.org/units/Nanomolar,872811.0,=,1.0,1.0,=,IC50,nM,23.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,23.0,CHEMBL378
1063,3056490.0,[],CHEMBL1064575,Antiviral activity against HIV1 infected in human PBMC assessed as inhibition of viral p24 antigen production after 7 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CCOC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)CS1,CHEMBL1152525,Bioorg Med Chem,2009.0,CHEMBL595812,CHEMBL595812,5.90,0.0,http://www.openphacts.org/units/Nanomolar,875900.0,=,1.0,1.0,=,IC50,nM,1270.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.27,CHEMBL378
1064,2517084.0,[],CHEMBL975243,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CSc2nc(Cc3ccc(Br)cc3)c(C)c(=O)[nH]2)cc1,CHEMBL1138559,Eur J Med Chem,2009.0,CHEMBL471946,CHEMBL471946,,0.0,http://www.openphacts.org/units/Nanomolar,734092.0,>,1.0,1.0,>,IC50,nM,290000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,290.0,CHEMBL378
1065,2003490.0,[],CHEMBL901904,Antiviral activity against Vaccinia virus-infected Vero cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(-c2nc3cc(NC(=O)C4CCCCC4)ncc3[nH]2)cc1)C1CCCCC1,CHEMBL1138288,J Med Chem,2007.0,CHEMBL239335,CHEMBL239335,7.22,0.0,http://www.openphacts.org/units/Nanomolar,666657.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,nM,UO_0000065,60.0,CHEMBL613493
1066,2149804.0,[],CHEMBL935680,Antiviral activity against HIV1 098 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL428503,CHEMBL428503,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708045.0,=,1.0,1.0,=,IC50,ug.mL-1,0.054,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.054,CHEMBL378
1067,19261849.0,[],CHEMBL4404364,Antiviral activity against HIV1 subtypeA/D QA790.204I.ENV.A4,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.54,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,290.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.29,CHEMBL378
1068,12627464.0,[],CHEMBL2317015,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(N/N=C/c1cccnc1)C1=NNC2CCCCC12,CHEMBL2311445,Bioorg Med Chem,2013.0,CHEMBL2311871,CHEMBL2311871,,0.0,http://www.openphacts.org/units/Nanomolar,1841365.0,>,1.0,1.0,>,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
1069,23274486.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CCC(=O)NC(C(=O)NCCS(=O)(=O)O)CNC(=O)CC[C@@H](C)[C@H]2CC[C@H]3[C@@H]4[C@@H](O)C[C@@H]5C[C@@H](CC[C@]5(C)[C@H]4CC[C@]23C)n2cc(nn2)CO[C@@H]2CC[C@@]3(C)[C@@H](C2)C[C@H](O)[C@@H]2[C@@H]3CC[C@]3(C)[C@@H]1CC[C@@H]23,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4865557,CHEMBL4865557,6.75,0.0,http://www.openphacts.org/units/Nanomolar,3621286.0,=,1.0,1.0,=,IC50,nM,178.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,178.0,CHEMBL613497
1070,2694309.0,[],CHEMBL1053929,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2nc3c(cc2c(CN2CCN(C)CC2)c1O)CSc1cc(F)ccc1-3,CHEMBL1152943,Bioorg Med Chem,2009.0,CHEMBL561184,CHEMBL561184,,0.0,,825021.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
1071,13972685.0,[],CHEMBL3134626,"Antiviral activity against NRTI-resistant HIV-1 D67N, T69D, K70R, A98G, V118I, M184V, T215F and K219Q mutant isolate infected in human PBMC cells assessed as inhibition of viral production by p24 antigen production/ELISA",F,BAO_0000190,BAO_0000218,organism-based format,CCCCCOC(=O)OC[C@@H]1CC[C@H](n2cnc3c(=O)nc[nH]c32)O1,CHEMBL3132835,Medchemcomm,2014.0,CHEMBL3132871,CHEMBL3132871,,0.0,http://www.openphacts.org/units/Nanomolar,1975641.0,=,1.0,1.0,=,IC50,nM,3537000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,3.537,CHEMBL378
1072,1471996.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C/c2ccncc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL187567,CHEMBL187567,8.00,0.0,http://www.openphacts.org/units/Nanomolar,380955.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
1073,10866416.0,[],CHEMBL2025516,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C/C(=C\C(=O)O[C@@H]1C[C@@H]2[C@@]3(C)CC[C@H](O)CC3=CC[C@@]2(O)[C@@]2(O)CC[C@@](O)(C(C)O)[C@@]12C)C(C)C,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024052,CHEMBL2024052,,0.0,http://www.openphacts.org/units/Nanomolar,1639774.0,=,1.0,1.0,=,IC50,nM,306550.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,306.55,CHEMBL613497
1074,1145667.0,[],CHEMBL679241,Concentration required to reduce vaccinia virus-inducted cytopathicity by 50% (E6SM cells),F,BAO_0000190,BAO_0000218,organism-based format,O=C([O-])CC(SCCCOCC1OC(OCCCSC(CC(=O)[O-])C(=O)[O-])C(OCCCSC(CC(=O)[O-])C(=O)[O-])C(OCCCSC(CC(=O)[O-])C(=O)[O-])C1COCC1OC(COCCCSC(CC(=O)[O-])C(=O)[O-])C(OCCCSC(CC(=O)[O-])C(=O)[O-])C(OCCCSC(CC(=O)[O-])C(=O)[O-])C1OCCCSC(CC(=O)[O-])C(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],CHEMBL1130336,J Med Chem,1997.0,CHEMBL384019,CHEMBL1207271,,0.0,http://www.openphacts.org/units/Nanomolar,225165.0,>,1.0,1.0,>,IC50,nM,181000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,181.0,CHEMBL613493
1075,2345607.0,[],CHEMBL956445,Antiviral activity against HIV1 assessed as syncytium inhibition by cell-cell fusion assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,CHEMBL1150796,Antimicrob Agents Chemother,2007.0,CHEMBL264938,CHEMBL264938,5.37,0.0,http://www.openphacts.org/units/Nanomolar,793821.0,=,1.0,1.0,=,IC50,nM,4320.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.32,CHEMBL378
1076,10938682.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4cccc(Br)c4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046576,CHEMBL2046576,4.84,0.0,http://www.openphacts.org/units/Nanomolar,1651459.0,=,1.0,1.0,=,IC50,nM,14360.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,14.36,CHEMBL613497
1077,12642407.0,[],CHEMBL2317522,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay in presence of human serum albumin,F,BAO_0000190,BAO_0000218,organism-based format,CS(=O)(=O)N1CCCN2C(=O)c3c(O)c(=O)c(C(=O)NCc4ccc(F)cc4)cn3CC21,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314677,CHEMBL2314677,6.92,0.0,http://www.openphacts.org/units/Nanomolar,1844809.0,=,1.0,1.0,=,IC50,nM,120.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,120.4,CHEMBL378
1078,24777521.0,[],CHEMBL5128764,Antiviral activity against HIV-1 YU2 (R4) infected in human TZM-bl cells assessed as reduction in viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@H](NC(=O)CCCCCCCNC(=O)[C@]12CCC(C)(C)C[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)[C@@H](O)CC(=O)O,CHEMBL5126557,Bioorg Med Chem Lett,2022.0,CHEMBL5169972,CHEMBL5169972,4.60,0.0,http://www.openphacts.org/units/Nanomolar,3867170.0,=,1.0,1.0,=,IC50,nM,25000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.0,CHEMBL378
1079,566896.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c2ccccc2sn1-c1ccc(S(=O)(=O)Nc2ccc(Cl)nn2)cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL169499,CHEMBL169499,4.72,0.0,http://www.openphacts.org/units/Nanomolar,334061.0,=,1.0,1.0,=,IC50,nM,19200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,19.2,CHEMBL378
1080,19450659.0,[],CHEMBL4433624,Antiviral activity against HIV1 12465 harboring protease M46I/I54V/Q58E/T74P/V82L/L90M mutant infected in human TZM-bl cells infected with supernatants from virus-infected human MT2 cells treated with compound for 72 hrs assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(CCOC(=O)c2ccc(COc3ccccc3-c3csc(N)n3)cc2)cs1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4455200,CHEMBL4597428,6.40,0.0,http://www.openphacts.org/units/Nanomolar,3249760.0,=,1.0,1.0,=,IC50,nM,400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.4,CHEMBL378
1081,16570463.0,[],CHEMBL3801388,Antiviral activity against Sindbis virus infected in African green monkey Vero cells treated for 10 mins measured after 1 to 2 days by crystal violet staining-based assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C#Cc1ccc2c3cccc4cccc(c5cccc1c52)c43,CHEMBL3797183,Medchemcomm,2016.0,CHEMBL3798024,CHEMBL3798024,8.70,0.0,http://www.openphacts.org/units/Nanomolar,2773085.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL613725,Sindbis virus,Sindbis virus,11034,IC50,nM,UO_0000065,2.0,CHEMBL613725
1082,3509179.0,[],CHEMBL1261042,Antiviral activity against HIV1 harboring reverse transcriptase V106A mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3Cl)CC2)ncc1Br,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1171403,CHEMBL1171403,8.70,0.0,http://www.openphacts.org/units/Nanomolar,963717.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
1083,2602099.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C(c1cccc(Cc2ccccc2)c1)c1ncc2cccnc2c1O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL36070,CHEMBL36070,7.40,0.0,http://www.openphacts.org/units/Nanomolar,808038.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
1084,1470293.0,[],CHEMBL833076,Inhibitory activity against HIV-1 mutant strain 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cc(Cl)cc(Cl)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188941,CHEMBL188941,8.00,0.0,http://www.openphacts.org/units/Nanomolar,380720.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
1085,2681630.0,[],CHEMBL1051717,Antiviral activity against HIV1 ZM109F.PB4 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL525076,CHEMBL525076,7.05,0.0,http://www.openphacts.org/units/Nanomolar,823863.0,=,1.0,1.0,=,IC50,nM,90.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.09,CHEMBL378
1086,24971698.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5218444,Anti-HIV activity against HIV-1 NL4-3 Nanoluc-sec virus infected in human MT4 cells assessed as viral growth inhibition by measuring luciferase activity measured after 3 days post-infection by Nano-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@]12C[C@@H](COC(=O)c3ccccc3)[C@@]34OC5(O[C@@H]1[C@@H]3[C@@H]1O[C@]1(CO)[C@@H](O)[C@@]1(O)[C@H]4[C@H]([C@H](C)[C@@H]1OC(=O)c1ccccc1)[C@H](C)CCCCCC[C@H]5O)O2,CHEMBL5215012,J Nat Prod,2022.0,CHEMBL3741746,CHEMBL3741746,9.82,0.0,http://www.openphacts.org/units/Nanomolar,3902020.0,=,1.0,1.0,=,IC50,nM,0.15,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.15,CHEMBL378
1087,492039.0,[],CHEMBL757967,Inhibition of cell growth against HIV-1 infected PBM (Human peripheral blood mononuclear) cells,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c(=O)n([C@H]2CS[C@@H](CO)O2)cc1Cl,CHEMBL1126792,J Med Chem,1993.0,CHEMBL90503,CHEMBL90503,,0.0,http://www.openphacts.org/units/Nanomolar,161296.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1088,22806637.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@@H](Sc3ccc(Cl)c(OC)c3)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4748042,CHEMBL4748042,7.00,0.0,http://www.openphacts.org/units/Nanomolar,3541921.0,=,1.0,1.0,=,IC50,nM,101.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.10099999999999999,CHEMBL613497
1089,17949627.0,[],CHEMBL3992323,Inhibition of human ASCT2 expressed in HEK cells assessed as reduction in [3H]-D-serine uptake after 1 min by beta counting analysis,B,BAO_0000190,BAO_0000219,cell-based format,O=C(O)[C@@H]1C[C@@H](O)CN1,CHEMBL3991947,,2014.0,CHEMBL352418,CHEMBL352418,,0.0,http://www.openphacts.org/units/Nanomolar,2973881.0,<,38.0,1.0,<,IC50,nM,2000000.0,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,mM,UO_0000065,2.0,CHEMBL3562162
1090,2244566.0,[],CHEMBL1003072,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase P236L mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL593,CHEMBL593,,0.0,http://www.openphacts.org/units/Nanomolar,798656.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2000.0,CHEMBL378
1091,14999573.0,[],CHEMBL3364433,Antiviral activity against HIV1 harboring reverse transcriptase K103N/P225H double mutant infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CNc2nc(-c3ccc(F)cc3F)c(Cc3ccccc3)s2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3330437,CHEMBL3330437,5.45,0.0,http://www.openphacts.org/units/Nanomolar,2248823.0,=,1.0,1.0,=,IC50,nM,3590.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.59,CHEMBL378
1092,18183406.0,[],CHEMBL4040187,Antiviral activity against CXCR4-tropic HIV-1 NL4-3 infected in human PHA-stimulated PBMC assessed as inhibition of viral replication by measuring reduction in p24 antigen production preincubated with cells for 30 mins followed by viral infection measured on day 10 post infection in presence of IL-2 by ELISA,F,BAO_0000190,BAO_0000019,assay format,CCCCCOC(=O)C[C@H](NP(=O)(CO[C@@H](CF)Cn1cnc2c(N)ncnc21)Oc1ccccc1)C(=O)OCCCCC,CHEMBL4038313,J Med Chem,2017.0,CHEMBL4073327,CHEMBL4073327,7.58,0.0,http://www.openphacts.org/units/Nanomolar,3016399.0,=,1.0,1.0,=,IC50,nM,26.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.026,CHEMBL378
1093,1470591.0,[],CHEMBL833075,Inhibitory activity against HIV-1 mutant strain 101E,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL57,CHEMBL57,6.51,0.0,http://www.openphacts.org/units/Nanomolar,380791.0,=,1.0,1.0,=,IC50,nM,310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.31,CHEMBL378
1094,2003506.0,[],CHEMBL901904,Antiviral activity against Vaccinia virus-infected Vero cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccccn1)c1ccc2[nH]c(-c3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3F)nc2c1,CHEMBL1138288,J Med Chem,2007.0,CHEMBL393953,CHEMBL393953,6.22,0.0,http://www.openphacts.org/units/Nanomolar,666641.0,=,1.0,1.0,=,IC50,nM,600.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,nM,UO_0000065,600.0,CHEMBL613493
1095,19261892.0,[],CHEMBL4404379,"Antiviral activity against HIV1 subtypeB TRO, clone 11",F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.35,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,450.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.45,CHEMBL378
1096,20663966.0,[],CHEMBL4618924,Antiviral activity against wild type HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CN2CCO[C@H](C)C2)cc1,CHEMBL4616700,ACS Med Chem Lett,2020.0,CHEMBL4648458,CHEMBL4648458,7.20,0.0,http://www.openphacts.org/units/Nanomolar,3479366.0,=,1.0,1.0,=,IC50,nM,63.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,63.6,CHEMBL378
1097,3363279.0,[],CHEMBL1176970,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral cytoplasmic DNA synthesis after 8 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(Cc2nc3ccccc3n2C2CCCCC2)nc1,CHEMBL1177679,Bioorg Med Chem,2010.0,CHEMBL1172801,CHEMBL1172801,,0.0,http://www.openphacts.org/units/Nanomolar,924516.0,>,1.0,1.0,>,IC50,nM,18200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,18.2,CHEMBL613497
1098,5250558.0,[],CHEMBL1686957,Antiviral activity against HIV1 00KENKU3006-D infected in human PBMC assessed as reduction of p24 antigen production after 7 days,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2c(c1)nc(Nc1cccc(C(F)(F)F)c1)c1nc(NC3CC3)ncc12,CHEMBL1681725,Bioorg Med Chem Lett,2011.0,CHEMBL1682297,CHEMBL1682297,6.89,0.0,http://www.openphacts.org/units/Nanomolar,1333376.0,=,1.0,1.0,=,IC50,nM,130.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.13,CHEMBL378
1099,5229508.0,[],CHEMBL1673684,Antiviral activity against R5 tropic HIV-1 Bal infected in human Raji cells expressing DC-SIGN gene assessed as inhibition of virus capture by Raji cells after 60 mins by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CN[C@@H]1[C@H](O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O[C@H]2c3cc(C)c(C(=O)N[C@H](C)C(=O)O)c(O)c3-c3c(cc4c(c3O)C(=O)c3cc(OC)cc(O)c3C4=O)[C@@H]2O)O[C@@H]1C,CHEMBL1671680,Antimicrob Agents Chemother,2010.0,CHEMBL1673205,CHEMBL1673205,4.68,0.0,http://www.openphacts.org/units/Nanomolar,1332108.0,=,1.0,1.0,=,IC50,nM,21000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,21.0,CHEMBL378
1100,2371525.0,[],CHEMBL1035741,Antiviral activity against HIV1 with reverse transcriptase Y188L mutant in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ncccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL491019,CHEMBL491019,6.05,0.0,http://www.openphacts.org/units/Nanomolar,773465.0,=,1.0,1.0,=,IC50,nM,900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,900.0,CHEMBL378
1101,2371155.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,CCn1c2ccccc2c2ccc(/C=N/n3cnnc3)cc21,CHEMBL1140145,J Med Chem,2008.0,CHEMBL492466,CHEMBL492466,,0.0,http://www.openphacts.org/units/Nanomolar,746521.0,=,1.0,1.0,=,IC50,nM,131000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,131.0,CHEMBL613493
1102,19450601.0,[],CHEMBL4433617,Antiviral activity against wild type HIV1 NL4-3 infected in human TZM-bl cells assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay based BiCycle assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(-c2ccccc2OCc2ccc(C(=O)NCCN3CCOCC3)cc2)cs1.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4449394,CHEMBL4595174,,0.0,http://www.openphacts.org/units/Nanomolar,3249763.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1103,15690084.0,[],CHEMBL3610403,Antiviral activity against HIV1 3B infected in CD4/CXCR4 expressing human MAGI cells incubated for 48 hrs by beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1nccc(CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)n1,CHEMBL3608277,ACS Med Chem Lett,2015.0,CHEMBL3608768,CHEMBL3608768,4.24,0.0,http://www.openphacts.org/units/Nanomolar,2496846.0,=,1.0,1.0,=,IC50,nM,57000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,57.0,CHEMBL378
1104,1045207.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(S)n(Nc2ccc(Cl)cc2)c1-c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL287755,CHEMBL287755,,0.0,http://www.openphacts.org/units/Nanomolar,62335.0,>,1.0,1.0,>,IC50,nM,134410.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,134.41,CHEMBL378
1105,2602107.0,[],CHEMBL1033990,Antiviral activity against Hepatitis B virus,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](OP(=O)(S)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)C[C@@H]3O)[C@@H](COP(=O)(S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3CO)O2)c(=O)[nH]c1=O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL1162548,CHEMBL1162548,5.68,0.0,http://www.openphacts.org/units/Nanomolar,806782.0,=,1.0,1.0,=,IC50,nM,2100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.1,CHEMBL613497
1106,24831023.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C1CCN(c2cc3oc4c(Cl)cccc4c(=O)c3cc2Cl)C1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5172404,CHEMBL5172404,,0.0,http://www.openphacts.org/units/Nanomolar,3878135.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
1107,3406167.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc2oc(-c3ccc(F)cc3)c(O)c(=O)c2c1,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1215738,CHEMBL1215738,4.03,0.0,http://www.openphacts.org/units/Nanomolar,933519.0,=,1.0,1.0,=,IC50,nM,92600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,92.6,CHEMBL378
1108,18508383.0,[],CHEMBL4191338,Antiviral activity against VSV-G pseudotyped HIV1 infected in human SupT1 cells after 48 hrs by firefly luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H](C)[C@]23Cc2c(O)cc(C)c(C=O)c2O3)C1(C)C,CHEMBL4190193,J Nat Prod,2017.0,CHEMBL4218326,CHEMBL4218326,4.81,0.0,http://www.openphacts.org/units/Nanomolar,3072810.0,=,1.0,1.0,=,IC50,nM,15600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,15.6,CHEMBL378
1109,20663974.0,[],CHEMBL4618924,Antiviral activity against wild type HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)CN1CCOCC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL4616700,ACS Med Chem Lett,2020.0,CHEMBL4634362,CHEMBL4634362,7.42,0.0,http://www.openphacts.org/units/Nanomolar,3479373.0,=,1.0,1.0,=,IC50,nM,37.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,37.7,CHEMBL378
1110,14653413.0,[],CHEMBL3266817,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)c3cccnc3)[C@H](O)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262982,CHEMBL3262982,4.40,0.0,http://www.openphacts.org/units/Nanomolar,2101864.0,=,1.0,1.0,=,IC50,nM,40000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,40.0,CHEMBL613497
1111,16544701.0,[],CHEMBL3789804,Antiviral activity against HIV1 virus-like particles harboring wild type reverse transcriptase infected in human U2OS cells after 24 hrs by Renilla luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Nc2nc(Nc3ccc(C)cc3)nc(Nc3ccc(C)cc3)n2)cc1,CHEMBL3784952,Bioorg Med Chem,2016.0,CHEMBL3786474,CHEMBL3786474,,0.0,,2769501.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1112,15166119.0,[],CHEMBL3404734,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBeAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C=C/C(=O)OC[C@H]2O[C@@H](Oc3ccc(C(C)=O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)cc1OC,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402784,CHEMBL3402784,,0.0,http://www.openphacts.org/units/Nanomolar,2284139.0,>,1.0,1.0,>,IC50,nM,1451700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1451.7,CHEMBL613497
1113,79070.0,[],CHEMBL809002,The compound was tested in vitro for the inhibitory concentration against influenza B/Mem/89 sialidase from whole virus by fetuin assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1c(OC(C)=O)cc(C(=O)O)cc1[N+](=O)[O-],CHEMBL1128587,J Med Chem,1995.0,CHEMBL321393,CHEMBL321393,,0.0,http://www.openphacts.org/units/Nanomolar,206092.0,=,1.0,1.0,=,IC50,nM,4000000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,mM,UO_0000065,4.0,CHEMBL613129
1114,1671956.0,[],CHEMBL870621,Antiviral activity against HIV1 Y181C mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C(=O)c2cc(Cl)ccc2OCC(=O)Nc2ccc(S(N)(=O)=O)cc2C)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL198347,CHEMBL198347,8.72,0.0,http://www.openphacts.org/units/Nanomolar,411933.0,=,1.0,1.0,=,IC50,nM,1.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.9,CHEMBL378
1115,22806676.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@H](Oc3cccc(OCc4ccccc4)c3)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4761300,CHEMBL4761300,6.17,0.0,http://www.openphacts.org/units/Nanomolar,3541880.0,=,1.0,1.0,=,IC50,nM,681.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.6809999999999999,CHEMBL613497
1116,10996092.0,[],CHEMBL2072873,Antiviral activity against VSV-G pseudotyped HIV1 lentiviral particles infected in human HeLa cells incubated for 48 hrs by spectrofluorometry,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1[C@@H](O)O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,CHEMBL2069294,Bioorg Med Chem,2012.0,CHEMBL252518,CHEMBL252518,,0.0,,1663493.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1117,3383630.0,[],CHEMBL1211563,Antiviral activity against HIV1 NL-BAL infected in CCR5-expressing human JC53-BL cells assessed as inhibition of viral replication after 16 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(N[C@@H](CCN1C[C@@H]2CN(C(=O)c3ccc(C(F)(F)F)nn3)C[C@@H]2C1)c1cccc(F)c1)C1CCOC1,CHEMBL1208790,Bioorg Med Chem Lett,2010.0,CHEMBL1209754,CHEMBL1209754,7.37,0.0,http://www.openphacts.org/units/Nanomolar,927527.0,=,1.0,1.0,=,IC50,nM,43.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,43.0,CHEMBL378
1118,22898292.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731090,Antiviral activity against LPV-resistant HIV1 infected in human MT4 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(=O)C[C@H]1C2CO[C@H]3OC[C@@H]1C3C2)S(=O)(=O)c1ccc2nc(NC3CC3)sc2c1,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL4743665,CHEMBL4743665,,0.0,http://www.openphacts.org/units/Nanomolar,3554415.0,=,1.0,1.0,=,IC50,nM,0.0011,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.0011,CHEMBL378
1119,926908.0,[],CHEMBL746207,Inhibitory concentration required to reduce virus Plaque formation (mumps),F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(F)nc2c1ncn2[C@@H]1C=C[C@@H](O)[C@H]1O,CHEMBL1129081,J Med Chem,1996.0,CHEMBL421655,CHEMBL421655,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,240306.0,=,1.0,1.0,=,IC50,ug.mL-1,21.0,CHEMBL613735,Mumps virus,Mumps virus,11161,IC50,ug ml-1,UO_0000274,21.0,CHEMBL613735
1120,1954172.0,[],CHEMBL891426,Antiviral activity against HIV1 RT 100I mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(C(F)(F)F)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL233663,CHEMBL233663,7.50,0.0,http://www.openphacts.org/units/Nanomolar,647183.0,=,1.0,1.0,=,IC50,nM,31.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.6,CHEMBL378
1121,1401926.0,[],CHEMBL837467,In vitro inhibitory concentration against HIV K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCNc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL174339,CHEMBL174339,6.50,0.0,http://www.openphacts.org/units/Nanomolar,360384.0,=,1.0,1.0,=,IC50,nM,316.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.316,CHEMBL378
1122,15158623.0,[],CHEMBL3398832,Inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,O=C1/C(=C/c2cccc3c2CCOC3=O)Oc2cc(O)ccc21,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397168,CHEMBL3397168,,0.0,http://www.openphacts.org/units/Nanomolar,2278966.0,>,1.0,1.0,>,IC50,nM,1810000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.81,CHEMBL613497
1123,14999585.0,[],CHEMBL3364435,Antiviral activity against HIV1 harboring reverse transcriptase K103N/G190A double mutant infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL223228,CHEMBL223228,7.25,0.0,http://www.openphacts.org/units/Nanomolar,2248840.0,=,1.0,1.0,=,IC50,nM,56.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.056,CHEMBL378
1124,18469018.0,[],CHEMBL4182244,Antiviral activity against HIV-1 3B infected in human TZM-bl cells treated for 2 hrs followed by compound washout measured after 2 days by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@H](C(=O)[O-])C(C)C)C(=O)C(O)=C3C(C)C)/C(=C/N[C@H](C(=O)[O-])C(C)C)C(=O)C(O)=C2C(C)C.[Na+].[Na+],CHEMBL4177704,Bioorg Med Chem Lett,2018.0,CHEMBL1949749,CHEMBL1963076,5.23,0.0,http://www.openphacts.org/units/Nanomolar,3065406.0,=,1.0,1.0,=,IC50,nM,5920.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,umol/L,UO_0000065,5.92,CHEMBL378
1125,15168044.0,[],CHEMBL3406882,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as HBeAg secretion after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)Nc1nc2cc(C(=O)c3cccc(F)c3)ccc2[nH]1,CHEMBL3399962,Bioorg Med Chem,2015.0,CHEMBL3401076,CHEMBL3401076,,0.0,http://www.openphacts.org/units/Nanomolar,2281852.0,=,1.0,1.0,=,IC50,nM,397400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,397.4,CHEMBL613497
1126,682960.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)c1ccc(SSc2ccc(C(C)(C)C)cc2)cc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120709,CHEMBL120709,,0.0,,228660.0,=,1.0,0.0,=,IC50,,12.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,12.4,CHEMBL378
1127,15679699.0,[],CHEMBL3607181,Antiviral activity against HBV infected in human HepG22.2.15 cells after 3 days by neutral red dye-based plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(F)cc2c1ncn2[C@@H]1C=C(CCO)[C@@H](O)[C@H]1O,CHEMBL3603790,Bioorg Med Chem,2015.0,CHEMBL3604364,CHEMBL3604364,6.00,0.0,http://www.openphacts.org/units/Nanomolar,2494267.0,=,1.0,1.0,=,IC50,nM,990.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.99,CHEMBL613497
1128,607857.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Oc3c(Br)cc(Br)cc3Br)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL72459,CHEMBL72459,7.21,0.0,http://www.openphacts.org/units/Nanomolar,126891.0,=,1.0,1.0,=,IC50,nM,61.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.061,CHEMBL378
1129,12717573.0,[],CHEMBL2350960,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion after 12 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=CCc1ccc(O)c(-c2cc(CC=C)ccc2O)c1,CHEMBL2346656,Bioorg Med Chem Lett,2013.0,CHEMBL180920,CHEMBL180920,5.69,0.0,http://www.openphacts.org/units/Nanomolar,1874409.0,=,1.0,1.0,=,IC50,nM,2030.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.03,CHEMBL613497
1130,3014827.0,[],CHEMBL1050519,Antiviral activity against multidrug-resistant HIV1 isolate MM infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL1156053,J Med Chem,2009.0,CHEMBL116,CHEMBL116,6.68,0.0,http://www.openphacts.org/units/Nanomolar,862428.0,=,1.0,1.0,=,IC50,nM,210.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.21,CHEMBL378
1131,14654426.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)c3ccco3)[C@H](O)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262984,CHEMBL3262984,5.03,0.0,http://www.openphacts.org/units/Nanomolar,2101866.0,=,1.0,1.0,=,IC50,nM,9300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,9.3,CHEMBL613497
1132,18754883.0,[],CHEMBL4265061,Antiviral activity against HIV1 cYTA48P infected in PM1/CCR5 cells by single round assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NC1CC2(CCCCC2)NC2(CCCCC2)C1)c1cc2ccc(Cl)cc2[nH]1,CHEMBL4261625,Bioorg Med Chem,2018.0,CHEMBL4277284,CHEMBL4277284,,0.0,http://www.openphacts.org/units/Nanomolar,3116229.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1133,239040.0,[],CHEMBL691099,In vitro antiviral activity against NNRTI-resistant R88703R-IIIB (Y181C) HIV-1 variant,F,BAO_0000190,BAO_0000218,organism-based format,CC(Sc1nc(N)cc(Cl)n1)c1cc2ccoc2cn1,CHEMBL1131332,J Med Chem,1998.0,CHEMBL280752,CHEMBL280752,6.77,0.0,http://www.openphacts.org/units/Nanomolar,41266.0,=,1.0,1.0,=,IC50,nM,170.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.17,CHEMBL378
1134,1219741.0,[],CHEMBL710537,Inhibitory activity against 188L strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C#Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(C)cc(C)cc1C,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL71881,CHEMBL71881,7.38,0.0,http://www.openphacts.org/units/Nanomolar,127453.0,=,1.0,1.0,=,IC50,nM,42.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.042,CHEMBL378
1135,3596604.0,[],CHEMBL1292013,Antiviral activity against HIV1 BaL in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(CNC(=O)N(c2cccc(F)c2)C2CCN(CCC3(c4cccc(F)c4)CCN(C(=O)c4cccnc4F)CC3)CC2)cc1,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288680,CHEMBL1288680,8.19,0.0,http://www.openphacts.org/units/Nanomolar,973790.0,=,1.0,1.0,=,IC50,nM,6.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.4,CHEMBL378
1136,1402174.0,[],CHEMBL837465,In vitro inhibitory concentration against HIV G190S mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL180008,CHEMBL180008,,0.0,http://www.openphacts.org/units/Nanomolar,360390.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1137,795180.0,[],CHEMBL711619,Antiviral activity against HIV-1 (strain RF) infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(COc1ccc(Cl)cc1C(=O)c1ccccc1)Cc1ccccc1,CHEMBL1128355,J Med Chem,1995.0,CHEMBL441039,CHEMBL441039,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,73226.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,100.0,CHEMBL378
1138,18775482.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC1Cc2cc(Br)ccc2-c2cc(=O)c(C(=O)O)cn21,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4280724,CHEMBL4280724,5.32,0.0,http://www.openphacts.org/units/Nanomolar,3119640.0,=,1.0,1.0,=,IC50,nM,4750.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,4.75,CHEMBL613497
1139,394373.0,[],CHEMBL881122,Inhibitory concentration required against vaccinia virus in Vero cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2C[C@H]1COP(=O)(O)CO1,CHEMBL1147452,Bioorg Med Chem Lett,2004.0,CHEMBL112159,CHEMBL112159,4.39,0.0,http://www.openphacts.org/units/Nanomolar,214242.0,=,1.0,1.0,=,IC50,nM,41000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,41.0,CHEMBL613493
1140,1470308.0,[],CHEMBL832527,Inhibitory activity against HIV-1 double mutants strain 227L and 106A,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL185715,CHEMBL185715,5.50,0.0,http://www.openphacts.org/units/Nanomolar,380721.0,=,1.0,1.0,=,IC50,nM,3160.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.16,CHEMBL378
1141,19262034.0,[],CHEMBL4404430,Antiviral activity against multidrug resistant HIV1 12243 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,5.64,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,2300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.3,CHEMBL378
1142,15166127.0,[],CHEMBL3404734,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBeAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(O[C@@H]2O[C@H](COC(=O)c3cccnc3)[C@@H](O)[C@H](O)[C@H]2O)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402791,CHEMBL3402791,,0.0,http://www.openphacts.org/units/Nanomolar,2284147.0,>,1.0,1.0,>,IC50,nM,1654300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1654.3,CHEMBL613497
1143,1471440.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cccc(F)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL361479,CHEMBL361479,8.70,0.0,http://www.openphacts.org/units/Nanomolar,380905.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.002,CHEMBL378
1144,511127.0,[],CHEMBL757967,Inhibition of cell growth against HIV-1 infected PBM (Human peripheral blood mononuclear) cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(=O)n([C@@H]2CS[C@@H](CO)O2)cc1F,CHEMBL1126792,J Med Chem,1993.0,CHEMBL89911,CHEMBL89911,,0.0,http://www.openphacts.org/units/Nanomolar,161286.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1145,3199200.0,[],CHEMBL1104121,Antiviral activity against HIV1 Ba-L infected in PBMCs assessed as reverse transcriptase activity after 7 days by MTS assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](CN[C@H](CN[C@H](CN[C@H](CNCCC(N)=O)Cc1ccc(O)cc1)Cc1ccc(O)cc1)Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@@H](N)Cc1ccc(O)cc1,CHEMBL1153724,Bioorg Med Chem Lett,2009.0,CHEMBL1075815,CHEMBL1075815,5.30,0.0,http://www.openphacts.org/units/Nanomolar,889158.0,=,1.0,1.0,=,IC50,nM,5000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.0,CHEMBL378
1146,697713.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)C(=S)SSC(=S)SSC(=S)N(C)C,CHEMBL1129635,J Med Chem,1996.0,CHEMBL121083,CHEMBL121083,,0.0,,228562.0,=,1.0,0.0,=,IC50,,0.53,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,0.53,CHEMBL378
1147,14596903.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2cccc(C(=O)O)c2)n(COCCO)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL119904,CHEMBL119904,5.46,0.0,http://www.openphacts.org/units/Nanomolar,2082745.0,=,1.0,1.0,=,IC50,nM,3450.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.45,CHEMBL378
1148,1403441.0,[],CHEMBL834756,Inhibitory concentration against 103N mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL223228,CHEMBL223228,7.40,0.0,http://www.openphacts.org/units/Nanomolar,360777.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
1149,6268208.0,[],CHEMBL1803184,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC1=O)C(=O)N[C@@H](CO)C(=O)N4)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC3=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N2,CHEMBL1799917,J Nat Prod,2010.0,CHEMBL525563,CHEMBL525563,6.30,0.0,http://www.openphacts.org/units/Nanomolar,1440219.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.5,CHEMBL378
1150,700573.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,S=C(SSC(=S)N1CCOCC1)N1CCOCC1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL121556,CHEMBL121556,,0.0,,228576.0,=,1.0,0.0,=,IC50,,0.52,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,0.52,CHEMBL378
1151,925775.0,[],CHEMBL758490,Anti-HIV activity against multidrug resistant HIV JSL strain by inhibition of HIV p24 antigen expression in peripheral blood mononuclear cells(PBMC),F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C[S+]([O-])c1ccc2ccccc2c1)NS(C)(=O)=O,CHEMBL1144922,J Med Chem,2003.0,CHEMBL49002,CHEMBL49002,6.66,0.0,http://www.openphacts.org/units/Nanomolar,83383.0,=,1.0,1.0,=,IC50,nM,220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,220.0,CHEMBL378
1152,10961062.0,[],CHEMBL2061264,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing wild type protease infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNC1CC1)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057470,CHEMBL2057470,7.62,0.0,http://www.openphacts.org/units/Nanomolar,1655132.0,=,1.0,1.0,=,IC50,nM,24.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,24.0,CHEMBL378
1153,1062583.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,SC1=NC(c2ccccc2)C(c2ccccc2)N1Nc1cccc(Cl)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL38980,CHEMBL38980,,0.0,http://www.openphacts.org/units/Nanomolar,62360.0,>,1.0,1.0,>,IC50,nM,36310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,36.31,CHEMBL378
1154,6216918.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(S(N)(=O)=O)cc2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784475,CHEMBL1784475,7.79,0.0,http://www.openphacts.org/units/Nanomolar,1429414.0,=,1.0,1.0,=,IC50,nM,16.22,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.79,CHEMBL378
1155,2649345.0,[],CHEMBL1024326,"Antiviral activity against HIV1 expressed in 293T cells assessed as protection against viral M33 envelope infection in human U87 cells coexpressing CD4, CCR5 receptors after 72 hrs by luciferase reporter gene pseudoviral assay",F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1ccc(N2CCOC2=O)cc1,CHEMBL1158460,J Med Chem,2009.0,CHEMBL563879,CHEMBL563879,4.92,0.0,http://www.openphacts.org/units/Nanomolar,816171.0,=,1.0,1.0,=,IC50,nM,12000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,12000.0,CHEMBL378
1156,24731870.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5115940,Antiviral activity against ZIKV-SMGC-1 infected in human BHK cells incubated for 7 days by CellTiter 96 luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(c1ccc(C(F)(F)F)cc1O)c1[nH]c(Cl)c(Cl)c1-n1c(C(=O)c2ccc(C(F)(F)F)cc2O)cc(Cl)c1Sc1cnccn1,CHEMBL5113415,Eur J Med Chem,2022.0,CHEMBL5190131,CHEMBL5190131,6.60,0.0,http://www.openphacts.org/units/Nanomolar,3857946.0,=,1.0,1.0,=,IC50,nM,250.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,0.25,CHEMBL4296612
1157,3465409.0,[],CHEMBL1250682,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C=C[C@@H](OCP(=O)(O)O)O2)c(=O)[nH]c1=O,CHEMBL1250548,Bioorg Med Chem,2010.0,CHEMBL122885,CHEMBL122885,4.92,0.0,http://www.openphacts.org/units/Nanomolar,955666.0,=,1.0,1.0,=,IC50,nM,12000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.0,CHEMBL378
1158,5198688.0,[],CHEMBL1670547,Antiviral activity against R5 tropic HIV1 Ba-L infected in human PBMC assessed as inhibition of HIN p24 antigen expression,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1667838,Bioorg Med Chem Lett,2011.0,CHEMBL129,CHEMBL129,8.15,0.0,http://www.openphacts.org/units/Nanomolar,1327567.0,=,1.0,1.0,=,IC50,nM,7.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.0,CHEMBL378
1159,14999539.0,[],CHEMBL3366529,Antiviral activity against HIV1 harboring reverse transcriptase Y181C mutant infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2nc(NCc3ccc(N(C)C)cc3)sc2Cc2ccccc2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3330423,CHEMBL3330423,4.14,0.0,http://www.openphacts.org/units/Nanomolar,2246860.0,=,1.0,1.0,=,IC50,nM,71600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,71.6,CHEMBL378
1160,3014803.0,[],CHEMBL1050516,Antiviral activity against multidrug-resistant HIV1 isolate C infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(c1)OCCC=CCCCCN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]3OCC[C@H]31)S2(=O)=O,CHEMBL1156053,J Med Chem,2009.0,CHEMBL2094013,CHEMBL2094013,7.36,0.0,http://www.openphacts.org/units/Nanomolar,862636.0,=,1.0,1.0,=,IC50,nM,44.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.044,CHEMBL378
1161,24788555.0,[],CHEMBL5131658,Antiviral activity against 3TC resistant HIV-1 mutant in monocyte,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,CHEMBL5131375,J Med Chem,2022.0,CHEMBL14762,CHEMBL14762,9.44,0.0,http://www.openphacts.org/units/Nanomolar,3869388.0,=,1.0,1.0,=,IC50,nM,0.36,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.36,CHEMBL378
1162,5246993.0,[],CHEMBL1687410,Antiviral activity against HIV1 Ba-L infected in human HOS cells expressing CCR5 after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@H]1C[C@H]2CC[C@@H](C1)N2CCC(CNC(=O)c1ccccc1)c1ccccc1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL3084351,CHEMBL3084351,,0.0,http://www.openphacts.org/units/Nanomolar,1333586.0,>,1.0,1.0,>,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
1163,630551.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Oc3c(Cl)cccc3Cl)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL70967,CHEMBL70967,8.51,0.0,http://www.openphacts.org/units/Nanomolar,126893.0,=,1.0,1.0,=,IC50,nM,3.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0031,CHEMBL378
1164,3254060.0,[],CHEMBL1114300,Antiviral activity against HIV1 3B in human HOS cells expressing human CXCR4/CXCR5/CD4/pHIV-LTR-luciferase assessed as blockade of viral infection into cells,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)CCCn1c(CN2CCC[C@H]3CCc4cccnc4[C@H]32)nc2ccccc21,CHEMBL1156293,Bioorg Med Chem Lett,2010.0,CHEMBL1093719,CHEMBL1093719,7.46,0.0,http://www.openphacts.org/units/Nanomolar,901196.0,=,1.0,1.0,=,IC50,nM,35.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,35.0,CHEMBL378
1165,18528898.0,[],CHEMBL4195001,Antiviral activity against HIV1 virions containing reverse transcriptase K103N mutant derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc([C@H]2c3cc(OC)c(OC)cc3C[C@H](C)[C@@H]2C)cc1OC,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4203607,CHEMBL4203607,5.86,0.0,http://www.openphacts.org/units/Nanomolar,3076499.0,=,1.0,1.0,=,IC50,nM,1380.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.38,CHEMBL378
1166,37601.0,[],CHEMBL692441,The effect of protein binding on the antiviral activity versus wild type virus strain K103N was tested in the presence of human serum in HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL223228,CHEMBL223228,,0.0,,20823.0,=,1.0,0.0,=,IC50,,5.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,5.1,CHEMBL378
1167,682944.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Nc1cc(C(=O)O)ccc1SSc1ccc(C(=O)O)cc1N,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120461,CHEMBL120461,,0.0,,228538.0,>,1.0,0.0,>,IC50,,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,200.0,CHEMBL378
1168,3253139.0,[],CHEMBL1107997,Antiviral activity against HIV1 NL4.3 infected in human MT4 cells expressing CD4 and CXCR4 assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NC/C=C\CN(Cc1nc2ccccc2[nH]1)C1CCCc2cccnc21,CHEMBL1156989,J Med Chem,2010.0,CHEMBL1089844,CHEMBL1089844,7.82,0.0,http://www.openphacts.org/units/Nanomolar,901983.0,=,1.0,1.0,=,IC50,nM,15.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.015,CHEMBL378
1169,662035.0,[],CHEMBL713512,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C1Cn2c(O)nc3cccc(c32)CN1,CHEMBL1128252,J Med Chem,1995.0,CHEMBL167899,CHEMBL167899,,0.0,http://www.openphacts.org/units/Nanomolar,326362.0,>,1.0,1.0,>,IC50,nM,250000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,250.0,CHEMBL378
1170,2091752.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1cc(C)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL300851,CHEMBL300851,,0.0,http://www.openphacts.org/units/Nanomolar,700534.0,=,1.0,1.0,=,IC50,nM,16595869074375.56,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,4.22,CHEMBL378
1171,2929680.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3ccnc3Br)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL568495,CHEMBL568495,,0.0,,852868.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1172,3129719.0,[],CHEMBL1065520,Antiviral activity against HIV1 LAI infected in human CEM-SS cells assessed as inhibition of viral replication by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=P([O-])(O)Cc1cc2c(O)c(c1)Cc1cc(CP(=O)([O-])O)cc(c1O)Cc1cc(CP(=O)([O-])O)cc(c1O)Cc1cc(CP(=O)([O-])O)cc(c1O)C2.[Na+].[Na+].[Na+].[Na+],CHEMBL1157689,Bioorg Med Chem,2010.0,CHEMBL590348,CHEMBL592901,,0.0,http://www.openphacts.org/units/Nanomolar,880945.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1173,6303623.0,[],CHEMBL1815966,Antiviral activity against R5 tropic HIV1 Ba-L infected PBMC assessed as inhibition of viral p24 antigen expression,F,BAO_0000190,BAO_0000218,organism-based format,CCCCN1C(=O)C(C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2.Cl,CHEMBL1811891,Bioorg Med Chem,2011.0,CHEMBL1813459,CHEMBL1851976,6.80,0.0,http://www.openphacts.org/units/Nanomolar,1447827.0,=,1.0,1.0,=,IC50,nM,160.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,160.0,CHEMBL378
1174,12651435.0,[],CHEMBL2327724,Antiviral activity against 0.001 MOI wild type Human immunodeficiency virus 1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCC(=O)N[C@@H](C)C(=O)OC)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324140,CHEMBL2324140,8.00,0.0,http://www.openphacts.org/units/Nanomolar,1850166.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
1175,2244589.0,[],CHEMBL1002204,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase K103N/P225H mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(COc1ccc(Cl)cc1C(=O)c1ccccc1)Nc1ccccc1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL296939,CHEMBL296939,7.25,0.0,http://www.openphacts.org/units/Nanomolar,798577.0,=,1.0,1.0,=,IC50,nM,56.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,56.0,CHEMBL378
1176,20668236.0,[],CHEMBL4620093,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells by solid phase radioimmunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@H](N)C(=O)OC1CCN(S(=O)(=O)c2cc(C(=O)Nc3cc(F)c(F)c(F)c3)ccc2F)CC1,CHEMBL4619714,Bioorg Med Chem Lett,2020.0,CHEMBL4645016,CHEMBL4645016,6.55,0.0,http://www.openphacts.org/units/Nanomolar,3480252.0,=,1.0,1.0,=,IC50,nM,280.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.28,CHEMBL613497
1177,3432916.0,[],CHEMBL1246459,Antiviral activity against R5 tropic HIV1 BaL infected in human CEMx174 5.25M7 cells after 3 days by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NN1C(=O)[C@@H]2C3C=CC(C4CC43)[C@@H]2C1=O)c1ccc(CN(Cc2ccccc2)c2ccccc2)cc1,CHEMBL1240449,Eur J Med Chem,2010.0,CHEMBL1242909,CHEMBL1242909,4.77,0.0,http://www.openphacts.org/units/Nanomolar,954309.0,=,1.0,1.0,=,IC50,nM,17060.82,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.768,CHEMBL378
1178,208495.0,[],CHEMBL815090,Inhibition of HIV-1 (ADA) entry into U-87 (human glioblastoma) cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(C)C)c3ccc(Br)cc3)CC2)CC1,CHEMBL1136595,Bioorg Med Chem Lett,2003.0,CHEMBL341758,CHEMBL341758,8.93,0.0,http://www.openphacts.org/units/Nanomolar,317559.0,=,1.0,1.0,=,IC50,nM,1.17,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.17,CHEMBL378
1179,16498307.0,[],CHEMBL3778316,Antiviral activity against HIV1 NL4-3 infected in human 293T cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2csc(N3N=C(C(F)(F)F)/C(=N/Nc4ccc5c(S(=O)(=O)O)cc(S(=O)(=O)O)cc5c4)C3=O)n2)cc1,CHEMBL3774382,Bioorg Med Chem,2016.0,CHEMBL3775379,CHEMBL3775379,,0.0,http://www.openphacts.org/units/Nanomolar,2762415.0,=,1.0,1.0,=,IC50,nM,103700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,103.7,CHEMBL378
1180,1471739.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL175522,CHEMBL175522,8.70,0.0,http://www.openphacts.org/units/Nanomolar,380740.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.002,CHEMBL378
1181,3198133.0,[],CHEMBL1104125,Antiviral activity against HIV1 UG/92/001 infected in PBMCs assessed as reverse transcriptase activity after 7 days by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)CCNC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@@H](N)Cc1ccc(O)cc1,CHEMBL1153724,Bioorg Med Chem Lett,2009.0,CHEMBL1075830,CHEMBL1075830,5.22,0.0,http://www.openphacts.org/units/Nanomolar,889153.0,=,1.0,1.0,=,IC50,nM,6000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.0,CHEMBL378
1182,799824.0,[],CHEMBL683814,Inhibitory activity against NNI-resistant HIV-1 strain A17 with Y181C mutation,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1133139,Bioorg Med Chem Lett,2000.0,CHEMBL57,CHEMBL57,,0.0,http://www.openphacts.org/units/Nanomolar,111932.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1183,3284631.0,[],CHEMBL1110057,Antiviral activity against HIV1 3B infected in human HOS cells expressing human CXCR4/CCR5/CD4/pHIV-LTR luciferase assessed as inhibition of viral infection to cells,F,BAO_0000190,BAO_0000218,organism-based format,CN(Cc1ncc2ccccc2c1C#N)[C@H]1CCCc2cccnc21,CHEMBL1157822,Bioorg Med Chem Lett,2010.0,CHEMBL1096141,CHEMBL1096141,7.14,0.0,http://www.openphacts.org/units/Nanomolar,911375.0,=,1.0,1.0,=,IC50,nM,72.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,72.0,CHEMBL378
1184,18314697.0,[],CHEMBL4132882,Antiviral activity against ENV pseudotyped CXCR4-tropic HIV1 HxB2 infected in human TZM-bl cells after 24 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(C1=NC[C@H](c2c[nH]c3cc(Br)ccc23)N1)c1c[nH]c2cc(Br)ccc12,CHEMBL4130397,J Nat Prod,2017.0,CHEMBL4160400,CHEMBL4160400,4.92,0.0,http://www.openphacts.org/units/Nanomolar,3040473.0,=,1.0,1.0,=,IC50,nM,12000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.0,CHEMBL378
1185,10937562.0,[],CHEMBL2051603,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccccc4C)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046552,CHEMBL2046552,5.14,0.0,http://www.openphacts.org/units/Nanomolar,1651435.0,=,1.0,1.0,=,IC50,nM,7200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,7.2,CHEMBL613497
1186,2614794.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)c2cccc(N)c2C#N)cc1,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL55043,CHEMBL55043,,0.0,http://www.openphacts.org/units/Nanomolar,731796.0,=,1.0,1.0,=,IC50,nM,25003453.62,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,1.602,CHEMBL378
1187,18940382.0,[],CHEMBL4328847,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Cn2ccc3ccc(-c4ccc5ccn(Cc6cccc(C(=O)O)c6)c5c4)cc32)cc(C(=O)O)c1,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4466565,CHEMBL4466565,,0.0,http://www.openphacts.org/units/Nanomolar,3159817.0,>,1.0,1.0,>,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
1188,945913.0,[],CHEMBL716463,Inhibitory concentration required to reduce virus Plaque formation (measles),F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](O)C1=C[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,CHEMBL1129081,J Med Chem,1996.0,CHEMBL113259,CHEMBL113259,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,240303.0,=,1.0,1.0,=,IC50,ug.mL-1,0.09,CHEMBL613738,Measles virus,Measles virus,11234,IC50,ug ml-1,UO_0000274,0.09,CHEMBL613738
1189,15158619.0,[],CHEMBL3398832,Inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)c1cccc2c1CCOC2=O,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397164,CHEMBL3397164,,0.0,http://www.openphacts.org/units/Nanomolar,2278962.0,>,1.0,1.0,>,IC50,nM,3290000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,3.29,CHEMBL613497
1190,309942.0,[],CHEMBL821329,Evaluated for 50% plaque inhibition of vaccinia virus replication in murine L929 cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nccc2c1ncn2CC=C(CO)CO,CHEMBL1124198,J Med Chem,1988.0,CHEMBL50600,CHEMBL50600,,0.0,http://www.openphacts.org/units/Nanomolar,80418.0,=,1.0,1.0,=,IC50,nM,500000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,500.0,CHEMBL613493
1191,19450680.0,[],CHEMBL4433628,Antiviral activity against HIV1 12229 harboring non-nucleoside reverse transcriptase L100I/K103N/H221Y mutant infected in human TZM-bl cells infected with supernatants from virus-infected human MT2 cells treated with compound for 72 hrs assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc(NCCNC(=O)c2ccc(COc3ccccc3-c3csc(N)n3)cc2)nc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4536687,CHEMBL4597553,4.92,0.0,http://www.openphacts.org/units/Nanomolar,3249764.0,=,1.0,1.0,=,IC50,nM,12000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.0,CHEMBL378
1192,18323334.0,[],CHEMBL4134874,Antiviral activity against VSV-G pseudotyped HIV1 infected in human SupT1 cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC1=C(c2ccc(O)cc2)[C@@H](Cc2ccc(O)cc2)OC1=O,CHEMBL4130477,J Nat Prod,2017.0,CHEMBL4174033,CHEMBL4174033,4.16,0.0,http://www.openphacts.org/units/Nanomolar,3042107.0,=,1.0,1.0,=,IC50,nM,68700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,68.7,CHEMBL378
1193,2179593.0,[],CHEMBL966469,Antiviral activity against HIV1 3B isolate replication in human H9 cells assessed as decrease in viral p24 level after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,CHEMBL1155638,J Nat Prod,2000.0,CHEMBL169,CHEMBL169,4.84,0.0,http://www.openphacts.org/units/Nanomolar,712150.0,=,1.0,1.0,=,IC50,nM,14300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,14.3,CHEMBL378
1194,18387167.0,[],CHEMBL4147078,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of viral replication by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CCCCOc1cnc2cc(C)c(C)cc2n1,CHEMBL4145483,Eur J Med Chem,2018.0,CHEMBL3331252,CHEMBL3331252,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,3051816.0,=,1.0,1.0,=,IC50,ug.mL-1,0.22,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.22,CHEMBL378
1195,3292039.0,[],CHEMBL1108227,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N[C@@H](CCN1C[C@@H]2CN(C(=O)c3c(C)cccc3C)C[C@@H]2C1)c1ccccc1,CHEMBL1157775,Bioorg Med Chem Lett,2010.0,CHEMBL1096446,CHEMBL1096446,6.88,0.0,http://www.openphacts.org/units/Nanomolar,910641.0,=,1.0,1.0,=,IC50,nM,132.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,132.0,CHEMBL378
1196,989005.0,[],CHEMBL714338,"Antiviral activity against HIV-1, IIIB, in MT-4 Cells",F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CN[C@@H](C(=O)NC2c3ccccc3C[C@H]2O)[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CSc2nnc(C)s2)C(C)(C)C)cc1,CHEMBL1129316,J Med Chem,1996.0,CHEMBL65470,CHEMBL65470,6.75,0.0,http://www.openphacts.org/units/Nanomolar,111237.0,=,1.0,1.0,=,IC50,nM,178.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,178.0,CHEMBL378
1197,1472422.0,[],CHEMBL833079,Inhibitory activity against HIV-1 mutant strain 181C,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cc(Cl)cc(Cl)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL184294,CHEMBL184294,6.80,0.0,http://www.openphacts.org/units/Nanomolar,380650.0,=,1.0,1.0,=,IC50,nM,160.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.16,CHEMBL378
1198,3603792.0,[],CHEMBL1291658,Antiviral activity against Hepatitis B virus infected in HepG2.2.15 assessed as inhibition of HBV replication by quantitative Southern blot hybridization analysis,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(SCc2nc3c(Cn4ccnc4C)c(O)ccc3n2C)cc1,CHEMBL1287795,Bioorg Med Chem Lett,2010.0,CHEMBL1288081,CHEMBL1288081,4.44,0.0,http://www.openphacts.org/units/Nanomolar,973092.0,=,1.0,1.0,=,IC50,nM,36100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,36.1,CHEMBL613497
1199,17602962.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(S(=O)(=O)c2cccs2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644897,CHEMBL3644897,8.22,0.0,http://www.openphacts.org/units/Nanomolar,2518017.0,=,37.0,1.0,=,IC50,nM,6.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,6.0,CHEMBL4620
1200,19262061.0,[],CHEMBL4404443,Antiviral activity against HIV1-3B infected in human H9 cells assessed as inhibition in cell to cell HIV1 transmission to human TZM-bl acceptor cells incubated for 24 hrs by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c12,CHEMBL4402563,J Med Chem,2020.0,CHEMBL3301620,CHEMBL3301620,7.70,0.0,http://www.openphacts.org/units/Nanomolar,3216300.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.02,CHEMBL378
1201,10866476.0,[],CHEMBL2025518,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)C(C#N)=C(C)C)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2023662,CHEMBL2023662,4.51,0.0,http://www.openphacts.org/units/Nanomolar,1639226.0,=,1.0,1.0,=,IC50,nM,30550.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,30.55,CHEMBL613497
1202,2649358.0,[],CHEMBL1024326,"Antiviral activity against HIV1 expressed in 293T cells assessed as protection against viral M33 envelope infection in human U87 cells coexpressing CD4, CCR5 receptors after 72 hrs by luciferase reporter gene pseudoviral assay",F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)cc2F)on1,CHEMBL1158460,J Med Chem,2009.0,CHEMBL551638,CHEMBL551638,6.89,0.0,http://www.openphacts.org/units/Nanomolar,816428.0,=,1.0,1.0,=,IC50,nM,130.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,130.0,CHEMBL378
1203,5198686.0,[],CHEMBL1670547,Antiviral activity against R5 tropic HIV1 Ba-L infected in human PBMC assessed as inhibition of HIN p24 antigen expression,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCC3)cc1.[Cl-],CHEMBL1667838,Bioorg Med Chem Lett,2011.0,CHEMBL41275,CHEMBL1178786,7.55,0.0,http://www.openphacts.org/units/Nanomolar,1327565.0,=,1.0,1.0,=,IC50,nM,28.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,28.0,CHEMBL378
1204,5199477.0,[],CHEMBL1670944,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)[Si](CCc1c(N2CCCCC2)nc2ccc(Cl)cc2c1-c1ccccc1Cl)(c1ccccc1)c1ccccc1,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668644,CHEMBL1668644,,0.0,http://www.openphacts.org/units/Nanomolar,1328428.0,>,1.0,1.0,>,IC50,nM,968800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,968.8,CHEMBL613497
1205,1037836.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1cccc(C2C(C)N=CN2Nc2cccc(Cl)c2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39815,CHEMBL39815,,0.0,http://www.openphacts.org/units/Nanomolar,62338.0,>,1.0,1.0,>,IC50,nM,33150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,33.15,CHEMBL378
1206,22933284.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)/C=C/c4ccc(OCc5cccc(Cl)c5)c(OC)c4)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4763632,CHEMBL4763632,,0.0,http://www.openphacts.org/units/Nanomolar,3560845.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
1207,18940402.0,[],CHEMBL4328847,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn(C(=O)OC(C)(C)C)c2cc(-c3ccc4ccn(Cc5cccc(C(=O)O)c5)c4c3)ccc12,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4592061,CHEMBL4592061,5.92,0.0,http://www.openphacts.org/units/Nanomolar,3159837.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.2,CHEMBL378
1208,631891.0,[],CHEMBL710534,Inhibitory activity against 188L strain of HIV-1 in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Cc2nc(N)nc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL304055,CHEMBL304055,7.35,0.0,http://www.openphacts.org/units/Nanomolar,126899.0,=,1.0,1.0,=,IC50,nM,45.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.045,CHEMBL378
1209,15200418.0,[],CHEMBL3413997,Antiviral activity against X4 tropic HIV-1 clone pNL4-3 infected in H9 cells assessed as reduction in p24 antigen after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)c1ccc(CC(C#N)c2nc3ccccc3[nH]2)cc1,CHEMBL3407469,Eur J Med Chem,2015.0,CHEMBL3410150,CHEMBL3410150,,0.0,http://www.openphacts.org/units/Nanomolar,2288887.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
1210,323432.0,[],CHEMBL653803,In vitro inhibition of CEM-SS cell growth by 50 %,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OCC,CHEMBL1125666,J Med Chem,1991.0,CHEMBL28645,CHEMBL28645,5.52,0.0,http://www.openphacts.org/units/Nanomolar,43718.0,=,1.0,1.0,=,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.0,CHEMBL378
1211,18342070.0,[],CHEMBL4139011,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1ccc(-c2cc(NC(=O)c3cccc(OC)c3O)c[nH]c2=O)cc1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL4171918,CHEMBL4171918,4.51,0.0,http://www.openphacts.org/units/Nanomolar,3045876.0,=,1.0,1.0,=,IC50,nM,30520.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,30.52,CHEMBL613497
1212,37602.0,[],CHEMBL692440,The effect of protein binding on the antiviral activity versus wild type virus strain K103N was tested in the presence of both acid glycoprotein and human serum in HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL223228,CHEMBL223228,,0.0,,20823.0,=,1.0,0.0,=,IC50,,5.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,5.8,CHEMBL378
1213,14927149.0,[],CHEMBL3391566,Antiviral activity against NNRTI-resistant HIV-1 LAI harboring reverse transcriptase K103N mutant infected in human MT4 cells assessed as inhibition of viral replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL3390846,Medchemcomm,2010.0,CHEMBL223228,CHEMBL223228,7.19,0.0,http://www.openphacts.org/units/Nanomolar,2173138.0,=,1.0,1.0,=,IC50,nM,65.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,65.0,CHEMBL378
1214,1403437.0,[],CHEMBL834757,Inhibitory concentration against 181C mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(S(=O)(=O)c2nc(Nc3ccc(C#N)cc3)c(=O)n(C)c2C)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL175570,CHEMBL175570,7.20,0.0,http://www.openphacts.org/units/Nanomolar,360772.0,=,1.0,1.0,=,IC50,nM,63.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.063,CHEMBL378
1215,14927175.0,[],CHEMBL3391564,Antiviral activity against wild type HIV-1 LAI infected in human MT4 cells assessed as inhibition of viral replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2c(F)c(CCc3ccncc3)[nH]c(=O)c2Br)c1,CHEMBL3390846,Medchemcomm,2010.0,CHEMBL3347281,CHEMBL3347281,8.30,0.0,http://www.openphacts.org/units/Nanomolar,2173090.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.0,CHEMBL378
1216,2929508.0,[],CHEMBL1056899,Antiviral activity against HIV1 HXB2 harboring 227C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSCc3csc(C)n3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567623,CHEMBL567623,7.40,0.0,http://www.openphacts.org/units/Nanomolar,852982.0,=,1.0,1.0,=,IC50,nM,39.81,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,39.81,CHEMBL378
1217,2003640.0,[],CHEMBL901910,Antiviral activity against Modoc virus-infected HeLa-H1 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NC12CC3CC(CC(C3)C1)C2)c1ccc2[nH]c(-c3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3)nc2c1,CHEMBL1138288,J Med Chem,2007.0,CHEMBL373757,CHEMBL373757,7.22,0.0,http://www.openphacts.org/units/Nanomolar,666644.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL612946,Modoc virus,Modoc virus,64300,IC50,nM,UO_0000065,60.0,CHEMBL612946
1218,18726965.0,[],CHEMBL4259330,Antiviral activity against HIV-1 subtype B JRFL pseudovirus assessed as inhibition of viral infection in Ghost (3)X4/R5 cells after 48 hrs by Bright-Glo luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@]1(C)CCC/C=C\CCC[C@](C)(NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O,CHEMBL4257519,Medchemcomm,2018.0,CHEMBL4287830,CHEMBL4287830,8.07,0.0,http://www.openphacts.org/units/Nanomolar,3111235.0,=,1.0,1.0,=,IC50,nM,8.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.6,CHEMBL378
1219,2203533.0,[],CHEMBL987023,Antiviral activity against HIV1 3B in human MT4 cells assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CCn1c(COc2ccc(NC(=S)NCC)cc2)n[nH]c1=S,CHEMBL1149790,Eur J Med Chem,2008.0,CHEMBL523858,CHEMBL523858,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,765678.0,>,1.0,1.0,>,IC50,ug.mL-1,76.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,76.5,CHEMBL378
1220,12651396.0,[],CHEMBL2327723,Antiviral activity against 0.001 MOI bevirimat-resistant Human immunodeficiency virus 1 NL4-3 harboring gag V370A mutant infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCNC(=O)[C@@H]3CCCN3C(=O)OC(C)(C)C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324151,CHEMBL2324151,6.02,0.0,http://www.openphacts.org/units/Nanomolar,1850177.0,=,1.0,1.0,=,IC50,nM,950.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.95,CHEMBL378
1221,858581.0,[],CHEMBL713546,Compound potency to achieve protection of MT-4 cells from HIV-1 cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)C(NC(=O)Nc1ccccc1[N+](=O)[O-])c1c(Cl)cccc1Cl,CHEMBL1134808,Bioorg Med Chem Lett,2001.0,CHEMBL70654,CHEMBL70654,,0.0,http://www.openphacts.org/units/Nanomolar,126258.0,>,1.0,1.0,>,IC50,nM,320000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,320.0,CHEMBL378
1222,1401902.0,[],CHEMBL837465,In vitro inhibitory concentration against HIV G190S mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)Nc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL435522,CHEMBL435522,,0.0,http://www.openphacts.org/units/Nanomolar,360379.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1223,3509162.0,[],CHEMBL1261041,Antiviral activity against HIV1 harboring reverse transcriptase Y188L mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(Cl)c1Oc1ccnc(NC2CCN(c3cccc(C(N)=O)c3)CC2)n1,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1257905,CHEMBL1257905,8.80,0.0,http://www.openphacts.org/units/Nanomolar,962831.0,=,1.0,1.0,=,IC50,nM,1.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.6,CHEMBL378
1224,2099745.0,[],CHEMBL949218,Antiviral activity against HIV1 JRCSF by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)N(CCCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nc4c2CCN(C)C4)C3)c2ccccc2)cc1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL272065,CHEMBL272065,6.54,0.0,http://www.openphacts.org/units/Nanomolar,699399.0,=,1.0,1.0,=,IC50,nM,291.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.291,CHEMBL378
1225,1954110.0,[],CHEMBL890377,Antiviral activity against HIV1 with RT 103N mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(Br)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL234077,CHEMBL234077,7.40,0.0,http://www.openphacts.org/units/Nanomolar,647172.0,=,1.0,1.0,=,IC50,nM,39.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,39.8,CHEMBL378
1226,24351635.0,[],CHEMBL5032296,Antiviral activity against Parainfluenza virus type 3,F,BAO_0000190,BAO_0000218,organism-based format,C=CCNC(=S)N1C[C@H]2C[C@@H](C1)c1cccc(=O)n1C2,CHEMBL5030562,Bioorg Med Chem Lett,2021.0,CHEMBL5076961,CHEMBL5076961,,0.0,http://www.openphacts.org/units/Nanomolar,3772756.0,>,1.0,1.0,>,IC50,nM,3000.0,CHEMBL613126,Human parainfluenza virus 3,Human parainfluenza virus 3,11216,IC50,uM,UO_0000065,3.0,CHEMBL613126
1227,15200432.0,[],CHEMBL3413997,Antiviral activity against X4 tropic HIV-1 clone pNL4-3 infected in H9 cells assessed as reduction in p24 antigen after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)c1ccc(/C=C(\C#N)c2nc3cc(Br)ccc3[nH]2)cc1,CHEMBL3407469,Eur J Med Chem,2015.0,CHEMBL3410137,CHEMBL3410137,,0.0,http://www.openphacts.org/units/Nanomolar,2288873.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
1228,1298304.0,[],CHEMBL691380,Compound was evaluated for anti-retrovirus activity against HIV-1 (D34) Diagen strain.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1126681,J Med Chem,1993.0,CHEMBL129,CHEMBL129,8.22,0.0,http://www.openphacts.org/units/Nanomolar,40482.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
1229,5199474.0,[],CHEMBL1670944,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,OCCc1c(OCc2c(F)cccc2F)nc2ccc(Cl)cc2c1-c1ccccc1Cl,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668641,CHEMBL1668641,4.36,0.0,http://www.openphacts.org/units/Nanomolar,1328425.0,=,1.0,1.0,=,IC50,nM,43500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,43.5,CHEMBL613497
1230,18202894.0,[],CHEMBL4043733,Antiviral activity against HIV-1 NL4-3 harboring reverse transcriptase E138A mutant infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL57,CHEMBL57,5.30,0.0,http://www.openphacts.org/units/Nanomolar,3019959.0,=,1.0,1.0,=,IC50,nM,4980.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.98,CHEMBL378
1231,22933247.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)c4cc5cc(OC)ccc5[nH]4)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4751059,CHEMBL4751059,7.28,0.0,http://www.openphacts.org/units/Nanomolar,3560857.0,=,1.0,1.0,=,IC50,nM,52.48,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.28,CHEMBL378
1232,8041787.0,[],CHEMBL1953242,Antiviral activity against HIV1 harboring VSV glycoprotein-G co-transfected with luciferase gene infected in human TZM-bl cells assessed as inhibition of viral replication after 48 hrs by microplate luminometer based luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1nc(C(C)(C)NC(=O)c2nnc(C)o2)nc(C(=O)NCc2ccc(F)cc2)c1[O-].[K+],CHEMBL1949625,Eur J Med Chem,2012.0,CHEMBL1949867,CHEMBL1949868,6.70,0.0,http://www.openphacts.org/units/Nanomolar,1576968.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,10'2 nM,UO_0000065,2.0,CHEMBL378
1233,2601678.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(O)c2ncn([C@H]3S[C@@H](CO)C=C3F)c2n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL473682,CHEMBL473682,4.36,0.0,http://www.openphacts.org/units/Nanomolar,807924.0,=,1.0,1.0,=,IC50,nM,43500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,43.5,CHEMBL378
1234,341568.0,[],CHEMBL697276,In vitro inhibition of HIV-1 plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1125666,J Med Chem,1991.0,CHEMBL129,CHEMBL129,8.40,0.0,http://www.openphacts.org/units/Nanomolar,43745.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.004,CHEMBL378
1235,2947390.0,[],CHEMBL1038497,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCC(=O)O[C@@H](C[C@@H](C)C1=C2C[C@H](OC(=O)CCCCCCC)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)[C@@H](OC(=O)CCCCCCC)C(C)(C)OC(=O)CCCCCCC,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL572925,CHEMBL572925,,0.0,http://www.openphacts.org/units/Nanomolar,850748.0,>,1.0,1.0,>,IC50,nM,1600000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.6,CHEMBL613497
1236,10961061.0,[],CHEMBL2061264,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing wild type protease infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNC(C)C)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057469,CHEMBL2057469,7.82,0.0,http://www.openphacts.org/units/Nanomolar,1655131.0,=,1.0,1.0,=,IC50,nM,15.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,15.0,CHEMBL378
1237,14653480.0,[],CHEMBL3267146,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(CO)[C@H](OC(=O)c3ccco3)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3263006,CHEMBL3263006,,0.0,http://www.openphacts.org/units/Nanomolar,2101889.0,=,1.0,1.0,=,IC50,nM,586000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,586.0,CHEMBL613497
1238,1438275.0,[],CHEMBL833076,Inhibitory activity against HIV-1 mutant strain 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccs1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL184934,CHEMBL184934,6.51,0.0,http://www.openphacts.org/units/Nanomolar,371561.0,=,1.0,1.0,=,IC50,nM,310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.31,CHEMBL378
1239,12684394.0,[],CHEMBL2344303,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)O[C@H]1C[C@H]2[C@]3(C)C(=O)C[C@]4(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](OC(=O)CC)C[C@@]4(C)[C@@H]3C[C@H]3O[C@]32C(C)(C)[C@@H]1OC(=O)CC,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332408,CHEMBL2332408,,0.0,http://www.openphacts.org/units/Nanomolar,1866102.0,>,1.0,1.0,>,IC50,nM,1667000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1667.0,CHEMBL613497
1240,6152691.0,[],CHEMBL1763333,Inhibition of c-Jun,B,BAO_0000190,BAO_0000357,single protein format,COc1c(-c2cnn(C)c2)ccc2cnc(Nc3ccc(-n4cnc(N5CCOCC5)n4)cc3)nc12,CHEMBL1759990,Bioorg Med Chem Lett,2011.0,CHEMBL1761584,CHEMBL1761584,7.30,0.0,http://www.openphacts.org/units/Nanomolar,1413800.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.05,CHEMBL4977
1241,301433.0,[],CHEMBL706841,Antiviral activity by observing cytopathic effect induced by HIV-1 strain IIIB in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)[C@@H](NCc1ccccc1)C(=O)N[C@H](C(=O)NCc1ccccc1)C(C)C,CHEMBL1127464,J Med Chem,1994.0,CHEMBL102428,CHEMBL102428,,0.0,http://www.openphacts.org/units/Nanomolar,195848.0,>,1.0,1.0,>,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3000.0,CHEMBL378
1242,533585.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1ccc(Br)cc1,CHEMBL1134494,J Med Chem,2001.0,CHEMBL57223,CHEMBL57223,4.70,0.0,http://www.openphacts.org/units/Nanomolar,94256.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
1243,1045213.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(NN2C(S)=NC(C)C2C)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL288339,CHEMBL288339,,0.0,http://www.openphacts.org/units/Nanomolar,62327.0,>,1.0,1.0,>,IC50,nM,359860.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,359.86,CHEMBL378
1244,1954146.0,[],CHEMBL891425,Antiviral activity against HIV1 RT 188L mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL233664,CHEMBL233664,7.30,0.0,http://www.openphacts.org/units/Nanomolar,647185.0,=,1.0,1.0,=,IC50,nM,50.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,50.1,CHEMBL378
1245,16498294.0,[],CHEMBL3777089,Antiviral activity against HIV1 dual CXCR4/CCR5-tropic strain 89.6 infected in human 293T cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2csc(N3N=C(COc4ccccc4)/C(=N/Nc4ccc5c(S(=O)(=O)O)cc(S(=O)(=O)O)cc5c4)C3=O)n2)cc1,CHEMBL3774382,Bioorg Med Chem,2016.0,CHEMBL3775025,CHEMBL3775025,4.84,0.0,http://www.openphacts.org/units/Nanomolar,2762416.0,=,1.0,1.0,=,IC50,nM,14600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,14.6,CHEMBL378
1246,657133.0,[],CHEMBL713512,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1Cc2cccc3[nH]c(=S)n(c23)C(C)C1C,CHEMBL1128252,J Med Chem,1995.0,CHEMBL66043,CHEMBL66043,4.84,0.0,http://www.openphacts.org/units/Nanomolar,326400.0,=,1.0,1.0,=,IC50,nM,14300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,14.3,CHEMBL378
1247,2929679.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3ncc4ccccc43)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL566997,CHEMBL566997,,0.0,,852815.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1248,1421802.0,[],CHEMBL824926,Inhibitory activity against human immunodeficiency virus type 1 (inactive>0.1),F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(SC2CCCCC2)n(COCN(c2ccccc2)c2ccccc2)c(=O)[nH]c1=O,CHEMBL1144258,Bioorg Med Chem Lett,2005.0,CHEMBL181181,CHEMBL181181,,0.0,http://www.openphacts.org/units/Nanomolar,364828.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1249,3383636.0,[],CHEMBL1211563,Antiviral activity against HIV1 NL-BAL infected in CCR5-expressing human JC53-BL cells assessed as inhibition of viral replication after 16 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(N[C@@H](CCN1C[C@@H]2CN(C(=O)c3cnccn3)C[C@@H]2C1)c1cccc(F)c1)C1CCCC1,CHEMBL1208790,Bioorg Med Chem Lett,2010.0,CHEMBL1209601,CHEMBL1209601,7.85,0.0,http://www.openphacts.org/units/Nanomolar,927341.0,=,1.0,1.0,=,IC50,nM,14.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,14.0,CHEMBL378
1250,1402314.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N2CCOCC2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL178061,CHEMBL178061,6.80,0.0,http://www.openphacts.org/units/Nanomolar,360425.0,=,1.0,1.0,=,IC50,nM,158.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.158,CHEMBL378
1251,2413716.0,[],CHEMBL987710,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@H](OC(=O)CCCC)[C@H](C[C@@H](C)C1=C2C[C@H](OC(=O)CCCC)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)OC(=O)CCCC,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL503823,CHEMBL503823,,0.0,http://www.openphacts.org/units/Nanomolar,810796.0,>,1.0,1.0,>,IC50,nM,920000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.92,CHEMBL613497
1252,22933238.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)/C=C/c4cccc(OCc5cccc([N+](=O)[O-])c5)c4)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4793259,CHEMBL4793259,6.24,0.0,http://www.openphacts.org/units/Nanomolar,3560843.0,=,1.0,1.0,=,IC50,nM,575.44,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.24,CHEMBL378
1253,721455.0,[],CHEMBL688961,Antiviral activity against HIV-1 IIIB in H9 (human leukemia) cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cn1ccnc1S(=O)(=O)Nc1cccc(C(c2c(O)cc(C(CC3CC3)CC3CC3)oc2=O)C2CC2)c1,CHEMBL1129838,Bioorg Med Chem Lett,1997.0,CHEMBL128629,CHEMBL128629,,0.0,http://www.openphacts.org/units/Nanomolar,248553.0,<,1.0,1.0,<,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.0,CHEMBL378
1254,2321209.0,[],CHEMBL1004248,Antiviral activity against HIV1 3B in human H9 cells after 4 days by p24 antigen ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1150942,J Nat Prod,1998.0,CHEMBL511805,CHEMBL511805,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,787865.0,=,1.0,1.0,=,IC50,ug.mL-1,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,4.0,CHEMBL378
1255,2462116.0,[],CHEMBL965355,Antiviral activity against hepatitis B virus infected Hep G2.2.15 cells assessed as inhibition of HBeAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1c(-c2ccccc2F)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1157443,Bioorg Med Chem Lett,2008.0,CHEMBL452291,CHEMBL452291,4.10,0.0,http://www.openphacts.org/units/Nanomolar,720745.0,=,1.0,1.0,=,IC50,nM,79000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.079,CHEMBL613497
1256,3498054.0,[],CHEMBL1259503,Antiviral activity against HIV1 3B infected in human PM1 cells expressing CCR5 assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(Cl)cc1)C(=O)NC1CCNCC1,CHEMBL1255517,Bioorg Med Chem Lett,2010.0,CHEMBL1256494,CHEMBL1256494,,0.0,,959451.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1257,85583.0,[],CHEMBL808329,The compound was tested in vitro for the inhibitory concentration against influenza B/Mem/89 sialidase from whole virus by MUN assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc(C(=O)O)cc1N,CHEMBL1128587,J Med Chem,1995.0,CHEMBL109162,CHEMBL109162,,0.0,http://www.openphacts.org/units/Nanomolar,206090.0,>,1.0,1.0,>,IC50,nM,20000000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,mM,UO_0000065,20.0,CHEMBL613129
1258,1671951.0,[],CHEMBL865135,Antiviral activity against HIV1 V106A mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL201793,CHEMBL201793,8.15,0.0,http://www.openphacts.org/units/Nanomolar,411917.0,=,1.0,1.0,=,IC50,nM,7.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.0,CHEMBL378
1259,6216910.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2cccc(C(=O)NO)c2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784468,CHEMBL1784468,7.60,0.0,http://www.openphacts.org/units/Nanomolar,1429407.0,=,1.0,1.0,=,IC50,nM,25.12,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.6,CHEMBL378
1260,6216935.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C2(CCN3C4CCC3CC(n3c(C)nc5ccccc53)C4)CCN(C(=O)c3ccc(Cl)c(S(N)(=O)=O)c3)CC2)c1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784492,CHEMBL1784492,8.85,0.0,http://www.openphacts.org/units/Nanomolar,1429431.0,=,1.0,1.0,=,IC50,nM,1.413,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,8.85,CHEMBL378
1261,1470151.0,[],CHEMBL832527,Inhibitory activity against HIV-1 double mutants strain 227L and 106A,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C#N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188580,CHEMBL188580,7.30,0.0,http://www.openphacts.org/units/Nanomolar,380698.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.05,CHEMBL378
1262,24831001.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c2ccc(N3CCC(O)C3)cc2oc2c(F)cccc12,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5170901,CHEMBL5170901,,0.0,http://www.openphacts.org/units/Nanomolar,3878113.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
1263,24777545.0,[],CHEMBL5128766,Antiviral activity against HIV-1 89.6 infected in human TZM-bl cells assessed as reduction in viral replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL5126557,Bioorg Med Chem Lett,2022.0,CHEMBL7447,CHEMBL7447,6.77,0.0,http://www.openphacts.org/units/Nanomolar,3867176.0,=,1.0,1.0,=,IC50,nM,170.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.17,CHEMBL378
1264,1520732.0,[],CHEMBL833990,Inhibitory concentration against wild type human immunodeficiency virus,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL1144377,Bioorg Med Chem Lett,2005.0,CHEMBL116,CHEMBL116,6.96,0.0,http://www.openphacts.org/units/Nanomolar,395357.0,=,1.0,1.0,=,IC50,nM,109.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.109,CHEMBL378
1265,5132782.0,[],CHEMBL1646271,Antiviral activity against protease-resistant HIV1 isolate 94UG103 infected in human PBMC assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)n2c3ccccc3n(C[C@@H](O)Nc3ccc(F)cc3)c2c1C#N,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645085,CHEMBL1645085,5.44,0.0,http://www.openphacts.org/units/Nanomolar,1321074.0,=,1.0,1.0,=,IC50,nM,3600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.6,CHEMBL378
1266,16394344.0,[],CHEMBL3744532,Inhibition of HBV antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC/N=C(\c1ccc(=O)n(CCCCC)c1)c1ccc(OC)cc1O,CHEMBL3739304,Medchemcomm,2015.0,CHEMBL568411,CHEMBL568411,5.30,0.0,http://www.openphacts.org/units/Nanomolar,2738867.0,=,1.0,1.0,=,IC50,nM,5000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,5.0,CHEMBL613497
1267,2601506.0,[],CHEMBL1034017,Antiviral activity against Vaccinia virus,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(N)n(CCOCP(=O)(O)O)c(=O)c1CC(=O)O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL149197,CHEMBL149197,8.92,0.0,http://www.openphacts.org/units/Nanomolar,807283.0,=,1.0,1.0,=,IC50,nM,1.2,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,0.0012,CHEMBL613493
1268,631885.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(C)c(Cc2nc(N)nc(Nc3ccc(C#N)cc3)n2)c1C,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL307865,CHEMBL307865,5.92,0.0,http://www.openphacts.org/units/Nanomolar,126890.0,=,1.0,1.0,=,IC50,nM,1190.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.19,CHEMBL378
1269,2099824.0,[],CHEMBL949222,Antiviral activity against HIV1 RU570 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2cccc(F)c2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL403954,CHEMBL403954,8.15,0.0,http://www.openphacts.org/units/Nanomolar,699410.0,=,1.0,1.0,=,IC50,nM,7.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.007,CHEMBL378
1270,24735319.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5116803,Antiviral activity against CHIKV infected in human Huh-7 cells assessed as inhibition of viral infection by measuring EGFP-positive cells measured 24 hrs post infection by fluorescent microscopic analysis,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(-c2c(O)c(O)c(O)c3c(=O)cc(-c4ccccc4)oc23)c1,CHEMBL5113447,Bioorg Med Chem Lett,2022.0,CHEMBL5194207,CHEMBL5194207,5.06,0.0,http://www.openphacts.org/units/Nanomolar,3858570.0,=,1.0,1.0,=,IC50,nM,8700.0,CHEMBL4296563,Chikungunya virus,Chikungunya virus,37124,IC50,uM,UO_0000065,8.7,CHEMBL4296563
1271,14658843.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)c3ccc(Cl)c(C)c3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262892,CHEMBL3262892,7.68,0.0,http://www.openphacts.org/units/Nanomolar,2101734.0,=,1.0,1.0,=,IC50,nM,21.0,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,IC50,nM,UO_0000065,21.0,CHEMBL3259471
1272,6216958.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,CNS(=O)(=O)c1cc(C(=O)N2CCC(CCN3C4CCC3CC(n3c(C)nc5ccccc53)C4)(c3cccc(F)c3)CC2)c(Cl)cc1F,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784521,CHEMBL1784521,8.37,0.0,http://www.openphacts.org/units/Nanomolar,1429460.0,=,1.0,1.0,=,IC50,nM,4.266,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,8.37,CHEMBL378
1273,2414488.0,[],CHEMBL953486,Antiviral activity against HIV1 with reverse transcriptase Y181C mutation in human CEM cells assessed as protection against virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1153955,J Med Chem,2009.0,CHEMBL223228,CHEMBL223228,6.80,0.0,http://www.openphacts.org/units/Nanomolar,809790.0,=,1.0,1.0,=,IC50,nM,160.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,160.0,CHEMBL378
1274,24830937.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c2cnc(N3CCCC3)cc2oc2c(Cl)cccc12,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5198147,CHEMBL5198147,6.29,0.0,http://www.openphacts.org/units/Nanomolar,3878110.0,=,1.0,1.0,=,IC50,nM,510.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.51,CHEMBL613497
1275,2929721.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)CC1CN(Cc2c(C)[nH]c(=O)c(I)c2Sc2cc(C)cc(C)c2)CCO1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL573720,CHEMBL573720,7.60,0.0,http://www.openphacts.org/units/Nanomolar,848369.0,=,1.0,1.0,=,IC50,nM,25.11,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,25.11,CHEMBL378
1276,24788597.0,[],CHEMBL5131699,Antiviral activity against ZIKV,F,BAO_0000190,BAO_0000218,organism-based format,CCCc1cnc(NC(=O)[C@@H](C)c2ccc(NC(C)=O)cc2)s1,CHEMBL5131375,J Med Chem,2022.0,CHEMBL5209307,CHEMBL5209307,7.05,0.0,http://www.openphacts.org/units/Nanomolar,3869445.0,=,1.0,1.0,=,IC50,nM,90.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,0.09,CHEMBL4296612
1277,14653443.0,[],CHEMBL3266817,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@]1(CO)[C@H]2CC[C@@]3(CO3)[C@@H](/C=C/C3=CCOC3=O)[C@]2(C)CC[C@H]1O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL208071,CHEMBL208071,,0.0,http://www.openphacts.org/units/Nanomolar,2101907.0,=,1.0,1.0,=,IC50,nM,1294000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1294.0,CHEMBL613497
1278,1401658.0,[],CHEMBL833792,In vitro inhibitory concentration against HIV-1 Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Cc2cc[nH]c(=O)c2N(C)C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369460,CHEMBL369460,4.00,0.0,http://www.openphacts.org/units/Nanomolar,360354.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1279,619392.0,[],CHEMBL710381,Inhibitory activity against 103N strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Oc3c(F)cc(F)cc3F)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL307474,CHEMBL307474,7.06,0.0,http://www.openphacts.org/units/Nanomolar,126916.0,=,1.0,1.0,=,IC50,nM,87.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.087,CHEMBL378
1280,1216081.0,[],CHEMBL645946,Concentration required to inhibit activator protein-1(AP-1) mediated transcriptional activation in human Jurkat T-cells,B,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccc(Cl)cc1C(F)(F)F,CHEMBL1133475,J Med Chem,2000.0,CHEMBL132457,CHEMBL132457,,1.0,http://www.openphacts.org/units/Nanomolar,247710.0,>,1.0,1.0,>,IC50,nM,30000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,30.0,CHEMBL4977
1281,10938687.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccc(Cl)c([N+](=O)[O-])c4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046591,CHEMBL2046591,5.02,0.0,http://www.openphacts.org/units/Nanomolar,1651475.0,=,1.0,1.0,=,IC50,nM,9520.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,9.52,CHEMBL613497
1282,908870.0,[],CHEMBL650153,Compound was tested for anti-retroviral activity against moloney murine sarcoma virus (MSV) in murine C3H/3T3 embryo fibroblast cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2nn(C[C@@H](CO)OCP(=O)(O)O)nc12,CHEMBL1129435,J Med Chem,1996.0,CHEMBL433664,CHEMBL433664,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251929.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL613501,Moloney murine sarcoma virus,Moloney murine sarcoma virus,11809,IC50,ug ml-1,UO_0000274,100.0,CHEMBL613501
1283,10863172.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCC6CCOCC6)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024633,CHEMBL2024633,,0.0,http://www.openphacts.org/units/Nanomolar,1640529.0,>,1.0,1.0,>,IC50,nM,478640.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,478.64,CHEMBL613497
1284,619398.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)c(Oc2ncnc(Nc3ccc(C#N)cc3)n2)c(Br)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL302542,CHEMBL302542,7.40,0.0,http://www.openphacts.org/units/Nanomolar,126919.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
1285,2363895.0,[],CHEMBL1026420,Antiviral activity against HIV1 ERS104 with protease L63P mutation in phytohemagglutininin-activated PBMC assessed as inhibition of p24G protein production,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2CCOCOC2)cc1,CHEMBL1140100,J Med Chem,2008.0,CHEMBL492254,CHEMBL492254,7.70,0.0,http://www.openphacts.org/units/Nanomolar,746805.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,20.0,CHEMBL378
1286,696253.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CCSSCCC(C)C,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120687,CHEMBL120687,,0.0,,228600.0,>,1.0,0.0,>,IC50,,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,200.0,CHEMBL378
1287,1402348.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(-n2cccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL360957,CHEMBL360957,7.90,0.0,http://www.openphacts.org/units/Nanomolar,360357.0,=,1.0,1.0,=,IC50,nM,12.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0126,CHEMBL378
1288,297509.0,[],CHEMBL706841,Antiviral activity by observing cytopathic effect induced by HIV-1 strain IIIB in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@H](NC(=O)[C@H](NCc1ccc(Cl)cc1)[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)(C)C)C(=O)NCc1nc2ccccc2[nH]1,CHEMBL1127464,J Med Chem,1994.0,CHEMBL317653,CHEMBL317653,7.47,0.0,http://www.openphacts.org/units/Nanomolar,195844.0,=,1.0,1.0,=,IC50,nM,34.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,34.0,CHEMBL378
1289,2614817.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(O)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL57064,CHEMBL57064,,0.0,http://www.openphacts.org/units/Nanomolar,732080.0,=,1.0,1.0,=,IC50,nM,429536.43,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,3.367,CHEMBL378
1290,10863206.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(/C=C/C(=O)O[C@H]2CC[C@]3(C)[C@H]4CC=C5[C@@H]6C[C@@](C)(C(=O)OCc7ccc(C(F)(F)F)cc7)CC[C@]6(C)CC[C@@]5(C)[C@]4(C)CC[C@H]3C2(C)C)c1,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022400,CHEMBL2022400,,0.0,http://www.openphacts.org/units/Nanomolar,1637652.0,>,1.0,1.0,>,IC50,nM,224720.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,224.72,CHEMBL613497
1291,16436240.0,[],CHEMBL3755173,Antiviral activity against R5-tropic HIV1 cYTA48P infected in TZM-bl cells by single round assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC(C)(C)N1,CHEMBL3751773,Bioorg Med Chem Lett,2016.0,CHEMBL254781,CHEMBL254781,6.20,0.0,http://www.openphacts.org/units/Nanomolar,2746199.0,=,1.0,1.0,=,IC50,nM,630.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.63,CHEMBL378
1292,24830918.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc2c(=O)c3cccc(F)c3oc2c1)c1ccccc1Cl,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5189081,CHEMBL5189081,5.58,0.0,http://www.openphacts.org/units/Nanomolar,3878091.0,=,1.0,1.0,=,IC50,nM,2620.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.62,CHEMBL613497
1293,8057971.0,[],CHEMBL1960698,Antiinfluenza activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)OCCCCCCn1cncn1)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL1955749,Bioorg Med Chem Lett,2012.0,CHEMBL1956543,CHEMBL1956543,,0.0,http://www.openphacts.org/units/Nanomolar,1580873.0,>,1.0,1.0,>,IC50,nM,31000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,31.0,CHEMBL613129
1294,2929653.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COCCC1CN(Cc2c(C)[nH]c(=O)c(I)c2Sc2cc(C)cc(C)c2)CCO1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL584571,CHEMBL584571,6.40,0.0,http://www.openphacts.org/units/Nanomolar,848383.0,=,1.0,1.0,=,IC50,nM,398.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,398.0,CHEMBL378
1295,2929572.0,[],CHEMBL1056893,Antiviral activity against HIV1 HXB2 harboring 101E mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSCc3ccco3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567204,CHEMBL567204,8.20,0.0,http://www.openphacts.org/units/Nanomolar,852794.0,=,1.0,1.0,=,IC50,nM,6.31,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.31,CHEMBL378
1296,22753445.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4700296,Antiviral activity against Cowpox virus Grishak infected in African green monkey Vero cells assessed as reduction in cell survival incubated for 4 days by neutral red dye based colorimetric analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@H]2CC=C(C(=O)NC3C4CC5CC(C4)CC3C5)[C@@H]1C2,CHEMBL4699424,RSC Med Chem,2020.0,CHEMBL4777797,CHEMBL4777797,5.14,0.0,http://www.openphacts.org/units/Nanomolar,3531614.0,=,1.0,1.0,=,IC50,nM,7200.0,CHEMBL612672,Cowpox virus,Cowpox virus,10243,IC50,uM,UO_0000065,7.2,CHEMBL612672
1297,486130.0,[],CHEMBL757967,Inhibition of cell growth against HIV-1 infected PBM (Human peripheral blood mononuclear) cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(F)nc2c1ncn2[C@H]1CS[C@@H](CO)O1,CHEMBL1126792,J Med Chem,1993.0,CHEMBL89759,CHEMBL89759,,0.0,http://www.openphacts.org/units/Nanomolar,161306.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1298,15606037.0,[],CHEMBL3579360,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(/C=C/C(=O)O)cc2c1OCO2,CHEMBL3576819,Eur J Med Chem,2015.0,CHEMBL3577783,CHEMBL3577783,,0.0,http://www.openphacts.org/units/Nanomolar,2480520.0,=,1.0,1.0,=,IC50,nM,476750.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,476.75,CHEMBL613497
1299,14653439.0,[],CHEMBL3266817,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(C=O)[C@H](O)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3263018,CHEMBL3263018,,0.0,http://www.openphacts.org/units/Nanomolar,2101901.0,=,1.0,1.0,=,IC50,nM,1840000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1840.0,CHEMBL613497
1300,2601813.0,[],CHEMBL1034017,Antiviral activity against Vaccinia virus,F,BAO_0000190,BAO_0000218,organism-based format,CCc1nn([C@H]2C[C@H](O)[C@@H](CO)S2)c(=O)nc1O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL189399,CHEMBL189399,,0.0,http://www.openphacts.org/units/Nanomolar,806762.0,=,1.0,1.0,=,IC50,nM,200000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,200.0,CHEMBL613493
1301,693371.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Nc1cc2ccccc2cc1SSc1cc2ccccc2cc1N,CHEMBL1129635,J Med Chem,1996.0,CHEMBL332569,CHEMBL332569,,0.0,,228616.0,=,1.0,0.0,=,IC50,,15.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,15.0,CHEMBL378
1302,2930359.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(=O)CSCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL577277,CHEMBL577277,8.80,0.0,http://www.openphacts.org/units/Nanomolar,852931.0,=,1.0,1.0,=,IC50,nM,1.58,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.58,CHEMBL378
1303,2947419.0,[],CHEMBL1038495,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)OC1=CC[C@@]2(C)[C@@H](CC[C@@]3(C)[C@H]2[C@@H](OC(C)=O)CC2=C([C@H](C)C[C@H](OC(C)=O)[C@@H](OC(C)=O)C(C)(C)OC(C)=O)CC[C@@]23C)C1(C)C,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL585001,CHEMBL585001,,0.0,http://www.openphacts.org/units/Nanomolar,850772.0,>,1.0,1.0,>,IC50,nM,2100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.1,CHEMBL613497
1304,2602297.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)Oc2ccc3cc(CN)c(=O)oc3c2[C@@H](OC(=O)[C@@]23CC[C@](C)(C(=O)O2)C3(C)C)[C@H]1OC(=O)[C@@]12CC[C@](C)(C(=O)O1)C2(C)C,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL504035,CHEMBL504035,4.81,0.0,http://www.openphacts.org/units/Nanomolar,807041.0,=,1.0,1.0,=,IC50,nM,15400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,15.4,CHEMBL378
1305,3467375.0,[],CHEMBL1250743,Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 6 hrs by p24 antigen based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)oc2c3c(ccc12)O[C@H](C)[C@H](OC(=O)[C@]12CC[C@](C)(C(=O)O1)C2(C)C)[C@@H]3OC(=O)[C@]12CC[C@](C)(C(=O)O1)C2(C)C,CHEMBL1250555,Bioorg Med Chem,2010.0,CHEMBL1253533,CHEMBL1253533,4.40,0.0,http://www.openphacts.org/units/Nanomolar,955458.0,=,1.0,1.0,=,IC50,nM,40200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,40.2,CHEMBL378
1306,151554.0,[],CHEMBL844408,Inhibition of 50% of the integrase-mediated catalysis of the V1/V2 substrate with 95% confidence interval,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C(=C\c1ccc(O)c(O)c1)/C(=C/c1ccc(O)c(O)c1)C(=O)O,CHEMBL1135546,J Med Chem,2002.0,CHEMBL332412,CHEMBL332412,6.08,0.0,http://www.openphacts.org/units/Nanomolar,231557.0,=,1.0,1.0,=,IC50,nM,830.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.83,CHEMBL378
1307,1402067.0,[],CHEMBL837469,In vitro inhibitory concentration against HIV V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,COCCCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL178689,CHEMBL178689,7.40,0.0,http://www.openphacts.org/units/Nanomolar,360393.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
1308,18320105.0,[],CHEMBL4134181,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA level incubated for 3 days followed by medium replacement measured after 3 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C2CCCN2C(c2nccs2)=NC1c1ccc(F)cc1C,CHEMBL4130455,ACS Med Chem Lett,2017.0,CHEMBL4170725,CHEMBL4170725,6.35,0.0,http://www.openphacts.org/units/Nanomolar,3041700.0,=,1.0,1.0,=,IC50,nM,450.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.45,CHEMBL613497
1309,238624.0,[],CHEMBL691105,Inhibition of cytopathogenicity against human HIV-1(IIIB) in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2ncn(CCOCP(=O)(O)O)c12,CHEMBL1134666,J Med Chem,2001.0,CHEMBL123655,CHEMBL123655,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,233588.0,=,1.0,1.0,=,IC50,ug.mL-1,7.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,7.8,CHEMBL378
1310,1437836.0,[],CHEMBL834618,Inhibitory activity against HIV-1 mutant strain 103N; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCNC(=O)Nc1cccc(C(=O)c2c(CC)c(C)nc(O)c2N(C)C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL425531,CHEMBL425531,,0.0,http://www.openphacts.org/units/Nanomolar,371467.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1311,1485863.0,[],CHEMBL833976,Inhibitory concentration against wild type human immunodeficiency virus type 1 was determined by recombinant virus assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCc1c(O)nc2ccc(Cl)cc2c1OC1CCCC1,CHEMBL1138845,J Med Chem,2004.0,CHEMBL190889,CHEMBL190889,7.22,0.0,http://www.openphacts.org/units/Nanomolar,383922.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,60.0,CHEMBL378
1312,12651407.0,[],CHEMBL2327723,Antiviral activity against 0.001 MOI bevirimat-resistant Human immunodeficiency virus 1 NL4-3 harboring gag V370A mutant infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCNC(=O)[C@H](CCC#N)NC(=O)OC(C)(C)C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324150,CHEMBL2324150,6.48,0.0,http://www.openphacts.org/units/Nanomolar,1850176.0,=,1.0,1.0,=,IC50,nM,330.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.33,CHEMBL378
1313,2003622.0,[],CHEMBL901910,Antiviral activity against Modoc virus-infected HeLa-H1 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(-c2nc3cc(NC(=O)C45CC6CC(C4)C(O)C(C6)C5)ncc3[nH]2)cc1)C12CC3CC(CC(C3)C1)C2,CHEMBL1138288,J Med Chem,2007.0,CHEMBL239543,CHEMBL239543,7.70,0.0,http://www.openphacts.org/units/Nanomolar,666662.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL612946,Modoc virus,Modoc virus,64300,IC50,nM,UO_0000065,20.0,CHEMBL612946
1314,8041804.0,[],CHEMBL1953242,Antiviral activity against HIV1 harboring VSV glycoprotein-G co-transfected with luciferase gene infected in human TZM-bl cells assessed as inhibition of viral replication after 48 hrs by microplate luminometer based luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)C(=O)C(=O)NC(C)(C)c1nc(OC)c(OC(C)=O)c(C(=O)NCc2ccc(F)cc2)n1,CHEMBL1949625,Eur J Med Chem,2012.0,CHEMBL1949995,CHEMBL1949995,,0.0,,1577164.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1315,18479602.0,[],CHEMBL4184680,Antiviral activity against Zika virus infected in human A549 cells preincubated for 5 hrs followed by compound wash measured after 48 hrs by viral plague-forming assay,F,BAO_0000190,BAO_0000218,organism-based format,C#CCSc1nsc(NC(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)n1,CHEMBL4184095,Bioorg Med Chem Lett,2018.0,CHEMBL4212750,CHEMBL4212750,7.57,0.0,http://www.openphacts.org/units/Nanomolar,3067003.0,=,1.0,1.0,=,IC50,nM,26.9,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,nM,UO_0000065,26.9,CHEMBL4296612
1316,2362930.0,[],CHEMBL1026412,Antiviral activity against HIV1 LAI in human MT2 cells assessed as inhibition of virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2CCCOCOC2)cc1,CHEMBL1140100,J Med Chem,2008.0,CHEMBL512807,CHEMBL512807,,0.0,,748111.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1317,3234774.0,[],CHEMBL1110484,Antiviral activity against HIV1 NL4-3 co-transfected with VSV glycoprotein plasmid in human 293T cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1153770,J Nat Prod,2009.0,CHEMBL129,CHEMBL129,7.32,0.0,http://www.openphacts.org/units/Nanomolar,894886.0,=,1.0,1.0,=,IC50,nM,48.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.048,CHEMBL378
1318,149021.0,[],CHEMBL756132,Compound was tested for the inhibition of LPS-induced TNF-alpha production in human peripheral blood mononuclear cells (PBMC),F,BAO_0000190,BAO_0000218,organism-based format,O=C1CCCC(=S)N1,CHEMBL1146001,J Med Chem,2003.0,CHEMBL342081,CHEMBL342081,,0.0,http://www.openphacts.org/units/Nanomolar,291263.0,>,1.0,1.0,>,IC50,nM,30000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,30.0,CHEMBL378
1319,627965.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Oc2nc(N)nc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL71521,CHEMBL71521,9.00,0.0,http://www.openphacts.org/units/Nanomolar,126896.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
1320,10937538.0,[],CHEMBL2051603,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccccc4Cl)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046573,CHEMBL2046573,4.64,0.0,http://www.openphacts.org/units/Nanomolar,1651456.0,=,1.0,1.0,=,IC50,nM,22890.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,22.89,CHEMBL613497
1321,1470578.0,[],CHEMBL833078,Inhibitory activity against HIV-1 mutant strain 179E,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL57,CHEMBL57,6.72,0.0,http://www.openphacts.org/units/Nanomolar,380791.0,=,1.0,1.0,=,IC50,nM,190.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.19,CHEMBL378
1322,2930184.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CN3CCCC(C#N)C3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL566556,CHEMBL566556,8.20,0.0,http://www.openphacts.org/units/Nanomolar,852935.0,=,1.0,1.0,=,IC50,nM,6.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.3,CHEMBL378
1323,22806664.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@@H](Sc3ccc(OC)cc3)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4785108,CHEMBL4785108,6.00,0.0,http://www.openphacts.org/units/Nanomolar,3541894.0,=,1.0,1.0,=,IC50,nM,990.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.99,CHEMBL613497
1324,953700.0,[],CHEMBL655544,Inhibition of wild type HIV-1-IIIB strain replication in CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(C)cnc(O)c2N)c1,CHEMBL1128194,J Med Chem,1995.0,CHEMBL140532,CHEMBL140532,8.00,0.0,http://www.openphacts.org/units/Nanomolar,276268.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
1325,14553714.0,[],CHEMBL3225005,Antiviral activity against HIV1 NL4-3 infected in human MT2 cells after 3 days by human JC53BL cell-based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CN(O)C(=O)c2ncc3c(ccn3Cc3ccc(F)cc3)c21,CHEMBL3217509,Medchemcomm,2013.0,CHEMBL3219147,CHEMBL3219147,9.00,0.0,http://www.openphacts.org/units/Nanomolar,2073844.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
1326,13475589.0,[],CHEMBL2439262,Antiviral activity against Human immunodeficiency virus 1 clade E isolate ID12 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435853,CHEMBL2435853,8.15,0.0,http://www.openphacts.org/units/Nanomolar,1924228.0,=,1.0,1.0,=,IC50,nM,7.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.0,CHEMBL378
1327,2244552.0,[],CHEMBL1002216,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase V106I mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL593,CHEMBL593,7.66,0.0,http://www.openphacts.org/units/Nanomolar,798656.0,=,1.0,1.0,=,IC50,nM,22.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,22.0,CHEMBL378
1328,18940433.0,[],CHEMBL4328848,Antiviral activity against HIV-1 3B infected in human MAGI-CXCR4 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(CN(C)c2cccc(-c3ccc4ccn(Cc5cccc(C(=O)O)c5)c4c3)c2)c1,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4464574,CHEMBL4464574,5.92,0.0,http://www.openphacts.org/units/Nanomolar,3159834.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.2,CHEMBL378
1329,14927164.0,[],CHEMBL3391566,Antiviral activity against NNRTI-resistant HIV-1 LAI harboring reverse transcriptase K103N mutant infected in human MT4 cells assessed as inhibition of viral replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2c(COCc3ccncc3)c[nH]c(=O)c2Br)c1,CHEMBL3390846,Medchemcomm,2010.0,CHEMBL3347290,CHEMBL3347290,7.89,0.0,http://www.openphacts.org/units/Nanomolar,2173103.0,=,1.0,1.0,=,IC50,nM,13.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,13.0,CHEMBL378
1330,649971.0,[],CHEMBL713945,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1CCn2c(S)nc3cc(Cl)cc(c32)C1CC(C)C,CHEMBL1128252,J Med Chem,1995.0,CHEMBL164637,CHEMBL164637,,0.0,http://www.openphacts.org/units/Nanomolar,326405.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.0,CHEMBL378
1331,2649321.0,[],CHEMBL1024326,"Antiviral activity against HIV1 expressed in 293T cells assessed as protection against viral M33 envelope infection in human U87 cells coexpressing CD4, CCR5 receptors after 72 hrs by luciferase reporter gene pseudoviral assay",F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1ccc(-c2ccccn2)s1,CHEMBL1158460,J Med Chem,2009.0,CHEMBL562354,CHEMBL562354,5.27,0.0,http://www.openphacts.org/units/Nanomolar,815688.0,=,1.0,1.0,=,IC50,nM,5400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5400.0,CHEMBL378
1332,1416674.0,[],CHEMBL833367,Inhibitory concentration to inhibit HIV-1 mediated cell to cell fusion,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Cc1cc(-c2ccc(-c3ccc(CCC(=O)O)cc3CC(C)C)cc2C(C)C)ccc1OCC(=O)O,CHEMBL1142687,J Med Chem,2005.0,CHEMBL175731,CHEMBL175731,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,363946.0,~,1.0,1.0,~,IC50,ug.mL-1,15.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,15.0,CHEMBL378
1333,1471571.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1ccc(Cl)cc1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL186723,CHEMBL186723,6.72,0.0,http://www.openphacts.org/units/Nanomolar,380929.0,=,1.0,1.0,=,IC50,nM,190.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.19,CHEMBL378
1334,1402277.0,[],CHEMBL837466,In vitro inhibitory concentration against HIV K101E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCCN(CCCC)c1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL179736,CHEMBL179736,,0.0,http://www.openphacts.org/units/Nanomolar,360413.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1335,2030609.0,[],CHEMBL886374,Inhibition of cJun translocation in IL-1-beta-stimulated A549 cells,B,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)N1CCC(Nc2nccc(-c3c(C(C)C)[nH]c4ccccc34)n2)CC1,CHEMBL1139954,Bioorg Med Chem Lett,2007.0,CHEMBL391794,CHEMBL391794,4.67,0.0,http://www.openphacts.org/units/Nanomolar,674120.0,=,1.0,1.0,=,IC50,nM,21160.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,nM,UO_0000065,21160.0,CHEMBL4977
1336,19183288.0,[],CHEMBL4387678,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as reduction in p24 Gag protein production incubated for 6 days and measured on day 7 by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)Nc2c(N[C@@H]3CO[C@@H]4OCC[C@@H]43)c(=O)c2=O)cc1,CHEMBL4385670,Bioorg Med Chem Lett,2019.0,CHEMBL4467544,CHEMBL4467544,,0.0,http://www.openphacts.org/units/Nanomolar,3202092.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
1337,18775792.0,[],CHEMBL4269043,Antiviral activity against Hepatitis B virus infected in human dHepaRG cells assessed as reduction in HBeAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1[C@H](CO)[C@@H](O)C[C@@H]1n1cnc2c(=O)[nH]c(N)nc21,CHEMBL4265974,J Med Chem,2018.0,CHEMBL713,CHEMBL713,,0.0,http://www.openphacts.org/units/Nanomolar,3119708.0,>,1.0,1.0,>,IC50,nM,1.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,1.0,CHEMBL613497
1338,24823541.0,[],CHEMBL5140686,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBsAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COCCCOc1cc2c(cc1OC)-c1cc(=O)c(C(=O)O)cn1C(C(C)C)C2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL4284226,CHEMBL4284226,8.29,0.0,http://www.openphacts.org/units/Nanomolar,3876716.0,=,1.0,1.0,=,IC50,nM,5.1,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0051,CHEMBL613497
1339,3083994.0,[],CHEMBL1072584,Antiviral activity against HIV1 infected in human JC53-BL cells after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)N1C[C@H]2CN(CCC3(c4ccccc4)CN(S(=O)(=O)C4CCCC4)C3)C[C@H]2C1,CHEMBL1153211,Bioorg Med Chem Lett,2010.0,CHEMBL594208,CHEMBL594208,7.40,0.0,http://www.openphacts.org/units/Nanomolar,872782.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,40.0,CHEMBL378
1340,2601674.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL129,CHEMBL129,8.30,0.0,http://www.openphacts.org/units/Nanomolar,807837.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.005,CHEMBL378
1341,24750961.0,[],CHEMBL5121091,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication by Nano-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCC(=O)O[C@@]12[C@H](OC(=O)c3ccccc3)[C@@H](C)[C@@]3(O)[C@@H](C(=O)C(CO)=C[C@]4(O)C(=O)C(C)=C[C@@H]34)[C@@H]1C2(C)C,CHEMBL5120745,J Nat Prod,2021.0,CHEMBL4744104,CHEMBL4744104,8.42,0.0,http://www.openphacts.org/units/Nanomolar,3861269.0,=,1.0,1.0,=,IC50,nM,3.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.8,CHEMBL378
1342,2442780.0,[],CHEMBL987533,Antiviral activity against HIV1 3B infected in human HOG.R5 cells after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,CCCc1cc(=O)oc2c3c(c4c(c12)OC(C)(C)C=C4)O[C@H](C)[C@@H](C)[C@@H]3O,CHEMBL1148153,J Nat Prod,2004.0,CHEMBL267447,CHEMBL267447,7.16,0.0,http://www.openphacts.org/units/Nanomolar,789732.0,=,1.0,1.0,=,IC50,nM,70.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.07,CHEMBL378
1343,11017267.0,[],CHEMBL2090658,Antiviral activity against HIV1 94US3393IN clade B clinical isolate infected in PHA-stimulated human PBMC assessed as inhibition of viral replication incubated for 6 hrs followed by compound-wash out measured after 6 days by liquid scintillation counting,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL2086298,J Med Chem,2012.0,CHEMBL141,CHEMBL141,7.06,0.0,http://www.openphacts.org/units/Nanomolar,1674767.0,=,1.0,1.0,=,IC50,nM,87.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,87.3,CHEMBL378
1344,1234141.0,[],CHEMBL652107,Inhibitory concentration required to inhibit HIV-induced cytopathicity in CEM-4 cells by 50% based in the MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N(CC)CCCCCCCCCCC(=O)NC(CCC(=O)[O-])C(=O)O.[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL1627028,CHEMBL1206127,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221530.0,=,1.0,1.0,=,IC50,ug.mL-1,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,1.0,CHEMBL378
1345,1148796.0,[],CHEMBL757806,Cytotoxicity against human peripheral blood mononuclear (PBM) cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(F)nc2c1ncn2[C@H]1CS[C@H](CO)O1,CHEMBL1126808,J Med Chem,1993.0,CHEMBL59576,CHEMBL59576,,0.0,http://www.openphacts.org/units/Nanomolar,100977.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1346,2371535.0,[],CHEMBL1035751,Antiviral activity against HIV1 with reverse transcriptase Y181C/G190A mutant in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ncccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL491019,CHEMBL491019,7.77,0.0,http://www.openphacts.org/units/Nanomolar,773465.0,=,1.0,1.0,=,IC50,nM,17.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,17.1,CHEMBL378
1347,15606022.0,[],CHEMBL3579360,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(/C=C/C(=O)O/N=C/c2cccs2)cc2c1OCO2,CHEMBL3576819,Eur J Med Chem,2015.0,CHEMBL3577795,CHEMBL3577795,,0.0,http://www.openphacts.org/units/Nanomolar,2480535.0,=,1.0,1.0,=,IC50,nM,104520.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,104.52,CHEMBL613497
1348,791767.0,[],CHEMBL683816,"Inhibitory activity against NNI-resistant HIV-1 strain A17 with Y181C,K103N mutation",F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](/N=C(\S)Nc1ccc(Cl)cn1)c1ccccc1,CHEMBL1133139,Bioorg Med Chem Lett,2000.0,CHEMBL292339,CHEMBL292339,4.99,0.0,http://www.openphacts.org/units/Nanomolar,111939.0,=,1.0,1.0,=,IC50,nM,10200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.2,CHEMBL378
1349,12642409.0,[],CHEMBL2317522,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay in presence of human serum albumin,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN1CCCCN2C(=O)c3c(O)c(=O)c(C(=O)NCc4ccc(F)cc4)cn3CC12,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314675,CHEMBL2314675,7.04,0.0,http://www.openphacts.org/units/Nanomolar,1844807.0,=,1.0,1.0,=,IC50,nM,91.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,91.8,CHEMBL378
1350,3084541.0,[],CHEMBL1065278,Antiviral activity against HIV1 KYAG primary isolate assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(NC(=O)C(=O)Nc2ccc(Br)cc2)CC(C)(C)N1,CHEMBL1153139,Bioorg Med Chem Lett,2010.0,CHEMBL594768,CHEMBL594768,,0.0,,873903.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1351,1251766.0,[],CHEMBL683624,In vitro integration activity provided by preintegration complexes isolated from HIV-infected cells,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC2(CC(C)(C)c3cc(O)c(O)cc32)c2cc(O)c(O)cc21,CHEMBL1133186,J Med Chem,2000.0,CHEMBL304266,CHEMBL304266,4.10,0.0,http://www.openphacts.org/units/Nanomolar,108743.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,80.0,CHEMBL378
1352,2602139.0,[],CHEMBL1033990,Antiviral activity against Hepatitis B virus,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc2c(ncn2/C=C2\CC2(F)CO)c(=O)[nH]1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL223933,CHEMBL223933,4.70,0.0,http://www.openphacts.org/units/Nanomolar,807312.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,20.0,CHEMBL613497
1353,2930230.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CN)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578979,CHEMBL578979,6.80,0.0,http://www.openphacts.org/units/Nanomolar,852920.0,=,1.0,1.0,=,IC50,nM,158.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,158.0,CHEMBL378
1354,18239570.0,[],CHEMBL4052029,Antiviral activity against darunavir-resistant HIV1 derived from 51 passages harboring protease L10I/I15V/K20R/L24I/V32I/L33F/M36I/M46L/I54M/L63P/K70Q/V82I/I84V/L89M mutant infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL4049446,J Med Chem,2017.0,CHEMBL1323,CHEMBL1323,5.50,0.0,http://www.openphacts.org/units/Nanomolar,3026807.0,=,1.0,1.0,=,IC50,nM,3200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3200.0,CHEMBL378
1355,24830934.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c2ccc(N3CCCCCC3)cc2oc2c(F)cccc12,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5182566,CHEMBL5182566,5.12,0.0,http://www.openphacts.org/units/Nanomolar,3878107.0,=,1.0,1.0,=,IC50,nM,7560.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,7.56,CHEMBL613497
1356,2149877.0,[],CHEMBL935683,Antiviral activity against HIV1 098-T651 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL427801,CHEMBL427801,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708029.0,=,1.0,1.0,=,IC50,ug.mL-1,7.599,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,7.599,CHEMBL378
1357,19243740.0,[],CHEMBL4400278,Antiviral activity against Zika virus infected in human A549 cells assessed as reduction in viral titer incubated for 48 hrs by plaque assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CCSc1nnc(NC(=O)Nc2ccc(Cl)cc2)s1,CHEMBL4396960,Bioorg Med Chem Lett,2019.0,CHEMBL4536703,CHEMBL4536703,9.72,0.0,http://www.openphacts.org/units/Nanomolar,3212367.0,=,1.0,1.0,=,IC50,nM,0.191,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,pM,UO_0000065,191.0,CHEMBL4296612
1358,22933245.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)/C=C/c4cccc(O)c4)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4797710,CHEMBL4797710,7.28,0.0,http://www.openphacts.org/units/Nanomolar,3560853.0,=,1.0,1.0,=,IC50,nM,52.48,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.28,CHEMBL378
1359,15128643.0,[],CHEMBL3390514,Antiviral activity against HIV1 NL4-3 in cell based assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC1=O,CHEMBL3352681,Eur J Med Chem,2014.0,CHEMBL3331162,CHEMBL3331162,5.11,0.0,http://www.openphacts.org/units/Nanomolar,2270564.0,=,1.0,1.0,=,IC50,nM,7800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.8,CHEMBL378
1360,2292388.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1[S+]([O-])c1cc(Cl)ccc1Cl,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL292012,CHEMBL292012,,0.0,http://www.openphacts.org/units/Nanomolar,813486.0,=,1.0,1.0,=,IC50,nM,9840111.06,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,2.007,CHEMBL378
1361,1421945.0,[],CHEMBL824926,Inhibitory activity against human immunodeficiency virus type 1 (inactive>0.1),F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2ccccc2)n(COCc2cc3ccccc3o2)c(=O)[nH]c1=O,CHEMBL1144258,Bioorg Med Chem Lett,2005.0,CHEMBL435881,CHEMBL435881,,0.0,http://www.openphacts.org/units/Nanomolar,364804.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1362,3383635.0,[],CHEMBL1211563,Antiviral activity against HIV1 NL-BAL infected in CCR5-expressing human JC53-BL cells assessed as inhibition of viral replication after 16 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N[C@@H](CCN1C[C@@H]2CN(C(=O)c3ccc(C(F)(F)F)cn3)C[C@@H]2C1)c1cccc(F)c1,CHEMBL1208790,Bioorg Med Chem Lett,2010.0,CHEMBL1209602,CHEMBL1209602,8.15,0.0,http://www.openphacts.org/units/Nanomolar,927342.0,=,1.0,1.0,=,IC50,nM,7.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.0,CHEMBL378
1363,693367.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(C=Nc2ccc(SSc3ccc(N=Cc4ccc(C)cc4)cc3)cc2)cc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120789,CHEMBL120789,,0.0,,228673.0,=,1.0,0.0,=,IC50,,26.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,26.8,CHEMBL378
1364,22897184.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4730788,Antiviral activity against Zika virus 976 Uganda infected in human HepG2 cells assessed as inhibition of viral infection measured after 4 days by CellTiter-Glo luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1[nH]c2ccc(Cl)cc2c1C(=O)c1cc(OC)c(O)c(OC)c1,CHEMBL4725430,ACS Med Chem Lett,2020.0,CHEMBL4441383,CHEMBL4441383,4.86,0.0,http://www.openphacts.org/units/Nanomolar,3554236.0,=,1.0,1.0,=,IC50,nM,13700.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,13.7,CHEMBL4296612
1365,2927899.0,[],CHEMBL1044799,Antiviral activity against HIV1 NL4-3 infected in human TZM-b1 cells assessed as reduction in luciferase activity after 2 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCC(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1154770,J Med Chem,2009.0,CHEMBL584781,CHEMBL584781,4.96,0.0,http://www.openphacts.org/units/Nanomolar,852842.0,=,1.0,1.0,=,IC50,nM,11100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,11.1,CHEMBL378
1366,1438441.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C\c2ccccn2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL182370,CHEMBL182370,5.80,0.0,http://www.openphacts.org/units/Nanomolar,371617.0,=,1.0,1.0,=,IC50,nM,1580.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.58,CHEMBL378
1367,10961147.0,[],CHEMBL2061266,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M9 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL1163,CHEMBL1163,5.60,0.0,http://www.openphacts.org/units/Nanomolar,1655449.0,=,1.0,1.0,=,IC50,nM,2500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2500.0,CHEMBL378
1368,1470150.0,[],CHEMBL832526,Inhibitory activity against HIV-1 double mutants strain 103N and 181C,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C#N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188580,CHEMBL188580,6.96,0.0,http://www.openphacts.org/units/Nanomolar,380698.0,=,1.0,1.0,=,IC50,nM,110.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.11,CHEMBL378
1369,15004825.0,[],CHEMBL3364311,Antiviral activity against hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C(CN2CCOCC2)NC(c2c(F)cc(F)cc2F)=NC1c1ccc(F)cc1Cl,CHEMBL3352024,Bioorg Med Chem Lett,2014.0,CHEMBL3326590,CHEMBL3326590,4.98,0.0,http://www.openphacts.org/units/Nanomolar,2266071.0,=,1.0,1.0,=,IC50,nM,10570.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol,UO_0000065,10.57,CHEMBL613497
1370,969011.0,[],CHEMBL655544,Inhibition of wild type HIV-1-IIIB strain replication in CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(O)nc(Sc2c(C)cnc(O)c2[N+](=O)[O-])n1,CHEMBL1128194,J Med Chem,1995.0,CHEMBL435674,CHEMBL435674,,0.0,http://www.openphacts.org/units/Nanomolar,276279.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,100000.0,CHEMBL378
1371,13476933.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)c1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435846,CHEMBL2435846,,0.0,,1924221.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1372,3129685.0,[],CHEMBL1064877,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1csc(-c2nc(COc3c4cc(CC(=O)[O-])cc3Cc3cc(CC(=O)[O-])cc(c3O)Cc3cc(CC(=O)[O-])cc(c3OCc3csc(-c5nc(C)cs5)n3)Cc3cc(CC(=O)[O-])cc(c3O)C4)cs2)n1.[Na+].[Na+].[Na+].[Na+],CHEMBL1157689,Bioorg Med Chem,2010.0,CHEMBL590677,CHEMBL1208390,4.78,0.0,http://www.openphacts.org/units/Nanomolar,880943.0,=,1.0,1.0,=,IC50,nM,16500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,16.5,CHEMBL378
1373,14653485.0,[],CHEMBL3267146,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(C)=O)[C@H](OC(C)=O)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3263013,CHEMBL3263013,,0.0,http://www.openphacts.org/units/Nanomolar,2101896.0,=,1.0,1.0,=,IC50,nM,260000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,260.0,CHEMBL613497
1374,1402026.0,[],CHEMBL837463,In vitro inhibitory concentration against HIV F227C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCCCO)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL176107,CHEMBL176107,,0.0,http://www.openphacts.org/units/Nanomolar,360364.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1375,1963828.0,[],CHEMBL897021,Antiviral activity against HIV1 TEK1 in PBMC,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C(\O)P(=O)(O)O)c1cn(Cc2ccccc2)c(=O)n(Cc2ccccc2)c1=O,CHEMBL1148834,Bioorg Med Chem Lett,2007.0,CHEMBL429790,CHEMBL429790,5.40,0.0,http://www.openphacts.org/units/Nanomolar,656767.0,=,1.0,1.0,=,IC50,nM,4000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.0,CHEMBL378
1376,12149736.0,[],CHEMBL2184885,Antiviral activity against Human immunodeficiency virus 1 ADA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc(-c2ccc(-c3cc4c(F)ccc(F)c4o3)[nH]2)cc1,CHEMBL2176887,J Med Chem,2012.0,CHEMBL99221,CHEMBL99221,9.22,0.0,http://www.openphacts.org/units/Nanomolar,1751487.0,=,1.0,1.0,=,IC50,nM,0.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.6,CHEMBL378
1377,24830980.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc2c(=O)c3cccc(F)c3oc2c1)c1ccccc1O,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5170996,CHEMBL5170996,,0.0,http://www.openphacts.org/units/Nanomolar,3878092.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
1378,19162196.0,[],CHEMBL4383613,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells after 7 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL4382211,Eur J Med Chem,2018.0,CHEMBL1323,CHEMBL1323,8.52,0.0,http://www.openphacts.org/units/Nanomolar,3198012.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
1379,1203882.0,[],CHEMBL710533,Inhibitory activity against 181C strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL223228,CHEMBL223228,8.70,0.0,http://www.openphacts.org/units/Nanomolar,127446.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.002,CHEMBL378
1380,2030627.0,[],CHEMBL886374,Inhibition of cJun translocation in IL-1-beta-stimulated A549 cells,B,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)N1CCC(Nc2ncc(Cl)c(-c3cnc4ccccn34)n2)CC1,CHEMBL1139954,Bioorg Med Chem Lett,2007.0,CHEMBL397531,CHEMBL397531,5.11,0.0,http://www.openphacts.org/units/Nanomolar,674101.0,=,1.0,1.0,=,IC50,nM,7723.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,nM,UO_0000065,7723.0,CHEMBL4977
1381,1472276.0,[],CHEMBL834619,Inhibitory activity against HIV-1 mutant strain 181C; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)/C(C#N)=C\c1cccc(C(=O)c2c(CC)c(C)nc(O)c2N(C)C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL360649,CHEMBL360649,,0.0,http://www.openphacts.org/units/Nanomolar,380886.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1382,5126313.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,COCCN/C=C1\C(=O)N(C)c2cc(Cl)ccc2N(c2ccccc2)C1=O,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642309,CHEMBL1642309,5.80,0.0,http://www.openphacts.org/units/Nanomolar,1317599.0,=,1.0,1.0,=,IC50,nM,1600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.6,CHEMBL378
1383,12680683.0,[],CHEMBL2342597,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral replication after 9 days by fluorescence PCR method,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)Nc3ccc(F)cc3)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333681,CHEMBL2333681,,0.0,http://www.openphacts.org/units/Nanomolar,1867757.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
1384,2719812.0,[],CHEMBL1061801,Antiviral activity against HIV-1 3B infected human MT4 cells assessed as protection against virus-induced cytopathogenicity,F,BAO_0000190,BAO_0000218,organism-based format,C=CCNC(=S)Nc1ccc(NS(C)(=O)=O)c(Oc2ccccc2)c1,CHEMBL1153581,Eur J Med Chem,2009.0,CHEMBL559053,CHEMBL559053,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,829985.0,>,1.0,1.0,>,IC50,ug.mL-1,87.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,87.2,CHEMBL378
1385,2244514.0,[],CHEMBL1002206,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase Y181C mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(C(F)(F)F)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL275658,CHEMBL275658,8.68,0.0,http://www.openphacts.org/units/Nanomolar,798655.0,=,1.0,1.0,=,IC50,nM,2.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.1,CHEMBL378
1386,3406127.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(/C=C/C(=O)c2cc(NC(C)=O)ccc2O)c1,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1215308,CHEMBL1215308,4.40,0.0,http://www.openphacts.org/units/Nanomolar,933016.0,=,1.0,1.0,=,IC50,nM,40000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,40.0,CHEMBL378
1387,2371523.0,[],CHEMBL1035739,Antiviral activity against HIV1 with reverse transcriptase K103N mutant in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ncccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL491019,CHEMBL491019,8.60,0.0,http://www.openphacts.org/units/Nanomolar,773465.0,=,1.0,1.0,=,IC50,nM,2.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.5,CHEMBL378
1388,19281748.0,[],CHEMBL4409363,Antiviral activity against HIV1 92/BR/018 infected in human TZM-bl cells incubated for 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL4406854,Eur J Med Chem,2019.0,CHEMBL129,CHEMBL129,7.80,0.0,http://www.openphacts.org/units/Nanomolar,3219945.0,=,1.0,1.0,=,IC50,nM,16.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.016,CHEMBL378
1389,19013471.0,[],CHEMBL4345978,Antiviral activity against HIV1 Env-pseudotyped virus in human U87.CD4.CCR5 target cells assessed as reduction in viral infection at early stage,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(N(C)C(=O)[C@H](Cc2ccccc2)NC(=O)CN2CCN(S(=O)(=O)c3ccc(N)cc3)CC2=O)cc1,CHEMBL4342517,J Med Chem,2020.0,CHEMBL4471665,CHEMBL4471665,8.05,0.0,http://www.openphacts.org/units/Nanomolar,3172773.0,=,1.0,1.0,=,IC50,nM,8.96,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.96,CHEMBL378
1390,10937536.0,[],CHEMBL2051603,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4cccc([N+](=O)[O-])c4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046590,CHEMBL2046590,4.25,0.0,http://www.openphacts.org/units/Nanomolar,1651474.0,=,1.0,1.0,=,IC50,nM,56710.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,56.71,CHEMBL613497
1391,1757246.0,[],CHEMBL864208,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(-n2c(C)nnc2SCC(=O)Nc2ccc(Cl)cc2)cc1,CHEMBL1146046,Bioorg Med Chem Lett,2006.0,CHEMBL211418,CHEMBL211418,,0.0,http://www.openphacts.org/units/Nanomolar,545150.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
1392,8041790.0,[],CHEMBL1953242,Antiviral activity against HIV1 harboring VSV glycoprotein-G co-transfected with luciferase gene infected in human TZM-bl cells assessed as inhibition of viral replication after 48 hrs by microplate luminometer based luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(S(=O)(=O)Oc2c(C(=O)NCc3ccc(F)cc3)nc(C(C)(C)NC(=O)c3nnc(C)o3)n(C)c2=O)c(C)c1,CHEMBL1949625,Eur J Med Chem,2012.0,CHEMBL1949873,CHEMBL1949873,10.40,0.0,http://www.openphacts.org/units/Nanomolar,1576974.0,=,1.0,1.0,=,IC50,nM,0.04,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,10'-2nM,UO_0000065,4.0,CHEMBL378
1393,1402086.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(CO)nc(O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL424772,CHEMBL424772,9.00,0.0,http://www.openphacts.org/units/Nanomolar,360403.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
1394,307926.0,[],CHEMBL653803,In vitro inhibition of CEM-SS cell growth by 50 %,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCOCC(C[N+](C)(C)C)OC.[Br-],CHEMBL1125666,J Med Chem,1991.0,CHEMBL28657,CHEMBL1178453,5.96,0.0,http://www.openphacts.org/units/Nanomolar,43723.0,=,1.0,1.0,=,IC50,nM,1100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.1,CHEMBL378
1395,18479592.0,[],CHEMBL4184680,Antiviral activity against Zika virus infected in human A549 cells preincubated for 5 hrs followed by compound wash measured after 48 hrs by viral plague-forming assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CCSc1nsc(NC(=O)Nc2ccc(Cl)cc2C(F)(F)F)n1,CHEMBL4184095,Bioorg Med Chem Lett,2018.0,CHEMBL4214443,CHEMBL4214443,9.50,0.0,http://www.openphacts.org/units/Nanomolar,3067001.0,=,1.0,1.0,=,IC50,nM,0.3177,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,pM,UO_0000065,317.7,CHEMBL4296612
1396,18509611.0,[],CHEMBL4191613,Antiviral activity against HIV1 virions derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(O[C@@H]3O[C@H](C)[C@@H](O)[C@H](O)[C@H]3O)c3c(c(-c4ccc5c(c4)OCO5)c2cc1OC)C(=O)OC3,CHEMBL4190218,J Nat Prod,2017.0,CHEMBL458904,CHEMBL458904,7.57,0.0,http://www.openphacts.org/units/Nanomolar,3073111.0,=,1.0,1.0,=,IC50,nM,26.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,26.9,CHEMBL378
1397,19281702.0,[],CHEMBL4409359,Antiviral activity against HIV1 VB59 infected in human TZM-bl cells incubated for 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(cnn2-c2ccc(F)c(F)c2)c(=O)[nH]1,CHEMBL4406854,Eur J Med Chem,2019.0,CHEMBL4464308,CHEMBL4464308,,0.0,http://www.openphacts.org/units/Nanomolar,3219942.0,>,1.0,1.0,>,IC50,nM,191570.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,191.57,CHEMBL378
1398,13449294.0,[],CHEMBL2428633,Antiviral activity against HIV1 LAI infected in human MT2 cells by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,CHEMBL2424573,J Med Chem,2013.0,CHEMBL114,CHEMBL114,7.82,0.0,http://www.openphacts.org/units/Nanomolar,1919752.0,=,1.0,1.0,=,IC50,nM,15.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,15.0,CHEMBL378
1399,19262022.0,[],CHEMBL4404424,Antiviral activity against multidrug resistant HIV1 12227 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.64,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,230.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.23,CHEMBL378
1400,1411540.0,[],CHEMBL832751,Inhibitory concentration against hepatitis C virus polymerase,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CCNC(=O)c2ccc3c(c2)nc(-c2ccccn2)n3C2CCCCC2)cc1OC,CHEMBL1145280,J Med Chem,2005.0,CHEMBL178076,CHEMBL178076,4.92,0.0,http://www.openphacts.org/units/Nanomolar,362336.0,=,1.0,1.0,=,IC50,nM,12000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,12.0,CHEMBL4620
1401,3188308.0,[],CHEMBL1107773,Antiviral activity against HIV1 NLBal infected JC53BL cells assessed as inhibition of replication by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCC[C@H]1CN(C[C@H]2CC[C@H](OCC)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2,CHEMBL1155421,Bioorg Med Chem Lett,2010.0,CHEMBL1077362,CHEMBL1077362,7.72,0.0,http://www.openphacts.org/units/Nanomolar,896406.0,=,1.0,1.0,=,IC50,nM,19.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.0,CHEMBL378
1402,2601956.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,NNC(=O)c1[nH]c2ccc(Cl)cc2c1Sc1ccc(Cl)cc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL79468,CHEMBL79468,5.00,0.0,http://www.openphacts.org/units/Nanomolar,808147.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
1403,108393.0,[],CHEMBL692689,Inhibition of HCV NS5B polymerase,B,BAO_0000190,BAO_0000357,single protein format,CC(=O)c1ccc(-c2cc(NS(=O)(=O)c3ccccc3C)c(C(=O)O)s2)cc1,CHEMBL1148275,Bioorg Med Chem Lett,2004.0,CHEMBL167155,CHEMBL167155,5.85,0.0,http://www.openphacts.org/units/Nanomolar,326843.0,=,1.0,1.0,=,IC50,nM,1400.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,1.4,CHEMBL4620
1404,2413696.0,[],CHEMBL987710,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)C1CCCC1)[C@@H](OC(=O)C1CCCC1)C(C)(C)O)C1=C2C[C@H](OC(=O)C3CCCC3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL510177,CHEMBL510177,,0.0,http://www.openphacts.org/units/Nanomolar,810684.0,>,1.0,1.0,>,IC50,nM,1100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.1,CHEMBL613497
1405,3397928.0,[],CHEMBL1217303,Antiviral activity against HIV1 3B infected in human MAGI cells after 40 to 48 hrs assessed as inhibition of viral life cycle,F,BAO_0000190,BAO_0000218,organism-based format,O=C1C(c2ccc(O)c(OS(=O)(=O)O)c2)=c2c(c3c(n2CCc2ccc(O)cc2)=C(c2ccc(O)c(OS(=O)(=O)O)c2)C(=O)c2cc(O)c(O)cc2-3)-c2cc(O)c(O)cc21,CHEMBL1212851,Bioorg Med Chem,2010.0,CHEMBL1214280,CHEMBL1214280,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,931712.0,=,1.0,1.0,=,IC50,ug.mL-1,1.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,1.2,CHEMBL378
1406,12642425.0,[],CHEMBL2317522,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay in presence of human serum albumin,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)OCCn1ccn2cc(C(=O)NCc3ccc(F)cc3)c(=O)c(O)c2c1=O,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314679,CHEMBL2314679,7.72,0.0,http://www.openphacts.org/units/Nanomolar,1844811.0,=,1.0,1.0,=,IC50,nM,19.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.0,CHEMBL378
1407,23274464.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C/C(=C5\CC[C@@]6(C)[C@@H](C5)C[C@H](O)[C@@H]5[C@@H]6CC[C@]6(C)[C@@H]([C@H](C)CCC(=O)NCCS(=O)(=O)O)CC[C@@H]56)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4872506,CHEMBL4872506,,0.0,http://www.openphacts.org/units/Nanomolar,3621264.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,10000.0,CHEMBL613497
1408,19450594.0,[],CHEMBL4433617,Antiviral activity against wild type HIV1 NL4-3 infected in human TZM-bl cells assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay based BiCycle assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(-c2ccc(C(=O)NCCCNC(=O)c3ccc(COc4ccccc4-c4csc(N)n4)cc3)cc2)cs1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4451842,CHEMBL4594930,4.82,0.0,http://www.openphacts.org/units/Nanomolar,3249756.0,=,1.0,1.0,=,IC50,nM,15000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,15.0,CHEMBL378
1409,5189227.0,[],CHEMBL1658800,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/c1cccc(F)c1)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652522,CHEMBL1652522,4.57,0.0,http://www.openphacts.org/units/Nanomolar,1326897.0,=,1.0,1.0,=,IC50,nM,27000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.027,CHEMBL613497
1410,22898307.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731092,Antiviral activity against DRV resistant HIV1 infected in human MT4 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL1323,CHEMBL1323,6.50,0.0,http://www.openphacts.org/units/Nanomolar,3554418.0,=,1.0,1.0,=,IC50,nM,316.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,316.0,CHEMBL378
1411,18202579.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C2NC(=O)NC(C)=C2c2nc(-c3ccc(C#N)cc3)cs2)cc1O,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4061785,CHEMBL4061785,6.42,0.0,http://www.openphacts.org/units/Nanomolar,3019963.0,=,1.0,1.0,=,IC50,nM,380.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.38,CHEMBL378
1412,22844951.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721621,Antiviral activity against HIV-1 HXB-2 infected in human TZM-bl cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based single cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(C)(C)c1csc([C@@H](CN)NC(=O)c2ccc(-c3cc(F)c(Cl)c(F)c3)[nH]2)n1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4758917,CHEMBL4758917,5.03,0.0,http://www.openphacts.org/units/Nanomolar,3547079.0,=,1.0,1.0,=,IC50,nM,9300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,9.3,CHEMBL378
1413,307922.0,[],CHEMBL697276,In vitro inhibition of HIV-1 plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCSCC(C[N+](C)(C)CCO)OCC.[Br-],CHEMBL1125666,J Med Chem,1991.0,CHEMBL28993,CHEMBL1178472,6.20,0.0,http://www.openphacts.org/units/Nanomolar,43726.0,=,1.0,1.0,=,IC50,nM,630.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.63,CHEMBL378
1414,5294526.0,[],CHEMBL1696681,Antiviral activity against HIV-1 3B infected in human MT4 cells assessed as inhibition of virus induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(CC)[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,CHEMBL1687706,Antimicrob Agents Chemother,2008.0,CHEMBL1651956,CHEMBL1651956,7.00,0.0,http://www.openphacts.org/units/Nanomolar,1337219.0,=,1.0,1.0,=,IC50,nM,99.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.099,CHEMBL378
1415,15165604.0,[],CHEMBL3404732,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBsAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C=C/C(=O)OC[C@H]2O[C@@H](Oc3ccc(C(C)=O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)cc1OC,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402784,CHEMBL3402784,,0.0,http://www.openphacts.org/units/Nanomolar,2284139.0,=,1.0,1.0,=,IC50,nM,695800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,695.8,CHEMBL613497
1416,2272926.0,[],CHEMBL956847,Antiviral activity against HIV1 Bal in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C(c1cccc(C)c1C)N1CCC(CCN2[C@@H]3CC[C@H]2C[C@@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1,CHEMBL1153314,Bioorg Med Chem Lett,2009.0,CHEMBL500824,CHEMBL500824,6.67,0.0,http://www.openphacts.org/units/Nanomolar,755544.0,=,1.0,1.0,=,IC50,nM,216.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.216,CHEMBL378
1417,1402407.0,[],CHEMBL833792,In vitro inhibitory concentration against HIV-1 Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)CCOC)c1C(=O)c1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369697,CHEMBL369697,6.20,0.0,http://www.openphacts.org/units/Nanomolar,360426.0,=,1.0,1.0,=,IC50,nM,631.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.631,CHEMBL378
1418,10863185.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCc6cccc(Cl)c6)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022381,CHEMBL2022381,,0.0,http://www.openphacts.org/units/Nanomolar,1637631.0,=,1.0,1.0,=,IC50,nM,529310.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,529.31,CHEMBL613497
1419,10861978.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)CCCCCOC(=O)[C@@]1(C)CC[C@]2(C)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024643,CHEMBL2024643,,0.0,http://www.openphacts.org/units/Nanomolar,1640539.0,=,1.0,1.0,=,IC50,nM,208960.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,208.96,CHEMBL613497
1420,3267349.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1Cn2c(=O)[nH]c3cc([N+](=O)[O-])cc(c32)CN1CC1CC1,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL291565,CHEMBL291565,4.48,0.0,http://www.openphacts.org/units/Nanomolar,905483.0,=,1.0,1.0,=,IC50,nM,33113.11,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.48,CHEMBL378
1421,911195.0,[],CHEMBL728516,Anti-HIV activity against HIV-1 IIIB chronically infected Molt-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1N1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCOC(C)=O)c3c2OC(F)F)CC1,CHEMBL1131862,Bioorg Med Chem Lett,1999.0,CHEMBL322429,CHEMBL322429,7.00,0.0,http://www.openphacts.org/units/Nanomolar,194328.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
1422,16544716.0,[],CHEMBL3789804,Antiviral activity against HIV1 virus-like particles harboring wild type reverse transcriptase infected in human U2OS cells after 24 hrs by Renilla luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(CCC(=O)NCC(=O)NCC(=O)O)c(=O)oc2c(C)c(O)ccc12,CHEMBL3784952,Bioorg Med Chem,2016.0,CHEMBL3785111,CHEMBL3785111,,0.0,http://www.openphacts.org/units/Nanomolar,2769486.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
1423,10866486.0,[],CHEMBL2025518,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(OC(=O)CCN2C(=O)c3ccccc3C2=O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCN4C(=O)c5ccccc5C4=O)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024045,CHEMBL2024045,,0.0,http://www.openphacts.org/units/Nanomolar,1639767.0,>,1.0,1.0,>,IC50,nM,202370.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,202.37,CHEMBL613497
1424,1497997.0,[],CHEMBL833971,Concentration required to inhibit 50% viral production of human immunodeficiency virus type 1 (HIV-1-IIIB),F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2ccccc2)n(COCCO)c(=O)[nH]c1=O,CHEMBL1143567,J Med Chem,2005.0,CHEMBL31871,CHEMBL31871,5.16,0.0,http://www.openphacts.org/units/Nanomolar,388197.0,=,1.0,1.0,=,IC50,nM,7000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.0,CHEMBL378
1425,5248977.0,[],CHEMBL1685193,Antiviral activity against X4 tropic HIV1 NL4.3 infected in CD4 and CXCR4 expressing human MT4 cells assessed as inhibition of viral cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,COCc1cccc(CN(CCCCN)C2CCCc3cccnc32)n1,CHEMBL1681661,Bioorg Med Chem Lett,2011.0,CHEMBL1682861,CHEMBL1682861,6.26,0.0,http://www.openphacts.org/units/Nanomolar,1333983.0,=,1.0,1.0,=,IC50,nM,553.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,553.0,CHEMBL378
1426,18727037.0,[],CHEMBL4259325,Antiviral activity against HIV1 subtype BC CNE15 pseudovirus assessed as inhibition of viral infection in Ghost (3)X4/R5 cells after 48 hrs by Bright-Glo luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O,CHEMBL4257519,Medchemcomm,2018.0,CHEMBL4289957,CHEMBL4289957,8.12,0.0,http://www.openphacts.org/units/Nanomolar,3111237.0,=,1.0,1.0,=,IC50,nM,7.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.5,CHEMBL378
1427,1223574.0,[],CHEMBL710530,Inhibitory activity against 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70442,CHEMBL70442,8.72,0.0,http://www.openphacts.org/units/Nanomolar,127467.0,=,1.0,1.0,=,IC50,nM,1.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0019,CHEMBL378
1428,14658838.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)c3ccc(C)cc3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262887,CHEMBL3262887,7.19,0.0,http://www.openphacts.org/units/Nanomolar,2101729.0,=,1.0,1.0,=,IC50,nM,65.0,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,IC50,nM,UO_0000065,65.0,CHEMBL3259471
1429,3315854.0,[],CHEMBL1119774,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1,CHEMBL1155507,Bioorg Med Chem Lett,2010.0,CHEMBL1085229,CHEMBL1085229,7.50,0.0,http://www.openphacts.org/units/Nanomolar,915692.0,=,1.0,1.0,=,IC50,nM,32.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,32.0,CHEMBL378
1430,24735358.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5116806,Antiviral activity against ZIKV infected in human Huh-7 cells assessed as inhibition of viral infection measured 24 hrs post infection by immunofluorescent assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1cc(-c2ccccc2)oc2c(-c3cccc(F)c3)c(O)c(O)c(O)c12,CHEMBL5113447,Bioorg Med Chem Lett,2022.0,CHEMBL5190082,CHEMBL5190082,5.46,0.0,http://www.openphacts.org/units/Nanomolar,3858569.0,=,1.0,1.0,=,IC50,nM,3500.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,3.5,CHEMBL4296612
1431,20677909.0,[],CHEMBL4622140,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in cytoplasmic HBV-DNA replication incubated for 8 days by real-time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(F)nc2F)nn(Cc2ccc(Cl)cc2)c1=O,CHEMBL4619801,J Med Chem,2020.0,CHEMBL4640807,CHEMBL4640807,7.01,0.0,http://www.openphacts.org/units/Nanomolar,3482209.0,=,1.0,1.0,=,IC50,nM,98.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.098,CHEMBL613497
1432,6216889.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784392,CHEMBL1784392,5.55,0.0,http://www.openphacts.org/units/Nanomolar,1429330.0,=,1.0,1.0,=,IC50,nM,2818.38,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.55,CHEMBL378
1433,18044790.0,[],CHEMBL4010395,"Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype C 6936-2, clone 21",F,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075766,CHEMBL4075766,6.50,0.0,http://www.openphacts.org/units/Nanomolar,2990214.0,=,1.0,1.0,=,IC50,nM,320.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.32,CHEMBL378
1434,1243468.0,[],CHEMBL677523,Concentration required to inhibit Vaccinia induced cytopathicity in E6SM cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCC(=O)NCCCCCCCCCCC(=O)NCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL113937,CHEMBL1205558,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221533.0,>,1.0,1.0,>,IC50,ug.mL-1,200.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,ug ml-1,UO_0000274,200.0,CHEMBL613493
1435,364351.0,[],CHEMBL711617,Antiviral activity against HIV-1 IIIB induced cytopathic effect in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)[C@H]1NCc2cccc(c2)OCCCCNC(=O)[C@H](C(C)C)NC1=O,CHEMBL1129607,J Med Chem,1996.0,CHEMBL420492,CHEMBL420492,7.54,0.0,http://www.openphacts.org/units/Nanomolar,210525.0,=,1.0,1.0,=,IC50,nM,29.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,29.0,CHEMBL378
1436,2149878.0,[],CHEMBL935683,Antiviral activity against HIV1 098-T651 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL427630,CHEMBL427630,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708028.0,=,1.0,1.0,=,IC50,ug.mL-1,8.14,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,8.14,CHEMBL378
1437,13476937.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435874,CHEMBL2435874,,0.0,,1924250.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1438,40613.0,[],CHEMBL857692,Inhibitory concentration against HCV NS3 protease was determined,B,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)c1cnccn1)[C@@H](C)CC)C(=O)C(=O)N[C@H](C(=O)O)C(C)C,CHEMBL1136650,Bioorg Med Chem Lett,2003.0,CHEMBL13442,CHEMBL13442,5.44,0.0,http://www.openphacts.org/units/Nanomolar,12748.0,=,1.0,1.0,=,IC50,nM,3600.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,3.6,CHEMBL4620
1439,24823622.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '144.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '6.0'}]",CHEMBL5140688,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in intracellular core HBV DNA level incubated for 6 days by qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3ccc(F)cc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5180441,CHEMBL5180441,8.24,0.0,http://www.openphacts.org/units/Nanomolar,3876720.0,=,1.0,1.0,=,IC50,nM,5.7,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0057,CHEMBL613497
1440,18044539.0,[],CHEMBL4010365,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of p24 antigen production pretreated with virus for 30 mins followed by 4 days incubation with cells by sandwich ELISA based multicycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(C(CN)NC(=O)c2ncc(-c3ccc(Cl)cc3)[nH]2)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4067467,CHEMBL4067467,,0.0,http://www.openphacts.org/units/Nanomolar,2990234.0,>,1.0,1.0,>,IC50,nM,26000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,26.0,CHEMBL378
1441,10865200.0,[],CHEMBL2025516,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CN(C)C)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2023667,CHEMBL2023667,4.06,0.0,http://www.openphacts.org/units/Nanomolar,1639231.0,=,1.0,1.0,=,IC50,nM,87210.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,87.21,CHEMBL613497
1442,654518.0,[],CHEMBL683819,Anti-HIV activity in cell culture assay expressed as IC50 values.,F,BAO_0000190,BAO_0000218,organism-based format,O=C1O[C@H]2[C@@H]3OC(=O)c4cc(O)c(O)c(O)c4-c4c(cc(O)c(O)c4O)C(=O)OC[C@H]2O[C@@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@@H]3OC(=O)c2cc(O)c(O)c3c2[C@@H]2C1=CC(=O)C(O)(O)C2(O)O3,CHEMBL1126373,Bioorg Med Chem Lett,1992.0,CHEMBL524666,CHEMBL524666,4.85,0.0,http://www.openphacts.org/units/Nanomolar,60645.0,=,1.0,1.0,=,IC50,nM,14000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,14.0,CHEMBL378
1443,2292412.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1Sc1cccc(Cl)c1,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL55599,CHEMBL55599,,0.0,http://www.openphacts.org/units/Nanomolar,813168.0,=,1.0,1.0,=,IC50,nM,7396052.75,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,2.131,CHEMBL378
1444,936961.0,[],CHEMBL758490,Anti-HIV activity against multidrug resistant HIV JSL strain by inhibition of HIV p24 antigen expression in peripheral blood mononuclear cells(PBMC),F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,CHEMBL1144922,J Med Chem,2003.0,CHEMBL114,CHEMBL114,6.26,0.0,http://www.openphacts.org/units/Nanomolar,83380.0,=,1.0,1.0,=,IC50,nM,550.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,550.0,CHEMBL378
1445,15748652.0,[],CHEMBL3630970,Antiviral activity against HIV1 3B assessed as inhibition of viral attachment to human MAGI cells,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(C[C@@H]1CNCCN1)[C@H]1CCCc2cccnc21,CHEMBL3627700,Bioorg Med Chem Lett,2015.0,CHEMBL3627789,CHEMBL3627789,5.96,0.0,http://www.openphacts.org/units/Nanomolar,2506617.0,=,1.0,1.0,=,IC50,nM,1100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.1,CHEMBL378
1446,14596882.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(Sc2ccccc2)n(COCC2CCCCC2)c(=S)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL135690,CHEMBL135690,5.19,0.0,http://www.openphacts.org/units/Nanomolar,2082724.0,=,1.0,1.0,=,IC50,nM,6450.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.45,CHEMBL378
1447,3114022.0,[],CHEMBL1073712,Antiviral activity against HIV1 NL4-3 infected in GFP expressing human CEM cells assessed as inhibition of viral infection measured after 9 days postinfection by microfluorometry,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1c(O)c(C(C)=O)c(O)c(C(CCc2ccccc2)c2c(O)c(C(C)=O)c(O)c(C(C)=O)c2O)c1O,CHEMBL1157554,Bioorg Med Chem,2010.0,CHEMBL597363,CHEMBL597363,,0.0,,888528.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1448,18202899.0,[],CHEMBL4043734,Antiviral activity against HIV-1 NL4-3 harboring reverse transcriptase Y181C mutant infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2cc3ccccc3n2C)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4061932,CHEMBL4061932,,0.0,http://www.openphacts.org/units/Nanomolar,3019978.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1449,6280162.0,[],CHEMBL1804130,Antiviral activity against HIV1 isolate NL4-3 harboring reverse transcriptase Y181C/G190A double mutant assessed as inhibition of viral replication by phenoscreen assay in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3cc(-c4ccncc4)[nH]n3)ccc2Cl)c1,CHEMBL1800064,Bioorg Med Chem Lett,2010.0,CHEMBL1801231,CHEMBL1801231,6.88,0.0,http://www.openphacts.org/units/Nanomolar,1440340.0,=,1.0,1.0,=,IC50,nM,130.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1309,CHEMBL378
1450,1750589.0,[],CHEMBL868005,Antiviral activity against multi drug-resistant HIV1 G variant in human PHA-PBMC cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,CHEMBL1146019,J Med Chem,2006.0,CHEMBL114,CHEMBL114,7.23,0.0,http://www.openphacts.org/units/Nanomolar,539998.0,=,1.0,1.0,=,IC50,nM,59.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,59.0,CHEMBL378
1451,1224897.0,[],CHEMBL710376,Inhibitory activity against 100I strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72335,CHEMBL72335,7.14,0.0,http://www.openphacts.org/units/Nanomolar,127434.0,=,1.0,1.0,=,IC50,nM,73.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.073,CHEMBL378
1452,2211572.0,[],CHEMBL979729,Antiviral activity against deltaTat/Rev deffective HIV1 in 1A2 cells assessed as inhibition of metabolic activity in uninfected cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(=O)oc3c(OC)c(O)cc4c(=O)oc(c1OC)c2c34,CHEMBL1149827,J Nat Prod,2008.0,CHEMBL451476,CHEMBL451476,,0.0,,718620.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1453,2665972.0,[],CHEMBL1061338,Inhibition of TPA-induced AP1 transfected in HEK293 cells assessed as inhibition of beta-lactamase reporter activity treated 1 hr before TPA stimulation measured after 18 hrs by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,CC1=C[C@H](O)[C@@H](O)[C@]2(C)[C@H]3[C@@]4(O)OC[C@]35[C@H]([C@@H](C)[C@H]4O)[C@@H](O)C(=O)O[C@@H]5C[C@@H]12,CHEMBL1152334,J Nat Prod,2009.0,CHEMBL472650,CHEMBL472650,,0.0,,818165.0,,1.0,0.0,,IC50,,,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,,,,CHEMBL4977
1454,13475641.0,[],CHEMBL2439394,Antiviral activity against Human immunodeficiency virus 1 clade B isolate US2 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435856,CHEMBL2435856,8.85,0.0,http://www.openphacts.org/units/Nanomolar,1924231.0,=,1.0,1.0,=,IC50,nM,1.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.4,CHEMBL378
1455,19261888.0,[],CHEMBL4404377,"Antiviral activity against HIV1 subtypeB QH0692, clone 42",F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.57,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,270.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.27,CHEMBL378
1456,1402517.0,[],CHEMBL834488,In vitro inhibitory concentration against HIV L100I and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL57,CHEMBL57,5.84,0.0,http://www.openphacts.org/units/Nanomolar,360370.0,=,1.0,1.0,=,IC50,nM,1452.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.452,CHEMBL378
1457,1472278.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C(\C#N)c2ccccc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL189301,CHEMBL189301,6.00,0.0,http://www.openphacts.org/units/Nanomolar,380908.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
1458,37597.0,[],CHEMBL692437,The effect of protein binding on the antiviral activity versus wild type virus strain HXB2 was tested in the presence of acid glycoprotein in HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL223228,CHEMBL223228,,0.0,,20823.0,=,1.0,0.0,=,IC50,,2.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,2.4,CHEMBL378
1459,501634.0,[],CHEMBL695382,Tested for inhibitory concentration on HIV-I nevirapine resistant strain.,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC(C)=O)c1Cc1cc(C)cc(C)c1,CHEMBL1133473,J Med Chem,2000.0,CHEMBL129144,CHEMBL129144,,0.0,http://www.openphacts.org/units/Nanomolar,245545.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10000.0,CHEMBL378
1460,5132871.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2[nH]c(=O)c(CN(Cc3ccco3)C(=O)CN3CCN(C)CC3)cc2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645048,CHEMBL1645048,,0.0,http://www.openphacts.org/units/Nanomolar,1321036.0,>,1.0,1.0,>,IC50,nM,24500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,24.5,CHEMBL378
1461,3014055.0,[],CHEMBL1042767,Antiviral activity against HIV1 3B infected in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)CCCn1c(CN(C)C2CCCc3cccnc32)nc2ccccc21,CHEMBL1155333,Bioorg Med Chem Lett,2009.0,CHEMBL568447,CHEMBL568447,7.77,0.0,http://www.openphacts.org/units/Nanomolar,854997.0,=,1.0,1.0,=,IC50,nM,17.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.017,CHEMBL378
1462,2929738.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCSCc1c(C)[nH]c(=O)c(I)c1Sc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL584137,CHEMBL584137,7.50,0.0,http://www.openphacts.org/units/Nanomolar,848266.0,=,1.0,1.0,=,IC50,nM,31.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.6,CHEMBL378
1463,10863189.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCc6ccc(C(F)(F)F)cc6)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022385,CHEMBL2022385,5.27,0.0,http://www.openphacts.org/units/Nanomolar,1637635.0,=,1.0,1.0,=,IC50,nM,5360.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,5.36,CHEMBL613497
1464,15602733.0,[],CHEMBL3578657,Inhibition of ASCT2-mediated [3H]glutamine uptake in HEK293 cells after 15 mins by Live-cell glutamine uptake assay,B,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(c2ccccc2CNC(=O)CC[C@H](N)C(=O)O)CC1,CHEMBL3576761,Bioorg Med Chem Lett,2015.0,CHEMBL3576939,CHEMBL3576939,,0.0,,2479436.0,,1.0,0.0,,IC50,,,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,,,,CHEMBL3562162
1465,2930376.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3cccc3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL574164,CHEMBL574164,8.60,0.0,http://www.openphacts.org/units/Nanomolar,848360.0,=,1.0,1.0,=,IC50,nM,2.51,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.51,CHEMBL378
1466,14714249.0,[],CHEMBL3293254,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#C/C=C/c1ccc(C(NN)c2ccnc(Nc3ccc(C#N)cc3)n2)cc1,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL3288563,CHEMBL3288563,8.76,0.0,http://www.openphacts.org/units/Nanomolar,2116121.0,=,1.0,1.0,=,IC50,nM,1.75,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.00175,CHEMBL378
1467,2614774.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)cc(Sc2cccc(N)c2C#N)c1,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL56324,CHEMBL56324,,0.0,http://www.openphacts.org/units/Nanomolar,732841.0,=,1.0,1.0,=,IC50,nM,1761976.05,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,2.754,CHEMBL378
1468,2203535.0,[],CHEMBL987023,Antiviral activity against HIV1 3B in human MT4 cells assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CCn1c(COc2ccc(NC(=S)NC)cc2)n[nH]c1=S,CHEMBL1149790,Eur J Med Chem,2008.0,CHEMBL493581,CHEMBL493581,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,765662.0,>,1.0,1.0,>,IC50,ug.mL-1,101.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,101.0,CHEMBL378
1469,12717504.0,[],CHEMBL2350955,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBV DNA replication after 72 hrs by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc([C@H]2Oc3c(OC)cc(/C=C/C(=O)O)cc3[C@@H]2CO)ccc1O,CHEMBL2346656,Bioorg Med Chem Lett,2013.0,CHEMBL2346742,CHEMBL2346742,,0.0,http://www.openphacts.org/units/Nanomolar,1874402.0,>,1.0,1.0,>,IC50,nM,1000000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1000.0,CHEMBL613497
1470,645107.0,[],CHEMBL696966,Concentration required for reduction of plaque against influenza B,F,BAO_0000190,BAO_0000218,organism-based format,CCCN(CCc1ccccc1)C(=O)[C@@H]1OC(C(=O)O)=C[C@H](N)[C@H]1NC(=O)C(F)(F)F,CHEMBL1134218,Bioorg Med Chem Lett,2001.0,CHEMBL348066,CHEMBL348066,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,313069.0,=,1.0,1.0,=,IC50,ug.mL-1,0.056,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,0.056,CHEMBL613129
1471,22933324.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)CC(C)(C)C(=O)O)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)/C=C/c6ccc7c(c6)OCO7)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4761031,CHEMBL4761031,,0.0,http://www.openphacts.org/units/Nanomolar,3560885.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
1472,13476674.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435913,CHEMBL2435913,,0.0,http://www.openphacts.org/units/Nanomolar,1924289.0,>,1.0,1.0,>,IC50,nM,358.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,358.3,CHEMBL378
1473,155945.0,[],CHEMBL683693,Tested in vitro against human immunodeficiency virus (HIV) infected CEM cells using XTT assay (LAV-BRU strain),F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(O)c2ncn(C[C@H](CCl)OCP(=O)(O)O)c2n1,CHEMBL1126801,J Med Chem,1993.0,CHEMBL90801,CHEMBL90801,4.30,0.0,http://www.openphacts.org/units/Nanomolar,169350.0,=,1.0,1.0,=,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
1474,12687128.0,[],CHEMBL2344305,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral e antigen production,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@H]1C[C@H]2[C@]3(C)C(=O)C[C@]4(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](OC(C)=O)C[C@@]4(C)[C@@H]3C[C@H]3O[C@]32C(C)(C)[C@@H]1OC(C)=O,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332407,CHEMBL2332407,,0.0,http://www.openphacts.org/units/Nanomolar,1866101.0,>,1.0,1.0,>,IC50,nM,960900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,960.9,CHEMBL613497
1475,1402523.0,[],CHEMBL833792,In vitro inhibitory concentration against HIV-1 Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL57,CHEMBL57,5.00,0.0,http://www.openphacts.org/units/Nanomolar,360370.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
1476,7967320.0,[],CHEMBL1930242,Antiviral activity against R5 tropic Human immunodeficiency virus 1 BAL infected in human PBMC cells assessed as reduction in viral replication by p24 detection based ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccc(Cl)cc2)c2ccc(Br)cc2)CC1,CHEMBL1926604,Bioorg Med Chem Lett,2011.0,CHEMBL1926881,CHEMBL1926881,,0.0,http://www.openphacts.org/units/Nanomolar,1563498.0,>,1.0,1.0,>,IC50,nM,1300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.3,CHEMBL378
1477,1117294.0,[],CHEMBL697278,Compound was tested for binding of HIV-1 to CEM-ss cells; NI = No inhibition,F,BAO_0000190,BAO_0000218,organism-based format,NCCSSCCN,CHEMBL1130070,J Med Chem,1997.0,CHEMBL61350,CHEMBL61350,,0.0,http://www.openphacts.org/units/Nanomolar,103195.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,I50,uM,UO_0000065,,CHEMBL378
1478,618110.0,[],CHEMBL710381,Inhibitory activity against 103N strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)c(Oc2nc(N)nc(Nc3ccc(C#N)cc3)n2)c(Br)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL69503,CHEMBL69503,8.30,0.0,http://www.openphacts.org/units/Nanomolar,126913.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.005,CHEMBL378
1479,3509176.0,[],CHEMBL1261042,Antiviral activity against HIV1 harboring reverse transcriptase V106A mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Nc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1Br,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1258478,CHEMBL1258478,9.05,0.0,http://www.openphacts.org/units/Nanomolar,963462.0,=,1.0,1.0,=,IC50,nM,0.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.9,CHEMBL378
1480,17602997.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(c2ccc(-c3ccccc3)cc2)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644932,CHEMBL3644932,8.30,0.0,http://www.openphacts.org/units/Nanomolar,2518052.0,=,37.0,1.0,=,IC50,nM,5.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,5.0,CHEMBL4620
1481,3013903.0,[],CHEMBL1045234,Antiviral activity against HIV1 3B infected human HOS cells expressing human CXCR4 and CD4 assessed as inhibition of viral infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)[C@H]1CCN(c2cccc3nc(CN(C)[C@H]4CCCc5cccnc54)cn23)C1,CHEMBL1156094,Bioorg Med Chem Lett,2009.0,CHEMBL570301,CHEMBL570301,8.10,0.0,http://www.openphacts.org/units/Nanomolar,860794.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
1482,24509240.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5055345,Antiviral activity against HIV1 931N101 infected in human SupT1 cells assessed as inhibition of viral entry mesaured after 96 hrs by p24- ELISA assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C(C)NC(=O)NC1c1cccc(Cl)c1,CHEMBL5053552,Bioorg Med Chem,2021.0,CHEMBL2041252,CHEMBL2041252,5.04,0.0,http://www.openphacts.org/units/Nanomolar,3837691.0,=,1.0,1.0,=,IC50,nM,9200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,9.2,CHEMBL378
1483,2149812.0,[],CHEMBL935680,Antiviral activity against HIV1 098 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL427784,CHEMBL427784,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708037.0,=,1.0,1.0,=,IC50,ug.mL-1,0.035,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.035,CHEMBL378
1484,1059820.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CCC1N=CN(Nc2cccc(C)c2)C1c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289591,CHEMBL289591,,0.0,http://www.openphacts.org/units/Nanomolar,62344.0,>,1.0,1.0,>,IC50,nM,27870.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,27.87,CHEMBL378
1485,516920.0,[],CHEMBL769300,Compound was evaluated for 50% inhibition of HBV polymerases (Hepatitis B virus),F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@@H]2C[C@@H](F)[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)nc1N,CHEMBL1131623,J Med Chem,1998.0,CHEMBL483492,CHEMBL483492,7.52,0.0,http://www.openphacts.org/units/Nanomolar,109351.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.03,CHEMBL613497
1486,1056088.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(NN2C(S)=NC(C)C2c2ccccc2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289785,CHEMBL289785,4.58,0.0,http://www.openphacts.org/units/Nanomolar,62325.0,=,1.0,1.0,=,IC50,nM,26100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,26.1,CHEMBL378
1487,10995181.0,[],CHEMBL2072873,Antiviral activity against VSV-G pseudotyped HIV1 lentiviral particles infected in human HeLa cells incubated for 48 hrs by spectrofluorometry,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](NC(=O)NCCNc3ccnc4cc(Cl)ccc34)[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL2069294,Bioorg Med Chem,2012.0,CHEMBL2071256,CHEMBL2071256,,0.0,,1663477.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1488,16499765.0,[],CHEMBL3776089,Antiretroviral activity against HIV-1 infected in HEK293T cells assessed as inhibition of viral replication by single-cycle assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1[nH]c2ccc(Cl)cc2c1C(SC)c1ccccc1,CHEMBL3774319,Bioorg Med Chem Lett,2016.0,CHEMBL3774725,CHEMBL3774725,7.41,0.0,http://www.openphacts.org/units/Nanomolar,2763418.0,=,1.0,1.0,=,IC50,nM,39.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.039,CHEMBL378
1489,1051210.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CCC1N=C(S)N(Nc2cccc(Cl)c2)C1c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39825,CHEMBL39825,5.04,0.0,http://www.openphacts.org/units/Nanomolar,62364.0,=,1.0,1.0,=,IC50,nM,9060.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,9.06,CHEMBL378
1490,10961141.0,[],CHEMBL2061266,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M9 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCCO)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058313,CHEMBL2058313,6.10,0.0,http://www.openphacts.org/units/Nanomolar,1656253.0,=,1.0,1.0,=,IC50,nM,800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,800.0,CHEMBL378
1491,3397929.0,[],CHEMBL1217302,Antiviral activity against HIV1 3B infected in human MT4 cells after 5 days by p24 antigen detection assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1C(c2ccc(O)c(O)c2)=c2c(c3c(n2CCc2ccc(O)cc2)=C(c2ccc(O)c(OS(=O)(=O)O)c2)C(=O)c2cc(O)c(OS(=O)(=O)O)cc2-3)-c2cc(O)c(O)cc21,CHEMBL1212851,Bioorg Med Chem,2010.0,CHEMBL1214282,CHEMBL1214282,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,931714.0,=,1.0,1.0,=,IC50,ug.mL-1,4.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,4.6,CHEMBL378
1492,23284027.0,[],CHEMBL4837921,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN(C)C2)cc1,CHEMBL4837199,Eur J Med Chem,2021.0,CHEMBL4862758,CHEMBL4862758,9.74,0.0,http://www.openphacts.org/units/Nanomolar,3622959.0,=,1.0,1.0,=,IC50,nM,0.18,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.18,CHEMBL378
1493,3432859.0,[],CHEMBL1246459,Antiviral activity against R5 tropic HIV1 BaL infected in human CEMx174 5.25M7 cells after 3 days by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NN1C(=O)[C@@H]2C3C=CC(C4CC43)[C@@H]2C1=O)c1ccc(CN(Cc2ccccc2)c2ccccc2)cc1,CHEMBL1240449,Eur J Med Chem,2010.0,CHEMBL1242909,CHEMBL1242909,4.77,0.0,http://www.openphacts.org/units/Nanomolar,954309.0,=,1.0,1.0,=,IC50,nM,17080.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,17.08,CHEMBL378
1494,1471863.0,[],CHEMBL833076,Inhibitory activity against HIV-1 mutant strain 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1ccc(OC)c(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL186129,CHEMBL186129,5.80,0.0,http://www.openphacts.org/units/Nanomolar,380838.0,=,1.0,1.0,=,IC50,nM,1580.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.58,CHEMBL378
1495,582892.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1cccc(S(=O)(=O)c2cccc(NC(=O)c3ccccc3SSc3ccccc3C(=O)Nc3cccc(S(=O)(=O)c4cccc(NC(C)=O)c4)c3)c2)c1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL354630,CHEMBL354630,4.23,0.0,http://www.openphacts.org/units/Nanomolar,334040.0,=,1.0,1.0,=,IC50,nM,59100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,59.1,CHEMBL378
1496,2371267.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2nc(NC(=N)N)nc(C)c2c1,CHEMBL1140145,J Med Chem,2008.0,CHEMBL495496,CHEMBL495496,5.13,0.0,http://www.openphacts.org/units/Nanomolar,745880.0,=,1.0,1.0,=,IC50,nM,7400.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,7.4,CHEMBL613493
1497,2601727.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(=O)n([C@@H]2C=C(F)[C@H](CO)O2)cc1F,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL448849,CHEMBL448849,7.75,0.0,http://www.openphacts.org/units/Nanomolar,807646.0,=,1.0,1.0,=,IC50,nM,18.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.018,CHEMBL378
1498,18890516.0,[],CHEMBL4314144,Antiviral activity against HIV-1 NL4-3 infected in human PBMC assessed as suppression of viral replication by measuring reduction in p24 level measured at 72 hrs post-infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)NC(=O)Cc1cc(-c2ccccc2)on1,CHEMBL4311980,Eur J Med Chem,2019.0,CHEMBL4443124,CHEMBL4443124,7.25,0.0,http://www.openphacts.org/units/Nanomolar,3151802.0,=,1.0,1.0,=,IC50,nM,56.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,56.2,CHEMBL378
1499,2670845.0,[],CHEMBL1035389,Antiviral activity against LASV infected in human A549 cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CN2C(=O)CN(C(=O)c3cc4ccccc4o3)CC2Cc2ccccc2)cc1,CHEMBL1151924,Bioorg Med Chem Lett,2009.0,CHEMBL563908,CHEMBL563908,6.22,0.0,http://www.openphacts.org/units/Nanomolar,820789.0,=,1.0,1.0,=,IC50,nM,600.0,CHEMBL615051,Lassa virus,Lassa virus,11620,IC50,uM,UO_0000065,0.6,CHEMBL615051
1500,1241154.0,[],CHEMBL878997,Inhibition of Hepatitis C RNA dependent RNA polymerase Nonstructural protein 5B activity.,B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Cl)ccc1C(=O)N(Cc1cccc(Br)c1)[C@@H](Cc1ccccc1)C(=O)O,CHEMBL1136248,Bioorg Med Chem Lett,2003.0,CHEMBL112293,CHEMBL112293,5.43,0.0,http://www.openphacts.org/units/Nanomolar,213330.0,=,1.0,1.0,=,IC50,nM,3700.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,3.7,CHEMBL4620
1501,8043654.0,[],CHEMBL1953039,Antiviral activity against HIV1 3B infected human TZM-bl cells assessed as inhibition of viral replication by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL1949531,Bioorg Med Chem Lett,2012.0,CHEMBL525076,CHEMBL525076,7.00,0.0,http://www.openphacts.org/units/Nanomolar,1579958.0,=,1.0,1.0,=,IC50,nM,98.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0988,CHEMBL378
1502,1750579.0,[],CHEMBL868009,Antiviral activity against multi drug-resistant HIV1 EV variant in human PHA-PBMC cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,CHEMBL1146019,J Med Chem,2006.0,CHEMBL114,CHEMBL114,,0.0,http://www.openphacts.org/units/Nanomolar,539998.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
1503,2244502.0,[],CHEMBL1002204,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase K103N/P225H mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL223228,CHEMBL223228,6.85,0.0,http://www.openphacts.org/units/Nanomolar,798658.0,=,1.0,1.0,=,IC50,nM,140.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,140.0,CHEMBL378
1504,3353613.0,[],CHEMBL1173869,Antiviral activity against HIV1 bearing VSV glycoprotein infected in human MT2 cells assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C#C[C@]1(CO)O[C@@H](n2ccc(N)nc2=O)[C@@H](F)[C@@H]1O,CHEMBL1177822,Bioorg Med Chem Lett,2010.0,CHEMBL1171597,CHEMBL1171597,8.87,0.0,http://www.openphacts.org/units/Nanomolar,922244.0,=,1.0,1.0,=,IC50,nM,1.34,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.00134,CHEMBL378
1505,1487028.0,[],CHEMBL833976,Inhibitory concentration against wild type human immunodeficiency virus type 1 was determined by recombinant virus assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1138845,J Med Chem,2004.0,CHEMBL223228,CHEMBL223228,9.00,0.0,http://www.openphacts.org/units/Nanomolar,384153.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
1506,3215769.0,[],CHEMBL1099858,Antiviral activity against Sindbis virus infected in BHK cells assessed as inhibition of RNA synthesis after 14 hrs by [3H]uridine incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1154369,J Nat Prod,2009.0,CHEMBL269277,CHEMBL269277,6.30,0.0,http://www.openphacts.org/units/Nanomolar,891230.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL613725,Sindbis virus,Sindbis virus,11034,IC50,uM,UO_0000065,0.5,CHEMBL613725
1507,18083430.0,[],CHEMBL4018068,Antiviral activity against HIV-1 NL4.3 infected in human TZM-b1 cells pretreated for 1 hr followed by viral infection measured after 2 days by CPRG assay,F,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1ccc(-c2ccc(/C=C3\SC(=S)N(CCc4ccc(Cl)c(Cl)c4)C3=O)o2)cc1O,CHEMBL4017470,Bioorg Med Chem Lett,2017.0,CHEMBL4086278,CHEMBL4086278,5.32,0.0,http://www.openphacts.org/units/Nanomolar,2998245.0,=,1.0,1.0,=,IC50,nM,4800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.8,CHEMBL378
1508,18754900.0,[],CHEMBL4265061,Antiviral activity against HIV1 cYTA48P infected in PM1/CCR5 cells by single round assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1CCN(C(=O)CNc2ccc3c(c2)OCO3)CC1,CHEMBL4261625,Bioorg Med Chem,2018.0,CHEMBL4286847,CHEMBL4286847,,0.0,http://www.openphacts.org/units/Nanomolar,3116246.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1509,5132826.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2[nH]c(=O)c(CN(Cc3cccs3)C(=O)C3CCCCC3)cc2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645068,CHEMBL1645068,4.93,0.0,http://www.openphacts.org/units/Nanomolar,1321057.0,=,1.0,1.0,=,IC50,nM,11700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,11.7,CHEMBL378
1510,1234154.0,[],CHEMBL824448,Concentration required to inhibit parainfluenza-3 induced cytopathicity in Vero cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N(CC)CCCCCCCCCCC(=O)NC(CCC(=O)[O-])C(=O)O.[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL1627028,CHEMBL1206127,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221530.0,>,1.0,1.0,>,IC50,ug.mL-1,10.0,CHEMBL613126,Human parainfluenza virus 3,Human parainfluenza virus 3,11216,IC50,ug ml-1,UO_0000274,10.0,CHEMBL613126
1511,24731864.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5115940,Antiviral activity against ZIKV-SMGC-1 infected in human BHK cells incubated for 7 days by CellTiter 96 luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(c1ccc(C(F)(F)F)cc1O)c1[nH]c(Cl)c(Cl)c1-n1c(C(=O)c2ccc(C(F)(F)F)cc2O)cc(Cl)c1Sc1nc[nH]n1,CHEMBL5113415,Eur J Med Chem,2022.0,CHEMBL5192362,CHEMBL5192362,5.25,0.0,http://www.openphacts.org/units/Nanomolar,3857940.0,=,1.0,1.0,=,IC50,nM,5670.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,5.67,CHEMBL4296612
1512,18044377.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(C(CCN)NC(=O)c2ccc(-c3ccc(F)c(Cl)c3)[nH]2)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4080427,CHEMBL4080427,5.10,0.0,http://www.openphacts.org/units/Nanomolar,2990194.0,=,1.0,1.0,=,IC50,nM,8000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.0,CHEMBL378
1513,5199553.0,[],CHEMBL1670948,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)[Si](CCc1c(N2CCOCC2)nc2ccc(Cl)cc2c1-c1ccccc1Cl)(c1ccccc1)c1ccccc1,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668645,CHEMBL1668645,,0.0,http://www.openphacts.org/units/Nanomolar,1328429.0,>,1.0,1.0,>,IC50,nM,1203100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1203.1,CHEMBL613497
1514,10961191.0,[],CHEMBL2061268,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M3 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCc1ccc3ccccc3n1)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058315,CHEMBL2058315,7.68,0.0,http://www.openphacts.org/units/Nanomolar,1656255.0,=,1.0,1.0,=,IC50,nM,21.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,21.0,CHEMBL378
1515,1230178.0,[],CHEMBL683624,In vitro integration activity provided by preintegration complexes isolated from HIV-infected cells,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC2(CC(C)(C)c3ccc(OS(=O)(=O)[O-])cc32)c2cc(OS(=O)(=O)[O-])ccc21.[K+].[K+],CHEMBL1133186,J Med Chem,2000.0,CHEMBL304673,CHEMBL1206758,4.10,0.0,http://www.openphacts.org/units/Nanomolar,108746.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,80.0,CHEMBL378
1516,2413687.0,[],CHEMBL987710,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CC(=O)O[C@@H](C[C@@H](C)C1=C2C[C@H](OC(=O)CC(C)C)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)[C@@H](OC(=O)CC(C)C)C(C)(C)O,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL448508,CHEMBL448508,,0.0,http://www.openphacts.org/units/Nanomolar,810675.0,>,1.0,1.0,>,IC50,nM,1200000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.2,CHEMBL613497
1517,18044397.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075766,CHEMBL4075766,6.35,0.0,http://www.openphacts.org/units/Nanomolar,2990214.0,=,1.0,1.0,=,IC50,nM,450.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.45,CHEMBL378
1518,6152216.0,[],CHEMBL1763053,Antiviral activity against Human immunodeficiency virus 1 BAL infected in human PBMC assessed as inhibition of viral replication by p24 antigen specific ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(CCNC(=O)c3c(Cl)cncc3Cl)CC2)CC1,CHEMBL1759996,Bioorg Med Chem Lett,2011.0,CHEMBL1762308,CHEMBL1762308,,0.0,http://www.openphacts.org/units/Nanomolar,1414758.0,>,1.0,1.0,>,IC50,nM,6600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.6,CHEMBL378
1519,7943065.0,[],CHEMBL1921170,Antiviral activity against R5 tropic HIV1 YTA infected in human TZM-bl cells assessed as beta-galactosidase activity preincubated for 15 mins before infection measured after 2 days by single-round assay using luminometry,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(Cl)cc1)C(=O)NC1CC2(CCCCC2)NC2(CCCCC2)C1,CHEMBL1914307,Bioorg Med Chem,2011.0,CHEMBL1917745,CHEMBL1917745,6.17,0.0,http://www.openphacts.org/units/Nanomolar,1560422.0,=,1.0,1.0,=,IC50,nM,680.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.68,CHEMBL378
1520,24735318.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5116803,Antiviral activity against CHIKV infected in human Huh-7 cells assessed as inhibition of viral infection by measuring EGFP-positive cells measured 24 hrs post infection by fluorescent microscopic analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=c1cc(-c2ccccc2)oc2c(-c3cccc(F)c3)c(O)c(O)c(O)c12,CHEMBL5113447,Bioorg Med Chem Lett,2022.0,CHEMBL5190082,CHEMBL5190082,5.37,0.0,http://www.openphacts.org/units/Nanomolar,3858569.0,=,1.0,1.0,=,IC50,nM,4300.0,CHEMBL4296563,Chikungunya virus,Chikungunya virus,37124,IC50,uM,UO_0000065,4.3,CHEMBL4296563
1521,2413698.0,[],CHEMBL987710,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)CCC1CCCCC1)[C@@H](OC(=O)CCC1CCCCC1)C(C)(C)O)C1=C2C[C@H](OC(=O)CCC3CCCCC3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL506294,CHEMBL506294,,0.0,http://www.openphacts.org/units/Nanomolar,810686.0,>,1.0,1.0,>,IC50,nM,810000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.81,CHEMBL613497
1522,18044399.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.32,0.0,http://www.openphacts.org/units/Nanomolar,2990216.0,=,1.0,1.0,=,IC50,nM,480.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.48,CHEMBL378
1523,12651428.0,[],CHEMBL2327724,Antiviral activity against 0.001 MOI wild type Human immunodeficiency virus 1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCNC(=O)[C@H](CCC(N)=O)NC(=O)OC(C)(C)C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324147,CHEMBL2324147,7.52,0.0,http://www.openphacts.org/units/Nanomolar,1850173.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.03,CHEMBL378
1524,22480468.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '120.0'}]",CHEMBL4687212,Antiviral activity against HIV-1 NL4-3 infected in human TZM-bl cells infected with supernatants from virus-infected human H9 cells treated with compound for 72 hrs assessed as reduction in luciferase expression measured after 48 hrs by luciferase reporter gene assay based BiCycle assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCc1cn(-c2ccc(NC(=O)Nc3cc(OP(=O)(OCC)OCC)ccc3C)cc2)nn1,CHEMBL4680261,Eur J Med Chem,2020.0,CHEMBL4787707,CHEMBL4787707,5.26,0.0,http://www.openphacts.org/units/Nanomolar,3523700.0,=,1.0,1.0,=,IC50,nM,5500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.5,CHEMBL378
1525,245878.0,[],CHEMBL883644,Compound was evaluated for the inhibition of SIV induced syncytia formation,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)OC,CHEMBL1125316,J Med Chem,1992.0,CHEMBL3349496,CHEMBL3349496,5.40,0.0,http://www.openphacts.org/units/Nanomolar,238398.0,=,1.0,1.0,=,IC50,nM,4000.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,4.0,CHEMBL613499
1526,6335915.0,[],CHEMBL1820050,"Antiviral activity against multidrug-resistant Human immunodeficiency virus 1 subtype B harboring protease L10I, L33I, M36I, M46I, F53L, K55R, I62 V, L63P, A71 V, G73S, V82A, L90M, I93L mutation infected in PHA-stimulated human PBMC assessed as inhibition of p24 Gag protein production",F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2C[C@@H]3[C@@H](O)CO[C@@H]3C2)cc1,CHEMBL1817554,J Med Chem,2011.0,CHEMBL1817686,CHEMBL1817686,7.54,0.0,http://www.openphacts.org/units/Nanomolar,1451706.0,=,1.0,1.0,=,IC50,nM,29.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.029,CHEMBL378
1527,2165080.0,[],CHEMBL926822,Antiviral activity against HIV1 in human MT4 cells in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ccccc34)ccc2Cl)c1,CHEMBL1145601,Bioorg Med Chem Lett,2008.0,CHEMBL402823,CHEMBL402823,8.33,0.0,http://www.openphacts.org/units/Nanomolar,711002.0,=,1.0,1.0,=,IC50,nM,4.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.7,CHEMBL378
1528,5126332.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,CN1c2ccc(Cl)cc2N(c2ccccc2)C(=O)c2c1ncn2Cc1cccc(O)c1,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642538,CHEMBL1642538,6.25,0.0,http://www.openphacts.org/units/Nanomolar,1317848.0,=,1.0,1.0,=,IC50,nM,560.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.56,CHEMBL378
1529,885612.0,[],CHEMBL653610,Inhibitory activity tested against the HIV-1 in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N(C)CC(=O)O)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL11517,CHEMBL11517,6.60,0.0,http://www.openphacts.org/units/Nanomolar,9060.0,=,1.0,1.0,=,IC50,nM,250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,250.0,CHEMBL378
1530,2178215.0,[],CHEMBL1019290,Antiviral activity against HIV1 HTLV-3B in human H9 cells after 3 days by p24 antigen capture assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(=O)/C=C/c1ccc(O)c(O)c1)CC2,CHEMBL1158954,J Nat Prod,1991.0,CHEMBL465445,CHEMBL465445,6.54,0.0,http://www.openphacts.org/units/Nanomolar,740183.0,=,1.0,1.0,=,IC50,nM,290.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.29,CHEMBL378
1531,2665973.0,[],CHEMBL1061338,Inhibition of TPA-induced AP1 transfected in HEK293 cells assessed as inhibition of beta-lactamase reporter activity treated 1 hr before TPA stimulation measured after 18 hrs by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,COC(=O)[C@]12OC[C@]34[C@H]([C@@H](O)[C@@H]1O)[C@@]1(C)C=C5OC(=O)C=C5[C@@H](C)[C@@H]1C[C@H]3OC(=O)[C@H](OC(C)=O)[C@@H]24,CHEMBL1152334,J Nat Prod,2009.0,CHEMBL521373,CHEMBL521373,,0.0,,818166.0,,1.0,0.0,,IC50,,,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,,,,CHEMBL4977
1532,15679578.0,[],CHEMBL3607086,Antiviral activity against Influenza B virus infected in MDCK cells after 3 days by neutral red dye-based plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncc(F)c2c1ncn2[C@@H]1C=C(CO)[C@@H](O)[C@H]1O,CHEMBL3603790,Bioorg Med Chem,2015.0,CHEMBL3604361,CHEMBL3604361,,0.0,http://www.openphacts.org/units/Nanomolar,2494263.0,<,1.0,1.0,<,IC50,nM,360.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,0.36,CHEMBL613129
1533,24502937.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5053572,Antiviral activity against HIV1 NL4-3 Env-deficient pseudotype virus infected in human U87.CD4.CCR5.CXCR4 cells assessed by reduction in viral infection in early stage measured after 48 hrs by luciferase activity based single-round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1[nH]c2ccccc2c1CC(=O)N[C@H](Cc1ccccc1)C(=O)N(C)c1ccccc1,CHEMBL5053482,J Med Chem,2021.0,CHEMBL5083267,CHEMBL5083267,,0.0,,3836463.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1534,5132809.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)n2c3ccccc3n(C[C@@H](O)Nc3ccc(F)cc3)c2c1C#N,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645085,CHEMBL1645085,5.17,0.0,http://www.openphacts.org/units/Nanomolar,1321074.0,=,1.0,1.0,=,IC50,nM,6690.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.69,CHEMBL378
1535,22844957.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721621,Antiviral activity against HIV-1 HXB-2 infected in human TZM-bl cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based single cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)c(F)c2)[nH]1)c1nc(CO)c(CO)s1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4789465,CHEMBL4789465,5.51,0.0,http://www.openphacts.org/units/Nanomolar,3547073.0,=,1.0,1.0,=,IC50,nM,3100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.1,CHEMBL378
1536,561795.0,[],CHEMBL694651,Inhibitory activity against HIV-1 IIIB to achieve 50% protection of MT-2 cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C[C@@]1(CO)C=C[C@H](n2cc(C)c(=O)[nH]c2=O)O1,CHEMBL1136327,Bioorg Med Chem Lett,2003.0,CHEMBL124389,CHEMBL124389,,0.0,http://www.openphacts.org/units/Nanomolar,236172.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1537,10866436.0,[],CHEMBL2025517,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HbeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CC#N)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2023665,CHEMBL2023665,,0.0,http://www.openphacts.org/units/Nanomolar,1639229.0,>,1.0,1.0,>,IC50,nM,161490.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,161.49,CHEMBL613497
1538,391495.0,[],CHEMBL756141,Inhibition of human peripheral blood mononuclear cell (PBMC)donor B proliferation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCC(=O)CC(=O)N[C@H]1CCOC1=O,CHEMBL1145979,J Med Chem,2003.0,CHEMBL267527,CHEMBL267527,4.52,0.0,http://www.openphacts.org/units/Nanomolar,4356.0,=,1.0,1.0,=,IC50,nM,30000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,30.0,CHEMBL378
1539,43599.0,[],CHEMBL695524,Antiviral activity against V108I/Y181C strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL57,CHEMBL57,,0.0,http://www.openphacts.org/units/Nanomolar,20821.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10000.0,CHEMBL378
1540,475833.0,[],CHEMBL698135,Concentration required to inhibit HIV infection by 50% in HeLa Magi cells,F,BAO_0000190,BAO_0000218,organism-based format,C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](C[C@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1,CHEMBL1149201,Bioorg Med Chem Lett,2004.0,CHEMBL120569,CHEMBL120569,6.52,0.0,http://www.openphacts.org/units/Nanomolar,227173.0,=,1.0,1.0,=,IC50,nM,300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,300.0,CHEMBL378
1541,2506764.0,[],CHEMBL946752,Antiviral activity against HIV1 3B replication in human PBMC assessed as reverse transcriptase activity after 7 days,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCc3ccc4c(c3)OCO4)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1141017,Bioorg Med Chem Lett,2008.0,CHEMBL444996,CHEMBL444996,8.05,0.0,http://www.openphacts.org/units/Nanomolar,752662.0,=,1.0,1.0,=,IC50,nM,9.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.009,CHEMBL378
1542,1234149.0,[],CHEMBL677521,Concentration required to inhibit HIV-1TK-(B2006) induced cytopathicity in E6SM cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N(CC)CCCCCCCCCCC(=O)NC(CCC(=O)[O-])C(=O)O.[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL1627028,CHEMBL1206127,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221530.0,=,1.0,1.0,=,IC50,ug.mL-1,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,40.0,CHEMBL378
1543,2602096.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)O[C@@H]1Cc2ccccc2C1C1=C(O)[C@](Cc2ccccc2)(C[C@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CCOC2)N=C1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL55070,CHEMBL55070,5.70,0.0,http://www.openphacts.org/units/Nanomolar,808034.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.0,CHEMBL378
1544,5126330.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,COCCn1cnc2c1C(=O)N(c1ccccc1)c1cc(Cl)ccc1N2C,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642536,CHEMBL1642536,6.44,0.0,http://www.openphacts.org/units/Nanomolar,1317846.0,=,1.0,1.0,=,IC50,nM,360.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.36,CHEMBL378
1545,662036.0,[],CHEMBL713945,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1Cc2cccc3nc(O)n(c23)C[C@@H]1C(C)C,CHEMBL1128252,J Med Chem,1995.0,CHEMBL163724,CHEMBL163724,,0.0,http://www.openphacts.org/units/Nanomolar,326359.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
1546,1420918.0,[],CHEMBL833369,Antiviral activity in an in vitro HIV replication assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1C(=O)CCC2CN(CC[C@](C)(CN(C)S(=O)(=O)c3ccccc3)c3ccccc3)CCC21,CHEMBL1141903,Bioorg Med Chem Lett,2005.0,CHEMBL182188,CHEMBL182188,,0.0,http://www.openphacts.org/units/Nanomolar,365511.0,>,1.0,1.0,>,IC50,nM,300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,300.0,CHEMBL378
1547,2362919.0,[],CHEMBL1026416,"Antiviral activity against multidrug-resistant HIV1 with protease L10I, K14R, L33I, M36I, M46I, F53I, K55R, I62V, L63P, A71V, G73S, V82A, L90M, I93L mutation in phytohemagglutininin-activated PBMC assessed as inhibition of p24G protein production",F,BAO_0000190,BAO_0000218,organism-based format,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,CHEMBL1140100,J Med Chem,2008.0,CHEMBL163,CHEMBL163,,0.0,http://www.openphacts.org/units/Nanomolar,747153.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
1548,5248976.0,[],CHEMBL1685193,Antiviral activity against X4 tropic HIV1 NL4.3 infected in CD4 and CXCR4 expressing human MT4 cells assessed as inhibition of viral cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(Cc1cccc(N)n1)C1CCCc2cccnc21,CHEMBL1681661,Bioorg Med Chem Lett,2011.0,CHEMBL1682860,CHEMBL1682860,7.52,0.0,http://www.openphacts.org/units/Nanomolar,1333982.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,30.0,CHEMBL378
1549,15602740.0,[],CHEMBL3578657,Inhibition of ASCT2-mediated [3H]glutamine uptake in HEK293 cells after 15 mins by Live-cell glutamine uptake assay,B,BAO_0000190,BAO_0000219,cell-based format,N[C@@H](CCC(=O)Nc1ccccc1-c1ccccc1)C(=O)O,CHEMBL3576761,Bioorg Med Chem Lett,2015.0,CHEMBL3576932,CHEMBL3576932,,0.0,,2479429.0,,1.0,0.0,,IC50,,,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,,,,CHEMBL3562162
1550,1402248.0,[],CHEMBL835252,In vitro inhibitory concentration against HIV K101E and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(CC)CC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175534,CHEMBL175534,,0.0,http://www.openphacts.org/units/Nanomolar,360399.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1551,2569057.0,[],CHEMBL972599,Antiviral activity against wild type HIV1 3B in human P4/R5 cells assessed as beta-galactosidase activity by single-cycle viral replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,CCN1C[C@H](C)n2c(c(O)c3c(=O)n(Cc4ccc(F)cc4)ncc32)C1=O,CHEMBL1156547,Bioorg Med Chem Lett,2008.0,CHEMBL456357,CHEMBL456357,7.80,0.0,http://www.openphacts.org/units/Nanomolar,798715.0,=,1.0,1.0,=,IC50,nM,16.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,16.0,CHEMBL378
1552,2032180.0,[],CHEMBL886779,Inhibition of cytoplasmic HBV DNA synthesis in HepG2.2.15 cells after 8 days,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)S(=O)(=O)n1c(N)nc2ccc(NC(=O)c3ccccc3Cl)cc21,CHEMBL1139980,Eur J Med Chem,2007.0,CHEMBL250177,CHEMBL250177,6.09,0.0,http://www.openphacts.org/units/Nanomolar,674618.0,=,1.0,1.0,=,IC50,nM,820.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.82,CHEMBL613497
1553,15158641.0,[],CHEMBL3398832,Inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OCc1cccc2c1CCOC2=O)c1cc(=O)c2ccccc2o1,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397184,CHEMBL3397184,,0.0,http://www.openphacts.org/units/Nanomolar,2278984.0,=,1.0,1.0,=,IC50,nM,1810000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.81,CHEMBL613497
1554,10866458.0,[],CHEMBL2025518,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@]3(O)[C@@H]2C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]2(C)[C@]3(O)CC[C@@]2(O)C(C)=O)C1,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2023661,CHEMBL2023661,,0.0,http://www.openphacts.org/units/Nanomolar,1639225.0,=,1.0,1.0,=,IC50,nM,103590.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,103.59,CHEMBL613497
1555,10961121.0,[],CHEMBL2061266,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M9 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(C)=C1C(=O)Nc2ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)cc21,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057466,CHEMBL2057466,7.77,0.0,http://www.openphacts.org/units/Nanomolar,1655128.0,=,1.0,1.0,=,IC50,nM,17.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,17.0,CHEMBL378
1556,15200427.0,[],CHEMBL3413997,Antiviral activity against X4 tropic HIV-1 clone pNL4-3 infected in H9 cells assessed as reduction in p24 antigen after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)c1ccc(/C=C(\C#N)c2nc3cc(C(=O)O)ccc3[nH]2)cc1,CHEMBL3407469,Eur J Med Chem,2015.0,CHEMBL3410142,CHEMBL3410142,,0.0,http://www.openphacts.org/units/Nanomolar,2288878.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
1557,18044416.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(C(CN)NC(=O)c2ncc(-c3ccc(Cl)cc3)[nH]2)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4067467,CHEMBL4067467,4.29,0.0,http://www.openphacts.org/units/Nanomolar,2990233.0,=,1.0,1.0,=,IC50,nM,51000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,51.0,CHEMBL378
1558,18987182.0,[],CHEMBL4340290,Antiviral activity against HIV NL4-3 infected in human MT4 cells measured on day 3 post-infection by Nano-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCC(=O)OCC1=C[C@@H]2C(=O)[C@]3(C=C(C)[C@H](O)[C@@]3(O)[C@@H]1O)[C@H](C)C[C@@H]1[C@H]2C1(C)C,CHEMBL4339238,J Nat Prod,2019.0,CHEMBL4470845,CHEMBL4470845,8.96,0.0,http://www.openphacts.org/units/Nanomolar,3167472.0,=,1.0,1.0,=,IC50,nM,1.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.1,CHEMBL378
1559,22435377.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4677393,Antiviral activity against HIV-1 NL4-3 infected in human MT-4 cells assessed as inhibition of viral replication by measuring inhibition of cell viability preincubated with cells for 15 mins followed by viral infection and measured after 4 days by MTS/PES assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCc2cc(CC(C)C)cc(n2)CCN(S(=O)(=O)c2ccc(C)cc2)C1.Cl,CHEMBL4673284,Bioorg Med Chem,2020.0,CHEMBL4786809,CHEMBL4803615,5.64,0.0,http://www.openphacts.org/units/Nanomolar,3515771.0,=,1.0,1.0,=,IC50,nM,2300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.3,CHEMBL378
1560,2601735.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)c1cc(OCCOCP(=O)(O)O)nc(N)n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL58026,CHEMBL58026,9.46,0.0,http://www.openphacts.org/units/Nanomolar,807649.0,=,1.0,1.0,=,IC50,nM,0.3425,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.000342466,CHEMBL378
1561,10862134.0,[],CHEMBL2024925,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B e-antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCc6cc(F)cc(F)c6)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022383,CHEMBL2022383,,0.0,http://www.openphacts.org/units/Nanomolar,1637633.0,>,1.0,1.0,>,IC50,nM,1233090.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1233.09,CHEMBL613497
1562,18528861.0,[],CHEMBL4194999,Antiviral activity against HIV1 virions derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)[C@@H](c1cc(OC)c(OC)c(OC)c1)[C@H](C)[C@@H](C)C2,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4214677,CHEMBL4214677,,0.0,http://www.openphacts.org/units/Nanomolar,3076504.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
1563,3407238.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1c(-c2ccc(C(F)(F)F)cc2)oc2ccc(N)cc2c1=O,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1214885,CHEMBL1214885,,0.0,http://www.openphacts.org/units/Nanomolar,932510.0,=,1.0,1.0,=,IC50,nM,289800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,289.8,CHEMBL378
1564,10866483.0,[],CHEMBL2025518,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(OC(=O)/C=C/c2ccccc2Cl)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccccc4Cl)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024042,CHEMBL2024042,,0.0,http://www.openphacts.org/units/Nanomolar,1639764.0,>,1.0,1.0,>,IC50,nM,148210.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,148.21,CHEMBL613497
1565,532401.0,[],CHEMBL699442,Inhibition of rous sarcoma virus (RSV) Integrase.,B,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1ccc2ccc(/C=C/c3ccccc3)nc2c1O,CHEMBL1133692,J Med Chem,2000.0,CHEMBL40148,CHEMBL40148,4.99,0.0,http://www.openphacts.org/units/Nanomolar,101673.0,=,1.0,1.0,=,IC50,nM,10300.0,CHEMBL2750,Rous sarcoma virus (strain Prague C) (RSV-PrC),Rous sarcoma virus integrase,11888,IC50,M l-1,UO_0000065,0.0000103,CHEMBL2750
1566,5189149.0,[],CHEMBL1658799,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Clc1ccc2nc3c(c(-c4ccccc4Cl)c2c1)CCO3,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652496,CHEMBL1652496,,0.0,http://www.openphacts.org/units/Nanomolar,1326871.0,>,1.0,1.0,>,IC50,nM,280000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.28,CHEMBL613497
1567,3407237.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1c(-c2cccc(C(F)(F)F)c2)oc2ccc(N)cc2c1=O,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1214884,CHEMBL1214884,4.30,0.0,http://www.openphacts.org/units/Nanomolar,932509.0,=,1.0,1.0,=,IC50,nM,50400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.4,CHEMBL378
1568,1471573.0,[],CHEMBL834618,Inhibitory activity against HIV-1 mutant strain 103N; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1ccc(Cl)cc1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL186723,CHEMBL186723,,0.0,http://www.openphacts.org/units/Nanomolar,380929.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1569,795825.0,[],CHEMBL772932,Inhibition of Hepatitis C virus NS3 protease in vitro.,B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](O)C(=O)N1C[C@H](c2ccccc2)C[C@H]1C(=O)N[C@@H](CC(F)F)C(=O)NCCc1c(F)cc(C(=O)O)cc1F,CHEMBL1147550,Bioorg Med Chem Lett,2004.0,CHEMBL302364,CHEMBL302364,4.75,0.0,http://www.openphacts.org/units/Nanomolar,119356.0,=,1.0,1.0,=,IC50,nM,18000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,18.0,CHEMBL4620
1570,42391.0,[],CHEMBL695522,Antiviral activity against V106I/Y181C strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL593,CHEMBL593,5.35,0.0,http://www.openphacts.org/units/Nanomolar,20822.0,=,1.0,1.0,=,IC50,nM,4500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4500.0,CHEMBL378
1571,24963886.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5216623,Antiviral activity against NNRTI resistant HIV1 harboring Lys103Asn mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect measured after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Cc3c(Cl)ccc4[nH]ccc34)n2)cc1,CHEMBL5214932,Eur J Med Chem,2022.0,CHEMBL313405,CHEMBL313405,7.20,0.0,http://www.openphacts.org/units/Nanomolar,3900015.0,=,1.0,1.0,=,IC50,nM,63.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.063,CHEMBL378
1572,3247255.0,[],CHEMBL1116114,Antiviral activity against HIV1 3B infected in human HOS cells expressing human CXCR4/CCR5/CD4 and HIV-LTR-luciferase,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCCC(Cn2c(CN(C)C3CCCc4cccnc43)nc3ccccc32)C1,CHEMBL1156326,Bioorg Med Chem Lett,2010.0,CHEMBL1088794,CHEMBL1088794,7.72,0.0,http://www.openphacts.org/units/Nanomolar,902951.0,=,1.0,1.0,=,IC50,nM,19.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.0,CHEMBL378
1573,16580176.0,[],CHEMBL3800939,Antiviral activity against HIV1 BAL infected in human TZM-bl cells assessed as inhibition of viral infection,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(Br)cc1-c1oc2ccccc2c(=O)c1O,CHEMBL3797057,Bioorg Med Chem,2016.0,CHEMBL2386682,CHEMBL2386682,4.36,0.0,http://www.openphacts.org/units/Nanomolar,2774363.0,=,1.0,1.0,=,IC50,nM,43700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,43.7,CHEMBL378
1574,2601870.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CSC(c2c(F)cccc2Cl)N1c1ccc(Cl)cn1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL149913,CHEMBL149913,5.67,0.0,http://www.openphacts.org/units/Nanomolar,807116.0,=,1.0,1.0,=,IC50,nM,2130.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.13,CHEMBL378
1575,3084573.0,[],CHEMBL1065275,Antiviral activity against HIV1 3B laboratory isolate assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(NC(=O)C(=O)Nc2ccc([N+](=O)[O-])cc2)CC(C)(C)N1,CHEMBL1153139,Bioorg Med Chem Lett,2010.0,CHEMBL593591,CHEMBL593591,,0.0,,873889.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1576,6336420.0,[],CHEMBL1821125,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by measuring HBsAg and HBeAg production after 9 days by EIA,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOc1ccc(C[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)c2ccccc2)C(=O)OC)cc1,CHEMBL1817553,Bioorg Med Chem,2011.0,CHEMBL1819244,CHEMBL1819244,,0.0,http://www.openphacts.org/units/Nanomolar,1451646.0,=,1.0,1.0,=,IC50,nM,174090.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,174.09,CHEMBL613497
1577,6299485.0,[],CHEMBL1811268,Antiviral activity against HIV1 3B infected in human MAGI-CCR5 cells assessed as inhibition of viral replication after 48 hrs by beta-galactosidase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccn2c(NC3CCCCC3)c(-c3ccccc3Cl)nc12,CHEMBL1806431,Bioorg Med Chem,2011.0,CHEMBL1807337,CHEMBL1807337,5.46,0.0,http://www.openphacts.org/units/Nanomolar,1443665.0,=,1.0,1.0,=,IC50,nM,3440.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.44,CHEMBL378
1578,1213162.0,[],CHEMBL710530,Inhibitory activity against 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Cc3c(Cl)cccc3Cl)n2)cc1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL307297,CHEMBL307297,7.40,0.0,http://www.openphacts.org/units/Nanomolar,127432.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
1579,13476905.0,[],CHEMBL2439256,Antiviral activity against Human immunodeficiency virus 1 clade B isolate CI#19 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc(Sc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2434978,CHEMBL2434978,,0.0,,1924232.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1580,16544707.0,[],CHEMBL3789804,Antiviral activity against HIV1 virus-like particles harboring wild type reverse transcriptase infected in human U2OS cells after 24 hrs by Renilla luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Nc2nc(NCC3CCCO3)nc(Nc3ccc(C)cc3)n2)cc1,CHEMBL3784952,Bioorg Med Chem,2016.0,CHEMBL3786003,CHEMBL3786003,6.48,0.0,http://www.openphacts.org/units/Nanomolar,2769495.0,=,1.0,1.0,=,IC50,nM,330.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.33,CHEMBL378
1581,3267369.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1Cn2c(=O)[nH]c3cccc(c32)CN1CC1CC1,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL1094610,CHEMBL1094610,4.36,0.0,http://www.openphacts.org/units/Nanomolar,906587.0,=,1.0,1.0,=,IC50,nM,43651.58,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.36,CHEMBL378
1582,2930467.0,[],CHEMBL1056903,Antiviral activity against HIV1 HXB2 harboring 227L and 106A mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL366692,CHEMBL366692,6.40,0.0,http://www.openphacts.org/units/Nanomolar,848229.0,=,1.0,1.0,=,IC50,nM,398.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,398.0,CHEMBL378
1583,1870792.0,[],CHEMBL904573,Antiviral activity against HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,C=CCOCn1c(C(=O)c2cccc3ccccc23)c(CC)c(=O)[nH]c1=O,CHEMBL1142880,Eur J Med Chem,2007.0,CHEMBL229101,CHEMBL229101,6.72,0.0,http://www.openphacts.org/units/Nanomolar,636400.0,=,1.0,1.0,=,IC50,nM,190.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.19,CHEMBL378
1584,2601701.0,[],CHEMBL1034017,Antiviral activity against Vaccinia virus,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL991,CHEMBL991,,0.0,http://www.openphacts.org/units/Nanomolar,807742.0,=,1.0,1.0,=,IC50,nM,446000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,446.0,CHEMBL613493
1585,1854926.0,[],CHEMBL917352,Antiviral activity against Cowpox virus,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(=O)c([C@@H]2C=C(CO)[C@@H](O)[C@H]2O)c[nH]1,CHEMBL1144551,Bioorg Med Chem,2007.0,CHEMBL225046,CHEMBL225046,,0.0,http://www.openphacts.org/units/Nanomolar,634122.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL612672,Cowpox virus,Cowpox virus,10243,IC50,uM,UO_0000065,100.0,CHEMBL612672
1586,14999529.0,[],CHEMBL3366185,Antiviral activity against HIV1 harboring reverse transcriptase K103N mutant infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL223228,CHEMBL223228,7.23,0.0,http://www.openphacts.org/units/Nanomolar,2248840.0,=,1.0,1.0,=,IC50,nM,58.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0588,CHEMBL378
1587,673502.0,[],CHEMBL683678,Tested for cytoprotection against production of HIV-1 p24.,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC2=NC(SSC3=C(C#N)C(c4ccc(Br)cc4)C4=C(O)CC(C)(C)CC4=N3)=C(C#N)C(c3ccc(Br)cc3)C2=C(O)C1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL333885,CHEMBL333885,,0.0,http://www.openphacts.org/units/Nanomolar,228606.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1588,2947421.0,[],CHEMBL1038497,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)C1CC1)[C@@H](OC(=O)C1CC1)C(C)(C)OC(=O)C1CC1)C1=C2C[C@H](OC(=O)C3CC3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL584176,CHEMBL584176,,0.0,http://www.openphacts.org/units/Nanomolar,850750.0,>,1.0,1.0,>,IC50,nM,2100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.1,CHEMBL613497
1589,910270.0,[],CHEMBL650153,Compound was tested for anti-retroviral activity against moloney murine sarcoma virus (MSV) in murine C3H/3T3 embryo fibroblast cell culture,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](Cn1nc2nc(N)nc(O)c2n1)OCP(=O)(O)O,CHEMBL1129435,J Med Chem,1996.0,CHEMBL132576,CHEMBL132576,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251935.0,>,1.0,1.0,>,IC50,ug.mL-1,40.0,CHEMBL613501,Moloney murine sarcoma virus,Moloney murine sarcoma virus,11809,IC50,ug ml-1,UO_0000274,40.0,CHEMBL613501
1590,1228617.0,[],CHEMBL693598,Concentration required to block the Nuclear translocation of HIV-1 pre-integration complex with Reverse Transcriptase protein,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1cc(Nc2cc(C)[n+](C)c(N)n2)cc(C(C)=O)c1,CHEMBL1134938,Bioorg Med Chem Lett,2002.0,CHEMBL321759,CHEMBL321759,7.00,0.0,http://www.openphacts.org/units/Nanomolar,197906.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,100.0,CHEMBL378
1591,587917.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(CCCC[n+]1ccccc1)Sc1ccccc1C(=O)Nc1ccc(S(=O)(=O)c2ccc(NS(=O)(=O)Cc3ccccc3[N+](=O)[O-])cc2)cc1.[Br-],CHEMBL1132203,J Med Chem,1999.0,CHEMBL168495,CHEMBL1181371,,0.0,http://www.openphacts.org/units/Nanomolar,334035.0,>,1.0,1.0,>,IC50,nM,316000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,316.0,CHEMBL378
1592,18683224.0,[],CHEMBL4237086,Antiviral activity against CCR5-dependent HIV1 SF162 infected in human TZM-bl cells assessed as reduction in virus infection measured after 48 hrs post infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1,CHEMBL4229569,J Med Chem,2018.0,CHEMBL4249798,CHEMBL4249798,8.82,0.0,http://www.openphacts.org/units/Nanomolar,3103111.0,=,1.0,1.0,=,IC50,nM,1.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.5,CHEMBL378
1593,2413695.0,[],CHEMBL987710,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)C1CC1)[C@@H](OC(=O)C1CC1)C(C)(C)O)C1=C2C[C@H](OC(=O)C3CC3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL506626,CHEMBL506626,,0.0,http://www.openphacts.org/units/Nanomolar,810683.0,>,1.0,1.0,>,IC50,nM,1000000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.0,CHEMBL613497
1594,1671905.0,[],CHEMBL870621,Antiviral activity against HIV1 Y181C mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C(=O)c2cc(Cl)ccc2OCC(=O)Nc2ccc(S(N)(=O)=O)nc2C)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL426480,CHEMBL426480,8.40,0.0,http://www.openphacts.org/units/Nanomolar,411916.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.0,CHEMBL378
1595,3498038.0,[],CHEMBL1259500,Antiviral activity against HIV1 MNA infected in human PM1 cells expressing CCR5 assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(Cl)cc1)C(=O)NC1CCNCC1,CHEMBL1255517,Bioorg Med Chem Lett,2010.0,CHEMBL1256494,CHEMBL1256494,5.10,0.0,http://www.openphacts.org/units/Nanomolar,959451.0,=,1.0,1.0,=,IC50,nM,8000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.0,CHEMBL378
1596,2464793.0,[],CHEMBL963691,Antiviral activity against HBV assessed as inhibition of viral e-antigen production by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1cc2c(CN3CCCC3)c(O)c(OC)cc2nc1CSc1ccc(F)cc1,CHEMBL1157455,Bioorg Med Chem,2008.0,CHEMBL471937,CHEMBL471937,5.03,0.0,http://www.openphacts.org/units/Nanomolar,720200.0,=,1.0,1.0,=,IC50,nM,9300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,9.3,CHEMBL613497
1597,22845265.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '49.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '49.0'}]",CHEMBL4721684,Antiviral activity against clinical isolate HIV-1 93RW018 infected in human PBMC cells assessed as reduction in viral transmission to TZM-bl cells pretreated for 1 hr before viral transmission and further incubated for 48 hrs by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1nc(CO)cs1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4761836,CHEMBL4761836,6.70,0.0,http://www.openphacts.org/units/Nanomolar,3547085.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.2,CHEMBL378
1598,19261975.0,[],CHEMBL4404406,Antiviral activity against HIV1 subtypeD QD435.100M.ENV.E1,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.72,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,190.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.19,CHEMBL378
1599,18528918.0,[],CHEMBL4195003,Antiviral activity against HIV1 virions containing reverse transcriptase Y181C mutant derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL57,CHEMBL57,5.54,0.0,http://www.openphacts.org/units/Nanomolar,3076518.0,=,1.0,1.0,=,IC50,nM,2860.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.86,CHEMBL378
1600,10961058.0,[],CHEMBL2061264,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing wild type protease infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(C)=C1C(=O)Nc2ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)cc21,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057466,CHEMBL2057466,8.00,0.0,http://www.openphacts.org/units/Nanomolar,1655128.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
1601,2929531.0,[],CHEMBL1056897,Antiviral activity against HIV1 HXB2 harboring 190A mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSCc3ccco3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567204,CHEMBL567204,8.50,0.0,http://www.openphacts.org/units/Nanomolar,852794.0,=,1.0,1.0,=,IC50,nM,3.16,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.16,CHEMBL378
1602,5132774.0,[],CHEMBL1646275,Antiviral activity against protease-resistant HIV1 isolate 92UG024 infected in human PBMC assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)n2c3ccccc3n(C[C@@H](O)N3CCN(C(c4ccccc4)c4ccccc4)CC3)c2c1C#N,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645090,CHEMBL1645090,5.52,0.0,http://www.openphacts.org/units/Nanomolar,1321079.0,=,1.0,1.0,=,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.0,CHEMBL378
1603,3509198.0,[],CHEMBL1261044,Antiviral activity against HIV1 harboring reverse transcriptase K103N/L100I double mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3Cl)CC2)ncc1Br,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1171403,CHEMBL1171403,8.23,0.0,http://www.openphacts.org/units/Nanomolar,963717.0,=,1.0,1.0,=,IC50,nM,5.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.9,CHEMBL378
1604,1251780.0,[],CHEMBL683624,In vitro integration activity provided by preintegration complexes isolated from HIV-infected cells,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC2(CC(C)(C)c3cc(Br)c(OS(=O)(=O)[O-])cc32)c2cc(OS(=O)(=O)[O-])c(Br)cc21.[K+].[K+],CHEMBL1133186,J Med Chem,2000.0,CHEMBL62715,CHEMBL1205192,4.10,0.0,http://www.openphacts.org/units/Nanomolar,108744.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,80.0,CHEMBL378
1605,18239594.0,[],CHEMBL4052020,Antiviral activity against amprenavir-resistant HIV1 NL4-3 harboring protease L10F/V32I/L33F/M46L/I54M/A71V mutant infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,CHEMBL4049446,J Med Chem,2017.0,CHEMBL729,CHEMBL729,6.51,0.0,http://www.openphacts.org/units/Nanomolar,3026806.0,=,1.0,1.0,=,IC50,nM,310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,310.0,CHEMBL378
1606,3267363.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)CN1Cc2cccc3[nH]c(=O)n(c23)C[C@@H]1C,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL1095239,CHEMBL1095239,4.33,0.0,http://www.openphacts.org/units/Nanomolar,906521.0,=,1.0,1.0,=,IC50,nM,46773.51,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.33,CHEMBL378
1607,22845268.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '49.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '49.0'}]",CHEMBL4721685,Antiviral activity against clinical isolate HIV-1 93RW034 infected in human PBMC cells assessed as reduction in viral transmission to TZM-bl cells pretreated for 1 hr before viral transmission and further incubated for 48 hrs by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)c(F)c2)[nH]1)c1nc(CO)cs1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4533529,CHEMBL4533529,6.72,0.0,http://www.openphacts.org/units/Nanomolar,3547069.0,=,1.0,1.0,=,IC50,nM,190.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.19,CHEMBL378
1608,1671960.0,[],CHEMBL870621,Antiviral activity against HIV1 Y181C mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Br)cc(C(F)(F)F)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL382630,CHEMBL382630,6.54,0.0,http://www.openphacts.org/units/Nanomolar,411929.0,=,1.0,1.0,=,IC50,nM,290.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,290.0,CHEMBL378
1609,19076333.0,[],CHEMBL4362885,Antiviral activity against Influenza B virus B/Yamagata/16/88(BY) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 40 hrs by Celltiter-Glo assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1.O=P(O)(O)O,CHEMBL4359890,Eur J Med Chem,2019.0,CHEMBL1200340,CHEMBL1229,4.63,0.0,http://www.openphacts.org/units/Nanomolar,3182796.0,=,1.0,1.0,=,IC50,nM,23450.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,23.45,CHEMBL613129
1610,14714274.0,[],CHEMBL3293255,Antiviral activity against HIV1 harboring reverse transcriptase K103N/Y181C mutant infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nccc(C(NN)c3ccc(C#N)cc3)n2)cc1,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL3288562,CHEMBL3288562,5.22,0.0,http://www.openphacts.org/units/Nanomolar,2116120.0,=,1.0,1.0,=,IC50,nM,5950.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.95,CHEMBL378
1611,10938674.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4cccc(C)c4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046553,CHEMBL2046553,4.59,0.0,http://www.openphacts.org/units/Nanomolar,1651436.0,=,1.0,1.0,=,IC50,nM,25440.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,25.44,CHEMBL613497
1612,2091743.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(C(C)=O)CCCN(S(=O)(=O)c2ccc(C)cc2)C1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL409699,CHEMBL409699,,0.0,http://www.openphacts.org/units/Nanomolar,700543.0,=,1.0,1.0,=,IC50,nM,380189396320561.25,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,5.58,CHEMBL378
1613,6216921.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(F)cc2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784478,CHEMBL1784478,,0.0,http://www.openphacts.org/units/Nanomolar,1429417.0,<,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.0,CHEMBL378
1614,556346.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,NS(=O)(=O)c1ccc(CNC(=O)c2ccccc2SC(=O)CCCC[n+]2ccccc2)cc1.[Br-],CHEMBL1132203,J Med Chem,1999.0,CHEMBL169678,CHEMBL1181402,4.26,0.0,http://www.openphacts.org/units/Nanomolar,334037.0,=,1.0,1.0,=,IC50,nM,55000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,55.0,CHEMBL378
1615,12680753.0,[],CHEMBL2342599,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)Nc3ccccc3OC)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333301,CHEMBL2333301,,0.0,http://www.openphacts.org/units/Nanomolar,1867266.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
1616,2601960.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)c1ccc(Sc2c(C(N)=O)[nH]c3ccc(Cl)cc23)cc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL83793,CHEMBL83793,5.72,0.0,http://www.openphacts.org/units/Nanomolar,808143.0,=,1.0,1.0,=,IC50,nM,1900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.9,CHEMBL378
1617,13940309.0,[],CHEMBL3131385,Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)NCc1cn(C2C=CCCC2)nn1)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL3124823,Eur J Med Chem,2014.0,CHEMBL3126783,CHEMBL3126783,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1972637.0,=,1.0,1.0,=,IC50,ug.mL-1,13.39,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,13.39,CHEMBL613129
1618,16626941.0,[],CHEMBL3821894,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 48 hrs by SYBR Green based RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,O=S(=O)(Oc1cc(CSc2ccccn2)[nH]n1)c1ccc(F)cc1,CHEMBL3817822,Medchemcomm,2016.0,CHEMBL3819294,CHEMBL3819294,,0.0,http://www.openphacts.org/units/Nanomolar,2783922.0,=,1.0,1.0,=,IC50,nM,197490.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,197.49,CHEMBL613497
1619,1470724.0,[],CHEMBL833913,Inhibitory activity against HIV-1 mutant strain 227C,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL223228,CHEMBL223228,6.82,0.0,http://www.openphacts.org/units/Nanomolar,380816.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.15,CHEMBL378
1620,836219.0,[],CHEMBL713546,Compound potency to achieve protection of MT-4 cells from HIV-1 cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1CC(=N)/N=C(\S)Nc1ccc(C#N)cc1,CHEMBL1134808,Bioorg Med Chem Lett,2001.0,CHEMBL440492,CHEMBL440492,7.52,0.0,http://www.openphacts.org/units/Nanomolar,126222.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.03,CHEMBL378
1621,1219747.0,[],CHEMBL710533,Inhibitory activity against 181C strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1cnc(Nc2ccc(C#N)cc2)nc1Oc1c(C)cc(C#N)cc1C,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72242,CHEMBL72242,7.52,0.0,http://www.openphacts.org/units/Nanomolar,127437.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.03,CHEMBL378
1622,12091429.0,[],CHEMBL2168515,Antiviral activity against R5 tropic HIV1 Ba-L infected human PBMC assessed as inhibition of viral replication by p-24 antigen specific ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1,CHEMBL2163215,ACS Med Chem Lett,2012.0,CHEMBL1926888,CHEMBL1926888,5.74,0.0,http://www.openphacts.org/units/Nanomolar,1736636.0,=,1.0,1.0,=,IC50,nM,1832.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1832.0,CHEMBL378
1623,1402335.0,[],CHEMBL837463,In vitro inhibitory concentration against HIV F227C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N2CCCCC2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175655,CHEMBL175655,,0.0,http://www.openphacts.org/units/Nanomolar,360430.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1624,18342082.0,[],CHEMBL4139012,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2cc(NC(=O)c3cccc(OC)c3O)c[nH]c2=O)cc1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL4167078,CHEMBL4167078,4.48,0.0,http://www.openphacts.org/units/Nanomolar,3045860.0,=,1.0,1.0,=,IC50,nM,32830.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,32.83,CHEMBL613497
1625,3267341.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1Cc2c(Br)ccc3nc(O)n(c23)C[C@@H]1C,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL58952,CHEMBL58952,7.33,0.0,http://www.openphacts.org/units/Nanomolar,906270.0,=,1.0,1.0,=,IC50,nM,46.77,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.33,CHEMBL378
1626,15690097.0,[],CHEMBL3610404,Antiviral activity against HIV1 BaL infected in CD4/CCR5 expressing human MAGI cells incubated for 48 hrs by beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncc(N2CCC(c3[nH]ncc3Cc3ccccc3)CC2)cn1,CHEMBL3608277,ACS Med Chem Lett,2015.0,CHEMBL3608770,CHEMBL3608770,4.02,0.0,http://www.openphacts.org/units/Nanomolar,2496848.0,=,1.0,1.0,=,IC50,nM,95000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,95.0,CHEMBL378
1627,15602741.0,[],CHEMBL3578657,Inhibition of ASCT2-mediated [3H]glutamine uptake in HEK293 cells after 15 mins by Live-cell glutamine uptake assay,B,BAO_0000190,BAO_0000219,cell-based format,N[C@@H](CCC(=O)Nc1ccccc1N1CCNCC1)C(=O)O,CHEMBL3576761,Bioorg Med Chem Lett,2015.0,CHEMBL3576931,CHEMBL3576931,,0.0,,2479428.0,,1.0,0.0,,IC50,,,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,,,,CHEMBL3562162
1628,18528916.0,[],CHEMBL4195003,Antiviral activity against HIV1 virions containing reverse transcriptase Y181C mutant derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc([C@H]2c3c(cc(OC)c(OC)c3OC)C[C@H](C)[C@@H]2C)cc(OC)c1OC,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4210278,CHEMBL4210278,,0.0,http://www.openphacts.org/units/Nanomolar,3076506.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
1629,12687123.0,[],CHEMBL2344305,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral e antigen production,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)OC(C)(C)CCC(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3C[C@@H](O)[C@]4(OC(=O)c5cccc(Cl)c5)[C@@H](C[C@H](O)[C@@H](O)C4(C)C)[C@]3(C)C(=O)C[C@]12C,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332412,CHEMBL2332412,4.51,0.0,http://www.openphacts.org/units/Nanomolar,1866106.0,=,1.0,1.0,=,IC50,nM,30900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,30.9,CHEMBL613497
1630,3292031.0,[],CHEMBL1108227,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1C[C@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@H]2C1,CHEMBL1157775,Bioorg Med Chem Lett,2010.0,CHEMBL1096101,CHEMBL1096101,,0.0,http://www.openphacts.org/units/Nanomolar,910776.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
1631,18044688.0,[],CHEMBL4010437,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype A QF495.23M.ENV.B2,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.17,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,680.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.68,CHEMBL378
1632,2947349.0,[],CHEMBL1038495,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)c1ccc(Cl)cc1Cl)[C@@H](OC(=O)c1ccc(Cl)cc1Cl)C(C)(C)OC(=O)c1ccc(Cl)cc1Cl)C1=C2C[C@H](OC(=O)c3ccc(Cl)cc3Cl)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL584380,CHEMBL584380,,0.0,http://www.openphacts.org/units/Nanomolar,850752.0,>,1.0,1.0,>,IC50,nM,1000000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.0,CHEMBL613497
1633,15158637.0,[],CHEMBL3398832,Inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OCc1cccc2c1CCOC2=O)c1cccnc1,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397181,CHEMBL3397181,,0.0,http://www.openphacts.org/units/Nanomolar,2278980.0,>,1.0,1.0,>,IC50,nM,2700000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.7,CHEMBL613497
1634,13933274.0,[],CHEMBL3124242,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV e antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,O=C1c2cccc(O)c2C(=O)c2c(O)cc(CO)cc21,CHEMBL3120134,Eur J Med Chem,2014.0,CHEMBL40275,CHEMBL40275,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1969502.0,=,1.0,1.0,=,IC50,ug.mL-1,300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,300.0,CHEMBL613497
1635,19235436.0,[],CHEMBL4398386,Antiviral activity against dengue virus infected in HeLa cells assessed as reduction in viral propagation after 72 hrs by RT-qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)Cc1ccc(C(=O)N(CCc2ccccc2OC)[C@@H]2CCNC2)cc1.Cl.Cl,CHEMBL4396891,Eur J Med Chem,2019.0,CHEMBL4568514,CHEMBL233611,4.44,0.0,http://www.openphacts.org/units/Nanomolar,3210864.0,=,1.0,1.0,=,IC50,nM,36500.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,36.5,CHEMBL613757
1636,1402087.0,[],CHEMBL837470,In vitro inhibitory concentration against HIV V179E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(CO)nc(O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL424772,CHEMBL424772,9.00,0.0,http://www.openphacts.org/units/Nanomolar,360403.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
1637,6200486.0,[],CHEMBL1781474,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 4 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[N+]([O-])(CCc1c[nH]c2ccccc12)CC(C)C,CHEMBL1777761,Bioorg Med Chem,2011.0,CHEMBL1779167,CHEMBL1779167,,0.0,http://www.openphacts.org/units/Nanomolar,1425123.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
1638,11017271.0,[],CHEMBL2090659,Antiviral activity against HIV1 98USMSC5016 clade C clinical isolate infected in PHA-stimulated human PBMC assessed as inhibition of viral replication incubated for 6 hrs followed by compound-wash out measured after 6 days by liquid scintillation counting,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL2086298,J Med Chem,2012.0,CHEMBL141,CHEMBL141,7.66,0.0,http://www.openphacts.org/units/Nanomolar,1674767.0,=,1.0,1.0,=,IC50,nM,21.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,21.8,CHEMBL378
1639,345051.0,[],CHEMBL873617,Inhibition of concanavalin A (con A)-induced proliferation of rat peripheral blood mononuclear cells.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1)c1ccncc1F,CHEMBL1133605,J Med Chem,2000.0,CHEMBL101896,CHEMBL101896,6.85,0.0,http://www.openphacts.org/units/Nanomolar,188097.0,=,1.0,1.0,=,IC50,nM,141.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,141.0,CHEMBL378
1640,1401980.0,[],CHEMBL837468,In vitro inhibitory concentration against HIV L100I mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C(C)COC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177709,CHEMBL177709,7.10,0.0,http://www.openphacts.org/units/Nanomolar,360424.0,=,1.0,1.0,=,IC50,nM,79.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.079,CHEMBL378
1641,18530796.0,[],CHEMBL4195355,Antiviral activity against HIV-1 LAI infected in human MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1C[C@@H]2CO[C@@H]3OCC[C@H]1[C@H]23)S(=O)(=O)c1ccc2nc(NC3CC3)sc2c1,CHEMBL4190391,J Med Chem,2018.0,CHEMBL4218875,CHEMBL4218875,9.05,0.0,http://www.openphacts.org/units/Nanomolar,3076697.0,=,1.0,1.0,=,IC50,nM,0.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.9,CHEMBL378
1642,1471419.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cccc(C(F)(F)F)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188995,CHEMBL188995,5.30,0.0,http://www.openphacts.org/units/Nanomolar,380836.0,=,1.0,1.0,=,IC50,nM,5010.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.01,CHEMBL378
1643,3406159.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc2oc(-c3cccc(C(F)(F)F)c3)c(O)c(=O)c2c1,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1215670,CHEMBL1215670,5.24,0.0,http://www.openphacts.org/units/Nanomolar,933439.0,=,1.0,1.0,=,IC50,nM,5700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.7,CHEMBL378
1644,24378529.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5037881,Antiviral activity against HIV1 harboring reverse transcriptase K103N mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect incubated for 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NC2CCC2)nc(Nc2ccc(C#N)cc2)n1,CHEMBL5036347,Eur J Med Chem,2021.0,CHEMBL5079114,CHEMBL5079114,7.36,0.0,http://www.openphacts.org/units/Nanomolar,3776746.0,=,1.0,1.0,=,IC50,nM,44.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.044000000000000004,CHEMBL378
1645,3104732.0,[],CHEMBL1065243,Antiviral activity against multi drug-resistant HIV1 isolate of subtype C in PHA-stimulated human PBMC assessed as inhibition of p24 antigen production,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,CHEMBL1159037,Bioorg Med Chem Lett,2010.0,CHEMBL1163,CHEMBL1163,7.35,0.0,http://www.openphacts.org/units/Nanomolar,883254.0,=,1.0,1.0,=,IC50,nM,45.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.045,CHEMBL378
1646,15156722.0,[],CHEMBL3399640,Decrease in hepatitis B viral surface antigen HBsAg secretion in human HepG2(2.2.15) cells at 0.75 to 3 uM after 72 hrs by EIA analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(C)=O)c(OS(=O)(=O)c2ccc(N)cc2)c1,CHEMBL3397002,Eur J Med Chem,2015.0,CHEMBL3397414,CHEMBL3397414,4.66,0.0,http://www.openphacts.org/units/Nanomolar,2279261.0,=,1.0,1.0,=,IC50,nM,21670.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,21.67,CHEMBL613497
1647,18202553.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2cccnc2F)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4097716,CHEMBL4097716,6.36,0.0,http://www.openphacts.org/units/Nanomolar,3019981.0,=,1.0,1.0,=,IC50,nM,440.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.44,CHEMBL378
1648,15166110.0,[],CHEMBL3404734,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBeAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(OC(=O)/C=C/c2ccc(F)c(F)c2)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402776,CHEMBL3402776,,0.0,http://www.openphacts.org/units/Nanomolar,2284130.0,=,1.0,1.0,=,IC50,nM,1709900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1709.9,CHEMBL613497
1649,1045209.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(S)n(Nc2ccc(Cl)cc2)c1-c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL287755,CHEMBL287755,,0.0,http://www.openphacts.org/units/Nanomolar,62335.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1650,12135671.0,[],CHEMBL2187933,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as p24 antigen level after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)OCCCCCC(=O)OCC)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2176886,J Med Chem,2012.0,CHEMBL2179614,CHEMBL2179614,7.25,0.0,http://www.openphacts.org/units/Nanomolar,1752713.0,=,1.0,1.0,=,IC50,nM,56.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.056,CHEMBL378
1651,14999574.0,[],CHEMBL3364433,Antiviral activity against HIV1 harboring reverse transcriptase K103N/P225H double mutant infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CNc2nc(-c3ccccc3Cl)c(Cc3ccccc3)s2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3330438,CHEMBL3330438,6.11,0.0,http://www.openphacts.org/units/Nanomolar,2248824.0,=,1.0,1.0,=,IC50,nM,780.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.78,CHEMBL378
1652,1030480.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=C(S)N(Nc2cccc([N+](=O)[O-])c2)C1c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL288680,CHEMBL288680,5.14,0.0,http://www.openphacts.org/units/Nanomolar,62326.0,=,1.0,1.0,=,IC50,nM,7290.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.29,CHEMBL378
1653,624214.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)cc(Cl)c1Oc1nc(N)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL73044,CHEMBL73044,7.46,0.0,http://www.openphacts.org/units/Nanomolar,126914.0,=,1.0,1.0,=,IC50,nM,35.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.035,CHEMBL378
1654,19288691.0,[],CHEMBL4410540,Antiviral activity against HIV-2 ROD infected in human MT4 cells,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)[C@H](C)NP(=O)(OC[C@@H]1C=C[C@H](n2cc(C)c(=O)[nH]c2=O)O1)Oc1ccccc1,CHEMBL4406893,Bioorg Med Chem Lett,2019.0,CHEMBL4562724,CHEMBL4562724,6.57,0.0,http://www.openphacts.org/units/Nanomolar,3220824.0,=,1.0,1.0,=,IC50,nM,270.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.27,CHEMBL378
1655,1470736.0,[],CHEMBL826114,Inhibitory activity against HIV-1 mutant strain 138K,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL223228,CHEMBL223228,8.70,0.0,http://www.openphacts.org/units/Nanomolar,380816.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.002,CHEMBL378
1656,12528725.0,[],CHEMBL3078221,Antiviral activity against HIV1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,[O-]c1on[n+](-c2ccc(Cc3ccc(-[n+]4noc([O-])c4CN4CCN(C5=Nc6ccccc6Sc6ccccc65)CC4)cc3)cc2)c1CN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,CHEMBL3044741,Med Chem Res,2013.0,CHEMBL2282178,CHEMBL2282178,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824337.0,>,1.0,1.0,>,IC50,ug.mL-1,11.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,11.6,CHEMBL378
1657,15159545.0,[],CHEMBL3398834,Inhibition of HBV DNA replication in HepG2(2.2.15) cells exposed to fresh medium supplemented with compound every other day for additional 5 days by real-time PCR-fluorescent probing method,F,BAO_0000190,BAO_0000218,organism-based format,O=Cc1cccc2c1CCOC2=O,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397161,CHEMBL3397161,,0.0,http://www.openphacts.org/units/Nanomolar,2278959.0,=,1.0,1.0,=,IC50,nM,760000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.76,CHEMBL613497
1658,15158622.0,[],CHEMBL3398832,Inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,O=C1OCCc2c1cccc2C1OCCO1,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397167,CHEMBL3397167,,0.0,http://www.openphacts.org/units/Nanomolar,2278965.0,=,1.0,1.0,=,IC50,nM,2180000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.18,CHEMBL613497
1659,18585177.0,[],CHEMBL4223289,Antiviral activity against Hepatitis B virus infected in human HepG2.215 cells assessed as reduction in covalently closed circular DNA level after 9 days by real time QF-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(O)[C@@H]1CC[C@]2(C)[C@H](C(=O)C=C3[C@@H]4C[C@@](C)(C(=O)O)CC[C@]4(C)CC[C@]32C)[C@@]1(C)CCC(=O)O,CHEMBL4219203,Bioorg Med Chem Lett,2018.0,CHEMBL4226405,CHEMBL4226405,4.91,0.0,http://www.openphacts.org/units/Nanomolar,3086249.0,=,1.0,1.0,=,IC50,nM,12300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,12.3,CHEMBL613497
1660,11014410.0,[],CHEMBL2089834,Antiviral activity against HIV1 in human TZM-bl cells assessed as viral infectivity by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N[C@@H](CC(C)C)[C@H](O)CC(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2086289,Eur J Med Chem,2012.0,CHEMBL137752,CHEMBL137752,7.00,0.0,http://www.openphacts.org/units/Nanomolar,1675632.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
1661,3432863.0,[],CHEMBL1246459,Antiviral activity against R5 tropic HIV1 BaL infected in human CEMx174 5.25M7 cells after 3 days by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NN1C(=O)[C@@H]2C3C=CC(C4CC43)[C@@H]2C1=O)c1ccc(COc2ccc(F)cc2)cc1,CHEMBL1240449,Eur J Med Chem,2010.0,CHEMBL1241648,CHEMBL1241648,4.50,0.0,http://www.openphacts.org/units/Nanomolar,952475.0,=,1.0,1.0,=,IC50,nM,31450.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,31.45,CHEMBL378
1662,12680737.0,[],CHEMBL2342599,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)NCCc3cccc(F)c3)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333290,CHEMBL2333290,,0.0,http://www.openphacts.org/units/Nanomolar,1867253.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
1663,19013474.0,[],CHEMBL4345977,Antiviral activity against HIV1 Env-pseudotyped virus in human U87.CD4.CCR5 target cells assessed as reduction in viral infection at late stage,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(N(C)C(=O)[C@H](Cc2ccccc2)NC(=O)CN2C(=O)Nc3ccccc3S2(=O)=O)cc1,CHEMBL4342517,J Med Chem,2020.0,CHEMBL4436876,CHEMBL4436876,5.61,0.0,http://www.openphacts.org/units/Nanomolar,3172756.0,=,1.0,1.0,=,IC50,nM,2440.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.44,CHEMBL378
1664,2929509.0,[],CHEMBL1056898,Antiviral activity against HIV1 HXB2 harboring 190S mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL223228,CHEMBL223228,6.60,0.0,http://www.openphacts.org/units/Nanomolar,848289.0,=,1.0,1.0,=,IC50,nM,251.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,251.0,CHEMBL378
1665,3014064.0,[],CHEMBL1042767,Antiviral activity against HIV1 3B infected in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(C(=O)c2cccc3nc(CN(C)C4CCCc5cccnc54)[nH]c23)CC1,CHEMBL1155333,Bioorg Med Chem Lett,2009.0,CHEMBL577486,CHEMBL577486,7.48,0.0,http://www.openphacts.org/units/Nanomolar,855060.0,=,1.0,1.0,=,IC50,nM,33.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.033,CHEMBL378
1666,2929621.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL566750,CHEMBL566750,6.90,0.0,http://www.openphacts.org/units/Nanomolar,852961.0,=,1.0,1.0,=,IC50,nM,125.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,125.0,CHEMBL378
1667,24830942.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C1CCN(c2ccc3c(=O)c4cccc(Cl)c4oc3c2)C1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5184189,CHEMBL5184189,5.76,0.0,http://www.openphacts.org/units/Nanomolar,3878115.0,=,1.0,1.0,=,IC50,nM,1740.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.74,CHEMBL613497
1668,1402247.0,[],CHEMBL834488,In vitro inhibitory concentration against HIV L100I and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(CC)CC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175534,CHEMBL175534,,0.0,http://www.openphacts.org/units/Nanomolar,360399.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1669,1229808.0,[],CHEMBL878997,Inhibition of Hepatitis C RNA dependent RNA polymerase Nonstructural protein 5B activity.,B,BAO_0000190,BAO_0000357,single protein format,O=C(O)[C@H](Cc1ccccc1)N(Cc1cccc(Br)c1)C(=O)c1ccc(Cl)c(Cl)c1,CHEMBL1136248,Bioorg Med Chem Lett,2003.0,CHEMBL326276,CHEMBL326276,4.52,0.0,http://www.openphacts.org/units/Nanomolar,213339.0,=,1.0,1.0,=,IC50,nM,30000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,30.0,CHEMBL4620
1670,2203579.0,[],CHEMBL987023,Antiviral activity against HIV1 3B in human MT4 cells assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CCNC(=S)Nc1ccc(-c2n[nH]c(=S)n2CC=C)cc1,CHEMBL1149790,Eur J Med Chem,2008.0,CHEMBL48014,CHEMBL48014,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,765677.0,>,1.0,1.0,>,IC50,ug.mL-1,65.43,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,65.43,CHEMBL378
1671,14658797.0,[],CHEMBL3266157,Antagonist activity at recombinant human EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1ccc(C(=O)N2CCN(C(=O)/C=C/c3ccc(OC)cc3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262890,CHEMBL3262890,7.77,0.0,http://www.openphacts.org/units/Nanomolar,2101732.0,=,1.0,1.0,=,IC50,nM,17.0,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,nM,UO_0000065,17.0,CHEMBL3259470
1672,13857139.0,[],CHEMBL3097945,Antiviral activity against enfuvirtide-resistant HIV-1 NL4-3 harboring gp41 (36G)V38A/N42T mutation infected in human MT2 cells assessed as inhibition of p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(/C=C2\SC(=S)N(Cc3ccc(C(C)(C)C)cc3)C2=O)c(C)n1-c1ccc(O)c(C(=O)O)c1,CHEMBL3091377,Bioorg Med Chem,2013.0,CHEMBL3092874,CHEMBL3092874,5.75,0.0,http://www.openphacts.org/units/Nanomolar,1952756.0,=,1.0,1.0,=,IC50,nM,1776.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.776,CHEMBL378
1673,12680660.0,[],CHEMBL2342597,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral replication after 9 days by fluorescence PCR method,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2CCOCP(=O)(O)O,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL484,CHEMBL484,6.29,0.0,http://www.openphacts.org/units/Nanomolar,1867264.0,=,1.0,1.0,=,IC50,nM,517.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.517,CHEMBL613497
1674,12663835.0,[],CHEMBL2330344,Antiviral activity against T20-resistant Human immunodeficiency virus 1 NL4-3 harboring gp41 NHR (36G)N42T/N43K mutation infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CCNC(=O)c1cc(-n2c(C)ccc2C)ccc1OCC(=O)O)[C@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O,CHEMBL2321797,J Med Chem,2013.0,CHEMBL2326372,CHEMBL2326372,6.64,0.0,http://www.openphacts.org/units/Nanomolar,1852841.0,=,1.0,1.0,=,IC50,nM,230.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,230.0,CHEMBL378
1675,18683222.0,[],CHEMBL4237086,Antiviral activity against CCR5-dependent HIV1 SF162 infected in human TZM-bl cells assessed as reduction in virus infection measured after 48 hrs post infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCCCC1)c1cccs1,CHEMBL4229569,J Med Chem,2018.0,CHEMBL4242114,CHEMBL4242114,7.96,0.0,http://www.openphacts.org/units/Nanomolar,3103097.0,=,1.0,1.0,=,IC50,nM,11.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,11.1,CHEMBL378
1676,884326.0,[],CHEMBL653610,Inhibitory activity tested against the HIV-1 in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)Nc3ccc(C(=O)O)cc3)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL262713,CHEMBL262713,7.16,0.0,http://www.openphacts.org/units/Nanomolar,9102.0,=,1.0,1.0,=,IC50,nM,70.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,70.0,CHEMBL378
1677,18940438.0,[],CHEMBL4328848,Antiviral activity against HIV-1 3B infected in human MAGI-CXCR4 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1cccc(Cn2ncc3ccc(-c4ccc5ccn(Cc6cccc(C(=O)O)c6)c5c4)cc32)c1,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4475861,CHEMBL4475861,5.85,0.0,http://www.openphacts.org/units/Nanomolar,3159839.0,=,1.0,1.0,=,IC50,nM,1400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.4,CHEMBL378
1678,16494770.0,[],CHEMBL3772328,Antiviral activity against HIV1 NL4-3 infected in human TZM-bl cells assessed as inhibition of viral replication administered 6 hrs postinfection measured 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1cccc(Nc2nc(-c3ccncc3)nc3ccccc23)c1,CHEMBL3769372,J Med Chem,2016.0,CHEMBL3770941,CHEMBL3770941,5.28,0.0,http://www.openphacts.org/units/Nanomolar,2761471.0,=,1.0,1.0,=,IC50,nM,5300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.3,CHEMBL378
1679,2930357.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COCC1CN(Cc2c(C)[nH]c(=O)c(I)c2Sc2cc(C)cc(C)c2)CCO1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL575246,CHEMBL575246,8.90,0.0,http://www.openphacts.org/units/Nanomolar,848287.0,=,1.0,1.0,=,IC50,nM,1.25,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.25,CHEMBL378
1680,2371266.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NCCCN1CCCC1)c1cc2c(Cl)nc3ccccc3c2s1,CHEMBL1140145,J Med Chem,2008.0,CHEMBL494474,CHEMBL494474,5.00,0.0,http://www.openphacts.org/units/Nanomolar,745881.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,10.0,CHEMBL613493
1681,1402171.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL180008,CHEMBL180008,8.40,0.0,http://www.openphacts.org/units/Nanomolar,360390.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.004,CHEMBL378
1682,5199512.0,[],CHEMBL1670946,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,OCCc1c(OCc2c(F)cccc2F)nc2ccc(Cl)cc2c1-c1ccccc1Cl,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668641,CHEMBL1668641,,0.0,http://www.openphacts.org/units/Nanomolar,1328425.0,=,1.0,1.0,=,IC50,nM,1634000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1634.0,CHEMBL613497
1683,15156717.0,[],CHEMBL3399640,Decrease in hepatitis B viral surface antigen HBsAg secretion in human HepG2(2.2.15) cells at 0.75 to 3 uM after 72 hrs by EIA analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(C)=O)c(OS(=O)(=O)c2ccc(Cl)cc2)c1,CHEMBL3397002,Eur J Med Chem,2015.0,CHEMBL3397409,CHEMBL3397409,5.55,0.0,http://www.openphacts.org/units/Nanomolar,2279256.0,=,1.0,1.0,=,IC50,nM,2830.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.83,CHEMBL613497
1684,5189178.0,[],CHEMBL1658799,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1/C=C/C(=O)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652523,CHEMBL1652523,4.21,0.0,http://www.openphacts.org/units/Nanomolar,1326898.0,=,1.0,1.0,=,IC50,nM,61000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.061,CHEMBL613497
1685,1242186.0,[],CHEMBL711623,Concentration required to inhibit HIV-1 induced cytopathicity in MT-4 cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCC(=O)N(C)CCCCCCCCCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL115571,CHEMBL1205564,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221518.0,=,1.0,1.0,=,IC50,ug.mL-1,28.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,28.0,CHEMBL378
1686,1402016.0,[],CHEMBL833792,In vitro inhibitory concentration against HIV-1 Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCOC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL368039,CHEMBL368039,6.50,0.0,http://www.openphacts.org/units/Nanomolar,360360.0,=,1.0,1.0,=,IC50,nM,316.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.316,CHEMBL378
1687,947100.0,[],CHEMBL655544,Inhibition of wild type HIV-1-IIIB strain replication in CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(Sc2cc(C)cc(C)c2)cc(O)nc1C,CHEMBL1128194,J Med Chem,1995.0,CHEMBL341931,CHEMBL341931,6.30,0.0,http://www.openphacts.org/units/Nanomolar,276272.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,500.0,CHEMBL378
1688,14986381.0,[],CHEMBL3387304,Antiviral activity against Tacaribe virus infected in African green monkey Vero 76 cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncc(F)c2c1ncn2[C@@H]1C[C@H](CCO)[C@@H](O)[C@H]1O,CHEMBL3351456,Bioorg Med Chem,2014.0,CHEMBL3357216,CHEMBL3357216,5.19,0.0,http://www.openphacts.org/units/Nanomolar,2258675.0,=,1.0,1.0,=,IC50,nM,6400.0,CHEMBL613131,Tacaribe virus,Tacaribe virus,11631,IC50,uM,UO_0000065,6.4,CHEMBL613131
1689,15064902.0,[],CHEMBL3366183,Antiviral activity against wild type HIV1 infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2nc(NCc3ccccc3OC)sc2Cc2ccccc2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3330419,CHEMBL3330419,5.16,0.0,http://www.openphacts.org/units/Nanomolar,2246856.0,=,1.0,1.0,=,IC50,nM,6970.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.97,CHEMBL378
1690,8027850.0,[],CHEMBL1948540,Antiviral activity against HIV1 NL432 infected in human ConA and IL2-stimulated PBMC assessed as inhibition of viral replication by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,O[C@]12COc3ccccc3[C@H]1c1ccccc1C2,CHEMBL1944615,Bioorg Med Chem Lett,2012.0,CHEMBL1945223,CHEMBL1945223,,0.0,,1574223.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1691,15199986.0,[],CHEMBL3411839,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL3407350,Bioorg Med Chem,2015.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,2287846.0,=,1.0,1.0,=,IC50,ug.mL-1,41.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,41.0,CHEMBL613497
1692,870935.0,[],CHEMBL710366,Inhibitory activity tested against the HIV-1 in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N[C@@H](C)C(=O)O)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL269462,CHEMBL269462,7.21,0.0,http://www.openphacts.org/units/Nanomolar,9064.0,=,1.0,1.0,=,IC50,nM,62.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,62.0,CHEMBL378
1693,18683308.0,[],CHEMBL4237099,Antiviral activity against CCR5-dependent HIV1 Ba-L infected in human HOS cells assessed as reduction in virus infection measured after 5 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1,CHEMBL4229569,J Med Chem,2018.0,CHEMBL4249798,CHEMBL4249798,8.92,0.0,http://www.openphacts.org/units/Nanomolar,3103111.0,=,1.0,1.0,=,IC50,nM,1.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.2,CHEMBL378
1694,2183998.0,[],CHEMBL951606,Antiviral activity against HIV1 NL43 infected in U87.CD4 cells expressing human CXCR4 D171N mutant,F,BAO_0000190,BAO_0000218,organism-based format,c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,CHEMBL1156482,J Biol Chem,2007.0,CHEMBL18442,CHEMBL18442,7.34,0.0,http://www.openphacts.org/units/Nanomolar,791970.0,=,1.0,1.0,=,IC50,nM,46.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,46.0,CHEMBL378
1695,1470444.0,[],CHEMBL833913,Inhibitory activity against HIV-1 mutant strain 227C,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C(C)=C/C#N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL363952,CHEMBL363952,5.90,0.0,http://www.openphacts.org/units/Nanomolar,380765.0,=,1.0,1.0,=,IC50,nM,1250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.25,CHEMBL378
1696,2033578.0,[],CHEMBL888216,Inhibition of AP1-mediated gene transcription in HepG2 cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c3c(c4cc(OC)c(OC)cc4c2cc1O)CN1CCC[C@H]1[C@H]3O,CHEMBL1140007,Bioorg Med Chem Lett,2007.0,CHEMBL400888,CHEMBL400888,,0.0,http://www.openphacts.org/units/Nanomolar,675149.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,nM,UO_0000065,1000.0,CHEMBL4977
1697,1402149.0,[],CHEMBL837469,In vitro inhibitory concentration against HIV V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCOC)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177275,CHEMBL177275,7.20,0.0,http://www.openphacts.org/units/Nanomolar,360374.0,=,1.0,1.0,=,IC50,nM,63.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.063,CHEMBL378
1698,15166158.0,[],CHEMBL3404736,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as decrease in viral DNA replication treated for 7 days by real time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C=C/C(=O)OC[C@H]2O[C@@H](Oc3ccc(C(C)=O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)cc1OC,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402784,CHEMBL3402784,5.06,0.0,http://www.openphacts.org/units/Nanomolar,2284139.0,=,1.0,1.0,=,IC50,nM,8800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,8.8,CHEMBL613497
1699,18812956.0,[],CHEMBL4276410,Antiviral activity against lopinavir-resistant HIV1 infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL4270667,J Med Chem,2018.0,CHEMBL116,CHEMBL116,,0.0,http://www.openphacts.org/units/Nanomolar,3125925.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
1700,2929602.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COC1CCCN(Cc2c(C)[nH]c(=O)c(I)c2Oc2cc(C)cc(C)c2)C1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578764,CHEMBL578764,7.40,0.0,http://www.openphacts.org/units/Nanomolar,852785.0,=,1.0,1.0,=,IC50,nM,39.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,39.8,CHEMBL378
1701,18812943.0,[],CHEMBL4276412,Antiviral activity against darunavir-resistant HIV1 at passage 21 infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2C[C@H]3OC(=O)N(CC(C)C)[C@H]3C2)cc1,CHEMBL4270667,J Med Chem,2018.0,CHEMBL4277539,CHEMBL4277539,,0.0,http://www.openphacts.org/units/Nanomolar,3125921.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
1702,2930232.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3cnc(C)c3/C=N/O)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL575040,CHEMBL575040,6.80,0.0,http://www.openphacts.org/units/Nanomolar,848228.0,=,1.0,1.0,=,IC50,nM,158.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,158.0,CHEMBL378
1703,3509194.0,[],CHEMBL1261044,Antiviral activity against HIV1 harboring reverse transcriptase K103N/L100I double mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Nc1ccnc(NC2CCN(c3cccc(C(N)=O)c3)CC2)n1,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1258477,CHEMBL1258477,,0.0,http://www.openphacts.org/units/Nanomolar,963461.0,>,1.0,1.0,>,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,100.0,CHEMBL378
1704,18044730.0,[],CHEMBL4010428,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 pRHPA4259 clone 7,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.24,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,570.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.57,CHEMBL378
1705,23306072.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL4843118,Antiviral activity against Zika virus H/PF/2013 infected in pre-seeded Huh-7 cells assessed as inhibition of viral replication incubated for 72 hrs by immunodetection based secondary yield reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,OCCNc1nc(Nc2cccc(C(F)(F)F)c2)c2nc[nH]c2n1,CHEMBL4842338,Eur J Med Chem,2021.0,CHEMBL4859678,CHEMBL4859678,4.97,0.0,http://www.openphacts.org/units/Nanomolar,3627088.0,=,1.0,1.0,=,IC50,nM,10600.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,10.6,CHEMBL4296612
1706,15027157.0,[],CHEMBL3367171,Inhibition of AP-1-mediated transcriptional activation in human Jurkat cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cnc(Cl)nc1-c1ccccc1,CHEMBL3352097,J Med Chem,2014.0,CHEMBL423150,CHEMBL423150,6.40,0.0,http://www.openphacts.org/units/Nanomolar,2265161.0,=,1.0,1.0,=,IC50,nM,400.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.4,CHEMBL4977
1707,1180436.0,[],CHEMBL694658,Inhibitory concentration against HIV-1 LTR polymerase chain reaction product,F,BAO_0000190,BAO_0000218,organism-based format,Cl.Cl.Cn1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4cc(N)cn4C)cn3C)cn2C)cc1C(=O)NCCC(=N)N,CHEMBL1132187,J Med Chem,1999.0,CHEMBL554203,CHEMBL1195278,4.70,0.0,http://www.openphacts.org/units/Nanomolar,289518.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
1708,18775496.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCCOc1cc2c(cc1OC)-c1cc(=O)c(C(=O)O)cn1C(CC)C2,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4284687,CHEMBL4284687,7.70,0.0,http://www.openphacts.org/units/Nanomolar,3119654.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.02,CHEMBL613497
1709,13475413.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)(C)C)C[C@H]2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435905,CHEMBL2435905,6.45,0.0,http://www.openphacts.org/units/Nanomolar,1924281.0,=,1.0,1.0,=,IC50,nM,351.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,351.7,CHEMBL378
1710,18044408.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(C(CN)NC(=O)c2ccc(-c3ccc(Cl)cc3)n2C)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4072179,CHEMBL4072179,4.59,0.0,http://www.openphacts.org/units/Nanomolar,2990225.0,=,1.0,1.0,=,IC50,nM,25800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.8,CHEMBL378
1711,15568227.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(Br)cc1)N1CCN(C(=O)c2ccccc2)CC1,CHEMBL1201862,,,CHEMBL3560864,CHEMBL3560864,9.21,0.0,http://www.openphacts.org/units/Nanomolar,2475682.0,=,7.0,1.0,=,IC50,nM,0.62,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.00062,CHEMBL3259470
1712,5189236.0,[],CHEMBL1658800,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/C(=O)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652531,CHEMBL1652531,4.66,0.0,http://www.openphacts.org/units/Nanomolar,1326906.0,=,1.0,1.0,=,IC50,nM,22000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.022,CHEMBL613497
1713,1471576.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1ccc(Br)cc1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188825,CHEMBL188825,5.80,0.0,http://www.openphacts.org/units/Nanomolar,380953.0,=,1.0,1.0,=,IC50,nM,1580.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.58,CHEMBL378
1714,24735310.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5116803,Antiviral activity against CHIKV infected in human Huh-7 cells assessed as inhibition of viral infection by measuring EGFP-positive cells measured 24 hrs post infection by fluorescent microscopic analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12,CHEMBL5113447,Bioorg Med Chem Lett,2022.0,CHEMBL8260,CHEMBL8260,4.77,0.0,http://www.openphacts.org/units/Nanomolar,3858561.0,=,1.0,1.0,=,IC50,nM,16900.0,CHEMBL4296563,Chikungunya virus,Chikungunya virus,37124,IC50,uM,UO_0000065,16.9,CHEMBL4296563
1715,2414497.0,[],CHEMBL954254,Antiviral activity against HIV1 with reverse transcriptase Y188L mutation in human CEM cells assessed as protection against virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)C(N)=O)[nH]c3ccc(Cl)cc23)c1,CHEMBL1153955,J Med Chem,2009.0,CHEMBL127012,CHEMBL127012,6.18,0.0,http://www.openphacts.org/units/Nanomolar,810480.0,=,1.0,1.0,=,IC50,nM,660.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,660.0,CHEMBL378
1716,15066678.0,[],CHEMBL3390094,Antiviral activity against HIV1 infected in HEK293T cells by p24 ELISA based phenotypic assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL3352750,Bioorg Med Chem Lett,2014.0,CHEMBL57,CHEMBL57,6.92,0.0,http://www.openphacts.org/units/Nanomolar,2270418.0,=,1.0,1.0,=,IC50,nM,120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.12,CHEMBL378
1717,1471579.0,[],CHEMBL834619,Inhibitory activity against HIV-1 mutant strain 181C; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1ccc(Br)cc1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188825,CHEMBL188825,,0.0,http://www.openphacts.org/units/Nanomolar,380953.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1718,18775544.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COCCCOc1cc2c(cc1OC)-c1cc(=O)c(C(=O)O)cn1C(c1ccccc1C)C2,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4286894,CHEMBL4286894,8.00,0.0,http://www.openphacts.org/units/Nanomolar,3119702.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.01,CHEMBL613497
1719,14927151.0,[],CHEMBL3391564,Antiviral activity against wild type HIV-1 LAI infected in human MT4 cells assessed as inhibition of viral replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL3390846,Medchemcomm,2010.0,CHEMBL223228,CHEMBL223228,8.70,0.0,http://www.openphacts.org/units/Nanomolar,2173138.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
1720,12091422.0,[],CHEMBL2168515,Antiviral activity against R5 tropic HIV1 Ba-L infected human PBMC assessed as inhibition of viral replication by p-24 antigen specific ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC2CCOCC2)CC1,CHEMBL2163215,ACS Med Chem Lett,2012.0,CHEMBL2164201,CHEMBL2164201,7.79,0.0,http://www.openphacts.org/units/Nanomolar,1736624.0,=,1.0,1.0,=,IC50,nM,16.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,16.1,CHEMBL378
1721,1022427.0,[],CHEMBL756465,Tested for the ability to inhibit the replication of HIV-1 strain HTLV IIIB in human peripheral blood mononuclear cells (PBMC),F,BAO_0000190,BAO_0000218,organism-based format,S=C(NCc1ccco1)Nc1nccs1,CHEMBL1134194,Bioorg Med Chem Lett,2001.0,CHEMBL148698,CHEMBL148698,9.00,0.0,http://www.openphacts.org/units/Nanomolar,292666.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
1722,1472138.0,[],CHEMBL834619,Inhibitory activity against HIV-1 mutant strain 181C; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C\c2ccco2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188729,CHEMBL188729,,0.0,http://www.openphacts.org/units/Nanomolar,380719.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1723,2929654.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(COCCO)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL565902,CHEMBL565902,6.30,0.0,http://www.openphacts.org/units/Nanomolar,852993.0,=,1.0,1.0,=,IC50,nM,501.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,501.0,CHEMBL378
1724,16626885.0,[],CHEMBL3821890,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg secretion by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1cc(CSc2ccccn2)[nH][nH]1,CHEMBL3817822,Medchemcomm,2016.0,CHEMBL1643569,CHEMBL1643569,,0.0,http://www.openphacts.org/units/Nanomolar,2783917.0,=,1.0,1.0,=,IC50,nM,814650.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,814.65,CHEMBL613497
1725,2601447.0,[],CHEMBL1033985,Antiviral activity against Cowpox virus,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C(C)NP1(=O)CO[C@@H](Cn2ccc(N)nc2=O)CO1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL460207,CHEMBL460207,4.58,0.0,http://www.openphacts.org/units/Nanomolar,807103.0,=,1.0,1.0,=,IC50,nM,26000.0,CHEMBL612672,Cowpox virus,Cowpox virus,10243,IC50,uM,UO_0000065,26.0,CHEMBL612672
1726,378462.0,[],CHEMBL711617,Antiviral activity against HIV-1 IIIB induced cytopathic effect in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)[C@H]1NCc2ccc(cc2)OCCOCCOCCNC(=O)[C@H](C(C)C)NC1=O,CHEMBL1129607,J Med Chem,1996.0,CHEMBL113085,CHEMBL113085,7.80,0.0,http://www.openphacts.org/units/Nanomolar,210527.0,=,1.0,1.0,=,IC50,nM,16.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,16.0,CHEMBL378
1727,19053989.0,[],CHEMBL4356049,Antiviral activity against Zika virus infected in African green monkey Vero E6 cells assessed as reduction in virus infectivity preincubated with virus for 1 hr followed by cell infection and measured after 96 hrs by crystal violet staining based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O,CHEMBL4354808,J Med Chem,2020.0,CHEMBL289277,CHEMBL289277,5.50,0.0,http://www.openphacts.org/units/Nanomolar,3179018.0,=,1.0,1.0,=,IC50,nM,3200.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,3.2,CHEMBL4296612
1728,252292.0,[],CHEMBL714981,Inhibition of antiviral activity against moloney murine sarcoma virus(MSV)in CEM cells in cell protection assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](OP(=O)(O)COCCn2cnc3ncnc(N)c32)[C@H]1O,CHEMBL1134666,J Med Chem,2001.0,CHEMBL1790862,CHEMBL1790862,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,233579.0,=,1.0,1.0,=,IC50,ug.mL-1,17.0,CHEMBL613501,Moloney murine sarcoma virus,Moloney murine sarcoma virus,11809,IC50,ug ml-1,UO_0000274,17.0,CHEMBL613501
1729,5249017.0,[],CHEMBL1685193,Antiviral activity against X4 tropic HIV1 NL4.3 infected in CD4 and CXCR4 expressing human MT4 cells assessed as inhibition of viral cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(Cc1nc2ccccc2[nH]1)Cc1ncccc1O,CHEMBL1681661,Bioorg Med Chem Lett,2011.0,CHEMBL1682873,CHEMBL1682873,,0.0,http://www.openphacts.org/units/Nanomolar,1333995.0,>,1.0,1.0,>,IC50,nM,149200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,149200.0,CHEMBL378
1730,17602948.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(S(=O)(=O)c2cccc(F)c2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644883,CHEMBL3644883,7.85,0.0,http://www.openphacts.org/units/Nanomolar,2518003.0,=,37.0,1.0,=,IC50,nM,14.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,14.0,CHEMBL4620
1731,5163190.0,[],CHEMBL1666140,Antiviral activity against NNRTI-resistant HIV1 HXB2 infected in HEK293 cells assessed as inhibition of viral replication after 2 days,F,BAO_0000190,BAO_0000218,organism-based format,c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,CHEMBL1649540,Antimicrob Agents Chemother,2009.0,CHEMBL18442,CHEMBL18442,8.15,0.0,http://www.openphacts.org/units/Nanomolar,1327043.0,=,1.0,1.0,=,IC50,nM,7.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.0,CHEMBL378
1732,2091774.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL54600,CHEMBL54600,,0.0,http://www.openphacts.org/units/Nanomolar,700512.0,=,1.0,1.0,=,IC50,nM,2511886431509.58,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,3.4,CHEMBL378
1733,5294586.0,[],CHEMBL1697321,Antiviral activity against Vaccinia virus infected in human embryonic lung cells assessed as reduction in viral yield measured after 3 days,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(CC)[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,CHEMBL1687706,Antimicrob Agents Chemother,2008.0,CHEMBL1651956,CHEMBL1651956,,0.0,http://www.openphacts.org/units/Nanomolar,1337219.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,25.0,CHEMBL613493
1734,1420527.0,[],CHEMBL833369,Antiviral activity in an in vitro HIV replication assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)Cc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1,CHEMBL1141903,Bioorg Med Chem Lett,2005.0,CHEMBL426048,CHEMBL426048,6.96,0.0,http://www.openphacts.org/units/Nanomolar,365577.0,=,1.0,1.0,=,IC50,nM,111.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,111.0,CHEMBL378
1735,13940310.0,[],CHEMBL3131385,Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)NCc1cn(Cc2ccc(Cl)c(Cl)c2)nn1)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL3124823,Eur J Med Chem,2014.0,CHEMBL3126782,CHEMBL3126782,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1972636.0,=,1.0,1.0,=,IC50,ug.mL-1,6.79,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,6.79,CHEMBL613129
1736,10961143.0,[],CHEMBL2061266,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M9 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCCN(C)C)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058054,CHEMBL2058054,,0.0,http://www.openphacts.org/units/Nanomolar,1655880.0,>,1.0,1.0,>,IC50,nM,400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,400.0,CHEMBL378
1737,3008344.0,[],CHEMBL1037279,Antiviral activity against Human immunodeficiency virus 1 NL4-3 infected HeLaP4 cells after 5 days by beta-galactosidase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(=O)c1ccc(O[C@@H](C)C(=O)N2CCN(C(=O)c3ccccc3)C[C@H]2C)c2cccnc12,CHEMBL1155317,Bioorg Med Chem Lett,2009.0,CHEMBL569386,CHEMBL569386,,0.0,,861764.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1738,19013468.0,[],CHEMBL4345978,Antiviral activity against HIV1 Env-pseudotyped virus in human U87.CD4.CCR5 target cells assessed as reduction in viral infection at early stage,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(N(C)C(=O)[C@H](Cc2ccccc2)NC(=O)CNS(=O)(=O)c2cccc(F)c2)cc1,CHEMBL4342517,J Med Chem,2020.0,CHEMBL4571968,CHEMBL4571968,5.08,0.0,http://www.openphacts.org/units/Nanomolar,3172748.0,=,1.0,1.0,=,IC50,nM,8220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.22,CHEMBL378
1739,14581359.0,[],CHEMBL3243468,"Antiviral activity against HIV-1 pseudotyped virus expressing HIV-1 isolate C envelope Du156, clone 12 (SVPC3) assessed as reduction of luciferase production after 3 days by single-cycle neutralization assay",F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]1CSCc2ccc(cc2)-c2ccc(cc2)CSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC1=O,CHEMBL3232893,Bioorg Med Chem Lett,2014.0,CHEMBL3233156,CHEMBL3233156,4.75,0.0,http://www.openphacts.org/units/Nanomolar,2081351.0,=,1.0,1.0,=,IC50,nM,17900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,17.9,CHEMBL378
1740,1401927.0,[],CHEMBL833792,In vitro inhibitory concentration against HIV-1 Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCNc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL174339,CHEMBL174339,4.00,0.0,http://www.openphacts.org/units/Nanomolar,360384.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1741,15666420.0,[],CHEMBL3602748,Antiviral activity against ENF-resistant HIV1 NL4-3 harboring gp41 N-terminal heptad repeat I37T/N43K double mutant infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL3600303,J Med Chem,2015.0,CHEMBL428607,CHEMBL428607,8.77,0.0,http://www.openphacts.org/units/Nanomolar,2492328.0,=,1.0,1.0,=,IC50,nM,1.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.7,CHEMBL378
1742,1402399.0,[],CHEMBL837465,In vitro inhibitory concentration against HIV G190S mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)CCOC)c1C(=O)c1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369697,CHEMBL369697,8.52,0.0,http://www.openphacts.org/units/Nanomolar,360426.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
1743,18342107.0,[],CHEMBL4139012,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/Nanomolar,3045885.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
1744,1402116.0,[],CHEMBL837462,In vitro inhibitory concentration against HIV E138K mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCO)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175692,CHEMBL175692,,0.0,http://www.openphacts.org/units/Nanomolar,360365.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1745,1403523.0,[],CHEMBL834756,Inhibitory concentration against 103N mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Oc2cn(C)c(=O)c(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL366432,CHEMBL366432,7.50,0.0,http://www.openphacts.org/units/Nanomolar,360665.0,=,1.0,1.0,=,IC50,nM,32.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.032,CHEMBL378
1746,15027205.0,[],CHEMBL3367187,Inhibition of UVB-induced AP-1 activation (unknown origin) by cell-based assay,B,BAO_0000190,BAO_0000219,cell-based format,COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]2[C@@H]1[C@@H]1O[C@@H]1[C@]2(O)C(=O)O/C=C(\C(=O)O)c1ccc(O)c(OC)c1,CHEMBL3352097,J Med Chem,2014.0,CHEMBL3341760,CHEMBL3341760,4.54,0.0,http://www.openphacts.org/units/Nanomolar,2265221.0,=,1.0,1.0,=,IC50,nM,29000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,29.0,CHEMBL4977
1747,2413703.0,[],CHEMBL987710,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)/C=C/c1ccccc1Cl)[C@@H](OC(=O)/C=C/c1ccccc1Cl)C(C)(C)O)C1=C2C[C@H](OC(=O)/C=C/c3ccccc3Cl)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL449385,CHEMBL449385,,0.0,http://www.openphacts.org/units/Nanomolar,810691.0,>,1.0,1.0,>,IC50,nM,1300000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.3,CHEMBL613497
1748,2009801.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-c3ccnc(N)n3)nccc12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL393331,CHEMBL393331,6.30,0.0,http://www.openphacts.org/units/Nanomolar,668112.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,500.0,CHEMBL378
1749,19281700.0,[],CHEMBL4409359,Antiviral activity against HIV1 VB59 infected in human TZM-bl cells incubated for 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(cnn2-c2cccc(Br)c2)c(=O)[nH]1,CHEMBL4406854,Eur J Med Chem,2019.0,CHEMBL4465887,CHEMBL4465887,,0.0,http://www.openphacts.org/units/Nanomolar,3219940.0,=,1.0,1.0,=,IC50,nM,139470.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,139.47,CHEMBL378
1750,5132815.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2[nH]c(=O)c(CN(Cc3ccco3)C(=O)c3ccc(C)cc3)cc2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645067,CHEMBL1645067,5.10,0.0,http://www.openphacts.org/units/Nanomolar,1321055.0,=,1.0,1.0,=,IC50,nM,7870.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.87,CHEMBL378
1751,810492.0,[],CHEMBL697279,Anti-HIV-1 activity against syncytial plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC,CHEMBL1125670,J Med Chem,1991.0,CHEMBL28509,CHEMBL28509,,0.0,http://www.openphacts.org/units/Nanomolar,47361.0,=,1.0,1.0,=,IC50,nM,1400000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,1.4,CHEMBL378
1752,3406138.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc2oc(-c3ccccc3F)cc(=O)c2c1,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1215458,CHEMBL1215458,,0.0,http://www.openphacts.org/units/Nanomolar,933192.0,=,1.0,1.0,=,IC50,nM,205300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,205.3,CHEMBL378
1753,2929698.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSCc3cccc(C#N)c3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL565477,CHEMBL565477,8.20,0.0,http://www.openphacts.org/units/Nanomolar,852782.0,=,1.0,1.0,=,IC50,nM,6.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.3,CHEMBL378
1754,1035438.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CSc1ccc(NN2C(S)=NC(C)C2c2ccccc2)cc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL288427,CHEMBL288427,,0.0,http://www.openphacts.org/units/Nanomolar,62350.0,>,1.0,1.0,>,IC50,nM,53040.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,53.04,CHEMBL378
1755,6200541.0,[],CHEMBL1781474,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 4 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1777761,Bioorg Med Chem,2011.0,CHEMBL141,CHEMBL141,6.48,0.0,http://www.openphacts.org/units/Nanomolar,1425119.0,=,1.0,1.0,=,IC50,nM,330.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.33,CHEMBL613497
1756,13475613.0,[],CHEMBL2439262,Antiviral activity against Human immunodeficiency virus 1 clade E isolate ID12 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(C(N)=O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435858,CHEMBL2435858,8.40,0.0,http://www.openphacts.org/units/Nanomolar,1924234.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.0,CHEMBL378
1757,10961162.0,[],CHEMBL2061267,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M10 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCN(C=C1C(=O)Nc2ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)cc21)CC,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058324,CHEMBL2058324,7.39,0.0,http://www.openphacts.org/units/Nanomolar,1656264.0,=,1.0,1.0,=,IC50,nM,41.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,41.0,CHEMBL378
1758,646458.0,[],CHEMBL713946,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)CN1Cc2cccc3[nH]c(=O)n(c23)C(C(C)C)C1,CHEMBL1128252,J Med Chem,1995.0,CHEMBL69775,CHEMBL69775,4.90,0.0,http://www.openphacts.org/units/Nanomolar,326340.0,=,1.0,1.0,=,IC50,nM,12600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.6,CHEMBL378
1759,3292118.0,[],CHEMBL1108227,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1,CHEMBL1157775,Bioorg Med Chem Lett,2010.0,CHEMBL324643,CHEMBL324643,8.40,0.0,http://www.openphacts.org/units/Nanomolar,911142.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.0,CHEMBL378
1760,3284619.0,[],CHEMBL1110057,Antiviral activity against HIV1 3B infected in human HOS cells expressing human CXCR4/CCR5/CD4/pHIV-LTR luciferase assessed as inhibition of viral infection to cells,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(Cc1nc2ccccc2[nH]1)C1CCCc2cccnc21,CHEMBL1157822,Bioorg Med Chem Lett,2010.0,CHEMBL1088913,CHEMBL1088913,7.64,0.0,http://www.openphacts.org/units/Nanomolar,911199.0,=,1.0,1.0,=,IC50,nM,23.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,23.0,CHEMBL378
1761,18528864.0,[],CHEMBL4194999,Antiviral activity against HIV1 virions derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc([C@H]2c3cc(OC)c(OC)cc3C[C@@H]2C)cc1OC,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4205385,CHEMBL4205385,5.36,0.0,http://www.openphacts.org/units/Nanomolar,3076507.0,=,1.0,1.0,=,IC50,nM,4420.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.42,CHEMBL378
1762,2165101.0,[],CHEMBL921436,Antiviral activity against HIV1 with RT K103N/P225H mutation in human MT4 cells in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ccccc34)ccc2Cl)c1,CHEMBL1145601,Bioorg Med Chem Lett,2008.0,CHEMBL402823,CHEMBL402823,7.53,0.0,http://www.openphacts.org/units/Nanomolar,711002.0,=,1.0,1.0,=,IC50,nM,29.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,29.3,CHEMBL378
1763,14596873.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CCOCn1c(Sc2ccccc2)c(C(C)C)c(=O)[nH]c1=S,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL133036,CHEMBL133036,5.10,0.0,http://www.openphacts.org/units/Nanomolar,2082393.0,=,1.0,1.0,=,IC50,nM,7890.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.89,CHEMBL378
1764,2292365.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL299001,CHEMBL299001,5.00,0.0,http://www.openphacts.org/units/Nanomolar,812440.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.0,CHEMBL378
1765,594042.0,[],CHEMBL710534,Inhibitory activity against 188L strain of HIV-1 in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Cc3c(Cl)cccc3Cl)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL307297,CHEMBL307297,6.50,0.0,http://www.openphacts.org/units/Nanomolar,126949.0,=,1.0,1.0,=,IC50,nM,316.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.316,CHEMBL378
1766,994780.0,[],CHEMBL714338,"Antiviral activity against HIV-1, IIIB, in MT-4 Cells",F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CN[C@@H](C(=O)NC(C(=O)NCc2nc3ccccc3[nH]2)C(C)C)[C@H](O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)cc1,CHEMBL1129316,J Med Chem,1996.0,CHEMBL435379,CHEMBL435379,6.29,0.0,http://www.openphacts.org/units/Nanomolar,111253.0,=,1.0,1.0,=,IC50,nM,510.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,510.0,CHEMBL378
1767,15568210.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,COc1cc(CN2CCN(C(=O)/C=C/c3ccc(Br)cc3)CC2)cc(OC)c1,CHEMBL1201862,,,CHEMBL3560415,CHEMBL3560415,8.44,0.0,http://www.openphacts.org/units/Nanomolar,2474927.0,=,7.0,1.0,=,IC50,nM,3.64,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.00364,CHEMBL3259470
1768,1982315.0,[],CHEMBL899339,Antiviral activity against HBV transfected Hep G2.2.15 cells assessed as inhibition of e antigen HBsAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,COC1=CC(=O)[C@]2(CC[C@@]34C(OC)=C(OC)C(=O)C[C@]32CCN4C)[C@@H]1O,CHEMBL1149710,Bioorg Med Chem Lett,2007.0,CHEMBL237764,CHEMBL237764,,0.0,http://www.openphacts.org/units/Nanomolar,661656.0,>,1.0,1.0,>,IC50,nM,2926000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.926,CHEMBL613497
1769,13357749.0,[],CHEMBL2401183,Inhibition of recombinant VHX (unknown origin) using pNPP as substrate by spectrophotometric analysis,B,BAO_0000190,BAO_0000357,single protein format,CCCNC(=O)COc1ccc(-c2oc3cc(O)c(C(=O)O)cc3c2C#Cc2cccc(Cl)c2)cc1,CHEMBL2396532,J Med Chem,2013.0,CHEMBL2396718,CHEMBL2396718,5.54,0.0,http://www.openphacts.org/units/Nanomolar,1901945.0,=,1.0,1.0,=,IC50,nM,2900.0,CHEMBL2396507,Homo sapiens,Dual specificity protein phosphatase 15,9606,IC50,uM,UO_0000065,2.9,CHEMBL2396507
1770,338018.0,[],CHEMBL821329,Evaluated for 50% plaque inhibition of vaccinia virus replication in murine L929 cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nccc2c1ncn2C/C=C\[C@@H](O)CO,CHEMBL1124198,J Med Chem,1988.0,CHEMBL296880,CHEMBL296880,4.16,0.0,http://www.openphacts.org/units/Nanomolar,80420.0,=,1.0,1.0,=,IC50,nM,70000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,70.0,CHEMBL613493
1771,1048974.0,[],CHEMBL692262,Compound was tested for inhibition of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2C=C=CCO,CHEMBL1126199,J Med Chem,1992.0,CHEMBL313478,CHEMBL313478,,0.0,http://www.openphacts.org/units/Nanomolar,252798.0,>,1.0,1.0,>,IC50,nM,200000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,200.0,CHEMBL378
1772,1402270.0,[],CHEMBL834487,In vitro inhibitory concentration value against HIV K103N and Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCCN(CCCC)c1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL179736,CHEMBL179736,,0.0,http://www.openphacts.org/units/Nanomolar,360413.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1773,10866443.0,[],CHEMBL2025517,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HbeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@]3(O)[C@@H]2C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]2(C)[C@]3(O)CC[C@@]2(OC(=O)COC)C(C)=O)C1,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024041,CHEMBL2024041,,0.0,http://www.openphacts.org/units/Nanomolar,1639763.0,>,1.0,1.0,>,IC50,nM,1403120.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1403.12,CHEMBL613497
1774,2244604.0,[],CHEMBL1003077,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase V106A/Y181C mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(COc1ccc(Cl)cc1C(=O)c1ccccc1)Nc1ccccc1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL296939,CHEMBL296939,6.04,0.0,http://www.openphacts.org/units/Nanomolar,798577.0,=,1.0,1.0,=,IC50,nM,902.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,902.0,CHEMBL378
1775,10862042.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](OC(=O)c2cc(=O)c3ccccc3o2)CC[C@]2(C)[C@H]3CC=C4[C@@H]5C[C@@](C)(C(=O)OCC(N)=O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2023711,CHEMBL2023711,,0.0,http://www.openphacts.org/units/Nanomolar,1639320.0,>,1.0,1.0,>,IC50,nM,944060.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,944.06,CHEMBL613497
1776,2432637.0,[],CHEMBL1027472,Antiviral activity against HIV1 3B infected in human HOG.R5 assessed as inhibition of viral replication by microtiter assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1159344,J Nat Prod,2003.0,CHEMBL431525,CHEMBL431525,4.67,0.0,http://www.openphacts.org/units/Nanomolar,735818.0,=,1.0,1.0,=,IC50,nM,21400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,21.4,CHEMBL378
1777,830718.0,[],CHEMBL686566,Anti-HIV activity in H9 lymphocytes.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)oc2c3c(ccc12)OC(C)(C)[C@H](O)[C@@H]3OC(=O)C12CCC(C)(C(=O)O1)C2(C)C,CHEMBL1132174,J Med Chem,1999.0,CHEMBL90442,CHEMBL90442,,0.0,http://www.openphacts.org/units/Nanomolar,163834.0,>,1.0,1.0,>,IC50,nM,219000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,219.0,CHEMBL378
1778,2203561.0,[],CHEMBL987023,Antiviral activity against HIV1 3B in human MT4 cells assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,S=C(Nc1ccccc1)Nc1ccc(-c2n[nH]c(=S)n2-c2ccccc2)cc1,CHEMBL1149790,Eur J Med Chem,2008.0,CHEMBL46345,CHEMBL46345,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,765618.0,>,1.0,1.0,>,IC50,ug.mL-1,28.57,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,28.57,CHEMBL378
1779,2091754.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(C(F)(F)F)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL55186,CHEMBL55186,,0.0,http://www.openphacts.org/units/Nanomolar,700532.0,=,1.0,1.0,=,IC50,nM,11220184543019.65,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,4.05,CHEMBL378
1780,3129667.0,[],CHEMBL1065520,Antiviral activity against HIV1 LAI infected in human CEM-SS cells assessed as inhibition of viral replication by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1157689,Bioorg Med Chem,2010.0,CHEMBL129,CHEMBL129,8.29,0.0,http://www.openphacts.org/units/Nanomolar,880947.0,=,1.0,1.0,=,IC50,nM,5.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0051,CHEMBL378
1781,12687181.0,[],CHEMBL2344307,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral surface antigen production,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)O[C@H]1C[C@@H]2C(=CC[C@@H]3[C@@]2(C)C(=O)C[C@]2(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](O)C[C@@]32C)C(C)(C)[C@@H]1O,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332398,CHEMBL2332398,,0.0,http://www.openphacts.org/units/Nanomolar,1866092.0,>,1.0,1.0,>,IC50,nM,12400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,12.4,CHEMBL613497
1782,12680684.0,[],CHEMBL2342597,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral replication after 9 days by fluorescence PCR method,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1ccc(NC(=O)/C=C/c2coc3cc(OC)ccc3c2=O)cc1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333680,CHEMBL2333680,,0.0,http://www.openphacts.org/units/Nanomolar,1867756.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
1783,1830887.0,[],CHEMBL918634,Antiviral activity against wild type HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C(C#N)c2cccc3ccccc23)nc(SCC(=O)c2ccc(Cl)cc2)[nH]c1=O,CHEMBL1144474,J Med Chem,2007.0,CHEMBL222488,CHEMBL222488,,0.0,http://www.openphacts.org/units/Nanomolar,629304.0,>=,1.0,1.0,>=,IC50,nM,35730.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,35.73,CHEMBL378
1784,607858.0,[],CHEMBL710534,Inhibitory activity against 188L strain of HIV-1 in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Oc3c(Br)cc(Br)cc3Br)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL72459,CHEMBL72459,6.21,0.0,http://www.openphacts.org/units/Nanomolar,126891.0,=,1.0,1.0,=,IC50,nM,619.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.619,CHEMBL378
1785,22480472.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '120.0'}]",CHEMBL4687212,Antiviral activity against HIV-1 NL4-3 infected in human TZM-bl cells infected with supernatants from virus-infected human H9 cells treated with compound for 72 hrs assessed as reduction in luciferase expression measured after 48 hrs by luciferase reporter gene assay based BiCycle assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)CCc1cn(-c2ccc(NC(=O)Nc3ccccc3C(F)(F)F)cc2)nn1,CHEMBL4680261,Eur J Med Chem,2020.0,CHEMBL4795681,CHEMBL4795681,,0.0,http://www.openphacts.org/units/Nanomolar,3523693.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
1786,1421941.0,[],CHEMBL834672,Inhibitory activity against human immunodeficiency virus type 1,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(Sc2ccccc2)n(COCc2cccs2)c(=O)[nH]c1=O,CHEMBL1144258,Bioorg Med Chem Lett,2005.0,CHEMBL367608,CHEMBL367608,,0.0,http://www.openphacts.org/units/Nanomolar,364787.0,<,1.0,1.0,<,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
1787,1030474.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=CN(Nc2cccc(Cl)c2)C1c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL38470,CHEMBL38470,5.76,0.0,http://www.openphacts.org/units/Nanomolar,62371.0,=,1.0,1.0,=,IC50,nM,1730.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.73,CHEMBL378
1788,5222673.0,[],CHEMBL1675427,Antiviral activity against HIV1 harboring reverse transcriptase L74V mutant infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL129,CHEMBL129,6.68,0.0,http://www.openphacts.org/units/Nanomolar,1332027.0,=,1.0,1.0,=,IC50,nM,210.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.21,CHEMBL378
1789,602913.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1Oc1nc(N)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL421114,CHEMBL421114,6.48,0.0,http://www.openphacts.org/units/Nanomolar,126895.0,=,1.0,1.0,=,IC50,nM,333.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.333,CHEMBL378
1790,5222685.0,[],CHEMBL1675429,Antiviral activity against HIV1 harboring reverse transcriptase Q151M mutant infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL129,CHEMBL129,,0.0,http://www.openphacts.org/units/Nanomolar,1332027.0,=,1.0,1.0,=,IC50,nM,213700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,213.7,CHEMBL378
1791,3077003.0,[],CHEMBL1067297,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(=O)C2=C(C1)NC(c1ccncc1)=NC2c1ccc(F)cc1Cl,CHEMBL1153099,Bioorg Med Chem Lett,2010.0,CHEMBL595051,CHEMBL595051,5.31,0.0,http://www.openphacts.org/units/Nanomolar,876962.0,=,1.0,1.0,=,IC50,nM,4920.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,4.92,CHEMBL613497
1792,2930412.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CSCc3ccco3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL575884,CHEMBL575884,8.20,0.0,http://www.openphacts.org/units/Nanomolar,848311.0,=,1.0,1.0,=,IC50,nM,6.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.3,CHEMBL378
1793,15606355.0,[],CHEMBL3579358,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(/C=C/C(=O)O/N=C/c2ccco2)cc2c1OCO2,CHEMBL3576819,Eur J Med Chem,2015.0,CHEMBL3577794,CHEMBL3577794,4.20,0.0,http://www.openphacts.org/units/Nanomolar,2480534.0,=,1.0,1.0,=,IC50,nM,63510.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,63.51,CHEMBL613497
1794,2601930.0,[],CHEMBL1034012,Antiviral activity against influenza virus,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)c1c(O)n(O)c2cc(NC(=O)Nc3ccc(Cl)cc3)ccc12,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL276589,CHEMBL276589,4.42,0.0,http://www.openphacts.org/units/Nanomolar,807202.0,=,1.0,1.0,=,IC50,nM,38000.0,CHEMBL613128,unidentified influenza virus,unidentified influenza virus,11309,IC50,uM,UO_0000065,38.0,CHEMBL613128
1795,1502785.0,[],CHEMBL834971,Inhibitory concentration against hepatitis C virus NS3 protease (IC50 spans 2.5 log units),B,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H](C(=O)N[C@H](C(=O)C1C[C@H](Oc2ccc(-c3ccccc3)cc2)C[C@H]1C(=O)CC1(C(=O)O)CC1)C(C)C)C1CCCCC1,CHEMBL1143583,J Med Chem,2005.0,CHEMBL190345,CHEMBL190345,4.50,0.0,http://www.openphacts.org/units/Nanomolar,388884.0,=,1.0,1.0,=,IC50,nM,31622.78,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,Log 1/IC50,,UO_0000065,4.5,CHEMBL4620
1796,18950387.0,[],CHEMBL4331193,Inhibition of ASCT2 (unknown origin),B,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(COc2ccccc2CN(CC[C@H](N)C(=O)O)Cc2ccccc2OCc2cccc(C)c2)c1,CHEMBL4330073,Eur J Med Chem,2019.0,CHEMBL3754053,CHEMBL3754053,5.02,0.0,http://www.openphacts.org/units/Nanomolar,3161333.0,=,1.0,1.0,=,IC50,nM,9600.0,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,uM,UO_0000065,9.6,CHEMBL3562162
1797,1221004.0,[],CHEMBL880061,Inhibitory activity against LAI strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2nc(Nc3ccc(C#N)cc3)ncc2C)c(C)c1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL431378,CHEMBL431378,8.77,0.0,http://www.openphacts.org/units/Nanomolar,127440.0,=,1.0,1.0,=,IC50,nM,1.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0017,CHEMBL378
1798,1185423.0,[],CHEMBL880061,Inhibitory activity against LAI strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL57,CHEMBL57,7.50,0.0,http://www.openphacts.org/units/Nanomolar,127448.0,=,1.0,1.0,=,IC50,nM,32.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.032,CHEMBL378
1799,13933315.0,[],CHEMBL3124190,Antiviral activity against Hepatitis B virus assessed as inhibition of Hepatitis B virus DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C1=C(C)NC(c2ncc(F)cc2F)=N[C@H]1c1ccc(F)cc1Cl,CHEMBL3120134,Eur J Med Chem,2014.0,CHEMBL605300,CHEMBL605300,7.30,0.0,http://www.openphacts.org/units/Nanomolar,1969497.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nmol/L,UO_0000065,50.0,CHEMBL613497
1800,22845259.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4721683,Antiviral activity against HIV-1 ADA infected in human MOLT-4 cells assessed as reduction in viral transmission to TZM-bl cells incubated for 48 hrs by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4547005,CHEMBL4547005,6.00,0.0,http://www.openphacts.org/units/Nanomolar,3547094.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
1801,13933305.0,[],CHEMBL3124245,Antiviral activity against Hepatitis B virus,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)OC[C@H]1O[C@@H](Sc2nnc(-c3ccc(Cl)cc3)n2N)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,CHEMBL3120134,Eur J Med Chem,2014.0,CHEMBL3121572,CHEMBL3121572,4.20,0.0,http://www.openphacts.org/units/Nanomolar,1969518.0,=,1.0,1.0,=,IC50,nM,63000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol/L,UO_0000065,63.0,CHEMBL613497
1802,2362893.0,[],CHEMBL1026415,"Antiviral activity against multidrug-resistant HIV1 with protease L10I, L24I, I33F, E35D, M36I, N37S, M46L, I54V, R57K, I62V, L63P, A71V, G73S, V82A mutation in phytohemagglutininin-activated PBMC assessed as inhibition of p24G protein production",F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL1140100,J Med Chem,2008.0,CHEMBL1323,CHEMBL1323,7.58,0.0,http://www.openphacts.org/units/Nanomolar,747151.0,=,1.0,1.0,=,IC50,nM,26.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,26.0,CHEMBL378
1803,6172013.0,[],CHEMBL1769297,Antiviral activity against HIV1 harboring reverse transcriptase Y181C mutant infected in human MT-4 cells assessed as inhibition of virus-induced cytopathicity after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCN3CCCC3)[nH]c3ccc(Cl)cc23)c1,CHEMBL1765016,J Med Chem,2011.0,CHEMBL1766209,CHEMBL1766209,6.36,0.0,http://www.openphacts.org/units/Nanomolar,1417007.0,=,1.0,1.0,=,IC50,nM,442.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,442.0,CHEMBL378
1804,2183997.0,[],CHEMBL951605,Antiviral activity against HIV1 clinical isolate 10 infected in U87.CD4 cells expressing human wild type CXCR4,F,BAO_0000190,BAO_0000218,organism-based format,c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,CHEMBL1156482,J Biol Chem,2007.0,CHEMBL18442,CHEMBL18442,8.52,0.0,http://www.openphacts.org/units/Nanomolar,791970.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.0,CHEMBL378
1805,2602144.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2/C=C1/CC1(F)CO,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL224595,CHEMBL224595,4.92,0.0,http://www.openphacts.org/units/Nanomolar,807307.0,=,1.0,1.0,=,IC50,nM,12000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.0,CHEMBL378
1806,2506757.0,[],CHEMBL946752,Antiviral activity against HIV1 3B replication in human PBMC assessed as reverse transcriptase activity after 7 days,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCc3cccc(OC)c3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1141017,Bioorg Med Chem Lett,2008.0,CHEMBL504027,CHEMBL504027,7.85,0.0,http://www.openphacts.org/units/Nanomolar,752646.0,=,1.0,1.0,=,IC50,nM,14.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.014,CHEMBL378
1807,14654439.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)c3ccccc3)[C@H](O)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262999,CHEMBL3262999,4.69,0.0,http://www.openphacts.org/units/Nanomolar,2101882.0,=,1.0,1.0,=,IC50,nM,20600.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,20.6,CHEMBL613497
1808,22958192.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4768135,Antiviral activity against HIV1 NL4-3 Env-deficient pseudotype virus infected in human U87/CD4/CCR5 cells assessed by reduction in viral production in early stage measured after 48 hrs by luciferase activity based single-round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1[nH]c2ccccc2c1CC(=O)N[C@@H](Cc1ccccc1)C(=O)N(C)c1ccccc1,CHEMBL4765266,Eur J Med Chem,2020.0,CHEMBL1229713,CHEMBL1229713,7.25,0.0,http://www.openphacts.org/units/Nanomolar,3565135.0,=,1.0,1.0,=,IC50,nM,56.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.055999999999999994,CHEMBL378
1809,14594146.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2cccc(C(F)(F)F)c2)n(COCCO)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL440274,CHEMBL440274,5.36,0.0,http://www.openphacts.org/units/Nanomolar,2082339.0,=,1.0,1.0,=,IC50,nM,4350.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.35,CHEMBL378
1810,13463748.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cccc(Sc2cccc(N)c2C#N)c1,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL293806,CHEMBL293806,5.76,0.0,http://www.openphacts.org/units/Nanomolar,1920677.0,=,1.0,1.0,=,IC50,nM,1737.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.76,CHEMBL378
1811,24963893.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5216626,Antiviral activity against NNRTI resistant HIV1 harboring Tyr188Leu mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect measured after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Cc3c(Cl)cccc3Cl)n2)cc1,CHEMBL5214932,Eur J Med Chem,2022.0,CHEMBL307297,CHEMBL307297,6.50,0.0,http://www.openphacts.org/units/Nanomolar,3900014.0,=,1.0,1.0,=,IC50,nM,316.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.316,CHEMBL378
1812,6200539.0,[],CHEMBL1781474,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 4 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,c1csc(CN(CCc2c[nH]c3ccccc23)Cc2cccs2)c1,CHEMBL1777761,Bioorg Med Chem,2011.0,CHEMBL1779161,CHEMBL1779161,5.41,0.0,http://www.openphacts.org/units/Nanomolar,1425116.0,=,1.0,1.0,=,IC50,nM,3900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,3.9,CHEMBL613497
1813,15158628.0,[],CHEMBL3398832,Inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)OCc1cccc2c1CCOC2=O,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397172,CHEMBL3397172,,0.0,http://www.openphacts.org/units/Nanomolar,2278971.0,>,1.0,1.0,>,IC50,nM,2430000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.43,CHEMBL613497
1814,1402539.0,[],CHEMBL837467,In vitro inhibitory concentration against HIV K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL223228,CHEMBL223228,7.40,0.0,http://www.openphacts.org/units/Nanomolar,360371.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
1815,1066165.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(NN2C(S)=NC(C)C2c2cccc(C#N)c2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289913,CHEMBL289913,,0.0,http://www.openphacts.org/units/Nanomolar,62356.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1816,1439774.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL426242,CHEMBL426242,5.00,0.0,http://www.openphacts.org/units/Nanomolar,371451.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
1817,16449876.0,[],CHEMBL3757559,Inhibition of ASCT2-mediated glutamine transport in human HEK293 cells using [3H]-glutamine after 15 mins by scintillation counting,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1COc1ccccc1CN(CC[C@H](N)C(=O)O)Cc1ccccc1OCc1ccccc1C,CHEMBL3751750,Bioorg Med Chem Lett,2016.0,CHEMBL3753173,CHEMBL3753173,4.59,0.0,http://www.openphacts.org/units/Nanomolar,2744502.0,=,1.0,1.0,=,IC50,nM,25600.0,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,uM,UO_0000065,25.6,CHEMBL3562162
1818,599381.0,[],CHEMBL712878,Concentration required for 50% protection of MT-4 cells against the cytopathic effect of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1Cc2ccc(Br)c3nc(S)n(c23)C[C@@H]1C,CHEMBL1128253,J Med Chem,1995.0,CHEMBL432516,CHEMBL432516,5.97,0.0,http://www.openphacts.org/units/Nanomolar,327815.0,=,1.0,1.0,=,IC50,nM,1075.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.075,CHEMBL378
1819,15748664.0,[],CHEMBL3630970,Antiviral activity against HIV1 3B assessed as inhibition of viral attachment to human MAGI cells,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(C[C@@H]1CN(C(=O)c2ccccc2)CCN1)[C@H]1CCCc2cccnc21,CHEMBL3627700,Bioorg Med Chem Lett,2015.0,CHEMBL3627794,CHEMBL3627794,7.70,0.0,http://www.openphacts.org/units/Nanomolar,2506622.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.02,CHEMBL378
1820,3100370.0,[],CHEMBL1064779,Antiviral activity against HIV1 LAI in human CEM-SS cells assessed as RT activity after 5 days by single passage assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)Cc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)nc1N,CHEMBL1156918,J Med Chem,2010.0,CHEMBL607569,CHEMBL607569,,0.0,http://www.openphacts.org/units/Nanomolar,887736.0,>,1.0,1.0,>,IC50,nM,200000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,200.0,CHEMBL378
1821,189423.0,[],CHEMBL815090,Inhibition of HIV-1 (ADA) entry into U-87 (human glioblastoma) cells.,F,BAO_0000190,BAO_0000218,organism-based format,CCCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1,CHEMBL1136595,Bioorg Med Chem Lett,2003.0,CHEMBL140390,CHEMBL140390,9.05,0.0,http://www.openphacts.org/units/Nanomolar,317561.0,=,1.0,1.0,=,IC50,nM,0.89,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.89,CHEMBL378
1822,2238629.0,[],CHEMBL1000357,Antiviral activity against HIV 3B in human MT4 cells assessed as inhibition of viral replication by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Oc3ccc4cc(Br)ccc4c3)n2)cc1,CHEMBL1156684,Eur J Med Chem,2008.0,CHEMBL517591,CHEMBL517591,7.09,0.0,http://www.openphacts.org/units/Nanomolar,723385.0,=,1.0,1.0,=,IC50,nM,80.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0808,CHEMBL378
1823,14596836.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)c1c(Sc2ccccc2)n(COCCO)c(=S)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL278186,CHEMBL278186,5.14,0.0,http://www.openphacts.org/units/Nanomolar,2082356.0,=,1.0,1.0,=,IC50,nM,7230.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.23,CHEMBL378
1824,15156736.0,[],CHEMBL3399645,Decrease in HBV viral DNA replication in human HepG2(2.2.15) cells at 0.75 to 3 uM after 72 hrs by real-time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(C)=O)c(OS(=O)(=O)c2ccc(Cl)cc2)c1,CHEMBL3397002,Eur J Med Chem,2015.0,CHEMBL3397409,CHEMBL3397409,6.24,0.0,http://www.openphacts.org/units/Nanomolar,2279256.0,=,1.0,1.0,=,IC50,nM,570.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.57,CHEMBL613497
1825,22933278.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)/C=C/c4ccc(Cl)cc4)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4757204,CHEMBL4757204,6.44,0.0,http://www.openphacts.org/units/Nanomolar,3560839.0,=,1.0,1.0,=,IC50,nM,360.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.36,CHEMBL378
1826,561003.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(S(=O)(=O)c3ccc(NC(=O)c4ccccc4SSc4ccccc4C(=O)Nc4ccc(S(=O)(=O)c5ccc(NS(=O)(=O)c6ccc(NC(C)=O)cc6)cc5)cc4)cc3)cc2)cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL279627,CHEMBL279627,4.90,0.0,http://www.openphacts.org/units/Nanomolar,334008.0,=,1.0,1.0,=,IC50,nM,12700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.7,CHEMBL378
1827,1750523.0,[],CHEMBL868008,Antiviral activity against multi drug-resistant HIV1 TM variant in human PHA-PBMC cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL1146019,J Med Chem,2006.0,CHEMBL1323,CHEMBL1323,8.46,0.0,http://www.openphacts.org/units/Nanomolar,540003.0,=,1.0,1.0,=,IC50,nM,3.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.5,CHEMBL378
1828,2930179.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL566750,CHEMBL566750,8.20,0.0,http://www.openphacts.org/units/Nanomolar,852961.0,=,1.0,1.0,=,IC50,nM,6.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.3,CHEMBL378
1829,2003626.0,[],CHEMBL901910,Antiviral activity against Modoc virus-infected HeLa-H1 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C1C2CC3CC1CC(C(=O)Nc1ccc(-c4nc5cc(NC(=O)C67CC8CC(C6)C(=O)C(C8)C7)ncc5[nH]4)cc1)(C3)C2,CHEMBL1138288,J Med Chem,2007.0,CHEMBL395451,CHEMBL395451,,0.0,http://www.openphacts.org/units/Nanomolar,666658.0,>,1.0,1.0,>,IC50,nM,600.0,CHEMBL612946,Modoc virus,Modoc virus,64300,IC50,nM,UO_0000065,600.0,CHEMBL612946
1830,628391.0,[],CHEMBL689615,Reduction of viral load in the cell supernatant.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2ccc(/C=C/c3ccc(O)cc3)nc2c1O,CHEMBL1135622,J Med Chem,2002.0,CHEMBL418613,CHEMBL418613,4.02,0.0,http://www.openphacts.org/units/Nanomolar,275328.0,=,1.0,1.0,=,IC50,nM,95000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,95.0,CHEMBL378
1831,2929618.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3cnc(C)n3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL573185,CHEMBL573185,7.00,0.0,http://www.openphacts.org/units/Nanomolar,848238.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,100.0,CHEMBL378
1832,6200482.0,[],CHEMBL1781474,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 4 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(CN(CCc2c[nH]c3ccccc23)Cc2ccccn2)nc1,CHEMBL1777761,Bioorg Med Chem,2011.0,CHEMBL1779159,CHEMBL1779159,,0.0,http://www.openphacts.org/units/Nanomolar,1425114.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,25.0,CHEMBL613497
1833,2602221.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N[C@@H](CC(C)C)C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL279562,CHEMBL279562,5.49,0.0,http://www.openphacts.org/units/Nanomolar,808044.0,=,1.0,1.0,=,IC50,nM,3220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.22,CHEMBL378
1834,2602152.0,[],CHEMBL1033990,Antiviral activity against Hepatitis B virus,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2/C=C1\CC1(F)CO,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL375155,CHEMBL375155,4.82,0.0,http://www.openphacts.org/units/Nanomolar,807311.0,=,1.0,1.0,=,IC50,nM,15000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,15.0,CHEMBL613497
1835,1199857.0,[],CHEMBL710530,Inhibitory activity against 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(C)cc(C#N)cc1C,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL308004,CHEMBL308004,8.77,0.0,http://www.openphacts.org/units/Nanomolar,127441.0,=,1.0,1.0,=,IC50,nM,1.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0017,CHEMBL378
1836,2614820.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOc1cc(C)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL55997,CHEMBL55997,,0.0,http://www.openphacts.org/units/Nanomolar,732152.0,=,1.0,1.0,=,IC50,nM,599791.08,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,3.222,CHEMBL378
1837,2601941.0,[],CHEMBL1034012,Antiviral activity against influenza virus,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc2c(c1)N(O)C(=O)/C2=C(\O)c1ccccc1)c1ccc(NS(=O)(=O)c2cccs2)cc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL517275,CHEMBL517275,4.32,0.0,http://www.openphacts.org/units/Nanomolar,806859.0,=,1.0,1.0,=,IC50,nM,48000.0,CHEMBL613128,unidentified influenza virus,unidentified influenza virus,11309,IC50,uM,UO_0000065,48.0,CHEMBL613128
1838,3267401.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1[C@H](C)Cn2c(=S)[nH]c3cc(Cl)cc(c32)[C@H]1C,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL164075,CHEMBL164075,6.32,0.0,http://www.openphacts.org/units/Nanomolar,906988.0,=,1.0,1.0,=,IC50,nM,478.63,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.32,CHEMBL378
1839,668546.0,[],CHEMBL713946,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,S=c1[nH]c2cccc3c2n1C(Cc1ccccc1)C(Cc1ccccc1)N(CC1CC1)C3,CHEMBL1128252,J Med Chem,1995.0,CHEMBL166809,CHEMBL166809,,0.0,http://www.openphacts.org/units/Nanomolar,326397.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
1840,619393.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Oc3c(F)cc(F)cc3F)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL307474,CHEMBL307474,5.44,0.0,http://www.openphacts.org/units/Nanomolar,126916.0,=,1.0,1.0,=,IC50,nM,3650.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.65,CHEMBL378
1841,1471708.0,[],CHEMBL834620,Inhibitory activity against HIV-1 mutant strain 188L; ND = not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cccc(C)c1C,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188595,CHEMBL188595,,0.0,http://www.openphacts.org/units/Nanomolar,381003.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1842,22449747.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.5', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.5'}]",CHEMBL4680706,Antiviral activity against HIV1 YU-2 infected in dog Cf2Th/CD4-CCR5 cells assessed as inhibition of viral entry incubated for 30 mins prior to infection and measured after 48 hrs post infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CNCc1ccc2c(c1)C[C@H](CNC(=N)N)[C@H]2NC(=O)C(=O)Nc1ccc(Cl)c(F)c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4680075,ACS Med Chem Lett,2016.0,CHEMBL4794754,CHEMBL4803962,5.89,0.0,http://www.openphacts.org/units/Nanomolar,3518672.0,=,1.0,1.0,=,IC50,nM,1300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.3,CHEMBL378
1843,3358047.0,[],CHEMBL1175765,Antiviral activity against HIV1 expressing reverse transcriptase G190A mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3Cl)CC2)ncc1Br,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1171403,CHEMBL1171403,8.22,0.0,http://www.openphacts.org/units/Nanomolar,921747.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.0,CHEMBL378
1844,19261880.0,[],CHEMBL4404375,Antiviral activity against HIV1 subtypeAE CRF01_AE clone 269,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.39,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,410.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.41,CHEMBL378
1845,822570.0,[],CHEMBL692690,In vitro inhibition of Hepatitis C polymerase.,B,BAO_0000190,BAO_0000357,single protein format,CC1CCC(C(=O)N(c2cc(-c3ccccc3)sc2C(=O)O)C(C)C)CC1,CHEMBL1137940,Bioorg Med Chem Lett,2004.0,CHEMBL352911,CHEMBL352911,5.82,0.0,http://www.openphacts.org/units/Nanomolar,327697.0,=,1.0,1.0,=,IC50,nM,1500.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,1.5,CHEMBL4620
1846,18382598.0,[],CHEMBL4146260,Antiviral activity against lamivudine/entecavir resistant HBV harboring reverse transcriptase L180M/M204V/T184L mutant infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 72 hrs by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(N[C@H](CO)Cc1ccccc1)/C(NC(=O)c1ccccc1)=C(/Br)c1ccc(O)cc1,CHEMBL4145455,Eur J Med Chem,2018.0,CHEMBL4174829,CHEMBL4174829,5.53,0.0,http://www.openphacts.org/units/Nanomolar,3051094.0,=,1.0,1.0,=,IC50,nM,2970.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.97,CHEMBL613497
1847,6257658.0,[],CHEMBL1798704,Antiviral activity against HIV1 3B infected in human MT4 cells coinjected with HTLV1 assessed as reduction in virus induced cytopathicity measured 5 days post infection by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1ccn([C@@H]2C=C[C@@]3(CO)C[C@@H]23)c(=O)[nH]1,CHEMBL1795267,Bioorg Med Chem,2011.0,CHEMBL1795529,CHEMBL1795529,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1435340.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,100.0,CHEMBL378
1848,24971687.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5218444,Anti-HIV activity against HIV-1 NL4-3 Nanoluc-sec virus infected in human MT4 cells assessed as viral growth inhibition by measuring luciferase activity measured after 3 days post-infection by Nano-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@]12C[C@@H](C)[C@]34OC5(CCCCCCC[C@@H](C)[C@@H]6[C@@H]3[C@@](O)(C(=O)[C@@]6(C)O)[C@H](O)[C@@]3(CO)O[C@H]3[C@H]4[C@H]1O5)O2,CHEMBL5215012,J Nat Prod,2022.0,CHEMBL5220009,CHEMBL5220009,7.04,0.0,http://www.openphacts.org/units/Nanomolar,3902009.0,=,1.0,1.0,=,IC50,nM,91.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,91.9,CHEMBL378
1849,1402205.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177744,CHEMBL177744,8.30,0.0,http://www.openphacts.org/units/Nanomolar,360400.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.005,CHEMBL378
1850,43591.0,[],CHEMBL695508,Antiviral activity against E138K strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL57,CHEMBL57,,0.0,http://www.openphacts.org/units/Nanomolar,20821.0,>,1.0,1.0,>,IC50,nM,65.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,65.0,CHEMBL378
1851,19472244.0,[],CHEMBL4478789,Antiviral activity against wild type HIV1 NL4-3,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL4477221,J Med Chem,2016.0,CHEMBL175691,CHEMBL175691,9.05,0.0,http://www.openphacts.org/units/Nanomolar,3256043.0,=,1.0,1.0,=,IC50,nM,0.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0009,CHEMBL378
1852,95433.0,[],CHEMBL808329,The compound was tested in vitro for the inhibitory concentration against influenza B/Mem/89 sialidase from whole virus by MUN assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc(C(=O)O)cc1O,CHEMBL1128587,J Med Chem,1995.0,CHEMBL1145,CHEMBL1145,,0.0,http://www.openphacts.org/units/Nanomolar,206081.0,>,1.0,1.0,>,IC50,nM,10000000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,mM,UO_0000065,10.0,CHEMBL613129
1853,6344569.0,[],CHEMBL1825887,Antiviral activity against HIV1 HxB2 infected in human TZM-bl cells assessed as inhibition of virus neutralization after 48 hrs by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCNc1nc(N)c2ncn([C@@H]3O[C@@]4(CO)CO[C@@H]3[C@@H]4OCc3ccccc3)c2n1,CHEMBL1821725,Bioorg Med Chem,2011.0,CHEMBL1821970,CHEMBL1821970,4.55,0.0,http://www.openphacts.org/units/Nanomolar,1452383.0,=,1.0,1.0,=,IC50,nM,28000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,28.0,CHEMBL378
1854,22845180.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721659,Antiviral activity against pseudovirus HIV-1 HXB-2 subtype B harboring pseudotyped Env p9021_14.B2.4571 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4547005,CHEMBL4547005,6.66,0.0,http://www.openphacts.org/units/Nanomolar,3547094.0,=,1.0,1.0,=,IC50,nM,220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.22,CHEMBL378
1855,2930151.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSCc3ccco3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567204,CHEMBL567204,9.00,0.0,http://www.openphacts.org/units/Nanomolar,852794.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
1856,15571661.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,Cc1cc(CN2CCN(C(=O)/C=C/c3ccc(Br)cc3)CC2)ccc1F,CHEMBL1201862,,,CHEMBL3561756,CHEMBL3561756,8.82,0.0,http://www.openphacts.org/units/Nanomolar,2477188.0,=,7.0,1.0,=,IC50,nM,1.5,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.0015,CHEMBL3259470
1857,16466896.0,[],CHEMBL3766104,Antiviral activity against HIV1 NL4-3 infected in TZM-bl cells incubated for 3 hrs measured after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=[N+]([O-])c1ccc(-c2n[nH]c(O)c2Cc2cccc(Cl)c2)cc1,CHEMBL3763152,Bioorg Med Chem Lett,2016.0,CHEMBL3763760,CHEMBL3763760,,0.0,http://www.openphacts.org/units/Nanomolar,2756657.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
1858,22983732.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '144.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '6.0'}]",CHEMBL4773497,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication supplemented with fresh medium containing compound every 2 days for 6 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)CCOc1ccc2nc(SCc3ccccc3)n(Cc3ccco3)c(=O)c2c1,CHEMBL4765418,Eur J Med Chem,2020.0,CHEMBL4800336,CHEMBL4800336,6.20,0.0,http://www.openphacts.org/units/Nanomolar,3569412.0,=,1.0,1.0,=,IC50,nM,630.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.63,CHEMBL613497
1859,558782.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)NS(=O)(=O)c1ccc(NC(=O)c2ccccc2SSc2ccccc2C(=O)Nc2ccc(S(=O)(=O)NC(C)=O)cc2)cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL355871,CHEMBL355871,,0.0,http://www.openphacts.org/units/Nanomolar,333980.0,>,1.0,1.0,>,IC50,nM,200000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,200.0,CHEMBL378
1860,15159557.0,[],CHEMBL3398834,Inhibition of HBV DNA replication in HepG2(2.2.15) cells exposed to fresh medium supplemented with compound every other day for additional 5 days by real-time PCR-fluorescent probing method,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)OCc1cccc2c1CCOC2=O,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397172,CHEMBL3397172,,0.0,http://www.openphacts.org/units/Nanomolar,2278971.0,>,1.0,1.0,>,IC50,nM,860000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.86,CHEMBL613497
1861,1750571.0,[],CHEMBL868011,Antiviral activity against multi drug-resistant HIV1 K variant in human PHA-PBMC cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,CHEMBL1146019,J Med Chem,2006.0,CHEMBL584,CHEMBL584,,0.0,http://www.openphacts.org/units/Nanomolar,540001.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
1862,3084548.0,[],CHEMBL1065275,Antiviral activity against HIV1 3B laboratory isolate assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(NC(=O)C(=O)Nc2ccccc2)CC(C)(C)N1,CHEMBL1153139,Bioorg Med Chem Lett,2010.0,CHEMBL610054,CHEMBL610054,,0.0,http://www.openphacts.org/units/Nanomolar,873913.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1863,1210456.0,[],CHEMBL710530,Inhibitory activity against 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1Cl,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72205,CHEMBL72205,8.59,0.0,http://www.openphacts.org/units/Nanomolar,127443.0,=,1.0,1.0,=,IC50,nM,2.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0026,CHEMBL378
1864,18399211.0,[],CHEMBL4149755,Inhibition of human Pit-2 expressed in HEK293 cells coexpressing tetracyclin assessed as reduction in uptake of 33P-radiolabeled Pi incubated for 20 to 30 mins prior to substrate addition,B,BAO_0000190,BAO_0000219,cell-based format,Cc1[nH]c2c(N3CCC(O)CC3)c(C#N)c(C(F)(F)F)nc2c1Cl,CHEMBL4145593,ACS Med Chem Lett,2018.0,CHEMBL4176684,CHEMBL4176684,,0.0,http://www.openphacts.org/units/Nanomolar,3053879.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL4295806,Homo sapiens,Sodium-dependent phosphate transporter 2,9606,IC50,uM,UO_0000065,25.0,CHEMBL4295806
1865,10981191.0,[],CHEMBL2065764,Antiviral activity against Human immunodeficiency virus 1 infected in human 293T cells assessed as inhibition of viral replication after 48 hrs by luminescence analysis,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL2062389,ACS Med Chem Lett,2012.0,CHEMBL57,CHEMBL57,7.06,0.0,http://www.openphacts.org/units/Nanomolar,1659050.0,=,1.0,1.0,=,IC50,nM,87.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.087,CHEMBL378
1866,691065.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,CSSCc1ccccc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL95973,CHEMBL95973,,0.0,,228585.0,=,1.0,0.0,=,IC50,,22.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,22.1,CHEMBL378
1867,18320103.0,[],CHEMBL4134181,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA level incubated for 3 days followed by medium replacement measured after 3 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C2CCCN2C(c2nccs2)=NC1c1ccc(F)cc1F,CHEMBL4130455,ACS Med Chem Lett,2017.0,CHEMBL4162381,CHEMBL4162381,6.29,0.0,http://www.openphacts.org/units/Nanomolar,3041698.0,=,1.0,1.0,=,IC50,nM,510.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.51,CHEMBL613497
1868,15168050.0,[],CHEMBL3406882,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as HBeAg secretion after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)Nc1nc2nc(C(=O)c3ccc(O)c(OC)c3)ccc2[nH]1,CHEMBL3399962,Bioorg Med Chem,2015.0,CHEMBL3401082,CHEMBL3401082,4.60,0.0,http://www.openphacts.org/units/Nanomolar,2281858.0,=,1.0,1.0,=,IC50,nM,25100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,25.1,CHEMBL613497
1869,3457975.0,[],CHEMBL1249120,Inhibition of AP1 expressed in HEK293 cells assessed as inhibition of PMA-induced transcriptional activation treated 24 hrs before PMA challenge by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(-c2ccccc2)c(-c2nc3ccccc3c(=O)n2-c2ccc(Cl)cc2)s1,CHEMBL1240423,Eur J Med Chem,2010.0,CHEMBL1242795,CHEMBL1242795,,0.0,http://www.openphacts.org/units/Nanomolar,954158.0,>,1.0,1.0,>,IC50,nM,500000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,500.0,CHEMBL4977
1870,1016108.0,[],CHEMBL714338,"Antiviral activity against HIV-1, IIIB, in MT-4 Cells",F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CN[C@@H](C(=O)NC(C(=O)NCc2nc3ccccc3[nH]2)c2ccccc2)[C@H](O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)cc1,CHEMBL1129316,J Med Chem,1996.0,CHEMBL305100,CHEMBL305100,6.42,0.0,http://www.openphacts.org/units/Nanomolar,111218.0,=,1.0,1.0,=,IC50,nM,380.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,380.0,CHEMBL378
1871,1470162.0,[],CHEMBL832527,Inhibitory activity against HIV-1 double mutants strain 227L and 106A,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL366692,CHEMBL366692,6.41,0.0,http://www.openphacts.org/units/Nanomolar,380699.0,=,1.0,1.0,=,IC50,nM,390.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.39,CHEMBL378
1872,1830872.0,[],CHEMBL918634,Antiviral activity against wild type HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C(=O)c2cccc3ccccc23)nc(SC(C)C)[nH]c1=O,CHEMBL1144474,J Med Chem,2007.0,CHEMBL222609,CHEMBL222609,5.17,0.0,http://www.openphacts.org/units/Nanomolar,629319.0,=,1.0,1.0,=,IC50,nM,6790.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.79,CHEMBL378
1873,18469032.0,[],CHEMBL4182244,Antiviral activity against HIV-1 3B infected in human TZM-bl cells treated for 2 hrs followed by compound washout measured after 2 days by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NC(C)C(=O)NCC(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/NC(C)C(=O)NCC(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+],CHEMBL4177704,Bioorg Med Chem Lett,2018.0,CHEMBL4206440,CHEMBL4301014,5.37,0.0,http://www.openphacts.org/units/Nanomolar,3065392.0,=,1.0,1.0,=,IC50,nM,4280.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,umol/L,UO_0000065,4.28,CHEMBL378
1874,2527514.0,[],CHEMBL1003778,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect albumin after 5 days by MTS method in presence of 40 mg/mL human serum albumin,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1c(O)c2ncc(Cc3ccccc3)cc2[nH]c1=O,CHEMBL1138484,J Med Chem,2009.0,CHEMBL523309,CHEMBL523309,,0.0,,735624.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1875,2601737.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@@H]2C=C(F)[C@H](CO)O2)c(=O)nc1O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL475712,CHEMBL475712,4.00,0.0,http://www.openphacts.org/units/Nanomolar,807651.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1876,22933248.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)/C=C/c4cccs4)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4754117,CHEMBL4754117,7.49,0.0,http://www.openphacts.org/units/Nanomolar,3560858.0,=,1.0,1.0,=,IC50,nM,32.36,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.49,CHEMBL378
1877,1402528.0,[],CHEMBL837462,In vitro inhibitory concentration against HIV E138K mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL57,CHEMBL57,7.30,0.0,http://www.openphacts.org/units/Nanomolar,360370.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.05,CHEMBL378
1878,16422830.0,[],CHEMBL3751454,Antiviral activity against recombinant HIV-1 NL4-3 expressing HIV-1 JR-CSF envelope infected in U87.CD4.CCR5 cells assessed as inhibition of Env mediated cell entry by HIV-1 single round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CC4CN(C(=O)C5=CCCCC5)CC4C3)c12,CHEMBL3745657,Bioorg Med Chem Lett,2016.0,CHEMBL3353052,CHEMBL3353052,8.70,0.0,http://www.openphacts.org/units/Nanomolar,2740458.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
1879,5230641.0,[],CHEMBL1680052,Antiviral activity against HIV-1 Bal infected in human PM1 cells after 7 days by RT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1671644,Antimicrob Agents Chemother,2009.0,CHEMBL70663,CHEMBL70663,8.22,0.0,http://www.openphacts.org/units/Nanomolar,1331935.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.0,CHEMBL378
1880,23228475.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '36.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '36.0'}]",CHEMBL4826198,Antiviral activity against Human hepatitis B virus in Huh-7 cells assessed as reduction in intracellular viral DNA level incubated for 36 hrs by qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CS(=O)(=O)c1nc(Nc2cc(F)c(F)c(F)c2)cc(NC2CCC(N)CC2)n1,CHEMBL4825668,J Med Chem,2021.0,CHEMBL4877397,CHEMBL4877397,6.54,0.0,http://www.openphacts.org/units/Nanomolar,3613093.0,=,1.0,1.0,=,IC50,nM,292.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.292,CHEMBL613497
1881,1206553.0,[],CHEMBL710537,Inhibitory activity against 188L strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Sc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70863,CHEMBL70863,7.70,0.0,http://www.openphacts.org/units/Nanomolar,127465.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.02,CHEMBL378
1882,413228.0,[],CHEMBL756141,Inhibition of human peripheral blood mononuclear cell (PBMC)donor B proliferation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCC(=O)CC(=O)N[C@H]1CCOC1=O,CHEMBL1145979,J Med Chem,2003.0,CHEMBL8463,CHEMBL8463,4.82,0.0,http://www.openphacts.org/units/Nanomolar,4336.0,=,1.0,1.0,=,IC50,nM,15000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,15.0,CHEMBL378
1883,2362882.0,[],CHEMBL1026418,Antiviral activity against multidrug-resistant HIV1/C with protease mutation in phytohemagglutininin-activated PBMC assessed as inhibition of p24G protein production,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2CCOCOC2)cc1,CHEMBL1140100,J Med Chem,2008.0,CHEMBL492254,CHEMBL492254,6.68,0.0,http://www.openphacts.org/units/Nanomolar,746805.0,=,1.0,1.0,=,IC50,nM,210.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,210.0,CHEMBL378
1884,6200479.0,[],CHEMBL1781474,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 4 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)CCc1c[nH]c2ccccc12,CHEMBL1777761,Bioorg Med Chem,2011.0,CHEMBL142936,CHEMBL142936,,0.0,http://www.openphacts.org/units/Nanomolar,1425107.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
1885,593058.0,[],CHEMBL712878,Concentration required for 50% protection of MT-4 cells against the cytopathic effect of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1cc2c3c(c1)[nH]c(=O)n3C[C@H](C)N(CC1CC1)C2,CHEMBL1128253,J Med Chem,1995.0,CHEMBL352555,CHEMBL352555,,0.0,http://www.openphacts.org/units/Nanomolar,327824.0,=,1.0,1.0,=,IC50,nM,159000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,159.0,CHEMBL378
1886,525669.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc([S+]([O-])c2cccc(N)c2C#N)cc1,CHEMBL1134494,J Med Chem,2001.0,CHEMBL54487,CHEMBL54487,,0.0,http://www.openphacts.org/units/Nanomolar,94241.0,>,1.0,1.0,>,IC50,nM,200000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,200.0,CHEMBL378
1887,3229727.0,[],CHEMBL1113200,Antiviral activity against recombinant HIV1 virus infected in human JC53BL cells after 3 days,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC1N(CC2CCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2,CHEMBL1154224,Bioorg Med Chem Lett,2009.0,CHEMBL1077989,CHEMBL1077989,,0.0,http://www.openphacts.org/units/Nanomolar,897937.0,>,1.0,1.0,>,IC50,nM,625.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,625.0,CHEMBL378
1888,13967467.0,[],CHEMBL3135324,Antiviral activity against HIV1 VSVG harboring reverse transcriptase Y181C mutant infected in 293ET cellsassessed as inhibition of viral replication by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)OC(=O)c1sccc1S(=O)(=O)N1c2cc(Cl)ccc2NC(=O)C1C,CHEMBL3132804,Medchemcomm,2014.0,CHEMBL3133047,CHEMBL3133047,,0.0,http://www.openphacts.org/units/Nanomolar,1974718.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
1889,15200445.0,[],CHEMBL3413997,Antiviral activity against X4 tropic HIV-1 clone pNL4-3 infected in H9 cells assessed as reduction in p24 antigen after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C=C(\C#N)c2nc3ccccc3[nH]2)cc1OC,CHEMBL3407469,Eur J Med Chem,2015.0,CHEMBL1933870,CHEMBL1933870,,0.0,http://www.openphacts.org/units/Nanomolar,2288860.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
1890,701699.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)c1ccc(C=Nc2ccc(SSc3ccc(N=Cc4ccc(N(C)C)cc4)cc3)cc2)cc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120642,CHEMBL120642,,0.0,,228672.0,=,1.0,0.0,=,IC50,,25.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,25.0,CHEMBL378
1891,6200484.0,[],CHEMBL1781474,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 4 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC[N+]([O-])(CC)CCc1c[nH]c2ccccc12,CHEMBL1777761,Bioorg Med Chem,2011.0,CHEMBL1779165,CHEMBL1779165,,0.0,http://www.openphacts.org/units/Nanomolar,1425121.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
1892,18323336.0,[],CHEMBL4134874,Antiviral activity against VSV-G pseudotyped HIV1 infected in human SupT1 cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)[C@@]1(Cc2ccc3c(c2)C[C@H](O)C(C)(C)O3)OC(=O)C(OC)=C1c1ccc(O)cc1,CHEMBL4130477,J Nat Prod,2017.0,CHEMBL4173012,CHEMBL4173012,4.32,0.0,http://www.openphacts.org/units/Nanomolar,3042105.0,=,1.0,1.0,=,IC50,nM,48000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,48.0,CHEMBL378
1893,2371527.0,[],CHEMBL1035743,Antiviral activity against HIV1 with reverse transcriptase V179E mutant in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ncccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL491019,CHEMBL491019,,0.0,,773465.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1894,2099777.0,[],CHEMBL949220,Antiviral activity against HIV1 BaL by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(F)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL408512,CHEMBL408512,8.05,0.0,http://www.openphacts.org/units/Nanomolar,699413.0,=,1.0,1.0,=,IC50,nM,9.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.009,CHEMBL378
1895,2947397.0,[],CHEMBL1038495,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)OC(C)(C)[C@H](OC(=O)c1ccccc1)[C@H](C[C@@H](C)C1=C2C[C@H](OC(=O)c3ccccc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)OC(=O)c1ccccc1,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL584997,CHEMBL584997,,0.0,http://www.openphacts.org/units/Nanomolar,850767.0,>,1.0,1.0,>,IC50,nM,1700000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.7,CHEMBL613497
1896,2930419.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCS(=O)(=O)Cc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL566546,CHEMBL566546,8.10,0.0,http://www.openphacts.org/units/Nanomolar,852916.0,=,1.0,1.0,=,IC50,nM,7.94,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.94,CHEMBL378
1897,1251118.0,[],CHEMBL652108,Inhibitory concentration required to inhibit HIV-induced cytopathicity in CEM-4 cells by 50% based in the MTT assay; Not active,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N(CC)CCCCCCCCCCC(=O)NCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL385443,CHEMBL1207278,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221527.0,,1.0,0.0,,IC50,ug.mL-1,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,,CHEMBL378
1898,10937533.0,[],CHEMBL2051603,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4cc(C(F)(F)F)cc(C(F)(F)F)c4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046587,CHEMBL2046587,,0.0,http://www.openphacts.org/units/Nanomolar,1651471.0,>,1.0,1.0,>,IC50,nM,320830.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,320.83,CHEMBL613497
1899,18057374.0,[],CHEMBL4012529,Antiviral activity against HBV infected in human HepaRG cells assessed as reduction in viral infection after 16 hrs,F,BAO_0000190,BAO_0000219,cell-based format,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,CHEMBL4011615,J Med Chem,2017.0,CHEMBL160,CHEMBL160,,0.0,http://www.openphacts.org/units/Nanomolar,2992836.0,<,1.0,1.0,<,IC50,nM,200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.2,CHEMBL613497
1900,2601656.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2ccc(/C=C/c3cccnc3)nc2c1O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL39143,CHEMBL39143,4.00,0.0,http://www.openphacts.org/units/Nanomolar,807394.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1901,1471596.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cccc(C)c1C,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188595,CHEMBL188595,7.00,0.0,http://www.openphacts.org/units/Nanomolar,381003.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
1902,11014403.0,[],CHEMBL2089834,Antiviral activity against HIV1 in human TZM-bl cells assessed as viral infectivity by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@]3(C)COC(c4ccc(O)cc4)O[C@@H]3CC[C@@]2(C)[C@@H]1C/C=C1/C(=O)OC[C@H]1O,CHEMBL2086289,Eur J Med Chem,2012.0,CHEMBL2088488,CHEMBL2088488,5.68,0.0,http://www.openphacts.org/units/Nanomolar,1675624.0,=,1.0,1.0,=,IC50,nM,2100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.1,CHEMBL378
1903,19450604.0,[],CHEMBL4433618,Antiviral activity against wild-type HIV1 NL4-3 infected in human TZM-bl cells infected with supernatants from virus-infected human MT2 cells treated with compound for 72 hrs assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay based monocycle assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(-c2ccc(OCc3cccc(C(=O)NCCNC(=O)c4ccc(COc5ccccc5-c5csc(N)n5)cc4)c3)cc2)cs1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4515612,CHEMBL4598021,5.30,0.0,http://www.openphacts.org/units/Nanomolar,3249748.0,=,1.0,1.0,=,IC50,nM,5000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.0,CHEMBL378
1904,19261834.0,[],CHEMBL4404359,Antiviral activity against HIV1 subtypeA QB726.70M.ENV.C4,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.51,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.31,CHEMBL378
1905,6335922.0,[],CHEMBL1820052,"Antiviral activity against multidrug-resistant Human immunodeficiency virus 1 MDR/G harboring protease L10I, V11I, T12E, I15 V, L19I, R41K, M46L, L63P, A71T, V82A, L90 M mutation infected in PHA-stimulated human PBMC assessed as inhibition of p24 Gag protein production",F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2C[C@@H]3[C@H](O)CO[C@@H]3C2)cc1,CHEMBL1817554,J Med Chem,2011.0,CHEMBL1819290,CHEMBL1819290,6.57,0.0,http://www.openphacts.org/units/Nanomolar,1451702.0,=,1.0,1.0,=,IC50,nM,270.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.27,CHEMBL378
1906,943345.0,[],CHEMBL712257,Inhibition of human immunodeficiency virus-1 (HIV-1) induced cytopathicity in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1nc2nc(N)nc(O)c2n1)OCP(=O)(O)O,CHEMBL1129435,J Med Chem,1996.0,CHEMBL132120,CHEMBL132120,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251942.0,=,1.0,1.0,=,IC50,ug.mL-1,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,20.0,CHEMBL378
1907,3056506.0,[],CHEMBL1064575,Antiviral activity against HIV1 infected in human PBMC assessed as inhibition of viral p24 antigen production after 7 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCOC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)CS1,CHEMBL1152525,Bioorg Med Chem,2009.0,CHEMBL593728,CHEMBL593728,6.70,0.0,http://www.openphacts.org/units/Nanomolar,875997.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.2,CHEMBL378
1908,3104768.0,[],CHEMBL1074496,Antiviral activity against HIV1 LAI in human MT2 cells after 7 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1CNC(=O)[C@H]1N(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CCOC2)CSC1(C)C,CHEMBL1159037,Bioorg Med Chem Lett,2010.0,CHEMBL603666,CHEMBL603666,,0.0,,883163.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
1909,18399195.0,[],CHEMBL4149754,Inhibition of human Pit-1 expressed in HEK293 cells coexpressing tetracyclin assessed as reduction in uptake of 33P-radiolabeled Pi incubated for 20 to 30 mins prior to substrate addition,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc2nc(C(F)(F)F)c(C#N)c(N3CCC4(CCNC4=O)CC3)c2[nH]1,CHEMBL4145593,ACS Med Chem Lett,2018.0,CHEMBL4164691,CHEMBL4164691,,0.0,http://www.openphacts.org/units/Nanomolar,3053875.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL4295909,Homo sapiens,Sodium-dependent phosphate transporter 1,9606,IC50,uM,UO_0000065,25.0,CHEMBL4295909
1910,10961104.0,[],CHEMBL2061265,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M8 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCc1ccncc1)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058318,CHEMBL2058318,6.57,0.0,http://www.openphacts.org/units/Nanomolar,1656258.0,=,1.0,1.0,=,IC50,nM,270.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,270.0,CHEMBL378
1911,18202572.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2cccc(O)c2)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4101364,CHEMBL4101364,6.36,0.0,http://www.openphacts.org/units/Nanomolar,3019956.0,=,1.0,1.0,=,IC50,nM,440.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.44,CHEMBL378
1912,933679.0,[],CHEMBL695338,In vitro inhibitory concentration against HRSV (Human respiratory syncytial virus) by using RSV A2 and the assay is by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)CCNS(=O)(=O)c1cccc(Nc2nc(Nc3cccc(S(=O)(=O)NCCC(N)=O)c3)nc(Nc3ccc(-c4ccc(Nc5nc(Nc6cccc(S(=O)(=O)NCCC(N)=O)c6)nc(Nc6cccc(S(=O)(=O)NCCC(N)=O)c6)n5)cc4S(=O)(=O)[O-])c(S(=O)(=O)[O-])c3)n2)c1.[Na+].[Na+],CHEMBL1134023,Bioorg Med Chem Lett,2001.0,CHEMBL268508,CHEMBL1160582,6.18,0.0,http://www.openphacts.org/units/Nanomolar,4998.0,=,1.0,1.0,=,IC50,nM,660.0,CHEMBL613127,Human respiratory syncytial virus,Human respiratory syncytial virus,11250,IC50,uM,UO_0000065,0.66,CHEMBL613127
1913,1750596.0,[],CHEMBL864975,Antiviral activity against HIV1 LAI isolate in human PHA-PBMC cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,CHEMBL1146019,J Med Chem,2006.0,CHEMBL163,CHEMBL163,7.37,0.0,http://www.openphacts.org/units/Nanomolar,539999.0,=,1.0,1.0,=,IC50,nM,43.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,43.0,CHEMBL378
1914,2462123.0,[],CHEMBL965355,Antiviral activity against hepatitis B virus infected Hep G2.2.15 cells assessed as inhibition of HBeAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CN2OC2(c2ccccc2)c2cc(Cl)ccc2N1,CHEMBL1157443,Bioorg Med Chem Lett,2008.0,CHEMBL503208,CHEMBL503208,,0.0,http://www.openphacts.org/units/Nanomolar,720924.0,>,1.0,1.0,>,IC50,nM,3280000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,3.28,CHEMBL613497
1915,622085.0,[],CHEMBL689615,Reduction of viral load in the cell supernatant.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2ccc(/C=C/c3cc(O)c(O)c(I)c3)nc2c1O,CHEMBL1135622,J Med Chem,2002.0,CHEMBL37845,CHEMBL37845,5.17,0.0,http://www.openphacts.org/units/Nanomolar,275317.0,=,1.0,1.0,=,IC50,nM,6800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.8,CHEMBL378
1916,2601897.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(Cl)n([C@H]2C[C@H](O)[C@@H](CO)O2)c2cc(Cl)c(Cl)cc12,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL475499,CHEMBL475499,4.46,0.0,http://www.openphacts.org/units/Nanomolar,807932.0,=,1.0,1.0,=,IC50,nM,35000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,35.0,CHEMBL378
1917,10842705.0,[],CHEMBL2016100,Antiviral activity against Human immunodeficiency virus 1 3B infected in human MT2 cells assessed as inhibition of viral replication after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)O,CHEMBL2010680,Bioorg Med Chem Lett,2012.0,CHEMBL2012800,CHEMBL2012800,,0.0,http://www.openphacts.org/units/Nanomolar,1633458.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1918,602209.0,[],CHEMBL691384,Inhibitory concentration for cytopathicity of HIV-1 (HTLV-IIIB) in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cc(Cc2cc(Br)c(O)c(C(=O)O)c2)cc(Br)c1O,CHEMBL1125737,J Med Chem,1991.0,CHEMBL114043,CHEMBL114043,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,217797.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,100.0,CHEMBL378
1919,2594529.0,[],CHEMBL958175,Antiviral activity against X4-tropic HIV1 3B assessed as inhibition of viral attachment,F,BAO_0000190,BAO_0000218,organism-based format,C1=C(CS/C(=N\C2CCCCC2)NC2CCCCCC2)N2CCN=C2S1,CHEMBL1151747,J Med Chem,2008.0,CHEMBL541728,CHEMBL541728,7.40,0.0,http://www.openphacts.org/units/Nanomolar,726870.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,40.0,CHEMBL378
1920,2368275.0,[],CHEMBL1031561,Antiviral activity against HIV1 infected in 8186 T cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1140132,J Med Chem,2008.0,CHEMBL57,CHEMBL57,7.40,0.0,http://www.openphacts.org/units/Nanomolar,745219.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,40.0,CHEMBL378
1921,2371430.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(CNc2ccc3c(ccc4c5ccccc5[nH]c34)n2)cc1,CHEMBL1140145,J Med Chem,2008.0,CHEMBL492476,CHEMBL492476,,0.0,http://www.openphacts.org/units/Nanomolar,746616.0,=,1.0,1.0,=,IC50,nM,114000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,114.0,CHEMBL613493
1922,5246982.0,[],CHEMBL1687410,Antiviral activity against HIV1 Ba-L infected in human HOS cells expressing CCR5 after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,Cn1nc(Cc2ccccc2)cc1C1CCN(CCC(CNS(=O)(=O)c2ccccc2)c2ccccc2)CC1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL1682477,CHEMBL1682477,7.06,0.0,http://www.openphacts.org/units/Nanomolar,1333575.0,=,1.0,1.0,=,IC50,nM,88.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.088,CHEMBL378
1923,22480467.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '120.0'}]",CHEMBL4687212,Antiviral activity against HIV-1 NL4-3 infected in human TZM-bl cells infected with supernatants from virus-infected human H9 cells treated with compound for 72 hrs assessed as reduction in luciferase expression measured after 48 hrs by luciferase reporter gene assay based BiCycle assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCc1cn(-c2ccc(NC(=O)Nc3cc(O[C@H]4O[C@@H](CO)[C@H](O)[C@@H]4O)ccc3C)cc2)nn1,CHEMBL4680261,Eur J Med Chem,2020.0,CHEMBL4740841,CHEMBL4740841,,0.0,http://www.openphacts.org/units/Nanomolar,3523701.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
1924,2292371.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1cccc(F)c1,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL58988,CHEMBL58988,,0.0,http://www.openphacts.org/units/Nanomolar,812362.0,=,1.0,1.0,=,IC50,nM,2999162.52,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,2.523,CHEMBL378
1925,2184002.0,[],CHEMBL951611,Antiviral activity against HIV1 clinical isolate 10 infected in U87.CD4 cells expressing human CXCR4 D262N mutant,F,BAO_0000190,BAO_0000218,organism-based format,c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,CHEMBL1156482,J Biol Chem,2007.0,CHEMBL18442,CHEMBL18442,5.59,0.0,http://www.openphacts.org/units/Nanomolar,791970.0,=,1.0,1.0,=,IC50,nM,2541.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2541.0,CHEMBL378
1926,3008364.0,[],CHEMBL1037279,Antiviral activity against Human immunodeficiency virus 1 NL4-3 infected HeLaP4 cells after 5 days by beta-galactosidase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(=O)c1cc(OC)c(O[C@@H](C)C(=O)N2CCN(c3nccc4[nH]ccc34)C[C@H]2C)cn1,CHEMBL1155317,Bioorg Med Chem Lett,2009.0,CHEMBL571613,CHEMBL571613,,0.0,http://www.openphacts.org/units/Nanomolar,861756.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
1927,10938669.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccccc4[N+](=O)[O-])CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046589,CHEMBL2046589,4.43,0.0,http://www.openphacts.org/units/Nanomolar,1651473.0,=,1.0,1.0,=,IC50,nM,36960.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,36.96,CHEMBL613497
1928,1870803.0,[],CHEMBL904573,Antiviral activity against HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCOCn1c(C(=O)c2cccc3ccccc23)c(C)c(=O)[nH]c1=O,CHEMBL1142880,Eur J Med Chem,2007.0,CHEMBL228994,CHEMBL228994,5.40,0.0,http://www.openphacts.org/units/Nanomolar,636389.0,=,1.0,1.0,=,IC50,nM,4020.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.02,CHEMBL378
1929,10866413.0,[],CHEMBL2025516,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@]23OC(C)(C)O[C@]24CC=C2C[C@@H](O)CC[C@]2(C)[C@H]4C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]31C,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2023675,CHEMBL2023675,,0.0,http://www.openphacts.org/units/Nanomolar,1639239.0,=,1.0,1.0,=,IC50,nM,168060.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,168.06,CHEMBL613497
1930,15165587.0,[],CHEMBL3404732,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBsAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(OC(=O)/C=C/c2ccccc2)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL1578081,CHEMBL1578081,,0.0,http://www.openphacts.org/units/Nanomolar,2284122.0,=,1.0,1.0,=,IC50,nM,2395800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2395.8,CHEMBL613497
1931,15571655.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(F)cc1)N1CCN(S(=O)(=O)c2cccc(F)c2)CC1,CHEMBL1201862,,,CHEMBL3561498,CHEMBL3561498,7.71,0.0,http://www.openphacts.org/units/Nanomolar,2476740.0,=,7.0,1.0,=,IC50,nM,19.6,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.0196,CHEMBL3259470
1932,904981.0,[],CHEMBL716463,Inhibitory concentration required to reduce virus Plaque formation (measles),F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2[C@@H]1C=C(CO)[C@@H](O)[C@H]1O,CHEMBL1129081,J Med Chem,1996.0,CHEMBL8771,CHEMBL8771,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,240300.0,=,1.0,1.0,=,IC50,ug.mL-1,0.1,CHEMBL613738,Measles virus,Measles virus,11234,IC50,ug ml-1,UO_0000274,0.1,CHEMBL613738
1933,1403417.0,[],CHEMBL837591,Inhibitory concentration against wild-type HIV-1 LAI Virus was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)c(=O)n(C)c1C,CHEMBL1145199,J Med Chem,2005.0,CHEMBL179871,CHEMBL179871,8.22,0.0,http://www.openphacts.org/units/Nanomolar,360757.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
1934,2681628.0,[],CHEMBL1051715,Antiviral activity against HIV1 ZM214M.PL15 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL525076,CHEMBL525076,5.57,0.0,http://www.openphacts.org/units/Nanomolar,823863.0,=,1.0,1.0,=,IC50,nM,2670.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.67,CHEMBL378
1935,12684387.0,[],CHEMBL2344303,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CCOCC(=O)O[C@H]1C[C@H]2[C@]3(C)C(=O)C[C@]4(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](OC(=O)COCC)C[C@@]4(C)[C@@H]3C[C@@H](O)[C@@]2(OC(=O)c2cccc(Cl)c2)C(C)(C)[C@@H]1OC(=O)COCC,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332415,CHEMBL2332415,,0.0,http://www.openphacts.org/units/Nanomolar,1866109.0,>,1.0,1.0,>,IC50,nM,710400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,710.4,CHEMBL613497
1936,2272922.0,[],CHEMBL956847,Antiviral activity against HIV1 Bal in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C(c1ccccc1)N1CCC(CCN2[C@@H]3CC[C@H]2C[C@@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1,CHEMBL1153314,Bioorg Med Chem Lett,2009.0,CHEMBL506273,CHEMBL506273,7.99,0.0,http://www.openphacts.org/units/Nanomolar,755542.0,=,1.0,1.0,=,IC50,nM,10.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0103,CHEMBL378
1937,2929705.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cncn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578802,CHEMBL578802,8.00,0.0,http://www.openphacts.org/units/Nanomolar,852866.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
1938,2929757.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3nc(CC#N)nc3C)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL575047,CHEMBL575047,7.40,0.0,http://www.openphacts.org/units/Nanomolar,848382.0,=,1.0,1.0,=,IC50,nM,39.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,39.8,CHEMBL378
1939,1199856.0,[],CHEMBL710376,Inhibitory activity against 100I strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(C)cc(C#N)cc1C,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL308004,CHEMBL308004,7.80,0.0,http://www.openphacts.org/units/Nanomolar,127441.0,=,1.0,1.0,=,IC50,nM,16.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.016,CHEMBL378
1940,5249015.0,[],CHEMBL1685193,Antiviral activity against X4 tropic HIV1 NL4.3 infected in CD4 and CXCR4 expressing human MT4 cells assessed as inhibition of viral cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(c1ccccn1)N(CCCCN)Cc1nc2ccccc2[nH]1,CHEMBL1681661,Bioorg Med Chem Lett,2011.0,CHEMBL1682871,CHEMBL1682871,5.60,0.0,http://www.openphacts.org/units/Nanomolar,1333993.0,=,1.0,1.0,=,IC50,nM,2500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2500.0,CHEMBL378
1941,15210776.0,[],CHEMBL3421426,Antiviral activity against Human immunodeficiency virus 1 3b infected in human MT4 cells assessed as inhibition of virus replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1,CHEMBL3414423,J Nat Prod,2014.0,CHEMBL1460,CHEMBL1460,4.97,0.0,http://www.openphacts.org/units/Nanomolar,2289956.0,=,1.0,1.0,=,IC50,nM,10800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.8,CHEMBL378
1942,1471516.0,[],CHEMBL834444,Inhibition concentration required to inhibit HIV-IIIB was determined by MT-4/MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2C1O[C@H](/C=C/C#CI)[C@@H](O)[C@H]1O,CHEMBL1138785,J Med Chem,2004.0,CHEMBL611106,CHEMBL611106,5.96,0.0,http://www.openphacts.org/units/Nanomolar,380484.0,=,1.0,1.0,=,IC50,nM,1100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.1,CHEMBL378
1943,1758935.0,[],CHEMBL869777,Antiviral activity against HIV1 3B in MT4 cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1c2c(c(O)c3ncn(Cc4ccccc4)c13)C(=O)N(Cc1ccc(F)cc1)C2,CHEMBL1138967,Bioorg Med Chem Lett,2006.0,CHEMBL214066,CHEMBL214066,,0.0,http://www.openphacts.org/units/Nanomolar,525172.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
1944,10866450.0,[],CHEMBL2025517,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HbeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(OC(=O)CCCC(=O)O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCCC(=O)O)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024048,CHEMBL2024048,,0.0,http://www.openphacts.org/units/Nanomolar,1639770.0,>,1.0,1.0,>,IC50,nM,267960.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,267.96,CHEMBL613497
1945,1830900.0,[],CHEMBL918634,Antiviral activity against wild type HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(C(C#N)c2cccc3ccccc23)nc(SC2CCCC2)[nH]c1=O,CHEMBL1144474,J Med Chem,2007.0,CHEMBL221874,CHEMBL221874,6.10,0.0,http://www.openphacts.org/units/Nanomolar,629291.0,=,1.0,1.0,=,IC50,nM,800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.8,CHEMBL378
1946,22898315.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731094,Antiviral activity against HIV1 DRVR P51 infected in human MT4 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)C[C@H]2C3CO[C@H]4OC[C@@H]2C4C3)cc1,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL4744116,CHEMBL4744116,,0.0,http://www.openphacts.org/units/Nanomolar,3554412.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
1947,17602957.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(S(=O)(=O)c2cccc(Cl)c2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644892,CHEMBL3644892,7.55,0.0,http://www.openphacts.org/units/Nanomolar,2518012.0,=,37.0,1.0,=,IC50,nM,28.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,28.0,CHEMBL4620
1948,1401662.0,[],CHEMBL837467,In vitro inhibitory concentration against HIV K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Cc2cc(C)[nH]c(=O)c2N(C)C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177961,CHEMBL177961,4.50,0.0,http://www.openphacts.org/units/Nanomolar,360254.0,=,1.0,1.0,=,IC50,nM,31623.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,31.623,CHEMBL378
1949,12103546.0,[],CHEMBL2175373,Inhibition of wild type HIV1 3B infected in human MT4 cells using cells pre-incubated with compound for 1 hr measured 4 days post viral infection in presence of 20 mg/ml HSA by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1[nH]cc(C(=O)NCc2ccc(F)cc2)c(=O)c1O,CHEMBL2169855,J Med Chem,2012.0,CHEMBL2171670,CHEMBL2171670,6.92,0.0,http://www.openphacts.org/units/Nanomolar,1741651.0,=,1.0,1.0,=,IC50,nM,120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,120.0,CHEMBL378
1950,22958193.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4768136,Antiviral activity against HIV1 NL4-3 Env-deficient pseudotype virus infected in human U87/CD4/CCR5 cells assessed by reduction in viral production in late stage measured after 48 hrs by luciferase activity based single-round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(N(C)C(=O)[C@H](Cc2ccccc2)NC(=O)Cn2cc(-c3ccccc3NC(=O)c3ccccc3F)nn2)cc1,CHEMBL4765266,Eur J Med Chem,2020.0,CHEMBL4777603,CHEMBL4777603,6.50,0.0,http://www.openphacts.org/units/Nanomolar,3565105.0,=,1.0,1.0,=,IC50,nM,320.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.32,CHEMBL378
1951,19261889.0,[],CHEMBL4404378,"Antiviral activity against HIV1 subtypeB PVO, clone 4",F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.48,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,330.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.33,CHEMBL378
1952,22980366.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4772765,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in intracellular viral DNA level incubated for 4 days by fluorogenic probe based RT-qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Cc1sc(-c2nccs2)nc1C(=O)NCc1ccc(F)cc1,CHEMBL4765395,Eur J Med Chem,2020.0,CHEMBL3740028,CHEMBL3740028,5.88,0.0,http://www.openphacts.org/units/Nanomolar,3568765.0,=,1.0,1.0,=,IC50,nM,1330.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol/L,UO_0000065,1.33,CHEMBL613497
1953,2009798.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,COCc1cn(-c2ncc(F)c3c(S(=O)(=O)N4CCN(C(=O)c5ccccc5)CC4C)c[nH]c23)nn1,CHEMBL1138356,J Med Chem,2007.0,CHEMBL236780,CHEMBL236780,6.24,0.0,http://www.openphacts.org/units/Nanomolar,668115.0,=,1.0,1.0,=,IC50,nM,580.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,580.0,CHEMBL378
1954,10938670.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccc(Br)cc4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046577,CHEMBL2046577,4.44,0.0,http://www.openphacts.org/units/Nanomolar,1651460.0,=,1.0,1.0,=,IC50,nM,36420.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,36.42,CHEMBL613497
1955,1156388.0,[],CHEMBL757806,Cytotoxicity against human peripheral blood mononuclear (PBM) cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c(=O)n([C@@H]2CS[C@H](CO)O2)cc1Br,CHEMBL1126808,J Med Chem,1993.0,CHEMBL60858,CHEMBL60858,,0.0,http://www.openphacts.org/units/Nanomolar,100991.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1956,5294475.0,[],CHEMBL1697298,Antiviral activity against influenza B virus infected in MDCK cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(CC)[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,CHEMBL1687706,Antimicrob Agents Chemother,2008.0,CHEMBL1651956,CHEMBL1651956,,0.0,http://www.openphacts.org/units/Nanomolar,1337219.0,>,1.0,1.0,>,IC50,nM,9900.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,9.9,CHEMBL613129
1957,16422843.0,[],CHEMBL3751456,Antiviral activity against recombinant HIV-1 NL4-3 expressing HIV-1 HxBc2 envelope infected in U87.CD4.CXCR4 cells by HIV-1 single round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CC(CCC(=O)c4ccccc4)C3)c12,CHEMBL3745657,Bioorg Med Chem Lett,2016.0,CHEMBL3746938,CHEMBL3746938,8.05,0.0,http://www.openphacts.org/units/Nanomolar,2740454.0,=,1.0,1.0,=,IC50,nM,9.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.009,CHEMBL378
1958,669424.0,[],CHEMBL683818,Compound was tested for anti-HIV activity in cell culture assay expressed as IC50 values,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O)c1cc(O)c(O)c(O)c1,CHEMBL1126373,Bioorg Med Chem Lett,1992.0,CHEMBL522251,CHEMBL522251,4.42,0.0,http://www.openphacts.org/units/Nanomolar,60621.0,=,1.0,1.0,=,IC50,nM,38000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,38.0,CHEMBL378
1959,15168046.0,[],CHEMBL3406882,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as HBeAg secretion after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)Nc1nc2cc(C(=O)c3ccccn3)ccc2[nH]1,CHEMBL3399962,Bioorg Med Chem,2015.0,CHEMBL3401078,CHEMBL3401078,,0.0,http://www.openphacts.org/units/Nanomolar,2281854.0,>,1.0,1.0,>,IC50,nM,1000000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1000.0,CHEMBL613497
1960,3076988.0,[],CHEMBL1067297,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CCCC2=C1C(c1ccccc1Cl)N=C(c1cnccn1)N2,CHEMBL1153099,Bioorg Med Chem Lett,2010.0,CHEMBL595974,CHEMBL595974,,0.0,,876958.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
1961,103298.0,[],CHEMBL683688,Inhibitory concentration against HIV-1 was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1126382,Bioorg Med Chem Lett,1992.0,CHEMBL57,CHEMBL57,7.40,0.0,http://www.openphacts.org/units/Nanomolar,70765.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
1962,22449761.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.5', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.5'}]",CHEMBL4680708,Antiviral activity against HIV1 pseudotyped with A-MLV envelop glycoprotein infected in dog Cf2Th/CD4-CCR5 cells assessed as inhibition of viral entry incubated for 30 mins prior to infection and measured after 48 hrs post infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CNCc1ccc2c(c1)[C@H](NC(=O)C(=O)Nc1ccc(Cl)c(F)c1)[C@@H](CNC(=N)N)C2.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4680075,ACS Med Chem Lett,2016.0,CHEMBL4755140,CHEMBL4802887,,0.0,http://www.openphacts.org/units/Nanomolar,3518671.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
1963,7843578.0,[],CHEMBL1913152,Antiviral activity against HIV1 Ba-L infected in human HOS cells assessed as reduction of viral replication after 4 days by Steady-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(C)(=O)=O)ccc1Oc1ccc(CN2CCC(N3C(=O)N(c4cc(C(N)=O)c(F)cc4F)C[C@H]3c3ccccc3)CC2)c(C)n1,CHEMBL1909524,Bioorg Med Chem Lett,2011.0,CHEMBL1909872,CHEMBL1909872,8.27,0.0,http://www.openphacts.org/units/Nanomolar,1542001.0,=,1.0,1.0,=,IC50,nM,5.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.4,CHEMBL378
1964,18940430.0,[],CHEMBL4328848,Antiviral activity against HIV-1 3B infected in human MAGI-CXCR4 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(CN2CCc3ccc(-c4ccc5ccn(Cc6cccc(C(=O)O)c6)c5c4)cc32)c1,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4513887,CHEMBL4513887,5.62,0.0,http://www.openphacts.org/units/Nanomolar,3159831.0,=,1.0,1.0,=,IC50,nM,2400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.4,CHEMBL378
1965,18044733.0,[],CHEMBL4010430,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 pCAAN5342 clone A2,F,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075766,CHEMBL4075766,6.29,0.0,http://www.openphacts.org/units/Nanomolar,2990214.0,=,1.0,1.0,=,IC50,nM,510.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.51,CHEMBL378
1966,18239608.0,[],CHEMBL4052036,Antiviral activity against atazanavir-resistant HIV1 NL4-3 harboring protease L23I/E34Q/K43I/M46I/I50L/G51A/L63P/A71V/V82A/T91A mutant infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,CHEMBL4049446,J Med Chem,2017.0,CHEMBL1163,CHEMBL1163,,0.0,http://www.openphacts.org/units/Nanomolar,3026808.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
1967,10961201.0,[],CHEMBL2061269,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M4 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCCC(C)(C)C)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058322,CHEMBL2058322,7.60,0.0,http://www.openphacts.org/units/Nanomolar,1656262.0,=,1.0,1.0,=,IC50,nM,25.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,25.0,CHEMBL378
1968,978030.0,[],CHEMBL683812,Antiviral activity against Human immunodeficiency virus 1 (HIV-1) up to 100 uM concentration; inactive,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@@H]2C[C@H](CO)N(O)C2)c(=O)[nH]c1=O,CHEMBL1124550,J Med Chem,1989.0,CHEMBL2374365,CHEMBL2374365,,0.0,http://www.openphacts.org/units/Nanomolar,82343.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
1969,1403313.0,[],CHEMBL834755,Inhibitory concentration against 100I mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1Oc1cn(C)c(=O)c(Nc2ccc(C#N)cc2)n1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL177653,CHEMBL177653,5.90,0.0,http://www.openphacts.org/units/Nanomolar,360722.0,=,1.0,1.0,=,IC50,nM,1259.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.259,CHEMBL378
1970,16556870.0,[],CHEMBL3795205,Antiviral activity against CXCR4 using HIV-1 NL4.3 infected in human MT4 cells assessed as reduction of viral replication preincubated for 15 mins with cells followed by viral infection measured after 4 days by MTS/PES method,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(Cc2ccccc2)CCCN(S(=O)(=O)c2ccc(SC)cc2)C1.Cl,CHEMBL3792300,J Med Chem,2016.0,CHEMBL3793490,CHEMBL3794630,5.84,0.0,http://www.openphacts.org/units/Nanomolar,2770900.0,=,1.0,1.0,=,IC50,nM,1440.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.44,CHEMBL378
1971,5132835.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)n2c3ccccc3n(C[C@H](O)Nc3ccccc3)c2c1C#N,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645084,CHEMBL1645084,4.47,0.0,http://www.openphacts.org/units/Nanomolar,1321073.0,=,1.0,1.0,=,IC50,nM,33500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,33.5,CHEMBL378
1972,1250806.0,[],CHEMBL683624,In vitro integration activity provided by preintegration complexes isolated from HIV-infected cells,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC2(CC(C)(C)c3cc(OS(=O)(=O)[O-])c(OS(=O)(=O)[O-])cc32)c2cc(OS(=O)(=O)[O-])c(OS(=O)(=O)[O-])cc21.[K+].[K+].[K+].[K+],CHEMBL1133186,J Med Chem,2000.0,CHEMBL292736,CHEMBL1206659,4.10,0.0,http://www.openphacts.org/units/Nanomolar,108747.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,80.0,CHEMBL378
1973,14714254.0,[],CHEMBL3293254,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCNC(c1ccc(/C=C/C#N)cc1)c1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL3288568,CHEMBL3288568,6.72,0.0,http://www.openphacts.org/units/Nanomolar,2116126.0,=,1.0,1.0,=,IC50,nM,192.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.192,CHEMBL378
1974,15159554.0,[],CHEMBL3398834,Inhibition of HBV DNA replication in HepG2(2.2.15) cells exposed to fresh medium supplemented with compound every other day for additional 5 days by real-time PCR-fluorescent probing method,F,BAO_0000190,BAO_0000218,organism-based format,O=C1OCCc2c(/C=C/c3ccccc3)cccc21,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397170,CHEMBL3397170,,0.0,http://www.openphacts.org/units/Nanomolar,2278968.0,=,1.0,1.0,=,IC50,nM,110000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.11,CHEMBL613497
1975,3284626.0,[],CHEMBL1110057,Antiviral activity against HIV1 3B infected in human HOS cells expressing human CXCR4/CCR5/CD4/pHIV-LTR luciferase assessed as inhibition of viral infection to cells,F,BAO_0000190,BAO_0000218,organism-based format,Cn1cncc1CN(CCCCN)C1CCCc2cccnc21,CHEMBL1157822,Bioorg Med Chem Lett,2010.0,CHEMBL1097460,CHEMBL1097460,,0.0,http://www.openphacts.org/units/Nanomolar,911320.0,>,1.0,1.0,>,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,20000.0,CHEMBL378
1976,3399320.0,[],CHEMBL1219622,Antiviral activity against R5X4 tropic HIV1 69/7 infected in human TZM-bl cells assessed as inhibition of virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)O,CHEMBL1212937,J Med Chem,2010.0,CHEMBL1215925,CHEMBL1215925,,0.0,http://www.openphacts.org/units/Nanomolar,933726.0,=,1.0,1.0,=,IC50,nM,208800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,208.8,CHEMBL378
1977,1751267.0,[],CHEMBL854523,Antiviral activity against wild type Measles virus Edmonston in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc(NC(=O)COc2ccccc2)c(O)c1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL377162,CHEMBL377162,,0.0,,532795.0,,1.0,0.0,,IC50,,,CHEMBL613738,Measles virus,Measles virus,11234,IC50,,,,CHEMBL613738
1978,642921.0,[],CHEMBL713945,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@H]1Cn2c(O)nc3cc(Cl)cc(c32)CN1,CHEMBL1128252,J Med Chem,1995.0,CHEMBL433903,CHEMBL433903,,0.0,http://www.openphacts.org/units/Nanomolar,326357.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
1979,2601469.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(N)n(CCOCP(=O)(O)O)c(=O)c1Cc1ccccc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL149664,CHEMBL149664,9.52,0.0,http://www.openphacts.org/units/Nanomolar,807188.0,=,1.0,1.0,=,IC50,nM,0.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0003,CHEMBL378
1980,18044787.0,[],CHEMBL4010394,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype D QD435.100M.ENV.A4,F,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075766,CHEMBL4075766,6.60,0.0,http://www.openphacts.org/units/Nanomolar,2990214.0,=,1.0,1.0,=,IC50,nM,250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.25,CHEMBL378
1981,18044690.0,[],CHEMBL4010438,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype A BG505-T332N,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.39,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,410.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.41,CHEMBL378
1982,12463722.0,[],CHEMBL3057688,Antiviral activity against wild type Human immunodeficiency virus 1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(NC(=O)NC(=N)Cc2c(Cl)cccc2Cl)cc1,CHEMBL3046335,Med Chem Res,2009.0,CHEMBL71717,CHEMBL71717,,0.0,http://www.openphacts.org/units/Nanomolar,1805837.0,=,1.0,1.0,=,IC50,nM,14996848.36,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,1.824,CHEMBL378
1983,3603838.0,[],CHEMBL1291726,Antiviral activity against Hepatitis B virus infected in HepG2.2.15 assessed as inhibition of HBV replication at <209.8 +/- 4.7 uM by quantitative Southern blot hybridization analysis,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(Cc2c(O)ccc3c2nc(CSc2ccccc2)n3C)CC1,CHEMBL1287795,Bioorg Med Chem Lett,2010.0,CHEMBL1287958,CHEMBL1287958,,0.0,,972963.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
1984,2413643.0,[],CHEMBL987708,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)Cc1ccc([N+](=O)[O-])cc1)[C@@H](OC(=O)Cc1ccc([N+](=O)[O-])cc1)C(C)(C)O)C1=C2C[C@H](OC(=O)Cc3ccc([N+](=O)[O-])cc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL454747,CHEMBL454747,,0.0,http://www.openphacts.org/units/Nanomolar,810692.0,>,1.0,1.0,>,IC50,nM,1000000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.0,CHEMBL613497
1985,679874.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(SSC(=O)c1ccccc1)c1ccccc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120631,CHEMBL120631,,0.0,,228601.0,=,1.0,0.0,=,IC50,,23.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,23.2,CHEMBL378
1986,1839867.0,[],CHEMBL916789,Antiviral activity against HIV1 BAL in human MDM cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(C(=O)N2CCN(C(=O)c3cc(OC)c(OC)c(OC)c3)C(CNC(=O)Nc3c(C)cccc3C)C2)cc(OC)c1OC,CHEMBL1149263,J Med Chem,2004.0,CHEMBL388847,CHEMBL388847,4.50,0.0,http://www.openphacts.org/units/Nanomolar,629986.0,=,1.0,1.0,=,IC50,nM,32000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,32.0,CHEMBL378
1987,15158571.0,[],CHEMBL3398830,Inhibition of HBV HBsAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,O=C1/C(=C/c2cccc3c2CCOC3=O)Oc2cc(O)ccc21,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397168,CHEMBL3397168,,0.0,http://www.openphacts.org/units/Nanomolar,2278966.0,>,1.0,1.0,>,IC50,nM,1810000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.81,CHEMBL613497
1988,1438152.0,[],CHEMBL833079,Inhibitory activity against HIV-1 mutant strain 181C,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cn(C)c2ccccc12,CHEMBL1138799,J Med Chem,2004.0,CHEMBL181747,CHEMBL181747,6.51,0.0,http://www.openphacts.org/units/Nanomolar,371548.0,=,1.0,1.0,=,IC50,nM,310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.31,CHEMBL378
1989,18044530.0,[],CHEMBL4010365,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of p24 antigen production pretreated with virus for 30 mins followed by 4 days incubation with cells by sandwich ELISA based multicycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(C(CN)NC(=O)c2ccc(-c3ccc(Cl)cc3)n2C)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4072179,CHEMBL4072179,,0.0,http://www.openphacts.org/units/Nanomolar,2990225.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.0,CHEMBL378
1990,24830925.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cn1ccnc1C(=O)Nc1ccc2c(=O)c3cccc(F)c3oc2c1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5190375,CHEMBL5190375,6.31,0.0,http://www.openphacts.org/units/Nanomolar,3878098.0,=,1.0,1.0,=,IC50,nM,490.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.49,CHEMBL613497
1991,2272916.0,[],CHEMBL956847,Antiviral activity against HIV1 Bal in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1C(C(=O)O)N1CCC(CCN2[C@@H]3CC[C@H]2C[C@@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1,CHEMBL1153314,Bioorg Med Chem Lett,2009.0,CHEMBL442619,CHEMBL442619,7.82,0.0,http://www.openphacts.org/units/Nanomolar,755539.0,=,1.0,1.0,=,IC50,nM,15.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.015,CHEMBL378
1992,2099733.0,[],CHEMBL949218,Antiviral activity against HIV1 JRCSF by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2ccc(F)cc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL256176,CHEMBL256176,6.94,0.0,http://www.openphacts.org/units/Nanomolar,699411.0,=,1.0,1.0,=,IC50,nM,115.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.115,CHEMBL378
1993,345038.0,[],CHEMBL873617,Inhibition of concanavalin A (con A)-induced proliferation of rat peripheral blood mononuclear cells.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2OC(F)F)cc1)c1ccncc1F,CHEMBL1133605,J Med Chem,2000.0,CHEMBL103517,CHEMBL103517,6.84,0.0,http://www.openphacts.org/units/Nanomolar,188110.0,=,1.0,1.0,=,IC50,nM,146.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,146.0,CHEMBL378
1994,1219740.0,[],CHEMBL710533,Inhibitory activity against 181C strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C#Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(C)cc(C)cc1C,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL71881,CHEMBL71881,7.37,0.0,http://www.openphacts.org/units/Nanomolar,127453.0,=,1.0,1.0,=,IC50,nM,43.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.043,CHEMBL378
1995,2244568.0,[],CHEMBL1003072,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase P236L mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL203420,CHEMBL203420,9.40,0.0,http://www.openphacts.org/units/Nanomolar,798654.0,=,1.0,1.0,=,IC50,nM,0.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.4,CHEMBL378
1996,2003639.0,[],CHEMBL901910,Antiviral activity against Modoc virus-infected HeLa-H1 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(-c2nc3cc(C(=O)NC45CC6CC(CC(C6)C4)C5)ccc3[nH]2)cc1)c1ccc(Cl)c(Cl)c1,CHEMBL1138288,J Med Chem,2007.0,CHEMBL223973,CHEMBL223973,8.22,0.0,http://www.openphacts.org/units/Nanomolar,666645.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL612946,Modoc virus,Modoc virus,64300,IC50,nM,UO_0000065,6.0,CHEMBL612946
1997,5189195.0,[],CHEMBL1658800,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c(CCO)c(-c2ccccc2Cl)c2cc(Cl)ccc2n1-c1c(F)cccc1F,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652494,CHEMBL1652494,,0.0,http://www.openphacts.org/units/Nanomolar,1326867.0,>,1.0,1.0,>,IC50,nM,2300000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.3,CHEMBL613497
1998,12687161.0,[],CHEMBL2344307,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral surface antigen production,F,BAO_0000190,BAO_0000218,organism-based format,CCOCC(=O)O[C@H]1C[C@@H]2C(=CC[C@@H]3[C@@]2(C)C(=O)C[C@]2(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(=O)COCC)[C@H](OC(=O)COCC)C[C@@]32C)C(C)(C)[C@@H]1OC(=O)COCC,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332417,CHEMBL2332417,,0.0,http://www.openphacts.org/units/Nanomolar,1866112.0,=,1.0,1.0,=,IC50,nM,225400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,225.4,CHEMBL613497
1999,2263395.0,[],CHEMBL1010846,Antiviral activity against R5 tropic HIV1 BaL infected in human JC53-BL cells expressing CCR5 after 2 days by cell-cell fusion assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCC[C@H]1CN(C(=O)NC)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2,CHEMBL1139267,Bioorg Med Chem Lett,2009.0,CHEMBL519278,CHEMBL519278,8.40,0.0,http://www.openphacts.org/units/Nanomolar,749932.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.0,CHEMBL378
2000,1403315.0,[],CHEMBL834757,Inhibitory concentration against 181C mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1Oc1cn(C)c(=O)c(Nc2ccc(C#N)cc2)n1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL177653,CHEMBL177653,5.60,0.0,http://www.openphacts.org/units/Nanomolar,360722.0,=,1.0,1.0,=,IC50,nM,2512.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.512,CHEMBL378
2001,12135667.0,[],CHEMBL2187933,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as p24 antigen level after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(CCCCC(=O)O)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2176886,J Med Chem,2012.0,CHEMBL2179591,CHEMBL2179591,8.23,0.0,http://www.openphacts.org/units/Nanomolar,1752685.0,=,1.0,1.0,=,IC50,nM,5.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0059,CHEMBL378
2002,14927157.0,[],CHEMBL3391567,Antiviral activity against NNRTI-resistant HIV-1 LAI harboring reverse transcriptase Y181C mutant infected in human MT4 cells assessed as inhibition of viral replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1[nH]c(=O)c(Cl)c(Oc2cc(Cl)cc(C#N)c2)c1CCOc1ccccc1,CHEMBL3390846,Medchemcomm,2010.0,CHEMBL3347299,CHEMBL3347299,7.96,0.0,http://www.openphacts.org/units/Nanomolar,2173115.0,=,1.0,1.0,=,IC50,nM,11.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,11.0,CHEMBL378
2003,3432872.0,[],CHEMBL1246459,Antiviral activity against R5 tropic HIV1 BaL infected in human CEMx174 5.25M7 cells after 3 days by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCC3)cc1.[Cl-],CHEMBL1240449,Eur J Med Chem,2010.0,CHEMBL41275,CHEMBL1178786,7.30,0.0,http://www.openphacts.org/units/Nanomolar,953138.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.05,CHEMBL378
2004,1064960.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=C(S)N(Nc2cccc(Cl)c2)C1c1cccc(C(=O)O)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL279411,CHEMBL279411,,0.0,http://www.openphacts.org/units/Nanomolar,62354.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2005,5222597.0,[],CHEMBL1675304,Antiviral activity against HIV1 infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,[N-]=[N+]=N[C@H]1C[C@H](n2cnc3c(N)ncnc32)O[C@@H]1CO,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL590121,CHEMBL590121,5.00,0.0,http://www.openphacts.org/units/Nanomolar,1332020.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
2006,13475406.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435906,CHEMBL2435906,6.26,0.0,http://www.openphacts.org/units/Nanomolar,1924282.0,=,1.0,1.0,=,IC50,nM,549.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,549.9,CHEMBL378
2007,2929552.0,[],CHEMBL1056895,Antiviral activity against HIV1 HXB2 harboring 138K mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCSCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578367,CHEMBL578367,7.60,0.0,http://www.openphacts.org/units/Nanomolar,852822.0,=,1.0,1.0,=,IC50,nM,25.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,25.1,CHEMBL378
2008,2997535.0,[],CHEMBL1046975,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C(=N/Cc2ccc(F)cc2)c2ccc(=O)n(Cc3ccc(F)cc3)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL566907,CHEMBL566907,,0.0,http://www.openphacts.org/units/Nanomolar,856682.0,>,1.0,1.0,>,IC50,nM,86900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,86.9,CHEMBL613497
2009,13463756.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1[S+]([O-])c1cccc(N)c1C#N,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL293331,CHEMBL293331,5.32,0.0,http://www.openphacts.org/units/Nanomolar,1920687.0,=,1.0,1.0,=,IC50,nM,4786.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.32,CHEMBL378
2010,2929641.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CNC=O)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL574141,CHEMBL574141,6.70,0.0,http://www.openphacts.org/units/Nanomolar,852965.0,=,1.0,1.0,=,IC50,nM,199.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,199.0,CHEMBL378
2011,24830917.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc2c(=O)c3cccc(F)c3oc2c1)c1ccccc1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5183467,CHEMBL5183467,5.72,0.0,http://www.openphacts.org/units/Nanomolar,3878090.0,=,1.0,1.0,=,IC50,nM,1890.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.89,CHEMBL613497
2012,629947.0,[],CHEMBL691383,Inhibitory concentration for cytopathicity of HIV-1 (HTLV-IIIB) in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cccc(Cc2cccc(C(=O)O)c2O)c1O,CHEMBL1125737,J Med Chem,1991.0,CHEMBL115052,CHEMBL115052,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,217795.0,>,1.0,1.0,>,IC50,ug.mL-1,125.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,125.0,CHEMBL378
2013,5188270.0,[],CHEMBL1664702,Antiviral activity against HIV1 LAI infected in human MT2 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,CHEMBL1649426,J Med Chem,2011.0,CHEMBL115,CHEMBL115,7.52,0.0,http://www.openphacts.org/units/Nanomolar,1324303.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.03,CHEMBL378
2014,3399345.0,[],CHEMBL1219621,Antiviral activity against R5 tropic HIV1 HXB2 infected in human TZM-bl cells assessed as inhibition of virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O,CHEMBL1212937,J Med Chem,2010.0,CHEMBL1215931,CHEMBL1215931,4.40,0.0,http://www.openphacts.org/units/Nanomolar,933733.0,=,1.0,1.0,=,IC50,nM,39900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,39.9,CHEMBL378
2015,3498067.0,[],CHEMBL1259504,Antiviral activity against HIV1 isolate 89.6 infected in human PM1 cells expressing CCR5 assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)CCC(=O)N1CCC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC1,CHEMBL1255517,Bioorg Med Chem Lett,2010.0,CHEMBL1258728,CHEMBL1258728,,0.0,http://www.openphacts.org/units/Nanomolar,963751.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2016,3100368.0,[],CHEMBL1064779,Antiviral activity against HIV1 LAI in human CEM-SS cells assessed as RT activity after 5 days by single passage assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1O,CHEMBL1156918,J Med Chem,2010.0,CHEMBL223557,CHEMBL223557,,0.0,http://www.openphacts.org/units/Nanomolar,887734.0,>,1.0,1.0,>,IC50,nM,200000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,200.0,CHEMBL378
2017,1150043.0,[],CHEMBL818227,Cytotoxicity was determined in the vero cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,O=c1ccn([C@@H]2CS[C@H](CO)O2)c(=O)[nH]1,CHEMBL1126808,J Med Chem,1993.0,CHEMBL300569,CHEMBL300569,,0.0,http://www.openphacts.org/units/Nanomolar,100999.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2018,1402282.0,[],CHEMBL837464,In vitro inhibitory concentration against HIV G190A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NCc2ccccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177491,CHEMBL177491,,0.0,http://www.openphacts.org/units/Nanomolar,360417.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2019,10862123.0,[],CHEMBL2024925,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B e-antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCC(N)=O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024637,CHEMBL2024637,,0.0,http://www.openphacts.org/units/Nanomolar,1640533.0,>,1.0,1.0,>,IC50,nM,1115360.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1115.36,CHEMBL613497
2020,1401603.0,[],CHEMBL837471,In vitro inhibitory concentration against HIV Y188L mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL338047,CHEMBL338047,6.60,0.0,http://www.openphacts.org/units/Nanomolar,360324.0,=,1.0,1.0,=,IC50,nM,251.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.251,CHEMBL378
2021,1148306.0,[],CHEMBL690006,Concentration required to inhibit by 50% human immunodeficiency virus-1 induced syncytium formation upon coculturing persistently HIV-infected HUT-78 cells with MOLT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C([O-])CC(SCCCOC[C@H]1O[C@@H](O[C@H]2[C@H](OCCCSC(CC(=O)[O-])C(=O)[O-])[C@@H](OCCCSC(CC(=O)[O-])C(=O)[O-])C(OCCCSC(CC(=O)[O-])C(=O)[O-])O[C@@H]2COCCCSC(CC(=O)[O-])C(=O)[O-])[C@H](OCCCSC(CC(=O)[O-])C(=O)[O-])[C@@H](OCCCSC(CC(=O)[O-])C(=O)[O-])[C@@H]1OCCCSC(CC(=O)[O-])C(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],CHEMBL1130336,J Med Chem,1997.0,CHEMBL3215377,CHEMBL3305942,5.75,0.0,http://www.openphacts.org/units/Nanomolar,225167.0,=,1.0,1.0,=,IC50,nM,1800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.8,CHEMBL378
2022,19243770.0,[],CHEMBL4400278,Antiviral activity against Zika virus infected in human A549 cells assessed as reduction in viral titer incubated for 48 hrs by plaque assay,F,BAO_0000190,BAO_0000218,organism-based format,C#CCSc1nsc(NC(=O)Nc2ccc(Br)cc2C(F)(F)F)n1,CHEMBL4396960,Bioorg Med Chem Lett,2019.0,CHEMBL4448764,CHEMBL4448764,,0.0,http://www.openphacts.org/units/Nanomolar,3212397.0,=,1.0,1.0,=,IC50,nM,3300000.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,mM,UO_0000065,3.3,CHEMBL4296612
2023,2997431.0,[],CHEMBL1046975,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C(=N/C2CCCCC2)c2ccc(=O)n(C3CCCCC3)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL566908,CHEMBL566908,4.15,0.0,http://www.openphacts.org/units/Nanomolar,856683.0,=,1.0,1.0,=,IC50,nM,71000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,71.0,CHEMBL613497
2024,3399350.0,[],CHEMBL1219622,Antiviral activity against R5X4 tropic HIV1 69/7 infected in human TZM-bl cells assessed as inhibition of virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O,CHEMBL1212937,J Med Chem,2010.0,CHEMBL1215931,CHEMBL1215931,4.62,0.0,http://www.openphacts.org/units/Nanomolar,933733.0,=,1.0,1.0,=,IC50,nM,24100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,24.1,CHEMBL378
2025,15166064.0,[],CHEMBL3404732,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBsAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(O[C@@H]2O[C@H](COC(=O)c3ccccc3)[C@@H](O)[C@H](O)[C@H]2O)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402789,CHEMBL3402789,,0.0,http://www.openphacts.org/units/Nanomolar,2284145.0,=,1.0,1.0,=,IC50,nM,678300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,678.3,CHEMBL613497
2026,1102817.0,[],CHEMBL709777,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1Cc2cccc3nc(O)n(c23)C[C@@H]1C,CHEMBL1125252,J Med Chem,1991.0,CHEMBL292197,CHEMBL292197,5.40,0.0,http://www.openphacts.org/units/Nanomolar,322375.0,=,1.0,1.0,=,IC50,nM,4000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.0,CHEMBL378
2027,1402195.0,[],CHEMBL834487,In vitro inhibitory concentration value against HIV K103N and Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369599,CHEMBL369599,,0.0,http://www.openphacts.org/units/Nanomolar,360395.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2028,17987398.0,[],CHEMBL3999574,Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 40 hrs,F,BAO_0000190,BAO_0000219,cell-based format,C=C(C(=O)OC)[C@@H]1CC[C@H](C)[C@H]2C(=C(C)C(=O)[C@@H]2[C@H](O)CC)C1,CHEMBL3997818,Bioorg Med Chem Lett,2017.0,CHEMBL4100166,CHEMBL4100166,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,2979916.0,=,1.0,1.0,=,IC50,ug.mL-1,18.52,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,18.52,CHEMBL613129
2029,2244608.0,[],CHEMBL1005599,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase V106I/Y181C mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL203420,CHEMBL203420,8.42,0.0,http://www.openphacts.org/units/Nanomolar,798654.0,=,1.0,1.0,=,IC50,nM,3.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.8,CHEMBL378
2030,1401615.0,[],CHEMBL834487,In vitro inhibitory concentration value against HIV K103N and Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL366692,CHEMBL366692,6.80,0.0,http://www.openphacts.org/units/Nanomolar,360329.0,=,1.0,1.0,=,IC50,nM,158.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.158,CHEMBL378
2031,15568199.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(Br)cc1)N1CCN(Cc2ccc(Cl)c(Cl)c2)CC1,CHEMBL1201862,,,CHEMBL3560041,CHEMBL3560041,8.76,0.0,http://www.openphacts.org/units/Nanomolar,2474322.0,=,7.0,1.0,=,IC50,nM,1.72,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.00172,CHEMBL3259470
2032,1865516.0,[],CHEMBL918387,Antiviral activity against PMA stimulated HIV1 expression in latently HIV1 infected OM10.1 cells assessed as inhibition of viral mRNA production,F,BAO_0000190,BAO_0000218,organism-based format,Cn1cc(C(=O)O)c(=O)c2ccc(N3CCN(c4nc5ccccc5s4)CC3)cc21,CHEMBL1147094,Antimicrob Agents Chemother,2007.0,CHEMBL227952,CHEMBL227952,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,634801.0,=,1.0,1.0,=,IC50,ug.mL-1,0.04,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.04,CHEMBL378
2033,1498107.0,[],CHEMBL833971,Concentration required to inhibit 50% viral production of human immunodeficiency virus type 1 (HIV-1-IIIB),F,BAO_0000190,BAO_0000218,organism-based format,CC1=C(C(=O)Nc2ccc(Cl)c(C(=O)OC(C)C)c2)SCCO1,CHEMBL1143567,J Med Chem,2005.0,CHEMBL190729,CHEMBL190729,7.38,0.0,http://www.openphacts.org/units/Nanomolar,388350.0,=,1.0,1.0,=,IC50,nM,42.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.042,CHEMBL378
2034,2930420.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(COCC3CCCO3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567214,CHEMBL567214,8.10,0.0,http://www.openphacts.org/units/Nanomolar,852932.0,=,1.0,1.0,=,IC50,nM,7.94,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.94,CHEMBL378
2035,487275.0,[],CHEMBL757967,Inhibition of cell growth against HIV-1 infected PBM (Human peripheral blood mononuclear) cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(=O)n([C@H]2CS[C@@H](CO)O2)cc1F,CHEMBL1126792,J Med Chem,1993.0,CHEMBL89554,CHEMBL89554,,0.0,http://www.openphacts.org/units/Nanomolar,161316.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2036,1148797.0,[],CHEMBL818227,Cytotoxicity was determined in the vero cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(F)nc2c1ncn2[C@H]1CS[C@H](CO)O1,CHEMBL1126808,J Med Chem,1993.0,CHEMBL59576,CHEMBL59576,,0.0,http://www.openphacts.org/units/Nanomolar,100977.0,<,1.0,1.0,<,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
2037,24823551.0,[],CHEMBL5140686,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBsAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3cccc(Cl)c3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5173167,CHEMBL5173167,8.47,0.0,http://www.openphacts.org/units/Nanomolar,3876725.0,=,1.0,1.0,=,IC50,nM,3.4,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0034,CHEMBL613497
2038,2224019.0,[],CHEMBL987023,Antiviral activity against HIV1 3B in human MT4 cells assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCNC(=S)Nc1ccc(OCc2n[nH]c(=S)n2-c2ccccc2)cc1,CHEMBL1149790,Eur J Med Chem,2008.0,CHEMBL493611,CHEMBL493611,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,765682.0,>,1.0,1.0,>,IC50,ug.mL-1,15.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,15.0,CHEMBL378
2039,2930453.0,[],CHEMBL1056902,Antiviral activity against HIV1 HXB2 harboring K103N and Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL233664,CHEMBL233664,7.40,0.0,http://www.openphacts.org/units/Nanomolar,848384.0,=,1.0,1.0,=,IC50,nM,39.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,39.8,CHEMBL378
2040,12103561.0,[],CHEMBL2175368,Inhibition of wild type HIV1 3B infected in human MT4 cells using cells pre-incubated with compound for 1 hr measured 4 days post viral infection by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)c1[nH]cc(C(=O)NCc2ccc(F)cc2)c(=O)c1O,CHEMBL2169855,J Med Chem,2012.0,CHEMBL2171667,CHEMBL2171667,5.26,0.0,http://www.openphacts.org/units/Nanomolar,1741646.0,=,1.0,1.0,=,IC50,nM,5500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5500.0,CHEMBL378
2041,3253134.0,[],CHEMBL1107997,Antiviral activity against HIV1 NL4.3 infected in human MT4 cells expressing CD4 and CXCR4 assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccccn1)c1ccc(CN(Cc2nc3ccccc3[nH]2)C2CCCc3cccnc32)cc1,CHEMBL1156989,J Med Chem,2010.0,CHEMBL1092322,CHEMBL1092322,6.01,0.0,http://www.openphacts.org/units/Nanomolar,901900.0,=,1.0,1.0,=,IC50,nM,980.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.98,CHEMBL378
2042,15168026.0,[],CHEMBL3406880,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBsAg secretion after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)Nc1nc2cc(C(=O)c3cccc(OC)c3)ccc2[nH]1,CHEMBL3399962,Bioorg Med Chem,2015.0,CHEMBL3401074,CHEMBL3401074,4.01,0.0,http://www.openphacts.org/units/Nanomolar,2281850.0,=,1.0,1.0,=,IC50,nM,97500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,97.5,CHEMBL613497
2043,1671925.0,[],CHEMBL870624,Antiviral activity against HIV1 K103N mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(N2CC[S+]([O-])CC2)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1ccccc1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL372818,CHEMBL372818,7.00,0.0,http://www.openphacts.org/units/Nanomolar,411921.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,100.0,CHEMBL378
2044,2263406.0,[],CHEMBL1010846,Antiviral activity against R5 tropic HIV1 BaL infected in human JC53-BL cells expressing CCR5 after 2 days by cell-cell fusion assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC1C(=O)C(CC2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2,CHEMBL1139267,Bioorg Med Chem Lett,2009.0,CHEMBL464054,CHEMBL464054,8.40,0.0,http://www.openphacts.org/units/Nanomolar,750089.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.0,CHEMBL378
2045,5189199.0,[],CHEMBL1658800,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Clc1ccc2nc3c(c(-c4ccccc4Cl)c2c1)CCO3,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652496,CHEMBL1652496,,0.0,http://www.openphacts.org/units/Nanomolar,1326871.0,>,1.0,1.0,>,IC50,nM,280000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.28,CHEMBL613497
2046,13475529.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435886,CHEMBL2435886,7.75,0.0,http://www.openphacts.org/units/Nanomolar,1924262.0,=,1.0,1.0,=,IC50,nM,18.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,18.0,CHEMBL378
2047,12680691.0,[],CHEMBL2342597,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral replication after 9 days by fluorescence PCR method,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)Nc3ccccc3C)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333693,CHEMBL2333693,,0.0,http://www.openphacts.org/units/Nanomolar,1867769.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
2048,523123.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(O)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL1134494,J Med Chem,2001.0,CHEMBL57064,CHEMBL57064,6.37,0.0,http://www.openphacts.org/units/Nanomolar,94224.0,=,1.0,1.0,=,IC50,nM,430.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.43,CHEMBL378
2049,2462133.0,[],CHEMBL965355,Antiviral activity against hepatitis B virus infected Hep G2.2.15 cells assessed as inhibition of HBeAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,O=c1cc(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]1,CHEMBL1157443,Bioorg Med Chem Lett,2008.0,CHEMBL452807,CHEMBL452807,,0.0,http://www.openphacts.org/units/Nanomolar,720748.0,>,1.0,1.0,>,IC50,nM,6000000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,6.0,CHEMBL613497
2050,3114771.0,[],CHEMBL1073712,Antiviral activity against HIV1 NL4-3 infected in GFP expressing human CEM cells assessed as inhibition of viral infection measured after 9 days postinfection by microfluorometry,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CC(=O)c1c(O)c(C(=O)CC(C)C)c(O)c(C(c2ccccn2)c2c(O)c(C(=O)CC(C)C)c(O)c(C(=O)CC(C)C)c2O)c1O,CHEMBL1157554,Bioorg Med Chem,2010.0,CHEMBL591220,CHEMBL591220,5.47,0.0,http://www.openphacts.org/units/Nanomolar,887096.0,=,1.0,1.0,=,IC50,nM,3370.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.37,CHEMBL378
2051,2464771.0,[],CHEMBL963689,Antiviral activity against HBV assessed as inhibition of viral surface-antigen production by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1cc2c(CN(C)C)c(O)c(OC)cc2nc1C[S+]([O-])c1ccc(F)cc1,CHEMBL1157455,Bioorg Med Chem,2008.0,CHEMBL454099,CHEMBL454099,4.44,0.0,http://www.openphacts.org/units/Nanomolar,720667.0,=,1.0,1.0,=,IC50,nM,36500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,36.5,CHEMBL613497
2052,1242214.0,[],CHEMBL711623,Concentration required to inhibit HIV-1 induced cytopathicity in MT-4 cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCCCCCCCCCCCC(=O)NCCCCCCCCCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL119862,CHEMBL1205597,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221529.0,=,1.0,1.0,=,IC50,ug.mL-1,55.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,55.0,CHEMBL378
2053,613881.0,[],CHEMBL710534,Inhibitory activity against 188L strain of HIV-1 in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Sc2ncnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL431572,CHEMBL431572,7.70,0.0,http://www.openphacts.org/units/Nanomolar,126917.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.02,CHEMBL378
2054,18775787.0,[],CHEMBL4269042,Antiviral activity against Hepatitis B virus infected in human dHepaRG cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)-c1cc(=O)c(C(=O)O)cn1C(C)C2,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4283241,CHEMBL4283241,6.06,0.0,http://www.openphacts.org/units/Nanomolar,3119626.0,=,1.0,1.0,=,IC50,nM,880.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.88,CHEMBL613497
2055,3056474.0,[],CHEMBL1064575,Antiviral activity against HIV1 infected in human PBMC assessed as inhibition of viral p24 antigen production after 7 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1152525,Bioorg Med Chem,2009.0,CHEMBL141,CHEMBL141,6.70,0.0,http://www.openphacts.org/units/Nanomolar,876033.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.2,CHEMBL378
2056,16626878.0,[],CHEMBL3821890,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg secretion by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)Oc2cc(CSc3ccccn3)[nH]n2)cc1,CHEMBL3817822,Medchemcomm,2016.0,CHEMBL3818752,CHEMBL3818752,4.84,0.0,http://www.openphacts.org/units/Nanomolar,2783924.0,=,1.0,1.0,=,IC50,nM,14530.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,14.53,CHEMBL613497
2057,12135663.0,[],CHEMBL2187933,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as p24 antigen level after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCC(CCCC(=O)NCCCN4CCOCC4)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2176886,J Med Chem,2012.0,CHEMBL509546,CHEMBL509546,7.51,0.0,http://www.openphacts.org/units/Nanomolar,1752693.0,=,1.0,1.0,=,IC50,nM,31.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.031,CHEMBL378
2058,1213169.0,[],CHEMBL710537,Inhibitory activity against 188L strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL308954,CHEMBL308954,8.34,0.0,http://www.openphacts.org/units/Nanomolar,127449.0,=,1.0,1.0,=,IC50,nM,4.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0046,CHEMBL378
2059,18044710.0,[],CHEMBL4010418,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype A/G CRF02_AG clone 266,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.32,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,480.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.48,CHEMBL378
2060,1402058.0,[],CHEMBL837464,In vitro inhibitory concentration against HIV G190A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)Nc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL128569,CHEMBL128569,,0.0,http://www.openphacts.org/units/Nanomolar,360373.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2061,811349.0,[],CHEMBL711619,Antiviral activity against HIV-1 (strain RF) infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)CCOc1ccc(NC(=O)COc2ccccc2C(=O)c2ccccc2)cc1,CHEMBL1128355,J Med Chem,1995.0,CHEMBL42823,CHEMBL42823,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,73202.0,<,1.0,1.0,<,IC50,ug.mL-1,0.001,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.001,CHEMBL378
2062,12108666.0,[],CHEMBL2173497,Antiviral activity against HIV1 harboring reverse transcriptase L100I/K103N mutant,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL2169791,J Med Chem,2012.0,CHEMBL72335,CHEMBL72335,6.10,0.0,http://www.openphacts.org/units/Nanomolar,1740558.0,=,1.0,1.0,=,IC50,nM,798.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,798.0,CHEMBL378
2063,22933261.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)OCCCOC(=O)/C=C/c3ccc(OC)cc3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4749647,CHEMBL4749647,6.07,0.0,http://www.openphacts.org/units/Nanomolar,3560872.0,=,1.0,1.0,=,IC50,nM,851.14,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.07,CHEMBL378
2064,23306077.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL4843118,Antiviral activity against Zika virus H/PF/2013 infected in pre-seeded Huh-7 cells assessed as inhibition of viral replication incubated for 72 hrs by immunodetection based secondary yield reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cccc(Nc2nc(NCCOc3ccccc3)nc3[nH]cnc23)c1,CHEMBL4842338,Eur J Med Chem,2021.0,CHEMBL4870507,CHEMBL4870507,4.54,0.0,http://www.openphacts.org/units/Nanomolar,3627093.0,=,1.0,1.0,=,IC50,nM,29000.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,29.0,CHEMBL4296612
2065,5137451.0,[],CHEMBL1646836,Antiviral activity against X4 tropic HIV1 NL4.3 infected in human MT4 cells expressing CD4 and CXCR4 assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NCc1ccc(CN(Cc2nc3ccccc3[nH]2)C2CCCc3cccnc32)s1,CHEMBL1641524,Bioorg Med Chem Lett,2011.0,CHEMBL1644086,CHEMBL1644086,5.61,0.0,http://www.openphacts.org/units/Nanomolar,1319760.0,=,1.0,1.0,=,IC50,nM,2480.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.48,CHEMBL378
2066,2930208.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3ncnc3C)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL573699,CHEMBL573699,7.80,0.0,http://www.openphacts.org/units/Nanomolar,848338.0,=,1.0,1.0,=,IC50,nM,15.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,15.8,CHEMBL378
2067,2061737.0,[],CHEMBL942898,Inhibition of HIV HXB2 in TZM-bl cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,CCC(C)/C=C(C)/C=C\C(O)C(C)(O)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1C(=O)N[C@H](COC)C(=O)NCC(=O)N[C@@H](C)C(=O)N(C)[C@@H]([C@@H](C)O)C(=O)N[C@H]([C@H](OC)c2ccc(O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)cc2)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]1C(C)C)[C@@H](C)[C@@H](C)C(N)=O)[C@@H](C)N)[C@@H](C)O,CHEMBL1141334,J Nat Prod,2007.0,CHEMBL398500,CHEMBL398500,6.72,0.0,http://www.openphacts.org/units/Nanomolar,684426.0,=,1.0,1.0,=,IC50,nM,189.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.189,CHEMBL378
2068,115110.0,[],CHEMBL692689,Inhibition of HCV NS5B polymerase,B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1C(=O)Nc1cc(-c2ccccc2)sc1C(=O)O,CHEMBL1148275,Bioorg Med Chem Lett,2004.0,CHEMBL167299,CHEMBL167299,4.85,0.0,http://www.openphacts.org/units/Nanomolar,326838.0,=,1.0,1.0,=,IC50,nM,14000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,14.0,CHEMBL4620
2069,5230922.0,[],CHEMBL1676981,Antiviral activity against Human immunodeficiency virus 1 3B infected in AA5 cells infected with 3.13 uL of virus stock assessed as expression of p24 antigen after 6 days postinfection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL129,CHEMBL129,8.10,0.0,http://www.openphacts.org/units/Nanomolar,1332124.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
2070,18452384.0,[],CHEMBL4178856,Antiviral activity against Chikungunya virus infected in African green monkey Vero cells after 72 hrs by MTT dye-based assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,CHEMBL4177563,Bioorg Med Chem,2017.0,CHEMBL151,CHEMBL151,4.65,0.0,http://www.openphacts.org/units/Nanomolar,3062355.0,=,1.0,1.0,=,IC50,nM,22500.0,CHEMBL4296563,Chikungunya virus,Chikungunya virus,37124,IC50,uM,UO_0000065,22.5,CHEMBL4296563
2071,5247012.0,[],CHEMBL1687411,Antiviral activity against HIV1 Ba-L infected in human PBL cells assessed as reverse transcriptase activity after 7 days,F,BAO_0000190,BAO_0000218,organism-based format,Cn1nc(Cc2ccccc2)cc1C1CCN(CCC(CNS(=O)(=O)c2ccccc2)c2ccccc2)CC1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL1682477,CHEMBL1682477,,0.0,,1333575.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2072,1402354.0,[],CHEMBL835252,In vitro inhibitory concentration against HIV K101E and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(-n2cccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL360957,CHEMBL360957,,0.0,http://www.openphacts.org/units/Nanomolar,360357.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2073,1751217.0,[],CHEMBL854523,Antiviral activity against wild type Measles virus Edmonston in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Cc1ccncc1)Nc1cccc([N+](=O)[O-])c1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL215451,CHEMBL215451,,0.0,http://www.openphacts.org/units/Nanomolar,532827.0,>,1.0,1.0,>,IC50,nM,75000.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,75.0,CHEMBL613738
2074,7924554.0,[],CHEMBL1921362,Antiviral activity against Human immunodeficiency virus 1 Ba-L in human PBL cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(NS(C)(=O)=O)cc2Cl)ccc1CN1CCC(N(C(=O)Nc2ccc(C(N)=O)nc2)c2cccc(F)c2)CC1,CHEMBL1914281,Bioorg Med Chem Lett,2011.0,CHEMBL1914528,CHEMBL1914528,8.96,0.0,http://www.openphacts.org/units/Nanomolar,1556603.0,=,1.0,1.0,=,IC50,nM,1.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.1,CHEMBL378
2075,24971691.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5218444,Anti-HIV activity against HIV-1 NL4-3 Nanoluc-sec virus infected in human MT4 cells assessed as viral growth inhibition by measuring luciferase activity measured after 3 days post-infection by Nano-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@]12C[C@@H](C)[C@@]34O[C@@]5(CCCCCCC[C@H](C)[C@H]6[C@H](C)C(=O)[C@@](O)([C@H](O)[C@@]7(CO)O[C@H]7[C@H]3[C@H]1O5)[C@@H]64)O2,CHEMBL5215012,J Nat Prod,2022.0,CHEMBL5087817,CHEMBL5087817,7.09,0.0,http://www.openphacts.org/units/Nanomolar,3902013.0,=,1.0,1.0,=,IC50,nM,81.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,81.7,CHEMBL378
2076,15200436.0,[],CHEMBL3413997,Antiviral activity against X4 tropic HIV-1 clone pNL4-3 infected in H9 cells assessed as reduction in p24 antigen after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)c1ccc(/C=C(\C#N)c2nc3ccccc3o2)cc1,CHEMBL3407469,Eur J Med Chem,2015.0,CHEMBL3410133,CHEMBL3410133,5.62,0.0,http://www.openphacts.org/units/Nanomolar,2288869.0,=,1.0,1.0,=,IC50,nM,2380.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.38,CHEMBL378
2077,10938686.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(/C=C/C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(O)C(C)=O)C2)ccc1OC(C)=O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046568,CHEMBL2046568,,0.0,http://www.openphacts.org/units/Nanomolar,1651451.0,<,1.0,1.0,<,IC50,nM,9970.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,9.97,CHEMBL613497
2078,1401892.0,[],CHEMBL837467,In vitro inhibitory concentration against HIV K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)Nc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL128569,CHEMBL128569,4.00,0.0,http://www.openphacts.org/units/Nanomolar,360373.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2079,5246990.0,[],CHEMBL1687410,Antiviral activity against HIV1 Ba-L infected in human HOS cells expressing CCR5 after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@H]1C[C@H]2CC[C@@H](C1)N2CCC(CNC(=O)C1CCC(F)(F)CC1)c1ccccc1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL3084349,CHEMBL3084349,6.06,0.0,http://www.openphacts.org/units/Nanomolar,1333583.0,=,1.0,1.0,=,IC50,nM,866.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.866,CHEMBL378
2080,18528859.0,[],CHEMBL4194999,Antiviral activity against HIV1 virions derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)[C@H](c1cc(OC)c(OC)c(OC)c1)[C@@H](C)CC2,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4202482,CHEMBL4202482,7.05,0.0,http://www.openphacts.org/units/Nanomolar,3076502.0,=,1.0,1.0,=,IC50,nM,90.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.09,CHEMBL378
2081,17602990.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@@H]1CN(c2ccc(-c3ccccc3)cc2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1,CHEMBL3639049,,2013.0,CHEMBL3644925,CHEMBL3644925,6.03,0.0,http://www.openphacts.org/units/Nanomolar,2518045.0,=,37.0,1.0,=,IC50,nM,940.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,940.0,CHEMBL4620
2082,13933242.0,[],CHEMBL3124196,Antiviral activity against Hepatitis B virus assessed as inhibition of Hepatitis B virus surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(c1OC)CN(C)c1c-2ccc2cc3c(cc12)OCO3,CHEMBL3120134,Eur J Med Chem,2014.0,CHEMBL400359,CHEMBL400359,,0.0,http://www.openphacts.org/units/Nanomolar,1969507.0,<,1.0,1.0,<,IC50,nM,50.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol/L,UO_0000065,0.05,CHEMBL613497
2083,618114.0,[],CHEMBL710373,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,C[S+]([O-])c1nc(Cc2c(Cl)cccc2Cl)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL308091,CHEMBL308091,,0.0,http://www.openphacts.org/units/Nanomolar,126932.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2084,18452386.0,[],CHEMBL4178857,Antiviral activity against Chikungunya virus MY/065/08/FN295485 infected in African green monkey Vero cells assessed as reduction in virus yield after 48 hrs by titration assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12,CHEMBL4177563,Bioorg Med Chem,2017.0,CHEMBL31574,CHEMBL31574,4.53,0.0,http://www.openphacts.org/units/Nanomolar,3062356.0,=,1.0,1.0,=,IC50,nM,29500.0,CHEMBL4296563,Chikungunya virus,Chikungunya virus,37124,IC50,uM,UO_0000065,29.5,CHEMBL4296563
2085,1755851.0,[],CHEMBL864208,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(-n2c(COc3ccccc3)nnc2SCC(=O)Nc2ccccc2Cl)cc1,CHEMBL1146046,Bioorg Med Chem Lett,2006.0,CHEMBL213502,CHEMBL213502,,0.0,http://www.openphacts.org/units/Nanomolar,545191.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
2086,1751247.0,[],CHEMBL854523,Antiviral activity against wild type Measles virus Edmonston in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1cc(NC(=O)Cc2ccccc2)cc([N+](=O)[O-])c1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL211249,CHEMBL211249,5.40,0.0,http://www.openphacts.org/units/Nanomolar,532812.0,=,1.0,1.0,=,IC50,nM,4000.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,4.0,CHEMBL613738
2087,1401945.0,[],CHEMBL837471,In vitro inhibitory concentration against HIV Y188L mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCNc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL424972,CHEMBL424972,4.00,0.0,http://www.openphacts.org/units/Nanomolar,360389.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2088,1472003.0,[],CHEMBL834618,Inhibitory activity against HIV-1 mutant strain 103N; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C\c2cnccn2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188309,CHEMBL188309,,0.0,http://www.openphacts.org/units/Nanomolar,380978.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2089,2244565.0,[],CHEMBL1003072,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase P236L mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL57,CHEMBL57,7.23,0.0,http://www.openphacts.org/units/Nanomolar,798657.0,=,1.0,1.0,=,IC50,nM,59.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,59.0,CHEMBL378
2090,2462103.0,[],CHEMBL964561,Antiviral activity against hepatitis B virus infected Hep G2.2.15 cells assessed as inhibition of HBsAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)OC1N=C(c2ccccc2F)c2cc(Cl)ccc2NC1=O,CHEMBL1157443,Bioorg Med Chem Lett,2008.0,CHEMBL453330,CHEMBL453330,,0.0,http://www.openphacts.org/units/Nanomolar,720922.0,=,1.0,1.0,=,IC50,nM,160000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.16,CHEMBL613497
2091,2149874.0,[],CHEMBL935683,Antiviral activity against HIV1 098-T651 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL436869,CHEMBL436869,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708032.0,=,1.0,1.0,=,IC50,ug.mL-1,0.25,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.25,CHEMBL378
2092,3509137.0,[],CHEMBL1261038,Antiviral activity against wild type HIV1 infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 40% human serum,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(Cl)c1Nc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1Br,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1258589,CHEMBL1258589,8.00,0.0,http://www.openphacts.org/units/Nanomolar,963590.0,=,1.0,1.0,=,IC50,nM,9.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,9.9,CHEMBL378
2093,3221778.0,[],CHEMBL1103038,Antiviral activity against HIV1 carrying reverse transcriptase K103N/P225H mutant infected human MT4 cells by phenoscreen assay in the presence of 40 percent normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,NS(=O)(=O)c1ccc(NC(=O)CSC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,CHEMBL1153798,Bioorg Med Chem Lett,2009.0,CHEMBL1079267,CHEMBL1079267,5.50,0.0,http://www.openphacts.org/units/Nanomolar,897986.0,=,1.0,1.0,=,IC50,nM,3200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,0.0032,CHEMBL378
2094,5137402.0,[],CHEMBL1646839,Antiviral activity against X4 tropic HIV1 infected in human PBMC assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NCc1cscc1N(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21,CHEMBL1641524,Bioorg Med Chem Lett,2011.0,CHEMBL1644081,CHEMBL1644081,8.70,0.0,http://www.openphacts.org/units/Nanomolar,1319755.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
2095,18044738.0,[],CHEMBL4010432,"Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype C Du 156, clone 12",F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.21,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,620.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.62,CHEMBL378
2096,12108676.0,[],CHEMBL2173502,Antiviral activity against wild type HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL2169791,J Med Chem,2012.0,CHEMBL72335,CHEMBL72335,8.96,0.0,http://www.openphacts.org/units/Nanomolar,1740558.0,=,1.0,1.0,=,IC50,nM,1.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.1,CHEMBL378
2097,13857144.0,[],CHEMBL3097950,Antiviral activity against enfuvirtide-sensitive HIV-1 NL4-3 harboring gp41 (36G)N42S mutation infected in human MT2 cells assessed as inhibition of p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(/C=C2\SC(=S)N(Cc3ccc(C(C)(C)C)cc3)C2=O)c(C)n1-c1ccc(O)c(C(=O)O)c1,CHEMBL3091377,Bioorg Med Chem,2013.0,CHEMBL3092874,CHEMBL3092874,6.33,0.0,http://www.openphacts.org/units/Nanomolar,1952756.0,=,1.0,1.0,=,IC50,nM,473.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.473,CHEMBL378
2098,1982317.0,[],CHEMBL899339,Antiviral activity against HBV transfected Hep G2.2.15 cells assessed as inhibition of e antigen HBsAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,COC1=CC(=O)[C@@]2([C@@H]1O)[C@@H](Cl)C[C@@]13C(OC)=C(OC)C(=O)C[C@@]21CCN3C,CHEMBL1149710,Bioorg Med Chem Lett,2007.0,CHEMBL391628,CHEMBL391628,,0.0,http://www.openphacts.org/units/Nanomolar,661654.0,>,1.0,1.0,>,IC50,nM,2980000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.98,CHEMBL613497
2099,23274460.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](OCC#CC#CCO[C@@H]5CC[C@@]6(C)[C@@H](C5)C[C@H](O)[C@@H]5[C@@H]6CC[C@]6(C)[C@@H]([C@H](C)CCC(=O)NCCS(=O)(=O)O)CC[C@@H]56)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4852372,CHEMBL4852372,5.73,0.0,http://www.openphacts.org/units/Nanomolar,3621260.0,=,1.0,1.0,=,IC50,nM,1866.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,1866.0,CHEMBL613497
2100,12651440.0,[],CHEMBL2327724,Antiviral activity against 0.001 MOI wild type Human immunodeficiency virus 1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(CCCCC(=O)O)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2179591,CHEMBL2179591,8.22,0.0,http://www.openphacts.org/units/Nanomolar,1850159.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
2101,2614784.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccccc1[S+]([O-])c1cccc(N)c1C#N,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL294212,CHEMBL294212,,0.0,http://www.openphacts.org/units/Nanomolar,731705.0,=,1.0,1.0,=,IC50,nM,3899419.87,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,2.409,CHEMBL378
2102,6216939.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccc(F)c(Cl)c2)CCN(C(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784496,CHEMBL1784496,6.34,0.0,http://www.openphacts.org/units/Nanomolar,1429435.0,=,1.0,1.0,=,IC50,nM,457.09,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.34,CHEMBL378
2103,12542813.0,[],CHEMBL3076900,Antiviral activity against Human immunodeficiency virus 1 IIIB infected MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2nc(NN)sc2c1,CHEMBL3046062,Med Chem Res,2013.0,CHEMBL1241418,CHEMBL1241418,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824474.0,>,1.0,1.0,>,IC50,ug.mL-1,4.52,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,4.52,CHEMBL378
2104,20677920.0,[],CHEMBL4622140,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in cytoplasmic HBV-DNA replication incubated for 8 days by real-time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1/C(Br)=C(/NC(=O)c1ccc([N+](=O)[O-])cc1)C(=O)N1CCCCC1,CHEMBL4619801,J Med Chem,2020.0,CHEMBL3901038,CHEMBL3901038,6.06,0.0,http://www.openphacts.org/units/Nanomolar,3482208.0,=,1.0,1.0,=,IC50,nM,870.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.87,CHEMBL613497
2105,3084571.0,[],CHEMBL1065278,Antiviral activity against HIV1 KYAG primary isolate assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(NC(=O)C(=O)Nc2ccc(C(F)(F)F)cc2)CC(C)(C)N1,CHEMBL1153139,Bioorg Med Chem Lett,2010.0,CHEMBL593361,CHEMBL593361,,0.0,,873885.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2106,18202581.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2ccc(OCc3ccccc3)cc2)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4100003,CHEMBL4100003,6.89,0.0,http://www.openphacts.org/units/Nanomolar,3019965.0,=,1.0,1.0,=,IC50,nM,130.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.13,CHEMBL378
2107,2321199.0,[],CHEMBL1004248,Antiviral activity against HIV1 3B in human H9 cells after 4 days by p24 antigen ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1150942,J Nat Prod,1998.0,CHEMBL129,CHEMBL129,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,787903.0,=,1.0,1.0,=,IC50,ug.mL-1,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,500.0,CHEMBL378
2108,13464665.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1ccccc1F,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL53684,CHEMBL53684,5.52,0.0,http://www.openphacts.org/units/Nanomolar,1920715.0,=,1.0,1.0,=,IC50,nM,3019.95,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.52,CHEMBL378
2109,18314681.0,[],CHEMBL4132881,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 isolate YU2 infected in human TZM-bl cells after 24 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Brc1ccc2c(C(C3=NC[C@H](c4c[nH]c5cc(Br)ccc45)N3)c3c[nH]c4cc(Br)ccc34)c[nH]c2c1,CHEMBL4130397,J Nat Prod,2017.0,CHEMBL4163765,CHEMBL4163765,5.41,0.0,http://www.openphacts.org/units/Nanomolar,3040471.0,=,1.0,1.0,=,IC50,nM,3900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.9,CHEMBL378
2110,2263407.0,[],CHEMBL1010846,Antiviral activity against R5 tropic HIV1 BaL infected in human JC53-BL cells expressing CCR5 after 2 days by cell-cell fusion assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC1C(=O)N(Cc2ccc(F)cc2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2,CHEMBL1139267,Bioorg Med Chem Lett,2009.0,CHEMBL451400,CHEMBL451400,7.00,0.0,http://www.openphacts.org/units/Nanomolar,750090.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,100.0,CHEMBL378
2111,2929626.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(-n3ccnc3C#N)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL565689,CHEMBL565689,6.90,0.0,http://www.openphacts.org/units/Nanomolar,852784.0,=,1.0,1.0,=,IC50,nM,125.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,125.0,CHEMBL378
2112,22449745.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.5', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.5'}]",CHEMBL4680706,Antiviral activity against HIV1 YU-2 infected in dog Cf2Th/CD4-CCR5 cells assessed as inhibition of viral entry incubated for 30 mins prior to infection and measured after 48 hrs post infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(Cc1ccc2c(c1)[C@H](NC(=O)C(=O)Nc1ccc(Cl)c(F)c1)[C@@H](CNC(=N)N)C2)C(=N)N.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4680075,ACS Med Chem Lett,2016.0,CHEMBL4763274,CHEMBL4803130,5.80,0.0,http://www.openphacts.org/units/Nanomolar,3518674.0,=,1.0,1.0,=,IC50,nM,1600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.6,CHEMBL378
2113,3407240.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL129,CHEMBL129,8.30,0.0,http://www.openphacts.org/units/Nanomolar,932591.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.005,CHEMBL378
2114,12627472.0,[],CHEMBL2317015,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)c1ccc(/N=N/c2ccc(Cl)cc2)cc1,CHEMBL2311445,Bioorg Med Chem,2013.0,CHEMBL2311897,CHEMBL2311897,,0.0,http://www.openphacts.org/units/Nanomolar,1841395.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2115,23306085.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL4843118,Antiviral activity against Zika virus H/PF/2013 infected in pre-seeded Huh-7 cells assessed as inhibition of viral replication incubated for 72 hrs by immunodetection based secondary yield reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,FC(F)(F)c1ccc(NNc2nc(NCCOc3ccccc3)nc3[nH]cnc23)cc1,CHEMBL4842338,Eur J Med Chem,2021.0,CHEMBL4877568,CHEMBL4877568,,0.0,,3627101.0,,1.0,0.0,,IC50,,,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,,,,CHEMBL4296612
2116,2444178.0,[],CHEMBL1000124,Antiviral activity against HIV1 infected in human PBMCs,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1148197,J Nat Prod,2004.0,CHEMBL8,CHEMBL8,,0.0,,789675.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2117,2149698.0,[],CHEMBL926964,Antiviral activity against HIV1 LAI in MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(COc2ccc(C[C@H](NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc4c(c3)OCO4)cc2)cs1,CHEMBL1147040,J Biol Chem,2007.0,CHEMBL206031,CHEMBL206031,9.70,0.0,http://www.openphacts.org/units/Nanomolar,707769.0,=,1.0,1.0,=,IC50,nM,0.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0002,CHEMBL378
2118,18202561.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2cccnc2)NC(=O)N1C,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4093135,CHEMBL4093135,5.54,0.0,http://www.openphacts.org/units/Nanomolar,3019973.0,=,1.0,1.0,=,IC50,nM,2900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.9,CHEMBL378
2119,148224.0,[],CHEMBL656397,Activity against HIV-1 by syncytial plaque assay performed in duplicate using CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,O=[N+]([O-])c1cccc(Cn2c(Cl)nc3cc(Cl)c(Cl)cc32)c1,CHEMBL1131326,J Med Chem,1998.0,CHEMBL22681,CHEMBL22681,4.70,0.0,http://www.openphacts.org/units/Nanomolar,30701.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
2120,3114763.0,[],CHEMBL1073712,Antiviral activity against HIV1 NL4-3 infected in GFP expressing human CEM cells assessed as inhibition of viral infection measured after 9 days postinfection by microfluorometry,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CC(=O)c1c(O)c(C(=O)CC(C)C)c(O)c(C(c2ccccc2)c2c(O)c(C(=O)CC(C)C)c(O)c(C(=O)CC(C)C)c2O)c1O,CHEMBL1157554,Bioorg Med Chem,2010.0,CHEMBL577877,CHEMBL577877,6.55,0.0,http://www.openphacts.org/units/Nanomolar,888532.0,=,1.0,1.0,=,IC50,nM,280.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.28,CHEMBL378
2121,1026351.0,[],CHEMBL714338,"Antiviral activity against HIV-1, IIIB, in MT-4 Cells",F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)NCc1ccc(CN[C@@H](C(=O)N[C@H]2c3ccccc3C[C@H]2O)[C@H](O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)cc1,CHEMBL1129316,J Med Chem,1996.0,CHEMBL292940,CHEMBL292940,5.58,0.0,http://www.openphacts.org/units/Nanomolar,111233.0,=,1.0,1.0,=,IC50,nM,2600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2600.0,CHEMBL378
2122,1401862.0,[],CHEMBL837462,In vitro inhibitory concentration against HIV E138K mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(CO)nc(O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL424772,CHEMBL424772,8.40,0.0,http://www.openphacts.org/units/Nanomolar,360403.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.004,CHEMBL378
2123,1472150.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C\c2nccs2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL186460,CHEMBL186460,6.82,0.0,http://www.openphacts.org/units/Nanomolar,380790.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.15,CHEMBL378
2124,8043636.0,[],CHEMBL1953039,Antiviral activity against HIV1 3B infected human TZM-bl cells assessed as inhibition of viral replication by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](N/C=C1\C(=O)C(O)=C(C(C)C)c2cc(C)c(-c3c(C)cc4c(c3O)/C(=C/N[C@H](C(=O)[O-])[C@@H](C)CC)C(=O)C(O)=C4C(C)C)c(O)c21)C(=O)[O-].[Na+].[Na+],CHEMBL1949531,Bioorg Med Chem Lett,2012.0,CHEMBL1949750,CHEMBL1963023,5.95,0.0,http://www.openphacts.org/units/Nanomolar,1576818.0,=,1.0,1.0,=,IC50,nM,1120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.12,CHEMBL378
2125,2670837.0,[],CHEMBL1035389,Antiviral activity against LASV infected in human A549 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(c1cc2ccccc2o1)N1CC(=O)N(Cc2ccc(Cl)cc2)C(Cc2ccccc2)C1,CHEMBL1151924,Bioorg Med Chem Lett,2009.0,CHEMBL563809,CHEMBL563809,6.10,0.0,http://www.openphacts.org/units/Nanomolar,820605.0,=,1.0,1.0,=,IC50,nM,800.0,CHEMBL615051,Lassa virus,Lassa virus,11620,IC50,uM,UO_0000065,0.8,CHEMBL615051
2126,18173484.0,[],CHEMBL4038383,Antiviral activity against VSV pseudotyped HIV1 infected in SupT1 cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC(=O)[C@@]1(O)C(=O)N2C(C)(C)[C@@H]3Cc4cccc5c4[C@@]4(O[C@@]1(O)[C@@]2(O)[C@H]34)C(=O)N5,CHEMBL4038266,J Nat Prod,2017.0,CHEMBL4071089,CHEMBL4071089,4.15,0.0,http://www.openphacts.org/units/Nanomolar,3015251.0,=,1.0,1.0,=,IC50,nM,70100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,70.1,CHEMBL378
2127,2244531.0,[],CHEMBL1002210,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase L100I mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL57,CHEMBL57,6.52,0.0,http://www.openphacts.org/units/Nanomolar,798657.0,=,1.0,1.0,=,IC50,nM,304.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,304.0,CHEMBL378
2128,2929502.0,[],CHEMBL1056899,Antiviral activity against HIV1 HXB2 harboring 227C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3ncnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL574163,CHEMBL574163,7.30,0.0,http://www.openphacts.org/units/Nanomolar,848359.0,=,1.0,1.0,=,IC50,nM,50.11,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,50.11,CHEMBL378
2129,2413645.0,[],CHEMBL987708,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)CCOc1ccccc1)[C@@H](OC(=O)CCOc1ccccc1)C(C)(C)O)C1=C2C[C@H](OC(=O)CCOc3ccccc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL510342,CHEMBL510342,,0.0,http://www.openphacts.org/units/Nanomolar,810694.0,>,1.0,1.0,>,IC50,nM,950000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.95,CHEMBL613497
2130,15158636.0,[],CHEMBL3398832,Inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OCc1cccc2c1CCOC2=O)c1ccco1,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397180,CHEMBL3397180,,0.0,http://www.openphacts.org/units/Nanomolar,2278979.0,>,1.0,1.0,>,IC50,nM,2350000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.35,CHEMBL613497
2131,3406140.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc2oc(-c3ccc(F)cc3)cc(=O)c2c1,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1215460,CHEMBL1215460,,0.0,http://www.openphacts.org/units/Nanomolar,933194.0,=,1.0,1.0,=,IC50,nM,203100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,203.1,CHEMBL378
2132,1470288.0,[],CHEMBL832524,Inhibitory activity against HIV-1 double mutants strain 100I and 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cc(Cl)cc(Cl)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188941,CHEMBL188941,6.30,0.0,http://www.openphacts.org/units/Nanomolar,380720.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.5,CHEMBL378
2133,12528650.0,[],CHEMBL3078221,Antiviral activity against HIV1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(Cc2c([O-])on[n+]2-c2ccc(Cc3ccc(-[n+]4noc([O-])c4CN4CCN(C)C(c5ccccc5)C4)cc3)cc2)CC1c1ccccc1,CHEMBL3044741,Med Chem Res,2013.0,CHEMBL2282181,CHEMBL2282181,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824340.0,>,1.0,1.0,>,IC50,ug.mL-1,14.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,14.0,CHEMBL378
2134,16449840.0,[],CHEMBL3757559,Inhibition of ASCT2-mediated glutamine transport in human HEK293 cells using [3H]-glutamine after 15 mins by scintillation counting,B,BAO_0000190,BAO_0000219,cell-based format,N[C@@H](CCC(=O)Nc1ccc([N+](=O)[O-])cc1)C(=O)O,CHEMBL3751750,Bioorg Med Chem Lett,2016.0,CHEMBL6251,CHEMBL6251,2.92,1.0,http://www.openphacts.org/units/Nanomolar,2744487.0,=,1.0,1.0,=,IC50,nM,1200000.0,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,mM,UO_0000065,1.2,CHEMBL3562162
2135,5222595.0,[],CHEMBL1675304,Antiviral activity against HIV1 infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL141,CHEMBL141,6.11,0.0,http://www.openphacts.org/units/Nanomolar,1332024.0,=,1.0,1.0,=,IC50,nM,780.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.78,CHEMBL378
2136,2371462.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(C)n1-c1cccc(C(=O)O)c1,CHEMBL1140145,J Med Chem,2008.0,CHEMBL213432,CHEMBL213432,4.00,0.0,http://www.openphacts.org/units/Nanomolar,746079.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,100.0,CHEMBL613493
2137,19237557.0,[],CHEMBL4399056,Antiviral activity against HIV-1 infected in HEK293 cells preincubated for 4 hrs with cell followed by viral infection measured after 24 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(CC(=O)c1c[nH]c2ccc(Cl)cc12)c1nnn[nH]1,CHEMBL4396909,Eur J Med Chem,2019.0,CHEMBL4451391,CHEMBL4451391,6.19,0.0,http://www.openphacts.org/units/Nanomolar,3211421.0,=,1.0,1.0,=,IC50,nM,650.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.65,CHEMBL378
2138,1401602.0,[],CHEMBL833792,In vitro inhibitory concentration against HIV-1 Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL338047,CHEMBL338047,7.00,0.0,http://www.openphacts.org/units/Nanomolar,360324.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
2139,1230611.0,[],CHEMBL677520,Concentration required to inhibit HIV-1(KOS) induced cytopathicity in E6SM cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)NCCCCCCCCCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL333191,CHEMBL1206998,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221517.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,100.0,CHEMBL378
2140,156682.0,[],CHEMBL656397,Activity against HIV-1 by syncytial plaque assay performed in duplicate using CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(Cn2c(N)nc3cc(Cl)c(Cl)cc32)c1,CHEMBL1131326,J Med Chem,1998.0,CHEMBL281111,CHEMBL281111,4.92,0.0,http://www.openphacts.org/units/Nanomolar,30672.0,=,1.0,1.0,=,IC50,nM,12000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.0,CHEMBL378
2141,1751222.0,[],CHEMBL854523,Antiviral activity against wild type Measles virus Edmonston in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Cc1ccc(F)cc1)Nc1cccc([N+](=O)[O-])c1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL215674,CHEMBL215674,5.05,0.0,http://www.openphacts.org/units/Nanomolar,532823.0,=,1.0,1.0,=,IC50,nM,9000.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,9.0,CHEMBL613738
2142,22806644.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@@H](Sc3cccc(NC)c3)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4747848,CHEMBL4747848,5.92,0.0,http://www.openphacts.org/units/Nanomolar,3541914.0,=,1.0,1.0,=,IC50,nM,1199.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.199,CHEMBL613497
2143,23274472.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CCCOC(=O)CC[C@@H](C)[C@H]2CC[C@H]3[C@@H]4[C@@H](O)C[C@@H]5C[C@@H](CC[C@]5(C)[C@H]4CC[C@]23C)NC(=O)CCCC(=O)N[C@@H]2CC[C@@]3(C)[C@@H](C2)C[C@H](O)[C@@H]2[C@@H]3CC[C@]3(C)[C@@H]1CC[C@@H]23,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4867979,CHEMBL4867979,6.28,0.0,http://www.openphacts.org/units/Nanomolar,3621272.0,=,1.0,1.0,=,IC50,nM,525.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,525.0,CHEMBL613497
2144,64708.0,[],CHEMBL857692,Inhibitory concentration against HCV NS3 protease was determined,B,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)c1cnccn1)[C@@H](C)CC)C(=O)C(=O)N[C@H](C)C(=O)O,CHEMBL1136650,Bioorg Med Chem Lett,2003.0,CHEMBL13664,CHEMBL13664,,0.0,http://www.openphacts.org/units/Nanomolar,12750.0,>,1.0,1.0,>,IC50,nM,60000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,60.0,CHEMBL4620
2145,1401706.0,[],CHEMBL837470,In vitro inhibitory concentration against HIV V179E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,COCCCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL178689,CHEMBL178689,8.10,0.0,http://www.openphacts.org/units/Nanomolar,360393.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
2146,2929788.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL233664,CHEMBL233664,7.70,0.0,http://www.openphacts.org/units/Nanomolar,848384.0,=,1.0,1.0,=,IC50,nM,19.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.9,CHEMBL378
2147,2371269.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1CCCC(C)N1CCNc1nc2ccccc2c2nc(-c3ccccc3)nn12,CHEMBL1140145,J Med Chem,2008.0,CHEMBL493866,CHEMBL493866,5.14,0.0,http://www.openphacts.org/units/Nanomolar,745781.0,=,1.0,1.0,=,IC50,nM,7300.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,7.3,CHEMBL613493
2148,3453359.0,[],CHEMBL1247798,Antiviral activity against HIV1 isolate 05-121777 assessed as inhibition of viral replication after 7 days by scintillation counting,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(c2cccc3nc(CN(C)[C@H]4CCCc5cccnc54)c(CO)n23)CC1,CHEMBL1240366,Antimicrob Agents Chemother,2010.0,CHEMBL1242210,CHEMBL1242210,9.00,0.0,http://www.openphacts.org/units/Nanomolar,953332.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
2149,1498004.0,[],CHEMBL833971,Concentration required to inhibit 50% viral production of human immunodeficiency virus type 1 (HIV-1-IIIB),F,BAO_0000190,BAO_0000218,organism-based format,O=C1c2ccccc2C2(c3ccccc3)SCCN12,CHEMBL1143567,J Med Chem,2005.0,CHEMBL430623,CHEMBL430623,7.80,0.0,http://www.openphacts.org/units/Nanomolar,388266.0,=,1.0,1.0,=,IC50,nM,16.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.016,CHEMBL378
2150,15156734.0,[],CHEMBL3399645,Decrease in HBV viral DNA replication in human HepG2(2.2.15) cells at 0.75 to 3 uM after 72 hrs by real-time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(C)=O)c(OS(=O)(=O)c2ccccc2)c1,CHEMBL3397002,Eur J Med Chem,2015.0,CHEMBL3397407,CHEMBL3397407,5.73,0.0,http://www.openphacts.org/units/Nanomolar,2279254.0,=,1.0,1.0,=,IC50,nM,1860.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.86,CHEMBL613497
2151,3008336.0,[],CHEMBL1037279,Antiviral activity against Human immunodeficiency virus 1 NL4-3 infected HeLaP4 cells after 5 days by beta-galactosidase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(Oc1cccc2nccnc12)C(=O)N1CCN(C(=O)c2ccccc2)C[C@H]1C,CHEMBL1155317,Bioorg Med Chem Lett,2009.0,CHEMBL571243,CHEMBL571243,,0.0,,861813.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2152,684419.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)Cc1ccc(SSc2ccc(CC(=O)O)cc2)cc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL1160967,CHEMBL1160967,,0.0,,228642.0,>,1.0,0.0,>,IC50,,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,200.0,CHEMBL378
2153,1288784.0,[],CHEMBL756142,Tested for the inhibition of p24 production in HIV-1 IIIB infected human peripheral blood mononuclear cells (PBMC),F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@@H](C[C@H](O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)COc1cccc2ccccc12)C(C)OP(=O)([O-])[O-])C(C)C)C(=O)N(C)c1ccccn1.[K+].[K+],CHEMBL1126785,J Med Chem,1993.0,CHEMBL2304048,CHEMBL1206831,8.08,0.0,http://www.openphacts.org/units/Nanomolar,156149.0,=,1.0,1.0,=,IC50,nM,8.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.3,CHEMBL378
2154,14658850.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,O=C(COc1ccc(Br)cc1)N1CCN(C(=O)Cc2ccccc2)CC1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262877,CHEMBL3262877,7.00,0.0,http://www.openphacts.org/units/Nanomolar,2101719.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,pIC50,,UO_0000065,7.0,CHEMBL3259471
2155,404764.0,[],CHEMBL756140,Inhibition of human peripheral blood mononuclear cell (PBMC)donor A proliferation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCC(=O)CC(=O)N[C@H]1CCOC1=O,CHEMBL1145979,J Med Chem,2003.0,CHEMBL8450,CHEMBL8450,,0.0,http://www.openphacts.org/units/Nanomolar,4334.0,=,1.0,1.0,=,IC50,nM,130000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,130.0,CHEMBL378
2156,18342093.0,[],CHEMBL4139012,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1ccc(-c2cc(NC(=O)c3ccccc3O)c[nH]c2=O)cc1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL4165801,CHEMBL4165801,4.61,0.0,http://www.openphacts.org/units/Nanomolar,3045871.0,=,1.0,1.0,=,IC50,nM,24630.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,24.63,CHEMBL613497
2157,1402495.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCOC)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL426046,CHEMBL426046,9.00,0.0,http://www.openphacts.org/units/Nanomolar,360366.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
2158,2149861.0,[],CHEMBL935683,Antiviral activity against HIV1 098-T651 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL428503,CHEMBL428503,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708045.0,=,1.0,1.0,=,IC50,ug.mL-1,0.242,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.242,CHEMBL378
2159,850912.0,[],CHEMBL686566,Anti-HIV activity in H9 lymphocytes.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)oc2c3c(ccc12)OC(C)(C)[C@H](OC(=O)Nc1cccc2ccccc12)[C@@H]3OC(=O)Nc1cccc2ccccc12,CHEMBL1132174,J Med Chem,1999.0,CHEMBL316237,CHEMBL316237,4.01,0.0,http://www.openphacts.org/units/Nanomolar,163835.0,=,1.0,1.0,=,IC50,nM,98000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,98.0,CHEMBL378
2160,646235.0,[],CHEMBL696967,Concentration required for reduction of plaque against influenza B; Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCCN(CCC)C(=O)[C@@H]1OC(C(=O)O)=C[C@H](NCC)[C@H]1NC(C)=O,CHEMBL1134218,Bioorg Med Chem Lett,2001.0,CHEMBL422016,CHEMBL422016,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,313066.0,,1.0,0.0,,IC50,ug.mL-1,,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,,CHEMBL613129
2161,8043641.0,[],CHEMBL1953039,Antiviral activity against HIV1 3B infected human TZM-bl cells assessed as inhibition of viral replication by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NCC(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/NCC(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+],CHEMBL1949531,Bioorg Med Chem Lett,2012.0,CHEMBL1949745,CHEMBL1962390,,0.0,,1576813.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2162,5137373.0,[],CHEMBL1646836,Antiviral activity against X4 tropic HIV1 NL4.3 infected in human MT4 cells expressing CD4 and CXCR4 assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1ccc(CN(Cc2nc3ccccc3[nH]2)C2CCCc3cccnc32)c(CN)c1,CHEMBL1641524,Bioorg Med Chem Lett,2011.0,CHEMBL1644077,CHEMBL1644077,6.98,0.0,http://www.openphacts.org/units/Nanomolar,1319751.0,=,1.0,1.0,=,IC50,nM,105.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.105,CHEMBL378
2163,18044722.0,[],CHEMBL4010424,"Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype B PVO, clone 4",F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.30,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.5,CHEMBL378
2164,12113554.0,[],CHEMBL2176187,Antiviral activity against HIV-1 clade B Env pseudovirus assessed as geometric mean titer for virus neutralization to infect human TZM-bl cells by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,N=C(N)N[C@@H]1Cc2ccccc2[C@H]1NC(=O)C(=O)Nc1ccc(Cl)c(F)c1.O=CO,CHEMBL2169814,J Med Chem,2012.0,CHEMBL2171087,CHEMBL2219814,5.05,0.0,http://www.openphacts.org/units/Nanomolar,1740956.0,=,1.0,1.0,=,IC50,nM,8900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.9,CHEMBL378
2165,2199542.0,[],CHEMBL937899,Antiviral activity against HBV assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH][nH]c(=O)c2c(-c3ccc4c(c3)OCO4)c3c4c(ccc3cc12)OCO4,CHEMBL1156464,Proc Natl Acad Sci U S A,2007.0,CHEMBL369673,CHEMBL369673,7.00,0.0,http://www.openphacts.org/units/Nanomolar,791641.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.1,CHEMBL613497
2166,1402013.0,[],CHEMBL835251,In vitro inhibitory concentration against HIV F227L and V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCOC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL368039,CHEMBL368039,5.60,0.0,http://www.openphacts.org/units/Nanomolar,360360.0,=,1.0,1.0,=,IC50,nM,2512.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.512,CHEMBL378
2167,24735323.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5116803,Antiviral activity against CHIKV infected in human Huh-7 cells assessed as inhibition of viral infection by measuring EGFP-positive cells measured 24 hrs post infection by fluorescent microscopic analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=c1cc(-c2ccccc2)oc2c(-c3ccc(OC(F)(F)F)cc3)c(O)c(O)c(O)c12,CHEMBL5113447,Bioorg Med Chem Lett,2022.0,CHEMBL5174882,CHEMBL5174882,5.28,0.0,http://www.openphacts.org/units/Nanomolar,3858574.0,=,1.0,1.0,=,IC50,nM,5200.0,CHEMBL4296563,Chikungunya virus,Chikungunya virus,37124,IC50,uM,UO_0000065,5.2,CHEMBL4296563
2168,2371529.0,[],CHEMBL1035745,Antiviral activity against HIV1 with reverse transcriptase F227L mutant in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ncccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL491019,CHEMBL491019,,0.0,,773465.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2169,2149847.0,[],CHEMBL935682,Antiviral activity against HIV1 098-T1249 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL415790,CHEMBL415790,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708040.0,=,1.0,1.0,=,IC50,ug.mL-1,0.025,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.025,CHEMBL378
2170,18528897.0,[],CHEMBL4195001,Antiviral activity against HIV1 virions containing reverse transcriptase K103N mutant derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)[C@H](c1cc(OC)c(OC)c(OC)c1)[C@@H](C)[C@@H](C)C2,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4215279,CHEMBL4215279,6.75,0.0,http://www.openphacts.org/units/Nanomolar,3076498.0,=,1.0,1.0,=,IC50,nM,180.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.18,CHEMBL378
2171,23165129.0,[],CHEMBL4813046,Antiviral activity against Zika virus infected in human SF-268 cells assessed as reduction in viral infection by DAPI staining based immunofluorescence assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@H]1CC[C@@]2(C)C(CC[C@]3(C)C2C(=O)C=C2C4C[C@@](C)(C(=O)Nc5cccnc5)CC[C@]4(C)CC[C@]23C)C1(C)C,CHEMBL4811277,Bioorg Med Chem,2021.0,CHEMBL4870229,CHEMBL4870229,6.89,0.0,http://www.openphacts.org/units/Nanomolar,3601577.0,=,1.0,1.0,=,IC50,nM,130.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,0.13,CHEMBL4296612
2172,914499.0,[],CHEMBL758490,Anti-HIV activity against multidrug resistant HIV JSL strain by inhibition of HIV p24 antigen expression in peripheral blood mononuclear cells(PBMC),F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@@H](/C=C/[C@@H](C[S+]([O-])c1ccc2ccccc2c1)NS(C)(=O)=O)Cc1ccccc1)S(=O)(=O)c1ccc(N)cc1,CHEMBL1144922,J Med Chem,2003.0,CHEMBL50945,CHEMBL50945,6.47,0.0,http://www.openphacts.org/units/Nanomolar,83376.0,=,1.0,1.0,=,IC50,nM,340.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,340.0,CHEMBL378
2173,5229805.0,[],CHEMBL1676984,Antiviral activity against Human immunodeficiency virus 1 3B infected in human H9 cells infected with 50 uL of virus stock assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,5.82,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,=,1.0,1.0,=,IC50,nM,1530.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.53,CHEMBL378
2174,3014904.0,[],CHEMBL1037215,Antiviral activity against indinavir-resistant HIV1 NL4-3,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(c1)OCCCC/C=C\CCCN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]3OCC[C@H]31)S2(=O)=O,CHEMBL1156053,J Med Chem,2009.0,CHEMBL577992,CHEMBL577992,7.70,0.0,http://www.openphacts.org/units/Nanomolar,862634.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,20.0,CHEMBL378
2175,3358078.0,[],CHEMBL1175710,Antiviral activity against HIV1 expressing reverse transcriptase K103N/Y181C double mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)ncc1Br,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1170386,CHEMBL1170386,7.45,0.0,http://www.openphacts.org/units/Nanomolar,922325.0,=,1.0,1.0,=,IC50,nM,35.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,35.7,CHEMBL378
2176,3276411.0,[],CHEMBL1104905,Antiviral activity against HBV infected in HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion after 8 days by radio immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)C(=O)/C(NC(=O)c1ccccc1)=C(/Br)c1snnc1C,CHEMBL1157863,Eur J Med Chem,2010.0,CHEMBL1088362,CHEMBL1088362,,0.0,,912505.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
2177,12651427.0,[],CHEMBL2327724,Antiviral activity against 0.001 MOI wild type Human immunodeficiency virus 1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCNC(=O)[C@H](CCC#N)NC(=O)OC(C)(C)C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324150,CHEMBL2324150,7.52,0.0,http://www.openphacts.org/units/Nanomolar,1850176.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.03,CHEMBL378
2178,15749738.0,[],CHEMBL3632389,Antiviral activity against HIV-1 LAI infected in MT-2 cells measured after 7 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL3627614,Bioorg Med Chem Lett,2015.0,CHEMBL1323,CHEMBL1323,8.52,0.0,http://www.openphacts.org/units/Nanomolar,2506715.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.0,CHEMBL378
2179,14658787.0,[],CHEMBL3266157,Antagonist activity at recombinant human EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(/C=C/C(=O)N2CCN(C(=O)Cc3ccccc3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262880,CHEMBL3262880,7.72,0.0,http://www.openphacts.org/units/Nanomolar,2101722.0,=,1.0,1.0,=,IC50,nM,19.0,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,nM,UO_0000065,19.0,CHEMBL3259470
2180,1470284.0,[],CHEMBL833078,Inhibitory activity against HIV-1 mutant strain 179E,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cc(Cl)cc(Cl)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188941,CHEMBL188941,8.00,0.0,http://www.openphacts.org/units/Nanomolar,380720.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
2181,16626949.0,[],CHEMBL3821894,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 48 hrs by SYBR Green based RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,O=S(=O)(Oc1cc(-c2ccccn2)[nH]n1)c1ccc(F)cc1,CHEMBL3817822,Medchemcomm,2016.0,CHEMBL3819057,CHEMBL3819057,4.04,0.0,http://www.openphacts.org/units/Nanomolar,2783931.0,=,1.0,1.0,=,IC50,nM,92070.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,92.07,CHEMBL613497
2182,1211880.0,[],CHEMBL880061,Inhibitory activity against LAI strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2cc(N)nc(Cc3c(Cl)cccc3Cl)n2)cc1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL74226,CHEMBL74226,6.34,0.0,http://www.openphacts.org/units/Nanomolar,127433.0,=,1.0,1.0,=,IC50,nM,452.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.452,CHEMBL378
2183,14658840.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)c3ccc(N(C)C)cc3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262889,CHEMBL3262889,7.70,0.0,http://www.openphacts.org/units/Nanomolar,2101731.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,IC50,nM,UO_0000065,20.0,CHEMBL3259471
2184,592856.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)CCNc1nc(Cc2c(Cl)cccc2Cl)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL306023,CHEMBL306023,6.42,0.0,http://www.openphacts.org/units/Nanomolar,126902.0,=,1.0,1.0,=,IC50,nM,379.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.379,CHEMBL378
2185,2099839.0,[],CHEMBL949222,Antiviral activity against HIV1 RU570 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)N(CCCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nc4cc(S(C)(=O)=O)ccc42)C3)c2ccccc2)cc1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL402353,CHEMBL402353,,0.0,http://www.openphacts.org/units/Nanomolar,699394.0,>,1.0,1.0,>,IC50,nM,10000000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10000.0,CHEMBL378
2186,5189144.0,[],CHEMBL1658799,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c(CCO)c(-c2ccccc2Cl)c2cc(Cl)ccc2n1-c1ccccc1,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652493,CHEMBL1652493,4.92,0.0,http://www.openphacts.org/units/Nanomolar,1326866.0,=,1.0,1.0,=,IC50,nM,12000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.012,CHEMBL613497
2187,7967169.0,[],CHEMBL1930242,Antiviral activity against R5 tropic Human immunodeficiency virus 1 BAL infected in human PBMC cells assessed as reduction in viral replication by p24 detection based ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1,CHEMBL1926604,Bioorg Med Chem Lett,2011.0,CHEMBL1926900,CHEMBL1926900,8.70,0.0,http://www.openphacts.org/units/Nanomolar,1563517.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
2188,14927160.0,[],CHEMBL3391567,Antiviral activity against NNRTI-resistant HIV-1 LAI harboring reverse transcriptase Y181C mutant infected in human MT4 cells assessed as inhibition of viral replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2c(F)c(CCc3ccncc3)[nH]c(=O)c2Br)c1,CHEMBL3390846,Medchemcomm,2010.0,CHEMBL3347281,CHEMBL3347281,7.96,0.0,http://www.openphacts.org/units/Nanomolar,2173090.0,=,1.0,1.0,=,IC50,nM,11.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,11.0,CHEMBL378
2189,2371280.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[n+]1cc(/C=C2\SC=CN2C)c(C)c2cc(OC)c3ccccc3c21,CHEMBL1140145,J Med Chem,2008.0,CHEMBL493889,CHEMBL493889,5.46,0.0,http://www.openphacts.org/units/Nanomolar,745586.0,=,1.0,1.0,=,IC50,nM,3500.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,3.5,CHEMBL613493
2190,19261856.0,[],CHEMBL4404367,Antiviral activity against HIV1 subtypeA2/D QG393.60M.ENV.B7,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.30,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.5,CHEMBL378
2191,18469014.0,[],CHEMBL4182244,Antiviral activity against HIV-1 3B infected in human TZM-bl cells treated for 2 hrs followed by compound washout measured after 2 days by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](N/C=C1\C(=O)C(O)=C(C(C)C)c2cc(C)c(-c3c(C)cc4c(c3O)/C(=C/N[C@H](C(=O)[O-])[C@@H](C)CC)C(=O)C(O)=C4C(C)C)c(O)c21)C(=O)[O-].[Na+].[Na+],CHEMBL4177704,Bioorg Med Chem Lett,2018.0,CHEMBL1949750,CHEMBL1963023,5.38,0.0,http://www.openphacts.org/units/Nanomolar,3065410.0,=,1.0,1.0,=,IC50,nM,4220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,umol/L,UO_0000065,4.22,CHEMBL378
2192,1401873.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177563,CHEMBL177563,8.10,0.0,http://www.openphacts.org/units/Nanomolar,360416.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
2193,1199860.0,[],CHEMBL710372,Inhibitory activity against 100I strain and 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(C)cc(C#N)cc1C,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL308004,CHEMBL308004,,0.0,http://www.openphacts.org/units/Nanomolar,127441.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
2194,800353.0,[],CHEMBL697279,Anti-HIV-1 activity against syncytial plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1,CHEMBL1125670,J Med Chem,1991.0,CHEMBL1460,CHEMBL1460,,0.0,http://www.openphacts.org/units/Nanomolar,47364.0,=,1.0,1.0,=,IC50,nM,1700000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,1.7,CHEMBL378
2195,2212961.0,[],CHEMBL989684,Antiviral activity against HBV assessed as inhibition of viral e-antigen secretion in HepG2.2.15 cells by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(OC)c(OC)c3C(=O)N1CC2,CHEMBL1150244,J Nat Prod,2008.0,CHEMBL468804,CHEMBL468804,,0.0,http://www.openphacts.org/units/Nanomolar,767836.0,>,1.0,1.0,>,IC50,nM,7470000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,7.47,CHEMBL613497
2196,3358088.0,[],CHEMBL1175709,Antiviral activity against HIV1 infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3Cl)CC2)n1,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1170387,CHEMBL1170387,7.61,0.0,http://www.openphacts.org/units/Nanomolar,922326.0,=,1.0,1.0,=,IC50,nM,24.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,24.6,CHEMBL378
2197,3358076.0,[],CHEMBL1175710,Antiviral activity against HIV1 expressing reverse transcriptase K103N/Y181C double mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3Cl)CC2)ncc1Br,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1170005,CHEMBL1170005,8.14,0.0,http://www.openphacts.org/units/Nanomolar,922327.0,=,1.0,1.0,=,IC50,nM,7.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.3,CHEMBL378
2198,5246994.0,[],CHEMBL1687410,Antiviral activity against HIV1 Ba-L infected in human HOS cells expressing CCR5 after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1[C@H]1C[C@H]2CC[C@@H](C1)N2CCC(C)(CN(C)S(=O)(=O)c1ccccc1)c1ccccc1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL3084352,CHEMBL3084352,8.05,0.0,http://www.openphacts.org/units/Nanomolar,1333587.0,=,1.0,1.0,=,IC50,nM,9.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.009,CHEMBL378
2199,1206558.0,[],CHEMBL710530,Inhibitory activity against 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Nc1nc(Nc2ccc(C#N)cc2)ncc1C#N,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL69890,CHEMBL69890,8.59,0.0,http://www.openphacts.org/units/Nanomolar,127450.0,=,1.0,1.0,=,IC50,nM,2.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0026,CHEMBL378
2200,19261756.0,[],CHEMBL4404352,Antiviral activity against HIV1 HXB2 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)nn2)[nH]1)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4586291,CHEMBL4586291,,0.0,http://www.openphacts.org/units/Nanomolar,3216295.0,>,1.0,1.0,>,IC50,nM,12000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.0,CHEMBL378
2201,1110122.0,[],CHEMBL698085,Inhibitory activity against HIV-1 mutant strain K103N/Y181C,F,BAO_0000190,BAO_0000218,organism-based format,CCN1c2ncc(CSc3cc(C)nc(C)c3)cc2C(=O)Nc2c(C)cc(Cl)nc21,CHEMBL1137947,Bioorg Med Chem Lett,2004.0,CHEMBL164261,CHEMBL164261,7.22,0.0,http://www.openphacts.org/units/Nanomolar,321329.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,60.0,CHEMBL378
2202,19162211.0,[],CHEMBL4383613,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells after 7 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2ccc3c(c2)[C@H](NC(=O)OC(C)(C)C)CCS3)cc1,CHEMBL4382211,Eur J Med Chem,2018.0,CHEMBL4561948,CHEMBL4561948,,0.0,http://www.openphacts.org/units/Nanomolar,3197997.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
2203,18320122.0,[],CHEMBL4134181,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA level incubated for 3 days followed by medium replacement measured after 3 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C2C[C@H](NS(C)(=O)=O)CN2C(c2nccs2)=N[C@H]1c1ccc(F)cc1Cl,CHEMBL4130455,ACS Med Chem Lett,2017.0,CHEMBL4171874,CHEMBL4171874,5.00,0.0,http://www.openphacts.org/units/Nanomolar,3041717.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.0,CHEMBL613497
2204,5132857.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)N(Cc2ccco2)Cc2cc3ccc(C)cc3[nH]c2=O)cc1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645076,CHEMBL1645076,,0.0,http://www.openphacts.org/units/Nanomolar,1321065.0,>,1.0,1.0,>,IC50,nM,15000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,15.0,CHEMBL378
2205,18509596.0,[],CHEMBL4191607,Antiviral activity against NNRTI-resistant HIV1 isolate N119 infected in PHA-stimulated human PBMC assessed as reduction in p24 level after 7 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(O[C@@H]3O[C@H](C)[C@@H](O)[C@H](O)[C@H]3O)c3c(c(-c4ccc5c(c4)OCO5)c2cc1OC)C(=O)OC3,CHEMBL4190218,J Nat Prod,2017.0,CHEMBL458904,CHEMBL458904,7.33,0.0,http://www.openphacts.org/units/Nanomolar,3073112.0,=,1.0,1.0,=,IC50,nM,47.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,47.0,CHEMBL378
2206,5247002.0,[],CHEMBL1687411,Antiviral activity against HIV1 Ba-L infected in human PBL cells assessed as reverse transcriptase activity after 7 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC(CNS(=O)(=O)c1cccc(C(N)=O)c1)c1ccccc1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL1682564,CHEMBL1682564,6.79,0.0,http://www.openphacts.org/units/Nanomolar,1333676.0,=,1.0,1.0,=,IC50,nM,161.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.161,CHEMBL378
2207,1470437.0,[],CHEMBL833075,Inhibitory activity against HIV-1 mutant strain 101E,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C/C#N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL190941,CHEMBL190941,8.10,0.0,http://www.openphacts.org/units/Nanomolar,380743.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
2208,3498064.0,[],CHEMBL1259504,Antiviral activity against HIV1 isolate 89.6 infected in human PM1 cells expressing CCR5 assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)CN1CCC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC1,CHEMBL1255517,Bioorg Med Chem Lett,2010.0,CHEMBL1258618,CHEMBL1258618,,0.0,,963623.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2209,18323346.0,[],CHEMBL4134874,Antiviral activity against VSV-G pseudotyped HIV1 infected in human SupT1 cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1[C@@H](C)[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]23OC(=O)/C=C/[C@H](C)[C@H](O)[C@@H](C)C/C=C/[C@H]3[C@@H]1O,CHEMBL4130477,J Nat Prod,2017.0,CHEMBL497529,CHEMBL497529,4.59,0.0,http://www.openphacts.org/units/Nanomolar,3042095.0,=,1.0,1.0,=,IC50,nM,25800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.8,CHEMBL378
2210,18775515.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCC1Cc2cc(OCCO)c(OC)cc2-c2cc(=O)c(C(=O)O)cn21,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4284095,CHEMBL4284095,6.25,0.0,http://www.openphacts.org/units/Nanomolar,3119673.0,=,1.0,1.0,=,IC50,nM,560.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.56,CHEMBL613497
2211,13475405.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435883,CHEMBL2435883,6.18,0.0,http://www.openphacts.org/units/Nanomolar,1924259.0,=,1.0,1.0,=,IC50,nM,658.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,658.2,CHEMBL378
2212,2183995.0,[],CHEMBL951603,Antiviral activity against HIV1 NL43 infected in U87.CD4 cells expressing human wild type CXCR4,F,BAO_0000190,BAO_0000218,organism-based format,c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,CHEMBL1156482,J Biol Chem,2007.0,CHEMBL18442,CHEMBL18442,7.85,0.0,http://www.openphacts.org/units/Nanomolar,791970.0,=,1.0,1.0,=,IC50,nM,14.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,14.0,CHEMBL378
2213,910271.0,[],CHEMBL712257,Inhibition of human immunodeficiency virus-1 (HIV-1) induced cytopathicity in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](Cn1nc2nc(N)nc(O)c2n1)OCP(=O)(O)O,CHEMBL1129435,J Med Chem,1996.0,CHEMBL132576,CHEMBL132576,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251935.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,100.0,CHEMBL378
2214,22806672.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2OC(C(C)=O)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL264029,CHEMBL264029,,0.0,http://www.openphacts.org/units/Nanomolar,3541886.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.0,CHEMBL613497
2215,321816.0,[],CHEMBL873617,Inhibition of concanavalin A (con A)-induced proliferation of rat peripheral blood mononuclear cells.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1)c1ccncc1,CHEMBL1133605,J Med Chem,2000.0,CHEMBL431431,CHEMBL431431,5.89,0.0,http://www.openphacts.org/units/Nanomolar,188092.0,=,1.0,1.0,=,IC50,nM,1279.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1279.0,CHEMBL378
2216,3498053.0,[],CHEMBL1259503,Antiviral activity against HIV1 3B infected in human PM1 cells expressing CCR5 assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC(C)(C)N1,CHEMBL1255517,Bioorg Med Chem Lett,2010.0,CHEMBL254781,CHEMBL254781,5.10,0.0,http://www.openphacts.org/units/Nanomolar,963494.0,=,1.0,1.0,=,IC50,nM,8000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.0,CHEMBL378
2217,1470585.0,[],CHEMBL832527,Inhibitory activity against HIV-1 double mutants strain 227L and 106A,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL57,CHEMBL57,7.70,0.0,http://www.openphacts.org/units/Nanomolar,380791.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.02,CHEMBL378
2218,3315839.0,[],CHEMBL1119774,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@@H]3c3ccccn3)CC2)CC1,CHEMBL1155507,Bioorg Med Chem Lett,2010.0,CHEMBL1085721,CHEMBL1085721,7.66,0.0,http://www.openphacts.org/units/Nanomolar,915818.0,=,1.0,1.0,=,IC50,nM,22.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,22.0,CHEMBL378
2219,14990567.0,[],CHEMBL3383781,Antiviral activity against HIV1 pseudotyped virus expressed in human U87 cells co-expressing AMLV envelope after 48 hrs by cell-based luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(Cl)c2[nH]cc(C(=O)C(=O)N3CC4CN(C(=O)c5ccccc5)CC4C3)c12,CHEMBL3351851,Bioorg Med Chem Lett,2014.0,CHEMBL3353049,CHEMBL3353049,,0.0,,2241678.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2220,19139097.0,[],CHEMBL4376259,Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition in virus-induced cytopathic effect incubated for 40 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)OC)[C@@H]1CC[C@H](C)[C@H]2C(=C(C)C(=O)[C@H]2NC(=O)c2ccccc2)C1,CHEMBL4373726,Bioorg Med Chem Lett,2019.0,CHEMBL4476416,CHEMBL4476416,4.36,0.0,http://www.openphacts.org/units/Nanomolar,3194252.0,=,1.0,1.0,=,IC50,nM,43800.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,43.8,CHEMBL613129
2221,162861.0,[],CHEMBL656397,Activity against HIV-1 by syncytial plaque assay performed in duplicate using CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(Cn2c(N)nc3cc(Cl)c(Cl)cc32)cc1,CHEMBL1131326,J Med Chem,1998.0,CHEMBL277486,CHEMBL277486,4.92,0.0,http://www.openphacts.org/units/Nanomolar,30660.0,=,1.0,1.0,=,IC50,nM,12000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.0,CHEMBL378
2222,19261884.0,[],CHEMBL4404376,Antiviral activity against HIV1 subtypeB B41,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.87,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,136.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.136,CHEMBL378
2223,12463721.0,[],CHEMBL3057688,Antiviral activity against wild type Human immunodeficiency virus 1,F,BAO_0000190,BAO_0000218,organism-based format,C/N=C(/Cc1c(Cl)cccc1Cl)NC(=O)Nc1ccc(C#N)cc1,CHEMBL3046335,Med Chem Res,2009.0,CHEMBL304819,CHEMBL304819,,0.0,http://www.openphacts.org/units/Nanomolar,1805838.0,=,1.0,1.0,=,IC50,nM,213796208.95,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,0.67,CHEMBL378
2224,12204005.0,[],CHEMBL2211838,Antiviral activity against HIV-1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)C1=NN(C(=O)Nc3c(C)cccc3C)C(c3ccc(F)cc3)C1C2,CHEMBL2203270,Bioorg Med Chem Lett,2012.0,CHEMBL1824321,CHEMBL1824321,,0.0,http://www.openphacts.org/units/Nanomolar,1758561.0,>,1.0,1.0,>,IC50,nM,9360.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,9.36,CHEMBL378
2225,5126328.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,CN1c2ccc(Cl)cc2N(c2ccccc2)C(=O)c2c1ncn2C,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642534,CHEMBL1642534,6.52,0.0,http://www.openphacts.org/units/Nanomolar,1317844.0,=,1.0,1.0,=,IC50,nM,300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.3,CHEMBL378
2226,14658793.0,[],CHEMBL3266157,Antagonist activity at recombinant human EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)c3ccc(Br)cc3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262886,CHEMBL3262886,7.15,0.0,http://www.openphacts.org/units/Nanomolar,2101728.0,=,1.0,1.0,=,IC50,nM,71.0,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,nM,UO_0000065,71.0,CHEMBL3259470
2227,2211579.0,[],CHEMBL979729,Antiviral activity against deltaTat/Rev deffective HIV1 in 1A2 cells assessed as inhibition of metabolic activity in uninfected cells,F,BAO_0000190,BAO_0000218,organism-based format,CO[C@@]1(C)CO[C@]2(C=C([C@@H]3CC[C@]45C[C@]34CC[C@@H]3[C@H]4CC=C6C[C@@H](c7ccc8c(c7)OCO8)OC[C@]6(C)[C@@H]4C[C@@H](O)[C@]35C)C(=O)O2)C1,CHEMBL1149827,J Nat Prod,2008.0,CHEMBL500777,CHEMBL500777,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,718588.0,>,1.0,1.0,>,IC50,ug.mL-1,125.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,125.0,CHEMBL378
2228,822567.0,[],CHEMBL692690,In vitro inhibition of Hepatitis C polymerase.,B,BAO_0000190,BAO_0000357,single protein format,CN(C(=O)c1ccc(C(F)(F)F)cc1)c1cc(-c2ccccc2)sc1C(=O)O,CHEMBL1137940,Bioorg Med Chem Lett,2004.0,CHEMBL353453,CHEMBL353453,4.47,0.0,http://www.openphacts.org/units/Nanomolar,327704.0,=,1.0,1.0,=,IC50,nM,34000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,34.0,CHEMBL4620
2229,678759.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Oc1ccccc1C=Nc1ccc(SSc2ccc(N=Cc3ccccc3O)cc2)cc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120460,CHEMBL120460,,0.0,,228630.0,=,1.0,0.0,=,IC50,,27.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,27.7,CHEMBL378
2230,5139127.0,[],CHEMBL1648257,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication by semi-quantitative EIA,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1641452,Bioorg Med Chem,2011.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321613.0,=,1.0,1.0,=,IC50,ug.mL-1,4.51,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,4.51,CHEMBL613497
2231,3083988.0,[],CHEMBL1072584,Antiviral activity against HIV1 infected in human JC53-BL cells after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)N1C[C@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)C)C3)C[C@H]2C1,CHEMBL1153211,Bioorg Med Chem Lett,2010.0,CHEMBL605727,CHEMBL605727,7.11,0.0,http://www.openphacts.org/units/Nanomolar,872780.0,=,1.0,1.0,=,IC50,nM,77.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,77.0,CHEMBL378
2232,2602031.0,[],CHEMBL1034017,Antiviral activity against Vaccinia virus,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL152,CHEMBL152,4.50,0.0,http://www.openphacts.org/units/Nanomolar,807753.0,=,1.0,1.0,=,IC50,nM,32000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,32.0,CHEMBL613493
2233,3498062.0,[],CHEMBL1259504,Antiviral activity against HIV1 isolate 89.6 infected in human PM1 cells expressing CCR5 assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(Cl)cc1)C(=O)NC1CCNCC1,CHEMBL1255517,Bioorg Med Chem Lett,2010.0,CHEMBL1256494,CHEMBL1256494,,0.0,,959451.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2234,13476939.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cn1nnc(-c2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)n1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435872,CHEMBL2435872,,0.0,,1924248.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2235,19281718.0,[],CHEMBL4409361,Antiviral activity against HIV1 UG070 infected in human TZM-bl cells incubated for 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(cnn2-c2ccc(C)c(C)c2)c(=O)[nH]1,CHEMBL4406854,Eur J Med Chem,2019.0,CHEMBL4588501,CHEMBL4588501,,0.0,,3219932.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2236,3194844.0,[],CHEMBL1102708,Antiviral activity against CCR5-tropic recombinant HIV1 NLBal virus infected in JC53-BL cells assessed as inhibition of viral replication after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C)n1[C@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCOCC1)c1cccc(F)c1,CHEMBL1154938,Bioorg Med Chem Lett,2010.0,CHEMBL1087028,CHEMBL1087028,6.66,0.0,http://www.openphacts.org/units/Nanomolar,892771.0,=,1.0,1.0,=,IC50,nM,220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,220.0,CHEMBL378
2237,3221779.0,[],CHEMBL1102818,Antiviral activity against HIV1 carrying reverse transcriptase K103N/V179E mutant infected human MT4 cells by phenoscreen assay in the presence of 40 percent normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,NS(=O)(=O)c1ccc(NC(=O)CSC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,CHEMBL1153798,Bioorg Med Chem Lett,2009.0,CHEMBL1079267,CHEMBL1079267,5.66,0.0,http://www.openphacts.org/units/Nanomolar,897986.0,=,1.0,1.0,=,IC50,nM,2200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,0.0022,CHEMBL378
2238,3453361.0,[],CHEMBL1247800,Antiviral activity against HIV1 isolate 05-121779 assessed as inhibition of viral replication after 7 days by scintillation counting,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(c2cccc3nc(CN(C)[C@H]4CCCc5cccnc54)c(CO)n23)CC1,CHEMBL1240366,Antimicrob Agents Chemother,2010.0,CHEMBL1242210,CHEMBL1242210,9.00,0.0,http://www.openphacts.org/units/Nanomolar,953332.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
2239,1402240.0,[],CHEMBL837469,In vitro inhibitory concentration against HIV V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCCNc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175925,CHEMBL175925,,0.0,http://www.openphacts.org/units/Nanomolar,360394.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2240,24351639.0,[],CHEMBL5032297,Antiviral activity against Hepatitis B virus,F,BAO_0000190,BAO_0000218,organism-based format,CN1C[C@H]2C[C@@H](C1)c1ccc(NCc3ccc(O)cc3)c(=O)n1C2,CHEMBL5030562,Bioorg Med Chem Lett,2021.0,CHEMBL5092408,CHEMBL5092408,,0.0,http://www.openphacts.org/units/Nanomolar,3772749.0,>,1.0,1.0,>,IC50,nM,3000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,3.0,CHEMBL613497
2241,10961195.0,[],CHEMBL2061269,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M4 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(N)=C1C(=O)Nc2ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)cc21,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057465,CHEMBL2057465,7.16,0.0,http://www.openphacts.org/units/Nanomolar,1655127.0,=,1.0,1.0,=,IC50,nM,70.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,70.0,CHEMBL378
2242,2099812.0,[],CHEMBL949221,Antiviral activity against HIV1 97-ZA-003 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)N(CCCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nc4c2CCN(C)C4)C3)c2ccccc2)cc1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL272065,CHEMBL272065,6.58,0.0,http://www.openphacts.org/units/Nanomolar,699399.0,=,1.0,1.0,=,IC50,nM,264.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.264,CHEMBL378
2243,12091425.0,[],CHEMBL2168515,Antiviral activity against R5 tropic HIV1 Ba-L infected human PBMC assessed as inhibition of viral replication by p-24 antigen specific ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1,CHEMBL2163215,ACS Med Chem Lett,2012.0,CHEMBL2164218,CHEMBL2164218,6.86,0.0,http://www.openphacts.org/units/Nanomolar,1736642.0,=,1.0,1.0,=,IC50,nM,138.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,138.0,CHEMBL378
2244,23284018.0,[],CHEMBL4837921,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@H]2CCCNC2)cc1,CHEMBL4837199,Eur J Med Chem,2021.0,CHEMBL4875597,CHEMBL4875597,7.35,0.0,http://www.openphacts.org/units/Nanomolar,3622950.0,=,1.0,1.0,=,IC50,nM,44.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,44.6,CHEMBL378
2245,2149795.0,[],CHEMBL935679,Antiviral activity against HIV1 3B infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL411406,CHEMBL411406,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708035.0,=,1.0,1.0,=,IC50,ug.mL-1,0.007,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.007,CHEMBL378
2246,1478927.0,[],CHEMBL837273,Antiviral activity against human immunodeficiency virus type 1 by using MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(c1ccccc1[N+](=O)[O-])c1ccc2ccc(/C=C/c3ccc(O)c(O)c3)nc2c1O,CHEMBL1140355,Bioorg Med Chem Lett,2005.0,CHEMBL189128,CHEMBL189128,5.40,0.0,http://www.openphacts.org/units/Nanomolar,382649.0,=,1.0,1.0,=,IC50,nM,4000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.0,CHEMBL378
2247,14927165.0,[],CHEMBL3391566,Antiviral activity against NNRTI-resistant HIV-1 LAI harboring reverse transcriptase K103N mutant infected in human MT4 cells assessed as inhibition of viral replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2c(F)c(CCc3ccncc3)[nH]c(=O)c2Br)c1,CHEMBL3390846,Medchemcomm,2010.0,CHEMBL3347281,CHEMBL3347281,8.30,0.0,http://www.openphacts.org/units/Nanomolar,2173090.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.0,CHEMBL378
2248,1471995.0,[],CHEMBL834620,Inhibitory activity against HIV-1 mutant strain 188L; ND = not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C\c2ccncc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL363979,CHEMBL363979,,0.0,http://www.openphacts.org/units/Nanomolar,380930.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2249,18044689.0,[],CHEMBL4010438,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype A BG505-T332N,F,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075766,CHEMBL4075766,6.41,0.0,http://www.openphacts.org/units/Nanomolar,2990214.0,=,1.0,1.0,=,IC50,nM,390.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.39,CHEMBL378
2250,2670852.0,[],CHEMBL1035389,Antiviral activity against LASV infected in human A549 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(CN2CCN(C(=O)c3cc4ccccc4o3)C[C@@H]2Cc2ccccc2)cc1,CHEMBL1151924,Bioorg Med Chem Lett,2009.0,CHEMBL564774,CHEMBL564774,5.51,0.0,http://www.openphacts.org/units/Nanomolar,820793.0,=,1.0,1.0,=,IC50,nM,3100.0,CHEMBL615051,Lassa virus,Lassa virus,11620,IC50,uM,UO_0000065,3.1,CHEMBL615051
2251,1421809.0,[],CHEMBL824926,Inhibitory activity against human immunodeficiency virus type 1 (inactive>0.1),F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(SC2CCCCC2)n(COCSc2ccccc2)c(=O)[nH]c1=O,CHEMBL1144258,Bioorg Med Chem Lett,2005.0,CHEMBL181671,CHEMBL181671,,0.0,http://www.openphacts.org/units/Nanomolar,364865.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2252,630563.0,[],CHEMBL710381,Inhibitory activity against 103N strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1nc(Cc2c(Cl)cccc2Cl)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL70613,CHEMBL70613,7.40,0.0,http://www.openphacts.org/units/Nanomolar,126929.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
2253,12680750.0,[],CHEMBL2342599,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1ccc(NC(=O)/C=C/c2coc3cc(OC)ccc3c2=O)cc1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333680,CHEMBL2333680,,0.0,http://www.openphacts.org/units/Nanomolar,1867756.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
2254,8027852.0,[],CHEMBL1948540,Antiviral activity against HIV1 NL432 infected in human ConA and IL2-stimulated PBMC assessed as inhibition of viral replication by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,Oc1cc2c(cc1O)[C@@H]1c3ccccc3OC[C@]1(O)C2,CHEMBL1944615,Bioorg Med Chem Lett,2012.0,CHEMBL1944934,CHEMBL1944934,,0.0,,1573825.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2255,12684386.0,[],CHEMBL2344303,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(O)CCC(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C[C@H](O)[C@@H](O)C4(C)C)[C@]3(C)C(=O)C[C@]12C,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL486260,CHEMBL486260,4.50,0.0,http://www.openphacts.org/units/Nanomolar,1866110.0,=,1.0,1.0,=,IC50,nM,31400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,31.4,CHEMBL613497
2256,1861508.0,[],CHEMBL914228,Antiviral activity against HIV1 infected MT4 cells by p24 core antigen ELISA in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NCc1ccccc1)c1nc(-c2cccs2)nc(O)c1O,CHEMBL1147159,J Med Chem,2007.0,CHEMBL437708,CHEMBL437708,5.30,0.0,http://www.openphacts.org/units/Nanomolar,635564.0,=,1.0,1.0,=,IC50,nM,5000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.0,CHEMBL378
2257,1470568.0,[],CHEMBL833077,Inhibitory activity against HIV-1 mutant strain 106A,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL338047,CHEMBL338047,7.40,0.0,http://www.openphacts.org/units/Nanomolar,380766.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
2258,143174.0,[],CHEMBL871946,Antiviral potency of compound determined against human immunodeficiency virus type 1,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c2c(oc(O)c1C(c1cccc(NS(=O)(=O)c3ccccc3)c1)C1CC1)CCCCCC2,CHEMBL1128214,J Med Chem,1995.0,CHEMBL16400,CHEMBL16400,5.30,0.0,http://www.openphacts.org/units/Nanomolar,284865.0,=,1.0,1.0,=,IC50,nM,5000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.0,CHEMBL378
2259,320598.0,[],CHEMBL873617,Inhibition of concanavalin A (con A)-induced proliferation of rat peripheral blood mononuclear cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1cc(C(F)(F)F)nn1-c1ccc(NC(=O)c2ccccc2F)cc1,CHEMBL1133605,J Med Chem,2000.0,CHEMBL318087,CHEMBL318087,6.06,0.0,http://www.openphacts.org/units/Nanomolar,188094.0,=,1.0,1.0,=,IC50,nM,869.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,869.0,CHEMBL378
2260,2091725.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1ccccc1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL55271,CHEMBL55271,,0.0,http://www.openphacts.org/units/Nanomolar,700507.0,=,1.0,1.0,=,IC50,nM,501187233627.27,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,2.7,CHEMBL378
2261,5132860.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)n2c3ccccc3n(C[C@H](O)N3CCC(C)(C)CC3)c2c1C#N,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645093,CHEMBL1645093,,0.0,http://www.openphacts.org/units/Nanomolar,1321082.0,>,1.0,1.0,>,IC50,nM,16500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,16.5,CHEMBL378
2262,2929745.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CN(C)Cc3ccco3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578797,CHEMBL578797,7.40,0.0,http://www.openphacts.org/units/Nanomolar,852814.0,=,1.0,1.0,=,IC50,nM,39.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,39.8,CHEMBL378
2263,22806671.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2OCC[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4753831,CHEMBL4753831,,0.0,http://www.openphacts.org/units/Nanomolar,3541885.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.0,CHEMBL613497
2264,10860657.0,[],CHEMBL2020780,Antiviral against R5 tropic HIV1 Bal infected in human CEMx174 5.25M7 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccccc3)CC2)c2ccc(C)c(Cl)c2)CC1,CHEMBL2016501,Bioorg Med Chem Lett,2012.0,CHEMBL2017368,CHEMBL2017368,7.83,0.0,http://www.openphacts.org/units/Nanomolar,1634924.0,=,1.0,1.0,=,IC50,nM,14.88,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,14.88,CHEMBL378
2265,3008326.0,[],CHEMBL1037279,Antiviral activity against Human immunodeficiency virus 1 NL4-3 infected HeLaP4 cells after 5 days by beta-galactosidase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(Oc1cccc2cnccc12)C(=O)N1CCN(C(=O)c2ccccc2)C[C@H]1C,CHEMBL1155317,Bioorg Med Chem Lett,2009.0,CHEMBL570517,CHEMBL570517,6.31,0.0,http://www.openphacts.org/units/Nanomolar,861762.0,=,1.0,1.0,=,IC50,nM,492.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,492.0,CHEMBL378
2266,3453419.0,[],CHEMBL1245735,Antiviral activity against HIV1 3B infected in human PBMC assessed as inhibition of viral replication after 7 days by scintillation counting,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(c2cccc3nc(CN(C)[C@H]4CCCc5cccnc54)c(CO)n23)CC1,CHEMBL1240366,Antimicrob Agents Chemother,2010.0,CHEMBL1242210,CHEMBL1242210,8.34,0.0,http://www.openphacts.org/units/Nanomolar,953332.0,=,1.0,1.0,=,IC50,nM,4.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.6,CHEMBL378
2267,12204003.0,[],CHEMBL2211838,Antiviral activity against HIV-1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)C1=NN(C(=O)Nc3c(C)cccc3C)C(c3ccccc3)C1C2,CHEMBL2203270,Bioorg Med Chem Lett,2012.0,CHEMBL1824323,CHEMBL1824323,,0.0,http://www.openphacts.org/units/Nanomolar,1758526.0,>,1.0,1.0,>,IC50,nM,211450.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,211.45,CHEMBL378
2268,12684388.0,[],CHEMBL2344303,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,COCC(=O)O[C@H]1C[C@H]2[C@]3(C)C(=O)C[C@]4(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](OC(=O)COC)C[C@@]4(C)[C@@H]3C[C@@H](O)[C@@]2(OC(=O)c2cccc(Cl)c2)C(C)(C)[C@@H]1OC(=O)COC,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332414,CHEMBL2332414,,0.0,http://www.openphacts.org/units/Nanomolar,1866108.0,>,1.0,1.0,>,IC50,nM,1744800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1744.8,CHEMBL613497
2269,3198125.0,[],CHEMBL1104128,Antiviral activity against HIV1 JV1083 infected in PBMCs assessed as reverse transcriptase activity after 7 days by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](CN[C@H](CN[C@H](CN[C@H](CNCCC(N)=O)Cc1ccc(O)cc1)Cc1ccc(O)cc1)Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@@H](N)Cc1ccc(O)cc1,CHEMBL1153724,Bioorg Med Chem Lett,2009.0,CHEMBL1075815,CHEMBL1075815,4.75,0.0,http://www.openphacts.org/units/Nanomolar,889158.0,=,1.0,1.0,=,IC50,nM,17800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,17.8,CHEMBL378
2270,2149827.0,[],CHEMBL935681,Antiviral activity against HIV1 098-T20 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL266465,CHEMBL266465,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708041.0,=,1.0,1.0,=,IC50,ug.mL-1,0.093,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.093,CHEMBL378
2271,19033635.0,[],CHEMBL4350064,Antiviral activity against HIV1 LAI infected in human LC5 cells expressing DsRed1 reporter gene assessed as inhibition of viral infection measured after 48 hrs post infection by reporter gene based luminescence assay,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)C(=O)Oc1ccc2cccnc2c1-c1cccc2cccnc12,CHEMBL4346738,Bioorg Med Chem,2019.0,CHEMBL4524935,CHEMBL4524935,,0.0,,3175421.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2272,1954135.0,[],CHEMBL891424,Antiviral activity against HIV1 RT 181C mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(Sc2ccccc2)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL233453,CHEMBL233453,6.80,0.0,http://www.openphacts.org/units/Nanomolar,647181.0,=,1.0,1.0,=,IC50,nM,158.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,158.0,CHEMBL378
2273,2601967.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)c1cn(S(=O)(=O)c2ccccc2)c2cc(Cl)ccc12,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL312729,CHEMBL312729,,0.0,http://www.openphacts.org/units/Nanomolar,808024.0,=,1.0,1.0,=,IC50,nM,200000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,200.0,CHEMBL378
2274,22933234.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)/C=C/c4ccc(OC)c(Cl)c4)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4780382,CHEMBL4780382,6.89,0.0,http://www.openphacts.org/units/Nanomolar,3560837.0,=,1.0,1.0,=,IC50,nM,128.82,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.89,CHEMBL378
2275,2649317.0,[],CHEMBL1024326,"Antiviral activity against HIV1 expressed in 293T cells assessed as protection against viral M33 envelope infection in human U87 cells coexpressing CD4, CCR5 receptors after 72 hrs by luciferase reporter gene pseudoviral assay",F,BAO_0000190,BAO_0000218,organism-based format,COc1ncc(OC)c2c(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c[nH]c12,CHEMBL1158460,J Med Chem,2009.0,CHEMBL238103,CHEMBL238103,7.58,0.0,http://www.openphacts.org/units/Nanomolar,815604.0,=,1.0,1.0,=,IC50,nM,26.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,26.0,CHEMBL378
2276,1402322.0,[],CHEMBL835251,In vitro inhibitory concentration against HIV F227L and V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N2CCOCC2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL178061,CHEMBL178061,,0.0,http://www.openphacts.org/units/Nanomolar,360425.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2277,18044709.0,[],CHEMBL4010418,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype A/G CRF02_AG clone 266,F,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075766,CHEMBL4075766,6.32,0.0,http://www.openphacts.org/units/Nanomolar,2990214.0,=,1.0,1.0,=,IC50,nM,480.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.48,CHEMBL378
2278,2929514.0,[],CHEMBL1056898,Antiviral activity against HIV1 HXB2 harboring 190S mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL233664,CHEMBL233664,8.70,0.0,http://www.openphacts.org/units/Nanomolar,848384.0,=,1.0,1.0,=,IC50,nM,1.99,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.99,CHEMBL378
2279,2602170.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C(\O)c1nnn[nH]1)c1c[nH]c2ccc(Cl)cc12,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL473489,CHEMBL473489,6.19,0.0,http://www.openphacts.org/units/Nanomolar,807498.0,=,1.0,1.0,=,IC50,nM,650.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.65,CHEMBL378
2280,3366701.0,[],CHEMBL1175913,Antiviral activity against HIV1 LAI infected in human CEM-SS cells assessed as inhibition of viral replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCNOC(CO)C(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)CO.CCCCCCCCCCCCCCCCNOC(CO)C(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)CO.CCCCCCCCCCCCCCCCNOC(CO)C(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)CO.CCCCCCCCCCCCCCCCNOC(CO)C(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)CO.CCCCCCCCCCCCCCCCNOC(CO)C(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)CO.CCCCCCCCCCCCCCCCNOC(CO)C(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)CO.CN(/N=C/c1ccc(OP2(Oc3ccc(/C=N/N(C)P(=S)(Oc4ccc(/C=C/P(=O)(O)O)cc4)Oc4ccc(/C=C/P(=O)(O)O)cc4)cc3)=NP(Oc3ccc(/C=N/N(C)P(=S)(Oc4ccc(/C=C/P(=O)(O)O)cc4)Oc4ccc(/C=C/P(=O)(O)O)cc4)cc3)(Oc3ccc(/C=N/N(C)P(=S)(Oc4ccc(/C=C/P(=O)(O)O)cc4)Oc4ccc(/C=C/P(=O)(O)O)cc4)cc3)=NP(Oc3ccc(/C=N/N(C)P(=S)(Oc4ccc(/C=C/P(=O)(O)O)cc4)Oc4ccc(/C=C/P(=O)(O)O)cc4)cc3)(Oc3ccc(/C=N/N(C)P(=S)(Oc4ccc(/C=C/P(=O)(O)O)cc4)Oc4ccc(/C=C/P(=O)(O)O)cc4)cc3)=N2)cc1)P(=S)(Oc1ccc(/C=C\P(=O)(O)O)cc1)Oc1ccc(/C=C/P(=O)(O)O)cc1,CHEMBL1177694,Bioorg Med Chem,2010.0,CHEMBL4524053,CHEMBL4524053,6.60,0.0,http://www.openphacts.org/units/Nanomolar,925685.0,=,1.0,1.0,=,IC50,nM,250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.25,CHEMBL378
2281,13940321.0,[],CHEMBL3131385,Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)NCc1cn(Cc2cccc(C)c2)nn1)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL3124823,Eur J Med Chem,2014.0,CHEMBL3126772,CHEMBL3126772,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1972625.0,=,1.0,1.0,=,IC50,ug.mL-1,11.76,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,11.76,CHEMBL613129
2282,1470448.0,[],CHEMBL832527,Inhibitory activity against HIV-1 double mutants strain 227L and 106A,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C(C)=C/C#N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL363952,CHEMBL363952,5.90,0.0,http://www.openphacts.org/units/Nanomolar,380765.0,=,1.0,1.0,=,IC50,nM,1250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.25,CHEMBL378
2283,3014808.0,[],CHEMBL1050514,Antiviral activity against wild type HIV1 isolate ERS104pre infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,CHEMBL1156053,J Med Chem,2009.0,CHEMBL114,CHEMBL114,8.10,0.0,http://www.openphacts.org/units/Nanomolar,862676.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
2284,863686.0,[],CHEMBL701249,"Inhibitory concentration was evaluated against human respiratory syncytial virus,(HRSV) strain A2.",F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)CCN(CCC(N)=O)S(=O)(=O)c1cccc(Nc2nc(Nc3cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c3)nc(Nc3ccc(CCc4ccc(Nc5nc(Nc6cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c6)nc(Nc6cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c6)n5)cc4S(=O)(=O)O)c(S(=O)(=O)O)c3)n2)c1,CHEMBL1131306,J Med Chem,1998.0,CHEMBL1160590,CHEMBL1160590,4.65,0.0,http://www.openphacts.org/units/Nanomolar,164096.0,=,1.0,1.0,=,IC50,nM,22500.0,CHEMBL613127,Human respiratory syncytial virus,Human respiratory syncytial virus,11250,IC50,uM,UO_0000065,22.5,CHEMBL613127
2285,13475487.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435880,CHEMBL2435880,7.40,0.0,http://www.openphacts.org/units/Nanomolar,1924256.0,=,1.0,1.0,=,IC50,nM,39.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,39.6,CHEMBL378
2286,19281763.0,[],CHEMBL4409368,Antiviral activity against HIV1 VB51 infected in human PBMC cells incubated for 5 days by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL4406854,Eur J Med Chem,2019.0,CHEMBL129,CHEMBL129,7.30,0.0,http://www.openphacts.org/units/Nanomolar,3219945.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.05,CHEMBL378
2287,708188.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(SSc2c(C)cc(C)cc2C)c(C)c1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL340104,CHEMBL340104,,0.0,,228661.0,=,1.0,0.0,=,IC50,,28.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,28.0,CHEMBL378
2288,10866434.0,[],CHEMBL2025517,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HbeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCC(C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(O)C(C)=O)C2)CC1,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024035,CHEMBL2024035,,0.0,http://www.openphacts.org/units/Nanomolar,1639757.0,<,1.0,1.0,<,IC50,nM,62130.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,62.13,CHEMBL613497
2289,24831188.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5142784,Antiviral activity against HBV infected in human primary hepatocyte cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBsAg secretion measured after 48 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C1CCN(c2ccc3c(=O)c4c(Cl)ccc(Cl)c4oc3c2)C1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5191678,CHEMBL5191678,5.94,0.0,http://www.openphacts.org/units/Nanomolar,3878139.0,=,1.0,1.0,=,IC50,nM,1160.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.16,CHEMBL613497
2290,12687170.0,[],CHEMBL2344307,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral surface antigen production,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)O[C@H]1C[C@H]2[C@]3(C)C(=O)C[C@]4(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](OC(=O)CCC)C[C@@]4(C)[C@@H]3C[C@H]3O[C@]32C(C)(C)[C@@H]1OC(=O)CCC,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332409,CHEMBL2332409,,0.0,http://www.openphacts.org/units/Nanomolar,1866103.0,>,1.0,1.0,>,IC50,nM,617600.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,617.6,CHEMBL613497
2291,5126303.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,CCCCN/C=C1\C(=O)Nc2ccc(Cl)cc2N(c2ccccc2)C1=O,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642299,CHEMBL1642299,5.85,0.0,http://www.openphacts.org/units/Nanomolar,1317589.0,=,1.0,1.0,=,IC50,nM,1400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.4,CHEMBL378
2292,24750962.0,[],CHEMBL5121091,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication by Nano-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCC(=O)O[C@@]12[C@H](OC(=O)c3ccccc3)[C@@H](C)[C@]3(O)[C@@H]4C=C(C)C(=O)[C@@]4(O)[C@H](O)C(CO)=C[C@H]3[C@@H]1C2(C)C,CHEMBL5120745,J Nat Prod,2021.0,CHEMBL2375488,CHEMBL2375488,7.89,0.0,http://www.openphacts.org/units/Nanomolar,3861271.0,=,1.0,1.0,=,IC50,nM,12.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,12.8,CHEMBL378
2293,12463727.0,[],CHEMBL3057688,Antiviral activity against wild type Human immunodeficiency virus 1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(NC(=S)NC(=N)Cc2ccccc2Cl)cc1,CHEMBL3046335,Med Chem Res,2009.0,CHEMBL70969,CHEMBL70969,,0.0,http://www.openphacts.org/units/Nanomolar,1805832.0,=,1.0,1.0,=,IC50,nM,13995873.23,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,1.854,CHEMBL378
2294,5306740.0,[],CHEMBL1696838,Antiviral activity against R5 tropic HIV1 R8.BaL infected in human PBMC assessed as inhibition of p24 antigen production after 2 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCOc1cc(NC(=S)c2ccoc2C)ccc1Cl,CHEMBL1687731,Antimicrob Agents Chemother,2009.0,CHEMBL54893,CHEMBL54893,7.99,0.0,http://www.openphacts.org/units/Nanomolar,1337340.0,=,1.0,1.0,=,IC50,nM,10.18,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.18,CHEMBL378
2295,15166160.0,[],CHEMBL3404736,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as decrease in viral DNA replication treated for 7 days by real time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(/C=C/C(=O)OC[C@H]2O[C@@H](Oc3ccc(C(C)=O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)cc(OC)c1OC,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3400176,CHEMBL3400176,5.24,0.0,http://www.openphacts.org/units/Nanomolar,2284141.0,=,1.0,1.0,=,IC50,nM,5800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,5.8,CHEMBL613497
2296,522134.0,[],CHEMBL769300,Compound was evaluated for 50% inhibition of HBV polymerases (Hepatitis B virus),F,BAO_0000190,BAO_0000218,organism-based format,O=c1ccn([C@@H]2C[C@@H](F)[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]1,CHEMBL1131623,J Med Chem,1998.0,CHEMBL2092834,CHEMBL2092834,4.60,0.0,http://www.openphacts.org/units/Nanomolar,109350.0,=,1.0,1.0,=,IC50,nM,25000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,25.0,CHEMBL613497
2297,2003627.0,[],CHEMBL901910,Antiviral activity against Modoc virus-infected HeLa-H1 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(-c2nc3cc(NC(=O)C4CCCCC4)ncc3[nH]2)cc1)C1CCCCC1,CHEMBL1138288,J Med Chem,2007.0,CHEMBL239335,CHEMBL239335,8.22,0.0,http://www.openphacts.org/units/Nanomolar,666657.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL612946,Modoc virus,Modoc virus,64300,IC50,nM,UO_0000065,6.0,CHEMBL612946
2298,2929604.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)CC1CN(Cc2c(C)[nH]c(=O)c(I)c2Sc2cc(C)cc(C)c2)CCO1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL573720,CHEMBL573720,7.30,0.0,http://www.openphacts.org/units/Nanomolar,848369.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,50.0,CHEMBL378
2299,13357748.0,[],CHEMBL2401183,Inhibition of recombinant VHX (unknown origin) using pNPP as substrate by spectrophotometric analysis,B,BAO_0000190,BAO_0000357,single protein format,O=C(COc1ccc(-c2oc3cc(O)c(C(=O)O)cc3c2C#Cc2cccc(Cl)c2)cc1)NC1CC1,CHEMBL2396532,J Med Chem,2013.0,CHEMBL2396719,CHEMBL2396719,5.34,0.0,http://www.openphacts.org/units/Nanomolar,1901946.0,=,1.0,1.0,=,IC50,nM,4600.0,CHEMBL2396507,Homo sapiens,Dual specificity protein phosphatase 15,9606,IC50,uM,UO_0000065,4.6,CHEMBL2396507
2300,853384.0,[],CHEMBL701249,"Inhibitory concentration was evaluated against human respiratory syncytial virus,(HRSV) strain A2.",F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)CCN(CCC(N)=O)S(=O)(=O)c1cccc(Nc2nc(Nc3cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c3)nc(Nc3ccc(/C=C/c4ccc(Nc5nc(Nc6cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c6)nc(Nc6cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c6)n5)cc4S(=O)(=O)[O-])c(S(=O)(=O)[O-])c3)n2)c1.[Na+].[Na+],CHEMBL1131306,J Med Chem,1998.0,CHEMBL425631,CHEMBL415008,6.82,0.0,http://www.openphacts.org/units/Nanomolar,164082.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL613127,Human respiratory syncytial virus,Human respiratory syncytial virus,11250,IC50,uM,UO_0000065,0.15,CHEMBL613127
2301,486127.0,[],CHEMBL757967,Inhibition of cell growth against HIV-1 infected PBM (Human peripheral blood mononuclear) cells,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c(=O)n([C@@H]2CS[C@@H](CO)O2)cc1Cl,CHEMBL1126792,J Med Chem,1993.0,CHEMBL330119,CHEMBL330119,,0.0,http://www.openphacts.org/units/Nanomolar,161277.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2302,1830893.0,[],CHEMBL918634,Antiviral activity against wild type HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCSc1nc(C(C#N)c2cccc3ccccc23)c(CC)c(=O)[nH]1,CHEMBL1144474,J Med Chem,2007.0,CHEMBL222148,CHEMBL222148,5.93,0.0,http://www.openphacts.org/units/Nanomolar,629298.0,=,1.0,1.0,=,IC50,nM,1170.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.17,CHEMBL378
2303,168643.0,[],CHEMBL756132,Compound was tested for the inhibition of LPS-induced TNF-alpha production in human peripheral blood mononuclear cells (PBMC),F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)CCC(C(=O)OC)N1C(=O)c2ccccc2C1=S,CHEMBL1146001,J Med Chem,2003.0,CHEMBL149833,CHEMBL149833,4.70,0.0,http://www.openphacts.org/units/Nanomolar,291254.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
2304,379876.0,[],CHEMBL711617,Antiviral activity against HIV-1 IIIB induced cytopathic effect in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@@H]1NC(=O)[C@@H]([C@H](O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)NCc2ccc(cc2)OCCOCCOCCOCCNC1=O,CHEMBL1129607,J Med Chem,1996.0,CHEMBL110586,CHEMBL110586,5.93,0.0,http://www.openphacts.org/units/Nanomolar,210524.0,=,1.0,1.0,=,IC50,nM,1170.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1170.0,CHEMBL378
2305,603093.0,[],CHEMBL712878,Concentration required for 50% protection of MT-4 cells against the cytopathic effect of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1Cn2c(=S)[nH]c3cc([N+](=O)[O-])cc(c32)CN1CC1CC1,CHEMBL1128253,J Med Chem,1995.0,CHEMBL60982,CHEMBL60982,5.61,0.0,http://www.openphacts.org/units/Nanomolar,327823.0,=,1.0,1.0,=,IC50,nM,2450.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.45,CHEMBL378
2306,1402157.0,[],CHEMBL837465,In vitro inhibitory concentration against HIV G190S mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCOCCN(C)c1c(Cc2cccc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL174536,CHEMBL174536,,0.0,http://www.openphacts.org/units/Nanomolar,360385.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2307,346591.0,[],CHEMBL693754,Evaluated in vitro for the concentration required to produce 50% inhibition of replication of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1124778,J Med Chem,1990.0,CHEMBL129,CHEMBL129,6.92,0.0,http://www.openphacts.org/units/Nanomolar,58325.0,=,1.0,1.0,=,IC50,nM,120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.12,CHEMBL378
2308,14654453.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)CCC(=O)O)[C@H](OC(=O)CCC(=O)O)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3263015,CHEMBL3263015,4.32,0.0,http://www.openphacts.org/units/Nanomolar,2101898.0,=,1.0,1.0,=,IC50,nM,47600.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,47.6,CHEMBL613497
2309,10937559.0,[],CHEMBL2051603,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccccc4F)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046570,CHEMBL2046570,5.12,0.0,http://www.openphacts.org/units/Nanomolar,1651453.0,=,1.0,1.0,=,IC50,nM,7680.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,7.68,CHEMBL613497
2310,18202573.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc4ccccc4c3)cs2)C(c2cccc(O)c2)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4083379,CHEMBL4083379,4.37,0.0,http://www.openphacts.org/units/Nanomolar,3019957.0,=,1.0,1.0,=,IC50,nM,43000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,43.0,CHEMBL378
2311,226267.0,[],CHEMBL690480,In vitro antiviral activity against NNRTI-resistant DLVR-MF (P236L) HIV-1 variant,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](Sc1nc(N)cc(Cl)n1)c1cc2ccoc2cn1,CHEMBL1131332,J Med Chem,1998.0,CHEMBL26752,CHEMBL26752,,0.0,http://www.openphacts.org/units/Nanomolar,41267.0,>,1.0,1.0,>,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
2312,18044372.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-c2ccc(C(=O)NC(CN(C)C)c3nc(C)c(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4077969,CHEMBL4077969,,0.0,http://www.openphacts.org/units/Nanomolar,2990189.0,>,1.0,1.0,>,IC50,nM,40000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,40.0,CHEMBL378
2313,15571651.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(Br)cc1)N1CCN(S(=O)(=O)c2ccc(Br)cc2)CC1,CHEMBL1201862,,,CHEMBL3561399,CHEMBL3561399,8.78,0.0,http://www.openphacts.org/units/Nanomolar,2476585.0,=,7.0,1.0,=,IC50,nM,1.66,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.00166,CHEMBL3259470
2314,15199938.0,[],CHEMBL3411839,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)N[C@]1(C)CCC[C@@]2(C)[C@@H]3CC[C@@]4(C)C[C@]3(CC[C@@H]21)CC4=O,CHEMBL3407350,Bioorg Med Chem,2015.0,CHEMBL3409324,CHEMBL3409324,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,2287835.0,=,1.0,1.0,=,IC50,ug.mL-1,5.76,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,5.76,CHEMBL613497
2315,19033619.0,[],CHEMBL4350060,Antiviral activity against HIV1 89.6 pseudovirus infected in human TZM-bl cells assessed as inhibition of viral infection incubated for 20 mins prior to infection and measured after 48 hrs post infection by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)C(=O)Oc1ccc2cccnc2c1-c1cccc2cccnc12,CHEMBL4346738,Bioorg Med Chem,2019.0,CHEMBL4524935,CHEMBL4524935,,0.0,,3175421.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2316,1223572.0,[],CHEMBL880061,Inhibitory activity against LAI strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70442,CHEMBL70442,9.40,0.0,http://www.openphacts.org/units/Nanomolar,127467.0,=,1.0,1.0,=,IC50,nM,0.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0004,CHEMBL378
2317,1402114.0,[],CHEMBL837466,In vitro inhibitory concentration against HIV K101E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCO)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175692,CHEMBL175692,,0.0,http://www.openphacts.org/units/Nanomolar,360365.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2318,18239539.0,[],CHEMBL4052028,Antiviral activity against darunavir-resistant HIV1 derived from 30 passages harboring protease L10I/I15V/K20R/L24I/V32I/M36I/M46L/L63P/K70R/V82A/I84V/L89M mutant infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,CHEMBL4049446,J Med Chem,2017.0,CHEMBL729,CHEMBL729,,0.0,http://www.openphacts.org/units/Nanomolar,3026806.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
2319,2032181.0,[],CHEMBL886779,Inhibition of cytoplasmic HBV DNA synthesis in HepG2.2.15 cells after 8 days,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)S(=O)(=O)n1c(N)nc2ccc(NC(=O)c3c(F)cccc3F)cc21,CHEMBL1139980,Eur J Med Chem,2007.0,CHEMBL401647,CHEMBL401647,6.16,0.0,http://www.openphacts.org/units/Nanomolar,674617.0,=,1.0,1.0,=,IC50,nM,700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.7,CHEMBL613497
2320,15680020.0,[],CHEMBL3606515,Antiviral activity against HIV1 LAI infected in human MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,CCN[C@H]1CO[C@@H]2OC[C@H](OC(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc(OC)cc3)[C@@H]21,CHEMBL3603748,J Med Chem,2015.0,CHEMBL3605646,CHEMBL3605646,7.66,0.0,http://www.openphacts.org/units/Nanomolar,2495845.0,=,1.0,1.0,=,IC50,nM,22.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,22.0,CHEMBL378
2321,13972688.0,[],CHEMBL3134627,Antiviral activity against wild type HIV-1 isolate infected in human PBMC cells assessed as inhibition of viral production by p24 antigen production/ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCOC(=O)OC[C@@H]1CC[C@H](n2cnc3c(=O)nc[nH]c32)O1,CHEMBL3132835,Medchemcomm,2014.0,CHEMBL3132871,CHEMBL3132871,5.19,0.0,http://www.openphacts.org/units/Nanomolar,1975641.0,=,1.0,1.0,=,IC50,nM,6485.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,0.006485,CHEMBL378
2322,1520843.0,[],CHEMBL837207,Inhibitory concentration against resistant (A17) human immunodeficiency virus,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,CHEMBL1144377,Bioorg Med Chem Lett,2005.0,CHEMBL163,CHEMBL163,5.46,0.0,http://www.openphacts.org/units/Nanomolar,395383.0,=,1.0,1.0,=,IC50,nM,3440.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.44,CHEMBL378
2323,600419.0,[],CHEMBL710374,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined.,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(Cl)nc(Cc3c(Cl)cccc3Cl)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL72011,CHEMBL72011,,0.0,http://www.openphacts.org/units/Nanomolar,126907.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2324,1401677.0,[],CHEMBL837467,In vitro inhibitory concentration against HIV K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C(=O)c2c(C)c(C)nc(O)c2N(C)C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL176207,CHEMBL176207,6.40,0.0,http://www.openphacts.org/units/Nanomolar,360265.0,=,1.0,1.0,=,IC50,nM,398.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.398,CHEMBL378
2325,2263411.0,[],CHEMBL1010846,Antiviral activity against R5 tropic HIV1 BaL infected in human JC53-BL cells expressing CCR5 after 2 days by cell-cell fusion assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC1C(=O)N(CC2CCN(C(=O)OC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2,CHEMBL1139267,Bioorg Med Chem Lett,2009.0,CHEMBL501383,CHEMBL501383,8.10,0.0,http://www.openphacts.org/units/Nanomolar,750092.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.0,CHEMBL378
2326,2601867.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CSC(c2c(Cl)cccc2Cl)N1c1ccc(Br)cn1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL357261,CHEMBL357261,5.82,0.0,http://www.openphacts.org/units/Nanomolar,807197.0,=,1.0,1.0,=,IC50,nM,1510.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.51,CHEMBL378
2327,3104746.0,[],CHEMBL1065873,Antiviral activity against multi drug-resistant HIV1 isolate of subtype JSL in PHA-stimulated human PBMC assessed as inhibition of p24 antigen production,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1CNC(=O)[C@H]1N(C(=O)[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CO[C@H]3OCC[C@H]32)CSC1(C)C,CHEMBL1159037,Bioorg Med Chem Lett,2010.0,CHEMBL589988,CHEMBL589988,6.63,0.0,http://www.openphacts.org/units/Nanomolar,883164.0,=,1.0,1.0,=,IC50,nM,235.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.235,CHEMBL378
2328,24383451.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.5', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.5'}]",CHEMBL5039282,Antiviral activity against HIV-1 IIIB assessed as inhibition of HIV-1 Env mediated cell-cell fusion in MT-2 cells preincubated for 30 mins followed by cell addition and measured after 2 hrs by calcein AM staining based fluorescence microscopy,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL5038580,J Med Chem,2022.0,CHEMBL525076,CHEMBL525076,7.62,0.0,http://www.openphacts.org/units/Nanomolar,3777694.0,=,1.0,1.0,=,IC50,nM,24.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,24.0,CHEMBL378
2329,12717544.0,[],CHEMBL2350956,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 12 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=CCc1ccc(O)c(-c2cc(CC=C)ccc2O)c1,CHEMBL2346656,Bioorg Med Chem Lett,2013.0,CHEMBL180920,CHEMBL180920,5.42,0.0,http://www.openphacts.org/units/Nanomolar,1874409.0,=,1.0,1.0,=,IC50,nM,3760.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,3.76,CHEMBL613497
2330,2009831.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL238073,CHEMBL238073,,0.0,http://www.openphacts.org/units/Nanomolar,668082.0,>,1.0,1.0,>,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,20000.0,CHEMBL378
2331,5189203.0,[],CHEMBL1658800,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C(=O)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652485,CHEMBL1652485,,0.0,http://www.openphacts.org/units/Nanomolar,1326857.0,>,1.0,1.0,>,IC50,nM,62000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.062,CHEMBL613497
2332,1681479.0,[],CHEMBL866396,Antiviral activity against HIV1 NL4.3 in MT4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(Cc2ccccc2)CCCN(S(=O)(=O)c2cccc3c(N(C)C)cccc23)C1,CHEMBL1149461,J Med Chem,2006.0,CHEMBL202316,CHEMBL202316,5.02,0.0,http://www.openphacts.org/units/Nanomolar,427686.0,=,1.0,1.0,=,IC50,nM,9500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,9.5,CHEMBL378
2333,18683284.0,[],CHEMBL4237095,Antiviral activity against CCR5-dependent HIV1 KM018 infected in human PBMC assessed as reduction in virus infection measured after 7 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1,CHEMBL4229569,J Med Chem,2018.0,CHEMBL4249798,CHEMBL4249798,8.64,0.0,http://www.openphacts.org/units/Nanomolar,3103111.0,=,1.0,1.0,=,IC50,nM,2.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.3,CHEMBL378
2334,672210.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Oc1c(Cl)cccc1SSc1cccc(Cl)c1O,CHEMBL1129635,J Med Chem,1996.0,CHEMBL332737,CHEMBL332737,,0.0,,228623.0,=,1.0,0.0,=,IC50,,34.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,34.7,CHEMBL378
2335,2203581.0,[],CHEMBL987023,Antiviral activity against HIV1 3B in human MT4 cells assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CCn1c(-c2ccc(NC(=S)NC)cc2)n[nH]c1=S,CHEMBL1149790,Eur J Med Chem,2008.0,CHEMBL47651,CHEMBL47651,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,765676.0,>,1.0,1.0,>,IC50,ug.mL-1,80.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,80.9,CHEMBL378
2336,2244512.0,[],CHEMBL1002205,Antiviral activity against wild type HIV1 in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(COc1ccc(Cl)cc1C(=O)c1ccccc1)Nc1ccccc1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL296939,CHEMBL296939,8.70,0.0,http://www.openphacts.org/units/Nanomolar,798577.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
2337,1671954.0,[],CHEMBL870621,Antiviral activity against HIV1 Y181C mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(C#N)cc(C(F)(F)F)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL199409,CHEMBL199409,8.70,0.0,http://www.openphacts.org/units/Nanomolar,411935.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
2338,10842713.0,[],CHEMBL2016100,Antiviral activity against Human immunodeficiency virus 1 3B infected in human MT2 cells assessed as inhibition of viral replication after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CSCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CS)NC1=O,CHEMBL2010680,Bioorg Med Chem Lett,2012.0,CHEMBL2012889,CHEMBL2012889,,0.0,http://www.openphacts.org/units/Nanomolar,1633578.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2339,346119.0,[],CHEMBL711617,Antiviral activity against HIV-1 IIIB induced cytopathic effect in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@@H]1NC(=O)[C@@H]([C@H](O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)NCc2ccc(cc2)OCCOCCOCCNC1=O,CHEMBL1129607,J Med Chem,1996.0,CHEMBL321250,CHEMBL321250,6.77,0.0,http://www.openphacts.org/units/Nanomolar,210510.0,=,1.0,1.0,=,IC50,nM,169.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,169.0,CHEMBL378
2340,2432633.0,[],CHEMBL1027472,Antiviral activity against HIV1 3B infected in human HOG.R5 assessed as inhibition of viral replication by microtiter assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)/C=C/C[C@@H](C)[C@H]1CC[C@@]2(C)[C@@H]3CC[C@H]4C(C)(C)C(=O)CC[C@@]45C[C@@]35CC[C@]12C,CHEMBL1159344,J Nat Prod,2003.0,CHEMBL498062,CHEMBL498062,4.82,0.0,http://www.openphacts.org/units/Nanomolar,785985.0,=,1.0,1.0,=,IC50,nM,15300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,15.3,CHEMBL378
2341,16494774.0,[],CHEMBL3772328,Antiviral activity against HIV1 NL4-3 infected in human TZM-bl cells assessed as inhibition of viral replication administered 6 hrs postinfection measured 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CSc1ccc(Nc2nc(-c3ccncc3)nc3ccccc23)cc1,CHEMBL3769372,J Med Chem,2016.0,CHEMBL3770243,CHEMBL3770243,5.00,0.0,http://www.openphacts.org/units/Nanomolar,2761475.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
2342,2930177.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCSCc1c(C)[nH]c(=O)c(I)c1Sc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL584137,CHEMBL584137,8.30,0.0,http://www.openphacts.org/units/Nanomolar,848266.0,=,1.0,1.0,=,IC50,nM,5.01,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.01,CHEMBL378
2343,14653365.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)/C=C/c3cc(OC)c(OC)c(OC)c3)[C@H](OC(=O)/C=C/c3cc(OC)c(OC)c(OC)c3)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3263011,CHEMBL3263011,,0.0,http://www.openphacts.org/units/Nanomolar,2101894.0,>,1.0,1.0,>,IC50,nM,458000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,458.0,CHEMBL613497
2344,64709.0,[],CHEMBL857692,Inhibitory concentration against HCV NS3 protease was determined,B,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)c1cnccn1)[C@@H](C)CC)C(=O)C(=O)NC(C)(C)C(=O)O,CHEMBL1136650,Bioorg Med Chem Lett,2003.0,CHEMBL13181,CHEMBL13181,,0.0,http://www.openphacts.org/units/Nanomolar,12749.0,>,1.0,1.0,>,IC50,nM,60000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,60.0,CHEMBL4620
2345,1401880.0,[],CHEMBL834487,In vitro inhibitory concentration value against HIV K103N and Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177563,CHEMBL177563,5.51,0.0,http://www.openphacts.org/units/Nanomolar,360416.0,=,1.0,1.0,=,IC50,nM,3122.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.122,CHEMBL378
2346,19262044.0,[],CHEMBL4404435,Antiviral activity against multiple-PI-resistant HIV1 11801 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.72,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,190.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.19,CHEMBL378
2347,1498006.0,[],CHEMBL833971,Concentration required to inhibit 50% viral production of human immunodeficiency virus type 1 (HIV-1-IIIB),F,BAO_0000190,BAO_0000218,organism-based format,CCN1c2cc([N+](=O)[O-])ccc2N(C)C(=O)c2cccnc21,CHEMBL1143567,J Med Chem,2005.0,CHEMBL71927,CHEMBL71927,6.40,0.0,http://www.openphacts.org/units/Nanomolar,388306.0,=,1.0,1.0,=,IC50,nM,400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.4,CHEMBL378
2348,7843563.0,[],CHEMBL1913152,Antiviral activity against HIV1 Ba-L infected in human HOS cells assessed as reduction of viral replication after 4 days by Steady-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(NS(C)(=O)=O)cc2)ccc1CN1CCC(N(Cc2ccccc2F)C(=O)Nc2cc(C(N)=O)c(F)cc2F)CC1,CHEMBL1909524,Bioorg Med Chem Lett,2011.0,CHEMBL1909865,CHEMBL1909865,8.77,0.0,http://www.openphacts.org/units/Nanomolar,1541994.0,=,1.0,1.0,=,IC50,nM,1.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.7,CHEMBL378
2349,2997344.0,[],CHEMBL1046975,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)c2ccc(=O)n(-c3ccc(C)cc3)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL567343,CHEMBL567343,5.70,0.0,http://www.openphacts.org/units/Nanomolar,856548.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.0,CHEMBL613497
2350,2184007.0,[],CHEMBL951616,Antiviral activity against HIV1 NDK infected in U87.CD4 cells expressing human CXCR4 E288A mutant,F,BAO_0000190,BAO_0000218,organism-based format,c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,CHEMBL1156482,J Biol Chem,2007.0,CHEMBL18442,CHEMBL18442,,0.0,http://www.openphacts.org/units/Nanomolar,791970.0,>,1.0,1.0,>,IC50,nM,6000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6000.0,CHEMBL378
2351,3292015.0,[],CHEMBL1108227,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Cl)nc(C)c1C(=O)N1C[C@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3ccccc3)C[C@H]2C1,CHEMBL1157775,Bioorg Med Chem Lett,2010.0,CHEMBL1094518,CHEMBL1094518,8.70,0.0,http://www.openphacts.org/units/Nanomolar,911139.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
2352,22844969.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721621,Antiviral activity against HIV-1 HXB-2 infected in human TZM-bl cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based single cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4761493,CHEMBL4761493,5.80,0.0,http://www.openphacts.org/units/Nanomolar,3547093.0,=,1.0,1.0,=,IC50,nM,1600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.6,CHEMBL378
2353,12680738.0,[],CHEMBL2342599,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)NCCc3ccccc3F)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333289,CHEMBL2333289,4.32,0.0,http://www.openphacts.org/units/Nanomolar,1867252.0,=,1.0,1.0,=,IC50,nM,47870.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,47.87,CHEMBL613497
2354,10981185.0,[],CHEMBL2065764,Antiviral activity against Human immunodeficiency virus 1 infected in human 293T cells assessed as inhibition of viral replication after 48 hrs by luminescence analysis,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1[nH]c2ccc(Cl)cc2c1C1(C)CC1,CHEMBL2062389,ACS Med Chem Lett,2012.0,CHEMBL2063264,CHEMBL2063264,5.65,0.0,http://www.openphacts.org/units/Nanomolar,1659044.0,=,1.0,1.0,=,IC50,nM,2250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.25,CHEMBL378
2355,1235129.0,[],CHEMBL683624,In vitro integration activity provided by preintegration complexes isolated from HIV-infected cells,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC2(CC(C)(C)c3cc(S(=O)(=O)O)c(O)cc32)c2cc(O)c(S(=O)(=O)O)cc21,CHEMBL1133186,J Med Chem,2000.0,CHEMBL60432,CHEMBL60432,4.10,0.0,http://www.openphacts.org/units/Nanomolar,108753.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,80.0,CHEMBL378
2356,13475491.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4cccc(Cl)c4)CC3)cn2)cc1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435851,CHEMBL2435851,7.44,0.0,http://www.openphacts.org/units/Nanomolar,1924226.0,=,1.0,1.0,=,IC50,nM,36.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,36.5,CHEMBL378
2357,3076998.0,[],CHEMBL1067297,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(=O)C2=C(C1)NC(c1cccnc1)=NC2c1ccc(F)cc1Cl,CHEMBL1153099,Bioorg Med Chem Lett,2010.0,CHEMBL593633,CHEMBL593633,6.36,0.0,http://www.openphacts.org/units/Nanomolar,877082.0,=,1.0,1.0,=,IC50,nM,440.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.44,CHEMBL613497
2358,2929477.0,[],CHEMBL1056901,Antiviral activity against HIV1 HXB2 harboring 101E and K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL233664,CHEMBL233664,7.80,0.0,http://www.openphacts.org/units/Nanomolar,848384.0,=,1.0,1.0,=,IC50,nM,15.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,15.8,CHEMBL378
2359,10938648.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4cc(C(F)(F)F)cc(C(F)(F)F)c4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046587,CHEMBL2046587,,0.0,http://www.openphacts.org/units/Nanomolar,1651471.0,=,1.0,1.0,=,IC50,nM,432570.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,432.57,CHEMBL613497
2360,10961099.0,[],CHEMBL2061265,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M8 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCC(C)(C)C)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058323,CHEMBL2058323,7.89,0.0,http://www.openphacts.org/units/Nanomolar,1656263.0,=,1.0,1.0,=,IC50,nM,13.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,13.0,CHEMBL378
2361,492033.0,[],CHEMBL757967,Inhibition of cell growth against HIV-1 infected PBM (Human peripheral blood mononuclear) cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@@H]2CS[C@@H](CO)O2)c(=O)nc1N,CHEMBL1126792,J Med Chem,1993.0,CHEMBL314404,CHEMBL314404,,0.0,http://www.openphacts.org/units/Nanomolar,161317.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2362,2601663.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2nc(/C=C/c3ccc(O)c(O)c3)ccc2c1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL142358,CHEMBL142358,4.70,0.0,http://www.openphacts.org/units/Nanomolar,807477.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
2363,14581337.0,[],CHEMBL3242937,Antiviral activity against HIV-1 3B infected in human MT-2 cells assessed as reduction in p24 antigen level incubated for overnight measured on fourth day post infection by multi-cycle infection assay based sandwich ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]1CSCc2ccc(cc2)-c2ccc(cc2)CSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC1=O,CHEMBL3232893,Bioorg Med Chem Lett,2014.0,CHEMBL3233161,CHEMBL3233161,4.85,0.0,http://www.openphacts.org/units/Nanomolar,2081356.0,=,1.0,1.0,=,IC50,nM,14000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,14.0,CHEMBL378
2364,24781029.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '5.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '5.0'}]",CHEMBL5129508,Antiviral activity against Hepatitis B virus infected in human HepG2 cells expressing NTCP assessed as inhibition of viral entry by measuring intracellular HBV DNA preincubated with compound for 2 hrs followed by viral infection and measured after 3 hrs by qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CCC[C@@H]1NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)CN(C)C(=O)CN(C)C1=O,CHEMBL5126594,Bioorg Med Chem,2022.0,CHEMBL5180716,CHEMBL5180716,6.36,0.0,http://www.openphacts.org/units/Nanomolar,3867966.0,=,1.0,1.0,=,IC50,nM,440.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.44,CHEMBL613497
2365,2929752.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CN3CCSCC3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567205,CHEMBL567205,7.40,0.0,http://www.openphacts.org/units/Nanomolar,852796.0,=,1.0,1.0,=,IC50,nM,39.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,39.8,CHEMBL378
2366,12627467.0,[],CHEMBL2317015,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COCC/N=c1/scc(-c2cccs2)n1/N=C/c1cc(Br)c(O)c(OC)c1,CHEMBL2311445,Bioorg Med Chem,2013.0,CHEMBL2311910,CHEMBL2311910,,0.0,http://www.openphacts.org/units/Nanomolar,1841410.0,>,1.0,1.0,>,IC50,nM,15000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,15.0,CHEMBL378
2367,12411959.0,[],CHEMBL3062410,Antiviral activity against Hepatitis B virus infected human HepG2(2.2.15) cells assessed as viral DNA level after 9 days by southern blot analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(Cn1cnc2c(Sc3ccc4c(c3)CCO4)nc(N)nc21)OCP(=O)(OCC(F)(F)F)OCC(F)(F)F,CHEMBL3046955,Med Chem Res,2012.0,CHEMBL2237814,CHEMBL2237814,6.82,0.0,http://www.openphacts.org/units/Nanomolar,1798782.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol,UO_0000065,0.15,CHEMBL613497
2368,5189214.0,[],CHEMBL1658800,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O)C1CCCCC1,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652509,CHEMBL1652509,4.47,0.0,http://www.openphacts.org/units/Nanomolar,1326884.0,=,1.0,1.0,=,IC50,nM,34000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.034,CHEMBL613497
2369,15066685.0,[],CHEMBL3390094,Antiviral activity against HIV1 infected in HEK293T cells by p24 ELISA based phenotypic assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1[nH]c2ccc(Cl)cc2c1C(OC)c1ccccc1,CHEMBL3352750,Bioorg Med Chem Lett,2014.0,CHEMBL3325515,CHEMBL3325515,7.70,0.0,http://www.openphacts.org/units/Nanomolar,2270411.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.02,CHEMBL378
2370,23191684.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4818692,Antiviral activity against HIV1 SG3.1 infected in human TZM-bl cells measured after 48 hrs by single round viral infectivity assay based Steady-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C1=CCC2(C(=O)N3[C@@H](C(=O)OC(c4ccccc4)c4ccccc4)C(C)(C)S[C@@H]32)C1C(=O)c1ccccc1,CHEMBL4814068,Eur J Med Chem,2021.0,CHEMBL4872463,CHEMBL4872463,7.24,0.0,http://www.openphacts.org/units/Nanomolar,3606465.0,=,1.0,1.0,=,IC50,nM,58.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.057999999999999996,CHEMBL378
2371,2570693.0,[],CHEMBL1000472,Antiviral activity against hepatitis B virus-infected human HepG2.2.15 cells assessed as inhibition of HBV surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)c1ccccc1)[C@@H](OC(=O)c1ccccc1)C(C)(C)O)[C@]12CC[C@@]3(C)[C@@]1(C[C@H](OC(=O)c1ccccc1)[C@H]1[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@@]13C)O2,CHEMBL1155923,Bioorg Med Chem Lett,2008.0,CHEMBL508315,CHEMBL508315,,0.0,http://www.openphacts.org/units/Nanomolar,769064.0,>,1.0,1.0,>,IC50,nM,1700000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.7,CHEMBL613497
2372,1854920.0,[],CHEMBL917352,Antiviral activity against Cowpox virus,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2[C@@H]1C=C(CO)[C@@H](O)[C@H]1O,CHEMBL1144551,Bioorg Med Chem,2007.0,CHEMBL8771,CHEMBL8771,,0.0,http://www.openphacts.org/units/Nanomolar,634125.0,>,1.0,1.0,>,IC50,nM,300000.0,CHEMBL612672,Cowpox virus,Cowpox virus,10243,IC50,uM,UO_0000065,300.0,CHEMBL612672
2373,2149833.0,[],CHEMBL935681,Antiviral activity against HIV1 098-T20 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL411406,CHEMBL411406,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708035.0,=,1.0,1.0,=,IC50,ug.mL-1,0.033,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.033,CHEMBL378
2374,13464654.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL55199,CHEMBL55199,6.04,0.0,http://www.openphacts.org/units/Nanomolar,1920704.0,=,1.0,1.0,=,IC50,nM,912.01,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.04,CHEMBL378
2375,468909.0,[],CHEMBL683810,Antiviral activities against HIV-1 replication in CEM cells and its ability to lower the viral charge supernatants was reported,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2ccc(/C=C/c3ccc(O)c(O)c3)nc2c1O,CHEMBL1133718,J Med Chem,2000.0,CHEMBL39092,CHEMBL39092,5.89,0.0,http://www.openphacts.org/units/Nanomolar,61396.0,=,1.0,1.0,=,IC50,nM,1300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.3,CHEMBL378
2376,2165105.0,[],CHEMBL921440,Antiviral activity against HIV1 with RT K103N/Y181C/G190A mutation in human MT4 cells in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ccccc34)ccc2Cl)c1,CHEMBL1145601,Bioorg Med Chem Lett,2008.0,CHEMBL402823,CHEMBL402823,6.77,0.0,http://www.openphacts.org/units/Nanomolar,711002.0,=,1.0,1.0,=,IC50,nM,171.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,171.0,CHEMBL378
2377,5126322.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,COCCn1cc2c(n1)N(C)c1ccc(Cl)cc1N(c1ccccc1)C2=O,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642528,CHEMBL1642528,5.82,0.0,http://www.openphacts.org/units/Nanomolar,1317838.0,=,1.0,1.0,=,IC50,nM,1500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.5,CHEMBL378
2378,1437989.0,[],CHEMBL833076,Inhibitory activity against HIV-1 mutant strain 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(-c2cccnc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL361250,CHEMBL361250,7.30,0.0,http://www.openphacts.org/units/Nanomolar,371602.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.05,CHEMBL378
2379,3014796.0,[],CHEMBL1050516,Antiviral activity against multidrug-resistant HIV1 isolate C infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(c1)OCCCC/C=C\CCCN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]3OCC[C@H]31)S2(=O)=O,CHEMBL1156053,J Med Chem,2009.0,CHEMBL577992,CHEMBL577992,7.54,0.0,http://www.openphacts.org/units/Nanomolar,862634.0,=,1.0,1.0,=,IC50,nM,29.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.029,CHEMBL378
2380,18342068.0,[],CHEMBL4139011,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1ccc(-c2cc(NC(=O)c3ccc(Cl)cc3O)c[nH]c2=O)cc1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL4167090,CHEMBL4167090,4.63,0.0,http://www.openphacts.org/units/Nanomolar,3045874.0,=,1.0,1.0,=,IC50,nM,23150.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,23.15,CHEMBL613497
2381,1403527.0,[],CHEMBL834755,Inhibitory concentration against 100I mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Sc2cn(C)c(=O)c(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL175152,CHEMBL175152,,0.0,http://www.openphacts.org/units/Nanomolar,360671.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
2382,13967500.0,[],CHEMBL3135326,Antiviral activity against wild type HIV1 VSVG infected in 293ET cells assessed as inhibition of viral replication by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1sc(I)cc1S(=O)(=O)N1c2cc(Cl)ccc2NC(=O)C1C,CHEMBL3132804,Medchemcomm,2014.0,CHEMBL3133063,CHEMBL3133063,7.12,0.0,http://www.openphacts.org/units/Nanomolar,1974735.0,=,1.0,1.0,=,IC50,nM,75.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.075,CHEMBL378
2383,1040104.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(SCc2ccccc2)n(Nc2cccc(Cl)c2)c1-c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL290648,CHEMBL290648,,0.0,http://www.openphacts.org/units/Nanomolar,62337.0,>,1.0,1.0,>,IC50,nM,39660.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,39.66,CHEMBL378
2384,1401663.0,[],CHEMBL833792,In vitro inhibitory concentration against HIV-1 Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Cc2cc(C)[nH]c(=O)c2N(C)C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177961,CHEMBL177961,4.10,0.0,http://www.openphacts.org/units/Nanomolar,360254.0,=,1.0,1.0,=,IC50,nM,79430.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,79.43,CHEMBL378
2385,15679753.0,[],CHEMBL3607182,Antiviral activity against Measles virus infected in African green monkey CV1 cells after 3 days by neutral red dye-based plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(F)cc2c1ncn2[C@@H]1C[C@H](CCO)[C@@H](O)[C@H]1O,CHEMBL3603790,Bioorg Med Chem,2015.0,CHEMBL3604366,CHEMBL3604366,,0.0,http://www.openphacts.org/units/Nanomolar,2494269.0,=,1.0,1.0,=,IC50,nM,162000.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,162.0,CHEMBL613738
2386,12651402.0,[],CHEMBL2327723,Antiviral activity against 0.001 MOI bevirimat-resistant Human immunodeficiency virus 1 NL4-3 harboring gag V370A mutant infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCC(=O)NCC#N)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324141,CHEMBL2324141,6.34,0.0,http://www.openphacts.org/units/Nanomolar,1850167.0,=,1.0,1.0,=,IC50,nM,460.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.46,CHEMBL378
2387,1236125.0,[],CHEMBL878997,Inhibition of Hepatitis C RNA dependent RNA polymerase Nonstructural protein 5B activity.,B,BAO_0000190,BAO_0000357,single protein format,O=C(O)[C@H](Cc1ccccc1)N(Cc1cccc(Br)c1)C(=O)c1ccccc1Cl,CHEMBL1136248,Bioorg Med Chem Lett,2003.0,CHEMBL280721,CHEMBL280721,4.51,0.0,http://www.openphacts.org/units/Nanomolar,213342.0,=,1.0,1.0,=,IC50,nM,31000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,31.0,CHEMBL4620
2388,1066167.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(NN2C(S)=NC(C)C2c2cccc(C#N)c2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289913,CHEMBL289913,,0.0,http://www.openphacts.org/units/Nanomolar,62356.0,>,1.0,1.0,>,IC50,nM,45630.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,45.63,CHEMBL613499
2389,3188306.0,[],CHEMBL1107773,Antiviral activity against HIV1 NLBal infected JC53BL cells assessed as inhibition of replication by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)C[C@H]3CN(C(=O)c4c(C)ncnc4C)C[C@H]3C1)CC2,CHEMBL1155421,Bioorg Med Chem Lett,2010.0,CHEMBL1077360,CHEMBL1077360,,0.0,http://www.openphacts.org/units/Nanomolar,896404.0,>=,1.0,1.0,>=,IC50,nM,625.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,625.0,CHEMBL378
2390,2244518.0,[],CHEMBL1002207,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase K103N mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL593,CHEMBL593,5.80,0.0,http://www.openphacts.org/units/Nanomolar,798656.0,=,1.0,1.0,=,IC50,nM,1598.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1598.0,CHEMBL378
2391,3085616.0,[],CHEMBL1047695,Antiviral activity against HIV1 3B in human MT2 cells assessed as reduction of virus-induced cytopathogenicity,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(C)n1-c1ccc(-c2ccc(CCC(=O)O)cc2)c(C(=O)O)c1,CHEMBL1153143,Bioorg Med Chem Lett,2010.0,CHEMBL595044,CHEMBL595044,4.88,0.0,http://www.openphacts.org/units/Nanomolar,877339.0,=,1.0,1.0,=,IC50,nM,13080.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,13.08,CHEMBL378
2392,891778.0,[],CHEMBL653610,Inhibitory activity tested against the HIV-1 in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N[C@@H](CC(C)C)[C@H](O)CC(=O)O)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL275740,CHEMBL275740,7.30,0.0,http://www.openphacts.org/units/Nanomolar,9095.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,50.0,CHEMBL378
2393,1246110.0,[],CHEMBL652107,Inhibitory concentration required to inhibit HIV-induced cytopathicity in CEM-4 cells by 50% based in the MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCCCC(=O)NCCCCCCCCCCC(=O)NC(CCC(=O)[O-])C(=O)O.[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL1627031,CHEMBL1205592,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221524.0,=,1.0,1.0,=,IC50,ug.mL-1,12.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,12.0,CHEMBL378
2394,5222668.0,[],CHEMBL1675426,Antiviral activity against HIV1 harboring reverse transcriptase K65R mutant infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL1460,CHEMBL1460,5.20,0.0,http://www.openphacts.org/units/Nanomolar,1332023.0,=,1.0,1.0,=,IC50,nM,6300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.3,CHEMBL378
2395,13940331.0,[],CHEMBL3131385,Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)OCc1cn(Cc2ccccc2Cl)nn1)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL3124823,Eur J Med Chem,2014.0,CHEMBL3126791,CHEMBL3126791,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1972648.0,=,1.0,1.0,=,IC50,ug.mL-1,14.82,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,14.82,CHEMBL613129
2396,2318411.0,[],CHEMBL991097,Antiviral activity against Hepatitis B virus infected in human Hep3B cells assessed as suppression of viral surface antigen secretion after 48 hrs by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1c(O)c2ccccc2c2occc12,CHEMBL1158241,J Nat Prod,1996.0,CHEMBL464791,CHEMBL464791,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,788840.0,=,1.0,1.0,=,IC50,ug.mL-1,2.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,2.0,CHEMBL613497
2397,6304746.0,[],CHEMBL1815967,Antiviral activity against R5 tropic multidrug-resistant HIV1 MM infected PBMC assessed as inhibition of viral p24 antigen expression,F,BAO_0000190,BAO_0000218,organism-based format,CCCCN1C(=O)C(C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2.Cl,CHEMBL1811891,Bioorg Med Chem,2011.0,CHEMBL1813459,CHEMBL1851976,,0.0,,1447827.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2398,15165606.0,[],CHEMBL3404732,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBsAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(/C=C/C(=O)OC[C@H]2O[C@@H](Oc3ccc(C(C)=O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)cc(OC)c1OC,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3400176,CHEMBL3400176,,0.0,http://www.openphacts.org/units/Nanomolar,2284141.0,=,1.0,1.0,=,IC50,nM,526500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,526.5,CHEMBL613497
2399,1402019.0,[],CHEMBL837466,In vitro inhibitory concentration against HIV K101E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCOC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL368039,CHEMBL368039,8.00,0.0,http://www.openphacts.org/units/Nanomolar,360360.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
2400,1184067.0,[],CHEMBL710537,Inhibitory activity against 188L strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)cc(Cl)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL305641,CHEMBL305641,7.07,0.0,http://www.openphacts.org/units/Nanomolar,127460.0,=,1.0,1.0,=,IC50,nM,86.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.086,CHEMBL378
2401,22933230.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)/C=C/c4cccc(OC)c4)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4790961,CHEMBL4790961,6.82,0.0,http://www.openphacts.org/units/Nanomolar,3560833.0,=,1.0,1.0,=,IC50,nM,151.36,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.82,CHEMBL378
2402,22845202.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721666,Antiviral activity against pseudovirus HIV-1 HXB-2 subtype C harboring pseudotyped Env ZM53M.PB12 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4547005,CHEMBL4547005,6.72,0.0,http://www.openphacts.org/units/Nanomolar,3547094.0,=,1.0,1.0,=,IC50,nM,190.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.19,CHEMBL378
2403,336043.0,[],CHEMBL873617,Inhibition of concanavalin A (con A)-induced proliferation of rat peripheral blood mononuclear cells.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1)c1cc(F)cc(F)c1F,CHEMBL1133605,J Med Chem,2000.0,CHEMBL103444,CHEMBL103444,6.91,0.0,http://www.openphacts.org/units/Nanomolar,188098.0,=,1.0,1.0,=,IC50,nM,122.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,122.0,CHEMBL378
2404,5189224.0,[],CHEMBL1658800,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(COc1ccccc1)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652519,CHEMBL1652519,,0.0,http://www.openphacts.org/units/Nanomolar,1326894.0,>,1.0,1.0,>,IC50,nM,81000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.081,CHEMBL613497
2405,606614.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(Cc3c(Cl)cccc3Cl)nc(NO)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL71683,CHEMBL71683,8.62,0.0,http://www.openphacts.org/units/Nanomolar,126901.0,=,1.0,1.0,=,IC50,nM,2.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0024,CHEMBL378
2406,2662934.0,[],CHEMBL1052276,Antiviral activity against Parainfluenza virus type 3 infected in human Hep2 cells assessed as inhibition of virus-induced cytopathogenic effect by plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,CHEMBL1151977,J Nat Prod,2009.0,CHEMBL1643,CHEMBL1643,4.97,0.0,http://www.openphacts.org/units/Nanomolar,817658.0,=,1.0,1.0,=,IC50,nM,10700.0,CHEMBL613126,Human parainfluenza virus 3,Human parainfluenza virus 3,11216,IC50,uM,UO_0000065,10.7,CHEMBL613126
2407,2929758.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3cc(Br)cn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL573467,CHEMBL573467,7.40,0.0,http://www.openphacts.org/units/Nanomolar,848268.0,=,1.0,1.0,=,IC50,nM,39.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,39.8,CHEMBL378
2408,2930149.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSCc3csc(C)n3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567623,CHEMBL567623,9.00,0.0,http://www.openphacts.org/units/Nanomolar,852982.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
2409,1403431.0,[],CHEMBL834756,Inhibitory concentration against 103N mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(S(=O)(=O)c2cn(C)c(=O)c(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL367833,CHEMBL367833,,0.0,http://www.openphacts.org/units/Nanomolar,360765.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
2410,13924644.0,[],CHEMBL3118712,Antiviral activity against HIV-1 3B infected in human MT4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCC(CC(=O)[O-])OP(=O)([O-])OC[C@@H]1C=C[C@H](n2cc(C)c(=O)[nH]c2=O)O1.[Na+].[Na+],CHEMBL3112419,Bioorg Med Chem Lett,2014.0,CHEMBL3114683,CHEMBL3140165,4.96,0.0,http://www.openphacts.org/units/Nanomolar,1965584.0,=,1.0,1.0,=,IC50,nM,10900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.9,CHEMBL378
2411,18044741.0,[],CHEMBL4010402,"Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype C Du422, clone 1",F,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075766,CHEMBL4075766,6.44,0.0,http://www.openphacts.org/units/Nanomolar,2990214.0,=,1.0,1.0,=,IC50,nM,360.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.36,CHEMBL378
2412,5132813.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2[nH]c(=O)c(CN(Cc3ccco3)C(=O)c3ccc(Cl)c(N4CCCCC4)c3)cc2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645052,CHEMBL1645052,5.15,0.0,http://www.openphacts.org/units/Nanomolar,1321040.0,=,1.0,1.0,=,IC50,nM,7100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.1,CHEMBL378
2413,1750616.0,[],CHEMBL864974,Antiviral activity against HIV1 LAI isolate in human MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,CHEMBL1146019,J Med Chem,2006.0,CHEMBL115,CHEMBL115,7.58,0.0,http://www.openphacts.org/units/Nanomolar,540000.0,=,1.0,1.0,=,IC50,nM,26.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,26.0,CHEMBL378
2414,1402108.0,[],CHEMBL835251,In vitro inhibitory concentration against HIV F227L and V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCO)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175692,CHEMBL175692,,0.0,http://www.openphacts.org/units/Nanomolar,360365.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2415,1188801.0,[],CHEMBL698758,Inhibition concentration against influenza B (WSN),F,BAO_0000190,BAO_0000218,organism-based format,O=C1N(CCCCCCOc2ccc(C(F)(F)F)cc2)CCN1c1ccncc1,CHEMBL1135916,J Med Chem,2002.0,CHEMBL296696,CHEMBL296696,,0.0,http://www.openphacts.org/units/Nanomolar,71838.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL613128,unidentified influenza virus,unidentified influenza virus,11309,IC50,uM,UO_0000065,25.0,CHEMBL613128
2416,816941.0,[],CHEMBL772932,Inhibition of Hepatitis C virus NS3 protease in vitro.,B,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc(F)c(CCNC(=O)[C@H](CC(F)F)NC(=O)[C@@H]2C[C@@H](c3ccccc3)CN2C(=O)CC2CCCC2)c(F)c1,CHEMBL1147550,Bioorg Med Chem Lett,2004.0,CHEMBL302988,CHEMBL302988,4.47,0.0,http://www.openphacts.org/units/Nanomolar,119343.0,=,1.0,1.0,=,IC50,nM,34000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,34.0,CHEMBL4620
2417,24502929.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5053572,Antiviral activity against HIV1 NL4-3 Env-deficient pseudotype virus infected in human U87.CD4.CCR5.CXCR4 cells assessed by reduction in viral infection in early stage measured after 48 hrs by luciferase activity based single-round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1[nH]c2ccccc2c1CC(=O)NC(Cc1ccccc1)C(=O)N(C)c1ccccc1,CHEMBL5053482,J Med Chem,2021.0,CHEMBL5091904,CHEMBL5091904,7.26,0.0,http://www.openphacts.org/units/Nanomolar,3836455.0,=,1.0,1.0,=,IC50,nM,55.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,55.5,CHEMBL378
2418,14714257.0,[],CHEMBL3293254,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCNC(c1ccc(/C=C/C#N)cc1)c1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL3288571,CHEMBL3288571,6.97,0.0,http://www.openphacts.org/units/Nanomolar,2116129.0,=,1.0,1.0,=,IC50,nM,107.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.107,CHEMBL378
2419,18530827.0,[],CHEMBL4195355,Antiviral activity against HIV-1 LAI infected in human MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,CHEMBL4190391,J Med Chem,2018.0,CHEMBL114,CHEMBL114,7.68,0.0,http://www.openphacts.org/units/Nanomolar,3076704.0,=,1.0,1.0,=,IC50,nM,21.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,21.0,CHEMBL378
2420,23284035.0,[],CHEMBL4837921,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)OC[C@H]1CCCNC1)S(=O)(=O)c1ccc(C(F)(F)F)cc1,CHEMBL4837199,Eur J Med Chem,2021.0,CHEMBL4877064,CHEMBL4877064,7.93,0.0,http://www.openphacts.org/units/Nanomolar,3622967.0,=,1.0,1.0,=,IC50,nM,11.66,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,11.66,CHEMBL378
2421,933427.0,[],CHEMBL728516,Anti-HIV activity against HIV-1 IIIB chronically infected Molt-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1N1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2OC(F)F)CC1,CHEMBL1131862,Bioorg Med Chem Lett,1999.0,CHEMBL323364,CHEMBL323364,6.96,0.0,http://www.openphacts.org/units/Nanomolar,194319.0,=,1.0,1.0,=,IC50,nM,110.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.11,CHEMBL378
2422,1672752.0,[],CHEMBL870624,Antiviral activity against HIV1 K103N mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(OCCCS(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(C(F)(F)F)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL202663,CHEMBL202663,8.40,0.0,http://www.openphacts.org/units/Nanomolar,411943.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.0,CHEMBL378
2423,1403308.0,[],CHEMBL834755,Inhibitory concentration against 100I mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Oc2nc(Nc3ccc(C#N)cc3)c(=O)n(C)c2C)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL175967,CHEMBL175967,,0.0,http://www.openphacts.org/units/Nanomolar,360716.0,>,1.0,1.0,>,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.05,CHEMBL378
2424,2149845.0,[],CHEMBL935682,Antiviral activity against HIV1 098-T1249 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL427982,CHEMBL427982,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708042.0,=,1.0,1.0,=,IC50,ug.mL-1,0.192,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.192,CHEMBL378
2425,5132768.0,[],CHEMBL1646273,Antiviral activity against protease-resistant HIV1 isolate 92US657 infected in human PBMC assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)n2c3ccccc3n(C[C@@H](O)Nc3ccc(F)cc3)c2c1C#N,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645085,CHEMBL1645085,5.57,0.0,http://www.openphacts.org/units/Nanomolar,1321074.0,=,1.0,1.0,=,IC50,nM,2700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.7,CHEMBL378
2426,1169310.0,[],CHEMBL679241,Concentration required to reduce vaccinia virus-inducted cytopathicity by 50% (E6SM cells),F,BAO_0000190,BAO_0000218,organism-based format,O=C([O-])CC(SCCCOCC1OC(OCCCSC(CC(=O)[O-])C(=O)[O-])C(OCCCSC(CC(=O)[O-])C(=O)[O-])C(OCCCSC(CC(=O)[O-])C(=O)[O-])C1COCC1OC(COCCCSC(CC(=O)[O-])C(=O)[O-])C(OCCCSC(CC(=O)[O-])C(=O)[O-])C(OCCCSC(CC(=O)[O-])C(=O)[O-])C1OCCCSC(CC(=O)[O-])C(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],CHEMBL1130336,J Med Chem,1997.0,CHEMBL384019,CHEMBL1207271,,0.0,http://www.openphacts.org/units/Nanomolar,225164.0,>,1.0,1.0,>,IC50,nM,181000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,181.0,CHEMBL613493
2427,5229804.0,[],CHEMBL1676983,Antiviral activity against Human immunodeficiency virus 1 3B infected in human CEM-SS cells infected with 3.13 uL of virus stock assessed as expression of p24 antigen after 6 days postinfection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,6.62,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,=,1.0,1.0,=,IC50,nM,240.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.24,CHEMBL378
2428,13933241.0,[],CHEMBL3124194,Antiviral activity against Hepatitis B virus assessed as inhibition of Hepatitis B virus e antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(c1OC)CN(C)c1c-2ccc2cc3c(cc12)OCO3,CHEMBL3120134,Eur J Med Chem,2014.0,CHEMBL400359,CHEMBL400359,,0.0,http://www.openphacts.org/units/Nanomolar,1969507.0,<,1.0,1.0,<,IC50,nM,50.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol/L,UO_0000065,0.05,CHEMBL613497
2429,1229381.0,[],CHEMBL711623,Concentration required to inhibit HIV-1 induced cytopathicity in MT-4 cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCC(=O)NCCCCCCCCCCC(=O)NCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL116133,CHEMBL1205571,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221535.0,=,1.0,1.0,=,IC50,ug.mL-1,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,6.0,CHEMBL378
2430,14596860.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2ccccc2)n(COCCF)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL286878,CHEMBL286878,5.22,0.0,http://www.openphacts.org/units/Nanomolar,2082380.0,=,1.0,1.0,=,IC50,nM,5960.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.96,CHEMBL378
2431,920471.0,[],CHEMBL712257,Inhibition of human immunodeficiency virus-1 (HIV-1) induced cytopathicity in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](Cn1nnc2c(O)nc(N)nc21)OCP(=O)(O)O,CHEMBL1129435,J Med Chem,1996.0,CHEMBL341005,CHEMBL341005,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251933.0,=,1.0,1.0,=,IC50,ug.mL-1,52.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,52.7,CHEMBL378
2432,2569052.0,[],CHEMBL972599,Antiviral activity against wild type HIV1 3B in human P4/R5 cells assessed as beta-galactosidase activity by single-cycle viral replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)N1C[C@H](C)n2c(c(O)c3c(=O)n(Cc4ccc(F)c(Cl)c4)ncc32)C1=O,CHEMBL1156547,Bioorg Med Chem Lett,2008.0,CHEMBL456164,CHEMBL456164,7.55,0.0,http://www.openphacts.org/units/Nanomolar,798806.0,=,1.0,1.0,=,IC50,nM,28.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,28.0,CHEMBL378
2433,15027190.0,[],CHEMBL3367181,Inhibition of AP-1-mediated collagenase production in IL1alpha-stimulated Lewis rat synovial cells,B,BAO_0000190,BAO_0000019,assay format,CCCc1c(C(=O)O)c(O)cc2c1C(=O)c1c(O)cccc1C2=O,CHEMBL3352097,J Med Chem,2014.0,CHEMBL3341957,CHEMBL3341957,4.22,0.0,http://www.openphacts.org/units/Nanomolar,2265205.0,=,1.0,1.0,=,IC50,nM,60000.0,CHEMBL3341579,Rattus norvegicus,Transcription factor AP-1,10116,IC50,uM,UO_0000065,60.0,CHEMBL3341579
2434,2930372.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3nc(-c4ccco4)nc3C)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL574374,CHEMBL574374,8.70,0.0,http://www.openphacts.org/units/Nanomolar,848346.0,=,1.0,1.0,=,IC50,nM,1.99,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.99,CHEMBL378
2435,1272812.0,[],CHEMBL656278,Inhibition of particle production in de novo infection assay of HIV infected CEM cells.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(O)c(O)c1)c1ccc2ccc(C(=O)O)c(O)c2n1,CHEMBL1146726,Bioorg Med Chem Lett,2004.0,CHEMBL312608,CHEMBL312608,4.52,0.0,http://www.openphacts.org/units/Nanomolar,147486.0,=,1.0,1.0,=,IC50,nM,30000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,30.0,CHEMBL378
2436,14714265.0,[],CHEMBL3293254,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#C/C=C/c1ccc(C(NC2CC2)c2ccnc(Nc3ccc(C#N)cc3)n2)cc1,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL3288579,CHEMBL3288579,6.71,0.0,http://www.openphacts.org/units/Nanomolar,2116137.0,=,1.0,1.0,=,IC50,nM,196.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.196,CHEMBL378
2437,15156728.0,[],CHEMBL3399641,Decrease in hepatitis B viral surface antigen HBeAg secretion in human HepG2(2.2.15) cells at 0.75 to 3 uM after 72 hrs by EIA analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)Oc2cc(OC)ccc2C(C)=O)cc1,CHEMBL3397002,Eur J Med Chem,2015.0,CHEMBL3397412,CHEMBL3397412,5.65,0.0,http://www.openphacts.org/units/Nanomolar,2279259.0,=,1.0,1.0,=,IC50,nM,2240.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.24,CHEMBL613497
2438,7967354.0,[],CHEMBL1930242,Antiviral activity against R5 tropic Human immunodeficiency virus 1 BAL infected in human PBMC cells assessed as reduction in viral replication by p24 detection based ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(N(Cc2ccccc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1,CHEMBL1926604,Bioorg Med Chem Lett,2011.0,CHEMBL1926873,CHEMBL1926873,5.66,0.0,http://www.openphacts.org/units/Nanomolar,1563490.0,=,1.0,1.0,=,IC50,nM,2170.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.17,CHEMBL378
2439,594039.0,[],CHEMBL710373,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Cc3c(Cl)cccc3Cl)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL307297,CHEMBL307297,6.40,0.0,http://www.openphacts.org/units/Nanomolar,126949.0,=,1.0,1.0,=,IC50,nM,398.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.398,CHEMBL378
2440,3407224.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2oc3ccc(NC(C)=O)cc3c(=O)c2OC)cc1,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1214670,CHEMBL1214670,,0.0,http://www.openphacts.org/units/Nanomolar,932261.0,=,1.0,1.0,=,IC50,nM,368700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,368.7,CHEMBL378
2441,2930234.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CNC(=O)c3cc4ccccc4o3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL583839,CHEMBL583839,6.70,0.0,http://www.openphacts.org/units/Nanomolar,852940.0,=,1.0,1.0,=,IC50,nM,199.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,199.0,CHEMBL378
2442,22806660.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@@H](Sc3ccc(N4CCOCC4)cc3)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4786833,CHEMBL4786833,5.90,0.0,http://www.openphacts.org/units/Nanomolar,3541898.0,=,1.0,1.0,=,IC50,nM,1266.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.266,CHEMBL613497
2443,2414469.0,[],CHEMBL953484,Antiviral activity against HIV1 with reverse transcriptase L100I mutation in human CEM cells assessed as protection against virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)C(N)=O)[nH]c3ccc(Cl)cc23)c1,CHEMBL1153955,J Med Chem,2009.0,CHEMBL127012,CHEMBL127012,8.05,0.0,http://www.openphacts.org/units/Nanomolar,810480.0,=,1.0,1.0,=,IC50,nM,9.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,9.0,CHEMBL378
2444,10961222.0,[],CHEMBL2061271,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M6 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(C)=C1C(=O)Nc2ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)cc21,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057466,CHEMBL2057466,7.70,0.0,http://www.openphacts.org/units/Nanomolar,1655128.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,20.0,CHEMBL378
2445,2149803.0,[],CHEMBL935680,Antiviral activity against HIV1 098 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL525076,CHEMBL525076,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708027.0,=,1.0,1.0,=,IC50,ug.mL-1,0.05,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.05,CHEMBL378
2446,16572633.0,[],CHEMBL3802807,Antiviral activity against HIV1 3B infected in MT2 cells assessed as reduction cell viability,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2nccc(OCCOCCOCCOCCOCCOCCn3cc(COCCOCCOCCOCCNc4ccc([N+](=O)[O-])cc4[N+](=O)[O-])nn3)c12,CHEMBL3797033,J Med Chem,2016.0,CHEMBL3800574,CHEMBL3800574,4.92,0.0,http://www.openphacts.org/units/Nanomolar,2773420.0,=,1.0,1.0,=,IC50,nM,12000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.0,CHEMBL378
2447,10961056.0,[],CHEMBL2061264,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing wild type protease infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC=C1C(=O)Nc2ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)cc21,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057464,CHEMBL2057464,7.22,0.0,http://www.openphacts.org/units/Nanomolar,1655126.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,60.0,CHEMBL378
2448,5230895.0,[],CHEMBL1678271,Antiviral activity against Human immunodeficiency virus 1 WEJO infected in phytohemagglutininin and interleukin-2-stimulated PBMC assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL129,CHEMBL129,8.70,0.0,http://www.openphacts.org/units/Nanomolar,1332124.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.002,CHEMBL378
2449,752528.0,[],CHEMBL688961,Antiviral activity against HIV-1 IIIB in H9 (human leukemia) cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cn1ccnc1S(=O)(=O)Nc1cccc(C(c2c(O)c3c(oc2=O)CCCCCC3)C2CC2)c1,CHEMBL1129838,Bioorg Med Chem Lett,1997.0,CHEMBL132275,CHEMBL132275,,0.0,http://www.openphacts.org/units/Nanomolar,248559.0,>,1.0,1.0,>,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.0,CHEMBL378
2450,704294.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=S)SSC(=S)OCC,CHEMBL1129635,J Med Chem,1996.0,CHEMBL331743,CHEMBL331743,,0.0,,228570.0,=,1.0,0.0,=,IC50,,107.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,107.7,CHEMBL378
2451,1954088.0,[],CHEMBL890376,Antiviral activity against HIV1 LAI assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL223228,CHEMBL223228,9.00,0.0,http://www.openphacts.org/units/Nanomolar,647186.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
2452,10938634.0,[],CHEMBL2051599,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccc5c(c4)OCO5)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046564,CHEMBL2046564,4.36,0.0,http://www.openphacts.org/units/Nanomolar,1651447.0,=,1.0,1.0,=,IC50,nM,43720.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,43.72,CHEMBL613497
2453,1750582.0,[],CHEMBL868009,Antiviral activity against multi drug-resistant HIV1 EV variant in human PHA-PBMC cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,CHEMBL1146019,J Med Chem,2006.0,CHEMBL584,CHEMBL584,,0.0,http://www.openphacts.org/units/Nanomolar,540001.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
2454,5189204.0,[],CHEMBL1658800,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652499,CHEMBL1652499,,0.0,http://www.openphacts.org/units/Nanomolar,1326874.0,>,1.0,1.0,>,IC50,nM,52000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.052,CHEMBL613497
2455,2670839.0,[],CHEMBL1035389,Antiviral activity against LASV infected in human A549 cells,F,BAO_0000190,BAO_0000218,organism-based format,CCC1CN(C(=O)c2cc3ccccc3[nH]2)CC(=O)N1Cc1cccc(C(F)(F)F)c1,CHEMBL1151924,Bioorg Med Chem Lett,2009.0,CHEMBL563380,CHEMBL563380,5.62,0.0,http://www.openphacts.org/units/Nanomolar,820607.0,=,1.0,1.0,=,IC50,nM,2400.0,CHEMBL615051,Lassa virus,Lassa virus,11620,IC50,uM,UO_0000065,2.4,CHEMBL615051
2456,149660.0,[],CHEMBL698765,Concentration required for 50% inhibition of influenza A/WS/33 by plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCO[C@@H]1C=C(C(=O)O)C[C@H](/N=C/N)[C@H]1NC(C)=O,CHEMBL1130481,Bioorg Med Chem Lett,1997.0,CHEMBL53507,CHEMBL53507,,0.0,http://www.openphacts.org/units/Nanomolar,90735.0,,1.0,0.0,,IC50,nM,,CHEMBL613128,unidentified influenza virus,unidentified influenza virus,11309,IC50,nM,UO_0000065,,CHEMBL613128
2457,2930361.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(=O)CSCc1c(C)[nH]c(=O)c(I)c1Sc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL573489,CHEMBL573489,8.80,0.0,http://www.openphacts.org/units/Nanomolar,848248.0,=,1.0,1.0,=,IC50,nM,1.58,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.58,CHEMBL378
2458,3525568.0,[],CHEMBL1273925,Antiviral activity against HIV1 HXB2 infected in human HeLaP4-2 cells assessed as inhibition of single-cycle viral replication,F,BAO_0000190,BAO_0000218,organism-based format,NCc1ccc(-c2cccc(Cc3cc(=O)n(O)c4ncccc34)c2)cc1,CHEMBL1268904,Bioorg Med Chem Lett,2010.0,CHEMBL1270511,CHEMBL1270511,6.37,0.0,http://www.openphacts.org/units/Nanomolar,966137.0,=,1.0,1.0,=,IC50,nM,430.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.43,CHEMBL378
2459,19450658.0,[],CHEMBL4433624,Antiviral activity against HIV1 12465 harboring protease M46I/I54V/Q58E/T74P/V82L/L90M mutant infected in human TZM-bl cells infected with supernatants from virus-infected human MT2 cells treated with compound for 72 hrs assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(-c2ccc(OCc3cccc(C(=O)NCCNC(=O)c4ccc(COc5ccc(Cl)cc5-c5csc(N)n5)cc4)c3)cc2)cs1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4446026,CHEMBL4598022,5.80,0.0,http://www.openphacts.org/units/Nanomolar,3249753.0,=,1.0,1.0,=,IC50,nM,1600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.6,CHEMBL378
2460,3276422.0,[],CHEMBL1104906,Antiviral activity against HBV infected in HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 8 days by radio immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)C(=O)/C(NC(=O)c1ccccc1)=C(/Br)c1snnc1C,CHEMBL1157863,Eur J Med Chem,2010.0,CHEMBL1088362,CHEMBL1088362,,0.0,,912505.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
2461,10862160.0,[],CHEMBL2024925,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B e-antigen release,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(/C=C/C(=O)O[C@H]2CC[C@]3(C)[C@H]4CC=C5[C@@H]6C[C@@](C)(C(=O)OCC(N)=O)CC[C@]6(C)CC[C@@]5(C)[C@]4(C)CC[C@H]3C2(C)C)cc(OC)c1OC,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2023710,CHEMBL2023710,,0.0,http://www.openphacts.org/units/Nanomolar,1639319.0,=,1.0,1.0,=,IC50,nM,251590.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,251.59,CHEMBL613497
2462,22449754.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.5', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.5'}]",CHEMBL4680707,Antiviral activity against HIV1 AD8 infected in dog Cf2Th/CD4-CCR5 cells assessed as inhibition of viral entry incubated for 30 mins prior to infection and measured after 48 hrs post infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CNCc1ccc2c(c1)[C@H](NC(=O)C(=O)Nc1ccc(Cl)c(F)c1)[C@@H](CNC(=N)N)C2.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4680075,ACS Med Chem Lett,2016.0,CHEMBL4755140,CHEMBL4802887,5.17,0.0,http://www.openphacts.org/units/Nanomolar,3518671.0,=,1.0,1.0,=,IC50,nM,6700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.7,CHEMBL378
2463,13933234.0,[],CHEMBL3124190,Antiviral activity against Hepatitis B virus assessed as inhibition of Hepatitis B virus DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Cc1sc(-c2nccs2)nc1C(=O)O,CHEMBL3120134,Eur J Med Chem,2014.0,CHEMBL3121567,CHEMBL3121567,4.22,0.0,http://www.openphacts.org/units/Nanomolar,1969512.0,=,1.0,1.0,=,IC50,nM,60000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol/L,UO_0000065,60.0,CHEMBL613497
2464,14641483.0,[],CHEMBL3268997,Antagonist activity at recombinant human EBI2 receptor expressed in CHO cells assessed as inhibition of 0.33 nM oxysterol-induced [35S]GTPgammaS binding after 1 hr by scintillation counting analysis,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(=O)N2CCN(C(=O)/C=C/c3ccc(Br)cc3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262896,CHEMBL3262896,8.07,0.0,http://www.openphacts.org/units/Nanomolar,2101738.0,=,1.0,1.0,=,IC50,nM,8.511,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,pIC50,,UO_0000065,8.07,CHEMBL3259470
2465,24731858.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5115939,Antiviral activity against DENV-NGC-1 infected in human BHK cells incubated for 7 days by CellTiter 96 luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,[N-]=[N+]=NCCCSc1c(Cl)cc(C(=O)c2ccc(C(F)(F)F)cc2O)n1-c1c(C(=O)c2ccc(C(F)(F)F)cc2O)[nH]c(Cl)c1Cl,CHEMBL5113415,Eur J Med Chem,2022.0,CHEMBL5205622,CHEMBL5205622,,0.0,,3857958.0,,1.0,0.0,,IC50,,,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,,,,CHEMBL613757
2466,1181514.0,[],CHEMBL757806,Cytotoxicity against human peripheral blood mononuclear (PBM) cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c(=O)n([C@@H]2CS[C@H](CO)O2)cc1Cl,CHEMBL1126808,J Med Chem,1993.0,CHEMBL301891,CHEMBL301891,,0.0,http://www.openphacts.org/units/Nanomolar,100993.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2467,3238674.0,[],CHEMBL1116129,Antiviral activity against Human immunodeficiency virus 1 NL4.3 infected human CEM cells expressing GFP measured up to 8 days postinfection by p24 antigen capture ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOc1c(CCCC)c(O)nc2ccccc12,CHEMBL1156233,Bioorg Med Chem,2010.0,CHEMBL1090248,CHEMBL1090248,4.46,0.0,http://www.openphacts.org/units/Nanomolar,904635.0,=,1.0,1.0,=,IC50,nM,34430.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,34.43,CHEMBL378
2468,1067359.0,[],CHEMBL709777,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,C=C(CC)CN1Cc2cccc3nc(O)n(c23)CC1C,CHEMBL1125252,J Med Chem,1991.0,CHEMBL165503,CHEMBL165503,4.43,0.0,http://www.openphacts.org/units/Nanomolar,322353.0,=,1.0,1.0,=,IC50,nM,37000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,37.0,CHEMBL378
2469,2432640.0,[],CHEMBL1027472,Antiviral activity against HIV1 3B infected in human HOG.R5 assessed as inhibition of viral replication by microtiter assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C/C=C/C(C)(C)O)[C@H]1CC[C@]2(C)[C@@H]1CC[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,CHEMBL1159344,J Nat Prod,2003.0,CHEMBL39909,CHEMBL39909,4.65,0.0,http://www.openphacts.org/units/Nanomolar,735815.0,=,1.0,1.0,=,IC50,nM,22600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,22.6,CHEMBL378
2470,2601742.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(O)cc(OCCOCP(=O)(O)O)n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL504793,CHEMBL504793,6.52,0.0,http://www.openphacts.org/units/Nanomolar,807737.0,=,1.0,1.0,=,IC50,nM,302.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,10'-1microM,UO_0000065,3.02,CHEMBL378
2471,19261994.0,[],CHEMBL4404413,Antiviral activity against HIV1 subtypeA mother MJ613.W0M.ENV.A2,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.20,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,630.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.63,CHEMBL378
2472,1471986.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C/c2cccnc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL361069,CHEMBL361069,8.52,0.0,http://www.openphacts.org/units/Nanomolar,380907.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
2473,1830894.0,[],CHEMBL918634,Antiviral activity against wild type HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(C(C#N)c2ccccc2)nc(SCC(=O)c2ccccc2)[nH]c1=O,CHEMBL1144474,J Med Chem,2007.0,CHEMBL221876,CHEMBL221876,5.14,0.0,http://www.openphacts.org/units/Nanomolar,629297.0,=,1.0,1.0,=,IC50,nM,7280.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.28,CHEMBL378
2474,17602956.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(S(=O)(=O)c2ccccc2Cl)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644891,CHEMBL3644891,7.80,0.0,http://www.openphacts.org/units/Nanomolar,2518011.0,=,37.0,1.0,=,IC50,nM,16.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,16.0,CHEMBL4620
2475,16449871.0,[],CHEMBL3757559,Inhibition of ASCT2-mediated glutamine transport in human HEK293 cells using [3H]-glutamine after 15 mins by scintillation counting,B,BAO_0000190,BAO_0000219,cell-based format,N[C@@H](CCN(Cc1ccccc1Oc1ccccn1)Cc1ccccc1Oc1ccccn1)C(=O)O,CHEMBL3751750,Bioorg Med Chem Lett,2016.0,CHEMBL3752494,CHEMBL3752494,4.22,0.0,http://www.openphacts.org/units/Nanomolar,2744497.0,=,1.0,1.0,=,IC50,nM,59600.0,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,uM,UO_0000065,59.6,CHEMBL3562162
2476,3267402.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1Cc2cc(Cl)cc3[nH]c(=O)n(c23)C[C@H]1C,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL168006,CHEMBL168006,6.74,0.0,http://www.openphacts.org/units/Nanomolar,906989.0,=,1.0,1.0,=,IC50,nM,181.97,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.74,CHEMBL378
2477,2272910.0,[],CHEMBL956847,Antiviral activity against HIV1 Bal in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(C(=O)O)N2CCC(CCN3[C@@H]4CC[C@H]3C[C@@H](n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)cc1,CHEMBL1153314,Bioorg Med Chem Lett,2009.0,CHEMBL499109,CHEMBL499109,7.61,0.0,http://www.openphacts.org/units/Nanomolar,755536.0,=,1.0,1.0,=,IC50,nM,24.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0248,CHEMBL378
2478,14658831.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(/C=C/C(=O)N2CCN(C(=O)Cc3ccccc3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262880,CHEMBL3262880,7.04,0.0,http://www.openphacts.org/units/Nanomolar,2101722.0,=,1.0,1.0,=,IC50,nM,92.0,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,IC50,nM,UO_0000065,92.0,CHEMBL3259471
2479,8043630.0,[],CHEMBL1953039,Antiviral activity against HIV1 3B infected human TZM-bl cells assessed as inhibition of viral replication by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NCCCCCC(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/NCCCCCC(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+],CHEMBL1949531,Bioorg Med Chem Lett,2012.0,CHEMBL1949756,CHEMBL1962958,5.68,0.0,http://www.openphacts.org/units/Nanomolar,1576824.0,=,1.0,1.0,=,IC50,nM,2090.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.09,CHEMBL378
2480,542933.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1ccccc1Br,CHEMBL1134494,J Med Chem,2001.0,CHEMBL293780,CHEMBL293780,5.30,0.0,http://www.openphacts.org/units/Nanomolar,94258.0,=,1.0,1.0,=,IC50,nM,5000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.0,CHEMBL378
2481,595276.0,[],CHEMBL710381,Inhibitory activity against 103N strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Oc3c(Cl)cc(F)cc3Cl)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL305805,CHEMBL305805,7.19,0.0,http://www.openphacts.org/units/Nanomolar,126915.0,=,1.0,1.0,=,IC50,nM,65.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.065,CHEMBL378
2482,910272.0,[],CHEMBL656269,Inhibition of human immunodeficiency virus-1 (HIV-1) induced cytopathicity in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](Cn1nc2nc(N)nc(O)c2n1)OCP(=O)(O)O,CHEMBL1129435,J Med Chem,1996.0,CHEMBL132576,CHEMBL132576,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251935.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,100.0,CHEMBL378
2483,631893.0,[],CHEMBL710374,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(N)cc(C)c1Oc1nc(N)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL302538,CHEMBL302538,,0.0,http://www.openphacts.org/units/Nanomolar,126908.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2484,1057464.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C1C(C)N=CN1Nc1cccc(Cl)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289379,CHEMBL289379,,0.0,http://www.openphacts.org/units/Nanomolar,62343.0,>,1.0,1.0,>,IC50,nM,106700.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,106.7,CHEMBL613499
2485,1671957.0,[],CHEMBL870621,Antiviral activity against HIV1 Y181C mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(N)cc(C#N)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL199947,CHEMBL199947,6.35,0.0,http://www.openphacts.org/units/Nanomolar,411932.0,=,1.0,1.0,=,IC50,nM,450.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,450.0,CHEMBL378
2486,1402266.0,[],CHEMBL837465,In vitro inhibitory concentration against HIV G190S mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCCN(CCCC)c1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL179736,CHEMBL179736,,0.0,http://www.openphacts.org/units/Nanomolar,360413.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2487,2178225.0,[],CHEMBL1019290,Antiviral activity against HIV1 HTLV-3B in human H9 cells after 3 days by p24 antigen capture assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(c(OC)c1OC)-c1ccc(=O)c(N(C)C)cc1[C@@H](N)CC2,CHEMBL1158954,J Nat Prod,1991.0,CHEMBL522985,CHEMBL522985,,0.0,http://www.openphacts.org/units/Nanomolar,763897.0,>,1.0,1.0,>,IC50,nM,2700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.7,CHEMBL378
2488,2184012.0,[],CHEMBL951603,Antiviral activity against HIV1 NL43 infected in U87.CD4 cells expressing human wild type CXCR4,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(CNCc2ccc(CN3CCCNCCNCCCNCC3)cc2)nc1,CHEMBL1156482,J Biol Chem,2007.0,CHEMBL477121,CHEMBL477121,4.44,0.0,http://www.openphacts.org/units/Nanomolar,791971.0,=,1.0,1.0,=,IC50,nM,36000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,36.0,CHEMBL378
2489,2930429.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSC3CCCC3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567215,CHEMBL567215,8.00,0.0,http://www.openphacts.org/units/Nanomolar,852933.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
2490,20677916.0,[],CHEMBL4622140,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in cytoplasmic HBV-DNA replication incubated for 8 days by real-time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,Cn1cc(-c2ccc(F)nc2F)nc(Cc2ccc(Cl)cc2)c1=O,CHEMBL4619801,J Med Chem,2020.0,CHEMBL4649723,CHEMBL4649723,5.72,0.0,http://www.openphacts.org/units/Nanomolar,3482204.0,=,1.0,1.0,=,IC50,nM,1890.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.89,CHEMBL613497
2491,6304751.0,[],CHEMBL1815967,Antiviral activity against R5 tropic multidrug-resistant HIV1 MM infected PBMC assessed as inhibition of viral p24 antigen expression,F,BAO_0000190,BAO_0000218,organism-based format,COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C,CHEMBL1811891,Bioorg Med Chem,2011.0,CHEMBL82301,CHEMBL82301,8.52,0.0,http://www.openphacts.org/units/Nanomolar,1447831.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.0,CHEMBL378
2492,2371526.0,[],CHEMBL1035742,Antiviral activity against HIV1 with reverse transcriptase V106A mutant in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ncccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL491019,CHEMBL491019,,0.0,,773465.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2493,10865212.0,[],CHEMBL2025516,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(OC(=O)CCN2C(=O)c3ccccc3C2=O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCN4C(=O)c5ccccc5C4=O)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024045,CHEMBL2024045,,0.0,http://www.openphacts.org/units/Nanomolar,1639767.0,>,1.0,1.0,>,IC50,nM,809480.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,809.48,CHEMBL613497
2494,17602966.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(S(=O)(=O)Nc2ccccc2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644901,CHEMBL3644901,7.21,0.0,http://www.openphacts.org/units/Nanomolar,2518021.0,=,37.0,1.0,=,IC50,nM,61.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,61.0,CHEMBL4620
2495,2997426.0,[],CHEMBL1046975,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=CCn1cc(C(=O)c2ccc(OC)cc2O)ccc1=O,CHEMBL1156796,J Med Chem,2010.0,CHEMBL568197,CHEMBL568197,4.24,0.0,http://www.openphacts.org/units/Nanomolar,856642.0,=,1.0,1.0,=,IC50,nM,58000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,58.0,CHEMBL613497
2496,5229798.0,[],CHEMBL1676879,Antiviral activity against Human immunodeficiency virus 1 harboring plasmid TAK-1 infected in CEM-SS cells assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
2497,12463733.0,[],CHEMBL3057688,Antiviral activity against wild type Human immunodeficiency virus 1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cccc(NC(=S)NC(=N)Cc2c(Cl)cccc2Cl)c1,CHEMBL3046335,Med Chem Res,2009.0,CHEMBL72704,CHEMBL72704,,0.0,http://www.openphacts.org/units/Nanomolar,1805826.0,=,1.0,1.0,=,IC50,nM,125892541.18,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,0.9,CHEMBL378
2498,2414478.0,[],CHEMBL953485,Antiviral activity against HIV1 with reverse transcriptase K103N mutation in human CEM cells assessed as protection against virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCS(N)(=O)=O)[nH]c3ccc(Cl)cc23)c1,CHEMBL1153955,J Med Chem,2009.0,CHEMBL470007,CHEMBL470007,7.40,0.0,http://www.openphacts.org/units/Nanomolar,810749.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,40.0,CHEMBL378
2499,3457967.0,[],CHEMBL1249120,Inhibition of AP1 expressed in HEK293 cells assessed as inhibition of PMA-induced transcriptional activation treated 24 hrs before PMA challenge by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(-n2c(-c3sc(Nc4ccc(Cl)cc4)nc3-c3ccccc3)nc3ccccc3c2=O)cc1,CHEMBL1240423,Eur J Med Chem,2010.0,CHEMBL1242519,CHEMBL1242519,4.85,0.0,http://www.openphacts.org/units/Nanomolar,953768.0,=,1.0,1.0,=,IC50,nM,14000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,14.0,CHEMBL4977
2500,2180958.0,[],CHEMBL979633,Antiviral activity against HIV1 assessed as inhibition of cytopathic effect by cell based XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1C(=O)O[C@H]2/C=C(\C)CC/C=C(\C(=O)O)CC/C=C(\C)CC[C@@H]12,CHEMBL1154570,J Nat Prod,2000.0,CHEMBL524633,CHEMBL524633,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,786036.0,=,1.0,1.0,=,IC50,ug.mL-1,7.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,7.6,CHEMBL378
2501,1066164.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(NN2C(S)=NC(C)C2c2cccc(C#N)c2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289913,CHEMBL289913,,0.0,http://www.openphacts.org/units/Nanomolar,62356.0,>,1.0,1.0,>,IC50,nM,45630.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,45.63,CHEMBL378
2502,12687127.0,[],CHEMBL2344305,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral e antigen production,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)O[C@H]1C[C@H]2[C@]3(C)C(=O)C[C@]4(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](OC(=O)CC)C[C@@]4(C)[C@@H]3C[C@H]3O[C@]32C(C)(C)[C@@H]1OC(=O)CC,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332408,CHEMBL2332408,,0.0,http://www.openphacts.org/units/Nanomolar,1866102.0,>,1.0,1.0,>,IC50,nM,1667000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1667.0,CHEMBL613497
2503,22806636.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@@H](Sc3ccc(Cl)c(OCc4ccccc4)c3)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4793564,CHEMBL4793564,6.67,0.0,http://www.openphacts.org/units/Nanomolar,3541922.0,=,1.0,1.0,=,IC50,nM,215.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.215,CHEMBL613497
2504,12150900.0,[],CHEMBL2187761,Antiviral activity against X4 HIV1 NL4.3 infected in human MT4 cells assessed as inhibition of viral replication pre-incubated for 30 mins measured 5 days post infection by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[n+]1ccc(-c2cc[n+](Cc3cc(C[n+]4ccc(-c5cc[n+](CC)cc5)cc4)cc(C[n+]4ccc(-c5cc[n+](Cc6cc(C[n+]7ccc(-c8cc[n+](Cc9cc(C[n+]%10ccc(-c%11cc[n+](CC)cc%11)cc%10)cc(C[n+]%10ccc(-c%11cc[n+](CC)cc%11)cc%10)c9)cc8)cc7)cc(C[n+]7ccc(-c8cc[n+](Cc9cc(C[n+]%10ccc(-c%11cc[n+](CC)cc%11)cc%10)cc(C[n+]%10ccc(-c%11cc[n+](CC)cc%11)cc%10)c9)cc8)cc7)c6)cc5)cc4)c3)cc2)cc1.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F,CHEMBL2177043,J Med Chem,2012.0,CHEMBL2179462,CHEMBL2221099,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1752525.0,=,1.0,1.0,=,IC50,ug.mL-1,0.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.8,CHEMBL378
2505,15166102.0,[],CHEMBL3404734,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBeAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(OC(=O)/C=C/c2ccccc2)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL1578081,CHEMBL1578081,,0.0,http://www.openphacts.org/units/Nanomolar,2284122.0,>,1.0,1.0,>,IC50,nM,2874900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2874.9,CHEMBL613497
2506,3077008.0,[],CHEMBL1067297,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(=O)C2=C(C1)NC(c1c(F)cc(F)cc1F)=NC2c1ccc(F)cc1Cl,CHEMBL1153099,Bioorg Med Chem Lett,2010.0,CHEMBL594570,CHEMBL594570,,0.0,,877094.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
2507,2947400.0,[],CHEMBL1038497,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)OC(C)(C)[C@H](OC(=O)c1ccccc1)[C@H](C[C@@H](C)C1=C2C[C@H](OC(=O)c3ccccc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)OC(=O)c1ccccc1,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL584997,CHEMBL584997,,0.0,http://www.openphacts.org/units/Nanomolar,850767.0,>,1.0,1.0,>,IC50,nM,1700000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.7,CHEMBL613497
2508,15158633.0,[],CHEMBL3398832,Inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OCc1cccc2c1CCOC2=O)c1cccc([N+](=O)[O-])c1,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397177,CHEMBL3397177,,0.0,http://www.openphacts.org/units/Nanomolar,2278976.0,>,1.0,1.0,>,IC50,nM,2720000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.72,CHEMBL613497
2509,2930174.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cncn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578802,CHEMBL578802,8.40,0.0,http://www.openphacts.org/units/Nanomolar,852866.0,=,1.0,1.0,=,IC50,nM,3.98,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.98,CHEMBL378
2510,18808340.0,[],CHEMBL4275448,Antiviral activity against Zika virus SMGC infected in BHK cells assessed as inhibition of virus induced cytopathic effect after 8 days by CellTiter-Glo luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)N(CCCNC(=O)Nc1ccc(F)cc1)C[C@H]1O[C@@H](n2cnc3c(NCc4cccc(F)c4)ncnc32)[C@H](O)[C@@H]1O,CHEMBL4270631,Eur J Med Chem,2018.0,CHEMBL4283887,CHEMBL4283887,,0.0,http://www.openphacts.org/units/Nanomolar,3125036.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,50.0,CHEMBL4296612
2511,516569.0,[],CHEMBL699442,Inhibition of rous sarcoma virus (RSV) Integrase.,B,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1ccc2ccc(/C=C/c3ccc(O)cc3)nc2c1O,CHEMBL1133692,J Med Chem,2000.0,CHEMBL418613,CHEMBL418613,4.68,0.0,http://www.openphacts.org/units/Nanomolar,101669.0,=,1.0,1.0,=,IC50,nM,20900.0,CHEMBL2750,Rous sarcoma virus (strain Prague C) (RSV-PrC),Rous sarcoma virus integrase,11888,IC50,M l-1,UO_0000065,0.0000209,CHEMBL2750
2512,19175403.0,[],CHEMBL4385901,Antiviral activity against Zika virus harboring subgenomic GFP replicon infected in African green monkey Vero cells assessed as reduction in viral infection preincubated for 30 mins followed by viral infection and measured after 72 hrs,F,BAO_0000190,BAO_0000218,organism-based format,c1coc(CNCc2cc(CNCc3ccco3)cc(-c3cc(CNCc4ccco4)cc(Cn4cc(COCCOCCOCCOCc5cn(Cc6cc(CNCc7ccco7)cc(-c7cc(CNCc8ccco8)cc(CNCc8ccco8)c7)c6)nn5)nn4)c3)c2)c1,CHEMBL4385601,J Med Chem,2019.0,CHEMBL4560040,CHEMBL4560040,4.91,0.0,http://www.openphacts.org/units/Nanomolar,3200405.0,=,1.0,1.0,=,IC50,nM,12370.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,12.37,CHEMBL4296612
2513,2713014.0,[],CHEMBL1054010,Antiviral activity against HIV1 3B in human MT4 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CO[C@H]1CCN(Cc2ccc(CN3CC[C@H](OC)OC[C@H](C)NC(=O)C[C@@H](OC)OC[C@@H]3C)cc2)[C@@H](C)CO[C@H](OC)CC(=O)N[C@@H](C)CO1,CHEMBL1153004,Eur J Med Chem,2009.0,CHEMBL554312,CHEMBL554312,,0.0,http://www.openphacts.org/units/Nanomolar,826162.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2514,681358.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,[O-][S+](c1ccccc1O)[S+]([O-])c1ccccc1O,CHEMBL1129635,J Med Chem,1996.0,CHEMBL119878,CHEMBL119878,,0.0,,228556.0,=,1.0,0.0,=,IC50,,25.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,25.4,CHEMBL378
2515,23191688.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4818692,Antiviral activity against HIV1 SG3.1 infected in human TZM-bl cells measured after 48 hrs by single round viral infectivity assay based Steady-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)C1C(C(=O)OCc2ccccc2)=CCC12C(=O)N1[C@@H](C(=O)OC(c3ccccc3)c3ccccc3)C(C)(C)S[C@@H]12,CHEMBL4814068,Eur J Med Chem,2021.0,CHEMBL4853574,CHEMBL4853574,6.19,0.0,http://www.openphacts.org/units/Nanomolar,3606477.0,=,1.0,1.0,=,IC50,nM,650.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.65,CHEMBL378
2516,1421933.0,[],CHEMBL834672,Inhibitory activity against human immunodeficiency virus type 1,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(Sc2cc(C)cc(C)c2)n(COCc2ccccc2)c(=O)[nH]c1=O,CHEMBL1144258,Bioorg Med Chem Lett,2005.0,CHEMBL291926,CHEMBL291926,,0.0,http://www.openphacts.org/units/Nanomolar,364899.0,<,1.0,1.0,<,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
2517,19261829.0,[],CHEMBL4404357,Antiviral activity against HIV1 subtypeA Q259ENV.W6,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.40,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.4,CHEMBL378
2518,12717512.0,[],CHEMBL2350955,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBV DNA replication after 72 hrs by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,C=CCc1ccc(O)c(-c2cc(C=O)ccc2O)c1,CHEMBL2346656,Bioorg Med Chem Lett,2013.0,CHEMBL550166,CHEMBL550166,,0.0,http://www.openphacts.org/units/Nanomolar,1874411.0,>,1.0,1.0,>,IC50,nM,1000000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1000.0,CHEMBL613497
2519,14654454.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)c3ccccc3C(=O)O)[C@H](OC(=O)c3ccccc3C(=O)O)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3263016,CHEMBL3263016,4.66,0.0,http://www.openphacts.org/units/Nanomolar,2101899.0,=,1.0,1.0,=,IC50,nM,22000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,22.0,CHEMBL613497
2520,23306070.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL4843118,Antiviral activity against Zika virus H/PF/2013 infected in pre-seeded Huh-7 cells assessed as inhibition of viral replication incubated for 72 hrs by immunodetection based secondary yield reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1cccc(Nc2nc(NCCOc3ccccc3)nc3[nH]cnc23)c1,CHEMBL4842338,Eur J Med Chem,2021.0,CHEMBL4870033,CHEMBL4870033,5.09,0.0,http://www.openphacts.org/units/Nanomolar,3627086.0,=,1.0,1.0,=,IC50,nM,8200.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,8.2,CHEMBL4296612
2521,3406131.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc(O)c(C(=O)/C=C/c2ccc(F)cc2)c1,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1215382,CHEMBL1215382,4.39,0.0,http://www.openphacts.org/units/Nanomolar,933099.0,=,1.0,1.0,=,IC50,nM,41100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,41.1,CHEMBL378
2522,1750626.0,[],CHEMBL864975,Antiviral activity against HIV1 LAI isolate in human PHA-PBMC cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,CHEMBL1146019,J Med Chem,2006.0,CHEMBL114,CHEMBL114,7.85,0.0,http://www.openphacts.org/units/Nanomolar,539998.0,=,1.0,1.0,=,IC50,nM,14.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,14.0,CHEMBL378
2523,18940410.0,[],CHEMBL4328848,Antiviral activity against HIV-1 3B infected in human MAGI-CXCR4 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cccc(Cn2ccc3ccc(-c4ccc5ccn(Cc6cccc(OC(F)(F)F)c6)c5c4)cc32)c1,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4465870,CHEMBL4465870,5.82,0.0,http://www.openphacts.org/units/Nanomolar,3159811.0,=,1.0,1.0,=,IC50,nM,1500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.5,CHEMBL378
2524,1472398.0,[],CHEMBL833076,Inhibitory activity against HIV-1 mutant strain 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C(C)=C(\C)C#N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL189760,CHEMBL189760,7.70,0.0,http://www.openphacts.org/units/Nanomolar,380979.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.02,CHEMBL378
2525,12627471.0,[],CHEMBL2317015,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(N/N=C2\Sc3ccccc3C2=O)cc1,CHEMBL2311445,Bioorg Med Chem,2013.0,CHEMBL2311903,CHEMBL2311903,,0.0,http://www.openphacts.org/units/Nanomolar,1841401.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2526,2506767.0,[],CHEMBL946752,Antiviral activity against HIV1 3B replication in human PBMC assessed as reverse transcriptase activity after 7 days,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCc3cccnc3C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1141017,Bioorg Med Chem Lett,2008.0,CHEMBL492402,CHEMBL492402,7.52,0.0,http://www.openphacts.org/units/Nanomolar,752671.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.03,CHEMBL378
2527,2930193.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cc(Br)cn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL583614,CHEMBL583614,8.10,0.0,http://www.openphacts.org/units/Nanomolar,852896.0,=,1.0,1.0,=,IC50,nM,7.94,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.94,CHEMBL378
2528,2681583.0,[],CHEMBL1052429,Antiviral activity against HIV1 CAP244.2.00.D3 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCNC(C)=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL508943,CHEMBL508943,6.40,0.0,http://www.openphacts.org/units/Nanomolar,823861.0,=,1.0,1.0,=,IC50,nM,400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.4,CHEMBL378
2529,3509136.0,[],CHEMBL1261038,Antiviral activity against wild type HIV1 infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 40% human serum,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Nc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1Br,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1258478,CHEMBL1258478,7.85,0.0,http://www.openphacts.org/units/Nanomolar,963462.0,=,1.0,1.0,=,IC50,nM,14.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,14.2,CHEMBL378
2530,5199521.0,[],CHEMBL1670946,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,OCCc1c(N2CCNCC2)nc2ccc(Cl)cc2c1-c1ccccc1Cl,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668650,CHEMBL1668650,,0.0,http://www.openphacts.org/units/Nanomolar,1328434.0,>,1.0,1.0,>,IC50,nM,5000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,5.0,CHEMBL613497
2531,1954130.0,[],CHEMBL891424,Antiviral activity against HIV1 RT 181C mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL223228,CHEMBL223228,8.70,0.0,http://www.openphacts.org/units/Nanomolar,647186.0,=,1.0,1.0,=,IC50,nM,1.99,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.99,CHEMBL378
2532,10911765.0,[],CHEMBL2038370,Antiviral activity against wild type HIV1 clade C 98USMSC5016 clinical isolate infected in PHA-P-stimulated human PBMC assessed as reverse transcriptase activity incubated for 6 hrs followed by incubated in drug-free medium for 6 days by multiround infection assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL2034836,J Med Chem,2012.0,CHEMBL141,CHEMBL141,7.66,0.0,http://www.openphacts.org/units/Nanomolar,1644919.0,=,1.0,1.0,=,IC50,nM,21.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,21.8,CHEMBL378
2533,2212965.0,[],CHEMBL989684,Antiviral activity against HBV assessed as inhibition of viral e-antigen secretion in HepG2.2.15 cells by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CO[C@H]1C(=O)C[C@]23CCN(C)[C@@]24C[C@@H](O[C@]14OC)c1cc2c(cc13)OCO2,CHEMBL1150244,J Nat Prod,2008.0,CHEMBL468389,CHEMBL468389,,0.0,http://www.openphacts.org/units/Nanomolar,767756.0,=,1.0,1.0,=,IC50,nM,3090000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,3.09,CHEMBL613497
2534,1472280.0,[],CHEMBL834618,Inhibitory activity against HIV-1 mutant strain 103N; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C(\C#N)c2ccccc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL189301,CHEMBL189301,,0.0,http://www.openphacts.org/units/Nanomolar,380908.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2535,2527519.0,[],CHEMBL1003778,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect albumin after 5 days by MTS method in presence of 40 mg/mL human serum albumin,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NC1CC1)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,CHEMBL1138484,J Med Chem,2009.0,CHEMBL526366,CHEMBL526366,,0.0,,734146.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2536,22933290.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)/C=C/c4ccc(OCOC)c(OCc5cccc(Cl)c5)c4)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4748022,CHEMBL4748022,6.34,0.0,http://www.openphacts.org/units/Nanomolar,3560851.0,=,1.0,1.0,=,IC50,nM,460.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.46,CHEMBL378
2537,2099750.0,[],CHEMBL949218,Antiviral activity against HIV1 JRCSF by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)N(CCCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nc4cc(S(C)(=O)=O)ccc42)C3)c2ccccc2)cc1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL402353,CHEMBL402353,,0.0,http://www.openphacts.org/units/Nanomolar,699394.0,>,1.0,1.0,>,IC50,nM,10000000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10000.0,CHEMBL378
2538,22844967.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721621,Antiviral activity against HIV-1 HXB-2 infected in human TZM-bl cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based single cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1nc(CO)cs1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4781427,CHEMBL4781427,6.33,0.0,http://www.openphacts.org/units/Nanomolar,3547095.0,=,1.0,1.0,=,IC50,nM,470.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.47,CHEMBL378
2539,2997365.0,[],CHEMBL1047854,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV DNA replication after 9 days by PCR,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C(=N/C2CCCCC2)c2ccc(=O)n(C3CCCCC3)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL566908,CHEMBL566908,5.40,0.0,http://www.openphacts.org/units/Nanomolar,856683.0,=,1.0,1.0,=,IC50,nM,4000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,4.0,CHEMBL613497
2540,19285282.0,[],CHEMBL4409787,Antiviral activity against oseltamivir resistant Victoria lineage of Influenza B virus (B/Brisbane/60/2008) BX-35 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect measured after 45 hrs by CellTiter-Glo luminescence assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1.O=P(O)(O)O,CHEMBL4406875,Bioorg Med Chem,2019.0,CHEMBL1200340,CHEMBL1229,,0.0,http://www.openphacts.org/units/Nanomolar,3220504.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,100.0,CHEMBL613129
2541,1138078.0,[],CHEMBL698085,Inhibitory activity against HIV-1 mutant strain K103N/Y181C,F,BAO_0000190,BAO_0000218,organism-based format,CCN1c2ncc(CSc3nc4ccccc4o3)cc2C(=O)Nc2c(C)cc(Cl)nc21,CHEMBL1137947,Bioorg Med Chem Lett,2004.0,CHEMBL422371,CHEMBL422371,6.64,0.0,http://www.openphacts.org/units/Nanomolar,321326.0,=,1.0,1.0,=,IC50,nM,230.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,230.0,CHEMBL378
2542,2318417.0,[],CHEMBL991097,Antiviral activity against Hepatitis B virus infected in human Hep3B cells assessed as suppression of viral surface antigen secretion after 48 hrs by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1c2c(c3ccccc3c1O)OC(C)(C)CC2,CHEMBL1158241,J Nat Prod,1996.0,CHEMBL459117,CHEMBL459117,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,788881.0,=,1.0,1.0,=,IC50,ug.mL-1,2.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,2.0,CHEMBL613497
2543,2614802.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1cccc(Br)c1,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL293989,CHEMBL293989,,0.0,http://www.openphacts.org/units/Nanomolar,731899.0,=,1.0,1.0,=,IC50,nM,539510.62,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,3.268,CHEMBL378
2544,936960.0,[],CHEMBL758491,Anti-HIV activity against multidrug resistant HIV MM strain by inhibition of HIV p24 antigen expression in peripheral blood mononuclear cells(PBMC),F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,CHEMBL1144922,J Med Chem,2003.0,CHEMBL114,CHEMBL114,6.50,0.0,http://www.openphacts.org/units/Nanomolar,83380.0,=,1.0,1.0,=,IC50,nM,320.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,320.0,CHEMBL378
2545,2199475.0,[],CHEMBL952475,Antiviral activity against HBV in adriamycin-resistant wild type HepW10 cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH][nH]c(=O)c2c(-c3ccc4c(c3)OCO4)c3c4c(ccc3cc12)OCO4,CHEMBL1156464,Proc Natl Acad Sci U S A,2007.0,CHEMBL369673,CHEMBL369673,6.70,0.0,http://www.openphacts.org/units/Nanomolar,791641.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.2,CHEMBL613497
2546,1830869.0,[],CHEMBL918634,Antiviral activity against wild type HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C(=O)c2ccc3ccccc3c2)nc(SCc2ccccc2)[nH]c1=O,CHEMBL1144474,J Med Chem,2007.0,CHEMBL374299,CHEMBL374299,,0.0,http://www.openphacts.org/units/Nanomolar,629322.0,>=,1.0,1.0,>=,IC50,nM,60750.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,60.75,CHEMBL378
2547,2179597.0,[],CHEMBL966469,Antiviral activity against HIV1 3B isolate replication in human H9 cells assessed as decrease in viral p24 level after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1155638,J Nat Prod,2000.0,CHEMBL404519,CHEMBL404519,5.16,0.0,http://www.openphacts.org/units/Nanomolar,712202.0,=,1.0,1.0,=,IC50,nM,7000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.0,CHEMBL378
2548,1402332.0,[],CHEMBL837470,In vitro inhibitory concentration against HIV V179E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N2CCCCC2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175655,CHEMBL175655,,0.0,http://www.openphacts.org/units/Nanomolar,360430.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2549,16422826.0,[],CHEMBL3751454,Antiviral activity against recombinant HIV-1 NL4-3 expressing HIV-1 JR-CSF envelope infected in U87.CD4.CCR5 cells assessed as inhibition of Env mediated cell entry by HIV-1 single round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CC(CCC(=O)c4ccccc4)C3)c12,CHEMBL3745657,Bioorg Med Chem Lett,2016.0,CHEMBL3746938,CHEMBL3746938,8.70,0.0,http://www.openphacts.org/units/Nanomolar,2740454.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.002,CHEMBL378
2550,15158627.0,[],CHEMBL3398832,Inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL483,CHEMBL483,,0.0,http://www.openphacts.org/units/Nanomolar,2278970.0,=,1.0,1.0,=,IC50,nM,1940000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.94,CHEMBL613497
2551,602911.0,[],CHEMBL710373,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1Oc1nc(N)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL421114,CHEMBL421114,6.07,0.0,http://www.openphacts.org/units/Nanomolar,126895.0,=,1.0,1.0,=,IC50,nM,851.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.851,CHEMBL378
2552,18940393.0,[],CHEMBL4328847,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cn1ncc2ccc(-c3ccc4cnn(Cc5ccc(F)c(C(=O)O)c5)c4c3)cc21,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4531799,CHEMBL4531799,,0.0,http://www.openphacts.org/units/Nanomolar,3159828.0,>,1.0,1.0,>,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
2553,896293.0,[],CHEMBL653610,Inhibitory activity tested against the HIV-1 in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N[C@@H](Cc3ccccc3)[C@@H](O)CC(=O)O)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL11646,CHEMBL11646,6.89,0.0,http://www.openphacts.org/units/Nanomolar,9096.0,=,1.0,1.0,=,IC50,nM,130.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,130.0,CHEMBL378
2554,10862030.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(/C=C/C(=O)O[C@H]2CC[C@]3(C)[C@H]4CC=C5[C@@H]6C[C@@](C)(C(=O)OCc7ccc(Br)cc7F)CC[C@]6(C)CC[C@@]5(C)[C@]4(C)CC[C@H]3C2(C)C)cc(OC)c1OC,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022402,CHEMBL2022402,,0.0,http://www.openphacts.org/units/Nanomolar,1637654.0,>,1.0,1.0,>,IC50,nM,1034510.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1034.51,CHEMBL613497
2555,2506758.0,[],CHEMBL946752,Antiviral activity against HIV1 3B replication in human PBMC assessed as reverse transcriptase activity after 7 days,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCc3ccc(OC)cc3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1141017,Bioorg Med Chem Lett,2008.0,CHEMBL500106,CHEMBL500106,7.63,0.0,http://www.openphacts.org/units/Nanomolar,752647.0,=,1.0,1.0,=,IC50,nM,23.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0235,CHEMBL378
2556,2263391.0,[],CHEMBL1010846,Antiviral activity against R5 tropic HIV1 BaL infected in human JC53-BL cells expressing CCR5 after 2 days by cell-cell fusion assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC1CN(C(=O)C2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2,CHEMBL1139267,Bioorg Med Chem Lett,2009.0,CHEMBL505595,CHEMBL505595,6.77,0.0,http://www.openphacts.org/units/Nanomolar,749928.0,=,1.0,1.0,=,IC50,nM,170.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,170.0,CHEMBL378
2557,10938678.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4cc(F)cc(F)c4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046580,CHEMBL2046580,4.69,0.0,http://www.openphacts.org/units/Nanomolar,1651463.0,=,1.0,1.0,=,IC50,nM,20320.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,20.32,CHEMBL613497
2558,5293939.0,[],CHEMBL1697614,Antiviral activity against HIV-1 ADA infected in PHA-stimulated human PBMC cells assessed as viral p24 core protein level after 7 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C,CHEMBL1687698,ACS Med Chem Lett,2010.0,CHEMBL1688242,CHEMBL1688242,7.92,0.0,http://www.openphacts.org/units/Nanomolar,1336883.0,=,1.0,1.0,=,IC50,nM,12.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,12.0,CHEMBL378
2559,14594148.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2cccc(Cl)c2)n(COCCO)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL418726,CHEMBL418726,5.31,0.0,http://www.openphacts.org/units/Nanomolar,2082341.0,=,1.0,1.0,=,IC50,nM,4890.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.89,CHEMBL378
2560,2929541.0,[],CHEMBL1056896,Antiviral activity against HIV1 HXB2 harboring 179E mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCSCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578367,CHEMBL578367,8.00,0.0,http://www.openphacts.org/units/Nanomolar,852822.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
2561,285194.0,[],CHEMBL706841,Antiviral activity by observing cytopathic effect induced by HIV-1 strain IIIB in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CN[C@@H](C(=O)N[C@H](C(=O)NCc2nc3ccccc3[nH]2)C(C)C)[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)OCc2ccccc2)C(C)C)cc1,CHEMBL1127464,J Med Chem,1994.0,CHEMBL318803,CHEMBL318803,7.60,0.0,http://www.openphacts.org/units/Nanomolar,195846.0,=,1.0,1.0,=,IC50,nM,25.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,25.0,CHEMBL378
2562,1471278.0,[],CHEMBL833079,Inhibitory activity against HIV-1 mutant strain 181C,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1ccccc1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL366120,CHEMBL366120,6.30,0.0,http://www.openphacts.org/units/Nanomolar,380786.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.5,CHEMBL378
2563,18044400.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1OC,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4078129,CHEMBL4078129,,0.0,http://www.openphacts.org/units/Nanomolar,2990217.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
2564,14653464.0,[],CHEMBL3267146,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)c3ccco3)[C@H](O)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262984,CHEMBL3262984,4.11,0.0,http://www.openphacts.org/units/Nanomolar,2101866.0,=,1.0,1.0,=,IC50,nM,77500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,77.5,CHEMBL613497
2565,2244504.0,[],CHEMBL1003076,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase K103N/Y181C mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL223228,CHEMBL223228,7.36,0.0,http://www.openphacts.org/units/Nanomolar,798658.0,=,1.0,1.0,=,IC50,nM,44.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,44.0,CHEMBL378
2566,14927171.0,[],CHEMBL3391564,Antiviral activity against wild type HIV-1 LAI infected in human MT4 cells assessed as inhibition of viral replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1[nH]c(=O)c(Cl)c(Oc2cc(Cl)cc(C#N)c2)c1CCCc1ccncc1,CHEMBL3390846,Medchemcomm,2010.0,CHEMBL3347300,CHEMBL3347300,8.70,0.0,http://www.openphacts.org/units/Nanomolar,2173116.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
2567,12684405.0,[],CHEMBL2344303,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)O[C@H]1C[C@@H]2C(=CC[C@@H]3[C@@]2(C)C(=O)C[C@]2(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](O)C[C@@]32C)C(C)(C)[C@@H]1OC(=O)CC,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332397,CHEMBL2332397,5.14,0.0,http://www.openphacts.org/units/Nanomolar,1866091.0,=,1.0,1.0,=,IC50,nM,7200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,7.2,CHEMBL613497
2568,12687132.0,[],CHEMBL2344305,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral e antigen production,F,BAO_0000190,BAO_0000218,organism-based format,COCC(=O)O[C@H]1C[C@@H]2C(=CC[C@@H]3[C@@]2(C)C(=O)C[C@]2(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](OC(C)=O)C[C@@]32C)C(C)(C)[C@@H]1OC(=O)COC,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332403,CHEMBL2332403,,0.0,http://www.openphacts.org/units/Nanomolar,1866097.0,>,1.0,1.0,>,IC50,nM,522400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,522.4,CHEMBL613497
2569,24823558.0,[],CHEMBL5140686,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBsAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3ccc([N+](=O)[O-])cc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5200859,CHEMBL5200859,8.34,0.0,http://www.openphacts.org/units/Nanomolar,3876732.0,=,1.0,1.0,=,IC50,nM,4.6,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0046,CHEMBL613497
2570,1401705.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,COCCCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL178689,CHEMBL178689,8.10,0.0,http://www.openphacts.org/units/Nanomolar,360393.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
2571,22844963.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721621,Antiviral activity against HIV-1 HXB-2 infected in human TZM-bl cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based single cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4796401,CHEMBL4796401,6.36,0.0,http://www.openphacts.org/units/Nanomolar,3547067.0,=,1.0,1.0,=,IC50,nM,440.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.44,CHEMBL378
2572,18044714.0,[],CHEMBL4010420,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype B B41,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.44,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,360.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.36,CHEMBL378
2573,24421212.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5048800,Antiviral activity against HIV-1 NL4-3(X4) pseudovirus infected in human TZM-bl cells assessed as reduction in viral infectivity measured after 48 hrs of postinfection by luminescence assay,F,BAO_0000190,BAO_0000218,organism-based format,c1cnc2c(c1)CN[C@@H](CN(CCCCNC1COC1)[C@H]1CCCc3cccnc31)C2,CHEMBL5046278,J Med Chem,2022.0,CHEMBL5083458,CHEMBL5083458,7.70,0.0,http://www.openphacts.org/units/Nanomolar,3784601.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,20.0,CHEMBL378
2574,2179589.0,[],CHEMBL966469,Antiviral activity against HIV1 3B isolate replication in human H9 cells assessed as decrease in viral p24 level after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)COCC(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,CHEMBL1155638,J Nat Prod,2000.0,CHEMBL449177,CHEMBL449177,4.32,0.0,http://www.openphacts.org/units/Nanomolar,712154.0,=,1.0,1.0,=,IC50,nM,48200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,48.2,CHEMBL378
2575,22844947.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721620,Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A/D harboring pseudotyped Env QA790.204I.ENV.A4 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4547005,CHEMBL4547005,6.55,0.0,http://www.openphacts.org/units/Nanomolar,3547094.0,=,1.0,1.0,=,IC50,nM,280.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.28,CHEMBL378
2576,3406151.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc2oc(-c3ccc(C(F)(F)F)cc3)cc(=O)c2c1,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1215599,CHEMBL1215599,,0.0,http://www.openphacts.org/units/Nanomolar,933356.0,=,1.0,1.0,=,IC50,nM,273200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,273.2,CHEMBL378
2577,1740019.0,[],CHEMBL854478,Inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Cn2c(CCN)nc3cc(Cl)c(Cl)cc32)cc1,CHEMBL1138932,J Med Chem,2006.0,CHEMBL211707,CHEMBL211707,5.85,0.0,http://www.openphacts.org/units/Nanomolar,520786.0,=,1.0,1.0,=,IC50,nM,1400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.4,CHEMBL613497
2578,932361.0,[],CHEMBL650153,Compound was tested for anti-retroviral activity against moloney murine sarcoma virus (MSV) in murine C3H/3T3 embryo fibroblast cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2nn(C[C@@H](CF)OCP(=O)(O)O)nc12,CHEMBL1129435,J Med Chem,1996.0,CHEMBL338786,CHEMBL338786,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251940.0,=,1.0,1.0,=,IC50,ug.mL-1,13.1,CHEMBL613501,Moloney murine sarcoma virus,Moloney murine sarcoma virus,11809,IC50,ug ml-1,UO_0000274,13.1,CHEMBL613501
2579,20677928.0,[],CHEMBL4622140,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in cytoplasmic HBV-DNA replication incubated for 8 days by real-time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)CCNc1nc(F)c(-c2nn(Cc3ccc(C#N)cc3)c(=O)c3ccccc23)cc1Cl,CHEMBL4619801,J Med Chem,2020.0,CHEMBL4637656,CHEMBL4637656,6.58,0.0,http://www.openphacts.org/units/Nanomolar,3482218.0,=,1.0,1.0,=,IC50,nM,260.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.26,CHEMBL613497
2580,7924558.0,[],CHEMBL1921361,Antiviral activity against Human immunodeficiency virus 1 Ba-L by in human HOS cells assessed as inhibition of viarl entry by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(NC(=O)N(c2cccc(F)c2)C2CCN(Cc3ccc(Oc4ccc(NS(C)(=O)=O)cc4)nc3C)CC2)cnc1C(N)=O,CHEMBL1914281,Bioorg Med Chem Lett,2011.0,CHEMBL1914524,CHEMBL1914524,8.72,0.0,http://www.openphacts.org/units/Nanomolar,1556599.0,=,1.0,1.0,=,IC50,nM,1.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.9,CHEMBL378
2581,400860.0,[],CHEMBL805567,Inhibitory concentration required against replication of small pox virus (strain India 3a) in Vero cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2C[C@H](O)CO,CHEMBL1147452,Bioorg Med Chem Lett,2004.0,CHEMBL494759,CHEMBL494759,4.39,0.0,http://www.openphacts.org/units/Nanomolar,214240.0,=,1.0,1.0,=,IC50,nM,41000.0,CHEMBL613494,Variola virus,Variola virus,10255,IC50,uM,UO_0000065,41.0,CHEMBL613494
2582,1833966.0,[],CHEMBL909275,Antiviral activity in long term culture of HIV1 KK infected PBMCs after 67 passages assessed as p24 antigen levels at escalating concentrations,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCC3)cc1.[Cl-],CHEMBL1142191,Antimicrob Agents Chemother,2007.0,CHEMBL41275,CHEMBL1178786,7.11,0.0,http://www.openphacts.org/units/Nanomolar,625895.0,=,1.0,1.0,=,IC50,nM,77.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,77.0,CHEMBL378
2583,23153209.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4810870,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 production treated at 48 hrs post-infection and measured on day 4 post-viral infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@@]12[C@H](OC(=O)/C=C/c3ccccc3)[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@H]34)[C@@H]1C2(C)C,CHEMBL4808236,Bioorg Med Chem Lett,2021.0,CHEMBL4870884,CHEMBL4870884,8.51,0.0,http://www.openphacts.org/units/Nanomolar,3599019.0,=,1.0,1.0,=,IC50,nM,3.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.1,CHEMBL378
2584,5199468.0,[],CHEMBL1670944,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,OCCc1c(Cl)nc2ccc(Cl)cc2c1-c1ccccc1Cl,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668635,CHEMBL1668635,4.34,0.0,http://www.openphacts.org/units/Nanomolar,1328419.0,=,1.0,1.0,=,IC50,nM,45300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,45.3,CHEMBL613497
2585,18183404.0,[],CHEMBL4040187,Antiviral activity against CXCR4-tropic HIV-1 NL4-3 infected in human PHA-stimulated PBMC assessed as inhibition of viral replication by measuring reduction in p24 antigen production preincubated with cells for 30 mins followed by viral infection measured on day 10 post infection in presence of IL-2 by ELISA,F,BAO_0000190,BAO_0000019,assay format,Nc1nc(O)c2ncn(C[C@H](CF)OCP(=O)(O)O)c2n1,CHEMBL4038313,J Med Chem,2017.0,CHEMBL93006,CHEMBL93006,5.85,0.0,http://www.openphacts.org/units/Nanomolar,3016395.0,=,1.0,1.0,=,IC50,nM,1420.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.42,CHEMBL378
2586,1403340.0,[],CHEMBL834757,Inhibitory concentration against 181C mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1Sc1nc(Nc2ccc(C#N)cc2)c(=O)n(C)c1C,CHEMBL1145199,J Med Chem,2005.0,CHEMBL180474,CHEMBL180474,,0.0,http://www.openphacts.org/units/Nanomolar,360749.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
2587,487231.0,[],CHEMBL752813,Inhibition to hepatitis C virus (HCV) NS3/NS4A serine protease,B,BAO_0000190,BAO_0000357,single protein format,CCC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(F)F)C(=O)C(=O)O,CHEMBL1135212,Bioorg Med Chem Lett,2002.0,CHEMBL162950,CHEMBL162950,5.03,0.0,http://www.openphacts.org/units/Nanomolar,317192.0,=,1.0,1.0,=,IC50,nM,9400.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,9.4,CHEMBL4620
2588,1014867.0,[],CHEMBL714338,"Antiviral activity against HIV-1, IIIB, in MT-4 Cells",F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)[C@@H](NCc1ccc(OCCN2CCOCC2)cc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,CHEMBL1129316,J Med Chem,1996.0,CHEMBL265225,CHEMBL265225,7.33,0.0,http://www.openphacts.org/units/Nanomolar,111225.0,=,1.0,1.0,=,IC50,nM,47.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,47.0,CHEMBL378
2589,1157683.0,[],CHEMBL757806,Cytotoxicity against human peripheral blood mononuclear (PBM) cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@@H]2CS[C@H](CO)O2)c(=O)nc1N,CHEMBL1126808,J Med Chem,1993.0,CHEMBL60483,CHEMBL60483,,0.0,http://www.openphacts.org/units/Nanomolar,100987.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2590,2713022.0,[],CHEMBL1054012,Antiviral activity against HIV1 LAI in human CEM-SS cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,CHEMBL1153004,Eur J Med Chem,2009.0,CHEMBL18442,CHEMBL18442,6.50,0.0,http://www.openphacts.org/units/Nanomolar,826238.0,=,1.0,1.0,=,IC50,nM,320.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.32,CHEMBL378
2591,18754876.0,[],CHEMBL4265061,Antiviral activity against HIV1 cYTA48P infected in PM1/CCR5 cells by single round assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1CCN(C(=O)c2cc3c(F)c(Cl)ccc3n2C)CC1,CHEMBL4261625,Bioorg Med Chem,2018.0,CHEMBL4278010,CHEMBL4278010,,0.0,http://www.openphacts.org/units/Nanomolar,3116222.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2592,22933306.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)/C(C)=C/c4ccc5c(c4)OCO5)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4743330,CHEMBL4743330,7.24,0.0,http://www.openphacts.org/units/Nanomolar,3560867.0,=,1.0,1.0,=,IC50,nM,57.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.057,CHEMBL378
2593,2997331.0,[],CHEMBL1047854,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV DNA replication after 9 days by PCR,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C/N=C(\c2ccc(=O)n(Cc3ccc(OC)cc3)c2)c2ccc(OC)cc2O)cc1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL567948,CHEMBL567948,6.00,0.0,http://www.openphacts.org/units/Nanomolar,856588.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.0,CHEMBL613497
2594,3013891.0,[],CHEMBL1045234,Antiviral activity against HIV1 3B infected human HOS cells expressing human CXCR4 and CD4 assessed as inhibition of viral infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCN(Cc1cn2c(N3CCN(C)CC3)cccc2n1)[C@H]1CCCc2cccnc21,CHEMBL1156094,Bioorg Med Chem Lett,2009.0,CHEMBL570791,CHEMBL570791,8.52,0.0,http://www.openphacts.org/units/Nanomolar,860759.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
2595,1470129.0,[],CHEMBL833082,Inhibitory activity against HIV-1 mutant strain 190S,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(Br)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188223,CHEMBL188223,8.52,0.0,http://www.openphacts.org/units/Nanomolar,380674.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
2596,2244547.0,[],CHEMBL1002213,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase G190E mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(COc1ccc(Cl)cc1C(=O)c1ccccc1)Nc1ccccc1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL296939,CHEMBL296939,8.08,0.0,http://www.openphacts.org/units/Nanomolar,798577.0,=,1.0,1.0,=,IC50,nM,8.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.3,CHEMBL378
2597,10938623.0,[],CHEMBL2051599,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccccc4C)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046552,CHEMBL2046552,,0.0,http://www.openphacts.org/units/Nanomolar,1651435.0,=,1.0,1.0,=,IC50,nM,230320.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,230.32,CHEMBL613497
2598,1471738.0,[],CHEMBL834620,Inhibitory activity against HIV-1 mutant strain 188L; ND = not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1ccc(OC)c(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL187891,CHEMBL187891,,0.0,http://www.openphacts.org/units/Nanomolar,380718.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2599,2601651.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc1O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL37139,CHEMBL37139,4.27,0.0,http://www.openphacts.org/units/Nanomolar,807291.0,=,1.0,1.0,=,IC50,nM,54000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,54.0,CHEMBL378
2600,5230937.0,[],CHEMBL1677714,Antiviral activity against Human immunodeficiency virus 1 3B infected in human H9 cells infected with 6.25 uL of virus stock assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL129,CHEMBL129,,0.0,http://www.openphacts.org/units/Nanomolar,1332124.0,<,1.0,1.0,<,IC50,nM,0.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0003,CHEMBL378
2601,2713026.0,[],CHEMBL1054012,Antiviral activity against HIV1 LAI in human CEM-SS cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CO[C@H]1CCN(Cc2ccc(CN3CC[C@H](OC)OC[C@H](C)NC(=O)C[C@@H](OC)OC[C@@H]3C)cc2)[C@@H](C)CO[C@H](OC)CC(=O)N[C@@H](C)CO1,CHEMBL1153004,Eur J Med Chem,2009.0,CHEMBL554312,CHEMBL554312,,0.0,http://www.openphacts.org/units/Nanomolar,826162.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2602,37585.0,[],CHEMBL695518,Antiviral activity against P236L strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL223228,CHEMBL223228,9.10,0.0,http://www.openphacts.org/units/Nanomolar,20823.0,=,1.0,1.0,=,IC50,nM,0.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.8,CHEMBL378
2603,14985542.0,[],CHEMBL3379676,Antiviral activity against VSV-G protein pseudotyped HIV1 system in HEK293T cells assessed as reduction in p24 level after 48 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H](O)[C@@]2(C)C[C@@H](OC(C)=O)C3=C(C(C)C)CC[C@]3(C)C[C@]12O,CHEMBL3351586,J Nat Prod,2014.0,CHEMBL3355402,CHEMBL3355402,4.79,0.0,http://www.openphacts.org/units/Nanomolar,2250121.0,=,1.0,1.0,=,IC50,nM,16100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,16.1,CHEMBL378
2604,19261855.0,[],CHEMBL4404366,Antiviral activity against HIV1 subtypeA2/D QG393.60M.ENV.A1,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.47,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,340.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.34,CHEMBL378
2605,1193340.0,[],CHEMBL710537,Inhibitory activity against 188L strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70976,CHEMBL70976,7.16,0.0,http://www.openphacts.org/units/Nanomolar,127457.0,=,1.0,1.0,=,IC50,nM,69.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.069,CHEMBL378
2606,14654447.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(CO)[C@H](OC(=O)c3cccs3)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3263007,CHEMBL3263007,5.09,0.0,http://www.openphacts.org/units/Nanomolar,2101890.0,=,1.0,1.0,=,IC50,nM,8100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,8.1,CHEMBL613497
2607,1049984.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(S)n(Nc2ccc(F)cc2)c1-c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289208,CHEMBL289208,,0.0,http://www.openphacts.org/units/Nanomolar,62361.0,>,1.0,1.0,>,IC50,nM,220130.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,220.13,CHEMBL378
2608,16422840.0,[],CHEMBL3751455,Antiviral activity against recombinant HIV-1 NL4-3 expressing HIV-1 B41 envelope infected in U87.CD4.CCR5 cells assessed as inhibition of Env mediated cell entry by HIV-1 single round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CC=C(CNC(=O)c4ccccc4)CC3)c12,CHEMBL3745657,Bioorg Med Chem Lett,2016.0,CHEMBL3747479,CHEMBL3747479,6.46,0.0,http://www.openphacts.org/units/Nanomolar,2740457.0,=,1.0,1.0,=,IC50,nM,350.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.35,CHEMBL378
2609,3056494.0,[],CHEMBL1064575,Antiviral activity against HIV1 infected in human PBMC assessed as inhibition of viral p24 antigen production after 7 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)CS1,CHEMBL1152525,Bioorg Med Chem,2009.0,CHEMBL594190,CHEMBL594190,6.70,0.0,http://www.openphacts.org/units/Nanomolar,875901.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.2,CHEMBL378
2610,1671944.0,[],CHEMBL865135,Antiviral activity against HIV1 V106A mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cccc(C#N)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL199328,CHEMBL199328,7.52,0.0,http://www.openphacts.org/units/Nanomolar,411925.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,30.0,CHEMBL378
2611,2030614.0,[],CHEMBL886374,Inhibition of cJun translocation in IL-1-beta-stimulated A549 cells,B,BAO_0000190,BAO_0000219,cell-based format,CC(=O)NCC(=O)N1CCC(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)CC1,CHEMBL1139954,Bioorg Med Chem Lett,2007.0,CHEMBL245535,CHEMBL245535,5.71,0.0,http://www.openphacts.org/units/Nanomolar,674115.0,=,1.0,1.0,=,IC50,nM,1938.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,nM,UO_0000065,1938.0,CHEMBL4977
2612,874493.0,[],CHEMBL685389,Inhibition of HIV replication in H9 cells.,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@]12CCCC[C@@]1(O)[C@@H](Cl)C(=O)C(C(N)=O)C2,CHEMBL1128512,J Med Chem,1995.0,CHEMBL107878,CHEMBL107878,5.03,0.0,http://www.openphacts.org/units/Nanomolar,204871.0,=,1.0,1.0,=,IC50,nM,9300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,9.3,CHEMBL378
2613,14653355.0,[],CHEMBL3267146,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)/C=C/c3cc(OC)c(OC)c(OC)c3)[C@H](OC(=O)/C=C/c3cc(OC)c(OC)c(OC)c3)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3263011,CHEMBL3263011,,0.0,http://www.openphacts.org/units/Nanomolar,2101894.0,>,1.0,1.0,>,IC50,nM,253000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,253.0,CHEMBL613497
2614,15571668.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(c1ccc(Br)cc1)N1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL1201862,,,CHEMBL3561875,CHEMBL3561875,6.32,0.0,http://www.openphacts.org/units/Nanomolar,2477370.0,=,7.0,1.0,=,IC50,nM,478.0,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.478,CHEMBL3259470
2615,15571654.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(Br)cc1)N1CCN(Cc2ccc(Cl)cc2C(F)(F)F)CC1,CHEMBL1201862,,,CHEMBL3561495,CHEMBL3561495,8.28,0.0,http://www.openphacts.org/units/Nanomolar,2476736.0,=,7.0,1.0,=,IC50,nM,5.23,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.00523,CHEMBL3259470
2616,15158638.0,[],CHEMBL3398832,Inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(/C=C/C(=O)OCc2cccc3c2CCOC3=O)c1,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397182,CHEMBL3397182,,0.0,http://www.openphacts.org/units/Nanomolar,2278981.0,=,1.0,1.0,=,IC50,nM,840000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.84,CHEMBL613497
2617,24823577.0,[],CHEMBL5140687,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBeAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC(C)c1ccc3c(c1)OCO3)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5197434,CHEMBL5197434,,0.0,http://www.openphacts.org/units/Nanomolar,3876714.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.0,CHEMBL613497
2618,37580.0,[],CHEMBL695523,Antiviral activity against V108I strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL223228,CHEMBL223228,8.68,0.0,http://www.openphacts.org/units/Nanomolar,20823.0,=,1.0,1.0,=,IC50,nM,2.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.1,CHEMBL378
2619,312016.0,[],CHEMBL697276,In vitro inhibition of HIV-1 plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCOCC(CP(=O)([O-])OCC[n+]1ccccc1)OC,CHEMBL1125666,J Med Chem,1991.0,CHEMBL28072,CHEMBL28072,5.66,0.0,http://www.openphacts.org/units/Nanomolar,43728.0,=,1.0,1.0,=,IC50,nM,2200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.2,CHEMBL378
2620,14999555.0,[],CHEMBL3366531,Antiviral activity against HIV1 harboring reverse transcriptase L1001/K103N double mutant infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL223228,CHEMBL223228,5.60,0.0,http://www.openphacts.org/units/Nanomolar,2248840.0,=,1.0,1.0,=,IC50,nM,2490.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.49,CHEMBL378
2621,14714267.0,[],CHEMBL3293254,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL57,CHEMBL57,7.00,0.0,http://www.openphacts.org/units/Nanomolar,2116139.0,=,1.0,1.0,=,IC50,nM,101.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.101,CHEMBL378
2622,5199475.0,[],CHEMBL1670944,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,OCCc1c(OCc2c(Cl)cccc2Cl)nc2ccc(Cl)cc2c1-c1ccccc1Cl,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668642,CHEMBL1668642,4.74,0.0,http://www.openphacts.org/units/Nanomolar,1328426.0,=,1.0,1.0,=,IC50,nM,18200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,18.2,CHEMBL613497
2623,13940324.0,[],CHEMBL3131385,Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)OCc1cn(C2C=CCCC2)nn1)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL3124823,Eur J Med Chem,2014.0,CHEMBL3126769,CHEMBL3126769,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1972622.0,>=,1.0,1.0,>=,IC50,ug.mL-1,5.14,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,5.14,CHEMBL613129
2624,10961152.0,[],CHEMBL2061267,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M10 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(N)=C1C(=O)Nc2ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)cc21,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057465,CHEMBL2057465,7.22,0.0,http://www.openphacts.org/units/Nanomolar,1655127.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,60.0,CHEMBL378
2625,18173481.0,[],CHEMBL4038383,Antiviral activity against VSV pseudotyped HIV1 infected in SupT1 cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(=O)n2c(n1)-c1c(cc3cccc4c3c1C(=O)N4C)C2(C)C,CHEMBL4038266,J Nat Prod,2017.0,CHEMBL4060867,CHEMBL4060867,4.11,0.0,http://www.openphacts.org/units/Nanomolar,3015254.0,=,1.0,1.0,=,IC50,nM,77900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,77.9,CHEMBL378
2626,15607385.0,[],CHEMBL3579414,Antiviral activity against HIV1 by cell based MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CO[C@H]3OC[C@H](OC)[C@H]32)cc1,CHEMBL3576781,J Med Chem,2015.0,CHEMBL3577576,CHEMBL3577576,8.62,0.0,http://www.openphacts.org/units/Nanomolar,2480258.0,=,1.0,1.0,=,IC50,nM,2.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.4,CHEMBL378
2627,16449874.0,[],CHEMBL3757559,Inhibition of ASCT2-mediated glutamine transport in human HEK293 cells using [3H]-glutamine after 15 mins by scintillation counting,B,BAO_0000190,BAO_0000219,cell-based format,N[C@@H](CCN(Cc1ccccc1OCc1cccc(Cl)c1)Cc1ccccc1OCc1cccc(Cl)c1)C(=O)O,CHEMBL3751750,Bioorg Med Chem Lett,2016.0,CHEMBL3753808,CHEMBL3753808,4.29,0.0,http://www.openphacts.org/units/Nanomolar,2744500.0,=,1.0,1.0,=,IC50,nM,50800.0,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,uM,UO_0000065,50.8,CHEMBL3562162
2628,1421940.0,[],CHEMBL824926,Inhibitory activity against human immunodeficiency virus type 1 (inactive>0.1),F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2ccccc2)n(COCc2cccs2)c(=O)[nH]c1=O,CHEMBL1144258,Bioorg Med Chem Lett,2005.0,CHEMBL179613,CHEMBL179613,,0.0,http://www.openphacts.org/units/Nanomolar,364776.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2629,6216936.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1C1(CCN2C3CCC2CC(n2c(C)nc4ccccc42)C3)CCN(C(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784493,CHEMBL1784493,6.21,0.0,http://www.openphacts.org/units/Nanomolar,1429432.0,=,1.0,1.0,=,IC50,nM,616.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.21,CHEMBL378
2630,341454.0,[],CHEMBL653803,In vitro inhibition of CEM-SS cell growth by 50 %,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCCCOCC[N+](C)(C)CC(O)CO.[I-],CHEMBL1125666,J Med Chem,1991.0,CHEMBL280747,CHEMBL1183116,5.54,0.0,http://www.openphacts.org/units/Nanomolar,43724.0,=,1.0,1.0,=,IC50,nM,2900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.9,CHEMBL378
2631,1402303.0,[],CHEMBL835252,In vitro inhibitory concentration against HIV K101E and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(Cc2ccccc2)Cc2ccccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL366811,CHEMBL366811,,0.0,http://www.openphacts.org/units/Nanomolar,360421.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2632,16449881.0,[],CHEMBL3757559,Inhibition of ASCT2-mediated glutamine transport in human HEK293 cells using [3H]-glutamine after 15 mins by scintillation counting,B,BAO_0000190,BAO_0000219,cell-based format,N[C@@H](CCN(Cc1ccccc1OCc1ccccn1)Cc1ccccc1OCc1ccccn1)C(=O)O,CHEMBL3751750,Bioorg Med Chem Lett,2016.0,CHEMBL3752103,CHEMBL3752103,4.32,0.0,http://www.openphacts.org/units/Nanomolar,2744507.0,=,1.0,1.0,=,IC50,nM,48300.0,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,uM,UO_0000065,48.3,CHEMBL3562162
2633,287445.0,[],CHEMBL706841,Antiviral activity by observing cytopathic effect induced by HIV-1 strain IIIB in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CN[C@@H](C(=O)N[C@H](C(=O)NCc2nc3ccccc3[nH]2)C(C)C)[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)C(C)Oc2ccccc2)C(C)(C)C)cc1,CHEMBL1127464,J Med Chem,1994.0,CHEMBL321943,CHEMBL321943,7.42,0.0,http://www.openphacts.org/units/Nanomolar,195841.0,=,1.0,1.0,=,IC50,nM,38.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,38.0,CHEMBL378
2634,3253114.0,[],CHEMBL1107997,Antiviral activity against HIV1 NL4.3 infected in human MT4 cells expressing CD4 and CXCR4 assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(CNCc2ccc(CN(Cc3ccccn3)C3CCc4cccnc43)cc2)nc1,CHEMBL1156989,J Med Chem,2010.0,CHEMBL1090513,CHEMBL1090513,5.31,0.0,http://www.openphacts.org/units/Nanomolar,902771.0,=,1.0,1.0,=,IC50,nM,4900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.9,CHEMBL378
2635,18183409.0,[],CHEMBL4040187,Antiviral activity against CXCR4-tropic HIV-1 NL4-3 infected in human PHA-stimulated PBMC assessed as inhibition of viral replication by measuring reduction in p24 antigen production preincubated with cells for 30 mins followed by viral infection measured on day 10 post infection in presence of IL-2 by ELISA,F,BAO_0000190,BAO_0000019,assay format,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,CHEMBL4038313,J Med Chem,2017.0,CHEMBL483,CHEMBL483,6.42,0.0,http://www.openphacts.org/units/Nanomolar,3016404.0,=,1.0,1.0,=,IC50,nM,380.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.38,CHEMBL378
2636,1671967.0,[],CHEMBL870621,Antiviral activity against HIV1 Y181C mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(N2CC[S+]([O-])CC2)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1ccccc1C#N,CHEMBL1147746,J Med Chem,2006.0,CHEMBL383375,CHEMBL383375,6.16,0.0,http://www.openphacts.org/units/Nanomolar,411922.0,=,1.0,1.0,=,IC50,nM,700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,700.0,CHEMBL378
2637,508988.0,[],CHEMBL691388,Inhibitory concentration against HIV-1 AZTres.,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC=O)c1Cc1cc(C)cc(C)c1,CHEMBL1133473,J Med Chem,2000.0,CHEMBL338936,CHEMBL338936,7.15,0.0,http://www.openphacts.org/units/Nanomolar,245543.0,=,1.0,1.0,=,IC50,nM,71.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,71.0,CHEMBL378
2638,16431305.0,[],CHEMBL3749631,Antiviral activity against HIV1 NL4-3 pseudotyped with JR-FL envelope infected in human U87.CD4.CCR5 cells by single-round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Cc1c[nH]c2ccccc12)NCC1(c2ccccc2)CC1,CHEMBL3745691,Bioorg Med Chem Lett,2016.0,CHEMBL3746679,CHEMBL3746679,4.74,0.0,http://www.openphacts.org/units/Nanomolar,2740812.0,=,1.0,1.0,=,IC50,nM,18100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,18.1,CHEMBL378
2639,1230633.0,[],CHEMBL652107,Inhibitory concentration required to inhibit HIV-induced cytopathicity in CEM-4 cells by 50% based in the MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCC(=O)N(CC)CCCCCCCCCCC(=O)NCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL264718,CHEMBL1206354,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221537.0,=,1.0,1.0,=,IC50,ug.mL-1,120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,120.0,CHEMBL378
2640,10938675.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1cccc(/C=C/C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(O)C(C)=O)C2)c1,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046566,CHEMBL2046566,4.60,0.0,http://www.openphacts.org/units/Nanomolar,1651449.0,=,1.0,1.0,=,IC50,nM,24920.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,24.92,CHEMBL613497
2641,10866481.0,[],CHEMBL2025518,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CO)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024040,CHEMBL2024040,,0.0,http://www.openphacts.org/units/Nanomolar,1639762.0,=,1.0,1.0,=,IC50,nM,219230.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,219.23,CHEMBL613497
2642,19033614.0,[],CHEMBL4350060,Antiviral activity against HIV1 89.6 pseudovirus infected in human TZM-bl cells assessed as inhibition of viral infection incubated for 20 mins prior to infection and measured after 48 hrs post infection by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Oc1ccc2cccnc2c1-c1cccc2ccccc12,CHEMBL4346738,Bioorg Med Chem,2019.0,CHEMBL4535359,CHEMBL4535359,5.33,0.0,http://www.openphacts.org/units/Nanomolar,3175416.0,=,1.0,1.0,=,IC50,nM,4700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.7,CHEMBL378
2643,2212934.0,[],CHEMBL989684,Antiviral activity against HBV assessed as inhibition of viral e-antigen secretion in HepG2.2.15 cells by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CO[C@@H]1C(=O)C[C@]23CCN(C)[C@@]24C[C@@H](O[C@]14OC)c1cc2c(cc13)OCO2,CHEMBL1150244,J Nat Prod,2008.0,CHEMBL512458,CHEMBL512458,,0.0,http://www.openphacts.org/units/Nanomolar,767755.0,=,1.0,1.0,=,IC50,nM,3410000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,3.41,CHEMBL613497
2644,300121.0,[],CHEMBL706841,Antiviral activity by observing cytopathic effect induced by HIV-1 strain IIIB in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@H](NC(=O)[C@H](NCc1ccccc1)[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)OCc1ccccc1)C(=O)NCc1ccccc1,CHEMBL1127464,J Med Chem,1994.0,CHEMBL102328,CHEMBL102328,,0.0,http://www.openphacts.org/units/Nanomolar,195819.0,>,1.0,1.0,>,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3000.0,CHEMBL378
2645,2464789.0,[],CHEMBL963691,Antiviral activity against HBV assessed as inhibition of viral e-antigen production by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1cc2c(Cn3ccnc3)c(O)c(OC)cc2nc1CSc1cccc(OC)c1,CHEMBL1157455,Bioorg Med Chem,2008.0,CHEMBL453335,CHEMBL453335,4.19,0.0,http://www.openphacts.org/units/Nanomolar,720664.0,=,1.0,1.0,=,IC50,nM,65100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,65.1,CHEMBL613497
2646,3509190.0,[],CHEMBL1261044,Antiviral activity against HIV1 harboring reverse transcriptase K103N/L100I double mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cnc(NC2CCN(c3cccc(C(N)=O)c3)CC2)nc1Oc1c(C)cc(C#N)cc1C,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1257665,CHEMBL1257665,8.17,0.0,http://www.openphacts.org/units/Nanomolar,962573.0,=,1.0,1.0,=,IC50,nM,6.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.7,CHEMBL378
2647,18585126.0,[],CHEMBL4223280,Antiviral activity against Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBeAg secretion after 3 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,CHEMBL4219203,Bioorg Med Chem Lett,2018.0,CHEMBL169,CHEMBL169,,0.0,http://www.openphacts.org/units/Nanomolar,3086244.0,=,1.0,1.0,=,IC50,nM,896700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,896.7,CHEMBL613497
2648,1750609.0,[],CHEMBL866134,Antiviral activity against multi drug-resistant HIV1 ET variant in human PHA-PBMC cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,CHEMBL1146019,J Med Chem,2006.0,CHEMBL114,CHEMBL114,7.77,0.0,http://www.openphacts.org/units/Nanomolar,539998.0,=,1.0,1.0,=,IC50,nM,17.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,17.0,CHEMBL378
2649,5198685.0,[],CHEMBL1670547,Antiviral activity against R5 tropic HIV1 Ba-L infected in human PBMC assessed as inhibition of HIN p24 antigen expression,F,BAO_0000190,BAO_0000218,organism-based format,CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2.Cl,CHEMBL1667838,Bioorg Med Chem Lett,2011.0,CHEMBL1668019,CHEMBL1255794,9.40,0.0,http://www.openphacts.org/units/Nanomolar,1327561.0,=,1.0,1.0,=,IC50,nM,0.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.4,CHEMBL378
2650,15199955.0,[],CHEMBL3411834,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of surface antigen secretion by EIA,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)N[C@]1(C)CCC[C@@]2(C)[C@@H]3CC[C@@]4(C)C[C@]3(CC[C@@H]21)CC4=O,CHEMBL3407350,Bioorg Med Chem,2015.0,CHEMBL3409323,CHEMBL3409323,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,2287834.0,=,1.0,1.0,=,IC50,ug.mL-1,32.45,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,32.45,CHEMBL613497
2651,6152679.0,[],CHEMBL1763333,Inhibition of c-Jun,B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cccc3cnc(Nc4ccc5c(c4)OCO5)nc23)cn1,CHEMBL1759990,Bioorg Med Chem Lett,2011.0,CHEMBL1761572,CHEMBL1761572,6.20,0.0,http://www.openphacts.org/units/Nanomolar,1413788.0,=,1.0,1.0,=,IC50,nM,630.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.63,CHEMBL4977
2652,18044509.0,[],CHEMBL4010365,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of p24 antigen production pretreated with virus for 30 mins followed by 4 days incubation with cells by sandwich ELISA based multicycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(C(CCN(C)C)NC(=O)c2ccc(-c3cccc(Cl)c3)[nH]2)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4074344,CHEMBL4074344,4.89,0.0,http://www.openphacts.org/units/Nanomolar,2990204.0,=,1.0,1.0,=,IC50,nM,12800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.8,CHEMBL378
2653,3358048.0,[],CHEMBL1175765,Antiviral activity against HIV1 expressing reverse transcriptase G190A mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3Cl)CC2)ncc1Br,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1170005,CHEMBL1170005,8.74,0.0,http://www.openphacts.org/units/Nanomolar,922327.0,=,1.0,1.0,=,IC50,nM,1.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.8,CHEMBL378
2654,2927893.0,[],CHEMBL1044799,Antiviral activity against HIV1 NL4-3 infected in human TZM-b1 cells assessed as reduction in luciferase activity after 2 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCC(=O)N[C@@H](C)C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1154770,J Med Chem,2009.0,CHEMBL584985,CHEMBL584985,4.31,0.0,http://www.openphacts.org/units/Nanomolar,852850.0,=,1.0,1.0,=,IC50,nM,48900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,48.9,CHEMBL378
2655,2003497.0,[],CHEMBL901904,Antiviral activity against Vaccinia virus-infected Vero cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(-c2nc3cc(NC(=O)C45CC6CC(CC(C6)C4)C5)ccc3[nH]2)cc1)C12CC3CC(CC(C3)C1)C2,CHEMBL1138288,J Med Chem,2007.0,CHEMBL397884,CHEMBL397884,6.40,0.0,http://www.openphacts.org/units/Nanomolar,666650.0,=,1.0,1.0,=,IC50,nM,400.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,nM,UO_0000065,400.0,CHEMBL613493
2656,1158957.0,[],CHEMBL757806,Cytotoxicity against human peripheral blood mononuclear (PBM) cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@@H]2CS[C@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1126808,J Med Chem,1993.0,CHEMBL294690,CHEMBL294690,,0.0,http://www.openphacts.org/units/Nanomolar,100996.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2657,37591.0,[],CHEMBL695512,Antiviral activity against K103N/G190A strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL223228,CHEMBL223228,6.31,0.0,http://www.openphacts.org/units/Nanomolar,20823.0,=,1.0,1.0,=,IC50,nM,490.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,490.0,CHEMBL378
2658,2530529.0,[],CHEMBL1011336,Antiviral activity against Rift Valley fever virus infected in african green monkey Vero cells after 6 days by plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H]2c3cc4c(cc3C(=O)N[C@H]2[C@@H]1OC(C)=O)OCO4,CHEMBL1150051,J Nat Prod,1992.0,CHEMBL516115,CHEMBL516115,,0.0,,790654.0,,1.0,0.0,,IC50,,,CHEMBL613130,Rift Valley fever virus,Rift Valley fever virus,11588,IC50,,,,CHEMBL613130
2659,1470715.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,CCOCn1c(Cc2ccccc2)c(C(C)C)c(=O)[nH]c1=O,CHEMBL1138799,J Med Chem,2004.0,CHEMBL35033,CHEMBL35033,4.40,0.0,http://www.openphacts.org/units/Nanomolar,380792.0,=,1.0,1.0,=,IC50,nM,39810.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,39.81,CHEMBL378
2660,590524.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(S(=O)(=O)c2ccc(NC(=O)c3ccccc3SSc3ccccc3C(=O)Nc3ccc(S(=O)(=O)c4ccc(NC(=O)c5ccc([N+](=O)[O-])cc5)cc4)cc3)cc2)cc1)c1ccc([N+](=O)[O-])cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL262491,CHEMBL262491,,0.0,http://www.openphacts.org/units/Nanomolar,334044.0,>,1.0,1.0,>,IC50,nM,316000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,316.0,CHEMBL378
2661,922839.0,[],CHEMBL656269,Inhibition of human immunodeficiency virus-1 (HIV-1) induced cytopathicity in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1nnc2c(N)nc(N)nc21)OCP(=O)(O)O,CHEMBL1129435,J Med Chem,1996.0,CHEMBL132902,CHEMBL132902,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251944.0,=,1.0,1.0,=,IC50,ug.mL-1,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,30.0,CHEMBL378
2662,3014826.0,[],CHEMBL1050518,Antiviral activity against multidrug-resistant HIV1 isolate TM infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL1156053,J Med Chem,2009.0,CHEMBL116,CHEMBL116,6.50,0.0,http://www.openphacts.org/units/Nanomolar,862428.0,=,1.0,1.0,=,IC50,nM,320.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.32,CHEMBL378
2663,1476900.0,[],CHEMBL837273,Antiviral activity against human immunodeficiency virus type 1 by using MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(c1ccc([N+](=O)[O-])cc1)c1ccc2ccc(/C=C/c3ccc(O)c(O)c3)nc2c1O,CHEMBL1140355,Bioorg Med Chem Lett,2005.0,CHEMBL187452,CHEMBL187452,5.70,0.0,http://www.openphacts.org/units/Nanomolar,382700.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.0,CHEMBL378
2664,2387337.0,[],CHEMBL1006279,Antiviral activity against HIV1 NL4-3 in HeLaP4 reporter cell assessed as virus replication by FluorAceTM beta-galactosidase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1n[nH]c2ccc(F)c(Oc3cc(C#N)cc(C#N)c3)c12,CHEMBL1140926,J Med Chem,2009.0,CHEMBL473119,CHEMBL473119,7.85,0.0,http://www.openphacts.org/units/Nanomolar,728665.0,=,1.0,1.0,=,IC50,nM,14.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,14.0,CHEMBL378
2665,19450588.0,[],CHEMBL4433617,Antiviral activity against wild type HIV1 NL4-3 infected in human TZM-bl cells assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay based BiCycle assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(-c2ccc(OCc3cccc(C(=O)NCCCCNC(=O)c4ccc(COc5ccccc5-c5csc(N)n5)cc4)c3)cc2)cs1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4516510,CHEMBL4595392,5.30,0.0,http://www.openphacts.org/units/Nanomolar,3249750.0,=,1.0,1.0,=,IC50,nM,5000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.0,CHEMBL378
2666,385594.0,[],CHEMBL711617,Antiviral activity against HIV-1 IIIB induced cytopathic effect in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CN[C@@H](C(=O)N[C@H](C(=O)NCc2nc3ccccc3[nH]2)C(C)C)[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)OCc2ccccc2)C(C)C)cc1,CHEMBL1129607,J Med Chem,1996.0,CHEMBL318803,CHEMBL318803,7.54,0.0,http://www.openphacts.org/units/Nanomolar,210516.0,=,1.0,1.0,=,IC50,nM,29.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,29.0,CHEMBL378
2667,2550838.0,[],CHEMBL980249,Antiviral activity against HIV1 3B assessed as reverse transcriptase activity by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CCCN2[C@@H](CC1)C[C@]13CN4CCCC/C=C\CC[C@](O)(C=C(c5nccc6c5[nH]c5ccc(O)cc56)[C@@H]1CC4)[C@H]23,CHEMBL1142603,J Nat Prod,2006.0,CHEMBL502434,CHEMBL502434,,0.0,,786994.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2668,5189392.0,[],CHEMBL1659267,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 6 days by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/C(=O)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652531,CHEMBL1652531,,0.0,,1326906.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
2669,1202633.0,[],CHEMBL710537,Inhibitory activity against 188L strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2nc(Nc3ccc(C#N)cc3)ncc2Cl)c(C)c1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70271,CHEMBL70271,7.47,0.0,http://www.openphacts.org/units/Nanomolar,127442.0,=,1.0,1.0,=,IC50,nM,34.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.034,CHEMBL378
2670,13967482.0,[],CHEMBL3135326,Antiviral activity against wild type HIV1 VSVG infected in 293ET cells assessed as inhibition of viral replication by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1C(=O)Nc2ccc(Cl)cc2N1S(=O)(=O)c1cc(Cl)sc1-c1cnco1,CHEMBL3132804,Medchemcomm,2014.0,CHEMBL3133058,CHEMBL3133058,5.35,0.0,http://www.openphacts.org/units/Nanomolar,1974729.0,=,1.0,1.0,=,IC50,nM,4440.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.44,CHEMBL378
2671,1255328.0,[],CHEMBL693599,Concentration required to block the Nuclear translocation of HIV-1 pre-integration complex with Reverse Transcriptase protein; NA: Not Active,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1cc(Nc2cc(C)[n+](C)c(N)n2)cc(C(=O)OC)c1,CHEMBL1134938,Bioorg Med Chem Lett,2002.0,CHEMBL421592,CHEMBL421592,,0.0,http://www.openphacts.org/units/Nanomolar,197908.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,,CHEMBL378
2672,609285.0,[],CHEMBL712878,Concentration required for 50% protection of MT-4 cells against the cytopathic effect of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1ccc2[nH]c(=S)n3c2c1CN(CC=C(C)C)[C@@H](C)C3,CHEMBL1128253,J Med Chem,1995.0,CHEMBL423825,CHEMBL423825,7.02,0.0,http://www.openphacts.org/units/Nanomolar,327825.0,=,1.0,1.0,=,IC50,nM,95.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0959,CHEMBL378
2673,22806683.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@@H](Sc3cccc(OCc4ccc(F)cc4)c3)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4758670,CHEMBL4758670,6.69,0.0,http://www.openphacts.org/units/Nanomolar,3541927.0,=,1.0,1.0,=,IC50,nM,206.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.20600000000000002,CHEMBL613497
2674,10860663.0,[],CHEMBL2020780,Antiviral against R5 tropic HIV1 Bal infected in human CEMx174 5.25M7 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2)c2ccc(C)c(Cl)c2)CC1.Cl,CHEMBL2016501,Bioorg Med Chem Lett,2012.0,CHEMBL2017374,CHEMBL2021684,8.21,0.0,http://www.openphacts.org/units/Nanomolar,1634930.0,=,1.0,1.0,=,IC50,nM,6.17,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.17,CHEMBL378
2675,10961113.0,[],CHEMBL2061265,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M8 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)CCN2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057724,CHEMBL2057724,6.97,0.0,http://www.openphacts.org/units/Nanomolar,1655447.0,=,1.0,1.0,=,IC50,nM,107.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,107.0,CHEMBL378
2676,5188261.0,[],CHEMBL1664702,Antiviral activity against HIV1 LAI infected in human MT2 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CCO[C@H]3COC[C@H]32)cc1,CHEMBL1649426,J Med Chem,2011.0,CHEMBL1651158,CHEMBL1651158,,0.0,http://www.openphacts.org/units/Nanomolar,1324309.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
2677,1403184.0,[],CHEMBL837591,Inhibitory concentration against wild-type HIV-1 LAI Virus was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Oc2cn(C)c(=O)c(Nc3ccc(F)cc3)n2)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL176139,CHEMBL176139,5.90,0.0,http://www.openphacts.org/units/Nanomolar,360636.0,=,1.0,1.0,=,IC50,nM,1258.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,umol,UO_0000065,1.258,CHEMBL378
2678,18812942.0,[],CHEMBL4276411,Antiviral activity against amprenavir-resistant HIV1 infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2C[C@H]3OC(=O)N(CC(C)C)[C@H]3C2)cc1,CHEMBL4270667,J Med Chem,2018.0,CHEMBL4277539,CHEMBL4277539,6.51,0.0,http://www.openphacts.org/units/Nanomolar,3125921.0,=,1.0,1.0,=,IC50,nM,309.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,309.0,CHEMBL378
2679,3229734.0,[],CHEMBL1113200,Antiviral activity against recombinant HIV1 virus infected in human JC53BL cells after 3 days,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC1CN(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2,CHEMBL1154224,Bioorg Med Chem Lett,2009.0,CHEMBL1078753,CHEMBL1078753,7.54,0.0,http://www.openphacts.org/units/Nanomolar,898093.0,=,1.0,1.0,=,IC50,nM,29.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,29.0,CHEMBL378
2680,1401648.0,[],CHEMBL835178,In vitro inhibitory concentration against HIV-1 Y181C mutant strain; not determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Cc2c(C)c(C(C)C)[nH]c(=O)c2N(C)C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL368999,CHEMBL368999,,0.0,http://www.openphacts.org/units/Nanomolar,360347.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2681,1498110.0,[],CHEMBL833971,Concentration required to inhibit 50% viral production of human immunodeficiency virus type 1 (HIV-1-IIIB),F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C1=CC(=C(c2ccc(O)c(C(=O)O)c2)c2ccc(O)c(C(=O)O)c2)C=CC1=O,CHEMBL1143567,J Med Chem,2005.0,CHEMBL275938,CHEMBL275938,5.30,0.0,http://www.openphacts.org/units/Nanomolar,388038.0,=,1.0,1.0,=,IC50,nM,5000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.0,CHEMBL378
2682,607011.0,[],CHEMBL689615,Reduction of viral load in the cell supernatant.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2ccc(/C=C/c3cc(Br)c(O)c(Br)c3)nc2c1O,CHEMBL1135622,J Med Chem,2002.0,CHEMBL39301,CHEMBL39301,4.52,0.0,http://www.openphacts.org/units/Nanomolar,275310.0,=,1.0,1.0,=,IC50,nM,30000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,30.0,CHEMBL378
2683,23274479.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CCC(=O)NCCCNC(=O)CC[C@@H](C)[C@H]2CC[C@H]3[C@@H]4[C@@H](O)C[C@@H]5C[C@@H](CC[C@]5(C)[C@H]4CC[C@]23C)NC(=O)CCCC(=O)N[C@@H]2CC[C@@]3(C)[C@@H](C2)C[C@H](O)[C@@H]2[C@@H]3CC[C@]3(C)[C@@H]1CC[C@@H]23,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4872828,CHEMBL4872828,6.25,0.0,http://www.openphacts.org/units/Nanomolar,3621279.0,=,1.0,1.0,=,IC50,nM,564.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,564.0,CHEMBL613497
2684,18528866.0,[],CHEMBL4194999,Antiviral activity against HIV1 virions derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)N(c1cc(OC)c(OC)c(OC)c1)CCC2,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4202911,CHEMBL4202911,5.30,0.0,http://www.openphacts.org/units/Nanomolar,3076509.0,=,1.0,1.0,=,IC50,nM,4960.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.96,CHEMBL378
2685,600418.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(Cl)nc(Cc3c(Cl)cccc3Cl)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL72011,CHEMBL72011,5.97,0.0,http://www.openphacts.org/units/Nanomolar,126907.0,=,1.0,1.0,=,IC50,nM,1080.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.08,CHEMBL378
2686,2929749.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CN3CCSC3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL576592,CHEMBL576592,7.40,0.0,http://www.openphacts.org/units/Nanomolar,852783.0,=,1.0,1.0,=,IC50,nM,39.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,39.8,CHEMBL378
2687,18342078.0,[],CHEMBL4139011,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1ccc(-n2cc(C(=O)c3ccc(OC)cc3O)ccc2=O)cc1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL567965,CHEMBL567965,,0.0,http://www.openphacts.org/units/Nanomolar,3045884.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
2688,13476915.0,[],CHEMBL2439259,Antiviral activity against Human immunodeficiency virus 1 clade B isolate SF162 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(C(N)=O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435858,CHEMBL2435858,,0.0,,1924234.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2689,3383650.0,[],CHEMBL1211563,Antiviral activity against HIV1 NL-BAL infected in CCR5-expressing human JC53-BL cells assessed as inhibition of viral replication after 16 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1ccc(C(=O)N2C[C@H]3CN(CC[C@H](NC(C)=O)c4ccccc4)C[C@H]3C2)cc1,CHEMBL1208790,Bioorg Med Chem Lett,2010.0,CHEMBL1209304,CHEMBL1209304,7.72,0.0,http://www.openphacts.org/units/Nanomolar,927006.0,=,1.0,1.0,=,IC50,nM,19.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.0,CHEMBL378
2690,3407227.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1c(-c2ccc(F)cc2)oc2ccc(NC(C)=O)cc2c1=O,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1214742,CHEMBL1214742,,0.0,http://www.openphacts.org/units/Nanomolar,932341.0,=,1.0,1.0,=,IC50,nM,316900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,316.9,CHEMBL378
2691,672216.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,S=C(SSC(=S)C1CCC/C1=N\c1ccccc1)C1CCC/C1=N\c1ccccc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL332287,CHEMBL332287,,0.0,,228572.0,=,1.0,0.0,=,IC50,,155.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,155.0,CHEMBL378
2692,13355177.0,[],CHEMBL2400652,Antiviral activity against Cowpox virus infected in african green monkey Vero 76 cells assessed as inhibition of virus-induced cytopathic effect after 3 days by microscopic analysis,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](O)C[C@H]1C[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,CHEMBL2396569,Bioorg Med Chem,2013.0,CHEMBL2397387,CHEMBL2397387,,0.0,http://www.openphacts.org/units/Nanomolar,1902767.0,=,1.0,1.0,=,IC50,nM,223000.0,CHEMBL612672,Cowpox virus,Cowpox virus,10243,IC50,uM,UO_0000065,223.0,CHEMBL612672
2693,12680721.0,[],CHEMBL2342598,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)Nc3cc(C)ccc3C)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333696,CHEMBL2333696,,0.0,http://www.openphacts.org/units/Nanomolar,1867772.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
2694,153546.0,[],CHEMBL683691,Tested in vitro against human immunodeficiency virus (HIV) infected CEM cells using XTT assay (HIV-HRF strain),F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](Cn1cnc2c(O)nc(N)nc21)OCP(=O)(O)O,CHEMBL1126801,J Med Chem,1993.0,CHEMBL90793,CHEMBL90793,4.27,0.0,http://www.openphacts.org/units/Nanomolar,169349.0,=,1.0,1.0,=,IC50,nM,54000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,54.0,CHEMBL378
2695,745208.0,[],CHEMBL697274,Inhibition of the replication of human immunodeficiency virus (HIV) at 10 uM concentration,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2OCC/C=C/P(=O)(O)O,CHEMBL1126377,Bioorg Med Chem Lett,1992.0,CHEMBL27301,CHEMBL27301,5.00,0.0,http://www.openphacts.org/units/Nanomolar,63350.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
2696,10961166.0,[],CHEMBL2061267,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M10 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNc1ccccc1)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058320,CHEMBL2058320,,0.0,http://www.openphacts.org/units/Nanomolar,1656260.0,>,1.0,1.0,>,IC50,nM,400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,400.0,CHEMBL378
2697,5222719.0,[],CHEMBL1675436,Antiviral activity against HIV1 harboring reverse transcriptase D67N/K70R/T215F/K219Q mutant infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,[N-]=[N+]=N[C@H]1C[C@H](n2cnc3c(O)nc(N)nc32)O[C@@H]1CO,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL578448,CHEMBL578448,5.12,0.0,http://www.openphacts.org/units/Nanomolar,1332019.0,=,1.0,1.0,=,IC50,nM,7600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.6,CHEMBL378
2698,6200546.0,[],CHEMBL1781474,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 4 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,C[N+](C)([O-])CCc1c[nH]c2ccc(Cl)cc12,CHEMBL1777761,Bioorg Med Chem,2011.0,CHEMBL1779177,CHEMBL1779177,5.08,0.0,http://www.openphacts.org/units/Nanomolar,1425133.0,=,1.0,1.0,=,IC50,nM,8400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,8.4,CHEMBL613497
2699,283936.0,[],CHEMBL706841,Antiviral activity by observing cytopathic effect induced by HIV-1 strain IIIB in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)[C@@H](NCc1ccccc1)C(=O)N[C@H](C(=O)NC(C)(C)C)C(C)C,CHEMBL1127464,J Med Chem,1994.0,CHEMBL104648,CHEMBL104648,,0.0,http://www.openphacts.org/units/Nanomolar,195836.0,>,1.0,1.0,>,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3000.0,CHEMBL378
2700,2930201.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CN3CCC(C(N)=O)CC3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL573700,CHEMBL573700,8.00,0.0,http://www.openphacts.org/units/Nanomolar,848340.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
2701,391496.0,[],CHEMBL874634,Inhibition of human peripheral blood mononuclear cell (PBMC)donor C proliferation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCC(=O)CC(=O)N[C@H]1CCOC1=O,CHEMBL1145979,J Med Chem,2003.0,CHEMBL267527,CHEMBL267527,4.35,0.0,http://www.openphacts.org/units/Nanomolar,4356.0,=,1.0,1.0,=,IC50,nM,45000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,45.0,CHEMBL378
2702,2032177.0,[],CHEMBL886779,Inhibition of cytoplasmic HBV DNA synthesis in HepG2.2.15 cells after 8 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)Nc2ccc3nc(N)n(S(=O)(=O)C(C)C)c3c2)cc1,CHEMBL1139980,Eur J Med Chem,2007.0,CHEMBL250380,CHEMBL250380,5.32,0.0,http://www.openphacts.org/units/Nanomolar,674621.0,=,1.0,1.0,=,IC50,nM,4800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,4.8,CHEMBL613497
2703,2032176.0,[],CHEMBL886779,Inhibition of cytoplasmic HBV DNA synthesis in HepG2.2.15 cells after 8 days,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)S(=O)(=O)n1c(N)nc2ccc(NS(=O)(=O)c3cccc([N+](=O)[O-])c3)cc21,CHEMBL1139980,Eur J Med Chem,2007.0,CHEMBL401851,CHEMBL401851,4.98,0.0,http://www.openphacts.org/units/Nanomolar,674622.0,=,1.0,1.0,=,IC50,nM,10500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.5,CHEMBL613497
2704,24788549.0,[],CHEMBL5131652,Antiviral activity against wild-type HIV-1 in monocyte,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,CHEMBL5131375,J Med Chem,2022.0,CHEMBL14762,CHEMBL14762,9.44,0.0,http://www.openphacts.org/units/Nanomolar,3869388.0,=,1.0,1.0,=,IC50,nM,0.36,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.36,CHEMBL378
2705,19261831.0,[],CHEMBL4404357,Antiviral activity against HIV1 subtypeA Q259ENV.W6,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.34,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,460.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.46,CHEMBL378
2706,794718.0,[],CHEMBL772932,Inhibition of Hepatitis C virus NS3 protease in vitro.,B,BAO_0000190,BAO_0000357,single protein format,CC(C)COC(=O)N[C@H](C(=O)N1C[C@H](c2ccccc2)C[C@H]1C(=O)N[C@@H](CC(F)F)C(=O)NCCc1c(F)cc(C(=O)O)cc1F)C(C)C,CHEMBL1147550,Bioorg Med Chem Lett,2004.0,CHEMBL68034,CHEMBL68034,6.05,0.0,http://www.openphacts.org/units/Nanomolar,119344.0,=,1.0,1.0,=,IC50,nM,900.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,0.9,CHEMBL4620
2707,18044754.0,[],CHEMBL4010408,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype C CAP210.2.00.E8,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.21,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,610.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.61,CHEMBL378
2708,1438282.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cc(Br)cs1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL182299,CHEMBL182299,5.00,0.0,http://www.openphacts.org/units/Nanomolar,371562.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
2709,1402005.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCOC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL368039,CHEMBL368039,8.70,0.0,http://www.openphacts.org/units/Nanomolar,360360.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.002,CHEMBL378
2710,2099773.0,[],CHEMBL949219,Antiviral activity against HIV1 ASM80 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)N(CCCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nc4cc(S(C)(=O)=O)ccc42)C3)c2ccccc2)cc1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL402353,CHEMBL402353,,0.0,http://www.openphacts.org/units/Nanomolar,699394.0,>,1.0,1.0,>,IC50,nM,10000000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10000.0,CHEMBL378
2711,16544719.0,[],CHEMBL3789804,Antiviral activity against HIV1 virus-like particles harboring wild type reverse transcriptase infected in human U2OS cells after 24 hrs by Renilla luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(COC(=O)c2c[nH]c3ccccc23)nc(Cc2ccc(F)cc2)n1,CHEMBL3784952,Bioorg Med Chem,2016.0,CHEMBL3786482,CHEMBL3786482,,0.0,http://www.openphacts.org/units/Nanomolar,2769333.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
2712,2371522.0,[],CHEMBL1035738,Antiviral activity against HIV1 with reverse transcriptase L100I mutant in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ncccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL491019,CHEMBL491019,8.96,0.0,http://www.openphacts.org/units/Nanomolar,773465.0,=,1.0,1.0,=,IC50,nM,1.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.1,CHEMBL378
2713,3509192.0,[],CHEMBL1261044,Antiviral activity against HIV1 harboring reverse transcriptase K103N/L100I double mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cnc(NC2CCN(c3cccc(C(N)=O)c3)CC2)nc1Oc1c(C)cc(C#N)cc1Cl,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1258135,CHEMBL1258135,8.13,0.0,http://www.openphacts.org/units/Nanomolar,963083.0,=,1.0,1.0,=,IC50,nM,7.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.4,CHEMBL378
2714,936293.0,[],CHEMBL728516,Anti-HIV activity against HIV-1 IIIB chronically infected Molt-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2OC(F)F)CC1,CHEMBL1131862,Bioorg Med Chem Lett,1999.0,CHEMBL106279,CHEMBL106279,,0.0,http://www.openphacts.org/units/Nanomolar,194317.0,>,1.0,1.0,>,IC50,nM,60000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,60.0,CHEMBL378
2715,16544718.0,[],CHEMBL3789804,Antiviral activity against HIV1 virus-like particles harboring wild type reverse transcriptase infected in human U2OS cells after 24 hrs by Renilla luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCn1c(NCCN(CC)CC)nc2c1c(=O)[nH]c(=O)n2C,CHEMBL3784952,Bioorg Med Chem,2016.0,CHEMBL3786054,CHEMBL3786054,,0.0,http://www.openphacts.org/units/Nanomolar,2769484.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
2716,15602738.0,[],CHEMBL3578657,Inhibition of ASCT2-mediated [3H]glutamine uptake in HEK293 cells after 15 mins by Live-cell glutamine uptake assay,B,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(c2ccccc2NC(=O)CC[C@H](N)C(=O)O)CC1,CHEMBL3576761,Bioorg Med Chem Lett,2015.0,CHEMBL3576934,CHEMBL3576934,,0.0,,2479431.0,,1.0,0.0,,IC50,,,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,,,,CHEMBL3562162
2717,3406143.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc2oc(-c3ccccc3)cc(=O)c2c1,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1215529,CHEMBL1215529,,0.0,http://www.openphacts.org/units/Nanomolar,933273.0,=,1.0,1.0,=,IC50,nM,209100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,209.1,CHEMBL378
2718,6280912.0,[],CHEMBL1804135,Antiviral activity against HIV1 isolate NL4-3 harboring reverse transcriptase V106A/G190A/F227L mutant assessed as inhibition of viral replication by phenoscreen assay in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3cc(-c4ccncc4)[nH]n3)ccc2Cl)c1,CHEMBL1800064,Bioorg Med Chem Lett,2010.0,CHEMBL1801231,CHEMBL1801231,,0.0,http://www.openphacts.org/units/Nanomolar,1440340.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
2719,162146.0,[],CHEMBL683692,Tested in vitro against human immunodeficiency virus (HIV) infected CEM cells using XTT assay (HIV-HRF strain); NA = not active at 100 uM,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(O)c2ncn(C[C@@H](OCP(=O)(O)O)C3CC3)c2n1,CHEMBL1126801,J Med Chem,1993.0,CHEMBL93102,CHEMBL93102,,0.0,http://www.openphacts.org/units/Nanomolar,169343.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2720,259097.0,[],CHEMBL691105,Inhibition of cytopathogenicity against human HIV-1(IIIB) in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,COC1=C(OC)/C(=C/COP(=O)(O)COCCn2cnc3c(O)nc(N)nc32)OC1=O,CHEMBL1134666,J Med Chem,2001.0,CHEMBL124297,CHEMBL124297,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,233583.0,=,1.0,1.0,=,IC50,ug.mL-1,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,6.0,CHEMBL378
2721,287959.0,[],CHEMBL878453,The compound was evaluated for the inhibition of influenza virus (X-31),F,BAO_0000190,BAO_0000218,organism-based format,C=CC[C@@]1(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H](C(O)C(O)CO)O1,CHEMBL1126096,J Med Chem,1992.0,CHEMBL2111960,CHEMBL2111960,,0.0,http://www.openphacts.org/units/Nanomolar,269801.0,=,1.0,1.0,=,IC50,nM,10000000.0,CHEMBL613128,unidentified influenza virus,unidentified influenza virus,11309,IC50,mM,UO_0000065,10.0,CHEMBL613128
2722,1224900.0,[],CHEMBL710537,Inhibitory activity against 188L strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72335,CHEMBL72335,7.72,0.0,http://www.openphacts.org/units/Nanomolar,127434.0,=,1.0,1.0,=,IC50,nM,19.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.019,CHEMBL378
2723,2929535.0,[],CHEMBL1056896,Antiviral activity against HIV1 HXB2 harboring 179E mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL338047,CHEMBL338047,,0.0,,848385.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2724,2462125.0,[],CHEMBL965355,Antiviral activity against hepatitis B virus infected Hep G2.2.15 cells assessed as inhibition of HBeAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)OC1N=C(c2ccccc2F)c2cc(Cl)ccc2NC1=O,CHEMBL1157443,Bioorg Med Chem Lett,2008.0,CHEMBL453330,CHEMBL453330,,0.0,http://www.openphacts.org/units/Nanomolar,720922.0,=,1.0,1.0,=,IC50,nM,1220000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.22,CHEMBL613497
2725,2371548.0,[],CHEMBL1035746,Antiviral activity against HIV1 with reverse transcriptase K101E/G190A mutant in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4nc(N)ccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL489586,CHEMBL489586,8.00,0.0,http://www.openphacts.org/units/Nanomolar,773548.0,=,1.0,1.0,=,IC50,nM,10.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.1,CHEMBL378
2726,619397.0,[],CHEMBL710381,Inhibitory activity against 103N strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)c(Oc2ncnc(Nc3ccc(C#N)cc3)n2)c(Br)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL302542,CHEMBL302542,8.22,0.0,http://www.openphacts.org/units/Nanomolar,126919.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
2727,16449873.0,[],CHEMBL3757559,Inhibition of ASCT2-mediated glutamine transport in human HEK293 cells using [3H]-glutamine after 15 mins by scintillation counting,B,BAO_0000190,BAO_0000219,cell-based format,N[C@@H](CCN(Cc1ccccc1OCc1ccccc1Cl)Cc1ccccc1OCc1ccccc1Cl)C(=O)O,CHEMBL3751750,Bioorg Med Chem Lett,2016.0,CHEMBL3752316,CHEMBL3752316,4.40,0.0,http://www.openphacts.org/units/Nanomolar,2744499.0,=,1.0,1.0,=,IC50,nM,40100.0,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,uM,UO_0000065,40.1,CHEMBL3562162
2728,847414.0,[],CHEMBL686566,Anti-HIV activity in H9 lymphocytes.,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@@H]1[C@H](OC(=O)C23CCC(C)(C(=O)O2)C3(C)C)c2c(ccc3c(C)cc(=O)oc23)OC1(C)C,CHEMBL1132174,J Med Chem,1999.0,CHEMBL315869,CHEMBL315869,,0.0,http://www.openphacts.org/units/Nanomolar,163831.0,=,1.0,1.0,=,IC50,nM,123000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,123.0,CHEMBL378
2729,1402287.0,[],CHEMBL834487,In vitro inhibitory concentration value against HIV K103N and Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NCc2ccccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177491,CHEMBL177491,,0.0,http://www.openphacts.org/units/Nanomolar,360417.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2730,405209.0,[],CHEMBL729931,Inhibitory concentration required against Monkeypox virus in Vero cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2C[C@@H]1COP(=O)(O)CO1,CHEMBL1147452,Bioorg Med Chem Lett,2004.0,CHEMBL114867,CHEMBL114867,,0.0,http://www.openphacts.org/units/Nanomolar,214243.0,>,1.0,1.0,>,IC50,nM,350000.0,CHEMBL613120,Monkeypox virus,Monkeypox virus,10244,IC50,uM,UO_0000065,350.0,CHEMBL613120
2731,1486780.0,[],CHEMBL833976,Inhibitory concentration against wild type human immunodeficiency virus type 1 was determined by recombinant virus assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)c1c(OC#CC2CC2)c2cc(F)ccc2[nH]c1=O,CHEMBL1138845,J Med Chem,2004.0,CHEMBL365845,CHEMBL365845,8.00,0.0,http://www.openphacts.org/units/Nanomolar,384099.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
2732,17720031.0,[],CHEMBL3887547,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,BAO_0000190,BAO_0000357,single protein format,C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1,CHEMBL3886356,,2015.0,CHEMBL3647967,CHEMBL3647967,5.47,1.0,http://www.openphacts.org/units/Nanomolar,2848961.0,=,37.0,1.0,=,IC50,nM,3346.0,CHEMBL3982,Homo sapiens,Tyrosine-protein kinase FER,9606,IC50,nM,UO_0000065,3346.0,CHEMBL3982
2733,18323355.0,[],CHEMBL4134874,Antiviral activity against VSV-G pseudotyped HIV1 infected in human SupT1 cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C/C(=C\CC/C(C)=C/C[C@]1(O)C(=O)c2c(O)cc(C)c3c(O)c(C)c(O)c(c23)C1=O)CC/C=C(\CC[C@@H](O)C(C)(C)O)C(=O)O,CHEMBL4130477,J Nat Prod,2017.0,CHEMBL4160927,CHEMBL4160927,4.49,0.0,http://www.openphacts.org/units/Nanomolar,3042086.0,=,1.0,1.0,=,IC50,nM,32600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,32.6,CHEMBL378
2734,2987755.0,[],CHEMBL1050601,Antiviral activity against Hepatitis B virus infected HepG2(2.2.15) cells assessed as inhibition of viral cytoplasmic DNA synthesis by real-time PCR,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)[C@H](C(C)C)N1CCCO[P@]1(=O)COCCn1cnc2c(N)ncnc21.O=C(O)/C=C/C(=O)O,CHEMBL1156738,Bioorg Med Chem Lett,2009.0,CHEMBL566630,CHEMBL1197310,6.92,0.0,http://www.openphacts.org/units/Nanomolar,863156.0,=,1.0,1.0,=,IC50,nM,120.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.12,CHEMBL613497
2735,1402033.0,[],CHEMBL833792,In vitro inhibitory concentration against HIV-1 Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCCCO)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL176107,CHEMBL176107,6.90,0.0,http://www.openphacts.org/units/Nanomolar,360364.0,=,1.0,1.0,=,IC50,nM,126.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.126,CHEMBL378
2736,600423.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,CONc1nc(Cc2c(Cl)cccc2Cl)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL419252,CHEMBL419252,8.21,0.0,http://www.openphacts.org/units/Nanomolar,126900.0,=,1.0,1.0,=,IC50,nM,6.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0062,CHEMBL378
2737,2929571.0,[],CHEMBL1056893,Antiviral activity against HIV1 HXB2 harboring 101E mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3ncnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL574163,CHEMBL574163,8.48,0.0,http://www.openphacts.org/units/Nanomolar,848359.0,=,1.0,1.0,=,IC50,nM,3.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.3,CHEMBL378
2738,15606372.0,[],CHEMBL3579358,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C=C/C(=O)O)cc1OC,CHEMBL3576819,Eur J Med Chem,2015.0,CHEMBL320295,CHEMBL320295,,0.0,http://www.openphacts.org/units/Nanomolar,2480517.0,>,1.0,1.0,>,IC50,nM,600000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,600.0,CHEMBL613497
2739,22898320.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731094,Antiviral activity against HIV1 DRVR P51 infected in human MT4 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(=O)O[C@H]1C2CO[C@H]3OC[C@@H]1C3C2)S(=O)(=O)c1ccc2nc(NC3CC3)sc2c1,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL4755541,CHEMBL4755541,8.30,0.0,http://www.openphacts.org/units/Nanomolar,3554419.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.0,CHEMBL378
2740,1471845.0,[],CHEMBL834620,Inhibitory activity against HIV-1 mutant strain 188L; ND = not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1ccc(C#N)cc1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL363762,CHEMBL363762,,0.0,http://www.openphacts.org/units/Nanomolar,380741.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2741,18044769.0,[],CHEMBL4010414,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype D QD435.100M.ENV.E1,F,BAO_0000190,BAO_0000019,assay format,Cc1nc(C(NC(=O)c2ccc(-c3ccc(Cl)cc3)[nH]2)C2CCCCN2)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4096918,CHEMBL4096918,5.64,0.0,http://www.openphacts.org/units/Nanomolar,2990237.0,=,1.0,1.0,=,IC50,nM,2300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.3,CHEMBL378
2742,18320085.0,[],CHEMBL4134181,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA level incubated for 3 days followed by medium replacement measured after 3 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C2CNCCN2C(c2nccs2)=NC1c1ccc(F)cc1Br,CHEMBL4130455,ACS Med Chem Lett,2017.0,CHEMBL4173708,CHEMBL4173708,5.03,0.0,http://www.openphacts.org/units/Nanomolar,3041680.0,=,1.0,1.0,=,IC50,nM,9300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,9.3,CHEMBL613497
2743,15568223.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(F)cc1)N1CCN(S(=O)(=O)c2cccc(Br)c2)CC1,CHEMBL1201862,,,CHEMBL3560750,CHEMBL3560750,7.76,0.0,http://www.openphacts.org/units/Nanomolar,2475492.0,=,7.0,1.0,=,IC50,nM,17.5,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.0175,CHEMBL3259470
2744,3603769.0,[],CHEMBL1291724,Antiviral activity against Hepatitis B virus infected in HepG2.2.15 assessed as inhibition of HBsAg production at <2183.1 +/- 4.1 by EIA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(SCc2nc3c(Cn4ccnc4C)c(O)ccc3n2C)cc1,CHEMBL1287795,Bioorg Med Chem Lett,2010.0,CHEMBL1288081,CHEMBL1288081,,0.0,,973092.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
2745,2414468.0,[],CHEMBL953484,Antiviral activity against HIV1 with reverse transcriptase L100I mutation in human CEM cells assessed as protection against virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCC(N)=O)[nH]c3ccc(Cl)cc23)c1,CHEMBL1153955,J Med Chem,2009.0,CHEMBL126603,CHEMBL126603,8.10,0.0,http://www.openphacts.org/units/Nanomolar,810400.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.0,CHEMBL378
2746,15568211.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(F)cc1)N1CCN(S(=O)(=O)c2ccc([N+](=O)[O-])cc2)CC1,CHEMBL1201862,,,CHEMBL3560431,CHEMBL3560431,7.89,0.0,http://www.openphacts.org/units/Nanomolar,2474959.0,=,7.0,1.0,=,IC50,nM,12.9,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.0129,CHEMBL3259470
2747,609110.0,[],CHEMBL710381,Inhibitory activity against 103N strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)cc(C)c1Oc1nc(N)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL302791,CHEMBL302791,8.10,0.0,http://www.openphacts.org/units/Nanomolar,126912.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
2748,2243662.0,[],CHEMBL998762,Growth inhibition of HIV1 3B infected human MOLT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,CHEMBL1156591,Bioorg Med Chem Lett,2008.0,CHEMBL501042,CHEMBL501042,4.47,0.0,http://www.openphacts.org/units/Nanomolar,796396.0,=,1.0,1.0,=,IC50,nM,34000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,34.0,CHEMBL378
2749,1690581.0,[],CHEMBL858236,Inhibition of replication of R5 HIV1 HKW in PMBC,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1.CS(=O)(=O)O,CHEMBL1139007,J Med Chem,2006.0,CHEMBL2105686,CHEMBL2110727,10.31,0.0,http://www.openphacts.org/units/Nanomolar,438963.0,=,1.0,1.0,=,IC50,nM,0.049,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.049,CHEMBL378
2750,19261965.0,[],CHEMBL4404403,Antiviral activity against HIV1 subtypeD QA013.70I.ENV.H1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.60,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.25,CHEMBL378
2751,6152677.0,[],CHEMBL1763333,Inhibition of c-Jun,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2cccc3cnc(Nc4ccc(-n5cnc(-c6ccccn6)n5)cc4)nc23)cc1F,CHEMBL1759990,Bioorg Med Chem Lett,2011.0,CHEMBL1761570,CHEMBL1761570,5.29,0.0,http://www.openphacts.org/units/Nanomolar,1413786.0,=,1.0,1.0,=,IC50,nM,5100.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,5.1,CHEMBL4977
2752,18940432.0,[],CHEMBL4328848,Antiviral activity against HIV-1 3B infected in human MAGI-CXCR4 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(CNc2cccc(-c3ccc4ccn(Cc5cccc(C(=O)O)c5)c4c3)c2)c1,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4437889,CHEMBL4437889,,0.0,http://www.openphacts.org/units/Nanomolar,3159833.0,>,1.0,1.0,>,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
2753,10961236.0,[],CHEMBL2061272,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M7 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCNC=C1C(=O)Nc2ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)cc21,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057471,CHEMBL2057471,8.30,0.0,http://www.openphacts.org/units/Nanomolar,1655133.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.0,CHEMBL378
2754,6327115.0,[],CHEMBL1821353,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as reduction in HBeAg antigen secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1cc2c(c([C@H](C)O)c1)CCOC2=O,CHEMBL1817662,J Nat Prod,2011.0,CHEMBL1817920,CHEMBL1817920,,0.0,http://www.openphacts.org/units/Nanomolar,1449977.0,>,1.0,1.0,>,IC50,nM,2690000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.69,CHEMBL613497
2755,1834533.0,[],CHEMBL909294,Antiviral activity against HIV1 isolate 5512 with M36I/M and V82T mutation in CBMCs,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL1142192,Antimicrob Agents Chemother,2007.0,CHEMBL116,CHEMBL116,8.52,0.0,http://www.openphacts.org/units/Nanomolar,625899.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
2756,18940392.0,[],CHEMBL4328847,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cn1cc2ccc(-c3ccc4ccn(Cc5cc(F)cc(C(=O)O)c5)c4c3)cc2n1,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4456878,CHEMBL4456878,4.85,0.0,http://www.openphacts.org/units/Nanomolar,3159827.0,=,1.0,1.0,=,IC50,nM,14000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,14.0,CHEMBL378
2757,2413699.0,[],CHEMBL987710,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)c1ccc(Cl)cc1)[C@@H](OC(=O)c1ccc(Cl)cc1)C(C)(C)O)C1=C2C[C@H](OC(=O)c3ccc(Cl)cc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL450168,CHEMBL450168,,0.0,http://www.openphacts.org/units/Nanomolar,810687.0,>,1.0,1.0,>,IC50,nM,900000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.9,CHEMBL613497
2758,1751245.0,[],CHEMBL854523,Antiviral activity against wild type Measles virus Edmonston in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)c1cc(NC(=O)Cc2ccccc2)cc([N+](=O)[O-])c1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL215469,CHEMBL215469,5.43,0.0,http://www.openphacts.org/units/Nanomolar,532810.0,=,1.0,1.0,=,IC50,nM,3700.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,3.7,CHEMBL613738
2759,2930166.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CN3CCOC(CCO)C3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL575458,CHEMBL575458,8.80,0.0,http://www.openphacts.org/units/Nanomolar,848354.0,=,1.0,1.0,=,IC50,nM,1.58,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.58,CHEMBL378
2760,2099830.0,[],CHEMBL949222,Antiviral activity against HIV1 RU570 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)N(CCCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nc4c2CCN(C(=O)C2CC2)C4)C3)c2ccccc2)cc1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL402396,CHEMBL402396,8.70,0.0,http://www.openphacts.org/units/Nanomolar,699403.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.002,CHEMBL378
2761,3383655.0,[],CHEMBL1211563,Antiviral activity against HIV1 NL-BAL infected in CCR5-expressing human JC53-BL cells assessed as inhibition of viral replication after 16 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C(=O)N[C@@H](CCN1C[C@@H]2CN(C(=O)c3ccccc3)C[C@@H]2C1)c1ccccc1,CHEMBL1208790,Bioorg Med Chem Lett,2010.0,CHEMBL1209240,CHEMBL1209240,8.10,0.0,http://www.openphacts.org/units/Nanomolar,926929.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.0,CHEMBL378
2762,2930455.0,[],CHEMBL1056902,Antiviral activity against HIV1 HXB2 harboring K103N and Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL366692,CHEMBL366692,6.80,0.0,http://www.openphacts.org/units/Nanomolar,848229.0,=,1.0,1.0,=,IC50,nM,158.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,158.0,CHEMBL378
2763,2929578.0,[],CHEMBL1056892,Antiviral activity against HIV1 HXB2 harboring 100I mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCSCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578367,CHEMBL578367,8.10,0.0,http://www.openphacts.org/units/Nanomolar,852822.0,=,1.0,1.0,=,IC50,nM,7.94,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.94,CHEMBL378
2764,5249062.0,[],CHEMBL1685193,Antiviral activity against X4 tropic HIV1 NL4.3 infected in CD4 and CXCR4 expressing human MT4 cells assessed as inhibition of viral cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cnc(CN(CCCCN)[C@H]2CCCc3cccnc32)c(C)c1,CHEMBL1681661,Bioorg Med Chem Lett,2011.0,CHEMBL1682995,CHEMBL1682995,8.11,0.0,http://www.openphacts.org/units/Nanomolar,1334130.0,=,1.0,1.0,=,IC50,nM,7.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.7,CHEMBL378
2765,547019.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(Sc2cccc(N)c2C#N)c1,CHEMBL1134494,J Med Chem,2001.0,CHEMBL51738,CHEMBL51738,5.22,0.0,http://www.openphacts.org/units/Nanomolar,94189.0,=,1.0,1.0,=,IC50,nM,6000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.0,CHEMBL378
2766,647637.0,[],CHEMBL713945,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1CCn2c(O)nc3cc(Cl)cc(c32)C1CC(C)C,CHEMBL1128252,J Med Chem,1995.0,CHEMBL164691,CHEMBL164691,,0.0,http://www.openphacts.org/units/Nanomolar,326406.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.0,CHEMBL378
2767,24502940.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5053572,Antiviral activity against HIV1 NL4-3 Env-deficient pseudotype virus infected in human U87.CD4.CCR5.CXCR4 cells assessed by reduction in viral infection in early stage measured after 48 hrs by luciferase activity based single-round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C(=O)[C@@H](Cc1ccccc1)NC(=O)Cc1n[nH]c2c(N)cccc12)c1ccc2[nH]ncc2c1,CHEMBL5053482,J Med Chem,2021.0,CHEMBL5079384,CHEMBL5079384,,0.0,,3836466.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2768,6326492.0,[],CHEMBL1821352,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as reduction in HBsAg antigen secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)/C=C/c1cccc2c1CCOC2=O,CHEMBL1817662,J Nat Prod,2011.0,CHEMBL1817922,CHEMBL1817922,,0.0,http://www.openphacts.org/units/Nanomolar,1449979.0,>,1.0,1.0,>,IC50,nM,1440000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.44,CHEMBL613497
2769,1402527.0,[],CHEMBL837469,In vitro inhibitory concentration against HIV V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL57,CHEMBL57,5.30,0.0,http://www.openphacts.org/units/Nanomolar,360370.0,=,1.0,1.0,=,IC50,nM,5012.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.012,CHEMBL378
2770,228884.0,[],CHEMBL691099,In vitro antiviral activity against NNRTI-resistant R88703R-IIIB (Y181C) HIV-1 variant,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1131332,J Med Chem,1998.0,CHEMBL593,CHEMBL593,6.00,0.0,http://www.openphacts.org/units/Nanomolar,41263.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
2771,1470594.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCOCn1c(Cc2ccccc2)c(C(C)C)c(=O)[nH]c1=O,CHEMBL1138799,J Med Chem,2004.0,CHEMBL35033,CHEMBL35033,8.10,0.0,http://www.openphacts.org/units/Nanomolar,380792.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
2772,5294496.0,[],CHEMBL1696700,Antiviral activity against HIV1 subtype C 92BR025 infected in human PBMC assessed as inhibition of viral replication by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(CC)[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,CHEMBL1687706,Antimicrob Agents Chemother,2008.0,CHEMBL1651956,CHEMBL1651956,7.82,0.0,http://www.openphacts.org/units/Nanomolar,1337219.0,=,1.0,1.0,=,IC50,nM,15.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.015,CHEMBL378
2773,2570691.0,[],CHEMBL1000472,Antiviral activity against hepatitis B virus-infected human HepG2.2.15 cells assessed as inhibition of HBV surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@H](OC(C)=O)[C@H](C[C@@H](C)[C@]12CC[C@@]3(C)[C@@]1(C[C@H](OC(C)=O)[C@H]1[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@@]13C)O2)OC(C)=O,CHEMBL1155923,Bioorg Med Chem Lett,2008.0,CHEMBL450426,CHEMBL450426,4.62,0.0,http://www.openphacts.org/units/Nanomolar,769066.0,=,1.0,1.0,=,IC50,nM,24000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.024,CHEMBL613497
2774,6280171.0,[],CHEMBL1805974,Antiviral activity against HIV1 isolate NL4-3 harboring reverse transcriptase L100I mutant assessed as inhibition of viral replication by phenoscreen assay in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3cc(-c4ccncc4)[nH]n3)ccc2Cl)c1,CHEMBL1800064,Bioorg Med Chem Lett,2010.0,CHEMBL1801231,CHEMBL1801231,7.66,0.0,http://www.openphacts.org/units/Nanomolar,1440340.0,=,1.0,1.0,=,IC50,nM,21.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0219,CHEMBL378
2775,1403519.0,[],CHEMBL834758,Inhibitory concentration against 188L mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Sc2cn(C)c(=O)c(Nc3ccc(Cl)cc3)n2)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL175765,CHEMBL175765,5.00,0.0,http://www.openphacts.org/units/Nanomolar,360654.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
2776,2601928.0,[],CHEMBL1034012,Antiviral activity against influenza virus,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)/C(O)=C/C(=O)c1ccc(C2CCCCC2)cc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL498902,CHEMBL498902,5.30,0.0,http://www.openphacts.org/units/Nanomolar,807204.0,=,1.0,1.0,=,IC50,nM,5000.0,CHEMBL613128,unidentified influenza virus,unidentified influenza virus,11309,IC50,uM,UO_0000065,5.0,CHEMBL613128
2777,12680751.0,[],CHEMBL2342599,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(NC(=O)/C=C/c2coc3cc(OC)ccc3c2=O)cc1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333679,CHEMBL2333679,,0.0,http://www.openphacts.org/units/Nanomolar,1867755.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
2778,24421207.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5048799,Antiviral activity against HIV-1 Z1800M E4.02 (R5) pseudovirus infected in human TZM-blcells assessed as reduction in viral infectivity measured after 48 hrs of postinfection by luminescence assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(CCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21)C1CCOCC1,CHEMBL5046278,J Med Chem,2022.0,CHEMBL5077132,CHEMBL5077132,,0.0,http://www.openphacts.org/units/Nanomolar,3784600.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10000.0,CHEMBL378
2779,15666367.0,[],CHEMBL3602699,Antiviral activity against HIV-1 SF162 pseudovirus infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL3600303,J Med Chem,2015.0,CHEMBL411406,CHEMBL411406,8.30,0.0,http://www.openphacts.org/units/Nanomolar,2492336.0,=,1.0,1.0,=,IC50,nM,4.98,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.98,CHEMBL378
2780,11014409.0,[],CHEMBL2089834,Antiviral activity against HIV1 in human TZM-bl cells assessed as viral infectivity by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(CO)[C@H](O)CC[C@@]2(C)[C@@H]1C/C=C1/C(=O)OC[C@H]1OC(=O)c1ccccc1O,CHEMBL2086289,Eur J Med Chem,2012.0,CHEMBL2088493,CHEMBL2088493,4.07,0.0,http://www.openphacts.org/units/Nanomolar,1675630.0,=,1.0,1.0,=,IC50,nM,84240.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,84.24,CHEMBL378
2781,508990.0,[],CHEMBL694654,Inhibitory concentration against HIV-1 IIIB strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC=O)c1Cc1cc(C)cc(C)c1,CHEMBL1133473,J Med Chem,2000.0,CHEMBL338936,CHEMBL338936,8.74,0.0,http://www.openphacts.org/units/Nanomolar,245543.0,=,1.0,1.0,=,IC50,nM,1.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.8,CHEMBL378
2782,32595.0,[],CHEMBL691108,Antiviral activity towards inhibition of HIV-1 replication using monocyte-derived macrophage infected by the HIV-1/Ba-L strain.,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(C(=O)N2CCN(C(=O)c3cc(OC)c(OC)c(OC)c3)C(COC(=O)N3CCCCC3)C2)cc(OC)c1OC,CHEMBL1133726,J Med Chem,2000.0,CHEMBL308930,CHEMBL308930,4.02,0.0,http://www.openphacts.org/units/Nanomolar,119296.0,=,1.0,1.0,=,IC50,nM,95000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,95.0,CHEMBL378
2783,18202891.0,[],CHEMBL4043732,Antiviral activity against HIV-1 NL4-3 harboring reverse transcriptase K103N mutant infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2cc3ccccc3n2C)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4061932,CHEMBL4061932,5.42,0.0,http://www.openphacts.org/units/Nanomolar,3019978.0,=,1.0,1.0,=,IC50,nM,3840.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.84,CHEMBL378
2784,880491.0,[],CHEMBL683811,Antiviral activity against HIV-1 using antiinfectivity assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)[C@H]1NCc1ccccc1,CHEMBL1134695,Bioorg Med Chem Lett,2001.0,CHEMBL293069,CHEMBL293069,6.66,0.0,http://www.openphacts.org/units/Nanomolar,100519.0,=,1.0,1.0,=,IC50,nM,218.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,218.0,CHEMBL378
2785,12528675.0,[],CHEMBL3078221,Antiviral activity against HIV1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,[O-]c1on[n+](-c2ccc(Cc3ccc(-[n+]4noc([O-])c4CN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)cc2)c1CN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL3044741,Med Chem Res,2013.0,CHEMBL2282180,CHEMBL2282180,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824339.0,>,1.0,1.0,>,IC50,ug.mL-1,20.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,20.8,CHEMBL378
2786,2670840.0,[],CHEMBL1035389,Antiviral activity against LASV infected in human A549 cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CN2C(=O)CN(C(=O)c3cc4ccccc4[nH]3)CC2CCc2ccccc2)cc1,CHEMBL1151924,Bioorg Med Chem Lett,2009.0,CHEMBL550698,CHEMBL550698,5.77,0.0,http://www.openphacts.org/units/Nanomolar,820608.0,=,1.0,1.0,=,IC50,nM,1700.0,CHEMBL615051,Lassa virus,Lassa virus,11620,IC50,uM,UO_0000065,1.7,CHEMBL615051
2787,3076987.0,[],CHEMBL1067297,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CCCC2=C1C(c1ccc(F)cc1Cl)N=C(c1cnccn1)N2,CHEMBL1153099,Bioorg Med Chem Lett,2010.0,CHEMBL594569,CHEMBL594569,5.64,0.0,http://www.openphacts.org/units/Nanomolar,877093.0,=,1.0,1.0,=,IC50,nM,2300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.3,CHEMBL613497
2788,1755827.0,[],CHEMBL864208,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(NC(=O)CSc2nnc(C)n2-c2ccc(C)cc2)c1,CHEMBL1146046,Bioorg Med Chem Lett,2006.0,CHEMBL213293,CHEMBL213293,,0.0,http://www.openphacts.org/units/Nanomolar,545159.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
2789,18202593.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2cc3ccccc3s2)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4083051,CHEMBL4083051,6.41,0.0,http://www.openphacts.org/units/Nanomolar,3019994.0,=,1.0,1.0,=,IC50,nM,390.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.39,CHEMBL378
2790,22401098.0,[],CHEMBL4669579,Antiviral activity against Zika virus,F,BAO_0000190,BAO_0000218,organism-based format,COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2,CHEMBL4665744,J Nat Prod,2020.0,CHEMBL866,CHEMBL866,9.49,0.0,http://www.openphacts.org/units/Nanomolar,3509398.0,=,1.0,1.0,=,IC50,nM,0.32,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,nM,UO_0000065,0.32,CHEMBL4296612
2791,2930153.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSCc3cccs3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL566761,CHEMBL566761,9.00,0.0,http://www.openphacts.org/units/Nanomolar,852781.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
2792,15666385.0,[],CHEMBL3602696,Antiviral activity against HIV1 NL4-3 pseudovirus infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)O,CHEMBL3600303,J Med Chem,2015.0,CHEMBL3600954,CHEMBL3600954,7.72,0.0,http://www.openphacts.org/units/Nanomolar,2492335.0,=,1.0,1.0,=,IC50,nM,18.88,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,18.88,CHEMBL378
2793,5189226.0,[],CHEMBL1658800,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/c1ccccc1)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652521,CHEMBL1652521,4.25,0.0,http://www.openphacts.org/units/Nanomolar,1326896.0,=,1.0,1.0,=,IC50,nM,56000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.056,CHEMBL613497
2794,23153192.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4810870,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 production treated at 48 hrs post-infection and measured on day 4 post-viral infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1=C[C@H]2[C@@]3(O)[C@H](C)[C@@H](O)[C@]4(OC(=O)/C=C/c5ccccc5)[C@H]([C@@H]3C=C(CO)C[C@]2(O)C1=O)C4(C)C,CHEMBL4808236,Bioorg Med Chem Lett,2021.0,CHEMBL4853598,CHEMBL4853598,,0.0,http://www.openphacts.org/units/Nanomolar,3599000.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10000.0,CHEMBL378
2795,1402238.0,[],CHEMBL837468,In vitro inhibitory concentration against HIV L100I mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCCNc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175925,CHEMBL175925,,0.0,http://www.openphacts.org/units/Nanomolar,360394.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2796,615361.0,[],CHEMBL710381,Inhibitory activity against 103N strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Sc2nc(N)nc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL73939,CHEMBL73939,8.22,0.0,http://www.openphacts.org/units/Nanomolar,126897.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
2797,181969.0,[],CHEMBL844823,Antiviral activity against sindbus virus,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](O[N+](=O)[O-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1136729,J Med Chem,2003.0,CHEMBL3144334,CHEMBL3144334,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,577.0,>,1.0,1.0,>,IC50,ug.mL-1,80.0,CHEMBL613725,Sindbis virus,Sindbis virus,11034,IC50,ug ml-1,UO_0000274,80.0,CHEMBL613725
2798,2602140.0,[],CHEMBL1033990,Antiviral activity against Hepatitis B virus,F,BAO_0000190,BAO_0000218,organism-based format,NC1C=CN(/C=C2\CC2(F)CO)C(=O)N1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL504176,CHEMBL504176,4.70,0.0,http://www.openphacts.org/units/Nanomolar,807410.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,20.0,CHEMBL613497
2799,6152683.0,[],CHEMBL1763333,Inhibition of c-Jun,B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cccc3cnc(N[C@H]4CC[C@@H](C(=O)N5CCCC5)CC4)nc23)cn1,CHEMBL1759990,Bioorg Med Chem Lett,2011.0,CHEMBL1761576,CHEMBL1761576,5.52,0.0,http://www.openphacts.org/units/Nanomolar,1413792.0,=,1.0,1.0,=,IC50,nM,3000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,3.0,CHEMBL4977
2800,2602034.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)c2c(C(=O)NN)[nH]c3ccc(Cl)cc23)cc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL419108,CHEMBL419108,7.30,0.0,http://www.openphacts.org/units/Nanomolar,807030.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.05,CHEMBL378
2801,10911779.0,[],CHEMBL2038372,Antiviral activity against multidrug-resistant HIV1 clade B 4775-5 clinical isolate infected in PHA-P-stimulated human PBMC assessed as reverse transcriptase activity incubated for 6 hrs followed by incubated in drug-free medium for 6 days by multiround infection assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)CC[C@H](NC(=O)CCC(=O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3F)C(=O)OC[C@@H]3O[C@H](n4ccc(N)nc4=O)CS3)O2)c(=O)[nH]c1=O,CHEMBL2034836,J Med Chem,2012.0,CHEMBL2035198,CHEMBL2035198,8.23,0.0,http://www.openphacts.org/units/Nanomolar,1644927.0,=,1.0,1.0,=,IC50,nM,5.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.9,CHEMBL378
2802,2203583.0,[],CHEMBL987023,Antiviral activity against HIV1 3B in human MT4 cells assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCNC(=S)Nc1ccc(-c2n[nH]c(=S)n2CC)cc1,CHEMBL1149790,Eur J Med Chem,2008.0,CHEMBL495452,CHEMBL495452,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,765675.0,>,1.0,1.0,>,IC50,ug.mL-1,2.58,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,2.58,CHEMBL378
2803,609109.0,[],CHEMBL710373,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)cc(C)c1Oc1nc(N)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL302791,CHEMBL302791,6.88,0.0,http://www.openphacts.org/units/Nanomolar,126912.0,=,1.0,1.0,=,IC50,nM,133.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.133,CHEMBL378
2804,3104734.0,[],CHEMBL1065873,Antiviral activity against multi drug-resistant HIV1 isolate of subtype JSL in PHA-stimulated human PBMC assessed as inhibition of p24 antigen production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL1159037,Bioorg Med Chem Lett,2010.0,CHEMBL116,CHEMBL116,6.28,0.0,http://www.openphacts.org/units/Nanomolar,883253.0,=,1.0,1.0,=,IC50,nM,531.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.531,CHEMBL378
2805,1402140.0,[],CHEMBL835252,In vitro inhibitory concentration against HIV K101E and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCOC)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177275,CHEMBL177275,7.00,0.0,http://www.openphacts.org/units/Nanomolar,360374.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
2806,18775499.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCC1Cc2cc(OCC3CC3)c(OC)cc2-c2cc(=O)c(C(=O)O)cn21,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4290772,CHEMBL4290772,7.82,0.0,http://www.openphacts.org/units/Nanomolar,3119657.0,=,1.0,1.0,=,IC50,nM,15.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.015,CHEMBL613497
2807,24780237.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5129319,Antiviral activity against Zika virus H/PAN/2016/BEI-259634 infected in African green monkey Vero cells assessed as reduction in viral titer incubated for 3 days by plaque assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,CHEMBL5126587,Bioorg Med Chem,2022.0,CHEMBL1643,CHEMBL1643,4.52,0.0,http://www.openphacts.org/units/Nanomolar,3867828.0,=,1.0,1.0,=,IC50,nM,29900.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,29.9,CHEMBL4296612
2808,12051185.0,[],CHEMBL2156564,Antiviral activity against CCR5-tropic HIV1 NL-AD87 infected in HEK293T cells assessed as inhibition of viral replication after 4 days by beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL2151018,J Nat Prod,2012.0,CHEMBL525076,CHEMBL525076,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1731138.0,=,1.0,1.0,=,IC50,ug.mL-1,0.001,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.001,CHEMBL378
2809,7967360.0,[],CHEMBL1930242,Antiviral activity against R5 tropic Human immunodeficiency virus 1 BAL infected in human PBMC cells assessed as reduction in viral replication by p24 detection based ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Br)cc2)CC1,CHEMBL1926604,Bioorg Med Chem Lett,2011.0,CHEMBL1762313,CHEMBL1762313,6.66,0.0,http://www.openphacts.org/units/Nanomolar,1563488.0,=,1.0,1.0,=,IC50,nM,220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.22,CHEMBL378
2810,3358043.0,[],CHEMBL1175766,Antiviral activity against HIV1 expressing reverse transcriptase V106A mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3Cl)CC2)ncc1Br,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1171403,CHEMBL1171403,8.64,0.0,http://www.openphacts.org/units/Nanomolar,921747.0,=,1.0,1.0,=,IC50,nM,2.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.3,CHEMBL378
2811,14654420.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(CO)[C@H](O)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL361568,CHEMBL361568,4.65,0.0,http://www.openphacts.org/units/Nanomolar,2101858.0,=,1.0,1.0,=,IC50,nM,22600.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,22.6,CHEMBL613497
2812,3603776.0,[],CHEMBL1291666,Antiviral activity against Hepatitis B virus infected in HepG2.2.15 assessed as inhibition of HBsAg production at <80.1 +/- 3.5 uM by EIA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2c(nc(CCc3ccc(F)cc3)n2C)c1Cn1ccnc1,CHEMBL1287795,Bioorg Med Chem Lett,2010.0,CHEMBL1288052,CHEMBL1288052,,0.0,,973061.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
2813,6268213.0,[],CHEMBL1803184,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CO)C(=O)N4)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC3=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N2,CHEMBL1799917,J Nat Prod,2010.0,CHEMBL1801136,CHEMBL1801136,6.25,0.0,http://www.openphacts.org/units/Nanomolar,1440224.0,=,1.0,1.0,=,IC50,nM,560.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.56,CHEMBL378
2814,6152309.0,[],CHEMBL1763053,Antiviral activity against Human immunodeficiency virus 1 BAL infected in human PBMC assessed as inhibition of viral replication by p24 antigen specific ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(S(C)(=O)=O)cc2)CC1,CHEMBL1759996,Bioorg Med Chem Lett,2011.0,CHEMBL1762463,CHEMBL1762463,8.40,0.0,http://www.openphacts.org/units/Nanomolar,1414950.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.004,CHEMBL378
2815,3013897.0,[],CHEMBL1045234,Antiviral activity against HIV1 3B infected human HOS cells expressing human CXCR4 and CD4 assessed as inhibition of viral infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CCN1CCN(c2cccc3nc(CN(C)[C@H]4CCCc5cccnc54)cn23)CC1,CHEMBL1156094,Bioorg Med Chem Lett,2009.0,CHEMBL585722,CHEMBL585722,8.40,0.0,http://www.openphacts.org/units/Nanomolar,860853.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.004,CHEMBL378
2816,5306736.0,[],CHEMBL1696838,Antiviral activity against R5 tropic HIV1 R8.BaL infected in human PBMC assessed as inhibition of p24 antigen production after 2 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,CHEMBL1687731,Antimicrob Agents Chemother,2009.0,CHEMBL483,CHEMBL483,6.00,0.0,http://www.openphacts.org/units/Nanomolar,1337339.0,=,1.0,1.0,=,IC50,nM,1007.42,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1007.42,CHEMBL378
2817,22958194.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4768136,Antiviral activity against HIV1 NL4-3 Env-deficient pseudotype virus infected in human U87/CD4/CCR5 cells assessed by reduction in viral production in late stage measured after 48 hrs by luciferase activity based single-round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1[nH]c2ccccc2c1CC(=O)N[C@@H](Cc1ccccc1)C(=O)N(C)c1ccccc1,CHEMBL4765266,Eur J Med Chem,2020.0,CHEMBL1229713,CHEMBL1229713,6.64,0.0,http://www.openphacts.org/units/Nanomolar,3565135.0,=,1.0,1.0,=,IC50,nM,230.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.23,CHEMBL378
2818,281503.0,[],CHEMBL824013,Tested for antiviral activity against HBV (Hep AD79),F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc2c(ncn2COCCO)c(=O)[nH]1,CHEMBL1134101,Bioorg Med Chem Lett,2001.0,CHEMBL184,CHEMBL184,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,66195.0,>,1.0,1.0,>,IC50,ug.mL-1,50.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,50.0,CHEMBL613497
2819,24959045.0,[],CHEMBL5215192,Antiviral activity against HIV-1 assessed as viral growth inhibition,F,BAO_0000190,BAO_0000218,organism-based format,Cl.Cl.[O-][n+]1onc2ncnc(N3CC[N+]4(CC3)CC[N+]3(CCN(c5ncnc6no[n+]([O-])c56)CC3)CC4)c21,CHEMBL5214887,Eur J Med Chem,2021.0,CHEMBL5218828,CHEMBL5222975,,0.0,http://www.openphacts.org/units/Nanomolar,3898746.0,=,1.0,1.0,=,IC50,nM,150000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,150.0,CHEMBL378
2820,24830998.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c2cnc(N3CCCC3)cc2oc2c(Cl)cccc12,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5198147,CHEMBL5198147,,0.0,http://www.openphacts.org/units/Nanomolar,3878110.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
2821,1977589.0,[],CHEMBL897738,Antiviral activity against influenza B/Jingfang/76/98 in MDCK cells by CPE assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCOCCCOC(=O)C1=C[C@H](NC(=N)N)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O1,CHEMBL1149649,Bioorg Med Chem Lett,2007.0,CHEMBL236092,CHEMBL236092,4.63,0.0,http://www.openphacts.org/units/Nanomolar,660255.0,=,1.0,1.0,=,IC50,nM,23300.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,23.3,CHEMBL613129
2822,2413631.0,[],CHEMBL987708,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCC(=O)O[C@@H](C[C@@H](C)C1=C2C[C@H](OC(=O)CCCCCCC)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)[C@@H](OC(=O)CCCCCCC)C(C)(C)O,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL449494,CHEMBL449494,,0.0,http://www.openphacts.org/units/Nanomolar,810680.0,>,1.0,1.0,>,IC50,nM,600000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.6,CHEMBL613497
2823,5246975.0,[],CHEMBL1687410,Antiviral activity against HIV1 Ba-L infected in human HOS cells expressing CCR5 after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC(CNS(C)(=O)=O)c1ccccc1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL1682567,CHEMBL1682567,7.64,0.0,http://www.openphacts.org/units/Nanomolar,1333679.0,=,1.0,1.0,=,IC50,nM,23.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.023,CHEMBL378
2824,18342101.0,[],CHEMBL4139012,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(-c2cc(NC(=O)c3ccccc3O)c[nH]c2=O)c1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL4167485,CHEMBL4167485,4.60,0.0,http://www.openphacts.org/units/Nanomolar,3045879.0,=,1.0,1.0,=,IC50,nM,25290.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,25.29,CHEMBL613497
2825,14986382.0,[],CHEMBL3387304,Antiviral activity against Tacaribe virus infected in African green monkey Vero 76 cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncc(F)c2c1ncn2[C@@H]1C[C@H](CO)[C@@H](O)[C@H]1O,CHEMBL3351456,Bioorg Med Chem,2014.0,CHEMBL3357215,CHEMBL3357215,4.85,0.0,http://www.openphacts.org/units/Nanomolar,2258674.0,=,1.0,1.0,=,IC50,nM,14000.0,CHEMBL613131,Tacaribe virus,Tacaribe virus,11631,IC50,uM,UO_0000065,14.0,CHEMBL613131
2826,3406137.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2cc(=O)c3cc(NC(C)=O)ccc3o2)cc1,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1215457,CHEMBL1215457,,0.0,http://www.openphacts.org/units/Nanomolar,933191.0,=,1.0,1.0,=,IC50,nM,225800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,225.8,CHEMBL378
2827,925549.0,[],CHEMBL712257,Inhibition of human immunodeficiency virus-1 (HIV-1) induced cytopathicity in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(N)c2nnn(C[C@@H](CO)OCP(=O)(O)O)c2n1,CHEMBL1129435,J Med Chem,1996.0,CHEMBL129687,CHEMBL129687,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251946.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,100.0,CHEMBL378
2828,312013.0,[],CHEMBL697276,In vitro inhibition of HIV-1 plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCOCC(COP(=O)(O)OCCNC(C)(C)C)OCC,CHEMBL1125666,J Med Chem,1991.0,CHEMBL283486,CHEMBL283486,,0.0,http://www.openphacts.org/units/Nanomolar,43740.0,>,1.0,1.0,>,IC50,nM,5000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.0,CHEMBL378
2829,2602253.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccnc2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)c12,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL337301,CHEMBL337301,9.07,0.0,http://www.openphacts.org/units/Nanomolar,808154.0,=,1.0,1.0,=,IC50,nM,0.85,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.00085,CHEMBL378
2830,16556886.0,[],CHEMBL3795205,Antiviral activity against CXCR4 using HIV-1 NL4.3 infected in human MT4 cells assessed as reduction of viral replication preincubated for 15 mins with cells followed by viral infection measured after 4 days by MTS/PES method,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(C(=O)c2ccc(OC)cc2)CCCN(Cc2ccccc2)CCCN(S(=O)(=O)c2ccc(C)cc2)C1.Cl,CHEMBL3792300,J Med Chem,2016.0,CHEMBL3793311,CHEMBL3794645,5.41,0.0,http://www.openphacts.org/units/Nanomolar,2770916.0,=,1.0,1.0,=,IC50,nM,3860.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.86,CHEMBL378
2831,10961206.0,[],CHEMBL2061269,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M4 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL1323,CHEMBL1323,7.52,0.0,http://www.openphacts.org/units/Nanomolar,1655448.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,30.0,CHEMBL378
2832,18890510.0,[],CHEMBL4314138,Antiviral activity against HIV-1 NL4-3 infected in human CEM-GFP cells assessed as suppression of viral replication by measuring reduction in p24 level measured at 72 hrs post-infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL4311980,Eur J Med Chem,2019.0,CHEMBL129,CHEMBL129,7.89,0.0,http://www.openphacts.org/units/Nanomolar,3151806.0,=,1.0,1.0,=,IC50,nM,12.74,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,12.74,CHEMBL378
2833,3114021.0,[],CHEMBL1073712,Antiviral activity against HIV1 NL4-3 infected in GFP expressing human CEM cells assessed as inhibition of viral infection measured after 9 days postinfection by microfluorometry,F,BAO_0000190,BAO_0000218,organism-based format,CCC(c1c(O)c(C(C)=O)c(O)c(C(C)=O)c1O)c1c(O)c(C(C)=O)c(O)c(C(C)=O)c1O,CHEMBL1157554,Bioorg Med Chem,2010.0,CHEMBL601738,CHEMBL601738,,0.0,,888448.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2834,15166106.0,[],CHEMBL3404734,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBeAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(OC(=O)/C=C/c2ccc3c(c2)OCO3)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402772,CHEMBL3402772,,0.0,http://www.openphacts.org/units/Nanomolar,2284126.0,>,1.0,1.0,>,IC50,nM,3036100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,3036.1,CHEMBL613497
2835,1037837.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1cccc(C2C(C)N=CN2Nc2cccc(Cl)c2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39815,CHEMBL39815,,0.0,http://www.openphacts.org/units/Nanomolar,62338.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2836,18727027.0,[],CHEMBL4259323,Antiviral activity against HIV1 subtype B' CNE6 pseudovirus assessed as inhibition of viral infection in Ghost (3)X4/R5 cells after 48 hrs by Bright-Glo luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@]1(C)CCC/C=C\CCC[C@](C)(NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O,CHEMBL4257519,Medchemcomm,2018.0,CHEMBL4287830,CHEMBL4287830,7.90,0.0,http://www.openphacts.org/units/Nanomolar,3111235.0,=,1.0,1.0,=,IC50,nM,12.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,12.5,CHEMBL378
2837,986891.0,[],CHEMBL683812,Antiviral activity against Human immunodeficiency virus 1 (HIV-1) up to 100 uM concentration; inactive,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N1CC(n2cc(C)c(=O)[nH]c2=O)C[C@H]1CO,CHEMBL1124550,J Med Chem,1989.0,CHEMBL606873,CHEMBL606873,,0.0,http://www.openphacts.org/units/Nanomolar,82345.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2838,2244572.0,[],CHEMBL1003073,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase Y188C mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(C(F)(F)F)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL275658,CHEMBL275658,9.52,0.0,http://www.openphacts.org/units/Nanomolar,798655.0,=,1.0,1.0,=,IC50,nM,0.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.3,CHEMBL378
2839,2009812.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnc3)nccc12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL392576,CHEMBL392576,6.80,0.0,http://www.openphacts.org/units/Nanomolar,668101.0,=,1.0,1.0,=,IC50,nM,160.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,160.0,CHEMBL378
2840,535149.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(S(=O)(=O)c2cccc(NC3CCCCC3)c2C#N)c1,CHEMBL1134494,J Med Chem,2001.0,CHEMBL301855,CHEMBL301855,,0.0,http://www.openphacts.org/units/Nanomolar,94217.0,>,1.0,1.0,>,IC50,nM,200000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,200.0,CHEMBL378
2841,2371531.0,[],CHEMBL1035747,Antiviral activity against HIV1 with reverse transcriptase K103N/G190A mutant in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ncccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL491019,CHEMBL491019,8.40,0.0,http://www.openphacts.org/units/Nanomolar,773465.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.0,CHEMBL378
2842,481404.0,[],CHEMBL757967,Inhibition of cell growth against HIV-1 infected PBM (Human peripheral blood mononuclear) cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(O)c2ncn([C@H]3CS[C@@H](CO)O3)c2n1,CHEMBL1126792,J Med Chem,1993.0,CHEMBL421176,CHEMBL421176,,0.0,http://www.openphacts.org/units/Nanomolar,161302.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2843,2550839.0,[],CHEMBL980249,Antiviral activity against HIV1 3B assessed as reverse transcriptase activity by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CCCN2[C@@H](CC1)C[C@]13CN4CCCC/C=C\CC[C@](O)(C=C(c5nccc6c5[nH]c5c(O)cccc56)C1CC4)[C@H]23,CHEMBL1142603,J Nat Prod,2006.0,CHEMBL399694,CHEMBL399694,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,786995.0,=,1.0,1.0,=,IC50,ug.mL-1,7.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,7.3,CHEMBL378
2844,13967488.0,[],CHEMBL3135326,Antiviral activity against wild type HIV1 VSVG infected in 293ET cells assessed as inhibition of viral replication by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1C(=O)Nc2ccc(Cl)cc2N1S(=O)(=O)c1ccsc1CO,CHEMBL3132804,Medchemcomm,2014.0,CHEMBL3133052,CHEMBL3133052,,0.0,,1974723.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2845,3292014.0,[],CHEMBL1108227,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)N1C[C@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cc(F)cc(F)c3)C[C@H]2C1,CHEMBL1157775,Bioorg Med Chem Lett,2010.0,CHEMBL1098664,CHEMBL1098664,7.39,0.0,http://www.openphacts.org/units/Nanomolar,911140.0,=,1.0,1.0,=,IC50,nM,41.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,41.0,CHEMBL378
2846,2930391.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cccn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578376,CHEMBL578376,8.30,0.0,http://www.openphacts.org/units/Nanomolar,852984.0,=,1.0,1.0,=,IC50,nM,5.01,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.01,CHEMBL378
2847,161269.0,[],CHEMBL844408,Inhibition of 50% of the integrase-mediated catalysis of the V1/V2 substrate with 95% confidence interval,F,BAO_0000190,BAO_0000218,organism-based format,CC(CCC(=O)O)C1CC[C@H]2[C@@H]3[C@H](OC(=O)/C=C/c4ccc(O)c(O)c4)CC4C[C@H](OC(=O)/C=C/c5ccc(O)c(O)c5)CC[C@]4(C)[C@H]3C[C@H](OC(=O)/C=C/c3ccc(O)c(O)c3)[C@]12C,CHEMBL1135546,J Med Chem,2002.0,CHEMBL3138254,CHEMBL3138254,6.01,0.0,http://www.openphacts.org/units/Nanomolar,231559.0,=,1.0,1.0,=,IC50,nM,970.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.97,CHEMBL378
2848,18044768.0,[],CHEMBL4010414,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype D QD435.100M.ENV.E1,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.30,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.5,CHEMBL378
2849,2602261.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=c1cc(Cc2c(F)cccc2F)nc(SC2CCCC2)[nH]1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL312874,CHEMBL312874,7.10,0.0,http://www.openphacts.org/units/Nanomolar,807505.0,=,1.0,1.0,=,IC50,nM,80.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.08,CHEMBL378
2850,15156738.0,[],CHEMBL3399645,Decrease in HBV viral DNA replication in human HepG2(2.2.15) cells at 0.75 to 3 uM after 72 hrs by real-time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(C)=O)c(OS(=O)(=O)c2ccc(C)cc2)c1,CHEMBL3397002,Eur J Med Chem,2015.0,CHEMBL3397411,CHEMBL3397411,5.98,0.0,http://www.openphacts.org/units/Nanomolar,2279258.0,=,1.0,1.0,=,IC50,nM,1040.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.04,CHEMBL613497
2851,15027149.0,[],CHEMBL3367171,Inhibition of AP-1-mediated transcriptional activation in human Jurkat cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,O=C1c2cnc(Cl)nc2C(=O)N1c1cc(C(F)(F)F)cc(C(F)(F)F)c1,CHEMBL3352097,J Med Chem,2014.0,CHEMBL3341906,CHEMBL3341906,5.03,0.0,http://www.openphacts.org/units/Nanomolar,2265175.0,=,1.0,1.0,=,IC50,nM,9400.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,9.4,CHEMBL4977
2852,23274467.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](CCc1cn([C@@H]2CC[C@@]3(C)[C@@H](C2)C[C@H](O)[C@@H]2[C@@H]3CC[C@]3(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]23)nn1)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4865020,CHEMBL4865020,7.60,0.0,http://www.openphacts.org/units/Nanomolar,3621267.0,=,1.0,1.0,=,IC50,nM,25.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,25.0,CHEMBL613497
2853,1063784.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=C(S)N(Nc2cccc(Cl)c2)C1c1cccc(C(N)=O)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39462,CHEMBL39462,,0.0,http://www.openphacts.org/units/Nanomolar,62352.0,>,1.0,1.0,>,IC50,nM,42160.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,42.16,CHEMBL378
2854,1401989.0,[],CHEMBL837470,In vitro inhibitory concentration against HIV V179E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCSC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL178936,CHEMBL178936,,0.0,http://www.openphacts.org/units/Nanomolar,360356.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2855,14653469.0,[],CHEMBL3267146,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)c3cccs3)[C@H](OC(=O)c3cccs3)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262989,CHEMBL3262989,,0.0,http://www.openphacts.org/units/Nanomolar,2101872.0,=,1.0,1.0,=,IC50,nM,822000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,822.0,CHEMBL613497
2856,3509124.0,[],CHEMBL1261037,Antiviral activity against wild type HIV1 infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(F)c1Oc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1Br,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1258364,CHEMBL1258364,8.14,0.0,http://www.openphacts.org/units/Nanomolar,963336.0,=,1.0,1.0,=,IC50,nM,7.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.3,CHEMBL378
2857,3194834.0,[],CHEMBL1102708,Antiviral activity against CCR5-tropic recombinant HIV1 NLBal virus infected in JC53-BL cells assessed as inhibition of viral replication after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOCC3)c3cccc(F)c3)C[C@@H]2C1,CHEMBL1154938,Bioorg Med Chem Lett,2010.0,CHEMBL1081477,CHEMBL1081477,,0.0,http://www.openphacts.org/units/Nanomolar,892622.0,>=,1.0,1.0,>=,IC50,nM,625.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,625.0,CHEMBL378
2858,19271313.0,[],CHEMBL4406719,Antiviral activity against darunavir resistant HIV1 harboring protease P30 L10I/I15V/K20R/L24I/V32I/M36I/ M46L/L63P/K70Q/V82A/I84V/L89M mutant infected in human MT4 cells assessed as reduction in p24 Gag production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1C[C@H]2CO[C@H]3OC1C[C@@H]23)S(=O)(=O)c1ccc2nc(NC(C)C)oc2c1,CHEMBL4402610,J Med Chem,2020.0,CHEMBL4568050,CHEMBL4568050,6.19,0.0,http://www.openphacts.org/units/Nanomolar,3217925.0,=,1.0,1.0,=,IC50,nM,640.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,640.0,CHEMBL378
2859,5249141.0,[],CHEMBL1685193,Antiviral activity against X4 tropic HIV1 NL4.3 infected in CD4 and CXCR4 expressing human MT4 cells assessed as inhibition of viral cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21,CHEMBL1681661,Bioorg Med Chem Lett,2011.0,CHEMBL518924,CHEMBL518924,8.32,0.0,http://www.openphacts.org/units/Nanomolar,1334134.0,=,1.0,1.0,=,IC50,nM,4.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.8,CHEMBL378
2860,19262027.0,[],CHEMBL4404427,Antiviral activity against multidrug resistant HIV1 12233 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,5.43,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,3700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.7,CHEMBL378
2861,18366994.0,[],CHEMBL4142849,Antiviral activity against HIV1 NL4-3 infected in human MT2 cells measured after 72 hrs post infection by fluorAce beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc2c1ccc1c3c(c4ocnc4c12)[C@@H](C)CO3,CHEMBL4138205,J Nat Prod,2017.0,CHEMBL4173552,CHEMBL4173552,5.27,0.0,http://www.openphacts.org/units/Nanomolar,3048519.0,=,1.0,1.0,=,IC50,nM,5400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.4,CHEMBL378
2862,19076336.0,[],CHEMBL4362887,Antiviral activity against Influenza B virus B/Massachusetts/2/2012(BV) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 40 hrs by Celltiter-Glo assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC[C@]2(C(=O)NCc3cn([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)nn3)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL4359890,Eur J Med Chem,2019.0,CHEMBL4539433,CHEMBL4539433,4.94,0.0,http://www.openphacts.org/units/Nanomolar,3182776.0,=,1.0,1.0,=,IC50,nM,11510.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,11.51,CHEMBL613129
2863,22844974.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721621,Antiviral activity against HIV-1 HXB-2 infected in human TZM-bl cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based single cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC[C@@H](NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1nc(CO)cs1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4777105,CHEMBL4777105,6.60,0.0,http://www.openphacts.org/units/Nanomolar,3547088.0,=,1.0,1.0,=,IC50,nM,250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.25,CHEMBL378
2864,580581.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c2ccccc2sn1-c1ccc(S(=O)(=O)Nc2ncccn2)cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL354765,CHEMBL354765,4.29,0.0,http://www.openphacts.org/units/Nanomolar,334059.0,=,1.0,1.0,=,IC50,nM,50800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.8,CHEMBL378
2865,15158624.0,[],CHEMBL3398832,Inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,O=C1OCCc2c(/C=C\c3ccccc3)cccc21,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397169,CHEMBL3397169,,0.0,http://www.openphacts.org/units/Nanomolar,2278967.0,>,1.0,1.0,>,IC50,nM,2160000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.16,CHEMBL613497
2866,10995196.0,[],CHEMBL2072873,Antiviral activity against VSV-G pseudotyped HIV1 lentiviral particles infected in human HeLa cells incubated for 48 hrs by spectrofluorometry,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL2069294,Bioorg Med Chem,2012.0,CHEMBL129,CHEMBL129,7.40,0.0,http://www.openphacts.org/units/Nanomolar,1663492.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
2867,869504.0,[],CHEMBL683811,Antiviral activity against HIV-1 using antiinfectivity assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCO[C@H]1C(=O)Nc2ccc(Cl)cc2[C@@]1(C#CC1CC1)C(F)(F)F,CHEMBL1134695,Bioorg Med Chem Lett,2001.0,CHEMBL294406,CHEMBL294406,7.21,0.0,http://www.openphacts.org/units/Nanomolar,100527.0,=,1.0,1.0,=,IC50,nM,62.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,62.0,CHEMBL378
2868,707053.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc2nc(SSc3nc4ccccc4s3)sc12,CHEMBL1129635,J Med Chem,1996.0,CHEMBL3706721,CHEMBL3706721,,0.0,,228612.0,>,1.0,0.0,>,IC50,,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,200.0,CHEMBL378
2869,3253250.0,[],CHEMBL1107990,Antiviral activity against HIV1 NL4.3 infected in human PBMC assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(CNCc2ccc(CN(Cc3nc4ccccc4[nH]3)C3CCCc4cccnc43)cc2)nc1,CHEMBL1156989,J Med Chem,2010.0,CHEMBL1089434,CHEMBL1089434,6.56,0.0,http://www.openphacts.org/units/Nanomolar,902935.0,=,1.0,1.0,=,IC50,nM,277.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.277,CHEMBL378
2870,619580.0,[],CHEMBL712878,Concentration required for 50% protection of MT-4 cells against the cytopathic effect of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1Cc2c(C#N)ccc3nc(S)n(c23)C[C@@H]1C,CHEMBL1128253,J Med Chem,1995.0,CHEMBL58506,CHEMBL58506,7.25,0.0,http://www.openphacts.org/units/Nanomolar,327800.0,=,1.0,1.0,=,IC50,nM,56.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0563,CHEMBL378
2871,381254.0,[],CHEMBL711617,Antiviral activity against HIV-1 IIIB induced cytopathic effect in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@@H]1NC(=O)[C@@H]([C@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CCOC2)NCc2ccc(cc2)OCCOCCOCCNC1=O,CHEMBL1129607,J Med Chem,1996.0,CHEMBL112801,CHEMBL112801,6.70,0.0,http://www.openphacts.org/units/Nanomolar,210517.0,=,1.0,1.0,=,IC50,nM,198.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,198.0,CHEMBL378
2872,1402273.0,[],CHEMBL837467,In vitro inhibitory concentration against HIV K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCCN(CCCC)c1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL179736,CHEMBL179736,4.00,0.0,http://www.openphacts.org/units/Nanomolar,360413.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2873,2601720.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2C=C(F)[C@H](CO)O2)c(=O)n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL473072,CHEMBL473072,7.05,0.0,http://www.openphacts.org/units/Nanomolar,807557.0,=,1.0,1.0,=,IC50,nM,89.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.089,CHEMBL378
2874,935282.0,[],CHEMBL656269,Inhibition of human immunodeficiency virus-1 (HIV-1) induced cytopathicity in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1nnn2C[C@@H](CF)OCP(=O)(O)O,CHEMBL1129435,J Med Chem,1996.0,CHEMBL133322,CHEMBL133322,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251941.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,100.0,CHEMBL378
2875,22752436.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '216.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '9.0'}]",CHEMBL4700093,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15.7 assessed as reduction in HBV DNA level incubated for 9 days media replaced every 3 days once with test compound by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,C=C1[C@@H](n2cc(F)c3c(N)ncnc32)[C@H](O)[C@H](O)[C@@]1(C)CO,CHEMBL4699415,RSC Med Chem,2020.0,CHEMBL4785677,CHEMBL4785677,,0.0,http://www.openphacts.org/units/Nanomolar,3531378.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
2876,1401894.0,[],CHEMBL834774,In vitro inhibitory concentration against HIV Y188L mutant strain; not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)Nc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL128569,CHEMBL128569,,0.0,http://www.openphacts.org/units/Nanomolar,360373.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2877,17602965.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(C(=O)Nc2ccccc2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644900,CHEMBL3644900,6.19,0.0,http://www.openphacts.org/units/Nanomolar,2518020.0,=,37.0,1.0,=,IC50,nM,640.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,640.0,CHEMBL4620
2878,2670836.0,[],CHEMBL1035389,Antiviral activity against LASV infected in human A549 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(CN2C(=O)CN(C(=O)c3cc4ccccc4o3)CC2Cc2ccccc2)cc1,CHEMBL1151924,Bioorg Med Chem Lett,2009.0,CHEMBL562567,CHEMBL562567,6.10,0.0,http://www.openphacts.org/units/Nanomolar,820509.0,=,1.0,1.0,=,IC50,nM,800.0,CHEMBL615051,Lassa virus,Lassa virus,11620,IC50,uM,UO_0000065,0.8,CHEMBL615051
2879,10865185.0,[],CHEMBL2025516,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCOCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@]3(O)[C@@H]2C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]2(C)[C@]3(O)CC[C@@]2(O)C(C)=O)C1,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2023663,CHEMBL2023663,4.17,0.0,http://www.openphacts.org/units/Nanomolar,1639227.0,=,1.0,1.0,=,IC50,nM,68200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,68.2,CHEMBL613497
2880,12680731.0,[],CHEMBL2342599,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(CNC(=O)/C=C/c2coc3cc(O)ccc3c2=O)cc1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333296,CHEMBL2333296,4.78,0.0,http://www.openphacts.org/units/Nanomolar,1867259.0,=,1.0,1.0,=,IC50,nM,16540.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,16.54,CHEMBL613497
2881,2694292.0,[],CHEMBL1053927,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV surface antigen,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2nc3c(cc2c(CN(C)C)c1O)CSc1ccc(C)cc1-3,CHEMBL1152943,Bioorg Med Chem,2009.0,CHEMBL561260,CHEMBL561260,4.66,0.0,http://www.openphacts.org/units/Nanomolar,824943.0,=,1.0,1.0,=,IC50,nM,22100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,22.1,CHEMBL613497
2882,3432918.0,[],CHEMBL1246459,Antiviral activity against R5 tropic HIV1 BaL infected in human CEMx174 5.25M7 cells after 3 days by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1Cc1ccc(C(=O)NN2C(=O)[C@@H]3C4C=CC(C5CC54)[C@@H]3C2=O)cc1,CHEMBL1240449,Eur J Med Chem,2010.0,CHEMBL1241647,CHEMBL1241647,5.78,0.0,http://www.openphacts.org/units/Nanomolar,952474.0,=,1.0,1.0,=,IC50,nM,1678.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.775,CHEMBL378
2883,1487542.0,[],CHEMBL833976,Inhibitory concentration against wild type human immunodeficiency virus type 1 was determined by recombinant virus assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(O)nc2ccccc2c1OCC1CCC1,CHEMBL1138845,J Med Chem,2004.0,CHEMBL188816,CHEMBL188816,,0.0,http://www.openphacts.org/units/Nanomolar,384238.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2000.0,CHEMBL378
2884,13475669.0,[],CHEMBL2439258,Antiviral activity against Human immunodeficiency virus 1 clade B isolate Ada infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc(Sc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2434978,CHEMBL2434978,9.22,0.0,http://www.openphacts.org/units/Nanomolar,1924232.0,=,1.0,1.0,=,IC50,nM,0.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.6,CHEMBL378
2885,1402344.0,[],CHEMBL837468,In vitro inhibitory concentration against HIV L100I mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N2CCCCC2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175655,CHEMBL175655,,0.0,http://www.openphacts.org/units/Nanomolar,360430.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2886,3407233.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2oc3ccc(N)cc3c(=O)c2OC)cc1,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1214820,CHEMBL1214820,,0.0,http://www.openphacts.org/units/Nanomolar,932429.0,=,1.0,1.0,=,IC50,nM,200200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,200.2,CHEMBL378
2887,24831018.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C1(C(F)(F)F)CCN(c2ccc3c(=O)c4cccc(Cl)c4oc3c2)C1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5184209,CHEMBL5184209,,0.0,http://www.openphacts.org/units/Nanomolar,3878130.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
2888,14581358.0,[],CHEMBL3243467,"Antiviral activity against HIV-1 pseudotyped virus expressing HIV-1 isolate B envelope SC422661, clone B (SVPB8) assessed as reduction of luciferase production after 3 days by single-cycle neutralization assay",F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]1CSCc2ccc(cc2)-c2ccc(cc2)CSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC1=O,CHEMBL3232893,Bioorg Med Chem Lett,2014.0,CHEMBL3233156,CHEMBL3233156,5.43,0.0,http://www.openphacts.org/units/Nanomolar,2081351.0,=,1.0,1.0,=,IC50,nM,3700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.7,CHEMBL378
2889,945992.0,[],CHEMBL656269,Inhibition of human immunodeficiency virus-1 (HIV-1) induced cytopathicity in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(O)c2nnn(CCOCP(=O)(O)O)c2n1,CHEMBL1129435,J Med Chem,1996.0,CHEMBL338348,CHEMBL338348,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251928.0,=,1.0,1.0,=,IC50,ug.mL-1,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,2.0,CHEMBL378
2890,23165150.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '96.0'}]",CHEMBL4813048,Antiviral activity against Zika virus infected in SF-268 cells assessed as inhibition of viral infection at entry stage measured after 96 hrs by DAPI staining based fluorescence microscopic analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@H]1CC[C@@]2(C)C(CC[C@]3(C)C2C(=O)C=C2C4C[C@@](C)(C(=O)Nc5cccnc5)CC[C@]4(C)CC[C@]23C)C1(C)C,CHEMBL4811277,Bioorg Med Chem,2021.0,CHEMBL4870229,CHEMBL4870229,6.17,0.0,http://www.openphacts.org/units/Nanomolar,3601577.0,=,1.0,1.0,=,IC50,nM,680.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,0.68,CHEMBL4296612
2891,8041796.0,[],CHEMBL1953242,Antiviral activity against HIV1 harboring VSV glycoprotein-G co-transfected with luciferase gene infected in human TZM-bl cells assessed as inhibition of viral replication after 48 hrs by microplate luminometer based luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1nc(C(C)(C)NC(=O)c2nnc(C)o2)nc(C(=O)NCc2ccc(F)cc2)c1OC(=O)c1ccccc1,CHEMBL1949625,Eur J Med Chem,2012.0,CHEMBL1949876,CHEMBL1949876,7.83,0.0,http://www.openphacts.org/units/Nanomolar,1576977.0,=,1.0,1.0,=,IC50,nM,14.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,14.7,CHEMBL378
2892,18726968.0,[],CHEMBL4259331,Antiviral activity against HIV-1 subtype B HXB2 pseudovirus assessed as inhibition of viral infection in Ghost (3)X4/R5 cells after 48 hrs by Bright-Glo luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@]1(C)CCC/C=C\CCC[C@@](C)(C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O,CHEMBL4257519,Medchemcomm,2018.0,CHEMBL4277174,CHEMBL4277174,9.30,0.0,http://www.openphacts.org/units/Nanomolar,3111234.0,=,1.0,1.0,=,IC50,nM,0.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.5,CHEMBL378
2893,1438147.0,[],CHEMBL834619,Inhibitory activity against HIV-1 mutant strain 181C; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1nccn1C,CHEMBL1138799,J Med Chem,2004.0,CHEMBL442222,CHEMBL442222,,0.0,http://www.openphacts.org/units/Nanomolar,371547.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2894,13463760.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc([S+]([O-])c2cccc(N)c2C#N)cc1,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL300934,CHEMBL300934,4.31,0.0,http://www.openphacts.org/units/Nanomolar,1920691.0,=,1.0,1.0,=,IC50,nM,48977.88,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.31,CHEMBL378
2895,1470278.0,[],CHEMBL833081,Inhibitory activity against HIV-1 mutant strain 190A,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL366692,CHEMBL366692,8.00,0.0,http://www.openphacts.org/units/Nanomolar,380699.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
2896,2601927.0,[],CHEMBL1034012,Antiviral activity against influenza virus,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)/C=C/C(=O)c1ccccc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL16365,CHEMBL16365,,0.0,http://www.openphacts.org/units/Nanomolar,807205.0,=,1.0,1.0,=,IC50,nM,500000.0,CHEMBL613128,unidentified influenza virus,unidentified influenza virus,11309,IC50,uM,UO_0000065,500.0,CHEMBL613128
2897,14658780.0,[],CHEMBL3266156,"Displacement of [3H]-7-alpha,25-OHC from recombinant human EBI2 receptor expressed in CHO cells after 10 mins by scintillation counting analysis",B,BAO_0000190,BAO_0000219,cell-based format,O=C(COc1ccc2ccccc2c1)N1CCN(C(=O)Cc2ccccc2)CC1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262876,CHEMBL3262876,7.08,0.0,http://www.openphacts.org/units/Nanomolar,2101717.0,=,1.0,1.0,=,IC50,nM,83.0,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,nM,UO_0000065,83.0,CHEMBL3259470
2898,12627437.0,[],CHEMBL2317015,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(NN)c2c1[nH]c1ccccc12,CHEMBL2311445,Bioorg Med Chem,2013.0,CHEMBL2311885,CHEMBL2311885,,0.0,http://www.openphacts.org/units/Nanomolar,1841383.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
2899,22753398.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4700293,Antiviral activity against Vaccinia virus Copenhagen infected in African green monkey Vero cells assessed as reduction in cell survival incubated for 4 days by neutral red dye based colorimetric analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NN1C(=O)C2C3C=CC(C4CC34)C2C1=O)c1ccc(C(F)(F)F)cc1,CHEMBL4699424,RSC Med Chem,2020.0,CHEMBL485653,CHEMBL485653,8.00,0.0,http://www.openphacts.org/units/Nanomolar,3531618.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,0.01,CHEMBL613493
2900,624215.0,[],CHEMBL710534,Inhibitory activity against 188L strain of HIV-1 in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)cc(Cl)c1Oc1nc(N)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL73044,CHEMBL73044,6.99,0.0,http://www.openphacts.org/units/Nanomolar,126914.0,=,1.0,1.0,=,IC50,nM,103.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.103,CHEMBL378
2901,10866455.0,[],CHEMBL2025517,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HbeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C/C(=C\C(=O)O[C@@H]1C[C@@H]2[C@@]3(C)CC[C@H](O)CC3=CC[C@@]2(O)[C@@]2(O)CC[C@@](O)(C(C)O)[C@@]12C)C(C)C,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024052,CHEMBL2024052,,0.0,http://www.openphacts.org/units/Nanomolar,1639774.0,>,1.0,1.0,>,IC50,nM,1054810.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1054.81,CHEMBL613497
2902,92532.0,[],CHEMBL808329,The compound was tested in vitro for the inhibitory concentration against influenza B/Mem/89 sialidase from whole virus by MUN assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc(C(=O)O)cc1NC(=O)CCCN,CHEMBL1128587,J Med Chem,1995.0,CHEMBL109781,CHEMBL109781,,0.0,http://www.openphacts.org/units/Nanomolar,206087.0,>,1.0,1.0,>,IC50,nM,10000000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,mM,UO_0000065,10.0,CHEMBL613129
2903,20677929.0,[],CHEMBL4622140,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in cytoplasmic HBV-DNA replication incubated for 8 days by real-time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)CCNc1nc(F)c(-c2nn(Cc3ccc(C#N)cc3)c(=O)c3ccccc23)cc1Cl,CHEMBL4619801,J Med Chem,2020.0,CHEMBL4638507,CHEMBL4638507,6.68,0.0,http://www.openphacts.org/units/Nanomolar,3482219.0,=,1.0,1.0,=,IC50,nM,210.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.21,CHEMBL613497
2904,2003642.0,[],CHEMBL901910,Antiviral activity against Modoc virus-infected HeLa-H1 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccccn1)c1ccc2[nH]c(-c3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3)nc2c1,CHEMBL1138288,J Med Chem,2007.0,CHEMBL222659,CHEMBL222659,7.22,0.0,http://www.openphacts.org/units/Nanomolar,666642.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL612946,Modoc virus,Modoc virus,64300,IC50,nM,UO_0000065,60.0,CHEMBL612946
2905,18479518.0,[],CHEMBL4184680,Antiviral activity against Zika virus infected in human A549 cells preincubated for 5 hrs followed by compound wash measured after 48 hrs by viral plague-forming assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,CHEMBL4184095,Bioorg Med Chem Lett,2018.0,CHEMBL63,CHEMBL63,7.35,0.0,http://www.openphacts.org/units/Nanomolar,3066988.0,=,1.0,1.0,=,IC50,nM,44.6,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,nM,UO_0000065,44.6,CHEMBL4296612
2906,5229768.0,[],CHEMBL1676849,Antiviral activity against Human immunodeficiency virus 1 BAL infected in human MDM cells assessed as expression of p24 antigen after 6 days postinfection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,7.75,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,=,1.0,1.0,=,IC50,nM,18.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.018,CHEMBL378
2907,8027837.0,[],CHEMBL1948542,Antiviral activity against HIV1 NF-462 expressing wild-type Vpr infected in human 293T cells containing 1 ng of viral p24 antigen after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Oc1cc2c(cc1O)[C@@H]1c3cccc(O)c3OC[C@]1(O)C2,CHEMBL1944615,Bioorg Med Chem Lett,2012.0,CHEMBL1944933,CHEMBL1944933,,0.0,,1573824.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2908,6344564.0,[],CHEMBL1825888,Antiviral activity against HIV1 SF162 infected in human TZM-bl cells assessed as inhibition of virus neutralization after 48 hrs by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CCNc1nc(N)c2ncn([C@@H]3O[C@@]4(CO)CO[C@@H]3[C@@H]4OCc3ccccc3)c2n1,CHEMBL1821725,Bioorg Med Chem,2011.0,CHEMBL1821969,CHEMBL1821969,4.22,0.0,http://www.openphacts.org/units/Nanomolar,1452382.0,=,1.0,1.0,=,IC50,nM,60000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,60.0,CHEMBL378
2909,1402310.0,[],CHEMBL837468,In vitro inhibitory concentration against HIV L100I mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(Cc2ccccc2)Cc2ccccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL366811,CHEMBL366811,,0.0,http://www.openphacts.org/units/Nanomolar,360421.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2910,651286.0,[],CHEMBL713946,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1CC(C)n2c(S)nc3cccc(c32)C1C,CHEMBL1128252,J Med Chem,1995.0,CHEMBL305070,CHEMBL305070,,0.0,http://www.openphacts.org/units/Nanomolar,326388.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
2911,2530538.0,[],CHEMBL1011336,Antiviral activity against Rift Valley fever virus infected in african green monkey Vero cells after 6 days by plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1N[C@H]2[C@H](O)[C@H](O)[C@@H](O)C[C@H]2c2cc3c(cc21)OCO3,CHEMBL1150051,J Nat Prod,1992.0,CHEMBL513930,CHEMBL513930,,0.0,,790678.0,,1.0,0.0,,IC50,,,CHEMBL613130,Rift Valley fever virus,Rift Valley fever virus,11588,IC50,,,,CHEMBL613130
2912,22898311.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731093,Antiviral activity against HIV1 DRVR P30 infected in human MT4 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL729,CHEMBL729,,0.0,http://www.openphacts.org/units/Nanomolar,3554416.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
2913,19236841.0,[],CHEMBL4398858,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in cytoplasmic DNA synthesis by reed and munch method,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](N)C(=O)OCCCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCCCOC(=O)[C@@H](N)[C@@H](C)CC.Cl,CHEMBL4396904,ACS Med Chem Lett,2019.0,CHEMBL4475750,CHEMBL4596771,,0.0,http://www.openphacts.org/units/Nanomolar,3211266.0,>,1.0,1.0,>,IC50,nM,49620.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,49.62,CHEMBL613497
2914,10861932.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL450046,CHEMBL450046,,0.0,http://www.openphacts.org/units/Nanomolar,1640516.0,=,1.0,1.0,=,IC50,nM,1357830.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1357.83,CHEMBL613497
2915,1470572.0,[],CHEMBL833913,Inhibitory activity against HIV-1 mutant strain 227C,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL338047,CHEMBL338047,,0.0,http://www.openphacts.org/units/Nanomolar,380766.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2916,1421944.0,[],CHEMBL824926,Inhibitory activity against human immunodeficiency virus type 1 (inactive>0.1),F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(Sc2ccccc2)n(COCc2ccc([N+](=O)[O-])s2)c(=O)[nH]c1=O,CHEMBL1144258,Bioorg Med Chem Lett,2005.0,CHEMBL179671,CHEMBL179671,,0.0,http://www.openphacts.org/units/Nanomolar,364798.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2917,24823556.0,[],CHEMBL5140686,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBsAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(c1)OCC(COc1cc3c(cc1OC)-c1cc(=O)c(C(=O)O)cn1C(C(C)C)C3)O2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5208401,CHEMBL5208401,6.39,0.0,http://www.openphacts.org/units/Nanomolar,3876730.0,=,1.0,1.0,=,IC50,nM,403.1,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.4031,CHEMBL613497
2918,342548.0,[],CHEMBL697276,In vitro inhibition of HIV-1 plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC,CHEMBL1125666,J Med Chem,1991.0,CHEMBL28509,CHEMBL28509,6.04,0.0,http://www.openphacts.org/units/Nanomolar,43721.0,=,1.0,1.0,=,IC50,nM,920.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.92,CHEMBL378
2919,6216897.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2cc(F)ccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784400,CHEMBL1784400,6.76,0.0,http://www.openphacts.org/units/Nanomolar,1429338.0,=,1.0,1.0,=,IC50,nM,173.78,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.76,CHEMBL378
2920,852866.0,[],CHEMBL713546,Compound potency to achieve protection of MT-4 cells from HIV-1 cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)C(/N=C(\S)Nc1ccccc1Cl)c1c(Cl)cccc1Cl,CHEMBL1134808,Bioorg Med Chem Lett,2001.0,CHEMBL72759,CHEMBL72759,,0.0,http://www.openphacts.org/units/Nanomolar,126255.0,>,1.0,1.0,>,IC50,nM,60000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,60.0,CHEMBL378
2921,10866417.0,[],CHEMBL2025516,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL483,CHEMBL483,,0.0,http://www.openphacts.org/units/Nanomolar,1639775.0,=,1.0,1.0,=,IC50,nM,1446350.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1446.35,CHEMBL613497
2922,338442.0,[],CHEMBL802188,Inhibitory activity against Avian Myeloblastosis Virus Reverse Transcriptase (AMV RT); IA=inactive,F,BAO_0000190,BAO_0000218,organism-based format,CCCc1cc(=O)oc2c3c(c4c(c12)OC(C)(C)C=C4)O[C@@H](C)C(C)[C@@H]3O,CHEMBL1129527,J Med Chem,1996.0,CHEMBL282382,CHEMBL282382,,0.0,http://www.openphacts.org/units/Nanomolar,35731.0,,1.0,0.0,,IC50,nM,,CHEMBL613550,Avian myeloblastosis virus,Avian myeloblastosis virus,11866,IC50,uM,UO_0000065,,CHEMBL613550
2923,1056101.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(NN2C=NC(C)C2c2cccc(C#N)c2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL288727,CHEMBL288727,,0.0,http://www.openphacts.org/units/Nanomolar,62341.0,>,1.0,1.0,>,IC50,nM,44700.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,44.7,CHEMBL613499
2924,2929710.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSCc3ccccc3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL565680,CHEMBL565680,7.80,0.0,http://www.openphacts.org/units/Nanomolar,852864.0,=,1.0,1.0,=,IC50,nM,15.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,15.8,CHEMBL378
2925,1403189.0,[],CHEMBL837591,Inhibitory concentration against wild-type HIV-1 LAI Virus was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Nc2nc(Oc3ccc(C)cc3C)cn(C)c2=O)cc1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL177583,CHEMBL177583,,0.0,http://www.openphacts.org/units/Nanomolar,360642.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,umol,UO_0000065,100.0,CHEMBL378
2926,2947377.0,[],CHEMBL1038495,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)COc1ccccc1)[C@@H](OC(=O)COc1ccccc1)C(C)(C)OC(=O)COc1ccccc1)C1=C2C[C@H](OC(=O)COc3ccccc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL574328,CHEMBL574328,,0.0,http://www.openphacts.org/units/Nanomolar,850757.0,>,1.0,1.0,>,IC50,nM,1400000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.4,CHEMBL613497
2927,5247007.0,[],CHEMBL1687411,Antiviral activity against HIV1 Ba-L infected in human PBL cells assessed as reverse transcriptase activity after 7 days,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)NCC(CCN1C2CCC1CC(n1c(C)nc3ccccc31)C2)c1ccccc1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL1682569,CHEMBL1682569,,0.0,,1333681.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2928,3253224.0,[],CHEMBL1108002,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathicity in presence of 10% human serum,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(CNCc2ccc(CN(Cc3nc4ccccc4[nH]3)[C@H]3CCCc4cccnc43)cc2)nc1,CHEMBL1156989,J Med Chem,2010.0,CHEMBL1093137,CHEMBL1093137,7.09,0.0,http://www.openphacts.org/units/Nanomolar,902936.0,=,1.0,1.0,=,IC50,nM,81.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.081,CHEMBL378
2929,1751274.0,[],CHEMBL854523,Antiviral activity against wild type Measles virus Edmonston in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1ccc(O)c(NC(=O)Cc2ccccc2)c1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL212593,CHEMBL212593,4.18,0.0,http://www.openphacts.org/units/Nanomolar,532802.0,=,1.0,1.0,=,IC50,nM,66000.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,66.0,CHEMBL613738
2930,15466541.0,[],CHEMBL3533061,Antiviral activity against HIV1 expressing Env-green fluorescent fusion protein infected in PBMC assessed as inhibition of viral activity after 72 hrs by flow cytometry analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2cc(O)c(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL3525980,Drug Metab Dispos,2013.0,CHEMBL3526537,CHEMBL3526537,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,2468773.0,=,1.0,1.0,=,IC50,ug.mL-1,0.04468,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ng/ml,UO_0000274,44.68,CHEMBL378
2931,20663969.0,[],CHEMBL4618924,Antiviral activity against wild type HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CN2CCO[C@@H](C)C2)cc1,CHEMBL4616700,ACS Med Chem Lett,2020.0,CHEMBL4647025,CHEMBL4647025,7.59,0.0,http://www.openphacts.org/units/Nanomolar,3479368.0,=,1.0,1.0,=,IC50,nM,25.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,25.5,CHEMBL378
2932,22449743.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.5', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.5'}]",CHEMBL4680706,Antiviral activity against HIV1 YU-2 infected in dog Cf2Th/CD4-CCR5 cells assessed as inhibition of viral entry incubated for 30 mins prior to infection and measured after 48 hrs post infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CNCc1ccc2c(c1)C[C@@H](CNC(=N)N)[C@@H]2NC(=O)C(=O)Nc1ccc(Cl)c(F)c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4680075,ACS Med Chem Lett,2016.0,CHEMBL4794935,CHEMBL4803995,4.68,0.0,http://www.openphacts.org/units/Nanomolar,3518676.0,=,1.0,1.0,=,IC50,nM,21000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,21.0,CHEMBL378
2933,1402295.0,[],CHEMBL837469,In vitro inhibitory concentration against HIV V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NCc2ccccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177491,CHEMBL177491,,0.0,http://www.openphacts.org/units/Nanomolar,360417.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2934,13475624.0,[],CHEMBL2439263,Antiviral activity against Human immunodeficiency virus 1 clade C isolate ETH2220 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435853,CHEMBL2435853,8.55,0.0,http://www.openphacts.org/units/Nanomolar,1924228.0,=,1.0,1.0,=,IC50,nM,2.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.8,CHEMBL378
2935,2929586.0,[],CHEMBL1056892,Antiviral activity against HIV1 HXB2 harboring 100I mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL366692,CHEMBL366692,8.20,0.0,http://www.openphacts.org/units/Nanomolar,848229.0,=,1.0,1.0,=,IC50,nM,6.31,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.31,CHEMBL378
2936,18323326.0,[],CHEMBL4134874,Antiviral activity against VSV-G pseudotyped HIV1 infected in human SupT1 cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1cc(O)cc(OC)c1Oc1c(Cl)c(C)c(Cl)c(O)c1C(=O)O,CHEMBL4130477,J Nat Prod,2017.0,CHEMBL2035564,CHEMBL2035564,,0.0,,3042115.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2937,12627458.0,[],CHEMBL2317015,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC/N=c1/scc(-c2ccc(Br)cc2)n1/N=C/c1ccc(O)c(O)c1O,CHEMBL2311445,Bioorg Med Chem,2013.0,CHEMBL2311913,CHEMBL2311913,,0.0,http://www.openphacts.org/units/Nanomolar,1841413.0,>,1.0,1.0,>,IC50,nM,35000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,35.0,CHEMBL378
2938,2930181.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCSCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578367,CHEMBL578367,8.20,0.0,http://www.openphacts.org/units/Nanomolar,852822.0,=,1.0,1.0,=,IC50,nM,6.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.3,CHEMBL378
2939,2244557.0,[],CHEMBL1002217,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase K101E mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL593,CHEMBL593,6.27,0.0,http://www.openphacts.org/units/Nanomolar,798656.0,=,1.0,1.0,=,IC50,nM,537.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,537.0,CHEMBL378
2940,688384.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,C(=Nc1ccc(SSc2ccc(N=Cc3ccccc3)cc2)cc1)c1ccccc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120739,CHEMBL120739,,0.0,,228632.0,=,1.0,0.0,=,IC50,,33.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,33.3,CHEMBL378
2941,12542815.0,[],CHEMBL3076900,Antiviral activity against Human immunodeficiency virus 1 IIIB infected MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,NNc1nc2ccc(Br)cc2s1,CHEMBL3046062,Med Chem Res,2013.0,CHEMBL1241372,CHEMBL1241372,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824472.0,>,1.0,1.0,>,IC50,ug.mL-1,8.01,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,8.01,CHEMBL378
2942,23228471.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '36.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '36.0'}]",CHEMBL4826198,Antiviral activity against Human hepatitis B virus in Huh-7 cells assessed as reduction in intracellular viral DNA level incubated for 36 hrs by qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CS(=O)(=O)c1nc(Nc2ccc(F)c(Br)c2)cc(N2CCNCC2)n1,CHEMBL4825668,J Med Chem,2021.0,CHEMBL4872332,CHEMBL4872332,6.26,0.0,http://www.openphacts.org/units/Nanomolar,3613089.0,=,1.0,1.0,=,IC50,nM,547.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.547,CHEMBL613497
2943,2570689.0,[],CHEMBL1000472,Antiviral activity against hepatitis B virus-infected human HepG2.2.15 cells assessed as inhibition of HBV surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@H](OC(=O)C(C)C)[C@H](C[C@@H](C)[C@]12CC[C@@]3(C)[C@@]1(C[C@H](OC(=O)C(C)C)[C@H]1[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@@]13C)O2)OC(=O)C(C)C,CHEMBL1155923,Bioorg Med Chem Lett,2008.0,CHEMBL505990,CHEMBL505990,,0.0,http://www.openphacts.org/units/Nanomolar,769068.0,>,1.0,1.0,>,IC50,nM,1300000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.3,CHEMBL613497
2944,3253150.0,[],CHEMBL1107997,Antiviral activity against HIV1 NL4.3 infected in human MT4 cells expressing CD4 and CXCR4 assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NCCCC(=O)N(Cc1nc2ccccc2[nH]1)C1CCCc2cccnc21,CHEMBL1156989,J Med Chem,2010.0,CHEMBL1092629,CHEMBL1092629,5.58,0.0,http://www.openphacts.org/units/Nanomolar,902151.0,=,1.0,1.0,=,IC50,nM,2640.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.64,CHEMBL378
2945,16556879.0,[],CHEMBL3795205,Antiviral activity against CXCR4 using HIV-1 NL4.3 infected in human MT4 cells assessed as reduction of viral replication preincubated for 15 mins with cells followed by viral infection measured after 4 days by MTS/PES method,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(CC2CCCCC2)CCCN(S(=O)(=O)c2ccc(O)cc2)C1.Cl,CHEMBL3792300,J Med Chem,2016.0,CHEMBL3793999,CHEMBL3794638,,0.0,,2770909.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
2946,14653360.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)/C=C/c3cccc(OC)c3)[C@H](O)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262979,CHEMBL3262979,,0.0,http://www.openphacts.org/units/Nanomolar,2101861.0,>,1.0,1.0,>,IC50,nM,513000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,513.0,CHEMBL613497
2947,13449288.0,[],CHEMBL2428633,Antiviral activity against HIV1 LAI infected in human MT2 cells by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2COC[C@H]3O[C@@H]4OCC[C@@H]4[C@@H]23)cc1,CHEMBL2424573,J Med Chem,2013.0,CHEMBL2426458,CHEMBL2426458,8.35,0.0,http://www.openphacts.org/units/Nanomolar,1919764.0,=,1.0,1.0,=,IC50,nM,4.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0045,CHEMBL378
2948,10863215.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C[C@H]4O[C@]45[C@@H]4C[C@@](C)(C(=O)O)CC[C@]4(C)CC[C@@]5(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2023712,CHEMBL2023712,4.74,0.0,http://www.openphacts.org/units/Nanomolar,1639321.0,=,1.0,1.0,=,IC50,nM,18370.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,18.37,CHEMBL613497
2949,18700309.0,[],CHEMBL4254757,Antiviral activity against HIV1 NL4-3 infected in human MT2 cells incubated for 72 hrs followed by reinfection in human TZM-bl cells measured after 48 hrs by luciferase reporter gene based bicycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c2cc(S(=O)(=O)Nc3ccc4[nH]ncc4c3)ccc2o1,CHEMBL4251639,Eur J Med Chem,2018.0,CHEMBL4288780,CHEMBL4288780,4.44,0.0,http://www.openphacts.org/units/Nanomolar,3105628.0,=,1.0,1.0,=,IC50,nM,36400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,36.4,CHEMBL378
2950,2530530.0,[],CHEMBL1011336,Antiviral activity against Rift Valley fever virus infected in african green monkey Vero cells after 6 days by plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](O)[C@@H]2c3cc4c(cc3C(=O)N[C@H]2[C@@H]1OC(C)=O)OCO4,CHEMBL1150051,J Nat Prod,1992.0,CHEMBL478100,CHEMBL478100,,0.0,,790655.0,,1.0,0.0,,IC50,,,CHEMBL613130,Rift Valley fever virus,Rift Valley fever virus,11588,IC50,,,,CHEMBL613130
2951,1401928.0,[],CHEMBL837471,In vitro inhibitory concentration against HIV Y188L mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCNc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL174339,CHEMBL174339,4.00,0.0,http://www.openphacts.org/units/Nanomolar,360384.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2952,15168042.0,[],CHEMBL3406882,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as HBeAg secretion after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)Nc1nc2cc(C(=O)c3cccc(OC)c3)ccc2[nH]1,CHEMBL3399962,Bioorg Med Chem,2015.0,CHEMBL3401074,CHEMBL3401074,,0.0,http://www.openphacts.org/units/Nanomolar,2281850.0,=,1.0,1.0,=,IC50,nM,478700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,478.7,CHEMBL613497
2953,1498121.0,[],CHEMBL833971,Concentration required to inhibit 50% viral production of human immunodeficiency virus type 1 (HIV-1-IIIB),F,BAO_0000190,BAO_0000218,organism-based format,Fc1cccc(Cl)c1CCNC(=S)Nc1nccs1,CHEMBL1143567,J Med Chem,2005.0,CHEMBL252137,CHEMBL252137,7.30,0.0,http://www.openphacts.org/units/Nanomolar,388177.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.05,CHEMBL378
2954,5306747.0,[],CHEMBL1696828,Antiviral activity against R5 tropic HIV1 BaL infected in human TZM-b1 cells after 2 hrs by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,CHEMBL1687731,Antimicrob Agents Chemother,2009.0,CHEMBL483,CHEMBL483,5.60,0.0,http://www.openphacts.org/units/Nanomolar,1337339.0,=,1.0,1.0,=,IC50,nM,2518.67,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2518.67,CHEMBL378
2955,3014060.0,[],CHEMBL1042767,Antiviral activity against HIV1 3B infected in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,CN(Cc1nc2cccc(C(=O)NCCCN)c2[nH]1)C1CCCc2cccnc21,CHEMBL1155333,Bioorg Med Chem Lett,2009.0,CHEMBL576427,CHEMBL576427,6.87,0.0,http://www.openphacts.org/units/Nanomolar,854954.0,=,1.0,1.0,=,IC50,nM,134.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.134,CHEMBL378
2956,1470275.0,[],CHEMBL833077,Inhibitory activity against HIV-1 mutant strain 106A,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL366692,CHEMBL366692,8.22,0.0,http://www.openphacts.org/units/Nanomolar,380699.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
2957,6216898.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2cccnc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784401,CHEMBL1784401,6.46,0.0,http://www.openphacts.org/units/Nanomolar,1429339.0,=,1.0,1.0,=,IC50,nM,346.74,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.46,CHEMBL378
2958,1402594.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(NC(=S)NC(=O)c2ccccc2)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177383,CHEMBL177383,5.20,0.0,http://www.openphacts.org/units/Nanomolar,360418.0,=,1.0,1.0,=,IC50,nM,6310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.31,CHEMBL378
2959,1221012.0,[],CHEMBL710376,Inhibitory activity against 100I strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL593,CHEMBL593,5.60,0.0,http://www.openphacts.org/units/Nanomolar,127447.0,=,1.0,1.0,=,IC50,nM,2512.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.512,CHEMBL378
2960,3253130.0,[],CHEMBL1107997,Antiviral activity against HIV1 NL4.3 infected in human MT4 cells expressing CD4 and CXCR4 assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(CNCc2ccc(CN(CCCc3nc4ccccc4[nH]3)C3CCCc4cccnc43)cc2)nc1,CHEMBL1156989,J Med Chem,2010.0,CHEMBL1092252,CHEMBL1092252,5.92,0.0,http://www.openphacts.org/units/Nanomolar,901825.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.2,CHEMBL378
2961,2929633.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(=O)CSCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL577277,CHEMBL577277,6.80,0.0,http://www.openphacts.org/units/Nanomolar,852931.0,=,1.0,1.0,=,IC50,nM,158.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,158.0,CHEMBL378
2962,18987178.0,[],CHEMBL4340290,Antiviral activity against HIV NL4-3 infected in human MT4 cells measured on day 3 post-infection by Nano-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC/C=C\C=C\C(=O)O[C@@H]1C(COC(C)=O)=C[C@@H]2C(=O)[C@]3(C=C(C)[C@H](O)[C@@]13O)[C@H](C)C[C@@H]1[C@H]2C1(C)C,CHEMBL4339238,J Nat Prod,2019.0,CHEMBL3814910,CHEMBL3814910,9.15,0.0,http://www.openphacts.org/units/Nanomolar,3167476.0,=,1.0,1.0,=,IC50,nM,0.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.7,CHEMBL378
2963,1402245.0,[],CHEMBL837465,In vitro inhibitory concentration against HIV G190S mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(CC)CC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175534,CHEMBL175534,,0.0,http://www.openphacts.org/units/Nanomolar,360399.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
2964,22845270.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '49.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '49.0'}]",CHEMBL4721685,Antiviral activity against clinical isolate HIV-1 93RW034 infected in human PBMC cells assessed as reduction in viral transmission to TZM-bl cells pretreated for 1 hr before viral transmission and further incubated for 48 hrs by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1nc(CO)cs1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4761836,CHEMBL4761836,6.54,0.0,http://www.openphacts.org/units/Nanomolar,3547085.0,=,1.0,1.0,=,IC50,nM,290.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.29,CHEMBL378
2965,2371543.0,[],CHEMBL1035741,Antiviral activity against HIV1 with reverse transcriptase Y188L mutant in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4nc(N)ccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL489586,CHEMBL489586,,0.0,http://www.openphacts.org/units/Nanomolar,773548.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
2966,37590.0,[],CHEMBL695514,Antiviral activity against K103N/P225H strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL223228,CHEMBL223228,6.82,0.0,http://www.openphacts.org/units/Nanomolar,20823.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,150.0,CHEMBL378
2967,18683218.0,[],CHEMBL4237086,Antiviral activity against CCR5-dependent HIV1 SF162 infected in human TZM-bl cells assessed as reduction in virus infection measured after 48 hrs post infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccnc1,CHEMBL4229569,J Med Chem,2018.0,CHEMBL4248733,CHEMBL4248733,5.82,0.0,http://www.openphacts.org/units/Nanomolar,3103080.0,=,1.0,1.0,=,IC50,nM,1520.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1520.3,CHEMBL378
2968,1502777.0,[],CHEMBL834971,Inhibitory concentration against hepatitis C virus NS3 protease (IC50 spans 2.5 log units),B,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H](C(=O)N[C@H](C(=O)C1C[C@H](Oc2ccccc2)C[C@H]1C(=O)CC1(C(=O)O)CC1)C(C)C)C1CCCCC1,CHEMBL1143583,J Med Chem,2005.0,CHEMBL189885,CHEMBL189885,4.10,0.0,http://www.openphacts.org/units/Nanomolar,388502.0,=,1.0,1.0,=,IC50,nM,79432.82,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,Log 1/IC50,,UO_0000065,4.1,CHEMBL4620
2969,2292389.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc([S+]([O-])c2cccc(N)c2C#N)c1,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL54318,CHEMBL54318,,0.0,http://www.openphacts.org/units/Nanomolar,813485.0,=,1.0,1.0,=,IC50,nM,339625.27,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,3.469,CHEMBL378
2970,15690078.0,[],CHEMBL3610403,Antiviral activity against HIV1 3B infected in CD4/CXCR4 expressing human MAGI cells incubated for 48 hrs by beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(Cc2cn[nH]c2C2CCN(Cc3cccnc3)CC2)cc1,CHEMBL3608277,ACS Med Chem Lett,2015.0,CHEMBL3608762,CHEMBL3608762,5.24,0.0,http://www.openphacts.org/units/Nanomolar,2496840.0,=,1.0,1.0,=,IC50,nM,5800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.8,CHEMBL378
2971,1982309.0,[],CHEMBL899339,Antiviral activity against HBV transfected Hep G2.2.15 cells assessed as inhibition of e antigen HBsAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c3c1-c1c(ccc(O)c1O)C[C@@H]3[N+](C)(C)CC2,CHEMBL1149710,Bioorg Med Chem Lett,2007.0,CHEMBL235213,CHEMBL235213,,0.0,http://www.openphacts.org/units/Nanomolar,661662.0,>,1.0,1.0,>,IC50,nM,3615000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,3.615,CHEMBL613497
2972,22845266.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '49.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '49.0'}]",CHEMBL4721684,Antiviral activity against clinical isolate HIV-1 93RW018 infected in human PBMC cells assessed as reduction in viral transmission to TZM-bl cells pretreated for 1 hr before viral transmission and further incubated for 48 hrs by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4747551,CHEMBL4747551,5.60,0.0,http://www.openphacts.org/units/Nanomolar,3547084.0,=,1.0,1.0,=,IC50,nM,2500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.5,CHEMBL378
2973,2997534.0,[],CHEMBL1046974,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C(=N/Cc2ccc(F)cc2)c2ccc(=O)n(Cc3ccc(F)cc3)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL566907,CHEMBL566907,,0.0,http://www.openphacts.org/units/Nanomolar,856682.0,>,1.0,1.0,>,IC50,nM,86900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,86.9,CHEMBL613497
2974,22806635.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@@H](Sc3c(OC)cccc3OC)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4744106,CHEMBL4744106,5.66,0.0,http://www.openphacts.org/units/Nanomolar,3541923.0,=,1.0,1.0,=,IC50,nM,2169.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.169,CHEMBL613497
2975,3253119.0,[],CHEMBL1107997,Antiviral activity against HIV1 NL4.3 infected in human MT4 cells expressing CD4 and CXCR4 assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NCCN(Cc1ccc(CNCc2ccccn2)cc1)C1CCCc2cccnc21,CHEMBL1156989,J Med Chem,2010.0,CHEMBL1091176,CHEMBL1091176,,0.0,http://www.openphacts.org/units/Nanomolar,902848.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.0,CHEMBL378
2976,19162200.0,[],CHEMBL4383613,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells after 7 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2ccc3c(c2)[C@H](N)CC[C@@H]3O)cc1,CHEMBL4382211,Eur J Med Chem,2018.0,CHEMBL4452621,CHEMBL4452621,,0.0,http://www.openphacts.org/units/Nanomolar,3198008.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
2977,2570669.0,[],CHEMBL1000470,Antiviral activity against hepatitis B virus-infected human HepG2.2.15 cells assessed as inhibition of HBV e antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)c1ccccc1)[C@@H](OC(=O)c1ccccc1)C(C)(C)O)C1=C2C[C@H](OC(=O)c3ccccc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1155923,Bioorg Med Chem Lett,2008.0,CHEMBL473889,CHEMBL473889,,0.0,http://www.openphacts.org/units/Nanomolar,768984.0,>,1.0,1.0,>,IC50,nM,1500000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.5,CHEMBL613497
2978,13475548.0,[],CHEMBL2439263,Antiviral activity against Human immunodeficiency virus 1 clade C isolate ETH2220 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435852,CHEMBL2435852,7.83,0.0,http://www.openphacts.org/units/Nanomolar,1924227.0,=,1.0,1.0,=,IC50,nM,14.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,14.7,CHEMBL378
2979,19261969.0,[],CHEMBL4404404,Antiviral activity against HIV1 subtypeD QA013.70I.ENV.M12,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.66,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.22,CHEMBL378
2980,19261873.0,[],CHEMBL4404372,Antiviral activity against HIV1 subtypeA/G CRF02_AG clone 257,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.41,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,390.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.39,CHEMBL378
2981,15666417.0,[],CHEMBL3602747,Antiviral activity against ENF-resistant HIV1 NL4-3 harboring gp41 N-terminal heptad repeat D36S/V38M double mutant infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL3600303,J Med Chem,2015.0,CHEMBL428607,CHEMBL428607,8.92,0.0,http://www.openphacts.org/units/Nanomolar,2492328.0,=,1.0,1.0,=,IC50,nM,1.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.2,CHEMBL378
2982,5132879.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)n2c3ccccc3n(C[C@H](O)N3CCN(CCO)CC3)c2c1C#N,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645091,CHEMBL1645091,,0.0,http://www.openphacts.org/units/Nanomolar,1321080.0,>,1.0,1.0,>,IC50,nM,30600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,30.6,CHEMBL378
2983,5109707.0,[],CHEMBL1636469,"Antiviral activity against HIV1 HXB-2D harboring reverse transcriptase M184V, M41L and T215Y mutant gene infected in human cord blood mononuclear cells",F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@H]2CO[C@@H](CO)S2)c(=O)n1,CHEMBL1629678,Antimicrob Agents Chemother,2009.0,CHEMBL210651,CHEMBL210651,4.87,0.0,http://www.openphacts.org/units/Nanomolar,1314778.0,=,1.0,1.0,=,IC50,nM,13390.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,13.39,CHEMBL378
2984,2199477.0,[],CHEMBL952477,Antiviral activity against HBV in mouse ayw wild type HBV-Met cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH][nH]c(=O)c2c(-c3ccc4c(c3)OCO4)c3c4c(ccc3cc12)OCO4,CHEMBL1156464,Proc Natl Acad Sci U S A,2007.0,CHEMBL369673,CHEMBL369673,6.52,0.0,http://www.openphacts.org/units/Nanomolar,791641.0,=,1.0,1.0,=,IC50,nM,300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.3,CHEMBL613497
2985,14653477.0,[],CHEMBL3267146,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(CO)[C@H](OC(=O)/C=C/c3ccccc3)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3263003,CHEMBL3263003,,0.0,http://www.openphacts.org/units/Nanomolar,2101886.0,=,1.0,1.0,=,IC50,nM,1169000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1169.0,CHEMBL613497
2986,2929548.0,[],CHEMBL1056895,Antiviral activity against HIV1 HXB2 harboring 138K mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3cnnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL584409,CHEMBL584409,8.96,0.0,http://www.openphacts.org/units/Nanomolar,848312.0,=,1.0,1.0,=,IC50,nM,1.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.1,CHEMBL378
2987,2601801.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C=C[C@@](C#CCl)(CO)O2)c(=O)[nH]c1=O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL504843,CHEMBL504843,4.00,0.0,http://www.openphacts.org/units/Nanomolar,808131.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
2988,843541.0,[],CHEMBL713546,Compound potency to achieve protection of MT-4 cells from HIV-1 cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(NC(=S)NC(=N)Cc2ccccc2)cc1,CHEMBL1134808,Bioorg Med Chem Lett,2001.0,CHEMBL69788,CHEMBL69788,6.42,0.0,http://www.openphacts.org/units/Nanomolar,126227.0,=,1.0,1.0,=,IC50,nM,380.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.38,CHEMBL378
2989,442632.0,[],CHEMBL683690,Inhibitory effect upon disintegration catalyzed by the (50-212) deletion mutant,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2ccc(/C=C/c3ccc([N+](=O)[O-])cc3)nc2c1O,CHEMBL1133718,J Med Chem,2000.0,CHEMBL431508,CHEMBL431508,5.66,0.0,http://www.openphacts.org/units/Nanomolar,61384.0,=,1.0,1.0,=,IC50,nM,2200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.2,CHEMBL378
2990,24726240.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5114457,Antiviral activity against HIV-1 IIIB infected in human MT4 cells assessed as reduction in cytopathic effect measured after 5 days by Cell Titer Glo assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(F)c(Oc2cc(N)nc(Nc3ccc(C#N)cc3)n2)c(F)c1,CHEMBL5113385,Eur J Med Chem,2022.0,CHEMBL5179344,CHEMBL5179344,8.52,0.0,http://www.openphacts.org/units/Nanomolar,3857034.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.0,CHEMBL378
2991,24830959.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)[C@H]1CN(c2ccc3c(=O)c4cccc(Cl)c4oc3c2)C[C@@H]1c1ccc(F)cc1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5185037,CHEMBL5185037,5.13,0.0,http://www.openphacts.org/units/Nanomolar,3878132.0,=,1.0,1.0,=,IC50,nM,7390.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,7.39,CHEMBL613497
2992,22753382.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4700293,Antiviral activity against Vaccinia virus Copenhagen infected in African green monkey Vero cells assessed as reduction in cell survival incubated for 4 days by neutral red dye based colorimetric analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCC/C(C)=C/CNC(=O)C12CC3CC(CC(C3)C1)C2,CHEMBL4699424,RSC Med Chem,2020.0,CHEMBL4753749,CHEMBL4753749,5.23,0.0,http://www.openphacts.org/units/Nanomolar,3531601.0,=,1.0,1.0,=,IC50,nM,5900.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,5.9,CHEMBL613493
2993,2292361.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(C(F)(F)F)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL55186,CHEMBL55186,4.05,0.0,http://www.openphacts.org/units/Nanomolar,812520.0,=,1.0,1.0,=,IC50,nM,89949.76,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.046,CHEMBL378
2994,5230921.0,[],CHEMBL1676882,Antiviral activity against of Human immunodeficiency virus 1 3B infected in AA5 cells infected with 3.13 uL of virus stock assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL129,CHEMBL129,9.40,0.0,http://www.openphacts.org/units/Nanomolar,1332124.0,=,1.0,1.0,=,IC50,nM,0.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0004,CHEMBL378
2995,23346025.0,[],CHEMBL4882592,Invitrogen kinase assay (FER),B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1,CHEMBL4507285,,2021.0,CHEMBL3685796,CHEMBL3685796,,0.0,http://www.openphacts.org/units/Nanomolar,3359699.0,,54.0,1.0,,IC50,nM,232.0,CHEMBL3982,Homo sapiens,Tyrosine-protein kinase FER,9606,IC50,nM,UO_0000065,232.0,CHEMBL3982
2996,637623.0,[],CHEMBL683819,Anti-HIV activity in cell culture assay expressed as IC50 values.,F,BAO_0000190,BAO_0000218,organism-based format,Oc1cc(O)c2c(c1)O[C@@]1(c3ccc(O)c(O)c3)Oc3cc(O)c4c(c3[C@@H]2[C@H]1O)O[C@H](c1ccc(O)c(O)c1)[C@H](O)C4,CHEMBL1126373,Bioorg Med Chem Lett,1992.0,CHEMBL286933,CHEMBL286933,,0.0,http://www.openphacts.org/units/Nanomolar,60623.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.0,CHEMBL378
2997,24830982.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc2c(=O)c3cccc(Cl)c3oc2c1)c1ccccc1[N+](=O)[O-],CHEMBL5137099,J Med Chem,2022.0,CHEMBL5178247,CHEMBL5178247,,0.0,http://www.openphacts.org/units/Nanomolar,3878094.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
2998,3253128.0,[],CHEMBL1107997,Antiviral activity against HIV1 NL4.3 infected in human MT4 cells expressing CD4 and CXCR4 assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(CNCc2ccc(CN(Cc3nc4ccccc4s3)C3CCCc4cccnc43)cc2)nc1,CHEMBL1156989,J Med Chem,2010.0,CHEMBL1089868,CHEMBL1089868,5.34,0.0,http://www.openphacts.org/units/Nanomolar,901749.0,=,1.0,1.0,=,IC50,nM,4600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.6,CHEMBL378
2999,23284026.0,[],CHEMBL4837921,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)C1CCNCC1)S(=O)(=O)c1ccc(C(F)(F)F)cc1,CHEMBL4837199,Eur J Med Chem,2021.0,CHEMBL4846696,CHEMBL4846696,7.58,0.0,http://www.openphacts.org/units/Nanomolar,3622958.0,=,1.0,1.0,=,IC50,nM,26.48,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,26.48,CHEMBL378
3000,16498271.0,[],CHEMBL3778315,Antiviral activity against HIV1 CXCR4-tropic strain HxB2 infected in human 293T cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2csc(N3N=C(c4ccccc4)/C(=N/Nc4ccc5c(S(=O)(=O)O)cc(S(=O)(=O)O)cc5c4)C3=O)n2)cc1,CHEMBL3774382,Bioorg Med Chem,2016.0,CHEMBL3775965,CHEMBL3775965,5.12,0.0,http://www.openphacts.org/units/Nanomolar,2762406.0,=,1.0,1.0,=,IC50,nM,7500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.5,CHEMBL378
3001,2570656.0,[],CHEMBL1000470,Antiviral activity against hepatitis B virus-infected human HepG2.2.15 cells assessed as inhibition of HBV e antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@H](OC(=O)CC)[C@H](C[C@@H](C)[C@]12CC[C@@]3(C)[C@@]1(C[C@H](OC(=O)CC)[C@H]1[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@@]13C)O2)OC(=O)CC,CHEMBL1155923,Bioorg Med Chem Lett,2008.0,CHEMBL504405,CHEMBL504405,,0.0,http://www.openphacts.org/units/Nanomolar,769067.0,>,1.0,1.0,>,IC50,nM,2500000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.5,CHEMBL613497
3002,2099784.0,[],CHEMBL949220,Antiviral activity against HIV1 BaL by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)N(CCCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nc4c2CCN(C(=O)C2CCCC2)C4)C3)c2ccccc2)cc1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL270579,CHEMBL270579,8.10,0.0,http://www.openphacts.org/units/Nanomolar,699405.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
3003,18044732.0,[],CHEMBL4010429,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 pTHR04156 clone 18,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.27,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,540.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.54,CHEMBL378
3004,2929665.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CN(C)CCC#N)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL573732,CHEMBL573732,6.00,0.0,http://www.openphacts.org/units/Nanomolar,848258.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
3005,2930448.0,[],CHEMBL1056902,Antiviral activity against HIV1 HXB2 harboring K103N and Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCSCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578367,CHEMBL578367,7.70,0.0,http://www.openphacts.org/units/Nanomolar,852822.0,=,1.0,1.0,=,IC50,nM,19.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.9,CHEMBL378
3006,1977611.0,[],CHEMBL897738,Antiviral activity against influenza B/Jingfang/76/98 in MDCK cells by CPE assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,CHEMBL1149649,Bioorg Med Chem Lett,2007.0,CHEMBL1643,CHEMBL1643,4.82,0.0,http://www.openphacts.org/units/Nanomolar,660259.0,=,1.0,1.0,=,IC50,nM,15200.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,15.2,CHEMBL613129
3007,12091419.0,[],CHEMBL2168515,Antiviral activity against R5 tropic HIV1 Ba-L infected human PBMC assessed as inhibition of viral replication by p-24 antigen specific ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)NO)CC1,CHEMBL2163215,ACS Med Chem Lett,2012.0,CHEMBL2164205,CHEMBL2164205,6.46,0.0,http://www.openphacts.org/units/Nanomolar,1736628.0,=,1.0,1.0,=,IC50,nM,344.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,344.0,CHEMBL378
3008,24731861.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5115940,Antiviral activity against ZIKV-SMGC-1 infected in human BHK cells incubated for 7 days by CellTiter 96 luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(c1ccc(C(F)(F)F)cc1O)c1[nH]c(Cl)c(Cl)c1-n1c(C(=O)c2ccc(C(F)(F)F)cc2O)cc(Cl)c1Cl,CHEMBL5113415,Eur J Med Chem,2022.0,CHEMBL3393622,CHEMBL3393622,,0.0,http://www.openphacts.org/units/Nanomolar,3857937.0,>,1.0,1.0,>,IC50,nM,300.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,0.3,CHEMBL4296612
3009,1401653.0,[],CHEMBL833792,In vitro inhibitory concentration against HIV-1 Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL174726,CHEMBL174726,6.50,0.0,http://www.openphacts.org/units/Nanomolar,360353.0,=,1.0,1.0,=,IC50,nM,316.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.316,CHEMBL378
3010,1751345.0,[],CHEMBL854523,Antiviral activity against wild type Measles virus Edmonston in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cccc(NC(=O)Cc2ccccc2)c1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL215684,CHEMBL215684,5.19,0.0,http://www.openphacts.org/units/Nanomolar,532790.0,=,1.0,1.0,=,IC50,nM,6500.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,6.5,CHEMBL613738
3011,912492.0,[],CHEMBL728516,Anti-HIV activity against HIV-1 IIIB chronically infected Molt-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1N1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C(C)C)c3c2OC(F)F)CC1,CHEMBL1131862,Bioorg Med Chem Lett,1999.0,CHEMBL102882,CHEMBL102882,7.00,0.0,http://www.openphacts.org/units/Nanomolar,194313.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
3012,18044392.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,NCC(NC(=O)c1ccc(-c2ccc(Cl)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4074477,CHEMBL4074477,5.89,0.0,http://www.openphacts.org/units/Nanomolar,2990209.0,=,1.0,1.0,=,IC50,nM,1300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.3,CHEMBL378
3013,15568226.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(F)cc1)N1CCN(S(=O)(=O)CCc2ccccc2)CC1,CHEMBL1201862,,,CHEMBL3560820,CHEMBL3560820,8.48,0.0,http://www.openphacts.org/units/Nanomolar,2475603.0,=,7.0,1.0,=,IC50,nM,3.27,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.00327,CHEMBL3259470
3014,3406153.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1-c1oc2ccc(NC(C)=O)cc2c(=O)c1O,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1215601,CHEMBL1215601,,0.0,http://www.openphacts.org/units/Nanomolar,933358.0,=,1.0,1.0,=,IC50,nM,384600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,384.6,CHEMBL378
3015,18044786.0,[],CHEMBL4010393,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype C ZM249M.PL1,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.15,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,710.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.71,CHEMBL378
3016,611395.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,CSc1nc(Cc2c(Cl)cccc2Cl)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL70990,CHEMBL70990,7.75,0.0,http://www.openphacts.org/units/Nanomolar,126936.0,=,1.0,1.0,=,IC50,nM,18.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.018,CHEMBL378
3017,18530804.0,[],CHEMBL4195355,Antiviral activity against HIV-1 LAI infected in human MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(=O)O[C@@H]1C[C@@H]2CO[C@@H]3OCC[C@H]1[C@H]23)S(=O)(=O)c1ccc2nc(NC3CC3)sc2c1,CHEMBL4190391,J Med Chem,2018.0,CHEMBL4214453,CHEMBL4214453,10.57,0.0,http://www.openphacts.org/units/Nanomolar,3076699.0,=,1.0,1.0,=,IC50,nM,0.027,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.027,CHEMBL378
3018,10961213.0,[],CHEMBL2061270,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M5 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCC(C)(C)C)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058323,CHEMBL2058323,8.15,0.0,http://www.openphacts.org/units/Nanomolar,1656263.0,=,1.0,1.0,=,IC50,nM,7.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.0,CHEMBL378
3019,13972696.0,[],CHEMBL3134629,Antiviral activity against HIV-1 HTLV-3B infected in human PBMC cells assessed as inhibition of viral production by p24 antigen production/ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCOC(=O)OC[C@@H]1CC[C@H](n2cnc3c(=O)nc[nH]c32)O1,CHEMBL3132835,Medchemcomm,2014.0,CHEMBL3133804,CHEMBL3133804,,0.0,http://www.openphacts.org/units/Nanomolar,1975643.0,=,1.0,1.0,=,IC50,nM,300000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,0.3,CHEMBL378
3020,16498311.0,[],CHEMBL3778319,Antiviral activity against HIV1 CXCR4-tropic strain HxB2 infected in human 293T cells at 400 uM after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1=NN(c2nc(C(F)(F)F)cs2)C(=O)/C1=N\Nc1ccc2c(S(=O)(=O)O)cc(S(=O)(=O)O)cc2c1,CHEMBL3774382,Bioorg Med Chem,2016.0,CHEMBL3774422,CHEMBL3774422,,0.0,,2762404.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
3021,670699.0,[],CHEMBL683819,Anti-HIV activity in cell culture assay expressed as IC50 values.,F,BAO_0000190,BAO_0000218,organism-based format,Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@H](O)[C@H]2c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2,CHEMBL1126373,Bioorg Med Chem Lett,1992.0,CHEMBL38714,CHEMBL38714,,0.0,http://www.openphacts.org/units/Nanomolar,60625.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.0,CHEMBL378
3022,24735328.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5116803,Antiviral activity against CHIKV infected in human Huh-7 cells assessed as inhibition of viral infection by measuring EGFP-positive cells measured 24 hrs post infection by fluorescent microscopic analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=c1cc(-c2ccc(Nc3ccc(Cl)cc3)cc2)oc2cc(O)c(O)c(O)c12,CHEMBL5113447,Bioorg Med Chem Lett,2022.0,CHEMBL5206997,CHEMBL5206997,5.47,0.0,http://www.openphacts.org/units/Nanomolar,3858579.0,=,1.0,1.0,=,IC50,nM,3400.0,CHEMBL4296563,Chikungunya virus,Chikungunya virus,37124,IC50,uM,UO_0000065,3.4,CHEMBL4296563
3023,594085.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,CNc1nc(Cc2c(Cl)cccc2Cl)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL72059,CHEMBL72059,8.15,0.0,http://www.openphacts.org/units/Nanomolar,126906.0,=,1.0,1.0,=,IC50,nM,7.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.007,CHEMBL378
3024,14654442.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)c3ccccc3C(=O)O)[C@H](O)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3263002,CHEMBL3263002,4.41,0.0,http://www.openphacts.org/units/Nanomolar,2101885.0,=,1.0,1.0,=,IC50,nM,39400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,39.4,CHEMBL613497
3025,15166162.0,[],CHEMBL3404736,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as decrease in viral DNA replication treated for 7 days by real time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(O[C@@H]2O[C@H](COC(=O)/C=C/c3ccc(F)cc3)[C@@H](O)[C@H](O)[C@H]2O)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402787,CHEMBL3402787,4.19,0.0,http://www.openphacts.org/units/Nanomolar,2284143.0,=,1.0,1.0,=,IC50,nM,64800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,64.8,CHEMBL613497
3026,1834526.0,[],CHEMBL909292,Antiviral activity against HIV1 isolate 5512 with V321 and M46L mutation in CBMCs,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,CHEMBL1142192,Antimicrob Agents Chemother,2007.0,CHEMBL584,CHEMBL584,7.51,0.0,http://www.openphacts.org/units/Nanomolar,625901.0,=,1.0,1.0,=,IC50,nM,31.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.031,CHEMBL378
3027,18044488.0,[],CHEMBL4010365,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of p24 antigen production pretreated with virus for 30 mins followed by 4 days incubation with cells by sandwich ELISA based multicycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,CNCC(NC(=O)c1ccc(-c2ccc(C)c(F)c2)[nH]1)c1nc(C)c(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4060002,CHEMBL4060002,5.96,0.0,http://www.openphacts.org/units/Nanomolar,2990183.0,=,1.0,1.0,=,IC50,nM,1100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.1,CHEMBL378
3028,2334907.0,[],CHEMBL996367,Antiviral activity against PIV3 in MDCK cells assessed as inhibition of virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,CHEMBL1151177,J Nat Prod,2004.0,CHEMBL474659,CHEMBL474659,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,738270.0,=,1.0,1.0,=,IC50,ug.mL-1,35.6,CHEMBL613126,Human parainfluenza virus 3,Human parainfluenza virus 3,11216,IC50,ug ml-1,UO_0000274,35.6,CHEMBL613126
3029,2601937.0,[],CHEMBL1034012,Antiviral activity against influenza virus,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc2c(c1)N(O)C(=O)/C2=C(\O)c1ccccc1)c1ccc(NC(=O)c2cccs2)cc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL461052,CHEMBL461052,4.70,0.0,http://www.openphacts.org/units/Nanomolar,807026.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL613128,unidentified influenza virus,unidentified influenza virus,11309,IC50,uM,UO_0000065,20.0,CHEMBL613128
3030,18342105.0,[],CHEMBL4139012,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)Nc2c[nH]c(=O)c(-c3cc(C)ccc3C)c2)c(O)c1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL4160642,CHEMBL4160642,4.59,0.0,http://www.openphacts.org/units/Nanomolar,3045883.0,=,1.0,1.0,=,IC50,nM,25800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,25.8,CHEMBL613497
3031,14999596.0,[],CHEMBL3364773,Antiviral activity against HIV1 harboring reverse transcriptase K103N/V108I double mutant infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL57,CHEMBL57,5.55,0.0,http://www.openphacts.org/units/Nanomolar,2248839.0,=,1.0,1.0,=,IC50,nM,2800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.8,CHEMBL378
3032,1502903.0,[],CHEMBL834971,Inhibitory concentration against hepatitis C virus NS3 protease (IC50 spans 2.5 log units),B,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H](C(=O)N[C@H](C(=O)C1C[C@H](Oc2cncc3ccccc23)C[C@H]1C(=O)CC1(C(=O)O)CC1)C(C)C)C1CCCCC1,CHEMBL1143583,J Med Chem,2005.0,CHEMBL190765,CHEMBL190765,5.40,0.0,http://www.openphacts.org/units/Nanomolar,389182.0,=,1.0,1.0,=,IC50,nM,3981.07,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,Log 1/IC50,,UO_0000065,5.4,CHEMBL4620
3033,2694303.0,[],CHEMBL1053929,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2nc3c(cc2c(CN2CCCC2)c1O)CSc1ccc(F)cc1-3,CHEMBL1152943,Bioorg Med Chem,2009.0,CHEMBL559036,CHEMBL559036,4.32,0.0,http://www.openphacts.org/units/Nanomolar,824940.0,=,1.0,1.0,=,IC50,nM,47700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,47.7,CHEMBL613497
3034,1472428.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(Br)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188223,CHEMBL188223,8.70,0.0,http://www.openphacts.org/units/Nanomolar,380674.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.002,CHEMBL378
3035,1401940.0,[],CHEMBL834487,In vitro inhibitory concentration value against HIV K103N and Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCNc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL424972,CHEMBL424972,,0.0,http://www.openphacts.org/units/Nanomolar,360389.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3036,19271303.0,[],CHEMBL4406717,Antiviral activity against atazanavir resistant HIV1 harboring protease L23I/E34Q/K43I/M46I/I50L/G51A/L63P/A71V/V82A/T91A mutant infected in human MT4 cells assessed as reduction in p24 Gag production,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,CHEMBL4402610,J Med Chem,2020.0,CHEMBL1163,CHEMBL1163,,0.0,http://www.openphacts.org/units/Nanomolar,3217934.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
3037,1041228.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CSc1nc(C)c(-c2ccccc2)n1Nc1cccc(Cl)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289337,CHEMBL289337,,0.0,http://www.openphacts.org/units/Nanomolar,62312.0,>,1.0,1.0,>,IC50,nM,42110.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,42.11,CHEMBL378
3038,1252270.0,[],CHEMBL677520,Concentration required to inhibit HIV-1(KOS) induced cytopathicity in E6SM cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCC(=O)N(CC)CCCCCCCCCCC(=O)NCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL116526,CHEMBL1205574,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221531.0,=,1.0,1.0,=,IC50,ug.mL-1,70.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,70.0,CHEMBL378
3039,15156740.0,[],CHEMBL3399645,Decrease in HBV viral DNA replication in human HepG2(2.2.15) cells at 0.75 to 3 uM after 72 hrs by real-time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(C)=O)c(OS(=O)(=O)c2ccc([N+](=O)[O-])cc2)c1,CHEMBL3397002,Eur J Med Chem,2015.0,CHEMBL3397413,CHEMBL3397413,5.94,0.0,http://www.openphacts.org/units/Nanomolar,2279260.0,=,1.0,1.0,=,IC50,nM,1150.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.15,CHEMBL613497
3040,13477925.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435911,CHEMBL2435911,,0.0,,1924287.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
3041,3100367.0,[],CHEMBL1064779,Antiviral activity against HIV1 LAI in human CEM-SS cells assessed as RT activity after 5 days by single passage assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1CO,CHEMBL1156918,J Med Chem,2010.0,CHEMBL376876,CHEMBL376876,4.52,0.0,http://www.openphacts.org/units/Nanomolar,887658.0,=,1.0,1.0,=,IC50,nM,30000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,30.0,CHEMBL378
3042,1472005.0,[],CHEMBL834620,Inhibitory activity against HIV-1 mutant strain 188L; ND = not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C\c2cnccn2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188309,CHEMBL188309,,0.0,http://www.openphacts.org/units/Nanomolar,380978.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3043,2188054.0,[],CHEMBL973323,Antiviral activity against HIV1 BaL in HOS-CD4-CCR5 cells by viral infectivity assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](C)NC(=O)CNC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C)C(=O)N[C@H](C)C(=O)O,CHEMBL1156527,Proc Natl Acad Sci U S A,2007.0,CHEMBL524891,CHEMBL524891,5.66,0.0,http://www.openphacts.org/units/Nanomolar,717672.0,=,1.0,1.0,=,IC50,nM,2200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.2,CHEMBL378
3044,5132877.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2[nH]c(=O)c(CN(Cc3ccco3)C(=O)c3cnn(C)c3)cc2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645059,CHEMBL1645059,,0.0,http://www.openphacts.org/units/Nanomolar,1321047.0,>,1.0,1.0,>,IC50,nM,26600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,26.6,CHEMBL378
3045,2602199.0,[],CHEMBL1034012,Antiviral activity against influenza virus,F,BAO_0000190,BAO_0000218,organism-based format,CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@@H](C(=O)O)C[C@H]1NC(=N)N,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL139367,CHEMBL139367,5.08,0.0,http://www.openphacts.org/units/Nanomolar,807946.0,=,1.0,1.0,=,IC50,nM,8400.0,CHEMBL613128,unidentified influenza virus,unidentified influenza virus,11309,IC50,uM,UO_0000065,8.4,CHEMBL613128
3046,24750963.0,[],CHEMBL5121091,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication by Nano-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCC(=O)O[C@@]12[C@H](OC(=O)c3ccccc3)[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@H]34)[C@@H]1C2(C)C,CHEMBL5120745,J Nat Prod,2021.0,CHEMBL5078905,CHEMBL5078905,9.74,0.0,http://www.openphacts.org/units/Nanomolar,3861272.0,=,1.0,1.0,=,IC50,nM,0.18,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.18,CHEMBL378
3047,5229740.0,[],CHEMBL1676712,Antiviral activity against Human immunodeficiency virus 1 subtype G JV 1083 infected in phytohemagglutininin and interleukin-2-stimulated PBMC assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,7.52,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.03,CHEMBL378
3048,2199482.0,[],CHEMBL952478,Antiviral activity against HBV in human HepG2(2.2.15) cells assessed as inhibition of viral pre-genomic RNA replication,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH][nH]c(=O)c2c(-c3ccc4c(c3)OCO4)c3c4c(ccc3cc12)OCO4,CHEMBL1156464,Proc Natl Acad Sci U S A,2007.0,CHEMBL369673,CHEMBL369673,6.52,0.0,http://www.openphacts.org/units/Nanomolar,791641.0,=,1.0,1.0,=,IC50,nM,300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.3,CHEMBL613497
3049,22933244.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)/C=C/c4ccc(O)c(O)c4)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL3936741,CHEMBL3936741,7.55,0.0,http://www.openphacts.org/units/Nanomolar,3560852.0,=,1.0,1.0,=,IC50,nM,28.18,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.55,CHEMBL378
3050,392808.0,[],CHEMBL874634,Inhibition of human peripheral blood mononuclear cell (PBMC)donor C proliferation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCC(=O)CC(=O)N[C@H]1CCOC1=O,CHEMBL1145979,J Med Chem,2003.0,CHEMBL8483,CHEMBL8483,4.46,0.0,http://www.openphacts.org/units/Nanomolar,4335.0,=,1.0,1.0,=,IC50,nM,35000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,35.0,CHEMBL378
3051,3129709.0,[],CHEMBL1064877,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=P([O-])(O)Cc1cc2c(O)c(c1)Cc1cc(CP(=O)([O-])O)cc(c1O)Cc1cc(CP(=O)([O-])O)cc(c1O)Cc1cc(CP(=O)([O-])O)cc(c1O)C2.[Na+].[Na+].[Na+].[Na+],CHEMBL1157689,Bioorg Med Chem,2010.0,CHEMBL590348,CHEMBL592901,,0.0,http://www.openphacts.org/units/Nanomolar,880945.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
3052,10969757.0,[],CHEMBL2065306,Antiviral activity against Influenza B virus (strain B/Jifang/13/97) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)Nc1cc(C(=O)Nc2ccc(C)cc2)ccc1OC,CHEMBL2062433,Eur J Med Chem,2012.0,CHEMBL2064581,CHEMBL2064581,,0.0,http://www.openphacts.org/units/Nanomolar,1660677.0,>,1.0,1.0,>,IC50,nM,23700.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,23.7,CHEMBL613129
3053,13463761.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1[S+]([O-])c1ccccc1Br,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL299781,CHEMBL299781,4.41,0.0,http://www.openphacts.org/units/Nanomolar,1920692.0,=,1.0,1.0,=,IC50,nM,38904.51,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.41,CHEMBL378
3054,18399198.0,[],CHEMBL4149754,Inhibition of human Pit-1 expressed in HEK293 cells coexpressing tetracyclin assessed as reduction in uptake of 33P-radiolabeled Pi incubated for 20 to 30 mins prior to substrate addition,B,BAO_0000190,BAO_0000219,cell-based format,Cc1[nH]c2c(N3CCC4(CCN(C)C4=O)CC3)c(C#N)c(C(F)(F)F)nc2c1Cl,CHEMBL4145593,ACS Med Chem Lett,2018.0,CHEMBL4168827,CHEMBL4168827,,0.0,http://www.openphacts.org/units/Nanomolar,3053878.0,>,1.0,1.0,>,IC50,nM,60000.0,CHEMBL4295909,Homo sapiens,Sodium-dependent phosphate transporter 1,9606,IC50,uM,UO_0000065,60.0,CHEMBL4295909
3055,3363272.0,[],CHEMBL1176970,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral cytoplasmic DNA synthesis after 8 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(CCc2nc3ccccc3n2C2CCCCC2)nc1,CHEMBL1177679,Bioorg Med Chem,2010.0,CHEMBL1173511,CHEMBL1173511,5.18,0.0,http://www.openphacts.org/units/Nanomolar,924433.0,=,1.0,1.0,=,IC50,nM,6600.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,6.6,CHEMBL613497
3056,1470281.0,[],CHEMBL832524,Inhibitory activity against HIV-1 double mutants strain 100I and 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL366692,CHEMBL366692,7.40,0.0,http://www.openphacts.org/units/Nanomolar,380699.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
3057,1402139.0,[],CHEMBL834488,In vitro inhibitory concentration against HIV L100I and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCOC)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177275,CHEMBL177275,6.10,0.0,http://www.openphacts.org/units/Nanomolar,360374.0,=,1.0,1.0,=,IC50,nM,794.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.794,CHEMBL378
3058,10995195.0,[],CHEMBL2072873,Antiviral activity against VSV-G pseudotyped HIV1 lentiviral particles infected in human HeLa cells incubated for 48 hrs by spectrofluorometry,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](NC(=O)CC3CCC4(CC3)OOC3(OO4)C4CC5CC(C4)CC3C5)[C@@H](CO[Si](c3ccccc3)(c3ccccc3)C(C)(C)C)O2)c(=O)[nH]c1=O,CHEMBL2069294,Bioorg Med Chem,2012.0,CHEMBL2071268,CHEMBL2071268,,0.0,,1663491.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
3059,2099797.0,[],CHEMBL949220,Antiviral activity against HIV1 BaL by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL1201187,CHEMBL1201187,8.40,0.0,http://www.openphacts.org/units/Nanomolar,699392.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.004,CHEMBL378
3060,14654421.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(CO)[C@H](O)CC[C@@]2(C)[C@@H]1C/C=C1/C(=O)OC[C@H]1O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL186141,CHEMBL186141,4.27,0.0,http://www.openphacts.org/units/Nanomolar,2101859.0,=,1.0,1.0,=,IC50,nM,54100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,54.1,CHEMBL613497
3061,12717533.0,[],CHEMBL2350956,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 12 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc([C@H]2Oc3c(OC)cc(CCCO)cc3[C@@H]2CO)ccc1O,CHEMBL2346656,Bioorg Med Chem Lett,2013.0,CHEMBL261907,CHEMBL261907,,0.0,http://www.openphacts.org/units/Nanomolar,1874403.0,>,1.0,1.0,>,IC50,nM,1000000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1000.0,CHEMBL613497
3062,2395642.0,[],CHEMBL944654,Antiviral activity against HIV1 LAI infected in human CEM-SS cells assessed as reverse transcriptase activity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@H](N)C(=O)NCCCCCC(=O)O[C@@H]1Cc2ccccc2[C@@H]1NC(=O)[C@H](Cc1ccccc1)C[C@H](O)CN1CCN(Cc2cccnc2)C[C@H]1C(=O)NC(C)(C)C.O=C(O)C(F)(F)F,CHEMBL1140955,Eur J Med Chem,2008.0,CHEMBL505494,CHEMBL1187503,7.44,0.0,http://www.openphacts.org/units/Nanomolar,728709.0,=,1.0,1.0,=,IC50,nM,36.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,36.0,CHEMBL378
3063,692277.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(C(=O)O)c(SSc2cc(C)cc(C)c2C(=O)O)c1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL121280,CHEMBL121280,,0.0,,228666.0,=,1.0,0.0,=,IC50,,125.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,125.0,CHEMBL378
3064,2929598.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cncc3-c3ccccc3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL583836,CHEMBL583836,7.50,0.0,http://www.openphacts.org/units/Nanomolar,852802.0,=,1.0,1.0,=,IC50,nM,31.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.6,CHEMBL378
3065,2601754.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=c1nc(O)ccn1[C@@H]1C=C(F)[C@H](CO)O1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL470502,CHEMBL470502,4.00,0.0,http://www.openphacts.org/units/Nanomolar,807835.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
3066,5198687.0,[],CHEMBL1670547,Antiviral activity against R5 tropic HIV1 Ba-L infected in human PBMC assessed as inhibition of HIN p24 antigen expression,F,BAO_0000190,BAO_0000218,organism-based format,COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C,CHEMBL1667838,Bioorg Med Chem Lett,2011.0,CHEMBL82301,CHEMBL82301,8.40,0.0,http://www.openphacts.org/units/Nanomolar,1327566.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.0,CHEMBL378
3067,1954078.0,[],CHEMBL890376,Antiviral activity against HIV1 LAI assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(C#Cc2ccccc2)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL233673,CHEMBL233673,4.80,0.0,http://www.openphacts.org/units/Nanomolar,647196.0,=,1.0,1.0,=,IC50,nM,15848.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,15848.0,CHEMBL378
3068,914498.0,[],CHEMBL758491,Anti-HIV activity against multidrug resistant HIV MM strain by inhibition of HIV p24 antigen expression in peripheral blood mononuclear cells(PBMC),F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@@H](/C=C/[C@@H](C[S+]([O-])c1ccc2ccccc2c1)NS(C)(=O)=O)Cc1ccccc1)S(=O)(=O)c1ccc(N)cc1,CHEMBL1144922,J Med Chem,2003.0,CHEMBL50945,CHEMBL50945,6.28,0.0,http://www.openphacts.org/units/Nanomolar,83376.0,=,1.0,1.0,=,IC50,nM,520.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,520.0,CHEMBL378
3069,15199951.0,[],CHEMBL3411834,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of surface antigen secretion by EIA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@]12CC[C@@H]3[C@@](CC[C@H]4[C@@]3(C)CCC[C@@]4(C)NC(=O)c3ccc(C#N)cc3)(CC1=O)C2,CHEMBL3407350,Bioorg Med Chem,2015.0,CHEMBL3409333,CHEMBL3409333,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,2287844.0,=,1.0,1.0,=,IC50,ug.mL-1,8.45,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,8.45,CHEMBL613497
3070,1437844.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(-n2cccc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL426247,CHEMBL426247,7.16,0.0,http://www.openphacts.org/units/Nanomolar,371567.0,=,1.0,1.0,=,IC50,nM,70.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.07,CHEMBL378
3071,6152279.0,[],CHEMBL1763053,Antiviral activity against Human immunodeficiency virus 1 BAL infected in human PBMC assessed as inhibition of viral replication by p24 antigen specific ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1,CHEMBL1759996,Bioorg Med Chem Lett,2011.0,CHEMBL1762330,CHEMBL1762330,5.71,0.0,http://www.openphacts.org/units/Nanomolar,1414781.0,=,1.0,1.0,=,IC50,nM,1960.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.96,CHEMBL378
3072,2570667.0,[],CHEMBL1000470,Antiviral activity against hepatitis B virus-infected human HepG2.2.15 cells assessed as inhibition of HBV e antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@H](OC(C)=O)[C@H](C[C@@H](C)C1=C2C[C@H](OC(C)=O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)OC(C)=O,CHEMBL1155923,Bioorg Med Chem Lett,2008.0,CHEMBL510361,CHEMBL510361,4.54,0.0,http://www.openphacts.org/units/Nanomolar,768986.0,=,1.0,1.0,=,IC50,nM,29000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.029,CHEMBL613497
3073,22845206.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721667,Antiviral activity against pseudovirus HIV-1 HXB-2 subtype C harboring pseudotyped Env ZM109F.PB4 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1nc(CO)cs1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4761836,CHEMBL4761836,6.82,0.0,http://www.openphacts.org/units/Nanomolar,3547085.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.15,CHEMBL378
3074,1169309.0,[],CHEMBL679241,Concentration required to reduce vaccinia virus-inducted cytopathicity by 50% (E6SM cells),F,BAO_0000190,BAO_0000218,organism-based format,O=C([O-])CC(SCCCOCC1OC(OCCCSC(CC(=O)[O-])C(=O)[O-])C(OCCCSC(CC(=O)[O-])C(=O)[O-])C(OCCCSC(CC(=O)[O-])C(=O)[O-])C1COCC1OC(COCCCSC(CC(=O)[O-])C(=O)[O-])C(OCCCSC(CC(=O)[O-])C(=O)[O-])C(OCCCSC(CC(=O)[O-])C(=O)[O-])C1OCCCSC(CC(=O)[O-])C(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],CHEMBL1130336,J Med Chem,1997.0,CHEMBL384019,CHEMBL1207271,,0.0,http://www.openphacts.org/units/Nanomolar,225164.0,>,1.0,1.0,>,IC50,nM,181000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,181.0,CHEMBL613493
3075,2149849.0,[],CHEMBL935682,Antiviral activity against HIV1 098-T1249 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL428455,CHEMBL428455,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708038.0,=,1.0,1.0,=,IC50,ug.mL-1,0.03,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.03,CHEMBL378
3076,16394340.0,[],CHEMBL3744528,Inhibition of HBV DNA replication in HepG2 cells by southern blot analysis,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C(CN2CCOCC2)NC(c2nccs2)=NC1c1ccc(F)cc1Br,CHEMBL3739304,Medchemcomm,2015.0,CHEMBL3742114,CHEMBL3742114,7.92,0.0,http://www.openphacts.org/units/Nanomolar,2738857.0,=,1.0,1.0,=,IC50,nM,12.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.012,CHEMBL613497
3077,5246971.0,[],CHEMBL1687410,Antiviral activity against HIV1 Ba-L infected in human HOS cells expressing CCR5 after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC(CNS(=O)(=O)c1ccccc1)c1ccccc1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL1682563,CHEMBL1682563,7.19,0.0,http://www.openphacts.org/units/Nanomolar,1333675.0,=,1.0,1.0,=,IC50,nM,65.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.065,CHEMBL378
3078,2930438.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CN)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578979,CHEMBL578979,7.70,0.0,http://www.openphacts.org/units/Nanomolar,852920.0,=,1.0,1.0,=,IC50,nM,19.95,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.95,CHEMBL378
3079,18044413.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(C(=O)NC(CN)c2nc(C)c(CO)s2)[nH]c1-c1ccc(Cl)cc1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075013,CHEMBL4075013,5.58,0.0,http://www.openphacts.org/units/Nanomolar,2990230.0,=,1.0,1.0,=,IC50,nM,2600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.6,CHEMBL378
3080,24963894.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5216626,Antiviral activity against NNRTI resistant HIV1 harboring Tyr188Leu mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect measured after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Cc3c(Cl)ccc4[nH]ccc34)n2)cc1,CHEMBL5214932,Eur J Med Chem,2022.0,CHEMBL313405,CHEMBL313405,6.00,0.0,http://www.openphacts.org/units/Nanomolar,3900015.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
3081,18399213.0,[],CHEMBL4149755,Inhibition of human Pit-2 expressed in HEK293 cells coexpressing tetracyclin assessed as reduction in uptake of 33P-radiolabeled Pi incubated for 20 to 30 mins prior to substrate addition,B,BAO_0000190,BAO_0000219,cell-based format,Cc1[nH]c2c(N3CCC(N)(C(N)=O)CC3)c(C#N)c(C(F)(F)F)nc2c1Cl,CHEMBL4145593,ACS Med Chem Lett,2018.0,CHEMBL4168403,CHEMBL4168403,,0.0,http://www.openphacts.org/units/Nanomolar,3053881.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL4295806,Homo sapiens,Sodium-dependent phosphate transporter 2,9606,IC50,uM,UO_0000065,25.0,CHEMBL4295806
3082,830712.0,[],CHEMBL686566,Anti-HIV activity in H9 lymphocytes.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2ccc3c(c2oc1=O)[C@@H](OC(=O)C12CCC(C)(C(=O)O1)C2(C)C)[C@@H](OC(=O)C12CCC(C)(C(=O)O1)C2(C)C)C(C)(C)O3,CHEMBL1132174,J Med Chem,1999.0,CHEMBL303397,CHEMBL303397,,0.0,http://www.openphacts.org/units/Nanomolar,163815.0,>,1.0,1.0,>,IC50,nM,113000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,113.0,CHEMBL378
3083,3453354.0,[],CHEMBL1247793,Antiviral activity against HIV1 isolate 05-121772 assessed as inhibition of viral replication after 7 days by scintillation counting,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(c2cccc3nc(CN(C)[C@H]4CCCc5cccnc54)c(CO)n23)CC1,CHEMBL1240366,Antimicrob Agents Chemother,2010.0,CHEMBL1242210,CHEMBL1242210,9.00,0.0,http://www.openphacts.org/units/Nanomolar,953332.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
3084,2244577.0,[],CHEMBL1003074,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase K103N/G190A mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(C(F)(F)F)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL275658,CHEMBL275658,7.89,0.0,http://www.openphacts.org/units/Nanomolar,798655.0,=,1.0,1.0,=,IC50,nM,13.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,13.0,CHEMBL378
3085,2362915.0,[],CHEMBL1026417,"Antiviral activity against multidrug-resistant HIV1 with protease L10I, V11I, T12E, I15V, L19I, R41K, M46L, L63P, A71T, V82A, L90M mutation in phytohemagglutininin-activated PBMC assessed as inhibition of p24G protein production",F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)OC2COCOC2)cc1,CHEMBL1140100,J Med Chem,2008.0,CHEMBL523528,CHEMBL523528,6.52,0.0,http://www.openphacts.org/units/Nanomolar,747070.0,=,1.0,1.0,=,IC50,nM,300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,300.0,CHEMBL378
3086,24735355.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5116806,Antiviral activity against ZIKV infected in human Huh-7 cells assessed as inhibition of viral infection measured 24 hrs post infection by immunofluorescent assay,F,BAO_0000190,BAO_0000218,organism-based format,Oc1c(O)c(O)c2c(=S)cc(-c3ccccc3)oc2c1-c1ccc(F)cc1,CHEMBL5113447,Bioorg Med Chem Lett,2022.0,CHEMBL5203342,CHEMBL5203342,5.11,0.0,http://www.openphacts.org/units/Nanomolar,3858565.0,=,1.0,1.0,=,IC50,nM,7700.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,7.7,CHEMBL4296612
3087,2929744.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CN3CCOC(CCO)C3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL575458,CHEMBL575458,7.50,0.0,http://www.openphacts.org/units/Nanomolar,848354.0,=,1.0,1.0,=,IC50,nM,31.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.6,CHEMBL378
3088,16556859.0,[],CHEMBL3795205,Antiviral activity against CXCR4 using HIV-1 NL4.3 infected in human MT4 cells assessed as reduction of viral replication preincubated for 15 mins with cells followed by viral infection measured after 4 days by MTS/PES method,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(Cc2ccccc2)CCCN(S(=O)(=O)c2ccc(OC)cc2OC)C1.Cl,CHEMBL3792300,J Med Chem,2016.0,CHEMBL3793796,CHEMBL3794619,5.16,0.0,http://www.openphacts.org/units/Nanomolar,2770889.0,=,1.0,1.0,=,IC50,nM,7000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.0,CHEMBL378
3089,5306761.0,[],CHEMBL1696830,Antiviral activity against X4 tropic HIV1 NL4.3 infected in human TZM-b1 cells after 2 hrs by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1687731,Antimicrob Agents Chemother,2009.0,CHEMBL70663,CHEMBL70663,9.43,0.0,http://www.openphacts.org/units/Nanomolar,1337341.0,=,1.0,1.0,=,IC50,nM,0.37,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.37,CHEMBL378
3090,1401616.0,[],CHEMBL835251,In vitro inhibitory concentration against HIV F227L and V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL366692,CHEMBL366692,6.40,0.0,http://www.openphacts.org/units/Nanomolar,360329.0,=,1.0,1.0,=,IC50,nM,398.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.398,CHEMBL378
3091,18775545.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COCCCOc1cc2c(cc1OC)-c1cc(=O)c(C(=O)O)cn1C(c1ccccc1)C2,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4280093,CHEMBL4280093,7.19,0.0,http://www.openphacts.org/units/Nanomolar,3119703.0,=,1.0,1.0,=,IC50,nM,64.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.064,CHEMBL613497
3092,18044540.0,[],CHEMBL4010365,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of p24 antigen production pretreated with virus for 30 mins followed by 4 days incubation with cells by sandwich ELISA based multicycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(C(CN)NC(=O)c2cnc(-c3ccc(Cl)cc3)[nH]2)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075452,CHEMBL4075452,,0.0,http://www.openphacts.org/units/Nanomolar,2990235.0,>,1.0,1.0,>,IC50,nM,26000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,26.0,CHEMBL378
3093,862223.0,[],CHEMBL686566,Anti-HIV activity in H9 lymphocytes.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)oc2c3c(ccc12)OC(C)(C)[C@H](OC(=O)CC(C)C)[C@@H]3OC(=O)CC(C)C,CHEMBL1132174,J Med Chem,1999.0,CHEMBL89774,CHEMBL89774,4.38,0.0,http://www.openphacts.org/units/Nanomolar,163819.0,=,1.0,1.0,=,IC50,nM,42000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,42.0,CHEMBL378
3094,1470296.0,[],CHEMBL833074,Inhibitory activity against HIV-1 mutant strain 100I,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cc(Cl)cc(Cl)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188941,CHEMBL188941,8.10,0.0,http://www.openphacts.org/units/Nanomolar,380720.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
3095,14596866.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CCOCn1c(Sc2cc(C)cc(C)c2)c(CC)c(=O)[nH]c1=S,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL337338,CHEMBL337338,5.08,0.0,http://www.openphacts.org/units/Nanomolar,2082386.0,=,1.0,1.0,=,IC50,nM,8300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.3,CHEMBL378
3096,15027138.0,[],CHEMBL3367171,Inhibition of AP-1-mediated transcriptional activation in human Jurkat cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)c1cnc(NN2C(=O)C=C(C)C2=O)nc1-c1ccc(C)s1,CHEMBL3352097,J Med Chem,2014.0,CHEMBL86615,CHEMBL86615,7.35,0.0,http://www.openphacts.org/units/Nanomolar,2265186.0,=,1.0,1.0,=,IC50,nM,45.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.045,CHEMBL4977
3097,2462099.0,[],CHEMBL964561,Antiviral activity against hepatitis B virus infected Hep G2.2.15 cells assessed as inhibition of HBsAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CN2OC2(c2ccccc2Cl)c2cc(Cl)ccc2N1,CHEMBL1157443,Bioorg Med Chem Lett,2008.0,CHEMBL518671,CHEMBL518671,,0.0,http://www.openphacts.org/units/Nanomolar,720926.0,=,1.0,1.0,=,IC50,nM,355000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.355,CHEMBL613497
3098,524411.0,[],CHEMBL699442,Inhibition of rous sarcoma virus (RSV) Integrase.,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2ccc(/C=C/c3ccc(O)c(O)c3)nc2c1O,CHEMBL1133692,J Med Chem,2000.0,CHEMBL59446,CHEMBL59446,4.42,0.0,http://www.openphacts.org/units/Nanomolar,101663.0,=,1.0,1.0,=,IC50,nM,38000.0,CHEMBL2750,Rous sarcoma virus (strain Prague C) (RSV-PrC),Rous sarcoma virus integrase,11888,IC50,M l-1,UO_0000065,0.000038,CHEMBL2750
3099,3267339.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1Cc2c(C=O)ccc3nc(S)n(c23)C[C@@H]1C,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL58453,CHEMBL58453,6.73,0.0,http://www.openphacts.org/units/Nanomolar,906268.0,=,1.0,1.0,=,IC50,nM,186.21,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.73,CHEMBL378
3100,13967478.0,[],CHEMBL3135325,Antiviral activity against HIV1 VSVG harboring reverse transcriptase K103N mutant infected in 293ET cells assessed as inhibition of viral replication by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1sc(Cl)cc1S(=O)(=O)N1c2cc(Cl)ccc2NC(=O)C1C,CHEMBL3132804,Medchemcomm,2014.0,CHEMBL3133061,CHEMBL3133061,5.10,0.0,http://www.openphacts.org/units/Nanomolar,1974733.0,=,1.0,1.0,=,IC50,nM,7940.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.94,CHEMBL378
3101,24823582.0,[],CHEMBL5140687,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBeAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3c(F)cccc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5200210,CHEMBL5200210,7.69,0.0,http://www.openphacts.org/units/Nanomolar,3876718.0,=,1.0,1.0,=,IC50,nM,20.6,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0206,CHEMBL613497
3102,1218420.0,[],CHEMBL710376,Inhibitory activity against 100I strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2nc(Nc3ccc(C#N)cc3)ncc2Br)c(C)c1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL71882,CHEMBL71882,7.96,0.0,http://www.openphacts.org/units/Nanomolar,127454.0,=,1.0,1.0,=,IC50,nM,11.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.011,CHEMBL378
3103,19261985.0,[],CHEMBL4404410,Antiviral activity against HIV1 subtypeA infant B1206.W6P.ENV.A1A,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,5.75,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,1800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.8,CHEMBL378
3104,1470561.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL338047,CHEMBL338047,8.10,0.0,http://www.openphacts.org/units/Nanomolar,380766.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
3105,5189155.0,[],CHEMBL1658799,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC(=O)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652500,CHEMBL1652500,4.09,0.0,http://www.openphacts.org/units/Nanomolar,1326875.0,=,1.0,1.0,=,IC50,nM,82000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.082,CHEMBL613497
3106,2099792.0,[],CHEMBL949220,Antiviral activity against HIV1 BaL by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL272748,CHEMBL272748,7.60,0.0,http://www.openphacts.org/units/Nanomolar,699397.0,=,1.0,1.0,=,IC50,nM,25.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.025,CHEMBL378
3107,6335911.0,[],CHEMBL1820048,Antiviral activity against Human immunodeficiency virus 1 LAI infected in human MT2 cells assessed as inhibition of p24 Gag protein production,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2C[C@@H]3[C@H](C)CO[C@@H]3C2)cc1,CHEMBL1817554,J Med Chem,2011.0,CHEMBL1819296,CHEMBL1819296,7.60,0.0,http://www.openphacts.org/units/Nanomolar,1451709.0,=,1.0,1.0,=,IC50,nM,25.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,25.0,CHEMBL378
3108,18775483.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC1Cc2cc(N(C)C)ccc2-c2cc(=O)c(C(=O)O)cn21,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4291371,CHEMBL4291371,6.24,0.0,http://www.openphacts.org/units/Nanomolar,3119641.0,=,1.0,1.0,=,IC50,nM,580.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.58,CHEMBL613497
3109,1049988.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(S)n(Nc2ccc(F)cc2)c1-c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289208,CHEMBL289208,,0.0,http://www.openphacts.org/units/Nanomolar,62361.0,>,1.0,1.0,>,IC50,nM,220130.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,220.13,CHEMBL613499
3110,18336742.0,[],CHEMBL4137336,Antiviral activity against recombinant pseudotyped HIV1 subtype C infected in human U87 cells expressing CD4/CCR5/CXCR4 by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c12,CHEMBL4130629,J Med Chem,2018.0,CHEMBL3301620,CHEMBL3301620,8.15,0.0,http://www.openphacts.org/units/Nanomolar,3044843.0,=,1.0,1.0,=,IC50,nM,7.09,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.09,CHEMBL378
3111,23284036.0,[],CHEMBL4837921,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL4837199,Eur J Med Chem,2021.0,CHEMBL1323,CHEMBL1323,9.09,0.0,http://www.openphacts.org/units/Nanomolar,3622968.0,=,1.0,1.0,=,IC50,nM,0.82,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.82,CHEMBL378
3112,2009850.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1csc(C(=O)N2CCN(S(=O)(=O)c3c[nH]c4ncccc34)[C@H](C)C2)c1,CHEMBL1138356,J Med Chem,2007.0,CHEMBL429809,CHEMBL429809,5.72,0.0,http://www.openphacts.org/units/Nanomolar,668063.0,=,1.0,1.0,=,IC50,nM,1900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1900.0,CHEMBL378
3113,1470276.0,[],CHEMBL826114,Inhibitory activity against HIV-1 mutant strain 138K,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL366692,CHEMBL366692,8.30,0.0,http://www.openphacts.org/units/Nanomolar,380699.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.005,CHEMBL378
3114,3083979.0,[],CHEMBL1072584,Antiviral activity against HIV1 infected in human JC53-BL cells after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)N1C[C@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCCC4)C3)C[C@H]2C1,CHEMBL1153211,Bioorg Med Chem Lett,2010.0,CHEMBL596081,CHEMBL596081,7.22,0.0,http://www.openphacts.org/units/Nanomolar,872584.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,60.0,CHEMBL378
3115,2550849.0,[],CHEMBL980249,Antiviral activity against HIV1 3B assessed as reverse transcriptase activity by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1142603,J Nat Prod,2006.0,CHEMBL129,CHEMBL129,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,787027.0,=,1.0,1.0,=,IC50,ug.mL-1,0.004,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.004,CHEMBL378
3116,2929704.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3ccnc3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL568526,CHEMBL568526,8.00,0.0,http://www.openphacts.org/units/Nanomolar,852832.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
3117,1402592.0,[],CHEMBL837469,In vitro inhibitory concentration against HIV V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC(=S)Nc2ccccc2)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177253,CHEMBL177253,,0.0,http://www.openphacts.org/units/Nanomolar,360414.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3118,13861113.0,[],CHEMBL3101351,Antiviral activity against HIV1 NL4.3 infected in human TZM-bl cells expressing CXCR4-tropic incubated for 1 hr prior to infection measured after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C12C=CC(=O)C(O)=C1CC=C(C)C2C/C=C(\C)C=O,CHEMBL3098125,Bioorg Med Chem Lett,2014.0,CHEMBL3099062,CHEMBL3099062,4.22,0.0,http://www.openphacts.org/units/Nanomolar,1956065.0,=,1.0,1.0,=,IC50,nM,60700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,60.7,CHEMBL378
3119,2321200.0,[],CHEMBL1004248,Antiviral activity against HIV1 3B in human H9 cells after 4 days by p24 antigen ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL1150942,J Nat Prod,1998.0,CHEMBL470029,CHEMBL470029,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,787901.0,=,1.0,1.0,=,IC50,ug.mL-1,0.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.8,CHEMBL378
3120,1402337.0,[],CHEMBL835252,In vitro inhibitory concentration against HIV K101E and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N2CCCCC2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175655,CHEMBL175655,,0.0,http://www.openphacts.org/units/Nanomolar,360430.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3121,22898296.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731090,Antiviral activity against LPV-resistant HIV1 infected in human MT4 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(=O)O[C@H]1C2CO[C@H]3OC[C@@H]1C3C2)S(=O)(=O)c1ccc2nc(NC3CC3)sc2c1,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL4755541,CHEMBL4755541,,0.0,http://www.openphacts.org/units/Nanomolar,3554419.0,=,1.0,1.0,=,IC50,nM,0.00018,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.00018,CHEMBL378
3122,341054.0,[],CHEMBL856171,Inhibitory concentration required to achieve 50% protection of MT-4 cells against cytopathicity of HSV-1 strain IIIB,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c(=O)n(C2COC(CO)C(O)C2)cc1I,CHEMBL1126736,J Med Chem,1993.0,CHEMBL7144,CHEMBL7144,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,108938.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,100.0,CHEMBL378
3123,16498304.0,[],CHEMBL3778316,Antiviral activity against HIV1 NL4-3 infected in human 293T cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)c1ccc(-c2csc(N3N=C(c4ccccc4)/C(=N/Nc4ccc5c(S(=O)(=O)O)cc(S(=O)(=O)O)cc5c4)C3=O)n2)cc1,CHEMBL3774382,Bioorg Med Chem,2016.0,CHEMBL3775330,CHEMBL3775330,5.54,0.0,http://www.openphacts.org/units/Nanomolar,2762412.0,=,1.0,1.0,=,IC50,nM,2900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.9,CHEMBL378
3124,7967282.0,[],CHEMBL1930242,Antiviral activity against R5 tropic Human immunodeficiency virus 1 BAL infected in human PBMC cells assessed as reduction in viral replication by p24 detection based ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cncc3C)CC2)cc1,CHEMBL1926604,Bioorg Med Chem Lett,2011.0,CHEMBL1926889,CHEMBL1926889,4.94,0.0,http://www.openphacts.org/units/Nanomolar,1563506.0,=,1.0,1.0,=,IC50,nM,11479.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,11479.0,CHEMBL378
3125,15064901.0,[],CHEMBL3366183,Antiviral activity against wild type HIV1 infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2nc(NCc3ccccc3)sc2Cc2ccccc2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3330418,CHEMBL3330418,6.19,0.0,http://www.openphacts.org/units/Nanomolar,2246855.0,=,1.0,1.0,=,IC50,nM,650.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.65,CHEMBL378
3126,1438294.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C\C#N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL182921,CHEMBL182921,7.40,0.0,http://www.openphacts.org/units/Nanomolar,371575.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
3127,3603781.0,[],CHEMBL1291662,Antiviral activity against Hepatitis B virus infected in HepG2.2.15 assessed as inhibition of HBsAg production at <86.9 +/- 3.6 uM by EIA,F,BAO_0000190,BAO_0000218,organism-based format,Cn1c(CSc2ccccc2)nc2c(CN3CCOCC3)c(O)ccc21,CHEMBL1287795,Bioorg Med Chem Lett,2010.0,CHEMBL1287957,CHEMBL1287957,,0.0,,972962.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
3128,2099762.0,[],CHEMBL949219,Antiviral activity against HIV1 ASM80 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)N(CCCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nc4c2CCN(C(=O)C2CCCC2)C4)C3)c2ccccc2)cc1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL270579,CHEMBL270579,8.30,0.0,http://www.openphacts.org/units/Nanomolar,699405.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.005,CHEMBL378
3129,10937552.0,[],CHEMBL2051603,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C=C/C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(O)C(C)=O)C2)cc1,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046559,CHEMBL2046559,4.96,0.0,http://www.openphacts.org/units/Nanomolar,1651442.0,=,1.0,1.0,=,IC50,nM,10880.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.88,CHEMBL613497
3130,18202580.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2ccc(Oc3ccccc3)cc2)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4073146,CHEMBL4073146,6.92,0.0,http://www.openphacts.org/units/Nanomolar,3019964.0,=,1.0,1.0,=,IC50,nM,120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.12,CHEMBL378
3131,1671961.0,[],CHEMBL870621,Antiviral activity against HIV1 Y181C mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(C(=O)c2cc(Cl)ccc2OCC(=O)Nc2ccc(S(N)(=O)=O)cc2C)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL201485,CHEMBL201485,8.52,0.0,http://www.openphacts.org/units/Nanomolar,411928.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.0,CHEMBL378
3132,875631.0,[],CHEMBL710366,Inhibitory activity tested against the HIV-1 in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)NCCC(=O)O)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL11261,CHEMBL11261,7.03,0.0,http://www.openphacts.org/units/Nanomolar,9086.0,=,1.0,1.0,=,IC50,nM,94.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,94.0,CHEMBL378
3133,2649329.0,[],CHEMBL1024326,"Antiviral activity against HIV1 expressed in 293T cells assessed as protection against viral M33 envelope infection in human U87 cells coexpressing CD4, CCR5 receptors after 72 hrs by luciferase reporter gene pseudoviral assay",F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1ccc(-c2ccsc2)cc1,CHEMBL1158460,J Med Chem,2009.0,CHEMBL562429,CHEMBL562429,6.27,0.0,http://www.openphacts.org/units/Nanomolar,815844.0,=,1.0,1.0,=,IC50,nM,540.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,540.0,CHEMBL378
3134,19407966.0,[],CHEMBL4426966,Antiviral activity against darunavir resistant HIV1 harboring protease L10I/I15V/K20R/L24I/V32I/M36I/M46L/L63P/A71T/V82A/L89M mutant at 20 passages infected in human MT4 cells by p24 assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](CC23CC4CC(CC(C4)C2)C3)NC(=O)O[C@H]2CO[C@H]3OCC[C@H]32)cc1,CHEMBL4425138,J Med Chem,2016.0,CHEMBL4516606,CHEMBL4516606,,0.0,http://www.openphacts.org/units/Nanomolar,3243721.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
3135,687092.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc(C=Nc2ccc(SSc3ccc(N=Cc4ccc(NC(C)=O)cc4)cc3)cc2)cc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL116484,CHEMBL116484,,0.0,,228671.0,=,1.0,0.0,=,IC50,,23.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,23.6,CHEMBL378
3136,18940383.0,[],CHEMBL4328847,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cccc(Cn2ccc3ccc(-c4ccc5ccn(Cc6cccc([N+](=O)[O-])c6)c5c4)cc32)c1,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4552770,CHEMBL4552770,5.55,0.0,http://www.openphacts.org/units/Nanomolar,3159818.0,=,1.0,1.0,=,IC50,nM,2800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.8,CHEMBL378
3137,16422838.0,[],CHEMBL3751455,Antiviral activity against recombinant HIV-1 NL4-3 expressing HIV-1 B41 envelope infected in U87.CD4.CCR5 cells assessed as inhibition of Env mediated cell entry by HIV-1 single round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CCC4(CCN(C(=O)c5ccccc5)CC4)C3)c12,CHEMBL3745657,Bioorg Med Chem Lett,2016.0,CHEMBL3746691,CHEMBL3746691,5.41,0.0,http://www.openphacts.org/units/Nanomolar,2740455.0,=,1.0,1.0,=,IC50,nM,3900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.9,CHEMBL378
3138,23284023.0,[],CHEMBL4837921,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCCN1)S(=O)(=O)c1ccc(C(F)(F)F)cc1,CHEMBL4837199,Eur J Med Chem,2021.0,CHEMBL4857293,CHEMBL4857293,7.69,0.0,http://www.openphacts.org/units/Nanomolar,3622955.0,=,1.0,1.0,=,IC50,nM,20.57,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,20.57,CHEMBL378
3139,16662897.0,[],CHEMBL3832828,AntiDengue activity HCI DV4/A549 IC50 (uM),F,BAO_0000190,BAO_0000218,organism-based format,O=C1[C@@H](Oc2ccccc2)[C@@H](c2ccc(Cl)cc2)N1CCn1cnc2c(NCc3ccccc3)ncnc21,CHEMBL3832761,,,CHEMBL2064298,CHEMBL2064298,5.70,0.0,http://www.openphacts.org/units/Nanomolar,2790121.0,=,34.0,1.0,=,IC50,nM,2000.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,2.0,CHEMBL613757
3140,1402409.0,[],CHEMBL837468,In vitro inhibitory concentration against HIV L100I mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)CCOC)c1C(=O)c1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369697,CHEMBL369697,8.10,0.0,http://www.openphacts.org/units/Nanomolar,360426.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
3141,2947360.0,[],CHEMBL1038497,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)/C=C/c1ccccc1)[C@@H](OC(=O)/C=C/c1ccccc1)C(C)(C)OC(=O)/C=C/c1ccccc1)C1=C2C[C@H](OC(=O)/C=C/c3ccccc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL574257,CHEMBL574257,,0.0,http://www.openphacts.org/units/Nanomolar,850755.0,>,1.0,1.0,>,IC50,nM,1200000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.2,CHEMBL613497
3142,1146185.0,[],CHEMBL818227,Cytotoxicity was determined in the vero cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(=O)n([C@H]2CS[C@H](CO)O2)cc1Br,CHEMBL1126808,J Med Chem,1993.0,CHEMBL301886,CHEMBL301886,,0.0,http://www.openphacts.org/units/Nanomolar,100980.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
3143,2601965.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL313011,CHEMBL313011,5.43,0.0,http://www.openphacts.org/units/Nanomolar,808026.0,=,1.0,1.0,=,IC50,nM,3700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.7,CHEMBL378
3144,15602734.0,[],CHEMBL3578657,Inhibition of ASCT2-mediated [3H]glutamine uptake in HEK293 cells after 15 mins by Live-cell glutamine uptake assay,B,BAO_0000190,BAO_0000219,cell-based format,N[C@@H](CCC(=O)Nc1ccccc1-c1nc2ccccc2[nH]1)C(=O)O,CHEMBL3576761,Bioorg Med Chem Lett,2015.0,CHEMBL3576938,CHEMBL3576938,,0.0,,2479435.0,,1.0,0.0,,IC50,,,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,,,,CHEMBL3562162
3145,1751278.0,[],CHEMBL854522,Antiviral activity against Measles virus variant in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Cc1ccccc1)Nc1ccccc1[N+](=O)[O-],CHEMBL1145335,J Med Chem,2006.0,CHEMBL386964,CHEMBL386964,,0.0,,532786.0,,1.0,0.0,,IC50,,,CHEMBL613738,Measles virus,Measles virus,11234,IC50,,,,CHEMBL613738
3146,19281722.0,[],CHEMBL4409361,Antiviral activity against HIV1 UG070 infected in human TZM-bl cells incubated for 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(cnn2-c2ccc(Cl)cc2)c(=O)[nH]1,CHEMBL4406854,Eur J Med Chem,2019.0,CHEMBL4456715,CHEMBL4456715,,0.0,,3219936.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
3147,17987400.0,[],CHEMBL3999574,Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 40 hrs,F,BAO_0000190,BAO_0000219,cell-based format,C=C(C(=O)OC)[C@@H]1CC[C@H](C)[C@H]2C(=C(C)C(=O)[C@@H]2[C@@H](O)c2ccccc2)C1,CHEMBL3997818,Bioorg Med Chem Lett,2017.0,CHEMBL4092427,CHEMBL4092427,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,2979918.0,>,1.0,1.0,>,IC50,ug.mL-1,6.17,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,6.17,CHEMBL613129
3148,22898302.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731091,Antiviral activity against ATV-resistant HIV1 infected in human MT4 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(=O)O[C@H]1C2CO[C@H]3OC[C@@H]1C3C2)S(=O)(=O)c1ccc2nc(NC3CC3)sc2c1,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL4755541,CHEMBL4755541,,0.0,http://www.openphacts.org/units/Nanomolar,3554419.0,=,1.0,1.0,=,IC50,nM,0.0025,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.0025,CHEMBL378
3149,11014435.0,[],CHEMBL2089834,Antiviral activity against HIV1 in human TZM-bl cells assessed as viral infectivity by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(CO)[C@H](O)CC[C@@]2(C)[C@@H]1C/C=C1/C(=O)OC[C@H]1OC(=O)c1ccccc1O,CHEMBL2086289,Eur J Med Chem,2012.0,CHEMBL2088493,CHEMBL2088493,4.07,0.0,http://www.openphacts.org/units/Nanomolar,1675630.0,=,1.0,1.0,=,IC50,nM,85113.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.07,CHEMBL378
3150,3465406.0,[],CHEMBL1250682,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,C#C[C@@]1(OCP(=O)(O)O)C=C[C@H](n2cnc3c(N)ncnc32)O1,CHEMBL1250548,Bioorg Med Chem,2010.0,CHEMBL1254004,CHEMBL1254004,5.77,0.0,http://www.openphacts.org/units/Nanomolar,956154.0,=,1.0,1.0,=,IC50,nM,1690.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.69,CHEMBL378
3151,16394335.0,[],CHEMBL3744526,Inhibition of HBV DNA replication in HepG2.2.15 cells,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C(C)NC(c2nccs2)=N[C@H]1c1ccc(F)cc1Cl,CHEMBL3739304,Medchemcomm,2015.0,CHEMBL3741774,CHEMBL3741774,7.52,0.0,http://www.openphacts.org/units/Nanomolar,2738856.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.03,CHEMBL613497
3152,19261927.0,[],CHEMBL4404390,"Antiviral activity against HIV1 subtypeC Du172, clone 17",F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.52,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.3,CHEMBL378
3153,2601650.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL39883,CHEMBL39883,4.30,0.0,http://www.openphacts.org/units/Nanomolar,807290.0,=,1.0,1.0,=,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
3154,797404.0,[],CHEMBL683816,"Inhibitory activity against NNI-resistant HIV-1 strain A17 with Y181C,K103N mutation",F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](/N=C(\S)Nc1nccs1)C1CCCCC1,CHEMBL1133139,Bioorg Med Chem Lett,2000.0,CHEMBL417737,CHEMBL417737,5.24,0.0,http://www.openphacts.org/units/Nanomolar,111934.0,=,1.0,1.0,=,IC50,nM,5800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.8,CHEMBL378
3155,12651413.0,[],CHEMBL2327724,Antiviral activity against 0.001 MOI wild type Human immunodeficiency virus 1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCC(=O)NCCC#N)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324142,CHEMBL2324142,6.82,0.0,http://www.openphacts.org/units/Nanomolar,1850168.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.15,CHEMBL378
3156,5247014.0,[],CHEMBL1687411,Antiviral activity against HIV1 Ba-L infected in human PBL cells assessed as reverse transcriptase activity after 7 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(-c2ccccc2)n1C1CCN(CCC(CNS(=O)(=O)c2ccccc2)c2ccccc2)CC1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL1682479,CHEMBL1682479,,0.0,,1333577.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
3157,13464657.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL54600,CHEMBL54600,6.40,0.0,http://www.openphacts.org/units/Nanomolar,1920707.0,=,1.0,1.0,=,IC50,nM,398.11,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.4,CHEMBL378
3158,10861936.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(/C=C/C(=O)O[C@H]2CC[C@]3(C)[C@H]4C(=O)C=C5[C@@H]6C[C@@](C)(C(=O)O)CC[C@]6(C)CC[C@@]5(C)[C@]4(C)CC[C@H]3C2(C)C)cc(OC)c1OC,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024624,CHEMBL2024624,,0.0,http://www.openphacts.org/units/Nanomolar,1640518.0,>,1.0,1.0,>,IC50,nM,1164430.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1164.43,CHEMBL613497
3159,8041792.0,[],CHEMBL1953242,Antiviral activity against HIV1 harboring VSV glycoprotein-G co-transfected with luciferase gene infected in human TZM-bl cells assessed as inhibition of viral replication after 48 hrs by microplate luminometer based luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)C(=O)C(=O)NC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(OS(C)(=O)=O)c(=O)n1C,CHEMBL1949625,Eur J Med Chem,2012.0,CHEMBL1949881,CHEMBL1949881,9.19,0.0,http://www.openphacts.org/units/Nanomolar,1576982.0,=,1.0,1.0,=,IC50,nM,0.64,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,10'-1nM,UO_0000065,6.4,CHEMBL378
3160,18044389.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(C(CCN(C)C)NC(=O)c2ccc(-c3ccc(F)c(Cl)c3)[nH]2)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4076809,CHEMBL4076809,5.75,0.0,http://www.openphacts.org/units/Nanomolar,2990206.0,=,1.0,1.0,=,IC50,nM,1800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.8,CHEMBL378
3161,2149805.0,[],CHEMBL935680,Antiviral activity against HIV1 098 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL428338,CHEMBL428338,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708044.0,>,1.0,1.0,>,IC50,ug.mL-1,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,20.0,CHEMBL378
3162,6200540.0,[],CHEMBL1781474,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 4 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(OC)c(OC)cc1CN(CCc1c[nH]c2ccccc12)Cc1cc(OC)c(OC)cc1OC,CHEMBL1777761,Bioorg Med Chem,2011.0,CHEMBL1779162,CHEMBL1779162,5.92,0.0,http://www.openphacts.org/units/Nanomolar,1425117.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.2,CHEMBL613497
3163,2423350.0,[],CHEMBL1024932,Antiviral activity against Hepatitis B virus infected in human Hep3B cells assessed as surface antigen production,F,BAO_0000190,BAO_0000218,organism-based format,C=CC[C@H]1OC(=O)CCNC(=O)[C@H](C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC)NC(=O)[C@@H]2CCCN2C1=O,CHEMBL1159235,J Nat Prod,1995.0,CHEMBL516054,CHEMBL516054,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,761949.0,=,1.0,1.0,=,IC50,ug.mL-1,0.4,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,0.4,CHEMBL613497
3164,2009853.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL236997,CHEMBL236997,6.07,0.0,http://www.openphacts.org/units/Nanomolar,668060.0,=,1.0,1.0,=,IC50,nM,860.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,860.0,CHEMBL378
3165,2602329.0,[],CHEMBL1034014,Antiviral activity against Monkeypox virus,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL152,CHEMBL152,,0.0,http://www.openphacts.org/units/Nanomolar,807051.0,=,1.0,1.0,=,IC50,nM,505000.0,CHEMBL613120,Monkeypox virus,Monkeypox virus,10244,IC50,uM,UO_0000065,505.0,CHEMBL613120
3166,18754899.0,[],CHEMBL4265061,Antiviral activity against HIV1 cYTA48P infected in PM1/CCR5 cells by single round assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(NC(=O)CNc2ccc3c(c2)OCO3)CC(C)(C)N1,CHEMBL4261625,Bioorg Med Chem,2018.0,CHEMBL4294754,CHEMBL4294754,,0.0,http://www.openphacts.org/units/Nanomolar,3116245.0,>,1.0,1.0,>,IC50,nM,30000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,30.0,CHEMBL378
3167,2929540.0,[],CHEMBL1056896,Antiviral activity against HIV1 HXB2 harboring 179E mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cnnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL577247,CHEMBL577247,8.85,0.0,http://www.openphacts.org/units/Nanomolar,852824.0,=,1.0,1.0,=,IC50,nM,1.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.4,CHEMBL378
3168,5132776.0,[],CHEMBL1646269,Antiviral activity against azidothymidine-resistant HIV1 SF2 infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)n2c3ccccc3n(C[C@@H](O)N3CCN(C(c4ccccc4)c4ccccc4)CC3)c2c1C#N,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645090,CHEMBL1645090,5.50,0.0,http://www.openphacts.org/units/Nanomolar,1321079.0,=,1.0,1.0,=,IC50,nM,3150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.15,CHEMBL378
3169,24735324.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5116803,Antiviral activity against CHIKV infected in human Huh-7 cells assessed as inhibition of viral infection by measuring EGFP-positive cells measured 24 hrs post infection by fluorescent microscopic analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2oc(-c3ccc(N4CCN(C)CC4)cc3)cc(=O)c2c(OC)c1OC,CHEMBL5113447,Bioorg Med Chem Lett,2022.0,CHEMBL5208469,CHEMBL5208469,4.94,0.0,http://www.openphacts.org/units/Nanomolar,3858575.0,=,1.0,1.0,=,IC50,nM,11500.0,CHEMBL4296563,Chikungunya virus,Chikungunya virus,37124,IC50,uM,UO_0000065,11.5,CHEMBL4296563
3170,664760.0,[],CHEMBL713946,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,CCCC1Cn2c(O)nc3cccc(c32)CN1,CHEMBL1128252,J Med Chem,1995.0,CHEMBL164494,CHEMBL164494,,0.0,http://www.openphacts.org/units/Nanomolar,326354.0,>,1.0,1.0,>,IC50,nM,250000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,250.0,CHEMBL378
3171,914291.0,[],CHEMBL656269,Inhibition of human immunodeficiency virus-1 (HIV-1) induced cytopathicity in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(O)c2nn(CCOCP(=O)(O)O)nc2n1,CHEMBL1129435,J Med Chem,1996.0,CHEMBL130314,CHEMBL130314,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251947.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,100.0,CHEMBL378
3172,12642493.0,[],CHEMBL2317525,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)N1CCCN2C(=O)c3c(O)c(=O)c(C(=O)NCc4ccc(F)cc4)cn3CC21,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314691,CHEMBL2314691,8.12,0.0,http://www.openphacts.org/units/Nanomolar,1844823.0,=,1.0,1.0,=,IC50,nM,7.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.5,CHEMBL378
3173,19288673.0,[],CHEMBL4410545,Antiviral activity against HIV-1 3IIB infected in thymidine kinase deficient human C8166 cells,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)[C@H](C)NP(=O)(OC[C@@H]1C=C[C@H](n2cc(C)c(=O)[nH]c2=O)O1)Oc1ccc(C(F)(F)F)cc1,CHEMBL4406893,Bioorg Med Chem Lett,2019.0,CHEMBL4585169,CHEMBL4585169,7.12,0.0,http://www.openphacts.org/units/Nanomolar,3220825.0,=,1.0,1.0,=,IC50,nM,75.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.075,CHEMBL378
3174,15165607.0,[],CHEMBL3404732,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBsAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(O[C@@H]2O[C@H](COC(=O)/C=C/c3cccc(F)c3)[C@@H](O)[C@H](O)[C@H]2O)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402786,CHEMBL3402786,,0.0,http://www.openphacts.org/units/Nanomolar,2284142.0,=,1.0,1.0,=,IC50,nM,433900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,433.9,CHEMBL613497
3175,5314281.0,[],CHEMBL1692275,Inhibition of HIV1 isolate YU2 infected in human TZM-bl cells expressing CD4 and CCR5 assessed as assessed inhibition of viral entry after 24 hrs by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C(\NC(=O)CNC(=O)C(C)C(O)/C=C\C(C)=C\C(C)CC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1C(=O)N[C@H](COC)C(=O)NCC(=O)N[C@@H](C)C(=O)N(C)[C@@H]([C@@H](C)O)C(=O)N[C@H]([C@H](OC)c2ccc(O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)cc2)C(=O)N2CC[C@H](Cl)C[C@H]2C(=O)O[C@@H]1C(C)C)[C@@H](C)[C@@H](C)C(N)=O)[C@H](C)N,CHEMBL1687884,J Nat Prod,2011.0,CHEMBL1689427,CHEMBL1689427,7.21,0.0,http://www.openphacts.org/units/Nanomolar,1339116.0,=,1.0,1.0,=,IC50,nM,62.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,62.0,CHEMBL378
3176,12135674.0,[],CHEMBL2187933,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as p24 antigen level after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)OCCC)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2176886,J Med Chem,2012.0,CHEMBL2179611,CHEMBL2179611,7.06,0.0,http://www.openphacts.org/units/Nanomolar,1752710.0,=,1.0,1.0,=,IC50,nM,88.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.088,CHEMBL378
3177,19261951.0,[],CHEMBL4404398,"Antiviral activity against HIV1 subtypeC HIV-16055-2, clone 3",F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.54,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,290.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.29,CHEMBL378
3178,18812934.0,[],CHEMBL4276413,Antiviral activity against darunavir-resistant HIV1 at passage 30 infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)CN1C(=O)O[C@@H]2C[C@H](OC(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc(OC)cc3)C[C@@H]21,CHEMBL4270667,J Med Chem,2018.0,CHEMBL4292006,CHEMBL4292006,,0.0,http://www.openphacts.org/units/Nanomolar,3125920.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
3179,5230701.0,[],CHEMBL1681335,Antiviral activity against HIV-1 Bal infected in 1 hr compound pretreated human ectocervical explant tissue assessed as inhibition of viral replication by RT-PCR,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1671644,Antimicrob Agents Chemother,2009.0,CHEMBL70663,CHEMBL70663,9.70,0.0,http://www.openphacts.org/units/Nanomolar,1331935.0,=,1.0,1.0,=,IC50,nM,0.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.2,CHEMBL378
3180,2276086.0,[],CHEMBL1030793,Inhibition of HIV1 replication in human 293T cells preincubated 15 mins prior to infection measured after 48 hrs postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1C(=O)Nc2ccc(F)cc2N1S(=O)(=O)c1cccc2cccnc12,CHEMBL1153359,Bioorg Med Chem,2009.0,CHEMBL492313,CHEMBL492313,5.16,0.0,http://www.openphacts.org/units/Nanomolar,754339.0,=,1.0,1.0,=,IC50,nM,7000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.0,CHEMBL378
3181,1402532.0,[],CHEMBL837465,In vitro inhibitory concentration against HIV G190S mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL223228,CHEMBL223228,6.60,0.0,http://www.openphacts.org/units/Nanomolar,360371.0,=,1.0,1.0,=,IC50,nM,251.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.251,CHEMBL378
3182,10862016.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3CC=C4[C@@H]5C[C@@](C)(C(=O)OCc6ccc(C(F)(F)F)cc6)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022395,CHEMBL2022395,,0.0,http://www.openphacts.org/units/Nanomolar,1637647.0,>,1.0,1.0,>,IC50,nM,1499930.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1499.93,CHEMBL613497
3183,149357.0,[],CHEMBL683676,Compound was tested for antiviral activity against matched pairs of HIV-1 resistant to AZT,F,BAO_0000190,BAO_0000218,organism-based format,O=[N+]([O-])c1cccc(Cn2c(Br)nc3cc(Cl)c(Cl)cc32)c1,CHEMBL1131326,J Med Chem,1998.0,CHEMBL25100,CHEMBL25100,4.96,0.0,http://www.openphacts.org/units/Nanomolar,30695.0,=,1.0,1.0,=,IC50,nM,11000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,11.0,CHEMBL378
3184,901223.0,[],CHEMBL685389,Inhibition of HIV replication in H9 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(NC(=O)C2C[C@]3(C)CCCC[C@]34O[C@@H]4C2=O)cc1,CHEMBL1128512,J Med Chem,1995.0,CHEMBL111446,CHEMBL111446,5.07,0.0,http://www.openphacts.org/units/Nanomolar,204866.0,=,1.0,1.0,=,IC50,nM,8500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.5,CHEMBL378
3185,1470450.0,[],CHEMBL833076,Inhibitory activity against HIV-1 mutant strain 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C(C)=C/C#N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL363952,CHEMBL363952,8.52,0.0,http://www.openphacts.org/units/Nanomolar,380765.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
3186,12663836.0,[],CHEMBL2330344,Antiviral activity against T20-resistant Human immunodeficiency virus 1 NL4-3 harboring gp41 NHR (36G)N42T/N43K mutation infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL2321797,J Med Chem,2013.0,CHEMBL2326636,CHEMBL2326636,,0.0,http://www.openphacts.org/units/Nanomolar,1853136.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2000.0,CHEMBL378
3187,789114.0,[],CHEMBL711619,Antiviral activity against HIV-1 (strain RF) infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)CCCOc1ccc(NC(=O)COc2ccc(Cl)cc2C(=O)c2ccccc2)cc1,CHEMBL1128355,J Med Chem,1995.0,CHEMBL46650,CHEMBL46650,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,73232.0,<,1.0,1.0,<,IC50,ug.mL-1,0.01,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.01,CHEMBL378
3188,10862119.0,[],CHEMBL2024925,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B e-antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCC6CCOCC6)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024633,CHEMBL2024633,,0.0,http://www.openphacts.org/units/Nanomolar,1640529.0,>,1.0,1.0,>,IC50,nM,1914570.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1914.57,CHEMBL613497
3189,15158582.0,[],CHEMBL3398830,Inhibition of HBV HBsAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OCc1cccc2c1CCOC2=O)c1ccc([N+](=O)[O-])cc1,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397178,CHEMBL3397178,,0.0,http://www.openphacts.org/units/Nanomolar,2278977.0,>,1.0,1.0,>,IC50,nM,2260000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.26,CHEMBL613497
3190,2061748.0,[],CHEMBL942900,Inhibition of HIV LAV in BSC1 cells after 2.5 hrs by cell fusion assay,F,BAO_0000190,BAO_0000218,organism-based format,CCC(C)/C=C(C)/C=C\C(O)C(C)(O)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1C(=O)N[C@H](COC)C(=O)NCC(=O)N[C@@H](C)C(=O)N(C)[C@@H]([C@@H](C)O)C(=O)N[C@H]([C@H](OC)c2ccc(O)cc2)C(=O)N2CC[C@H](Cl)C[C@H]2C(=O)O[C@@H]1C(C)C)[C@@H](C)[C@@H](C)C(N)=O)[C@@H](C)N)[C@@H](C)O,CHEMBL1141334,J Nat Prod,2007.0,CHEMBL439403,CHEMBL439403,5.89,0.0,http://www.openphacts.org/units/Nanomolar,684425.0,=,1.0,1.0,=,IC50,nM,1300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.3,CHEMBL378
3191,6216943.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(O)c2)CCN(C(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784501,CHEMBL1784501,4.72,0.0,http://www.openphacts.org/units/Nanomolar,1429440.0,=,1.0,1.0,=,IC50,nM,19054.61,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.72,CHEMBL378
3192,15158639.0,[],CHEMBL3398832,Inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OCc1cccc2c1CCOC2=O)c1cc2ccccc2o1,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397047,CHEMBL3397047,,0.0,http://www.openphacts.org/units/Nanomolar,2278982.0,>,1.0,1.0,>,IC50,nM,2670000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.67,CHEMBL613497
3193,15027154.0,[],CHEMBL3367171,Inhibition of AP-1-mediated transcriptional activation in human Jurkat cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccc(Cl)cc1C(F)(F)F,CHEMBL3352097,J Med Chem,2014.0,CHEMBL132457,CHEMBL132457,,0.0,http://www.openphacts.org/units/Nanomolar,2265164.0,>,1.0,1.0,>,IC50,nM,30000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,30.0,CHEMBL4977
3194,1439770.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL426242,CHEMBL426242,8.00,0.0,http://www.openphacts.org/units/Nanomolar,371451.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
3195,329551.0,[],CHEMBL756133,Inhibition of concanavalin A (con A)-induced proliferation of human peripheral blood mononuclear cells.,F,BAO_0000190,BAO_0000218,organism-based format,CSc1cc(C(F)(F)F)nn1-c1ccc(NC(=O)c2ccncc2F)cc1,CHEMBL1133605,J Med Chem,2000.0,CHEMBL100778,CHEMBL100778,7.37,0.0,http://www.openphacts.org/units/Nanomolar,188102.0,=,1.0,1.0,=,IC50,nM,43.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,43.0,CHEMBL378
3196,1278765.0,[],CHEMBL756142,Tested for the inhibition of p24 production in HIV-1 IIIB infected human peripheral blood mononuclear cells (PBMC),F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@H](C(=O)N[C@H]1C(O)=Cc2ccccc21)[C@H](O)[C@@H](O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)COc1cccc2ccccc12)[C@@H](C)O,CHEMBL1126785,J Med Chem,1993.0,CHEMBL1790706,CHEMBL1790706,8.08,0.0,http://www.openphacts.org/units/Nanomolar,156151.0,=,1.0,1.0,=,IC50,nM,8.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.3,CHEMBL378
3197,2009804.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnc3)ncc(F)c12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL238266,CHEMBL238266,7.44,0.0,http://www.openphacts.org/units/Nanomolar,668109.0,=,1.0,1.0,=,IC50,nM,36.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,36.0,CHEMBL378
3198,16494765.0,[],CHEMBL3772328,Antiviral activity against HIV1 NL4-3 infected in human TZM-bl cells assessed as inhibition of viral replication administered 6 hrs postinfection measured 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(Nc2nc(-c3ccncc3)nc3ccccc23)cc1,CHEMBL3769372,J Med Chem,2016.0,CHEMBL3770712,CHEMBL3770712,5.34,0.0,http://www.openphacts.org/units/Nanomolar,2761466.0,=,1.0,1.0,=,IC50,nM,4600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.6,CHEMBL378
3199,18320113.0,[],CHEMBL4134181,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA level incubated for 3 days followed by medium replacement measured after 3 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,COCOC(=O)C1=C2CCCN2C(c2nccs2)=NC1c1ccc(F)cc1Cl,CHEMBL4130455,ACS Med Chem Lett,2017.0,CHEMBL4166055,CHEMBL4166055,5.68,0.0,http://www.openphacts.org/units/Nanomolar,3041708.0,=,1.0,1.0,=,IC50,nM,2100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.1,CHEMBL613497
3200,14658800.0,[],CHEMBL3266157,Antagonist activity at recombinant human EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)c3ccc(C)c(C)c3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262893,CHEMBL3262893,7.36,0.0,http://www.openphacts.org/units/Nanomolar,2101735.0,=,1.0,1.0,=,IC50,nM,44.0,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,nM,UO_0000065,44.0,CHEMBL3259470
3201,226266.0,[],CHEMBL691098,In vitro antiviral activity against NNRTI-resistant IIIB (WT) HIV-1 variant; not determined,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](Sc1nc(N)cc(Cl)n1)c1cc2ccoc2cn1,CHEMBL1131332,J Med Chem,1998.0,CHEMBL26752,CHEMBL26752,,0.0,http://www.openphacts.org/units/Nanomolar,41267.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3202,2149809.0,[],CHEMBL935680,Antiviral activity against HIV1 098 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL415790,CHEMBL415790,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708040.0,=,1.0,1.0,=,IC50,ug.mL-1,0.045,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.045,CHEMBL378
3203,1830866.0,[],CHEMBL918634,Antiviral activity against wild type HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2ccccc2)n(COCCO)c(=O)[nH]c1=O,CHEMBL1144474,J Med Chem,2007.0,CHEMBL31871,CHEMBL31871,5.30,0.0,http://www.openphacts.org/units/Nanomolar,629325.0,=,1.0,1.0,=,IC50,nM,5060.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.06,CHEMBL378
3204,2929492.0,[],CHEMBL1056900,Antiviral activity against HIV1 HXB2 harboring 100I and K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cnnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL577247,CHEMBL577247,8.33,0.0,http://www.openphacts.org/units/Nanomolar,852824.0,=,1.0,1.0,=,IC50,nM,4.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.7,CHEMBL378
3205,15568192.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(Cl)c(Cl)c1)N1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL1201862,,,CHEMBL3559855,CHEMBL3559855,7.84,0.0,http://www.openphacts.org/units/Nanomolar,2473990.0,=,7.0,1.0,=,IC50,nM,14.3,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.0143,CHEMBL3259470
3206,15568193.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(CCc1ccc(F)cc1)N1CCN(S(=O)(=O)/C=C/c2ccccc2)CC1,CHEMBL1201862,,,CHEMBL3559877,CHEMBL3559877,6.95,0.0,http://www.openphacts.org/units/Nanomolar,2474028.0,=,7.0,1.0,=,IC50,nM,113.0,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.113,CHEMBL3259470
3207,18239567.0,[],CHEMBL4052029,Antiviral activity against darunavir-resistant HIV1 derived from 51 passages harboring protease L10I/I15V/K20R/L24I/V32I/L33F/M36I/M46L/I54M/L63P/K70Q/V82I/I84V/L89M mutant infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1C2CO[C@H]3OCC1C3C2)S(=O)(=O)c1ccc(N)cc1,CHEMBL4049446,J Med Chem,2017.0,CHEMBL4088111,CHEMBL4088111,,0.0,http://www.openphacts.org/units/Nanomolar,3026803.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
3208,23274487.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](CCC(=O)N[C@@H]1CC[C@@]2(C)[C@@H](C1)C[C@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCC(=O)NCCS(=O)(=O)O)CC[C@@H]12)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4875567,CHEMBL4875567,8.30,0.0,http://www.openphacts.org/units/Nanomolar,3621289.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,5.0,CHEMBL613497
3209,22933323.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)/C=C/c6ccc(OCOC)c(OCOC)c6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4758815,CHEMBL4758815,,0.0,http://www.openphacts.org/units/Nanomolar,3560884.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
3210,6271301.0,[],CHEMBL1804201,Antiviral activity against HIV1 harboring vesicular stomatitis virus glycoprotein infected in human 293T cells assessed as inhibition of viral replication after 48 hrs by luciferase activity based luminometer analysis,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1800058,J Nat Prod,2011.0,CHEMBL129,CHEMBL129,7.30,0.0,http://www.openphacts.org/units/Nanomolar,1441034.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.05,CHEMBL378
3211,3258193.0,[],CHEMBL1114358,Antiviral activity against HIV1 infected in human MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cc(NC(=O)c2cc3c(O)c(c2)Cc2cc(C(=O)Nc4cc(C(=O)O)cc(C(=O)O)c4)cc(c2O)Cc2cc(C(=O)Nc4cc(C(=O)O)cc(C(=O)O)c4)cc(c2O)Cc2cc(C(=O)Nc4cc(C(=O)O)cc(C(=O)O)c4)cc(c2O)C3)cc(C(=O)O)c1,CHEMBL1156302,Bioorg Med Chem Lett,2010.0,CHEMBL1090300,CHEMBL1090300,5.17,0.0,http://www.openphacts.org/units/Nanomolar,901404.0,=,1.0,1.0,=,IC50,nM,6700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.7,CHEMBL378
3212,3267346.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,C#Cc1ccc2nc(S)n3c2c1CN(CC=C(C)C)[C@@H](C)C3,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL58811,CHEMBL58811,7.53,0.0,http://www.openphacts.org/units/Nanomolar,905423.0,=,1.0,1.0,=,IC50,nM,29.51,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.53,CHEMBL378
3213,18202582.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2ccc(OC(F)(F)F)cc2)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4087994,CHEMBL4087994,5.80,0.0,http://www.openphacts.org/units/Nanomolar,3019966.0,=,1.0,1.0,=,IC50,nM,1600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.6,CHEMBL378
3214,332247.0,[],CHEMBL697276,In vitro inhibition of HIV-1 plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCSCCOP(=O)([O-])OCC[N+](C)(C)C,CHEMBL1125666,J Med Chem,1991.0,CHEMBL281533,CHEMBL281533,6.55,0.0,http://www.openphacts.org/units/Nanomolar,43730.0,=,1.0,1.0,=,IC50,nM,280.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.28,CHEMBL378
3215,3432549.0,[],CHEMBL1247392,Antiviral activity against HIV1 infected in human CEM cells assessed as protection against virus-induced cytopathic effect after 6 days by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1240504,Eur J Med Chem,2010.0,CHEMBL129,CHEMBL129,4.45,0.0,http://www.openphacts.org/units/Nanomolar,951072.0,=,1.0,1.0,=,IC50,nM,35600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM/L,UO_0000065,35.6,CHEMBL378
3216,1040099.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Clc1cccc(NN2C=NC3CCCCC32)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL290093,CHEMBL290093,,0.0,http://www.openphacts.org/units/Nanomolar,62349.0,>,1.0,1.0,>,IC50,nM,67290.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,67.29,CHEMBL378
3217,2442770.0,[],CHEMBL987533,Antiviral activity against HIV1 3B infected in human HOG.R5 cells after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,CHEMBL1148153,J Nat Prod,2004.0,CHEMBL584,CHEMBL584,7.05,0.0,http://www.openphacts.org/units/Nanomolar,789733.0,=,1.0,1.0,=,IC50,nM,90.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.09,CHEMBL378
3218,3315840.0,[],CHEMBL1119774,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C)C[C@H]3c3ccccc3)CC2)CC1,CHEMBL1155507,Bioorg Med Chem Lett,2010.0,CHEMBL1083126,CHEMBL1083126,7.66,0.0,http://www.openphacts.org/units/Nanomolar,915817.0,=,1.0,1.0,=,IC50,nM,22.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,22.0,CHEMBL378
3219,5306745.0,[],CHEMBL1696826,Antiviral activity against X4 tropic HIV1 RF infected in human TZM-b1 cells after 2 hrs by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,CHEMBL1687731,Antimicrob Agents Chemother,2009.0,CHEMBL483,CHEMBL483,5.39,0.0,http://www.openphacts.org/units/Nanomolar,1337339.0,=,1.0,1.0,=,IC50,nM,4027.42,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4027.42,CHEMBL378
3220,1229387.0,[],CHEMBL677521,Concentration required to inhibit HIV-1TK-(B2006) induced cytopathicity in E6SM cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCC(=O)NCCCCCCCCCCC(=O)NCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL116133,CHEMBL1205571,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221535.0,=,1.0,1.0,=,IC50,ug.mL-1,70.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,70.0,CHEMBL378
3221,891779.0,[],CHEMBL710366,Inhibitory activity tested against the HIV-1 in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N[C@@H](CC(C)C)[C@H](O)CC(=O)O)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL275740,CHEMBL275740,7.36,0.0,http://www.openphacts.org/units/Nanomolar,9095.0,=,1.0,1.0,=,IC50,nM,44.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,44.0,CHEMBL378
3222,12651353.0,[],CHEMBL2327723,Antiviral activity against 0.001 MOI bevirimat-resistant Human immunodeficiency virus 1 NL4-3 harboring gag V370A mutant infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(CCCCC(=O)O)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2179591,CHEMBL2179591,,0.0,http://www.openphacts.org/units/Nanomolar,1850159.0,>,1.0,1.0,>,IC50,nM,3300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.3,CHEMBL378
3223,1403422.0,[],CHEMBL834708,Inhibitory concentration against 100I and 103N mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)c(=O)n(C)c1C,CHEMBL1145199,J Med Chem,2005.0,CHEMBL179871,CHEMBL179871,6.80,0.0,http://www.openphacts.org/units/Nanomolar,360757.0,=,1.0,1.0,=,IC50,nM,158.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.158,CHEMBL378
3224,12627452.0,[],CHEMBL2317015,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(/N=N/C(=N/Nc2ccccc2)c2ccccc2)cc1,CHEMBL2311445,Bioorg Med Chem,2013.0,CHEMBL2311896,CHEMBL2311896,,0.0,http://www.openphacts.org/units/Nanomolar,1841394.0,>,1.0,1.0,>,IC50,nM,5000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.0,CHEMBL378
3225,1439782.0,[],CHEMBL834618,Inhibitory activity against HIV-1 mutant strain 103N; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(NC(C)=O)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL359490,CHEMBL359490,,0.0,http://www.openphacts.org/units/Nanomolar,371457.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3226,850074.0,[],CHEMBL701249,"Inhibitory concentration was evaluated against human respiratory syncytial virus,(HRSV) strain A2.",F,BAO_0000190,BAO_0000218,organism-based format,NS(=O)(=O)c1cccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)nc(Nc3ccc(-c4ccc(Nc5nc(Nc6cccc(S(N)(=O)=O)c6)nc(Nc6cccc(S(N)(=O)=O)c6)n5)cc4S(=O)(=O)O)c(S(=O)(=O)O)c3)n2)c1,CHEMBL1131306,J Med Chem,1998.0,CHEMBL1160588,CHEMBL1160588,5.77,0.0,http://www.openphacts.org/units/Nanomolar,164086.0,=,1.0,1.0,=,IC50,nM,1700.0,CHEMBL613127,Human respiratory syncytial virus,Human respiratory syncytial virus,11250,IC50,uM,UO_0000065,1.7,CHEMBL613127
3227,400858.0,[],CHEMBL665058,Inhibitory concentration required against Cowpox virus in Vero cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2C[C@H](O)CO,CHEMBL1147452,Bioorg Med Chem Lett,2004.0,CHEMBL494759,CHEMBL494759,4.31,0.0,http://www.openphacts.org/units/Nanomolar,214240.0,=,1.0,1.0,=,IC50,nM,49000.0,CHEMBL612672,Cowpox virus,Cowpox virus,10243,IC50,uM,UO_0000065,49.0,CHEMBL612672
3228,371542.0,[],CHEMBL873878,Concentration required to inhibit the entry of HIV-1 reporter virus [ADA] into U-87 cells,F,BAO_0000190,BAO_0000218,organism-based format,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1,CHEMBL1134621,J Med Chem,2001.0,CHEMBL105821,CHEMBL105821,9.70,0.0,http://www.openphacts.org/units/Nanomolar,213218.0,=,1.0,1.0,=,IC50,nM,0.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.2,CHEMBL378
3229,23284021.0,[],CHEMBL4837921,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCCN2)cc1,CHEMBL4837199,Eur J Med Chem,2021.0,CHEMBL4860352,CHEMBL4860352,8.84,0.0,http://www.openphacts.org/units/Nanomolar,3622953.0,=,1.0,1.0,=,IC50,nM,1.46,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.46,CHEMBL378
3230,1471287.0,[],CHEMBL833076,Inhibitory activity against HIV-1 mutant strain 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cccc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL187786,CHEMBL187786,7.70,0.0,http://www.openphacts.org/units/Nanomolar,380812.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.02,CHEMBL378
3231,1041344.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(S)n(Nc2cccc(Cl)c2)c1-c1cccc(Cl)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL285907,CHEMBL285907,5.73,0.0,http://www.openphacts.org/units/Nanomolar,62372.0,=,1.0,1.0,=,IC50,nM,1860.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.86,CHEMBL378
3232,23165137.0,[],CHEMBL4813046,Antiviral activity against Zika virus infected in human SF-268 cells assessed as reduction in viral infection by DAPI staining based immunofluorescence assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)[C@@]1(C)CC[C@]2(C)CC[C@]3(C)C(=CCC4[C@@]5(C)Cc6snnc6C(C)(C)C5CC[C@]43C)C2C1,CHEMBL4811277,Bioorg Med Chem,2021.0,CHEMBL4875833,CHEMBL4875833,,0.0,,3601585.0,,1.0,0.0,,IC50,,,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,,,,CHEMBL4296612
3233,2516306.0,[],CHEMBL975243,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(Cc2cc(C)cc(C)c2)nc(SCc2ccc(OC)cc2)[nH]c1=O,CHEMBL1138559,Eur J Med Chem,2009.0,CHEMBL474242,CHEMBL474242,6.92,0.0,http://www.openphacts.org/units/Nanomolar,733184.0,=,1.0,1.0,=,IC50,nM,120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.12,CHEMBL378
3234,15166154.0,[],CHEMBL3404736,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as decrease in viral DNA replication treated for 7 days by real time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(OC(=O)c2cccs2)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL1332768,CHEMBL1332768,,0.0,http://www.openphacts.org/units/Nanomolar,2284135.0,>,1.0,1.0,>,IC50,nM,926600.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,926.6,CHEMBL613497
3235,2371343.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,CCN1CCCC1CNC(=O)c1cc2c(=O)n(C)c3ccccc3c2n1C,CHEMBL1140145,J Med Chem,2008.0,CHEMBL494081,CHEMBL494081,4.41,0.0,http://www.openphacts.org/units/Nanomolar,745487.0,=,1.0,1.0,=,IC50,nM,39000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,39.0,CHEMBL613493
3236,5247018.0,[],CHEMBL1687411,Antiviral activity against HIV1 Ba-L infected in human PBL cells assessed as reverse transcriptase activity after 7 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1[C@H]1C[C@H]2CC[C@@H](C1)N2CCC(C)(CN(C)S(=O)(=O)c1ccccc1)c1ccccc1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL3084352,CHEMBL3084352,9.00,0.0,http://www.openphacts.org/units/Nanomolar,1333587.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
3237,2997316.0,[],CHEMBL1047854,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV DNA replication after 9 days by PCR,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)c2ccc(=O)n(-c3cc(C)ccc3C)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL567982,CHEMBL567982,6.30,0.0,http://www.openphacts.org/units/Nanomolar,856566.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.5,CHEMBL613497
3238,1672768.0,[],CHEMBL870621,Antiviral activity against HIV1 Y181C mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,COCCOCCOc1ccc(NC(=O)COc2ccc(Cl)cc2C(=O)c2cc(F)cc(C(C)(C)C)c2)c(C)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL370201,CHEMBL370201,7.92,0.0,http://www.openphacts.org/units/Nanomolar,411945.0,=,1.0,1.0,=,IC50,nM,12.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,12.0,CHEMBL378
3239,1051222.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CCc1ccc(NN2C(S)=NC(C)C2c2ccccc2)cc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL38630,CHEMBL38630,,0.0,http://www.openphacts.org/units/Nanomolar,62351.0,>,1.0,1.0,>,IC50,nM,34450.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,34.45,CHEMBL613499
3240,1471733.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cc(F)cc(F)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188877,CHEMBL188877,6.30,0.0,http://www.openphacts.org/units/Nanomolar,380717.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.5,CHEMBL378
3241,2149830.0,[],CHEMBL935681,Antiviral activity against HIV1 098-T20 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL428455,CHEMBL428455,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708038.0,=,1.0,1.0,=,IC50,ug.mL-1,0.035,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.035,CHEMBL378
3242,2368195.0,[],CHEMBL1031556,Antiviral activity against HIV1 infected in human 293T cells assessed as inhibition of pseudovirus infection,F,BAO_0000190,BAO_0000218,organism-based format,O=S(=O)(Nc1n[nH]cc1Br)c1cccc2nsnc12,CHEMBL1140132,J Med Chem,2008.0,CHEMBL510800,CHEMBL510800,6.43,0.0,http://www.openphacts.org/units/Nanomolar,746152.0,=,1.0,1.0,=,IC50,nM,370.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.37,CHEMBL378
3243,668171.0,[],CHEMBL683819,Anti-HIV activity in cell culture assay expressed as IC50 values.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O[C@@H]1O[C@@H]2CC(=O)c3cc(O)c(O)c(O)c3-c3c(cc(O)c(O)c3O)C(=O)O[C@H]2[C@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@H]1OC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,CHEMBL1126373,Bioorg Med Chem Lett,1992.0,CHEMBL1159556,CHEMBL1159556,4.40,0.0,http://www.openphacts.org/units/Nanomolar,60607.0,=,1.0,1.0,=,IC50,nM,40000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,40.0,CHEMBL378
3244,10862018.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3CC=C4[C@@H]5C[C@@](C)(C(=O)OCc6ccc(Br)cc6F)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022396,CHEMBL2022396,,0.0,http://www.openphacts.org/units/Nanomolar,1637648.0,>,1.0,1.0,>,IC50,nM,1526370.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1526.37,CHEMBL613497
3245,594097.0,[],CHEMBL710381,Inhibitory activity against 103N strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)cc(C)c1Nc1ncnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL306385,CHEMBL306385,8.22,0.0,http://www.openphacts.org/units/Nanomolar,126922.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
3246,862596.0,[],CHEMBL701249,"Inhibitory concentration was evaluated against human respiratory syncytial virus,(HRSV) strain A2.",F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(Nc3nc(Nc4cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c4)nc(Nc4cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c4)n3)c(C)c2)ccc1Nc1nc(Nc2cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c2)nc(Nc2cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c2)n1,CHEMBL1131306,J Med Chem,1998.0,CHEMBL263362,CHEMBL263362,,0.0,http://www.openphacts.org/units/Nanomolar,164083.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL613127,Human respiratory syncytial virus,Human respiratory syncytial virus,11250,IC50,uM,UO_0000065,25.0,CHEMBL613127
3247,10961812.0,[],CHEMBL2061272,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M7 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CNC=C1C(=O)Nc2ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)cc21,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057460,CHEMBL2057460,8.68,0.0,http://www.openphacts.org/units/Nanomolar,1655122.0,=,1.0,1.0,=,IC50,nM,2.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.1,CHEMBL378
3248,3406156.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc2oc(-c3ccccc3F)c(O)c(=O)c2c1,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1215667,CHEMBL1215667,,0.0,http://www.openphacts.org/units/Nanomolar,933436.0,=,1.0,1.0,=,IC50,nM,171300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,171.3,CHEMBL378
3249,615378.0,[],CHEMBL710534,Inhibitory activity against 188L strain of HIV-1 in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)/C=N\c1nc(Cc2c(Cl)cccc2Cl)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL73673,CHEMBL73673,6.60,0.0,http://www.openphacts.org/units/Nanomolar,126928.0,=,1.0,1.0,=,IC50,nM,251.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.251,CHEMBL378
3250,3267385.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CCCN1Cc2cccc3[nH]c(=O)n(c23)C(C(C)C)C1,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL163883,CHEMBL163883,4.13,0.0,http://www.openphacts.org/units/Nanomolar,906730.0,=,1.0,1.0,=,IC50,nM,74131.02,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.13,CHEMBL378
3251,2601958.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(C(N)=O)[nH]c3ccc(Cl)cc23)c1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL312702,CHEMBL312702,8.22,0.0,http://www.openphacts.org/units/Nanomolar,808145.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
3252,3129671.0,[],CHEMBL1064877,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1csc(-c2nc(COc3c4cc(S(=O)(=O)[O-])cc3Cc3cc(S(=O)(=O)[O-])cc(c3O)Cc3cc(S(=O)(=O)[O-])cc(c3Oc3csc(-c5nc(C)cs5)n3)Cc3cc(S(=O)(=O)[O-])cc(c3O)C4)cs2)n1.[Na+].[Na+].[Na+].[Na+],CHEMBL1157689,Bioorg Med Chem,2010.0,CHEMBL590662,CHEMBL1208389,5.80,0.0,http://www.openphacts.org/units/Nanomolar,880939.0,=,1.0,1.0,=,IC50,nM,1600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.6,CHEMBL378
3253,22898304.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731092,Antiviral activity against DRV resistant HIV1 infected in human MT4 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(=O)C[C@H]1C2CO[C@H]3OC[C@@H]1C3C2)S(=O)(=O)c1ccc2nc(NC3CC3)sc2c1,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL4743665,CHEMBL4743665,,0.0,http://www.openphacts.org/units/Nanomolar,3554415.0,=,1.0,1.0,=,IC50,nM,0.004,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.004,CHEMBL378
3254,1224902.0,[],CHEMBL710380,Inhibitory activity against 103N strain and 181C strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72335,CHEMBL72335,7.03,0.0,http://www.openphacts.org/units/Nanomolar,127434.0,=,1.0,1.0,=,IC50,nM,94.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.094,CHEMBL378
3255,2099771.0,[],CHEMBL949219,Antiviral activity against HIV1 ASM80 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)N(CCCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nc4c2CCN(S(C)(=O)=O)C4)C3)c2ccccc2)cc1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL272580,CHEMBL272580,8.40,0.0,http://www.openphacts.org/units/Nanomolar,699396.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.004,CHEMBL378
3256,614674.0,[],CHEMBL691383,Inhibitory concentration for cytopathicity of HIV-1 (HTLV-IIIB) in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C(c2cc(C)c(O)c(C(=O)O)c2)c2cc(C)c(O)c(C(=O)O)c2)cc(C(=O)O)c1O,CHEMBL1125737,J Med Chem,1991.0,CHEMBL113891,CHEMBL113891,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,217788.0,>,1.0,1.0,>,IC50,ug.mL-1,186.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,186.0,CHEMBL378
3257,18940425.0,[],CHEMBL4328848,Antiviral activity against HIV-1 3B infected in human MAGI-CXCR4 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cn1ncc2ccc(-c3ccc4ccn(Cc5cc(F)cc(C(=O)O)c5)c4c3)cc21,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4548603,CHEMBL4548603,4.95,0.0,http://www.openphacts.org/units/Nanomolar,3159826.0,=,1.0,1.0,=,IC50,nM,11300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,11.3,CHEMBL378
3258,5222670.0,[],CHEMBL1675427,Antiviral activity against HIV1 harboring reverse transcriptase L74V mutant infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL141,CHEMBL141,,0.0,,1332024.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
3259,13463721.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,[N-]=[N+]=N[C@H]1C[C@H](n2cnc3nc(N)nc(OCc4ccccc4)c32)O[C@@H]1CO,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL2430341,CHEMBL2430341,5.10,0.0,http://www.openphacts.org/units/Nanomolar,1920838.0,=,1.0,1.0,=,IC50,nM,7943.28,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.1,CHEMBL378
3260,5132821.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2[nH]c(=O)c(CN(Cc3ccco3)C(=O)c3ccc(Cl)c(Cl)c3)cc2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645050,CHEMBL1645050,5.04,0.0,http://www.openphacts.org/units/Nanomolar,1321038.0,=,1.0,1.0,=,IC50,nM,9200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,9.2,CHEMBL378
3261,1681482.0,[],CHEMBL866396,Antiviral activity against HIV1 NL4.3 in MT4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(OC)cc2)CCCNCCCN(S(=O)(=O)c2ccc(OC)cc2)C1,CHEMBL1149461,J Med Chem,2006.0,CHEMBL202658,CHEMBL202658,5.20,0.0,http://www.openphacts.org/units/Nanomolar,427689.0,=,1.0,1.0,=,IC50,nM,6300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.3,CHEMBL378
3262,2601497.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(N)n(CCOCP(=O)(O)O)c(=O)c1CC(=O)O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL149197,CHEMBL149197,9.52,0.0,http://www.openphacts.org/units/Nanomolar,807283.0,=,1.0,1.0,=,IC50,nM,0.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0003,CHEMBL378
3263,2317082.0,[],CHEMBL989318,Antiviral activity against HIV1 3B in human H9 cells assessed as inhibition of p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1c2c(cc3c1-c1c(cc4c(c1OC)OCO4)[C@H](OC(=O)c1ccccc1)[C@@H](C)[C@@H](C)C3)OCO2,CHEMBL1158229,J Nat Prod,1996.0,CHEMBL484669,CHEMBL484669,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,788553.0,=,1.0,1.0,=,IC50,ug.mL-1,41.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,41.0,CHEMBL378
3264,1470306.0,[],CHEMBL832525,Inhibitory activity against HIV-1 double mutants strain 101E and 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL185715,CHEMBL185715,7.70,0.0,http://www.openphacts.org/units/Nanomolar,380721.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.02,CHEMBL378
3265,13398971.0,[],CHEMBL2417107,Antiviral activity against Human immunodeficiency virus 1 R5 primary isolate YTA48P infected in CCR5-expressing human PM1 cells assessed as inhibition of virus-induced cytopathogenicity after 7 days by WST8 assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(Cl)c(Cl)c1)C(=O)NC1CC2(CCCCC2)NC2(CCCCC2)C1,CHEMBL2412961,Bioorg Med Chem,2013.0,CHEMBL2413383,CHEMBL2413383,6.21,0.0,http://www.openphacts.org/units/Nanomolar,1911014.0,=,1.0,1.0,=,IC50,nM,620.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.62,CHEMBL378
3266,5294575.0,[],CHEMBL1696681,Antiviral activity against HIV-1 3B infected in human MT4 cells assessed as inhibition of virus induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,CHEMBL1687706,Antimicrob Agents Chemother,2008.0,CHEMBL160,CHEMBL160,,0.0,http://www.openphacts.org/units/Nanomolar,1337217.0,>,1.0,1.0,>,IC50,nM,830.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.83,CHEMBL378
3267,3383640.0,[],CHEMBL1211563,Antiviral activity against HIV1 NL-BAL infected in CCR5-expressing human JC53-BL cells assessed as inhibition of viral replication after 16 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(N[C@@H](CCN1C[C@@H]2CN(C(=O)c3cccnc3)C[C@@H]2C1)c1cccc(F)c1)C1CCCC1,CHEMBL1208790,Bioorg Med Chem Lett,2010.0,CHEMBL1209528,CHEMBL1209528,8.15,0.0,http://www.openphacts.org/units/Nanomolar,927260.0,=,1.0,1.0,=,IC50,nM,7.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.0,CHEMBL378
3268,5229802.0,[],CHEMBL1676981,Antiviral activity against Human immunodeficiency virus 1 3B infected in AA5 cells infected with 3.13 uL of virus stock assessed as expression of p24 antigen after 6 days postinfection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,>,1.0,1.0,>,IC50,nM,53100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,53.1,CHEMBL378
3269,1437864.0,[],CHEMBL834619,Inhibitory activity against HIV-1 mutant strain 181C; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(-c2ccccc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL368028,CHEMBL368028,,0.0,http://www.openphacts.org/units/Nanomolar,371585.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3270,12150895.0,[],CHEMBL2187761,Antiviral activity against X4 HIV1 NL4.3 infected in human MT4 cells assessed as inhibition of viral replication pre-incubated for 30 mins measured 5 days post infection by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn(CCC[n+]2ccc(-c3cc[n+](Cc4cc(C[n+]5ccc(-c6cc[n+](CCCn7cc(C)c(=O)[nH]c7=O)cc6)cc5)cc(C[n+]5ccc(-c6cc[n+](Cc7cc(C[n+]8ccc(-c9cc[n+](Cc%10cc(C[n+]%11ccc(-c%12cc[n+](CCCn%13cc(C)c(=O)[nH]c%13=O)cc%12)cc%11)cc(C[n+]%11ccc(-c%12cc[n+](CCCn%13cc(C)c(=O)[nH]c%13=O)cc%12)cc%11)c%10)cc9)cc8)cc(C[n+]8ccc(-c9cc[n+](Cc%10cc(C[n+]%11ccc(-c%12cc[n+](Cc%13cc(C[n+]%14ccc(-c%15cc[n+](Cc%16cc(C[n+]%17ccc(-c%18cc[n+](CCCn%19cc(C)c(=O)[nH]c%19=O)cc%18)cc%17)cc(C[n+]%17ccc(-c%18cc[n+](CCCn%19cc(C)c(=O)[nH]c%19=O)cc%18)cc%17)c%16)cc%15)cc%14)cc(C[n+]%14ccc(-c%15cc[n+](Cc%16cc(C[n+]%17ccc(-c%18cc[n+](CCCn%19cc(C)c(=O)[nH]c%19=O)cc%18)cc%17)cc(C[n+]%17ccc(-c%18cc[n+](CCCn%19cc(C)c(=O)[nH]c%19=O)cc%18)cc%17)c%16)cc%15)cc%14)c%13)cc%12)cc%11)cc(C[n+]%11ccc(-c%12cc[n+](Cc%13cc(C[n+]%14ccc(-c%15cc[n+](Cc%16cc(C[n+]%17ccc(-c%18cc[n+](CCCn%19cc(C)c(=O)[nH]c%19=O)cc%18)cc%17)cc(C[n+]%17ccc(-c%18cc[n+](CCCn%19cc(C)c(=O)[nH]c%19=O)cc%18)cc%17)c%16)cc%15)cc%14)cc(C[n+]%14ccc(-c%15cc[n+](Cc%16cc(C[n+]%17ccc(-c%18cc[n+](CCCn%19cc(C)c(=O)[nH]c%19=O)cc%18)cc%17)cc(C[n+]%17ccc(-c%18cc[n+](CCCn%19cc(C)c(=O)[nH]c%19=O)cc%18)cc%17)c%16)cc%15)cc%14)c%13)cc%12)cc%11)c%10)cc9)cc8)c7)cc6)cc5)c4)cc3)cc2)c(=O)[nH]c1=O.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F,CHEMBL2177043,J Med Chem,2012.0,CHEMBL2179464,CHEMBL2220891,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1752528.0,=,1.0,1.0,=,IC50,ug.mL-1,1.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,1.5,CHEMBL378
3271,498856.0,[],CHEMBL757967,Inhibition of cell growth against HIV-1 infected PBM (Human peripheral blood mononuclear) cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@@H]2CS[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1126792,J Med Chem,1993.0,CHEMBL313615,CHEMBL313615,,0.0,http://www.openphacts.org/units/Nanomolar,161289.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
3272,1027889.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NN2C(S)=NC(C)C2c2ccccc2)cc1C,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289210,CHEMBL289210,,0.0,http://www.openphacts.org/units/Nanomolar,62370.0,>,1.0,1.0,>,IC50,nM,55580.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,55.58,CHEMBL378
3273,644160.0,[],CHEMBL713512,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1Cn2c(S)nc3cc(Cl)cc(c32)CN1CC1CC1,CHEMBL1128252,J Med Chem,1995.0,CHEMBL352774,CHEMBL352774,7.47,0.0,http://www.openphacts.org/units/Nanomolar,326375.0,=,1.0,1.0,=,IC50,nM,34.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.034,CHEMBL378
3274,12680756.0,[],CHEMBL2342599,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)Nc3cccc(C)c3)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333694,CHEMBL2333694,,0.0,http://www.openphacts.org/units/Nanomolar,1867770.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
3275,1498130.0,[],CHEMBL833971,Concentration required to inhibit 50% viral production of human immunodeficiency virus type 1 (HIV-1-IIIB),F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)C(Nc1ccccc1[N+](=O)[O-])c1c(Cl)cccc1Cl,CHEMBL1143567,J Med Chem,2005.0,CHEMBL70329,CHEMBL70329,7.48,0.0,http://www.openphacts.org/units/Nanomolar,388267.0,=,1.0,1.0,=,IC50,nM,33.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.033,CHEMBL378
3276,1422381.0,[],CHEMBL837251,Antiviral activity in an in vitro HIV replication assay; ND means not determined,F,BAO_0000190,BAO_0000218,organism-based format,CN(C[C@@H](CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1,CHEMBL1141903,Bioorg Med Chem Lett,2005.0,CHEMBL360522,CHEMBL360522,,0.0,http://www.openphacts.org/units/Nanomolar,365551.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,,CHEMBL378
3277,13475395.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435892,CHEMBL2435892,5.75,0.0,http://www.openphacts.org/units/Nanomolar,1924268.0,=,1.0,1.0,=,IC50,nM,1777.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1777.0,CHEMBL378
3278,1751279.0,[],CHEMBL854522,Antiviral activity against Measles virus variant in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Cc1ccccc1)Nc1ccccc1C(=O)O,CHEMBL1145335,J Med Chem,2006.0,CHEMBL211692,CHEMBL211692,,0.0,,532787.0,,1.0,0.0,,IC50,,,CHEMBL613738,Measles virus,Measles virus,11234,IC50,,,,CHEMBL613738
3279,16498292.0,[],CHEMBL3777089,Antiviral activity against HIV1 dual CXCR4/CCR5-tropic strain 89.6 infected in human 293T cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1/C(=N\Nc2ccc3c(S(=O)(=O)O)cc(S(=O)(=O)O)cc3c2)C(c2ccccc2)=NN1c1nc(-c2nccs2)cs1,CHEMBL3774382,Bioorg Med Chem,2016.0,CHEMBL3775261,CHEMBL3775261,5.17,0.0,http://www.openphacts.org/units/Nanomolar,2762413.0,=,1.0,1.0,=,IC50,nM,6700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.7,CHEMBL378
3280,20677913.0,[],CHEMBL4622140,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in cytoplasmic HBV-DNA replication incubated for 8 days by real-time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(-c2ccc(F)nc2F)nn(Cc2ccc(Cl)cc2)c(=O)c1C,CHEMBL4619801,J Med Chem,2020.0,CHEMBL4642856,CHEMBL4642856,5.91,0.0,http://www.openphacts.org/units/Nanomolar,3482200.0,=,1.0,1.0,=,IC50,nM,1220.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.22,CHEMBL613497
3281,666845.0,[],CHEMBL683819,Anti-HIV activity in cell culture assay expressed as IC50 values.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O[C@@H]1[C@@H](c2c(O)cc(O)c3c2O[C@H](c2ccc(O)c(O)c2)[C@H](OC(=O)c2cc(O)c(O)c(O)c2)C3)c2c(O)cc(O)c([C@H]3c4c(O)cc(O)cc4O[C@H](c4ccc(O)c(O)c4)[C@@H]3OC(=O)c3cc(O)c(O)c(O)c3)c2O[C@@H]1c1ccc(O)c(O)c1)c1cc(O)c(O)c(O)c1,CHEMBL1126373,Bioorg Med Chem Lett,1992.0,CHEMBL262261,CHEMBL262261,,0.0,http://www.openphacts.org/units/Nanomolar,60637.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.0,CHEMBL378
3282,3276408.0,[],CHEMBL1104905,Antiviral activity against HBV infected in HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion after 8 days by radio immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnsc1/C=C(/NC(=O)c1ccccc1)C(=O)N1CCCCC1,CHEMBL1157863,Eur J Med Chem,2010.0,CHEMBL1099040,CHEMBL1099040,,0.0,,912502.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
3283,1248543.0,[],CHEMBL824448,Concentration required to inhibit parainfluenza-3 induced cytopathicity in Vero cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCC(=O)NCCCCCCCCCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL118801,CHEMBL1205590,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221516.0,>,1.0,1.0,>,IC50,ug.mL-1,200.0,CHEMBL613126,Human parainfluenza virus 3,Human parainfluenza virus 3,11216,IC50,ug ml-1,UO_0000274,200.0,CHEMBL613126
3284,1751360.0,[],CHEMBL854523,Antiviral activity against wild type Measles virus Edmonston in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc2oc(Cc3ccccc3)nc2c1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL214087,CHEMBL214087,4.26,0.0,http://www.openphacts.org/units/Nanomolar,532783.0,=,1.0,1.0,=,IC50,nM,55000.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,55.0,CHEMBL613738
3285,13861115.0,[],CHEMBL3101351,Antiviral activity against HIV1 NL4.3 infected in human TZM-bl cells expressing CXCR4-tropic incubated for 1 hr prior to infection measured after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C12C=CC(=O)C(O)=C1CC=C(C)C2CC=C(C)C,CHEMBL3098125,Bioorg Med Chem Lett,2014.0,CHEMBL3099060,CHEMBL3099060,5.30,0.0,http://www.openphacts.org/units/Nanomolar,1956063.0,=,1.0,1.0,=,IC50,nM,5000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.0,CHEMBL378
3286,1030481.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=C(S)N(Nc2cccc([N+](=O)[O-])c2)C1c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL288680,CHEMBL288680,4.95,0.0,http://www.openphacts.org/units/Nanomolar,62326.0,=,1.0,1.0,=,IC50,nM,11250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,11.25,CHEMBL378
3287,489613.0,[],CHEMBL757967,Inhibition of cell growth against HIV-1 infected PBM (Human peripheral blood mononuclear) cells,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c(=O)n([C@@H]2CS[C@@H](CO)O2)cc1I,CHEMBL1126792,J Med Chem,1993.0,CHEMBL89365,CHEMBL89365,,0.0,http://www.openphacts.org/units/Nanomolar,161314.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
3288,18707048.0,[],CHEMBL4256228,Antiviral activity against HIV1 92HT599 infected in human MT2 cells assessed as reduction in p24 production in presence of 40% serum by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C1=C2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)[C@H]6C[C@@H](C(=O)O)C6(C)C)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(c2ncc(-c3ccc(Cl)cc3)[nH]2)CC1=O,CHEMBL4251729,ACS Med Chem Lett,2018.0,CHEMBL4293505,CHEMBL4293505,8.00,0.0,http://www.openphacts.org/units/Nanomolar,3106952.0,=,1.0,1.0,=,IC50,nM,10.01,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.01,CHEMBL378
3289,10938680.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccc(O)c(O)c4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046556,CHEMBL2046556,4.79,0.0,http://www.openphacts.org/units/Nanomolar,1651439.0,=,1.0,1.0,=,IC50,nM,16060.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,16.06,CHEMBL613497
3290,1402154.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCOCCN(C)c1c(Cc2cccc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL174536,CHEMBL174536,7.89,0.0,http://www.openphacts.org/units/Nanomolar,360385.0,=,1.0,1.0,=,IC50,nM,13.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.013,CHEMBL378
3291,15066687.0,[],CHEMBL3390094,Antiviral activity against HIV1 infected in HEK293T cells by p24 ELISA based phenotypic assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NCCO)c1[nH]c2ccc(Cl)cc2c1C1(c2ccccc2)CC1,CHEMBL3352750,Bioorg Med Chem Lett,2014.0,CHEMBL3325513,CHEMBL3325513,6.68,0.0,http://www.openphacts.org/units/Nanomolar,2270409.0,=,1.0,1.0,=,IC50,nM,209.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.209,CHEMBL378
3292,219076.0,[],CHEMBL815090,Inhibition of HIV-1 (ADA) entry into U-87 (human glioblastoma) cells.,F,BAO_0000190,BAO_0000218,organism-based format,CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(OC)nc3C)CC2)CC1,CHEMBL1136595,Bioorg Med Chem Lett,2003.0,CHEMBL343520,CHEMBL343520,9.89,0.0,http://www.openphacts.org/units/Nanomolar,317565.0,=,1.0,1.0,=,IC50,nM,0.13,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.13,CHEMBL378
3293,14927161.0,[],CHEMBL3391566,Antiviral activity against NNRTI-resistant HIV-1 LAI harboring reverse transcriptase K103N mutant infected in human MT4 cells assessed as inhibition of viral replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1[nH]c(=O)c(Cl)c(Oc2cc(Cl)cc(C#N)c2)c1CCCc1ccncc1,CHEMBL3390846,Medchemcomm,2010.0,CHEMBL3347300,CHEMBL3347300,8.70,0.0,http://www.openphacts.org/units/Nanomolar,2173116.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
3294,1403439.0,[],CHEMBL837591,Inhibitory concentration against wild-type HIV-1 LAI Virus was determined,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL223228,CHEMBL223228,9.00,0.0,http://www.openphacts.org/units/Nanomolar,360777.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
3295,3198126.0,[],CHEMBL1104128,Antiviral activity against HIV1 JV1083 infected in PBMCs assessed as reverse transcriptase activity after 7 days by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)CCNC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@@H](N)Cc1ccc(O)cc1,CHEMBL1153724,Bioorg Med Chem Lett,2009.0,CHEMBL1075830,CHEMBL1075830,4.88,0.0,http://www.openphacts.org/units/Nanomolar,889153.0,=,1.0,1.0,=,IC50,nM,13100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,13.1,CHEMBL378
3296,19261863.0,[],CHEMBL4404369,Antiviral activity against HIV1 subtypeA/G CRF02_AG clone 250,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.68,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,210.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.21,CHEMBL378
3297,5230906.0,[],CHEMBL1676715,Antiviral activity against Human immunodeficiency virus 1 subtype O BCF03 infected in phytohemagglutininin and interleukin-2-stimulated PBMC assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL129,CHEMBL129,,0.0,http://www.openphacts.org/units/Nanomolar,1332124.0,<,1.0,1.0,<,IC50,nM,0.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0001,CHEMBL378
3298,19139096.0,[],CHEMBL4376259,Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition in virus-induced cytopathic effect incubated for 40 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)OC)[C@@H]1CC[C@H](C)[C@H]2C(=C(C)C(=O)[C@H]2NC(=O)C(C)CCl)C1,CHEMBL4373726,Bioorg Med Chem Lett,2019.0,CHEMBL4450376,CHEMBL4450376,,0.0,http://www.openphacts.org/units/Nanomolar,3194253.0,>,1.0,1.0,>,IC50,nM,422400.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,422.4,CHEMBL613129
3299,19261733.0,[],CHEMBL4404352,Antiviral activity against HIV1 HXB2 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2ccc(F)cn2)[nH]1)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4544639,CHEMBL4544639,,0.0,http://www.openphacts.org/units/Nanomolar,3216269.0,>,1.0,1.0,>,IC50,nM,11000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,11.0,CHEMBL378
3300,15691297.0,[],CHEMBL3611387,Antiviral activity against HIV1 by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL3608235,Bioorg Med Chem,2015.0,CHEMBL462018,CHEMBL462018,7.70,0.0,http://www.openphacts.org/units/Nanomolar,2496310.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.02,CHEMBL378
3301,15166140.0,[],CHEMBL3404736,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as decrease in viral DNA replication treated for 7 days by real time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL483,CHEMBL483,5.54,0.0,http://www.openphacts.org/units/Nanomolar,2284121.0,=,1.0,1.0,=,IC50,nM,2900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.9,CHEMBL613497
3302,18940384.0,[],CHEMBL4328847,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc(Cn2ccc3ccc(-c4ccc5ccn(Cc6cccc(C(=O)O)c6)c5c4)cc32)cc1,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4459522,CHEMBL4459522,5.96,0.0,http://www.openphacts.org/units/Nanomolar,3159819.0,=,1.0,1.0,=,IC50,nM,1100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.1,CHEMBL378
3303,10866431.0,[],CHEMBL2025517,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HbeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(O)C(C)=O)C2)on1,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024032,CHEMBL2024032,,0.0,http://www.openphacts.org/units/Nanomolar,1639754.0,>,1.0,1.0,>,IC50,nM,1179080.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1179.08,CHEMBL613497
3304,5199479.0,[],CHEMBL1670944,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)[Si](CCc1c(N2CCNCC2)nc2ccc(Cl)cc2c1-c1ccccc1Cl)(c1ccccc1)c1ccccc1,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668646,CHEMBL1668646,4.73,0.0,http://www.openphacts.org/units/Nanomolar,1328430.0,=,1.0,1.0,=,IC50,nM,18800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,18.8,CHEMBL613497
3305,1977618.0,[],CHEMBL897739,Antiviral activity against influenza B/Sichuan/83/2000 virus in MDCK cells by CPE assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCOCCCOC(=O)C1=C[C@H](NC(=N)N)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O1,CHEMBL1149649,Bioorg Med Chem Lett,2007.0,CHEMBL140893,CHEMBL140893,4.65,0.0,http://www.openphacts.org/units/Nanomolar,660256.0,=,1.0,1.0,=,IC50,nM,22300.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,22.3,CHEMBL613129
3306,10866447.0,[],CHEMBL2025517,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HbeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(OC(=O)CCN2C(=O)c3ccccc3C2=O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCN4C(=O)c5ccccc5C4=O)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024045,CHEMBL2024045,,0.0,http://www.openphacts.org/units/Nanomolar,1639767.0,>,1.0,1.0,>,IC50,nM,809480.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,809.48,CHEMBL613497
3307,2601675.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=c1ccn([C@H]2S[C@@H](CO)C=C2F)c(=O)[nH]1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL129037,CHEMBL129037,4.00,0.0,http://www.openphacts.org/units/Nanomolar,807921.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
3308,1049994.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(NN2C=NC(C)C2c2cccc(C(N)=O)c2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289608,CHEMBL289608,,0.0,http://www.openphacts.org/units/Nanomolar,62339.0,>,1.0,1.0,>,IC50,nM,162310.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,162.31,CHEMBL613499
3309,1401634.0,[],CHEMBL837471,In vitro inhibitory concentration against HIV Y188L mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1[nH]c(=O)c(N(C)C)c(Cc2cc(C)cc(C)c2)c1C,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175823,CHEMBL175823,5.30,0.0,http://www.openphacts.org/units/Nanomolar,360335.0,=,1.0,1.0,=,IC50,nM,5012.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.012,CHEMBL378
3310,22933259.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)CCc4ccc5c(c4)OCO5)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4740647,CHEMBL4740647,7.66,0.0,http://www.openphacts.org/units/Nanomolar,3560869.0,=,1.0,1.0,=,IC50,nM,21.88,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.66,CHEMBL378
3311,3457973.0,[],CHEMBL1249120,Inhibition of AP1 expressed in HEK293 cells assessed as inhibition of PMA-induced transcriptional activation treated 24 hrs before PMA challenge by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(Nc2ccc(Cl)cc2)sc1-c1nc2ccccc2c(=O)n1-c1ccc(Cl)cc1,CHEMBL1240423,Eur J Med Chem,2010.0,CHEMBL485904,CHEMBL485904,5.92,1.0,http://www.openphacts.org/units/Nanomolar,954027.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,1.2,CHEMBL4977
3312,3229747.0,[],CHEMBL1113200,Antiviral activity against recombinant HIV1 virus infected in human JC53BL cells after 3 days,F,BAO_0000190,BAO_0000218,organism-based format,CCCC[C@H]1CN(CC2CCC(F)(F)CC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2,CHEMBL1154224,Bioorg Med Chem Lett,2009.0,CHEMBL1078714,CHEMBL1078714,8.70,0.0,http://www.openphacts.org/units/Nanomolar,898391.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
3313,3383665.0,[],CHEMBL1211563,Antiviral activity against HIV1 NL-BAL infected in CCR5-expressing human JC53-BL cells assessed as inhibition of viral replication after 16 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc(C)c1C(=O)N1C[C@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@H]2C1,CHEMBL1208790,Bioorg Med Chem Lett,2010.0,CHEMBL1097169,CHEMBL1097169,8.68,0.0,http://www.openphacts.org/units/Nanomolar,926851.0,=,1.0,1.0,=,IC50,nM,2.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.1,CHEMBL378
3314,2244521.0,[],CHEMBL1002207,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase K103N mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(COc1ccc(Cl)cc1C(=O)c1ccccc1)Nc1ccccc1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL296939,CHEMBL296939,7.60,0.0,http://www.openphacts.org/units/Nanomolar,798577.0,=,1.0,1.0,=,IC50,nM,25.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,25.0,CHEMBL378
3315,2602138.0,[],CHEMBL1033990,Antiviral activity against Hepatitis B virus,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn(/C=C2/CC2(F)CO)c(=O)[nH]c1=O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL376591,CHEMBL376591,4.70,0.0,http://www.openphacts.org/units/Nanomolar,807310.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,20.0,CHEMBL613497
3316,3358092.0,[],CHEMBL1175709,Antiviral activity against HIV1 infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(Cc3ccccc3)CC2)n1,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1171331,CHEMBL1171331,8.48,0.0,http://www.openphacts.org/units/Nanomolar,922872.0,=,1.0,1.0,=,IC50,nM,3.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.3,CHEMBL378
3317,1045223.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=C(S)N(Nc2cccc(Cl)c2)C1C(=O)O,CHEMBL1144865,J Med Chem,2003.0,CHEMBL290626,CHEMBL290626,,0.0,http://www.openphacts.org/units/Nanomolar,62358.0,>,1.0,1.0,>,IC50,nM,265560.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,265.56,CHEMBL613499
3318,1750599.0,[],CHEMBL868004,Antiviral activity against multi drug-resistant HIV1 C variant in human PHA-PBMC cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,CHEMBL1146019,J Med Chem,2006.0,CHEMBL114,CHEMBL114,7.00,0.0,http://www.openphacts.org/units/Nanomolar,539998.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,100.0,CHEMBL378
3319,22845249.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4721681,Antiviral activity against HIV-1 3B infected in human H9 cells assessed as reduction in viral transmission to TZM-bl cells incubated for 48 hrs by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)c(F)c2)[nH]1)c1nc(CO)cs1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4533529,CHEMBL4533529,7.01,0.0,http://www.openphacts.org/units/Nanomolar,3547069.0,=,1.0,1.0,=,IC50,nM,97.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.09699999999999999,CHEMBL378
3320,3014058.0,[],CHEMBL1042767,Antiviral activity against HIV1 3B infected in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21,CHEMBL1155333,Bioorg Med Chem Lett,2009.0,CHEMBL518924,CHEMBL518924,8.00,0.0,http://www.openphacts.org/units/Nanomolar,854921.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
3321,18509589.0,[],CHEMBL4191605,Antiviral activity against HIV1 isolate 89.6 infected in PHA-stimulated human PBMC assessed as reduction in p24 level after 7 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL4190218,J Nat Prod,2017.0,CHEMBL129,CHEMBL129,7.02,0.0,http://www.openphacts.org/units/Nanomolar,3073113.0,=,1.0,1.0,=,IC50,nM,95.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,95.0,CHEMBL378
3322,15679813.0,[],CHEMBL3607181,Antiviral activity against HBV infected in human HepG22.2.15 cells after 3 days by neutral red dye-based plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL3603790,Bioorg Med Chem,2015.0,CHEMBL141,CHEMBL141,7.41,0.0,http://www.openphacts.org/units/Nanomolar,2494273.0,=,1.0,1.0,=,IC50,nM,39.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.039,CHEMBL613497
3323,2614772.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1Sc1cccc(N)c1,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL52458,CHEMBL52458,,0.0,http://www.openphacts.org/units/Nanomolar,732839.0,=,1.0,1.0,=,IC50,nM,31477483.14,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,1.502,CHEMBL378
3324,12651421.0,[],CHEMBL2327724,Antiviral activity against 0.001 MOI wild type Human immunodeficiency virus 1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCCNC(=O)[C@H](CC(N)=O)NC(=O)OC(C)(C)C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324134,CHEMBL2324134,7.40,0.0,http://www.openphacts.org/units/Nanomolar,1850158.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
3325,1058649.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C1N=C(S)N(Nc2cccc(Cl)c2)C1C,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39105,CHEMBL39105,,0.0,http://www.openphacts.org/units/Nanomolar,62357.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3326,2292315.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1cc(Cl)cc(Cl)c1,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL55951,CHEMBL55951,4.16,0.0,http://www.openphacts.org/units/Nanomolar,812525.0,=,1.0,1.0,=,IC50,nM,69984.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.155,CHEMBL378
3327,594095.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)cc(C)c1Nc1ncnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL306385,CHEMBL306385,9.22,0.0,http://www.openphacts.org/units/Nanomolar,126922.0,=,1.0,1.0,=,IC50,nM,0.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0006,CHEMBL378
3328,2371264.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,CCN1CCN(c2ccc(Nc3ccnc4cc5ccccc5cc34)cc2)CC1,CHEMBL1140145,J Med Chem,2008.0,CHEMBL494487,CHEMBL494487,6.30,0.0,http://www.openphacts.org/units/Nanomolar,745583.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,0.5,CHEMBL613493
3329,10961184.0,[],CHEMBL2061268,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M3 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCNC=C1C(=O)Nc2ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)cc21,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057471,CHEMBL2057471,7.82,0.0,http://www.openphacts.org/units/Nanomolar,1655133.0,=,1.0,1.0,=,IC50,nM,15.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,15.0,CHEMBL378
3330,5306742.0,[],CHEMBL1696836,Antiviral activity against R5 tropic HIV1 YU.2 infected in human PBMC assessed as inhibition of p24 antigen production after 2 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1687731,Antimicrob Agents Chemother,2009.0,CHEMBL70663,CHEMBL70663,8.96,0.0,http://www.openphacts.org/units/Nanomolar,1337341.0,=,1.0,1.0,=,IC50,nM,1.11,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.11,CHEMBL378
3331,10866437.0,[],CHEMBL2025517,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HbeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)C(C#N)=C(C)C)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2023662,CHEMBL2023662,,0.0,http://www.openphacts.org/units/Nanomolar,1639226.0,=,1.0,1.0,=,IC50,nM,221140.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,221.14,CHEMBL613497
3332,18239597.0,[],CHEMBL4052024,Antiviral activity against lopinavir-resistant HIV1 NL4-3 harboring protease L10F/V32I/M46I/I47A/A71V/I84V mutant infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL4049446,J Med Chem,2017.0,CHEMBL1323,CHEMBL1323,6.37,0.0,http://www.openphacts.org/units/Nanomolar,3026807.0,=,1.0,1.0,=,IC50,nM,430.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,430.0,CHEMBL378
3333,2614814.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL291983,CHEMBL291983,4.52,0.0,http://www.openphacts.org/units/Nanomolar,732077.0,=,1.0,1.0,=,IC50,nM,29991.63,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.523,CHEMBL378
3334,5199519.0,[],CHEMBL1670946,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,OCCc1c(N2CCCCC2)nc2ccc(Cl)cc2c1-c1ccccc1Cl,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668648,CHEMBL1668648,4.30,0.0,http://www.openphacts.org/units/Nanomolar,1328432.0,=,1.0,1.0,=,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
3335,12529811.0,[],CHEMBL3078221,Antiviral activity against HIV1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(-[n+]2noc([O-])c2CN2CCN(C)C(c3ccccc3)C2)cc1,CHEMBL3044741,Med Chem Res,2013.0,CHEMBL2282169,CHEMBL2282169,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824328.0,>,1.0,1.0,>,IC50,ug.mL-1,14.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,14.4,CHEMBL378
3336,2292400.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1[S+]([O-])c1cccc(N)c1C#N,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL293331,CHEMBL293331,,0.0,http://www.openphacts.org/units/Nanomolar,813330.0,=,1.0,1.0,=,IC50,nM,4797334.49,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,2.319,CHEMBL378
3337,807341.0,[],CHEMBL879785,"Inhibitory activity against NNI-resistant HIV-1 strain A17 with Y181C,K103N mutation; ND is not determined.",F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](/N=C(\S)Nc1ccc(Cl)cn1)c1ccccc1,CHEMBL1133139,Bioorg Med Chem Lett,2000.0,CHEMBL291886,CHEMBL291886,,0.0,http://www.openphacts.org/units/Nanomolar,111938.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3338,852868.0,[],CHEMBL713546,Compound potency to achieve protection of MT-4 cells from HIV-1 cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)C(Cc1c(Cl)cccc1Cl)/N=C(\S)Nc1ccc(C#N)cc1,CHEMBL1134808,Bioorg Med Chem Lett,2001.0,CHEMBL306909,CHEMBL306909,5.29,0.0,http://www.openphacts.org/units/Nanomolar,126238.0,=,1.0,1.0,=,IC50,nM,5130.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.13,CHEMBL378
3339,3432915.0,[],CHEMBL1246459,Antiviral activity against R5 tropic HIV1 BaL infected in human CEMx174 5.25M7 cells after 3 days by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CCN(Cc1ccc(C(=O)NN2C(=O)[C@@H]3C4C=CC(C5CC54)[C@@H]3C2=O)cc1)c1ccccc1,CHEMBL1240449,Eur J Med Chem,2010.0,CHEMBL1242814,CHEMBL1242814,4.24,0.0,http://www.openphacts.org/units/Nanomolar,954179.0,=,1.0,1.0,=,IC50,nM,57147.86,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.243,CHEMBL378
3340,18812960.0,[],CHEMBL4276414,Antiviral activity against darunavir-resistant HIV1 at passage 51 infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL4270667,J Med Chem,2018.0,CHEMBL116,CHEMBL116,,0.0,http://www.openphacts.org/units/Nanomolar,3125925.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
3341,2602249.0,[],CHEMBL1034017,Antiviral activity against Vaccinia virus,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOC(=O)C[C@H](C)NP(=O)(COCCn1cnc2c(N)ncnc21)N[C@@H](C)C(=O)OCCCC,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL514621,CHEMBL514621,5.36,0.0,http://www.openphacts.org/units/Nanomolar,808073.0,=,1.0,1.0,=,IC50,nM,4400.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,4.4,CHEMBL613493
3342,5189216.0,[],CHEMBL1658800,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC12CCC(C(=O)OCCc3c(-c4ccccc4Cl)c4cc(Cl)ccc4[nH]c3=O)(OC1=O)C2(C)C,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652511,CHEMBL1652511,,0.0,http://www.openphacts.org/units/Nanomolar,1326886.0,>,1.0,1.0,>,IC50,nM,1800000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.8,CHEMBL613497
3343,2420935.0,[],CHEMBL981023,Antiviral activity against HIV1 assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)OCO2,CHEMBL1153435,J Med Chem,2009.0,CHEMBL178593,CHEMBL178593,8.85,0.0,http://www.openphacts.org/units/Nanomolar,781714.0,=,1.0,1.0,=,IC50,nM,1.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.4,CHEMBL378
3344,12676025.0,[],CHEMBL2346109,Antiviral activity against HIV1 NL4.3 infected in MAGIC-5B cells after 48 hrs by beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2331496,Eur J Med Chem,2013.0,CHEMBL404519,CHEMBL404519,7.40,0.0,http://www.openphacts.org/units/Nanomolar,1871269.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
3345,1402098.0,[],CHEMBL837469,In vitro inhibitory concentration against HIV V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCO)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175873,CHEMBL175873,,0.0,http://www.openphacts.org/units/Nanomolar,360361.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3346,13475435.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435847,CHEMBL2435847,6.97,0.0,http://www.openphacts.org/units/Nanomolar,1924222.0,=,1.0,1.0,=,IC50,nM,107.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,107.1,CHEMBL378
3347,10938635.0,[],CHEMBL2051599,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccc(F)cc4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046572,CHEMBL2046572,4.40,0.0,http://www.openphacts.org/units/Nanomolar,1651455.0,=,1.0,1.0,=,IC50,nM,39540.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,39.54,CHEMBL613497
3348,317075.0,[],CHEMBL697276,In vitro inhibition of HIV-1 plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCSCC(COP(=O)([O-])OCC[N+](C)(C)C)OCC,CHEMBL1125666,J Med Chem,1991.0,CHEMBL286705,CHEMBL286705,6.16,0.0,http://www.openphacts.org/units/Nanomolar,43734.0,=,1.0,1.0,=,IC50,nM,700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.7,CHEMBL378
3349,1751252.0,[],CHEMBL854523,Antiviral activity against wild type Measles virus Edmonston in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)c1cc(N)cc(NC(=O)Cc2ccccc2)c1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL209923,CHEMBL209923,4.75,0.0,http://www.openphacts.org/units/Nanomolar,532815.0,=,1.0,1.0,=,IC50,nM,18000.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,18.0,CHEMBL613738
3350,12529991.0,[],CHEMBL3078221,Antiviral activity against HIV1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCN(Cc2c([O-])on[n+]2-c2ccc(C)cc2)CC1,CHEMBL3044741,Med Chem Res,2013.0,CHEMBL2282186,CHEMBL2282186,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824356.0,>,1.0,1.0,>,IC50,ug.mL-1,17.28,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,17.28,CHEMBL378
3351,14653462.0,[],CHEMBL3267146,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)c3cccnc3)[C@H](O)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262982,CHEMBL3262982,4.20,0.0,http://www.openphacts.org/units/Nanomolar,2101864.0,=,1.0,1.0,=,IC50,nM,63500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,63.5,CHEMBL613497
3352,555225.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(NS(=O)(=O)c2ccc(-n3sc4ccccc4c3=O)cc2)s1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL168487,CHEMBL168487,4.76,0.0,http://www.openphacts.org/units/Nanomolar,333990.0,=,1.0,1.0,=,IC50,nM,17300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,17.3,CHEMBL378
3353,24777541.0,[],CHEMBL5128766,Antiviral activity against HIV-1 89.6 infected in human TZM-bl cells assessed as reduction in viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@H](NC(=O)CCCCCCCNC(=O)[C@]12CC[C@@H](C)[C@H](C)[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)[C@@H](O)CC(=O)O,CHEMBL5126557,Bioorg Med Chem Lett,2022.0,CHEMBL5186619,CHEMBL5186619,5.46,0.0,http://www.openphacts.org/units/Nanomolar,3867172.0,=,1.0,1.0,=,IC50,nM,3500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.5,CHEMBL378
3354,305192.0,[],CHEMBL873617,Inhibition of concanavalin A (con A)-induced proliferation of rat peripheral blood mononuclear cells.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2Br)cc1)c1ccncc1F,CHEMBL1133605,J Med Chem,2000.0,CHEMBL323065,CHEMBL323065,6.65,0.0,http://www.openphacts.org/units/Nanomolar,188108.0,=,1.0,1.0,=,IC50,nM,224.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,224.0,CHEMBL378
3355,930575.0,[],CHEMBL728516,Anti-HIV activity against HIV-1 IIIB chronically infected Molt-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(CCO)c2c(OC(F)F)c(N3CCN(c4ncccn4)CC3)c(F)cc2c1=O,CHEMBL1131862,Bioorg Med Chem Lett,1999.0,CHEMBL317019,CHEMBL317019,6.10,0.0,http://www.openphacts.org/units/Nanomolar,194320.0,=,1.0,1.0,=,IC50,nM,790.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.79,CHEMBL378
3356,5132793.0,[],CHEMBL1646267,Antiviral activity against HIV1 BaL infected in human PBMC assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)n2c3ccccc3n(C[C@@H](O)Nc3ccc(F)cc3)c2c1C#N,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645085,CHEMBL1645085,5.31,0.0,http://www.openphacts.org/units/Nanomolar,1321074.0,=,1.0,1.0,=,IC50,nM,4900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.9,CHEMBL378
3357,2997428.0,[],CHEMBL1047854,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV DNA replication after 9 days by PCR,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C(=N/Cc2ccc(F)cc2)c2ccc(=O)n(Cc3ccc(F)cc3)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL566907,CHEMBL566907,4.19,0.0,http://www.openphacts.org/units/Nanomolar,856682.0,=,1.0,1.0,=,IC50,nM,64500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,64.5,CHEMBL613497
3358,5126306.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2NC(=O)/C1=C/NCCO,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642302,CHEMBL1642302,6.07,0.0,http://www.openphacts.org/units/Nanomolar,1317592.0,=,1.0,1.0,=,IC50,nM,850.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.85,CHEMBL378
3359,6216934.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(C(C)C)c2)CCN(C(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784491,CHEMBL1784491,6.69,0.0,http://www.openphacts.org/units/Nanomolar,1429430.0,=,1.0,1.0,=,IC50,nM,204.17,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.69,CHEMBL378
3360,2930380.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3nc(C)nc3C)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL572798,CHEMBL572798,8.50,0.0,http://www.openphacts.org/units/Nanomolar,848361.0,=,1.0,1.0,=,IC50,nM,3.16,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.16,CHEMBL378
3361,162150.0,[],CHEMBL683691,Tested in vitro against human immunodeficiency virus (HIV) infected CEM cells using XTT assay (HIV-HRF strain),F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H](Cn1cnc2c(O)nc(N)nc21)OCP(=O)(O)O,CHEMBL1126801,J Med Chem,1993.0,CHEMBL329605,CHEMBL329605,,0.0,http://www.openphacts.org/units/Nanomolar,169342.0,=,1.0,1.0,=,IC50,nM,252000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,252.0,CHEMBL378
3362,176169.0,[],CHEMBL656397,Activity against HIV-1 by syncytial plaque assay performed in duplicate using CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc2cc(Cl)c(Cl)cc2n1Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1,CHEMBL1131326,J Med Chem,1998.0,CHEMBL22792,CHEMBL22792,,0.0,http://www.openphacts.org/units/Nanomolar,30665.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
3363,6335908.0,[],CHEMBL1820048,Antiviral activity against Human immunodeficiency virus 1 LAI infected in human MT2 cells assessed as inhibition of p24 Gag protein production,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2C[C@@H]3[C@@H](O)CO[C@@H]3C2)cc1,CHEMBL1817554,J Med Chem,2011.0,CHEMBL1817686,CHEMBL1817686,8.54,0.0,http://www.openphacts.org/units/Nanomolar,1451706.0,=,1.0,1.0,=,IC50,nM,2.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.9,CHEMBL378
3364,2681622.0,[],CHEMBL1062326,Antiviral activity against HIV1 REJO4541.67 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL525076,CHEMBL525076,5.96,0.0,http://www.openphacts.org/units/Nanomolar,823863.0,=,1.0,1.0,=,IC50,nM,1110.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.11,CHEMBL378
3365,13967451.0,[],CHEMBL3135326,Antiviral activity against wild type HIV1 VSVG infected in 293ET cells assessed as inhibition of viral replication by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL3132804,Medchemcomm,2014.0,CHEMBL57,CHEMBL57,7.40,0.0,http://www.openphacts.org/units/Nanomolar,1974713.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
3366,1402401.0,[],CHEMBL834488,In vitro inhibitory concentration against HIV L100I and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)CCOC)c1C(=O)c1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369697,CHEMBL369697,7.77,0.0,http://www.openphacts.org/units/Nanomolar,360426.0,=,1.0,1.0,=,IC50,nM,17.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.017,CHEMBL378
3367,10938666.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccccc4C(F)(F)F)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046585,CHEMBL2046585,4.33,0.0,http://www.openphacts.org/units/Nanomolar,1651468.0,=,1.0,1.0,=,IC50,nM,46940.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,46.94,CHEMBL613497
3368,15027175.0,[],CHEMBL3367176,Inhibition of AP-1-mediated transcriptional activation in HEK293 cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(C)c(-c2nc3ccccc3c(=O)n2-c2ccccc2C)s1,CHEMBL3352097,J Med Chem,2014.0,CHEMBL515276,CHEMBL515276,5.26,0.0,http://www.openphacts.org/units/Nanomolar,2265197.0,=,1.0,1.0,=,IC50,nM,5500.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,5.5,CHEMBL4977
3369,590520.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,NS(=O)(=O)c1ccc(Cn2sc3ccccc3c2=O)cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL168996,CHEMBL168996,4.27,0.0,http://www.openphacts.org/units/Nanomolar,334047.0,=,1.0,1.0,=,IC50,nM,53700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,53.7,CHEMBL378
3370,2413657.0,[],CHEMBL987708,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@H](OC(=O)COCC)[C@H](C[C@@H](C)C1=C2C[C@H](OC(=O)COCC)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)OC(=O)COCC,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL502081,CHEMBL502081,4.70,0.0,http://www.openphacts.org/units/Nanomolar,810798.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.02,CHEMBL613497
3371,22845267.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '49.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '49.0'}]",CHEMBL4721685,Antiviral activity against clinical isolate HIV-1 93RW034 infected in human PBMC cells assessed as reduction in viral transmission to TZM-bl cells pretreated for 1 hr before viral transmission and further incubated for 48 hrs by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c12,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL3301620,CHEMBL3301620,7.00,0.0,http://www.openphacts.org/units/Nanomolar,3547082.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
3372,18202560.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2ccncc2)NC(=O)N1C,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4082877,CHEMBL4082877,5.85,0.0,http://www.openphacts.org/units/Nanomolar,3019974.0,=,1.0,1.0,=,IC50,nM,1400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.4,CHEMBL378
3373,22484650.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '144.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '6.0'}]",CHEMBL4688345,Antiviral activity against HBV infected in human HepG2 2.2.15 cells assessed as decrease in extracellular viral DNA level measured after incubation of 6 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(N[C@H](CO)Cc1ccccc1)/C(NC(=O)c1ccc(F)c(F)c1)=C(/Br)c1ccccc1,CHEMBL4680304,Bioorg Med Chem,2021.0,CHEMBL4752101,CHEMBL4752101,6.32,0.0,http://www.openphacts.org/units/Nanomolar,3524612.0,=,1.0,1.0,=,IC50,nM,480.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.48,CHEMBL613497
3374,13857129.0,[],CHEMBL3097947,Antiviral activity against enfuvirtide-resistant HIV-1 NL4-3 harboring gp41 (36G)N42T/N43K mutation infected in human MT2 cells assessed as inhibition of p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL3091377,Bioorg Med Chem,2013.0,CHEMBL525076,CHEMBL525076,,0.0,http://www.openphacts.org/units/Nanomolar,1952747.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.0,CHEMBL378
3375,18320119.0,[],CHEMBL4134181,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA level incubated for 3 days followed by medium replacement measured after 3 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C1=C2C[C@H](NC(=O)OC(C)(C)C)CN2C(c2nccs2)=N[C@H]1c1ccc(F)cc1Cl,CHEMBL4130455,ACS Med Chem Lett,2017.0,CHEMBL4174262,CHEMBL4174262,4.52,0.0,http://www.openphacts.org/units/Nanomolar,3041714.0,=,1.0,1.0,=,IC50,nM,30000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,30.0,CHEMBL613497
3376,15210764.0,[],CHEMBL3421426,Antiviral activity against Human immunodeficiency virus 1 3b infected in human MT4 cells assessed as inhibition of virus replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1[C@H](OC(C)=O)[C@H]2[C@@H](OC(C)=O)[C@](C)(O)C[C@]2(OC(C)=O)C(=O)[C@H](C)/C=C/C(C)(C)C(=O)[C@H](OC(=O)/C(C)=C/C)[C@H]1OC(C)=O,CHEMBL3414423,J Nat Prod,2014.0,CHEMBL3414608,CHEMBL3414608,6.47,0.0,http://www.openphacts.org/units/Nanomolar,2289943.0,=,1.0,1.0,=,IC50,nM,340.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.34,CHEMBL378
3377,16626947.0,[],CHEMBL3821894,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 48 hrs by SYBR Green based RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)Oc2cc(-c3ccccn3)[nH]n2)cc1,CHEMBL3817822,Medchemcomm,2016.0,CHEMBL3818104,CHEMBL3818104,4.50,0.0,http://www.openphacts.org/units/Nanomolar,2783928.0,=,1.0,1.0,=,IC50,nM,31330.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,31.33,CHEMBL613497
3378,629313.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Cc3ccccc3)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL311132,CHEMBL311132,,0.0,http://www.openphacts.org/units/Nanomolar,126944.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
3379,1438015.0,[],CHEMBL833079,Inhibitory activity against HIV-1 mutant strain 181C,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(CC#N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL434518,CHEMBL434518,6.92,0.0,http://www.openphacts.org/units/Nanomolar,371616.0,=,1.0,1.0,=,IC50,nM,120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.12,CHEMBL378
3380,2464790.0,[],CHEMBL963691,Antiviral activity against HBV assessed as inhibition of viral e-antigen production by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1cc2c(Cn3ccnc3C)c(O)c(OC)cc2nc1CSc1ccc(F)cc1,CHEMBL1157455,Bioorg Med Chem,2008.0,CHEMBL487626,CHEMBL487626,4.79,0.0,http://www.openphacts.org/units/Nanomolar,720575.0,=,1.0,1.0,=,IC50,nM,16200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,16.2,CHEMBL613497
3381,1402294.0,[],CHEMBL837466,In vitro inhibitory concentration against HIV K101E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NCc2ccccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177491,CHEMBL177491,,0.0,http://www.openphacts.org/units/Nanomolar,360417.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3382,18202882.0,[],CHEMBL4043730,Antiviral activity against HIV-1 A17 harboring reverse transcriptase K103N/Y181C double mutant infected in human MAGI-CCR5 cells after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2cc3ccccc3s2)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4083051,CHEMBL4083051,5.19,0.0,http://www.openphacts.org/units/Nanomolar,3019994.0,=,1.0,1.0,=,IC50,nM,6400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.4,CHEMBL378
3383,16449872.0,[],CHEMBL3757559,Inhibition of ASCT2-mediated glutamine transport in human HEK293 cells using [3H]-glutamine after 15 mins by scintillation counting,B,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(COc2ccccc2CN(CC[C@H](N)C(=O)O)Cc2ccccc2OCc2cccc(OC)c2)c1,CHEMBL3751750,Bioorg Med Chem Lett,2016.0,CHEMBL3754498,CHEMBL3754498,5.14,0.0,http://www.openphacts.org/units/Nanomolar,2744498.0,=,1.0,1.0,=,IC50,nM,7200.0,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,uM,UO_0000065,7.2,CHEMBL3562162
3384,2099796.0,[],CHEMBL949220,Antiviral activity against HIV1 BaL by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)N(CCCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nc4ccccc42)C3)c2ccccc2)cc1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL404112,CHEMBL404112,7.30,0.0,http://www.openphacts.org/units/Nanomolar,699393.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.05,CHEMBL378
3385,19162203.0,[],CHEMBL4383613,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells after 7 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2ccc3c(c2)[C@@H](NC(=O)OC(C)(C)C)CC[C@@H]3O)cc1,CHEMBL4382211,Eur J Med Chem,2018.0,CHEMBL4526105,CHEMBL4526105,6.59,0.0,http://www.openphacts.org/units/Nanomolar,3198005.0,=,1.0,1.0,=,IC50,nM,254.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,254.0,CHEMBL378
3386,16556857.0,[],CHEMBL3795205,Antiviral activity against CXCR4 using HIV-1 NL4.3 infected in human MT4 cells assessed as reduction of viral replication preincubated for 15 mins with cells followed by viral infection measured after 4 days by MTS/PES method,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(Cc2ccccc2)CCCN(S(=O)(=O)c2ccccc2[N+](=O)[O-])C1.Cl,CHEMBL3792300,J Med Chem,2016.0,CHEMBL3792432,CHEMBL3794617,4.56,0.0,http://www.openphacts.org/units/Nanomolar,2770887.0,=,1.0,1.0,=,IC50,nM,27700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,27.7,CHEMBL378
3387,22844979.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721621,Antiviral activity against HIV-1 HXB-2 infected in human TZM-bl cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based single cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4780615,CHEMBL4780615,6.32,0.0,http://www.openphacts.org/units/Nanomolar,3547083.0,=,1.0,1.0,=,IC50,nM,480.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.48,CHEMBL378
3388,12108681.0,[],CHEMBL2173505,Antiviral activity against HIV1 3B infected in MT4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1Cc2cccc3[nH]c(=S)n(c23)C[C@@H]1C,CHEMBL2169791,J Med Chem,2012.0,CHEMBL46961,CHEMBL46961,7.55,0.0,http://www.openphacts.org/units/Nanomolar,1740562.0,=,1.0,1.0,=,IC50,nM,28.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,28.0,CHEMBL378
3389,151530.0,[],CHEMBL823035,Antiviral activity against parainfluenza-3 virus,F,BAO_0000190,BAO_0000218,organism-based format,O=c1ccn([C@H]2C[C@H](O[N+](=O)[O-])[C@@H](CO)O2)c(=O)[nH]1,CHEMBL1136729,J Med Chem,2003.0,CHEMBL3143915,CHEMBL3143915,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,589.0,>,1.0,1.0,>,IC50,ug.mL-1,80.0,CHEMBL613126,Human parainfluenza virus 3,Human parainfluenza virus 3,11216,IC50,ug ml-1,UO_0000274,80.0,CHEMBL613126
3390,874487.0,[],CHEMBL685389,Inhibition of HIV replication in H9 cells.,F,BAO_0000190,BAO_0000218,organism-based format,C[C@]12CCC3C(CC[C@@]45O[C@H]4C(=O)C(S(C)(=O)=O)C[C@]35C)C1CC[C@@H]2O,CHEMBL1128512,J Med Chem,1995.0,CHEMBL2373330,CHEMBL2373330,5.85,0.0,http://www.openphacts.org/units/Nanomolar,204885.0,=,1.0,1.0,=,IC50,nM,1400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.4,CHEMBL378
3391,24831034.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)[C@@H]1CCN(c2ccc3c(=O)c4cccc(Cl)c4oc3c2)C1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5207881,CHEMBL5207881,,0.0,http://www.openphacts.org/units/Nanomolar,3878146.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
3392,15166115.0,[],CHEMBL3404734,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBeAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(OC(=O)c2cccs2)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL1332768,CHEMBL1332768,,0.0,http://www.openphacts.org/units/Nanomolar,2284135.0,>,1.0,1.0,>,IC50,nM,3706300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,3706.3,CHEMBL613497
3393,16626938.0,[],CHEMBL3821894,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 48 hrs by SYBR Green based RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)Oc2cc(CSc3ccccn3)[nH]n2)cc1,CHEMBL3817822,Medchemcomm,2016.0,CHEMBL3819256,CHEMBL3819256,4.84,0.0,http://www.openphacts.org/units/Nanomolar,2783919.0,=,1.0,1.0,=,IC50,nM,14290.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,14.29,CHEMBL613497
3394,18564555.0,[],CHEMBL4202340,Antiviral activity against HIV1 infected in human PBMC incubated for 24 hrs in presence of 10% NHS by GFP based single cycle HIV replication assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn(C2CC(O)C(C#N)(CO)C2)c(=O)[nH]c1=O,CHEMBL4196238,J Med Chem,2018.0,CHEMBL4206223,CHEMBL4206223,,0.0,http://www.openphacts.org/units/Nanomolar,3082369.0,>,1.0,1.0,>,IC50,nM,2100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.1,CHEMBL378
3395,12680747.0,[],CHEMBL2342599,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)Nc3cccc(Cl)c3)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333683,CHEMBL2333683,,0.0,http://www.openphacts.org/units/Nanomolar,1867759.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
3396,2929569.0,[],CHEMBL1056893,Antiviral activity against HIV1 HXB2 harboring 101E mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL233664,CHEMBL233664,8.20,0.0,http://www.openphacts.org/units/Nanomolar,848384.0,=,1.0,1.0,=,IC50,nM,6.31,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.31,CHEMBL378
3397,418487.0,[],CHEMBL805567,Inhibitory concentration required against replication of small pox virus (strain India 3a) in Vero cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2C[C@H](O)C(=O)O,CHEMBL1147452,Bioorg Med Chem Lett,2004.0,CHEMBL112398,CHEMBL112398,4.04,0.0,http://www.openphacts.org/units/Nanomolar,214247.0,=,1.0,1.0,=,IC50,nM,91000.0,CHEMBL613494,Variola virus,Variola virus,10255,IC50,uM,UO_0000065,91.0,CHEMBL613494
3398,2602056.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)NC1=CC(=O)c2ccc(-c3[nH]c(C(=O)O)cc4c5ccccc5nc3-4)nc2C1=O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL346794,CHEMBL346794,4.88,0.0,http://www.openphacts.org/units/Nanomolar,807496.0,=,1.0,1.0,=,IC50,nM,13300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,13.3,CHEMBL378
3399,629351.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(Cc3c(Cl)cccc3Cl)nc(N=[N+]=[N-])n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL71298,CHEMBL71298,7.85,0.0,http://www.openphacts.org/units/Nanomolar,126938.0,=,1.0,1.0,=,IC50,nM,14.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.014,CHEMBL378
3400,2930347.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSCc3csc(C)n3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567623,CHEMBL567623,9.00,0.0,http://www.openphacts.org/units/Nanomolar,852982.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
3401,10863192.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCc6ccc([N+](=O)[O-])cc6)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022388,CHEMBL2022388,5.05,0.0,http://www.openphacts.org/units/Nanomolar,1637638.0,=,1.0,1.0,=,IC50,nM,8900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,8.9,CHEMBL613497
3402,19236840.0,[],CHEMBL4398858,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in cytoplasmic DNA synthesis by reed and munch method,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@H](N)C(=O)OCCCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCCCOC(=O)[C@@H](N)CC(C)C.Cl,CHEMBL4396904,ACS Med Chem Lett,2019.0,CHEMBL4470591,CHEMBL4598216,5.38,0.0,http://www.openphacts.org/units/Nanomolar,3211265.0,=,1.0,1.0,=,IC50,nM,4220.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,4.22,CHEMBL613497
3403,58110.0,[],CHEMBL857692,Inhibitory concentration against HCV NS3 protease was determined,B,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)c1cnccn1)[C@@H](C)CC)C(=O)C(=O)N1CCOCC1,CHEMBL1136650,Bioorg Med Chem Lett,2003.0,CHEMBL13155,CHEMBL13155,,0.0,http://www.openphacts.org/units/Nanomolar,12760.0,>,1.0,1.0,>,IC50,nM,60000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,60.0,CHEMBL4620
3404,5189182.0,[],CHEMBL1658799,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/c1ccc(C(F)(F)F)cc1)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652527,CHEMBL1652527,,0.0,http://www.openphacts.org/units/Nanomolar,1326902.0,=,1.0,1.0,=,IC50,nM,230000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.23,CHEMBL613497
3405,1671934.0,[],CHEMBL865135,Antiviral activity against HIV1 V106A mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(C#N)cc(C(F)(F)F)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL199409,CHEMBL199409,8.25,0.0,http://www.openphacts.org/units/Nanomolar,411935.0,=,1.0,1.0,=,IC50,nM,5.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.6,CHEMBL378
3406,614672.0,[],CHEMBL691384,Inhibitory concentration for cytopathicity of HIV-1 (HTLV-IIIB) in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C(c2cc(C)c(O)c(C(=O)O)c2)c2cc(C)c(O)c(C(=O)O)c2)cc(C(=O)O)c1O,CHEMBL1125737,J Med Chem,1991.0,CHEMBL113891,CHEMBL113891,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,217788.0,=,1.0,1.0,=,IC50,ug.mL-1,80.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,80.0,CHEMBL378
3407,1045232.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(NN2C=NC(C)C2C)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39431,CHEMBL39431,,0.0,http://www.openphacts.org/units/Nanomolar,62346.0,>,1.0,1.0,>,IC50,nM,312120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,312.12,CHEMBL378
3408,1963829.0,[],CHEMBL897022,Antiviral activity against HIV1 NL4-3 in PBMC,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C(\O)P(=O)(O)O)c1cc(OCc2ccccc2)cc(OCc2ccccc2)c1,CHEMBL1148834,Bioorg Med Chem Lett,2007.0,CHEMBL394025,CHEMBL394025,4.93,0.0,http://www.openphacts.org/units/Nanomolar,656768.0,=,1.0,1.0,=,IC50,nM,11800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,11.8,CHEMBL378
3409,6327114.0,[],CHEMBL1821353,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as reduction in HBeAg antigen secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)C[C@@H]1O[C@@H](C)C(=O)C2=C1C(=O)OCC2,CHEMBL1817662,J Nat Prod,2011.0,CHEMBL1817919,CHEMBL1817919,,0.0,http://www.openphacts.org/units/Nanomolar,1449976.0,=,1.0,1.0,=,IC50,nM,880000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.88,CHEMBL613497
3410,509503.0,[],CHEMBL698135,Concentration required to inhibit HIV infection by 50% in HeLa Magi cells,F,BAO_0000190,BAO_0000218,organism-based format,C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](C[C@@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1,CHEMBL1149201,Bioorg Med Chem Lett,2004.0,CHEMBL261935,CHEMBL261935,6.96,0.0,http://www.openphacts.org/units/Nanomolar,227175.0,=,1.0,1.0,=,IC50,nM,111.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,111.0,CHEMBL378
3411,15666368.0,[],CHEMBL3602699,Antiviral activity against HIV-1 SF162 pseudovirus infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL3600303,J Med Chem,2015.0,CHEMBL3600949,CHEMBL3600949,8.24,0.0,http://www.openphacts.org/units/Nanomolar,2492329.0,=,1.0,1.0,=,IC50,nM,5.75,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.75,CHEMBL378
3412,2371341.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,N/N=C1\CCCc2c1[nH]c1ccc(C(=O)NN)cc21,CHEMBL1140145,J Med Chem,2008.0,CHEMBL443080,CHEMBL443080,,0.0,http://www.openphacts.org/units/Nanomolar,745581.0,=,1.0,1.0,=,IC50,nM,708000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,708.0,CHEMBL613493
3413,323431.0,[],CHEMBL697276,In vitro inhibition of HIV-1 plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OCC,CHEMBL1125666,J Med Chem,1991.0,CHEMBL28645,CHEMBL28645,6.57,0.0,http://www.openphacts.org/units/Nanomolar,43718.0,=,1.0,1.0,=,IC50,nM,270.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.27,CHEMBL378
3414,175210.0,[],CHEMBL698765,Concentration required for 50% inhibition of influenza A/WS/33 by plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCO[C@@H]1C=C(C(=O)O)C[C@H](/N=C(\N)NC)[C@H]1NC(C)=O.O=C(O)C(F)(F)F,CHEMBL1130481,Bioorg Med Chem Lett,1997.0,CHEMBL432329,CHEMBL1185775,8.80,0.0,http://www.openphacts.org/units/Nanomolar,90733.0,=,1.0,1.0,=,IC50,nM,1.6,CHEMBL613128,unidentified influenza virus,unidentified influenza virus,11309,IC50,nM,UO_0000065,1.6,CHEMBL613128
3415,1045221.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=C(S)N(Nc2cccc(Cl)c2)C1C(=O)O,CHEMBL1144865,J Med Chem,2003.0,CHEMBL290626,CHEMBL290626,,0.0,http://www.openphacts.org/units/Nanomolar,62358.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3416,16394332.0,[],CHEMBL3744526,Inhibition of HBV DNA replication in HepG2.2.15 cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2nc3c(cc2c(Cn2ccnc2C)c1O)CSc1cc(F)ccc1-3,CHEMBL3739304,Medchemcomm,2015.0,CHEMBL3741827,CHEMBL3741827,5.77,0.0,http://www.openphacts.org/units/Nanomolar,2738865.0,=,1.0,1.0,=,IC50,nM,1700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.7,CHEMBL613497
3417,15158630.0,[],CHEMBL3398832,Inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,CCC(CC)C(=O)OCc1cccc2c1CCOC2=O,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397174,CHEMBL3397174,,0.0,http://www.openphacts.org/units/Nanomolar,2278973.0,>,1.0,1.0,>,IC50,nM,2590000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.59,CHEMBL613497
3418,24731849.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5115939,Antiviral activity against DENV-NGC-1 infected in human BHK cells incubated for 7 days by CellTiter 96 luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(c1ccc(C(F)(F)F)cc1O)c1[nH]c(Cl)c(Cl)c1-n1c(C(=O)c2ccc(C(F)(F)F)cc2O)cc(Cl)c1Sc1cccc[n+]1[O-],CHEMBL5113415,Eur J Med Chem,2022.0,CHEMBL5202001,CHEMBL5202001,5.43,0.0,http://www.openphacts.org/units/Nanomolar,3857949.0,=,1.0,1.0,=,IC50,nM,3680.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,3.68,CHEMBL613757
3419,3596590.0,[],CHEMBL1292013,Antiviral activity against HIV1 BaL in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(CNC(=O)N(c2cccc(F)c2)C2CCN(CCC3(c4cccc(F)c4)CCN(C(=O)c4cc(S(=O)(=O)N5CCCC5)c(F)cc4Cl)CC3)CC2)cc1,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288666,CHEMBL1288666,8.82,0.0,http://www.openphacts.org/units/Nanomolar,973776.0,=,1.0,1.0,=,IC50,nM,1.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.5,CHEMBL378
3420,5189221.0,[],CHEMBL1658800,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O)c1cccs1,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652516,CHEMBL1652516,,0.0,http://www.openphacts.org/units/Nanomolar,1326891.0,>,1.0,1.0,>,IC50,nM,1700000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.7,CHEMBL613497
3421,12680748.0,[],CHEMBL2342599,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)Nc3ccccc3Cl)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333682,CHEMBL2333682,,0.0,http://www.openphacts.org/units/Nanomolar,1867758.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
3422,42378.0,[],CHEMBL871983,Antiviral activity against L100I strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL593,CHEMBL593,6.04,0.0,http://www.openphacts.org/units/Nanomolar,20822.0,=,1.0,1.0,=,IC50,nM,920.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,920.0,CHEMBL378
3423,10996093.0,[],CHEMBL2072873,Antiviral activity against VSV-G pseudotyped HIV1 lentiviral particles infected in human HeLa cells incubated for 48 hrs by spectrofluorometry,F,BAO_0000190,BAO_0000218,organism-based format,C1OOCOO1,CHEMBL2069294,Bioorg Med Chem,2012.0,CHEMBL2071269,CHEMBL2071269,,0.0,,1663494.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
3424,2602255.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CC(c1cc(=O)[nH]c(NC2CCCC2)n1)c1c(F)cccc1F,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL177201,CHEMBL177201,7.40,0.0,http://www.openphacts.org/units/Nanomolar,807596.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
3425,5229509.0,[],CHEMBL1673684,Antiviral activity against R5 tropic HIV-1 Bal infected in human Raji cells expressing DC-SIGN gene assessed as inhibition of virus capture by Raji cells after 60 mins by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CN[C@@H]1[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](OS(=O)(=O)O)[C@H]2O)[C@@H](O)[C@H](O[C@H]2c3cc(C)c(C(=O)N[C@H](C)C(=O)O)c(O)c3-c3c(cc4c(c3O)C(=O)c3cc(OC)cc(O)c3C4=O)[C@@H]2O)O[C@@H]1C,CHEMBL1671680,Antimicrob Agents Chemother,2010.0,CHEMBL1673204,CHEMBL1673204,4.62,0.0,http://www.openphacts.org/units/Nanomolar,1332107.0,=,1.0,1.0,=,IC50,nM,24000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,24.0,CHEMBL378
3426,5229810.0,[],CHEMBL1677604,Antiviral activity against Human immunodeficiency virus 1 3B infected in AA5 cells infected with 0.78 uL of virus stock assessed as expression of p24 antigen after 6 days postinfection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,>,1.0,1.0,>,IC50,nM,53100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,53.1,CHEMBL378
3427,15568189.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(F)cc1)N1CCN(S(=O)(=O)/C=C/c2ccccc2)CC1,CHEMBL1201862,,,CHEMBL1580410,CHEMBL1580410,8.45,0.0,http://www.openphacts.org/units/Nanomolar,2473848.0,=,7.0,1.0,=,IC50,nM,3.59,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.00359,CHEMBL3259470
3428,2947364.0,[],CHEMBL1038495,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)CN1C(=O)c2ccccc2C1=O)[C@@H](OC(=O)CN1C(=O)c2ccccc2C1=O)C(C)(C)OC(=O)CN1C(=O)c2ccccc2C1=O)C1=C2C[C@H](OC(=O)CN3C(=O)c4ccccc4C3=O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL574407,CHEMBL574407,,0.0,http://www.openphacts.org/units/Nanomolar,850760.0,>,1.0,1.0,>,IC50,nM,1300000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.3,CHEMBL613497
3429,14654443.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(CO)[C@H](OC(=O)/C=C/c3ccccc3)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3263003,CHEMBL3263003,4.51,0.0,http://www.openphacts.org/units/Nanomolar,2101886.0,=,1.0,1.0,=,IC50,nM,30700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,30.7,CHEMBL613497
3430,16422847.0,[],CHEMBL3751457,Antiviral activity against recombinant HIV-1 NL4-3 expressing AMLV envelope infected in U87.CD4.CCR5 cells assessed as inhibition of Env mediated cell entry by HIV-1 single round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CC4C=NN(c5ccccc5)C4C3)c12,CHEMBL3745657,Bioorg Med Chem Lett,2016.0,CHEMBL3747044,CHEMBL3747044,,0.0,,2740452.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
3431,1433303.0,[],CHEMBL833131,Concentration required for 50% inhibition of adohcy hydrolase by the compound against vaccinia virus in vero 76 cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2[C@@H]1C[C@H](CCO)[C@@H](O)[C@H]1O,CHEMBL1145143,Bioorg Med Chem Lett,2005.0,CHEMBL360506,CHEMBL360506,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,369818.0,=,1.0,1.0,=,IC50,ug.mL-1,1.2,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,ug ml-1,UO_0000274,1.2,CHEMBL613493
3432,3003263.0,[],CHEMBL1045518,Antiviral activity against HIV1 Ba-L infected in HOS cells assessed as inhibition of viral infection,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1[C@H]1C[C@H]2CC[C@@H](C1)N2[C@]1(C)CC[C@H](NC(=O)c2c(Cl)ccc(S(N)(=O)=O)c2Cl)CC1,CHEMBL1155363,Bioorg Med Chem Lett,2009.0,CHEMBL577344,CHEMBL577344,4.70,0.0,http://www.openphacts.org/units/Nanomolar,857696.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
3433,1750574.0,[],CHEMBL868010,Antiviral activity against multi drug-resistant HIV1 ES variant in human PHA-PBMC cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,CHEMBL1146019,J Med Chem,2006.0,CHEMBL114,CHEMBL114,,0.0,http://www.openphacts.org/units/Nanomolar,539998.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
3434,1401930.0,[],CHEMBL837466,In vitro inhibitory concentration against HIV K101E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCNc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL174339,CHEMBL174339,,0.0,http://www.openphacts.org/units/Nanomolar,360384.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3435,6268211.0,[],CHEMBL1803184,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H]4CCCN4C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H]5CCCN5C1=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC3=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N2,CHEMBL1799917,J Nat Prod,2010.0,CHEMBL508235,CHEMBL508235,6.30,0.0,http://www.openphacts.org/units/Nanomolar,1440222.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.5,CHEMBL378
3436,791221.0,[],CHEMBL692690,In vitro inhibition of Hepatitis C polymerase.,B,BAO_0000190,BAO_0000357,single protein format,CC(C)N(C(=O)C1CCCCC1)c1cc(-c2ccccc2)sc1C(=O)O,CHEMBL1137940,Bioorg Med Chem Lett,2004.0,CHEMBL353754,CHEMBL353754,5.05,0.0,http://www.openphacts.org/units/Nanomolar,327706.0,=,1.0,1.0,=,IC50,nM,9000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,9.0,CHEMBL4620
3437,2681618.0,[],CHEMBL1062322,Antiviral activity against HIV1 QH0515.1 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL525076,CHEMBL525076,5.65,0.0,http://www.openphacts.org/units/Nanomolar,823863.0,=,1.0,1.0,=,IC50,nM,2230.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.23,CHEMBL378
3438,5189206.0,[],CHEMBL1658800,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCC(=O)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652501,CHEMBL1652501,,0.0,http://www.openphacts.org/units/Nanomolar,1326876.0,>,1.0,1.0,>,IC50,nM,78000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.078,CHEMBL613497
3439,14658839.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)c3ccc(OC)cc3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262888,CHEMBL3262888,7.26,0.0,http://www.openphacts.org/units/Nanomolar,2101730.0,=,1.0,1.0,=,IC50,nM,55.0,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,IC50,nM,UO_0000065,55.0,CHEMBL3259471
3440,634425.0,[],CHEMBL713512,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)CN1Cc2cccc3[nH]c(=O)n(c23)C(C)C1,CHEMBL1128252,J Med Chem,1995.0,CHEMBL68175,CHEMBL68175,4.49,0.0,http://www.openphacts.org/units/Nanomolar,326346.0,=,1.0,1.0,=,IC50,nM,32100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,32.1,CHEMBL378
3441,252858.0,[],CHEMBL691099,In vitro antiviral activity against NNRTI-resistant R88703R-IIIB (Y181C) HIV-1 variant,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Sc1nc(N)cc(Cl)n1)c1cc2ccoc2cn1,CHEMBL1131332,J Med Chem,1998.0,CHEMBL280541,CHEMBL280541,6.77,0.0,http://www.openphacts.org/units/Nanomolar,41262.0,=,1.0,1.0,=,IC50,nM,170.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.17,CHEMBL378
3442,2099730.0,[],CHEMBL949218,Antiviral activity against HIV1 JRCSF by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(Cl)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL270571,CHEMBL270571,8.15,0.0,http://www.openphacts.org/units/Nanomolar,699414.0,=,1.0,1.0,=,IC50,nM,7.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.007,CHEMBL378
3443,1437981.0,[],CHEMBL834620,Inhibitory activity against HIV-1 mutant strain 188L; ND = not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(-c2ccco2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL182477,CHEMBL182477,,0.0,http://www.openphacts.org/units/Nanomolar,371591.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3444,13967483.0,[],CHEMBL3135326,Antiviral activity against wild type HIV1 VSVG infected in 293ET cells assessed as inhibition of viral replication by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1C(=O)Nc2ccc(Cl)cc2N1S(=O)(=O)c1cc(Cl)sc1/C=N\c1nccs1,CHEMBL3132804,Medchemcomm,2014.0,CHEMBL3133057,CHEMBL3133057,,0.0,,1974728.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
3445,2272882.0,[],CHEMBL956847,Antiviral activity against HIV1 Bal in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1[C@H]1C[C@H]2CC[C@@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC2CCCCC2)CC1,CHEMBL1153314,Bioorg Med Chem Lett,2009.0,CHEMBL471149,CHEMBL471149,6.99,0.0,http://www.openphacts.org/units/Nanomolar,755374.0,=,1.0,1.0,=,IC50,nM,103.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.103,CHEMBL378
3446,1421801.0,[],CHEMBL824926,Inhibitory activity against human immunodeficiency virus type 1 (inactive>0.1),F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(SC2CCCCC2)n(COCNc2ccccc2)c(=O)[nH]c1=O,CHEMBL1144258,Bioorg Med Chem Lett,2005.0,CHEMBL178283,CHEMBL178283,,0.0,http://www.openphacts.org/units/Nanomolar,364820.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3447,2930214.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CN3CCN(C(=O)c4ccco4)CC3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL583425,CHEMBL583425,7.60,0.0,http://www.openphacts.org/units/Nanomolar,852816.0,=,1.0,1.0,=,IC50,nM,25.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,25.1,CHEMBL378
3448,2032169.0,[],CHEMBL886779,Inhibition of cytoplasmic HBV DNA synthesis in HepG2.2.15 cells after 8 days,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2CCOCP(=O)(O)O,CHEMBL1139980,Eur J Med Chem,2007.0,CHEMBL484,CHEMBL484,5.77,0.0,http://www.openphacts.org/units/Nanomolar,674629.0,=,1.0,1.0,=,IC50,nM,1700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.7,CHEMBL613497
3449,3114018.0,[],CHEMBL1073712,Antiviral activity against HIV1 NL4-3 infected in GFP expressing human CEM cells assessed as inhibition of viral infection measured after 9 days postinfection by microfluorometry,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1c(O)c(Cc2c(O)c(C(C)=O)c(O)c(C(C)=O)c2O)c(O)c(C(C)=O)c1O,CHEMBL1157554,Bioorg Med Chem,2010.0,CHEMBL598590,CHEMBL598590,,0.0,,888444.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
3450,1755801.0,[],CHEMBL864208,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CCn1c(C)nnc1SCC(=O)Nc1ccccc1Cl,CHEMBL1146046,Bioorg Med Chem Lett,2006.0,CHEMBL209398,CHEMBL209398,,0.0,http://www.openphacts.org/units/Nanomolar,545185.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
3451,1402575.0,[],CHEMBL837469,In vitro inhibitory concentration against HIV V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCNC(=S)Nc1c(Cc2cccc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL178043,CHEMBL178043,,0.0,http://www.openphacts.org/units/Nanomolar,360408.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3452,24830972.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1ccc(Cl)c2oc3cc(N4CCC(C(=O)O)C4)ccc3c(=O)c12,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5176719,CHEMBL5176719,5.54,0.0,http://www.openphacts.org/units/Nanomolar,3878145.0,=,1.0,1.0,=,IC50,nM,2860.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.86,CHEMBL613497
3453,12680706.0,[],CHEMBL2342598,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)NCc3ccc(F)cc3F)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333691,CHEMBL2333691,4.83,0.0,http://www.openphacts.org/units/Nanomolar,1867767.0,=,1.0,1.0,=,IC50,nM,14820.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,14.82,CHEMBL613497
3454,609122.0,[],CHEMBL710534,Inhibitory activity against 188L strain of HIV-1 in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2ncnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL71728,CHEMBL71728,7.40,0.0,http://www.openphacts.org/units/Nanomolar,126924.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
3455,6316700.0,[],CHEMBL1817334,Antiviral activity against Human immunodeficiency virus 1 assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(C[C@H](C)[C@H](C)Cc2cc(OC)c(O[C@@H](C)[C@@H](O)c3ccc(O)c(OC)c3)c(OC)c2)ccc1O,CHEMBL1811877,J Nat Prod,2011.0,CHEMBL1812647,CHEMBL1812647,5.70,0.0,http://www.openphacts.org/units/Nanomolar,1446806.0,=,1.0,1.0,=,IC50,nM,2010.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.01,CHEMBL378
3456,8057989.0,[],CHEMBL1960698,Antiinfluenza activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)OCCCCCCN1CCN(C)CC1)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL1955749,Bioorg Med Chem Lett,2012.0,CHEMBL1956536,CHEMBL1956536,,0.0,http://www.openphacts.org/units/Nanomolar,1580866.0,>,1.0,1.0,>,IC50,nM,9600.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,9.6,CHEMBL613129
3457,2649342.0,[],CHEMBL1024326,"Antiviral activity against HIV1 expressed in 293T cells assessed as protection against viral M33 envelope infection in human U87 cells coexpressing CD4, CCR5 receptors after 72 hrs by luciferase reporter gene pseudoviral assay",F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(-c2ccc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)cc2)o1,CHEMBL1158460,J Med Chem,2009.0,CHEMBL562865,CHEMBL562865,5.55,0.0,http://www.openphacts.org/units/Nanomolar,816091.0,=,1.0,1.0,=,IC50,nM,2800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2800.0,CHEMBL378
3458,3188304.0,[],CHEMBL1107773,Antiviral activity against HIV1 NLBal infected JC53BL cells assessed as inhibition of replication by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2,CHEMBL1155421,Bioorg Med Chem Lett,2010.0,CHEMBL1077358,CHEMBL1077358,6.58,0.0,http://www.openphacts.org/units/Nanomolar,896402.0,=,1.0,1.0,=,IC50,nM,262.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,262.0,CHEMBL378
3459,264859.0,[],CHEMBL856186,In vitro antiviral activity against NNRTI-resistant L-697661R-IIIB (Y181C) HIV-1 variant,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccccc1NC(C(N)=O)c1c(Cl)cccc1Cl,CHEMBL1131332,J Med Chem,1998.0,CHEMBL283861,CHEMBL283861,,0.0,http://www.openphacts.org/units/Nanomolar,41265.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
3460,2417970.0,[],CHEMBL1018899,Antiviral activity against HBV in human HepG2(2.2.15) cells assessed as inhibition of viral genome replication after 9 days by Southern blot hybridization,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1153412,Bioorg Med Chem,2009.0,CHEMBL141,CHEMBL141,4.08,0.0,http://www.openphacts.org/units/Nanomolar,753679.0,=,1.0,1.0,=,IC50,nM,82420.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,82.42,CHEMBL613497
3461,5139126.0,[],CHEMBL1648257,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication by semi-quantitative EIA,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)OC(=O)N1C[C@@H](O)[C@@H](O)[C@H](O)[C@H]1n1cc(F)c(=O)[nH]c1=O,CHEMBL1641452,Bioorg Med Chem,2011.0,CHEMBL1645543,CHEMBL1645543,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321612.0,=,1.0,1.0,=,IC50,ug.mL-1,2.74,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,2.74,CHEMBL613497
3462,407662.0,[],CHEMBL729931,Inhibitory concentration required against Monkeypox virus in Vero cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2C[C@H](CO)OP(=O)(O)O,CHEMBL1147452,Bioorg Med Chem Lett,2004.0,CHEMBL326139,CHEMBL326139,,0.0,http://www.openphacts.org/units/Nanomolar,214245.0,>,1.0,1.0,>,IC50,nM,300000.0,CHEMBL613120,Monkeypox virus,Monkeypox virus,10244,IC50,uM,UO_0000065,300.0,CHEMBL613120
3463,15606418.0,[],CHEMBL3579362,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBV DNA replication by real-time fluorescence quantitative PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C=O)cc1OC,CHEMBL3576819,Eur J Med Chem,2015.0,CHEMBL1088937,CHEMBL1088937,,0.0,,2480513.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
3464,561006.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)NS(=O)(=O)c1ccc(NC(=O)c2ccccc2NC(=O)CCCl)cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL171435,CHEMBL171435,,0.0,http://www.openphacts.org/units/Nanomolar,334039.0,>,1.0,1.0,>,IC50,nM,316000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,316.0,CHEMBL378
3465,10863193.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCc6ccc(OC(F)(F)F)cc6)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022389,CHEMBL2022389,,0.0,http://www.openphacts.org/units/Nanomolar,1637639.0,=,1.0,1.0,=,IC50,nM,159710.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,159.71,CHEMBL613497
3466,3406147.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc2oc(-c3ccccc3F)cc(=O)c2c1,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1215533,CHEMBL1215533,,0.0,http://www.openphacts.org/units/Nanomolar,933277.0,=,1.0,1.0,=,IC50,nM,284300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,284.3,CHEMBL378
3467,2032175.0,[],CHEMBL886779,Inhibition of cytoplasmic HBV DNA synthesis in HepG2.2.15 cells after 8 days,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(CN(Cc2cccc(OC)c2)c2ccc3nc(N)n(S(=O)(=O)C(C)C)c3c2)c1,CHEMBL1139980,Eur J Med Chem,2007.0,CHEMBL401254,CHEMBL401254,6.16,0.0,http://www.openphacts.org/units/Nanomolar,674623.0,=,1.0,1.0,=,IC50,nM,700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.7,CHEMBL613497
3468,10865203.0,[],CHEMBL2025516,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)COCC(=O)O)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024036,CHEMBL2024036,,0.0,http://www.openphacts.org/units/Nanomolar,1639758.0,=,1.0,1.0,=,IC50,nM,523670.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,523.67,CHEMBL613497
3469,12687119.0,[],CHEMBL2344305,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral e antigen production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(O)CCC(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C[C@H](O)[C@@H](O)C4(C)C)[C@]3(C)C(=O)C[C@]12C,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL486260,CHEMBL486260,,0.0,http://www.openphacts.org/units/Nanomolar,1866110.0,>,1.0,1.0,>,IC50,nM,60600.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,60.6,CHEMBL613497
3470,10866482.0,[],CHEMBL2025518,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@]3(O)[C@@H]2C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]2(C)[C@]3(O)CC[C@@]2(OC(=O)COC)C(C)=O)C1,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024041,CHEMBL2024041,,0.0,http://www.openphacts.org/units/Nanomolar,1639763.0,=,1.0,1.0,=,IC50,nM,288400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,288.4,CHEMBL613497
3471,2009820.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(C#N)cc(F)cc12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL238107,CHEMBL238107,5.00,0.0,http://www.openphacts.org/units/Nanomolar,668093.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10000.0,CHEMBL378
3472,2997392.0,[],CHEMBL1046974,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)c2ccc(=O)n(-c3ccccc3C)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL579274,CHEMBL579274,4.75,0.0,http://www.openphacts.org/units/Nanomolar,856557.0,=,1.0,1.0,=,IC50,nM,18000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,18.0,CHEMBL613497
3473,2244548.0,[],CHEMBL1002214,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase V106M mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL57,CHEMBL57,,0.0,http://www.openphacts.org/units/Nanomolar,798657.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2000.0,CHEMBL378
3474,2614780.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc([S+]([O-])c2cccc(N)c2C#N)cc1,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL300934,CHEMBL300934,,0.0,http://www.openphacts.org/units/Nanomolar,731473.0,=,1.0,1.0,=,IC50,nM,48977881.94,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,1.31,CHEMBL378
3475,2602214.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCCCC(=O)N[C@@H](CC(C)C)C(=O)OC)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL334566,CHEMBL334566,4.50,0.0,http://www.openphacts.org/units/Nanomolar,807954.0,=,1.0,1.0,=,IC50,nM,32000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,32.0,CHEMBL378
3476,1165757.0,[],CHEMBL818227,Cytotoxicity was determined in the vero cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1126808,J Med Chem,1993.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/Nanomolar,100970.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
3477,169867.0,[],CHEMBL844410,Inhibition of 50% of the integrase-mediated catalysis of the Y-oligo substrate with 95% confidence interval,F,BAO_0000190,BAO_0000218,organism-based format,CC(CCC(=O)O)C1CC[C@H]2[C@@H]3CCC4C[C@H](OC(=O)/C=C/c5ccc(O)c(O)c5)CC[C@]4(C)[C@H]3C[C@H](OC(=O)/C=C/c3ccc(O)c(O)c3)[C@]12C,CHEMBL1135546,J Med Chem,2002.0,CHEMBL3137931,CHEMBL3137931,5.71,0.0,http://www.openphacts.org/units/Nanomolar,231560.0,=,1.0,1.0,=,IC50,nM,1970.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.97,CHEMBL378
3478,2009796.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3cc(CN(C)C)nn3)nccc12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL237675,CHEMBL237675,5.96,0.0,http://www.openphacts.org/units/Nanomolar,668117.0,=,1.0,1.0,=,IC50,nM,1100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1100.0,CHEMBL378
3479,23274465.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4CC(C5CC[C@@]6(C)[C@@H](C5)C[C@H](O)[C@@H]5[C@@H]6CC[C@]6(C)[C@@H]([C@H](C)CCC(=O)NCCS(=O)(=O)O)CC[C@@H]56)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4877776,CHEMBL4877776,,0.0,http://www.openphacts.org/units/Nanomolar,3621265.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,10000.0,CHEMBL613497
3480,15606427.0,[],CHEMBL3579362,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBV DNA replication by real-time fluorescence quantitative PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,O/N=C/c1ccco1,CHEMBL3576819,Eur J Med Chem,2015.0,CHEMBL3577784,CHEMBL3577784,,0.0,,2480522.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
3481,841166.0,[],CHEMBL713546,Compound potency to achieve protection of MT-4 cells from HIV-1 cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(NC(=S)NS(=O)(=O)Cc2c(Cl)cccc2Cl)cc1,CHEMBL1134808,Bioorg Med Chem Lett,2001.0,CHEMBL72170,CHEMBL72170,4.00,0.0,http://www.openphacts.org/units/Nanomolar,126250.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
3482,14581344.0,[],CHEMBL3242938,Antiviral activity against HIV-1 NL4-3-HXB2 pseudovirus co-transfected with luciferase gene infected in human TZM-bl cells assessed as reduction of luciferase production after 3 days by single-cycle neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]1CSCc2ccc(cc2)-c2ccc(cc2)CSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC1=O,CHEMBL3232893,Bioorg Med Chem Lett,2014.0,CHEMBL3233160,CHEMBL3233160,5.85,0.0,http://www.openphacts.org/units/Nanomolar,2081355.0,=,1.0,1.0,=,IC50,nM,1400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.4,CHEMBL378
3483,2292390.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1[S+]([O-])c1cccc(C(F)(F)F)c1,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL292644,CHEMBL292644,,0.0,http://www.openphacts.org/units/Nanomolar,813414.0,=,1.0,1.0,=,IC50,nM,39994474.98,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,1.398,CHEMBL378
3484,1470726.0,[],CHEMBL832525,Inhibitory activity against HIV-1 double mutants strain 101E and 103N,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL223228,CHEMBL223228,6.82,0.0,http://www.openphacts.org/units/Nanomolar,380816.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.15,CHEMBL378
3485,1027895.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=CN(Nc2cccc(F)c2)C1c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39070,CHEMBL39070,,0.0,http://www.openphacts.org/units/Nanomolar,62345.0,>,1.0,1.0,>,IC50,nM,30820.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,30.82,CHEMBL378
3486,15064916.0,[],CHEMBL3366183,Antiviral activity against wild type HIV1 infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2nc(NCc3cccnc3)sc2Cc2ccccc2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3330433,CHEMBL3330433,5.33,0.0,http://www.openphacts.org/units/Nanomolar,2246870.0,=,1.0,1.0,=,IC50,nM,4670.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.67,CHEMBL378
3487,2987762.0,[],CHEMBL1050601,Antiviral activity against Hepatitis B virus infected HepG2(2.2.15) cells assessed as inhibition of viral cytoplasmic DNA synthesis by real-time PCR,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)[C@@H](C(C)C)N1CCCO[P@@]1(=O)COCCn1cnc2c(N)ncnc21.O=C(O)/C=C/C(=O)O,CHEMBL1156738,Bioorg Med Chem Lett,2009.0,CHEMBL585020,CHEMBL1197768,4.30,0.0,http://www.openphacts.org/units/Nanomolar,863303.0,=,1.0,1.0,=,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
3488,2244510.0,[],CHEMBL1002205,Antiviral activity against wild type HIV1 in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(C(F)(F)F)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL275658,CHEMBL275658,8.92,0.0,http://www.openphacts.org/units/Nanomolar,798655.0,=,1.0,1.0,=,IC50,nM,1.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.2,CHEMBL378
3489,18775520.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCC1Cc2cc(OCC3CCOCC3)c(OC)cc2-c2cc(=O)c(C(=O)O)cn21,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4279144,CHEMBL4279144,7.55,0.0,http://www.openphacts.org/units/Nanomolar,3119678.0,=,1.0,1.0,=,IC50,nM,28.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.028,CHEMBL613497
3490,1437849.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(CN)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL367366,CHEMBL367366,6.41,0.0,http://www.openphacts.org/units/Nanomolar,371568.0,=,1.0,1.0,=,IC50,nM,390.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.39,CHEMBL378
3491,15066681.0,[],CHEMBL3390094,Antiviral activity against HIV1 infected in HEK293T cells by p24 ELISA based phenotypic assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1[nH]c2ccc(Cl)cc2c1C(OC)c1cc(C)cc(C)c1,CHEMBL3352750,Bioorg Med Chem Lett,2014.0,CHEMBL3325519,CHEMBL3325519,7.52,0.0,http://www.openphacts.org/units/Nanomolar,2270415.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.03,CHEMBL378
3492,13463713.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,[N-]=[N+]=N[C@H]1C[C@H](n2cnc3nc(N)nc(O)c32)O[C@@H]1CO,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL2430333,CHEMBL2430333,5.30,0.0,http://www.openphacts.org/units/Nanomolar,1920830.0,=,1.0,1.0,=,IC50,nM,5011.87,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.3,CHEMBL378
3493,1219737.0,[],CHEMBL880061,Inhibitory activity against LAI strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C#Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(C)cc(C)cc1C,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL71881,CHEMBL71881,8.38,0.0,http://www.openphacts.org/units/Nanomolar,127453.0,=,1.0,1.0,=,IC50,nM,4.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0042,CHEMBL378
3494,1830888.0,[],CHEMBL918634,Antiviral activity against wild type HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C(C#N)c2cccc3ccccc23)nc(SCc2ccc([N+](=O)[O-])cc2)[nH]c1=O,CHEMBL1144474,J Med Chem,2007.0,CHEMBL269554,CHEMBL269554,5.90,0.0,http://www.openphacts.org/units/Nanomolar,629303.0,=,1.0,1.0,=,IC50,nM,1250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.25,CHEMBL378
3495,10961814.0,[],CHEMBL2061272,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M7 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCC(C)(C)C)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058323,CHEMBL2058323,8.82,0.0,http://www.openphacts.org/units/Nanomolar,1656263.0,=,1.0,1.0,=,IC50,nM,1.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.5,CHEMBL378
3496,18890504.0,[],CHEMBL4314138,Antiviral activity against HIV-1 NL4-3 infected in human CEM-GFP cells assessed as suppression of viral replication by measuring reduction in p24 level measured at 72 hrs post-infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Cc1cc(-c2ccccc2)on1)Nc1ccccc1,CHEMBL4311980,Eur J Med Chem,2019.0,CHEMBL4458854,CHEMBL4458854,6.54,0.0,http://www.openphacts.org/units/Nanomolar,3151791.0,=,1.0,1.0,=,IC50,nM,287.92,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,287.92,CHEMBL378
3497,3229735.0,[],CHEMBL1113200,Antiviral activity against recombinant HIV1 virus infected in human JC53BL cells after 3 days,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC1CN(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)ncnc3C)CC1)CC2,CHEMBL1154224,Bioorg Med Chem Lett,2009.0,CHEMBL1078013,CHEMBL1078013,7.51,0.0,http://www.openphacts.org/units/Nanomolar,898180.0,=,1.0,1.0,=,IC50,nM,31.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.0,CHEMBL378
3498,1403540.0,[],CHEMBL837591,Inhibitory concentration against wild-type HIV-1 LAI Virus was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1Oc1nc(Nc2ccc(C#N)cc2)c(=O)n(C)c1C,CHEMBL1145199,J Med Chem,2005.0,CHEMBL175579,CHEMBL175579,8.30,0.0,http://www.openphacts.org/units/Nanomolar,360696.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.005,CHEMBL378
3499,18320125.0,[],CHEMBL4134181,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA level incubated for 3 days followed by medium replacement measured after 3 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C2C[C@H](O)CN2C(c2nccs2)=NC1c1ccc(F)cc1Cl,CHEMBL4130455,ACS Med Chem Lett,2017.0,CHEMBL4175714,CHEMBL4175714,,0.0,http://www.openphacts.org/units/Nanomolar,3041720.0,=,1.0,1.0,=,IC50,nM,320000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,320.0,CHEMBL613497
3500,18044523.0,[],CHEMBL4010365,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of p24 antigen production pretreated with virus for 30 mins followed by 4 days incubation with cells by sandwich ELISA based multicycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1OC,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4078129,CHEMBL4078129,,0.0,http://www.openphacts.org/units/Nanomolar,2990218.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
3501,1402268.0,[],CHEMBL834488,In vitro inhibitory concentration against HIV L100I and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCCN(CCCC)c1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL179736,CHEMBL179736,,0.0,http://www.openphacts.org/units/Nanomolar,360413.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3502,1063785.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=C(S)N(Nc2cccc(Cl)c2)C1c1cccc(C(N)=O)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39462,CHEMBL39462,,0.0,http://www.openphacts.org/units/Nanomolar,62352.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3503,22933327.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)CC(=O)CC(C)(C)C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)/C=C/N6CCN(C(=O)OC(C)(C)C)CC6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4754736,CHEMBL4754736,,0.0,http://www.openphacts.org/units/Nanomolar,3560888.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
3504,705588.0,[],CHEMBL683678,Tested for cytoprotection against production of HIV-1 p24.,F,BAO_0000190,BAO_0000218,organism-based format,NNC(=O)c1ccccc1SSc1ccccc1C(=O)NN,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120248,CHEMBL120248,4.02,0.0,http://www.openphacts.org/units/Nanomolar,228641.0,=,1.0,1.0,=,IC50,nM,96000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,96.0,CHEMBL378
3505,3378811.0,[],CHEMBL1211757,Antiviral activity against HIV1 NL4.3 infected in human CEM-GFP cells assessed as inhibition p24 antigen production after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1208742,Bioorg Med Chem Lett,2010.0,CHEMBL129,CHEMBL129,5.98,0.0,http://www.openphacts.org/units/Nanomolar,926952.0,=,1.0,1.0,=,IC50,nM,1040.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.04,CHEMBL378
3506,24868586.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5152416,Antiviral activity against HBV infected in human HepG2-hNTCP cells assessed as reduction in intracellular HBV RNA incubated for 16 hrs followed by compound washout and measured after 6 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C1NC(=O)C(Cc2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)S1,CHEMBL5150016,J Med Chem,2022.0,CHEMBL5196428,CHEMBL5196428,5.28,0.0,http://www.openphacts.org/units/Nanomolar,3886067.0,=,1.0,1.0,=,IC50,nM,5200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,5.2,CHEMBL613497
3507,2929751.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3ccc(N)n3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL568496,CHEMBL568496,7.40,0.0,http://www.openphacts.org/units/Nanomolar,852869.0,=,1.0,1.0,=,IC50,nM,39.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,39.8,CHEMBL378
3508,649970.0,[],CHEMBL879743,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,CCCN1CCn2c(=O)[nH]c3cccc(c32)C1C,CHEMBL1128252,J Med Chem,1995.0,CHEMBL163910,CHEMBL163910,,0.0,http://www.openphacts.org/units/Nanomolar,326344.0,>,1.0,1.0,>,IC50,nM,83000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,83.0,CHEMBL378
3509,12717576.0,[],CHEMBL2350960,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion after 12 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=CCc1ccc2c(c1)-c1cc([C@@H](O)[C@H](C)O)ccc1Oc1ccc(CC=C)cc1-c1cc([C@@H](O)[C@H](C)O)ccc1O2,CHEMBL2346656,Bioorg Med Chem Lett,2013.0,CHEMBL2346744,CHEMBL2346744,5.80,0.0,http://www.openphacts.org/units/Nanomolar,1874406.0,=,1.0,1.0,=,IC50,nM,1580.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.58,CHEMBL613497
3510,3194847.0,[],CHEMBL1102708,Antiviral activity against CCR5-tropic recombinant HIV1 NLBal virus infected in JC53-BL cells assessed as inhibition of viral replication after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,CHEMBL1154938,Bioorg Med Chem Lett,2010.0,CHEMBL1201187,CHEMBL1201187,8.55,0.0,http://www.openphacts.org/units/Nanomolar,892843.0,=,1.0,1.0,=,IC50,nM,2.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.8,CHEMBL378
3511,1671969.0,[],CHEMBL870621,Antiviral activity against HIV1 Y181C mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ncc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL198398,CHEMBL198398,8.70,0.0,http://www.openphacts.org/units/Nanomolar,411919.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
3512,15568219.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(Br)cc1)N1CCN(Cc2cc(F)cc(F)c2)CC1,CHEMBL1201862,,,CHEMBL3560573,CHEMBL3560573,8.66,0.0,http://www.openphacts.org/units/Nanomolar,2475189.0,=,7.0,1.0,=,IC50,nM,2.21,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.00221,CHEMBL3259470
3513,2947379.0,[],CHEMBL1038497,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)c1ccccc1)[C@@H](OC(=O)c1ccccc1)C(C)(C)OC(=O)c1ccccc1)C1=C2C[C@H](OC(=O)c3ccccc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL584379,CHEMBL584379,,0.0,http://www.openphacts.org/units/Nanomolar,850751.0,>,1.0,1.0,>,IC50,nM,1400000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.4,CHEMBL613497
3514,5189154.0,[],CHEMBL1658799,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652499,CHEMBL1652499,4.46,0.0,http://www.openphacts.org/units/Nanomolar,1326874.0,=,1.0,1.0,=,IC50,nM,35000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.035,CHEMBL613497
3515,5199549.0,[],CHEMBL1670948,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,OCCc1c(OCc2c(F)cccc2F)nc2ccc(Cl)cc2c1-c1ccccc1Cl,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668641,CHEMBL1668641,5.32,0.0,http://www.openphacts.org/units/Nanomolar,1328425.0,=,1.0,1.0,=,IC50,nM,4800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,4.8,CHEMBL613497
3516,18044748.0,[],CHEMBL4010405,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype C ZM109F.PB4,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.18,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,660.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.66,CHEMBL378
3517,8043653.0,[],CHEMBL1953039,Antiviral activity against HIV1 3B infected human TZM-bl cells assessed as inhibition of viral replication by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,CHEMBL1949531,Bioorg Med Chem Lett,2012.0,CHEMBL51483,CHEMBL51483,,0.0,,1579959.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
3518,5132759.0,[],CHEMBL1646270,Antiviral activity against protease-resistant HIV1 RF/L-323-12-3 infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2[nH]c(=O)c(CN(Cc3ccco3)C(=O)c3ccc(Cl)cc3)cc2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645043,CHEMBL1645043,5.93,0.0,http://www.openphacts.org/units/Nanomolar,1321031.0,=,1.0,1.0,=,IC50,nM,1180.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.18,CHEMBL378
3519,1402368.0,[],CHEMBL837465,In vitro inhibitory concentration against HIV G190S mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCO)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175873,CHEMBL175873,,0.0,http://www.openphacts.org/units/Nanomolar,360361.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3520,15621460.0,[],CHEMBL3584167,Antiviral activity against HIV1 NL4.3-Ren infected in human MT2 cells assessed as inhibition of viral growth measured 48 hrs post infection by luminometry,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(O)[C@@H]1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5[C@H](O)C[C@]43C)[C@@H]12,CHEMBL3580560,J Nat Prod,2015.0,CHEMBL3581944,CHEMBL3581944,5.16,0.0,http://www.openphacts.org/units/Nanomolar,2482782.0,=,1.0,1.0,=,IC50,nM,7000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.0,CHEMBL378
3521,611983.0,[],CHEMBL691383,Inhibitory concentration for cytopathicity of HIV-1 (HTLV-IIIB) in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1cc(C(c2ccc(O)c(C(=O)OC)c2)c2ccc(O)c(C(=O)OC)c2)ccc1O,CHEMBL1125737,J Med Chem,1991.0,CHEMBL114154,CHEMBL114154,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,217793.0,>,1.0,1.0,>,IC50,ug.mL-1,78.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,78.0,CHEMBL378
3522,182441.0,[],CHEMBL656397,Activity against HIV-1 by syncytial plaque assay performed in duplicate using CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc2cc(Cl)c(Cl)cc2n1Cc1cccc(Cl)c1,CHEMBL1131326,J Med Chem,1998.0,CHEMBL23023,CHEMBL23023,,0.0,http://www.openphacts.org/units/Nanomolar,30662.0,>,1.0,1.0,>,IC50,nM,30000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,30.0,CHEMBL378
3523,3596599.0,[],CHEMBL1292013,Antiviral activity against HIV1 BaL in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(CNC(=O)N(c2cccc(F)c2)C2CCN(CCC3(c4cccc(F)c4)CCN(C(=O)c4ccc(F)cc4O)CC3)CC2)cc1,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288675,CHEMBL1288675,8.18,0.0,http://www.openphacts.org/units/Nanomolar,973785.0,=,1.0,1.0,=,IC50,nM,6.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.6,CHEMBL378
3524,23306069.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL4843118,Antiviral activity against Zika virus H/PF/2013 infected in pre-seeded Huh-7 cells assessed as inhibition of viral replication incubated for 72 hrs by immunodetection based secondary yield reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1cccc(Nc2nc(NCCO)nc3[nH]cnc23)c1,CHEMBL4842338,Eur J Med Chem,2021.0,CHEMBL4859049,CHEMBL4859049,5.21,0.0,http://www.openphacts.org/units/Nanomolar,3627085.0,=,1.0,1.0,=,IC50,nM,6200.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,6.2,CHEMBL4296612
3525,3509122.0,[],CHEMBL1261037,Antiviral activity against wild type HIV1 infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(Cl)c1Oc1ccnc(NC2CCN(c3cccc(C(N)=O)c3)CC2)n1,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1257905,CHEMBL1257905,9.40,0.0,http://www.openphacts.org/units/Nanomolar,962831.0,=,1.0,1.0,=,IC50,nM,0.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.4,CHEMBL378
3526,2413704.0,[],CHEMBL987710,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)Cc1ccc([N+](=O)[O-])cc1)[C@@H](OC(=O)Cc1ccc([N+](=O)[O-])cc1)C(C)(C)O)C1=C2C[C@H](OC(=O)Cc3ccc([N+](=O)[O-])cc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL454747,CHEMBL454747,,0.0,http://www.openphacts.org/units/Nanomolar,810692.0,>,1.0,1.0,>,IC50,nM,1000000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.0,CHEMBL613497
3527,14596880.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(Sc2ccccc2)n(COC(C)C)c(=S)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL3233024,CHEMBL3233024,5.18,0.0,http://www.openphacts.org/units/Nanomolar,2082722.0,=,1.0,1.0,=,IC50,nM,6660.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.66,CHEMBL378
3528,794717.0,[],CHEMBL772932,Inhibition of Hepatitis C virus NS3 protease in vitro.,B,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)[C@H](O)C(=O)N1C[C@H](c2ccccc2)C[C@H]1C(=O)N[C@@H](CC(F)F)C(=O)NCCc1c(F)cc(C(=O)O)cc1F,CHEMBL1147550,Bioorg Med Chem Lett,2004.0,CHEMBL68314,CHEMBL68314,4.75,0.0,http://www.openphacts.org/units/Nanomolar,119341.0,=,1.0,1.0,=,IC50,nM,18000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,18.0,CHEMBL4620
3529,1755835.0,[],CHEMBL864208,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(-n2c(C)nnc2SCC(=O)Nc2cccc(Br)c2)cc1,CHEMBL1146046,Bioorg Med Chem Lett,2006.0,CHEMBL212722,CHEMBL212722,,0.0,http://www.openphacts.org/units/Nanomolar,545152.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
3530,19450590.0,[],CHEMBL4433617,Antiviral activity against wild type HIV1 NL4-3 infected in human TZM-bl cells assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay based BiCycle assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(-c2ccc(OCc3cccc(C(=O)NCCNC(=O)c4ccc(COc5ccc(F)cc5-c5csc(N)n5)cc4)c3)cc2)cs1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4459450,CHEMBL4597427,5.96,0.0,http://www.openphacts.org/units/Nanomolar,3249752.0,=,1.0,1.0,=,IC50,nM,1100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.1,CHEMBL378
3531,3199197.0,[],CHEMBL1104122,Antiviral activity against HIV1 UG/92/029 infected in PBMCs assessed as reverse transcriptase activity after 7 days by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)CCNC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@@H](N)Cc1ccc(O)cc1,CHEMBL1153724,Bioorg Med Chem Lett,2009.0,CHEMBL1075830,CHEMBL1075830,5.17,0.0,http://www.openphacts.org/units/Nanomolar,889153.0,=,1.0,1.0,=,IC50,nM,6700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.7,CHEMBL378
3532,621782.0,[],CHEMBL712878,Concentration required for 50% protection of MT-4 cells against the cytopathic effect of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1Cc2c(F)ccc3nc(S)n(c23)C[C@@H]1C,CHEMBL1128253,J Med Chem,1995.0,CHEMBL58119,CHEMBL58119,8.24,0.0,http://www.openphacts.org/units/Nanomolar,327789.0,=,1.0,1.0,=,IC50,nM,5.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0058,CHEMBL378
3533,619402.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1ncnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL302551,CHEMBL302551,8.40,0.0,http://www.openphacts.org/units/Nanomolar,126918.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.004,CHEMBL378
3534,19175402.0,[],CHEMBL4385901,Antiviral activity against Zika virus harboring subgenomic GFP replicon infected in African green monkey Vero cells assessed as reduction in viral infection preincubated for 30 mins followed by viral infection and measured after 72 hrs,F,BAO_0000190,BAO_0000218,organism-based format,c1c[nH]c(CNCc2cc(CNCc3ccc[nH]3)cc(-c3cc(CNCc4ccc[nH]4)cc(Cn4cc(COCCOCCOCCOCc5cn(Cc6cc(CNCc7ccc[nH]7)cc(-c7cc(CNCc8ccc[nH]8)cc(CNCc8ccc[nH]8)c7)c6)nn5)nn4)c3)c2)c1,CHEMBL4385601,J Med Chem,2019.0,CHEMBL4522922,CHEMBL4522922,6.80,0.0,http://www.openphacts.org/units/Nanomolar,3200404.0,=,1.0,1.0,=,IC50,nM,160.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,0.16,CHEMBL4296612
3535,10866446.0,[],CHEMBL2025517,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HbeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(OC(=O)/C=C/c2cc(F)cc(F)c2)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4cc(F)cc(F)c4)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024044,CHEMBL2024044,,0.0,http://www.openphacts.org/units/Nanomolar,1639766.0,>,1.0,1.0,>,IC50,nM,1580930.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1580.93,CHEMBL613497
3536,197574.0,[],CHEMBL815090,Inhibition of HIV-1 (ADA) entry into U-87 (human glioblastoma) cells.,F,BAO_0000190,BAO_0000218,organism-based format,CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC2)CC1,CHEMBL1136595,Bioorg Med Chem Lett,2003.0,CHEMBL140552,CHEMBL140552,9.59,0.0,http://www.openphacts.org/units/Nanomolar,317555.0,=,1.0,1.0,=,IC50,nM,0.26,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.26,CHEMBL378
3537,19162209.0,[],CHEMBL4383613,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells after 7 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2ccc3c(c2)[C@H](N)CCS3(=O)=O)cc1,CHEMBL4382211,Eur J Med Chem,2018.0,CHEMBL4588251,CHEMBL4588251,,0.0,http://www.openphacts.org/units/Nanomolar,3197999.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
3538,2414473.0,[],CHEMBL953484,Antiviral activity against HIV1 with reverse transcriptase L100I mutation in human CEM cells assessed as protection against virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1153955,J Med Chem,2009.0,CHEMBL57,CHEMBL57,7.22,0.0,http://www.openphacts.org/units/Nanomolar,809634.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,60.0,CHEMBL378
3539,2462092.0,[],CHEMBL964561,Antiviral activity against hepatitis B virus infected Hep G2.2.15 cells assessed as inhibition of HBsAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1157443,Bioorg Med Chem Lett,2008.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/Nanomolar,721013.0,=,1.0,1.0,=,IC50,nM,11700000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,11.7,CHEMBL613497
3540,1954085.0,[],CHEMBL890376,Antiviral activity against HIV1 LAI assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)/C=C/c1c(Oc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL388642,CHEMBL388642,5.20,0.0,http://www.openphacts.org/units/Nanomolar,647189.0,=,1.0,1.0,=,IC50,nM,6310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6310.0,CHEMBL378
3541,13463732.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CCCN(C)c1nc(N)nc2ncn([C@H]3C[C@H](N=[N+]=[N-])[C@@H](CO)O3)c12,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL2430352,CHEMBL2430352,4.96,0.0,http://www.openphacts.org/units/Nanomolar,1920849.0,=,1.0,1.0,=,IC50,nM,10964.78,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.96,CHEMBL378
3542,19076335.0,[],CHEMBL4362886,Antiviral activity against Influenza B virus B/Sichuan/531/2018(BV) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 40 hrs by Celltiter-Glo assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1.O=P(O)(O)O,CHEMBL4359890,Eur J Med Chem,2019.0,CHEMBL1200340,CHEMBL1229,,0.0,http://www.openphacts.org/units/Nanomolar,3182796.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,100.0,CHEMBL613129
3543,14927168.0,[],CHEMBL3391565,Antiviral activity against wild type HIV-1 LAI infected in human MT4 cells assessed as inhibition of viral replication after 5 days by MTT assay in presence of 40% human serum,F,BAO_0000190,BAO_0000218,organism-based format,Cc1[nH]c(=O)c(Br)c(Oc2cc(Cl)cc(C#N)c2)c1Cc1ccccc1,CHEMBL3390846,Medchemcomm,2010.0,CHEMBL3347298,CHEMBL3347298,7.50,0.0,http://www.openphacts.org/units/Nanomolar,2173114.0,=,1.0,1.0,=,IC50,nM,32.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,32.0,CHEMBL378
3544,19175394.0,[],CHEMBL4385901,Antiviral activity against Zika virus harboring subgenomic GFP replicon infected in African green monkey Vero cells assessed as reduction in viral infection preincubated for 30 mins followed by viral infection and measured after 72 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C(=N/Cc1cc(C/N=C/c2ccc[nH]2)cc(-c2cc(C/N=C/c3ccc[nH]3)cc(C/N=C/c3ccc[nH]3)c2)c1)\c1ccc[nH]1,CHEMBL4385601,J Med Chem,2019.0,CHEMBL4463375,CHEMBL4463375,5.87,0.0,http://www.openphacts.org/units/Nanomolar,3200396.0,=,1.0,1.0,=,IC50,nM,1360.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,1.36,CHEMBL4296612
3545,1442328.0,[],CHEMBL874199,"Compound was evaluated for activity in Recombinant virus assay at concentration that reduces luciferase activity, thus recombinant virus replication",F,BAO_0000190,BAO_0000218,organism-based format,CCn1c2ccccc2c2cc(C3(C4COC(=O)C4)SCCCS3)ccc21,CHEMBL1137184,Bioorg Med Chem Lett,2004.0,CHEMBL365078,CHEMBL365078,5.34,0.0,http://www.openphacts.org/units/Nanomolar,373788.0,=,1.0,1.0,=,IC50,nM,4520.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.52,CHEMBL378
3546,2527504.0,[],CHEMBL1003777,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 5 days by MTS method,F,BAO_0000190,BAO_0000218,organism-based format,CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,CHEMBL1138484,J Med Chem,2009.0,CHEMBL521793,CHEMBL521793,7.52,0.0,http://www.openphacts.org/units/Nanomolar,735726.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,30.0,CHEMBL378
3547,3229732.0,[],CHEMBL1113200,Antiviral activity against recombinant HIV1 virus infected in human JC53BL cells after 3 days,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2,CHEMBL1154224,Bioorg Med Chem Lett,2009.0,CHEMBL1077912,CHEMBL1077912,7.34,0.0,http://www.openphacts.org/units/Nanomolar,898091.0,=,1.0,1.0,=,IC50,nM,46.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,46.0,CHEMBL378
3548,2244528.0,[],CHEMBL1002209,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase Y188L mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(C(F)(F)F)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL275658,CHEMBL275658,7.18,0.0,http://www.openphacts.org/units/Nanomolar,798655.0,=,1.0,1.0,=,IC50,nM,66.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,66.0,CHEMBL378
3549,15466540.0,[],CHEMBL3533061,Antiviral activity against HIV1 expressing Env-green fluorescent fusion protein infected in PBMC assessed as inhibition of viral activity after 72 hrs by flow cytometry analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2c(O)cc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL3525980,Drug Metab Dispos,2013.0,CHEMBL1309,CHEMBL1309,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,2468772.0,=,1.0,1.0,=,IC50,ug.mL-1,0.04225,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ng/ml,UO_0000274,42.25,CHEMBL378
3550,12651404.0,[],CHEMBL2327723,Antiviral activity against 0.001 MOI bevirimat-resistant Human immunodeficiency virus 1 NL4-3 harboring gag V370A mutant infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCNC(=O)[C@H](C)NC(=O)OC(C)(C)C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324146,CHEMBL2324146,6.43,0.0,http://www.openphacts.org/units/Nanomolar,1850172.0,=,1.0,1.0,=,IC50,nM,370.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.37,CHEMBL378
3551,1520715.0,[],CHEMBL833990,Inhibitory concentration against wild type human immunodeficiency virus,F,BAO_0000190,BAO_0000218,organism-based format,C=Cc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@H](C(C)C)N2CCN(Cc3csc(C)n3)C2=O)cc1,CHEMBL1144377,Bioorg Med Chem Lett,2005.0,CHEMBL435935,CHEMBL435935,7.00,0.0,http://www.openphacts.org/units/Nanomolar,395298.0,=,1.0,1.0,=,IC50,nM,101.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.101,CHEMBL378
3552,5222616.0,[],CHEMBL1675306,Antiviral activity against HIV1 infected in human PBMC assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1.O=S(=O)(O)O,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL1200619,CHEMBL1380,6.04,0.0,http://www.openphacts.org/units/Nanomolar,1332021.0,=,1.0,1.0,=,IC50,nM,910.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.91,CHEMBL378
3553,1402328.0,[],CHEMBL837466,In vitro inhibitory concentration against HIV K101E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N2CCOCC2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL178061,CHEMBL178061,,0.0,http://www.openphacts.org/units/Nanomolar,360425.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3554,22435371.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4677393,Antiviral activity against HIV-1 NL4-3 infected in human MT-4 cells assessed as inhibition of viral replication by measuring inhibition of cell viability preincubated with cells for 15 mins followed by viral infection and measured after 4 days by MTS/PES assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCc2cc(OC)cc(n2)CCN(S(=O)(=O)c2ccc(C)cc2)C1.Cl,CHEMBL4673284,Bioorg Med Chem,2020.0,CHEMBL4743003,CHEMBL4802467,4.90,0.0,http://www.openphacts.org/units/Nanomolar,3515765.0,=,1.0,1.0,=,IC50,nM,12590.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.59,CHEMBL378
3555,3432855.0,[],CHEMBL1246459,Antiviral activity against R5 tropic HIV1 BaL infected in human CEMx174 5.25M7 cells after 3 days by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(Cc2ccc(C(=O)NN3C(=O)[C@@H]4C5C=CC(C6CC65)[C@@H]4C3=O)cc2)CC1,CHEMBL1240449,Eur J Med Chem,2010.0,CHEMBL1242722,CHEMBL1242722,4.08,0.0,http://www.openphacts.org/units/Nanomolar,954046.0,=,1.0,1.0,=,IC50,nM,82810.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,82.81,CHEMBL378
3556,24823628.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '144.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '6.0'}]",CHEMBL5140688,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in intracellular core HBV DNA level incubated for 6 days by qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3cc(Br)ccc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5195944,CHEMBL5195944,7.43,0.0,http://www.openphacts.org/units/Nanomolar,3876726.0,=,1.0,1.0,=,IC50,nM,36.9,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0369,CHEMBL613497
3557,6152669.0,[],CHEMBL1763333,Inhibition of c-Jun,B,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc3cnc(Nc4ccc(-n5cnc(-c6ccccn6)n5)cc4)nc3c2)cn1,CHEMBL1759990,Bioorg Med Chem Lett,2011.0,CHEMBL1761562,CHEMBL1761562,6.54,0.0,http://www.openphacts.org/units/Nanomolar,1413778.0,=,1.0,1.0,=,IC50,nM,290.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.29,CHEMBL4977
3558,12663823.0,[],CHEMBL2330349,Antiviral activity against T20-sensitive Human immunodeficiency virus 1 NL4-3 harboring gp41 NHR D36G mutation infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CCNC(=O)c1cc(-n2c(C)ccc2C)ccc1OCC(=O)O)[C@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O,CHEMBL2321797,J Med Chem,2013.0,CHEMBL2326372,CHEMBL2326372,6.89,0.0,http://www.openphacts.org/units/Nanomolar,1852841.0,=,1.0,1.0,=,IC50,nM,130.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,130.0,CHEMBL378
3559,17602972.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(c2ccc(-n3cccn3)cc2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644907,CHEMBL3644907,8.05,0.0,http://www.openphacts.org/units/Nanomolar,2518027.0,=,37.0,1.0,=,IC50,nM,9.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,9.0,CHEMBL4620
3560,5137365.0,[],CHEMBL1646836,Antiviral activity against X4 tropic HIV1 NL4.3 infected in human MT4 cells expressing CD4 and CXCR4 assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NCc1ccccc1CN(Cc1nc2ccccc2[nH]1)C1CCCc2cccnc21,CHEMBL1641524,Bioorg Med Chem Lett,2011.0,CHEMBL1093008,CHEMBL1093008,7.68,0.0,http://www.openphacts.org/units/Nanomolar,1319743.0,=,1.0,1.0,=,IC50,nM,21.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.021,CHEMBL378
3561,3453343.0,[],CHEMBL1245753,Antiviral activity against HIV1 3B infected in human HOS cells after 72 hrs by luminescence assay in presence of 1 mg/ml alpha-acid glycoprotein,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(c2cccc3nc(CN(C)[C@H]4CCCc5cccnc54)c(CO)n23)CC1,CHEMBL1240366,Antimicrob Agents Chemother,2010.0,CHEMBL1242210,CHEMBL1242210,8.54,0.0,http://www.openphacts.org/units/Nanomolar,953332.0,=,1.0,1.0,=,IC50,nM,2.87,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.87,CHEMBL378
3562,1498104.0,[],CHEMBL833971,Concentration required to inhibit 50% viral production of human immunodeficiency virus type 1 (HIV-1-IIIB),F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCOc1cc(NC(=S)c2ccoc2C)ccc1Cl,CHEMBL1143567,J Med Chem,2005.0,CHEMBL54893,CHEMBL54893,8.05,0.0,http://www.openphacts.org/units/Nanomolar,388328.0,=,1.0,1.0,=,IC50,nM,9.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.009,CHEMBL378
3563,2997443.0,[],CHEMBL1046974,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)c2ccc(=O)n(C3CCCCC3)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL567947,CHEMBL567947,4.00,0.0,http://www.openphacts.org/units/Nanomolar,856586.0,=,1.0,1.0,=,IC50,nM,99000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,99.0,CHEMBL613497
3564,18183402.0,[],CHEMBL4040187,Antiviral activity against CXCR4-tropic HIV-1 NL4-3 infected in human PHA-stimulated PBMC assessed as inhibition of viral replication by measuring reduction in p24 antigen production preincubated with cells for 30 mins followed by viral infection measured on day 10 post infection in presence of IL-2 by ELISA,F,BAO_0000190,BAO_0000019,assay format,Nc1ncnc2c1ncn2C[C@H](CF)OCP(=O)(O)O,CHEMBL4038313,J Med Chem,2017.0,CHEMBL482465,CHEMBL482465,5.39,0.0,http://www.openphacts.org/units/Nanomolar,3016391.0,=,1.0,1.0,=,IC50,nM,4040.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.04,CHEMBL378
3565,3315846.0,[],CHEMBL1119774,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,CCO[C@H]1CC[C@H](CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1,CHEMBL1155507,Bioorg Med Chem Lett,2010.0,CHEMBL1085223,CHEMBL1085223,8.52,0.0,http://www.openphacts.org/units/Nanomolar,915686.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.0,CHEMBL378
3566,19261982.0,[],CHEMBL4404409,Antiviral activity against HIV1 subtypeA mother MG505.W0M.ENV.A2,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,5.80,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,1600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.6,CHEMBL378
3567,18683280.0,[],CHEMBL4237095,Antiviral activity against CCR5-dependent HIV1 KM018 infected in human PBMC assessed as reduction in virus infection measured after 7 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1,CHEMBL4229569,J Med Chem,2018.0,CHEMBL4244935,CHEMBL4244935,8.32,0.0,http://www.openphacts.org/units/Nanomolar,3103078.0,=,1.0,1.0,=,IC50,nM,4.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.8,CHEMBL378
3568,2694328.0,[],CHEMBL1053931,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV surface antigen at < TC50,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2nc3c(cc2c(CN2CCCCC2)c1O)CSc1c(C)cc(C)cc1-3,CHEMBL1152943,Bioorg Med Chem,2009.0,CHEMBL563873,CHEMBL563873,,0.0,,824939.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
3569,22898284.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731088,Antiviral activity against HIV1 LAI infected in human MT2 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(=O)C[C@H]1C2CO[C@H]3OC[C@@H]1C3C2)S(=O)(=O)c1ccc2nc(NC3CC3)sc2c1,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL4743665,CHEMBL4743665,10.10,0.0,http://www.openphacts.org/units/Nanomolar,3554415.0,=,1.0,1.0,=,IC50,nM,0.079,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.079,CHEMBL378
3570,10862156.0,[],CHEMBL2024925,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B e-antigen release,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(/C=C/C(=O)O[C@H]2CC[C@]3(C)[C@H]4CC=C5[C@@H]6C[C@@](C)(C(=O)OCc7ccc(Br)cc7F)CC[C@]6(C)CC[C@@]5(C)[C@]4(C)CC[C@H]3C2(C)C)c1,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2023706,CHEMBL2023706,,0.0,http://www.openphacts.org/units/Nanomolar,1639315.0,>,1.0,1.0,>,IC50,nM,1001890.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1001.89,CHEMBL613497
3571,22435376.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4677393,Antiviral activity against HIV-1 NL4-3 infected in human MT-4 cells assessed as inhibition of viral replication by measuring inhibition of cell viability preincubated with cells for 15 mins followed by viral infection and measured after 4 days by MTS/PES assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCc2cc(CCCC)cc(n2)CCN(S(=O)(=O)c2ccc(C)cc2)C1.Cl,CHEMBL4673284,Bioorg Med Chem,2020.0,CHEMBL4750983,CHEMBL4802708,5.62,0.0,http://www.openphacts.org/units/Nanomolar,3515770.0,=,1.0,1.0,=,IC50,nM,2410.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.41,CHEMBL378
3572,674961.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Clc1ccc(SSc2ccc(Cl)cc2Cl)c(Cl)c1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120960,CHEMBL120960,,0.0,,228657.0,=,1.0,0.0,=,IC50,,6.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,6.8,CHEMBL378
3573,10907706.0,[],CHEMBL2039355,Antiviral activity against HIV1 infected in CEM cells after 72 hrs by GFP reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)[C@@]1(n2ccc(N)nc2=O)C[C@H](P(=O)(OCC)OCC)N(C)O1,CHEMBL2034829,Bioorg Med Chem,2012.0,CHEMBL2035677,CHEMBL2035677,,0.0,http://www.openphacts.org/units/Nanomolar,1645486.0,=,1.0,1.0,=,IC50,nM,180000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,180.0,CHEMBL378
3574,16466898.0,[],CHEMBL3766104,Antiviral activity against HIV1 NL4-3 infected in TZM-bl cells incubated for 3 hrs measured after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=[N+]([O-])c1ccc(-c2n[nH]c(O)c2CCc2cccc(Cl)c2)cc1,CHEMBL3763152,Bioorg Med Chem Lett,2016.0,CHEMBL3765493,CHEMBL3765493,,0.0,http://www.openphacts.org/units/Nanomolar,2756509.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
3575,1403319.0,[],CHEMBL834756,Inhibitory concentration against 103N mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1Sc1cn(C)c(=O)c(Nc2ccc(C#N)cc2)n1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL366644,CHEMBL366644,,0.0,http://www.openphacts.org/units/Nanomolar,360622.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
3576,2462117.0,[],CHEMBL965355,Antiviral activity against hepatitis B virus infected Hep G2.2.15 cells assessed as inhibition of HBeAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1157443,Bioorg Med Chem Lett,2008.0,CHEMBL462122,CHEMBL462122,,0.0,http://www.openphacts.org/units/Nanomolar,721011.0,=,1.0,1.0,=,IC50,nM,1870000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.87,CHEMBL613497
3577,608431.0,[],CHEMBL691383,Inhibitory concentration for cytopathicity of HIV-1 (HTLV-IIIB) in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cc(Br)cc(Cc2cc(Br)cc(C(=O)O)c2O)c1O,CHEMBL1125737,J Med Chem,1991.0,CHEMBL323654,CHEMBL323654,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,217800.0,=,1.0,1.0,=,IC50,ug.mL-1,72.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,72.1,CHEMBL378
3578,405208.0,[],CHEMBL881122,Inhibitory concentration required against vaccinia virus in Vero cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2C[C@@H]1COP(=O)(O)CO1,CHEMBL1147452,Bioorg Med Chem Lett,2004.0,CHEMBL114867,CHEMBL114867,,0.0,http://www.openphacts.org/units/Nanomolar,214243.0,>,1.0,1.0,>,IC50,nM,350000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,350.0,CHEMBL613493
3579,7969195.0,[],CHEMBL1930947,"Antiviral activity against LacZ-containing HIV1 in COS7 cells expressing HXB2 Env, R8.91, and pTY-EFnLacZ assessed as reduction of viral vector infection into human HeLa cells expressing CD4 after 2 days using 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside staining",F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2ccn3c(c(-c4ccc(OC)c(OS(=O)(=O)[O-])c4)c4c5cc(OC)c(OS(=O)(=O)[O-])cc5oc(=O)c43)c2cc1OC.[Na+].[Na+],CHEMBL1926605,Bioorg Med Chem,2011.0,CHEMBL1928867,CHEMBL1962903,4.82,0.0,http://www.openphacts.org/units/Nanomolar,1565983.0,=,1.0,1.0,=,IC50,nM,15100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,15.1,CHEMBL378
3580,5126308.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,COCCN/C=C1/C(=O)Nc2cc(Cl)ccc2N(C)C1=O,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642304,CHEMBL1642304,6.23,0.0,http://www.openphacts.org/units/Nanomolar,1317594.0,=,1.0,1.0,=,IC50,nM,590.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.59,CHEMBL378
3581,1194679.0,[],CHEMBL710380,Inhibitory activity against 103N strain and 181C strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70554,CHEMBL70554,6.40,0.0,http://www.openphacts.org/units/Nanomolar,127459.0,=,1.0,1.0,=,IC50,nM,401.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.401,CHEMBL378
3582,2997414.0,[],CHEMBL1046975,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCn1cc(C(=O)c2ccc(OC)cc2O)ccc1=O,CHEMBL1156796,J Med Chem,2010.0,CHEMBL566274,CHEMBL566274,4.41,0.0,http://www.openphacts.org/units/Nanomolar,856599.0,=,1.0,1.0,=,IC50,nM,39000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,39.0,CHEMBL613497
3583,2362877.0,[],CHEMBL1026413,"Antiviral activity against multidrug-resistant HIV1 with protease L10I, K14R, R41K, M46L, I54V, L63P, A71V, V82A, L90M, I93L mutation in phytohemagglutininin-activated PBMC assessed as inhibition of p24Gag protein production",F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2CCOCOC2)cc1,CHEMBL1140100,J Med Chem,2008.0,CHEMBL492254,CHEMBL492254,6.66,0.0,http://www.openphacts.org/units/Nanomolar,746805.0,=,1.0,1.0,=,IC50,nM,220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,220.0,CHEMBL378
3584,1438276.0,[],CHEMBL833079,Inhibitory activity against HIV-1 mutant strain 181C,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccs1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL184934,CHEMBL184934,,0.0,http://www.openphacts.org/units/Nanomolar,371561.0,=,1.0,1.0,=,IC50,nM,3981000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3981.0,CHEMBL378
3585,12651412.0,[],CHEMBL2327724,Antiviral activity against 0.001 MOI wild type Human immunodeficiency virus 1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCNC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324148,CHEMBL2324148,6.82,0.0,http://www.openphacts.org/units/Nanomolar,1850174.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.15,CHEMBL378
3586,3397924.0,[],CHEMBL1217303,Antiviral activity against HIV1 3B infected in human MAGI cells after 40 to 48 hrs assessed as inhibition of viral life cycle,F,BAO_0000190,BAO_0000218,organism-based format,O=C1C(c2ccc(O)c(O)c2)=c2c(c3c(n2CCc2ccc(O)cc2)=C(c2ccc(O)c(O)c2)C(=O)c2cc(O)c(OS(=O)(=O)O)cc2-3)-c2cc(O)c(O)cc21,CHEMBL1212851,Bioorg Med Chem,2010.0,CHEMBL1214278,CHEMBL1214278,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,931710.0,=,1.0,1.0,=,IC50,ug.mL-1,3.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,3.7,CHEMBL378
3587,16556882.0,[],CHEMBL3795205,Antiviral activity against CXCR4 using HIV-1 NL4.3 infected in human MT4 cells assessed as reduction of viral replication preincubated for 15 mins with cells followed by viral infection measured after 4 days by MTS/PES method,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(CC2CCCCC2)CCCN(S(=O)(=O)c2ccc(OCCCN)cc2)C1.Cl,CHEMBL3792300,J Med Chem,2016.0,CHEMBL3793275,CHEMBL3794641,,0.0,,2770912.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
3588,19004636.0,[],CHEMBL4344048,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells measured on day 3 post-infection by Nano-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@]12O[C@@]3(/C=C/C=C/CCCCC)O[C@@H]1[C@@H]1[C@@H]4O[C@]4(CO)[C@@H](O)[C@]4(O)C(=O)C(C)=C[C@H]4[C@@]1(O3)[C@H](C)[C@H]2OC(=O)CCCC,CHEMBL4342444,J Nat Prod,2020.0,CHEMBL4471778,CHEMBL4471778,,0.0,http://www.openphacts.org/units/Nanomolar,3171227.0,<,1.0,1.0,<,IC50,nM,0.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.8,CHEMBL378
3589,10938683.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4cccc(F)c4F)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046578,CHEMBL2046578,4.88,0.0,http://www.openphacts.org/units/Nanomolar,1651461.0,=,1.0,1.0,=,IC50,nM,13150.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,13.15,CHEMBL613497
3590,8057979.0,[],CHEMBL1960698,Antiinfluenza activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)O)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL1955749,Bioorg Med Chem Lett,2012.0,CHEMBL1956398,CHEMBL1956398,,0.0,http://www.openphacts.org/units/Nanomolar,1580686.0,>,1.0,1.0,>,IC50,nM,4032000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,4032.0,CHEMBL613129
3591,18775795.0,[],CHEMBL4269044,Antiviral activity against Hepatitis B virus infected in human dHepaRG cells assessed as reduction in extracellular viral DNA levels after 6 days by qPCR/TaqMan assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1[C@H](CO)[C@@H](O)C[C@@H]1n1cnc2c(=O)[nH]c(N)nc21,CHEMBL4265974,J Med Chem,2018.0,CHEMBL713,CHEMBL713,10.22,0.0,http://www.openphacts.org/units/Nanomolar,3119708.0,=,1.0,1.0,=,IC50,nM,0.06,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,0.06,CHEMBL613497
3592,16422833.0,[],CHEMBL3751454,Antiviral activity against recombinant HIV-1 NL4-3 expressing HIV-1 JR-CSF envelope infected in U87.CD4.CCR5 cells assessed as inhibition of Env mediated cell entry by HIV-1 single round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CC4CN(C(=O)c5ccccc5)CC4C3)c12,CHEMBL3745657,Bioorg Med Chem Lett,2016.0,CHEMBL3353051,CHEMBL3353051,9.10,0.0,http://www.openphacts.org/units/Nanomolar,2740460.0,=,1.0,1.0,=,IC50,nM,0.7943,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,9.1,CHEMBL378
3593,1754746.0,[],CHEMBL864208,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(-n2c(SCC(=O)Nc3ccccc3Cl)nnc2-c2ccncc2)cc1,CHEMBL1146046,Bioorg Med Chem Lett,2006.0,CHEMBL213755,CHEMBL213755,,0.0,http://www.openphacts.org/units/Nanomolar,545189.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
3594,24830964.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc2c(=O)c3cccc(Cl)c3oc2cc1N1CCC(C(=O)O)C1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5178238,CHEMBL5178238,5.08,0.0,http://www.openphacts.org/units/Nanomolar,3878137.0,=,1.0,1.0,=,IC50,nM,8230.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,8.23,CHEMBL613497
3595,1402057.0,[],CHEMBL837470,In vitro inhibitory concentration against HIV V179E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)Nc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL128569,CHEMBL128569,,0.0,http://www.openphacts.org/units/Nanomolar,360373.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3596,15621466.0,[],CHEMBL3584167,Antiviral activity against HIV1 NL4.3-Ren infected in human MT2 cells assessed as inhibition of viral growth measured 48 hrs post infection by luminometry,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL3580560,J Nat Prod,2015.0,CHEMBL140040,CHEMBL140040,5.06,0.0,http://www.openphacts.org/units/Nanomolar,2482788.0,=,1.0,1.0,=,IC50,nM,8800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.8,CHEMBL378
3597,18940389.0,[],CHEMBL4328847,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)OC(=O)n1ccc2ccc(-c3ccc4ccn(Cc5cccc(C(=O)O)c5)c4c3)cc21,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4440451,CHEMBL4440451,6.05,0.0,http://www.openphacts.org/units/Nanomolar,3159824.0,=,1.0,1.0,=,IC50,nM,900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.9,CHEMBL378
3598,2371433.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,C/N=C1/c2c(C)c3cc(OC)ccc3n2CCN1C,CHEMBL1140145,J Med Chem,2008.0,CHEMBL492474,CHEMBL492474,4.05,0.0,http://www.openphacts.org/units/Nanomolar,746613.0,=,1.0,1.0,=,IC50,nM,89000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,89.0,CHEMBL613493
3599,14658861.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)c3ccc(OC)cc3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262888,CHEMBL3262888,7.26,0.0,http://www.openphacts.org/units/Nanomolar,2101730.0,=,1.0,1.0,=,IC50,nM,54.95,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,pIC50,,UO_0000065,7.26,CHEMBL3259471
3600,2516315.0,[],CHEMBL975243,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CSc2nc(Cc3ccccc3Br)c(C)c(=O)[nH]2)cc1,CHEMBL1138559,Eur J Med Chem,2009.0,CHEMBL472625,CHEMBL472625,5.98,0.0,http://www.openphacts.org/units/Nanomolar,734013.0,=,1.0,1.0,=,IC50,nM,1040.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.04,CHEMBL378
3601,10961179.0,[],CHEMBL2061267,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M10 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL1163,CHEMBL1163,5.48,0.0,http://www.openphacts.org/units/Nanomolar,1655449.0,=,1.0,1.0,=,IC50,nM,3300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3300.0,CHEMBL378
3602,2601947.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc2[nH]c(C(N)=O)c(S(=O)(=O)c3cc(C)cc(C)c3)c2c1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL84002,CHEMBL84002,7.82,0.0,http://www.openphacts.org/units/Nanomolar,807028.0,=,1.0,1.0,=,IC50,nM,15.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.015,CHEMBL378
3603,19261916.0,[],CHEMBL4404387,Antiviral activity against HIV1 subtypeB 1058 11.B11.1550,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.31,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,490.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.49,CHEMBL378
3604,2570664.0,[],CHEMBL1000470,Antiviral activity against hepatitis B virus-infected human HepG2.2.15 cells assessed as inhibition of HBV e antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@H](OC(=O)c1ccccc1)[C@H](C[C@@H](C)C1=C2C[C@H](OC(=O)c3ccccc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)OC(=O)c1ccccc1,CHEMBL1155923,Bioorg Med Chem Lett,2008.0,CHEMBL504157,CHEMBL504157,,0.0,http://www.openphacts.org/units/Nanomolar,768989.0,>,1.0,1.0,>,IC50,nM,2300000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.3,CHEMBL613497
3605,23306093.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL4843119,Antiviral activity against Zika virus H/PF/2013 infected in pre-seeded Huh-7 cells assessed as inhibition of viral replication incubated for 72 hrs by immunodetection based direct yield reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,CHEMBL4842338,Eur J Med Chem,2021.0,CHEMBL1643,CHEMBL1643,5.42,0.0,http://www.openphacts.org/units/Nanomolar,3627097.0,=,1.0,1.0,=,IC50,nM,3800.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,3.8,CHEMBL4296612
3606,3406165.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc2oc(-c3ccccc3F)c(O)c(=O)c2c1,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1215736,CHEMBL1215736,4.35,0.0,http://www.openphacts.org/units/Nanomolar,933517.0,=,1.0,1.0,=,IC50,nM,44500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,44.5,CHEMBL378
3607,2003499.0,[],CHEMBL901904,Antiviral activity against Vaccinia virus-infected Vero cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)OC1CCC(C(=O)Nc2ccc(-c3nc4cc(NC(=O)C5CCC(OC(C)=O)CC5)ccc4[nH]3)cc2)CC1,CHEMBL1138288,J Med Chem,2007.0,CHEMBL240596,CHEMBL240596,,0.0,http://www.openphacts.org/units/Nanomolar,666648.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,nM,UO_0000065,2000.0,CHEMBL613493
3608,24731874.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5115940,Antiviral activity against ZIKV-SMGC-1 infected in human BHK cells incubated for 7 days by CellTiter 96 luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(c1ccc(C(F)(F)F)cc1O)c1[nH]c(Cl)c(Cl)c1-n1c(C(=O)c2ccc(C(F)(F)F)cc2O)cc(Cl)c1SCc1ccccn1,CHEMBL5113415,Eur J Med Chem,2022.0,CHEMBL5186684,CHEMBL5186684,,0.0,,3857950.0,,1.0,0.0,,IC50,,,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,,,,CHEMBL4296612
3609,3221771.0,[],CHEMBL1102830,Antiviral activity against HIV1 carrying reverse transcriptase Y181C mutant infected human MT4 cells by phenoscreen assay in the presence of 40 percent normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,NS(=O)(=O)c1ccc(NC(=O)CSC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,CHEMBL1153798,Bioorg Med Chem Lett,2009.0,CHEMBL1079267,CHEMBL1079267,4.78,0.0,http://www.openphacts.org/units/Nanomolar,897986.0,=,1.0,1.0,=,IC50,nM,16800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,0.0168,CHEMBL378
3610,5249043.0,[],CHEMBL1685193,Antiviral activity against X4 tropic HIV1 NL4.3 infected in CD4 and CXCR4 expressing human MT4 cells assessed as inhibition of viral cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cnc(CN(CCCCN)C(C)c2ccccn2)c(C)c1,CHEMBL1681661,Bioorg Med Chem Lett,2011.0,CHEMBL1682992,CHEMBL1682992,8.74,0.0,http://www.openphacts.org/units/Nanomolar,1334127.0,=,1.0,1.0,=,IC50,nM,1.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.8,CHEMBL378
3611,3014837.0,[],CHEMBL1050515,Antiviral activity against multidrug-resistant HIV1 isolate B infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL1156053,J Med Chem,2009.0,CHEMBL1323,CHEMBL1323,7.72,0.0,http://www.openphacts.org/units/Nanomolar,862439.0,=,1.0,1.0,=,IC50,nM,19.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.019,CHEMBL378
3612,1254671.0,[],CHEMBL652107,Inhibitory concentration required to inhibit HIV-induced cytopathicity in CEM-4 cells by 50% based in the MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCCCC(=O)NCCCCCCCCCCC(=O)NCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL115808,CHEMBL1205569,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221540.0,=,1.0,1.0,=,IC50,ug.mL-1,15.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,15.0,CHEMBL378
3613,1520705.0,[],CHEMBL833990,Inhibitory concentration against wild type human immunodeficiency virus,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(CN2CCN([C@H](C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc(C(=O)O)cc3)C(C)C)C2=O)cs1,CHEMBL1144377,Bioorg Med Chem Lett,2005.0,CHEMBL371279,CHEMBL371279,5.00,0.0,http://www.openphacts.org/units/Nanomolar,395293.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
3614,5294507.0,[],CHEMBL1696689,Antiviral activity against HIV1 subtype A 92RW016 infected in human PBMC assessed as inhibition of viral replication by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(CC)[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,CHEMBL1687706,Antimicrob Agents Chemother,2008.0,CHEMBL1651956,CHEMBL1651956,8.10,0.0,http://www.openphacts.org/units/Nanomolar,1337219.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
3615,6336413.0,[],CHEMBL1821125,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by measuring HBsAg and HBeAg production after 9 days by EIA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](CCl)Cc2ccccc2)cc1,CHEMBL1817553,Bioorg Med Chem,2011.0,CHEMBL1819343,CHEMBL1819343,6.15,0.0,http://www.openphacts.org/units/Nanomolar,1451757.0,=,1.0,1.0,=,IC50,nM,710.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.71,CHEMBL613497
3616,1839858.0,[],CHEMBL916789,Antiviral activity against HIV1 BAL in human MDM cells,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)C(=O)OCC1CN(C(=O)c2cc(OC)c(OC)c(OC)c2)CCN1C(=O)c1cc(OC)c(OC)c(OC)c1,CHEMBL1149263,J Med Chem,2004.0,CHEMBL6322,CHEMBL6322,4.96,0.0,http://www.openphacts.org/units/Nanomolar,629981.0,=,1.0,1.0,=,IC50,nM,11000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,11.0,CHEMBL378
3617,1954160.0,[],CHEMBL891427,Antiviral activity against HIV1 RT 100I/103N mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(OC)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL233662,CHEMBL233662,6.50,0.0,http://www.openphacts.org/units/Nanomolar,647182.0,=,1.0,1.0,=,IC50,nM,316.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,316.0,CHEMBL378
3618,13398973.0,[],CHEMBL2417107,Antiviral activity against Human immunodeficiency virus 1 R5 primary isolate YTA48P infected in CCR5-expressing human PM1 cells assessed as inhibition of virus-induced cytopathogenicity after 7 days by WST8 assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(Cl)cc1)C(=O)NC1CC2(CCCCC2)NC2(CCCCC2)C1,CHEMBL2412961,Bioorg Med Chem,2013.0,CHEMBL1917745,CHEMBL1917745,6.37,0.0,http://www.openphacts.org/units/Nanomolar,1911012.0,=,1.0,1.0,=,IC50,nM,430.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.43,CHEMBL378
3619,18775539.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COCCCOc1cc2c(cc1OC)-c1cc(=O)c(C(=O)O)cn1C(C(C)(C)COC)C2,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4292535,CHEMBL4292535,8.30,0.0,http://www.openphacts.org/units/Nanomolar,3119697.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.005,CHEMBL613497
3620,5222671.0,[],CHEMBL1675427,Antiviral activity against HIV1 harboring reverse transcriptase L74V mutant infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,[N-]=[N+]=N[C@H]1C[C@H](n2cnc3c(N)ncnc32)O[C@@H]1CO,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL590121,CHEMBL590121,4.86,0.0,http://www.openphacts.org/units/Nanomolar,1332020.0,=,1.0,1.0,=,IC50,nM,13700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,13.7,CHEMBL378
3621,2292392.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccccc1[S+]([O-])c1cccc(N)c1C#N,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL294212,CHEMBL294212,,0.0,http://www.openphacts.org/units/Nanomolar,813412.0,=,1.0,1.0,=,IC50,nM,3899419.87,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,2.409,CHEMBL378
3622,688391.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,COC(=S)SSC(=S)N(CC/N=C(/S)SSC(=S)OC)CC/N=C(\S)SSC(=S)OC,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120050,CHEMBL120050,,0.0,,228559.0,=,1.0,0.0,=,IC50,,210.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,210.5,CHEMBL378
3623,1740450.0,[],CHEMBL854478,Inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,O=C1c2ccccc2C(=O)N1CCc1nc2cc(Cl)c(Cl)cc2n1S(=O)(=O)c1ccc([N+](=O)[O-])cc1,CHEMBL1138932,J Med Chem,2006.0,CHEMBL377580,CHEMBL377580,4.30,0.0,http://www.openphacts.org/units/Nanomolar,520773.0,=,1.0,1.0,=,IC50,nM,50200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.2,CHEMBL613497
3624,672214.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,CSSc1ccccc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL118504,CHEMBL118504,,0.0,,228586.0,=,1.0,0.0,=,IC50,,7.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,7.9,CHEMBL378
3625,3254068.0,[],CHEMBL1114300,Antiviral activity against HIV1 3B in human HOS cells expressing human CXCR4/CXCR5/CD4/pHIV-LTR-luciferase assessed as blockade of viral infection into cells,F,BAO_0000190,BAO_0000218,organism-based format,c1cnc2c(c1)CC[C@@H]1CCCN(Cc3cn4c(N5CCOCC5)cccc4n3)[C@H]21,CHEMBL1156293,Bioorg Med Chem Lett,2010.0,CHEMBL1093030,CHEMBL1093030,5.92,0.0,http://www.openphacts.org/units/Nanomolar,901377.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1200.0,CHEMBL378
3626,2930209.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COCC1CCN(Cc2c(C)[nH]c(=O)c(I)c2Sc2cc(C)cc(C)c2)CC1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL574592,CHEMBL574592,7.70,0.0,http://www.openphacts.org/units/Nanomolar,848347.0,=,1.0,1.0,=,IC50,nM,19.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.9,CHEMBL378
3627,2602284.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(OCCn2c([N+](=O)[O-])cnc2C)c2ccccc2)cc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL288543,CHEMBL288543,4.07,0.0,http://www.openphacts.org/units/Nanomolar,807134.0,=,1.0,1.0,=,IC50,nM,86000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,86.0,CHEMBL378
3628,1486922.0,[],CHEMBL833976,Inhibitory concentration against wild type human immunodeficiency virus type 1 was determined by recombinant virus assay,F,BAO_0000190,BAO_0000218,organism-based format,CCC(C)C#COc1c(C(C)C)c(O)nc2ccc(F)cc12,CHEMBL1138845,J Med Chem,2004.0,CHEMBL189684,CHEMBL189684,7.55,0.0,http://www.openphacts.org/units/Nanomolar,384152.0,=,1.0,1.0,=,IC50,nM,28.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,28.0,CHEMBL378
3629,1199858.0,[],CHEMBL710533,Inhibitory activity against 181C strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(C)cc(C#N)cc1C,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL308004,CHEMBL308004,7.92,0.0,http://www.openphacts.org/units/Nanomolar,127441.0,=,1.0,1.0,=,IC50,nM,12.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.012,CHEMBL378
3630,15064931.0,[],CHEMBL3366183,Antiviral activity against wild type HIV1 infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CNc2nc(-c3ccc(OC)cc3)c(Cc3ccc(OC)cc3)s2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3329465,CHEMBL3329465,,0.0,http://www.openphacts.org/units/Nanomolar,2248834.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
3631,2929575.0,[],CHEMBL1056893,Antiviral activity against HIV1 HXB2 harboring 101E mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3ccnc3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL568526,CHEMBL568526,8.04,0.0,http://www.openphacts.org/units/Nanomolar,852832.0,=,1.0,1.0,=,IC50,nM,9.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,9.2,CHEMBL378
3632,42376.0,[],CHEMBL695523,Antiviral activity against V108I strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL593,CHEMBL593,7.11,0.0,http://www.openphacts.org/units/Nanomolar,20822.0,=,1.0,1.0,=,IC50,nM,78.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,78.0,CHEMBL378
3633,1470138.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(Br)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188223,CHEMBL188223,6.10,0.0,http://www.openphacts.org/units/Nanomolar,380674.0,=,1.0,1.0,=,IC50,nM,790.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.79,CHEMBL378
3634,3596595.0,[],CHEMBL1292013,Antiviral activity against HIV1 BaL in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(CNC(=O)N(c2cccc(F)c2)C2CCN(CCC3(c4cccc(F)c4)CCN(C(=O)c4c(Cl)ccc(S(N)(=O)=O)c4Cl)CC3)CC2)cc1,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288671,CHEMBL1288671,8.24,0.0,http://www.openphacts.org/units/Nanomolar,973781.0,=,1.0,1.0,=,IC50,nM,5.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.7,CHEMBL378
3635,16626871.0,[],CHEMBL3821890,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg secretion by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,O=S(=O)(Oc1cc(-c2ccccn2)[nH]n1)c1ccc(F)cc1,CHEMBL3817822,Medchemcomm,2016.0,CHEMBL3819057,CHEMBL3819057,4.34,0.0,http://www.openphacts.org/units/Nanomolar,2783931.0,=,1.0,1.0,=,IC50,nM,45910.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,45.91,CHEMBL613497
3636,2188046.0,[],CHEMBL973319,Antiviral activity against HIV1 HXB2 in HOS-CD4-CXCR4 cells by viral infectivity assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C)C(=O)N[C@H](C)C(=O)O,CHEMBL1156527,Proc Natl Acad Sci U S A,2007.0,CHEMBL2368542,CHEMBL2368542,5.77,0.0,http://www.openphacts.org/units/Nanomolar,717673.0,=,1.0,1.0,=,IC50,nM,1700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.7,CHEMBL378
3637,19281705.0,[],CHEMBL4409359,Antiviral activity against HIV1 VB59 infected in human TZM-bl cells incubated for 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL4406854,Eur J Med Chem,2019.0,CHEMBL129,CHEMBL129,7.52,0.0,http://www.openphacts.org/units/Nanomolar,3219945.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.03,CHEMBL378
3638,3315835.0,[],CHEMBL1119774,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC1CN(C2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC2)CC1,CHEMBL1155507,Bioorg Med Chem Lett,2010.0,CHEMBL1085723,CHEMBL1085723,7.39,0.0,http://www.openphacts.org/units/Nanomolar,915822.0,=,1.0,1.0,=,IC50,nM,41.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,41.0,CHEMBL378
3639,15159570.0,[],CHEMBL3398834,Inhibition of HBV DNA replication in HepG2(2.2.15) cells exposed to fresh medium supplemented with compound every other day for additional 5 days by real-time PCR-fluorescent probing method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OCc1cccc2c1CCOC2=O)c1cc(=O)c2ccccc2o1,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397184,CHEMBL3397184,,0.0,http://www.openphacts.org/units/Nanomolar,2278984.0,=,1.0,1.0,=,IC50,nM,520000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.52,CHEMBL613497
3640,1211890.0,[],CHEMBL710372,Inhibitory activity against 100I strain and 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL309456,CHEMBL309456,5.62,0.0,http://www.openphacts.org/units/Nanomolar,127435.0,=,1.0,1.0,=,IC50,nM,2371.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.371,CHEMBL378
3641,18044403.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,CNCC(NC(=O)c1ccc(-c2ccc(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4067326,CHEMBL4067326,6.02,0.0,http://www.openphacts.org/units/Nanomolar,2990220.0,=,1.0,1.0,=,IC50,nM,950.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.95,CHEMBL378
3642,206632.0,[],CHEMBL731743,Antiretroviral activity in the XC-plaque assay using Moloney leukemia virus (MoLV) as a model for human immunodeficiency virus (HIV).,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2[C@@H]1O/C(=C/F)[C@@H](O)[C@@H]1O,CHEMBL1125244,J Med Chem,1991.0,CHEMBL2051968,CHEMBL2051968,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,311003.0,=,1.0,1.0,=,IC50,ug.mL-1,4.4,CHEMBL613500,Moloney murine leukemia virus,Moloney murine leukemia virus,11801,IC50,ug ml-1,UO_0000274,4.4,CHEMBL613500
3643,6200548.0,[],CHEMBL1781474,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 4 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CCN(CCc1c[nH]c2ccccc12)CC(C)C,CHEMBL1777761,Bioorg Med Chem,2011.0,CHEMBL1779299,CHEMBL1779299,5.96,0.0,http://www.openphacts.org/units/Nanomolar,1425267.0,=,1.0,1.0,=,IC50,nM,1100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.1,CHEMBL613497
3644,2930399.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COCC1CCN(Cc2c(C)[nH]c(=O)c(I)c2Sc2cc(C)cc(C)c2)CC1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL574592,CHEMBL574592,8.30,0.0,http://www.openphacts.org/units/Nanomolar,848347.0,=,1.0,1.0,=,IC50,nM,5.01,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.01,CHEMBL378
3645,12687160.0,[],CHEMBL2344307,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral surface antigen production,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL483,CHEMBL483,,0.0,http://www.openphacts.org/units/Nanomolar,1866113.0,=,1.0,1.0,=,IC50,nM,1572100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1572.1,CHEMBL613497
3646,3008374.0,[],CHEMBL1037279,Antiviral activity against Human immunodeficiency virus 1 NL4-3 infected HeLaP4 cells after 5 days by beta-galactosidase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(=O)c1cc(OC)c(O[C@@H](C)C(=O)N2CCN(c3nccc4ncccc34)C[C@H]2C)cn1,CHEMBL1155317,Bioorg Med Chem Lett,2009.0,CHEMBL569851,CHEMBL569851,6.90,0.0,http://www.openphacts.org/units/Nanomolar,861700.0,=,1.0,1.0,=,IC50,nM,126.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,126.0,CHEMBL378
3647,14594142.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1Sc1c(C)c(=O)[nH]c(=O)n1COCCO,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL278944,CHEMBL278944,5.33,0.0,http://www.openphacts.org/units/Nanomolar,2082335.0,=,1.0,1.0,=,IC50,nM,4720.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.72,CHEMBL378
3648,615374.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)/C=N\c1nc(Cc2c(Cl)cccc2Cl)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL73673,CHEMBL73673,8.60,0.0,http://www.openphacts.org/units/Nanomolar,126928.0,=,1.0,1.0,=,IC50,nM,2.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0025,CHEMBL378
3649,6152687.0,[],CHEMBL1763333,Inhibition of c-Jun,B,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc3cnc(Nc4ccc(-n5cnc(N6CCOCC6)n5)cc4)nc3c2C(F)(F)F)cn1,CHEMBL1759990,Bioorg Med Chem Lett,2011.0,CHEMBL1761580,CHEMBL1761580,,0.0,,1413796.0,,1.0,0.0,,IC50,,,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,,,,CHEMBL4977
3650,2149876.0,[],CHEMBL935683,Antiviral activity against HIV1 098-T651 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL428147,CHEMBL428147,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708030.0,=,1.0,1.0,=,IC50,ug.mL-1,4.975,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,4.975,CHEMBL378
3651,15166098.0,[],CHEMBL3404734,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBeAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc(O)c1C(C)=O,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402766,CHEMBL3402766,,0.0,http://www.openphacts.org/units/Nanomolar,2284118.0,>,1.0,1.0,>,IC50,nM,2365500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2365.5,CHEMBL613497
3652,2997536.0,[],CHEMBL1046975,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)c2ccc(=O)n(/C=C/Nc3cccc4ccccc34)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL585894,CHEMBL585894,,0.0,http://www.openphacts.org/units/Nanomolar,856691.0,>,1.0,1.0,>,IC50,nM,97000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,97.0,CHEMBL613497
3653,6257660.0,[],CHEMBL1798704,Antiviral activity against HIV1 3B infected in human MT4 cells coinjected with HTLV1 assessed as reduction in virus induced cytopathicity measured 5 days post infection by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1,CHEMBL1795267,Bioorg Med Chem,2011.0,CHEMBL1460,CHEMBL1460,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1435350.0,=,1.0,1.0,=,IC50,ug.mL-1,2.31,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,2.31,CHEMBL378
3654,1063787.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=C(S)N(Nc2cccc(Cl)c2)C1c1cccc(C(N)=O)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39462,CHEMBL39462,,0.0,http://www.openphacts.org/units/Nanomolar,62352.0,>,1.0,1.0,>,IC50,nM,42160.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,42.16,CHEMBL613499
3655,2527513.0,[],CHEMBL1003778,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect albumin after 5 days by MTS method in presence of 40 mg/mL human serum albumin,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1c(O)c2ncccc2[nH]c1=O,CHEMBL1138484,J Med Chem,2009.0,CHEMBL509274,CHEMBL509274,,0.0,,735623.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
3656,573272.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,NS(=O)(=O)c1ccc(CCn2sc3ccccc3c2=O)cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL172615,CHEMBL172615,4.34,0.0,http://www.openphacts.org/units/Nanomolar,334012.0,=,1.0,1.0,=,IC50,nM,45500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,45.5,CHEMBL378
3657,15568188.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,CC(C)(C)c1ccc(CN2CCN(C(=O)/C=C/c3ccc(Br)cc3)CC2)cc1,CHEMBL1201862,,,CHEMBL3559757,CHEMBL3559757,8.03,0.0,http://www.openphacts.org/units/Nanomolar,2473817.0,=,7.0,1.0,=,IC50,nM,9.36,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.00936,CHEMBL3259470
3658,2033580.0,[],CHEMBL888216,Inhibition of AP1-mediated gene transcription in HepG2 cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c3c(c4cc(OC)c(OC)cc4c2cc1OC)[C@@H](O)[C@@H]1CCCN1C3,CHEMBL1140007,Bioorg Med Chem Lett,2007.0,CHEMBL399965,CHEMBL399965,,0.0,http://www.openphacts.org/units/Nanomolar,675147.0,>,1.0,1.0,>,IC50,nM,300.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,nM,UO_0000065,300.0,CHEMBL4977
3659,1671912.0,[],CHEMBL870624,Antiviral activity against HIV1 K103N mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL203420,CHEMBL203420,9.00,0.0,http://www.openphacts.org/units/Nanomolar,411934.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
3660,3284628.0,[],CHEMBL1110057,Antiviral activity against HIV1 3B infected in human HOS cells expressing human CXCR4/CCR5/CD4/pHIV-LTR luciferase assessed as inhibition of viral infection to cells,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(Cc1nccs1)C1CCCc2cccnc21,CHEMBL1157822,Bioorg Med Chem Lett,2010.0,CHEMBL1099358,CHEMBL1099358,6.47,0.0,http://www.openphacts.org/units/Nanomolar,911322.0,=,1.0,1.0,=,IC50,nM,340.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,340.0,CHEMBL378
3661,5222618.0,[],CHEMBL1675306,Antiviral activity against HIV1 infected in human PBMC assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,[N-]=[N+]=N[C@H]1C[C@H](n2cnc3c(O)nc(N)nc32)O[C@@H]1CO,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL578448,CHEMBL578448,6.72,0.0,http://www.openphacts.org/units/Nanomolar,1332019.0,=,1.0,1.0,=,IC50,nM,190.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.19,CHEMBL378
3662,15161566.0,[],CHEMBL3399069,Antiviral activity against HIV1 infected in human MAGI-R5 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C(\O)C(=O)N1CCN(c2ccc(-n3cccc3)cc2)CC1)c1cc(Cc2cc(F)cc(F)c2)cn(Cc2ccccc2F)c1=O,CHEMBL3397011,Bioorg Med Chem Lett,2015.0,CHEMBL3398252,CHEMBL3398252,7.30,0.0,http://www.openphacts.org/units/Nanomolar,2280232.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,50.0,CHEMBL378
3663,685738.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOC(=O)CSSCC(=O)OCCCC,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120738,CHEMBL120738,,0.0,,228592.0,=,1.0,0.0,=,IC50,,62.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,62.4,CHEMBL378
3664,1401698.0,[],CHEMBL835178,In vitro inhibitory concentration against HIV-1 Y181C mutant strain; not determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C(=O)C2=C(N(C)C)C(=O)NC3(CCC3)C23CCC3)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL435904,CHEMBL435904,,0.0,http://www.openphacts.org/units/Nanomolar,360383.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3665,15054442.0,[],CHEMBL3366317,Antiviral activity against VSV-G protein pseudotyped HIV1 infected in 293T cells assessed as inhibition of viral replication after 48 hrs by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL3351428,J Nat Prod,2014.0,CHEMBL3314506,CHEMBL3314506,4.38,0.0,http://www.openphacts.org/units/Nanomolar,2244389.0,=,1.0,1.0,=,IC50,nM,41700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,41.7,CHEMBL378
3666,18183410.0,[],CHEMBL4040187,Antiviral activity against CXCR4-tropic HIV-1 NL4-3 infected in human PHA-stimulated PBMC assessed as inhibition of viral replication by measuring reduction in p24 antigen production preincubated with cells for 30 mins followed by viral infection measured on day 10 post infection in presence of IL-2 by ELISA,F,BAO_0000190,BAO_0000019,assay format,CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C.O=C(O)/C=C/C(=O)O,CHEMBL4038313,J Med Chem,2017.0,CHEMBL1486,CHEMBL1538,7.10,0.0,http://www.openphacts.org/units/Nanomolar,3016405.0,=,1.0,1.0,=,IC50,nM,80.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.08,CHEMBL378
3667,2601554.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)Cc1c(N)nc(N)nc1OCCOCP(=O)(O)O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL348215,CHEMBL348215,9.52,0.0,http://www.openphacts.org/units/Nanomolar,807384.0,=,1.0,1.0,=,IC50,nM,0.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0003,CHEMBL378
3668,18754901.0,[],CHEMBL4265061,Antiviral activity against HIV1 cYTA48P infected in PM1/CCR5 cells by single round assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(CNc1ccc2c(c1)OCO2)NC1CC2(CCCCC2)NC2(CCCCC2)C1,CHEMBL4261625,Bioorg Med Chem,2018.0,CHEMBL4277747,CHEMBL4277747,4.97,0.0,http://www.openphacts.org/units/Nanomolar,3116247.0,=,1.0,1.0,=,IC50,nM,10800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.8,CHEMBL378
3669,1143873.0,[],CHEMBL694658,Inhibitory concentration against HIV-1 LTR polymerase chain reaction product,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)CCOc1cc2c(cc1OC)C(=O)N1CCC[C@H]1C=N2,CHEMBL1132187,J Med Chem,1999.0,CHEMBL300580,CHEMBL300580,,0.0,http://www.openphacts.org/units/Nanomolar,289523.0,>,1.0,1.0,>,IC50,nM,250000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,250.0,CHEMBL378
3670,1470580.0,[],CHEMBL833082,Inhibitory activity against HIV-1 mutant strain 190S,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL57,CHEMBL57,7.40,0.0,http://www.openphacts.org/units/Nanomolar,380791.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
3671,2987761.0,[],CHEMBL1050601,Antiviral activity against Hepatitis B virus infected HepG2(2.2.15) cells assessed as inhibition of viral cytoplasmic DNA synthesis by real-time PCR,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)OC(=O)[C@H](C(C)C)N1CCCO[P@]1(=O)COCCn1cnc2c(N)ncnc21.O=C(O)/C=C/C(=O)O,CHEMBL1156738,Bioorg Med Chem Lett,2009.0,CHEMBL567490,CHEMBL1197328,5.24,0.0,http://www.openphacts.org/units/Nanomolar,863271.0,=,1.0,1.0,=,IC50,nM,5760.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,5.76,CHEMBL613497
3672,2602103.0,[],CHEMBL1034017,Antiviral activity against Vaccinia virus,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCCCOCCOP1(=O)CO[C@@H](Cn2ccc(N)nc2=O)CO1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL511437,CHEMBL511437,6.24,0.0,http://www.openphacts.org/units/Nanomolar,808151.0,=,1.0,1.0,=,IC50,nM,580.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,0.58,CHEMBL613493
3673,306247.0,[],CHEMBL653791,Inhibition of HIV-1 mediated cytotoxicity in CEM (human leukemia) cells.,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](CCC(=O)NC(CO)CS(=O)(=O)O)[C@H]1[C@@H](O)[C@H](O)[C@H]2[C@@H]3C[C@@H](O)[C@@]4(O)C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL1127706,J Med Chem,1994.0,CHEMBL3138014,CHEMBL3138014,,0.0,http://www.openphacts.org/units/Nanomolar,327171.0,>,1.0,1.0,>,IC50,nM,174000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,174.0,CHEMBL378
3674,1472144.0,[],CHEMBL834620,Inhibitory activity against HIV-1 mutant strain 188L; ND = not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C/c2ccco2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL189020,CHEMBL189020,,0.0,http://www.openphacts.org/units/Nanomolar,380742.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3675,2930382.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cnc(C)n3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL577276,CHEMBL577276,8.40,0.0,http://www.openphacts.org/units/Nanomolar,852963.0,=,1.0,1.0,=,IC50,nM,3.98,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.98,CHEMBL378
3676,6257653.0,[],CHEMBL1798704,Antiviral activity against HIV1 3B infected in human MT4 cells coinjected with HTLV1 assessed as reduction in virus induced cytopathicity measured 5 days post infection by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@H]2C=C[C@]3(CO)C[C@H]23)c(=O)n1,CHEMBL1795267,Bioorg Med Chem,2011.0,CHEMBL1795535,CHEMBL1795535,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1435347.0,>,1.0,1.0,>,IC50,ug.mL-1,61.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,61.8,CHEMBL378
3677,883177.0,[],CHEMBL653610,Inhibitory activity tested against the HIV-1 in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCNC(=O)CC(=O)O)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL9996,CHEMBL9996,7.30,0.0,http://www.openphacts.org/units/Nanomolar,9067.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,50.0,CHEMBL378
3678,24502936.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5053572,Antiviral activity against HIV1 NL4-3 Env-deficient pseudotype virus infected in human U87.CD4.CCR5.CXCR4 cells assessed by reduction in viral infection in early stage measured after 48 hrs by luciferase activity based single-round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C(=O)[C@H](Cc1ccccc1)NC(=O)Cc1n[nH]c2c(N)cccc12)c1ccc2[nH]ncc2c1,CHEMBL5053482,J Med Chem,2021.0,CHEMBL5087414,CHEMBL5087414,6.55,0.0,http://www.openphacts.org/units/Nanomolar,3836462.0,=,1.0,1.0,=,IC50,nM,279.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,279.0,CHEMBL378
3679,926551.0,[],CHEMBL728516,Anti-HIV activity against HIV-1 IIIB chronically infected Molt-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CNn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(c4ncccn4)CC3)c(OC(F)F)c21,CHEMBL1131862,Bioorg Med Chem Lett,1999.0,CHEMBL103925,CHEMBL103925,6.30,0.0,http://www.openphacts.org/units/Nanomolar,194310.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.5,CHEMBL378
3680,2184017.0,[],CHEMBL951608,Antiviral activity against HIV1 clinical isolate 10 infected in U87.CD4 cells expressing human CXCR4 D171N mutant,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(CNCc2ccc(CN3CCCNCCNCCCNCC3)cc2)nc1,CHEMBL1156482,J Biol Chem,2007.0,CHEMBL477121,CHEMBL477121,,0.0,http://www.openphacts.org/units/Nanomolar,791971.0,=,1.0,1.0,=,IC50,nM,183000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,183.0,CHEMBL378
3681,1064948.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(S)n(Nc2cccc(Cl)c2)c1-c1ccc(Br)cc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL38556,CHEMBL38556,,0.0,http://www.openphacts.org/units/Nanomolar,62334.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3682,19261962.0,[],CHEMBL4404402,Antiviral activity against HIV1 subtypeC QB099.391M.ENV.B1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.93,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,118.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.118,CHEMBL378
3683,799649.0,[],CHEMBL736575,Compound was tested for its antagonistic activity against Moloney leukemia virus (MoLV) replication,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/C/C=C/CCC(=O)[C@H]1O[C@H]1C(N)=O,CHEMBL1126537,Bioorg Med Chem Lett,1993.0,CHEMBL45627,CHEMBL45627,5.57,0.0,http://www.openphacts.org/units/Nanomolar,78985.0,=,1.0,1.0,=,IC50,nM,2700.0,CHEMBL613500,Moloney murine leukemia virus,Moloney murine leukemia virus,11801,IC50,uM,UO_0000065,2.7,CHEMBL613500
3684,15568233.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(CCCc1ccc(Br)cc1)N1CCN(C(=O)c2ccc(Cl)cc2)CC1,CHEMBL1201862,,,CHEMBL3561045,CHEMBL3561045,,0.0,http://www.openphacts.org/units/Nanomolar,2475991.0,>,7.0,1.0,>,IC50,nM,1000.0,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,1.0,CHEMBL3259470
3685,71456.0,[],CHEMBL691108,Antiviral activity towards inhibition of HIV-1 replication using monocyte-derived macrophage infected by the HIV-1/Ba-L strain.,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)C(=O)OCC1CN(C(=O)c2cc(OC)c(OC)c(OC)c2)CCN1C(=O)c1cc(OC)c(OC)c(OC)c1,CHEMBL1133726,J Med Chem,2000.0,CHEMBL6322,CHEMBL6322,4.96,0.0,http://www.openphacts.org/units/Nanomolar,119301.0,=,1.0,1.0,=,IC50,nM,11000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,11.0,CHEMBL378
3686,5132853.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2[nH]c(=O)c(CN(Cc3ccco3)C(=O)c3ccc(Br)cc3)cc2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645066,CHEMBL1645066,,0.0,http://www.openphacts.org/units/Nanomolar,1321054.0,>,1.0,1.0,>,IC50,nM,13000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,13.0,CHEMBL378
3687,13375622.0,[],CHEMBL2405241,Antiviral activity against Human immunodeficiency virus 1 Ba-L infected human PBMC after 7 days by [methyl-3H]dTTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1CO[C@@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,CHEMBL2401737,J Med Chem,2013.0,CHEMBL2403238,CHEMBL2403238,9.70,0.0,http://www.openphacts.org/units/Nanomolar,1906381.0,=,1.0,1.0,=,IC50,nM,0.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.2,CHEMBL378
3688,14596847.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2ccccc2)n(COCCO)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL31871,CHEMBL31871,5.29,0.0,http://www.openphacts.org/units/Nanomolar,2082367.0,=,1.0,1.0,=,IC50,nM,5150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.15,CHEMBL378
3689,696259.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc(S(=O)(=O)S(=O)(=O)c2ccc(N)cc2)cc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120274,CHEMBL120274,,0.0,,228550.0,=,1.0,0.0,=,IC50,,78.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,78.6,CHEMBL378
3690,18469030.0,[],CHEMBL4182244,Antiviral activity against HIV-1 3B infected in human TZM-bl cells treated for 2 hrs followed by compound washout measured after 2 days by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NC(C)C(=O)NC(C)C(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/NC(C)C(=O)NC(C)C(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+],CHEMBL4177704,Bioorg Med Chem Lett,2018.0,CHEMBL4203285,CHEMBL4301755,5.24,0.0,http://www.openphacts.org/units/Nanomolar,3065394.0,=,1.0,1.0,=,IC50,nM,5820.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,umol/L,UO_0000065,5.82,CHEMBL378
3691,24351642.0,[],CHEMBL5032297,Antiviral activity against Hepatitis B virus,F,BAO_0000190,BAO_0000218,organism-based format,Cn1cc(CNc2ccc3n(c2=O)C[C@@H]2C[C@H]3CN(C(=O)Nc3ccccc3)C2)c(=O)n(C)c1=O,CHEMBL5030562,Bioorg Med Chem Lett,2021.0,CHEMBL5077292,CHEMBL5077292,,0.0,http://www.openphacts.org/units/Nanomolar,3772764.0,>,1.0,1.0,>,IC50,nM,3000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,3.0,CHEMBL613497
3692,24830970.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C1CCN(c2ccc3c(=O)c4c(O)ccc(Cl)c4oc3c2)C1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5187412,CHEMBL5187412,5.76,0.0,http://www.openphacts.org/units/Nanomolar,3878143.0,=,1.0,1.0,=,IC50,nM,1740.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.74,CHEMBL613497
3693,18528860.0,[],CHEMBL4194999,Antiviral activity against HIV1 virions derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)[C@@H](c1cc(OC)c(OC)c(OC)c1)[C@H](C)CC2,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4214167,CHEMBL4214167,5.99,0.0,http://www.openphacts.org/units/Nanomolar,3076503.0,=,1.0,1.0,=,IC50,nM,1020.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.02,CHEMBL378
3694,10863169.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCOC(=O)[C@@]1(C)CC[C@]2(C)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024630,CHEMBL2024630,,0.0,http://www.openphacts.org/units/Nanomolar,1640526.0,>,1.0,1.0,>,IC50,nM,256940.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,256.94,CHEMBL613497
3695,2091762.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(S(=O)(=O)c2cccc(N)c2C#N)cc1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL292436,CHEMBL292436,,0.0,http://www.openphacts.org/units/Nanomolar,700524.0,=,1.0,1.0,=,IC50,nM,12589254117.94,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,1.1,CHEMBL378
3696,5306760.0,[],CHEMBL1696829,Antiviral activity against R5 tropic HIV1 YU.2 infected in human TZM-b1 cells after 2 hrs by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1687731,Antimicrob Agents Chemother,2009.0,CHEMBL70663,CHEMBL70663,9.82,0.0,http://www.openphacts.org/units/Nanomolar,1337341.0,=,1.0,1.0,=,IC50,nM,0.15,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.15,CHEMBL378
3697,18528854.0,[],CHEMBL4194998,Antiviral activity against human HIV1 by VSV-G/HIV1 infection assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc([C@H]2c3cc(OC)c(OC)cc3C[C@H](C)[C@@H]2C)cc1OC,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4203607,CHEMBL4203607,5.97,0.0,http://www.openphacts.org/units/Nanomolar,3076499.0,=,1.0,1.0,=,IC50,nM,1070.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.07,CHEMBL378
3698,618113.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,C[S+]([O-])c1nc(Cc2c(Cl)cccc2Cl)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL308091,CHEMBL308091,5.81,0.0,http://www.openphacts.org/units/Nanomolar,126932.0,=,1.0,1.0,=,IC50,nM,1550.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.55,CHEMBL378
3699,239038.0,[],CHEMBL856186,In vitro antiviral activity against NNRTI-resistant L-697661R-IIIB (Y181C) HIV-1 variant,F,BAO_0000190,BAO_0000218,organism-based format,CC(Sc1nc(N)cc(Cl)n1)c1cc2ccoc2cn1,CHEMBL1131332,J Med Chem,1998.0,CHEMBL280752,CHEMBL280752,5.62,0.0,http://www.openphacts.org/units/Nanomolar,41266.0,=,1.0,1.0,=,IC50,nM,2400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.4,CHEMBL378
3700,2947357.0,[],CHEMBL1038495,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)/C=C/c1ccccc1)[C@@H](OC(=O)/C=C/c1ccccc1)C(C)(C)OC(=O)/C=C/c1ccccc1)C1=C2C[C@H](OC(=O)/C=C/c3ccccc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL574257,CHEMBL574257,,0.0,http://www.openphacts.org/units/Nanomolar,850755.0,>,1.0,1.0,>,IC50,nM,1200000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.2,CHEMBL613497
3701,5246979.0,[],CHEMBL1687410,Antiviral activity against HIV1 Ba-L infected in human HOS cells expressing CCR5 after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CCC(CNS(=O)(=O)c1ccccc1)c1ccccc1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL3084358,CHEMBL3084358,6.93,0.0,http://www.openphacts.org/units/Nanomolar,1333683.0,=,1.0,1.0,=,IC50,nM,117.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.117,CHEMBL378
3702,1472008.0,[],CHEMBL833076,Inhibitory activity against HIV-1 mutant strain 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C/c2cnccn2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL189458,CHEMBL189458,7.30,0.0,http://www.openphacts.org/units/Nanomolar,381004.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.05,CHEMBL378
3703,12651417.0,[],CHEMBL2327724,Antiviral activity against 0.001 MOI wild type Human immunodeficiency virus 1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCC(=O)N[C@@H](Cc3ccccc3)C(=O)OC)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324137,CHEMBL2324137,7.16,0.0,http://www.openphacts.org/units/Nanomolar,1850163.0,=,1.0,1.0,=,IC50,nM,70.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.07,CHEMBL378
3704,14999540.0,[],CHEMBL3366529,Antiviral activity against HIV1 harboring reverse transcriptase Y181C mutant infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CNc2nc(-c3ccccc3F)c(Cc3ccccc3)s2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3330435,CHEMBL3330435,5.90,0.0,http://www.openphacts.org/units/Nanomolar,2246872.0,=,1.0,1.0,=,IC50,nM,1260.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.26,CHEMBL378
3705,15054170.0,[],CHEMBL3363277,Antiviral activity against Human immunodeficiency virus 1 3B,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)CNc1nc(Nc2ccc(C)cc2)nc(OCc2cc3ccccc3oc2=O)n1,CHEMBL3351862,Bioorg Med Chem,2014.0,CHEMBL3309835,CHEMBL3309835,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,2259126.0,=,1.0,1.0,=,IC50,ug.mL-1,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,1.0,CHEMBL378
3706,1437995.0,[],CHEMBL834619,Inhibitory activity against HIV-1 mutant strain 181C; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C#Cc2ccccc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL182253,CHEMBL182253,,0.0,http://www.openphacts.org/units/Nanomolar,371606.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3707,1402281.0,[],CHEMBL837470,In vitro inhibitory concentration against HIV V179E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NCc2ccccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177491,CHEMBL177491,,0.0,http://www.openphacts.org/units/Nanomolar,360417.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3708,15066680.0,[],CHEMBL3390094,Antiviral activity against HIV1 infected in HEK293T cells by p24 ELISA based phenotypic assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(c1ccccc1)c1c[nH]c2ccc(Cl)cc12,CHEMBL3352750,Bioorg Med Chem Lett,2014.0,CHEMBL3325520,CHEMBL3325520,5.61,0.0,http://www.openphacts.org/units/Nanomolar,2270416.0,=,1.0,1.0,=,IC50,nM,2430.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.43,CHEMBL378
3709,1439773.0,[],CHEMBL833079,Inhibitory activity against HIV-1 mutant strain 181C,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL426242,CHEMBL426242,5.00,0.0,http://www.openphacts.org/units/Nanomolar,371451.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
3710,13403794.0,[],CHEMBL2415634,Antiviral activity against HIV1 NL4-3 assessed as inhibition of viral fusion with human TZM-bl cells after 48 hrs by steady glo luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC,CHEMBL2413030,Bioorg Med Chem,2013.0,CHEMBL2414506,CHEMBL2414506,8.74,0.0,http://www.openphacts.org/units/Nanomolar,1912461.0,=,1.0,1.0,=,IC50,nM,1.82,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.82,CHEMBL378
3711,2371547.0,[],CHEMBL1035745,Antiviral activity against HIV1 with reverse transcriptase F227L mutant in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4nc(N)ccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL489586,CHEMBL489586,9.15,0.0,http://www.openphacts.org/units/Nanomolar,773548.0,=,1.0,1.0,=,IC50,nM,0.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.7,CHEMBL378
3712,10866428.0,[],CHEMBL2025517,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HbeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(O)C(C)=O)C2)cn1,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2023674,CHEMBL2023674,4.55,0.0,http://www.openphacts.org/units/Nanomolar,1639238.0,=,1.0,1.0,=,IC50,nM,28160.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,28.16,CHEMBL613497
3713,249610.0,[],CHEMBL714981,Inhibition of antiviral activity against moloney murine sarcoma virus(MSV)in CEM cells in cell protection assay,F,BAO_0000190,BAO_0000218,organism-based format,COC1=C(OC)/C(=C/COP(=O)(O)COCCn2cnc3c(N)ncnc32)OC1=O,CHEMBL1134666,J Med Chem,2001.0,CHEMBL121723,CHEMBL121723,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,233580.0,=,1.0,1.0,=,IC50,ug.mL-1,0.93,CHEMBL613501,Moloney murine sarcoma virus,Moloney murine sarcoma virus,11809,IC50,ug ml-1,UO_0000274,0.9300000000000004,CHEMBL613501
3714,1223573.0,[],CHEMBL710376,Inhibitory activity against 100I strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70442,CHEMBL70442,7.47,0.0,http://www.openphacts.org/units/Nanomolar,127467.0,=,1.0,1.0,=,IC50,nM,34.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.034,CHEMBL378
3715,663408.0,[],CHEMBL713946,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)CN1Cc2cccc3nc(O)n(c23)CC1CCC,CHEMBL1128252,J Med Chem,1995.0,CHEMBL349269,CHEMBL349269,,0.0,http://www.openphacts.org/units/Nanomolar,326353.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
3716,22752439.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '216.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '9.0'}]",CHEMBL4700093,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15.7 assessed as reduction in HBV DNA level incubated for 9 days media replaced every 3 days once with test compound by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,C=C1[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@H](O)[C@@]1(C)CO,CHEMBL4699415,RSC Med Chem,2020.0,CHEMBL4799584,CHEMBL4799584,5.47,0.0,http://www.openphacts.org/units/Nanomolar,3531381.0,=,1.0,1.0,=,IC50,nM,3400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,3.4,CHEMBL613497
3717,3358065.0,[],CHEMBL1175711,Antiviral activity against HIV1 expressing reverse transcriptase Y188L mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3Cl)CC2)ncc1Br,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1170005,CHEMBL1170005,8.55,0.0,http://www.openphacts.org/units/Nanomolar,922327.0,=,1.0,1.0,=,IC50,nM,2.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.8,CHEMBL378
3718,10937535.0,[],CHEMBL2051603,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(OC(=O)/C=C/c2ccc(Cl)cc2)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccc(Cl)cc4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046594,CHEMBL2046594,,0.0,http://www.openphacts.org/units/Nanomolar,1651478.0,>,1.0,1.0,>,IC50,nM,290240.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,290.24,CHEMBL613497
3719,1754743.0,[],CHEMBL864208,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(-n2c(Cc3ccccc3)nnc2SCC(=O)Nc2ccccc2Cl)cc1,CHEMBL1146046,Bioorg Med Chem Lett,2006.0,CHEMBL377896,CHEMBL377896,,0.0,http://www.openphacts.org/units/Nanomolar,545190.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
3720,10866794.0,[],CHEMBL2027345,Antiviral activity against Human immunodeficiency virus 1 Clade B REJO4541.67 infected in human TZM-bl cells after 2 days by luciferase reporter gene analysis,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOc1c2cc(C(=O)Nc3cc(C(=O)O)cc(C(=O)O)c3)cc1Cc1cc(C(=O)Nc3cc(C(=O)O)cc(C(=O)O)c3)cc(c1OCCCC)Cc1cc(C(=O)Nc3cc(C(=O)O)cc(C(=O)O)c3)cc(c1OCCCC)Cc1cc(C(=O)Nc3cc(C(=O)O)cc(C(=O)O)c3)cc(c1OCCCC)C2,CHEMBL2021873,Bioorg Med Chem Lett,2012.0,CHEMBL1090293,CHEMBL1090293,5.72,0.0,http://www.openphacts.org/units/Nanomolar,1638074.0,=,1.0,1.0,=,IC50,nM,1900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.9,CHEMBL378
3721,1470574.0,[],CHEMBL832525,Inhibitory activity against HIV-1 double mutants strain 101E and 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL338047,CHEMBL338047,,0.0,http://www.openphacts.org/units/Nanomolar,380766.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3722,512730.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1Sc1cccc(N)c1C#N,CHEMBL1134494,J Med Chem,2001.0,CHEMBL299014,CHEMBL299014,4.80,0.0,http://www.openphacts.org/units/Nanomolar,94190.0,=,1.0,1.0,=,IC50,nM,16000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,16.0,CHEMBL378
3723,15666391.0,[],CHEMBL3602696,Antiviral activity against HIV1 NL4-3 pseudovirus infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL3600303,J Med Chem,2015.0,CHEMBL3600949,CHEMBL3600949,8.97,0.0,http://www.openphacts.org/units/Nanomolar,2492329.0,=,1.0,1.0,=,IC50,nM,1.07,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.07,CHEMBL378
3724,2362898.0,[],CHEMBL1026416,"Antiviral activity against multidrug-resistant HIV1 with protease L10I, K14R, L33I, M36I, M46I, F53I, K55R, I62V, L63P, A71V, G73S, V82A, L90M, I93L mutation in phytohemagglutininin-activated PBMC assessed as inhibition of p24G protein production",F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL1140100,J Med Chem,2008.0,CHEMBL116,CHEMBL116,6.50,0.0,http://www.openphacts.org/units/Nanomolar,747077.0,=,1.0,1.0,=,IC50,nM,320.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,320.0,CHEMBL378
3725,14596859.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2ccccc2)n(COCCN=[N+]=[N-])c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL38039,CHEMBL38039,5.28,0.0,http://www.openphacts.org/units/Nanomolar,2082379.0,=,1.0,1.0,=,IC50,nM,5240.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.24,CHEMBL378
3726,24830974.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)[C@H]1CCN(c2ccc3c(=O)c4cccc(Cl)c4oc3c2)C1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5202800,CHEMBL5202800,5.72,0.0,http://www.openphacts.org/units/Nanomolar,3878147.0,=,1.0,1.0,=,IC50,nM,1920.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.92,CHEMBL613497
3727,3509153.0,[],CHEMBL1261040,Antiviral activity against HIV1 harboring reverse transcriptase K103N/Y181C double mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cnc(NC2CCN(c3cccc(C(N)=O)c3)CC2)nc1Oc1c(C)cc(C#N)cc1Cl,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1258135,CHEMBL1258135,8.26,0.0,http://www.openphacts.org/units/Nanomolar,963083.0,=,1.0,1.0,=,IC50,nM,5.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.5,CHEMBL378
3728,1048832.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(NN2C=NC(C)C2c2ccccc2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39904,CHEMBL39904,,0.0,http://www.openphacts.org/units/Nanomolar,62362.0,>,1.0,1.0,>,IC50,nM,20440.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,20.44,CHEMBL613499
3729,14714261.0,[],CHEMBL3293254,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)NC(c1ccnc(Nc2ccc(C#N)cc2)n1)c1ccccc1Cl,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL3288575,CHEMBL3288575,7.40,0.0,http://www.openphacts.org/units/Nanomolar,2116133.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
3730,1013387.0,[],CHEMBL714338,"Antiviral activity against HIV-1, IIIB, in MT-4 Cells",F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CN[C@@H](C(=O)NC2c3ccccc3C[C@H]2O)[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)/C=C/c2ccc(OC)c(O)c2)C(C)(C)C)cc1,CHEMBL1129316,J Med Chem,1996.0,CHEMBL293470,CHEMBL293470,6.90,0.0,http://www.openphacts.org/units/Nanomolar,111247.0,=,1.0,1.0,=,IC50,nM,125.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,125.0,CHEMBL378
3731,15666355.0,[],CHEMBL3602704,Antiviral activity against ENF-resistant HIV1 NL4-3 harboring gp41 N-terminal heptad repeat I37T mutant infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL3600303,J Med Chem,2015.0,CHEMBL428607,CHEMBL428607,8.74,0.0,http://www.openphacts.org/units/Nanomolar,2492328.0,=,1.0,1.0,=,IC50,nM,1.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.8,CHEMBL378
3732,2244583.0,[],CHEMBL1002203,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase K103N/L100I mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL203420,CHEMBL203420,9.05,0.0,http://www.openphacts.org/units/Nanomolar,798654.0,=,1.0,1.0,=,IC50,nM,0.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.9,CHEMBL378
3733,5249064.0,[],CHEMBL1685193,Antiviral activity against X4 tropic HIV1 NL4.3 infected in CD4 and CXCR4 expressing human MT4 cells assessed as inhibition of viral cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](c1ccccn1)N(CCCCN)Cc1nc2ccccc2[nH]1,CHEMBL1681661,Bioorg Med Chem Lett,2011.0,CHEMBL1682997,CHEMBL1682997,8.85,0.0,http://www.openphacts.org/units/Nanomolar,1334132.0,=,1.0,1.0,=,IC50,nM,1.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.4,CHEMBL378
3734,1403331.0,[],CHEMBL834757,Inhibitory concentration against 181C mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Oc2cn(Cc3ccccc3)c(=O)c(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL435548,CHEMBL435548,5.80,0.0,http://www.openphacts.org/units/Nanomolar,360637.0,=,1.0,1.0,=,IC50,nM,1585.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.585,CHEMBL378
3735,5249073.0,[],CHEMBL1685197,Antiviral activity against X4 tropic HIV1 NL4.3 infected in human PBMC assessed as inhibition of viral cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(Cc1ncccc1N)[C@H]1CCCc2cccnc21,CHEMBL1681661,Bioorg Med Chem Lett,2011.0,CHEMBL1682996,CHEMBL1682996,8.68,0.0,http://www.openphacts.org/units/Nanomolar,1334131.0,=,1.0,1.0,=,IC50,nM,2.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.1,CHEMBL378
3736,2184004.0,[],CHEMBL939669,Antiviral activity against HIV1 NDK infected in U87.CD4 cells expressing human CXCR4 D171ND262N mutant,F,BAO_0000190,BAO_0000218,organism-based format,c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,CHEMBL1156482,J Biol Chem,2007.0,CHEMBL18442,CHEMBL18442,,0.0,http://www.openphacts.org/units/Nanomolar,791970.0,>,1.0,1.0,>,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3000.0,CHEMBL378
3737,3596614.0,[],CHEMBL1292012,Antiviral activity against HIV1 BaL in human PBL cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NS(=O)(=O)c1cc(C(=O)N2CCC(CCN3CCC(N(C(=O)NCc4ccc(C#N)cc4)c4cccc(F)c4)CC3)(c3cccc(F)c3)CC2)c(Cl)cc1F,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288663,CHEMBL1288663,8.77,0.0,http://www.openphacts.org/units/Nanomolar,973773.0,=,1.0,1.0,=,IC50,nM,1.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.7,CHEMBL378
3738,1497518.0,[],CHEMBL874207,Inhibitory concentration that required to induced a 50% decrease in PBMC+PHA (healthy human's peripheral blood cells) cells survival ,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)c1ccc(C(=O)CC(SCC(=O)O)C(=O)O)c(C(C)C)c1,CHEMBL1141166,J Med Chem,2005.0,CHEMBL363305,CHEMBL363305,5.15,0.0,http://www.openphacts.org/units/Nanomolar,386607.0,=,1.0,1.0,=,IC50,nM,7140.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.14,CHEMBL378
3739,2602097.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)C[C@H](O)[C@@H](CC(=O)OC(C)(C)C)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL52868,CHEMBL52868,6.22,0.0,http://www.openphacts.org/units/Nanomolar,808035.0,=,1.0,1.0,=,IC50,nM,600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.6,CHEMBL378
3740,2602292.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)oc2c3c(c(CBr)cc12)OC(C)(C)[C@H](OC(=O)[C@@]12CC[C@](C)(C(=O)O1)C2(C)C)[C@@H]3OC(=O)[C@@]12CC[C@](C)(C(=O)O1)C2(C)C,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL509061,CHEMBL509061,4.86,0.0,http://www.openphacts.org/units/Nanomolar,807046.0,=,1.0,1.0,=,IC50,nM,13700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,13.7,CHEMBL378
3741,2929558.0,[],CHEMBL1056894,Antiviral activity against HIV1 HXB2 harboring 106A mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL233664,CHEMBL233664,8.30,0.0,http://www.openphacts.org/units/Nanomolar,848384.0,=,1.0,1.0,=,IC50,nM,5.01,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.01,CHEMBL378
3742,1030468.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(S)n(Nc2cccc(Cl)c2)c1-c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39414,CHEMBL39414,5.09,0.0,http://www.openphacts.org/units/Nanomolar,62313.0,=,1.0,1.0,=,IC50,nM,8200.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,8.2,CHEMBL613499
3743,3596593.0,[],CHEMBL1292013,Antiviral activity against HIV1 BaL in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(CNC(=O)N(c2cccc(F)c2)C2CCN(CCC3(c4cccc(F)c4)CCN(C(=O)c4cc(S(N)(=O)=O)c(F)cc4F)CC3)CC2)cc1,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288669,CHEMBL1288669,8.40,0.0,http://www.openphacts.org/units/Nanomolar,973779.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.0,CHEMBL378
3744,3432864.0,[],CHEMBL1246459,Antiviral activity against R5 tropic HIV1 BaL infected in human CEMx174 5.25M7 cells after 3 days by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(C)n1-c1ccc(C(=O)NN2C(=O)C3C4C=CC(C5CC45)C3C2=O)cc1,CHEMBL1240449,Eur J Med Chem,2010.0,CHEMBL1241742,CHEMBL1241742,5.11,0.0,http://www.openphacts.org/units/Nanomolar,952615.0,=,1.0,1.0,=,IC50,nM,7800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.8,CHEMBL378
3745,10862111.0,[],CHEMBL2024925,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B e-antigen release,F,BAO_0000190,BAO_0000218,organism-based format,C=CCOC(=O)[C@@]1(C)CC[C@]2(C)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024625,CHEMBL2024625,,0.0,http://www.openphacts.org/units/Nanomolar,1640521.0,>,1.0,1.0,>,IC50,nM,2310550.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2310.55,CHEMBL613497
3746,3267376.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,C=C(CC)CN1Cc2cccc3[nH]c(=O)n(c23)C[C@@H]1C,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL1095567,CHEMBL1095567,4.43,0.0,http://www.openphacts.org/units/Nanomolar,906654.0,=,1.0,1.0,=,IC50,nM,37153.52,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.43,CHEMBL378
3747,18812965.0,[],CHEMBL4276412,Antiviral activity against darunavir-resistant HIV1 at passage 21 infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,CHEMBL4270667,J Med Chem,2018.0,CHEMBL1163,CHEMBL1163,,0.0,http://www.openphacts.org/units/Nanomolar,3125926.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
3748,16556866.0,[],CHEMBL3795205,Antiviral activity against CXCR4 using HIV-1 NL4.3 infected in human MT4 cells assessed as reduction of viral replication preincubated for 15 mins with cells followed by viral infection measured after 4 days by MTS/PES method,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(Cc2ccccc2)CCCN(S(=O)(=O)c2ccc(F)cc2)C1.Cl,CHEMBL3792300,J Med Chem,2016.0,CHEMBL3793018,CHEMBL3794626,5.33,0.0,http://www.openphacts.org/units/Nanomolar,2770896.0,=,1.0,1.0,=,IC50,nM,4660.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.66,CHEMBL378
3749,24735354.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5116806,Antiviral activity against ZIKV infected in human Huh-7 cells assessed as inhibition of viral infection measured 24 hrs post infection by immunofluorescent assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12,CHEMBL5113447,Bioorg Med Chem Lett,2022.0,CHEMBL8260,CHEMBL8260,4.71,0.0,http://www.openphacts.org/units/Nanomolar,3858561.0,=,1.0,1.0,=,IC50,nM,19600.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,19.6,CHEMBL4296612
3750,1402220.0,[],CHEMBL837469,In vitro inhibitory concentration against HIV V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177744,CHEMBL177744,,0.0,http://www.openphacts.org/units/Nanomolar,360400.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3751,14653361.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)c3ccc(OC)nc3)[C@H](O)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262983,CHEMBL3262983,,0.0,http://www.openphacts.org/units/Nanomolar,2101865.0,>,1.0,1.0,>,IC50,nM,584000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,584.0,CHEMBL613497
3752,18528912.0,[],CHEMBL4195003,Antiviral activity against HIV1 virions containing reverse transcriptase Y181C mutant derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)[C@H](c1cc(OC)c(OC)c(OC)c1)[C@@H](C)[C@@H](C)C2,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4215279,CHEMBL4215279,4.97,0.0,http://www.openphacts.org/units/Nanomolar,3076498.0,=,1.0,1.0,=,IC50,nM,10800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.8,CHEMBL378
3753,10961054.0,[],CHEMBL2061264,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing wild type protease infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CN(C)C)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057462,CHEMBL2057462,7.03,0.0,http://www.openphacts.org/units/Nanomolar,1655124.0,=,1.0,1.0,=,IC50,nM,93.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,93.0,CHEMBL378
3754,607854.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Oc3c(Br)cc(Br)cc3Br)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL72459,CHEMBL72459,8.27,0.0,http://www.openphacts.org/units/Nanomolar,126891.0,=,1.0,1.0,=,IC50,nM,5.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0054,CHEMBL378
3755,2371465.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(c1ccccc1C(=O)O)S(=O)(=O)c1ccc2c3c(cccc13)C(=O)N2,CHEMBL1140145,J Med Chem,2008.0,CHEMBL522990,CHEMBL522990,4.12,0.0,http://www.openphacts.org/units/Nanomolar,745983.0,=,1.0,1.0,=,IC50,nM,75000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,75.0,CHEMBL613493
3756,3509159.0,[],CHEMBL1261040,Antiviral activity against HIV1 harboring reverse transcriptase K103N/Y181C double mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3Cl)CC2)ncc1Br,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1171403,CHEMBL1171403,8.14,0.0,http://www.openphacts.org/units/Nanomolar,963717.0,=,1.0,1.0,=,IC50,nM,7.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.3,CHEMBL378
3757,930573.0,[],CHEMBL728516,Anti-HIV activity against HIV-1 IIIB chronically infected Molt-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2c(OC(F)F)c(N3CCN(c4ccc(Cl)cc4)CC3)c(F)cc2c1=O,CHEMBL1131862,Bioorg Med Chem Lett,1999.0,CHEMBL317853,CHEMBL317853,6.32,0.0,http://www.openphacts.org/units/Nanomolar,194308.0,=,1.0,1.0,=,IC50,nM,480.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.48,CHEMBL378
3758,2929671.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CSCC(C)C)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL573960,CHEMBL573960,5.60,0.0,http://www.openphacts.org/units/Nanomolar,848332.0,=,1.0,1.0,=,IC50,nM,2511.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2511.0,CHEMBL378
3759,2413662.0,[],CHEMBL987708,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,CCOCC(=O)O[C@@H](C[C@@H](C)[C@]12CC[C@@]3(C)[C@@]1(C[C@H](OC(=O)COCC)[C@H]1[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@@]13C)O2)[C@@H](OC(=O)COCC)C(C)(C)OC(=O)COCC,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL500263,CHEMBL500263,,0.0,http://www.openphacts.org/units/Nanomolar,810803.0,=,1.0,1.0,=,IC50,nM,250000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.25,CHEMBL613497
3760,19281720.0,[],CHEMBL4409361,Antiviral activity against HIV1 UG070 infected in human TZM-bl cells incubated for 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(cnn2-c2cccc(C(F)(F)F)c2)c(=O)[nH]1,CHEMBL4406854,Eur J Med Chem,2019.0,CHEMBL4585125,CHEMBL4585125,,0.0,,3219934.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
3761,18406019.0,[],CHEMBL4150963,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1=C[C@@]2(C[C@H]([C@H]3CC[C@@]4(C)[C@@H]5CC[C@H]6C(C)(C)C(=O)C=C[C@]67C[C@]57CC[C@]34C)CO2)OC1=O,CHEMBL4145651,J Nat Prod,2018.0,CHEMBL4163024,CHEMBL4163024,6.10,0.0,http://www.openphacts.org/units/Nanomolar,3054865.0,=,1.0,1.0,=,IC50,nM,800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.8,CHEMBL378
3762,2570705.0,[],CHEMBL1000472,Antiviral activity against hepatitis B virus-infected human HepG2.2.15 cells assessed as inhibition of HBV surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)O[C@@H](C[C@@H](C)C1=C2C[C@H](OC(=O)CC)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)[C@@H](OC(=O)CC)C(C)(C)O,CHEMBL1155923,Bioorg Med Chem Lett,2008.0,CHEMBL446746,CHEMBL446746,,0.0,http://www.openphacts.org/units/Nanomolar,768982.0,>,1.0,1.0,>,IC50,nM,1400000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.4,CHEMBL613497
3763,345055.0,[],CHEMBL873617,Inhibition of concanavalin A (con A)-induced proliferation of rat peripheral blood mononuclear cells.,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(C(F)(F)F)nn1-c1ccc(NC(=O)c2ccccc2F)cc1,CHEMBL1133605,J Med Chem,2000.0,CHEMBL323120,CHEMBL323120,6.55,0.0,http://www.openphacts.org/units/Nanomolar,188104.0,=,1.0,1.0,=,IC50,nM,284.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,284.0,CHEMBL378
3764,14658781.0,[],CHEMBL3266156,"Displacement of [3H]-7-alpha,25-OHC from recombinant human EBI2 receptor expressed in CHO cells after 10 mins by scintillation counting analysis",B,BAO_0000190,BAO_0000219,cell-based format,O=C(COc1ccc2ccccc2c1)N1CCN(C(=O)Cc2ccccc2)CC1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262876,CHEMBL3262876,7.13,0.0,http://www.openphacts.org/units/Nanomolar,2101717.0,=,1.0,1.0,=,IC50,nM,74.13,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,pIC50,,UO_0000065,7.13,CHEMBL3259470
3765,1401901.0,[],CHEMBL837464,In vitro inhibitory concentration against HIV G190A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)Nc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL435522,CHEMBL435522,,0.0,http://www.openphacts.org/units/Nanomolar,360379.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3766,18323339.0,[],CHEMBL4134874,Antiviral activity against VSV-G pseudotyped HIV1 infected in human SupT1 cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1O/C(=C\c2ccc(O)cc2)C(O)=C1c1ccc(O)c(O)c1,CHEMBL4130477,J Nat Prod,2017.0,CHEMBL4161142,CHEMBL4161142,4.14,0.0,http://www.openphacts.org/units/Nanomolar,3042102.0,=,1.0,1.0,=,IC50,nM,72400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,72.4,CHEMBL378
3767,2527503.0,[],CHEMBL1003777,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 5 days by MTS method,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(C)c1=O,CHEMBL1138484,J Med Chem,2009.0,CHEMBL522283,CHEMBL522283,5.89,0.0,http://www.openphacts.org/units/Nanomolar,735724.0,=,1.0,1.0,=,IC50,nM,1300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1300.0,CHEMBL378
3768,24823526.0,[],CHEMBL5140686,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBsAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1CCCO1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5195720,CHEMBL5195720,6.29,0.0,http://www.openphacts.org/units/Nanomolar,3876701.0,=,1.0,1.0,=,IC50,nM,509.2,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.5092,CHEMBL613497
3769,897347.0,[],CHEMBL683811,Antiviral activity against HIV-1 using antiinfectivity assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1cccc(CO[C@H]2C(=O)Nc3ccc(Cl)cc3[C@@]2(C#CC2CC2)C(F)(F)F)c1,CHEMBL1134695,Bioorg Med Chem Lett,2001.0,CHEMBL292468,CHEMBL292468,6.86,0.0,http://www.openphacts.org/units/Nanomolar,100529.0,=,1.0,1.0,=,IC50,nM,138.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,138.0,CHEMBL378
3770,18469016.0,[],CHEMBL4182244,Antiviral activity against HIV-1 3B infected in human TZM-bl cells treated for 2 hrs followed by compound washout measured after 2 days by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@@H](CC(C)C)C(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/N[C@@H](CC(C)C)C(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+],CHEMBL4177704,Bioorg Med Chem Lett,2018.0,CHEMBL1952322,CHEMBL1963075,5.14,0.0,http://www.openphacts.org/units/Nanomolar,3065408.0,=,1.0,1.0,=,IC50,nM,7160.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,umol/L,UO_0000065,7.16,CHEMBL378
3771,2099729.0,[],CHEMBL949222,Antiviral activity against HIV1 RU570 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)N(CCCN2[C@@H]3CC[C@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)cc1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL257081,CHEMBL257081,7.55,0.0,http://www.openphacts.org/units/Nanomolar,699383.0,=,1.0,1.0,=,IC50,nM,28.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.028,CHEMBL378
3772,1954097.0,[],CHEMBL890376,Antiviral activity against HIV1 LAI assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(CC)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL395522,CHEMBL395522,8.51,0.0,http://www.openphacts.org/units/Nanomolar,647177.0,=,1.0,1.0,=,IC50,nM,3.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.1,CHEMBL378
3773,1402372.0,[],CHEMBL834487,In vitro inhibitory concentration value against HIV K103N and Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCO)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175873,CHEMBL175873,,0.0,http://www.openphacts.org/units/Nanomolar,360361.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3774,14653363.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)CCCC(=O)O)[C@H](OC(=O)CCCC(=O)O)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262991,CHEMBL3262991,,0.0,http://www.openphacts.org/units/Nanomolar,2101874.0,>,1.0,1.0,>,IC50,nM,429000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,429.0,CHEMBL613497
3775,14658855.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(Cl)c(Cl)c1)N1CCN(C(=O)Cc2ccccc2)CC1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262882,CHEMBL3262882,7.36,0.0,http://www.openphacts.org/units/Nanomolar,2101724.0,=,1.0,1.0,=,IC50,nM,43.65,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,pIC50,,UO_0000065,7.36,CHEMBL3259471
3776,150541.0,[],CHEMBL656397,Activity against HIV-1 by syncytial plaque assay performed in duplicate using CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(Cn2c(Cl)nc3cc(Cl)c(Cl)cc32)c1,CHEMBL1131326,J Med Chem,1998.0,CHEMBL281627,CHEMBL281627,4.85,0.0,http://www.openphacts.org/units/Nanomolar,30674.0,=,1.0,1.0,=,IC50,nM,14000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,14.0,CHEMBL378
3777,10961084.0,[],CHEMBL2061264,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing wild type protease infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL1163,CHEMBL1163,8.46,0.0,http://www.openphacts.org/units/Nanomolar,1655449.0,=,1.0,1.0,=,IC50,nM,3.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.5,CHEMBL378
3778,590514.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)NS(=O)(=O)c1ccc(NC(=O)c2ccccc2NC(=O)CCCC[n+]2ccccc2)cc1.[Br-],CHEMBL1132203,J Med Chem,1999.0,CHEMBL169431,CHEMBL1181390,,0.0,http://www.openphacts.org/units/Nanomolar,333979.0,>,1.0,1.0,>,IC50,nM,316000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,316.0,CHEMBL378
3779,22933325.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)CC(C)=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)/C=C/N6CCN(C(=O)OC(C)(C)C)CC6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4777208,CHEMBL4777208,,0.0,http://www.openphacts.org/units/Nanomolar,3560886.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
3780,5222606.0,[],CHEMBL1675305,Antiviral activity against HIV1 infected in human MT2 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1.O=S(=O)(O)O,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL1200619,CHEMBL1380,5.32,0.0,http://www.openphacts.org/units/Nanomolar,1332021.0,=,1.0,1.0,=,IC50,nM,4800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.8,CHEMBL378
3781,5236393.0,[],CHEMBL1686407,Antiviral activity against HIV1 NL4-3 infected in human HeLa37 cells assessed as inhibition of viral infectivity after 40 hrs by single round infectivity assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1c(O)c(C=O)c(O)c2c1OC(C)(C)CC2,CHEMBL1681680,Bioorg Med Chem Lett,2011.0,CHEMBL1683658,CHEMBL1683658,4.40,0.0,http://www.openphacts.org/units/Nanomolar,1334876.0,=,1.0,1.0,=,IC50,nM,39800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,39.8,CHEMBL378
3782,19236836.0,[],CHEMBL4398858,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in cytoplasmic DNA synthesis by reed and munch method,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@H](N)C(=O)OCCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCCOC(=O)[C@@H](N)CC(C)C.Cl,CHEMBL4396904,ACS Med Chem Lett,2019.0,CHEMBL4455329,CHEMBL4597420,,0.0,http://www.openphacts.org/units/Nanomolar,3211261.0,>,1.0,1.0,>,IC50,nM,12980.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,12.98,CHEMBL613497
3783,2292394.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1[S+]([O-])c1cccc(Br)c1,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL55998,CHEMBL55998,4.10,0.0,http://www.openphacts.org/units/Nanomolar,813410.0,=,1.0,1.0,=,IC50,nM,79983.43,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.097,CHEMBL378
3784,1520729.0,[],CHEMBL837207,Inhibitory concentration against resistant (A17) human immunodeficiency virus,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(CN2CCN([C@H](C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN(CC(C)C)S(=O)(=O)c3cccc(/C=N\O)c3)C(C)C)C2=O)cs1,CHEMBL1144377,Bioorg Med Chem Lett,2005.0,CHEMBL196034,CHEMBL196034,6.65,0.0,http://www.openphacts.org/units/Nanomolar,395355.0,=,1.0,1.0,=,IC50,nM,222.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.222,CHEMBL378
3785,15054441.0,[],CHEMBL3366317,Antiviral activity against VSV-G protein pseudotyped HIV1 infected in 293T cells assessed as inhibition of viral replication after 48 hrs by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL3351428,J Nat Prod,2014.0,CHEMBL230006,CHEMBL230006,4.54,0.0,http://www.openphacts.org/units/Nanomolar,2244390.0,=,1.0,1.0,=,IC50,nM,28800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,28.8,CHEMBL378
3786,14654432.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(C)=O)[C@H](OC(C)=O)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262990,CHEMBL3262990,,0.0,http://www.openphacts.org/units/Nanomolar,2101873.0,=,1.0,1.0,=,IC50,nM,455000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,455.0,CHEMBL613497
3787,1221011.0,[],CHEMBL880061,Inhibitory activity against LAI strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL593,CHEMBL593,7.20,0.0,http://www.openphacts.org/units/Nanomolar,127447.0,=,1.0,1.0,=,IC50,nM,63.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.063,CHEMBL378
3788,2947410.0,[],CHEMBL1038497,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)O[C@@H](C[C@@H](C)[C@]12CC[C@@]3(C)[C@@]1(C[C@H](OC(=O)CCC)[C@H]1[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@@]13C)O2)[C@@H](OC(=O)CCC)C(C)(C)OC(=O)CCC,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL574768,CHEMBL574768,,0.0,http://www.openphacts.org/units/Nanomolar,850770.0,>,1.0,1.0,>,IC50,nM,1900000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.9,CHEMBL613497
3789,5189201.0,[],CHEMBL1658800,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652498,CHEMBL1652498,,0.0,http://www.openphacts.org/units/Nanomolar,1326873.0,>,1.0,1.0,>,IC50,nM,27000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.027,CHEMBL613497
3790,12463711.0,[],CHEMBL3057688,Antiviral activity against wild type Human immunodeficiency virus 1,F,BAO_0000190,BAO_0000218,organism-based format,CN/C(Cc1c(Cl)cccc1Cl)=N\C(S)=N\c1ccc(C#N)cc1,CHEMBL3046335,Med Chem Res,2009.0,CHEMBL305850,CHEMBL305850,,0.0,http://www.openphacts.org/units/Nanomolar,1805848.0,=,1.0,1.0,=,IC50,nM,77446179.78,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,1.111,CHEMBL378
3791,15166114.0,[],CHEMBL3404734,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBeAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(OC(=O)c2ccco2)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402780,CHEMBL3402780,,0.0,http://www.openphacts.org/units/Nanomolar,2284134.0,>,1.0,1.0,>,IC50,nM,4049400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,4049.4,CHEMBL613497
3792,19262021.0,[],CHEMBL4404424,Antiviral activity against multidrug resistant HIV1 12227 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.32,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,480.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.48,CHEMBL378
3793,12717510.0,[],CHEMBL2350955,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBV DNA replication after 72 hrs by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,C=CCc1ccc(O)c(-c2cc([C@@H](O)[C@@H](C)O)ccc2O)c1,CHEMBL2346656,Bioorg Med Chem Lett,2013.0,CHEMBL2346747,CHEMBL2346747,,0.0,http://www.openphacts.org/units/Nanomolar,1874413.0,>,1.0,1.0,>,IC50,nM,1000000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1000.0,CHEMBL613497
3794,18455417.0,[],CHEMBL4179270,Antiviral activity against Influenza B virus (B/Maryland/1/59) infected in MDCK cells assessed as reduction in virus-induced cytopathogenicity incubated for 48 hrs by SRB assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(CN2CCN(c3ccc(C)cc3)CC2)c2cc3[n+](cc2c1O)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL4177585,Bioorg Med Chem,2017.0,CHEMBL4212028,CHEMBL4300650,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,3062860.0,=,1.0,1.0,=,IC50,ug.mL-1,5.1,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,5.1,CHEMBL613129
3795,14658818.0,[],CHEMBL3266157,Antagonist activity at recombinant human EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)c3ccc(N(C)C)cc3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262889,CHEMBL3262889,7.72,0.0,http://www.openphacts.org/units/Nanomolar,2101731.0,=,1.0,1.0,=,IC50,nM,19.05,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,pIC50,,UO_0000065,7.72,CHEMBL3259470
3796,10969763.0,[],CHEMBL2065306,Antiviral activity against Influenza B virus (strain B/Jifang/13/97) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)Nc1cc(C(=O)Nc2ccc([N+](=O)[O-])cc2)ccc1OC,CHEMBL2062433,Eur J Med Chem,2012.0,CHEMBL2064593,CHEMBL2064593,4.19,0.0,http://www.openphacts.org/units/Nanomolar,1660690.0,=,1.0,1.0,=,IC50,nM,64800.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,64.8,CHEMBL613129
3797,10861944.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOC(=O)[C@@]1(C)CC[C@]2(C)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024626,CHEMBL2024626,,0.0,http://www.openphacts.org/units/Nanomolar,1640522.0,>,1.0,1.0,>,IC50,nM,986330.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,986.33,CHEMBL613497
3798,679862.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(SSc2cc(OC)cc([N+](=O)[O-])c2N)c(N)c([N+](=O)[O-])c1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL116548,CHEMBL116548,,0.0,,228539.0,=,1.0,0.0,=,IC50,,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,4.0,CHEMBL378
3799,813729.0,[],CHEMBL683816,"Inhibitory activity against NNI-resistant HIV-1 strain A17 with Y181C,K103N mutation",F,BAO_0000190,BAO_0000218,organism-based format,S=C(NCCc1ccccn1)Nc1ccc(Br)cn1,CHEMBL1133139,Bioorg Med Chem Lett,2000.0,CHEMBL39999,CHEMBL39999,,0.0,http://www.openphacts.org/units/Nanomolar,111929.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
3800,896291.0,[],CHEMBL653610,Inhibitory activity tested against the HIV-1 in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCNC(=O)CCC(=O)O)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL11453,CHEMBL11453,7.02,0.0,http://www.openphacts.org/units/Nanomolar,9066.0,=,1.0,1.0,=,IC50,nM,95.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,95.0,CHEMBL378
3801,24421211.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5048800,Antiviral activity against HIV-1 NL4-3(X4) pseudovirus infected in human TZM-bl cells assessed as reduction in viral infectivity measured after 48 hrs of postinfection by luminescence assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(CCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21)C1CCOCC1,CHEMBL5046278,J Med Chem,2022.0,CHEMBL5077132,CHEMBL5077132,8.22,0.0,http://www.openphacts.org/units/Nanomolar,3784600.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.0,CHEMBL378
3802,22844968.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721621,Antiviral activity against HIV-1 HXB-2 infected in human TZM-bl cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based single cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4547005,CHEMBL4547005,6.57,0.0,http://www.openphacts.org/units/Nanomolar,3547094.0,=,1.0,1.0,=,IC50,nM,270.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.27,CHEMBL378
3803,23317005.0,[],CHEMBL4845562,Antiviral activity against Influenza B virus (B/Sichuan/531/2018(Victoria)) infected in cells assessed as reduction in infected cells,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC[C@]2(C(=O)NCCCCc3cn(Cc4cc(Cn5cc(CCCCNC(=O)[C@]67CCC(C)(C)C[C@H]6C6=CC[C@@H]8[C@@]9(C)CC[C@H](O)C(C)(C)[C@@H]9CC[C@@]8(C)[C@]6(C)CC7)nn5)cc(Cn5cc(CCCCNC(=O)[C@]67CCC(C)(C)C[C@H]6C6=CC[C@@H]8[C@@]9(C)CC[C@H](O)C(C)(C)[C@@H]9CC[C@@]8(C)[C@]6(C)CC7)nn5)c4)nn3)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL4842395,ACS Med Chem Lett,2021.0,CHEMBL4855404,CHEMBL4855404,5.73,0.0,http://www.openphacts.org/units/Nanomolar,3629105.0,=,1.0,1.0,=,IC50,nM,1870.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,1.87,CHEMBL613129
3804,1194675.0,[],CHEMBL710530,Inhibitory activity against 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70554,CHEMBL70554,7.89,0.0,http://www.openphacts.org/units/Nanomolar,127459.0,=,1.0,1.0,=,IC50,nM,13.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.013,CHEMBL378
3805,1221001.0,[],CHEMBL710537,Inhibitory activity against 188L strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70663,CHEMBL70663,7.32,0.0,http://www.openphacts.org/units/Nanomolar,127468.0,=,1.0,1.0,=,IC50,nM,48.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.048,CHEMBL378
3806,1402039.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC(C)=O)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL129144,CHEMBL129144,6.40,0.0,http://www.openphacts.org/units/Nanomolar,360368.0,=,1.0,1.0,=,IC50,nM,398.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.398,CHEMBL378
3807,1049985.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(S)n(Nc2ccc(F)cc2)c1-c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289208,CHEMBL289208,,0.0,http://www.openphacts.org/units/Nanomolar,62361.0,>,1.0,1.0,>,IC50,nM,220130.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,220.13,CHEMBL378
3808,6216925.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(C(F)(F)F)cc2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784482,CHEMBL1784482,,0.0,http://www.openphacts.org/units/Nanomolar,1429421.0,<,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.0,CHEMBL378
3809,1403325.0,[],CHEMBL834757,Inhibitory concentration against 181C mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Sc2cn(C)c(=O)c(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL175827,CHEMBL175827,,0.0,http://www.openphacts.org/units/Nanomolar,360628.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
3810,2419856.0,[],CHEMBL961012,Antiviral activity against Measles virus,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2[C@@H]1C[C@H](F)[C@@H](O)[C@H]1O,CHEMBL1153449,Bioorg Med Chem,2009.0,CHEMBL259773,CHEMBL259773,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,782229.0,=,1.0,1.0,=,IC50,ug.mL-1,14.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,ug ml-1,UO_0000274,14.0,CHEMBL613738
3811,18044364.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,CNCC(NC(=O)c1ccc(-c2ccc(Cl)c(F)c2)[nH]1)c1nc(C)c(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4068655,CHEMBL4068655,5.80,0.0,http://www.openphacts.org/units/Nanomolar,2990181.0,=,1.0,1.0,=,IC50,nM,1600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.6,CHEMBL378
3812,19262050.0,[],CHEMBL4404438,Antiviral activity against multiple-PI-resistant HIV1 11805 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.57,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,270.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.27,CHEMBL378
3813,3129694.0,[],CHEMBL1065523,Antiviral activity against HIV1 BaL infected in human PBMC assessed as inhibition of viral replication by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=S(=O)([O-])c1cc2c(O)c(c1)Cc1cc(S(=O)(=O)[O-])cc(c1O)Cc1cc(S(=O)(=O)[O-])cc(c1O)Cc1cc(S(=O)(=O)[O-])cc(c1O)C2.[Na+].[Na+].[Na+].[Na+],CHEMBL1157689,Bioorg Med Chem,2010.0,CHEMBL590572,CHEMBL1092710,4.35,0.0,http://www.openphacts.org/units/Nanomolar,880938.0,=,1.0,1.0,=,IC50,nM,45000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,45.0,CHEMBL378
3814,2263400.0,[],CHEMBL1010846,Antiviral activity against R5 tropic HIV1 BaL infected in human JC53-BL cells expressing CCR5 after 2 days by cell-cell fusion assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC1CN(S(=O)(=O)C2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2,CHEMBL1139267,Bioorg Med Chem Lett,2009.0,CHEMBL454253,CHEMBL454253,8.22,0.0,http://www.openphacts.org/units/Nanomolar,750007.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.0,CHEMBL378
3815,5222601.0,[],CHEMBL1675304,Antiviral activity against HIV1 infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL853,CHEMBL853,5.85,0.0,http://www.openphacts.org/units/Nanomolar,1332026.0,=,1.0,1.0,=,IC50,nM,1400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.4,CHEMBL378
3816,18528915.0,[],CHEMBL4195003,Antiviral activity against HIV1 virions containing reverse transcriptase Y181C mutant derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)[C@@H](c1cc(OC)c(OC)c(OC)c1)[C@H](C)CC2,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4214167,CHEMBL4214167,,0.0,http://www.openphacts.org/units/Nanomolar,3076503.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
3817,18890506.0,[],CHEMBL4314138,Antiviral activity against HIV-1 NL4-3 infected in human CEM-GFP cells assessed as suppression of viral replication by measuring reduction in p24 level measured at 72 hrs post-infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Cc1cc(-c2ccccc2)on1)Nc1ccc(F)cc1,CHEMBL4311980,Eur J Med Chem,2019.0,CHEMBL4469431,CHEMBL4469431,7.06,0.0,http://www.openphacts.org/units/Nanomolar,3151795.0,=,1.0,1.0,=,IC50,nM,87.05,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,87.05,CHEMBL378
3818,3129687.0,[],CHEMBL1065520,Antiviral activity against HIV1 LAI infected in human CEM-SS cells assessed as inhibition of viral replication by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(-c2nc(COc3c4cc(C(C)(C)C)cc3Cc3cc(C(C)(C)C)cc(c3O)Cc3cc(C(C)(C)C)cc(c3Oc3nc(-c5nc(C)c(C(=O)[O-])s5)sc3C(=O)[O-])Cc3cc(C(C)(C)C)cc(c3O)C4)c(C(=O)[O-])s2)sc1C(=O)[O-].[Na+].[Na+].[Na+].[Na+],CHEMBL1157689,Bioorg Med Chem,2010.0,CHEMBL590509,CHEMBL1208387,4.71,0.0,http://www.openphacts.org/units/Nanomolar,880941.0,=,1.0,1.0,=,IC50,nM,19500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,19.5,CHEMBL378
3819,2517110.0,[],CHEMBL975243,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)nc(SCc2ccc(OC)cc2)[nH]c1=O,CHEMBL1138559,Eur J Med Chem,2009.0,CHEMBL475579,CHEMBL475579,,0.0,http://www.openphacts.org/units/Nanomolar,733187.0,>=,1.0,1.0,>=,IC50,nM,9470.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,9.47,CHEMBL378
3820,24788619.0,[],CHEMBL5131713,Antiviral activity against HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,CHEMBL5131375,J Med Chem,2022.0,CHEMBL50894,CHEMBL50894,6.82,0.0,http://www.openphacts.org/units/Nanomolar,3869447.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,150.0,CHEMBL378
3821,2099806.0,[],CHEMBL949221,Antiviral activity against HIV1 97-ZA-003 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)N(CCCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nc4c2CCN(C(=O)C2CCCC2)C4)C3)c2ccccc2)cc1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL270579,CHEMBL270579,8.52,0.0,http://www.openphacts.org/units/Nanomolar,699405.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
3822,13967499.0,[],CHEMBL3135326,Antiviral activity against wild type HIV1 VSVG infected in 293ET cells assessed as inhibition of viral replication by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1sc(-c2ccccc2)cc1S(=O)(=O)N1c2cc(Cl)ccc2NC(=O)C1C,CHEMBL3132804,Medchemcomm,2014.0,CHEMBL3133064,CHEMBL3133064,5.04,0.0,http://www.openphacts.org/units/Nanomolar,1974736.0,=,1.0,1.0,=,IC50,nM,9050.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,9.05,CHEMBL378
3823,24830986.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,Cn1ccnc1C(=O)Nc1ccc2c(=O)c3cccc(F)c3oc2c1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5190375,CHEMBL5190375,,0.0,http://www.openphacts.org/units/Nanomolar,3878098.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
3824,1470716.0,[],CHEMBL833074,Inhibitory activity against HIV-1 mutant strain 100I,F,BAO_0000190,BAO_0000218,organism-based format,CCOCn1c(Cc2ccccc2)c(C(C)C)c(=O)[nH]c1=O,CHEMBL1138799,J Med Chem,2004.0,CHEMBL35033,CHEMBL35033,7.40,0.0,http://www.openphacts.org/units/Nanomolar,380792.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
3825,1052401.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C1C(C)N=C(S)N1Nc1cccc(Cl)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39101,CHEMBL39101,,0.0,http://www.openphacts.org/units/Nanomolar,62359.0,>,1.0,1.0,>,IC50,nM,190310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,190.31,CHEMBL378
3826,539017.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1cc(Cl)ccc1Cl,CHEMBL1134494,J Med Chem,2001.0,CHEMBL301055,CHEMBL301055,6.52,0.0,http://www.openphacts.org/units/Nanomolar,94195.0,=,1.0,1.0,=,IC50,nM,300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.3,CHEMBL378
3827,37587.0,[],CHEMBL688336,Antiviral activity against Y188C strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL223228,CHEMBL223228,8.85,0.0,http://www.openphacts.org/units/Nanomolar,20823.0,=,1.0,1.0,=,IC50,nM,1.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.4,CHEMBL378
3828,18044695.0,[],CHEMBL4010441,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype A/D QA790.204I.ENV.C8,F,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075766,CHEMBL4075766,6.27,0.0,http://www.openphacts.org/units/Nanomolar,2990214.0,=,1.0,1.0,=,IC50,nM,540.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.54,CHEMBL378
3829,22435374.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4677393,Antiviral activity against HIV-1 NL4-3 infected in human MT-4 cells assessed as inhibition of viral replication by measuring inhibition of cell viability preincubated with cells for 15 mins followed by viral infection and measured after 4 days by MTS/PES assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCc2cc(OCC3CCCCC3)cc(n2)CCN(S(=O)(=O)c2ccc(C)cc2)C1.Cl,CHEMBL4673284,Bioorg Med Chem,2020.0,CHEMBL4747494,CHEMBL4802676,6.03,0.0,http://www.openphacts.org/units/Nanomolar,3515768.0,=,1.0,1.0,=,IC50,nM,930.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.93,CHEMBL378
3830,10866411.0,[],CHEMBL2025516,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(OC(=O)CCCC(=O)O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCCC(=O)O)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024048,CHEMBL2024048,,0.0,http://www.openphacts.org/units/Nanomolar,1639770.0,>,1.0,1.0,>,IC50,nM,267960.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,267.96,CHEMBL613497
3831,2929479.0,[],CHEMBL1056901,Antiviral activity against HIV1 HXB2 harboring 101E and K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3ncnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL574163,CHEMBL574163,8.30,0.0,http://www.openphacts.org/units/Nanomolar,848359.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.0,CHEMBL378
3832,5229738.0,[],CHEMBL1678277,Antiviral activity against Human immunodeficiency virus 1 subtype E CMU02 infected in phytohemagglutininin and interleukin-2-stimulated PBMC assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,7.05,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,=,1.0,1.0,=,IC50,nM,90.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.09,CHEMBL378
3833,1239422.0,[],CHEMBL652107,Inhibitory concentration required to inhibit HIV-induced cytopathicity in CEM-4 cells by 50% based in the MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCC(=O)N(CC)CCCCCCCCCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL115589,CHEMBL1205566,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221545.0,=,1.0,1.0,=,IC50,ug.mL-1,25.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,25.0,CHEMBL378
3834,24509232.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5055345,Antiviral activity against HIV1 931N101 infected in human SupT1 cells assessed as inhibition of viral entry mesaured after 96 hrs by p24- ELISA assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C(C)NC(=S)NC1c1ccc(O)c(OC)c1,CHEMBL5053552,Bioorg Med Chem,2021.0,CHEMBL2013079,CHEMBL2013079,5.66,0.0,http://www.openphacts.org/units/Nanomolar,3837683.0,=,1.0,1.0,=,IC50,nM,2200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.2,CHEMBL378
3835,2997529.0,[],CHEMBL1047854,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV DNA replication after 9 days by PCR,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C(=N/C2CC2)c2ccc(=O)n(C3CC3)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL566275,CHEMBL566275,,0.0,http://www.openphacts.org/units/Nanomolar,856684.0,>,1.0,1.0,>,IC50,nM,462400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,462.4,CHEMBL613497
3836,15054440.0,[],CHEMBL3366317,Antiviral activity against VSV-G protein pseudotyped HIV1 infected in 293T cells assessed as inhibition of viral replication after 48 hrs by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL3351428,J Nat Prod,2014.0,CHEMBL223228,CHEMBL223228,8.82,0.0,http://www.openphacts.org/units/Nanomolar,2244391.0,=,1.0,1.0,=,IC50,nM,1.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0015,CHEMBL378
3837,532303.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cccc(Sc2cccc(N)c2C#N)c1,CHEMBL1134494,J Med Chem,2001.0,CHEMBL293806,CHEMBL293806,5.76,0.0,http://www.openphacts.org/units/Nanomolar,94253.0,=,1.0,1.0,=,IC50,nM,1730.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.73,CHEMBL378
3838,19261846.0,[],CHEMBL4404363,Antiviral activity against HIV1 subtypeA KNH1144,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.21,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,620.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.62,CHEMBL378
3839,1243470.0,[],CHEMBL824448,Concentration required to inhibit parainfluenza-3 induced cytopathicity in Vero cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCC(=O)NCCCCCCCCCCC(=O)NCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL113937,CHEMBL1205558,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221533.0,>,1.0,1.0,>,IC50,ug.mL-1,200.0,CHEMBL613126,Human parainfluenza virus 3,Human parainfluenza virus 3,11216,IC50,ug ml-1,UO_0000274,200.0,CHEMBL613126
3840,13390563.0,[],CHEMBL2412660,Antiviral activity against HIV1 3B infected in human CEM-SS cells assessed as reduction in virus-induced cytopathogenicity after 6 days by MTS assay,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)C(OC(C)=O)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,CHEMBL2407038,Bioorg Med Chem Lett,2013.0,CHEMBL2407578,CHEMBL2407578,6.92,0.0,http://www.openphacts.org/units/Nanomolar,1907804.0,=,1.0,1.0,=,IC50,nM,119.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,119.0,CHEMBL378
3841,12642420.0,[],CHEMBL2317522,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay in presence of human serum albumin,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NCc1ccc(F)cc1)c1cn2c(c(O)c1=O)C(=O)N(C1CCCCC1)CC2,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314684,CHEMBL2314684,7.54,0.0,http://www.openphacts.org/units/Nanomolar,1844816.0,=,1.0,1.0,=,IC50,nM,29.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,29.0,CHEMBL378
3842,10866470.0,[],CHEMBL2025518,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(O)C(C)=O)C2)on1,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024032,CHEMBL2024032,4.77,0.0,http://www.openphacts.org/units/Nanomolar,1639754.0,=,1.0,1.0,=,IC50,nM,16970.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,16.97,CHEMBL613497
3843,14653417.0,[],CHEMBL3266817,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)c3ccco3)[C@H](OC(=O)c3ccco3)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262988,CHEMBL3262988,,0.0,http://www.openphacts.org/units/Nanomolar,2101871.0,=,1.0,1.0,=,IC50,nM,1407000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1407.0,CHEMBL613497
3844,3358049.0,[],CHEMBL1175764,Antiviral activity against HIV1 expressing reverse transcriptase K103N/L100I double mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL308954,CHEMBL308954,8.02,0.0,http://www.openphacts.org/units/Nanomolar,921826.0,=,1.0,1.0,=,IC50,nM,9.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,9.5,CHEMBL378
3845,3292019.0,[],CHEMBL1108227,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)N1C[C@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3ccccc3)C[C@H]2C1,CHEMBL1157775,Bioorg Med Chem Lett,2010.0,CHEMBL1095815,CHEMBL1095815,8.52,0.0,http://www.openphacts.org/units/Nanomolar,911078.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.0,CHEMBL378
3846,617838.0,[],CHEMBL698606,In vitro antiviral activity was evaluated in a plaque reduction assay against influenza B,F,BAO_0000190,BAO_0000218,organism-based format,CCCNC(=O)[C@@H]1OC(C(=O)O)=C[C@H](NC(=N)N)[C@H]1NC(C)=O,CHEMBL1159157,Bioorg Med Chem Lett,1996.0,CHEMBL54149,CHEMBL54149,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,87337.0,=,1.0,1.0,=,IC50,ug.mL-1,3.8,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,3.8,CHEMBL613129
3847,17602952.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(S(=O)(=O)c2cccc3cccnc23)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644887,CHEMBL3644887,6.80,0.0,http://www.openphacts.org/units/Nanomolar,2518007.0,=,37.0,1.0,=,IC50,nM,160.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,160.0,CHEMBL4620
3848,12680676.0,[],CHEMBL2342597,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral replication after 9 days by fluorescence PCR method,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)NCc3ccccc3F)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333688,CHEMBL2333688,4.16,0.0,http://www.openphacts.org/units/Nanomolar,1867764.0,=,1.0,1.0,=,IC50,nM,68560.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,68.56,CHEMBL613497
3849,2602300.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)Oc2ccc3cc(CBr)c(=O)oc3c2[C@@H](OC(=O)[C@@]23CC[C@](C)(C(=O)O2)C3(C)C)[C@H]1OC(=O)[C@@]12CC[C@](C)(C(=O)O1)C2(C)C,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL503587,CHEMBL503587,4.96,0.0,http://www.openphacts.org/units/Nanomolar,807038.0,=,1.0,1.0,=,IC50,nM,11100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,11.1,CHEMBL378
3850,6152273.0,[],CHEMBL1763053,Antiviral activity against Human immunodeficiency virus 1 BAL infected in human PBMC assessed as inhibition of viral replication by p24 antigen specific ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccncc2)c2ccc(Br)cc2)CC1,CHEMBL1759996,Bioorg Med Chem Lett,2011.0,CHEMBL1762328,CHEMBL1762328,,0.0,http://www.openphacts.org/units/Nanomolar,1414779.0,>,1.0,1.0,>,IC50,nM,240.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.24,CHEMBL378
3851,5246992.0,[],CHEMBL1687410,Antiviral activity against HIV1 Ba-L infected in human HOS cells expressing CCR5 after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@H]1C[C@H]2CC[C@@H](C1)N2CCC(CNC(=O)C1CC(F)(F)C1)c1ccccc1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL3084350,CHEMBL3084350,,0.0,http://www.openphacts.org/units/Nanomolar,1333585.0,>,1.0,1.0,>,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
3852,3432544.0,[],CHEMBL1247392,Antiviral activity against HIV1 infected in human CEM cells assessed as protection against virus-induced cytopathic effect after 6 days by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](Sc2nc3sc4c(c3c(=S)[nH]2)CCCC4)[C@@H](O)[C@@H]1O,CHEMBL1240504,Eur J Med Chem,2010.0,CHEMBL1243368,CHEMBL1243368,,0.0,http://www.openphacts.org/units/Nanomolar,954932.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM/L,UO_0000065,100.0,CHEMBL378
3853,2929493.0,[],CHEMBL1056900,Antiviral activity against HIV1 HXB2 harboring 100I and K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCSCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578367,CHEMBL578367,7.80,0.0,http://www.openphacts.org/units/Nanomolar,852822.0,=,1.0,1.0,=,IC50,nM,15.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,15.8,CHEMBL378
3854,15200451.0,[],CHEMBL3413997,Antiviral activity against X4 tropic HIV-1 clone pNL4-3 infected in H9 cells assessed as reduction in p24 antigen after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,N#C/C(=C\c1ccc(-n2ccnc2)cc1)c1nc2ccccc2[nH]1,CHEMBL3407469,Eur J Med Chem,2015.0,CHEMBL3410124,CHEMBL3410124,,0.0,http://www.openphacts.org/units/Nanomolar,2288854.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
3855,368713.0,[],CHEMBL711617,Antiviral activity against HIV-1 IIIB induced cytopathic effect in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)[C@H]1NCc2cccc(c2)OCCOCCNC(=O)[C@H](C(C)C)NC1=O,CHEMBL1129607,J Med Chem,1996.0,CHEMBL321422,CHEMBL321422,7.22,0.0,http://www.openphacts.org/units/Nanomolar,210512.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,60.0,CHEMBL378
3856,14986423.0,[],CHEMBL3387289,Antiviral activity against Vaccinia virus infected in HFF cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncc(F)c2c1ncn2[C@@H]1C[C@H](CCO)[C@@H](O)[C@H]1O,CHEMBL3351456,Bioorg Med Chem,2014.0,CHEMBL3357216,CHEMBL3357216,4.26,0.0,http://www.openphacts.org/units/Nanomolar,2258675.0,=,1.0,1.0,=,IC50,nM,55210.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,55.21,CHEMBL613493
3857,1830897.0,[],CHEMBL918634,Antiviral activity against wild type HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(C(C#N)c2cccc3ccccc23)nc(SCC(=O)c2ccc(Cl)cc2)[nH]c1=O,CHEMBL1144474,J Med Chem,2007.0,CHEMBL223728,CHEMBL223728,5.33,0.0,http://www.openphacts.org/units/Nanomolar,629294.0,=,1.0,1.0,=,IC50,nM,4710.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.71,CHEMBL378
3858,1402173.0,[],CHEMBL837464,In vitro inhibitory concentration against HIV G190A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL180008,CHEMBL180008,,0.0,http://www.openphacts.org/units/Nanomolar,360390.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3859,12463735.0,[],CHEMBL3057688,Antiviral activity against wild type Human immunodeficiency virus 1,F,BAO_0000190,BAO_0000218,organism-based format,N=C(Cc1c(Cl)cccc1Cl)NC(=S)Nc1ccc(Cl)cc1Cl,CHEMBL3046335,Med Chem Res,2009.0,CHEMBL69947,CHEMBL69947,,0.0,http://www.openphacts.org/units/Nanomolar,1805824.0,=,1.0,1.0,=,IC50,nM,346736850.45,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,0.46,CHEMBL378
3860,22484647.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '144.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '6.0'}]",CHEMBL4688345,Antiviral activity against HBV infected in human HepG2 2.2.15 cells assessed as decrease in extracellular viral DNA level measured after incubation of 6 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL4680304,Bioorg Med Chem,2021.0,CHEMBL141,CHEMBL141,7.51,0.0,http://www.openphacts.org/units/Nanomolar,3524619.0,=,1.0,1.0,=,IC50,nM,31.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.031,CHEMBL613497
3861,14596916.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c(=O)n(COCCO)c(Sc2ccccc2)c1Br,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL311494,CHEMBL311494,5.33,0.0,http://www.openphacts.org/units/Nanomolar,2082758.0,=,1.0,1.0,=,IC50,nM,4700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.7,CHEMBL378
3862,18683220.0,[],CHEMBL4237086,Antiviral activity against CCR5-dependent HIV1 SF162 infected in human TZM-bl cells assessed as reduction in virus infection measured after 48 hrs post infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1,CHEMBL4229569,J Med Chem,2018.0,CHEMBL4248282,CHEMBL4248282,7.94,0.0,http://www.openphacts.org/units/Nanomolar,3103083.0,=,1.0,1.0,=,IC50,nM,11.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,11.5,CHEMBL378
3863,2009845.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1CN(C(=O)c2cnc3ccccc3n2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL393400,CHEMBL393400,5.27,0.0,http://www.openphacts.org/units/Nanomolar,668068.0,=,1.0,1.0,=,IC50,nM,5400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5400.0,CHEMBL378
3864,22845274.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '49.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '49.0'}]",CHEMBL4721686,Antiviral activity against Laboratory adapted HIV-1 LA1 infected in human PBMC cells assessed as reduction in viral transmission to TZM-bl cells pretreated for 1 hr before viral transmission and further incubated for 48 hrs by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4547005,CHEMBL4547005,6.51,0.0,http://www.openphacts.org/units/Nanomolar,3547094.0,=,1.0,1.0,=,IC50,nM,310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.31,CHEMBL378
3865,22933268.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL404519,CHEMBL404519,7.19,0.0,http://www.openphacts.org/units/Nanomolar,3560829.0,=,1.0,1.0,=,IC50,nM,65.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.065,CHEMBL378
3866,861027.0,[],CHEMBL686566,Anti-HIV activity in H9 lymphocytes.,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@@H]1c2c(ccc3c(C)cc(=O)oc23)OC(C)(C)[C@@H]1OC(C)=O,CHEMBL1132174,J Med Chem,1999.0,CHEMBL89792,CHEMBL89792,,0.0,http://www.openphacts.org/units/Nanomolar,163820.0,=,1.0,1.0,=,IC50,nM,171000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,171.0,CHEMBL378
3867,1671928.0,[],CHEMBL870624,Antiviral activity against HIV1 K103N mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C(=O)c2cc(Cl)ccc2OCC(=O)Nc2cnc(S(N)(=O)=O)cc2C)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL201527,CHEMBL201527,8.15,0.0,http://www.openphacts.org/units/Nanomolar,411918.0,=,1.0,1.0,=,IC50,nM,7.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.0,CHEMBL378
3868,1830880.0,[],CHEMBL918634,Antiviral activity against wild type HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CSc2nc(C(C#N)c3c(Cl)cccc3Cl)c(C(C)C)c(=O)[nH]2)cc1,CHEMBL1144474,J Med Chem,2007.0,CHEMBL388776,CHEMBL388776,,0.0,http://www.openphacts.org/units/Nanomolar,629311.0,>,1.0,1.0,>,IC50,nM,23530.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,23.53,CHEMBL378
3869,315837.0,[],CHEMBL697276,In vitro inhibition of HIV-1 plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCC(=O)NCC(COP(=O)([O-])OCC[N+](C)(C)C)OCC,CHEMBL1125666,J Med Chem,1991.0,CHEMBL285629,CHEMBL285629,6.34,0.0,http://www.openphacts.org/units/Nanomolar,43737.0,=,1.0,1.0,=,IC50,nM,460.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.46,CHEMBL378
3870,20677914.0,[],CHEMBL4622140,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in cytoplasmic HBV-DNA replication incubated for 8 days by real-time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c2c(c(-c3ccc(F)nc3F)nn1Cc1ccc(Cl)cc1)CCCC2,CHEMBL4619801,J Med Chem,2020.0,CHEMBL4647530,CHEMBL4647530,5.84,0.0,http://www.openphacts.org/units/Nanomolar,3482201.0,=,1.0,1.0,=,IC50,nM,1450.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.45,CHEMBL613497
3871,18044785.0,[],CHEMBL4010393,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype C ZM249M.PL1,F,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075766,CHEMBL4075766,6.39,0.0,http://www.openphacts.org/units/Nanomolar,2990214.0,=,1.0,1.0,=,IC50,nM,410.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.41,CHEMBL378
3872,2003638.0,[],CHEMBL901910,Antiviral activity against Modoc virus-infected HeLa-H1 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccccn1)c1ccc2[nH]c(-c3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3)nc2c1,CHEMBL1138288,J Med Chem,2007.0,CHEMBL222659,CHEMBL222659,7.22,0.0,http://www.openphacts.org/units/Nanomolar,666646.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL612946,Modoc virus,Modoc virus,64300,IC50,nM,UO_0000065,60.0,CHEMBL612946
3873,3366686.0,[],CHEMBL1175913,Antiviral activity against HIV1 LAI infected in human CEM-SS cells assessed as inhibition of viral replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(/N=C/c1ccc(OP2(Oc3ccc(/C=N/N(C)P(=S)(Oc4ccc(C(O)P(=O)([O-])O)cc4)Oc4ccc(C(O)P(=O)([O-])O)cc4)cc3)=NP(Oc3ccc(/C=N/N(C)P(=S)(Oc4ccc(C(O)P(=O)([O-])O)cc4)Oc4ccc(C(O)P(=O)([O-])O)cc4)cc3)(Oc3ccc(/C=N/N(C)P(=S)(Oc4ccc(C(O)P(=O)([O-])O)cc4)Oc4ccc(C(O)P(=O)([O-])O)cc4)cc3)=NP(Oc3ccc(/C=N/N(C)P(=S)(Oc4ccc(C(O)P(=O)([O-])O)cc4)Oc4ccc(C(O)P(=O)([O-])O)cc4)cc3)(Oc3ccc(/C=N/N(C)P(=S)(Oc4ccc(C(O)P(=O)([O-])O)cc4)Oc4ccc(C(O)P(=O)([O-])O)cc4)cc3)=N2)cc1)P(=S)(Oc1ccc(C(O)P(=O)([O-])O)cc1)Oc1ccc(C(O)P(=O)([O-])O)cc1.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],CHEMBL1177694,Bioorg Med Chem,2010.0,CHEMBL1169668,CHEMBL1208636,4.30,0.0,http://www.openphacts.org/units/Nanomolar,924953.0,=,1.0,1.0,=,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
3874,1402264.0,[],CHEMBL837470,In vitro inhibitory concentration against HIV V179E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCCN(CCCC)c1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL179736,CHEMBL179736,,0.0,http://www.openphacts.org/units/Nanomolar,360413.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3875,1402312.0,[],CHEMBL837469,In vitro inhibitory concentration against HIV V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(Cc2ccccc2)Cc2ccccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL366811,CHEMBL366811,,0.0,http://www.openphacts.org/units/Nanomolar,360421.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3876,10961192.0,[],CHEMBL2061268,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M3 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)CCN2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057724,CHEMBL2057724,7.10,0.0,http://www.openphacts.org/units/Nanomolar,1655447.0,=,1.0,1.0,=,IC50,nM,80.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,80.0,CHEMBL378
3877,19261730.0,[],CHEMBL4404352,Antiviral activity against HIV1 HXB2 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(Cl)cn2)[nH]1)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4465611,CHEMBL4465611,5.30,0.0,http://www.openphacts.org/units/Nanomolar,3216266.0,=,1.0,1.0,=,IC50,nM,5000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.0,CHEMBL378
3878,1174962.0,[],CHEMBL683809,Anti-HIV activity against HIV-1 in Molt-4 cells using 7-day infective assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1[C@@H](C)Oc2c3c(c4c(-c5ccccc5)cc(=O)oc4c2[C@@H]1O)OC(C)(C)C=C3,CHEMBL1126563,J Med Chem,1993.0,CHEMBL422798,CHEMBL422798,5.80,0.0,http://www.openphacts.org/units/Nanomolar,254406.0,=,1.0,1.0,=,IC50,nM,1600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.6,CHEMBL378
3879,811354.0,[],CHEMBL711619,Antiviral activity against HIV-1 (strain RF) infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(COc1ccc(Cl)cc1C(=O)C1CCCC1)Nc1ccccc1,CHEMBL1128355,J Med Chem,1995.0,CHEMBL42066,CHEMBL42066,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,73229.0,=,1.0,1.0,=,IC50,ug.mL-1,0.22,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.22,CHEMBL378
3880,2244542.0,[],CHEMBL1002212,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase G190S mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL203420,CHEMBL203420,9.15,0.0,http://www.openphacts.org/units/Nanomolar,798654.0,=,1.0,1.0,=,IC50,nM,0.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.7,CHEMBL378
3881,5222612.0,[],CHEMBL1675305,Antiviral activity against HIV1 infected in human MT2 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL1460,CHEMBL1460,6.31,0.0,http://www.openphacts.org/units/Nanomolar,1332023.0,=,1.0,1.0,=,IC50,nM,490.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.49,CHEMBL378
3882,922836.0,[],CHEMBL677528,Antiviral activity against vaccinia virus (VV) in E6SM cell culture,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1nnc2c(N)nc(N)nc21)OCP(=O)(O)O,CHEMBL1129435,J Med Chem,1996.0,CHEMBL132902,CHEMBL132902,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251944.0,>,1.0,1.0,>,IC50,ug.mL-1,400.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,ug ml-1,UO_0000274,400.0,CHEMBL613493
3883,1218708.0,[],CHEMBL645946,Concentration required to inhibit activator protein-1(AP-1) mediated transcriptional activation in human Jurkat T-cells,B,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cnc(Cl)nc1-c1cccs1,CHEMBL1133475,J Med Chem,2000.0,CHEMBL128599,CHEMBL128599,5.10,0.0,http://www.openphacts.org/units/Nanomolar,247723.0,=,1.0,1.0,=,IC50,nM,8000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,8.0,CHEMBL4977
3884,5189162.0,[],CHEMBL1658799,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)NCC(=O)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652507,CHEMBL1652507,4.13,0.0,http://www.openphacts.org/units/Nanomolar,1326882.0,=,1.0,1.0,=,IC50,nM,74000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.074,CHEMBL613497
3885,3366926.0,[],CHEMBL1176162,Antiviral activity against HIV1 infected in human H9 cells after 4 days by p24 antigen ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CCC(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1177695,J Nat Prod,2010.0,CHEMBL446317,CHEMBL446317,4.80,0.0,http://www.openphacts.org/units/Nanomolar,924355.0,=,1.0,1.0,=,IC50,nM,16000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,16.0,CHEMBL378
3886,506276.0,[],CHEMBL752813,Inhibition to hepatitis C virus (HCV) NS3/NS4A serine protease,B,BAO_0000190,BAO_0000357,single protein format,CCC(C)[C@H](NC(=O)NCc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(F)F)C(=O)C(=O)O,CHEMBL1135212,Bioorg Med Chem Lett,2002.0,CHEMBL162162,CHEMBL162162,5.48,0.0,http://www.openphacts.org/units/Nanomolar,317200.0,=,1.0,1.0,=,IC50,nM,3300.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,3.3,CHEMBL4620
3887,8051466.0,[],CHEMBL1959807,Antiviral activity against HIV1 LAL infected in human MT2 cells by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2C[C@@H]3[C@@H](NS(C)(=O)=O)CO[C@@H]3C2)cc1,CHEMBL1955842,Bioorg Med Chem Lett,2012.0,CHEMBL1958485,CHEMBL1958485,7.30,0.0,http://www.openphacts.org/units/Nanomolar,1583261.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,50.0,CHEMBL378
3888,19450616.0,[],CHEMBL4433618,Antiviral activity against wild-type HIV1 NL4-3 infected in human TZM-bl cells infected with supernatants from virus-infected human MT2 cells treated with compound for 72 hrs assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay based monocycle assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(CCOC(=O)c2ccc(COc3ccccc3-c3csc(N)n3)cc2)cs1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4455200,CHEMBL4597428,5.92,0.0,http://www.openphacts.org/units/Nanomolar,3249760.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.2,CHEMBL378
3889,5230645.0,[],CHEMBL1680056,Antiviral activity against HIV-1 RF infected in human PM1 cells after 7 days by RT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1671644,Antimicrob Agents Chemother,2009.0,CHEMBL70663,CHEMBL70663,8.62,0.0,http://www.openphacts.org/units/Nanomolar,1331935.0,=,1.0,1.0,=,IC50,nM,2.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.4,CHEMBL378
3890,3284621.0,[],CHEMBL1110057,Antiviral activity against HIV1 3B infected in human HOS cells expressing human CXCR4/CCR5/CD4/pHIV-LTR luciferase assessed as inhibition of viral infection to cells,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(Cc1cccnc1)C1CCCc2cccnc21,CHEMBL1157822,Bioorg Med Chem Lett,2010.0,CHEMBL1097820,CHEMBL1097820,,0.0,http://www.openphacts.org/units/Nanomolar,911252.0,>,1.0,1.0,>,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,20000.0,CHEMBL378
3891,5230939.0,[],CHEMBL1677716,Antiviral activity against Human immunodeficiency virus 1 3B infected in human H9 cells infected with 12.5 uL of virus stock assessed as expression of p24 antigen after 6 days postinfection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL129,CHEMBL129,9.00,0.0,http://www.openphacts.org/units/Nanomolar,1332124.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
3892,3432856.0,[],CHEMBL1246459,Antiviral activity against R5 tropic HIV1 BaL infected in human CEMx174 5.25M7 cells after 3 days by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NN1C(=O)[C@@H]2C3C=CC(C4CC43)[C@@H]2C1=O)c1ccc(CNc2cccc(Cl)c2)cc1,CHEMBL1240449,Eur J Med Chem,2010.0,CHEMBL1242723,CHEMBL1242723,4.88,0.0,http://www.openphacts.org/units/Nanomolar,954047.0,=,1.0,1.0,=,IC50,nM,13260.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,13.26,CHEMBL378
3893,18585141.0,[],CHEMBL4223279,Antiviral activity against Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBsAg secretion after 3 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CCC(=O)OC(C)(C)[C@@H]5CC[C@]43C)[C@H]12,CHEMBL4219203,Bioorg Med Chem Lett,2018.0,CHEMBL596403,CHEMBL596403,,0.0,http://www.openphacts.org/units/Nanomolar,3086245.0,=,1.0,1.0,=,IC50,nM,284300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,284.3,CHEMBL613497
3894,18336744.0,[],CHEMBL4137334,Antiviral activity against recombinant pseudotyped HIV1 subtype B infected in human U87 cells expressing CD4/CCR5/CXCR4 by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c12,CHEMBL4130629,J Med Chem,2018.0,CHEMBL3301620,CHEMBL3301620,8.34,0.0,http://www.openphacts.org/units/Nanomolar,3044843.0,=,1.0,1.0,=,IC50,nM,4.59,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.59,CHEMBL378
3895,24823549.0,[],CHEMBL5140686,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBsAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3cc(Cl)ccc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5177922,CHEMBL5177922,8.43,0.0,http://www.openphacts.org/units/Nanomolar,3876723.0,=,1.0,1.0,=,IC50,nM,3.7,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0037,CHEMBL613497
3896,2929605.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(COCc3cccs3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL565690,CHEMBL565690,7.30,0.0,http://www.openphacts.org/units/Nanomolar,852894.0,=,1.0,1.0,=,IC50,nM,50.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,50.1,CHEMBL378
3897,18808329.0,[],CHEMBL4275448,Antiviral activity against Zika virus SMGC infected in BHK cells assessed as inhibition of virus induced cytopathic effect after 8 days by CellTiter-Glo luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)N(CCCNC(=O)Nc1cccc(C(F)(F)F)c1)C[C@H]1O[C@@H](n2cnc3c(NCc4cccc(Cl)c4)ncnc32)[C@H](O)[C@@H]1O,CHEMBL4270631,Eur J Med Chem,2018.0,CHEMBL4288845,CHEMBL4288845,5.34,0.0,http://www.openphacts.org/units/Nanomolar,3125049.0,=,1.0,1.0,=,IC50,nM,4560.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,4.56,CHEMBL4296612
3898,843551.0,[],CHEMBL713546,Compound potency to achieve protection of MT-4 cells from HIV-1 cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(NC(=O)NC(=N)/C=C/c2c(Cl)cccc2Cl)cc1,CHEMBL1134808,Bioorg Med Chem Lett,2001.0,CHEMBL71087,CHEMBL71087,5.70,0.0,http://www.openphacts.org/units/Nanomolar,126218.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.0,CHEMBL378
3899,18202556.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2cc3ccccc3n2C)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4061932,CHEMBL4061932,6.16,0.0,http://www.openphacts.org/units/Nanomolar,3019978.0,=,1.0,1.0,=,IC50,nM,700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.7,CHEMBL378
3900,1403524.0,[],CHEMBL834757,Inhibitory concentration against 181C mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Oc2cn(C)c(=O)c(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL366432,CHEMBL366432,6.80,0.0,http://www.openphacts.org/units/Nanomolar,360665.0,=,1.0,1.0,=,IC50,nM,159.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.159,CHEMBL378
3901,24509234.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5055345,Antiviral activity against HIV1 931N101 infected in human SupT1 cells assessed as inhibition of viral entry mesaured after 96 hrs by p24- ELISA assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C(C)NC(=S)NC1c1ccccc1C,CHEMBL5053552,Bioorg Med Chem,2021.0,CHEMBL4209320,CHEMBL4209320,5.28,0.0,http://www.openphacts.org/units/Nanomolar,3837685.0,=,1.0,1.0,=,IC50,nM,5200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.2,CHEMBL378
3902,12642509.0,[],CHEMBL2317525,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NCc1ccc(F)cc1)c1cn2ccn(CCN3CCOCC3)c(=O)c2c(O)c1=O,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314695,CHEMBL2314695,8.18,0.0,http://www.openphacts.org/units/Nanomolar,1844830.0,=,1.0,1.0,=,IC50,nM,6.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.6,CHEMBL378
3903,2263393.0,[],CHEMBL1010846,Antiviral activity against R5 tropic HIV1 BaL infected in human JC53-BL cells expressing CCR5 after 2 days by cell-cell fusion assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC1CN(CC2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2,CHEMBL1139267,Bioorg Med Chem Lett,2009.0,CHEMBL473651,CHEMBL473651,,0.0,http://www.openphacts.org/units/Nanomolar,749930.0,>,1.0,1.0,>,IC50,nM,5000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5000.0,CHEMBL378
3904,2602011.0,[],CHEMBL1034017,Antiviral activity against Vaccinia virus,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc2c(ncn2COC(CO)CO)c(=O)[nH]1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL182,CHEMBL182,,0.0,http://www.openphacts.org/units/Nanomolar,807579.0,=,1.0,1.0,=,IC50,nM,392000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,392.0,CHEMBL613493
3905,3104758.0,[],CHEMBL1074496,Antiviral activity against HIV1 LAI in human MT2 cells after 7 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1CNC(=O)[C@H]1N(C(=O)[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2CCOCOC2)CSC1(C)C,CHEMBL1159037,Bioorg Med Chem Lett,2010.0,CHEMBL599785,CHEMBL599785,,0.0,,883168.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
3906,13857140.0,[],CHEMBL3097946,Antiviral activity against enfuvirtide-resistant HIV-1 NL4-3 harboring gp41 (36G)V38E/N42S mutation infected in human MT2 cells assessed as inhibition of p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(/C=C2\SC(=S)N(Cc3ccc(C(C)(C)C)cc3)C2=O)c(C)n1-c1ccc(O)c(C(=O)O)c1,CHEMBL3091377,Bioorg Med Chem,2013.0,CHEMBL3092874,CHEMBL3092874,5.57,0.0,http://www.openphacts.org/units/Nanomolar,1952756.0,=,1.0,1.0,=,IC50,nM,2670.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.67,CHEMBL378
3907,593274.0,[],CHEMBL689615,Reduction of viral load in the cell supernatant.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2nc(/C=C/c3ccc(O)c(O)c3)ccc2c1,CHEMBL1135622,J Med Chem,2002.0,CHEMBL142358,CHEMBL142358,4.70,0.0,http://www.openphacts.org/units/Nanomolar,275331.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
3908,2930192.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CN3CC=CC3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL565702,CHEMBL565702,8.10,0.0,http://www.openphacts.org/units/Nanomolar,852918.0,=,1.0,1.0,=,IC50,nM,7.94,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.94,CHEMBL378
3909,19243760.0,[],CHEMBL4400278,Antiviral activity against Zika virus infected in human A549 cells assessed as reduction in viral titer incubated for 48 hrs by plaque assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CCSc1nnc(NC(=S)Nc2ccc(I)cc2)s1,CHEMBL4396960,Bioorg Med Chem Lett,2019.0,CHEMBL4514485,CHEMBL4514485,9.81,0.0,http://www.openphacts.org/units/Nanomolar,3212387.0,=,1.0,1.0,=,IC50,nM,0.1563,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,pM,UO_0000065,156.3,CHEMBL4296612
3910,15166097.0,[],CHEMBL3404734,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBeAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL1512620,CHEMBL1512620,,0.0,http://www.openphacts.org/units/Nanomolar,2284117.0,>,1.0,1.0,>,IC50,nM,3947900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,3947.9,CHEMBL613497
3911,2201549.0,[],CHEMBL949630,Antiviral activity against Parainfluenza virus type 3 infected in human Hep2 cells assessed as inhibition of virus-induced cytopathogenic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@@H]1[C@@H]2[C@H](Cc3occc3[C@@]2(C)O)[C@@]2(C)[C@@H](OC(C)=O)CCC(C)(C)[C@]2(O)[C@H]1OC(C)=O,CHEMBL1156352,J Nat Prod,2001.0,CHEMBL517323,CHEMBL517323,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,741014.0,=,1.0,1.0,=,IC50,ug.mL-1,10.3,CHEMBL613126,Human parainfluenza virus 3,Human parainfluenza virus 3,11216,IC50,ug ml-1,UO_0000274,10.3,CHEMBL613126
3912,3198130.0,[],CHEMBL1104126,Antiviral activity against HIV1 CMU06 infected in PBMCs assessed as reverse transcriptase activity after 7 days by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)CCNC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@@H](N)Cc1ccc(O)cc1,CHEMBL1153724,Bioorg Med Chem Lett,2009.0,CHEMBL1075830,CHEMBL1075830,4.72,0.0,http://www.openphacts.org/units/Nanomolar,889153.0,=,1.0,1.0,=,IC50,nM,19000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,19.0,CHEMBL378
3913,1438144.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1nccn1C,CHEMBL1138799,J Med Chem,2004.0,CHEMBL442222,CHEMBL442222,4.00,0.0,http://www.openphacts.org/units/Nanomolar,371547.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
3914,18509576.0,[],CHEMBL4191602,Antiviral activity against HIV1 isolate SF162 infected in PHA-stimulated human PBMC assessed as reduction in p24 level after 7 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(O[C@@H]3O[C@H](C)[C@@H](O)[C@H](O)[C@H]3O)c3c(c(-c4ccc5c(c4)OCO5)c2cc1OC)C(=O)OC3,CHEMBL4190218,J Nat Prod,2017.0,CHEMBL458904,CHEMBL458904,7.52,0.0,http://www.openphacts.org/units/Nanomolar,3073112.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,30.0,CHEMBL378
3915,3315845.0,[],CHEMBL1119774,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C[C@H]4CC[C@H](O)CC4)C[C@H]3c3ccccc3)CC2)CC1,CHEMBL1155507,Bioorg Med Chem Lett,2010.0,CHEMBL1085224,CHEMBL1085224,8.10,0.0,http://www.openphacts.org/units/Nanomolar,915687.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.0,CHEMBL378
3916,6218347.0,[],CHEMBL1785353,Antiviral activity against Human immunodeficiency virus 1 Bal-PBL,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2c(F)ccc(NS(C)(=O)=O)c2F)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784524,CHEMBL1784524,8.58,0.0,http://www.openphacts.org/units/Nanomolar,1429464.0,=,1.0,1.0,=,IC50,nM,2.63,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,8.58,CHEMBL378
3917,7924548.0,[],CHEMBL1921362,Antiviral activity against Human immunodeficiency virus 1 Ba-L in human PBL cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(NS(C)(=O)=O)cc2)ccc1CN1CCC(N(C(=O)Nc2cnc(C(N)=O)c(F)c2)c2cccc(F)c2)CC1,CHEMBL1914281,Bioorg Med Chem Lett,2011.0,CHEMBL1914521,CHEMBL1914521,8.96,0.0,http://www.openphacts.org/units/Nanomolar,1556596.0,=,1.0,1.0,=,IC50,nM,1.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.1,CHEMBL378
3918,5132856.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2cc(CN(Cc3ccco3)C(=O)c3ccc(C(C)(C)C)cc3)c(=O)[nH]c2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645075,CHEMBL1645075,,0.0,http://www.openphacts.org/units/Nanomolar,1321064.0,>,1.0,1.0,>,IC50,nM,14600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,14.6,CHEMBL378
3919,2601800.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C=C[C@@](C#N)(CO)O2)c(=O)[nH]c1=O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL512553,CHEMBL512553,5.16,0.0,http://www.openphacts.org/units/Nanomolar,806757.0,=,1.0,1.0,=,IC50,nM,7000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.0,CHEMBL378
3920,24788558.0,[],CHEMBL5131661,Antiviral activity against TIBO resistant HIV-1 mutant in monocyte,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,CHEMBL5131375,J Med Chem,2022.0,CHEMBL14762,CHEMBL14762,9.44,0.0,http://www.openphacts.org/units/Nanomolar,3869388.0,=,1.0,1.0,=,IC50,nM,0.36,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.36,CHEMBL378
3921,1199842.0,[],CHEMBL710376,Inhibitory activity against 100I strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Nc1nc(Nc2ccc(C#N)cc2)ncc1Br,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70517,CHEMBL70517,8.15,0.0,http://www.openphacts.org/units/Nanomolar,127456.0,=,1.0,1.0,=,IC50,nM,7.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.007,CHEMBL378
3922,18508387.0,[],CHEMBL4191338,Antiviral activity against VSV-G pseudotyped HIV1 infected in human SupT1 cells after 48 hrs by firefly luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL4190193,J Nat Prod,2017.0,CHEMBL223228,CHEMBL223228,8.40,0.0,http://www.openphacts.org/units/Nanomolar,3072817.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.0,CHEMBL378
3923,2594527.0,[],CHEMBL958175,Antiviral activity against X4-tropic HIV1 3B assessed as inhibition of viral attachment,F,BAO_0000190,BAO_0000218,organism-based format,C1=C(CS/C(=N\C2CCCCC2)NC2CCCC2)N2CCN=C2S1,CHEMBL1151747,J Med Chem,2008.0,CHEMBL460299,CHEMBL460299,6.33,0.0,http://www.openphacts.org/units/Nanomolar,726966.0,=,1.0,1.0,=,IC50,nM,470.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,470.0,CHEMBL378
3924,2099826.0,[],CHEMBL949222,Antiviral activity against HIV1 RU570 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1nc2c(n1[C@@H]1C[C@H]3CC[C@@H](C1)N3CCCN(C(=O)Nc1ccc(C)cc1)c1ccccc1)CCN(C(C)=O)C2,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL404843,CHEMBL404843,8.00,0.0,http://www.openphacts.org/units/Nanomolar,699408.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
3925,19262014.0,[],CHEMBL4404420,Antiviral activity against enfuvirtide-resistant HIV1 9490 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.03,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,940.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.94,CHEMBL378
3926,1401700.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,COCCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369066,CHEMBL369066,8.40,0.0,http://www.openphacts.org/units/Nanomolar,360388.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.004,CHEMBL378
3927,19261748.0,[],CHEMBL4404352,Antiviral activity against HIV1 HXB2 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cn2)[nH]1)c1nc(CO)c(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4563428,CHEMBL4563428,,0.0,http://www.openphacts.org/units/Nanomolar,3216287.0,>,1.0,1.0,>,IC50,nM,13000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,13.0,CHEMBL378
3928,15668309.0,[],CHEMBL3603049,Antiviral activity against HIV-1 HXB2 assessed as inhibition of viral fusion with human TZM-bl cells after 6 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O,CHEMBL3600350,Medchemcomm,2014.0,CHEMBL3601613,CHEMBL3601613,5.54,0.0,http://www.openphacts.org/units/Nanomolar,2493148.0,=,1.0,1.0,=,IC50,nM,2864.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2864.0,CHEMBL378
3929,1236127.0,[],CHEMBL878997,Inhibition of Hepatitis C RNA dependent RNA polymerase Nonstructural protein 5B activity.,B,BAO_0000190,BAO_0000357,single protein format,O=C(O)[C@H](Cc1ccccc1)N(Cc1cccc(Br)c1)C(=O)Nc1ccc(Cl)cc1Cl,CHEMBL1136248,Bioorg Med Chem Lett,2003.0,CHEMBL112120,CHEMBL112120,4.51,0.0,http://www.openphacts.org/units/Nanomolar,213335.0,=,1.0,1.0,=,IC50,nM,31000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,31.0,CHEMBL4620
3930,8051462.0,[],CHEMBL1959807,Antiviral activity against HIV1 LAL infected in human MT2 cells by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2C[C@@H]3[C@@H](NC(C)=O)CO[C@@H]3C2)cc1,CHEMBL1955842,Bioorg Med Chem Lett,2012.0,CHEMBL1958481,CHEMBL1958481,7.51,0.0,http://www.openphacts.org/units/Nanomolar,1583257.0,=,1.0,1.0,=,IC50,nM,31.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.0,CHEMBL378
3931,1740516.0,[],CHEMBL854478,Inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)n2c(CCN3C(=O)c4ccccc4C3=O)nc3cc(Cl)c(Cl)cc32)cc1,CHEMBL1138932,J Med Chem,2006.0,CHEMBL209545,CHEMBL209545,5.54,0.0,http://www.openphacts.org/units/Nanomolar,520770.0,=,1.0,1.0,=,IC50,nM,2900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.9,CHEMBL613497
3932,2713010.0,[],CHEMBL1054010,Antiviral activity against HIV1 3B in human MT4 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,CHEMBL1153004,Eur J Med Chem,2009.0,CHEMBL18442,CHEMBL18442,6.39,0.0,http://www.openphacts.org/units/Nanomolar,826238.0,=,1.0,1.0,=,IC50,nM,410.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.41,CHEMBL378
3933,309938.0,[],CHEMBL821329,Evaluated for 50% plaque inhibition of vaccinia virus replication in murine L929 cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nccc2c1ncn2C/C=C\CO,CHEMBL1124198,J Med Chem,1988.0,CHEMBL49737,CHEMBL49737,,0.0,http://www.openphacts.org/units/Nanomolar,80421.0,=,1.0,1.0,=,IC50,nM,300000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,300.0,CHEMBL613493
3934,612637.0,[],CHEMBL710381,Inhibitory activity against 103N strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Cc2nc(N)nc(Nc3ccc(C#N)cc3)n2)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL70745,CHEMBL70745,5.29,0.0,http://www.openphacts.org/units/Nanomolar,126889.0,=,1.0,1.0,=,IC50,nM,5080.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.08,CHEMBL378
3935,18452494.0,[],CHEMBL4178825,Antiviral activity against Chikungunya virus KC969208 infected in African green monkey Vero cells after 48 hrs by MTT dye-based assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOC(=O)c1ccccc1C(=O)O,CHEMBL4177563,Bioorg Med Chem,2017.0,CHEMBL2447930,CHEMBL2447930,4.54,0.0,http://www.openphacts.org/units/Nanomolar,3062340.0,=,1.0,1.0,=,IC50,nM,28620.0,CHEMBL4296563,Chikungunya virus,Chikungunya virus,37124,IC50,uM,UO_0000065,28.62,CHEMBL4296563
3936,2602159.0,[],CHEMBL1033990,Antiviral activity against Hepatitis B virus,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn(/C=C2\CC2(F)CO)c(=O)[nH]c1=O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL426177,CHEMBL426177,4.70,0.0,http://www.openphacts.org/units/Nanomolar,807411.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,20.0,CHEMBL613497
3937,43080.0,[],CHEMBL857692,Inhibitory concentration against HCV NS3 protease was determined,B,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)c1cnccn1)[C@@H](C)CC)C(=O)C(=O)NC1CC1,CHEMBL1136650,Bioorg Med Chem Lett,2003.0,CHEMBL13514,CHEMBL13514,5.66,0.0,http://www.openphacts.org/units/Nanomolar,12758.0,=,1.0,1.0,=,IC50,nM,2200.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,2.2,CHEMBL4620
3938,7967345.0,[],CHEMBL1930242,Antiviral activity against R5 tropic Human immunodeficiency virus 1 BAL infected in human PBMC cells assessed as reduction in viral replication by p24 detection based ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1ccc(N(Cc2ccccc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1,CHEMBL1926604,Bioorg Med Chem Lett,2011.0,CHEMBL1926876,CHEMBL1926876,6.75,0.0,http://www.openphacts.org/units/Nanomolar,1563493.0,=,1.0,1.0,=,IC50,nM,177.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.177,CHEMBL378
3939,1471284.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1ccccc1C,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188745,CHEMBL188745,5.10,0.0,http://www.openphacts.org/units/Nanomolar,380787.0,=,1.0,1.0,=,IC50,nM,7940.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.94,CHEMBL378
3940,24383448.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.5', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '12.5'}]",CHEMBL5039281,Antiviral activity against HIV 1 JRFL subtype B assessed as inhibition of viral entry preincubated for 30 min followed by U87-CD4-CRC5 positive cells addition and culture medium replacement after 12 hrs post infection and measured after 48 hrs by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC,CHEMBL5038580,J Med Chem,2022.0,CHEMBL5078598,CHEMBL5078598,6.45,0.0,http://www.openphacts.org/units/Nanomolar,3777695.0,=,1.0,1.0,=,IC50,nM,353.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,353.0,CHEMBL378
3941,3258187.0,[],CHEMBL1114358,Antiviral activity against HIV1 infected in human MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOc1c2cc(C(=O)Nc3cc(C(=O)O)cc(C(=O)NC4CCCCC4)c3)cc1Cc1cc(C(=O)Nc3cc(C(=O)O)cc(C(=O)NC4CCCCC4)c3)cc(c1OCCCC)Cc1cc(C(=O)Nc3cc(C(=O)O)cc(C(=O)NC4CCCCC4)c3)cc(c1OCCCC)Cc1cc(C(=O)Nc3cc(C(=O)O)cc(C(=O)NC4CCCCC4)c3)cc(c1OCCCC)C2,CHEMBL1156302,Bioorg Med Chem Lett,2010.0,CHEMBL1090294,CHEMBL1090294,,0.0,http://www.openphacts.org/units/Nanomolar,901398.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
3942,24777531.0,[],CHEMBL5128765,Antiviral activity against HIV-1 NL4-3(X4) infected in human TZM-bl cells assessed as reduction in viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@H](NC(=O)CCCCCCCNC(=O)[C@]12CCC(C)(C)C[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)[C@H](O)CC(=O)O,CHEMBL5126557,Bioorg Med Chem Lett,2022.0,CHEMBL5207868,CHEMBL5207868,5.50,0.0,http://www.openphacts.org/units/Nanomolar,3867171.0,=,1.0,1.0,=,IC50,nM,3200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.2,CHEMBL378
3943,170708.0,[],CHEMBL683693,Tested in vitro against human immunodeficiency virus (HIV) infected CEM cells using XTT assay (LAV-BRU strain),F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1cnc2c(O)nc(N)nc21)OCP(=O)(O)O,CHEMBL1126801,J Med Chem,1993.0,CHEMBL92761,CHEMBL92761,6.00,0.0,http://www.openphacts.org/units/Nanomolar,169340.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
3944,18342080.0,[],CHEMBL4139012,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2cc(NC(=O)c3ccccc3O)c[nH]c2=O)cc1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL4175367,CHEMBL4175367,4.33,0.0,http://www.openphacts.org/units/Nanomolar,3045858.0,=,1.0,1.0,=,IC50,nM,46380.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,46.38,CHEMBL613497
3945,3358063.0,[],CHEMBL1175711,Antiviral activity against HIV1 expressing reverse transcriptase Y188L mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3Cl)CC2)ncc1Br,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1171403,CHEMBL1171403,8.49,0.0,http://www.openphacts.org/units/Nanomolar,921747.0,=,1.0,1.0,=,IC50,nM,3.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.2,CHEMBL378
3946,2930147.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3cnnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL584409,CHEMBL584409,9.51,0.0,http://www.openphacts.org/units/Nanomolar,848312.0,=,1.0,1.0,=,IC50,nM,0.31,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.31,CHEMBL378
3947,2601461.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,C=CCc1c(N)nc(N)n(CCOCP(=O)(O)O)c1=O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL148716,CHEMBL148716,9.52,0.0,http://www.openphacts.org/units/Nanomolar,807187.0,=,1.0,1.0,=,IC50,nM,0.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0003,CHEMBL378
3948,5188256.0,[],CHEMBL1664702,Antiviral activity against HIV1 LAI infected in human MT2 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CCC[C@H]3OCC[C@@H]23)cc1,CHEMBL1649426,J Med Chem,2011.0,CHEMBL1651155,CHEMBL1651155,8.10,0.0,http://www.openphacts.org/units/Nanomolar,1324306.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
3949,2929601.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSCc3cccs3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL566761,CHEMBL566761,7.40,0.0,http://www.openphacts.org/units/Nanomolar,852781.0,=,1.0,1.0,=,IC50,nM,39.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,39.8,CHEMBL378
3950,19450607.0,[],CHEMBL4433618,Antiviral activity against wild-type HIV1 NL4-3 infected in human TZM-bl cells infected with supernatants from virus-infected human MT2 cells treated with compound for 72 hrs assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay based monocycle assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(-c2ccc(OCc3cccc(C(=O)N4CCN(C(=O)c5ccc(COc6ccccc6-c6csc(N)n6)cc5)CC4)c3)cc2)cs1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4581293,CHEMBL4595987,,0.0,http://www.openphacts.org/units/Nanomolar,3249751.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
3951,24823596.0,[],CHEMBL5140687,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBeAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3ccc([N+](=O)[O-])cc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5200859,CHEMBL5200859,7.74,0.0,http://www.openphacts.org/units/Nanomolar,3876732.0,=,1.0,1.0,=,IC50,nM,18.2,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0182,CHEMBL613497
3952,5230655.0,[],CHEMBL1680066,Antiviral activity against HIV-1 Bal infected in human TZM-bl cells after 24 hrs by luciferase reporter gene assay in presence of 12.5% cervical mucus,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1671644,Antimicrob Agents Chemother,2009.0,CHEMBL70663,CHEMBL70663,8.08,0.0,http://www.openphacts.org/units/Nanomolar,1331935.0,=,1.0,1.0,=,IC50,nM,8.32,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.32,CHEMBL378
3953,3221764.0,[],CHEMBL1102832,Antiviral activity against HIV1 carrying reverse transcriptase G109A mutant infected human MT4 cells by phenoscreen assay in the presence of 40 percent normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,CS(=O)(=O)c1ccc(NC(=O)CSC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,CHEMBL1153798,Bioorg Med Chem Lett,2009.0,CHEMBL1078944,CHEMBL1078944,,0.0,http://www.openphacts.org/units/Nanomolar,898067.0,=,1.0,1.0,=,IC50,nM,156800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,0.1568,CHEMBL378
3954,1402201.0,[],CHEMBL837468,In vitro inhibitory concentration against HIV L100I mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369599,CHEMBL369599,,0.0,http://www.openphacts.org/units/Nanomolar,360395.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3955,1219742.0,[],CHEMBL710372,Inhibitory activity against 100I strain and 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C#Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(C)cc(C)cc1C,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL71881,CHEMBL71881,7.15,0.0,http://www.openphacts.org/units/Nanomolar,127453.0,=,1.0,1.0,=,IC50,nM,71.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.071,CHEMBL378
3956,1173626.0,[],CHEMBL757806,Cytotoxicity against human peripheral blood mononuclear (PBM) cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c(=O)n([C@@H]2CS[C@H](CO)O2)cc1F,CHEMBL1126808,J Med Chem,1993.0,CHEMBL301450,CHEMBL301450,,0.0,http://www.openphacts.org/units/Nanomolar,100995.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
3957,2003643.0,[],CHEMBL901910,Antiviral activity against Modoc virus-infected HeLa-H1 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccccn1)c1ccc2[nH]c(-c3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3F)nc2c1,CHEMBL1138288,J Med Chem,2007.0,CHEMBL393953,CHEMBL393953,7.22,0.0,http://www.openphacts.org/units/Nanomolar,666641.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL612946,Modoc virus,Modoc virus,64300,IC50,nM,UO_0000065,60.0,CHEMBL612946
3958,24830977.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc2c(=O)c3cccc(F)c3oc2c1)c1ccccc1F,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5172274,CHEMBL5172274,,0.0,http://www.openphacts.org/units/Nanomolar,3878089.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
3959,19261986.0,[],CHEMBL4404410,Antiviral activity against HIV1 subtypeA infant B1206.W6P.ENV.A1A,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.28,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,530.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.53,CHEMBL378
3960,10863166.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=CCCOC(=O)[C@@]1(C)CC[C@]2(C)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024627,CHEMBL2024627,,0.0,http://www.openphacts.org/units/Nanomolar,1640523.0,=,1.0,1.0,=,IC50,nM,332040.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,332.04,CHEMBL613497
3961,16498300.0,[],CHEMBL3778316,Antiviral activity against HIV1 NL4-3 infected in human 293T cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1/C(=N\Nc2ccc3c(S(=O)(=O)O)cc(S(=O)(=O)O)cc3c2)C(c2ccccc2)=NN1c1nc(-c2ccccc2)cs1,CHEMBL3774382,Bioorg Med Chem,2016.0,CHEMBL3774987,CHEMBL3774987,5.15,0.0,http://www.openphacts.org/units/Nanomolar,2762408.0,=,1.0,1.0,=,IC50,nM,7100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.1,CHEMBL378
3962,24963905.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5216630,Antiviral activity against NNRTI resistant HIV1 LAI infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect measured after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Cc3c(Cl)cccc3Cl)n2)cc1,CHEMBL5214932,Eur J Med Chem,2022.0,CHEMBL307297,CHEMBL307297,8.20,0.0,http://www.openphacts.org/units/Nanomolar,3900014.0,=,1.0,1.0,=,IC50,nM,6.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0063,CHEMBL378
3963,18509575.0,[],CHEMBL4191602,Antiviral activity against HIV1 isolate SF162 infected in PHA-stimulated human PBMC assessed as reduction in p24 level after 7 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(O[C@@H]3O[C@H](C)[C@@H](O)[C@H](O)[C@H]3O)c3c(c(-c4ccc5c(c4)OCO5)c2cc1OC)C(=O)OC3,CHEMBL4190218,J Nat Prod,2017.0,CHEMBL458904,CHEMBL458904,7.43,0.0,http://www.openphacts.org/units/Nanomolar,3073111.0,=,1.0,1.0,=,IC50,nM,37.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,37.0,CHEMBL378
3964,2413644.0,[],CHEMBL987708,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)COc1ccccc1)[C@@H](OC(=O)COc1ccccc1)C(C)(C)O)C1=C2C[C@H](OC(=O)COc3ccccc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL455738,CHEMBL455738,,0.0,http://www.openphacts.org/units/Nanomolar,810693.0,>,1.0,1.0,>,IC50,nM,1300000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.3,CHEMBL613497
3965,70208.0,[],CHEMBL691106,Antiviral activity towards inhibition of replication of HIV-1-DAS infected monocyte-derived macrophage,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)c1ccn2c1CSC2c1cccnc1,CHEMBL1133726,J Med Chem,2000.0,CHEMBL67588,CHEMBL67588,4.30,0.0,http://www.openphacts.org/units/Nanomolar,119295.0,=,1.0,1.0,=,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
3966,20663978.0,[],CHEMBL4618924,Antiviral activity against wild type HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NCC(=O)N2CCOCC2)cc1,CHEMBL4616700,ACS Med Chem Lett,2020.0,CHEMBL4635226,CHEMBL4635226,5.88,0.0,http://www.openphacts.org/units/Nanomolar,3479377.0,=,1.0,1.0,=,IC50,nM,1332.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1332.0,CHEMBL378
3967,19262031.0,[],CHEMBL4404429,Antiviral activity against multidrug resistant HIV1 12241 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,5.77,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,1700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.7,CHEMBL378
3968,12660436.0,[],CHEMBL2329372,Antiviral activity against wild type Measles virus mWTFb infected in simian B95a cells assessed as virus-induced cytopathogenicity incubated for 30 mins prior to inoculation measured after 3 days by phase contrast microscopy,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,CHEMBL2321734,J Med Chem,2013.0,CHEMBL1643,CHEMBL1643,,0.0,http://www.openphacts.org/units/Nanomolar,1852696.0,=,1.0,1.0,=,IC50,nM,1160000.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,1160.0,CHEMBL613738
3969,1177575.0,[],CHEMBL757806,Cytotoxicity against human peripheral blood mononuclear (PBM) cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(F)nc2c1ncn2[C@@H]1CS[C@H](CO)O1,CHEMBL1126808,J Med Chem,1993.0,CHEMBL58544,CHEMBL58544,,0.0,http://www.openphacts.org/units/Nanomolar,100978.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
3970,10862014.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3CC=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL487933,CHEMBL487933,4.31,0.0,http://www.openphacts.org/units/Nanomolar,1637646.0,=,1.0,1.0,=,IC50,nM,48660.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,48.66,CHEMBL613497
3971,1437833.0,[],CHEMBL834620,Inhibitory activity against HIV-1 mutant strain 188L; ND = not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(NS(C)(=O)=O)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL359743,CHEMBL359743,,0.0,http://www.openphacts.org/units/Nanomolar,371462.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
3972,18528899.0,[],CHEMBL4195001,Antiviral activity against HIV1 virions containing reverse transcriptase K103N mutant derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)[C@H](c1cc(OC)c(OC)c(OC)c1)[C@@H](C)CC2,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4202482,CHEMBL4202482,6.82,0.0,http://www.openphacts.org/units/Nanomolar,3076502.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.15,CHEMBL378
3973,2649333.0,[],CHEMBL1024326,"Antiviral activity against HIV1 expressed in 293T cells assessed as protection against viral M33 envelope infection in human U87 cells coexpressing CD4, CCR5 receptors after 72 hrs by luciferase reporter gene pseudoviral assay",F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1ccc(-c2ncccc2F)cc1,CHEMBL1158460,J Med Chem,2009.0,CHEMBL559641,CHEMBL559641,5.70,0.0,http://www.openphacts.org/units/Nanomolar,815927.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2000.0,CHEMBL378
3974,578154.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3SSc3ccccc3C(=O)Nc3ccc(S(=O)(=O)Nc4cc(C)nc(C)n4)cc3)cc2)nc(C)n1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL354032,CHEMBL354032,4.74,0.0,http://www.openphacts.org/units/Nanomolar,333996.0,=,1.0,1.0,=,IC50,nM,18200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,18.2,CHEMBL378
3975,15568239.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,Cc1ccc(CN2CCN(C(=O)/C=C/c3ccc(Br)cc3)CC2)cc1,CHEMBL1201862,,,CHEMBL3561255,CHEMBL3561255,8.75,0.0,http://www.openphacts.org/units/Nanomolar,2476333.0,=,7.0,1.0,=,IC50,nM,1.77,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.00177,CHEMBL3259470
3976,2244492.0,[],CHEMBL1002214,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase V106M mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL223228,CHEMBL223228,8.14,0.0,http://www.openphacts.org/units/Nanomolar,798658.0,=,1.0,1.0,=,IC50,nM,7.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.2,CHEMBL378
3977,489741.0,[],CHEMBL871947,In vitro inhibition of recombinant HIV-1 IIIB mutant WT,F,BAO_0000190,BAO_0000218,organism-based format,CCN(c1ncccc1NC(C)(C)C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1129647,J Med Chem,1996.0,CHEMBL338979,CHEMBL338979,6.50,0.0,http://www.openphacts.org/units/Nanomolar,236794.0,=,1.0,1.0,=,IC50,nM,320.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.32,CHEMBL378
3978,17949623.0,[],CHEMBL3992323,Inhibition of human ASCT2 expressed in HEK cells assessed as reduction in [3H]-D-serine uptake after 1 min by beta counting analysis,B,BAO_0000190,BAO_0000219,cell-based format,N[C@H](C(=O)O)c1ccccc1,CHEMBL3991947,,2014.0,CHEMBL378605,CHEMBL378605,,0.0,http://www.openphacts.org/units/Nanomolar,2973775.0,<,38.0,1.0,<,IC50,nM,2000000.0,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,mM,UO_0000065,2.0,CHEMBL3562162
3979,12642430.0,[],CHEMBL2317522,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay in presence of human serum albumin,F,BAO_0000190,BAO_0000218,organism-based format,COCCN1CCn2cc(C(=O)NCc3ccc(F)cc3)c(=O)c(O)c2C1=O,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314694,CHEMBL2314694,7.75,0.0,http://www.openphacts.org/units/Nanomolar,1844829.0,=,1.0,1.0,=,IC50,nM,18.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,18.0,CHEMBL378
3980,18202592.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2ccc(Oc3ccccc3)nc2)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4062905,CHEMBL4062905,6.19,0.0,http://www.openphacts.org/units/Nanomolar,3019993.0,=,1.0,1.0,=,IC50,nM,640.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.64,CHEMBL378
3981,19450617.0,[],CHEMBL4433618,Antiviral activity against wild-type HIV1 NL4-3 infected in human TZM-bl cells infected with supernatants from virus-infected human MT2 cells treated with compound for 72 hrs assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay based monocycle assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(CCNC(=O)c2ccc(COc3ccccc3-c3csc(N)n3)cc2)cs1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4452270,CHEMBL4595393,,0.0,http://www.openphacts.org/units/Nanomolar,3249761.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
3982,2947335.0,[],CHEMBL1038497,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)O[C@@H](C[C@@H](C)C1=C2C[C@H](OC(=O)CCC)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)[C@@H](OC(=O)CCC)C(C)(C)OC(=O)CCC,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL573947,CHEMBL573947,,0.0,http://www.openphacts.org/units/Nanomolar,850746.0,=,1.0,1.0,=,IC50,nM,1800000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.8,CHEMBL613497
3983,5189190.0,[],CHEMBL1658799,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(/C=C/C(=O)OCCCc2c(-c3ccccc3Cl)c3cc(Cl)ccc3[nH]c2=O)c1,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652535,CHEMBL1652535,4.70,0.0,http://www.openphacts.org/units/Nanomolar,1326910.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.02,CHEMBL613497
3984,888106.0,[],CHEMBL685389,Inhibition of HIV replication in H9 cells.,F,BAO_0000190,BAO_0000218,organism-based format,C[C@]12CCCC[C@@]13O[C@H]3C(=O)C(C(N)=O)C2,CHEMBL1128512,J Med Chem,1995.0,CHEMBL320265,CHEMBL320265,4.99,0.0,http://www.openphacts.org/units/Nanomolar,204872.0,=,1.0,1.0,=,IC50,nM,10300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.3,CHEMBL378
3985,24731883.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5115940,Antiviral activity against ZIKV-SMGC-1 infected in human BHK cells incubated for 7 days by CellTiter 96 luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(c1ccc(C(F)(F)F)cc1O)c1[nH]c(Cl)c(Cl)c1-n1c(C(=O)c2ccc(C(F)(F)F)cc2O)cc(Cl)c1SCCO,CHEMBL5113415,Eur J Med Chem,2022.0,CHEMBL5201783,CHEMBL5201783,7.16,0.0,http://www.openphacts.org/units/Nanomolar,3857959.0,=,1.0,1.0,=,IC50,nM,70.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,0.07,CHEMBL4296612
3986,19261990.0,[],CHEMBL4404411,Antiviral activity against HIV1 subtypeA mother MI206.W0M.ENV.D1,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.16,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.7,CHEMBL378
3987,14658791.0,[],CHEMBL3266157,Antagonist activity at recombinant human EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)c3cccc(C)c3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262884,CHEMBL3262884,7.51,0.0,http://www.openphacts.org/units/Nanomolar,2101726.0,=,1.0,1.0,=,IC50,nM,31.0,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,nM,UO_0000065,31.0,CHEMBL3259470
3988,12680735.0,[],CHEMBL2342599,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/c1coc2cc(O)ccc2c1=O)Nc1ccccc1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333292,CHEMBL2333292,4.34,0.0,http://www.openphacts.org/units/Nanomolar,1867255.0,=,1.0,1.0,=,IC50,nM,45540.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,45.54,CHEMBL613497
3989,2602130.0,[],CHEMBL1033985,Antiviral activity against Cowpox virus,F,BAO_0000190,BAO_0000218,organism-based format,COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL866,CHEMBL866,5.50,0.0,http://www.openphacts.org/units/Nanomolar,808036.0,=,1.0,1.0,=,IC50,nM,3200.0,CHEMBL612672,Cowpox virus,Cowpox virus,10243,IC50,uM,UO_0000065,3.2,CHEMBL612672
3990,2929591.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cnnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL577247,CHEMBL577247,7.99,0.0,http://www.openphacts.org/units/Nanomolar,852824.0,=,1.0,1.0,=,IC50,nM,10.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.3,CHEMBL378
3991,2099838.0,[],CHEMBL949222,Antiviral activity against HIV1 RU570 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL272555,CHEMBL272555,8.30,0.0,http://www.openphacts.org/units/Nanomolar,699395.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.005,CHEMBL378
3992,3498040.0,[],CHEMBL1259500,Antiviral activity against HIV1 MNA infected in human PM1 cells expressing CCR5 assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)C(=O)NC2CCNCC2)cc1,CHEMBL1255517,Bioorg Med Chem Lett,2010.0,CHEMBL1256526,CHEMBL1256526,4.70,0.0,http://www.openphacts.org/units/Nanomolar,959552.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
3993,5250560.0,[],CHEMBL1687030,Antiviral activity against HIV1 93TH073-E infected in human PBMC assessed as reduction of p24 antigen production after 7 days,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2c(c1)nc(Nc1cccc(C(F)(F)F)c1)c1nc(NC3CC3)ncc12,CHEMBL1681725,Bioorg Med Chem Lett,2011.0,CHEMBL1682297,CHEMBL1682297,6.85,0.0,http://www.openphacts.org/units/Nanomolar,1333376.0,=,1.0,1.0,=,IC50,nM,140.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.14,CHEMBL378
3994,15054438.0,[],CHEMBL3366317,Antiviral activity against VSV-G protein pseudotyped HIV1 infected in 293T cells assessed as inhibition of viral replication after 48 hrs by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@@H]1C[C@](C)(C(=O)O)C[C@H]2C3=CC(=O)[C@@H]4[C@@]5(C)CC[C@H](O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]12C,CHEMBL3351428,J Nat Prod,2014.0,CHEMBL3314501,CHEMBL3314501,4.53,0.0,http://www.openphacts.org/units/Nanomolar,2244383.0,=,1.0,1.0,=,IC50,nM,29500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,29.5,CHEMBL378
3995,2244497.0,[],CHEMBL1003071,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase P225H mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL223228,CHEMBL223228,8.89,0.0,http://www.openphacts.org/units/Nanomolar,798658.0,=,1.0,1.0,=,IC50,nM,1.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.3,CHEMBL378
3996,1952444.0,[],CHEMBL890115,Anti-infective activity against HIV1 BAL in MAGI CCR5+ cells,F,BAO_0000190,BAO_0000218,organism-based format,CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2.Cl,CHEMBL1146303,Bioorg Med Chem Lett,2007.0,CHEMBL536754,CHEMBL1188566,8.22,0.0,http://www.openphacts.org/units/Nanomolar,646646.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.0,CHEMBL378
3997,2292378.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1ccccc1Cl,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL301086,CHEMBL301086,,0.0,http://www.openphacts.org/units/Nanomolar,813577.0,=,1.0,1.0,=,IC50,nM,4102041.03,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,2.387,CHEMBL378
3998,2201558.0,[],CHEMBL949630,Antiviral activity against Parainfluenza virus type 3 infected in human Hep2 cells assessed as inhibition of virus-induced cytopathogenic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](/C=C/[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,CHEMBL1156352,J Nat Prod,2001.0,CHEMBL400247,CHEMBL400247,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,741034.0,=,1.0,1.0,=,IC50,ug.mL-1,37.5,CHEMBL613126,Human parainfluenza virus 3,Human parainfluenza virus 3,11216,IC50,ug ml-1,UO_0000274,37.5,CHEMBL613126
3999,733248.0,[],CHEMBL688961,Antiviral activity against HIV-1 IIIB in H9 (human leukemia) cells.,F,BAO_0000190,BAO_0000218,organism-based format,O=c1cc(C(CC2CC2)CC2CC2)oc(O)c1C(c1cccc(NS(=O)(=O)c2ccccn2)c1)C1CC1,CHEMBL1129838,Bioorg Med Chem Lett,1997.0,CHEMBL130184,CHEMBL130184,,0.0,http://www.openphacts.org/units/Nanomolar,248554.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
4000,1401660.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Cc2cc(C)[nH]c(=O)c2N(C)C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177961,CHEMBL177961,6.40,0.0,http://www.openphacts.org/units/Nanomolar,360254.0,=,1.0,1.0,=,IC50,nM,398.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.398,CHEMBL378
4001,10863179.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCCCCCCCCO)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024640,CHEMBL2024640,4.88,0.0,http://www.openphacts.org/units/Nanomolar,1640536.0,=,1.0,1.0,=,IC50,nM,13230.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,13.23,CHEMBL613497
4002,663409.0,[],CHEMBL713945,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,Oc1nc2cccc3c2n1CC(c1ccccc1)NC3,CHEMBL1128252,J Med Chem,1995.0,CHEMBL163841,CHEMBL163841,,0.0,http://www.openphacts.org/units/Nanomolar,326352.0,>,1.0,1.0,>,IC50,nM,250000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,250.0,CHEMBL378
4003,3188302.0,[],CHEMBL1107773,Antiviral activity against HIV1 NLBal infected JC53BL cells assessed as inhibition of replication by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C2)C[C@@H]1C,CHEMBL1155421,Bioorg Med Chem Lett,2010.0,CHEMBL1077355,CHEMBL1077355,7.23,0.0,http://www.openphacts.org/units/Nanomolar,896400.0,=,1.0,1.0,=,IC50,nM,59.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,59.0,CHEMBL378
4004,24502932.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5053572,Antiviral activity against HIV1 NL4-3 Env-deficient pseudotype virus infected in human U87.CD4.CCR5.CXCR4 cells assessed by reduction in viral infection in early stage measured after 48 hrs by luciferase activity based single-round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C(=O)C(Cc1ccccc1)NC(=O)Cc1n[nH]c2c(N)cccc12)c1ccc2[nH]ncc2c1,CHEMBL5053482,J Med Chem,2021.0,CHEMBL5079461,CHEMBL5079461,5.62,0.0,http://www.openphacts.org/units/Nanomolar,3836458.0,=,1.0,1.0,=,IC50,nM,2420.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2420.0,CHEMBL378
4005,2601790.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(O)cc(OCCOCP(=O)(O)O)n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL504793,CHEMBL504793,,0.0,http://www.openphacts.org/units/Nanomolar,808010.0,=,1.0,1.0,=,IC50,nM,0.003,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.000003,CHEMBL378
4006,1402066.0,[],CHEMBL837466,In vitro inhibitory concentration against HIV K101E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,COCCCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL178689,CHEMBL178689,7.50,0.0,http://www.openphacts.org/units/Nanomolar,360393.0,=,1.0,1.0,=,IC50,nM,32.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.032,CHEMBL378
4007,312019.0,[],CHEMBL697276,In vitro inhibition of HIV-1 plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCSCC(C[N+](C)(C)CCO)OC.[Br-],CHEMBL1125666,J Med Chem,1991.0,CHEMBL28293,CHEMBL1178442,6.43,0.0,http://www.openphacts.org/units/Nanomolar,43720.0,=,1.0,1.0,=,IC50,nM,370.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.37,CHEMBL378
4008,1750569.0,[],CHEMBL868011,Antiviral activity against multi drug-resistant HIV1 K variant in human PHA-PBMC cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,CHEMBL1146019,J Med Chem,2006.0,CHEMBL163,CHEMBL163,7.24,0.0,http://www.openphacts.org/units/Nanomolar,539999.0,=,1.0,1.0,=,IC50,nM,57.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,57.0,CHEMBL378
4009,5202681.0,[],CHEMBL1671348,Antiviral activity against HIV1 pseudovirus infected in human B cell assessed as inhibition of infection,F,BAO_0000190,BAO_0000218,organism-based format,CCCOC(=O)CCCNC(=S)Nc1cc(OC)c(Cl)cc1OC,CHEMBL1667744,Eur J Med Chem,2011.0,CHEMBL1668155,CHEMBL1668155,8.96,0.0,http://www.openphacts.org/units/Nanomolar,1327744.0,=,1.0,1.0,=,IC50,nM,1.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.1,CHEMBL378
4010,18044749.0,[],CHEMBL4010406,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype C ZM135M.PL10a,F,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075766,CHEMBL4075766,6.60,0.0,http://www.openphacts.org/units/Nanomolar,2990214.0,=,1.0,1.0,=,IC50,nM,250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.25,CHEMBL378
4011,10961072.0,[],CHEMBL2061264,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing wild type protease infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCc1ccccc1)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058319,CHEMBL2058319,7.85,0.0,http://www.openphacts.org/units/Nanomolar,1656259.0,=,1.0,1.0,=,IC50,nM,14.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,14.0,CHEMBL378
4012,15679625.0,[],CHEMBL3607082,Antiviral activity against Tacaribe virus infected in African green monkey Vero 76 cells after 3 days by neutral red dye-based plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cnc(N)c2ncn([C@@H]3C=C(CO)[C@@H](O)[C@H]3O)c12,CHEMBL3603790,Bioorg Med Chem,2015.0,CHEMBL3603846,CHEMBL3603846,5.92,0.0,http://www.openphacts.org/units/Nanomolar,2494265.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL613131,Tacaribe virus,Tacaribe virus,11631,IC50,uM,UO_0000065,1.2,CHEMBL613131
4013,22806685.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@@H](Sc3cccc(OCc4ccccc4F)c3)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4788478,CHEMBL4788478,6.50,0.0,http://www.openphacts.org/units/Nanomolar,3541925.0,=,1.0,1.0,=,IC50,nM,318.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.318,CHEMBL613497
4014,19261725.0,[],CHEMBL4404352,Antiviral activity against HIV1 HXB2 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(N)[C@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cn2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4472326,CHEMBL4472326,6.30,0.0,http://www.openphacts.org/units/Nanomolar,3216261.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.5,CHEMBL378
4015,312014.0,[],CHEMBL653803,In vitro inhibition of CEM-SS cell growth by 50 %,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCOCC(COP(=O)(O)OCCNC(C)(C)C)OCC,CHEMBL1125666,J Med Chem,1991.0,CHEMBL283486,CHEMBL283486,5.00,0.0,http://www.openphacts.org/units/Nanomolar,43740.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
4016,18585117.0,[],CHEMBL4223280,Antiviral activity against Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBeAg secretion after 3 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CCC(=O)OC(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL4219203,Bioorg Med Chem Lett,2018.0,CHEMBL1631521,CHEMBL1631521,6.07,0.0,http://www.openphacts.org/units/Nanomolar,3086258.0,=,1.0,1.0,=,IC50,nM,860.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.86,CHEMBL613497
4017,323525.0,[],CHEMBL697276,In vitro inhibition of HIV-1 plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCOCC(CO)OCC,CHEMBL1125666,J Med Chem,1991.0,CHEMBL28985,CHEMBL28985,,0.0,http://www.openphacts.org/units/Nanomolar,43747.0,>,1.0,1.0,>,IC50,nM,5000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.0,CHEMBL378
4018,12687133.0,[],CHEMBL2344305,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral e antigen production,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)O[C@H]1C[C@@H]2C(=CC[C@@H]3[C@@]2(C)C(=O)C[C@]2(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](OC(C)=O)C[C@@]32C)C(C)(C)[C@@H]1OC(=O)CCC,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332402,CHEMBL2332402,,0.0,http://www.openphacts.org/units/Nanomolar,1866096.0,>,1.0,1.0,>,IC50,nM,608000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,608.0,CHEMBL613497
4019,149913.0,[],CHEMBL683865,Tested in vitro against human immunodeficiency virus (HIV) infected CEM cells using XTT assay (LAV-BRU strain); NA = not active at 100 uM,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(O)c2ncn(C[C@H](CCF)OCP(=O)(O)O)c2n1,CHEMBL1126801,J Med Chem,1993.0,CHEMBL92671,CHEMBL92671,,0.0,http://www.openphacts.org/units/Nanomolar,169332.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4020,600435.0,[],CHEMBL710381,Inhibitory activity against 103N strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)NC(=O)Nc1nc(Cc2c(Cl)cccc2Cl)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL303212,CHEMBL303212,5.12,0.0,http://www.openphacts.org/units/Nanomolar,126930.0,=,1.0,1.0,=,IC50,nM,7550.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.55,CHEMBL378
4021,2601672.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C(C)NP(=O)(OC[C@@H]1C=C[C@H](n2cc(C)c(=O)[nH]c2=O)O1)Oc1ccc(Br)cc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL320833,CHEMBL320833,8.52,0.0,http://www.openphacts.org/units/Nanomolar,807741.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
4022,1185688.0,[],CHEMBL645946,Concentration required to inhibit activator protein-1(AP-1) mediated transcriptional activation in human Jurkat T-cells,B,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1nnc(Cl)cc1C(F)(F)F,CHEMBL1133475,J Med Chem,2000.0,CHEMBL128708,CHEMBL128708,5.00,1.0,http://www.openphacts.org/units/Nanomolar,247709.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,10.0,CHEMBL4977
4023,2095562.0,[],CHEMBL932073,Antiviral activity against HIV1 infected MT4 cells in presence of 50% NHS,F,BAO_0000190,BAO_0000218,organism-based format,CNC(=O)c1nn2c(c1O)C(=O)N(Cc1ccc(F)cc1)CC2,CHEMBL1142310,Bioorg Med Chem Lett,2008.0,CHEMBL255326,CHEMBL255326,,0.0,http://www.openphacts.org/units/Nanomolar,693931.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10000.0,CHEMBL378
4024,6152236.0,[],CHEMBL1763053,Antiviral activity against Human immunodeficiency virus 1 BAL infected in human PBMC assessed as inhibition of viral replication by p24 antigen specific ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2(c3ccc(C(F)(F)F)cc3)Cc3ccccc3O2)CC1,CHEMBL1759996,Bioorg Med Chem Lett,2011.0,CHEMBL1762314,CHEMBL1762314,6.66,0.0,http://www.openphacts.org/units/Nanomolar,1414765.0,=,1.0,1.0,=,IC50,nM,220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.22,CHEMBL378
4025,15602730.0,[],CHEMBL3578657,Inhibition of ASCT2-mediated [3H]glutamine uptake in HEK293 cells after 15 mins by Live-cell glutamine uptake assay,B,BAO_0000190,BAO_0000219,cell-based format,N[C@@H](CCC(=O)NCc1ccccc1N1CCOCC1)C(=O)O,CHEMBL3576761,Bioorg Med Chem Lett,2015.0,CHEMBL3576942,CHEMBL3576942,,0.0,,2479439.0,,1.0,0.0,,IC50,,,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,,,,CHEMBL3562162
4026,14641486.0,[],CHEMBL3268999,Antagonist activity at EBI2 receptor in human U937 cells assessed as inhibition of oxysterol-induced calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(=O)N2CCN(C(=O)/C=C/c3ccc(Br)cc3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262896,CHEMBL3262896,8.05,0.0,http://www.openphacts.org/units/Nanomolar,2101738.0,=,1.0,1.0,=,IC50,nM,9.0,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,nM,UO_0000065,9.0,CHEMBL3259470
4027,23227906.0,[],CHEMBL4825946,Antiviral activity against Respiratory syncytial virus A by Plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,NCc1ccc2c(c1)nc(CN1C(=O)C3(CC3)c3ccc(F)cc31)n2CCCC(F)(F)F,CHEMBL4825662,J Med Chem,2021.0,CHEMBL4297497,CHEMBL4297497,8.85,0.0,http://www.openphacts.org/units/Nanomolar,3612995.0,=,1.0,1.0,=,IC50,nM,1.4,CHEMBL613127,Human respiratory syncytial virus,Human respiratory syncytial virus,11250,IC50,nM,UO_0000065,1.4,CHEMBL613127
4028,1204238.0,[],CHEMBL645946,Concentration required to inhibit activator protein-1(AP-1) mediated transcriptional activation in human Jurkat T-cells,B,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cnc(Cl)nc1Cl,CHEMBL1133475,J Med Chem,2000.0,CHEMBL340779,CHEMBL340779,6.70,1.0,http://www.openphacts.org/units/Nanomolar,247702.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.2,CHEMBL4977
4029,1252277.0,[],CHEMBL824448,Concentration required to inhibit parainfluenza-3 induced cytopathicity in Vero cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCC(=O)N(CC)CCCCCCCCCCC(=O)NCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL116526,CHEMBL1205574,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221531.0,>,1.0,1.0,>,IC50,ug.mL-1,200.0,CHEMBL613126,Human parainfluenza virus 3,Human parainfluenza virus 3,11216,IC50,ug ml-1,UO_0000274,200.0,CHEMBL613126
4030,18754888.0,[],CHEMBL4265061,Antiviral activity against HIV1 cYTA48P infected in PM1/CCR5 cells by single round assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1CCN(C(=O)c2cc3ccc(Cl)cc3n2C)CC1,CHEMBL4261625,Bioorg Med Chem,2018.0,CHEMBL4292005,CHEMBL4292005,,0.0,http://www.openphacts.org/units/Nanomolar,3116234.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
4031,3129679.0,[],CHEMBL1065523,Antiviral activity against HIV1 BaL infected in human PBMC assessed as inhibition of viral replication by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(-c2nc(COc3c4cccc3Cc3cccc(c3O)Cc3cccc(c3Oc3nc(-c5nc(C)c(C(=O)[O-])s5)sc3C(=O)[O-])Cc3cccc(c3O)C4)c(C(=O)[O-])s2)sc1C(=O)[O-].[Na+].[Na+].[Na+].[Na+],CHEMBL1157689,Bioorg Med Chem,2010.0,CHEMBL590717,CHEMBL1208391,4.92,0.0,http://www.openphacts.org/units/Nanomolar,880940.0,=,1.0,1.0,=,IC50,nM,12000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.0,CHEMBL378
4032,2061735.0,[],CHEMBL942898,Inhibition of HIV HXB2 in TZM-bl cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,CCC(C)/C=C(C)/C=C\C(O)C(C)(O)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1C(=O)N[C@H](COC)C(=O)NCC(=O)N[C@@H](C)C(=O)N(C)[C@@H]([C@@H](C)O)C(=O)N[C@H]([C@H](OC)c2ccc(O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)cc2)C(=O)N2CC[C@H](Cl)C[C@H]2C(=O)O[C@@H]1C(C)C)[C@@H](C)[C@@H](C)C(N)=O)[C@@H](C)N)[C@@H](C)O,CHEMBL1141334,J Nat Prod,2007.0,CHEMBL429406,CHEMBL429406,6.85,0.0,http://www.openphacts.org/units/Nanomolar,684423.0,=,1.0,1.0,=,IC50,nM,140.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.14,CHEMBL378
4033,2601974.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1cc2ccc(Cl)cc2n1S(=O)(=O)c1ccc(Cl)cc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL82103,CHEMBL82103,,0.0,http://www.openphacts.org/units/Nanomolar,807853.0,=,1.0,1.0,=,IC50,nM,200000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,200.0,CHEMBL378
4034,1088560.0,[],CHEMBL750937,In vitro inhibitory activity against influenza B neuraminidase using enzymatic assay,F,BAO_0000190,BAO_0000218,organism-based format,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](N)[C@H]1NC(C)=O,CHEMBL1132511,Bioorg Med Chem Lett,1999.0,CHEMBL674,CHEMBL674,8.40,0.0,http://www.openphacts.org/units/Nanomolar,176014.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,nM,UO_0000065,4.0,CHEMBL613129
4035,537842.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1[S+]([O-])c1cc(Cl)ccc1Cl,CHEMBL1134494,J Med Chem,2001.0,CHEMBL292012,CHEMBL292012,5.01,0.0,http://www.openphacts.org/units/Nanomolar,94206.0,=,1.0,1.0,=,IC50,nM,9850.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,9.85,CHEMBL378
4036,608333.0,[],CHEMBL691383,Inhibitory concentration for cytopathicity of HIV-1 (HTLV-IIIB) in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C1=CC(=C(c2ccc(O)c(C(=O)O)c2)c2ccc(O)c(C(=O)O)c2)C=CC1=O,CHEMBL1125737,J Med Chem,1991.0,CHEMBL275938,CHEMBL275938,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,217786.0,=,1.0,1.0,=,IC50,ug.mL-1,2.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,2.1,CHEMBL378
4037,19261857.0,[],CHEMBL4404367,Antiviral activity against HIV1 subtypeA2/D QG393.60M.ENV.B7,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.77,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,170.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.17,CHEMBL378
4038,1470575.0,[],CHEMBL832526,Inhibitory activity against HIV-1 double mutants strain 103N and 181C,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL338047,CHEMBL338047,6.10,0.0,http://www.openphacts.org/units/Nanomolar,380766.0,=,1.0,1.0,=,IC50,nM,790.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.79,CHEMBL378
4039,1224901.0,[],CHEMBL710372,Inhibitory activity against 100I strain and 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72335,CHEMBL72335,6.10,0.0,http://www.openphacts.org/units/Nanomolar,127434.0,=,1.0,1.0,=,IC50,nM,798.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.798,CHEMBL378
4040,1402479.0,[],CHEMBL834488,In vitro inhibitory concentration against HIV L100I and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177666,CHEMBL177666,6.70,0.0,http://www.openphacts.org/units/Nanomolar,360358.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.2,CHEMBL378
4041,2099734.0,[],CHEMBL949218,Antiviral activity against HIV1 JRCSF by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2cccc(F)c2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL403954,CHEMBL403954,8.05,0.0,http://www.openphacts.org/units/Nanomolar,699410.0,=,1.0,1.0,=,IC50,nM,9.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.009,CHEMBL378
4042,5126317.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,COCCN/C=C1\C(=O)N(C)c2ccc(C(F)(F)F)cc2N(c2cccc(Cl)c2)C1=O,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642313,CHEMBL1642313,5.11,0.0,http://www.openphacts.org/units/Nanomolar,1317603.0,=,1.0,1.0,=,IC50,nM,7800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.8,CHEMBL378
4043,293618.0,[],CHEMBL706841,Antiviral activity by observing cytopathic effect induced by HIV-1 strain IIIB in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)[C@@H](NCc1ccc(Cl)cc1)C(=O)N[C@H](C(=O)NCc1nc2ccccc2[nH]1)C(C)C,CHEMBL1127464,J Med Chem,1994.0,CHEMBL104612,CHEMBL104612,6.92,0.0,http://www.openphacts.org/units/Nanomolar,195845.0,=,1.0,1.0,=,IC50,nM,120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,120.0,CHEMBL378
4044,8043639.0,[],CHEMBL1953039,Antiviral activity against HIV1 3B infected human TZM-bl cells assessed as inhibition of viral replication by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@@H](C)C(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/N[C@@H](C)C(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+],CHEMBL1949531,Bioorg Med Chem Lett,2012.0,CHEMBL1949747,CHEMBL1962391,5.91,0.0,http://www.openphacts.org/units/Nanomolar,1576815.0,=,1.0,1.0,=,IC50,nM,1220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.22,CHEMBL378
4045,16466899.0,[],CHEMBL3766104,Antiviral activity against HIV1 NL4-3 infected in TZM-bl cells incubated for 3 hrs measured after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=S)n1nc(-c2ccc([N+](=O)[O-])cc2)c(CCc2cccc(Cl)c2)c1O,CHEMBL3763152,Bioorg Med Chem Lett,2016.0,CHEMBL3764253,CHEMBL3764253,6.16,0.0,http://www.openphacts.org/units/Nanomolar,2756508.0,=,1.0,1.0,=,IC50,nM,690.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.69,CHEMBL378
4046,2930374.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3ccnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL568278,CHEMBL568278,8.60,0.0,http://www.openphacts.org/units/Nanomolar,852867.0,=,1.0,1.0,=,IC50,nM,2.51,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.51,CHEMBL378
4047,10938650.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4cccc(OC(F)(F)F)c4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046569,CHEMBL2046569,,0.0,http://www.openphacts.org/units/Nanomolar,1651452.0,=,1.0,1.0,=,IC50,nM,235590.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,235.59,CHEMBL613497
4048,551569.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)cc(Sc2cccc(N)c2C#N)c1,CHEMBL1134494,J Med Chem,2001.0,CHEMBL56324,CHEMBL56324,5.75,0.0,http://www.openphacts.org/units/Nanomolar,94246.0,=,1.0,1.0,=,IC50,nM,1760.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.76,CHEMBL378
4049,15571662.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,CCC(C)N1CCN(C(=O)/C=C/c2ccc(Br)cc2)CC1,CHEMBL1201862,,,CHEMBL3561798,CHEMBL3561798,8.65,0.0,http://www.openphacts.org/units/Nanomolar,2477260.0,=,7.0,1.0,=,IC50,nM,2.23,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.00223,CHEMBL3259470
4050,1472287.0,[],CHEMBL834620,Inhibitory activity against HIV-1 mutant strain 188L; ND = not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C(\C#N)c2cccs2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188837,CHEMBL188837,,0.0,http://www.openphacts.org/units/Nanomolar,380931.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4051,18044692.0,[],CHEMBL4010439,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype A KNH1144,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.28,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,530.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.53,CHEMBL378
4052,1220997.0,[],CHEMBL880061,Inhibitory activity against LAI strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70663,CHEMBL70663,9.00,0.0,http://www.openphacts.org/units/Nanomolar,127468.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
4053,15159565.0,[],CHEMBL3398834,Inhibition of HBV DNA replication in HepG2(2.2.15) cells exposed to fresh medium supplemented with compound every other day for additional 5 days by real-time PCR-fluorescent probing method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OCc1cccc2c1CCOC2=O)c1ccco1,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397180,CHEMBL3397180,,0.0,http://www.openphacts.org/units/Nanomolar,2278979.0,>,1.0,1.0,>,IC50,nM,840000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.84,CHEMBL613497
4054,396624.0,[],CHEMBL754011,Inhibition of human peripheral blood mononuclear cell (PBMC)donor B proliferation; ND means not determined.,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCC(=O)CC(=O)N[C@H]1CCOC1=O,CHEMBL1145979,J Med Chem,2003.0,CHEMBL463321,CHEMBL463321,,0.0,,4333.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4055,2091770.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1ccc(Cl)cc1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL433488,CHEMBL433488,,0.0,http://www.openphacts.org/units/Nanomolar,700516.0,=,1.0,1.0,=,IC50,nM,331131121482.59,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,2.52,CHEMBL378
4056,2099789.0,[],CHEMBL949220,Antiviral activity against HIV1 BaL by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL271854,CHEMBL271854,7.75,0.0,http://www.openphacts.org/units/Nanomolar,699400.0,=,1.0,1.0,=,IC50,nM,18.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.018,CHEMBL378
4057,1672755.0,[],CHEMBL870624,Antiviral activity against HIV1 K103N mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(NCCCN2CCCC2)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(F)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL200988,CHEMBL200988,6.96,0.0,http://www.openphacts.org/units/Nanomolar,411940.0,=,1.0,1.0,=,IC50,nM,109.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,109.0,CHEMBL378
4058,2614789.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)cc([S+]([O-])c2cccc(N)c2C#N)c1,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL55862,CHEMBL55862,,0.0,http://www.openphacts.org/units/Nanomolar,731710.0,=,1.0,1.0,=,IC50,nM,319889.51,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,3.495,CHEMBL378
4059,18469024.0,[],CHEMBL4182244,Antiviral activity against HIV-1 3B infected in human TZM-bl cells treated for 2 hrs followed by compound washout measured after 2 days by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NCC(=O)NCC(=O)NCC(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/NCC(=O)NCC(=O)NCC(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+],CHEMBL4177704,Bioorg Med Chem Lett,2018.0,CHEMBL4204518,CHEMBL4301015,5.18,0.0,http://www.openphacts.org/units/Nanomolar,3065400.0,=,1.0,1.0,=,IC50,nM,6620.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,umol/L,UO_0000065,6.62,CHEMBL378
4060,2149853.0,[],CHEMBL935682,Antiviral activity against HIV1 098-T1249 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL428607,CHEMBL428607,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708034.0,=,1.0,1.0,=,IC50,ug.mL-1,0.015,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.015,CHEMBL378
4061,13464660.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1cccc(Cl)c1,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL291532,CHEMBL291532,6.23,0.0,http://www.openphacts.org/units/Nanomolar,1920710.0,=,1.0,1.0,=,IC50,nM,588.84,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.23,CHEMBL378
4062,350500.0,[],CHEMBL693754,Evaluated in vitro for the concentration required to produce 50% inhibition of replication of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C3=CN(C)C=CC3)O2)c(=O)[nH]c1=O,CHEMBL1124778,J Med Chem,1990.0,CHEMBL3350999,CHEMBL3350999,7.30,0.0,http://www.openphacts.org/units/Nanomolar,58320.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.05,CHEMBL378
4063,18406014.0,[],CHEMBL4150963,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)/C=C1/C=C([C@H]2CC[C@@]3(C)[C@@H]4CC[C@H]5C(C)(C)C(=O)C=C[C@@]56C[C@@]46CC[C@]23C)C(=O)N1,CHEMBL4145651,J Nat Prod,2018.0,CHEMBL4165278,CHEMBL4165278,,0.0,,3054860.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4064,3397925.0,[],CHEMBL1217302,Antiviral activity against HIV1 3B infected in human MT4 cells after 5 days by p24 antigen detection assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1C(c2ccc(O)c(O)c2)=c2c(c3c(n2CCc2ccc(O)cc2)=C(c2ccc(O)c(OS(=O)(=O)O)c2)C(=O)c2cc(O)c(O)cc2-3)-c2cc(O)c(O)cc21,CHEMBL1212851,Bioorg Med Chem,2010.0,CHEMBL1214279,CHEMBL1214279,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,931711.0,=,1.0,1.0,=,IC50,ug.mL-1,2.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,2.2,CHEMBL378
4065,18044521.0,[],CHEMBL4010365,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of p24 antigen production pretreated with virus for 30 mins followed by 4 days incubation with cells by sandwich ELISA based multicycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.01,0.0,http://www.openphacts.org/units/Nanomolar,2990216.0,=,1.0,1.0,=,IC50,nM,970.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.97,CHEMBL378
4066,16768173.0,[],CHEMBL3863543,Inhibition of CD4-dependent CCR5-tropic HIV1 ADA cell to cell transmission using Ghost X4/R5 cells as target cells and MOLT4 as effector cells assessed as p24 release incubated for 4 hrs by sandwich ELISA method,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nc([C@H](CN)NC(=O)c2ccc(-c3ccc(Cl)c(F)c3)[nH]2)sc1CO,CHEMBL3862013,Bioorg Med Chem,2016.0,CHEMBL3964137,CHEMBL3964137,4.62,0.0,http://www.openphacts.org/units/Nanomolar,2803412.0,=,1.0,1.0,=,IC50,nM,24000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,24.0,CHEMBL378
4067,5132811.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)n2c3ccccc3n(C[C@H](O)N3CCN(CCOc4ccc(Cl)cc4)CC3)c2c1C#N,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645089,CHEMBL1645089,5.16,0.0,http://www.openphacts.org/units/Nanomolar,1321078.0,=,1.0,1.0,=,IC50,nM,6900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.9,CHEMBL378
4068,619399.0,[],CHEMBL710534,Inhibitory activity against 188L strain of HIV-1 in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)c(Oc2ncnc(Nc3ccc(C#N)cc3)n2)c(Br)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL302542,CHEMBL302542,6.40,0.0,http://www.openphacts.org/units/Nanomolar,126919.0,=,1.0,1.0,=,IC50,nM,398.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.398,CHEMBL378
4069,22845187.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721661,"Antiviral activity against pseudovirus HIV-1 HXB-2 subtype C harboring pseudotyped Env Du156, clone 12 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based assay",F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1nc(CO)cs1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4761836,CHEMBL4761836,7.03,0.0,http://www.openphacts.org/units/Nanomolar,3547085.0,=,1.0,1.0,=,IC50,nM,94.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.094,CHEMBL378
4070,2929583.0,[],CHEMBL1056892,Antiviral activity against HIV1 HXB2 harboring 100I mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3cnnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL584409,CHEMBL584409,9.10,0.0,http://www.openphacts.org/units/Nanomolar,848312.0,=,1.0,1.0,=,IC50,nM,0.79,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.79,CHEMBL378
4071,18683294.0,[],CHEMBL4237097,Antiviral activity against CCR5-dependent HIV1 Ba-L infected in human PBMC assessed as reduction in virus infection measured 7 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCCCC1)c1cccs1,CHEMBL4229569,J Med Chem,2018.0,CHEMBL4242114,CHEMBL4242114,6.33,0.0,http://www.openphacts.org/units/Nanomolar,3103097.0,=,1.0,1.0,=,IC50,nM,463.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,463.9,CHEMBL378
4072,13463737.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1Sc1ccccc1,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL52068,CHEMBL52068,4.84,0.0,http://www.openphacts.org/units/Nanomolar,1920854.0,=,1.0,1.0,=,IC50,nM,14454.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.84,CHEMBL378
4073,6218334.0,[],CHEMBL1785353,Antiviral activity against Human immunodeficiency virus 1 Bal-PBL,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2F)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784512,CHEMBL1784512,7.37,0.0,http://www.openphacts.org/units/Nanomolar,1429451.0,=,1.0,1.0,=,IC50,nM,42.66,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.37,CHEMBL378
4074,2614813.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL56135,CHEMBL56135,4.70,0.0,http://www.openphacts.org/units/Nanomolar,732076.0,=,1.0,1.0,=,IC50,nM,19998.62,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.699,CHEMBL378
4075,18849439.0,[],CHEMBL4305534,Inhibition of recombinant N-terminal His-tagged human FER (SH2 domain to C-terminal) expressed in Escherichia coli assessed as decrease in FL-Peptide22 substrate phosphorylation incubated for 90 mins,B,BAO_0000190,BAO_0000019,assay format,CC(=O)N[C@H]1CCCC[C@H]1Nc1nc(Nc2cccc(C)c2)c(C(N)=O)cc1C#N,CHEMBL4304751,ACS Med Chem Lett,2019.0,CHEMBL4552333,CHEMBL4552333,6.36,0.0,http://www.openphacts.org/units/Nanomolar,3145965.0,=,1.0,1.0,=,IC50,nM,440.0,CHEMBL3982,Homo sapiens,Tyrosine-protein kinase FER,9606,IC50,nM,UO_0000065,440.0,CHEMBL3982
4076,2371539.0,[],CHEMBL1035737,Antiviral activity against HIV1 with reverse transcriptase G190S mutant in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4nc(N)ccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL489586,CHEMBL489586,8.12,0.0,http://www.openphacts.org/units/Nanomolar,773548.0,=,1.0,1.0,=,IC50,nM,7.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.6,CHEMBL378
4077,1403520.0,[],CHEMBL837591,Inhibitory concentration against wild-type HIV-1 LAI Virus was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Oc2cn(C)c(=O)c(Nc3ccc(C(F)(F)F)cc3)n2)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL177506,CHEMBL177506,6.30,0.0,http://www.openphacts.org/units/Nanomolar,360659.0,=,1.0,1.0,=,IC50,nM,501.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.501,CHEMBL378
4078,16662892.0,[],CHEMBL3832827,AntiDengue activity HCI DV3/A549 IC50 (uM),F,BAO_0000190,BAO_0000218,organism-based format,O=C1[C@@H](Oc2ccccc2)[C@@H](c2ccc(Cl)cc2)N1CCn1cnc2c(NCc3ccccc3)ncnc21,CHEMBL3832761,,,CHEMBL2064298,CHEMBL2064298,5.40,0.0,http://www.openphacts.org/units/Nanomolar,2790121.0,=,34.0,1.0,=,IC50,nM,4000.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,4.0,CHEMBL613757
4079,541623.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1Sc1cccc(C(F)(F)F)c1,CHEMBL1134494,J Med Chem,2001.0,CHEMBL293963,CHEMBL293963,4.89,0.0,http://www.openphacts.org/units/Nanomolar,94248.0,=,1.0,1.0,=,IC50,nM,12800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.8,CHEMBL378
4080,14596861.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CCCOCn1c(Sc2ccccc2)c(C)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL40091,CHEMBL40091,5.26,0.0,http://www.openphacts.org/units/Nanomolar,2082381.0,=,1.0,1.0,=,IC50,nM,5480.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.48,CHEMBL378
4081,2371457.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2c(c1)NC(=O)C(CSCc1ccccc1Cl)N2,CHEMBL1140145,J Med Chem,2008.0,CHEMBL493098,CHEMBL493098,,0.0,http://www.openphacts.org/units/Nanomolar,746084.0,=,1.0,1.0,=,IC50,nM,450000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,450.0,CHEMBL613493
4082,13311255.0,[],CHEMBL2383586,Antiviral activity against HIV1 HXB2 infected in HEK293T cells by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC)[C@@H](C)O,CHEMBL2380233,Bioorg Med Chem Lett,2013.0,CHEMBL3037905,CHEMBL3037905,5.88,0.0,http://www.openphacts.org/units/Nanomolar,1893452.0,=,1.0,1.0,=,IC50,nM,1310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1310.0,CHEMBL378
4083,18183422.0,[],CHEMBL4040188,Antiviral activity against CCR5 tropic HIV1 BaL infected in human PHA-stimulated PBMC assessed as inhibition of viral replication by measuring reduction in p24 antigen production preincubated with cells for 30 mins followed by viral infection measured on day 10 post infection in presence of IL-2 by ELISA,F,BAO_0000190,BAO_0000019,assay format,CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)Oc1ccccc1,CHEMBL4038313,J Med Chem,2017.0,CHEMBL2107825,CHEMBL2107825,8.00,0.0,http://www.openphacts.org/units/Nanomolar,3016406.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
4084,2602276.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C(Cc1ccc(O)c(O)c1)C(Cc1ccc(O)c(O)c1)C(=O)O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL120931,CHEMBL120931,5.37,0.0,http://www.openphacts.org/units/Nanomolar,807223.0,=,1.0,1.0,=,IC50,nM,4320.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.32,CHEMBL378
4085,22845193.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721663,"Antiviral activity against pseudovirus HIV-1 HXB-2 subtype C harboring pseudotyped Env Du422, clone 1 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based assay",F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1nc(CO)cs1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4761836,CHEMBL4761836,6.70,0.0,http://www.openphacts.org/units/Nanomolar,3547085.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.2,CHEMBL378
4086,24823548.0,[],CHEMBL5140686,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBsAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3c(Cl)cccc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5189086,CHEMBL5189086,8.92,0.0,http://www.openphacts.org/units/Nanomolar,3876722.0,=,1.0,1.0,=,IC50,nM,1.2,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0012,CHEMBL613497
4087,974141.0,[],CHEMBL655544,Inhibition of wild type HIV-1-IIIB strain replication in CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)nc(Sc2c(C)cnc(O)c2[N+](=O)[O-])n1,CHEMBL1128194,J Med Chem,1995.0,CHEMBL142301,CHEMBL142301,4.76,0.0,http://www.openphacts.org/units/Nanomolar,276280.0,=,1.0,1.0,=,IC50,nM,17500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,17500.0,CHEMBL378
4088,1502790.0,[],CHEMBL834971,Inhibitory concentration against hepatitis C virus NS3 protease (IC50 spans 2.5 log units),B,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H](C(=O)N[C@H](C(=O)C1C[C@H](Oc2ccccc2-c2ccccc2)C[C@H]1C(=O)CC1(C(=O)O)CC1)C(C)C)C1CCCCC1,CHEMBL1143583,J Med Chem,2005.0,CHEMBL364225,CHEMBL364225,,0.0,http://www.openphacts.org/units/Nanomolar,389120.0,<,1.0,1.0,>,IC50,nM,199526.23,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,Log 1/IC50,,UO_0000065,3.7,CHEMBL4620
4089,1401914.0,[],CHEMBL837469,In vitro inhibitory concentration against HIV V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)Nc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL435522,CHEMBL435522,,0.0,http://www.openphacts.org/units/Nanomolar,360379.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4090,2601603.0,[],CHEMBL1033985,Antiviral activity against Cowpox virus,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL991,CHEMBL991,,0.0,http://www.openphacts.org/units/Nanomolar,807742.0,=,1.0,1.0,=,IC50,nM,446000.0,CHEMBL612672,Cowpox virus,Cowpox virus,10243,IC50,uM,UO_0000065,446.0,CHEMBL612672
4091,1403338.0,[],CHEMBL834755,Inhibitory concentration against 100I mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1Sc1nc(Nc2ccc(C#N)cc2)c(=O)n(C)c1C,CHEMBL1145199,J Med Chem,2005.0,CHEMBL180474,CHEMBL180474,,0.0,http://www.openphacts.org/units/Nanomolar,360749.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
4092,1672749.0,[],CHEMBL870624,Antiviral activity against HIV1 K103N mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,CNS(=O)(=O)c1ccc(NC(=O)COc2ccc(Cl)cc2C(=O)c2cc(F)cc(C(F)(F)F)c2)c(C)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL199539,CHEMBL199539,8.70,0.0,http://www.openphacts.org/units/Nanomolar,411946.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
4093,16662889.0,[],CHEMBL3832827,AntiDengue activity HCI DV3/A549 IC50 (uM),F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)OC(=O)N1CCN(c2nccc(-c3ccc(-c4ccc(Cl)cc4)s3)n2)CC1,CHEMBL3832761,,,CHEMBL3637932,CHEMBL3637932,5.70,0.0,http://www.openphacts.org/units/Nanomolar,2790030.0,=,34.0,1.0,=,IC50,nM,2000.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,2.0,CHEMBL613757
4094,552907.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1[S+]([O-])c1cccc(N)c1C#N,CHEMBL1134494,J Med Chem,2001.0,CHEMBL293331,CHEMBL293331,5.32,0.0,http://www.openphacts.org/units/Nanomolar,94243.0,=,1.0,1.0,=,IC50,nM,4800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.8,CHEMBL378
4095,3014052.0,[],CHEMBL1042767,Antiviral activity against HIV1 3B infected in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,CN(Cc1nc2ccccc2n1CCCN)C1CCCc2cccnc21,CHEMBL1155333,Bioorg Med Chem Lett,2009.0,CHEMBL577268,CHEMBL577268,7.36,0.0,http://www.openphacts.org/units/Nanomolar,855059.0,=,1.0,1.0,=,IC50,nM,44.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.044,CHEMBL378
4096,2662918.0,[],CHEMBL1052276,Antiviral activity against Parainfluenza virus type 3 infected in human Hep2 cells assessed as inhibition of virus-induced cytopathogenic effect by plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc([C@@H]2CC(=O)c3c(OC)cc(O)cc3O2)cc1,CHEMBL1151977,J Nat Prod,2009.0,CHEMBL537954,CHEMBL537954,,0.0,http://www.openphacts.org/units/Nanomolar,817596.0,=,1.0,1.0,=,IC50,nM,154400.0,CHEMBL613126,Human parainfluenza virus 3,Human parainfluenza virus 3,11216,IC50,uM,UO_0000065,154.4,CHEMBL613126
4097,1219749.0,[],CHEMBL710372,Inhibitory activity against 100I strain and 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1cnc(Nc2ccc(C#N)cc2)nc1Oc1c(C)cc(C#N)cc1C,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72242,CHEMBL72242,6.69,0.0,http://www.openphacts.org/units/Nanomolar,127437.0,=,1.0,1.0,=,IC50,nM,205.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.205,CHEMBL378
4098,605500.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc([N+](=O)[O-])cc(C)c1Oc1nc(N)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL70468,CHEMBL70468,8.70,0.0,http://www.openphacts.org/units/Nanomolar,126909.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.002,CHEMBL378
4099,18469010.0,[],CHEMBL4182244,Antiviral activity against HIV-1 3B infected in human TZM-bl cells treated for 2 hrs followed by compound washout measured after 2 days by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@@H](Cc1ccccc1)C(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/N[C@@H](Cc1ccccc1)C(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+],CHEMBL4177704,Bioorg Med Chem Lett,2018.0,CHEMBL1949744,CHEMBL1962956,5.09,0.0,http://www.openphacts.org/units/Nanomolar,3065414.0,=,1.0,1.0,=,IC50,nM,8210.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,umol/L,UO_0000065,8.21,CHEMBL378
4100,13476677.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Sc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435857,CHEMBL2435857,10.00,0.0,http://www.openphacts.org/units/Nanomolar,1924233.0,=,1.0,1.0,=,IC50,nM,0.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.1,CHEMBL378
4101,3509135.0,[],CHEMBL1261038,Antiviral activity against wild type HIV1 infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 40% human serum,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Nc1ccnc(NC2CCN(c3cccc(C(N)=O)c3)CC2)n1,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1258477,CHEMBL1258477,7.86,0.0,http://www.openphacts.org/units/Nanomolar,963461.0,=,1.0,1.0,=,IC50,nM,13.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,13.9,CHEMBL378
4102,3014806.0,[],CHEMBL1050519,Antiviral activity against multidrug-resistant HIV1 isolate MM infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(c1)OCCC=CCCCCN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]3OCC[C@H]31)S2(=O)=O,CHEMBL1156053,J Med Chem,2009.0,CHEMBL2094013,CHEMBL2094013,7.48,0.0,http://www.openphacts.org/units/Nanomolar,862636.0,=,1.0,1.0,=,IC50,nM,33.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.033,CHEMBL378
4103,1219745.0,[],CHEMBL710376,Inhibitory activity against 100I strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1cnc(Nc2ccc(C#N)cc2)nc1Oc1c(C)cc(C#N)cc1C,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72242,CHEMBL72242,7.51,0.0,http://www.openphacts.org/units/Nanomolar,127437.0,=,1.0,1.0,=,IC50,nM,31.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.031,CHEMBL378
4104,22845250.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4721681,Antiviral activity against HIV-1 3B infected in human H9 cells assessed as reduction in viral transmission to TZM-bl cells incubated for 48 hrs by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4547005,CHEMBL4547005,6.39,0.0,http://www.openphacts.org/units/Nanomolar,3547094.0,=,1.0,1.0,=,IC50,nM,410.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.41,CHEMBL378
4105,6335924.0,[],CHEMBL1820053,"Antiviral activity against multidrug-resistant Human immunodeficiency virus 1 MDR/TM harboring protease L10I, K14R, R41K, M46L, I54V, L63P, A71V, V82A, L90M, I93L mutation infected in PHA-stimulated human PBMC assessed as inhibition of p24 Gag protein production",F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL1817554,J Med Chem,2011.0,CHEMBL116,CHEMBL116,6.72,0.0,http://www.openphacts.org/units/Nanomolar,1451587.0,=,1.0,1.0,=,IC50,nM,190.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.19,CHEMBL378
4106,18479581.0,[],CHEMBL4184680,Antiviral activity against Zika virus infected in human A549 cells preincubated for 5 hrs followed by compound wash measured after 48 hrs by viral plague-forming assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CCSc1nsc(NC(=O)Nc2cccc(C(C)=O)c2)n1,CHEMBL4184095,Bioorg Med Chem Lett,2018.0,CHEMBL1531435,CHEMBL1531435,6.79,0.0,http://www.openphacts.org/units/Nanomolar,3066987.0,=,1.0,1.0,=,IC50,nM,160.3,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,nM,UO_0000065,160.3,CHEMBL4296612
4107,22845190.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721662,"Antiviral activity against pseudovirus HIV-1 HXB-2 subtype C harboring pseudotyped Env Du172, clone 17 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based assay",F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1nc(CO)cs1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4761836,CHEMBL4761836,6.80,0.0,http://www.openphacts.org/units/Nanomolar,3547085.0,=,1.0,1.0,=,IC50,nM,160.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.16,CHEMBL378
4108,2601804.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(O)c2ncn([C@@H]3C=C(F)[C@H](CO)O3)c2n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL472672,CHEMBL472672,4.42,0.0,http://www.openphacts.org/units/Nanomolar,808128.0,=,1.0,1.0,=,IC50,nM,38500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,38.5,CHEMBL378
4109,3221777.0,[],CHEMBL1102827,Antiviral activity against HIV1 infected human MT4 cells by phenoscreen assay in the presence of 40 percent normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,CS(=O)(=O)c1ccc(NC(=O)CSC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,CHEMBL1153798,Bioorg Med Chem Lett,2009.0,CHEMBL1078944,CHEMBL1078944,5.35,0.0,http://www.openphacts.org/units/Nanomolar,898067.0,=,1.0,1.0,=,IC50,nM,4500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,0.0045,CHEMBL378
4110,934946.0,[],CHEMBL728516,Anti-HIV activity against HIV-1 IIIB chronically infected Molt-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(CCF)c2c(OC(F)F)c(N3CCN(c4ncccn4)CC3)c(F)cc2c1=O,CHEMBL1131862,Bioorg Med Chem Lett,1999.0,CHEMBL323365,CHEMBL323365,6.03,0.0,http://www.openphacts.org/units/Nanomolar,194321.0,=,1.0,1.0,=,IC50,nM,930.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.93,CHEMBL378
4111,669429.0,[],CHEMBL683819,Anti-HIV activity in cell culture assay expressed as IC50 values.,F,BAO_0000190,BAO_0000218,organism-based format,Oc1cc(O)c2c(c1)O[C@@]1(c3ccc(O)c(O)c3)Oc3cc(O)c4c(c3[C@@H]2[C@H]1O)O[C@H](c1ccc(O)c(O)c1)[C@H](O)[C@H]4c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2,CHEMBL1126373,Bioorg Med Chem Lett,1992.0,CHEMBL540956,CHEMBL540956,,0.0,http://www.openphacts.org/units/Nanomolar,60636.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.0,CHEMBL378
4112,1213163.0,[],CHEMBL710533,Inhibitory activity against 181C strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Cc3c(Cl)cccc3Cl)n2)cc1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL307297,CHEMBL307297,6.70,0.0,http://www.openphacts.org/units/Nanomolar,127432.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.2,CHEMBL378
4113,6336418.0,[],CHEMBL1821125,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by measuring HBsAg and HBeAg production after 9 days by EIA,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)Nc1ccc(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc([N+](=O)[O-])cc2)C(=O)OC)cc1,CHEMBL1817553,Bioorg Med Chem,2011.0,CHEMBL1819246,CHEMBL1819246,5.36,0.0,http://www.openphacts.org/units/Nanomolar,1451648.0,=,1.0,1.0,=,IC50,nM,4370.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,4.37,CHEMBL613497
4114,405210.0,[],CHEMBL665058,Inhibitory concentration required against Cowpox virus in Vero cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2C[C@@H]1COP(=O)(O)CO1,CHEMBL1147452,Bioorg Med Chem Lett,2004.0,CHEMBL114867,CHEMBL114867,,0.0,http://www.openphacts.org/units/Nanomolar,214243.0,>,1.0,1.0,>,IC50,nM,350000.0,CHEMBL612672,Cowpox virus,Cowpox virus,10243,IC50,uM,UO_0000065,350.0,CHEMBL612672
4115,23191683.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4818692,Antiviral activity against HIV1 SG3.1 infected in human TZM-bl cells measured after 48 hrs by single round viral infectivity assay based Steady-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=CCC2(C(=O)N3[C@@H](C(=O)OC(c4ccccc4)c4ccccc4)C(C)(C)S[C@@H]32)C1C(=O)c1ccccc1,CHEMBL4814068,Eur J Med Chem,2021.0,CHEMBL4863153,CHEMBL4863153,6.52,0.0,http://www.openphacts.org/units/Nanomolar,3606464.0,=,1.0,1.0,=,IC50,nM,305.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.305,CHEMBL378
4116,1402476.0,[],CHEMBL837464,In vitro inhibitory concentration against HIV G190A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177666,CHEMBL177666,8.00,0.0,http://www.openphacts.org/units/Nanomolar,360358.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
4117,2244610.0,[],CHEMBL1005550,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase V108I/Y181C mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL57,CHEMBL57,,0.0,http://www.openphacts.org/units/Nanomolar,798657.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2000.0,CHEMBL378
4118,1402296.0,[],CHEMBL837462,In vitro inhibitory concentration against HIV E138K mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NCc2ccccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177491,CHEMBL177491,,0.0,http://www.openphacts.org/units/Nanomolar,360417.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4119,18530794.0,[],CHEMBL4195355,Antiviral activity against HIV-1 LAI infected in human MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CC2CO[C@H]3OCC[C@@H]1[C@@H]23)S(=O)(=O)c1ccc2nc(NC3CC3)sc2c1,CHEMBL4190391,J Med Chem,2018.0,CHEMBL4211505,CHEMBL4211505,8.85,0.0,http://www.openphacts.org/units/Nanomolar,3076696.0,=,1.0,1.0,=,IC50,nM,1.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.4,CHEMBL378
4120,607855.0,[],CHEMBL710373,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Oc3c(Br)cc(Br)cc3Br)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL72459,CHEMBL72459,6.88,0.0,http://www.openphacts.org/units/Nanomolar,126891.0,=,1.0,1.0,=,IC50,nM,131.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.131,CHEMBL378
4121,5246974.0,[],CHEMBL1687410,Antiviral activity against HIV1 Ba-L infected in human HOS cells expressing CCR5 after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC(CNC(=O)C1CCC(F)(F)CC1)c1ccccc1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL1682566,CHEMBL1682566,6.39,0.0,http://www.openphacts.org/units/Nanomolar,1333678.0,=,1.0,1.0,=,IC50,nM,411.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.411,CHEMBL378
4122,14714247.0,[],CHEMBL3293254,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#C/C=C/c1ccc(C(NO)c2ccnc(Nc3ccc(C#N)cc3)n2)cc1,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL3286419,CHEMBL3286419,7.79,0.0,http://www.openphacts.org/units/Nanomolar,2116119.0,=,1.0,1.0,=,IC50,nM,16.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0163,CHEMBL378
4123,15720839.0,[],CHEMBL3618898,Antiviral activity against HBV infected in human HepG2 cells expressing hNTCP-C4 assessed as viral envelope surface protein secretion treated for 16 hrs followed by compound washout measured after 12 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)CC1(O)CC(=O)c2c(C)cc(O)cc2O1,CHEMBL3616413,Bioorg Med Chem Lett,2015.0,CHEMBL3617548,CHEMBL3617548,4.28,0.0,http://www.openphacts.org/units/Nanomolar,2502044.0,=,1.0,1.0,=,IC50,nM,52100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,52.1,CHEMBL613497
4124,1099091.0,[],CHEMBL712251,Inhibition of HIV-1 replication in infected MT-4 human T-lymphoid cells.,F,BAO_0000190,BAO_0000218,organism-based format,COC[C@@H]1SCC[C@@H]1OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,CHEMBL1129277,J Med Chem,1996.0,CHEMBL324223,CHEMBL324223,7.71,0.0,http://www.openphacts.org/units/Nanomolar,209988.0,=,1.0,1.0,=,IC50,nM,19.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.7,CHEMBL378
4125,2930242.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL366692,CHEMBL366692,8.00,0.0,http://www.openphacts.org/units/Nanomolar,848229.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
4126,628604.0,[],CHEMBL691384,Inhibitory concentration for cytopathicity of HIV-1 (HTLV-IIIB) in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cc(Cc2cc(Cl)c(O)c(C(=O)O)c2)cc(Cl)c1O,CHEMBL1125737,J Med Chem,1991.0,CHEMBL116347,CHEMBL116347,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,217799.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,100.0,CHEMBL378
4127,18509609.0,[],CHEMBL4191613,Antiviral activity against HIV1 virions derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)c3c(c(-c4ccc5c(c4)OCO5)c2cc1OC)C(=O)OC3,CHEMBL4190218,J Nat Prod,2017.0,CHEMBL1929098,CHEMBL1929098,6.29,0.0,http://www.openphacts.org/units/Nanomolar,3073109.0,=,1.0,1.0,=,IC50,nM,510.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,510.0,CHEMBL378
4128,2516312.0,[],CHEMBL975243,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(Cc2c(Cl)cccc2Cl)nc(SCc2ccc([N+](=O)[O-])cc2)[nH]c1=O,CHEMBL1138559,Eur J Med Chem,2009.0,CHEMBL237025,CHEMBL237025,6.44,0.0,http://www.openphacts.org/units/Nanomolar,733267.0,=,1.0,1.0,=,IC50,nM,360.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.36,CHEMBL378
4129,12680661.0,[],CHEMBL2342597,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral replication after 9 days by fluorescence PCR method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/c1coc2cc(O)ccc2c1=O)NCCc1ccc(F)cc1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333300,CHEMBL2333300,,0.0,http://www.openphacts.org/units/Nanomolar,1867263.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
4130,24830951.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1c2ccc(N3CCCC3)cc2Oc2c(Cl)cccc21,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5186066,CHEMBL5186066,5.82,0.0,http://www.openphacts.org/units/Nanomolar,3878124.0,=,1.0,1.0,=,IC50,nM,1500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.5,CHEMBL613497
4131,597915.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2nc(N)nc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL74174,CHEMBL74174,9.00,0.0,http://www.openphacts.org/units/Nanomolar,126898.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
4132,24830924.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc2c(=O)c3cccc(F)c3oc2c1)c1ccncc1F,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5191242,CHEMBL5191242,5.61,0.0,http://www.openphacts.org/units/Nanomolar,3878097.0,=,1.0,1.0,=,IC50,nM,2430.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.43,CHEMBL613497
4133,2099731.0,[],CHEMBL949218,Antiviral activity against HIV1 JRCSF by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(F)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL408512,CHEMBL408512,8.40,0.0,http://www.openphacts.org/units/Nanomolar,699413.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.004,CHEMBL378
4134,3253145.0,[],CHEMBL1107997,Antiviral activity against HIV1 NL4.3 infected in human MT4 cells expressing CD4 and CXCR4 assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCCN(Cc1nc2ccccc2[nH]1)C1CCCc2cccnc21,CHEMBL1156989,J Med Chem,2010.0,CHEMBL1092596,CHEMBL1092596,7.13,0.0,http://www.openphacts.org/units/Nanomolar,902064.0,=,1.0,1.0,=,IC50,nM,74.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.074,CHEMBL378
4135,16494762.0,[],CHEMBL3772328,Antiviral activity against HIV1 NL4-3 infected in human TZM-bl cells assessed as inhibition of viral replication administered 6 hrs postinfection measured 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CON(C)C(=O)c1ccc(Nc2nc(-c3cccnc3)nc3ccccc23)cc1,CHEMBL3769372,J Med Chem,2016.0,CHEMBL3770739,CHEMBL3770739,,0.0,http://www.openphacts.org/units/Nanomolar,2761357.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
4136,3406139.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc2oc(-c3cccc(F)c3)cc(=O)c2c1,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1215459,CHEMBL1215459,,0.0,http://www.openphacts.org/units/Nanomolar,933193.0,=,1.0,1.0,=,IC50,nM,239700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,239.7,CHEMBL378
4137,12680687.0,[],CHEMBL2342597,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral replication after 9 days by fluorescence PCR method,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)Nc3ccccc3OC)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333301,CHEMBL2333301,,0.0,http://www.openphacts.org/units/Nanomolar,1867266.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
4138,12642414.0,[],CHEMBL2317522,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay in presence of human serum albumin,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCCN2C(=O)c3c(O)c(=O)c(C(=O)NCc4ccc(F)cc4)cn3CC12,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314690,CHEMBL2314690,7.79,0.0,http://www.openphacts.org/units/Nanomolar,1844822.0,=,1.0,1.0,=,IC50,nM,16.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,16.3,CHEMBL378
4139,2099770.0,[],CHEMBL949219,Antiviral activity against HIV1 ASM80 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL272748,CHEMBL272748,7.85,0.0,http://www.openphacts.org/units/Nanomolar,699397.0,=,1.0,1.0,=,IC50,nM,14.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.014,CHEMBL378
4140,1402191.0,[],CHEMBL837465,In vitro inhibitory concentration against HIV G190S mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369599,CHEMBL369599,,0.0,http://www.openphacts.org/units/Nanomolar,360395.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4141,19183290.0,[],CHEMBL4387678,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as reduction in p24 Gag protein production incubated for 6 days and measured on day 7 by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)Nc2c(N(C)[C@@H]3CCOC3)c(=O)c2=O)cc1,CHEMBL4385670,Bioorg Med Chem Lett,2019.0,CHEMBL4444017,CHEMBL4444017,,0.0,http://www.openphacts.org/units/Nanomolar,3202090.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
4142,13449286.0,[],CHEMBL2428633,Antiviral activity against HIV1 LAI infected in human MT2 cells by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2CC(C)(C)C[C@@H]3O[C@H]4OCC[C@H]4[C@@H]32)cc1,CHEMBL2424573,J Med Chem,2013.0,CHEMBL2426456,CHEMBL2426456,,0.0,,1919762.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4143,18808322.0,[],CHEMBL4275448,Antiviral activity against Zika virus SMGC infected in BHK cells assessed as inhibition of virus induced cytopathic effect after 8 days by CellTiter-Glo luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)CCN(C[C@H]1O[C@@H](n2cnc3c(NCc4cccc(F)c4)ncnc32)[C@H](O)[C@@H]1O)C(C)C,CHEMBL4270631,Eur J Med Chem,2018.0,CHEMBL4281511,CHEMBL4281511,,0.0,http://www.openphacts.org/units/Nanomolar,3125056.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,50.0,CHEMBL4296612
4144,2601982.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C(=O)CC(=O)c1cc2ccccc2n1C,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL188686,CHEMBL188686,,0.0,http://www.openphacts.org/units/Nanomolar,807762.0,=,1.0,1.0,=,IC50,nM,106000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,106.0,CHEMBL378
4145,19033632.0,[],CHEMBL4350064,Antiviral activity against HIV1 LAI infected in human LC5 cells expressing DsRed1 reporter gene assessed as inhibition of viral infection measured after 48 hrs post infection by reporter gene based luminescence assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Oc1ccc2cccnc2c1-c1cccc2cccnc12,CHEMBL4346738,Bioorg Med Chem,2019.0,CHEMBL4465677,CHEMBL4465677,,0.0,,3175418.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4146,19237556.0,[],CHEMBL4399056,Antiviral activity against HIV-1 infected in HEK293 cells preincubated for 4 hrs with cell followed by viral infection measured after 24 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C(=O)CC(=O)c1cc(OCc2ccccc2)cc(OCc2ccccc2)c1,CHEMBL4396909,Eur J Med Chem,2019.0,CHEMBL19977,CHEMBL19977,6.32,0.0,http://www.openphacts.org/units/Nanomolar,3211420.0,=,1.0,1.0,=,IC50,nM,480.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.48,CHEMBL378
4147,2947324.0,[],CHEMBL1038497,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@@H](C[C@@H](C)[C@]12CC[C@@]3(C)[C@@]1(C[C@H](OC(C)=O)[C@H]1[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@@]13C)O2)[C@@H](OC(C)=O)C(C)(C)OC(C)=O,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL584998,CHEMBL584998,4.21,0.0,http://www.openphacts.org/units/Nanomolar,850768.0,=,1.0,1.0,=,IC50,nM,61000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.061,CHEMBL613497
4148,3014798.0,[],CHEMBL1050518,Antiviral activity against multidrug-resistant HIV1 isolate TM infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(c1)OCCCC/C=C\CCCN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]3OCC[C@H]31)S2(=O)=O,CHEMBL1156053,J Med Chem,2009.0,CHEMBL577992,CHEMBL577992,7.14,0.0,http://www.openphacts.org/units/Nanomolar,862634.0,=,1.0,1.0,=,IC50,nM,72.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.072,CHEMBL378
4149,15571653.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(Br)cc1)N1CCN(Cc2ccc(Cl)cc2F)CC1,CHEMBL1201862,,,CHEMBL3561484,CHEMBL3561484,8.09,0.0,http://www.openphacts.org/units/Nanomolar,2476720.0,=,7.0,1.0,=,IC50,nM,8.11,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.00811,CHEMBL3259470
4150,1401655.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Cc2cc[nH]c(=O)c2N(C)C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369460,CHEMBL369460,5.10,0.0,http://www.openphacts.org/units/Nanomolar,360354.0,=,1.0,1.0,=,IC50,nM,7943.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.943,CHEMBL378
4151,18239599.0,[],CHEMBL4052035,Antiviral activity against indinavir-resistant HIV1 NL4-3 harboring protease L10F/L24I/M46I/I54V/L63P/A71V/G73S/V82T mutant infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1C2CO[C@H]3OCC1C3C2)S(=O)(=O)c1ccc2nc(NC3CC3)sc2c1,CHEMBL4049446,J Med Chem,2017.0,CHEMBL4098771,CHEMBL4098771,10.92,0.0,http://www.openphacts.org/units/Nanomolar,3026805.0,=,1.0,1.0,=,IC50,nM,0.012,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.012,CHEMBL378
4152,2244573.0,[],CHEMBL1003073,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase Y188C mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL203420,CHEMBL203420,10.40,0.0,http://www.openphacts.org/units/Nanomolar,798654.0,=,1.0,1.0,=,IC50,nM,0.04,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.04,CHEMBL378
4153,1498118.0,[],CHEMBL833971,Concentration required to inhibit 50% viral production of human immunodeficiency virus type 1 (HIV-1-IIIB),F,BAO_0000190,BAO_0000218,organism-based format,CC1Oc2c3c(c4c(-c5ccccc5)cc(=O)oc4c2C(O)C1C)OC(C)(C)C=C3,CHEMBL1143567,J Med Chem,2005.0,CHEMBL192847,CHEMBL192847,5.85,0.0,http://www.openphacts.org/units/Nanomolar,388132.0,=,1.0,1.0,=,IC50,nM,1400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.4,CHEMBL378
4154,5229733.0,[],CHEMBL1678272,Antiviral activity against Human immunodeficiency virus 1 MDR 769 infected in phytohemagglutininin and interleukin-2-stimulated PBMC assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,7.10,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,=,1.0,1.0,=,IC50,nM,80.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.08,CHEMBL378
4155,2462115.0,[],CHEMBL965355,Antiviral activity against hepatitis B virus infected Hep G2.2.15 cells assessed as inhibition of HBeAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1157443,Bioorg Med Chem Lett,2008.0,CHEMBL511188,CHEMBL511188,4.10,0.0,http://www.openphacts.org/units/Nanomolar,721012.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.08,CHEMBL613497
4156,1402088.0,[],CHEMBL837464,In vitro inhibitory concentration against HIV G190A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(CO)nc(O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL424772,CHEMBL424772,8.52,0.0,http://www.openphacts.org/units/Nanomolar,360403.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
4157,2417960.0,[],CHEMBL1018899,Antiviral activity against HBV in human HepG2(2.2.15) cells assessed as inhibition of viral genome replication after 9 days by Southern blot hybridization,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(F)cc1,CHEMBL1153412,Bioorg Med Chem,2009.0,CHEMBL474026,CHEMBL474026,5.85,0.0,http://www.openphacts.org/units/Nanomolar,754077.0,=,1.0,1.0,=,IC50,nM,1400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.4,CHEMBL613497
4158,2362916.0,[],CHEMBL1026413,"Antiviral activity against multidrug-resistant HIV1 with protease L10I, K14R, R41K, M46L, I54V, L63P, A71V, V82A, L90M, I93L mutation in phytohemagglutininin-activated PBMC assessed as inhibition of p24Gag protein production",F,BAO_0000190,BAO_0000218,organism-based format,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,CHEMBL1140100,J Med Chem,2008.0,CHEMBL163,CHEMBL163,,0.0,http://www.openphacts.org/units/Nanomolar,747153.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
4159,18727035.0,[],CHEMBL4259325,Antiviral activity against HIV1 subtype BC CNE15 pseudovirus assessed as inhibition of viral infection in Ghost (3)X4/R5 cells after 48 hrs by Bright-Glo luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@]1(C)CCC/C=C\CCC[C@](C)(NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O,CHEMBL4257519,Medchemcomm,2018.0,CHEMBL4287830,CHEMBL4287830,8.48,0.0,http://www.openphacts.org/units/Nanomolar,3111235.0,=,1.0,1.0,=,IC50,nM,3.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.3,CHEMBL378
4160,18239603.0,[],CHEMBL4052030,Antiviral activity against nelfinavir-resistant HIV1 NL4-3 harboring protease L10F/K20T/D30N/K45I/A71V/V77I mutant infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1C2CO[C@H]3OCC1C3C2)S(=O)(=O)c1ccc2nc(NC3CC3)sc2c1,CHEMBL4049446,J Med Chem,2017.0,CHEMBL4098771,CHEMBL4098771,10.55,0.0,http://www.openphacts.org/units/Nanomolar,3026805.0,=,1.0,1.0,=,IC50,nM,0.028,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.028,CHEMBL378
4161,14999526.0,[],CHEMBL3366185,Antiviral activity against HIV1 harboring reverse transcriptase K103N mutant infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CNc2nc(-c3ccccc3F)c(Cc3ccccc3)s2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3330435,CHEMBL3330435,6.27,0.0,http://www.openphacts.org/units/Nanomolar,2246872.0,=,1.0,1.0,=,IC50,nM,540.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.54,CHEMBL378
4162,1041350.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(NN2C(S)=NC(C)C2c2ccccc2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL290703,CHEMBL290703,5.32,0.0,http://www.openphacts.org/units/Nanomolar,62322.0,=,1.0,1.0,=,IC50,nM,4780.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.78,CHEMBL378
4163,10863207.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](OC(=O)c2cc(=O)c3ccccc3o2)CC[C@]2(C)[C@H]3CC=C4[C@@H]5C[C@@](C)(C(=O)OCc6ccc(C(F)(F)F)cc6)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022401,CHEMBL2022401,,0.0,http://www.openphacts.org/units/Nanomolar,1637653.0,>,1.0,1.0,>,IC50,nM,292970.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,292.97,CHEMBL613497
4164,12642415.0,[],CHEMBL2317522,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay in presence of human serum albumin,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)N1CCN2C(=O)c3c(O)c(=O)c(C(=O)NCc4ccc(F)cc4)cn3CC21,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314689,CHEMBL2314689,8.11,0.0,http://www.openphacts.org/units/Nanomolar,1844821.0,=,1.0,1.0,=,IC50,nM,7.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.8,CHEMBL378
4165,15064933.0,[],CHEMBL3366183,Antiviral activity against wild type HIV1 infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2nc(/N=C/c3ccc(F)cc3)sc2Cc2ccccc2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3329467,CHEMBL3329467,,0.0,http://www.openphacts.org/units/Nanomolar,2248836.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
4166,15166145.0,[],CHEMBL3404736,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as decrease in viral DNA replication treated for 7 days by real time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(OC(=O)/C=C/c2ccc3c(c2)OCO3)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402772,CHEMBL3402772,,0.0,http://www.openphacts.org/units/Nanomolar,2284126.0,>,1.0,1.0,>,IC50,nM,759000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,759.0,CHEMBL613497
4167,5126321.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc2c(n1)N(C)c1ccc(Cl)cc1N(c1ccccc1)C2=O,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642317,CHEMBL1642317,5.66,0.0,http://www.openphacts.org/units/Nanomolar,1317607.0,=,1.0,1.0,=,IC50,nM,2200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.2,CHEMBL378
4168,24726250.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5114464,Antiviral activity against HIV-1 E138K mutant infected in human MT4 cells assessed as reduction in viral replication incubated for 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nccc(/C(=N\O)c3ccc(-c4ccc(F)cc4)cc3F)n2)cc1,CHEMBL5113385,Eur J Med Chem,2022.0,CHEMBL5178635,CHEMBL5178635,7.57,0.0,http://www.openphacts.org/units/Nanomolar,3857017.0,=,1.0,1.0,=,IC50,nM,27.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.027000000000000003,CHEMBL378
4169,793102.0,[],CHEMBL711619,Antiviral activity against HIV-1 (strain RF) infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(COc1ccc(Cl)cc1C(=O)c1cccnc1)Nc1ccccc1,CHEMBL1128355,J Med Chem,1995.0,CHEMBL297010,CHEMBL297010,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,73230.0,<,1.0,1.0,<,IC50,ug.mL-1,0.01,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.01,CHEMBL378
4170,10862024.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(/C=C/C(=O)O[C@H]2CC[C@]3(C)[C@H]4CC=C5[C@@H]6C[C@@](C)(C(=O)OCc7ccc(C(F)(F)F)cc7)CC[C@]6(C)CC[C@@]5(C)[C@]4(C)CC[C@H]3C2(C)C)cc(OC)c1OC,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022399,CHEMBL2022399,,0.0,http://www.openphacts.org/units/Nanomolar,1637651.0,>,1.0,1.0,>,IC50,nM,986850.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,986.85,CHEMBL613497
4171,13403792.0,[],CHEMBL2415634,Antiviral activity against HIV1 NL4-3 assessed as inhibition of viral fusion with human TZM-bl cells after 48 hrs by steady glo luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)O,CHEMBL2413030,Bioorg Med Chem,2013.0,CHEMBL2414505,CHEMBL2414505,6.33,0.0,http://www.openphacts.org/units/Nanomolar,1912460.0,=,1.0,1.0,=,IC50,nM,465.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,465.0,CHEMBL378
4172,2649338.0,[],CHEMBL1024326,"Antiviral activity against HIV1 expressed in 293T cells assessed as protection against viral M33 envelope infection in human U87 cells coexpressing CD4, CCR5 receptors after 72 hrs by luciferase reporter gene pseudoviral assay",F,BAO_0000190,BAO_0000218,organism-based format,CC1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1ccc(-n2nccn2)cc1,CHEMBL1158460,J Med Chem,2009.0,CHEMBL559440,CHEMBL559440,6.06,0.0,http://www.openphacts.org/units/Nanomolar,816008.0,=,1.0,1.0,=,IC50,nM,870.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,870.0,CHEMBL378
4173,646145.0,[],CHEMBL683819,Anti-HIV activity in cell culture assay expressed as IC50 values.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C1=C[C@@H](O)[C@@H](O)[C@H](OC(=O)c2cc(O)c(O)c(O)c2)C1,CHEMBL1126373,Bioorg Med Chem Lett,1992.0,CHEMBL289369,CHEMBL289369,4.60,0.0,http://www.openphacts.org/units/Nanomolar,60615.0,=,1.0,1.0,=,IC50,nM,25000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.0,CHEMBL378
4174,1403526.0,[],CHEMBL837591,Inhibitory concentration against wild-type HIV-1 LAI Virus was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Sc2cn(C)c(=O)c(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL175152,CHEMBL175152,7.80,0.0,http://www.openphacts.org/units/Nanomolar,360671.0,=,1.0,1.0,=,IC50,nM,16.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.016,CHEMBL378
4175,10938656.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccc(Cl)c(Cl)c4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046584,CHEMBL2046584,,0.0,http://www.openphacts.org/units/Nanomolar,1651467.0,=,1.0,1.0,=,IC50,nM,111850.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,111.85,CHEMBL613497
4176,1194674.0,[],CHEMBL710376,Inhibitory activity against 100I strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70554,CHEMBL70554,6.49,0.0,http://www.openphacts.org/units/Nanomolar,127459.0,=,1.0,1.0,=,IC50,nM,327.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.327,CHEMBL378
4177,1402378.0,[],CHEMBL837462,In vitro inhibitory concentration against HIV E138K mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(NC(=S)NC(=O)c2ccccc2)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177383,CHEMBL177383,,0.0,http://www.openphacts.org/units/Nanomolar,360418.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4178,1064947.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(S)n(Nc2cccc(Cl)c2)c1-c1ccc(Br)cc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL38556,CHEMBL38556,,0.0,http://www.openphacts.org/units/Nanomolar,62334.0,>,1.0,1.0,>,IC50,nM,33240.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,33.24,CHEMBL378
4179,2530533.0,[],CHEMBL1011336,Antiviral activity against Rift Valley fever virus infected in african green monkey Vero cells after 6 days by plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1N[C@H]2C=C[C@@H](O)[C@H](O)[C@@H]2c2cc3c(cc21)OCO3,CHEMBL1150051,J Nat Prod,1992.0,CHEMBL478802,CHEMBL478802,,0.0,,790658.0,,1.0,0.0,,IC50,,,CHEMBL613130,Rift Valley fever virus,Rift Valley fever virus,11588,IC50,,,,CHEMBL613130
4180,581724.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(S(=O)(=O)c3ccc(-n4sc5ccccc5c4=O)cc3)cc2)cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL169755,CHEMBL169755,,0.0,http://www.openphacts.org/units/Nanomolar,334007.0,=,1.0,1.0,=,IC50,nM,188000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,188.0,CHEMBL378
4181,17602994.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(c2cc(OC)nc(Cl)n2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644929,CHEMBL3644929,5.96,0.0,http://www.openphacts.org/units/Nanomolar,2518049.0,=,37.0,1.0,=,IC50,nM,1090.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,1090.0,CHEMBL4620
4182,10861958.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCC6CCOCC6)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024633,CHEMBL2024633,,0.0,http://www.openphacts.org/units/Nanomolar,1640529.0,>,1.0,1.0,>,IC50,nM,1914570.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1914.57,CHEMBL613497
4183,3453355.0,[],CHEMBL1247794,Antiviral activity against HIV1 isolate 05-121773 assessed as inhibition of viral replication after 7 days by scintillation counting,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(c2cccc3nc(CN(C)[C@H]4CCCc5cccnc54)c(CO)n23)CC1,CHEMBL1240366,Antimicrob Agents Chemother,2010.0,CHEMBL1242210,CHEMBL1242210,9.00,0.0,http://www.openphacts.org/units/Nanomolar,953332.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
4184,2149688.0,[],CHEMBL926964,Antiviral activity against HIV1 LAI in MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](CSc1ccccc1)NC(=O)O[C@@H]1C[C@@H]2CCO[C@@H]2C1)S(=O)(=O)c1ccc(CO)cc1,CHEMBL1147040,J Biol Chem,2007.0,CHEMBL403306,CHEMBL403306,8.30,0.0,http://www.openphacts.org/units/Nanomolar,707764.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.005,CHEMBL378
4185,12642416.0,[],CHEMBL2317522,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay in presence of human serum albumin,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NCc1ccc(F)cc1)c1cn2c(c(O)c1=O)C(=O)N1CCCCOC1C2,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314688,CHEMBL2314688,7.66,0.0,http://www.openphacts.org/units/Nanomolar,1844820.0,=,1.0,1.0,=,IC50,nM,22.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,22.0,CHEMBL378
4186,1438410.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)/C=C/C=C/c1cccc(C(=O)c2c(CC)c(C)nc(O)c2N(C)C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL185487,CHEMBL185487,6.20,0.0,http://www.openphacts.org/units/Nanomolar,371586.0,=,1.0,1.0,=,IC50,nM,630.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.63,CHEMBL378
4187,2292380.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL54600,CHEMBL54600,,0.0,http://www.openphacts.org/units/Nanomolar,813575.0,=,1.0,1.0,=,IC50,nM,399944.75,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,3.398,CHEMBL378
4188,5137369.0,[],CHEMBL1646836,Antiviral activity against X4 tropic HIV1 NL4.3 infected in human MT4 cells expressing CD4 and CXCR4 assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NCc1ccc(CN(Cc2nc3ccccc3[nH]2)C2CCCc3cccnc32)c(CN)c1,CHEMBL1641524,Bioorg Med Chem Lett,2011.0,CHEMBL1644073,CHEMBL1644073,8.70,0.0,http://www.openphacts.org/units/Nanomolar,1319747.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.002,CHEMBL378
4189,2136595.0,[],CHEMBL939089,Inhibition of HIV1 5'-long terminal repeat promoter expression in human 293T cells by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc([C@@H](O)[C@@H](CO)c2ccc(O)c(OC)c2)ccc1O,CHEMBL1144024,Bioorg Med Chem,2008.0,CHEMBL407339,CHEMBL407339,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,705089.0,>,1.0,1.0,>,IC50,ug.mL-1,150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,150.0,CHEMBL378
4190,2530524.0,[],CHEMBL1011336,Antiviral activity against Rift Valley fever virus infected in african green monkey Vero cells after 6 days by plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1N[C@@H]2C(=C[C@H](O)[C@@H](O)[C@H]2O)c2cc3c(cc21)OCO3,CHEMBL1150051,J Nat Prod,1992.0,CHEMBL487798,CHEMBL487798,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,790637.0,=,1.0,1.0,=,IC50,ug.mL-1,0.15,CHEMBL613130,Rift Valley fever virus,Rift Valley fever virus,11588,IC50,ug ml-1,UO_0000274,0.15,CHEMBL613130
4191,940684.0,[],CHEMBL650153,Compound was tested for anti-retroviral activity against moloney murine sarcoma virus (MSV) in murine C3H/3T3 embryo fibroblast cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2nn(C[C@H](O)CO)nc12,CHEMBL1129435,J Med Chem,1996.0,CHEMBL130251,CHEMBL130251,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251937.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL613501,Moloney murine sarcoma virus,Moloney murine sarcoma virus,11809,IC50,ug ml-1,UO_0000274,100.0,CHEMBL613501
4192,594046.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(C)c(Cc2nc(N)nc(Nc3ccc(C#N)cc3)n2)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL74409,CHEMBL74409,5.80,0.0,http://www.openphacts.org/units/Nanomolar,126942.0,=,1.0,1.0,=,IC50,nM,1570.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.57,CHEMBL378
4193,15004832.0,[],CHEMBL3364311,Antiviral activity against hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C(CN2CCOCC2)NC(c2c(F)cc(F)cc2F)=NC1c1ccc(F)cc1Cl.Cl,CHEMBL3352024,Bioorg Med Chem Lett,2014.0,CHEMBL3326601,CHEMBL3326590,5.63,0.0,http://www.openphacts.org/units/Nanomolar,2268179.0,=,1.0,1.0,=,IC50,nM,2350.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol,UO_0000065,2.35,CHEMBL613497
4194,13940307.0,[],CHEMBL3131385,Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)O)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL3124823,Eur J Med Chem,2014.0,CHEMBL1956398,CHEMBL1956398,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1972639.0,=,1.0,1.0,=,IC50,ug.mL-1,180.6,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,180.6,CHEMBL613129
4195,10961074.0,[],CHEMBL2061264,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing wild type protease infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(CNC=C2C(=O)Nc3ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc4ccccc4)NC(=O)O[C@H]4CO[C@H]5OCC[C@H]54)cc32)cs1,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058317,CHEMBL2058317,7.35,0.0,http://www.openphacts.org/units/Nanomolar,1656257.0,=,1.0,1.0,=,IC50,nM,45.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,45.0,CHEMBL378
4196,15210769.0,[],CHEMBL3421426,Antiviral activity against Human immunodeficiency virus 1 3b infected in human MT4 cells assessed as inhibition of virus replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1[C@H](OC(C)=O)[C@H]2[C@@H](OC(=O)c3ccccc3)[C@@H](C)C[C@]2(O)[C@H](O)[C@H](C)/C=C/C(C)(C)C(=O)[C@H](OC(C)=O)[C@H]1OC(C)=O,CHEMBL3414423,J Nat Prod,2014.0,CHEMBL3414613,CHEMBL3414613,,0.0,http://www.openphacts.org/units/Nanomolar,2289948.0,>,1.0,1.0,>,IC50,nM,38000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,38.0,CHEMBL378
4197,375835.0,[],CHEMBL873878,Concentration required to inhibit the entry of HIV-1 reporter virus [ADA] into U-87 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1,CHEMBL1134621,J Med Chem,2001.0,CHEMBL106247,CHEMBL106247,8.00,0.0,http://www.openphacts.org/units/Nanomolar,213212.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
4198,19261718.0,[],CHEMBL4404352,Antiviral activity against HIV1 HXB2 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2ccc(Cl)cn2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4436189,CHEMBL4436189,5.57,0.0,http://www.openphacts.org/units/Nanomolar,3216253.0,=,1.0,1.0,=,IC50,nM,2700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.7,CHEMBL378
4199,1213166.0,[],CHEMBL710376,Inhibitory activity against 100I strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL308954,CHEMBL308954,8.48,0.0,http://www.openphacts.org/units/Nanomolar,127449.0,=,1.0,1.0,=,IC50,nM,3.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0033,CHEMBL378
4200,3406166.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc2oc(-c3cccc(F)c3)c(O)c(=O)c2c1,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1215737,CHEMBL1215737,4.45,0.0,http://www.openphacts.org/units/Nanomolar,933518.0,=,1.0,1.0,=,IC50,nM,35300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,35.3,CHEMBL378
4201,3014819.0,[],CHEMBL1050518,Antiviral activity against multidrug-resistant HIV1 isolate TM infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,CHEMBL1156053,J Med Chem,2009.0,CHEMBL115,CHEMBL115,,0.0,http://www.openphacts.org/units/Nanomolar,862677.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
4202,15690092.0,[],CHEMBL3610404,Antiviral activity against HIV1 BaL infected in CD4/CCR5 expressing human MAGI cells incubated for 48 hrs by beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1cc(CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[nH]n1,CHEMBL3608277,ACS Med Chem Lett,2015.0,CHEMBL3608765,CHEMBL3608765,4.22,0.0,http://www.openphacts.org/units/Nanomolar,2496843.0,=,1.0,1.0,=,IC50,nM,60000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,60.0,CHEMBL378
4203,15027150.0,[],CHEMBL3367171,Inhibition of AP-1-mediated transcriptional activation in human Jurkat cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cnc(Cl)nc1C(F)(F)F)N1COCc2ccc(C(F)(F)F)cc21,CHEMBL3352097,J Med Chem,2014.0,CHEMBL3341905,CHEMBL3341905,5.00,0.0,http://www.openphacts.org/units/Nanomolar,2265174.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,10.0,CHEMBL4977
4204,1402202.0,[],CHEMBL837466,In vitro inhibitory concentration against HIV K101E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369599,CHEMBL369599,,0.0,http://www.openphacts.org/units/Nanomolar,360395.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4205,14596902.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(Sc2c(C)c(=O)[nH]c(=O)n2COCCO)cc1,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL116695,CHEMBL116695,5.40,0.0,http://www.openphacts.org/units/Nanomolar,2082744.0,=,1.0,1.0,=,IC50,nM,3960.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.96,CHEMBL378
4206,18202557.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2cc3ccccc3[nH]2)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4088789,CHEMBL4088789,5.68,0.0,http://www.openphacts.org/units/Nanomolar,3019977.0,=,1.0,1.0,=,IC50,nM,2100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.1,CHEMBL378
4207,2570688.0,[],CHEMBL1000472,Antiviral activity against hepatitis B virus-infected human HepG2.2.15 cells assessed as inhibition of HBV surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@H](OC(=O)c1ccccc1)[C@H](C[C@@H](C)[C@]12CC[C@@]3(C)[C@@]1(C[C@H](OC(=O)c1ccccc1)[C@H]1[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@@]13C)O2)OC(=O)c1ccccc1,CHEMBL1155923,Bioorg Med Chem Lett,2008.0,CHEMBL491988,CHEMBL491988,,0.0,http://www.openphacts.org/units/Nanomolar,769069.0,>,1.0,1.0,>,IC50,nM,1600000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.6,CHEMBL613497
4208,18202567.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccccc3)cs2)C(c2cccc(O)c2)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4067066,CHEMBL4067066,4.10,0.0,http://www.openphacts.org/units/Nanomolar,3019948.0,=,1.0,1.0,=,IC50,nM,79000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,79.0,CHEMBL378
4209,12463717.0,[],CHEMBL3057688,Antiviral activity against wild type Human immunodeficiency virus 1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(NC(=S)NC(=N)c2c(Cl)cccc2Cl)cc1,CHEMBL3046335,Med Chem Res,2009.0,CHEMBL305778,CHEMBL305778,,0.0,http://www.openphacts.org/units/Nanomolar,1805842.0,=,1.0,1.0,=,IC50,nM,43651583.22,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,1.36,CHEMBL378
4210,2292364.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL56135,CHEMBL56135,4.70,0.0,http://www.openphacts.org/units/Nanomolar,812441.0,=,1.0,1.0,=,IC50,nM,19998.62,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.699,CHEMBL378
4211,13475563.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435860,CHEMBL2435860,7.91,0.0,http://www.openphacts.org/units/Nanomolar,1924236.0,=,1.0,1.0,=,IC50,nM,12.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,12.3,CHEMBL378
4212,2091733.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(C(=O)OCC)CCCN(S(=O)(=O)c2ccc(C)cc2)C1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL411130,CHEMBL411130,,0.0,http://www.openphacts.org/units/Nanomolar,700553.0,=,1.0,1.0,=,IC50,nM,37153522909717.28,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,4.57,CHEMBL378
4213,19450620.0,[],CHEMBL4433618,Antiviral activity against wild-type HIV1 NL4-3 infected in human TZM-bl cells infected with supernatants from virus-infected human MT2 cells treated with compound for 72 hrs assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay based monocycle assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc(NCCNC(=O)c2ccc(COc3ccccc3-c3csc(N)n3)cc2)nc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4536687,CHEMBL4597553,,0.0,http://www.openphacts.org/units/Nanomolar,3249764.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
4214,1242479.0,[],CHEMBL644201,Compound was evaluated as inhibitor of avian myeloblastosis virus (AMV) reverse transcriptase,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1126397,Bioorg Med Chem Lett,1992.0,CHEMBL129,CHEMBL129,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,54746.0,=,1.0,1.0,=,IC50,ug.mL-1,600.0,CHEMBL613550,Avian myeloblastosis virus,Avian myeloblastosis virus,11866,IC50,ug ml-1,UO_0000274,600.0,CHEMBL613550
4215,3358061.0,[],CHEMBL1175711,Antiviral activity against HIV1 expressing reverse transcriptase Y188L mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(N)=O)cc3Cl)CC2)ncc1Br,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1169982,CHEMBL1169982,7.52,0.0,http://www.openphacts.org/units/Nanomolar,921823.0,=,1.0,1.0,=,IC50,nM,30.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,30.2,CHEMBL378
4216,10863208.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(/C=C/C(=O)O[C@H]2CC[C@]3(C)[C@H]4CC=C5[C@@H]6C[C@@](C)(C(=O)OCc7ccc(Br)cc7F)CC[C@]6(C)CC[C@@]5(C)[C@]4(C)CC[C@H]3C2(C)C)cc(OC)c1OC,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022402,CHEMBL2022402,,0.0,http://www.openphacts.org/units/Nanomolar,1637654.0,>,1.0,1.0,>,IC50,nM,258630.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,258.63,CHEMBL613497
4217,3198121.0,[],CHEMBL1104129,Antiviral activity against HIV1 BCF02 infected in PBMCs assessed as reverse transcriptase activity after 7 days by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](CN[C@H](CN[C@H](CN[C@H](CNCCC(N)=O)Cc1ccc(O)cc1)Cc1ccc(O)cc1)Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@@H](N)Cc1ccc(O)cc1,CHEMBL1153724,Bioorg Med Chem Lett,2009.0,CHEMBL1075825,CHEMBL1075825,4.79,0.0,http://www.openphacts.org/units/Nanomolar,889166.0,=,1.0,1.0,=,IC50,nM,16300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,16.3,CHEMBL378
4218,1030482.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=C(S)N(Nc2cccc([N+](=O)[O-])c2)C1c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL288680,CHEMBL288680,4.38,0.0,http://www.openphacts.org/units/Nanomolar,62326.0,=,1.0,1.0,=,IC50,nM,42180.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,42.18,CHEMBL378
4219,10862036.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)CCCOC(=O)[C@@]1(C)CC[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)/C=C/c6cc(OC)c(OC)c(OC)c6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2023708,CHEMBL2023708,,0.0,http://www.openphacts.org/units/Nanomolar,1639317.0,>,1.0,1.0,>,IC50,nM,1227810.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1227.81,CHEMBL613497
4220,3432865.0,[],CHEMBL1246459,Antiviral activity against R5 tropic HIV1 BaL infected in human CEMx174 5.25M7 cells after 3 days by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1-c1ccc(C(=O)NN2C(=O)C3C4C=CC(C5CC45)C3C2=O)cc1,CHEMBL1240449,Eur J Med Chem,2010.0,CHEMBL1241743,CHEMBL1241743,,0.0,http://www.openphacts.org/units/Nanomolar,952616.0,>,1.0,1.0,>,IC50,nM,185400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,185.4,CHEMBL378
4221,5230902.0,[],CHEMBL1678278,Antiviral activity against Human immunodeficiency virus 1 subtype F BR/93/020 infected in phytohemagglutininin and interleukin-2-stimulated PBMC assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL129,CHEMBL129,9.52,0.0,http://www.openphacts.org/units/Nanomolar,1332124.0,=,1.0,1.0,=,IC50,nM,0.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0003,CHEMBL378
4222,23228463.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '36.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '36.0'}]",CHEMBL4826198,Antiviral activity against Human hepatitis B virus in Huh-7 cells assessed as reduction in intracellular viral DNA level incubated for 36 hrs by qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ncccc1C(=O)NCCNc1cc(Nc2ccc(F)c(F)c2)nc([S+](C)[O-])n1,CHEMBL4825668,J Med Chem,2021.0,CHEMBL4847109,CHEMBL4847109,,0.0,http://www.openphacts.org/units/Nanomolar,3613081.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.0,CHEMBL613497
4223,1167529.0,[],CHEMBL694658,Inhibitory concentration against HIV-1 LTR polymerase chain reaction product,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCCC(=O)Nc1cc(C(=O)Nc3cc(C(=O)NCCC(=N)N)n(C)c3)n(C)c1)N=C[C@@H]1CCCN1C2=O.Cl,CHEMBL1132187,J Med Chem,1999.0,CHEMBL553022,CHEMBL1194630,6.10,0.0,http://www.openphacts.org/units/Nanomolar,289519.0,=,1.0,1.0,=,IC50,nM,800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.8,CHEMBL378
4224,5222622.0,[],CHEMBL1675306,Antiviral activity against HIV1 infected in human PBMC assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL1460,CHEMBL1460,7.00,0.0,http://www.openphacts.org/units/Nanomolar,1332023.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
4225,19450608.0,[],CHEMBL4433618,Antiviral activity against wild-type HIV1 NL4-3 infected in human TZM-bl cells infected with supernatants from virus-infected human MT2 cells treated with compound for 72 hrs assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay based monocycle assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(-c2ccc(OCc3cccc(C(=O)NCCNC(=O)c4ccc(COc5ccc(F)cc5-c5csc(N)n5)cc4)c3)cc2)cs1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4459450,CHEMBL4597427,,0.0,http://www.openphacts.org/units/Nanomolar,3249752.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
4226,2048689.0,[],CHEMBL925406,Antiviral activity against Hepatitis B virus infected human HepG2 cells after 9 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2CCOCP(=O)(O)O,CHEMBL1140514,Bioorg Med Chem Lett,2007.0,CHEMBL484,CHEMBL484,4.38,0.0,http://www.openphacts.org/units/Nanomolar,679850.0,=,1.0,1.0,=,IC50,nM,42100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,42.1,CHEMBL613497
4227,3358070.0,[],CHEMBL1175711,Antiviral activity against HIV1 expressing reverse transcriptase Y188L mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(Cc3ccccc3)CC2)n1,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1171331,CHEMBL1171331,7.36,0.0,http://www.openphacts.org/units/Nanomolar,922872.0,=,1.0,1.0,=,IC50,nM,43.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,43.6,CHEMBL378
4228,16498297.0,[],CHEMBL3778316,Antiviral activity against HIV1 NL4-3 infected in human 293T cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1=NN(c2nc(-c3ccccc3)cs2)C(=O)/C1=N\Nc1ccc2c(S(=O)(=O)O)cc(S(=O)(=O)O)cc2c1,CHEMBL3774382,Bioorg Med Chem,2016.0,CHEMBL3774420,CHEMBL3774420,4.48,0.0,http://www.openphacts.org/units/Nanomolar,2762405.0,=,1.0,1.0,=,IC50,nM,33100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,33.1,CHEMBL378
4229,2929518.0,[],CHEMBL1056898,Antiviral activity against HIV1 HXB2 harboring 190S mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cnnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL577247,CHEMBL577247,9.40,0.0,http://www.openphacts.org/units/Nanomolar,852824.0,=,1.0,1.0,=,IC50,nM,0.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.4,CHEMBL378
4230,1834537.0,[],CHEMBL909294,Antiviral activity against HIV1 isolate 5512 with M36I/M and V82T mutation in CBMCs,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,CHEMBL1142192,Antimicrob Agents Chemother,2007.0,CHEMBL115,CHEMBL115,7.85,0.0,http://www.openphacts.org/units/Nanomolar,625900.0,=,1.0,1.0,=,IC50,nM,14.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.014,CHEMBL378
4231,1401644.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Cc2c(C)c(C(C)C)[nH]c(=O)c2N(C)C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL368999,CHEMBL368999,6.10,0.0,http://www.openphacts.org/units/Nanomolar,360347.0,=,1.0,1.0,=,IC50,nM,794.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.794,CHEMBL378
4232,16490581.0,[],CHEMBL3773511,Antiretroviral activity against HIV-1 based virus like particles infected in U2OS cells,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1c(O)cc2cccccc1-2,CHEMBL3769349,Bioorg Med Chem,2016.0,CHEMBL3771320,CHEMBL3771320,5.00,0.0,http://www.openphacts.org/units/Nanomolar,2760348.0,=,1.0,1.0,=,IC50,nM,10100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.1,CHEMBL378
4233,2091749.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(C(=O)c2ccccc2)CCCN(S(=O)(=O)c2ccc(C)cc2)C1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL407177,CHEMBL407177,,0.0,http://www.openphacts.org/units/Nanomolar,700537.0,=,1.0,1.0,=,IC50,nM,831763771102670.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,5.92,CHEMBL378
4234,14596898.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2ccc([N+](=O)[O-])cc2)n(COCCO)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL116799,CHEMBL116799,5.43,0.0,http://www.openphacts.org/units/Nanomolar,2082740.0,=,1.0,1.0,=,IC50,nM,3720.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.72,CHEMBL378
4235,15027148.0,[],CHEMBL3367171,Inhibition of AP-1-mediated transcriptional activation in human Jurkat cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,O=C1c2cnc(Cl)nc2C(=O)N1Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1,CHEMBL3352097,J Med Chem,2014.0,CHEMBL3341907,CHEMBL3341907,5.03,0.0,http://www.openphacts.org/units/Nanomolar,2265176.0,=,1.0,1.0,=,IC50,nM,9400.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,9.4,CHEMBL4977
4236,1740535.0,[],CHEMBL854478,Inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)n2c(CCN3C(=O)c4ccccc4C3=O)nc3cc(F)c(F)cc32)cc1,CHEMBL1138932,J Med Chem,2006.0,CHEMBL213844,CHEMBL213844,5.92,0.0,http://www.openphacts.org/units/Nanomolar,520769.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.2,CHEMBL613497
4237,14654435.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)/C=C/c3cc(OC)c(OC)c(OC)c3)[C@H](O)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262995,CHEMBL3262995,4.65,0.0,http://www.openphacts.org/units/Nanomolar,2101878.0,=,1.0,1.0,=,IC50,nM,22300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,22.3,CHEMBL613497
4238,1086980.0,[],CHEMBL709777,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,C#CCN1Cc2cccc3nc(O)n(c23)CC1C,CHEMBL1125252,J Med Chem,1991.0,CHEMBL165302,CHEMBL165302,,0.0,http://www.openphacts.org/units/Nanomolar,322387.0,=,1.0,1.0,=,IC50,nM,580000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,580.0,CHEMBL378
4239,13967474.0,[],CHEMBL3135325,Antiviral activity against HIV1 VSVG harboring reverse transcriptase K103N mutant infected in 293ET cells assessed as inhibition of viral replication by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)OC(=O)c1sccc1S(=O)(=O)N1c2cc(Cl)ccc2NC(=O)C1C,CHEMBL3132804,Medchemcomm,2014.0,CHEMBL3133047,CHEMBL3133047,,0.0,http://www.openphacts.org/units/Nanomolar,1974718.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
4240,5247013.0,[],CHEMBL1687411,Antiviral activity against HIV1 Ba-L infected in human PBL cells assessed as reverse transcriptase activity after 7 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1C1CCN(CCC(CNS(=O)(=O)c2ccccc2)c2ccccc2)CC1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL1682478,CHEMBL1682478,,0.0,,1333576.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4241,3525572.0,[],CHEMBL1273925,Antiviral activity against HIV1 HXB2 infected in human HeLaP4-2 cells assessed as inhibition of single-cycle viral replication,F,BAO_0000190,BAO_0000218,organism-based format,O=c1cc(-c2cccc(-c3ccccc3)c2)c2cccnc2n1O,CHEMBL1268904,Bioorg Med Chem Lett,2010.0,CHEMBL1270317,CHEMBL1270317,4.47,0.0,http://www.openphacts.org/units/Nanomolar,965889.0,=,1.0,1.0,=,IC50,nM,34000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,34.0,CHEMBL378
4242,693369.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Clc1ccc(Cl)c(SSc2cc(Cl)ccc2Cl)c1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL121701,CHEMBL121701,,0.0,,228629.0,=,1.0,0.0,=,IC50,,13.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,13.7,CHEMBL378
4243,12642431.0,[],CHEMBL2317522,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay in presence of human serum albumin,F,BAO_0000190,BAO_0000218,organism-based format,COCCn1ccn2cc(C(=O)NCc3ccc(F)cc3)c(=O)c(O)c2c1=O,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314693,CHEMBL2314693,7.57,0.0,http://www.openphacts.org/units/Nanomolar,1844828.0,=,1.0,1.0,=,IC50,nM,27.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,27.0,CHEMBL378
4244,2516317.0,[],CHEMBL975243,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(Cc2cccc3ccccc23)nc(SCc2ccc(OC)cc2)[nH]c1=O,CHEMBL1138559,Eur J Med Chem,2009.0,CHEMBL514506,CHEMBL514506,5.88,0.0,http://www.openphacts.org/units/Nanomolar,733268.0,=,1.0,1.0,=,IC50,nM,1320.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.32,CHEMBL378
4245,157533.0,[],CHEMBL756132,Compound was tested for the inhibition of LPS-induced TNF-alpha production in human peripheral blood mononuclear cells (PBMC),F,BAO_0000190,BAO_0000218,organism-based format,S=C1c2ccccc2C(=S)N1C1C=CCCC1,CHEMBL1146001,J Med Chem,2003.0,CHEMBL357779,CHEMBL357779,4.82,0.0,http://www.openphacts.org/units/Nanomolar,291261.0,=,1.0,1.0,=,IC50,nM,15000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,15.0,CHEMBL378
4246,17603003.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(c2cc(OC)nc(N3CCCCC3)n2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644938,CHEMBL3644938,5.94,0.0,http://www.openphacts.org/units/Nanomolar,2518058.0,=,37.0,1.0,=,IC50,nM,1150.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,1150.0,CHEMBL4620
4247,863445.0,[],CHEMBL686566,Anti-HIV activity in H9 lymphocytes.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)oc2c3c(ccc12)OC(C)(C)[C@H](OC(=O)C12CCC(C)(C(=O)O1)C2(C)C)[C@@H]3OC(=O)C12CC3CC(CC(C3)C1)C2,CHEMBL1132174,J Med Chem,1999.0,CHEMBL330107,CHEMBL330107,4.67,0.0,http://www.openphacts.org/units/Nanomolar,163829.0,=,1.0,1.0,=,IC50,nM,21300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,21.3,CHEMBL378
4248,22980432.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '192.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '8.0'}]",CHEMBL4772774,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in intracellular viral DNA level incubated for 4 days prior to compound washout followed by compound addition and measured after 4 days by fluorogenic probe based RT-qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Cc1sc(-c2nccs2)nc1C(=O)NCc1ccc(F)cc1,CHEMBL4765395,Eur J Med Chem,2020.0,CHEMBL3740028,CHEMBL3740028,5.64,0.0,http://www.openphacts.org/units/Nanomolar,3568765.0,=,1.0,1.0,=,IC50,nM,2300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol/L,UO_0000065,2.3,CHEMBL613497
4249,13857137.0,[],CHEMBL3097949,Antiviral activity against enfuvirtide-resistant HIV-1 NL4-3 harboring gp41 (36G)V38A/N42D mutation infected in human MT2 cells assessed as inhibition of p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1cccc(CN2C(=O)/C(=C/c3cc(C)n(-c4ccc(O)c(C(=O)O)c4)c3C)SC2=S)c1,CHEMBL3091377,Bioorg Med Chem,2013.0,CHEMBL3092878,CHEMBL3092878,6.14,0.0,http://www.openphacts.org/units/Nanomolar,1952760.0,=,1.0,1.0,=,IC50,nM,725.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.725,CHEMBL378
4250,1402321.0,[],CHEMBL834487,In vitro inhibitory concentration value against HIV K103N and Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N2CCOCC2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL178061,CHEMBL178061,,0.0,http://www.openphacts.org/units/Nanomolar,360425.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4251,2997503.0,[],CHEMBL1046974,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)c2ccc(=O)n(-c3ccc(C(C)=O)cc3)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL567995,CHEMBL567995,,0.0,http://www.openphacts.org/units/Nanomolar,856576.0,>,1.0,1.0,>,IC50,nM,110200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,110.2,CHEMBL613497
4252,3104766.0,[],CHEMBL1074496,Antiviral activity against HIV1 LAI in human MT2 cells after 7 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1CNC(=O)[C@H]1N(C(=O)[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CO[C@H]3OCC[C@H]32)CSC1(C)C,CHEMBL1159037,Bioorg Med Chem Lett,2010.0,CHEMBL589988,CHEMBL589988,8.05,0.0,http://www.openphacts.org/units/Nanomolar,883164.0,=,1.0,1.0,=,IC50,nM,9.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.009,CHEMBL378
4253,23228469.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '36.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '36.0'}]",CHEMBL4826198,Antiviral activity against Human hepatitis B virus in Huh-7 cells assessed as reduction in intracellular viral DNA level incubated for 36 hrs by qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CS(=O)(=O)c1nc(Nc2cc(F)c(F)c(F)c2)cc(N2CCNCC2)n1,CHEMBL4825668,J Med Chem,2021.0,CHEMBL4868648,CHEMBL4868648,6.69,0.0,http://www.openphacts.org/units/Nanomolar,3613087.0,=,1.0,1.0,=,IC50,nM,203.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.203,CHEMBL613497
4254,2030625.0,[],CHEMBL886374,Inhibition of cJun translocation in IL-1-beta-stimulated A549 cells,B,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)N1CCC(Nc2nccc(-c3cnc4ccccn34)n2)CC1,CHEMBL1139954,Bioorg Med Chem Lett,2007.0,CHEMBL246543,CHEMBL246543,4.71,0.0,http://www.openphacts.org/units/Nanomolar,674103.0,=,1.0,1.0,=,IC50,nM,19331.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,nM,UO_0000065,19331.0,CHEMBL4977
4255,280422.0,[],CHEMBL706841,Antiviral activity by observing cytopathic effect induced by HIV-1 strain IIIB in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@H](NC(=O)[C@H](NCc1ccccc1)[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OCc1ccccc1)c1ccccc1)C(=O)NCc1ccccc1,CHEMBL1127464,J Med Chem,1994.0,CHEMBL105301,CHEMBL105301,,0.0,http://www.openphacts.org/units/Nanomolar,195860.0,>,1.0,1.0,>,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3000.0,CHEMBL378
4256,5222664.0,[],CHEMBL1675426,Antiviral activity against HIV1 harboring reverse transcriptase K65R mutant infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL141,CHEMBL141,4.22,0.0,http://www.openphacts.org/units/Nanomolar,1332024.0,=,1.0,1.0,=,IC50,nM,60500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,60.5,CHEMBL378
4257,22933256.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)/C=C/c4ccc5c(c4)OC(F)(F)O5)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4763138,CHEMBL4763138,6.23,0.0,http://www.openphacts.org/units/Nanomolar,3560866.0,=,1.0,1.0,=,IC50,nM,588.84,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.23,CHEMBL378
4258,11017281.0,[],CHEMBL2090661,Antiviral activity against NRTI-resistant HIV1 71361-1 clade B clinical isolate infected in PHA-stimulated human PBMC assessed as inhibition of viral replication incubated for 6 hrs followed by compound-wash out measured after 6 days by liquid scintillation counting,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCC(=O)OC[C@@H]1O[C@H](n2ccc(N)nc2=O)CS1,CHEMBL2086298,J Med Chem,2012.0,CHEMBL2087753,CHEMBL2087753,7.36,0.0,http://www.openphacts.org/units/Nanomolar,1674773.0,=,1.0,1.0,=,IC50,nM,43.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,43.3,CHEMBL378
4259,6218346.0,[],CHEMBL1785353,Antiviral activity against Human immunodeficiency virus 1 Bal-PBL,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(NS(C)(=O)=O)c(F)cc2F)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784523,CHEMBL1784523,8.14,0.0,http://www.openphacts.org/units/Nanomolar,1429463.0,=,1.0,1.0,=,IC50,nM,7.244,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,8.14,CHEMBL378
4260,16768172.0,[],CHEMBL3863542,Inhibition of CD4-dependent CXCR4-tropic HIV1 3B cell to cell transmission using Ghost X4/R5 cells as target cells and H9 as effector cells assessed as p24 release incubated for 4 hrs by sandwich ELISA method,F,BAO_0000190,BAO_0000019,assay format,Cc1nc([C@H](CN)NC(=O)c2ccc(-c3ccc(Cl)c(F)c3)[nH]2)sc1CO,CHEMBL3862013,Bioorg Med Chem,2016.0,CHEMBL3964137,CHEMBL3964137,5.19,0.0,http://www.openphacts.org/units/Nanomolar,2803412.0,=,1.0,1.0,=,IC50,nM,6400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.4,CHEMBL378
4261,3014906.0,[],CHEMBL1050534,Antiviral activity against lopinavir-resistant HIV1 NL4-3,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(c1)OCCC=CCCCCN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]3OCC[C@H]31)S2(=O)=O,CHEMBL1156053,J Med Chem,2009.0,CHEMBL2094013,CHEMBL2094013,7.70,0.0,http://www.openphacts.org/units/Nanomolar,862636.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,20.0,CHEMBL378
4262,2601660.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2ccc(/C=C/c3ccc(F)c(F)c3)nc2c1O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL341951,CHEMBL341951,4.52,0.0,http://www.openphacts.org/units/Nanomolar,807474.0,=,1.0,1.0,=,IC50,nM,30000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,30.0,CHEMBL378
4263,525666.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1Sc1cccc(Cl)c1,CHEMBL1134494,J Med Chem,2001.0,CHEMBL55599,CHEMBL55599,5.13,0.0,http://www.openphacts.org/units/Nanomolar,94191.0,=,1.0,1.0,=,IC50,nM,7400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.4,CHEMBL378
4264,3397943.0,[],CHEMBL1217302,Antiviral activity against HIV1 3B infected in human MT4 cells after 5 days by p24 antigen detection assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)CN1C(=O)C(c2ccc(O)c(O)c2)=C2C1=C(c1ccc(O)c(O)c1)C(=O)c1cc(O)c(O)cc12,CHEMBL1212851,Bioorg Med Chem,2010.0,CHEMBL1214291,CHEMBL1214291,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,931723.0,=,1.0,1.0,=,IC50,ug.mL-1,4.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,4.4,CHEMBL378
4265,19407956.0,[],CHEMBL4426963,Antiviral activity against wild type HIV1 NL4-3 infected in human MT4 cells by p24 assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL4425138,J Med Chem,2016.0,CHEMBL1323,CHEMBL1323,8.74,0.0,http://www.openphacts.org/units/Nanomolar,3243729.0,=,1.0,1.0,=,IC50,nM,1.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0018,CHEMBL378
4266,2371350.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(cc3c(=O)n(CC(=O)NCCN4CCOCC4)ncn32)s1,CHEMBL1140145,J Med Chem,2008.0,CHEMBL493659,CHEMBL493659,4.38,0.0,http://www.openphacts.org/units/Nanomolar,745248.0,=,1.0,1.0,=,IC50,nM,42000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,42.0,CHEMBL613493
4267,1158961.0,[],CHEMBL818227,Cytotoxicity was determined in the vero cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,OC[C@@H]1O[C@@H](n2cnc3c(Cl)ncnc32)CS1,CHEMBL1126808,J Med Chem,1993.0,CHEMBL263438,CHEMBL263438,4.49,0.0,http://www.openphacts.org/units/Nanomolar,100966.0,=,1.0,1.0,=,IC50,nM,32700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,32.7,CHEMBL378
4268,23306094.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL4843120,Antiviral activity against Zika virus H/PF/2013 infected in pre-seeded Huh-7 cells assessed as inhibition of viral replication incubated for 72 hrs by immunodetection based plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,FC(F)(F)c1cccc(Nc2nc(NCCOc3ccccc3)nc3[nH]cnc23)c1,CHEMBL4842338,Eur J Med Chem,2021.0,CHEMBL4848338,CHEMBL4848338,6.30,0.0,http://www.openphacts.org/units/Nanomolar,3627089.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,0.5,CHEMBL4296612
4269,823166.0,[],CHEMBL711619,Antiviral activity against HIV-1 (strain RF) infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1128355,J Med Chem,1995.0,CHEMBL57,CHEMBL57,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,73215.0,=,1.0,1.0,=,IC50,ug.mL-1,0.01,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.01,CHEMBL378
4270,1740001.0,[],CHEMBL854478,Inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,Cn1c(CCC2CCCCC2)nc2cc(Cl)c(Cl)cc21,CHEMBL1138932,J Med Chem,2006.0,CHEMBL208546,CHEMBL208546,4.73,0.0,http://www.openphacts.org/units/Nanomolar,520789.0,=,1.0,1.0,=,IC50,nM,18500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,18.5,CHEMBL613497
4271,12051184.0,[],CHEMBL2156564,Antiviral activity against CCR5-tropic HIV1 NL-AD87 infected in HEK293T cells assessed as inhibition of viral replication after 4 days by beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(c(-c3cc(O)c4c(O)c5oc6c(C(=O)O)cc(C)cc6c(=O)c5c(OC)c4c3OC)c1)CC(C)OC2=O,CHEMBL2151018,J Nat Prod,2012.0,CHEMBL2152441,CHEMBL2152441,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1731137.0,=,1.0,1.0,=,IC50,ug.mL-1,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,2.0,CHEMBL378
4272,3084551.0,[],CHEMBL1065278,Antiviral activity against HIV1 KYAG primary isolate assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(NC(=O)C(=O)Nc2ccccc2)CC(C)(C)N1,CHEMBL1153139,Bioorg Med Chem Lett,2010.0,CHEMBL610054,CHEMBL610054,,0.0,http://www.openphacts.org/units/Nanomolar,873913.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
4273,2048679.0,[],CHEMBL925406,Antiviral activity against Hepatitis B virus infected human HepG2 cells after 9 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,CHEMBL1140514,Bioorg Med Chem Lett,2007.0,CHEMBL483,CHEMBL483,4.91,0.0,http://www.openphacts.org/units/Nanomolar,679849.0,=,1.0,1.0,=,IC50,nM,12300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,12.3,CHEMBL613497
4274,848380.0,[],CHEMBL713546,Compound potency to achieve protection of MT-4 cells from HIV-1 cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)C(/N=C(\S)Nc1cccc(Cl)c1)c1c(Cl)cccc1Cl,CHEMBL1134808,Bioorg Med Chem Lett,2001.0,CHEMBL74468,CHEMBL74468,5.28,0.0,http://www.openphacts.org/units/Nanomolar,126215.0,=,1.0,1.0,=,IC50,nM,5200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.2,CHEMBL378
4275,1401890.0,[],CHEMBL835251,In vitro inhibitory concentration against HIV F227L and V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)Nc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL128569,CHEMBL128569,,0.0,http://www.openphacts.org/units/Nanomolar,360373.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4276,2276085.0,[],CHEMBL1030793,Inhibition of HIV1 replication in human 293T cells preincubated 15 mins prior to infection measured after 48 hrs postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1sccc1S(=O)(=O)N1CC(=O)Nc2ccc(F)cc21,CHEMBL1153359,Bioorg Med Chem,2009.0,CHEMBL521976,CHEMBL521976,5.70,0.0,http://www.openphacts.org/units/Nanomolar,754338.0,=,1.0,1.0,=,IC50,nM,2020.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.02,CHEMBL378
4277,18044740.0,[],CHEMBL4010401,"Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype C Du 172, clone 17",F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.21,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,610.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.61,CHEMBL378
4278,5222598.0,[],CHEMBL1675304,Antiviral activity against HIV1 infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,[N-]=[N+]=N[C@H]1C[C@H](n2cnc3c(O)nc(N)nc32)O[C@@H]1CO,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL578448,CHEMBL578448,5.68,0.0,http://www.openphacts.org/units/Nanomolar,1332019.0,=,1.0,1.0,=,IC50,nM,2100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.1,CHEMBL378
4279,5222687.0,[],CHEMBL1675429,Antiviral activity against HIV1 harboring reverse transcriptase Q151M mutant infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C.O=C(O)/C=C/C(=O)O,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL1486,CHEMBL1538,,0.0,,1332022.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4280,2601833.0,[],CHEMBL1033990,Antiviral activity against Hepatitis B virus,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(Sc2nc(N)nc3c2ncn3CCOCP(=O)(OCC(F)(F)F)OCC(F)(F)F)c1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL104475,CHEMBL104475,7.40,0.0,http://www.openphacts.org/units/Nanomolar,806768.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.04,CHEMBL613497
4281,1233650.0,[],CHEMBL683624,In vitro integration activity provided by preintegration complexes isolated from HIV-infected cells,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC2(CC(C)(C)c3cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c32)c2cc(O)c([N+](=O)[O-])cc21,CHEMBL1133186,J Med Chem,2000.0,CHEMBL303764,CHEMBL303764,4.10,0.0,http://www.openphacts.org/units/Nanomolar,108749.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,80.0,CHEMBL378
4282,12680668.0,[],CHEMBL2342597,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral replication after 9 days by fluorescence PCR method,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1NC(=O)/C=C/c1coc2cc(O)ccc2c1=O,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333293,CHEMBL2333293,,0.0,http://www.openphacts.org/units/Nanomolar,1867256.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
4283,533757.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1ccc(Cl)cc1,CHEMBL1134494,J Med Chem,2001.0,CHEMBL433488,CHEMBL433488,5.52,0.0,http://www.openphacts.org/units/Nanomolar,94199.0,=,1.0,1.0,=,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.0,CHEMBL378
4284,3258186.0,[],CHEMBL1114358,Antiviral activity against HIV1 infected in human MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOc1c2cc(C(=O)Nc3cc(C(=O)O)cc(C(=O)O)c3)cc1Cc1cc(C(=O)Nc3cc(C(=O)O)cc(C(=O)O)c3)cc(c1OCCCC)Cc1cc(C(=O)Nc3cc(C(=O)O)cc(C(=O)O)c3)cc(c1OCCCC)Cc1cc(C(=O)Nc3cc(C(=O)O)cc(C(=O)O)c3)cc(c1OCCCC)C2,CHEMBL1156302,Bioorg Med Chem Lett,2010.0,CHEMBL1090293,CHEMBL1090293,6.44,0.0,http://www.openphacts.org/units/Nanomolar,901397.0,=,1.0,1.0,=,IC50,nM,360.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.36,CHEMBL378
4285,1057456.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=CN(Nc2cccc(Cl)c2)C1c1cccc(Br)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289423,CHEMBL289423,6.18,0.0,http://www.openphacts.org/units/Nanomolar,62316.0,=,1.0,1.0,=,IC50,nM,660.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,0.66,CHEMBL613499
4286,412371.0,[],CHEMBL844144,Compound was tested in vitro for antiviral activity against vaccinia virus (Concentration required for the 50%inhibition of virus-induced cell death),F,BAO_0000190,BAO_0000218,organism-based format,C/N=C(/N)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1.Cl,CHEMBL1125541,J Med Chem,1992.0,CHEMBL3143953,CHEMBL1162073,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,207056.0,=,1.0,1.0,=,IC50,ug.mL-1,198.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,ug ml-1,UO_0000274,198.0,CHEMBL613493
4287,2601996.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(O)c2ncn([C@@H]3O[C@H](CO)C=C3F)c2n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL472871,CHEMBL472871,5.58,0.0,http://www.openphacts.org/units/Nanomolar,807487.0,=,1.0,1.0,=,IC50,nM,2600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.6,CHEMBL378
4288,24823571.0,[],CHEMBL5140687,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBeAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3ccccc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5199892,CHEMBL5199892,8.70,0.0,http://www.openphacts.org/units/Nanomolar,3876708.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.002,CHEMBL613497
4289,5229812.0,[],CHEMBL1677606,Antiviral activity against Human immunodeficiency virus 1 3B infected in human CEM-SS cells infected with 0.78 uL of virus stock assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,7.10,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,=,1.0,1.0,=,IC50,nM,80.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.08,CHEMBL378
4290,1672807.0,[],CHEMBL863516,Antiviral activity against HIV1 HxB2 using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(OCCCS(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(C(F)(F)F)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL202663,CHEMBL202663,8.52,0.0,http://www.openphacts.org/units/Nanomolar,411943.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.0,CHEMBL378
4291,593927.0,[],CHEMBL698606,In vitro antiviral activity was evaluated in a plaque reduction assay against influenza B,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1N,CHEMBL1159157,Bioorg Med Chem Lett,1996.0,CHEMBL52270,CHEMBL52270,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,87342.0,=,1.0,1.0,=,IC50,ug.mL-1,0.02,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,0.02,CHEMBL613129
4292,2009839.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2cccc(Cl)c2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL240063,CHEMBL240063,5.08,0.0,http://www.openphacts.org/units/Nanomolar,668074.0,=,1.0,1.0,=,IC50,nM,8400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8400.0,CHEMBL378
4293,2530543.0,[],CHEMBL1011336,Antiviral activity against Rift Valley fever virus infected in african green monkey Vero cells after 6 days by plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1O)[C@@H]1[C@H](O)[C@@H](O)C=C3CCN(C2)[C@H]31,CHEMBL1150051,J Nat Prod,1992.0,CHEMBL586091,CHEMBL586091,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,790700.0,=,1.0,1.0,=,IC50,ug.mL-1,0.63,CHEMBL613130,Rift Valley fever virus,Rift Valley fever virus,11588,IC50,ug ml-1,UO_0000274,0.63,CHEMBL613130
4294,145831.0,[],CHEMBL656397,Activity against HIV-1 by syncytial plaque assay performed in duplicate using CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(Cn2c(Cl)nc3cc(Cl)c(Cl)cc32)cc1,CHEMBL1131326,J Med Chem,1998.0,CHEMBL283158,CHEMBL283158,4.58,0.0,http://www.openphacts.org/units/Nanomolar,30680.0,=,1.0,1.0,=,IC50,nM,26000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,26.0,CHEMBL378
4295,1411780.0,[],CHEMBL832815,Inhibitory concentration against hepatitis C virus NS2/3 protease,B,BAO_0000190,BAO_0000357,single protein format,CC[C@H](C)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(C)=O)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC,CHEMBL1145280,J Med Chem,2005.0,CHEMBL409509,CHEMBL409509,5.47,0.0,http://www.openphacts.org/units/Nanomolar,362390.0,=,1.0,1.0,=,IC50,nM,3400.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,3.4,CHEMBL4620
4296,1411538.0,[],CHEMBL832751,Inhibitory concentration against hepatitis C virus polymerase,B,BAO_0000190,BAO_0000357,single protein format,O=C(N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)c1ccc2c(c1)nc(-c1ccoc1)n2C1CCCCC1,CHEMBL1145280,J Med Chem,2005.0,CHEMBL353549,CHEMBL353549,,0.0,http://www.openphacts.org/units/Nanomolar,362327.0,<,1.0,1.0,<,IC50,nM,1000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,1.0,CHEMBL4620
4297,2244591.0,[],CHEMBL1003075,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase K103N/V108I mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL593,CHEMBL593,,0.0,http://www.openphacts.org/units/Nanomolar,798656.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2000.0,CHEMBL378
4298,2929486.0,[],CHEMBL1056900,Antiviral activity against HIV1 HXB2 harboring 100I and K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL57,CHEMBL57,5.84,0.0,http://www.openphacts.org/units/Nanomolar,848288.0,=,1.0,1.0,=,IC50,nM,1452.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1452.0,CHEMBL378
4299,1750644.0,[],CHEMBL864975,Antiviral activity against HIV1 LAI isolate in human PHA-PBMC cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,CHEMBL1146019,J Med Chem,2006.0,CHEMBL115,CHEMBL115,7.50,0.0,http://www.openphacts.org/units/Nanomolar,540000.0,=,1.0,1.0,=,IC50,nM,32.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,32.0,CHEMBL378
4300,20650864.0,[],CHEMBL4615708,Antiviral activity against HIV1 pNL4.3deltaenvLuc-ADA 8 pseudotyped virus infected in human U373-CD4-CCR5 cells assessed as reduction in viral infection measured after 48 hrs by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(CN)c(CC)c2c(CC)c1CNCc1ccc([nH]1)CNCc1c(CC)c(CNCc3ccc[nH]3)c(CC)c(c1CC)CNCc1ccc([nH]1)CNC2,CHEMBL4613284,ACS Med Chem Lett,2020.0,CHEMBL4637605,CHEMBL4637605,5.75,0.0,http://www.openphacts.org/units/Nanomolar,3476142.0,=,1.0,1.0,=,IC50,nM,1800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.8,CHEMBL378
4301,656492.0,[],CHEMBL683681,Effect upon disintegration catalyzed by the deletion mutant,F,BAO_0000190,BAO_0000218,organism-based format,Oc1ccc(/C=C/c2ccc3cccc(O)c3n2)cc1O,CHEMBL1131039,J Med Chem,1998.0,CHEMBL58057,CHEMBL58057,5.60,0.0,http://www.openphacts.org/units/Nanomolar,179409.0,=,1.0,1.0,=,IC50,nM,2500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.5,CHEMBL378
4302,5199484.0,[],CHEMBL1670944,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,OCCc1c(Nn2nnc3ccccc32)nc2ccc(Cl)cc2c1-c1ccccc1Cl,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668651,CHEMBL1668651,4.42,0.0,http://www.openphacts.org/units/Nanomolar,1328435.0,=,1.0,1.0,=,IC50,nM,37700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,37.7,CHEMBL613497
4303,15606035.0,[],CHEMBL3579360,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O/N=C/c1ccco1,CHEMBL3576819,Eur J Med Chem,2015.0,CHEMBL3577784,CHEMBL3577784,,0.0,http://www.openphacts.org/units/Nanomolar,2480522.0,=,1.0,1.0,=,IC50,nM,519470.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,519.47,CHEMBL613497
4304,13876366.0,[],CHEMBL3107507,Antiviral activity against HIV-1 infected in human SupT1 cells assessed as inhibition of viral infectivity after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(Cl)cc3)CC2)c2cccc(Cl)c2)CC1,CHEMBL3102803,Eur J Med Chem,2014.0,CHEMBL3104684,CHEMBL3104684,7.03,0.0,http://www.openphacts.org/units/Nanomolar,1959709.0,=,1.0,1.0,=,IC50,nM,94.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,94.1,CHEMBL378
4305,22933279.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)/C=C/c4ccc([N+](=O)[O-])cc4)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4760162,CHEMBL4760162,6.96,0.0,http://www.openphacts.org/units/Nanomolar,3560840.0,=,1.0,1.0,=,IC50,nM,110.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.11,CHEMBL378
4306,18044533.0,[],CHEMBL4010365,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of p24 antigen production pretreated with virus for 30 mins followed by 4 days incubation with cells by sandwich ELISA based multicycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(-c2ccc(Cl)cc2)[nH]c1C(=O)NC(CN)c1nc(C)c(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4084817,CHEMBL4084817,5.39,0.0,http://www.openphacts.org/units/Nanomolar,2990228.0,=,1.0,1.0,=,IC50,nM,4100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.1,CHEMBL378
4307,932360.0,[],CHEMBL677528,Antiviral activity against vaccinia virus (VV) in E6SM cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2nn(C[C@@H](CF)OCP(=O)(O)O)nc12,CHEMBL1129435,J Med Chem,1996.0,CHEMBL338786,CHEMBL338786,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251940.0,>,1.0,1.0,>,IC50,ug.mL-1,40.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,ug ml-1,UO_0000274,40.0,CHEMBL613493
4308,17602970.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(c2ccc(N3CCCCC3)cc2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644905,CHEMBL3644905,8.05,0.0,http://www.openphacts.org/units/Nanomolar,2518025.0,=,37.0,1.0,=,IC50,nM,9.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,9.0,CHEMBL4620
4309,13475496.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435856,CHEMBL2435856,7.46,0.0,http://www.openphacts.org/units/Nanomolar,1924231.0,=,1.0,1.0,=,IC50,nM,34.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,34.7,CHEMBL378
4310,5222716.0,[],CHEMBL1675435,Antiviral activity against HIV1 harboring reverse transcriptase M41L/D67N/K70R/T215F/K219Q mutant infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,[N-]=[N+]=N[C@H]1C[C@H](n2cnc3c(O)nc(N)nc32)O[C@@H]1CO,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL578448,CHEMBL578448,5.43,0.0,http://www.openphacts.org/units/Nanomolar,1332019.0,=,1.0,1.0,=,IC50,nM,3700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.7,CHEMBL378
4311,1755793.0,[],CHEMBL864208,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1146046,Bioorg Med Chem Lett,2006.0,CHEMBL223228,CHEMBL223228,5.00,0.0,http://www.openphacts.org/units/Nanomolar,545193.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
4312,2601612.0,[],CHEMBL1033990,Antiviral activity against Hepatitis B virus,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(Sc2ccc([N+](=O)[O-])cc2)c2ncn(CCOCP(=O)(OCC(F)(F)F)OCC(F)(F)F)c2n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL107215,CHEMBL107215,6.28,0.0,http://www.openphacts.org/units/Nanomolar,807016.0,=,1.0,1.0,=,IC50,nM,520.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.52,CHEMBL613497
4313,2371552.0,[],CHEMBL1035750,Antiviral activity against HIV1 with reverse transcriptase K103N/Y181C mutant in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4nc(N)ccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL489586,CHEMBL489586,7.08,0.0,http://www.openphacts.org/units/Nanomolar,773548.0,=,1.0,1.0,=,IC50,nM,84.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,84.0,CHEMBL378
4314,1471843.0,[],CHEMBL834618,Inhibitory activity against HIV-1 mutant strain 103N; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1ccc(C#N)cc1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL363762,CHEMBL363762,,0.0,http://www.openphacts.org/units/Nanomolar,380741.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4315,2997448.0,[],CHEMBL1046974,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCC/N=C(\c1ccc(=O)n(CCCC)c1)c1ccc(OC)cc1O,CHEMBL1156796,J Med Chem,2010.0,CHEMBL576397,CHEMBL576397,,0.0,http://www.openphacts.org/units/Nanomolar,856720.0,=,1.0,1.0,=,IC50,nM,111000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,111.0,CHEMBL613497
4316,5199557.0,[],CHEMBL1670948,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,OCCc1c(N2CCOCC2)nc2ccc(Cl)cc2c1-c1ccccc1Cl,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668649,CHEMBL1668649,,0.0,http://www.openphacts.org/units/Nanomolar,1328433.0,>,1.0,1.0,>,IC50,nM,1592000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1592.0,CHEMBL613497
4317,170200.0,[],CHEMBL656397,Activity against HIV-1 by syncytial plaque assay performed in duplicate using CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Cn2c(N)nc3cc(Cl)c(Cl)cc32)cc1,CHEMBL1131326,J Med Chem,1998.0,CHEMBL22263,CHEMBL22263,4.70,0.0,http://www.openphacts.org/units/Nanomolar,30661.0,=,1.0,1.0,=,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
4318,12108680.0,[],CHEMBL2173505,Antiviral activity against HIV1 3B infected in MT4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL2169791,J Med Chem,2012.0,CHEMBL129,CHEMBL129,8.82,0.0,http://www.openphacts.org/units/Nanomolar,1740561.0,=,1.0,1.0,=,IC50,nM,1.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.5,CHEMBL378
4319,19183286.0,[],CHEMBL4387678,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as reduction in p24 Gag protein production incubated for 6 days and measured on day 7 by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)Nc2c(N(C)[C@@H]3CO[C@@H]4OCC[C@@H]43)c(=O)c2=O)cc1,CHEMBL4385670,Bioorg Med Chem Lett,2019.0,CHEMBL4570048,CHEMBL4570048,,0.0,http://www.openphacts.org/units/Nanomolar,3202094.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
4320,16449879.0,[],CHEMBL3757559,Inhibition of ASCT2-mediated glutamine transport in human HEK293 cells using [3H]-glutamine after 15 mins by scintillation counting,B,BAO_0000190,BAO_0000219,cell-based format,N[C@@H](CCN(Cc1ccccc1OCc1ccccc1F)Cc1ccccc1OCc1ccccc1F)C(=O)O,CHEMBL3751750,Bioorg Med Chem Lett,2016.0,CHEMBL3752210,CHEMBL3752210,5.10,0.0,http://www.openphacts.org/units/Nanomolar,2744505.0,=,1.0,1.0,=,IC50,nM,7900.0,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,uM,UO_0000065,7.9,CHEMBL3562162
4321,5249040.0,[],CHEMBL1685193,Antiviral activity against X4 tropic HIV1 NL4.3 infected in CD4 and CXCR4 expressing human MT4 cells assessed as inhibition of viral cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,CC(c1ccccn1)N(CCCCN)Cc1ncccc1C(C)(C)C,CHEMBL1681661,Bioorg Med Chem Lett,2011.0,CHEMBL1682989,CHEMBL1682989,8.80,0.0,http://www.openphacts.org/units/Nanomolar,1334124.0,=,1.0,1.0,=,IC50,nM,1.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.6,CHEMBL378
4322,492198.0,[],CHEMBL691389,Inhibitory concentration against HIV-1 Bal/Mono,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N)c1C(O)c1cc(C)cc(C)c1,CHEMBL1133473,J Med Chem,2000.0,CHEMBL128812,CHEMBL128812,6.75,0.0,http://www.openphacts.org/units/Nanomolar,245571.0,=,1.0,1.0,=,IC50,nM,180.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,180.0,CHEMBL378
4323,24830952.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C1CCN(c2ccc3c(c2)Oc2c(Cl)cccc2S3(=O)=O)C1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5181365,CHEMBL5181365,,0.0,http://www.openphacts.org/units/Nanomolar,3878125.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
4324,22898301.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731091,Antiviral activity against ATV-resistant HIV1 infected in human MT4 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL1323,CHEMBL1323,7.96,0.0,http://www.openphacts.org/units/Nanomolar,3554418.0,=,1.0,1.0,=,IC50,nM,11.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,11.0,CHEMBL378
4325,3077002.0,[],CHEMBL1067297,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CCCC2=C1C(c1ccc(F)cc1Cl)N=C(c1ccncc1)N2,CHEMBL1153099,Bioorg Med Chem Lett,2010.0,CHEMBL609293,CHEMBL609293,4.78,0.0,http://www.openphacts.org/units/Nanomolar,876961.0,=,1.0,1.0,=,IC50,nM,16470.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,16.47,CHEMBL613497
4326,2570702.0,[],CHEMBL1000472,Antiviral activity against hepatitis B virus-infected human HepG2.2.15 cells assessed as inhibition of HBV surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)/C=C/c1ccccc1)[C@@H](OC(=O)/C=C/c1ccccc1)C(C)(C)O)C1=C2C[C@H](O/C=C/c3ccccc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1155923,Bioorg Med Chem Lett,2008.0,CHEMBL499135,CHEMBL499135,,0.0,http://www.openphacts.org/units/Nanomolar,768985.0,>,1.0,1.0,>,IC50,nM,1400000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.4,CHEMBL613497
4327,18469028.0,[],CHEMBL4182244,Antiviral activity against HIV-1 3B infected in human TZM-bl cells treated for 2 hrs followed by compound washout measured after 2 days by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NC(CC(=O)[O-])C(=O)NC(C)C(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/NC(CC(=O)[O-])C(=O)NC(C)C(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+].[Na+].[Na+],CHEMBL4177704,Bioorg Med Chem Lett,2018.0,CHEMBL4203582,CHEMBL4301002,5.27,0.0,http://www.openphacts.org/units/Nanomolar,3065396.0,=,1.0,1.0,=,IC50,nM,5350.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,umol/L,UO_0000065,5.35,CHEMBL378
4328,37595.0,[],CHEMBL695522,Antiviral activity against V106I/Y181C strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL223228,CHEMBL223228,8.44,0.0,http://www.openphacts.org/units/Nanomolar,20823.0,=,1.0,1.0,=,IC50,nM,3.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.6,CHEMBL378
4329,2602267.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(=O)n([C@@H]2S[C@H](CO)C=C2F)cc1F,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL343457,CHEMBL343457,4.94,0.0,http://www.openphacts.org/units/Nanomolar,807419.0,=,1.0,1.0,=,IC50,nM,11600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,11.6,CHEMBL378
4330,2929739.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3cnc(C)c3C#N)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL575885,CHEMBL575885,7.50,0.0,http://www.openphacts.org/units/Nanomolar,848313.0,=,1.0,1.0,=,IC50,nM,31.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.6,CHEMBL378
4331,15199934.0,[],CHEMBL3411837,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of e antigen secretion by EIA,F,BAO_0000190,BAO_0000218,organism-based format,CCc1ccc(C(=O)N[C@]2(C)CCC[C@@]3(C)[C@@H]4CC[C@@]5(C)C[C@]4(CC[C@@H]32)CC5=O)cc1,CHEMBL3407350,Bioorg Med Chem,2015.0,CHEMBL3409331,CHEMBL3409331,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,2287842.0,=,1.0,1.0,=,IC50,ug.mL-1,7.38,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,7.38,CHEMBL613497
4332,1438415.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,C=Cc1cccc(C(=O)c2c(CC)c(C)nc(O)c2N(C)C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL182846,CHEMBL182846,6.10,0.0,http://www.openphacts.org/units/Nanomolar,371592.0,=,1.0,1.0,=,IC50,nM,790.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.79,CHEMBL378
4333,14658854.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)Cc3ccccc3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262881,CHEMBL3262881,6.68,0.0,http://www.openphacts.org/units/Nanomolar,2101723.0,=,1.0,1.0,=,IC50,nM,208.93,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,pIC50,,UO_0000065,6.68,CHEMBL3259471
4334,20677921.0,[],CHEMBL4622140,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in cytoplasmic HBV-DNA replication incubated for 8 days by real-time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(-c2nn(Cc3ccc(C#N)cc3)c(=O)c3ccccc23)c(F)n1,CHEMBL4619801,J Med Chem,2020.0,CHEMBL4639542,CHEMBL4639542,6.09,0.0,http://www.openphacts.org/units/Nanomolar,3482210.0,=,1.0,1.0,=,IC50,nM,820.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.82,CHEMBL613497
4335,18044685.0,[],CHEMBL4010436,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype A QF495.23M.ENV.A3,F,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075766,CHEMBL4075766,6.22,0.0,http://www.openphacts.org/units/Nanomolar,2990214.0,=,1.0,1.0,=,IC50,nM,600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.6,CHEMBL378
4336,1401630.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1[nH]c(=O)c(N(C)C)c(Cc2cc(C)cc(C)c2)c1C,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175823,CHEMBL175823,8.00,0.0,http://www.openphacts.org/units/Nanomolar,360335.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
4337,1471435.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1ccccc1Br,CHEMBL1138799,J Med Chem,2004.0,CHEMBL189030,CHEMBL189030,8.22,0.0,http://www.openphacts.org/units/Nanomolar,380884.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
4338,12687176.0,[],CHEMBL2344307,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral surface antigen production,F,BAO_0000190,BAO_0000218,organism-based format,COCC(=O)O[C@H]1C[C@@H]2C(=CC[C@@H]3[C@@]2(C)C(=O)C[C@]2(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](OC(C)=O)C[C@@]32C)C(C)(C)[C@@H]1OC(=O)COC,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332403,CHEMBL2332403,,0.0,http://www.openphacts.org/units/Nanomolar,1866097.0,>,1.0,1.0,>,IC50,nM,522400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,522.4,CHEMBL613497
4339,8027841.0,[],CHEMBL1948541,Antiviral activity against HIV1 NF-462 expressing wild-type Vpr infected in human 293T cells containing 4 ng of viral p24 antigen after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O[C@]12COc3ccccc3[C@H]1c1ccccc1C2,CHEMBL1944615,Bioorg Med Chem Lett,2012.0,CHEMBL1945223,CHEMBL1945223,,0.0,,1574223.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4340,2009818.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3nccn3)ccc(F)c12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL238108,CHEMBL238108,6.70,0.0,http://www.openphacts.org/units/Nanomolar,668095.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,200.0,CHEMBL378
4341,2091751.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,CCCOc1cc(C)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL55757,CHEMBL55757,,0.0,http://www.openphacts.org/units/Nanomolar,700535.0,=,1.0,1.0,=,IC50,nM,16595869074375.56,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,4.22,CHEMBL378
4342,14714280.0,[],CHEMBL3293255,Antiviral activity against HIV1 harboring reverse transcriptase K103N/Y181C mutant infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCNC(c1ccc(/C=C/C#N)cc1)c1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL3288568,CHEMBL3288568,,0.0,http://www.openphacts.org/units/Nanomolar,2116126.0,>,1.0,1.0,>,IC50,nM,37324.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,37.324,CHEMBL378
4343,17603001.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(c2cc(-c3ccccc3)nc(OC)n2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644936,CHEMBL3644936,5.85,0.0,http://www.openphacts.org/units/Nanomolar,2518056.0,=,37.0,1.0,=,IC50,nM,1420.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,1420.0,CHEMBL4620
4344,880680.0,[],CHEMBL653610,Inhibitory activity tested against the HIV-1 in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N3CCCC(C(=O)O)C3)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL439717,CHEMBL439717,6.73,0.0,http://www.openphacts.org/units/Nanomolar,9100.0,=,1.0,1.0,=,IC50,nM,185.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,185.0,CHEMBL378
4345,5126326.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,CN1c2ccc(Cl)cc2N(c2ccccc2)C(=O)c2cn(Cc3cccc(O)c3)nc21,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642532,CHEMBL1642532,6.22,0.0,http://www.openphacts.org/units/Nanomolar,1317842.0,=,1.0,1.0,=,IC50,nM,600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.6,CHEMBL378
4346,14581366.0,[],CHEMBL3243475,Antiviral activity against HIV-1 pseudotyped virus expressing HIV-1 isolate D envelope QA465.59M.ENV.D1 assessed as reduction of luciferase production after 3 days by single-cycle neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]1CSCc2ccc(cc2)-c2ccc(cc2)CSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC1=O,CHEMBL3232893,Bioorg Med Chem Lett,2014.0,CHEMBL3233156,CHEMBL3233156,5.11,0.0,http://www.openphacts.org/units/Nanomolar,2081351.0,=,1.0,1.0,=,IC50,nM,7700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.7,CHEMBL378
4347,14990584.0,[],CHEMBL3383790,Antiviral activity against HIV1 subtype D isolate 99UG_A07412M1 infected in human PBMC,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CC4CN(C(=O)C5=CCCCC5)CC4C3)c12,CHEMBL3351851,Bioorg Med Chem Lett,2014.0,CHEMBL3353052,CHEMBL3353052,6.31,0.0,http://www.openphacts.org/units/Nanomolar,2241681.0,=,1.0,1.0,=,IC50,nM,490.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.49,CHEMBL378
4348,2929778.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CN)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578979,CHEMBL578979,6.10,0.0,http://www.openphacts.org/units/Nanomolar,852920.0,=,1.0,1.0,=,IC50,nM,794.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,794.0,CHEMBL378
4349,5126327.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,CN1c2ccc(Cl)cc2N(c2ccccc2)C(=O)c2[nH]cnc21,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642533,CHEMBL1642533,6.68,0.0,http://www.openphacts.org/units/Nanomolar,1317843.0,=,1.0,1.0,=,IC50,nM,210.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.21,CHEMBL378
4350,19258693.0,[],CHEMBL4403491,Antiviral activity against Dengue virus assessed as reduction in virus replication,F,BAO_0000190,BAO_0000218,organism-based format,O=C(N[C@@H]1CCCc2c1[nH]c1ccc(Cl)cc21)c1ccccn1,CHEMBL4402534,Eur J Med Chem,2019.0,CHEMBL551051,CHEMBL551051,7.88,0.0,http://www.openphacts.org/units/Nanomolar,3215467.0,=,1.0,1.0,=,IC50,nM,13.3,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,nM,UO_0000065,13.3,CHEMBL613757
4351,13464656.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1S(=O)(=O)c1cccc(N)c1C#N,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL54444,CHEMBL54444,5.64,0.0,http://www.openphacts.org/units/Nanomolar,1920706.0,=,1.0,1.0,=,IC50,nM,2290.87,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.64,CHEMBL378
4352,1471839.0,[],CHEMBL834619,Inhibitory activity against HIV-1 mutant strain 181C; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL175522,CHEMBL175522,,0.0,http://www.openphacts.org/units/Nanomolar,380740.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4353,18382577.0,[],CHEMBL4146252,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 6 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(N[C@H](CO)Cc1ccccc1)/C(NC(=O)c1ccccc1F)=C(/Br)c1ccccc1,CHEMBL4145455,Eur J Med Chem,2018.0,CHEMBL4159713,CHEMBL4159713,5.61,0.0,http://www.openphacts.org/units/Nanomolar,3051100.0,=,1.0,1.0,=,IC50,nM,2440.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.44,CHEMBL613497
4354,1402186.0,[],CHEMBL837469,In vitro inhibitory concentration against HIV V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL180008,CHEMBL180008,,0.0,http://www.openphacts.org/units/Nanomolar,360390.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4355,2371143.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)n1c2ccccc2c2nc(C)sc21,CHEMBL1140145,J Med Chem,2008.0,CHEMBL526118,CHEMBL526118,,0.0,http://www.openphacts.org/units/Nanomolar,746702.0,=,1.0,1.0,=,IC50,nM,111000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,111.0,CHEMBL613493
4356,23306090.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL4843118,Antiviral activity against Zika virus H/PF/2013 infected in pre-seeded Huh-7 cells assessed as inhibition of viral replication incubated for 72 hrs by immunodetection based secondary yield reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,FC(F)(F)c1ccc(/N=N/c2nc(NCCOc3ccccc3)nc3[nH]cnc23)cc1,CHEMBL4842338,Eur J Med Chem,2021.0,CHEMBL4850491,CHEMBL4850491,,0.0,,3627106.0,,1.0,0.0,,IC50,,,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,,,,CHEMBL4296612
4357,23284029.0,[],CHEMBL4837921,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN(C)C1)S(=O)(=O)c1ccc(C(F)(F)F)cc1,CHEMBL4837199,Eur J Med Chem,2021.0,CHEMBL4861507,CHEMBL4861507,9.08,0.0,http://www.openphacts.org/units/Nanomolar,3622961.0,=,1.0,1.0,=,IC50,nM,0.84,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.84,CHEMBL378
4358,14714252.0,[],CHEMBL3293254,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(c1ccnc(Nc2ccc(C#N)cc2)n1)c1ccccc1Cl,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL3288566,CHEMBL3288566,7.20,0.0,http://www.openphacts.org/units/Nanomolar,2116124.0,=,1.0,1.0,=,IC50,nM,63.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.063,CHEMBL378
4359,14999583.0,[],CHEMBL3364435,Antiviral activity against HIV1 harboring reverse transcriptase K103N/G190A double mutant infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CNc2nc(-c3ccc(F)cc3F)c(Cc3ccccc3)s2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3330437,CHEMBL3330437,6.40,0.0,http://www.openphacts.org/units/Nanomolar,2248823.0,=,1.0,1.0,=,IC50,nM,400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.4,CHEMBL378
4360,12135672.0,[],CHEMBL2187933,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as p24 antigen level after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)OCCCCCC)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2176886,J Med Chem,2012.0,CHEMBL2179613,CHEMBL2179613,5.75,0.0,http://www.openphacts.org/units/Nanomolar,1752712.0,=,1.0,1.0,=,IC50,nM,1800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.8,CHEMBL378
4361,5248978.0,[],CHEMBL1685193,Antiviral activity against X4 tropic HIV1 NL4.3 infected in CD4 and CXCR4 expressing human MT4 cells assessed as inhibition of viral cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(Cc1ncccc1O)C1CCCc2cccnc21,CHEMBL1681661,Bioorg Med Chem Lett,2011.0,CHEMBL1682862,CHEMBL1682862,6.95,0.0,http://www.openphacts.org/units/Nanomolar,1333984.0,=,1.0,1.0,=,IC50,nM,113.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,113.0,CHEMBL378
4362,2413661.0,[],CHEMBL987708,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,CCOCC(=O)O[C@@H](C[C@@H](C)[C@]12CC[C@@]3(C)[C@@]1(C[C@H](OC(=O)COCC)[C@H]1[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@@]13C)O2)[C@@H](OC(=O)COCC)C(C)(C)O,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL446924,CHEMBL446924,,0.0,http://www.openphacts.org/units/Nanomolar,810802.0,=,1.0,1.0,=,IC50,nM,130000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.13,CHEMBL613497
4363,1750638.0,[],CHEMBL866135,Antiviral activity against multi drug-resistant HIV1 B variant in human PHA-PBMC cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)O[C@@H]1C[C@@H]2CCO[C@@H]2C1)S(=O)(=O)c1ccc(CO)cc1,CHEMBL1146019,J Med Chem,2006.0,CHEMBL377329,CHEMBL377329,7.82,0.0,http://www.openphacts.org/units/Nanomolar,539996.0,=,1.0,1.0,=,IC50,nM,15.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,15.0,CHEMBL378
4364,779808.0,[],CHEMBL691758,Inhibition of HIV-cell fusion was determined at 10 uM by using cellular FIGS assay; Inactive,F,BAO_0000190,BAO_0000218,organism-based format,N=C(N)c1cccc(OCc2ccc(OCc3ccccc3)cc2)c1,CHEMBL1146750,Bioorg Med Chem Lett,2004.0,CHEMBL328096,CHEMBL328096,,0.0,http://www.openphacts.org/units/Nanomolar,164106.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4365,2601668.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc2c(ncn2C2C=CC(OCP(=O)(O)OP(=O)(O)C(F)(F)P(=O)(O)O)C2)c(=O)[nH]1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL24118,CHEMBL24118,4.60,0.0,http://www.openphacts.org/units/Nanomolar,807653.0,=,1.0,1.0,=,IC50,nM,25000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.0,CHEMBL378
4366,18940390.0,[],CHEMBL4328847,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cn1ccc2ccc(-c3ccc4cnn(Cc5cc(F)cc(C(=O)O)c5)c4c3)cc21,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4442212,CHEMBL4442212,,0.0,http://www.openphacts.org/units/Nanomolar,3159825.0,>,1.0,1.0,>,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
4367,2929527.0,[],CHEMBL1056897,Antiviral activity against HIV1 HXB2 harboring 190A mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3ncnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL574163,CHEMBL574163,9.00,0.0,http://www.openphacts.org/units/Nanomolar,848359.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
4368,3363284.0,[],CHEMBL1176970,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral cytoplasmic DNA synthesis after 8 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1ccc2c(c1)nc(CCc1ccccn1)n2Cc1ccccc1,CHEMBL1177679,Bioorg Med Chem,2010.0,CHEMBL1173582,CHEMBL1173582,5.68,0.0,http://www.openphacts.org/units/Nanomolar,924649.0,=,1.0,1.0,=,IC50,nM,2100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.1,CHEMBL613497
4369,2929625.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cncc3C)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567838,CHEMBL567838,6.90,0.0,http://www.openphacts.org/units/Nanomolar,852985.0,=,1.0,1.0,=,IC50,nM,125.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,125.0,CHEMBL378
4370,24830990.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)c1ccc2c(=O)c3cccc(Cl)c3oc2c1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5197583,CHEMBL5197583,,0.0,http://www.openphacts.org/units/Nanomolar,3878102.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
4371,14654445.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(CO)[C@H](OC(=O)c3cccnc3)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3263005,CHEMBL3263005,4.42,0.0,http://www.openphacts.org/units/Nanomolar,2101888.0,=,1.0,1.0,=,IC50,nM,38400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,38.4,CHEMBL613497
4372,354920.0,[],CHEMBL693754,Evaluated in vitro for the concentration required to produce 50% inhibition of replication of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(N)Cc3ccccc3)O2)c(=O)[nH]c1=O.O=C(O)C(F)(F)F,CHEMBL1124778,J Med Chem,1990.0,CHEMBL1743596,CHEMBL1789166,6.96,0.0,http://www.openphacts.org/units/Nanomolar,58328.0,=,1.0,1.0,=,IC50,nM,110.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.11,CHEMBL378
4373,1671938.0,[],CHEMBL865135,Antiviral activity against HIV1 V106A mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)cc(C(=O)c2cc(Cl)ccc2OCC(=O)Nc2ccc(S(N)(=O)=O)cc2C)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL201343,CHEMBL201343,8.03,0.0,http://www.openphacts.org/units/Nanomolar,411931.0,=,1.0,1.0,=,IC50,nM,9.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,9.4,CHEMBL378
4374,16544809.0,[],CHEMBL3789812,Antiviral activity against HIV1 virion infected in human TZM-bl cells after 48 hrs by firefly luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Nc2nc(NCC3CCCO3)nc(Nc3ccc(C)cc3)n2)cc1,CHEMBL3784952,Bioorg Med Chem,2016.0,CHEMBL3786003,CHEMBL3786003,,0.0,,2769495.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4375,13475621.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435878,CHEMBL2435878,8.49,0.0,http://www.openphacts.org/units/Nanomolar,1924254.0,=,1.0,1.0,=,IC50,nM,3.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.2,CHEMBL378
4376,12684406.0,[],CHEMBL2344303,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)O[C@@H]1[C@@H](O)C[C@@H]2C(=CC[C@@H]3[C@@]2(C)C(=O)C[C@]2(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](O)C[C@@]32C)C1(C)C,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332396,CHEMBL2332396,5.51,0.0,http://www.openphacts.org/units/Nanomolar,1866090.0,=,1.0,1.0,=,IC50,nM,3100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,3.1,CHEMBL613497
4377,3014821.0,[],CHEMBL1050520,Antiviral activity against multidrug-resistant HIV1 isolate JSL infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,CHEMBL1156053,J Med Chem,2009.0,CHEMBL115,CHEMBL115,,0.0,http://www.openphacts.org/units/Nanomolar,862677.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
4378,2032171.0,[],CHEMBL886779,Inhibition of cytoplasmic HBV DNA synthesis in HepG2.2.15 cells after 8 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)Nc2ccc3c(c2)nc(N)n3S(=O)(=O)C(C)C)cc1,CHEMBL1139980,Eur J Med Chem,2007.0,CHEMBL250986,CHEMBL250986,4.80,0.0,http://www.openphacts.org/units/Nanomolar,674627.0,=,1.0,1.0,=,IC50,nM,16000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,16.0,CHEMBL613497
4379,18239543.0,[],CHEMBL4052028,Antiviral activity against darunavir-resistant HIV1 derived from 30 passages harboring protease L10I/I15V/K20R/L24I/V32I/M36I/M46L/L63P/K70R/V82A/I84V/L89M mutant infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1C2CO[C@H]3OCC1C3C2)S(=O)(=O)c1ccc(N)cc1,CHEMBL4049446,J Med Chem,2017.0,CHEMBL4088111,CHEMBL4088111,6.47,0.0,http://www.openphacts.org/units/Nanomolar,3026803.0,=,1.0,1.0,=,IC50,nM,340.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,340.0,CHEMBL378
4380,1202635.0,[],CHEMBL710380,Inhibitory activity against 103N strain and 181C strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2nc(Nc3ccc(C#N)cc3)ncc2Cl)c(C)c1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70271,CHEMBL70271,6.86,0.0,http://www.openphacts.org/units/Nanomolar,127442.0,=,1.0,1.0,=,IC50,nM,138.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.138,CHEMBL378
4381,6216963.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(NS(C)(=O)=O)ccc2Cl)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784525,CHEMBL1784525,8.44,0.0,http://www.openphacts.org/units/Nanomolar,1429465.0,=,1.0,1.0,=,IC50,nM,3.631,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,8.44,CHEMBL378
4382,10981181.0,[],CHEMBL2065764,Antiviral activity against Human immunodeficiency virus 1 infected in human 293T cells assessed as inhibition of viral replication after 48 hrs by luminescence analysis,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)c1[nH]c2ccc(Cl)cc2c1C1(c2ccccc2)CC1,CHEMBL2062389,ACS Med Chem Lett,2012.0,CHEMBL2063263,CHEMBL2063263,7.02,0.0,http://www.openphacts.org/units/Nanomolar,1659043.0,=,1.0,1.0,=,IC50,nM,96.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.096,CHEMBL378
4383,10961215.0,[],CHEMBL2061270,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M5 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCC1CCCCC1)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058321,CHEMBL2058321,7.75,0.0,http://www.openphacts.org/units/Nanomolar,1656261.0,=,1.0,1.0,=,IC50,nM,18.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,18.0,CHEMBL378
4384,2420904.0,[],CHEMBL981023,Antiviral activity against HIV1 assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CO[C@@H]3OCC[C@@H]32)cc1,CHEMBL1153435,J Med Chem,2009.0,CHEMBL461482,CHEMBL461482,8.39,0.0,http://www.openphacts.org/units/Nanomolar,781712.0,=,1.0,1.0,=,IC50,nM,4.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.1,CHEMBL378
4385,5230938.0,[],CHEMBL1677715,Antiviral activity against Human immunodeficiency virus 1 3B infected in human H9 cells infected with 25 uL of virus stock assessed as expression of p24 antigen after 6 days postinfection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL129,CHEMBL129,,0.0,http://www.openphacts.org/units/Nanomolar,1332124.0,>,1.0,1.0,>,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
4386,2527510.0,[],CHEMBL1003777,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 5 days by MTS method,F,BAO_0000190,BAO_0000218,organism-based format,COCCNC(=O)c1c(O)c2ncc(Cc3ccccc3)cc2[nH]c1=O,CHEMBL1138484,J Med Chem,2009.0,CHEMBL490337,CHEMBL490337,7.04,0.0,http://www.openphacts.org/units/Nanomolar,735545.0,=,1.0,1.0,=,IC50,nM,91.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,91.0,CHEMBL378
4387,10866471.0,[],CHEMBL2025518,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)Cc4ccncc4)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024033,CHEMBL2024033,,0.0,http://www.openphacts.org/units/Nanomolar,1639755.0,>,1.0,1.0,>,IC50,nM,414100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,414.1,CHEMBL613497
4388,287443.0,[],CHEMBL706841,Antiviral activity by observing cytopathic effect induced by HIV-1 strain IIIB in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@H](NC(=O)[C@H](NCc1ccccc1)[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)OCc1ccccc1)C(=O)NCc1ccccc1,CHEMBL1127464,J Med Chem,1994.0,CHEMBL318349,CHEMBL318349,5.70,0.0,http://www.openphacts.org/units/Nanomolar,195851.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2000.0,CHEMBL378
4389,5236397.0,[],CHEMBL1686407,Antiviral activity against HIV1 NL4-3 infected in human HeLa37 cells assessed as inhibition of viral infectivity after 40 hrs by single round infectivity assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CCc2c(O)c(C(=O)CC(=O)c3ccccc3)c(O)c(C=O)c2O1,CHEMBL1681680,Bioorg Med Chem Lett,2011.0,CHEMBL1683662,CHEMBL1683662,4.39,0.0,http://www.openphacts.org/units/Nanomolar,1334880.0,=,1.0,1.0,=,IC50,nM,40700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,40.7,CHEMBL378
4390,2243652.0,[],CHEMBL998762,Growth inhibition of HIV1 3B infected human MOLT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC,CHEMBL1156591,Bioorg Med Chem Lett,2008.0,CHEMBL451503,CHEMBL451503,4.30,0.0,http://www.openphacts.org/units/Nanomolar,796302.0,=,1.0,1.0,=,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
4391,2179588.0,[],CHEMBL966469,Antiviral activity against HIV1 3B isolate replication in human H9 cells assessed as decrease in viral p24 level after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CCC(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,CHEMBL1155638,J Nat Prod,2000.0,CHEMBL508934,CHEMBL508934,4.35,0.0,http://www.openphacts.org/units/Nanomolar,712155.0,=,1.0,1.0,=,IC50,nM,44900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,44.9,CHEMBL378
4392,2413694.0,[],CHEMBL987710,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/C=C/C(=O)O[C@@H](C[C@@H](C)C1=C2C[C@H](OC(=O)/C=C/C=C/C)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)[C@@H](OC(=O)/C=C/C=C/C)C(C)(C)O,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL443940,CHEMBL443940,,0.0,http://www.openphacts.org/units/Nanomolar,810682.0,>,1.0,1.0,>,IC50,nM,900000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.9,CHEMBL613497
4393,615362.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Sc2nc(N)nc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL73939,CHEMBL73939,7.72,0.0,http://www.openphacts.org/units/Nanomolar,126897.0,=,1.0,1.0,=,IC50,nM,19.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.019,CHEMBL378
4394,15568217.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(F)cc1)N1CCN(S(=O)(=O)c2ccccc2Br)CC1,CHEMBL1201862,,,CHEMBL3560529,CHEMBL3560529,8.10,0.0,http://www.openphacts.org/units/Nanomolar,2475117.0,=,7.0,1.0,=,IC50,nM,8.01,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.00801,CHEMBL3259470
4395,24509238.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5055345,Antiviral activity against HIV1 931N101 infected in human SupT1 cells assessed as inhibition of viral entry mesaured after 96 hrs by p24- ELISA assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C(C)NC(=O)NC1c1ccc(OC)cc1,CHEMBL5053552,Bioorg Med Chem,2021.0,CHEMBL385187,CHEMBL385187,5.21,0.0,http://www.openphacts.org/units/Nanomolar,3837689.0,=,1.0,1.0,=,IC50,nM,6200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.2,CHEMBL378
4396,18802834.0,[],CHEMBL4274747,Antiviral activity against Human immunodeficiency virus 1 NL4-3 infected in human CEM-GFP cells after 7 days by p24 ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL4270602,Eur J Med Chem,2018.0,CHEMBL129,CHEMBL129,7.25,0.0,http://www.openphacts.org/units/Nanomolar,3124187.0,=,1.0,1.0,=,IC50,nM,55.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,55.7,CHEMBL378
4397,2244545.0,[],CHEMBL1002213,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase G190E mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(C(F)(F)F)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL275658,CHEMBL275658,8.41,0.0,http://www.openphacts.org/units/Nanomolar,798655.0,=,1.0,1.0,=,IC50,nM,3.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.9,CHEMBL378
4398,18382575.0,[],CHEMBL4146252,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 6 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(N[C@H](CO)Cc1ccccc1)/C(NC(=O)c1ccccc1)=C(/Br)c1ccccc1Cl,CHEMBL4145455,Eur J Med Chem,2018.0,CHEMBL4163085,CHEMBL4163085,5.73,0.0,http://www.openphacts.org/units/Nanomolar,3051098.0,=,1.0,1.0,=,IC50,nM,1880.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.88,CHEMBL613497
4399,13449285.0,[],CHEMBL2428633,Antiviral activity against HIV1 LAI infected in human MT2 cells by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CC(C)(C)C[C@H]3O[C@@H]4OCC[C@@H]4[C@@H]23)cc1,CHEMBL2424573,J Med Chem,2013.0,CHEMBL2426455,CHEMBL2426455,,0.0,,1919761.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4400,2272870.0,[],CHEMBL956847,Antiviral activity against HIV1 Bal in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1[C@H]1C[C@H]2CC[C@@H](C1)N2CCC1(c2ccccc2)CCN(c2nnn[nH]2)CC1,CHEMBL1153314,Bioorg Med Chem Lett,2009.0,CHEMBL493312,CHEMBL493312,5.54,0.0,http://www.openphacts.org/units/Nanomolar,755117.0,=,1.0,1.0,=,IC50,nM,2860.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.86,CHEMBL378
4401,24351633.0,[],CHEMBL5032296,Antiviral activity against Parainfluenza virus type 3,F,BAO_0000190,BAO_0000218,organism-based format,CN1C[C@H]2C[C@@H](C1)c1ccc([N+](=O)[O-])c(=O)n1C2,CHEMBL5030562,Bioorg Med Chem Lett,2021.0,CHEMBL5080811,CHEMBL5080811,,0.0,http://www.openphacts.org/units/Nanomolar,3772748.0,>,1.0,1.0,>,IC50,nM,3000.0,CHEMBL613126,Human parainfluenza virus 3,Human parainfluenza virus 3,11216,IC50,uM,UO_0000065,3.0,CHEMBL613126
4402,13940333.0,[],CHEMBL3131385,Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)OCc1cn(Cc2cccc(OC)c2)nn1)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL3124823,Eur J Med Chem,2014.0,CHEMBL3126789,CHEMBL3126789,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1972646.0,>,1.0,1.0,>,IC50,ug.mL-1,22.22,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,22.22,CHEMBL613129
4403,2930352.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCSCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578367,CHEMBL578367,8.90,0.0,http://www.openphacts.org/units/Nanomolar,852822.0,=,1.0,1.0,=,IC50,nM,1.25,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.25,CHEMBL378
4404,15156720.0,[],CHEMBL3399640,Decrease in hepatitis B viral surface antigen HBsAg secretion in human HepG2(2.2.15) cells at 0.75 to 3 uM after 72 hrs by EIA analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)Oc2cc(OC)ccc2C(C)=O)cc1,CHEMBL3397002,Eur J Med Chem,2015.0,CHEMBL3397412,CHEMBL3397412,5.81,0.0,http://www.openphacts.org/units/Nanomolar,2279259.0,=,1.0,1.0,=,IC50,nM,1550.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.55,CHEMBL613497
4405,107935.0,[],CHEMBL871946,Antiviral potency of compound determined against human immunodeficiency virus type 1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(S(=O)(=O)Nc2cccc(C(c3c(O)c4c(oc3=O)CCCCCC4)C3CC3)c2)cc1,CHEMBL1128214,J Med Chem,1995.0,CHEMBL2062136,CHEMBL2062136,5.82,0.0,http://www.openphacts.org/units/Nanomolar,284868.0,=,1.0,1.0,=,IC50,nM,1500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.5,CHEMBL378
4406,19450685.0,[],CHEMBL4433629,Antiviral activity against HIV1 11845 harboring integrase 140S/148H double mutant infected in human TZM-bl cells infected with supernatants from virus-infected human MT2 cells treated with compound for 72 hrs assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc(NCCNC(=O)c2ccc(COc3ccccc3-c3csc(N)n3)cc2)nc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4536687,CHEMBL4597553,5.64,0.0,http://www.openphacts.org/units/Nanomolar,3249764.0,=,1.0,1.0,=,IC50,nM,2300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.3,CHEMBL378
4407,492006.0,[],CHEMBL752813,Inhibition to hepatitis C virus (HCV) NS3/NS4A serine protease,B,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H](C(=O)[C@H](CCC(=O)O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(F)F)C(=O)O)C(c1ccccc1)c1ccccc1,CHEMBL1135212,Bioorg Med Chem Lett,2002.0,CHEMBL349123,CHEMBL349123,,0.0,http://www.openphacts.org/units/Nanomolar,317190.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,50.0,CHEMBL4620
4408,2997304.0,[],CHEMBL1046975,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)c2ccc(=O)n(-c3ccccc3C)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL579274,CHEMBL579274,7.00,0.0,http://www.openphacts.org/units/Nanomolar,856557.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.1,CHEMBL613497
4409,5189198.0,[],CHEMBL1658800,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)Cc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652495,CHEMBL1652495,,0.0,http://www.openphacts.org/units/Nanomolar,1326870.0,>,1.0,1.0,>,IC50,nM,950000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.95,CHEMBL613497
4410,1045233.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(NN2C=NC(C)C2C)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39431,CHEMBL39431,,0.0,http://www.openphacts.org/units/Nanomolar,62346.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4411,6166539.0,[],CHEMBL1769966,Inhibition of TPA-induced AP-1 activation in cells expressing beta-lactamase after 18 hrs using FRET substrate by cell-based high-throughput screening assay,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)[C@H]1OC(=O)C=C2[C@]3(C)[C@H]4[C@H](OC(=O)[C@@]4(C)[C@@H](O)[C@H]4O[C@H]43)[C@H]3O[C@]213,CHEMBL1765002,J Nat Prod,2011.0,CHEMBL1765575,CHEMBL1765575,5.40,1.0,http://www.openphacts.org/units/Nanomolar,1416218.0,=,1.0,1.0,=,IC50,nM,4000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,4.0,CHEMBL4977
4412,10862116.0,[],CHEMBL2024925,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B e-antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCOC(=O)[C@@]1(C)CC[C@]2(C)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024630,CHEMBL2024630,,0.0,http://www.openphacts.org/units/Nanomolar,1640526.0,>,1.0,1.0,>,IC50,nM,1027760.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1027.76,CHEMBL613497
4413,2929669.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSCc3nccs3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL565691,CHEMBL565691,5.70,0.0,http://www.openphacts.org/units/Nanomolar,852895.0,=,1.0,1.0,=,IC50,nM,1995.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1995.0,CHEMBL378
4414,2635007.0,[],CHEMBL1000603,Antiviral activity against HIV1 LAI in human MT2 cells by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc(S(=O)(=O)N(C[C@H]2CCC(=O)N2)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CO[C@H]3OCC[C@H]32)cc1,CHEMBL1136990,J Med Chem,2009.0,CHEMBL500616,CHEMBL500616,,0.0,http://www.openphacts.org/units/Nanomolar,785237.0,>,1.0,1.0,>,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
4415,2003644.0,[],CHEMBL901910,Antiviral activity against Modoc virus-infected HeLa-H1 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)OC1C2CC3CC1CC(C(=O)Nc1ccc(-c4nc5cc(C(=O)Nc6ccccn6)ccc5[nH]4)cc1)(C3)C2,CHEMBL1138288,J Med Chem,2007.0,CHEMBL241197,CHEMBL241197,6.70,0.0,http://www.openphacts.org/units/Nanomolar,666640.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL612946,Modoc virus,Modoc virus,64300,IC50,nM,UO_0000065,200.0,CHEMBL612946
4416,3014065.0,[],CHEMBL1042767,Antiviral activity against HIV1 3B infected in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,CN(Cc1nc2cccc(CN)c2[nH]1)C1CCCc2cccnc21,CHEMBL1155333,Bioorg Med Chem Lett,2009.0,CHEMBL567586,CHEMBL567586,5.89,0.0,http://www.openphacts.org/units/Nanomolar,855069.0,=,1.0,1.0,=,IC50,nM,1300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.3,CHEMBL378
4417,1402514.0,[],CHEMBL837464,In vitro inhibitory concentration against HIV G190A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL57,CHEMBL57,5.10,0.0,http://www.openphacts.org/units/Nanomolar,360370.0,=,1.0,1.0,=,IC50,nM,7943.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.943,CHEMBL378
4418,2930431.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cnc(C#N)c3C#N)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL583428,CHEMBL583428,8.00,0.0,http://www.openphacts.org/units/Nanomolar,852934.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
4419,2203549.0,[],CHEMBL987023,Antiviral activity against HIV1 3B in human MT4 cells assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCNC(=S)Nc1ccc(OCc2n[nH]c(=S)n2C)cc1,CHEMBL1149790,Eur J Med Chem,2008.0,CHEMBL494393,CHEMBL494393,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,765640.0,>,1.0,1.0,>,IC50,ug.mL-1,107.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,107.0,CHEMBL378
4420,2929528.0,[],CHEMBL1056897,Antiviral activity against HIV1 HXB2 harboring 190A mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3ccnc3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL568526,CHEMBL568526,8.10,0.0,http://www.openphacts.org/units/Nanomolar,852832.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.0,CHEMBL378
4421,1502789.0,[],CHEMBL834971,Inhibitory concentration against hepatitis C virus NS3 protease (IC50 spans 2.5 log units),B,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1cccc(-c2cccc(O[C@H]3CC(C(=O)[C@@H](NC(=O)[C@@H](NC(C)=O)C4CCCCC4)C(C)C)[C@H](C(=O)CC4(C(=O)O)CC4)C3)c2)c1,CHEMBL1143583,J Med Chem,2005.0,CHEMBL364026,CHEMBL364026,5.20,0.0,http://www.openphacts.org/units/Nanomolar,389119.0,=,1.0,1.0,=,IC50,nM,6309.57,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,Log 1/IC50,,UO_0000065,5.2,CHEMBL4620
4422,10862145.0,[],CHEMBL2024925,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B e-antigen release,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(COC(=O)[C@@]2(C)CC[C@]3(C)CC[C@]4(C)C(=CC(=O)[C@@H]5[C@@]6(C)CC[C@H](O)C(C)(C)[C@@H]6CC[C@]54C)[C@@H]3C2)cs1,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022394,CHEMBL2022394,,0.0,http://www.openphacts.org/units/Nanomolar,1637644.0,>,1.0,1.0,>,IC50,nM,1483900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1483.9,CHEMBL613497
4423,2635009.0,[],CHEMBL1000603,Antiviral activity against HIV1 LAI in human MT2 cells by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(C[C@@H]2COC(=O)N2)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CO[C@H]3OCC[C@H]32)cc1,CHEMBL1136990,J Med Chem,2009.0,CHEMBL508514,CHEMBL508514,9.32,0.0,http://www.openphacts.org/units/Nanomolar,785239.0,=,1.0,1.0,=,IC50,nM,0.48,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.48,CHEMBL378
4424,19261929.0,[],CHEMBL4404391,"Antiviral activity against HIV1 subtypeC Du422, clone 1",F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.64,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,230.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.23,CHEMBL378
4425,24830994.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c2ccc(N3CCCCC3)cc2oc2c(Cl)cccc12,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5207806,CHEMBL5207806,,0.0,http://www.openphacts.org/units/Nanomolar,3878106.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
4426,1211885.0,[],CHEMBL880061,Inhibitory activity against LAI strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL309456,CHEMBL309456,8.54,0.0,http://www.openphacts.org/units/Nanomolar,127435.0,=,1.0,1.0,=,IC50,nM,2.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0029,CHEMBL378
4427,18683306.0,[],CHEMBL4237099,Antiviral activity against CCR5-dependent HIV1 Ba-L infected in human HOS cells assessed as reduction in virus infection measured after 5 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCCCC1)c1cccs1,CHEMBL4229569,J Med Chem,2018.0,CHEMBL4242114,CHEMBL4242114,7.90,0.0,http://www.openphacts.org/units/Nanomolar,3103097.0,=,1.0,1.0,=,IC50,nM,12.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,12.5,CHEMBL378
4428,1755822.0,[],CHEMBL864208,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(-n2c(C)nnc2SCC(=O)Nc2cccc([N+](=O)[O-])c2)cc1,CHEMBL1146046,Bioorg Med Chem Lett,2006.0,CHEMBL266833,CHEMBL266833,,0.0,http://www.openphacts.org/units/Nanomolar,545165.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
4429,18044517.0,[],CHEMBL4010365,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of p24 antigen production pretreated with virus for 30 mins followed by 4 days incubation with cells by sandwich ELISA based multicycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,NCC(NC(=O)c1ccc(-c2ccc(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4069596,CHEMBL4069596,5.92,0.0,http://www.openphacts.org/units/Nanomolar,2990212.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.2,CHEMBL378
4430,3194837.0,[],CHEMBL1102708,Antiviral activity against CCR5-tropic recombinant HIV1 NLBal virus infected in JC53-BL cells assessed as inhibition of viral replication after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1,CHEMBL1154938,Bioorg Med Chem Lett,2010.0,CHEMBL1082191,CHEMBL1082191,7.13,0.0,http://www.openphacts.org/units/Nanomolar,892697.0,=,1.0,1.0,=,IC50,nM,74.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,74.0,CHEMBL378
4431,941896.0,[],CHEMBL695338,In vitro inhibitory concentration against HRSV (Human respiratory syncytial virus) by using RSV A2 and the assay is by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)CCN(CCC(N)=O)S(=O)(=O)c1cccc(Nc2nc(Nc3cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c3)nc(Nc3ccc(-c4ccc(Nc5nc(Nc6cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c6)nc(Nc6cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c6)n5)cc4S(=O)(=O)[O-])c(S(=O)(=O)[O-])c3)n2)c1.[Na+].[Na+],CHEMBL1134023,Bioorg Med Chem Lett,2001.0,CHEMBL413946,CHEMBL414291,7.10,0.0,http://www.openphacts.org/units/Nanomolar,4996.0,=,1.0,1.0,=,IC50,nM,80.0,CHEMBL613127,Human respiratory syncytial virus,Human respiratory syncytial virus,11250,IC50,uM,UO_0000065,0.08,CHEMBL613127
4432,19450678.0,[],CHEMBL4433628,Antiviral activity against HIV1 12229 harboring non-nucleoside reverse transcriptase L100I/K103N/H221Y mutant infected in human TZM-bl cells infected with supernatants from virus-infected human MT2 cells treated with compound for 72 hrs assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(-c2ccc(OCc3cccc(C(=O)NCCNC(=O)c4ccc(COc5ccc(Cl)cc5-c5csc(N)n5)cc4)c3)cc2)cs1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4446026,CHEMBL4598022,6.00,0.0,http://www.openphacts.org/units/Nanomolar,3249753.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
4433,309421.0,[],CHEMBL697276,In vitro inhibition of HIV-1 plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCOCC(CN(C)CCO)OC,CHEMBL1125666,J Med Chem,1991.0,CHEMBL285791,CHEMBL285791,5.68,0.0,http://www.openphacts.org/units/Nanomolar,43722.0,=,1.0,1.0,=,IC50,nM,2100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.1,CHEMBL378
4434,6280165.0,[],CHEMBL1804127,Antiviral activity against HIV1 isolate NL4-3 harboring reverse transcriptase K103N/V179E double mutant assessed as inhibition of viral replication by phenoscreen assay in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3cc(-c4ccncc4)[nH]n3)ccc2Cl)c1,CHEMBL1800064,Bioorg Med Chem Lett,2010.0,CHEMBL1801231,CHEMBL1801231,7.04,0.0,http://www.openphacts.org/units/Nanomolar,1440340.0,=,1.0,1.0,=,IC50,nM,90.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0902,CHEMBL378
4435,615902.0,[],CHEMBL691384,Inhibitory concentration for cytopathicity of HIV-1 (HTLV-IIIB) in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cc2cc(C)c(O)c(C(=O)O)c2)cc(C(=O)O)c1O,CHEMBL1125737,J Med Chem,1991.0,CHEMBL113835,CHEMBL113835,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,217794.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,100.0,CHEMBL378
4436,10969756.0,[],CHEMBL2065306,Antiviral activity against Influenza B virus (strain B/Jifang/13/97) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)Nc1cc(C(=O)Nc2ccccc2)ccc1OC,CHEMBL2062433,Eur J Med Chem,2012.0,CHEMBL2064580,CHEMBL2064580,,0.0,http://www.openphacts.org/units/Nanomolar,1660676.0,>,1.0,1.0,>,IC50,nM,223500.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,223.5,CHEMBL613129
4437,2032173.0,[],CHEMBL886779,Inhibition of cytoplasmic HBV DNA synthesis in HepG2.2.15 cells after 8 days,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)S(=O)(=O)n1c(N)nc2cc(NC(=O)c3ccccc3)ccc21,CHEMBL1139980,Eur J Med Chem,2007.0,CHEMBL250789,CHEMBL250789,5.70,0.0,http://www.openphacts.org/units/Nanomolar,674625.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.0,CHEMBL613497
4438,24735365.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5116806,Antiviral activity against ZIKV infected in human Huh-7 cells assessed as inhibition of viral infection measured 24 hrs post infection by immunofluorescent assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1cc(-c2ccc(N3CCN(c4ccc(O)cc4)CC3)cc2)oc2cc(O)c(O)c(O)c12,CHEMBL5113447,Bioorg Med Chem Lett,2022.0,CHEMBL5194820,CHEMBL5194820,5.16,0.0,http://www.openphacts.org/units/Nanomolar,3858582.0,=,1.0,1.0,=,IC50,nM,6900.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,6.9,CHEMBL4296612
4439,5126315.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,COCCN/C=C1\C(=O)N(C)c2ccc(C3CC3)cc2N(c2ccccc2)C1=O,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642311,CHEMBL1642311,5.85,0.0,http://www.openphacts.org/units/Nanomolar,1317601.0,=,1.0,1.0,=,IC50,nM,1400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.4,CHEMBL378
4440,587908.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(CCCC[n+]1ccccc1)Sc1ccccc1C(=O)Nc1ccc(S(=O)(=O)c2ccc([N+](=O)[O-])cc2)cc1.[Br-],CHEMBL1132203,J Med Chem,1999.0,CHEMBL169259,CHEMBL1181387,,0.0,http://www.openphacts.org/units/Nanomolar,334013.0,>,1.0,1.0,>,IC50,nM,316000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,316.0,CHEMBL378
4441,1040108.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(SCc2ccccc2)n(Nc2cccc(Cl)c2)c1-c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL290648,CHEMBL290648,,0.0,http://www.openphacts.org/units/Nanomolar,62337.0,>,1.0,1.0,>,IC50,nM,39660.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,39.66,CHEMBL613499
4442,16499764.0,[],CHEMBL3776089,Antiretroviral activity against HIV-1 infected in HEK293T cells assessed as inhibition of viral replication by single-cycle assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1[nH]c2ccc(Cl)cc2c1C(SC)c1cc(C)cc(C)c1,CHEMBL3774319,Bioorg Med Chem Lett,2016.0,CHEMBL3775346,CHEMBL3775346,7.22,0.0,http://www.openphacts.org/units/Nanomolar,2763419.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.06,CHEMBL378
4443,1212215.0,[],CHEMBL645946,Concentration required to inhibit activator protein-1(AP-1) mediated transcriptional activation in human Jurkat T-cells,B,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cnc(C(F)(F)F)nc1C(F)(F)F,CHEMBL1133475,J Med Chem,2000.0,CHEMBL128314,CHEMBL128314,,1.0,http://www.openphacts.org/units/Nanomolar,247720.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,10.0,CHEMBL4977
4444,624334.0,[],CHEMBL712878,Concentration required for 50% protection of MT-4 cells against the cytopathic effect of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1Cn2c(=O)[nH]c3ccc(N(C)C)c(c32)CN1CC1CC1,CHEMBL1128253,J Med Chem,1995.0,CHEMBL349465,CHEMBL349465,5.18,0.0,http://www.openphacts.org/units/Nanomolar,327804.0,=,1.0,1.0,=,IC50,nM,6650.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.65,CHEMBL378
4445,6152254.0,[],CHEMBL1763053,Antiviral activity against Human immunodeficiency virus 1 BAL infected in human PBMC assessed as inhibition of viral replication by p24 antigen specific ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)c2)c2ccc(C(F)(F)F)cc2)CC1,CHEMBL1759996,Bioorg Med Chem Lett,2011.0,CHEMBL1762320,CHEMBL1762320,7.16,0.0,http://www.openphacts.org/units/Nanomolar,1414771.0,=,1.0,1.0,=,IC50,nM,70.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.07,CHEMBL378
4446,2091745.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(CCC)CCCN(S(=O)(=O)c2ccc(C)cc2)C1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL272782,CHEMBL272782,,0.0,http://www.openphacts.org/units/Nanomolar,700541.0,=,1.0,1.0,=,IC50,nM,416869383470336.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,5.62,CHEMBL378
4447,17602979.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(c2ccc(-c3ccccc3F)cc2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644914,CHEMBL3644914,7.47,0.0,http://www.openphacts.org/units/Nanomolar,2518034.0,=,37.0,1.0,=,IC50,nM,34.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,34.0,CHEMBL4620
4448,2614796.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL54600,CHEMBL54600,,0.0,http://www.openphacts.org/units/Nanomolar,731798.0,=,1.0,1.0,=,IC50,nM,399944.75,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,3.398,CHEMBL378
4449,14990561.0,[],CHEMBL3383781,Antiviral activity against HIV1 pseudotyped virus expressed in human U87 cells co-expressing AMLV envelope after 48 hrs by cell-based luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(c1ccccc1)N1CCN(C(=O)c2ccc3c4c(cccc24)CC3)CC1,CHEMBL3351851,Bioorg Med Chem Lett,2014.0,CHEMBL3353044,CHEMBL3353044,,0.0,,2241672.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4450,15606026.0,[],CHEMBL3579360,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/c1ccc2c(c1)OCO2)O/N=C/c1ccco1,CHEMBL3576819,Eur J Med Chem,2015.0,CHEMBL3577791,CHEMBL3577791,4.09,0.0,http://www.openphacts.org/units/Nanomolar,2480531.0,=,1.0,1.0,=,IC50,nM,81830.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,81.83,CHEMBL613497
4451,10961129.0,[],CHEMBL2061266,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M9 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNC1CCC1)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058325,CHEMBL2058325,7.51,0.0,http://www.openphacts.org/units/Nanomolar,1656265.0,=,1.0,1.0,=,IC50,nM,31.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.0,CHEMBL378
4452,2930157.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CN3CCOC(CC#N)C3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL576184,CHEMBL576184,9.00,0.0,http://www.openphacts.org/units/Nanomolar,848315.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
4453,6152675.0,[],CHEMBL1763333,Inhibition of c-Jun,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2cccc3cnc(Nc4ccc(-n5cnc(C)n5)cc4)nc23)cc1F,CHEMBL1759990,Bioorg Med Chem Lett,2011.0,CHEMBL1761568,CHEMBL1761568,6.30,0.0,http://www.openphacts.org/units/Nanomolar,1413784.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.5,CHEMBL4977
4454,3129695.0,[],CHEMBL1065523,Antiviral activity against HIV1 BaL infected in human PBMC assessed as inhibition of viral replication by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1csc(-c2nc(COc3c4cc(CP(=O)([O-])O)cc3Cc3cc(CP(=O)([O-])O)cc(c3O)Cc3cc(CP(=O)([O-])O)cc(c3OCc3csc(-c5nc(C)cs5)n3)Cc3cc(CP(=O)([O-])O)cc(c3O)C4)cs2)n1.[Na+].[Na+].[Na+].[Na+],CHEMBL1157689,Bioorg Med Chem,2010.0,CHEMBL590813,CHEMBL1208393,4.24,0.0,http://www.openphacts.org/units/Nanomolar,880946.0,=,1.0,1.0,=,IC50,nM,57000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,57.0,CHEMBL378
4455,2149854.0,[],CHEMBL935682,Antiviral activity against HIV1 098-T1249 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL437618,CHEMBL437618,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708033.0,=,1.0,1.0,=,IC50,ug.mL-1,0.072,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.072,CHEMBL378
4456,2003636.0,[],CHEMBL901910,Antiviral activity against Modoc virus-infected HeLa-H1 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)OC1CCC(C(=O)Nc2ccc(-c3nc4cc(NC(=O)C5CCC(OC(C)=O)CC5)ccc4[nH]3)cc2)CC1,CHEMBL1138288,J Med Chem,2007.0,CHEMBL240596,CHEMBL240596,,0.0,http://www.openphacts.org/units/Nanomolar,666648.0,>,1.0,1.0,>,IC50,nM,600.0,CHEMBL612946,Modoc virus,Modoc virus,64300,IC50,nM,UO_0000065,600.0,CHEMBL612946
4457,6152689.0,[],CHEMBL1763333,Inhibition of c-Jun,B,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc3cnc(Nc4ccc(-n5cnc(N6CCOCC6)n5)cc4)nc3c2-c2cnn(C)c2)cn1,CHEMBL1759990,Bioorg Med Chem Lett,2011.0,CHEMBL1761582,CHEMBL1761582,7.40,0.0,http://www.openphacts.org/units/Nanomolar,1413798.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.04,CHEMBL4977
4458,2371541.0,[],CHEMBL1035739,Antiviral activity against HIV1 with reverse transcriptase K103N mutant in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4nc(N)ccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL489586,CHEMBL489586,8.36,0.0,http://www.openphacts.org/units/Nanomolar,773548.0,=,1.0,1.0,=,IC50,nM,4.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.4,CHEMBL378
4459,3267345.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,C#Cc1ccc2nc(O)n3c2c1CN(CC=C(C)C)[C@@H](C)C3,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL298626,CHEMBL298626,6.36,0.0,http://www.openphacts.org/units/Nanomolar,905422.0,=,1.0,1.0,=,IC50,nM,436.52,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.36,CHEMBL378
4460,1252264.0,[],CHEMBL652108,Inhibitory concentration required to inhibit HIV-induced cytopathicity in CEM-4 cells by 50% based in the MTT assay; Not active,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCC(=O)N(CC)CCCCCCCCCCC(=O)NCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL116526,CHEMBL1205574,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221531.0,,1.0,0.0,,IC50,ug.mL-1,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,,CHEMBL378
4461,528332.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(Sc2cccc(N)c2C#N)cc(C(F)(F)F)c1,CHEMBL1134494,J Med Chem,2001.0,CHEMBL54970,CHEMBL54970,5.29,0.0,http://www.openphacts.org/units/Nanomolar,94244.0,=,1.0,1.0,=,IC50,nM,5100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.1,CHEMBL378
4462,2930227.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COCCOCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL566751,CHEMBL566751,7.30,0.0,http://www.openphacts.org/units/Nanomolar,852962.0,=,1.0,1.0,=,IC50,nM,50.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,50.1,CHEMBL378
4463,1031664.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(S)n(Nc2cccc(Cl)c2)c1-c1cccc(Br)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL37967,CHEMBL37967,5.07,0.0,http://www.openphacts.org/units/Nanomolar,62314.0,=,1.0,1.0,=,IC50,nM,8540.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.54,CHEMBL378
4464,14596862.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2ccccc2)n(COCc2ccccc2)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL37067,CHEMBL37067,5.15,0.0,http://www.openphacts.org/units/Nanomolar,2082382.0,=,1.0,1.0,=,IC50,nM,7060.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.06,CHEMBL378
4465,1230631.0,[],CHEMBL652107,Inhibitory concentration required to inhibit HIV-induced cytopathicity in CEM-4 cells by 50% based in the MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N(CC)CCCCCCCCCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL413723,CHEMBL1207521,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221542.0,=,1.0,1.0,=,IC50,ug.mL-1,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,5.0,CHEMBL378
4466,10961185.0,[],CHEMBL2061268,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M3 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CNC=C1C(=O)Nc2ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)cc21,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057460,CHEMBL2057460,8.10,0.0,http://www.openphacts.org/units/Nanomolar,1655122.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.0,CHEMBL378
4467,1401912.0,[],CHEMBL837468,In vitro inhibitory concentration against HIV L100I mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)Nc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL435522,CHEMBL435522,,0.0,http://www.openphacts.org/units/Nanomolar,360379.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4468,19407967.0,[],CHEMBL4426966,Antiviral activity against darunavir resistant HIV1 harboring protease L10I/I15V/K20R/L24I/V32I/M36I/M46L/L63P/A71T/V82A/L89M mutant at 20 passages infected in human MT4 cells by p24 assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL4425138,J Med Chem,2016.0,CHEMBL116,CHEMBL116,,0.0,http://www.openphacts.org/units/Nanomolar,3243728.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
4469,2640553.0,[],CHEMBL970478,Antiviral activity against Influenza B virus (B/Mie/1/93) assessed viral plaque reduction,F,BAO_0000190,BAO_0000218,organism-based format,CO[C@@H]([C@@H]1OC(C(=O)O)=C[C@H](NC(=N)N)[C@H]1NC(C)=O)[C@H](O)CO,CHEMBL1136912,Bioorg Med Chem Lett,2009.0,CHEMBL466246,CHEMBL466246,8.38,0.0,http://www.openphacts.org/units/Nanomolar,757381.0,=,1.0,1.0,=,IC50,nM,4.2,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,nM,UO_0000065,4.2,CHEMBL613129
4470,2987753.0,[],CHEMBL1050601,Antiviral activity against Hepatitis B virus infected HepG2(2.2.15) cells assessed as inhibition of viral cytoplasmic DNA synthesis by real-time PCR,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)[C@H](C)N1CCCO[P@]1(=O)COCCn1cnc2c(N)ncnc21.O=C(O)/C=C/C(=O)O,CHEMBL1156738,Bioorg Med Chem Lett,2009.0,CHEMBL566843,CHEMBL1197315,6.29,0.0,http://www.openphacts.org/units/Nanomolar,863243.0,=,1.0,1.0,=,IC50,nM,510.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.51,CHEMBL613497
4471,1402391.0,[],CHEMBL834774,In vitro inhibitory concentration against HIV Y188L mutant strain; not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC(N)=S)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369148,CHEMBL369148,,0.0,http://www.openphacts.org/units/Nanomolar,360422.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4472,1216119.0,[],CHEMBL689611,Antiviral activity against Human immunodeficiency virus type-1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@H]2C[C@H](O)[C@@](/C=C/Cl)(CO)O2)c(=O)n1,CHEMBL1132321,J Med Chem,1999.0,CHEMBL95945,CHEMBL95945,5.34,0.0,http://www.openphacts.org/units/Nanomolar,183166.0,=,1.0,1.0,=,IC50,nM,4600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.6,CHEMBL378
4473,23153205.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4810870,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 production treated at 48 hrs post-infection and measured on day 4 post-viral infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)OCC1=C[C@H]2[C@@H]3C(C)(C)[C@]3(OC(=O)CCC)[C@H](OC(=O)/C=C/c3ccccc3)[C@@H](C)[C@]2(O)[C@@H]2C=C(C)C(=O)[C@@]2(O)C1,CHEMBL4808236,Bioorg Med Chem Lett,2021.0,CHEMBL4855510,CHEMBL4855510,7.13,0.0,http://www.openphacts.org/units/Nanomolar,3599015.0,=,1.0,1.0,=,IC50,nM,73.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,73.3,CHEMBL378
4474,19243758.0,[],CHEMBL4400278,Antiviral activity against Zika virus infected in human A549 cells assessed as reduction in viral titer incubated for 48 hrs by plaque assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CCSc1nsc(NC(=S)Nc2ccc(I)cc2)n1,CHEMBL4396960,Bioorg Med Chem Lett,2019.0,CHEMBL4466194,CHEMBL4466194,5.58,0.0,http://www.openphacts.org/units/Nanomolar,3212385.0,=,1.0,1.0,=,IC50,nM,2600.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,2.6,CHEMBL4296612
4475,2149852.0,[],CHEMBL935682,Antiviral activity against HIV1 098-T1249 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL411406,CHEMBL411406,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708035.0,=,1.0,1.0,=,IC50,ug.mL-1,0.014,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.014,CHEMBL378
4476,2178217.0,[],CHEMBL1019290,Antiviral activity against HIV1 HTLV-3B in human H9 cells after 3 days by p24 antigen capture assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(c(OC)c1OC)-c1ccc(=O)c(OC)cc1[C@@H](N)CC2,CHEMBL1158954,J Nat Prod,1991.0,CHEMBL465446,CHEMBL465446,5.55,0.0,http://www.openphacts.org/units/Nanomolar,740184.0,=,1.0,1.0,=,IC50,nM,2800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.8,CHEMBL378
4477,1243457.0,[],CHEMBL652108,Inhibitory concentration required to inhibit HIV-induced cytopathicity in CEM-4 cells by 50% based in the MTT assay; Not active,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCC(=O)NCCCCCCCCCCC(=O)NCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL113937,CHEMBL1205558,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221533.0,,1.0,0.0,,IC50,ug.mL-1,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,,CHEMBL378
4478,146119.0,[],CHEMBL698766,Concentration required for 50% inhibition of influenza A/WS/33 by plaque reduction assay; not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCCO[C@@H]1C=C(C(=O)O)C[C@H](N)[C@H]1NS(C)(=O)=O,CHEMBL1130481,Bioorg Med Chem Lett,1997.0,CHEMBL52862,CHEMBL52862,,0.0,http://www.openphacts.org/units/Nanomolar,90736.0,,1.0,0.0,,IC50,nM,,CHEMBL613128,unidentified influenza virus,unidentified influenza virus,11309,IC50,nM,UO_0000065,,CHEMBL613128
4479,2997466.0,[],CHEMBL1046974,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=CCn1cc(C(=O)c2ccc(OC)cc2O)ccc1=O,CHEMBL1156796,J Med Chem,2010.0,CHEMBL568197,CHEMBL568197,,0.0,http://www.openphacts.org/units/Nanomolar,856642.0,=,1.0,1.0,=,IC50,nM,276000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,276.0,CHEMBL613497
4480,2602272.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OC(C(=O)O)C(OC(=O)c1ccsc1)C(=O)O)c1ccsc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL472862,CHEMBL472862,5.00,0.0,http://www.openphacts.org/units/Nanomolar,807316.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
4481,6200550.0,[],CHEMBL1781474,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 4 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CCN(CCc1c[nH]c2ccccc12)Cc1cccs1,CHEMBL1777761,Bioorg Med Chem,2011.0,CHEMBL1779298,CHEMBL1779298,5.00,0.0,http://www.openphacts.org/units/Nanomolar,1425266.0,=,1.0,1.0,=,IC50,nM,10100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.1,CHEMBL613497
4482,1472416.0,[],CHEMBL832524,Inhibitory activity against HIV-1 double mutants strain 100I and 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cc(Cl)cc(Cl)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL184294,CHEMBL184294,6.51,0.0,http://www.openphacts.org/units/Nanomolar,380650.0,=,1.0,1.0,=,IC50,nM,310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.31,CHEMBL378
4483,8027835.0,[],CHEMBL1948542,Antiviral activity against HIV1 NF-462 expressing wild-type Vpr infected in human 293T cells containing 1 ng of viral p24 antigen after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Oc1ccc2c(c1)C[C@@]1(O)COc3ccccc3[C@@H]21,CHEMBL1944615,Bioorg Med Chem Lett,2012.0,CHEMBL1945222,CHEMBL1945222,,0.0,,1574222.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4484,936295.0,[],CHEMBL728516,Anti-HIV activity against HIV-1 IIIB chronically infected Molt-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)n1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(c4ncccn4)CC3)c(OC(F)F)c21,CHEMBL1131862,Bioorg Med Chem Lett,1999.0,CHEMBL104055,CHEMBL104055,6.64,0.0,http://www.openphacts.org/units/Nanomolar,194322.0,=,1.0,1.0,=,IC50,nM,230.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.23,CHEMBL378
4485,18119232.0,[],CHEMBL4026153,Antiviral activity against HIV1 isolate 96USNG031 infected in human PBMC,F,BAO_0000190,BAO_0000019,assay format,CC(C)C1=C2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(C(=O)C(=O)NC2(c3ccc(Cl)cc3)CC2)CC1=O,CHEMBL4024732,Bioorg Med Chem Lett,2017.0,CHEMBL4094428,CHEMBL4094428,,0.0,http://www.openphacts.org/units/Nanomolar,3004581.0,>,1.0,1.0,>,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,60.0,CHEMBL378
4486,1477300.0,[],CHEMBL837273,Antiviral activity against human immunodeficiency virus type 1 by using MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2ccc(/C=C/c3ccc(O)c(O)c3)nc2c1O,CHEMBL1140355,Bioorg Med Chem Lett,2005.0,CHEMBL39092,CHEMBL39092,6.00,0.0,http://www.openphacts.org/units/Nanomolar,382534.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
4487,18044801.0,[],CHEMBL4010398,"Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype C 26191-2, clone 48",F,BAO_0000190,BAO_0000019,assay format,Cc1nc(C(NC(=O)c2ccc(-c3ccc(Cl)cc3)[nH]2)C2CCCCN2)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4096918,CHEMBL4096918,5.64,0.0,http://www.openphacts.org/units/Nanomolar,2990237.0,=,1.0,1.0,=,IC50,nM,2300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.3,CHEMBL378
4488,2413646.0,[],CHEMBL987708,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,COCC(=O)O[C@@H](C[C@@H](C)C1=C2C[C@H](OC(=O)COC)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)[C@@H](OC(=O)COC)C(C)(C)O,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL453739,CHEMBL453739,,0.0,http://www.openphacts.org/units/Nanomolar,810695.0,=,1.0,1.0,=,IC50,nM,140000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.14,CHEMBL613497
4489,19261977.0,[],CHEMBL4404407,Antiviral activity against HIV1 subtypeG CRF02_G clone 252,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.96,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,110.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.11,CHEMBL378
4490,2244596.0,[],CHEMBL1003076,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase K103N/Y181C mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL593,CHEMBL593,,0.0,http://www.openphacts.org/units/Nanomolar,798656.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2000.0,CHEMBL378
4491,13476938.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(N3CCOCC3)cc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435873,CHEMBL2435873,,0.0,,1924249.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4492,1672766.0,[],CHEMBL870621,Antiviral activity against HIV1 Y181C mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(=O)(=O)N(C)C)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(C(F)(F)F)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL199506,CHEMBL199506,,0.0,,411947.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4493,14658782.0,[],CHEMBL3266157,Antagonist activity at recombinant human EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,O=C(COc1ccc2ccccc2c1)N1CCN(C(=O)Cc2ccccc2)CC1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262876,CHEMBL3262876,6.71,0.0,http://www.openphacts.org/units/Nanomolar,2101717.0,=,1.0,1.0,=,IC50,nM,196.0,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,nM,UO_0000065,196.0,CHEMBL3259470
4494,18044744.0,[],CHEMBL4010403,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype C ZM197M.PB7,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.44,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,360.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.36,CHEMBL378
4495,18044409.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(C(CN)NC(=O)c2ccc(-c3ccc(Cl)cc3)n2C)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4072179,CHEMBL4072179,4.58,0.0,http://www.openphacts.org/units/Nanomolar,2990226.0,=,1.0,1.0,=,IC50,nM,26000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,26.0,CHEMBL378
4496,18044751.0,[],CHEMBL4010407,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype C CAP45.2.00.G3,F,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075766,CHEMBL4075766,6.57,0.0,http://www.openphacts.org/units/Nanomolar,2990214.0,=,1.0,1.0,=,IC50,nM,270.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.27,CHEMBL378
4497,3085617.0,[],CHEMBL1047696,Antiviral activity against HIV1 3B in human MT2 cells assessed as inhibition of cell-cell fusion,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(C)n1-c1ccc(O)c(C(=O)O)c1,CHEMBL1153143,Bioorg Med Chem Lett,2010.0,CHEMBL214344,CHEMBL214344,4.36,0.0,http://www.openphacts.org/units/Nanomolar,877329.0,=,1.0,1.0,=,IC50,nM,43240.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,43.24,CHEMBL378
4498,2601802.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,C=CC[C@@]1(CO)C=C[C@H](n2cc(C)c(=O)[nH]c2=O)O1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL514605,CHEMBL514605,4.00,0.0,http://www.openphacts.org/units/Nanomolar,808130.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
4499,1954132.0,[],CHEMBL891424,Antiviral activity against HIV1 RT 181C mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(C(C)C)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL397934,CHEMBL397934,7.40,0.0,http://www.openphacts.org/units/Nanomolar,647184.0,=,1.0,1.0,=,IC50,nM,39.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,39.8,CHEMBL378
4500,902552.0,[],CHEMBL653610,Inhibitory activity tested against the HIV-1 in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)Nc3cccc(C(=O)O)c3)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL11320,CHEMBL11320,7.10,0.0,http://www.openphacts.org/units/Nanomolar,9092.0,=,1.0,1.0,=,IC50,nM,80.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,80.0,CHEMBL378
4501,2362924.0,[],CHEMBL1026412,Antiviral activity against HIV1 LAI in human MT2 cells assessed as inhibition of virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL1140100,J Med Chem,2008.0,CHEMBL1323,CHEMBL1323,,0.0,,748016.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4502,19261984.0,[],CHEMBL4404409,Antiviral activity against HIV1 subtypeA mother MG505.W0M.ENV.A2,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.03,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,930.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.93,CHEMBL378
4503,2276103.0,[],CHEMBL1030793,Inhibition of HIV1 replication in human 293T cells preincubated 15 mins prior to infection measured after 48 hrs postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1153359,Bioorg Med Chem,2009.0,CHEMBL223228,CHEMBL223228,8.89,0.0,http://www.openphacts.org/units/Nanomolar,754644.0,=,1.0,1.0,=,IC50,nM,1.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.3,CHEMBL378
4504,2602302.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(F)cc1-c1nc2c(N)cccc2n1Cc1c(F)cccc1F,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL517104,CHEMBL517104,5.57,0.0,http://www.openphacts.org/units/Nanomolar,806788.0,=,1.0,1.0,=,IC50,nM,2710.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.71,CHEMBL378
4505,15139707.0,[],CHEMBL3384587,Antiviral activity against Dengue virus assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c(OC2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(OC3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c2)oc2cc(O)cc(O)c12,CHEMBL3352310,Eur J Med Chem,2014.0,CHEMBL3344315,CHEMBL3344315,5.77,0.0,http://www.openphacts.org/units/Nanomolar,2241356.0,=,1.0,1.0,=,IC50,nM,1700.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,1.7,CHEMBL613757
4506,3199205.0,[],CHEMBL1104121,Antiviral activity against HIV1 Ba-L infected in PBMCs assessed as reverse transcriptase activity after 7 days by MTS assay,F,BAO_0000190,BAO_0000218,organism-based format,NCCCC[C@@H](CN[C@H](CN[C@H](CN[C@H](CNCCC(N)=O)Cc1ccc(O)cc1)Cc1ccc(O)cc1)Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@@H](N)Cc1ccc(O)cc1,CHEMBL1153724,Bioorg Med Chem Lett,2009.0,CHEMBL1075821,CHEMBL1075821,5.16,0.0,http://www.openphacts.org/units/Nanomolar,889162.0,=,1.0,1.0,=,IC50,nM,7000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.0,CHEMBL378
4507,2033571.0,[],CHEMBL888216,Inhibition of AP1-mediated gene transcription in HepG2 cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1OC)-c1cc(OC)c(OC)cc1C1CN3CCC[C@H]3C=C21,CHEMBL1140007,Bioorg Med Chem Lett,2007.0,CHEMBL399317,CHEMBL399317,,0.0,http://www.openphacts.org/units/Nanomolar,675156.0,>,1.0,1.0,>,IC50,nM,300.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,nM,UO_0000065,300.0,CHEMBL4977
4508,702938.0,[],CHEMBL683678,Tested for cytoprotection against production of HIV-1 p24.,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)NCCSS(=O)(=O)CCCCS(=O)(=O)SCCNC(C)=O,CHEMBL1129635,J Med Chem,1996.0,CHEMBL121159,CHEMBL121159,,0.0,http://www.openphacts.org/units/Nanomolar,228544.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
4509,15679583.0,[],CHEMBL3607081,Antiviral activity against Rift Valley fever virus infected in African green monkey Vero 76 cells after 3 days by neutral red dye-based plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncc(F)c2c1ncn2[C@@H]1C=C(CO)[C@@H](O)[C@H]1O,CHEMBL3603790,Bioorg Med Chem,2015.0,CHEMBL3604361,CHEMBL3604361,5.19,0.0,http://www.openphacts.org/units/Nanomolar,2494263.0,=,1.0,1.0,=,IC50,nM,6400.0,CHEMBL613130,Rift Valley fever virus,Rift Valley fever virus,11588,IC50,uM,UO_0000065,6.4,CHEMBL613130
4510,17720010.0,[],CHEMBL3887547,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,BAO_0000190,BAO_0000357,single protein format,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,CHEMBL3886356,,2015.0,CHEMBL1873475,CHEMBL1873475,5.09,1.0,http://www.openphacts.org/units/Nanomolar,2848960.0,=,37.0,1.0,=,IC50,nM,8070.0,CHEMBL3982,Homo sapiens,Tyrosine-protein kinase FER,9606,IC50,nM,UO_0000065,8070.0,CHEMBL3982
4511,2184018.0,[],CHEMBL951609,Antiviral activity against HIV1 NDK infected in U87.CD4 cells expressing human CXCR4 D262N mutant,F,BAO_0000190,BAO_0000218,organism-based format,c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,CHEMBL1156482,J Biol Chem,2007.0,CHEMBL18442,CHEMBL18442,,0.0,http://www.openphacts.org/units/Nanomolar,791970.0,>,1.0,1.0,>,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3000.0,CHEMBL378
4512,1201119.0,[],CHEMBL880061,Inhibitory activity against LAI strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL309975,CHEMBL309975,9.15,0.0,http://www.openphacts.org/units/Nanomolar,127461.0,=,1.0,1.0,=,IC50,nM,0.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0007,CHEMBL378
4513,6216957.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,CCCNS(=O)(=O)c1cc(C(=O)N2CCC(CCN3C4CCC3CC(n3c(C)nc5ccccc53)C4)(c3cccc(F)c3)CC2)c(Cl)cc1F,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784520,CHEMBL1784520,7.81,0.0,http://www.openphacts.org/units/Nanomolar,1429459.0,=,1.0,1.0,=,IC50,nM,15.49,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.81,CHEMBL378
4514,1251773.0,[],CHEMBL683624,In vitro integration activity provided by preintegration complexes isolated from HIV-infected cells,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC2(CC(C)(C)c3ccc(O)c(N)c32)c2cc(O)c(N)cc21.Cl.Cl,CHEMBL1133186,J Med Chem,2000.0,CHEMBL305598,CHEMBL1183570,4.10,0.0,http://www.openphacts.org/units/Nanomolar,108748.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,80.0,CHEMBL378
4515,3358071.0,[],CHEMBL1175710,Antiviral activity against HIV1 expressing reverse transcriptase K103N/Y181C double mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(=O)O)cc3Cl)CC2)ncc1Br,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1172334,CHEMBL1172334,7.13,0.0,http://www.openphacts.org/units/Nanomolar,921824.0,=,1.0,1.0,=,IC50,nM,74.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,74.2,CHEMBL378
4516,42385.0,[],CHEMBL695516,Antiviral activity against K103N/Y181C strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL593,CHEMBL593,,0.0,http://www.openphacts.org/units/Nanomolar,20822.0,>,1.0,1.0,>,IC50,nM,8400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8400.0,CHEMBL378
4517,1830884.0,[],CHEMBL918634,Antiviral activity against wild type HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C(C#N)c2c(Cl)cccc2Cl)nc(SCc2ccc([N+](=O)[O-])cc2)[nH]c1=O,CHEMBL1144474,J Med Chem,2007.0,CHEMBL222246,CHEMBL222246,5.65,0.0,http://www.openphacts.org/units/Nanomolar,629307.0,=,1.0,1.0,=,IC50,nM,2220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.22,CHEMBL378
4518,8041800.0,[],CHEMBL1953242,Antiviral activity against HIV1 harboring VSV glycoprotein-G co-transfected with luciferase gene infected in human TZM-bl cells assessed as inhibition of viral replication after 48 hrs by microplate luminometer based luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(=O)NC(C)(C)c2nc(NCc3ccc(F)cc3)c(O)c(C(=O)NCc3ccc(F)cc3)n2)o1,CHEMBL1949625,Eur J Med Chem,2012.0,CHEMBL1949869,CHEMBL1949869,,0.0,,1576970.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4519,1402573.0,[],CHEMBL837468,In vitro inhibitory concentration against HIV L100I mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCNC(=S)Nc1c(Cc2cccc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL178043,CHEMBL178043,,0.0,http://www.openphacts.org/units/Nanomolar,360408.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4520,6218345.0,[],CHEMBL1785353,Antiviral activity against Human immunodeficiency virus 1 Bal-PBL,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(NS(C)(=O)=O)c(F)cc2Cl)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1782081,CHEMBL1782081,8.13,0.0,http://www.openphacts.org/units/Nanomolar,1429462.0,=,1.0,1.0,=,IC50,nM,7.413,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,8.13,CHEMBL378
4521,2929694.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL566750,CHEMBL566750,8.20,0.0,http://www.openphacts.org/units/Nanomolar,852961.0,=,1.0,1.0,=,IC50,nM,6.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.3,CHEMBL378
4522,13933255.0,[],CHEMBL3124237,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV DNA production,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2nc3c(cc2c(CN2CCCCC2)c1O)CSc1c(C)cc(C)cc1-3,CHEMBL3120134,Eur J Med Chem,2014.0,CHEMBL563873,CHEMBL563873,,0.0,http://www.openphacts.org/units/Nanomolar,1969534.0,<,1.0,1.0,<,IC50,nM,10000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol/L,UO_0000065,10.0,CHEMBL613497
4523,15027128.0,[],CHEMBL3367171,Inhibition of AP-1-mediated transcriptional activation in human Jurkat cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2nc(-c3cccs3)nc(NN3C(=O)C=C(C)C3=O)c2c1,CHEMBL3352097,J Med Chem,2014.0,CHEMBL337665,CHEMBL337665,8.52,0.0,http://www.openphacts.org/units/Nanomolar,2265196.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.003,CHEMBL4977
4524,926949.0,[],CHEMBL650153,Compound was tested for anti-retroviral activity against moloney murine sarcoma virus (MSV) in murine C3H/3T3 embryo fibroblast cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(N)c2nnn(CCOCP(=O)(O)O)c2n1,CHEMBL1129435,J Med Chem,1996.0,CHEMBL132569,CHEMBL132569,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251927.0,=,1.0,1.0,=,IC50,ug.mL-1,0.75,CHEMBL613501,Moloney murine sarcoma virus,Moloney murine sarcoma virus,11809,IC50,ug ml-1,UO_0000274,0.75,CHEMBL613501
4525,626668.0,[],CHEMBL710373,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1Cc1nc(N)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL74410,CHEMBL74410,5.84,0.0,http://www.openphacts.org/units/Nanomolar,126943.0,=,1.0,1.0,=,IC50,nM,1460.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.46,CHEMBL378
4526,5137367.0,[],CHEMBL1646836,Antiviral activity against X4 tropic HIV1 NL4.3 infected in human MT4 cells expressing CD4 and CXCR4 assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NCc1cc(C(F)(F)F)ccc1CN(Cc1nc2ccccc2[nH]1)C1CCCc2cccnc21,CHEMBL1641524,Bioorg Med Chem Lett,2011.0,CHEMBL1644071,CHEMBL1644071,6.98,0.0,http://www.openphacts.org/units/Nanomolar,1319745.0,=,1.0,1.0,=,IC50,nM,104.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.104,CHEMBL378
4527,5230909.0,[],CHEMBL1676718,Antiviral activity against simian immunodeficiency virus Mac251 infected in phytohemagglutininin and interleukin-2-stimulated PBMC assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL129,CHEMBL129,8.00,0.0,http://www.openphacts.org/units/Nanomolar,1332124.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,0.01,CHEMBL613499
4528,5249041.0,[],CHEMBL1685193,Antiviral activity against X4 tropic HIV1 NL4.3 infected in CD4 and CXCR4 expressing human MT4 cells assessed as inhibition of viral cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(CN(CCCCN)C(C)c2ccccn2)nc1,CHEMBL1681661,Bioorg Med Chem Lett,2011.0,CHEMBL1682990,CHEMBL1682990,7.32,0.0,http://www.openphacts.org/units/Nanomolar,1334125.0,=,1.0,1.0,=,IC50,nM,48.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,48.1,CHEMBL378
4529,10938642.0,[],CHEMBL2051599,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4cccc(F)c4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046571,CHEMBL2046571,4.90,0.0,http://www.openphacts.org/units/Nanomolar,1651454.0,=,1.0,1.0,=,IC50,nM,12560.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,12.56,CHEMBL613497
4530,677549.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(SSc2ccc(C)cc2)cc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL121676,CHEMBL121676,,0.0,,228640.0,=,1.0,0.0,=,IC50,,3.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,3.5,CHEMBL378
4531,18940391.0,[],CHEMBL4328847,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cn1ncc2ccc(-c3ccc4ccn(Cc5cc(F)cc(C(=O)O)c5)c4c3)cc21,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4548603,CHEMBL4548603,5.00,0.0,http://www.openphacts.org/units/Nanomolar,3159826.0,=,1.0,1.0,=,IC50,nM,10100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.1,CHEMBL378
4532,514091.0,[],CHEMBL699442,Inhibition of rous sarcoma virus (RSV) Integrase.,B,BAO_0000190,BAO_0000357,single protein format,CC(=O)Oc1cccc2ccc(/C=C/c3ccccc3)nc12,CHEMBL1133692,J Med Chem,2000.0,CHEMBL293788,CHEMBL293788,,0.0,http://www.openphacts.org/units/Nanomolar,101662.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL2750,Rous sarcoma virus (strain Prague C) (RSV-PrC),Rous sarcoma virus integrase,11888,IC50,M l-1,UO_0000065,0.0001,CHEMBL2750
4533,2601972.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1cn(S(=O)(=O)c2ccccc2)c2cc(Cl)ccc12,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL82780,CHEMBL82780,5.46,0.0,http://www.openphacts.org/units/Nanomolar,807935.0,=,1.0,1.0,=,IC50,nM,3500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.5,CHEMBL378
4534,399397.0,[],CHEMBL881122,Inhibitory concentration required against vaccinia virus in Vero cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2C[C@@H](CO)OP(=O)(O)O,CHEMBL1147452,Bioorg Med Chem Lett,2004.0,CHEMBL113930,CHEMBL113930,4.90,0.0,http://www.openphacts.org/units/Nanomolar,214244.0,=,1.0,1.0,=,IC50,nM,12500.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,12.5,CHEMBL613493
4535,22898277.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731088,Antiviral activity against HIV1 LAI infected in human MT2 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)C[C@H]2CO[C@H]3OCC[C@@H]23)cc1,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL256107,CHEMBL256107,,0.0,http://www.openphacts.org/units/Nanomolar,3554408.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
4536,8027851.0,[],CHEMBL1948540,Antiviral activity against HIV1 NL432 infected in human ConA and IL2-stimulated PBMC assessed as inhibition of viral replication by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,Oc1ccc2c(c1)C[C@@]1(O)COc3ccccc3[C@@H]21,CHEMBL1944615,Bioorg Med Chem Lett,2012.0,CHEMBL1945222,CHEMBL1945222,4.60,0.0,http://www.openphacts.org/units/Nanomolar,1574222.0,=,1.0,1.0,=,IC50,nM,25100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.1,CHEMBL378
4537,1402535.0,[],CHEMBL835252,In vitro inhibitory concentration against HIV K101E and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL223228,CHEMBL223228,6.80,0.0,http://www.openphacts.org/units/Nanomolar,360371.0,=,1.0,1.0,=,IC50,nM,158.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.158,CHEMBL378
4538,14658806.0,[],CHEMBL3266157,Antagonist activity at recombinant human EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,O=C(COc1ccc(Br)cc1)N1CCN(C(=O)Cc2ccccc2)CC1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262877,CHEMBL3262877,7.55,0.0,http://www.openphacts.org/units/Nanomolar,2101719.0,=,1.0,1.0,=,IC50,nM,28.18,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,pIC50,,UO_0000065,7.55,CHEMBL3259470
4539,5199476.0,[],CHEMBL1670944,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)[Si](CCc1c(OS(=O)(=O)C(F)(F)F)nc2ccc(Cl)cc2c1-c1ccccc1Cl)(c1ccccc1)c1ccccc1,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668643,CHEMBL1668643,,0.0,http://www.openphacts.org/units/Nanomolar,1328427.0,=,1.0,1.0,=,IC50,nM,454500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,454.5,CHEMBL613497
4540,16494757.0,[],CHEMBL3772328,Antiviral activity against HIV1 NL4-3 infected in human TZM-bl cells assessed as inhibition of viral replication administered 6 hrs postinfection measured 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)Cc1ccc(Nc2nc(-c3cccnc3)nc3ccccc23)cc1,CHEMBL3769372,J Med Chem,2016.0,CHEMBL3769554,CHEMBL3769554,,0.0,http://www.openphacts.org/units/Nanomolar,2761352.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
4541,2243665.0,[],CHEMBL998762,Growth inhibition of HIV1 3B infected human MOLT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCOCCOCCOCCOCCO,CHEMBL1156591,Bioorg Med Chem Lett,2008.0,CHEMBL500128,CHEMBL500128,4.43,0.0,http://www.openphacts.org/units/Nanomolar,796303.0,=,1.0,1.0,=,IC50,nM,37000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,37.0,CHEMBL378
4542,1045241.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=CN(Nc2cccc(Cl)c2)C1c1cccc(C(N)=O)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39499,CHEMBL39499,,0.0,http://www.openphacts.org/units/Nanomolar,62340.0,>,1.0,1.0,>,IC50,nM,260500.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,260.5,CHEMBL613499
4543,5224096.0,[],CHEMBL1675627,Antiviral activity of wild-type Human immunodeficiency virus 1 infected in human TZM-bl cells human assessed as inhibition of viral replication by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1671672,Antimicrob Agents Chemother,2009.0,CHEMBL223228,CHEMBL223228,,0.0,http://www.openphacts.org/units/Nanomolar,1332056.0,=,1.0,1.0,=,IC50,nM,106000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,106.0,CHEMBL378
4544,17602985.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(c2ccc(-c3ccc(OC)cc3)cc2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644920,CHEMBL3644920,7.18,0.0,http://www.openphacts.org/units/Nanomolar,2518040.0,=,37.0,1.0,=,IC50,nM,66.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,66.0,CHEMBL4620
4545,1402159.0,[],CHEMBL834488,In vitro inhibitory concentration against HIV L100I and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCOCCN(C)c1c(Cc2cccc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL174536,CHEMBL174536,,0.0,http://www.openphacts.org/units/Nanomolar,360385.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4546,3253138.0,[],CHEMBL1107997,Antiviral activity against HIV1 NL4.3 infected in human MT4 cells expressing CD4 and CXCR4 assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NCc1ccccc1CN(Cc1nc2ccccc2[nH]1)C1CCCc2cccnc21,CHEMBL1156989,J Med Chem,2010.0,CHEMBL1093008,CHEMBL1093008,7.68,0.0,http://www.openphacts.org/units/Nanomolar,901982.0,=,1.0,1.0,=,IC50,nM,21.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.021,CHEMBL378
4547,2413719.0,[],CHEMBL987710,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@H](OC(=O)COC(C)=O)[C@H](C[C@@H](C)C1=C2C[C@H](OC(=O)COC(C)=O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)OC(=O)COC(C)=O,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL449184,CHEMBL449184,,0.0,http://www.openphacts.org/units/Nanomolar,810799.0,<,1.0,1.0,<,IC50,nM,32000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.032,CHEMBL613497
4548,15690083.0,[],CHEMBL3610403,Antiviral activity against HIV1 3B infected in CD4/CXCR4 expressing human MAGI cells incubated for 48 hrs by beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1cc(CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)ncn1,CHEMBL3608277,ACS Med Chem Lett,2015.0,CHEMBL3608767,CHEMBL3608767,4.89,0.0,http://www.openphacts.org/units/Nanomolar,2496845.0,=,1.0,1.0,=,IC50,nM,13000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,13.0,CHEMBL378
4549,15166126.0,[],CHEMBL3404734,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBeAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(C(=O)OC[C@H]2O[C@@H](Oc3ccc(C(C)=O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)cc(OC)c1OC,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402790,CHEMBL3402790,,0.0,http://www.openphacts.org/units/Nanomolar,2284146.0,>,1.0,1.0,>,IC50,nM,1494500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1494.5,CHEMBL613497
4550,1192402.0,[],CHEMBL645946,Concentration required to inhibit activator protein-1(AP-1) mediated transcriptional activation in human Jurkat T-cells,B,BAO_0000190,BAO_0000219,cell-based format,CCCc1nc(Cl)ncc1C(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1,CHEMBL1133475,J Med Chem,2000.0,CHEMBL262514,CHEMBL262514,6.30,0.0,http://www.openphacts.org/units/Nanomolar,247704.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.5,CHEMBL4977
4551,3358072.0,[],CHEMBL1175710,Antiviral activity against HIV1 expressing reverse transcriptase K103N/Y181C double mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(N)=O)cc3Cl)CC2)ncc1Br,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1169982,CHEMBL1169982,7.28,0.0,http://www.openphacts.org/units/Nanomolar,921823.0,=,1.0,1.0,=,IC50,nM,52.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,52.7,CHEMBL378
4552,10866945.0,[],CHEMBL2027390,Antiviral activity against luciferase tagged VSV envelope pseudotyped HIV1 infected in human MT2 cells dosed simultaneously with virus infection measured 48 hrs post-infection by recombinant virus assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3CC[C@@H]4C5=C[C@](C)(CO)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021887,Eur J Med Chem,2012.0,CHEMBL2022918,CHEMBL2022918,5.18,0.0,http://www.openphacts.org/units/Nanomolar,1638344.0,=,1.0,1.0,=,IC50,nM,6557.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.557,CHEMBL378
4553,16498287.0,[],CHEMBL3777089,Antiviral activity against HIV1 dual CXCR4/CCR5-tropic strain 89.6 infected in human 293T cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1/C(=N\Nc2ccc3c(S(=O)(=O)O)cc(S(=O)(=O)O)cc3c2)C(c2ccccc2)=NN1c1nc(-c2ccccc2)cs1,CHEMBL3774382,Bioorg Med Chem,2016.0,CHEMBL3774987,CHEMBL3774987,5.08,0.0,http://www.openphacts.org/units/Nanomolar,2762408.0,=,1.0,1.0,=,IC50,nM,8400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.4,CHEMBL378
4554,1186901.0,[],CHEMBL710376,Inhibitory activity against 100I strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Oc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL305803,CHEMBL305803,7.66,0.0,http://www.openphacts.org/units/Nanomolar,127464.0,=,1.0,1.0,=,IC50,nM,22.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.022,CHEMBL378
4555,2462101.0,[],CHEMBL964561,Antiviral activity against hepatitis B virus infected Hep G2.2.15 cells assessed as inhibition of HBsAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CN2OC2(c2ccccc2)c2cc(Cl)ccc2N1,CHEMBL1157443,Bioorg Med Chem Lett,2008.0,CHEMBL503208,CHEMBL503208,,0.0,http://www.openphacts.org/units/Nanomolar,720924.0,=,1.0,1.0,=,IC50,nM,728000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.728,CHEMBL613497
4556,11017876.0,[],CHEMBL2090662,Antiviral activity against multidrug-resistant HIV1 4755-5 clade B clinical isolate infected in PHA-stimulated human PBMC assessed as inhibition of viral replication incubated for 6 hrs followed by compound-wash out measured after 6 days by liquid scintillation counting,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCC(=O)OC[C@@H]1O[C@H](n2ccc(N)nc2=O)CS1,CHEMBL2086298,J Med Chem,2012.0,CHEMBL2087753,CHEMBL2087753,5.29,0.0,http://www.openphacts.org/units/Nanomolar,1674773.0,=,1.0,1.0,=,IC50,nM,5086.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5086.0,CHEMBL378
4557,15158621.0,[],CHEMBL3398832,Inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,O=C1OCCc2c(/C=N\O)cccc21,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397166,CHEMBL3397166,,0.0,http://www.openphacts.org/units/Nanomolar,2278964.0,=,1.0,1.0,=,IC50,nM,2330000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.33,CHEMBL613497
4558,547028.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL1134494,J Med Chem,2001.0,CHEMBL291983,CHEMBL291983,7.52,0.0,http://www.openphacts.org/units/Nanomolar,94227.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.03,CHEMBL378
4559,2244581.0,[],CHEMBL1002203,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase K103N/L100I mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL593,CHEMBL593,,0.0,http://www.openphacts.org/units/Nanomolar,798656.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2000.0,CHEMBL378
4560,2602164.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)/C(O)=C/C(=O)c1c[nH]c2ccccc12,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL449902,CHEMBL449902,5.84,0.0,http://www.openphacts.org/units/Nanomolar,807413.0,=,1.0,1.0,=,IC50,nM,1430.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.43,CHEMBL378
4561,3399385.0,[],CHEMBL1219622,Antiviral activity against R5X4 tropic HIV1 69/7 infected in human TZM-bl cells assessed as inhibition of virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,CHEMBL1212937,J Med Chem,2010.0,CHEMBL267345,CHEMBL267345,,0.0,,933740.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4562,18044756.0,[],CHEMBL4010409,"Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype C 6055-2, clone 3",F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.46,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,350.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.35,CHEMBL378
4563,1671908.0,[],CHEMBL870621,Antiviral activity against HIV1 Y181C mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL201793,CHEMBL201793,8.52,0.0,http://www.openphacts.org/units/Nanomolar,411917.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.0,CHEMBL378
4564,2413629.0,[],CHEMBL987708,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC(=O)O[C@@H](C[C@@H](C)C1=C2C[C@H](OC(=O)CCCC)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)[C@@H](OC(=O)CCCC)C(C)(C)O,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL503753,CHEMBL503753,,0.0,http://www.openphacts.org/units/Nanomolar,810678.0,>,1.0,1.0,>,IC50,nM,1300000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.3,CHEMBL613497
4565,663985.0,[],CHEMBL683681,Effect upon disintegration catalyzed by the deletion mutant,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2ccc(/C=C/c3ccc(O)cc3O)nc2c1O,CHEMBL1131039,J Med Chem,1998.0,CHEMBL36586,CHEMBL36586,5.60,0.0,http://www.openphacts.org/units/Nanomolar,179407.0,=,1.0,1.0,=,IC50,nM,2500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.5,CHEMBL378
4566,5189156.0,[],CHEMBL1658799,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCC(=O)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652501,CHEMBL1652501,4.40,0.0,http://www.openphacts.org/units/Nanomolar,1326876.0,=,1.0,1.0,=,IC50,nM,40000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.04,CHEMBL613497
4567,2929483.0,[],CHEMBL1056901,Antiviral activity against HIV1 HXB2 harboring 101E and K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCSCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578367,CHEMBL578367,7.70,0.0,http://www.openphacts.org/units/Nanomolar,852822.0,=,1.0,1.0,=,IC50,nM,19.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.9,CHEMBL378
4568,14596851.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c(=O)n(COCCO)c(Sc2ccccc2)c1/C=C/c1ccccc1,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL120535,CHEMBL120535,5.28,0.0,http://www.openphacts.org/units/Nanomolar,2082371.0,=,1.0,1.0,=,IC50,nM,5220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.22,CHEMBL378
4569,24735313.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5116803,Antiviral activity against CHIKV infected in human Huh-7 cells assessed as inhibition of viral infection by measuring EGFP-positive cells measured 24 hrs post infection by fluorescent microscopic analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1c(OC)c(OC)c2c(=O)cc(-c3ccccc3)oc2c1-c1ccc(OC(F)(F)F)cc1,CHEMBL5113447,Bioorg Med Chem Lett,2022.0,CHEMBL5189719,CHEMBL5189719,4.75,0.0,http://www.openphacts.org/units/Nanomolar,3858564.0,=,1.0,1.0,=,IC50,nM,17800.0,CHEMBL4296563,Chikungunya virus,Chikungunya virus,37124,IC50,uM,UO_0000065,17.8,CHEMBL4296563
4570,811889.0,[],CHEMBL772932,Inhibition of Hepatitis C virus NS3 protease in vitro.,B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](O)C(=O)N1C[C@H](OC2CCCCC2)C[C@H]1C(=O)N[C@@H](CC(F)F)C(=O)NCCc1c(F)cc(C(=O)O)cc1F,CHEMBL1147550,Bioorg Med Chem Lett,2004.0,CHEMBL305435,CHEMBL305435,4.50,0.0,http://www.openphacts.org/units/Nanomolar,119347.0,=,1.0,1.0,=,IC50,nM,32000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,32.0,CHEMBL4620
4571,5132804.0,[],CHEMBL1646717,Antiviral activity against protease-resistant HIV1 isolate BCF02 infected in human PBMC assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2[nH]c(=O)c(CN(Cc3ccco3)C(=O)c3ccc(Cl)cc3)cc2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645043,CHEMBL1645043,5.22,0.0,http://www.openphacts.org/units/Nanomolar,1321031.0,=,1.0,1.0,=,IC50,nM,6070.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.07,CHEMBL378
4572,15621458.0,[],CHEMBL3584167,Antiviral activity against HIV1 NL4.3-Ren infected in human MT2 cells assessed as inhibition of viral growth measured 48 hrs post infection by luminometry,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)O)[C@@H]1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL3580560,J Nat Prod,2015.0,CHEMBL3581942,CHEMBL3581942,4.00,0.0,http://www.openphacts.org/units/Nanomolar,2482780.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
4573,502598.0,[],CHEMBL752813,Inhibition to hepatitis C virus (HCV) NS3/NS4A serine protease,B,BAO_0000190,BAO_0000357,single protein format,CCC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(=O)O)CC(F)F,CHEMBL1135212,Bioorg Med Chem Lett,2002.0,CHEMBL161665,CHEMBL161665,,0.0,http://www.openphacts.org/units/Nanomolar,317185.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,50.0,CHEMBL4620
4574,2997399.0,[],CHEMBL1047854,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV DNA replication after 9 days by PCR,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C(=N/Cc2ccc(C)cc2)c2ccc(=O)n(Cc3ccc(C)cc3)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL582798,CHEMBL582798,4.66,0.0,http://www.openphacts.org/units/Nanomolar,856643.0,=,1.0,1.0,=,IC50,nM,21700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,21.7,CHEMBL613497
4575,6218349.0,[],CHEMBL1785353,Antiviral activity against Human immunodeficiency virus 1 Bal-PBL,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(NS(=O)(=O)C(C)C)c(F)cc2F)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784526,CHEMBL1784526,7.15,0.0,http://www.openphacts.org/units/Nanomolar,1429466.0,=,1.0,1.0,=,IC50,nM,70.79,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.15,CHEMBL378
4576,1402387.0,[],CHEMBL835251,In vitro inhibitory concentration against HIV F227L and V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC(N)=S)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369148,CHEMBL369148,,0.0,http://www.openphacts.org/units/Nanomolar,360422.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4577,2929675.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COCC1CCN(Cc2c(C)[nH]c(=O)c(I)c2Sc2cc(C)cc(C)c2)CC1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL574592,CHEMBL574592,5.50,0.0,http://www.openphacts.org/units/Nanomolar,848347.0,=,1.0,1.0,=,IC50,nM,3162.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3162.0,CHEMBL378
4578,15200426.0,[],CHEMBL3413997,Antiviral activity against X4 tropic HIV-1 clone pNL4-3 infected in H9 cells assessed as reduction in p24 antigen after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)c1ccc(/C=C(\C#N)c2nc3cc(C)c(C)cc3[nH]2)cc1,CHEMBL3407469,Eur J Med Chem,2015.0,CHEMBL3410143,CHEMBL3410143,5.79,0.0,http://www.openphacts.org/units/Nanomolar,2288879.0,=,1.0,1.0,=,IC50,nM,1640.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.64,CHEMBL378
4579,1401932.0,[],CHEMBL837462,In vitro inhibitory concentration against HIV E138K mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCNc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL174339,CHEMBL174339,,0.0,http://www.openphacts.org/units/Nanomolar,360384.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4580,1502782.0,[],CHEMBL834971,Inhibitory concentration against hepatitis C virus NS3 protease (IC50 spans 2.5 log units),B,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H](C(=O)N[C@H](C(=O)C1C[C@H](Sc2ccc(Br)cc2)C[C@H]1C(=O)CC1(C(=O)O)CC1)C(C)C)C1CCCCC1,CHEMBL1143583,J Med Chem,2005.0,CHEMBL372230,CHEMBL372230,4.40,0.0,http://www.openphacts.org/units/Nanomolar,389175.0,=,1.0,1.0,=,IC50,nM,39810.72,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,Log 1/IC50,,UO_0000065,4.4,CHEMBL4620
4581,15210762.0,[],CHEMBL3421426,Antiviral activity against Human immunodeficiency virus 1 3b infected in human MT4 cells assessed as inhibition of virus replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1[C@H](OC(C)=O)[C@H]2[C@@H](OC(C)=O)[C@](C)(O)C[C@]2(OC(C)=O)C(=O)[C@H](C)/C=C/C(C)(C)C(=O)[C@H](OC(C)=O)[C@H]1OC(C)=O,CHEMBL3414423,J Nat Prod,2014.0,CHEMBL3414606,CHEMBL3414606,,0.0,,2289941.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4582,321808.0,[],CHEMBL873617,Inhibition of concanavalin A (con A)-induced proliferation of rat peripheral blood mononuclear cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1noc(C)c1C(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1,CHEMBL1133605,J Med Chem,2000.0,CHEMBL101176,CHEMBL101176,5.90,0.0,http://www.openphacts.org/units/Nanomolar,188107.0,=,1.0,1.0,=,IC50,nM,1266.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1266.0,CHEMBL378
4583,1471590.0,[],CHEMBL834620,Inhibitory activity against HIV-1 mutant strain 188L; ND = not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1cccc(Cc2c(CC)c(C)nc(O)c2N(C)C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL185817,CHEMBL185817,,0.0,http://www.openphacts.org/units/Nanomolar,380977.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4584,10865197.0,[],CHEMBL2025516,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)Cc4ccncc4)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024033,CHEMBL2024033,4.71,0.0,http://www.openphacts.org/units/Nanomolar,1639755.0,=,1.0,1.0,=,IC50,nM,19680.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,19.68,CHEMBL613497
4585,1186908.0,[],CHEMBL710376,Inhibitory activity against 100I strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2nc(Nc3ccc(C#N)cc3)ncc2C#N)c(C)c1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL74164,CHEMBL74164,7.20,0.0,http://www.openphacts.org/units/Nanomolar,127445.0,=,1.0,1.0,=,IC50,nM,63.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.063,CHEMBL378
4586,3358091.0,[],CHEMBL1175709,Antiviral activity against HIV1 infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccccc3)CC2)ncc1Br,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1170190,CHEMBL1170190,8.19,0.0,http://www.openphacts.org/units/Nanomolar,922873.0,=,1.0,1.0,=,IC50,nM,6.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.5,CHEMBL378
4587,12717540.0,[],CHEMBL2350956,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 12 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=CCc1ccc(O)c(-c2cc([C@@H](O)[C@@H](C)O)ccc2O)c1,CHEMBL2346656,Bioorg Med Chem Lett,2013.0,CHEMBL2346747,CHEMBL2346747,,0.0,http://www.openphacts.org/units/Nanomolar,1874413.0,=,1.0,1.0,=,IC50,nM,147160.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,147.16,CHEMBL613497
4588,1498114.0,[],CHEMBL833971,Concentration required to inhibit 50% viral production of human immunodeficiency virus type 1 (HIV-1-IIIB),F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)N1,CHEMBL1143567,J Med Chem,2005.0,CHEMBL283619,CHEMBL283619,9.44,0.0,http://www.openphacts.org/units/Nanomolar,388084.0,=,1.0,1.0,=,IC50,nM,0.36,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.00036,CHEMBL378
4589,10937549.0,[],CHEMBL2051603,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccc(C)cc4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046554,CHEMBL2046554,4.92,0.0,http://www.openphacts.org/units/Nanomolar,1651437.0,=,1.0,1.0,=,IC50,nM,11950.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,11.95,CHEMBL613497
4590,16662890.0,[],CHEMBL3832827,AntiDengue activity HCI DV3/A549 IC50 (uM),F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)C(=O)N(CCCCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO)C1CCCCCC1,CHEMBL3832761,,,CHEMBL2348373,CHEMBL2348373,7.10,0.0,http://www.openphacts.org/units/Nanomolar,2790263.0,=,34.0,1.0,=,IC50,nM,80.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,0.08,CHEMBL613757
4591,18044765.0,[],CHEMBL4010413,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype D QD435.100M.ENV.B5,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.39,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,410.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.41,CHEMBL378
4592,16499767.0,[],CHEMBL3776089,Antiretroviral activity against HIV-1 infected in HEK293T cells assessed as inhibition of viral replication by single-cycle assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1[nH]c2ccc(Cl)cc2c1C(OC)c1cccc(Cl)c1,CHEMBL3774319,Bioorg Med Chem Lett,2016.0,CHEMBL3775424,CHEMBL3775424,7.48,0.0,http://www.openphacts.org/units/Nanomolar,2763416.0,=,1.0,1.0,=,IC50,nM,33.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.033,CHEMBL378
4593,3191541.0,[],CHEMBL1104268,Antiviral activity against HIV1 3B-infected in human MT4 cells assessed as protection from virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,CHEMBL1154855,Eur J Med Chem,2010.0,CHEMBL116438,CHEMBL116438,7.43,0.0,http://www.openphacts.org/units/Nanomolar,894222.0,=,1.0,1.0,=,IC50,nM,37.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.037,CHEMBL378
4594,14594141.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2ccccc2[N+](=O)[O-])n(COCCO)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL274458,CHEMBL274458,5.42,0.0,http://www.openphacts.org/units/Nanomolar,2082334.0,=,1.0,1.0,=,IC50,nM,3850.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.85,CHEMBL378
4595,2930466.0,[],CHEMBL1056903,Antiviral activity against HIV1 HXB2 harboring 227L and 106A mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL338047,CHEMBL338047,,0.0,,848385.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4596,7967255.0,[],CHEMBL1930242,Antiviral activity against R5 tropic Human immunodeficiency virus 1 BAL infected in human PBMC cells assessed as reduction in viral replication by p24 detection based ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1,CHEMBL1926604,Bioorg Med Chem Lett,2011.0,CHEMBL1926893,CHEMBL1926893,8.66,0.0,http://www.openphacts.org/units/Nanomolar,1563510.0,=,1.0,1.0,=,IC50,nM,2.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.2,CHEMBL378
4597,1402042.0,[],CHEMBL837465,In vitro inhibitory concentration against HIV G190S mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC(C)=O)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL129144,CHEMBL129144,,0.0,http://www.openphacts.org/units/Nanomolar,360368.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4598,12651433.0,[],CHEMBL2327724,Antiviral activity against 0.001 MOI wild type Human immunodeficiency virus 1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCNC(=O)[C@H](C)NC(=O)OC(C)(C)C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324146,CHEMBL2324146,8.00,0.0,http://www.openphacts.org/units/Nanomolar,1850172.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
4599,5222613.0,[],CHEMBL1675305,Antiviral activity against HIV1 infected in human MT2 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(=O)n([C@@H]2CS[C@H](CO)O2)cc1F,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL885,CHEMBL885,7.36,0.0,http://www.openphacts.org/units/Nanomolar,1332025.0,=,1.0,1.0,=,IC50,nM,44.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.044,CHEMBL378
4600,2670841.0,[],CHEMBL1035389,Antiviral activity against LASV infected in human A549 cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CN2C(=O)CN(C(=O)c3cc4ccccc4[nH]3)CC2Cc2ccccc2)cc1,CHEMBL1151924,Bioorg Med Chem Lett,2009.0,CHEMBL559776,CHEMBL559776,5.92,0.0,http://www.openphacts.org/units/Nanomolar,820694.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL615051,Lassa virus,Lassa virus,11620,IC50,uM,UO_0000065,1.2,CHEMBL615051
4601,12651418.0,[],CHEMBL2327724,Antiviral activity against 0.001 MOI wild type Human immunodeficiency virus 1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCCNC(=O)[C@H](C)NC(=O)OC(C)(C)C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324132,CHEMBL2324132,7.30,0.0,http://www.openphacts.org/units/Nanomolar,1850156.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.05,CHEMBL378
4602,14581364.0,[],CHEMBL3243473,Antiviral activity against HIV-1 pseudotyped virus expressing HIV-1 isolate D envelope QA013.70I.ENV.M12 assessed as reduction of luciferase production after 3 days by single-cycle neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]1CSCc2ccc(cc2)-c2ccc(cc2)CSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC1=O,CHEMBL3232893,Bioorg Med Chem Lett,2014.0,CHEMBL3233156,CHEMBL3233156,4.81,0.0,http://www.openphacts.org/units/Nanomolar,2081351.0,=,1.0,1.0,=,IC50,nM,15400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,15.4,CHEMBL378
4603,19162201.0,[],CHEMBL4383613,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells after 7 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2ccc3c(c2)[C@H](NC(=O)OC(C)(C)C)CC[C@@H]3O)cc1,CHEMBL4382211,Eur J Med Chem,2018.0,CHEMBL4444545,CHEMBL4444545,,0.0,http://www.openphacts.org/units/Nanomolar,3198007.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
4604,3383658.0,[],CHEMBL1211563,Antiviral activity against HIV1 NL-BAL infected in CCR5-expressing human JC53-BL cells assessed as inhibition of viral replication after 16 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nn(-c2ccccc2)c(C)c1C(=O)N1C[C@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@H]2C1,CHEMBL1208790,Bioorg Med Chem Lett,2010.0,CHEMBL1209182,CHEMBL1209182,,0.0,http://www.openphacts.org/units/Nanomolar,926850.0,<=,1.0,1.0,<=,IC50,nM,1.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.5,CHEMBL378
4605,19261958.0,[],CHEMBL4404401,"Antiviral activity against HIV1 subtypeC HIV-225925-2, clone 22",F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.34,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,460.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.46,CHEMBL378
4606,5230915.0,[],CHEMBL1676873,Antiviral activity against Human immunodeficiency virus 1 3B expressing nef protein infecting in CEM-SS cells assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL129,CHEMBL129,8.40,0.0,http://www.openphacts.org/units/Nanomolar,1332124.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.004,CHEMBL378
4607,14581347.0,[],CHEMBL3242942,Antiviral activity against HIV-1 pseudotyped virus expressing HIV-1 isolate A envelope QF495.23M.ENV.A3 assessed as reduction of luciferase production after 3 days by single-cycle neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]1CSCc2ccc(cc2)-c2ccc(cc2)CSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC1=O,CHEMBL3232893,Bioorg Med Chem Lett,2014.0,CHEMBL3233156,CHEMBL3233156,5.85,0.0,http://www.openphacts.org/units/Nanomolar,2081351.0,=,1.0,1.0,=,IC50,nM,1400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.4,CHEMBL378
4608,1049979.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=C(S)N(Nc2cccc(Br)c2)C1c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289726,CHEMBL289726,5.34,0.0,http://www.openphacts.org/units/Nanomolar,62317.0,=,1.0,1.0,=,IC50,nM,4520.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.52,CHEMBL378
4609,2244520.0,[],CHEMBL1002207,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase K103N mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL203420,CHEMBL203420,9.40,0.0,http://www.openphacts.org/units/Nanomolar,798654.0,=,1.0,1.0,=,IC50,nM,0.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.4,CHEMBL378
4610,1402105.0,[],CHEMBL834488,In vitro inhibitory concentration against HIV L100I and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCO)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175692,CHEMBL175692,,0.0,http://www.openphacts.org/units/Nanomolar,360365.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4611,2362881.0,[],CHEMBL1026417,"Antiviral activity against multidrug-resistant HIV1 with protease L10I, V11I, T12E, I15V, L19I, R41K, M46L, L63P, A71T, V82A, L90M mutation in phytohemagglutininin-activated PBMC assessed as inhibition of p24G protein production",F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2CCOCOC2)cc1,CHEMBL1140100,J Med Chem,2008.0,CHEMBL492254,CHEMBL492254,6.44,0.0,http://www.openphacts.org/units/Nanomolar,746805.0,=,1.0,1.0,=,IC50,nM,360.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,360.0,CHEMBL378
4612,1487158.0,[],CHEMBL833976,Inhibitory concentration against wild type human immunodeficiency virus type 1 was determined by recombinant virus assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCc1c(O)nc2ccc(Cl)cc2c1OCC1CCC1,CHEMBL1138845,J Med Chem,2004.0,CHEMBL190406,CHEMBL190406,7.44,0.0,http://www.openphacts.org/units/Nanomolar,384151.0,=,1.0,1.0,=,IC50,nM,36.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,36.0,CHEMBL378
4613,6196019.0,[],CHEMBL1777271,Antiviral activity against HBV transfected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCc1cc(-c2oc3cc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)c3c(=O)c2CO)cc(O)c1O,CHEMBL1772944,J Nat Prod,2011.0,CHEMBL1773497,CHEMBL1773497,4.15,0.0,http://www.openphacts.org/units/Nanomolar,1421169.0,=,1.0,1.0,=,IC50,nM,70500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,70.5,CHEMBL613497
4614,17987403.0,[],CHEMBL3999574,Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 40 hrs,F,BAO_0000190,BAO_0000219,cell-based format,C=C(C(=O)OC)[C@@H]1CC[C@H](C)[C@H]2C(=C(C)C(=O)[C@@H]2[C@@H](O)c2ccc(OC(F)(F)F)cc2)C1,CHEMBL3997818,Bioorg Med Chem Lett,2017.0,CHEMBL4105298,CHEMBL4105298,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,2979921.0,>,1.0,1.0,>,IC50,ug.mL-1,18.52,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,18.52,CHEMBL613129
4615,15606025.0,[],CHEMBL3579360,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/c1ccc2c(c1)OCO2)O/N=C/c1cccs1,CHEMBL3576819,Eur J Med Chem,2015.0,CHEMBL3577792,CHEMBL3577792,,0.0,http://www.openphacts.org/units/Nanomolar,2480532.0,=,1.0,1.0,=,IC50,nM,117670.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,117.67,CHEMBL613497
4616,12683867.0,[],CHEMBL2339981,Antiviral activity against Hepatitis B virus transfected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc2c(ncn2COCCOC(=O)CCCC(=O)NCCC[Si]23OCCN(CCO2)CCO3)c(=O)[nH]1,CHEMBL2331251,Bioorg Med Chem Lett,2013.0,CHEMBL2333794,CHEMBL2333794,4.04,0.0,http://www.openphacts.org/units/Nanomolar,1867887.0,=,1.0,1.0,=,IC50,nM,90400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,90.4,CHEMBL613497
4617,455554.0,[],CHEMBL879473,Viral protection was determined in a 24 hr HIV-1 viral infectivity assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1Oc2cc3c(-c4c(O)cc(O)c5c(O)c6c(cc45)OC(C)C(C)C6=O)c(O)cc(O)c3c(O)c2C(=O)C1C,CHEMBL1136596,Bioorg Med Chem Lett,2003.0,CHEMBL162783,CHEMBL162783,5.52,0.0,http://www.openphacts.org/units/Nanomolar,317954.0,=,1.0,1.0,=,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.0,CHEMBL378
4618,2334911.0,[],CHEMBL996367,Antiviral activity against PIV3 in MDCK cells assessed as inhibition of virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,CHEMBL1151177,J Nat Prod,2004.0,CHEMBL250450,CHEMBL250450,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,738274.0,=,1.0,1.0,=,IC50,ug.mL-1,23.4,CHEMBL613126,Human parainfluenza virus 3,Human parainfluenza virus 3,11216,IC50,ug ml-1,UO_0000274,23.4,CHEMBL613126
4619,2649328.0,[],CHEMBL1024326,"Antiviral activity against HIV1 expressed in 293T cells assessed as protection against viral M33 envelope infection in human U87 cells coexpressing CD4, CCR5 receptors after 72 hrs by luciferase reporter gene pseudoviral assay",F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1ccc(-c2cccs2)cc1,CHEMBL1158460,J Med Chem,2009.0,CHEMBL564340,CHEMBL564340,6.36,0.0,http://www.openphacts.org/units/Nanomolar,815843.0,=,1.0,1.0,=,IC50,nM,440.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,440.0,CHEMBL378
4620,5250552.0,[],CHEMBL1686951,Antiviral activity against HIV1 00KNH1209-A infected in human PBMC assessed as reduction of p24 antigen production after 7 days,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2c(c1)nc(Nc1cccc(C(F)(F)F)c1)c1nc(NC3CC3)ncc12,CHEMBL1681725,Bioorg Med Chem Lett,2011.0,CHEMBL1682297,CHEMBL1682297,6.77,0.0,http://www.openphacts.org/units/Nanomolar,1333376.0,=,1.0,1.0,=,IC50,nM,170.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.17,CHEMBL378
4621,12642510.0,[],CHEMBL2317525,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COCCN1CCn2cc(C(=O)NCc3ccc(F)cc3)c(=O)c(O)c2C1=O,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314694,CHEMBL2314694,8.23,0.0,http://www.openphacts.org/units/Nanomolar,1844829.0,=,1.0,1.0,=,IC50,nM,5.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.9,CHEMBL378
4622,12135670.0,[],CHEMBL2187933,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as p24 antigen level after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)OCc3cn([C@H]4C[C@H](n5cc(C)c(=O)[nH]c5=O)O[C@@H]4CO)nn3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2176886,J Med Chem,2012.0,CHEMBL2177443,CHEMBL2177443,7.00,0.0,http://www.openphacts.org/units/Nanomolar,1750139.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
4623,2997439.0,[],CHEMBL1047854,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV DNA replication after 9 days by PCR,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C(=N/Cc2ccc(F)c(F)c2)c2ccc(=O)n(Cc3ccc(F)c(F)c3)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL567996,CHEMBL567996,4.01,0.0,http://www.openphacts.org/units/Nanomolar,856577.0,=,1.0,1.0,=,IC50,nM,97500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,97.5,CHEMBL613497
4624,5189220.0,[],CHEMBL1658800,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O)c1cccnc1,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652515,CHEMBL1652515,4.26,0.0,http://www.openphacts.org/units/Nanomolar,1326890.0,=,1.0,1.0,=,IC50,nM,55000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.055,CHEMBL613497
4625,1402395.0,[],CHEMBL837462,In vitro inhibitory concentration against HIV E138K mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC(N)=S)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369148,CHEMBL369148,,0.0,http://www.openphacts.org/units/Nanomolar,360422.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4626,16544723.0,[],CHEMBL3789804,Antiviral activity against HIV1 virus-like particles harboring wild type reverse transcriptase infected in human U2OS cells after 24 hrs by Renilla luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Nc2nc(N)nc(COC(=O)c3cnc4ccccc4n3)n2)cc1,CHEMBL3784952,Bioorg Med Chem,2016.0,CHEMBL3785615,CHEMBL3785615,,0.0,http://www.openphacts.org/units/Nanomolar,2769329.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
4627,3383646.0,[],CHEMBL1211563,Antiviral activity against HIV1 NL-BAL infected in CCR5-expressing human JC53-BL cells assessed as inhibition of viral replication after 16 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cccc(C(=O)N2C[C@H]3CN(CC[C@H](NC(=O)C4CCCC4)c4ccccc4)C[C@H]3C2)c1,CHEMBL1208790,Bioorg Med Chem Lett,2010.0,CHEMBL1209444,CHEMBL1209444,7.89,0.0,http://www.openphacts.org/units/Nanomolar,927163.0,=,1.0,1.0,=,IC50,nM,13.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,13.0,CHEMBL378
4628,1411642.0,[],CHEMBL832751,Inhibitory concentration against hepatitis C virus polymerase,B,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1ccc2c(c1)nc(-c1ccccn1)n2C1CCCCC1,CHEMBL1145280,J Med Chem,2005.0,CHEMBL174683,CHEMBL174683,5.37,0.0,http://www.openphacts.org/units/Nanomolar,362360.0,=,1.0,1.0,=,IC50,nM,4300.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,4.3,CHEMBL4620
4629,1402302.0,[],CHEMBL834488,In vitro inhibitory concentration against HIV L100I and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(Cc2ccccc2)Cc2ccccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL366811,CHEMBL366811,,0.0,http://www.openphacts.org/units/Nanomolar,360421.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4630,3258189.0,[],CHEMBL1114358,Antiviral activity against HIV1 infected in human MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOc1c2cc(C(=O)N[C@@H](CC(=O)O)C(=O)O)cc1Cc1cc(C(=O)N[C@@H](CC(=O)O)C(=O)O)cc(c1OCCCC)Cc1cc(C(=O)N[C@H](CC(=O)O)C(=O)O)cc(c1OCCCC)Cc1cc(C(=O)N[C@@H](CC(=O)O)C(=O)O)cc(c1OCCC)C2,CHEMBL1156302,Bioorg Med Chem Lett,2010.0,CHEMBL1090296,CHEMBL1090296,5.52,0.0,http://www.openphacts.org/units/Nanomolar,901400.0,=,1.0,1.0,=,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.0,CHEMBL378
4631,20663973.0,[],CHEMBL4618924,Antiviral activity against wild type HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)CN1CCOCC1)S(=O)(=O)c1ccc(C(F)(F)F)cc1,CHEMBL4616700,ACS Med Chem Lett,2020.0,CHEMBL4642888,CHEMBL4642888,7.36,0.0,http://www.openphacts.org/units/Nanomolar,3479372.0,=,1.0,1.0,=,IC50,nM,44.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,44.2,CHEMBL378
4632,2602161.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn(/C=C2\CC2(F)CO)c(=O)[nH]c1=O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL426177,CHEMBL426177,4.00,0.0,http://www.openphacts.org/units/Nanomolar,807411.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
4633,6304752.0,[],CHEMBL1815967,Antiviral activity against R5 tropic multidrug-resistant HIV1 MM infected PBMC assessed as inhibition of viral p24 antigen expression,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1811891,Bioorg Med Chem,2011.0,CHEMBL129,CHEMBL129,6.60,0.0,http://www.openphacts.org/units/Nanomolar,1447832.0,=,1.0,1.0,=,IC50,nM,250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,250.0,CHEMBL378
4634,1755840.0,[],CHEMBL864208,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)CSc2nnc(C)n2-c2ccc(C)cc2)cc1,CHEMBL1146046,Bioorg Med Chem Lett,2006.0,CHEMBL211869,CHEMBL211869,,0.0,http://www.openphacts.org/units/Nanomolar,545147.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
4635,7924552.0,[],CHEMBL1921362,Antiviral activity against Human immunodeficiency virus 1 Ba-L in human PBL cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(NS(C)(=O)=O)cc2)ncc1CN1CCC(N(C(=O)Nc2ccc(C(N)=O)nc2)c2cccc(F)c2)CC1,CHEMBL1914281,Bioorg Med Chem Lett,2011.0,CHEMBL1914532,CHEMBL1914532,9.05,0.0,http://www.openphacts.org/units/Nanomolar,1556607.0,=,1.0,1.0,=,IC50,nM,0.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.9,CHEMBL378
4636,3267360.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1Cc2cc(Cl)c(Cl)c3nc(S)n(c23)C[C@@H]1C,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL293814,CHEMBL293814,7.60,0.0,http://www.openphacts.org/units/Nanomolar,906457.0,=,1.0,1.0,=,IC50,nM,25.12,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.6,CHEMBL378
4637,10861946.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,C=CCCOC(=O)[C@@]1(C)CC[C@]2(C)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2024627,CHEMBL2024627,,0.0,http://www.openphacts.org/units/Nanomolar,1640523.0,>,1.0,1.0,>,IC50,nM,1754390.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1754.39,CHEMBL613497
4638,18044503.0,[],CHEMBL4010365,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of p24 antigen production pretreated with virus for 30 mins followed by 4 days incubation with cells by sandwich ELISA based multicycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,CNCCC(NC(=O)c1ccc(-c2cccc(Cl)c2)[nH]1)c1nc(C)c(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4061047,CHEMBL4061047,4.98,0.0,http://www.openphacts.org/units/Nanomolar,2990198.0,=,1.0,1.0,=,IC50,nM,10400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.4,CHEMBL378
4639,2368196.0,[],CHEMBL1031556,Antiviral activity against HIV1 infected in human 293T cells assessed as inhibition of pseudovirus infection,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)CCCNC(=S)Nc1ccc(Cl)c(C(F)(F)F)c1,CHEMBL1140132,J Med Chem,2008.0,CHEMBL493711,CHEMBL493711,5.80,0.0,http://www.openphacts.org/units/Nanomolar,746151.0,=,1.0,1.0,=,IC50,nM,1600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.6,CHEMBL378
4640,18320087.0,[],CHEMBL4134181,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA level incubated for 3 days followed by medium replacement measured after 3 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C2CN(C(C)=O)CCN2C(c2nccs2)=NC1c1ccc(F)cc1Br,CHEMBL4130455,ACS Med Chem Lett,2017.0,CHEMBL4161224,CHEMBL4161224,6.11,0.0,http://www.openphacts.org/units/Nanomolar,3041682.0,=,1.0,1.0,=,IC50,nM,770.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.77,CHEMBL613497
4641,10938612.0,[],CHEMBL2051599,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccc(O)c(O)c4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046556,CHEMBL2046556,,0.0,http://www.openphacts.org/units/Nanomolar,1651439.0,>,1.0,1.0,>,IC50,nM,567210.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,567.21,CHEMBL613497
4642,8027848.0,[],CHEMBL1948540,Antiviral activity against HIV1 NL432 infected in human ConA and IL2-stimulated PBMC assessed as inhibition of viral replication by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)Oc2cc3c(cc2O1)[C@@H]1c2cccc(O)c2OC[C@]1(O)C3,CHEMBL1944615,Bioorg Med Chem Lett,2012.0,CHEMBL1945225,CHEMBL1945225,4.52,0.0,http://www.openphacts.org/units/Nanomolar,1574225.0,=,1.0,1.0,=,IC50,nM,30100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,30.1,CHEMBL378
4643,2681570.0,[],CHEMBL1062323,Antiviral activity against HIV1 SS1196.1 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCNC(C)=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL508943,CHEMBL508943,6.66,0.0,http://www.openphacts.org/units/Nanomolar,823861.0,=,1.0,1.0,=,IC50,nM,220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.22,CHEMBL378
4644,2929730.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cncc3C)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567838,CHEMBL567838,7.50,0.0,http://www.openphacts.org/units/Nanomolar,852985.0,=,1.0,1.0,=,IC50,nM,31.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.6,CHEMBL378
4645,2413639.0,[],CHEMBL987708,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)c1ccc(Br)cc1)[C@@H](OC(=O)c1ccc(Br)cc1)C(C)(C)O)C1=C2C[C@H](OC(=O)c3ccc(Br)cc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL506776,CHEMBL506776,,0.0,http://www.openphacts.org/units/Nanomolar,810688.0,>,1.0,1.0,>,IC50,nM,650000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.65,CHEMBL613497
4646,1438010.0,[],CHEMBL833079,Inhibitory activity against HIV-1 mutant strain 181C,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C(C)=O)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL362435,CHEMBL362435,6.00,0.0,http://www.openphacts.org/units/Nanomolar,371615.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
4647,18314692.0,[],CHEMBL4132881,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 isolate YU2 infected in human TZM-bl cells after 24 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O[C@H](C1=NC[C@H](c2c[nH]c3cc(Br)ccc23)N1)c1c[nH]c2cc(Br)ccc12,CHEMBL4130397,J Nat Prod,2017.0,CHEMBL4171001,CHEMBL4171001,5.46,0.0,http://www.openphacts.org/units/Nanomolar,3040472.0,=,1.0,1.0,=,IC50,nM,3500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.5,CHEMBL378
4648,24735329.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5116803,Antiviral activity against CHIKV infected in human Huh-7 cells assessed as inhibition of viral infection by measuring EGFP-positive cells measured 24 hrs post infection by fluorescent microscopic analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=c1cc(-c2ccc(Nc3ccc(F)cc3)cc2)oc2cc(O)c(O)c(O)c12,CHEMBL5113447,Bioorg Med Chem Lett,2022.0,CHEMBL5187468,CHEMBL5187468,5.32,0.0,http://www.openphacts.org/units/Nanomolar,3858580.0,=,1.0,1.0,=,IC50,nM,4800.0,CHEMBL4296563,Chikungunya virus,Chikungunya virus,37124,IC50,uM,UO_0000065,4.8,CHEMBL4296563
4649,1213425.0,[],CHEMBL645946,Concentration required to inhibit activator protein-1(AP-1) mediated transcriptional activation in human Jurkat T-cells,B,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(Cl)ncc1C(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1,CHEMBL1133475,J Med Chem,2000.0,CHEMBL132495,CHEMBL132495,7.70,1.0,http://www.openphacts.org/units/Nanomolar,247705.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.02,CHEMBL4977
4650,18726961.0,[],CHEMBL4259329,Antiviral activity against HIV-1 subtype B SF162 pseudovirus assessed as inhibition of viral infection in Ghost (3)X4/R5 cells after 48 hrs by Bright-Glo luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@]1(C)CCC/C=C\CCC[C@](C)(NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O,CHEMBL4257519,Medchemcomm,2018.0,CHEMBL4287830,CHEMBL4287830,8.48,0.0,http://www.openphacts.org/units/Nanomolar,3111235.0,=,1.0,1.0,=,IC50,nM,3.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.3,CHEMBL378
4651,16466897.0,[],CHEMBL3766104,Antiviral activity against HIV1 NL4-3 infected in TZM-bl cells incubated for 3 hrs measured after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=S)n1nc(-c2ccc([N+](=O)[O-])cc2)c(Cc2cccc(Cl)c2)c1O,CHEMBL3763152,Bioorg Med Chem Lett,2016.0,CHEMBL3764840,CHEMBL3764840,5.45,0.0,http://www.openphacts.org/units/Nanomolar,2756656.0,=,1.0,1.0,=,IC50,nM,3540.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.54,CHEMBL378
4652,10911777.0,[],CHEMBL2038370,Antiviral activity against wild type HIV1 clade C 98USMSC5016 clinical isolate infected in PHA-P-stimulated human PBMC assessed as reverse transcriptase activity incubated for 6 hrs followed by incubated in drug-free medium for 6 days by multiround infection assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)CC[C@H](NC(=O)CCC(=O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3F)C(=O)OC[C@@H]3O[C@H](n4ccc(N)nc4=O)CS3)O2)c(=O)[nH]c1=O,CHEMBL2034836,J Med Chem,2012.0,CHEMBL2035198,CHEMBL2035198,7.64,0.0,http://www.openphacts.org/units/Nanomolar,1644927.0,=,1.0,1.0,=,IC50,nM,22.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,22.7,CHEMBL378
4653,14594143.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(Sc2c(C)c(=O)[nH]c(=O)n2COCCO)c1,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL16535,CHEMBL16535,5.25,0.0,http://www.openphacts.org/units/Nanomolar,2082336.0,=,1.0,1.0,=,IC50,nM,5590.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.59,CHEMBL378
4654,1218424.0,[],CHEMBL710372,Inhibitory activity against 100I strain and 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2nc(Nc3ccc(C#N)cc3)ncc2Br)c(C)c1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL71882,CHEMBL71882,6.46,0.0,http://www.openphacts.org/units/Nanomolar,127454.0,=,1.0,1.0,=,IC50,nM,348.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.348,CHEMBL378
4655,10961229.0,[],CHEMBL2061271,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M6 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCc1ccccc1)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058319,CHEMBL2058319,7.75,0.0,http://www.openphacts.org/units/Nanomolar,1656259.0,=,1.0,1.0,=,IC50,nM,18.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,18.0,CHEMBL378
4656,1471864.0,[],CHEMBL833079,Inhibitory activity against HIV-1 mutant strain 181C,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1ccc(OC)c(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL186129,CHEMBL186129,4.00,0.0,http://www.openphacts.org/units/Nanomolar,380838.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
4657,16449867.0,[],CHEMBL3757559,Inhibition of ASCT2-mediated glutamine transport in human HEK293 cells using [3H]-glutamine after 15 mins by scintillation counting,B,BAO_0000190,BAO_0000219,cell-based format,N[C@@H](CCN(Cc1ccccc1Oc1ccc(Cl)cc1)Cc1ccccc1Oc1ccc(Cl)cc1)C(=O)O,CHEMBL3751750,Bioorg Med Chem Lett,2016.0,CHEMBL3752943,CHEMBL3752943,4.58,0.0,http://www.openphacts.org/units/Nanomolar,2744493.0,=,1.0,1.0,=,IC50,nM,26000.0,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,uM,UO_0000065,26.0,CHEMBL3562162
4658,536510.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1Sc1cccc(N)c1C#N,CHEMBL1134494,J Med Chem,2001.0,CHEMBL292464,CHEMBL292464,5.37,0.0,http://www.openphacts.org/units/Nanomolar,94230.0,=,1.0,1.0,=,IC50,nM,4300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.3,CHEMBL378
4659,19257032.0,[],CHEMBL4403223,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C#CCOc1ccc(OCc2ccccc2)cc1,CHEMBL4402520,Eur J Med Chem,2019.0,CHEMBL4467489,CHEMBL4467489,5.17,0.0,http://www.openphacts.org/units/Nanomolar,3215080.0,=,1.0,1.0,=,IC50,nM,6680.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.68,CHEMBL378
4660,10866492.0,[],CHEMBL2025518,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CCC(=O)CC3=CC(=O)[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024050,CHEMBL2024050,,0.0,http://www.openphacts.org/units/Nanomolar,1639772.0,=,1.0,1.0,=,IC50,nM,112780.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,112.78,CHEMBL613497
4661,2602251.0,[],CHEMBL1034017,Antiviral activity against Vaccinia virus,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc21)OCOC(=O)C(C)(C)C,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL922,CHEMBL922,5.29,0.0,http://www.openphacts.org/units/Nanomolar,808153.0,=,1.0,1.0,=,IC50,nM,5100.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,5.1,CHEMBL613493
4662,13967466.0,[],CHEMBL3135324,Antiviral activity against HIV1 VSVG harboring reverse transcriptase Y181C mutant infected in 293ET cellsassessed as inhibition of viral replication by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCOC(=O)c1sccc1S(=O)(=O)N1c2cc(Cl)ccc2NC(=O)C1C,CHEMBL3132804,Medchemcomm,2014.0,CHEMBL3133048,CHEMBL3133048,,0.0,http://www.openphacts.org/units/Nanomolar,1974719.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
4663,13390575.0,[],CHEMBL2412660,Antiviral activity against HIV1 3B infected in human CEM-SS cells assessed as reduction in virus-induced cytopathogenicity after 6 days by MTS assay,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/C[C@@H](C)[C@@H](OC(C)=O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)C(OC(C)=O)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,CHEMBL2407038,Bioorg Med Chem Lett,2013.0,CHEMBL2407579,CHEMBL2407579,6.94,0.0,http://www.openphacts.org/units/Nanomolar,1907805.0,=,1.0,1.0,=,IC50,nM,115.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,115.0,CHEMBL378
4664,24971695.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5218444,Anti-HIV activity against HIV-1 NL4-3 Nanoluc-sec virus infected in human MT4 cells assessed as viral growth inhibition by measuring luciferase activity measured after 3 days post-infection by Nano-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@]12C[C@@H](COC(=O)c3ccccc3)[C@]34OC5(CCCCC[C@@H](OC(=O)c6ccccc6)C[C@@H](C)[C@@H]6[C@@H]3[C@]3(O[C@]6(C)OC3=O)[C@H](O)[C@@]3(CO)O[C@H]3[C@H]4[C@H]1O5)O2,CHEMBL5215012,J Nat Prod,2022.0,CHEMBL5220834,CHEMBL5220834,6.37,0.0,http://www.openphacts.org/units/Nanomolar,3902017.0,=,1.0,1.0,=,IC50,nM,423.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,423.0,CHEMBL378
4665,10961118.0,[],CHEMBL2061266,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M9 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CN)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057463,CHEMBL2057463,6.70,0.0,http://www.openphacts.org/units/Nanomolar,1655125.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,200.0,CHEMBL378
4666,12676021.0,[],CHEMBL2346109,Antiviral activity against HIV1 NL4.3 infected in MAGIC-5B cells after 48 hrs by beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCN)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2331496,Eur J Med Chem,2013.0,CHEMBL2336392,CHEMBL2336392,7.80,0.0,http://www.openphacts.org/units/Nanomolar,1871273.0,=,1.0,1.0,=,IC50,nM,16.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.016,CHEMBL378
4667,16449865.0,[],CHEMBL3757559,Inhibition of ASCT2-mediated glutamine transport in human HEK293 cells using [3H]-glutamine after 15 mins by scintillation counting,B,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(Oc2ccccc2CN(CC[C@H](N)C(=O)O)Cc2ccccc2Oc2cccc(OC)c2)c1,CHEMBL3751750,Bioorg Med Chem Lett,2016.0,CHEMBL3753869,CHEMBL3753869,4.24,0.0,http://www.openphacts.org/units/Nanomolar,2744491.0,=,1.0,1.0,=,IC50,nM,57200.0,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,uM,UO_0000065,57.2,CHEMBL3562162
4668,2929619.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3cnc(C)c3C#N)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL575885,CHEMBL575885,7.00,0.0,http://www.openphacts.org/units/Nanomolar,848313.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,100.0,CHEMBL378
4669,1199846.0,[],CHEMBL710372,Inhibitory activity against 100I strain and 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Nc1nc(Nc2ccc(C#N)cc2)ncc1Br,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70517,CHEMBL70517,7.43,0.0,http://www.openphacts.org/units/Nanomolar,127456.0,=,1.0,1.0,=,IC50,nM,37.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.037,CHEMBL378
4670,14658823.0,[],CHEMBL3266157,Antagonist activity at recombinant human EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(Cl)cc1)N1CCN(C(=O)c2ccc3c(c2)CCO3)CC1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262894,CHEMBL3262894,7.80,0.0,http://www.openphacts.org/units/Nanomolar,2101736.0,=,1.0,1.0,=,IC50,nM,15.85,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,pIC50,,UO_0000065,7.8,CHEMBL3259470
4671,2527521.0,[],CHEMBL1003778,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect albumin after 5 days by MTS method in presence of 40 mg/mL human serum albumin,F,BAO_0000190,BAO_0000218,organism-based format,CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(C)c1=O,CHEMBL1138484,J Med Chem,2009.0,CHEMBL522802,CHEMBL522802,,0.0,,735542.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4672,1022432.0,[],CHEMBL756465,Tested for the ability to inhibit the replication of HIV-1 strain HTLV IIIB in human peripheral blood mononuclear cells (PBMC),F,BAO_0000190,BAO_0000218,organism-based format,S=C(NCCc1c[nH]c2ccccc12)Nc1nccs1,CHEMBL1134194,Bioorg Med Chem Lett,2001.0,CHEMBL356247,CHEMBL356247,,0.0,http://www.openphacts.org/units/Nanomolar,292652.0,<,1.0,1.0,<,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
4673,5294577.0,[],CHEMBL1696678,Antiviral activity against HIV-1 SF2 infected in human PBMC assessed as inhibition of viral replication by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1687706,Antimicrob Agents Chemother,2008.0,CHEMBL129,CHEMBL129,7.85,0.0,http://www.openphacts.org/units/Nanomolar,1337220.0,=,1.0,1.0,=,IC50,nM,14.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.014,CHEMBL378
4674,12204004.0,[],CHEMBL2211838,Antiviral activity against HIV-1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C2C3Cc4cc(OC)c(OC)cc4C3=NN2C(=O)Nc2c(C)cccc2C)cc1OC,CHEMBL2203270,Bioorg Med Chem Lett,2012.0,CHEMBL1824322,CHEMBL1824322,,0.0,http://www.openphacts.org/units/Nanomolar,1758525.0,>,1.0,1.0,>,IC50,nM,182440.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,182.44,CHEMBL378
4675,615376.0,[],CHEMBL710381,Inhibitory activity against 103N strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)/C=N\c1nc(Cc2c(Cl)cccc2Cl)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL73673,CHEMBL73673,7.80,0.0,http://www.openphacts.org/units/Nanomolar,126928.0,=,1.0,1.0,=,IC50,nM,16.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.016,CHEMBL378
4676,1740614.0,[],CHEMBL854478,Inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,O=C1c2ccccc2C(=O)N1CCc1nc2ccccc2n1S(=O)(=O)c1ccccc1,CHEMBL1138932,J Med Chem,2006.0,CHEMBL210080,CHEMBL210080,5.66,0.0,http://www.openphacts.org/units/Nanomolar,520763.0,=,1.0,1.0,=,IC50,nM,2200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.2,CHEMBL613497
4677,2244605.0,[],CHEMBL1005599,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase V106I/Y181C mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL57,CHEMBL57,,0.0,http://www.openphacts.org/units/Nanomolar,798657.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2000.0,CHEMBL378
4678,18754871.0,[],CHEMBL4265061,Antiviral activity against HIV1 cYTA48P infected in PM1/CCR5 cells by single round assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c2cc(C(=O)NC3CC(C)(C)NC(C)(C)C3)[nH]c2c1,CHEMBL4261625,Bioorg Med Chem,2018.0,CHEMBL4279082,CHEMBL4279082,,0.0,http://www.openphacts.org/units/Nanomolar,3116217.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
4679,1221006.0,[],CHEMBL710530,Inhibitory activity against 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2nc(Nc3ccc(C#N)cc3)ncc2C)c(C)c1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL431378,CHEMBL431378,8.59,0.0,http://www.openphacts.org/units/Nanomolar,127440.0,=,1.0,1.0,=,IC50,nM,2.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0026,CHEMBL378
4680,10961193.0,[],CHEMBL2061268,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M3 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL1323,CHEMBL1323,7.96,0.0,http://www.openphacts.org/units/Nanomolar,1655448.0,=,1.0,1.0,=,IC50,nM,11.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,11.0,CHEMBL378
4681,2570699.0,[],CHEMBL1000472,Antiviral activity against hepatitis B virus-infected human HepG2.2.15 cells assessed as inhibition of HBV surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@H](OC(=O)C(C)C)[C@H](C[C@@H](C)C1=C2C[C@H](OC(=O)C(C)C)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)OC(=O)C(C)C,CHEMBL1155923,Bioorg Med Chem Lett,2008.0,CHEMBL509543,CHEMBL509543,,0.0,http://www.openphacts.org/units/Nanomolar,768988.0,>,1.0,1.0,>,IC50,nM,1600000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.6,CHEMBL613497
4682,15680000.0,[],CHEMBL3606515,Antiviral activity against HIV1 LAI infected in human MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N[C@H]1CO[C@@H]2OC[C@H](OC(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc(OC)cc3)[C@@H]21,CHEMBL3603748,J Med Chem,2015.0,CHEMBL3605641,CHEMBL3605641,8.43,0.0,http://www.openphacts.org/units/Nanomolar,2495840.0,=,1.0,1.0,=,IC50,nM,3.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.7,CHEMBL378
4683,5246999.0,[],CHEMBL1687410,Antiviral activity against HIV1 Ba-L infected in human HOS cells expressing CCR5 after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CCC(C)(CNC(=O)C1CCC(F)(F)CC1)c1ccccc1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL3084357,CHEMBL3084357,6.23,0.0,http://www.openphacts.org/units/Nanomolar,1333592.0,=,1.0,1.0,=,IC50,nM,583.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.583,CHEMBL378
4684,15027179.0,[],CHEMBL3367176,Inhibition of AP-1-mediated transcriptional activation in HEK293 cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(-c2ccccc2)c(-c2nc3ccccc3c(=O)n2-c2ccccc2OC)s1,CHEMBL3352097,J Med Chem,2014.0,CHEMBL3341956,CHEMBL3341956,6.30,0.0,http://www.openphacts.org/units/Nanomolar,2265201.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.5,CHEMBL4977
4685,681349.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)CSSCC(N)=O,CHEMBL1129635,J Med Chem,1996.0,CHEMBL332509,CHEMBL332509,,0.0,,228589.0,=,1.0,0.0,=,IC50,,83.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,83.9,CHEMBL378
4686,2947399.0,[],CHEMBL1038497,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)CCC1CCCCC1)[C@@H](OC(=O)CCC1CCCCC1)C(C)(C)OC(=O)CCC1CCCCC1)C1=C2C[C@H](OC(=O)CCC3CCCCC3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL584175,CHEMBL584175,,0.0,http://www.openphacts.org/units/Nanomolar,850749.0,>,1.0,1.0,>,IC50,nM,1700000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.7,CHEMBL613497
4687,12723415.0,[],CHEMBL2351030,Antiviral activity against Hepatitis B virus-infected human HepG2(2.2.15) cells assessed as inhibition of HBeAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,O=C1C=CCCN1,CHEMBL2346644,Bioorg Med Chem Lett,2013.0,CHEMBL2347636,CHEMBL2347636,,0.0,http://www.openphacts.org/units/Nanomolar,1875476.0,>,1.0,1.0,>,IC50,nM,14000000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,14.0,CHEMBL613497
4688,6216891.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(n2c(=O)[nH]c4ccccc42)C3)(c2ccccc2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784394,CHEMBL1784394,5.13,0.0,http://www.openphacts.org/units/Nanomolar,1429332.0,=,1.0,1.0,=,IC50,nM,7413.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.13,CHEMBL378
4689,631886.0,[],CHEMBL710534,Inhibitory activity against 188L strain of HIV-1 in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(C)c(Cc2nc(N)nc(Nc3ccc(C#N)cc3)n2)c1C,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL307865,CHEMBL307865,6.43,0.0,http://www.openphacts.org/units/Nanomolar,126890.0,=,1.0,1.0,=,IC50,nM,367.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.367,CHEMBL378
4690,22845271.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '49.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '49.0'}]",CHEMBL4721685,Antiviral activity against clinical isolate HIV-1 93RW034 infected in human PBMC cells assessed as reduction in viral transmission to TZM-bl cells pretreated for 1 hr before viral transmission and further incubated for 48 hrs by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4747551,CHEMBL4747551,6.05,0.0,http://www.openphacts.org/units/Nanomolar,3547084.0,=,1.0,1.0,=,IC50,nM,890.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.89,CHEMBL378
4691,2244540.0,[],CHEMBL1002211,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase G190A mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(COc1ccc(Cl)cc1C(=O)c1ccccc1)Nc1ccccc1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL296939,CHEMBL296939,7.51,0.0,http://www.openphacts.org/units/Nanomolar,798577.0,=,1.0,1.0,=,IC50,nM,31.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.0,CHEMBL378
4692,813723.0,[],CHEMBL879785,"Inhibitory activity against NNI-resistant HIV-1 strain A17 with Y181C,K103N mutation; ND is not determined.",F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](/N=C(\S)Nc1ccc(Br)cn1)C1CCCCC1,CHEMBL1133139,Bioorg Med Chem Lett,2000.0,CHEMBL63222,CHEMBL63222,,0.0,http://www.openphacts.org/units/Nanomolar,111941.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4693,15666350.0,[],CHEMBL3602705,Antiviral activity against ENF-resistant HIV1 NL4-3 harboring gp41 N-terminal heptad repeat V38A mutant infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL3600303,J Med Chem,2015.0,CHEMBL525076,CHEMBL525076,6.15,0.0,http://www.openphacts.org/units/Nanomolar,2492339.0,=,1.0,1.0,=,IC50,nM,708.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,708.6,CHEMBL378
4694,1402230.0,[],CHEMBL835251,In vitro inhibitory concentration against HIV F227L and V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCNC(=S)Nc1c(Cc2cccc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL178043,CHEMBL178043,,0.0,http://www.openphacts.org/units/Nanomolar,360408.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4695,14990562.0,[],CHEMBL3383781,Antiviral activity against HIV1 pseudotyped virus expressed in human U87 cells co-expressing AMLV envelope after 48 hrs by cell-based luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(COc1cccc2ccccc12)N1CCN(C(=O)c2ccccc2)CC1,CHEMBL3351851,Bioorg Med Chem Lett,2014.0,CHEMBL3353045,CHEMBL3353045,,0.0,,2241673.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4696,19250060.0,[],CHEMBL4401356,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of viral replication after 7 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ncc(Cc2ccc(Cl)cc2)s1)c1cccs1,CHEMBL4400536,Eur J Med Chem,2019.0,CHEMBL477554,CHEMBL477554,5.44,0.0,http://www.openphacts.org/units/Nanomolar,3213521.0,=,1.0,1.0,=,IC50,nM,3620.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,3.62,CHEMBL613497
4697,10866463.0,[],CHEMBL2025518,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)c4cc5ccccc5[nH]4)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2023669,CHEMBL2023669,5.44,0.0,http://www.openphacts.org/units/Nanomolar,1639233.0,=,1.0,1.0,=,IC50,nM,3630.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,3.63,CHEMBL613497
4698,19262066.0,[],CHEMBL4404444,Antiviral activity against HIV1-ADA infected in human MOLT4 cells assessed as inhibition in cell to cell HIV1 transmission to human TZM-bl acceptor cells incubated for 24 hrs by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.05,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,890.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.89,CHEMBL378
4699,2929707.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3ccnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL584160,CHEMBL584160,8.00,0.0,http://www.openphacts.org/units/Nanomolar,848339.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.0,CHEMBL378
4700,3221765.0,[],CHEMBL1103039,Antiviral activity against HIV1 carrying reverse transcriptase K103E/G190A mutant infected human MT4 cells by phenoscreen assay in the presence of 40 percent normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,NS(=O)(=O)c1ccc(NC(=O)CSC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,CHEMBL1153798,Bioorg Med Chem Lett,2009.0,CHEMBL1079267,CHEMBL1079267,,0.0,http://www.openphacts.org/units/Nanomolar,897986.0,=,1.0,1.0,=,IC50,nM,113100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,0.1131,CHEMBL378
4701,2263434.0,[],CHEMBL1010866,Inhibition of R5 tropic HIV1 BaL replication in human PBMC,F,BAO_0000190,BAO_0000218,organism-based format,CCCC[C@H]1C(=O)N(C[C@H]2CC[C@H](OCC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2,CHEMBL1139267,Bioorg Med Chem Lett,2009.0,CHEMBL503224,CHEMBL503224,9.10,0.0,http://www.openphacts.org/units/Nanomolar,750167.0,=,1.0,1.0,=,IC50,nM,0.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.8,CHEMBL378
4702,10863198.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(COC(=O)[C@@]2(C)CC[C@]3(C)CC[C@]4(C)C(=CC(=O)[C@@H]5[C@@]6(C)CC[C@H](O)C(C)(C)[C@@H]6CC[C@]54C)[C@@H]3C2)cs1,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022394,CHEMBL2022394,5.04,0.0,http://www.openphacts.org/units/Nanomolar,1637644.0,=,1.0,1.0,=,IC50,nM,9080.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,9.08,CHEMBL613497
4703,3397931.0,[],CHEMBL1217302,Antiviral activity against HIV1 3B infected in human MT4 cells after 5 days by p24 antigen detection assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1C(c2ccc(O)c(OS(=O)(=O)O)c2)=c2c(c3c(n2CCc2ccc(O)cc2)=C(c2ccc(O)c(O)c2)C(=O)c2cc(O)c(OS(=O)(=O)O)cc2-3)-c2cc(O)c(O)cc21,CHEMBL1212851,Bioorg Med Chem,2010.0,CHEMBL1214283,CHEMBL1214283,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,931715.0,=,1.0,1.0,=,IC50,ug.mL-1,4.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,4.6,CHEMBL378
4704,2681602.0,[],CHEMBL1051713,Antiviral activity against HIV1 Du422.1 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N[C@@H](CC(C)C)[C@H](O)CC(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL137752,CHEMBL137752,6.19,0.0,http://www.openphacts.org/units/Nanomolar,823862.0,=,1.0,1.0,=,IC50,nM,650.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.65,CHEMBL378
4705,10866438.0,[],CHEMBL2025517,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HbeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)COCC(=O)O)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024036,CHEMBL2024036,,0.0,http://www.openphacts.org/units/Nanomolar,1639758.0,=,1.0,1.0,=,IC50,nM,115450.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,115.45,CHEMBL613497
4706,14654431.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)c3cccs3)[C@H](OC(=O)c3cccs3)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262989,CHEMBL3262989,,0.0,http://www.openphacts.org/units/Nanomolar,2101872.0,=,1.0,1.0,=,IC50,nM,185000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,185.0,CHEMBL613497
4707,15680004.0,[],CHEMBL3606515,Antiviral activity against HIV1 LAI infected in human MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CO[C@H]3OC[C@H](N)[C@H]32)cc1,CHEMBL3603748,J Med Chem,2015.0,CHEMBL3605639,CHEMBL3605639,7.32,0.0,http://www.openphacts.org/units/Nanomolar,2495838.0,=,1.0,1.0,=,IC50,nM,48.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,48.0,CHEMBL378
4708,2601787.0,[],CHEMBL1034017,Antiviral activity against Vaccinia virus,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(O)cc(OCCOCP(=O)(O)O)n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL504793,CHEMBL504793,9.74,0.0,http://www.openphacts.org/units/Nanomolar,808010.0,=,1.0,1.0,=,IC50,nM,0.18,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,0.00018,CHEMBL613493
4709,2179595.0,[],CHEMBL966469,Antiviral activity against HIV1 3B isolate replication in human H9 cells assessed as decrease in viral p24 level after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL1155638,J Nat Prod,2000.0,CHEMBL211369,CHEMBL211369,4.72,0.0,http://www.openphacts.org/units/Nanomolar,712204.0,=,1.0,1.0,=,IC50,nM,19200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,19.2,CHEMBL378
4710,24788554.0,[],CHEMBL5131657,Antiviral activity against 3TC resistant HIV-1 mutant in T cells,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,CHEMBL5131375,J Med Chem,2022.0,CHEMBL14762,CHEMBL14762,9.44,0.0,http://www.openphacts.org/units/Nanomolar,3869388.0,=,1.0,1.0,=,IC50,nM,0.36,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.36,CHEMBL378
4711,2694307.0,[],CHEMBL1053929,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2nc3c(cc2c(CN2CCOCC2)c1O)CSc1ccc(C)cc1-3,CHEMBL1152943,Bioorg Med Chem,2009.0,CHEMBL563995,CHEMBL563995,4.83,0.0,http://www.openphacts.org/units/Nanomolar,825019.0,=,1.0,1.0,=,IC50,nM,14700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,14.7,CHEMBL613497
4712,888095.0,[],CHEMBL653610,Inhibitory activity tested against the HIV-1 in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N[C@H](CCC(=O)O)CC(C)C)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL11465,CHEMBL11465,7.28,0.0,http://www.openphacts.org/units/Nanomolar,9097.0,=,1.0,1.0,=,IC50,nM,52.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,52.0,CHEMBL378
4713,15199939.0,[],CHEMBL3411839,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@]12CC[C@@H]3[C@@](CC[C@H]4[C@@]3(C)CCC[C@@]4(C)NC(=O)c3ccc(F)cc3)(CC1=O)C2,CHEMBL3407350,Bioorg Med Chem,2015.0,CHEMBL3409326,CHEMBL3409326,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,2287837.0,=,1.0,1.0,=,IC50,ug.mL-1,7.44,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,7.44,CHEMBL613497
4714,6216899.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,COc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784402,CHEMBL1784402,5.60,0.0,http://www.openphacts.org/units/Nanomolar,1429340.0,=,1.0,1.0,=,IC50,nM,2511.89,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.6,CHEMBL378
4715,24383455.0,[],CHEMBL5039284,Antiviral activity against HIV 1 IIIB(X5) incubated overnight by ELISA analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL5038580,J Med Chem,2022.0,CHEMBL525076,CHEMBL525076,7.75,0.0,http://www.openphacts.org/units/Nanomolar,3777694.0,=,1.0,1.0,=,IC50,nM,17.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,17.8,CHEMBL378
4716,14581360.0,[],CHEMBL3243469,"Antiviral activity against HIV-1 pseudotyped virus expressing HIV-1 isolate C envelope ZM233M.PB6, SVPC9 assessed as reduction of luciferase production after 3 days by single-cycle neutralization assay",F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]1CSCc2ccc(cc2)-c2ccc(cc2)CSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC1=O,CHEMBL3232893,Bioorg Med Chem Lett,2014.0,CHEMBL3233156,CHEMBL3233156,5.44,0.0,http://www.openphacts.org/units/Nanomolar,2081351.0,=,1.0,1.0,=,IC50,nM,3600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.6,CHEMBL378
4717,1672773.0,[],CHEMBL870621,Antiviral activity against HIV1 Y181C mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(NCCCN2CCCC2)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(F)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL200988,CHEMBL200988,,0.0,,411940.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4718,1401601.0,[],CHEMBL837467,In vitro inhibitory concentration against HIV K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL338047,CHEMBL338047,7.50,0.0,http://www.openphacts.org/units/Nanomolar,360324.0,=,1.0,1.0,=,IC50,nM,32.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.032,CHEMBL378
4719,935281.0,[],CHEMBL650153,Compound was tested for anti-retroviral activity against moloney murine sarcoma virus (MSV) in murine C3H/3T3 embryo fibroblast cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1nnn2C[C@@H](CF)OCP(=O)(O)O,CHEMBL1129435,J Med Chem,1996.0,CHEMBL133322,CHEMBL133322,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251941.0,>,1.0,1.0,>,IC50,ug.mL-1,200.0,CHEMBL613501,Moloney murine sarcoma virus,Moloney murine sarcoma virus,11809,IC50,ug ml-1,UO_0000274,200.0,CHEMBL613501
4720,1487413.0,[],CHEMBL833976,Inhibitory concentration against wild type human immunodeficiency virus type 1 was determined by recombinant virus assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1c(O)nc2ccc(F)cc2c1OCC1CCC1,CHEMBL1138845,J Med Chem,2004.0,CHEMBL190118,CHEMBL190118,6.24,0.0,http://www.openphacts.org/units/Nanomolar,384205.0,=,1.0,1.0,=,IC50,nM,580.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,580.0,CHEMBL378
4721,24764405.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124700,Anti-HIV activity against HIV-1 NL4-3 Nanoluc-sec virus infected in human MT4 cells assessed as luciferase activity and measured 3 days post-infection by Nano-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@]12C[C@@H](COC(=O)c3ccccc3)[C@@]34OC5(O[C@@H]1[C@@H]3[C@@H]1O[C@]1(CO)[C@@H](O)[C@@]1(O)[C@H]4[C@H]([C@H](C)[C@@H]1OC(=O)c1ccccc1)[C@H](C)CCCCCC[C@H]5O)O2,CHEMBL5120897,J Nat Prod,2022.0,CHEMBL3741746,CHEMBL3741746,9.82,0.0,http://www.openphacts.org/units/Nanomolar,3864033.0,=,1.0,1.0,=,IC50,nM,0.15,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.15,CHEMBL378
4722,19261997.0,[],CHEMBL4404414,Antiviral activity against HIV1 subtypeD/A infant BL035.W6M.ENV.C1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.27,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,540.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.54,CHEMBL378
4723,16494754.0,[],CHEMBL3772328,Antiviral activity against HIV1 NL4-3 infected in human TZM-bl cells assessed as inhibition of viral replication administered 6 hrs postinfection measured 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1cccc(Nc2nc(-c3cccnc3)nc3ccccc23)c1,CHEMBL3769372,J Med Chem,2016.0,CHEMBL1622298,CHEMBL1622298,5.30,0.0,http://www.openphacts.org/units/Nanomolar,2761349.0,=,1.0,1.0,=,IC50,nM,5000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.0,CHEMBL378
4724,2929642.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CSCCc3cnccn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL574840,CHEMBL574840,6.70,0.0,http://www.openphacts.org/units/Nanomolar,848257.0,=,1.0,1.0,=,IC50,nM,199.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,199.0,CHEMBL378
4725,12542789.0,[],CHEMBL3076900,Antiviral activity against Human immunodeficiency virus 1 IIIB infected MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=[N+]([O-])c1cccc2sc(Nn3c(-c4ccc(Cl)cc4)nnc3-c3cccnc3)nc12,CHEMBL3046062,Med Chem Res,2013.0,CHEMBL2282288,CHEMBL2282288,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824498.0,>,1.0,1.0,>,IC50,ug.mL-1,21.33,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,21.33,CHEMBL378
4726,22845194.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721664,Antiviral activity against pseudovirus HIV-1 HXB-2 subtype C harboring pseudotyped Env ZM197M.PB7 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)c(F)c2)[nH]1)c1nc(CO)cs1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4533529,CHEMBL4533529,7.00,0.0,http://www.openphacts.org/units/Nanomolar,3547069.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
4727,2930366.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3ccnc3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL568526,CHEMBL568526,8.70,0.0,http://www.openphacts.org/units/Nanomolar,852832.0,=,1.0,1.0,=,IC50,nM,1.99,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.99,CHEMBL378
4728,43586.0,[],CHEMBL695509,Antiviral activity against G190A strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL57,CHEMBL57,,0.0,http://www.openphacts.org/units/Nanomolar,20821.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10000.0,CHEMBL378
4729,2371439.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)CCNC(=O)c1cc2c(s1)-c1ccc(Cl)cc1SC2,CHEMBL1140145,J Med Chem,2008.0,CHEMBL492468,CHEMBL492468,4.43,0.0,http://www.openphacts.org/units/Nanomolar,746523.0,=,1.0,1.0,=,IC50,nM,37000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,37.0,CHEMBL613493
4730,6216905.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2C(=O)O)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784408,CHEMBL1784408,7.51,0.0,http://www.openphacts.org/units/Nanomolar,1429346.0,=,1.0,1.0,=,IC50,nM,30.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.51,CHEMBL378
4731,1740060.0,[],CHEMBL854478,Inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)n2c(CCCN3C(=O)c4ccccc4C3=O)nc3cc(Cl)c(Cl)cc32)cc1,CHEMBL1138932,J Med Chem,2006.0,CHEMBL387302,CHEMBL387302,6.47,0.0,http://www.openphacts.org/units/Nanomolar,520781.0,=,1.0,1.0,=,IC50,nM,340.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.34,CHEMBL613497
4732,3453369.0,[],CHEMBL1247808,Antiviral activity against HIV1 isolate 05-121794 assessed as inhibition of viral replication after 7 days by scintillation counting,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(c2cccc3nc(CN(C)[C@H]4CCCc5cccnc54)c(CO)n23)CC1,CHEMBL1240366,Antimicrob Agents Chemother,2010.0,CHEMBL1242210,CHEMBL1242210,9.00,0.0,http://www.openphacts.org/units/Nanomolar,953332.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
4733,1471709.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cc(C)ccc1C,CHEMBL1138799,J Med Chem,2004.0,CHEMBL187515,CHEMBL187515,6.82,0.0,http://www.openphacts.org/units/Nanomolar,380671.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.15,CHEMBL378
4734,24971686.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5218444,Anti-HIV activity against HIV-1 NL4-3 Nanoluc-sec virus infected in human MT4 cells assessed as viral growth inhibition by measuring luciferase activity measured after 3 days post-infection by Nano-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@]12C[C@@H](C)[C@]34OC5(CCCCCCC[C@H](C)[C@@H]6[C@@H]3[C@@](O)(C(=O)[C@@]6(C)O)[C@H](O)[C@@]3(CO)O[C@H]3[C@H]4[C@H]1O5)O2,CHEMBL5215012,J Nat Prod,2022.0,CHEMBL5218618,CHEMBL5218618,6.97,0.0,http://www.openphacts.org/units/Nanomolar,3902008.0,=,1.0,1.0,=,IC50,nM,107.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,107.0,CHEMBL378
4735,2929504.0,[],CHEMBL1056899,Antiviral activity against HIV1 HXB2 harboring 227C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cnnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL577247,CHEMBL577247,8.59,0.0,http://www.openphacts.org/units/Nanomolar,852824.0,=,1.0,1.0,=,IC50,nM,2.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.6,CHEMBL378
4736,15064934.0,[],CHEMBL3366183,Antiviral activity against wild type HIV1 infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CCNc2nc(-c3ccc(OC)cc3)c(Cc3ccccc3)s2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3329468,CHEMBL3329468,,0.0,http://www.openphacts.org/units/Nanomolar,2248837.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
4737,10842702.0,[],CHEMBL2016100,Antiviral activity against Human immunodeficiency virus 1 3B infected in human MT2 cells assessed as inhibition of viral replication after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)O,CHEMBL2010680,Bioorg Med Chem Lett,2012.0,CHEMBL2012797,CHEMBL2012797,,0.0,http://www.openphacts.org/units/Nanomolar,1633455.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
4738,19162199.0,[],CHEMBL4383613,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells after 7 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL4382211,Eur J Med Chem,2018.0,CHEMBL116,CHEMBL116,7.52,0.0,http://www.openphacts.org/units/Nanomolar,3198009.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.03,CHEMBL378
4739,1402331.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N2CCCCC2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175655,CHEMBL175655,6.20,0.0,http://www.openphacts.org/units/Nanomolar,360430.0,=,1.0,1.0,=,IC50,nM,631.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.631,CHEMBL378
4740,22806675.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2OC(OCC(=O)OC)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4762041,CHEMBL4762041,,0.0,http://www.openphacts.org/units/Nanomolar,3541889.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.0,CHEMBL613497
4741,490814.0,[],CHEMBL757967,Inhibition of cell growth against HIV-1 infected PBM (Human peripheral blood mononuclear) cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(=O)n([C@H]2CS[C@@H](CO)O2)cc1Br,CHEMBL1126792,J Med Chem,1993.0,CHEMBL89357,CHEMBL89357,,0.0,http://www.openphacts.org/units/Nanomolar,161283.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
4742,508994.0,[],CHEMBL691389,Inhibitory concentration against HIV-1 Bal/Mono,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC=O)c1Cc1cc(C)cc(C)c1,CHEMBL1133473,J Med Chem,2000.0,CHEMBL338936,CHEMBL338936,7.68,0.0,http://www.openphacts.org/units/Nanomolar,245543.0,=,1.0,1.0,=,IC50,nM,21.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,21.0,CHEMBL378
4743,12651349.0,[],CHEMBL2327721,Antiviral activity against 0.001 MOI bevirimat-resistant Human immunodeficiency virus 1 NL4-3 harboring gag V370 deletion mutant infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCC(=O)N[C@@H](CCC(N)=O)C(=O)OC)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324156,CHEMBL2324156,6.50,0.0,http://www.openphacts.org/units/Nanomolar,1850183.0,=,1.0,1.0,=,IC50,nM,320.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.32,CHEMBL378
4744,15166065.0,[],CHEMBL3404732,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBsAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(C(=O)OC[C@H]2O[C@@H](Oc3ccc(C(C)=O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)cc(OC)c1OC,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402790,CHEMBL3402790,,0.0,http://www.openphacts.org/units/Nanomolar,2284146.0,=,1.0,1.0,=,IC50,nM,1346200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1346.2,CHEMBL613497
4745,560091.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)NS(=O)(=O)c1ccc(NC(=O)c2ccccc2SC(=O)CCCl)cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL353114,CHEMBL353114,4.21,0.0,http://www.openphacts.org/units/Nanomolar,334017.0,=,1.0,1.0,=,IC50,nM,62000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,62.0,CHEMBL378
4746,15748665.0,[],CHEMBL3630970,Antiviral activity against HIV1 3B assessed as inhibition of viral attachment to human MAGI cells,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(C[C@H]1CN(S(=O)(=O)c2ccc(Cl)cc2)CCN1)[C@H]1CCCc2cccnc21,CHEMBL3627700,Bioorg Med Chem Lett,2015.0,CHEMBL3627862,CHEMBL3627862,7.30,0.0,http://www.openphacts.org/units/Nanomolar,2506693.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.05,CHEMBL378
4747,12723414.0,[],CHEMBL2351030,Antiviral activity against Hepatitis B virus-infected human HepG2(2.2.15) cells assessed as inhibition of HBeAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/C=C/c1ccc2c(c1)OCO2)N1CCCCC1,CHEMBL2346644,Bioorg Med Chem Lett,2013.0,CHEMBL43185,CHEMBL43185,,0.0,http://www.openphacts.org/units/Nanomolar,1875477.0,=,1.0,1.0,=,IC50,nM,140000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.14,CHEMBL613497
4748,17602998.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(c2ccc(-c3ccccc3)cc2)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644933,CHEMBL3644933,8.70,0.0,http://www.openphacts.org/units/Nanomolar,2518053.0,=,37.0,1.0,=,IC50,nM,2.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,2.0,CHEMBL4620
4749,2362901.0,[],CHEMBL1026417,"Antiviral activity against multidrug-resistant HIV1 with protease L10I, V11I, T12E, I15V, L19I, R41K, M46L, L63P, A71T, V82A, L90M mutation in phytohemagglutininin-activated PBMC assessed as inhibition of p24G protein production",F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL1140100,J Med Chem,2008.0,CHEMBL1323,CHEMBL1323,8.15,0.0,http://www.openphacts.org/units/Nanomolar,747151.0,=,1.0,1.0,=,IC50,nM,7.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.0,CHEMBL378
4750,5222603.0,[],CHEMBL1675304,Antiviral activity against HIV1 infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(=O)n([C@@H]2CS[C@H](CO)O2)cc1F,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL885,CHEMBL885,6.77,0.0,http://www.openphacts.org/units/Nanomolar,1332025.0,=,1.0,1.0,=,IC50,nM,170.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.17,CHEMBL378
4751,14596838.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(C(C)C)c(=O)[nH]c(=S)n2COCCO)c1,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL274265,CHEMBL274265,5.08,0.0,http://www.openphacts.org/units/Nanomolar,2082358.0,=,1.0,1.0,=,IC50,nM,8300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.3,CHEMBL378
4752,2048683.0,[],CHEMBL925406,Antiviral activity against Hepatitis B virus infected human HepG2 cells after 9 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(OCOC(=O)OCc1ccccc1)OCOC(=O)OCc1ccccc1.O=C(O)/C=C/C(=O)O,CHEMBL1140514,Bioorg Med Chem Lett,2007.0,CHEMBL398321,CHEMBL1185214,5.26,0.0,http://www.openphacts.org/units/Nanomolar,679856.0,=,1.0,1.0,=,IC50,nM,5500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,5.5,CHEMBL613497
4753,10995185.0,[],CHEMBL2072873,Antiviral activity against VSV-G pseudotyped HIV1 lentiviral particles infected in human HeLa cells incubated for 48 hrs by spectrofluorometry,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)n(CCNc2ccnc3cc(Cl)ccc23)c1=O,CHEMBL2069294,Bioorg Med Chem,2012.0,CHEMBL2071260,CHEMBL2071260,5.15,0.0,http://www.openphacts.org/units/Nanomolar,1663481.0,=,1.0,1.0,=,IC50,nM,7150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.15,CHEMBL378
4754,14658820.0,[],CHEMBL3266157,Antagonist activity at recombinant human EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)c3ccc4c(c3)CCO4)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262891,CHEMBL3262891,7.74,0.0,http://www.openphacts.org/units/Nanomolar,2101733.0,=,1.0,1.0,=,IC50,nM,18.2,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,pIC50,,UO_0000065,7.74,CHEMBL3259470
4755,2272890.0,[],CHEMBL956847,Antiviral activity against HIV1 Bal in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1[C@H]1C[C@H]2CC[C@@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)N(C(C)C)C(C)C)CC1,CHEMBL1153314,Bioorg Med Chem Lett,2009.0,CHEMBL506788,CHEMBL506788,6.86,0.0,http://www.openphacts.org/units/Nanomolar,755454.0,=,1.0,1.0,=,IC50,nM,137.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.137,CHEMBL378
4756,16499762.0,[],CHEMBL3776089,Antiretroviral activity against HIV-1 infected in HEK293T cells assessed as inhibition of viral replication by single-cycle assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1[nH]c2ccc(Cl)cc2c1C(SC)c1cccc(Cl)c1,CHEMBL3774319,Bioorg Med Chem Lett,2016.0,CHEMBL3774727,CHEMBL3774727,7.38,0.0,http://www.openphacts.org/units/Nanomolar,2763421.0,=,1.0,1.0,=,IC50,nM,42.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.042,CHEMBL378
4757,1954145.0,[],CHEMBL891425,Antiviral activity against HIV1 RT 188L mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL223228,CHEMBL223228,6.80,0.0,http://www.openphacts.org/units/Nanomolar,647186.0,=,1.0,1.0,=,IC50,nM,158.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,158.0,CHEMBL378
4758,17949399.0,[],CHEMBL3992313,Inhibition of human ASCT2 expressed in HEK cells assessed as reduction in [3H]-L-serine uptake after 1 min by beta counting analysis,B,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CO)C(=O)O,CHEMBL3991947,,2014.0,CHEMBL285123,CHEMBL285123,,0.0,http://www.openphacts.org/units/Nanomolar,2973861.0,=,38.0,1.0,=,IC50,nM,4913000.0,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,uM,UO_0000065,4913.0,CHEMBL3562162
4759,2244554.0,[],CHEMBL1002216,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase V106I mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL203420,CHEMBL203420,9.10,0.0,http://www.openphacts.org/units/Nanomolar,798654.0,=,1.0,1.0,=,IC50,nM,0.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.8,CHEMBL378
4760,2602145.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc2c(ncn2/C=C2/CC2(F)CO)c(=O)[nH]1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL390155,CHEMBL390155,4.00,0.0,http://www.openphacts.org/units/Nanomolar,807308.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
4761,1672639.0,[],CHEMBL863516,Antiviral activity against HIV1 HxB2 using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(F)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL201084,CHEMBL201084,8.10,0.0,http://www.openphacts.org/units/Nanomolar,411938.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.0,CHEMBL378
4762,1751282.0,[],CHEMBL854522,Antiviral activity against Measles virus variant in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc(NC(=O)Cc2ccccc2)cc1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL213385,CHEMBL213385,,0.0,,532793.0,,1.0,0.0,,IC50,,,CHEMBL613738,Measles virus,Measles virus,11234,IC50,,,,CHEMBL613738
4763,3267404.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CCCN1Cc2cccc3[nH]c(=S)n(c23)CC1C,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL67451,CHEMBL67451,5.78,0.0,http://www.openphacts.org/units/Nanomolar,906991.0,=,1.0,1.0,=,IC50,nM,1659.59,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.78,CHEMBL378
4764,22435370.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4677393,Antiviral activity against HIV-1 NL4-3 infected in human MT-4 cells assessed as inhibition of viral replication by measuring inhibition of cell viability preincubated with cells for 15 mins followed by viral infection and measured after 4 days by MTS/PES assay,F,BAO_0000190,BAO_0000218,organism-based format,Br.C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCc2cc(O)cc(n2)CCN(S(=O)(=O)c2ccc(C)cc2)C1,CHEMBL4673284,Bioorg Med Chem,2020.0,CHEMBL4750160,CHEMBL4802704,,0.0,http://www.openphacts.org/units/Nanomolar,3515764.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
4765,16601525.0,[],CHEMBL3811914,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection against virus-induced cytopathogenic effect after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Fc1cc2nccnc2cc1Cl,CHEMBL3808294,Eur J Med Chem,2016.0,CHEMBL3809109,CHEMBL3809109,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,2779104.0,>,1.0,1.0,>,IC50,ug.mL-1,91.15,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,91.15,CHEMBL378
4766,3114024.0,[],CHEMBL1073712,Antiviral activity against HIV1 NL4-3 infected in GFP expressing human CEM cells assessed as inhibition of viral infection measured after 9 days postinfection by microfluorometry,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1c(O)c(C(C)=O)c(O)c(C(c2ccc(O)cc2)c2c(O)c(C(C)=O)c(O)c(C(C)=O)c2O)c1O,CHEMBL1157554,Bioorg Med Chem,2010.0,CHEMBL604093,CHEMBL604093,,0.0,,888531.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4767,3056478.0,[],CHEMBL1064575,Antiviral activity against HIV1 infected in human PBMC assessed as inhibition of viral p24 antigen production after 7 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)CS1,CHEMBL1152525,Bioorg Med Chem,2009.0,CHEMBL609884,CHEMBL609884,6.01,0.0,http://www.openphacts.org/units/Nanomolar,876034.0,=,1.0,1.0,=,IC50,nM,967.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.967,CHEMBL378
4768,672212.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C#N)C(C)(C)SSC(C)(C)C(C)(C)C#N,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120120,CHEMBL120120,,0.0,,228594.0,=,1.0,0.0,=,IC50,,177.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,177.0,CHEMBL378
4769,1402334.0,[],CHEMBL837465,In vitro inhibitory concentration against HIV G190S mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N2CCCCC2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175655,CHEMBL175655,,0.0,http://www.openphacts.org/units/Nanomolar,360430.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4770,1271632.0,[],CHEMBL656278,Inhibition of particle production in de novo infection assay of HIV infected CEM cells.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(NCc1ccc(O)c(O)c1)c1ccc2ccc(C(=O)O)c(O)c2n1,CHEMBL1146726,Bioorg Med Chem Lett,2004.0,CHEMBL81182,CHEMBL81182,5.70,0.0,http://www.openphacts.org/units/Nanomolar,147504.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.0,CHEMBL378
4771,13933261.0,[],CHEMBL3124237,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV DNA production,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(O)c2c(c1)C(=O)c1cc(C)cc(O)c1C2=O,CHEMBL3120134,Eur J Med Chem,2014.0,CHEMBL42624,CHEMBL42624,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1969501.0,=,1.0,1.0,=,IC50,ug.mL-1,300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,300.0,CHEMBL613497
4772,18808338.0,[],CHEMBL4275448,Antiviral activity against Zika virus SMGC infected in BHK cells assessed as inhibition of virus induced cytopathic effect after 8 days by CellTiter-Glo luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(NC(=O)NCCCN(C[C@H]2O[C@@H](n3cnc4c(NCc5cccc(F)c5)ncnc43)[C@H](O)[C@@H]2O)C(C)C)cc1,CHEMBL4270631,Eur J Med Chem,2018.0,CHEMBL4280425,CHEMBL4280425,,0.0,http://www.openphacts.org/units/Nanomolar,3125038.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,50.0,CHEMBL4296612
4773,12680730.0,[],CHEMBL2342599,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CNC(=O)/C=C/c2coc3cc(O)ccc3c2=O)cc1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333297,CHEMBL2333297,4.99,0.0,http://www.openphacts.org/units/Nanomolar,1867260.0,=,1.0,1.0,=,IC50,nM,10220.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.22,CHEMBL613497
4774,637628.0,[],CHEMBL683819,Anti-HIV activity in cell culture assay expressed as IC50 values.,F,BAO_0000190,BAO_0000218,organism-based format,O=C1OCC2OC(=O)c3cc(O)c(O)c(O)c3-c3c(O)c(O)c(O)c4c3C(=O)OC(C2OC(=O)c2cc(O)c(O)c(O)c2-c2c1cc(O)c(O)c2O)C1OC(=O)C2C4=C(O)C(=O)C23Oc2cc(O)c4c(c2[C@H]13)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C4,CHEMBL1126373,Bioorg Med Chem Lett,1992.0,CHEMBL407914,CHEMBL407914,4.82,0.0,http://www.openphacts.org/units/Nanomolar,60633.0,=,1.0,1.0,=,IC50,nM,15000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,15.0,CHEMBL378
4775,2601468.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#CCc1c(N)nc(N)n(CCOCP(=O)(O)O)c1=O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL356695,CHEMBL356695,9.52,0.0,http://www.openphacts.org/units/Nanomolar,807189.0,=,1.0,1.0,=,IC50,nM,0.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0003,CHEMBL378
4776,1830868.0,[],CHEMBL918634,Antiviral activity against wild type HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C(=O)c2ccccc2)nc(SC2CCCC2)[nH]c1=O,CHEMBL1144474,J Med Chem,2007.0,CHEMBL222991,CHEMBL222991,5.33,0.0,http://www.openphacts.org/units/Nanomolar,629323.0,=,1.0,1.0,=,IC50,nM,4690.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.69,CHEMBL378
4777,14999565.0,[],CHEMBL3366533,Antiviral activity against HIV1 harboring reverse transcriptase Y188L mutant infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL223228,CHEMBL223228,6.32,0.0,http://www.openphacts.org/units/Nanomolar,2248840.0,=,1.0,1.0,=,IC50,nM,480.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.48,CHEMBL378
4778,2413655.0,[],CHEMBL987708,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@H](OC(=O)CCCC)[C@H](C[C@@H](C)C1=C2C[C@H](OC(=O)CCCC)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)OC(=O)CCCC,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL503823,CHEMBL503823,,0.0,http://www.openphacts.org/units/Nanomolar,810796.0,>,1.0,1.0,>,IC50,nM,920000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.92,CHEMBL613497
4779,18342099.0,[],CHEMBL4139012,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1ccc(-c2cc(NC(=O)c3ccc(C)cc3O)c[nH]c2=O)cc1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL4164045,CHEMBL4164045,4.04,0.0,http://www.openphacts.org/units/Nanomolar,3045877.0,=,1.0,1.0,=,IC50,nM,91910.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,91.91,CHEMBL613497
4780,3498071.0,[],CHEMBL1259505,Antiviral activity against HIV1 MTA infected in human PM1 cells expressing CCR5 assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC1,CHEMBL1255517,Bioorg Med Chem Lett,2010.0,CHEMBL1256527,CHEMBL1256527,,0.0,,959553.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4781,12651391.0,[],CHEMBL2327723,Antiviral activity against 0.001 MOI bevirimat-resistant Human immunodeficiency virus 1 NL4-3 harboring gag V370A mutant infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCC(=O)NCC(=O)OC)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324154,CHEMBL2324154,5.82,0.0,http://www.openphacts.org/units/Nanomolar,1850181.0,=,1.0,1.0,=,IC50,nM,1510.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.51,CHEMBL378
4782,23228454.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '36.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '36.0'}]",CHEMBL4826198,Antiviral activity against Human hepatitis B virus in Huh-7 cells assessed as reduction in intracellular viral DNA level incubated for 36 hrs by qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ncccc1C(=O)N1CCN(c2cc(Nc3ccc(N4CCOCC4)cc3)nc(SC)n2)CC1,CHEMBL4825668,J Med Chem,2021.0,CHEMBL4861083,CHEMBL4861083,,0.0,http://www.openphacts.org/units/Nanomolar,3613072.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.0,CHEMBL613497
4783,1256187.0,[],CHEMBL652107,Inhibitory concentration required to inhibit HIV-induced cytopathicity in CEM-4 cells by 50% based in the MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N(CC)CCCCCCCCCCC(=O)NCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL117041,CHEMBL1205577,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221536.0,=,1.0,1.0,=,IC50,ug.mL-1,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,4.0,CHEMBL378
4784,2244551.0,[],CHEMBL1002216,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase V106I mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL57,CHEMBL57,7.05,0.0,http://www.openphacts.org/units/Nanomolar,798657.0,=,1.0,1.0,=,IC50,nM,89.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,89.0,CHEMBL378
4785,16544816.0,[],CHEMBL3789812,Antiviral activity against HIV1 virion infected in human TZM-bl cells after 48 hrs by firefly luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Nc2nc(Nc3ccc(C)cc3)nc(Nc3ccc(C)cc3)n2)cc1,CHEMBL3784952,Bioorg Med Chem,2016.0,CHEMBL3786474,CHEMBL3786474,,0.0,,2769501.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4786,2099844.0,[],CHEMBL949222,Antiviral activity against HIV1 RU570 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(ncn2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL403457,CHEMBL403457,,0.0,http://www.openphacts.org/units/Nanomolar,699407.0,>,1.0,1.0,>,IC50,nM,10000000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10000.0,CHEMBL378
4787,1057462.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C1C(C)N=CN1Nc1cccc(Cl)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289379,CHEMBL289379,,0.0,http://www.openphacts.org/units/Nanomolar,62343.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4788,24823591.0,[],CHEMBL5140687,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBeAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3ccc(Br)cc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5206176,CHEMBL5206176,6.90,0.0,http://www.openphacts.org/units/Nanomolar,3876727.0,=,1.0,1.0,=,IC50,nM,127.2,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.1272,CHEMBL613497
4789,10862022.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3CC=C4[C@@H]5C[C@@](C)(C(=O)OCC(N)=O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022398,CHEMBL2022398,,0.0,http://www.openphacts.org/units/Nanomolar,1637650.0,=,1.0,1.0,=,IC50,nM,346510.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,346.51,CHEMBL613497
4790,1751331.0,[],CHEMBL854522,Antiviral activity against Measles virus variant in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1cccc(NC(=O)Cc2ccccc2)c1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL441539,CHEMBL441539,,0.0,http://www.openphacts.org/units/Nanomolar,532792.0,>,1.0,1.0,>,IC50,nM,150000.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,150.0,CHEMBL613738
4791,1471840.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL175522,CHEMBL175522,5.70,0.0,http://www.openphacts.org/units/Nanomolar,380740.0,=,1.0,1.0,=,IC50,nM,1990.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.99,CHEMBL378
4792,2929765.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COCCC1CN(Cc2c(C)[nH]c(=O)c(I)c2Sc2cc(C)cc(C)c2)CCO1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL584571,CHEMBL584571,7.20,0.0,http://www.openphacts.org/units/Nanomolar,848383.0,=,1.0,1.0,=,IC50,nM,63.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,63.0,CHEMBL378
4793,12651405.0,[],CHEMBL2327723,Antiviral activity against 0.001 MOI bevirimat-resistant Human immunodeficiency virus 1 NL4-3 harboring gag V370A mutant infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCNC(=O)[C@H](CCC(N)=O)NC(=O)OC(C)(C)C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324147,CHEMBL2324147,6.44,0.0,http://www.openphacts.org/units/Nanomolar,1850173.0,=,1.0,1.0,=,IC50,nM,360.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.36,CHEMBL378
4794,480324.0,[],CHEMBL694654,Inhibitory concentration against HIV-1 IIIB strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1133473,J Med Chem,2000.0,CHEMBL128931,CHEMBL128931,7.70,0.0,http://www.openphacts.org/units/Nanomolar,245548.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,20.0,CHEMBL378
4795,3013908.0,[],CHEMBL1045234,Antiviral activity against HIV1 3B infected human HOS cells expressing human CXCR4 and CD4 assessed as inhibition of viral infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(c2cccc3nc(CN(C)[C@H]4CCCc5cccnc54)[nH]c23)CC1,CHEMBL1156094,Bioorg Med Chem Lett,2009.0,CHEMBL570532,CHEMBL570532,9.22,0.0,http://www.openphacts.org/units/Nanomolar,860802.0,=,1.0,1.0,=,IC50,nM,0.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0006,CHEMBL378
4796,1041354.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(NN2C(S)=NC(C)C2c2ccccc2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL290703,CHEMBL290703,,0.0,http://www.openphacts.org/units/Nanomolar,62322.0,>,1.0,1.0,>,IC50,nM,38020.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,38.02,CHEMBL613499
4797,59302.0,[],CHEMBL857692,Inhibitory concentration against HCV NS3 protease was determined,B,BAO_0000190,BAO_0000357,single protein format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)c1cnccn1)C(=O)N[C@@H](CC1CCCCC1)C(=O)NC1(C(=O)C(=O)NCC(=O)O)CC1,CHEMBL1136650,Bioorg Med Chem Lett,2003.0,CHEMBL275116,CHEMBL275116,,0.0,http://www.openphacts.org/units/Nanomolar,12744.0,>,1.0,1.0,>,IC50,nM,60000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,60.0,CHEMBL4620
4798,2263435.0,[],CHEMBL1010866,Inhibition of R5 tropic HIV1 BaL replication in human PBMC,F,BAO_0000190,BAO_0000218,organism-based format,CCCC[C@@H]1C(=O)N(C[C@H]2CC[C@H](OCC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2,CHEMBL1139267,Bioorg Med Chem Lett,2009.0,CHEMBL508596,CHEMBL508596,9.30,0.0,http://www.openphacts.org/units/Nanomolar,750168.0,=,1.0,1.0,=,IC50,nM,0.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.5,CHEMBL378
4799,1004896.0,[],CHEMBL714338,"Antiviral activity against HIV-1, IIIB, in MT-4 Cells",F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CN[C@@H](C(=O)N[C@H]2c3ccccc3C[C@H]2O)[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)Nc2cccc(OC)c2OC)C(C)(C)C)cc1,CHEMBL1129316,J Med Chem,1996.0,CHEMBL292742,CHEMBL292742,6.27,0.0,http://www.openphacts.org/units/Nanomolar,111228.0,=,1.0,1.0,=,IC50,nM,532.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,532.0,CHEMBL378
4800,22449757.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.5', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.5'}]",CHEMBL4680708,Antiviral activity against HIV1 pseudotyped with A-MLV envelop glycoprotein infected in dog Cf2Th/CD4-CCR5 cells assessed as inhibition of viral entry incubated for 30 mins prior to infection and measured after 48 hrs post infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CNCc1ccc2c(c1)[C@@H](NC(=O)C(=O)Nc1ccc(Cl)c(F)c1)[C@H](CNC(=N)N)C2.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4680075,ACS Med Chem Lett,2016.0,CHEMBL4780279,CHEMBL4803321,,0.0,http://www.openphacts.org/units/Nanomolar,3518675.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
4801,2244618.0,[],CHEMBL1002218,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase E138K mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(C(F)(F)F)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL275658,CHEMBL275658,8.57,0.0,http://www.openphacts.org/units/Nanomolar,798655.0,=,1.0,1.0,=,IC50,nM,2.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.7,CHEMBL378
4802,1402167.0,[],CHEMBL837468,In vitro inhibitory concentration against HIV L100I mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCOCCN(C)c1c(Cc2cccc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL174536,CHEMBL174536,,0.0,http://www.openphacts.org/units/Nanomolar,360385.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4803,3596613.0,[],CHEMBL1292013,Antiviral activity against HIV1 BaL in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(O)C(=O)N1CCC(CCN2CCC(N(C(=O)NCc3ccc(C#N)cc3)c3cccc(F)c3)CC2)(c2cccc(F)c2)CC1,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288689,CHEMBL1288689,8.10,0.0,http://www.openphacts.org/units/Nanomolar,973799.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.0,CHEMBL378
4804,1401941.0,[],CHEMBL835251,In vitro inhibitory concentration against HIV F227L and V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCNc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL424972,CHEMBL424972,,0.0,http://www.openphacts.org/units/Nanomolar,360389.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4805,24726192.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5114432,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in viral replication incubated for 48 hrs followed by addition of fresh medium containing compound measured after 2 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC/C=C\C=C/O[C@@]12[C@@H]([C@H]3OCO[C@@]3(C(C)=O)[C@H](OC(C)=O)[C@H]1C)[C@@H]1O[C@]1(CO)[C@@H](O)[C@]1(O)C(=O)C(C)=C[C@H]12,CHEMBL5113385,Eur J Med Chem,2022.0,CHEMBL5181635,CHEMBL5181635,9.05,0.0,http://www.openphacts.org/units/Nanomolar,3856994.0,=,1.0,1.0,=,IC50,nM,0.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.9,CHEMBL378
4806,1438411.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,C=Cc1cccc(C(=O)c2c(CC)c(C)nc(O)c2N(C)C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL182846,CHEMBL182846,8.70,0.0,http://www.openphacts.org/units/Nanomolar,371592.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.002,CHEMBL378
4807,14596876.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CCCCOCn1c(Sc2ccccc2)c(C)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL142271,CHEMBL142271,5.27,0.0,http://www.openphacts.org/units/Nanomolar,2082718.0,=,1.0,1.0,=,IC50,nM,5330.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.33,CHEMBL378
4808,1472396.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C(C)=C(\C)C#N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL189760,CHEMBL189760,8.22,0.0,http://www.openphacts.org/units/Nanomolar,380979.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
4809,24830957.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C1(C(F)(F)F)CCN(c2ccc3c(=O)c4cccc(Cl)c4oc3c2)C1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5184209,CHEMBL5184209,4.57,0.0,http://www.openphacts.org/units/Nanomolar,3878130.0,=,1.0,1.0,=,IC50,nM,27000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,27.0,CHEMBL613497
4810,22933282.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)/C=C/c4cccc(OCc5cccc([N+](=O)[O-])c5)c4)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4793259,CHEMBL4793259,6.24,0.0,http://www.openphacts.org/units/Nanomolar,3560843.0,=,1.0,1.0,=,IC50,nM,580.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.58,CHEMBL378
4811,1213160.0,[],CHEMBL880061,Inhibitory activity against LAI strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Cc3c(Cl)cccc3Cl)n2)cc1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL307297,CHEMBL307297,8.22,0.0,http://www.openphacts.org/units/Nanomolar,127432.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
4812,18044727.0,[],CHEMBL4010427,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 pREJ04541 clone 67,F,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2ccc(C(=O)NC(CN)c3ncc(CO)s3)[nH]2)cc1F,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4075766,CHEMBL4075766,6.24,0.0,http://www.openphacts.org/units/Nanomolar,2990214.0,=,1.0,1.0,=,IC50,nM,570.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.57,CHEMBL378
4813,18727028.0,[],CHEMBL4259323,Antiviral activity against HIV1 subtype B' CNE6 pseudovirus assessed as inhibition of viral infection in Ghost (3)X4/R5 cells after 48 hrs by Bright-Glo luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@]1(C)CCC/C=C\CCC[C@](C)(NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@]2(C)CCC/C=C\CCC[C@](C)(NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N2)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O,CHEMBL4257519,Medchemcomm,2018.0,CHEMBL4281745,CHEMBL4281745,8.92,0.0,http://www.openphacts.org/units/Nanomolar,3111236.0,=,1.0,1.0,=,IC50,nM,1.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.2,CHEMBL378
4814,2371551.0,[],CHEMBL1035749,Antiviral activity against HIV1 with reverse transcriptase K103N/V179E mutant in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4nc(N)ccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL489586,CHEMBL489586,8.02,0.0,http://www.openphacts.org/units/Nanomolar,773548.0,=,1.0,1.0,=,IC50,nM,9.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,9.6,CHEMBL378
4815,3292023.0,[],CHEMBL1108227,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)N1C[C@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@H]2C1,CHEMBL1157775,Bioorg Med Chem Lett,2010.0,CHEMBL1095517,CHEMBL1095517,7.57,0.0,http://www.openphacts.org/units/Nanomolar,911009.0,=,1.0,1.0,=,IC50,nM,27.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,27.0,CHEMBL378
4816,10863195.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCc6cccc7cccnc67)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022391,CHEMBL2022391,4.82,0.0,http://www.openphacts.org/units/Nanomolar,1637641.0,=,1.0,1.0,=,IC50,nM,15300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,15.3,CHEMBL613497
4817,5247023.0,[],CHEMBL1687411,Antiviral activity against HIV1 Ba-L infected in human PBL cells assessed as reverse transcriptase activity after 7 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CCC(C)(CNC(=O)C1CCC(F)(F)CC1)c1ccccc1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL3084357,CHEMBL3084357,,0.0,,1333592.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4818,1865501.0,[],CHEMBL918386,Antiviral activity against human TNF-alpha stimulated HIV1 expression in latently HIV1 infected OM10.1 cells assessed as inhibition of viral mRNA production,F,BAO_0000190,BAO_0000218,organism-based format,Cn1cc(C(=O)O)c(=O)c2ccc(N3CCN(c4cccc(C(F)(F)F)c4)CC3)cc21,CHEMBL1147094,Antimicrob Agents Chemother,2007.0,CHEMBL227951,CHEMBL227951,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,634800.0,=,1.0,1.0,=,IC50,ug.mL-1,0.067,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.067,CHEMBL378
4819,18890514.0,[],CHEMBL4314142,Antiviral activity against HIV-1 NL4-3 infected in human Jurkat J6 cells assessed as suppression of viral replication by measuring reduction in p24 level measured at 72 hrs post-infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)NC(=O)Cc1cc(-c2ccccc2)on1,CHEMBL4311980,Eur J Med Chem,2019.0,CHEMBL4443124,CHEMBL4443124,7.28,0.0,http://www.openphacts.org/units/Nanomolar,3151802.0,=,1.0,1.0,=,IC50,nM,52.67,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,52.67,CHEMBL378
4820,1438268.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1ccnc2ccccc12,CHEMBL1138799,J Med Chem,2004.0,CHEMBL184880,CHEMBL184880,5.30,0.0,http://www.openphacts.org/units/Nanomolar,371556.0,=,1.0,1.0,=,IC50,nM,5010.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.01,CHEMBL378
4821,18775489.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCC1Cc2cc(OC)c(OC)cc2-c2cc(=O)c(C(=O)O)cn21,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4283108,CHEMBL4283108,6.96,0.0,http://www.openphacts.org/units/Nanomolar,3119647.0,=,1.0,1.0,=,IC50,nM,110.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.11,CHEMBL613497
4822,2184000.0,[],CHEMBL951608,Antiviral activity against HIV1 clinical isolate 10 infected in U87.CD4 cells expressing human CXCR4 D171N mutant,F,BAO_0000190,BAO_0000218,organism-based format,c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,CHEMBL1156482,J Biol Chem,2007.0,CHEMBL18442,CHEMBL18442,7.72,0.0,http://www.openphacts.org/units/Nanomolar,791970.0,=,1.0,1.0,=,IC50,nM,19.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.0,CHEMBL378
4823,19450671.0,[],CHEMBL4433627,Antiviral activity against HIV1 12231 harboring non-nucleoside reverse transcriptase 103N/179F/181C mutant infected in human TZM-bl cells infected with supernatants from virus-infected human MT2 cells treated with compound for 72 hrs assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(-c2ccc(OCc3cccc(C(=O)NCCNC(=O)c4ccc(COc5ccccc5-c5csc(N)n5)cc4)c3)cc2)cs1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4515612,CHEMBL4598021,6.10,0.0,http://www.openphacts.org/units/Nanomolar,3249748.0,=,1.0,1.0,=,IC50,nM,800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.8,CHEMBL378
4824,15156726.0,[],CHEMBL3399641,Decrease in hepatitis B viral surface antigen HBeAg secretion in human HepG2(2.2.15) cells at 0.75 to 3 uM after 72 hrs by EIA analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(C)=O)c(OS(=O)(=O)c2ccc(Br)cc2)c1,CHEMBL3397002,Eur J Med Chem,2015.0,CHEMBL3397410,CHEMBL3397410,5.73,0.0,http://www.openphacts.org/units/Nanomolar,2279257.0,=,1.0,1.0,=,IC50,nM,1860.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.86,CHEMBL613497
4825,725018.0,[],CHEMBL697274,Inhibition of the replication of human immunodeficiency virus (HIV) at 10 uM concentration,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2OCCOCP(=O)(O)O,CHEMBL1126377,Bioorg Med Chem Lett,1992.0,CHEMBL285316,CHEMBL285316,6.52,0.0,http://www.openphacts.org/units/Nanomolar,63349.0,=,1.0,1.0,=,IC50,nM,300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.3,CHEMBL378
4826,2694325.0,[],CHEMBL1053931,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV surface antigen at < TC50,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)Cc1c(O)c(OC)cc2nc3c(cc12)CSc1ccccc1-3,CHEMBL1152943,Bioorg Med Chem,2009.0,CHEMBL563120,CHEMBL563120,,0.0,,824858.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
4827,1671914.0,[],CHEMBL870624,Antiviral activity against HIV1 K103N mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(N)cc(C#N)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL199947,CHEMBL199947,6.85,0.0,http://www.openphacts.org/units/Nanomolar,411932.0,=,1.0,1.0,=,IC50,nM,140.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,140.0,CHEMBL378
4828,594091.0,[],CHEMBL710374,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined.,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(O)nc(Cc3c(Cl)cccc3Cl)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL74003,CHEMBL74003,,0.0,http://www.openphacts.org/units/Nanomolar,126933.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4829,504063.0,[],CHEMBL683679,"Concentration required to inhibit P24 production by 90% against U-90,152 of HIV-1 IIIB (L100I, M230L); Not tested",F,BAO_0000190,BAO_0000218,organism-based format,CN(c1ncccc1NC1CC1)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1129647,J Med Chem,1996.0,CHEMBL122343,CHEMBL122343,,0.0,http://www.openphacts.org/units/Nanomolar,236822.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4830,3509160.0,[],CHEMBL1261041,Antiviral activity against HIV1 harboring reverse transcriptase Y188L mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL308954,CHEMBL308954,8.51,0.0,http://www.openphacts.org/units/Nanomolar,962442.0,=,1.0,1.0,=,IC50,nM,3.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.1,CHEMBL378
4831,5188259.0,[],CHEMBL1664702,Antiviral activity against HIV1 LAI infected in human MT2 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CCC[C@H]3CCC[C@H]32)cc1,CHEMBL1649426,J Med Chem,2011.0,CHEMBL1651157,CHEMBL1651157,,0.0,http://www.openphacts.org/units/Nanomolar,1324308.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
4832,22933316.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCNC(=O)/C=C/c3ccc4c(c3)OCO4)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4752724,CHEMBL4752724,7.89,0.0,http://www.openphacts.org/units/Nanomolar,3560877.0,=,1.0,1.0,=,IC50,nM,13.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.013000000000000001,CHEMBL378
4833,1750614.0,[],CHEMBL864974,Antiviral activity against HIV1 LAI isolate in human MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,CHEMBL1146019,J Med Chem,2006.0,CHEMBL114,CHEMBL114,7.62,0.0,http://www.openphacts.org/units/Nanomolar,539998.0,=,1.0,1.0,=,IC50,nM,24.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,24.0,CHEMBL378
4834,16662874.0,[],CHEMBL3832824,AntiDengue activity HCI DV1/A549 IC50 (uM),F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)OC(=O)N1CCN(c2nccc(-c3ccc(-c4ccc(Cl)cc4)s3)n2)CC1,CHEMBL3832761,,,CHEMBL3637932,CHEMBL3637932,5.16,0.0,http://www.openphacts.org/units/Nanomolar,2790030.0,=,34.0,1.0,=,IC50,nM,7000.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,7.0,CHEMBL613757
4835,1219748.0,[],CHEMBL710537,Inhibitory activity against 188L strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1cnc(Nc2ccc(C#N)cc2)nc1Oc1c(C)cc(C#N)cc1C,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72242,CHEMBL72242,8.08,0.0,http://www.openphacts.org/units/Nanomolar,127437.0,=,1.0,1.0,=,IC50,nM,8.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0084,CHEMBL378
4836,1437847.0,[],CHEMBL834619,Inhibitory activity against HIV-1 mutant strain 181C; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(-n2cccc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL426247,CHEMBL426247,,0.0,http://www.openphacts.org/units/Nanomolar,371567.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4837,825625.0,[],CHEMBL711619,Antiviral activity against HIV-1 (strain RF) infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,CHEMBL1128355,J Med Chem,1995.0,CHEMBL114,CHEMBL114,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,73216.0,=,1.0,1.0,=,IC50,ug.mL-1,0.028,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.028,CHEMBL378
4838,16544814.0,[],CHEMBL3789812,Antiviral activity against HIV1 virion infected in human TZM-bl cells after 48 hrs by firefly luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Nc2nc(N)nc(Nc3ccc(C)cc3)n2)cc1,CHEMBL3784952,Bioorg Med Chem,2016.0,CHEMBL3785409,CHEMBL3785409,5.25,0.0,http://www.openphacts.org/units/Nanomolar,2769499.0,=,1.0,1.0,=,IC50,nM,5600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.6,CHEMBL378
4839,10961173.0,[],CHEMBL2061267,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M10 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCCO)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058313,CHEMBL2058313,6.40,0.0,http://www.openphacts.org/units/Nanomolar,1656253.0,=,1.0,1.0,=,IC50,nM,400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,400.0,CHEMBL378
4840,801113.0,[],CHEMBL711619,Antiviral activity against HIV-1 (strain RF) infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(COc1ccc(F)cc1C(=O)c1ccccc1)Nc1ccccc1,CHEMBL1128355,J Med Chem,1995.0,CHEMBL46745,CHEMBL46745,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,73213.0,=,1.0,1.0,=,IC50,ug.mL-1,0.09,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.09,CHEMBL378
4841,10961156.0,[],CHEMBL2061267,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M10 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNC(C)C)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057469,CHEMBL2057469,7.22,0.0,http://www.openphacts.org/units/Nanomolar,1655131.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,60.0,CHEMBL378
4842,18528855.0,[],CHEMBL4194999,Antiviral activity against HIV1 virions derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)[C@H](c1cc(OC)c(OC)c(OC)c1)[C@@H](C)[C@@H](C)C2,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4215279,CHEMBL4215279,6.80,0.0,http://www.openphacts.org/units/Nanomolar,3076498.0,=,1.0,1.0,=,IC50,nM,160.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.16,CHEMBL378
4843,22898306.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731092,Antiviral activity against DRV resistant HIV1 infected in human MT4 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL1163,CHEMBL1163,,0.0,http://www.openphacts.org/units/Nanomolar,3554417.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
4844,162867.0,[],CHEMBL656397,Activity against HIV-1 by syncytial plaque assay performed in duplicate using CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Cn2c(Cl)nc3cc(Cl)c(Cl)cc32)cc1,CHEMBL1131326,J Med Chem,1998.0,CHEMBL23032,CHEMBL23032,4.48,0.0,http://www.openphacts.org/units/Nanomolar,30679.0,=,1.0,1.0,=,IC50,nM,33000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,33.0,CHEMBL378
4845,15200454.0,[],CHEMBL3413997,Antiviral activity against X4 tropic HIV-1 clone pNL4-3 infected in H9 cells assessed as reduction in p24 antigen after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(c2ccc(/C=C(\C#N)c3nc4ccccc4[nH]3)cc2)CC1,CHEMBL3407469,Eur J Med Chem,2015.0,CHEMBL3410121,CHEMBL3410121,,0.0,http://www.openphacts.org/units/Nanomolar,2288851.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
4846,2947319.0,[],CHEMBL1038495,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,CCOCC(=O)OC(C)(C)[C@H](OC(C)=O)[C@H](C[C@@H](C)C1=C2C[C@H](OC(C)=O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)OC(C)=O,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL584798,CHEMBL584798,4.85,0.0,http://www.openphacts.org/units/Nanomolar,850764.0,=,1.0,1.0,=,IC50,nM,14000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.014,CHEMBL613497
4847,3353620.0,[],CHEMBL1173872,Antiviral activity against HIV1 NL4-3 with reverse transcriptase K101E mutant infected in human TZM-bl cells assessed as inhibition of viral replication after 4 days by p24 based ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C#C[C@]1(CO)O[C@@H](n2ccc(N)nc2=O)[C@@H](F)[C@@H]1O,CHEMBL1177822,Bioorg Med Chem Lett,2010.0,CHEMBL1171597,CHEMBL1171597,8.82,0.0,http://www.openphacts.org/units/Nanomolar,922244.0,=,1.0,1.0,=,IC50,nM,1.52,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.00152,CHEMBL378
4848,11014406.0,[],CHEMBL2089834,Antiviral activity against HIV1 in human TZM-bl cells assessed as viral infectivity by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@]3(C)COC(c4ccc(Cl)cc4)O[C@@H]3CC[C@@]2(C)[C@@H]1C/C=C1/C(=O)OC[C@H]1O,CHEMBL2086289,Eur J Med Chem,2012.0,CHEMBL377422,CHEMBL377422,5.00,0.0,http://www.openphacts.org/units/Nanomolar,1675627.0,=,1.0,1.0,=,IC50,nM,9940.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,9.94,CHEMBL378
4849,2212947.0,[],CHEMBL989682,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion in HepG2.2.15 cells by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(OC)c(OC)c3C(=O)N1CC2,CHEMBL1150244,J Nat Prod,2008.0,CHEMBL468804,CHEMBL468804,,0.0,http://www.openphacts.org/units/Nanomolar,767836.0,=,1.0,1.0,=,IC50,nM,140000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.14,CHEMBL613497
4850,6218331.0,[],CHEMBL1785353,Antiviral activity against Human immunodeficiency virus 1 Bal-PBL,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(S(N)(=O)=O)c(F)cc2Cl)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784509,CHEMBL1784509,8.36,0.0,http://www.openphacts.org/units/Nanomolar,1429448.0,=,1.0,1.0,=,IC50,nM,4.365,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,8.36,CHEMBL378
4851,15158625.0,[],CHEMBL3398832,Inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,O=C1OCCc2c(/C=C/c3ccccc3)cccc21,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397170,CHEMBL3397170,,0.0,http://www.openphacts.org/units/Nanomolar,2278968.0,>,1.0,1.0,>,IC50,nM,2430000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.43,CHEMBL613497
4852,23306088.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL4843118,Antiviral activity against Zika virus H/PF/2013 infected in pre-seeded Huh-7 cells assessed as inhibition of viral replication incubated for 72 hrs by immunodetection based secondary yield reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,Fc1cc(F)cc(/N=N/c2nc(NCCOc3ccccc3)nc3[nH]cnc23)c1,CHEMBL4842338,Eur J Med Chem,2021.0,CHEMBL4867349,CHEMBL4867349,,0.0,,3627104.0,,1.0,0.0,,IC50,,,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,,,,CHEMBL4296612
4853,1206561.0,[],CHEMBL710372,Inhibitory activity against 100I strain and 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Nc1nc(Nc2ccc(C#N)cc2)ncc1C#N,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL69890,CHEMBL69890,6.51,0.0,http://www.openphacts.org/units/Nanomolar,127450.0,=,1.0,1.0,=,IC50,nM,312.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.312,CHEMBL378
4854,3596612.0,[],CHEMBL1292013,Antiviral activity against HIV1 BaL in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C#N)C(=O)N1CCC(CCN2CCC(N(C(=O)NCc3ccc(C#N)cc3)c3cccc(F)c3)CC2)(c2cccc(F)c2)CC1,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288688,CHEMBL1288688,8.19,0.0,http://www.openphacts.org/units/Nanomolar,973798.0,=,1.0,1.0,=,IC50,nM,6.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.4,CHEMBL378
4855,2099757.0,[],CHEMBL949219,Antiviral activity against HIV1 ASM80 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2cccc(F)c2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL403954,CHEMBL403954,7.96,0.0,http://www.openphacts.org/units/Nanomolar,699410.0,=,1.0,1.0,=,IC50,nM,11.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.011,CHEMBL378
4856,14581332.0,[],CHEMBL3242937,Antiviral activity against HIV-1 3B infected in human MT-2 cells assessed as reduction in p24 antigen level incubated for overnight measured on fourth day post infection by multi-cycle infection assay based sandwich ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]1CSCc2ccc(cc2)-c2ccc(cc2)CSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC1=O,CHEMBL3232893,Bioorg Med Chem Lett,2014.0,CHEMBL3233156,CHEMBL3233156,5.55,0.0,http://www.openphacts.org/units/Nanomolar,2081351.0,=,1.0,1.0,=,IC50,nM,2800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.8,CHEMBL378
4857,1470708.0,[],CHEMBL832524,Inhibitory activity against HIV-1 double mutants strain 100I and 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCOCn1c(Cc2ccccc2)c(C(C)C)c(=O)[nH]c1=O,CHEMBL1138799,J Med Chem,2004.0,CHEMBL35033,CHEMBL35033,4.60,0.0,http://www.openphacts.org/units/Nanomolar,380792.0,=,1.0,1.0,=,IC50,nM,25120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.12,CHEMBL378
4858,3498070.0,[],CHEMBL1259505,Antiviral activity against HIV1 MTA infected in human PM1 cells expressing CCR5 assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(Cl)cc1)C(=O)NC1CCNCC1,CHEMBL1255517,Bioorg Med Chem Lett,2010.0,CHEMBL1256494,CHEMBL1256494,,0.0,,959451.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4859,2997412.0,[],CHEMBL1046974,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C/N=C(\c2ccc(=O)n(Cc3ccc(OC)cc3)c2)c2ccc(OC)cc2O)cc1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL567948,CHEMBL567948,4.44,0.0,http://www.openphacts.org/units/Nanomolar,856588.0,=,1.0,1.0,=,IC50,nM,36000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,36.0,CHEMBL613497
4860,18320100.0,[],CHEMBL4134181,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA level incubated for 3 days followed by medium replacement measured after 3 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C2CCCN2C(c2nccs2)=NC1c1cccc(F)c1Cl,CHEMBL4130455,ACS Med Chem Lett,2017.0,CHEMBL4161325,CHEMBL4161325,6.51,0.0,http://www.openphacts.org/units/Nanomolar,3041695.0,=,1.0,1.0,=,IC50,nM,310.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.31,CHEMBL613497
4861,24823597.0,[],CHEMBL5140687,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBeAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3cccnc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5185557,CHEMBL5185557,7.02,0.0,http://www.openphacts.org/units/Nanomolar,3876733.0,=,1.0,1.0,=,IC50,nM,94.9,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0949,CHEMBL613497
4862,90501.0,[],CHEMBL808329,The compound was tested in vitro for the inhibitory concentration against influenza B/Mem/89 sialidase from whole virus by MUN assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1cc([N+](=O)[O-])c(C(=O)O)c([N+](=O)[O-])c1O,CHEMBL1128587,J Med Chem,1995.0,CHEMBL111756,CHEMBL111756,,0.0,http://www.openphacts.org/units/Nanomolar,206095.0,=,1.0,1.0,=,IC50,nM,1000000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,mM,UO_0000065,1.0,CHEMBL613129
4863,2442781.0,[],CHEMBL987533,Antiviral activity against HIV1 3B infected in human HOG.R5 cells after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1148153,J Nat Prod,2004.0,CHEMBL141,CHEMBL141,5.92,0.0,http://www.openphacts.org/units/Nanomolar,789731.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.2,CHEMBL378
4864,43598.0,[],CHEMBL695522,Antiviral activity against V106I/Y181C strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL57,CHEMBL57,,0.0,http://www.openphacts.org/units/Nanomolar,20821.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10000.0,CHEMBL378
4865,2413658.0,[],CHEMBL987708,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@H](OC(=O)COC(C)=O)[C@H](C[C@@H](C)C1=C2C[C@H](OC(=O)COC(C)=O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)OC(=O)COC(C)=O,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL449184,CHEMBL449184,,0.0,http://www.openphacts.org/units/Nanomolar,810799.0,<,1.0,1.0,<,IC50,nM,32000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.032,CHEMBL613497
4866,1402520.0,[],CHEMBL835251,In vitro inhibitory concentration against HIV F227L and V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL57,CHEMBL57,6.79,0.0,http://www.openphacts.org/units/Nanomolar,360370.0,=,1.0,1.0,=,IC50,nM,163.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.163,CHEMBL378
4867,1672726.0,[],CHEMBL863515,Antiviral activity against HIV1 3B in MT4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(F)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL201084,CHEMBL201084,7.60,0.0,http://www.openphacts.org/units/Nanomolar,411938.0,=,1.0,1.0,=,IC50,nM,25.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,25.0,CHEMBL378
4868,10961144.0,[],CHEMBL2061266,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M9 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCCNc1ccccc1)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057723,CHEMBL2057723,7.10,0.0,http://www.openphacts.org/units/Nanomolar,1655446.0,=,1.0,1.0,=,IC50,nM,80.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,80.0,CHEMBL378
4869,2244603.0,[],CHEMBL1003077,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase V106A/Y181C mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL203420,CHEMBL203420,9.00,0.0,http://www.openphacts.org/units/Nanomolar,798654.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
4870,18585122.0,[],CHEMBL4223280,Antiviral activity against Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBeAg secretion after 3 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)OC(=O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL4219203,Bioorg Med Chem Lett,2018.0,CHEMBL1807167,CHEMBL1807167,4.09,0.0,http://www.openphacts.org/units/Nanomolar,3086248.0,=,1.0,1.0,=,IC50,nM,81900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,81.9,CHEMBL613497
4871,5294474.0,[],CHEMBL1697299,Antiviral activity against Parainfluenza 3 infected in african green monkey Vero cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(CC)[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,CHEMBL1687706,Antimicrob Agents Chemother,2008.0,CHEMBL1651956,CHEMBL1651956,,0.0,http://www.openphacts.org/units/Nanomolar,1337219.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL613126,Human parainfluenza virus 3,Human parainfluenza virus 3,11216,IC50,uM,UO_0000065,25.0,CHEMBL613126
4872,24781030.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '5.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '5.0'}]",CHEMBL5129508,Antiviral activity against Hepatitis B virus infected in human HepG2 cells expressing NTCP assessed as inhibition of viral entry by measuring intracellular HBV DNA preincubated with compound for 2 hrs followed by viral infection and measured after 3 hrs by qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CCC[C@@H]1NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)CN(CC(C)C)C(=O)CN(C)C1=O,CHEMBL5126594,Bioorg Med Chem,2022.0,CHEMBL5197341,CHEMBL5197341,6.38,0.0,http://www.openphacts.org/units/Nanomolar,3867967.0,=,1.0,1.0,=,IC50,nM,420.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.42,CHEMBL613497
4873,821148.0,[],CHEMBL697279,Anti-HIV-1 activity against syncytial plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)C[C@@H]1N=[N+]=[N-])OCC.[Na+],CHEMBL1125670,J Med Chem,1991.0,CHEMBL3350979,CHEMBL3558649,4.52,0.0,http://www.openphacts.org/units/Nanomolar,47353.0,=,1.0,1.0,=,IC50,nM,30000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,0.03,CHEMBL378
4874,22844965.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721621,Antiviral activity against HIV-1 HXB-2 infected in human TZM-bl cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based single cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC[C@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1nc(CO)cs1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4797114,CHEMBL4797114,6.51,0.0,http://www.openphacts.org/units/Nanomolar,3547065.0,=,1.0,1.0,=,IC50,nM,310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.31,CHEMBL378
4875,17602978.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(c2ccc(-c3ccccc3OC)cc2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644913,CHEMBL3644913,7.68,0.0,http://www.openphacts.org/units/Nanomolar,2518033.0,=,37.0,1.0,=,IC50,nM,21.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,21.0,CHEMBL4620
4876,2602098.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C(=O)CC(=O)c1cccc(Cc2ccccc2)c1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL19464,CHEMBL19464,7.00,0.0,http://www.openphacts.org/units/Nanomolar,808037.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
4877,3014834.0,[],CHEMBL1050519,Antiviral activity against multidrug-resistant HIV1 isolate MM infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,CHEMBL1156053,J Med Chem,2009.0,CHEMBL729,CHEMBL729,,0.0,http://www.openphacts.org/units/Nanomolar,862429.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
4878,13967472.0,[],CHEMBL3135324,Antiviral activity against HIV1 VSVG harboring reverse transcriptase Y181C mutant infected in 293ET cellsassessed as inhibition of viral replication by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1sccc1S(=O)(=O)N1c2cc(Cl)ccc2NC(=O)C1C,CHEMBL3132804,Medchemcomm,2014.0,CHEMBL492730,CHEMBL492730,,0.0,http://www.openphacts.org/units/Nanomolar,1974732.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
4879,337493.0,[],CHEMBL653803,In vitro inhibition of CEM-SS cell growth by 50 %,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCCCS(=O)(=O)CC(COP(=O)([O-])OCC[N+](C)(C)C)OCC,CHEMBL1125666,J Med Chem,1991.0,CHEMBL28775,CHEMBL28775,5.05,0.0,http://www.openphacts.org/units/Nanomolar,43732.0,=,1.0,1.0,=,IC50,nM,9000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,9.0,CHEMBL378
4880,19262053.0,[],CHEMBL4404440,Antiviral activity against multiple-PI-resistant HIV1 11808 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.33,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,470.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.47,CHEMBL378
4881,22845261.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4721683,Antiviral activity against HIV-1 ADA infected in human MOLT-4 cells assessed as reduction in viral transmission to TZM-bl cells incubated for 48 hrs by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4747551,CHEMBL4747551,5.77,0.0,http://www.openphacts.org/units/Nanomolar,3547084.0,=,1.0,1.0,=,IC50,nM,1700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.7,CHEMBL378
4882,2601659.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2ccc(/C=C/c3ccc4c(c3)OCO4)nc2c1O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL142246,CHEMBL142246,5.00,0.0,http://www.openphacts.org/units/Nanomolar,807473.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
4883,1421806.0,[],CHEMBL824926,Inhibitory activity against human immunodeficiency virus type 1 (inactive>0.1),F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(SC2CCCCC2)n(COCNC(=O)CCCl)c(=O)[nH]c1=O,CHEMBL1144258,Bioorg Med Chem Lett,2005.0,CHEMBL182190,CHEMBL182190,,0.0,http://www.openphacts.org/units/Nanomolar,364847.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4884,12642488.0,[],CHEMBL2317525,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCCN2C(=O)c3c(O)c(=O)c(C(=O)NCc4ccc(F)cc4)cn3CC12,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314676,CHEMBL2314676,7.54,0.0,http://www.openphacts.org/units/Nanomolar,1844808.0,=,1.0,1.0,=,IC50,nM,29.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,29.0,CHEMBL378
4885,226269.0,[],CHEMBL856186,In vitro antiviral activity against NNRTI-resistant L-697661R-IIIB (Y181C) HIV-1 variant,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](Sc1nc(N)cc(Cl)n1)c1cc2ccoc2cn1,CHEMBL1131332,J Med Chem,1998.0,CHEMBL26752,CHEMBL26752,,0.0,http://www.openphacts.org/units/Nanomolar,41267.0,>,1.0,1.0,>,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.0,CHEMBL378
4886,18202571.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(Br)cc3)cs2)C(c2cccc(O)c2)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4102276,CHEMBL4102276,5.64,0.0,http://www.openphacts.org/units/Nanomolar,3019955.0,=,1.0,1.0,=,IC50,nM,2300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.3,CHEMBL378
4887,23306082.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL4843118,Antiviral activity against Zika virus H/PF/2013 infected in pre-seeded Huh-7 cells assessed as inhibition of viral replication incubated for 72 hrs by immunodetection based secondary yield reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,Fc1cccc(NNc2nc(NCCOc3ccccc3)nc3[nH]cnc23)c1,CHEMBL4842338,Eur J Med Chem,2021.0,CHEMBL4847429,CHEMBL4847429,5.62,0.0,http://www.openphacts.org/units/Nanomolar,3627098.0,=,1.0,1.0,=,IC50,nM,2400.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,2.4,CHEMBL4296612
4888,502632.0,[],CHEMBL757967,Inhibition of cell growth against HIV-1 infected PBM (Human peripheral blood mononuclear) cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2CS[C@@H](CO)O2)c(=O)nc1N,CHEMBL1126792,J Med Chem,1993.0,CHEMBL313807,CHEMBL313807,,0.0,http://www.openphacts.org/units/Nanomolar,161315.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
4889,19450657.0,[],CHEMBL4433624,Antiviral activity against HIV1 12465 harboring protease M46I/I54V/Q58E/T74P/V82L/L90M mutant infected in human TZM-bl cells infected with supernatants from virus-infected human MT2 cells treated with compound for 72 hrs assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(-c2ccc(OCc3cccc(C(=O)NCCNC(=O)c4ccc(COc5ccc(F)cc5-c5csc(N)n5)cc4)c3)cc2)cs1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4459450,CHEMBL4597427,5.70,0.0,http://www.openphacts.org/units/Nanomolar,3249752.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.0,CHEMBL378
4890,2929529.0,[],CHEMBL1056897,Antiviral activity against HIV1 HXB2 harboring 190A mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cnnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL577247,CHEMBL577247,8.43,0.0,http://www.openphacts.org/units/Nanomolar,852824.0,=,1.0,1.0,=,IC50,nM,3.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.7,CHEMBL378
4891,19243757.0,[],CHEMBL4400278,Antiviral activity against Zika virus infected in human A549 cells assessed as reduction in viral titer incubated for 48 hrs by plaque assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CCNc1nc(NC(=O)Nc2ccc(I)cc2)ns1,CHEMBL4396960,Bioorg Med Chem Lett,2019.0,CHEMBL4469100,CHEMBL4469100,10.00,0.0,http://www.openphacts.org/units/Nanomolar,3212384.0,=,1.0,1.0,=,IC50,nM,0.1002,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,pM,UO_0000065,100.2,CHEMBL4296612
4892,525974.0,[],CHEMBL769300,Compound was evaluated for 50% inhibition of HBV polymerases (Hepatitis B virus),F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2C[C@@H](F)[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)n1,CHEMBL1131623,J Med Chem,1998.0,CHEMBL2092835,CHEMBL2092835,5.16,0.0,http://www.openphacts.org/units/Nanomolar,109356.0,=,1.0,1.0,=,IC50,nM,7000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,7.0,CHEMBL613497
4893,12642507.0,[],CHEMBL2317525,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)C(=O)Cn1ccn2cc(C(=O)NCc3ccc(F)cc3)c(=O)c(O)c2c1=O,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314697,CHEMBL2314697,7.46,0.0,http://www.openphacts.org/units/Nanomolar,1844832.0,=,1.0,1.0,=,IC50,nM,35.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,35.0,CHEMBL378
4894,2362905.0,[],CHEMBL1026418,Antiviral activity against multidrug-resistant HIV1/C with protease mutation in phytohemagglutininin-activated PBMC assessed as inhibition of p24G protein production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL1140100,J Med Chem,2008.0,CHEMBL116,CHEMBL116,6.64,0.0,http://www.openphacts.org/units/Nanomolar,747077.0,=,1.0,1.0,=,IC50,nM,230.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,230.0,CHEMBL378
4895,2371142.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1/C(=C/C2CCCO2)CC/C1=C\C1CCCO1,CHEMBL1140145,J Med Chem,2008.0,CHEMBL445205,CHEMBL445205,,0.0,http://www.openphacts.org/units/Nanomolar,746703.0,=,1.0,1.0,=,IC50,nM,239000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,239.0,CHEMBL613493
4896,2681627.0,[],CHEMBL1051714,Antiviral activity against HIV1 ZM197M.PB7 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL525076,CHEMBL525076,5.65,0.0,http://www.openphacts.org/units/Nanomolar,823863.0,=,1.0,1.0,=,IC50,nM,2230.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.23,CHEMBL378
4897,15166157.0,[],CHEMBL3404736,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as decrease in viral DNA replication treated for 7 days by real time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C=C/C(=O)OC[C@H]2O[C@@H](Oc3ccc(C(C)=O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402783,CHEMBL3402783,4.73,0.0,http://www.openphacts.org/units/Nanomolar,2284138.0,=,1.0,1.0,=,IC50,nM,18500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,18.5,CHEMBL613497
4898,1043699.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,SC1=NC2CCCCC2N1Nc1cccc(Cl)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL288161,CHEMBL288161,,0.0,http://www.openphacts.org/units/Nanomolar,62332.0,>,1.0,1.0,>,IC50,nM,126420.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,126.42,CHEMBL613499
4899,3383651.0,[],CHEMBL1211563,Antiviral activity against HIV1 NL-BAL infected in CCR5-expressing human JC53-BL cells assessed as inhibition of viral replication after 16 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(N[C@@H](CCN1C[C@@H]2CN(C(=O)C3CCCCC3)C[C@@H]2C1)c1cccc(F)c1)C1CCCC1,CHEMBL1208790,Bioorg Med Chem Lett,2010.0,CHEMBL1209303,CHEMBL1209303,7.22,0.0,http://www.openphacts.org/units/Nanomolar,927005.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,60.0,CHEMBL378
4900,24774806.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '73.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '73.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '97.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '97.0'}]",CHEMBL5127502,Antiviral activity against HIV-1 IIIB(X4) infected in human CEMx174 5.25M7 cells assessed as inactivation of HIV-1 free virions by measuring p24 antigen level preincubated for 1 hr followed by infection with cells and measured after 3 to 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(NC(=O)C(=O)Nc2ccc(Cl)c(F)c2)CC(C)(C)N1C(=O)COc1ccc(CCN2C(=O)/C(=C/c3ccc(-c4ccc(Cl)c(C(=O)O)c4)o3)SC2=S)cc1,CHEMBL5126520,Eur J Med Chem,2022.0,CHEMBL5191694,CHEMBL5191694,6.15,0.0,http://www.openphacts.org/units/Nanomolar,3866047.0,=,1.0,1.0,=,IC50,nM,710.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.71,CHEMBL378
4901,12651437.0,[],CHEMBL2327724,Antiviral activity against 0.001 MOI wild type Human immunodeficiency virus 1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCC(=O)N[C@@H](CCC(N)=O)C(=O)OC(C)(C)C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324157,CHEMBL2324157,8.00,0.0,http://www.openphacts.org/units/Nanomolar,1850184.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
4902,3509134.0,[],CHEMBL1261038,Antiviral activity against wild type HIV1 infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 40% human serum,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(F)c1Oc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1Br,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1258364,CHEMBL1258364,7.74,0.0,http://www.openphacts.org/units/Nanomolar,963336.0,=,1.0,1.0,=,IC50,nM,18.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,18.2,CHEMBL378
4903,610822.0,[],CHEMBL691383,Inhibitory concentration for cytopathicity of HIV-1 (HTLV-IIIB) in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cc(Cc2cc(C(=O)O)c(O)c3ccccc23)c2ccccc2c1O,CHEMBL1125737,J Med Chem,1991.0,CHEMBL114721,CHEMBL114721,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,217796.0,=,1.0,1.0,=,IC50,ug.mL-1,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,20.0,CHEMBL378
4904,1403312.0,[],CHEMBL837591,Inhibitory concentration against wild-type HIV-1 LAI Virus was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1Oc1cn(C)c(=O)c(Nc2ccc(C#N)cc2)n1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL177653,CHEMBL177653,8.40,0.0,http://www.openphacts.org/units/Nanomolar,360722.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.004,CHEMBL378
4905,6303622.0,[],CHEMBL1815966,Antiviral activity against R5 tropic HIV1 Ba-L infected PBMC assessed as inhibition of viral p24 antigen expression,F,BAO_0000190,BAO_0000218,organism-based format,CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2.Cl,CHEMBL1811891,Bioorg Med Chem,2011.0,CHEMBL1170878,CHEMBL1200019,7.41,0.0,http://www.openphacts.org/units/Nanomolar,1447829.0,=,1.0,1.0,=,IC50,nM,39.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,39.0,CHEMBL378
4906,3358056.0,[],CHEMBL1175712,Antiviral activity against wild type HIV1 infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect in presence of 40 % human serum,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3Cl)CC2)ncc1Br,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1170005,CHEMBL1170005,7.31,0.0,http://www.openphacts.org/units/Nanomolar,922327.0,=,1.0,1.0,=,IC50,nM,48.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,48.7,CHEMBL378
4907,328210.0,[],CHEMBL756133,Inhibition of concanavalin A (con A)-induced proliferation of human peripheral blood mononuclear cells.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2[N+](=O)[O-])cc1)c1ccncc1F,CHEMBL1133605,J Med Chem,2000.0,CHEMBL101460,CHEMBL101460,6.39,0.0,http://www.openphacts.org/units/Nanomolar,188093.0,=,1.0,1.0,=,IC50,nM,410.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,410.0,CHEMBL378
4908,2930353.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CNC=O)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL574141,CHEMBL574141,8.90,0.0,http://www.openphacts.org/units/Nanomolar,852965.0,=,1.0,1.0,=,IC50,nM,1.25,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.25,CHEMBL378
4909,23149289.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL4810078,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(c1)CCN(C1=Nc3c(Cl)cccc3C(C)N1)C2=O,CHEMBL4808206,ACS Med Chem Lett,2021.0,CHEMBL4865047,CHEMBL4865047,7.57,0.0,http://www.openphacts.org/units/Nanomolar,3598128.0,=,1.0,1.0,=,IC50,nM,27.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.027000000000000003,CHEMBL613497
4910,2179590.0,[],CHEMBL966469,Antiviral activity against HIV1 3B isolate replication in human H9 cells assessed as decrease in viral p24 level after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)CC(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,CHEMBL1155638,J Nat Prod,2000.0,CHEMBL266607,CHEMBL266607,5.16,0.0,http://www.openphacts.org/units/Nanomolar,712153.0,=,1.0,1.0,=,IC50,nM,7000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.0,CHEMBL378
4911,2099794.0,[],CHEMBL949220,Antiviral activity against HIV1 BaL by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL272555,CHEMBL272555,7.55,0.0,http://www.openphacts.org/units/Nanomolar,699395.0,=,1.0,1.0,=,IC50,nM,28.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.028,CHEMBL378
4912,2550843.0,[],CHEMBL980249,Antiviral activity against HIV1 3B assessed as reverse transcriptase activity by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CCCN2[C@@H]3[C@@]45CN6CCCC/C=C\CC[C@@]3(C=C(c3nccc7c3[nH]c3ccccc37)[C@@H]4CC6)O[C@]2(CC1)C5,CHEMBL1142603,J Nat Prod,2006.0,CHEMBL501843,CHEMBL501843,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,787000.0,=,1.0,1.0,=,IC50,ug.mL-1,17.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,17.5,CHEMBL378
4913,19261963.0,[],CHEMBL4404402,Antiviral activity against HIV1 subtypeC QB099.391M.ENV.B1,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.38,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,420.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.42,CHEMBL378
4914,1954101.0,[],CHEMBL890376,Antiviral activity against HIV1 LAI assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(Cl)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL234282,CHEMBL234282,8.20,0.0,http://www.openphacts.org/units/Nanomolar,647173.0,=,1.0,1.0,=,IC50,nM,6.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.3,CHEMBL378
4915,330906.0,[],CHEMBL697276,In vitro inhibition of HIV-1 plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCCC(=O)NCC(COP(=O)([O-])OCC[N+](C)(C)C)OC,CHEMBL1125666,J Med Chem,1991.0,CHEMBL31303,CHEMBL31303,6.52,0.0,http://www.openphacts.org/units/Nanomolar,43736.0,=,1.0,1.0,=,IC50,nM,300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.3,CHEMBL378
4916,19261979.0,[],CHEMBL4404408,Antiviral activity against HIV1 subtypeA infant BG505.W6M.ENV.C2,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,5.86,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,1380.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.38,CHEMBL378
4917,1064952.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1cccc(C2C(C)N=C(S)N2Nc2cccc(Cl)c2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL38391,CHEMBL38391,,0.0,http://www.openphacts.org/units/Nanomolar,62355.0,>,1.0,1.0,>,IC50,nM,67360.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,67.36,CHEMBL378
4918,18119233.0,[],CHEMBL4026154,Antiviral activity against HIV1 isolate 01ET188 infected in human PBMC,F,BAO_0000190,BAO_0000019,assay format,CC(C)C1=C2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(C(=O)C(=O)NC2(c3ccc(Cl)cc3)CC2)CC1=O,CHEMBL4024732,Bioorg Med Chem Lett,2017.0,CHEMBL4094428,CHEMBL4094428,,0.0,http://www.openphacts.org/units/Nanomolar,3004581.0,>,1.0,1.0,>,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,60.0,CHEMBL378
4919,5212152.0,[],CHEMBL1678856,Antiviral activity against influenza B virus infected in MDCK cells assessed as inhibition of neuraminidase activity by fluorimetric assay,F,BAO_0000190,BAO_0000218,organism-based format,CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@@H](C(=O)O)C[C@H]1NC(=N)N,CHEMBL1671747,Antimicrob Agents Chemother,2010.0,CHEMBL139367,CHEMBL139367,8.52,0.0,http://www.openphacts.org/units/Nanomolar,1332655.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,nmol/L,UO_0000065,3.0,CHEMBL613129
4920,1402209.0,[],CHEMBL837463,In vitro inhibitory concentration against HIV F227C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177744,CHEMBL177744,,0.0,http://www.openphacts.org/units/Nanomolar,360400.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4921,3254061.0,[],CHEMBL1114300,Antiviral activity against HIV1 3B in human HOS cells expressing human CXCR4/CXCR5/CD4/pHIV-LTR-luciferase assessed as blockade of viral infection into cells,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)CCCn1c(CN2CCC[C@@H]3CCc4cccnc4[C@@H]32)nc2ccccc21,CHEMBL1156293,Bioorg Med Chem Lett,2010.0,CHEMBL1093720,CHEMBL1093720,6.28,0.0,http://www.openphacts.org/units/Nanomolar,901197.0,=,1.0,1.0,=,IC50,nM,530.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,530.0,CHEMBL378
4922,16498280.0,[],CHEMBL3778315,Antiviral activity against HIV1 CXCR4-tropic strain HxB2 infected in human 293T cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2csc(N3N=C(C(F)(F)F)/C(=N/Nc4ccc5c(S(=O)(=O)O)cc(S(=O)(=O)O)cc5c4)C3=O)n2)cc1,CHEMBL3774382,Bioorg Med Chem,2016.0,CHEMBL3775379,CHEMBL3775379,4.10,0.0,http://www.openphacts.org/units/Nanomolar,2762415.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,80.0,CHEMBL378
4923,19243751.0,[],CHEMBL4400278,Antiviral activity against Zika virus infected in human A549 cells assessed as reduction in viral titer incubated for 48 hrs by plaque assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CCSc1nc(NC(=S)Nc2ccc(Br)cc2)ns1,CHEMBL4396960,Bioorg Med Chem Lett,2019.0,CHEMBL4461661,CHEMBL4461661,5.39,0.0,http://www.openphacts.org/units/Nanomolar,3212378.0,=,1.0,1.0,=,IC50,nM,4100.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,4.1,CHEMBL4296612
4924,1169823.0,[],CHEMBL818227,Cytotoxicity was determined in the vero cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c(=O)n([C@@H]2CS[C@H](CO)O2)cc1I,CHEMBL1126808,J Med Chem,1993.0,CHEMBL418146,CHEMBL418146,,0.0,http://www.openphacts.org/units/Nanomolar,100989.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
4925,1438429.0,[],CHEMBL834619,Inhibitory activity against HIV-1 mutant strain 181C; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C\Cc2ccccc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL362584,CHEMBL362584,,0.0,http://www.openphacts.org/units/Nanomolar,371603.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4926,1066163.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(NN2C(S)=NC(C)C2c2cccc(C#N)c2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL289913,CHEMBL289913,,0.0,http://www.openphacts.org/units/Nanomolar,62356.0,>,1.0,1.0,>,IC50,nM,45630.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,45.63,CHEMBL378
4927,12680666.0,[],CHEMBL2342597,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral replication after 9 days by fluorescence PCR method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/c1coc2cc(O)ccc2c1=O)NCc1ccccc1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333295,CHEMBL2333295,,0.0,http://www.openphacts.org/units/Nanomolar,1867258.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
4928,2292377.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1cccc(Cl)c1,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL291532,CHEMBL291532,,0.0,http://www.openphacts.org/units/Nanomolar,813578.0,=,1.0,1.0,=,IC50,nM,590201.08,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,3.229,CHEMBL378
4929,24830978.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc2c(=O)c3cccc(F)c3oc2c1)c1ccccc1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5183467,CHEMBL5183467,,0.0,http://www.openphacts.org/units/Nanomolar,3878090.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
4930,1402482.0,[],CHEMBL835251,In vitro inhibitory concentration against HIV F227L and V106A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177666,CHEMBL177666,5.50,0.0,http://www.openphacts.org/units/Nanomolar,360358.0,=,1.0,1.0,=,IC50,nM,3162.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.162,CHEMBL378
4931,11017273.0,[],CHEMBL2090659,Antiviral activity against HIV1 98USMSC5016 clade C clinical isolate infected in PHA-stimulated human PBMC assessed as inhibition of viral replication incubated for 6 hrs followed by compound-wash out measured after 6 days by liquid scintillation counting,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCC(=O)OC[C@@H]1O[C@H](n2ccc(N)nc2=O)CS1,CHEMBL2086298,J Med Chem,2012.0,CHEMBL2087753,CHEMBL2087753,8.72,0.0,http://www.openphacts.org/units/Nanomolar,1674773.0,=,1.0,1.0,=,IC50,nM,1.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.9,CHEMBL378
4932,5246970.0,[],CHEMBL1687410,Antiviral activity against HIV1 Ba-L infected in human HOS cells expressing CCR5 after 4 days,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC(CN(C)S(=O)(=O)c1ccccc1)c1ccccc1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL1682562,CHEMBL1682562,8.10,0.0,http://www.openphacts.org/units/Nanomolar,1333674.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
4933,2321207.0,[],CHEMBL1004248,Antiviral activity against HIV1 3B in human H9 cells after 4 days by p24 antigen ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)C(C)(C)CC(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL1150942,J Nat Prod,1998.0,CHEMBL503032,CHEMBL503032,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,787868.0,=,1.0,1.0,=,IC50,ug.mL-1,9.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,9.7,CHEMBL378
4934,1750522.0,[],CHEMBL868009,Antiviral activity against multi drug-resistant HIV1 EV variant in human PHA-PBMC cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL1146019,J Med Chem,2006.0,CHEMBL1323,CHEMBL1323,,0.0,,540003.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
4935,1834532.0,[],CHEMBL909293,"Antiviral activity against HIV1 isolate 5512 with D30N, M461 and V771 mutation in CBMCs",F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,CHEMBL1142192,Antimicrob Agents Chemother,2007.0,CHEMBL115,CHEMBL115,7.60,0.0,http://www.openphacts.org/units/Nanomolar,625900.0,=,1.0,1.0,=,IC50,nM,25.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.025,CHEMBL378
4936,2099825.0,[],CHEMBL949222,Antiviral activity against HIV1 RU570 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(nc(C(C)C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL257274,CHEMBL257274,7.29,0.0,http://www.openphacts.org/units/Nanomolar,699409.0,=,1.0,1.0,=,IC50,nM,51.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.051,CHEMBL378
4937,3457971.0,[],CHEMBL1249120,Inhibition of AP1 expressed in HEK293 cells assessed as inhibition of PMA-induced transcriptional activation treated 24 hrs before PMA challenge by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,CNc1nc(C)c(-c2nc3ccccc3c(=O)n2-c2ccc(Cl)cc2)s1,CHEMBL1240423,Eur J Med Chem,2010.0,CHEMBL487336,CHEMBL487336,5.52,0.0,http://www.openphacts.org/units/Nanomolar,953897.0,=,1.0,1.0,=,IC50,nM,3000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,3.0,CHEMBL4977
4938,18202527.0,[],CHEMBL4043712,Antiviral activity against HIV1 LAI infected in human MT2 cells assessed as reduction in p24 Gag protein production incubated for 6 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cccc(C(=O)N3CC[C@H](c4nc(C)cs4)C3)c2)cc1,CHEMBL4043088,Bioorg Med Chem,2017.0,CHEMBL4072694,CHEMBL4072694,6.96,0.0,http://www.openphacts.org/units/Nanomolar,3019941.0,=,1.0,1.0,=,IC50,nM,109.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,109.0,CHEMBL378
4939,5189386.0,[],CHEMBL1659267,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 6 days by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C=C/C(=O)OCCc2c(-c3ccccc3Cl)c3cc(Cl)ccc3[nH]c2=O)cc1,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652525,CHEMBL1652525,,0.0,,1326900.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
4940,19450651.0,[],CHEMBL4433623,Antiviral activity against HIV1 11808 harboring protease L10F/K20T/V32I/L33F/I54V/G73S/I84V/L89V/L90M mutant infected in human TZM-bl cells infected with supernatants from virus-infected human MT2 cells treated with compound for 72 hrs assessed as reduction in viral replication after 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(-c2ccc(OCc3cccc(C(=O)NCCNC(=O)c4ccc(COc5ccccc5-c5csc(N)n5)cc4)c3)cc2)cs1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4433210,ACS Med Chem Lett,2019.0,CHEMBL4515612,CHEMBL4598021,5.68,0.0,http://www.openphacts.org/units/Nanomolar,3249748.0,=,1.0,1.0,=,IC50,nM,2100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.1,CHEMBL378
4941,708196.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)c1ccc(SS(=O)(=O)c2ccc(C(C)(C)C)cc2)cc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120540,CHEMBL120540,,0.0,,228547.0,=,1.0,0.0,=,IC50,,21.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,21.3,CHEMBL378
4942,1402347.0,[],CHEMBL837462,In vitro inhibitory concentration against HIV E138K mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N2CCCCC2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175655,CHEMBL175655,,0.0,http://www.openphacts.org/units/Nanomolar,360430.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4943,6299482.0,[],CHEMBL1811268,Antiviral activity against HIV1 3B infected in human MAGI-CCR5 cells assessed as inhibition of viral replication after 48 hrs by beta-galactosidase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc2nc(-c3ccccc3Cl)c(NC3CCCCC3)n12,CHEMBL1806431,Bioorg Med Chem,2011.0,CHEMBL1807340,CHEMBL1807340,6.72,0.0,http://www.openphacts.org/units/Nanomolar,1443668.0,=,1.0,1.0,=,IC50,nM,190.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.19,CHEMBL378
4944,3083952.0,[],CHEMBL1072584,Antiviral activity against HIV1 infected in human JC53-BL cells after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)N1C[C@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)C)CC3)C[C@H]2C1,CHEMBL1153211,Bioorg Med Chem Lett,2010.0,CHEMBL596299,CHEMBL596299,,0.0,http://www.openphacts.org/units/Nanomolar,872504.0,>,1.0,1.0,>,IC50,nM,400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,400.0,CHEMBL378
4945,10961103.0,[],CHEMBL2061265,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M8 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCc1ccccc1)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058319,CHEMBL2058319,7.46,0.0,http://www.openphacts.org/units/Nanomolar,1656259.0,=,1.0,1.0,=,IC50,nM,35.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,35.0,CHEMBL378
4946,624213.0,[],CHEMBL710381,Inhibitory activity against 103N strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)cc(Cl)c1Oc1nc(N)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL73044,CHEMBL73044,8.22,0.0,http://www.openphacts.org/units/Nanomolar,126914.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
4947,3363276.0,[],CHEMBL1176970,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral cytoplasmic DNA synthesis after 8 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)n1c(CCc2cccn2C)nc2ccccc21,CHEMBL1177679,Bioorg Med Chem,2010.0,CHEMBL1172799,CHEMBL1172799,,0.0,,924513.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
4948,137554.0,[],CHEMBL692689,Inhibition of HCV NS5B polymerase,B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)Nc2cc(-c3ccccc3)sc2C(=O)O)c(C)c1,CHEMBL1148275,Bioorg Med Chem Lett,2004.0,CHEMBL167790,CHEMBL167790,6.00,0.0,http://www.openphacts.org/units/Nanomolar,326844.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,1.0,CHEMBL4620
4949,2601942.0,[],CHEMBL1034012,Antiviral activity against influenza virus,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1c(O)n(O)c2cc(NC(=O)c3ccc4ccccc4c3)ccc12,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL16377,CHEMBL16377,5.05,0.0,http://www.openphacts.org/units/Nanomolar,806773.0,=,1.0,1.0,=,IC50,nM,9000.0,CHEMBL613128,unidentified influenza virus,unidentified influenza virus,11309,IC50,uM,UO_0000065,9.0,CHEMBL613128
4950,1470283.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cc(Cl)cc(Cl)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188941,CHEMBL188941,8.70,0.0,http://www.openphacts.org/units/Nanomolar,380720.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.002,CHEMBL378
4951,1402279.0,[],CHEMBL837462,In vitro inhibitory concentration against HIV E138K mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCCN(CCCC)c1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL179736,CHEMBL179736,,0.0,http://www.openphacts.org/units/Nanomolar,360413.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
4952,854275.0,[],CHEMBL686566,Anti-HIV activity in H9 lymphocytes.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(c3oc(=O)ccc13)[C@@H](OC(=O)C13CCC(C)(C(=O)O1)C3(C)C)[C@@H](OC(=O)C13CCC(C)(C(=O)O1)C3(C)C)C(C)(C)O2,CHEMBL1132174,J Med Chem,1999.0,CHEMBL305179,CHEMBL305179,,0.0,http://www.openphacts.org/units/Nanomolar,163813.0,>,1.0,1.0,>,IC50,nM,95000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,95.0,CHEMBL378
4953,18683265.0,[],CHEMBL4237092,Antiviral activity against CCR5-dependent HIV1 SF162 infected in human HOS cells assessed as reduction in virus infection measured after 5 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCCC1)c1cccs1,CHEMBL4229569,J Med Chem,2018.0,CHEMBL4238063,CHEMBL4238063,7.68,0.0,http://www.openphacts.org/units/Nanomolar,3103098.0,=,1.0,1.0,=,IC50,nM,21.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,21.0,CHEMBL378
4954,24731881.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5115940,Antiviral activity against ZIKV-SMGC-1 infected in human BHK cells incubated for 7 days by CellTiter 96 luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(c1ccc(C(F)(F)F)cc1O)c1[nH]c(Cl)c(Cl)c1-n1c(C(=O)c2ccc(C(F)(F)F)cc2O)cc(Cl)c1Sc1nc2ccccc2o1,CHEMBL5113415,Eur J Med Chem,2022.0,CHEMBL5195868,CHEMBL5195868,6.44,0.0,http://www.openphacts.org/units/Nanomolar,3857957.0,=,1.0,1.0,=,IC50,nM,360.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,0.36,CHEMBL4296612
4955,575626.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(NS(=O)(=O)c2ccc(-n3sc4ccccc4c3=O)cc2)nc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL167600,CHEMBL167600,4.24,0.0,http://www.openphacts.org/units/Nanomolar,333994.0,=,1.0,1.0,=,IC50,nM,57600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,57.6,CHEMBL378
4956,18754898.0,[],CHEMBL4265061,Antiviral activity against HIV1 cYTA48P infected in PM1/CCR5 cells by single round assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(CNc1ccc(Cl)cc1)NC1CC2(CCCCC2)NC2(CCCCC2)C1,CHEMBL4261625,Bioorg Med Chem,2018.0,CHEMBL4281550,CHEMBL4281550,5.66,0.0,http://www.openphacts.org/units/Nanomolar,3116244.0,=,1.0,1.0,=,IC50,nM,2200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.2,CHEMBL378
4957,5126336.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,CN1C(=O)C(c2ccccc2)C(=O)N(c2ccccc2)c2cc(C(F)(F)F)ccc21,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642544,CHEMBL1642544,5.92,0.0,http://www.openphacts.org/units/Nanomolar,1317854.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.2,CHEMBL378
4958,1238995.0,[],CHEMBL683624,In vitro integration activity provided by preintegration complexes isolated from HIV-infected cells,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC2(CC(C)(C)c3ccc(O)cc32)c2cc(O)ccc21,CHEMBL1133186,J Med Chem,2000.0,CHEMBL60955,CHEMBL60955,4.10,0.0,http://www.openphacts.org/units/Nanomolar,108759.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,80.0,CHEMBL378
4959,14553709.0,[],CHEMBL3225005,Antiviral activity against HIV1 NL4-3 infected in human MT2 cells after 3 days by human JC53BL cell-based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1c2ncc3c(ccn3Cc3ccc(F)cc3)c2CCN1O,CHEMBL3217509,Medchemcomm,2013.0,CHEMBL1773312,CHEMBL1773312,9.00,0.0,http://www.openphacts.org/units/Nanomolar,2073839.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
4960,5132874.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2[nH]c(=O)c(CN(Cc3ccco3)C(=O)c3ccc(C#N)cc3)cc2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645053,CHEMBL1645053,,0.0,http://www.openphacts.org/units/Nanomolar,1321041.0,>,1.0,1.0,>,IC50,nM,25200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.2,CHEMBL378
4961,345037.0,[],CHEMBL756133,Inhibition of concanavalin A (con A)-induced proliferation of human peripheral blood mononuclear cells.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2OC(F)F)cc1)c1ccncc1F,CHEMBL1133605,J Med Chem,2000.0,CHEMBL103517,CHEMBL103517,7.09,0.0,http://www.openphacts.org/units/Nanomolar,188110.0,=,1.0,1.0,=,IC50,nM,82.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,82.0,CHEMBL378
4962,1403420.0,[],CHEMBL834757,Inhibitory concentration against 181C mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)c(=O)n(C)c1C,CHEMBL1145199,J Med Chem,2005.0,CHEMBL179871,CHEMBL179871,7.60,0.0,http://www.openphacts.org/units/Nanomolar,360757.0,=,1.0,1.0,=,IC50,nM,25.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.025,CHEMBL378
4963,1135610.0,[],CHEMBL698085,Inhibitory activity against HIV-1 mutant strain K103N/Y181C,F,BAO_0000190,BAO_0000218,organism-based format,CCN1c2ncc(CSc3ccncc3C)cc2C(=O)Nc2c(C)cc(Cl)nc21,CHEMBL1137947,Bioorg Med Chem Lett,2004.0,CHEMBL162272,CHEMBL162272,5.79,0.0,http://www.openphacts.org/units/Nanomolar,321328.0,=,1.0,1.0,=,IC50,nM,1640.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1640.0,CHEMBL378
4964,1497623.0,[],CHEMBL826653,Inhibitory concentration that required to Induced a 50% decrease in PBMC (healthy human's peripheral blood cells) cells survival,F,BAO_0000190,BAO_0000218,organism-based format,CCc1cc(CC)c(C(=O)CC(SCC(=O)O)C(=O)O)c(CC)c1,CHEMBL1141166,J Med Chem,2005.0,CHEMBL192916,CHEMBL192916,4.72,0.0,http://www.openphacts.org/units/Nanomolar,386652.0,=,1.0,1.0,=,IC50,nM,18970.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,18.97,CHEMBL378
4965,2371146.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,N=C1S/C(=C/c2ccco2)C(=O)N1c1nccs1,CHEMBL1140145,J Med Chem,2008.0,CHEMBL504977,CHEMBL504977,4.50,0.0,http://www.openphacts.org/units/Nanomolar,746699.0,=,1.0,1.0,=,IC50,nM,32000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,32.0,CHEMBL613493
4966,2413636.0,[],CHEMBL987708,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)C1CCCCC1)[C@@H](OC(=O)C1CCCCC1)C(C)(C)O)C1=C2C[C@H](OC(=O)C3CCCCC3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL506181,CHEMBL506181,,0.0,http://www.openphacts.org/units/Nanomolar,810685.0,>,1.0,1.0,>,IC50,nM,800000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.8,CHEMBL613497
4967,15165603.0,[],CHEMBL3404732,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBsAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C=C/C(=O)OC[C@H]2O[C@@H](Oc3ccc(C(C)=O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402783,CHEMBL3402783,,0.0,http://www.openphacts.org/units/Nanomolar,2284138.0,=,1.0,1.0,=,IC50,nM,781900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,781.9,CHEMBL613497
4968,1402082.0,[],CHEMBL837468,In vitro inhibitory concentration against HIV L100I mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,COCCCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175693,CHEMBL175693,8.10,0.0,http://www.openphacts.org/units/Nanomolar,360398.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
4969,18342073.0,[],CHEMBL4139011,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(-c2cc(NC(=O)c3ccccc3O)c[nH]c2=O)c1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL4167485,CHEMBL4167485,4.60,0.0,http://www.openphacts.org/units/Nanomolar,3045879.0,=,1.0,1.0,=,IC50,nM,25280.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,25.28,CHEMBL613497
4970,1194685.0,[],CHEMBL710372,Inhibitory activity against 100I strain and 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1[N+](=O)[O-],CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70514,CHEMBL70514,,0.0,http://www.openphacts.org/units/Nanomolar,127439.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
4971,19281716.0,[],CHEMBL4409361,Antiviral activity against HIV1 UG070 infected in human TZM-bl cells incubated for 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(cnn2-c2ccccc2)c(=O)[nH]1,CHEMBL4406854,Eur J Med Chem,2019.0,CHEMBL4542326,CHEMBL4542326,,0.0,http://www.openphacts.org/units/Nanomolar,3219930.0,=,1.0,1.0,=,IC50,nM,444440.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,444.44,CHEMBL378
4972,1213170.0,[],CHEMBL710372,Inhibitory activity against 100I strain and 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL308954,CHEMBL308954,7.72,0.0,http://www.openphacts.org/units/Nanomolar,127449.0,=,1.0,1.0,=,IC50,nM,19.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.019,CHEMBL378
4973,1497530.0,[],CHEMBL874975,Inhibitory concentration that required to induce 50% decrease in PBMC (healthy human's peripheral blood cells) cells survival,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)c1ccc(C(C)(C)C)c(C(=O)CC(SCC(=O)O)C(=O)O)c1,CHEMBL1141166,J Med Chem,2005.0,CHEMBL372501,CHEMBL372501,4.36,0.0,http://www.openphacts.org/units/Nanomolar,386651.0,=,1.0,1.0,=,IC50,nM,43720.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,43.72,CHEMBL378
4974,23317002.0,[],CHEMBL4845562,Antiviral activity against Influenza B virus (B/Sichuan/531/2018(Victoria)) infected in cells assessed as reduction in infected cells,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC[C@]2(C(=O)NCCCc3cn(CC(CO)(Cn4cc(CCCNC(=O)[C@]56CCC(C)(C)C[C@H]5C5=CC[C@@H]7[C@@]8(C)CC[C@H](O)C(C)(C)[C@@H]8CC[C@@]7(C)[C@]5(C)CC6)nn4)Cn4cc(CCCNC(=O)[C@]56CCC(C)(C)C[C@H]5C5=CC[C@@H]7[C@@]8(C)CC[C@H](O)C(C)(C)[C@@H]8CC[C@@]7(C)[C@]5(C)CC6)nn4)nn3)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL4842395,ACS Med Chem Lett,2021.0,CHEMBL4870860,CHEMBL4870860,4.42,0.0,http://www.openphacts.org/units/Nanomolar,3629099.0,=,1.0,1.0,=,IC50,nM,37630.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,37.63,CHEMBL613129
4975,22845181.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721659,Antiviral activity against pseudovirus HIV-1 HXB-2 subtype B harboring pseudotyped Env p9021_14.B2.4571 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1nc(CO)cs1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4761836,CHEMBL4761836,6.66,0.0,http://www.openphacts.org/units/Nanomolar,3547085.0,=,1.0,1.0,=,IC50,nM,220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.22,CHEMBL378
4976,13355179.0,[],CHEMBL2400652,Antiviral activity against Cowpox virus infected in african green monkey Vero 76 cells assessed as inhibition of virus-induced cytopathic effect after 3 days by microscopic analysis,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2[C@@H]1C[C@H](CCO)[C@@H](O)[C@H]1O,CHEMBL2396569,Bioorg Med Chem,2013.0,CHEMBL360506,CHEMBL360506,6.31,0.0,http://www.openphacts.org/units/Nanomolar,1902769.0,=,1.0,1.0,=,IC50,nM,490.0,CHEMBL612672,Cowpox virus,Cowpox virus,10243,IC50,uM,UO_0000065,0.49,CHEMBL612672
4977,2091760.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1cc(Cl)ccc1Cl,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL301055,CHEMBL301055,,0.0,http://www.openphacts.org/units/Nanomolar,700526.0,=,1.0,1.0,=,IC50,nM,3311311214825.91,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,3.52,CHEMBL378
4978,18950386.0,[],CHEMBL4331193,Inhibition of ASCT2 (unknown origin),B,BAO_0000190,BAO_0000357,single protein format,N[C@@H](CCC(=O)Nc1ccc([N+](=O)[O-])cc1)C(=O)O,CHEMBL4330073,Eur J Med Chem,2019.0,CHEMBL6251,CHEMBL6251,,0.0,http://www.openphacts.org/units/Nanomolar,3161334.0,=,1.0,1.0,=,IC50,nM,1200000.0,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,uM,UO_0000065,1200.0,CHEMBL3562162
4979,15139710.0,[],CHEMBL3384587,Antiviral activity against Dengue virus assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,CHEMBL3352310,Eur J Med Chem,2014.0,CHEMBL251254,CHEMBL251254,5.77,0.0,http://www.openphacts.org/units/Nanomolar,2241353.0,=,1.0,1.0,=,IC50,nM,1700.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,1.7,CHEMBL613757
4980,14653427.0,[],CHEMBL3266817,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(CO)[C@H](OC(=O)/C=C/c3cc(OC)c(OC)c(OC)c3)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3263004,CHEMBL3263004,,0.0,http://www.openphacts.org/units/Nanomolar,2101887.0,=,1.0,1.0,=,IC50,nM,753000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,753.0,CHEMBL613497
4981,18202895.0,[],CHEMBL4043733,Antiviral activity against HIV-1 NL4-3 harboring reverse transcriptase E138A mutant infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2cc3ccccc3n2C)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4061932,CHEMBL4061932,4.36,0.0,http://www.openphacts.org/units/Nanomolar,3019978.0,=,1.0,1.0,=,IC50,nM,43500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,43.5,CHEMBL378
4982,1224898.0,[],CHEMBL710530,Inhibitory activity against 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72335,CHEMBL72335,8.57,0.0,http://www.openphacts.org/units/Nanomolar,127434.0,=,1.0,1.0,=,IC50,nM,2.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0027,CHEMBL378
4983,14986395.0,[],CHEMBL3387299,Antiviral activity against Rift Valley fever virus infected in African green monkey Vero 76 cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncc(F)c2c1ncn2[C@@H]1C[C@H](CO)[C@@H](O)[C@H]1O,CHEMBL3351456,Bioorg Med Chem,2014.0,CHEMBL3357215,CHEMBL3357215,4.25,0.0,http://www.openphacts.org/units/Nanomolar,2258674.0,=,1.0,1.0,=,IC50,nM,56000.0,CHEMBL613130,Rift Valley fever virus,Rift Valley fever virus,11588,IC50,uM,UO_0000065,56.0,CHEMBL613130
4984,12051181.0,[],CHEMBL2156563,Antiviral activity against CXCR4-tropic HIV1 NL4-3 infected in HEK293T cells assessed as inhibition of viral replication after 4 days by beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(c(-c3cc(O)c4c(O)c5oc6c(C(=O)O)cc(C)cc6c(=O)c5c(OC)c4c3OC)c1)CC(C)OC2=O,CHEMBL2151018,J Nat Prod,2012.0,CHEMBL2152441,CHEMBL2152441,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1731137.0,=,1.0,1.0,=,IC50,ug.mL-1,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,2.0,CHEMBL378
4985,5294573.0,[],CHEMBL1696678,Antiviral activity against HIV-1 SF2 infected in human PBMC assessed as inhibition of viral replication by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,CHEMBL1687706,Antimicrob Agents Chemother,2008.0,CHEMBL160,CHEMBL160,6.27,0.0,http://www.openphacts.org/units/Nanomolar,1337217.0,=,1.0,1.0,=,IC50,nM,540.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.54,CHEMBL378
4986,22806645.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@@H](Sc3cccc(OCc4ccc(=O)n(C)c4)c3)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4784908,CHEMBL4784908,6.32,0.0,http://www.openphacts.org/units/Nanomolar,3541913.0,=,1.0,1.0,=,IC50,nM,480.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.48,CHEMBL613497
4987,15027139.0,[],CHEMBL3367171,Inhibition of AP-1-mediated transcriptional activation in human Jurkat cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)c1cnc(N(C)N2C(=O)C=C(C)C2=O)nc1CC,CHEMBL3352097,J Med Chem,2014.0,CHEMBL85822,CHEMBL85822,7.46,0.0,http://www.openphacts.org/units/Nanomolar,2265185.0,=,1.0,1.0,=,IC50,nM,35.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.035,CHEMBL4977
4988,15748726.0,[],CHEMBL3630976,Antiviral activity against HIV1 3B infected in PBMC,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(C[C@@H]1CN(C(=O)c2ccccc2)CCN1)[C@H]1CCCc2cccnc21,CHEMBL3627700,Bioorg Med Chem Lett,2015.0,CHEMBL3627794,CHEMBL3627794,7.06,0.0,http://www.openphacts.org/units/Nanomolar,2506622.0,=,1.0,1.0,=,IC50,nM,88.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,88.0,CHEMBL378
4989,12717513.0,[],CHEMBL2350955,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBV DNA replication after 72 hrs by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,C=CCc1ccc(Oc2cc(CC=C)ccc2O)cc1,CHEMBL2346656,Bioorg Med Chem Lett,2013.0,CHEMBL183320,CHEMBL183320,4.89,0.0,http://www.openphacts.org/units/Nanomolar,1874410.0,=,1.0,1.0,=,IC50,nM,12920.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,12.92,CHEMBL613497
4990,6218336.0,[],CHEMBL1785353,Antiviral activity against Human immunodeficiency virus 1 Bal-PBL,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(N)(=O)=O)c(C)c1C(=O)N1CCC(CCN2C3CCC2CC(n2c(C)nc4ccccc42)C3)(c2cccc(F)c2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784514,CHEMBL1784514,7.18,0.0,http://www.openphacts.org/units/Nanomolar,1429453.0,=,1.0,1.0,=,IC50,nM,66.07,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.18,CHEMBL378
4991,1037841.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=CN(Nc2cccc(Cl)c2)C1c1cccc(Cl)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL273996,CHEMBL273996,6.14,0.0,http://www.openphacts.org/units/Nanomolar,62369.0,=,1.0,1.0,=,IC50,nM,720.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.72,CHEMBL378
4992,2930218.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(COCc3ccccc3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL566547,CHEMBL566547,7.50,0.0,http://www.openphacts.org/units/Nanomolar,852917.0,=,1.0,1.0,=,IC50,nM,31.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.6,CHEMBL378
4993,2293107.0,[],CHEMBL1019824,Inhibition of AP1 expressed in HEK293 cells assessed as inhibition of TNF-alpha-induced transcriptional activation treated 24 hrs before TNFalpha challenge measured after 20 to 24 hrs by luciferase assay,B,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(Nc2ccccc2)sc1-c1nc2ccccc2c(=O)n1-c1ccc(Cl)cc1,CHEMBL1137748,Eur J Med Chem,2009.0,CHEMBL487337,CHEMBL487337,,0.0,,812370.0,,1.0,0.0,,IC50,,,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,,,,CHEMBL4977
4994,839804.0,[],CHEMBL713546,Compound potency to achieve protection of MT-4 cells from HIV-1 cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)C(Nc1ccc(Cl)cc1)c1c(Cl)cccc1Cl,CHEMBL1134808,Bioorg Med Chem Lett,2001.0,CHEMBL419819,CHEMBL419819,,0.0,http://www.openphacts.org/units/Nanomolar,126259.0,>,1.0,1.0,>,IC50,nM,160000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,160.0,CHEMBL378
4995,2244575.0,[],CHEMBL1003074,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase K103N/G190A mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL57,CHEMBL57,,0.0,http://www.openphacts.org/units/Nanomolar,798657.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2000.0,CHEMBL378
4996,24731882.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5115940,Antiviral activity against ZIKV-SMGC-1 infected in human BHK cells incubated for 7 days by CellTiter 96 luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,[N-]=[N+]=NCCCSc1c(Cl)cc(C(=O)c2ccc(C(F)(F)F)cc2O)n1-c1c(C(=O)c2ccc(C(F)(F)F)cc2O)[nH]c(Cl)c1Cl,CHEMBL5113415,Eur J Med Chem,2022.0,CHEMBL5205622,CHEMBL5205622,7.05,0.0,http://www.openphacts.org/units/Nanomolar,3857958.0,=,1.0,1.0,=,IC50,nM,90.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,0.09,CHEMBL4296612
4997,2136592.0,[],CHEMBL939089,Inhibition of HIV1 5'-long terminal repeat promoter expression in human 293T cells by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc([C@H]2Oc3c(OC)cc(/C=C/CO)cc3[C@@H]2CO)ccc1O,CHEMBL1144024,Bioorg Med Chem,2008.0,CHEMBL406378,CHEMBL406378,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,705092.0,=,1.0,1.0,=,IC50,ug.mL-1,34.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,34.0,CHEMBL378
4998,891775.0,[],CHEMBL653610,Inhibitory activity tested against the HIV-1 in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N3CCC[C@H]3C(=O)O)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL10514,CHEMBL10514,6.19,0.0,http://www.openphacts.org/units/Nanomolar,9059.0,=,1.0,1.0,=,IC50,nM,640.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,640.0,CHEMBL378
4999,15602742.0,[],CHEMBL3578657,Inhibition of ASCT2-mediated [3H]glutamine uptake in HEK293 cells after 15 mins by Live-cell glutamine uptake assay,B,BAO_0000190,BAO_0000219,cell-based format,N[C@@H](CCC(=O)Nc1ccccc1CN1CCCC1)C(=O)O,CHEMBL3576761,Bioorg Med Chem Lett,2015.0,CHEMBL3576930,CHEMBL3576930,,0.0,,2479427.0,,1.0,0.0,,IC50,,,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,,,,CHEMBL3562162
5000,1403536.0,[],CHEMBL834755,Inhibitory concentration against 100I mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1Oc1nc(Nc2ccc(Cl)cc2)c(=O)n(C)c1C,CHEMBL1145199,J Med Chem,2005.0,CHEMBL368765,CHEMBL368765,5.30,0.0,http://www.openphacts.org/units/Nanomolar,360689.0,=,1.0,1.0,=,IC50,nM,5011.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.011,CHEMBL378
5001,10981184.0,[],CHEMBL2065764,Antiviral activity against Human immunodeficiency virus 1 infected in human 293T cells assessed as inhibition of viral replication after 48 hrs by luminescence analysis,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1[nH]c2ccc(Cl)cc2c1C1(c2cccs2)CC1,CHEMBL2062389,ACS Med Chem Lett,2012.0,CHEMBL2063260,CHEMBL2063260,7.19,0.0,http://www.openphacts.org/units/Nanomolar,1659040.0,=,1.0,1.0,=,IC50,nM,65.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.065,CHEMBL378
5002,838119.0,[],CHEMBL701249,"Inhibitory concentration was evaluated against human respiratory syncytial virus,(HRSV) strain A2.",F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1cc(Nc2nc(Nc3cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c3)nc(Nc3cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c3)n2)ccc1-c1ccc(Nc2nc(Nc3cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c3)nc(Nc3cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c3)n2)cc1C(=O)OC,CHEMBL1131306,J Med Chem,1998.0,CHEMBL414257,CHEMBL414257,,0.0,http://www.openphacts.org/units/Nanomolar,164084.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL613127,Human respiratory syncytial virus,Human respiratory syncytial virus,11250,IC50,uM,UO_0000065,25.0,CHEMBL613127
5003,18585118.0,[],CHEMBL4223280,Antiviral activity against Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBeAg secretion after 3 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL4219203,Bioorg Med Chem Lett,2018.0,CHEMBL168,CHEMBL168,,0.0,http://www.openphacts.org/units/Nanomolar,3086252.0,=,1.0,1.0,=,IC50,nM,813600.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,813.6,CHEMBL613497
5004,1161956.0,[],CHEMBL694658,Inhibitory concentration against HIV-1 LTR polymerase chain reaction product,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCCC(=O)Nc1cc(C(=O)Nc3cc(C(=O)Nc4cc(C(=O)Nc5cc(C(=O)NCCC(=N)N)n(C)c5)n(C)c4)n(C)c3)n(C)c1)N=C[C@@H]1CCCN1C2=O.Cl,CHEMBL1132187,J Med Chem,1999.0,CHEMBL552873,CHEMBL1194569,5.70,0.0,http://www.openphacts.org/units/Nanomolar,289525.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.0,CHEMBL378
5005,2929685.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CN)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578979,CHEMBL578979,,0.0,http://www.openphacts.org/units/Nanomolar,852920.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,10'4nM,UO_0000065,1.0,CHEMBL378
5006,6336412.0,[],CHEMBL1821125,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by measuring HBsAg and HBeAg production after 9 days by EIA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(N[C@@H](Cc1ccccc1)C(=O)N[C@H](CO)Cc1ccccc1)c1ccccc1O,CHEMBL1817553,Bioorg Med Chem,2011.0,CHEMBL1819344,CHEMBL1819344,4.24,0.0,http://www.openphacts.org/units/Nanomolar,1451758.0,=,1.0,1.0,=,IC50,nM,57830.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,57.83,CHEMBL613497
5007,630555.0,[],CHEMBL710534,Inhibitory activity against 188L strain of HIV-1 in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Oc3c(Cl)cccc3Cl)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL70967,CHEMBL70967,5.34,0.0,http://www.openphacts.org/units/Nanomolar,126893.0,=,1.0,1.0,=,IC50,nM,4570.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.57,CHEMBL378
5008,18585135.0,[],CHEMBL4223279,Antiviral activity against Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBsAg secretion after 3 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1OC(=O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@@]2(C)CC[C@@]2(C)[C@@H]3CC(C)(C)CC[C@]3(C)CC[C@]12C,CHEMBL4219203,Bioorg Med Chem Lett,2018.0,CHEMBL1641908,CHEMBL1641908,,0.0,http://www.openphacts.org/units/Nanomolar,3086251.0,=,1.0,1.0,=,IC50,nM,765400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,765.4,CHEMBL613497
5009,2272898.0,[],CHEMBL956847,Antiviral activity against HIV1 Bal in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,CS/C(=N/C#N)N1CCC(CCN2[C@@H]3CC[C@H]2C[C@@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1,CHEMBL1153314,Bioorg Med Chem Lett,2009.0,CHEMBL523512,CHEMBL523512,,0.0,,755458.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5010,6200481.0,[],CHEMBL1781474,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 4 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc2c(CCN(CC3CCCCC3)CC3CCCCC3)c[nH]c2c1,CHEMBL1777761,Bioorg Med Chem,2011.0,CHEMBL1779157,CHEMBL1779157,,0.0,http://www.openphacts.org/units/Nanomolar,1425112.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
5011,18812919.0,[],CHEMBL4276408,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(N2C(=O)O[C@@H]3C[C@H](OC(=O)N[C@@H](Cc4ccccc4)[C@H](O)CN(CC(C)C)S(=O)(=O)c4ccc(OC)cc4)C[C@@H]32)cc1,CHEMBL4270667,J Med Chem,2018.0,CHEMBL4279922,CHEMBL4279922,,0.0,http://www.openphacts.org/units/Nanomolar,3125915.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
5012,18508385.0,[],CHEMBL4191338,Antiviral activity against VSV-G pseudotyped HIV1 infected in human SupT1 cells after 48 hrs by firefly luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@H]2C(C)(C)[C@H](O)CC[C@]2(C)[C@@]12Cc1c(O)cc(COC(C)=O)c(C=O)c1O2,CHEMBL4190193,J Nat Prod,2017.0,CHEMBL4207922,CHEMBL4207922,4.81,0.0,http://www.openphacts.org/units/Nanomolar,3072812.0,=,1.0,1.0,=,IC50,nM,15600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,15.6,CHEMBL378
5013,1442599.0,[],CHEMBL874199,"Compound was evaluated for activity in Recombinant virus assay at concentration that reduces luciferase activity, thus recombinant virus replication",F,BAO_0000190,BAO_0000218,organism-based format,CCn1c2ccccc2c2cc(C3(C4COC(=O)[C@@H]4C(O)c4cc(OC)c(OC)c(OC)c4)SCCCS3)ccc21,CHEMBL1137184,Bioorg Med Chem Lett,2004.0,CHEMBL361473,CHEMBL361473,4.57,0.0,http://www.openphacts.org/units/Nanomolar,373851.0,=,1.0,1.0,=,IC50,nM,26830.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,26.83,CHEMBL378
5014,12108650.0,[],CHEMBL2173424,Antiviral activity against HIV1 infected in MT4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)CCOc1ccc(NC(=O)COc2ccccc2C(=O)c2ccc(OC)cc2)cc1,CHEMBL2169791,J Med Chem,2012.0,CHEMBL415908,CHEMBL415908,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1740548.0,=,1.0,1.0,=,IC50,ug.mL-1,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,10.0,CHEMBL378
5015,2929716.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(COCc3ccc(F)cc3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL565713,CHEMBL565713,7.60,0.0,http://www.openphacts.org/units/Nanomolar,852942.0,=,1.0,1.0,=,IC50,nM,25.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,25.1,CHEMBL378
5016,24731845.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5115939,Antiviral activity against DENV-NGC-1 infected in human BHK cells incubated for 7 days by CellTiter 96 luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,Cn1nnnc1Sc1c(Cl)cc(C(=O)c2ccc(C(F)(F)F)cc2O)n1-c1c(C(=O)c2ccc(C(F)(F)F)cc2O)[nH]c(Cl)c1Cl,CHEMBL5113415,Eur J Med Chem,2022.0,CHEMBL5197837,CHEMBL5197837,5.76,0.0,http://www.openphacts.org/units/Nanomolar,3857945.0,=,1.0,1.0,=,IC50,nM,1740.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,1.74,CHEMBL613757
5017,13475477.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435885,CHEMBL2435885,7.31,0.0,http://www.openphacts.org/units/Nanomolar,1924261.0,=,1.0,1.0,=,IC50,nM,49.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,49.2,CHEMBL378
5018,2602155.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc2c(ncn2/C=C2\CC2(F)CO)c(=O)[nH]1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL223933,CHEMBL223933,4.00,0.0,http://www.openphacts.org/units/Nanomolar,807312.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5019,2371464.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)/C=C/C=C1C(=O)CCCC1=O,CHEMBL1140145,J Med Chem,2008.0,CHEMBL494891,CHEMBL494891,4.07,0.0,http://www.openphacts.org/units/Nanomolar,745984.0,=,1.0,1.0,=,IC50,nM,86000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,86.0,CHEMBL613493
5020,15166117.0,[],CHEMBL3404734,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBeAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(/C=C/C(=O)OC[C@H]2O[C@@H](Oc3ccc(C(C)=O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)c1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402782,CHEMBL3402782,,0.0,http://www.openphacts.org/units/Nanomolar,2284137.0,>,1.0,1.0,>,IC50,nM,1519800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1519.8,CHEMBL613497
5021,879447.0,[],CHEMBL685389,Inhibition of HIV replication in H9 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(C(=O)Nc2c(Cl)cccc2Cl)C(=O)C2OC21,CHEMBL1128512,J Med Chem,1995.0,CHEMBL111424,CHEMBL111424,5.57,0.0,http://www.openphacts.org/units/Nanomolar,204876.0,=,1.0,1.0,=,IC50,nM,2700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.7,CHEMBL378
5022,13967468.0,[],CHEMBL3135324,Antiviral activity against HIV1 VSVG harboring reverse transcriptase Y181C mutant infected in 293ET cellsassessed as inhibition of viral replication by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1sc(-c2ccco2)cc1S(=O)(=O)N1c2cc(Cl)ccc2NC(=O)C1C,CHEMBL3132804,Medchemcomm,2014.0,CHEMBL3133044,CHEMBL3133044,,0.0,http://www.openphacts.org/units/Nanomolar,1974715.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
5023,19252633.0,[],CHEMBL4401992,Antiviral activity against HIV-1 NL4-3,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)O[Si](c3ccccc3)(c3ccccc3)C(C)(C)C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4400557,Bioorg Med Chem Lett,2019.0,CHEMBL4462295,CHEMBL4462295,6.72,0.0,http://www.openphacts.org/units/Nanomolar,3214321.0,=,1.0,1.0,=,IC50,nM,190.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.19,CHEMBL378
5024,1403545.0,[],CHEMBL837591,Inhibitory concentration against wild-type HIV-1 LAI Virus was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Oc2nc(Nc3ccc(Cl)cc3)c(=O)n(C)c2C)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL178054,CHEMBL178054,6.90,0.0,http://www.openphacts.org/units/Nanomolar,360703.0,=,1.0,1.0,=,IC50,nM,126.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.126,CHEMBL378
5025,1045215.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(NN2C(S)=NC(C)C2C)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL288339,CHEMBL288339,,0.0,http://www.openphacts.org/units/Nanomolar,62327.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5026,8057970.0,[],CHEMBL1960698,Antiinfluenza activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)OCCCCCCCCBr)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL1955749,Bioorg Med Chem Lett,2012.0,CHEMBL1956404,CHEMBL1956404,,0.0,http://www.openphacts.org/units/Nanomolar,1580692.0,>,1.0,1.0,>,IC50,nM,28200.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,28.2,CHEMBL613129
5027,43597.0,[],CHEMBL695520,Antiviral activity against V106A/Y181C strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL57,CHEMBL57,,0.0,http://www.openphacts.org/units/Nanomolar,20821.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10000.0,CHEMBL378
5028,1145640.0,[],CHEMBL679241,Concentration required to reduce vaccinia virus-inducted cytopathicity by 50% (E6SM cells),F,BAO_0000190,BAO_0000218,organism-based format,O=S(=O)([O-])CCSCCCOC[C@H]1O[C@@](COCCCSCCS(=O)(=O)[O-])(O[C@H]2O[C@H](COCCCSCCS(=O)(=O)[O-])[C@@H](OCCCSCCS(=O)(=O)[O-])[C@H](OCCCSCCS(=O)(=O)[O-])[C@H]2OCCCSCCS(=O)(=O)[O-])[C@@H](OCCCSCCS(=O)(=O)[O-])[C@@H]1OCCCSCCS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],CHEMBL1130336,J Med Chem,1997.0,CHEMBL3142956,CHEMBL3305971,,0.0,http://www.openphacts.org/units/Nanomolar,225168.0,>,1.0,1.0,>,IC50,nM,101000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,101.0,CHEMBL613493
5029,15690089.0,[],CHEMBL3610404,Antiviral activity against HIV1 BaL infected in CD4/CCR5 expressing human MAGI cells incubated for 48 hrs by beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,c1ccc(Cc2cn[nH]c2C2CCN(Cc3cccnc3)CC2)cc1,CHEMBL3608277,ACS Med Chem Lett,2015.0,CHEMBL3608762,CHEMBL3608762,4.80,0.0,http://www.openphacts.org/units/Nanomolar,2496840.0,=,1.0,1.0,=,IC50,nM,16000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,16.0,CHEMBL378
5030,2930187.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CN(C)CCC#N)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL573732,CHEMBL573732,8.20,0.0,http://www.openphacts.org/units/Nanomolar,848258.0,=,1.0,1.0,=,IC50,nM,6.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.3,CHEMBL378
5031,18044763.0,[],CHEMBL4010412,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype D QA013.70I.ENV.M12,F,BAO_0000190,BAO_0000019,assay format,Cc1nc(C(NC(=O)c2ccc(-c3ccc(Cl)cc3)[nH]2)C2CCCCN2)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4096918,CHEMBL4096918,6.10,0.0,http://www.openphacts.org/units/Nanomolar,2990237.0,=,1.0,1.0,=,IC50,nM,790.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.79,CHEMBL378
5032,18528904.0,[],CHEMBL4195001,Antiviral activity against HIV1 virions containing reverse transcriptase K103N mutant derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL141,CHEMBL141,,0.0,,3076519.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5033,897541.0,[],CHEMBL685389,Inhibition of HIV replication in H9 cells.,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@]12CCCC[C@]13O[C@@H]3C(=O)C(C#N)C2,CHEMBL1128512,J Med Chem,1995.0,CHEMBL110573,CHEMBL110573,4.96,0.0,http://www.openphacts.org/units/Nanomolar,204857.0,=,1.0,1.0,=,IC50,nM,11000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,11.0,CHEMBL378
5034,15679629.0,[],CHEMBL3607086,Antiviral activity against Influenza B virus infected in MDCK cells after 3 days by neutral red dye-based plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cnc(N)c2ncn([C@@H]3C=C(CO)[C@@H](O)[C@H]3O)c12,CHEMBL3603790,Bioorg Med Chem,2015.0,CHEMBL3603846,CHEMBL3603846,5.96,0.0,http://www.openphacts.org/units/Nanomolar,2494265.0,=,1.0,1.0,=,IC50,nM,1100.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,1.1,CHEMBL613129
5035,1252268.0,[],CHEMBL709463,Concentration required to inhibit by 50% syncytium formation between MOLT-4 cells and HIV-1(IIIB),F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCC(=O)N(CC)CCCCCCCCCCC(=O)NCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL116526,CHEMBL1205574,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221531.0,=,1.0,1.0,=,IC50,ug.mL-1,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,30.0,CHEMBL378
5036,2930458.0,[],CHEMBL1056903,Antiviral activity against HIV1 HXB2 harboring 227L and 106A mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSCc3ccco3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567204,CHEMBL567204,6.90,0.0,http://www.openphacts.org/units/Nanomolar,852794.0,=,1.0,1.0,=,IC50,nM,125.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,125.0,CHEMBL378
5037,15166100.0,[],CHEMBL3404734,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBeAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(O[C@@H]2O[C@H](COC(=O)/C=C/c3ccc(O)c(O)c3)[C@@H](O)[C@H](O)[C@H]2O)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402768,CHEMBL3402768,,0.0,http://www.openphacts.org/units/Nanomolar,2284120.0,=,1.0,1.0,=,IC50,nM,1277100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1277.1,CHEMBL613497
5038,1672772.0,[],CHEMBL870621,Antiviral activity against HIV1 Y181C mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)CCCNc1ccc(NC(=O)COc2ccc(Cl)cc2C(=O)c2cc(F)cc(F)c2)c(C)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL201352,CHEMBL201352,,0.0,,411941.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5039,2929623.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CN3CC=CC3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL565702,CHEMBL565702,6.90,0.0,http://www.openphacts.org/units/Nanomolar,852918.0,=,1.0,1.0,=,IC50,nM,125.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,125.0,CHEMBL378
5040,15159560.0,[],CHEMBL3398834,Inhibition of HBV DNA replication in HepG2(2.2.15) cells exposed to fresh medium supplemented with compound every other day for additional 5 days by real-time PCR-fluorescent probing method,F,BAO_0000190,BAO_0000218,organism-based format,CCOCC(=O)OCc1cccc2c1CCOC2=O,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397175,CHEMBL3397175,,0.0,http://www.openphacts.org/units/Nanomolar,2278974.0,>,1.0,1.0,>,IC50,nM,920000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.92,CHEMBL613497
5041,1146178.0,[],CHEMBL757806,Cytotoxicity against human peripheral blood mononuclear (PBM) cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c(=O)n([C@H]2CS[C@H](CO)O2)cc1Cl,CHEMBL1126808,J Med Chem,1993.0,CHEMBL299930,CHEMBL299930,,0.0,http://www.openphacts.org/units/Nanomolar,100992.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5042,8027846.0,[],CHEMBL1948540,Antiviral activity against HIV1 NL432 infected in human ConA and IL2-stimulated PBMC assessed as inhibition of viral replication by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,Oc1cc2c(cc1O)[C@@H]1c3cccc(O)c3OC[C@]1(O)C2,CHEMBL1944615,Bioorg Med Chem Lett,2012.0,CHEMBL1944933,CHEMBL1944933,,0.0,,1573824.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5043,24815378.0,[],CHEMBL5138356,Antiviral activity against HIV-1 harboring K103N mutant infected in human MT4 cells by MTS assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(C(=O)c2cc(Cl)ccc2OCC(=O)Nc2ccc(S(N)(=O)=O)cc2Cl)c1,CHEMBL5136999,J Med Chem,2022.0,CHEMBL5206840,CHEMBL5206840,8.50,0.0,http://www.openphacts.org/units/Nanomolar,3874916.0,=,1.0,1.0,=,IC50,nM,3.16,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.16,CHEMBL378
5044,22898310.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731093,Antiviral activity against HIV1 DRVR P30 infected in human MT4 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(=O)C[C@H]1C2CO[C@H]3OC[C@@H]1C3C2)S(=O)(=O)c1ccc2nc(NC3CC3)sc2c1,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL4743665,CHEMBL4743665,10.41,0.0,http://www.openphacts.org/units/Nanomolar,3554415.0,=,1.0,1.0,=,IC50,nM,0.039,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.039,CHEMBL378
5045,6216948.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cc(F)cc(F)c2)CCN(C(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784506,CHEMBL1784506,6.94,0.0,http://www.openphacts.org/units/Nanomolar,1429445.0,=,1.0,1.0,=,IC50,nM,114.82,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.94,CHEMBL378
5046,2550846.0,[],CHEMBL980249,Antiviral activity against HIV1 3B assessed as reverse transcriptase activity by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CCCN2[C@@H]3[C@@]45CN6CCCC/C=C\CC[C@@]3(C=C(c3nccc7c3[nH]c3ccc(O)cc37)[C@@H]4CC6)O[C@]2(CC1)C5,CHEMBL1142603,J Nat Prod,2006.0,CHEMBL508040,CHEMBL508040,,0.0,,787003.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5047,625421.0,[],CHEMBL710381,Inhibitory activity against 103N strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Oc2ncnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL73008,CHEMBL73008,8.52,0.0,http://www.openphacts.org/units/Nanomolar,126920.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
5048,10862106.0,[],CHEMBL2024925,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B e-antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL450046,CHEMBL450046,4.31,0.0,http://www.openphacts.org/units/Nanomolar,1640516.0,=,1.0,1.0,=,IC50,nM,49200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,49.2,CHEMBL613497
5049,24777538.0,[],CHEMBL5128765,Antiviral activity against HIV-1 NL4-3(X4) infected in human TZM-bl cells assessed as reduction in viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@H](NC(=O)CCCCCCCNC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)[C@@H](O)CC(=O)O,CHEMBL5126557,Bioorg Med Chem Lett,2022.0,CHEMBL5178959,CHEMBL5178959,6.30,0.0,http://www.openphacts.org/units/Nanomolar,3867178.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.5,CHEMBL378
5050,5199510.0,[],CHEMBL1670946,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)[Si](CCc1c(OCc2c(F)cccc2F)nc2ccc(Cl)cc2c1-c1ccccc1Cl)(c1ccccc1)c1ccccc1,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668639,CHEMBL1668639,,0.0,http://www.openphacts.org/units/Nanomolar,1328423.0,>,1.0,1.0,>,IC50,nM,1865100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1865.1,CHEMBL613497
5051,1470728.0,[],CHEMBL832527,Inhibitory activity against HIV-1 double mutants strain 227L and 106A,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL223228,CHEMBL223228,7.70,0.0,http://www.openphacts.org/units/Nanomolar,380816.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.02,CHEMBL378
5052,12680685.0,[],CHEMBL2342597,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral replication after 9 days by fluorescence PCR method,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(NC(=O)/C=C/c2coc3cc(OC)ccc3c2=O)cc1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333679,CHEMBL2333679,4.85,0.0,http://www.openphacts.org/units/Nanomolar,1867755.0,=,1.0,1.0,=,IC50,nM,14250.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,14.25,CHEMBL613497
5053,2244606.0,[],CHEMBL1005599,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase V106I/Y181C mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL593,CHEMBL593,6.03,0.0,http://www.openphacts.org/units/Nanomolar,798656.0,=,1.0,1.0,=,IC50,nM,943.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,943.0,CHEMBL378
5054,10862138.0,[],CHEMBL2024925,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B e-antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCc6ccc(S(C)(=O)=O)cc6)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022387,CHEMBL2022387,,0.0,http://www.openphacts.org/units/Nanomolar,1637637.0,>,1.0,1.0,>,IC50,nM,1212240.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1212.24,CHEMBL613497
5055,3498084.0,[],CHEMBL1259507,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N=C(N)NCCCC(NC(=O)[C@H]1CSSC[C@@H](NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c2ccc(F)cc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCNC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCNC(=O)CCC(=O)NCCCCN2CCC(NC(=O)C(=O)Nc3ccc(Cl)cc3)CC2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(N)=O)C(=O)N1)C(N)=O,CHEMBL1255517,Bioorg Med Chem Lett,2010.0,CHEMBL1256528,CHEMBL1256528,7.29,0.0,http://www.openphacts.org/units/Nanomolar,959554.0,=,1.0,1.0,=,IC50,nM,50.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0509,CHEMBL378
5056,811691.0,[],CHEMBL697279,Anti-HIV-1 activity against syncytial plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCCC(=O)[N-]CC(COP(=O)([O-])OCC[N+](C)(C)C)OCC.[Na+],CHEMBL1125670,J Med Chem,1991.0,CHEMBL2079705,CHEMBL416753,,0.0,http://www.openphacts.org/units/Nanomolar,47362.0,=,1.0,1.0,=,IC50,nM,110000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,0.11,CHEMBL378
5057,16498298.0,[],CHEMBL3778316,Antiviral activity against HIV1 NL4-3 infected in human 293T cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2csc(N3N=C(c4ccccc4)/C(=N/Nc4ccc5c(S(=O)(=O)O)cc(S(=O)(=O)O)cc5c4)C3=O)n2)cc1,CHEMBL3774382,Bioorg Med Chem,2016.0,CHEMBL3775965,CHEMBL3775965,5.24,0.0,http://www.openphacts.org/units/Nanomolar,2762406.0,=,1.0,1.0,=,IC50,nM,5800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.8,CHEMBL378
5058,2930154.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3ccnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL584160,CHEMBL584160,9.00,0.0,http://www.openphacts.org/units/Nanomolar,848339.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
5059,10863199.0,[],CHEMBL2024927,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL483,CHEMBL483,6.05,0.0,http://www.openphacts.org/units/Nanomolar,1637645.0,=,1.0,1.0,=,IC50,nM,890.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.89,CHEMBL613497
5060,2292379.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)c2cccc(N)c2C#N)cc1,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL53896,CHEMBL53896,,0.0,http://www.openphacts.org/units/Nanomolar,813576.0,=,1.0,1.0,=,IC50,nM,9506047.94,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,2.022,CHEMBL378
5061,1259483.0,[],CHEMBL683624,In vitro integration activity provided by preintegration complexes isolated from HIV-infected cells,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC2(CC(C)(C)c3cc(N)c(O)cc32)c2cc(O)c(N)cc21.Cl.Cl,CHEMBL1133186,J Med Chem,2000.0,CHEMBL60891,CHEMBL1179111,4.10,0.0,http://www.openphacts.org/units/Nanomolar,108755.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,80.0,CHEMBL378
5062,3114768.0,[],CHEMBL1073712,Antiviral activity against HIV1 NL4-3 infected in GFP expressing human CEM cells assessed as inhibition of viral infection measured after 9 days postinfection by microfluorometry,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1c(O)c(C(C)=O)c(O)c(C(c2ccc(N(C)C)cc2)c2c(O)c(C(C)=O)c(O)c(C(C)=O)c2O)c1O,CHEMBL1157554,Bioorg Med Chem,2010.0,CHEMBL603489,CHEMBL603489,5.22,0.0,http://www.openphacts.org/units/Nanomolar,887095.0,=,1.0,1.0,=,IC50,nM,6060.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.06,CHEMBL378
5063,14653414.0,[],CHEMBL3266817,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)c3ccco3)[C@H](O)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262984,CHEMBL3262984,4.72,0.0,http://www.openphacts.org/units/Nanomolar,2101866.0,=,1.0,1.0,=,IC50,nM,19200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,19.2,CHEMBL613497
5064,2091776.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)c2cccc(N)c2C#N)cc1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL55043,CHEMBL55043,,0.0,http://www.openphacts.org/units/Nanomolar,700510.0,=,1.0,1.0,=,IC50,nM,39810717055.35,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,1.6,CHEMBL378
5065,22980455.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '192.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '8.0'}]",CHEMBL4772778,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBeAg secretion incubated for 4 days prior to compound washout followed by compound addition and measured after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Cc1nc(-c2ccncc2)sc1C(=O)NCc1ccc(F)cc1,CHEMBL4765395,Eur J Med Chem,2020.0,CHEMBL4784545,CHEMBL4784545,4.21,0.0,http://www.openphacts.org/units/Nanomolar,3568773.0,=,1.0,1.0,=,IC50,nM,62300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,umol/L,UO_0000065,62.3,CHEMBL613497
5066,19183292.0,[],CHEMBL4387678,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as reduction in p24 Gag protein production incubated for 6 days and measured on day 7 by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)Nc2c(N[C@@H]3CCOC3)c(=O)c2=O)cc1,CHEMBL4385670,Bioorg Med Chem Lett,2019.0,CHEMBL4474819,CHEMBL4474819,,0.0,http://www.openphacts.org/units/Nanomolar,3202088.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
5067,3083970.0,[],CHEMBL1072584,Antiviral activity against HIV1 infected in human JC53-BL cells after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)nc(C)c1C(=O)N1C[C@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@H]2C1,CHEMBL1153211,Bioorg Med Chem Lett,2010.0,CHEMBL595610,CHEMBL595610,7.62,0.0,http://www.openphacts.org/units/Nanomolar,872510.0,=,1.0,1.0,=,IC50,nM,24.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,24.0,CHEMBL378
5068,13924638.0,[],CHEMBL3118712,Antiviral activity against HIV-1 3B infected in human MT4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL3112419,Bioorg Med Chem Lett,2014.0,CHEMBL129,CHEMBL129,8.15,0.0,http://www.openphacts.org/units/Nanomolar,1965590.0,=,1.0,1.0,=,IC50,nM,7.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.007,CHEMBL378
5069,3596635.0,[],CHEMBL1292012,Antiviral activity against HIV1 BaL in human PBL cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(O)C(=O)N1CCC(CCN2CCC(N(C(=O)NCc3ccc(C#N)cc3)c3cccc(F)c3)CC2)(c2cccc(F)c2)CC1,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288689,CHEMBL1288689,8.09,0.0,http://www.openphacts.org/units/Nanomolar,973799.0,=,1.0,1.0,=,IC50,nM,8.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.1,CHEMBL378
5070,3596587.0,[],CHEMBL1292013,Antiviral activity against HIV1 BaL in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NS(=O)(=O)c1cc(C(=O)N2CCC(CCN3CCC(N(C(=O)NCc4ccc(C#N)cc4)c4cccc(F)c4)CC3)(c3cccc(F)c3)CC2)c(Cl)cc1F,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288663,CHEMBL1288663,9.40,0.0,http://www.openphacts.org/units/Nanomolar,973773.0,=,1.0,1.0,=,IC50,nM,0.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.4,CHEMBL378
5071,926907.0,[],CHEMBL716463,Inhibitory concentration required to reduce virus Plaque formation (measles),F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(F)nc2c1ncn2[C@@H]1C=C[C@@H](O)[C@H]1O,CHEMBL1129081,J Med Chem,1996.0,CHEMBL421655,CHEMBL421655,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,240306.0,>,1.0,1.0,>,IC50,ug.mL-1,25.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,ug ml-1,UO_0000274,25.0,CHEMBL613738
5072,2930450.0,[],CHEMBL1056902,Antiviral activity against HIV1 HXB2 harboring K103N and Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3ccnc3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL568526,CHEMBL568526,7.15,0.0,http://www.openphacts.org/units/Nanomolar,852832.0,=,1.0,1.0,=,IC50,nM,71.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,71.2,CHEMBL378
5073,971642.0,[],CHEMBL655544,Inhibition of wild type HIV-1-IIIB strain replication in CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c([N+](=O)[O-])c(O)nc3ccccc23)c1,CHEMBL1128194,J Med Chem,1995.0,CHEMBL143635,CHEMBL143635,5.42,0.0,http://www.openphacts.org/units/Nanomolar,276295.0,=,1.0,1.0,=,IC50,nM,3800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3800.0,CHEMBL378
5074,1402110.0,[],CHEMBL837467,In vitro inhibitory concentration against HIV K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCO)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175692,CHEMBL175692,6.50,0.0,http://www.openphacts.org/units/Nanomolar,360365.0,=,1.0,1.0,=,IC50,nM,316.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.316,CHEMBL378
5075,18342081.0,[],CHEMBL4139012,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2cc(NC(=O)c3ccc(OC)cc3O)c[nH]c2=O)cc1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL4167492,CHEMBL4167492,4.76,0.0,http://www.openphacts.org/units/Nanomolar,3045859.0,=,1.0,1.0,=,IC50,nM,17470.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,17.47,CHEMBL613497
5076,10938685.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(/C=C/C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(O)C(C)=O)C2)c1,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046558,CHEMBL2046558,4.98,0.0,http://www.openphacts.org/units/Nanomolar,1651441.0,=,1.0,1.0,=,IC50,nM,10540.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.54,CHEMBL613497
5077,2091737.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(CC2CC2)CCCN(S(=O)(=O)c2ccc(C)cc2)C1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL273111,CHEMBL273111,,0.0,http://www.openphacts.org/units/Nanomolar,700549.0,=,1.0,1.0,=,IC50,nM,151356124843620.72,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,5.18,CHEMBL378
5078,1470563.0,[],CHEMBL833076,Inhibitory activity against HIV-1 mutant strain 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL338047,CHEMBL338047,7.52,0.0,http://www.openphacts.org/units/Nanomolar,380766.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.03,CHEMBL378
5079,5147570.0,[],CHEMBL1662265,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COP(=O)(c1cc(C)cc(/C=C/C#N)c1)c1c(C(N)=O)[nH]c2ccc(Cl)cc12,CHEMBL1649173,Antimicrob Agents Chemother,2009.0,CHEMBL1652111,CHEMBL1652111,8.92,0.0,http://www.openphacts.org/units/Nanomolar,1325975.0,=,1.0,1.0,=,IC50,nM,1.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.2,CHEMBL378
5080,1402605.0,[],CHEMBL833792,In vitro inhibitory concentration against HIV-1 Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(NC(=S)NC(=O)c2ccccc2)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177383,CHEMBL177383,4.00,0.0,http://www.openphacts.org/units/Nanomolar,360418.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5081,6216893.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784396,CHEMBL1784396,5.90,0.0,http://www.openphacts.org/units/Nanomolar,1429334.0,=,1.0,1.0,=,IC50,nM,1258.93,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.9,CHEMBL378
5082,252290.0,[],CHEMBL691105,Inhibition of cytopathogenicity against human HIV-1(IIIB) in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](OP(=O)(O)COCCn2cnc3ncnc(N)c32)[C@H]1O,CHEMBL1134666,J Med Chem,2001.0,CHEMBL1790862,CHEMBL1790862,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,233579.0,=,1.0,1.0,=,IC50,ug.mL-1,5.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,5.9,CHEMBL378
5083,495633.0,[],CHEMBL694654,Inhibitory concentration against HIV-1 IIIB strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1133473,J Med Chem,2000.0,CHEMBL338047,CHEMBL338047,9.24,0.0,http://www.openphacts.org/units/Nanomolar,245553.0,=,1.0,1.0,=,IC50,nM,0.58,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.58,CHEMBL378
5084,1438137.0,[],CHEMBL834619,Inhibitory activity against HIV-1 mutant strain 181C; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(C(C)O)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL180248,CHEMBL180248,,0.0,http://www.openphacts.org/units/Nanomolar,371540.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5085,2930449.0,[],CHEMBL1056902,Antiviral activity against HIV1 HXB2 harboring K103N and Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cnnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL577247,CHEMBL577247,7.76,0.0,http://www.openphacts.org/units/Nanomolar,852824.0,=,1.0,1.0,=,IC50,nM,17.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,17.4,CHEMBL378
5086,5132861.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2[nH]c(=O)c(CN(Cc3ccco3)C(=O)c3cccnc3)cc2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645044,CHEMBL1645044,,0.0,http://www.openphacts.org/units/Nanomolar,1321032.0,>,1.0,1.0,>,IC50,nM,16700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,16.7,CHEMBL378
5087,19308407.0,[],CHEMBL4415741,Antiviral activity against HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)OCCCCCCCC(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4414578,Eur J Med Chem,2019.0,CHEMBL4570662,CHEMBL4570662,7.30,0.0,http://www.openphacts.org/units/Nanomolar,3224194.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,50.0,CHEMBL378
5088,5199465.0,[],CHEMBL1670944,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CS(=O)(=O)OCCc1c(OS(C)(=O)=O)nc2ccc(Cl)cc2c1-c1ccccc1Cl,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668632,CHEMBL1668632,4.78,0.0,http://www.openphacts.org/units/Nanomolar,1328416.0,=,1.0,1.0,=,IC50,nM,16500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,16.5,CHEMBL613497
5089,5189147.0,[],CHEMBL1658799,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=CCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1649612,CHEMBL1649612,4.12,0.0,http://www.openphacts.org/units/Nanomolar,1326869.0,=,1.0,1.0,=,IC50,nM,76000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.076,CHEMBL613497
5090,19261890.0,[],CHEMBL4404378,"Antiviral activity against HIV1 subtypeB PVO, clone 4",F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.96,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,110.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.11,CHEMBL378
5091,943346.0,[],CHEMBL656269,Inhibition of human immunodeficiency virus-1 (HIV-1) induced cytopathicity in CEM cells,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1nc2nc(N)nc(O)c2n1)OCP(=O)(O)O,CHEMBL1129435,J Med Chem,1996.0,CHEMBL132120,CHEMBL132120,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251942.0,=,1.0,1.0,=,IC50,ug.mL-1,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,20.0,CHEMBL378
5092,13940308.0,[],CHEMBL3131385,Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)NCc1cn(C2CCCCC2)nn1)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL3124823,Eur J Med Chem,2014.0,CHEMBL3126784,CHEMBL3126784,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1972638.0,=,1.0,1.0,=,IC50,ug.mL-1,19.73,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,19.73,CHEMBL613129
5093,15064913.0,[],CHEMBL3366183,Antiviral activity against wild type HIV1 infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2nc(NCc3ccc(O)c(OC)c3)sc2Cc2ccccc2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3330430,CHEMBL3330430,6.48,0.0,http://www.openphacts.org/units/Nanomolar,2246867.0,=,1.0,1.0,=,IC50,nM,330.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.33,CHEMBL378
5094,18775549.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COCCCOc1cc2c(cc1OC)-c1cc(=O)c(C(=O)O)cn1C(c1cccs1)C2,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4291816,CHEMBL4291816,8.52,0.0,http://www.openphacts.org/units/Nanomolar,3119707.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.003,CHEMBL613497
5095,14658865.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)c3ccc(Cl)c(C)c3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262892,CHEMBL3262892,7.68,0.0,http://www.openphacts.org/units/Nanomolar,2101734.0,=,1.0,1.0,=,IC50,nM,20.89,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,pIC50,,UO_0000065,7.68,CHEMBL3259471
5096,2601961.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1cc2ccccc2n1S(=O)(=O)c1ccccc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL84490,CHEMBL84490,,0.0,http://www.openphacts.org/units/Nanomolar,808142.0,=,1.0,1.0,=,IC50,nM,200000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,200.0,CHEMBL378
5097,14654449.0,[],CHEMBL3267148,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(CO)[C@H](OC(C)=O)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3263009,CHEMBL3263009,4.35,0.0,http://www.openphacts.org/units/Nanomolar,2101892.0,=,1.0,1.0,=,IC50,nM,44400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,44.4,CHEMBL613497
5098,16556868.0,[],CHEMBL3795205,Antiviral activity against CXCR4 using HIV-1 NL4.3 infected in human MT4 cells assessed as reduction of viral replication preincubated for 15 mins with cells followed by viral infection measured after 4 days by MTS/PES method,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(CC2CCCCC2)CCCN(S(=O)(=O)c2ccc(OCCCC)cc2)C1.Cl,CHEMBL3792300,J Med Chem,2016.0,CHEMBL3793791,CHEMBL3794628,5.71,0.0,http://www.openphacts.org/units/Nanomolar,2770898.0,=,1.0,1.0,=,IC50,nM,1950.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.95,CHEMBL378
5099,14653419.0,[],CHEMBL3266817,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(C)=O)[C@H](OC(C)=O)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262990,CHEMBL3262990,,0.0,http://www.openphacts.org/units/Nanomolar,2101873.0,=,1.0,1.0,=,IC50,nM,1010000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1010.0,CHEMBL613497
5100,18239588.0,[],CHEMBL4052034,Antiviral activity against saquinavir-resistant HIV1 NL4-3 harboring protease L10I/N37D/G48V/I54V/L63P/G73C/I84V/L90M mutant infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,CHEMBL4049446,J Med Chem,2017.0,CHEMBL1163,CHEMBL1163,6.29,0.0,http://www.openphacts.org/units/Nanomolar,3026808.0,=,1.0,1.0,=,IC50,nM,510.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,510.0,CHEMBL378
5101,3221766.0,[],CHEMBL1102830,Antiviral activity against HIV1 carrying reverse transcriptase Y181C mutant infected human MT4 cells by phenoscreen assay in the presence of 40 percent normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,CS(=O)(=O)c1ccc(NC(=O)CSC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,CHEMBL1153798,Bioorg Med Chem Lett,2009.0,CHEMBL1078944,CHEMBL1078944,4.06,0.0,http://www.openphacts.org/units/Nanomolar,898067.0,=,1.0,1.0,=,IC50,nM,86600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,0.0866,CHEMBL378
5102,2947318.0,[],CHEMBL1038497,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,COCC(=O)OC(C)(C)[C@H](OC(C)=O)[C@H](C[C@@H](C)C1=C2C[C@H](OC(C)=O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)OC(C)=O,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL584797,CHEMBL584797,4.92,0.0,http://www.openphacts.org/units/Nanomolar,850763.0,=,1.0,1.0,=,IC50,nM,12000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.012,CHEMBL613497
5103,1000862.0,[],CHEMBL714338,"Antiviral activity against HIV-1, IIIB, in MT-4 Cells",F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CN[C@@H](C(=O)NC2c3ccccc3C[C@H]2O)[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)/C=C/c2ccc(OC)cc2O)C(C)(C)C)cc1,CHEMBL1129316,J Med Chem,1996.0,CHEMBL292525,CHEMBL292525,6.62,0.0,http://www.openphacts.org/units/Nanomolar,111248.0,=,1.0,1.0,=,IC50,nM,238.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,238.0,CHEMBL378
5104,18528929.0,[],CHEMBL4195005,Antiviral activity against HIV1 virions containing reverse transcriptase E138K/M184V mutant derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)[C@H](c1cc(OC)c(OC)c(OC)c1)[C@@H](C)CC2,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4202482,CHEMBL4202482,6.75,0.0,http://www.openphacts.org/units/Nanomolar,3076502.0,=,1.0,1.0,=,IC50,nM,180.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.18,CHEMBL378
5105,18044380.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,CNCCC(NC(=O)c1ccc(-c2cccc(Cl)c2)[nH]1)c1nc(C)c(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4061047,CHEMBL4061047,5.20,0.0,http://www.openphacts.org/units/Nanomolar,2990197.0,=,1.0,1.0,=,IC50,nM,6300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.3,CHEMBL378
5106,1401905.0,[],CHEMBL835252,In vitro inhibitory concentration against HIV K101E and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)Nc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL435522,CHEMBL435522,,0.0,http://www.openphacts.org/units/Nanomolar,360379.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5107,492192.0,[],CHEMBL691388,Inhibitory concentration against HIV-1 AZTres.,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N)c1C(O)c1cc(C)cc(C)c1,CHEMBL1133473,J Med Chem,2000.0,CHEMBL128812,CHEMBL128812,6.38,0.0,http://www.openphacts.org/units/Nanomolar,245571.0,=,1.0,1.0,=,IC50,nM,420.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,420.0,CHEMBL378
5108,8057963.0,[],CHEMBL1960698,Antiinfluenza activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)OCCCCCCCCCCN1CCN(C)CC1)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL1955749,Bioorg Med Chem Lett,2012.0,CHEMBL1956538,CHEMBL1956538,,0.0,http://www.openphacts.org/units/Nanomolar,1580868.0,>,1.0,1.0,>,IC50,nM,25400.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,25.4,CHEMBL613129
5109,2099787.0,[],CHEMBL949220,Antiviral activity against HIV1 BaL by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)N(CCCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nc4c2CCN(C(=O)C(C)(C)C)C4)C3)c2ccccc2)cc1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL255574,CHEMBL255574,8.30,0.0,http://www.openphacts.org/units/Nanomolar,699402.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.005,CHEMBL378
5110,3084543.0,[],CHEMBL1065275,Antiviral activity against HIV1 3B laboratory isolate assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC(C)(C)N1,CHEMBL1153139,Bioorg Med Chem Lett,2010.0,CHEMBL254781,CHEMBL254781,5.10,0.0,http://www.openphacts.org/units/Nanomolar,873907.0,=,1.0,1.0,=,IC50,nM,8000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.0,CHEMBL378
5111,1471985.0,[],CHEMBL834620,Inhibitory activity against HIV-1 mutant strain 188L; ND = not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(/C=C\c2cccnc2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL365911,CHEMBL365911,,0.0,http://www.openphacts.org/units/Nanomolar,380885.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5112,963892.0,[],CHEMBL655544,Inhibition of wild type HIV-1-IIIB strain replication in CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1128194,J Med Chem,1995.0,CHEMBL129,CHEMBL129,8.52,0.0,http://www.openphacts.org/units/Nanomolar,276264.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.0,CHEMBL378
5113,22897175.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4730780,Antiviral activity against Zika virus MR766 infected in human Huh-7 cells assessed as reduction in viral RNA synthesis incubated for 3 days by qRT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1[nH]c2ccc(Cl)cc2c1C(=O)c1cc(OC)c(O)c(OC)c1,CHEMBL4725430,ACS Med Chem Lett,2020.0,CHEMBL4441383,CHEMBL4441383,4.86,0.0,http://www.openphacts.org/units/Nanomolar,3554236.0,=,1.0,1.0,=,IC50,nM,13900.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,13.9,CHEMBL4296612
5114,19257029.0,[],CHEMBL4403220,Antiviral activity against wild type HIV1 3B infected in human MT4 cells using [3H]dGTP by radio-labelled binding assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(N2C(=O)CSC2c2c(F)cccc2F)n1,CHEMBL4402520,Eur J Med Chem,2019.0,CHEMBL296589,CHEMBL296589,7.09,0.0,http://www.openphacts.org/units/Nanomolar,3215074.0,=,1.0,1.0,=,IC50,nM,82.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.082,CHEMBL378
5115,18044395.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,NCC(NC(=O)c1ccc(-c2ccc(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4069596,CHEMBL4069596,6.24,0.0,http://www.openphacts.org/units/Nanomolar,2990212.0,=,1.0,1.0,=,IC50,nM,570.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.57,CHEMBL378
5116,10938619.0,[],CHEMBL2051599,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4cccc(Cl)c4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046574,CHEMBL2046574,,0.0,http://www.openphacts.org/units/Nanomolar,1651457.0,=,1.0,1.0,=,IC50,nM,359000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,359.0,CHEMBL613497
5117,7965919.0,[],CHEMBL1930242,Antiviral activity against R5 tropic Human immunodeficiency virus 1 BAL infected in human PBMC cells assessed as reduction in viral replication by p24 detection based ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1,CHEMBL1926604,Bioorg Med Chem Lett,2011.0,CHEMBL1927008,CHEMBL1927008,8.41,0.0,http://www.openphacts.org/units/Nanomolar,1563644.0,=,1.0,1.0,=,IC50,nM,3.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.9,CHEMBL378
5118,2030615.0,[],CHEMBL886374,Inhibition of cJun translocation in IL-1-beta-stimulated A549 cells,B,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C(=O)N2CCC(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)CC2)CC1,CHEMBL1139954,Bioorg Med Chem Lett,2007.0,CHEMBL245534,CHEMBL245534,5.56,0.0,http://www.openphacts.org/units/Nanomolar,674114.0,=,1.0,1.0,=,IC50,nM,2770.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,nM,UO_0000065,2770.0,CHEMBL4977
5119,705591.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(SSc2ccc(C)cc2[N+](=O)[O-])c([N+](=O)[O-])c1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL333408,CHEMBL333408,,0.0,,228651.0,=,1.0,0.0,=,IC50,,15.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,15.5,CHEMBL378
5120,2930155.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COCC1CN(Cc2c(C)[nH]c(=O)c(I)c2Sc2cc(C)cc(C)c2)CCO1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL575246,CHEMBL575246,9.00,0.0,http://www.openphacts.org/units/Nanomolar,848287.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
5121,12204022.0,[],CHEMBL2211838,Antiviral activity against HIV-1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)C1=NN(C(=O)Nc3ccc(Br)cc3)C(c3ccncc3)C1C2,CHEMBL2203270,Bioorg Med Chem Lett,2012.0,CHEMBL1808367,CHEMBL1808367,,0.0,http://www.openphacts.org/units/Nanomolar,1758544.0,>,1.0,1.0,>,IC50,nM,26470.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,26.47,CHEMBL378
5122,24378492.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5037880,Antiviral activity against HIV1 harboring reverse transcriptase L100I mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect incubated for 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NC2CCCC2)nc(Nc2ccc(C#N)cc2)n1,CHEMBL5036347,Eur J Med Chem,2021.0,CHEMBL5074692,CHEMBL5074692,5.43,0.0,http://www.openphacts.org/units/Nanomolar,3776747.0,=,1.0,1.0,=,IC50,nM,3690.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.69,CHEMBL378
5123,18775481.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCc1ccccc1)CC(C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4287969,CHEMBL4287969,7.00,0.0,http://www.openphacts.org/units/Nanomolar,3119639.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.1,CHEMBL613497
5124,3292021.0,[],CHEMBL1108227,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)nc(C)c1C(=O)N1C[C@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@H]2C1,CHEMBL1157775,Bioorg Med Chem Lett,2010.0,CHEMBL1095827,CHEMBL1095827,9.40,0.0,http://www.openphacts.org/units/Nanomolar,911011.0,=,1.0,1.0,=,IC50,nM,0.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.4,CHEMBL378
5125,3104727.0,[],CHEMBL1065874,Antiviral activity against wild type HIV1 isolate ERS104pre in PHA-stimulated human PBMC assessed as inhibition of p24 antigen production,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,CHEMBL1159037,Bioorg Med Chem Lett,2010.0,CHEMBL1163,CHEMBL1163,8.52,0.0,http://www.openphacts.org/units/Nanomolar,883254.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
5126,18320097.0,[],CHEMBL4134181,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA level incubated for 3 days followed by medium replacement measured after 3 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C2CCCN2C(C2CC2)=NC1c1ccc(F)cc1Cl,CHEMBL4130455,ACS Med Chem Lett,2017.0,CHEMBL4165824,CHEMBL4165824,,0.0,http://www.openphacts.org/units/Nanomolar,3041692.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.0,CHEMBL613497
5127,18543596.0,[],CHEMBL4197995,Antiviral activity against HIV1 NL4-3 infected in human PBMC after 1 hr by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Clc1cc(CN2CCCNCCNCCCNCC2)cc(Cl)n1,CHEMBL4196057,Eur J Med Chem,2018.0,CHEMBL3781567,CHEMBL3781567,5.92,0.0,http://www.openphacts.org/units/Nanomolar,3078718.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.2,CHEMBL378
5128,1252281.0,[],CHEMBL824445,Concentration required to inhibit Junin induced cytopathicity in Vero cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCC(=O)N(CC)CCCCCCCCCCC(=O)NCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL116526,CHEMBL1205574,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221531.0,>,1.0,1.0,>,IC50,ug.mL-1,50.0,CHEMBL612675,Junin virus,Junin virus,11619,IC50,ug ml-1,UO_0000274,50.0,CHEMBL612675
5129,2614777.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc([S+]([O-])c2cccc(N)c2C#N)c1,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL55007,CHEMBL55007,,0.0,http://www.openphacts.org/units/Nanomolar,731470.0,=,1.0,1.0,=,IC50,nM,15995580.29,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,1.796,CHEMBL378
5130,18044526.0,[],CHEMBL4010365,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of p24 antigen production pretreated with virus for 30 mins followed by 4 days incubation with cells by sandwich ELISA based multicycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,CNCC(NC(=O)c1ccc(-c2ccc(C)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4062459,CHEMBL4062459,5.36,0.0,http://www.openphacts.org/units/Nanomolar,2990221.0,=,1.0,1.0,=,IC50,nM,4400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.4,CHEMBL378
5131,3267381.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)CN1Cc2cccc3[nH]c(=O)n(c23)CC1(C)C,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL348749,CHEMBL348749,4.64,0.0,http://www.openphacts.org/units/Nanomolar,906726.0,=,1.0,1.0,=,IC50,nM,22908.68,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.64,CHEMBL378
5132,23274478.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CCC(=O)NCCNC(=O)CC[C@@H](C)[C@H]2CC[C@H]3[C@@H]4[C@@H](O)C[C@@H]5C[C@H](CC[C@]5(C)[C@H]4CC[C@]23C)NC(=O)CN(C)CC(=O)N[C@@H]2CC[C@@]3(C)[C@@H](C2)C[C@H](O)[C@@H]2[C@@H]3CC[C@]3(C)[C@@H]1CC[C@@H]23,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4859530,CHEMBL4859530,5.92,0.0,http://www.openphacts.org/units/Nanomolar,3621278.0,=,1.0,1.0,=,IC50,nM,1206.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,1206.0,CHEMBL613497
5133,693373.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)CCSSCCC(=O)O,CHEMBL1129635,J Med Chem,1996.0,CHEMBL338743,CHEMBL338743,,0.0,,228593.0,>,1.0,0.0,>,IC50,,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,200.0,CHEMBL378
5134,23274468.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](CCc1cn([C@@H]2CC[C@@]3(C)[C@@H](C2)C[C@H](O)[C@@H]2[C@@H]3CC[C@]3(C)[C@@H]([C@H](C)CCC(=O)NCCS(=O)(=O)O)CC[C@@H]23)nn1)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4862057,CHEMBL4862057,7.62,0.0,http://www.openphacts.org/units/Nanomolar,3621268.0,=,1.0,1.0,=,IC50,nM,24.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,24.0,CHEMBL613497
5135,14653478.0,[],CHEMBL3267146,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(CO)[C@H](OC(=O)/C=C/c3cc(OC)c(OC)c(OC)c3)CC[C@@]2(C)[C@@H]1C/C=C1\C=COC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3263004,CHEMBL3263004,,0.0,http://www.openphacts.org/units/Nanomolar,2101887.0,=,1.0,1.0,=,IC50,nM,518000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,518.0,CHEMBL613497
5136,2292366.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1cc(Cl)ccc1Cl,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL301055,CHEMBL301055,,0.0,http://www.openphacts.org/units/Nanomolar,812439.0,=,1.0,1.0,=,IC50,nM,299916.25,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,3.523,CHEMBL378
5137,15200442.0,[],CHEMBL3413997,Antiviral activity against X4 tropic HIV-1 clone pNL4-3 infected in H9 cells assessed as reduction in p24 antigen after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)c1ccc(/C=C(\C#N)c2nc3ccccc3[nH]2)c(O)c1,CHEMBL3407469,Eur J Med Chem,2015.0,CHEMBL1164812,CHEMBL1164812,5.82,0.0,http://www.openphacts.org/units/Nanomolar,2288863.0,=,1.0,1.0,=,IC50,nM,1500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.5,CHEMBL378
5138,24774805.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '72.5', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '72.5'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '96.5', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '96.5'}]",CHEMBL5127501,Antiviral activity against HIV-1 Bal(R5) infected in human CEMx174 5.25M7 cells assessed as reduction in p24 antigen level preincubated for 30 mins followed by infection with cells and measured after 3 to 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cc(-c2ccc(/C=C3\SC(=S)N(CCc4ccc(O)cc4)C3=O)o2)ccc1Cl,CHEMBL5126520,Eur J Med Chem,2022.0,CHEMBL5171918,CHEMBL5171918,6.08,0.0,http://www.openphacts.org/units/Nanomolar,3866046.0,=,1.0,1.0,=,IC50,nM,830.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.83,CHEMBL378
5139,2238637.0,[],CHEMBL1000357,Antiviral activity against HIV 3B in human MT4 cells assessed as inhibition of viral replication by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Oc3ccc4ccccc4c3Br)n2)cc1,CHEMBL1156684,Eur J Med Chem,2008.0,CHEMBL517404,CHEMBL517404,8.03,0.0,http://www.openphacts.org/units/Nanomolar,723239.0,=,1.0,1.0,=,IC50,nM,9.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0094,CHEMBL378
5140,2601649.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc(O)c1O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL36640,CHEMBL36640,4.92,0.0,http://www.openphacts.org/units/Nanomolar,807289.0,=,1.0,1.0,=,IC50,nM,12000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.0,CHEMBL378
5141,12542811.0,[],CHEMBL3076900,Antiviral activity against Human immunodeficiency virus 1 IIIB infected MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,NNc1nc2ccc(Cl)cc2s1,CHEMBL3046062,Med Chem Res,2013.0,CHEMBL1241420,CHEMBL1241420,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824476.0,>,1.0,1.0,>,IC50,ug.mL-1,2.48,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,2.48,CHEMBL378
5142,15568212.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,N#Cc1ccc(C(=O)N2CCN(C(=O)/C=C/c3ccc(Br)cc3)CC2)cc1,CHEMBL1201862,,,CHEMBL3560453,CHEMBL3560453,8.76,0.0,http://www.openphacts.org/units/Nanomolar,2474999.0,=,7.0,1.0,=,IC50,nM,1.74,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.00174,CHEMBL3259470
5143,15156715.0,[],CHEMBL3399640,Decrease in hepatitis B viral surface antigen HBsAg secretion in human HepG2(2.2.15) cells at 0.75 to 3 uM after 72 hrs by EIA analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(C)=O)c(OS(=O)(=O)c2ccccc2)c1,CHEMBL3397002,Eur J Med Chem,2015.0,CHEMBL3397407,CHEMBL3397407,5.14,0.0,http://www.openphacts.org/units/Nanomolar,2279254.0,=,1.0,1.0,=,IC50,nM,7300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,7.3,CHEMBL613497
5144,1486525.0,[],CHEMBL833976,Inhibitory concentration against wild type human immunodeficiency virus type 1 was determined by recombinant virus assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCc1c(O)nc2ccc(Cl)cc2c1OCC1CCCCC1,CHEMBL1138845,J Med Chem,2004.0,CHEMBL191541,CHEMBL191541,5.92,0.0,http://www.openphacts.org/units/Nanomolar,384050.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1200.0,CHEMBL378
5145,23153193.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4810870,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 production treated at 48 hrs post-infection and measured on day 4 post-viral infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1=C[C@H]2[C@@]3(O)[C@H](C)[C@@H](O)[C@]4(OC(=O)CCc5ccccc5)[C@H]([C@@H]3C=C(CO)C[C@]2(O)C1=O)C4(C)C,CHEMBL4808236,Bioorg Med Chem Lett,2021.0,CHEMBL4862166,CHEMBL4862166,5.26,0.0,http://www.openphacts.org/units/Nanomolar,3599001.0,=,1.0,1.0,=,IC50,nM,5460.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5460.0,CHEMBL378
5146,20597793.0,[],CHEMBL4602746,Antiviral activity against CHIKV,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(S(=O)(=O)Nc2cccc(C(c3c(O)c4c(oc3=O)CCCCCC4)C3CC3)c2)cc1,CHEMBL4602601,Eur J Med Chem,2019.0,CHEMBL2062136,CHEMBL2062136,8.82,0.0,http://www.openphacts.org/units/Nanomolar,3464606.0,=,1.0,1.0,=,IC50,nM,1.5,CHEMBL4296563,Chikungunya virus,Chikungunya virus,37124,IC50,nM,UO_0000065,1.5,CHEMBL4296563
5147,2649361.0,[],CHEMBL1024326,"Antiviral activity against HIV1 expressed in 293T cells assessed as protection against viral M33 envelope infection in human U87 cells coexpressing CD4, CCR5 receptors after 72 hrs by luciferase reporter gene pseudoviral assay",F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1ccc(-c2cc[nH]n2)nc1,CHEMBL1158460,J Med Chem,2009.0,CHEMBL538684,CHEMBL538684,6.00,0.0,http://www.openphacts.org/units/Nanomolar,816500.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
5148,3008332.0,[],CHEMBL1037279,Antiviral activity against Human immunodeficiency virus 1 NL4-3 infected HeLaP4 cells after 5 days by beta-galactosidase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(Oc1cncc2ccccc12)C(=O)N1CCN(C(=O)c2ccccc2)C[C@H]1C,CHEMBL1155317,Bioorg Med Chem Lett,2009.0,CHEMBL576516,CHEMBL576516,,0.0,,861799.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5149,18775537.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COCCCOc1cc2c(cc1OC)-c1cc(=O)c(C(=O)O)cn1C(CC(F)(F)F)C2,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4291031,CHEMBL4291031,7.41,0.0,http://www.openphacts.org/units/Nanomolar,3119695.0,=,1.0,1.0,=,IC50,nM,39.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.039,CHEMBL613497
5150,22449758.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.5', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.5'}]",CHEMBL4680708,Antiviral activity against HIV1 pseudotyped with A-MLV envelop glycoprotein infected in dog Cf2Th/CD4-CCR5 cells assessed as inhibition of viral entry incubated for 30 mins prior to infection and measured after 48 hrs post infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(Cc1ccc2c(c1)[C@H](NC(=O)C(=O)Nc1ccc(Cl)c(F)c1)[C@@H](CNC(=N)N)C2)C(=N)N.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4680075,ACS Med Chem Lett,2016.0,CHEMBL4763274,CHEMBL4803130,4.08,0.0,http://www.openphacts.org/units/Nanomolar,3518674.0,=,1.0,1.0,=,IC50,nM,83700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,83.7,CHEMBL378
5151,10961087.0,[],CHEMBL2061265,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M8 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CN)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057463,CHEMBL2057463,6.70,0.0,http://www.openphacts.org/units/Nanomolar,1655125.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,200.0,CHEMBL378
5152,7924563.0,[],CHEMBL1921361,Antiviral activity against Human immunodeficiency virus 1 Ba-L by in human HOS cells assessed as inhibition of viarl entry by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(NS(C)(=O)=O)cc2Cl)ccc1CN1CCC(N(C(=O)Nc2ccc(C(N)=O)nc2)c2cccc(F)c2)CC1,CHEMBL1914281,Bioorg Med Chem Lett,2011.0,CHEMBL1914528,CHEMBL1914528,8.92,0.0,http://www.openphacts.org/units/Nanomolar,1556603.0,=,1.0,1.0,=,IC50,nM,1.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.2,CHEMBL378
5153,15606419.0,[],CHEMBL3579362,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBV DNA replication by real-time fluorescence quantitative PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(C=O)cc(OC)c1OC,CHEMBL3576819,Eur J Med Chem,2015.0,CHEMBL3577781,CHEMBL3577781,,0.0,,2480514.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
5154,1283594.0,[],CHEMBL756142,Tested for the inhibition of p24 production in HIV-1 IIIB infected human peripheral blood mononuclear cells (PBMC),F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@@H](C[C@H](O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)COc1cccc2ccccc12)C(C)C)C(=O)N(C)c1ccccn1,CHEMBL1126785,J Med Chem,1993.0,CHEMBL313256,CHEMBL313256,6.52,0.0,http://www.openphacts.org/units/Nanomolar,156146.0,=,1.0,1.0,=,IC50,nM,300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.3,CHEMBL378
5155,613867.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Cl)cc(C)c1Oc1nc(N)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL71659,CHEMBL71659,8.46,0.0,http://www.openphacts.org/units/Nanomolar,126911.0,=,1.0,1.0,=,IC50,nM,3.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0035,CHEMBL378
5156,18812976.0,[],CHEMBL4276408,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,CHEMBL4270667,J Med Chem,2018.0,CHEMBL729,CHEMBL729,8.22,0.0,http://www.openphacts.org/units/Nanomolar,3125924.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.0,CHEMBL378
5157,6216964.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(NS(=O)(=O)C(C)C)c(F)cc2F)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784526,CHEMBL1784526,8.37,0.0,http://www.openphacts.org/units/Nanomolar,1429466.0,=,1.0,1.0,=,IC50,nM,4.266,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,8.37,CHEMBL378
5158,2929762.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CSCC3CCCO3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL576627,CHEMBL576627,7.20,0.0,http://www.openphacts.org/units/Nanomolar,852994.0,=,1.0,1.0,=,IC50,nM,63.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,63.0,CHEMBL378
5159,14999586.0,[],CHEMBL3364435,Antiviral activity against HIV1 harboring reverse transcriptase K103N/G190A double mutant infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL57,CHEMBL57,,0.0,http://www.openphacts.org/units/Nanomolar,2248839.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
5160,2929655.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(COCC3CCCO3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567214,CHEMBL567214,6.30,0.0,http://www.openphacts.org/units/Nanomolar,852932.0,=,1.0,1.0,=,IC50,nM,501.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,501.0,CHEMBL378
5161,2997378.0,[],CHEMBL1046975,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C(=N/C2CC2)c2ccc(=O)n(C3CC3)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL566275,CHEMBL566275,5.00,0.0,http://www.openphacts.org/units/Nanomolar,856684.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.0,CHEMBL613497
5162,2997411.0,[],CHEMBL1047854,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV DNA replication after 9 days by PCR,F,BAO_0000190,BAO_0000218,organism-based format,CCC/N=C(\c1ccc(=O)n(CCC)c1)c1ccc(OC)cc1O,CHEMBL1156796,J Med Chem,2010.0,CHEMBL567347,CHEMBL567347,4.47,0.0,http://www.openphacts.org/units/Nanomolar,856558.0,=,1.0,1.0,=,IC50,nM,33800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,33.8,CHEMBL613497
5163,2694338.0,[],CHEMBL1053931,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBV surface antigen at < TC50,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2nc3c(cc2c(CN2CCCC2)c1O)CSc1cc(F)ccc1-3,CHEMBL1152943,Bioorg Med Chem,2009.0,CHEMBL558704,CHEMBL558704,,0.0,,825103.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
5164,18044766.0,[],CHEMBL4010413,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype D QD435.100M.ENV.B5,F,BAO_0000190,BAO_0000019,assay format,Cc1nc(C(NC(=O)c2ccc(-c3ccc(Cl)cc3)[nH]2)C2CCCCN2)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4096918,CHEMBL4096918,5.85,0.0,http://www.openphacts.org/units/Nanomolar,2990237.0,=,1.0,1.0,=,IC50,nM,1400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.4,CHEMBL378
5165,2149875.0,[],CHEMBL935683,Antiviral activity against HIV1 098-T651 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL440443,CHEMBL440443,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708031.0,=,1.0,1.0,=,IC50,ug.mL-1,0.167,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.167,CHEMBL378
5166,19261924.0,[],CHEMBL4404389,Antiviral activity against HIV1 subtypeB WEAUd15.410.5017,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.12,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,760.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.76,CHEMBL378
5167,22806641.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@@H](Sc3nccc(C(F)(F)F)n3)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4758962,CHEMBL4758962,5.30,0.0,http://www.openphacts.org/units/Nanomolar,3541917.0,=,1.0,1.0,=,IC50,nM,4955.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,4.955,CHEMBL613497
5168,18202523.0,[],CHEMBL4043712,Antiviral activity against HIV1 LAI infected in human MT2 cells assessed as reduction in p24 Gag protein production incubated for 6 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cccc(C(=O)N3CCC[C@@H]3c3nc(C)co3)c2)cc1,CHEMBL4043088,Bioorg Med Chem,2017.0,CHEMBL4099188,CHEMBL4099188,7.48,0.0,http://www.openphacts.org/units/Nanomolar,3019937.0,=,1.0,1.0,=,IC50,nM,33.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,33.0,CHEMBL378
5169,242760.0,[],CHEMBL714981,Inhibition of antiviral activity against moloney murine sarcoma virus(MSV)in CEM cells in cell protection assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc2c(ncn2CCOCP(=O)(O)O)c(=O)[nH]1,CHEMBL1134666,J Med Chem,2001.0,CHEMBL223737,CHEMBL223737,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,233584.0,=,1.0,1.0,=,IC50,ug.mL-1,0.19,CHEMBL613501,Moloney murine sarcoma virus,Moloney murine sarcoma virus,11809,IC50,ug ml-1,UO_0000274,0.19,CHEMBL613501
5170,22983731.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '144.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '6.0'}]",CHEMBL4773497,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication supplemented with fresh medium containing compound every 2 days for 6 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)CCOc1ccc2nc(SCc3ccccc3OC)n(Cc3ccco3)c(=O)c2c1,CHEMBL4765418,Eur J Med Chem,2020.0,CHEMBL4777824,CHEMBL4777824,6.11,0.0,http://www.openphacts.org/units/Nanomolar,3569409.0,=,1.0,1.0,=,IC50,nM,770.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.77,CHEMBL613497
5171,18940424.0,[],CHEMBL4328848,Antiviral activity against HIV-1 3B infected in human MAGI-CXCR4 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cn1ccc2ccc(-c3ccc4cnn(Cc5cc(F)cc(C(=O)O)c5)c4c3)cc21,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4442212,CHEMBL4442212,,0.0,http://www.openphacts.org/units/Nanomolar,3159825.0,>,1.0,1.0,>,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
5172,1193616.0,[],CHEMBL645946,Concentration required to inhibit activator protein-1(AP-1) mediated transcriptional activation in human Jurkat T-cells,B,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cnc(Cl)nc1-c1ccccc1,CHEMBL1133475,J Med Chem,2000.0,CHEMBL423150,CHEMBL423150,6.40,1.0,http://www.openphacts.org/units/Nanomolar,247706.0,=,1.0,1.0,=,IC50,nM,400.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.4,CHEMBL4977
5173,435963.0,[],CHEMBL683810,Antiviral activities against HIV-1 replication in CEM cells and its ability to lower the viral charge supernatants was reported,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2ccc(/C=C/c3cc(O)c(O)c(O)c3)nc2c1O,CHEMBL1133718,J Med Chem,2000.0,CHEMBL37869,CHEMBL37869,5.92,0.0,http://www.openphacts.org/units/Nanomolar,61393.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.2,CHEMBL378
5174,1477165.0,[],CHEMBL837273,Antiviral activity against human immunodeficiency virus type 1 by using MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(CCc1ccccc1)c1ccc2ccc(/C=C/c3ccc(O)c(O)c3)nc2c1O,CHEMBL1140355,Bioorg Med Chem Lett,2005.0,CHEMBL188040,CHEMBL188040,5.70,0.0,http://www.openphacts.org/units/Nanomolar,382483.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.0,CHEMBL378
5175,16556873.0,[],CHEMBL3795205,Antiviral activity against CXCR4 using HIV-1 NL4.3 infected in human MT4 cells assessed as reduction of viral replication preincubated for 15 mins with cells followed by viral infection measured after 4 days by MTS/PES method,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(Cc2ccccc2)CCCN(S(=O)(=O)c2ccc(N)cc2)C1.Cl,CHEMBL3792300,J Med Chem,2016.0,CHEMBL3793524,CHEMBL3794633,5.11,0.0,http://www.openphacts.org/units/Nanomolar,2770903.0,=,1.0,1.0,=,IC50,nM,7720.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.72,CHEMBL378
5176,1401893.0,[],CHEMBL833792,In vitro inhibitory concentration against HIV-1 Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)Nc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL128569,CHEMBL128569,4.00,0.0,http://www.openphacts.org/units/Nanomolar,360373.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5177,2930172.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(=O)CSCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL577277,CHEMBL577277,8.40,0.0,http://www.openphacts.org/units/Nanomolar,852931.0,=,1.0,1.0,=,IC50,nM,3.98,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.98,CHEMBL378
5178,24726194.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5114432,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in viral replication incubated for 48 hrs followed by addition of fresh medium containing compound measured after 2 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCCC/C=C/C=C/O[C@@]12[C@@H]([C@H]3OCO[C@@]3(C(C)=O)[C@H](OC(=O)CCCCC)[C@H]1C)[C@@H]1O[C@]1(CO)[C@@H](O)[C@]1(O)C(=O)C(C)=C[C@H]12,CHEMBL5113385,Eur J Med Chem,2022.0,CHEMBL5205083,CHEMBL5205083,9.05,0.0,http://www.openphacts.org/units/Nanomolar,3856996.0,=,1.0,1.0,=,IC50,nM,0.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.9,CHEMBL378
5179,12204018.0,[],CHEMBL2211838,Antiviral activity against HIV-1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)C1=NN(C(=O)Nc3ccc(Br)cc3)C(c3ccccc3)C1C2,CHEMBL2203270,Bioorg Med Chem Lett,2012.0,CHEMBL1808371,CHEMBL1808371,,0.0,http://www.openphacts.org/units/Nanomolar,1758548.0,>,1.0,1.0,>,IC50,nM,86030.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,86.03,CHEMBL378
5180,2930145.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL338047,CHEMBL338047,7.50,0.0,http://www.openphacts.org/units/Nanomolar,848385.0,=,1.0,1.0,=,IC50,nM,31.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.6,CHEMBL378
5181,12663841.0,[],CHEMBL2330342,Antiviral activity against T20-resistant Human immunodeficiency virus 1 NL4-3 harboring gp41 NHR (36G)V38A/N42T mutation infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@@H](C)CC)[C@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O,CHEMBL2321797,J Med Chem,2013.0,CHEMBL2326637,CHEMBL2326637,7.07,0.0,http://www.openphacts.org/units/Nanomolar,1853137.0,=,1.0,1.0,=,IC50,nM,85.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,85.5,CHEMBL378
5182,677553.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,S=C(SSC(=S)N1CCCCC1)N1CCCCC1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL121516,CHEMBL121516,,0.0,,228577.0,=,1.0,0.0,=,IC50,,29.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,29.5,CHEMBL378
5183,905038.0,[],CHEMBL650153,Compound was tested for anti-retroviral activity against moloney murine sarcoma virus (MSV) in murine C3H/3T3 embryo fibroblast cell culture,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(N)c2nnn(C[C@H](O)CO)c2n1,CHEMBL1129435,J Med Chem,1996.0,CHEMBL340543,CHEMBL340543,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251936.0,>,1.0,1.0,>,IC50,ug.mL-1,40.0,CHEMBL613501,Moloney murine sarcoma virus,Moloney murine sarcoma virus,11809,IC50,ug ml-1,UO_0000274,40.0,CHEMBL613501
5184,615365.0,[],CHEMBL710373,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)c1nc(Cc2c(Cl)cccc2Cl)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL421492,CHEMBL421492,4.49,0.0,http://www.openphacts.org/units/Nanomolar,126905.0,=,1.0,1.0,=,IC50,nM,32200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,32.2,CHEMBL378
5185,2203591.0,[],CHEMBL987023,Antiviral activity against HIV1 3B in human MT4 cells assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CCNC(=S)Nc1ccc(-c2n[nH]c(=S)n2C)cc1,CHEMBL1149790,Eur J Med Chem,2008.0,CHEMBL48049,CHEMBL48049,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,765656.0,>,1.0,1.0,>,IC50,ug.mL-1,78.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,78.2,CHEMBL378
5186,3407241.0,[],CHEMBL1219014,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1,CHEMBL1212869,Bioorg Med Chem,2010.0,CHEMBL1460,CHEMBL1460,5.27,0.0,http://www.openphacts.org/units/Nanomolar,932592.0,=,1.0,1.0,=,IC50,nM,5370.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.37,CHEMBL378
5187,10866430.0,[],CHEMBL2025517,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HbeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)c4ccnn4C)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024031,CHEMBL2024031,,0.0,http://www.openphacts.org/units/Nanomolar,1639753.0,>,1.0,1.0,>,IC50,nM,720990.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,720.99,CHEMBL613497
5188,1402038.0,[],CHEMBL837462,In vitro inhibitory concentration against HIV E138K mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCCCO)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL176107,CHEMBL176107,,0.0,http://www.openphacts.org/units/Nanomolar,360364.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5189,13861111.0,[],CHEMBL3101351,Antiviral activity against HIV1 NL4.3 infected in human TZM-bl cells expressing CXCR4-tropic incubated for 1 hr prior to infection measured after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCCC1=CCc2ccc(O)c(O)c2C1,CHEMBL3098125,Bioorg Med Chem Lett,2014.0,CHEMBL3099064,CHEMBL3099064,4.91,0.0,http://www.openphacts.org/units/Nanomolar,1956067.0,=,1.0,1.0,=,IC50,nM,12300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.3,CHEMBL378
5190,6257659.0,[],CHEMBL1798704,Antiviral activity against HIV1 3B infected in human MT4 cells coinjected with HTLV1 assessed as reduction in virus induced cytopathicity measured 5 days post infection by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2[C@H]1C=C[C@]2(CO)C[C@H]12,CHEMBL1795267,Bioorg Med Chem,2011.0,CHEMBL1795536,CHEMBL1795536,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1435348.0,=,1.0,1.0,=,IC50,ug.mL-1,40.47,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,40.47,CHEMBL378
5191,684414.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,COS(=O)CCOC(=O)c1ccccc1SSc1ccccc1C(=O)OCCS(=O)OC,CHEMBL1129635,J Med Chem,1996.0,CHEMBL333765,CHEMBL333765,,0.0,,228643.0,>,1.0,0.0,>,IC50,,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,200.0,CHEMBL378
5192,3596589.0,[],CHEMBL1292013,Antiviral activity against HIV1 BaL in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(CNC(=O)N(c2cccc(F)c2)C2CCN(CCC3(c4cccc(F)c4)CCN(C(=O)c4cc(S(=O)(=O)N5CC[C@H](O)C5)c(F)cc4Cl)CC3)CC2)cc1,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288665,CHEMBL1288665,8.82,0.0,http://www.openphacts.org/units/Nanomolar,973775.0,=,1.0,1.0,=,IC50,nM,1.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.5,CHEMBL378
5193,18342079.0,[],CHEMBL4139011,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/Nanomolar,3045885.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
5194,5199505.0,[],CHEMBL1670946,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1nc2ccc(Cl)cc2c(-c2ccccc2Cl)c1CCO,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668634,CHEMBL1668634,,0.0,http://www.openphacts.org/units/Nanomolar,1328418.0,>,1.0,1.0,>,IC50,nM,2708900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2708.9,CHEMBL613497
5195,2930176.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CSCc3ccco3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL575884,CHEMBL575884,8.30,0.0,http://www.openphacts.org/units/Nanomolar,848311.0,=,1.0,1.0,=,IC50,nM,5.01,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.01,CHEMBL378
5196,994785.0,[],CHEMBL714338,"Antiviral activity against HIV-1, IIIB, in MT-4 Cells",F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CN[C@@H](C(=O)NC2c3ccccc3C[C@H]2O)[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CSc2nncn2C)C(C)(C)C)cc1,CHEMBL1129316,J Med Chem,1996.0,CHEMBL66085,CHEMBL66085,6.72,0.0,http://www.openphacts.org/units/Nanomolar,111236.0,=,1.0,1.0,=,IC50,nM,190.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,190.0,CHEMBL378
5197,468960.0,[],CHEMBL683810,Antiviral activities against HIV-1 replication in CEM cells and its ability to lower the viral charge supernatants was reported,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc(OC)c1O,CHEMBL1133718,J Med Chem,2000.0,CHEMBL37431,CHEMBL37431,5.05,0.0,http://www.openphacts.org/units/Nanomolar,61378.0,=,1.0,1.0,=,IC50,nM,9000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,9.0,CHEMBL378
5198,627969.0,[],CHEMBL710534,Inhibitory activity against 188L strain of HIV-1 in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Oc2nc(N)nc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL71521,CHEMBL71521,6.74,0.0,http://www.openphacts.org/units/Nanomolar,126896.0,=,1.0,1.0,=,IC50,nM,182.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.182,CHEMBL378
5199,24823552.0,[],CHEMBL5140686,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBsAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3cc(Br)ccc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5195944,CHEMBL5195944,7.46,0.0,http://www.openphacts.org/units/Nanomolar,3876726.0,=,1.0,1.0,=,IC50,nM,34.3,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0343,CHEMBL613497
5200,18683319.0,[],CHEMBL4237101,Antiviral activity against CCR5-dependent HIV1 Ba-L infected in human PM1 cells assessed as reduction in virus infection measured after 5 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCCC1)c1cccs1,CHEMBL4229569,J Med Chem,2018.0,CHEMBL4238063,CHEMBL4238063,8.47,0.0,http://www.openphacts.org/units/Nanomolar,3103098.0,=,1.0,1.0,=,IC50,nM,3.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.4,CHEMBL378
5201,1402485.0,[],CHEMBL833792,In vitro inhibitory concentration against HIV-1 Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177666,CHEMBL177666,7.50,0.0,http://www.openphacts.org/units/Nanomolar,360358.0,=,1.0,1.0,=,IC50,nM,32.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.032,CHEMBL378
5202,2371282.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,BrCc1ccc(-c2noc(-c3ccncc3)n2)cc1,CHEMBL1140145,J Med Chem,2008.0,CHEMBL494691,CHEMBL494691,5.89,0.0,http://www.openphacts.org/units/Nanomolar,745584.0,=,1.0,1.0,=,IC50,nM,1300.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,1.3,CHEMBL613493
5203,8043655.0,[],CHEMBL1953039,Antiviral activity against HIV1 3B infected human TZM-bl cells assessed as inhibition of viral replication by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1949531,Bioorg Med Chem Lett,2012.0,CHEMBL129,CHEMBL129,8.55,0.0,http://www.openphacts.org/units/Nanomolar,1579957.0,=,1.0,1.0,=,IC50,nM,2.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0028,CHEMBL378
5204,10938630.0,[],CHEMBL2051599,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C=C/C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(O)C(C)=O)C2)cc1OC,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046560,CHEMBL2046560,4.07,0.0,http://www.openphacts.org/units/Nanomolar,1651443.0,=,1.0,1.0,=,IC50,nM,85250.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,85.25,CHEMBL613497
5205,10961146.0,[],CHEMBL2061266,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M9 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL1323,CHEMBL1323,7.60,0.0,http://www.openphacts.org/units/Nanomolar,1655448.0,=,1.0,1.0,=,IC50,nM,25.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,25.0,CHEMBL378
5206,1402045.0,[],CHEMBL835252,In vitro inhibitory concentration against HIV K101E and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC(C)=O)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL129144,CHEMBL129144,,0.0,http://www.openphacts.org/units/Nanomolar,360368.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5207,5248973.0,[],CHEMBL1685193,Antiviral activity against X4 tropic HIV1 NL4.3 infected in CD4 and CXCR4 expressing human MT4 cells assessed as inhibition of viral cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(CN(CCCCN)C2CCCc3cccnc32)n1,CHEMBL1681661,Bioorg Med Chem Lett,2011.0,CHEMBL1682857,CHEMBL1682857,8.54,0.0,http://www.openphacts.org/units/Nanomolar,1333979.0,=,1.0,1.0,=,IC50,nM,2.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.9,CHEMBL378
5208,3008372.0,[],CHEMBL1037279,Antiviral activity against Human immunodeficiency virus 1 NL4-3 infected HeLaP4 cells after 5 days by beta-galactosidase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(=O)c1cc(OC)c(O[C@@H](C)C(=O)N2CCN(c3nccc4ccccc34)C[C@H]2C)cn1,CHEMBL1155317,Bioorg Med Chem Lett,2009.0,CHEMBL569621,CHEMBL569621,9.92,0.0,http://www.openphacts.org/units/Nanomolar,861699.0,=,1.0,1.0,=,IC50,nM,0.12,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.12,CHEMBL378
5209,1421805.0,[],CHEMBL824926,Inhibitory activity against human immunodeficiency virus type 1 (inactive>0.1),F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(SC2CCCCC2)n(COCN(C(=O)c2ccccc2)C(=O)c2ccccc2)c(=O)[nH]c1=O,CHEMBL1144258,Bioorg Med Chem Lett,2005.0,CHEMBL182189,CHEMBL182189,,0.0,http://www.openphacts.org/units/Nanomolar,364846.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5210,1032895.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(NN2C(S)=NC(C(C)C)C2c2ccccc2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL287787,CHEMBL287787,,0.0,http://www.openphacts.org/units/Nanomolar,62365.0,>,1.0,1.0,>,IC50,nM,42630.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,42.63,CHEMBL613499
5211,24823550.0,[],CHEMBL5140686,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBsAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3ccc(Cl)cc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5179481,CHEMBL5179481,8.11,0.0,http://www.openphacts.org/units/Nanomolar,3876724.0,=,1.0,1.0,=,IC50,nM,7.7,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0077,CHEMBL613497
5212,3509152.0,[],CHEMBL1261040,Antiviral activity against HIV1 harboring reverse transcriptase K103N/Y181C double mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(Cl)c1Oc1ccnc(NC2CCN(c3cccc(C(N)=O)c3)CC2)n1,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1257905,CHEMBL1257905,8.28,0.0,http://www.openphacts.org/units/Nanomolar,962831.0,=,1.0,1.0,=,IC50,nM,5.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.3,CHEMBL378
5213,609121.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Nc2ncnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL71728,CHEMBL71728,8.10,0.0,http://www.openphacts.org/units/Nanomolar,126924.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
5214,12135666.0,[],CHEMBL2187933,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as p24 antigen level after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCC(CCCC(=O)NC)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2176886,J Med Chem,2012.0,CHEMBL450069,CHEMBL450069,6.62,0.0,http://www.openphacts.org/units/Nanomolar,1752690.0,=,1.0,1.0,=,IC50,nM,240.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.24,CHEMBL378
5215,15606027.0,[],CHEMBL3579360,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/c1ccc2c(c1)OCO2)O/N=C/c1ccccn1,CHEMBL3576819,Eur J Med Chem,2015.0,CHEMBL3577790,CHEMBL3577790,5.21,0.0,http://www.openphacts.org/units/Nanomolar,2480530.0,=,1.0,1.0,=,IC50,nM,6200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,6.2,CHEMBL613497
5216,1402383.0,[],CHEMBL837463,In vitro inhibitory concentration against HIV F227C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC(N)=S)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369148,CHEMBL369148,,0.0,http://www.openphacts.org/units/Nanomolar,360422.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5217,14658864.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)c3ccc4c(c3)CCO4)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262891,CHEMBL3262891,7.54,0.0,http://www.openphacts.org/units/Nanomolar,2101733.0,=,1.0,1.0,=,IC50,nM,28.84,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,pIC50,,UO_0000065,7.54,CHEMBL3259471
5218,12542801.0,[],CHEMBL3076900,Antiviral activity against Human immunodeficiency virus 1 IIIB infected MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=[N+]([O-])c1ccc(-c2nnc(-c3cccnc3)n2Nc2nc3ccc(Cl)cc3s2)cc1,CHEMBL3046062,Med Chem Res,2013.0,CHEMBL2282276,CHEMBL2282276,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824486.0,>,1.0,1.0,>,IC50,ug.mL-1,53.68,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,53.68,CHEMBL378
5219,18399193.0,[],CHEMBL4149754,Inhibition of human Pit-1 expressed in HEK293 cells coexpressing tetracyclin assessed as reduction in uptake of 33P-radiolabeled Pi incubated for 20 to 30 mins prior to substrate addition,B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(NS(=O)(=O)c2cccc(C(F)(F)F)c2)c(C(=O)Nc2ccc(Cl)cc2)c1,CHEMBL4145593,ACS Med Chem Lett,2018.0,CHEMBL4170023,CHEMBL4170023,5.82,0.0,http://www.openphacts.org/units/Nanomolar,3053873.0,=,1.0,1.0,=,IC50,nM,1500.0,CHEMBL4295909,Homo sapiens,Sodium-dependent phosphate transporter 1,9606,IC50,uM,UO_0000065,1.5,CHEMBL4295909
5220,24383454.0,[],CHEMBL5039284,Antiviral activity against HIV 1 IIIB(X5) incubated overnight by ELISA analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC,CHEMBL5038580,J Med Chem,2022.0,CHEMBL5078598,CHEMBL5078598,7.73,0.0,http://www.openphacts.org/units/Nanomolar,3777695.0,=,1.0,1.0,=,IC50,nM,18.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,18.5,CHEMBL378
5221,23284028.0,[],CHEMBL4837921,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN(C)C1)S(=O)(=O)c1ccc(N)cc1,CHEMBL4837199,Eur J Med Chem,2021.0,CHEMBL4863180,CHEMBL4863180,8.87,0.0,http://www.openphacts.org/units/Nanomolar,3622960.0,=,1.0,1.0,=,IC50,nM,1.35,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.35,CHEMBL378
5222,24421208.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5048799,Antiviral activity against HIV-1 Z1800M E4.02 (R5) pseudovirus infected in human TZM-blcells assessed as reduction in viral infectivity measured after 48 hrs of postinfection by luminescence assay,F,BAO_0000190,BAO_0000218,organism-based format,c1cnc2c(c1)CN[C@@H](CN(CCCCNC1COC1)[C@H]1CCCc3cccnc31)C2,CHEMBL5046278,J Med Chem,2022.0,CHEMBL5083458,CHEMBL5083458,,0.0,http://www.openphacts.org/units/Nanomolar,3784601.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10000.0,CHEMBL378
5223,24777533.0,[],CHEMBL5128765,Antiviral activity against HIV-1 NL4-3(X4) infected in human TZM-bl cells assessed as reduction in viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@H](NC(=O)CCCCCCCNC(=O)[C@]12CC[C@@H](C)[C@H](C)[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)[C@H](O)CC(=O)O,CHEMBL5126557,Bioorg Med Chem Lett,2022.0,CHEMBL5201771,CHEMBL5201771,5.41,0.0,http://www.openphacts.org/units/Nanomolar,3867173.0,=,1.0,1.0,=,IC50,nM,3900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.9,CHEMBL378
5224,18044773.0,[],CHEMBL4010388,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype D/A BF535.W6M.ENV.A1,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.03,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,940.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.94,CHEMBL378
5225,2099813.0,[],CHEMBL949221,Antiviral activity against HIV1 97-ZA-003 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL257271,CHEMBL257271,8.30,0.0,http://www.openphacts.org/units/Nanomolar,699398.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.005,CHEMBL378
5226,1206567.0,[],CHEMBL710537,Inhibitory activity against 188L strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1N,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72528,CHEMBL72528,8.24,0.0,http://www.openphacts.org/units/Nanomolar,127438.0,=,1.0,1.0,=,IC50,nM,5.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0057,CHEMBL378
5227,18812977.0,[],CHEMBL4276409,Antiviral activity against Atazanavir-resistant HIV1 infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,CHEMBL4270667,J Med Chem,2018.0,CHEMBL729,CHEMBL729,6.51,0.0,http://www.openphacts.org/units/Nanomolar,3125924.0,=,1.0,1.0,=,IC50,nM,311.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,311.0,CHEMBL378
5228,1755861.0,[],CHEMBL865477,Antiviral activity against HIV1 NL4-3,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1146190,Bioorg Med Chem Lett,2006.0,CHEMBL129,CHEMBL129,8.76,0.0,http://www.openphacts.org/units/Nanomolar,547150.0,=,1.0,1.0,=,IC50,nM,1.75,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.75,CHEMBL378
5229,697711.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(SSc2ccc(C)c(Cl)c2)cc1Cl,CHEMBL1129635,J Med Chem,1996.0,CHEMBL332954,CHEMBL332954,,0.0,,228625.0,>,1.0,0.0,>,IC50,,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,200.0,CHEMBL378
5230,2272906.0,[],CHEMBL956847,Antiviral activity against HIV1 Bal in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1[C@H]1C[C@H]2CC[C@@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)N2CCOCC2)CC1,CHEMBL1153314,Bioorg Med Chem Lett,2009.0,CHEMBL508250,CHEMBL508250,7.68,0.0,http://www.openphacts.org/units/Nanomolar,755534.0,=,1.0,1.0,=,IC50,nM,20.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0207,CHEMBL378
5231,5248982.0,[],CHEMBL1685193,Antiviral activity against X4 tropic HIV1 NL4.3 infected in CD4 and CXCR4 expressing human MT4 cells assessed as inhibition of viral cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(Cc1ncccc1Cl)C1CCCc2cccnc21,CHEMBL1681661,Bioorg Med Chem Lett,2011.0,CHEMBL1682866,CHEMBL1682866,9.40,0.0,http://www.openphacts.org/units/Nanomolar,1333988.0,=,1.0,1.0,=,IC50,nM,0.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.4,CHEMBL378
5232,5222669.0,[],CHEMBL1675426,Antiviral activity against HIV1 harboring reverse transcriptase K65R mutant infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C.O=C(O)/C=C/C(=O)O,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL1486,CHEMBL1538,4.94,0.0,http://www.openphacts.org/units/Nanomolar,1332022.0,=,1.0,1.0,=,IC50,nM,11400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,11.4,CHEMBL378
5233,3465407.0,[],CHEMBL1250682,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,C#C[C@@]1(OCP(=O)(O)O)C=C[C@H](n2cc(C)c(=O)[nH]c2=O)O1,CHEMBL1250548,Bioorg Med Chem,2010.0,CHEMBL1254005,CHEMBL1254005,,0.0,http://www.openphacts.org/units/Nanomolar,956155.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5234,13463770.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc([S+]([O-])c2cccc(N)c2C#N)cc(C(F)(F)F)c1,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL55387,CHEMBL55387,5.68,0.0,http://www.openphacts.org/units/Nanomolar,1920701.0,=,1.0,1.0,=,IC50,nM,2089.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.68,CHEMBL378
5235,15679665.0,[],CHEMBL3607181,Antiviral activity against HBV infected in human HepG22.2.15 cells after 3 days by neutral red dye-based plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(F)cc2c1ncn2[C@@H]1C=C(CO)[C@@H](O)[C@H]1O,CHEMBL3603790,Bioorg Med Chem,2015.0,CHEMBL3604363,CHEMBL3604363,6.17,0.0,http://www.openphacts.org/units/Nanomolar,2494266.0,=,1.0,1.0,=,IC50,nM,670.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.67,CHEMBL613497
5236,1671924.0,[],CHEMBL870624,Antiviral activity against HIV1 K103N mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(N2CC[S+]([O-])CC2)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1ccccc1C#N,CHEMBL1147746,J Med Chem,2006.0,CHEMBL383375,CHEMBL383375,6.81,0.0,http://www.openphacts.org/units/Nanomolar,411922.0,=,1.0,1.0,=,IC50,nM,155.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,155.0,CHEMBL378
5237,19261907.0,[],CHEMBL4404384,Antiviral activity against HIV1 subtypeB 1006_11.C3.1601,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.57,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,270.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.27,CHEMBL378
5238,12091415.0,[],CHEMBL2168515,Antiviral activity against R5 tropic HIV1 Ba-L infected human PBMC assessed as inhibition of viral replication by p-24 antigen specific ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)[n+]([O-])c2Cl)CC1,CHEMBL2163215,ACS Med Chem Lett,2012.0,CHEMBL2164209,CHEMBL2164209,8.14,0.0,http://www.openphacts.org/units/Nanomolar,1736632.0,=,1.0,1.0,=,IC50,nM,7.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.3,CHEMBL378
5239,24830941.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,NC1CCN(c2ccc3c(=O)c4cccc(F)c4oc3c2)C1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5209207,CHEMBL5209207,5.31,0.0,http://www.openphacts.org/units/Nanomolar,3878114.0,=,1.0,1.0,=,IC50,nM,4850.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,4.85,CHEMBL613497
5240,2530525.0,[],CHEMBL1011336,Antiviral activity against Rift Valley fever virus infected in african green monkey Vero cells after 6 days by plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@H](OC(C)=O)C=C2c3cc4c(cc3C(=O)N[C@H]21)OCO4,CHEMBL1150051,J Nat Prod,1992.0,CHEMBL490147,CHEMBL490147,,0.0,,790638.0,,1.0,0.0,,IC50,,,CHEMBL613130,Rift Valley fever virus,Rift Valley fever virus,11588,IC50,,,,CHEMBL613130
5241,3509133.0,[],CHEMBL1261038,Antiviral activity against wild type HIV1 infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 40% human serum,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cnc(NC2CCN(c3cccc(C(N)=O)c3)CC2)nc1Oc1c(C)cc(C#N)cc1Cl,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1258135,CHEMBL1258135,7.85,0.0,http://www.openphacts.org/units/Nanomolar,963083.0,=,1.0,1.0,=,IC50,nM,14.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,14.2,CHEMBL378
5242,13475515.0,[],CHEMBL2439255,Antiviral activity against Human immunodeficiency virus 1 clade B isolate BaL infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435853,CHEMBL2435853,7.63,0.0,http://www.openphacts.org/units/Nanomolar,1924228.0,=,1.0,1.0,=,IC50,nM,23.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,23.4,CHEMBL378
5243,1185685.0,[],CHEMBL645946,Concentration required to inhibit activator protein-1(AP-1) mediated transcriptional activation in human Jurkat T-cells,B,BAO_0000190,BAO_0000219,cell-based format,CCc1nc(Cl)ncc1C(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1,CHEMBL1133475,J Med Chem,2000.0,CHEMBL339462,CHEMBL339462,6.52,0.0,http://www.openphacts.org/units/Nanomolar,247701.0,=,1.0,1.0,=,IC50,nM,300.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.3,CHEMBL4977
5244,10866489.0,[],CHEMBL2025518,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(OC(=O)CCCC(=O)O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCCC(=O)O)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024048,CHEMBL2024048,,0.0,http://www.openphacts.org/units/Nanomolar,1639770.0,>,1.0,1.0,>,IC50,nM,267960.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,267.96,CHEMBL613497
5245,2601667.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc2c(ncn2C2C=CC(OCP(=O)(O)OP(=O)(O)OP(=O)(O)O)C2)c(=O)[nH]1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL538904,CHEMBL538904,6.52,0.0,http://www.openphacts.org/units/Nanomolar,807572.0,=,1.0,1.0,=,IC50,nM,300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.3,CHEMBL378
5246,16498286.0,[],CHEMBL3777089,Antiviral activity against HIV1 dual CXCR4/CCR5-tropic strain 89.6 infected in human 293T cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1/C(=N\Nc2ccc3c(S(=O)(=O)O)cc(S(=O)(=O)O)cc3c2)C(c2ccccc2)=NN1c1nc(C(F)(F)F)cs1,CHEMBL3774382,Bioorg Med Chem,2016.0,CHEMBL3775022,CHEMBL3775022,5.62,0.0,http://www.openphacts.org/units/Nanomolar,2762407.0,=,1.0,1.0,=,IC50,nM,2400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.4,CHEMBL378
5247,5132767.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(C(=O)N(Cc2ccco2)Cc2cc3cccc(C)c3[nH]c2=O)cc1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645042,CHEMBL1645042,5.57,0.0,http://www.openphacts.org/units/Nanomolar,1321030.0,=,1.0,1.0,=,IC50,nM,2670.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.67,CHEMBL378
5248,12717570.0,[],CHEMBL2350960,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion after 12 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=CCc1ccc(O)c(-c2cc(O)ccc2O)c1,CHEMBL2346656,Bioorg Med Chem Lett,2013.0,CHEMBL555924,CHEMBL555924,,0.0,http://www.openphacts.org/units/Nanomolar,1874412.0,=,1.0,1.0,=,IC50,nM,162430.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,162.43,CHEMBL613497
5249,13967502.0,[],CHEMBL3135326,Antiviral activity against wild type HIV1 VSVG infected in 293ET cells assessed as inhibition of viral replication by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1sc(Cl)cc1S(=O)(=O)N1c2cc(Cl)ccc2NC(=O)C1C,CHEMBL3132804,Medchemcomm,2014.0,CHEMBL3133061,CHEMBL3133061,7.16,0.0,http://www.openphacts.org/units/Nanomolar,1974733.0,=,1.0,1.0,=,IC50,nM,70.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.07,CHEMBL378
5250,19281689.0,[],CHEMBL4409359,Antiviral activity against HIV1 VB59 infected in human TZM-bl cells incubated for 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(-n2ncc3c(=O)[nH]c(C)cc32)cc1,CHEMBL4406854,Eur J Med Chem,2019.0,CHEMBL4575970,CHEMBL4575970,4.24,0.0,http://www.openphacts.org/units/Nanomolar,3219929.0,=,1.0,1.0,=,IC50,nM,58080.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,58.08,CHEMBL378
5251,1040094.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=C(S)N(Nc2ccccc2)C1C,CHEMBL1144865,J Med Chem,2003.0,CHEMBL291072,CHEMBL291072,,0.0,http://www.openphacts.org/units/Nanomolar,62328.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5252,14596868.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(Sc2cc(C)cc(C)c2)n(COCc2ccccc2)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL291926,CHEMBL291926,5.07,0.0,http://www.openphacts.org/units/Nanomolar,2082388.0,=,1.0,1.0,=,IC50,nM,8550.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.55,CHEMBL378
5253,2276089.0,[],CHEMBL1030793,Inhibition of HIV1 replication in human 293T cells preincubated 15 mins prior to infection measured after 48 hrs postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1sccc1S(=O)(=O)N1c2cc(F)ccc2NC(=O)C1C,CHEMBL1153359,Bioorg Med Chem,2009.0,CHEMBL522024,CHEMBL522024,6.70,0.0,http://www.openphacts.org/units/Nanomolar,754444.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.2,CHEMBL378
5254,14658816.0,[],CHEMBL3266157,Antagonist activity at recombinant human EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)c3ccc(C)cc3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262887,CHEMBL3262887,7.40,0.0,http://www.openphacts.org/units/Nanomolar,2101729.0,=,1.0,1.0,=,IC50,nM,39.81,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,pIC50,,UO_0000065,7.4,CHEMBL3259470
5255,22898288.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731089,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL1163,CHEMBL1163,8.30,0.0,http://www.openphacts.org/units/Nanomolar,3554417.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.0,CHEMBL378
5256,24788553.0,[],CHEMBL5131656,Antiviral activity against AZT resistant HIV-1 mutant in PBMC,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,CHEMBL5131375,J Med Chem,2022.0,CHEMBL14762,CHEMBL14762,9.44,0.0,http://www.openphacts.org/units/Nanomolar,3869388.0,=,1.0,1.0,=,IC50,nM,0.36,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.36,CHEMBL378
5257,2930182.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cccn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578376,CHEMBL578376,8.20,0.0,http://www.openphacts.org/units/Nanomolar,852984.0,=,1.0,1.0,=,IC50,nM,6.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.3,CHEMBL378
5258,1471866.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(N(C)C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188689,CHEMBL188689,6.41,0.0,http://www.openphacts.org/units/Nanomolar,380839.0,=,1.0,1.0,=,IC50,nM,390.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.39,CHEMBL378
5259,2929723.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CNC(=O)c3cc4ccccc4o3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL583839,CHEMBL583839,7.50,0.0,http://www.openphacts.org/units/Nanomolar,852940.0,=,1.0,1.0,=,IC50,nM,31.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.6,CHEMBL378
5260,1401863.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC=O)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL338936,CHEMBL338936,7.10,0.0,http://www.openphacts.org/units/Nanomolar,360411.0,=,1.0,1.0,=,IC50,nM,79.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.079,CHEMBL378
5261,3247259.0,[],CHEMBL1116114,Antiviral activity against HIV1 3B infected in human HOS cells expressing human CXCR4/CCR5/CD4 and HIV-LTR-luciferase,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCCCC1CCn1c(CN(C)C2CCCc3cccnc32)nc2ccccc21,CHEMBL1156326,Bioorg Med Chem Lett,2010.0,CHEMBL1090858,CHEMBL1090858,7.48,0.0,http://www.openphacts.org/units/Nanomolar,901667.0,=,1.0,1.0,=,IC50,nM,33.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,33.0,CHEMBL378
5262,13476909.0,[],CHEMBL2439257,Antiviral activity against Human immunodeficiency virus 1 clade B isolate CI#15 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(C(N)=O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435858,CHEMBL2435858,,0.0,,1924234.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5263,1954125.0,[],CHEMBL890377,Antiviral activity against HIV1 with RT 103N mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(C2CC2)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL234285,CHEMBL234285,6.70,0.0,http://www.openphacts.org/units/Nanomolar,647178.0,=,1.0,1.0,=,IC50,nM,199.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,199.0,CHEMBL378
5264,3229730.0,[],CHEMBL1113200,Antiviral activity against recombinant HIV1 virus infected in human JC53BL cells after 3 days,F,BAO_0000190,BAO_0000218,organism-based format,CCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2,CHEMBL1154224,Bioorg Med Chem Lett,2009.0,CHEMBL1078648,CHEMBL1078648,,0.0,http://www.openphacts.org/units/Nanomolar,898021.0,>,1.0,1.0,>,IC50,nM,625.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,625.0,CHEMBL378
5265,1401877.0,[],CHEMBL837463,In vitro inhibitory concentration against HIV F227C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177563,CHEMBL177563,5.95,0.0,http://www.openphacts.org/units/Nanomolar,360416.0,=,1.0,1.0,=,IC50,nM,1119.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.119,CHEMBL378
5266,2997315.0,[],CHEMBL1046975,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C(=N/Cc2cccc(F)c2)c2ccc(=O)n(Cc3cccc(F)c3)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL566694,CHEMBL566694,6.30,0.0,http://www.openphacts.org/units/Nanomolar,856681.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.5,CHEMBL613497
5267,2929547.0,[],CHEMBL1056895,Antiviral activity against HIV1 HXB2 harboring 138K mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL233664,CHEMBL233664,8.40,0.0,http://www.openphacts.org/units/Nanomolar,848384.0,=,1.0,1.0,=,IC50,nM,3.98,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.98,CHEMBL378
5268,19033610.0,[],CHEMBL4350059,Antiviral activity against HIV1 YU2 pseudovirus infected in human TZM-bl cells assessed as inhibition of viral infection incubated for 20 mins prior to infection and measured after 48 hrs post infection by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)C(=O)Oc1ccc2cccnc2c1-c1cccc2ccccc12,CHEMBL4346738,Bioorg Med Chem,2019.0,CHEMBL4561320,CHEMBL4561320,4.11,0.0,http://www.openphacts.org/units/Nanomolar,3175419.0,=,1.0,1.0,=,IC50,nM,77600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,77.6,CHEMBL378
5269,20663972.0,[],CHEMBL4618924,Antiviral activity against wild type HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CN2CCOCC2)cc1,CHEMBL4616700,ACS Med Chem Lett,2020.0,CHEMBL4638254,CHEMBL4638254,7.48,0.0,http://www.openphacts.org/units/Nanomolar,3479371.0,=,1.0,1.0,=,IC50,nM,33.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,33.2,CHEMBL378
5270,15166139.0,[],CHEMBL3404736,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as decrease in viral DNA replication treated for 7 days by real time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(O[C@@H]2O[C@H](COC(=O)/C=C/c3ccc(O)c(O)c3)[C@@H](O)[C@H](O)[C@H]2O)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402768,CHEMBL3402768,5.10,0.0,http://www.openphacts.org/units/Nanomolar,2284120.0,=,1.0,1.0,=,IC50,nM,8000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,8.0,CHEMBL613497
5271,405212.0,[],CHEMBL805567,Inhibitory concentration required against replication of small pox virus (strain India 3a) in Vero cells,F,BAO_0000190,BAO_0000218,organism-based format,COC(CO)O[C@@H](CO)Cn1cnc2c(N)ncnc21,CHEMBL1147452,Bioorg Med Chem Lett,2004.0,CHEMBL324496,CHEMBL324496,4.21,0.0,http://www.openphacts.org/units/Nanomolar,214246.0,=,1.0,1.0,=,IC50,nM,62000.0,CHEMBL613494,Variola virus,Variola virus,10255,IC50,uM,UO_0000065,62.0,CHEMBL613494
5272,2244564.0,[],CHEMBL1003071,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase P225H mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(COc1ccc(Cl)cc1C(=O)c1ccccc1)Nc1ccccc1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL296939,CHEMBL296939,8.48,0.0,http://www.openphacts.org/units/Nanomolar,798577.0,=,1.0,1.0,=,IC50,nM,3.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.3,CHEMBL378
5273,13463722.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,[N-]=[N+]=N[C@H]1C[C@H](n2cnc3nc(N)nc(N)c32)O[C@@H]1CO,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL2430342,CHEMBL2430342,5.70,0.0,http://www.openphacts.org/units/Nanomolar,1920839.0,=,1.0,1.0,=,IC50,nM,1995.26,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.7,CHEMBL378
5274,907732.0,[],CHEMBL712257,Inhibition of human immunodeficiency virus-1 (HIV-1) induced cytopathicity in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1nnc2nc(N)nc(O)c21)OCP(=O)(O)O,CHEMBL1129435,J Med Chem,1996.0,CHEMBL335422,CHEMBL335422,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251934.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,100.0,CHEMBL378
5275,929309.0,[],CHEMBL728516,Anti-HIV activity against HIV-1 IIIB chronically infected Molt-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn2c3c(c(N4CCN(c5ccccn5)CC4)c(F)cc3c1=O)OCC2CF,CHEMBL1131862,Bioorg Med Chem Lett,1999.0,CHEMBL323328,CHEMBL323328,5.77,0.0,http://www.openphacts.org/units/Nanomolar,194306.0,=,1.0,1.0,=,IC50,nM,1700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.7,CHEMBL378
5276,18455420.0,[],CHEMBL4179270,Antiviral activity against Influenza B virus (B/Maryland/1/59) infected in MDCK cells assessed as reduction in virus-induced cytopathogenicity incubated for 48 hrs by SRB assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,CHEMBL4177585,Bioorg Med Chem,2017.0,CHEMBL1229,CHEMBL1229,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,3062883.0,=,1.0,1.0,=,IC50,ug.mL-1,33.17,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,33.17,CHEMBL613129
5277,19472237.0,[],CHEMBL4478790,Antiviral activity against NNRTI resistant HIV1 harboring reverse transcriptase V106I/Y181C/G190A/H221Y mutant assessed as inhibition of viral infection in human TZM-bl cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL4477221,J Med Chem,2016.0,CHEMBL175691,CHEMBL175691,5.46,0.0,http://www.openphacts.org/units/Nanomolar,3256043.0,=,1.0,1.0,=,IC50,nM,3500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.5,CHEMBL378
5278,3267355.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1Cn2c(=S)[nH]c3cc([N+](=O)[O-])cc(c32)CN1CC1CC1,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL60982,CHEMBL60982,5.61,0.0,http://www.openphacts.org/units/Nanomolar,906452.0,=,1.0,1.0,=,IC50,nM,2454.71,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.61,CHEMBL378
5279,622082.0,[],CHEMBL689615,Reduction of viral load in the cell supernatant.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cccc2ccc(/C=C/c3ccc(O)c(O)c3)nc12,CHEMBL1135622,J Med Chem,2002.0,CHEMBL142412,CHEMBL142412,4.92,0.0,http://www.openphacts.org/units/Nanomolar,275332.0,=,1.0,1.0,=,IC50,nM,12000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.0,CHEMBL378
5280,1502783.0,[],CHEMBL834971,Inhibitory concentration against hepatitis C virus NS3 protease (IC50 spans 2.5 log units),B,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H](C(=O)N[C@H](C(=O)C1C[C@H](Oc2cccc(Br)c2)C[C@H]1C(=O)CC1(C(=O)O)CC1)C(C)C)C1CCCCC1,CHEMBL1143583,J Med Chem,2005.0,CHEMBL193263,CHEMBL193263,4.30,0.0,http://www.openphacts.org/units/Nanomolar,388781.0,=,1.0,1.0,=,IC50,nM,50118.72,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,Log 1/IC50,,UO_0000065,4.3,CHEMBL4620
5281,22806651.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@H](Sc3cccc(OCc4ccccc4)c3)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4749010,CHEMBL4749010,7.89,0.0,http://www.openphacts.org/units/Nanomolar,3541907.0,=,1.0,1.0,=,IC50,nM,13.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.013000000000000001,CHEMBL613497
5282,15621471.0,[],CHEMBL3584167,Antiviral activity against HIV1 NL4.3-Ren infected in human MT2 cells assessed as inhibition of viral growth measured 48 hrs post infection by luminometry,F,BAO_0000190,BAO_0000218,organism-based format,C=C(COC(C)=O)[C@@H]1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL3580560,J Nat Prod,2015.0,CHEMBL3581948,CHEMBL3581948,4.88,0.0,http://www.openphacts.org/units/Nanomolar,2482793.0,=,1.0,1.0,=,IC50,nM,13100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,13.1,CHEMBL378
5283,22484652.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '144.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '6.0'}]",CHEMBL4688345,Antiviral activity against HBV infected in human HepG2 2.2.15 cells assessed as decrease in extracellular viral DNA level measured after incubation of 6 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(N[C@H](CO)Cc1ccccc1)/C(NC(=O)c1ccc(Cl)cc1Cl)=C(/Br)c1ccccc1,CHEMBL4680304,Bioorg Med Chem,2021.0,CHEMBL4742126,CHEMBL4742126,6.72,0.0,http://www.openphacts.org/units/Nanomolar,3524615.0,=,1.0,1.0,=,IC50,nM,190.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.19,CHEMBL613497
5284,23173986.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4815100,Potentiation of KD-247-induced viral neutralizing activity against SHIV KS2661 infected in human TZM-bl cells assessed as KD-247 IC50 for viral neutralization at 10 uM measured after 48 hrs by luciferase assay (Rvb = 2.422 ug/ml),F,BAO_0000190,BAO_0000218,organism-based format,N=C(N)NCCCCC(=O)NCCN1CCC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC12CCCCC2,CHEMBL4813943,J Med Chem,2021.0,CHEMBL4863990,CHEMBL4863990,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,3603249.0,=,1.0,1.0,=,IC50,ug.mL-1,0.099,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,ug ml-1,UO_0000274,0.099,CHEMBL613499
5285,18987183.0,[],CHEMBL4340290,Antiviral activity against HIV NL4-3 infected in human MT4 cells measured on day 3 post-infection by Nano-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCC(=O)OCC1=C[C@@H]2C(=O)[C@]3(C=C(C)[C@H](O)[C@@]3(O)[C@@H]1O)[C@H](C)C[C@@H]1[C@H]2C1(C)C,CHEMBL4339238,J Nat Prod,2019.0,CHEMBL4455151,CHEMBL4455151,8.07,0.0,http://www.openphacts.org/units/Nanomolar,3167471.0,=,1.0,1.0,=,IC50,nM,8.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.6,CHEMBL378
5286,18320110.0,[],CHEMBL4134181,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA level incubated for 3 days followed by medium replacement measured after 3 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C2CCCN2C(c2nccs2)=NC1c1cc(Cl)sc1Cl,CHEMBL4130455,ACS Med Chem Lett,2017.0,CHEMBL4162205,CHEMBL4162205,5.77,0.0,http://www.openphacts.org/units/Nanomolar,3041705.0,=,1.0,1.0,=,IC50,nM,1700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.7,CHEMBL613497
5287,17602984.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(c2ccc(-c3cncnc3)cc2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644919,CHEMBL3644919,4.35,0.0,http://www.openphacts.org/units/Nanomolar,2518039.0,=,37.0,1.0,=,IC50,nM,45000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,45000.0,CHEMBL4620
5288,2929487.0,[],CHEMBL1056900,Antiviral activity against HIV1 HXB2 harboring 100I and K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL338047,CHEMBL338047,,0.0,,848385.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5289,3603807.0,[],CHEMBL1291656,Antiviral activity against Hepatitis B virus infected in HepG2.2.15 assessed as inhibition of HBsAg production by EIA,F,BAO_0000190,BAO_0000218,organism-based format,Cn1c(CS(=O)(=O)c2ccccc2)nc2c(CN3CCOCC3)c(O)ccc21,CHEMBL1287795,Bioorg Med Chem Lett,2010.0,CHEMBL1288174,CHEMBL1288174,,0.0,http://www.openphacts.org/units/Nanomolar,973193.0,=,1.0,1.0,=,IC50,nM,325700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,325.7,CHEMBL613497
5290,18202590.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(C2NC(=O)NC(C)=C2c2nc(-c3ccc(C#N)cc3)cs2)n1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4071525,CHEMBL4071525,5.80,0.0,http://www.openphacts.org/units/Nanomolar,3019991.0,=,1.0,1.0,=,IC50,nM,1600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.6,CHEMBL378
5291,2462110.0,[],CHEMBL964561,Antiviral activity against hepatitis B virus infected Hep G2.2.15 cells assessed as inhibition of HBsAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1CCO,CHEMBL1157443,Bioorg Med Chem Lett,2008.0,CHEMBL510657,CHEMBL510657,,0.0,http://www.openphacts.org/units/Nanomolar,720832.0,=,1.0,1.0,=,IC50,nM,300000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.3,CHEMBL613497
5292,15606036.0,[],CHEMBL3579360,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O/N=C/c1ccccn1,CHEMBL3576819,Eur J Med Chem,2015.0,CHEMBL77510,CHEMBL77510,,0.0,http://www.openphacts.org/units/Nanomolar,2480521.0,=,1.0,1.0,=,IC50,nM,469110.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,469.11,CHEMBL613497
5293,5306734.0,[],CHEMBL1696836,Antiviral activity against R5 tropic HIV1 YU.2 infected in human PBMC assessed as inhibition of p24 antigen production after 2 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,CHEMBL1687731,Antimicrob Agents Chemother,2009.0,CHEMBL483,CHEMBL483,6.05,0.0,http://www.openphacts.org/units/Nanomolar,1337339.0,=,1.0,1.0,=,IC50,nM,884.24,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,884.24,CHEMBL378
5294,1438295.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)/C=C/c1cccc(C(=O)c2c(CC)c(C)nc(O)c2N(C)C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL183249,CHEMBL183249,8.52,0.0,http://www.openphacts.org/units/Nanomolar,371580.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
5295,19183291.0,[],CHEMBL4387678,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as reduction in p24 Gag protein production incubated for 6 days and measured on day 7 by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)Nc2c(N(C)[C@H]3CCOC3)c(=O)c2=O)cc1,CHEMBL4385670,Bioorg Med Chem Lett,2019.0,CHEMBL4558365,CHEMBL4558365,,0.0,http://www.openphacts.org/units/Nanomolar,3202089.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
5296,11014400.0,[],CHEMBL2089834,Antiviral activity against HIV1 in human TZM-bl cells assessed as viral infectivity by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(CO)[C@H](O)CC[C@@]2(C)[C@@H]1C/C=C1/C(=O)OC[C@H]1O,CHEMBL2086289,Eur J Med Chem,2012.0,CHEMBL186141,CHEMBL186141,6.23,0.0,http://www.openphacts.org/units/Nanomolar,1675621.0,=,1.0,1.0,=,IC50,nM,590.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.59,CHEMBL378
5297,10961214.0,[],CHEMBL2061270,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M5 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCCC(C)(C)C)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058322,CHEMBL2058322,7.77,0.0,http://www.openphacts.org/units/Nanomolar,1656262.0,=,1.0,1.0,=,IC50,nM,17.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,17.0,CHEMBL378
5298,2997405.0,[],CHEMBL1046975,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C(=N/Cc2ccccc2F)c2ccc(=O)n(Cc3ccccc3F)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL585877,CHEMBL585877,4.52,0.0,http://www.openphacts.org/units/Nanomolar,856630.0,=,1.0,1.0,=,IC50,nM,30000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,30.0,CHEMBL613497
5299,10862032.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(/C=C/C(=O)O[C@H]2CC[C@]3(C)[C@H]4CC=C5[C@@H]6C[C@@](C)(C(=O)OCc7ccc(Br)cc7F)CC[C@]6(C)CC[C@@]5(C)[C@]4(C)CC[C@H]3C2(C)C)c1,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2023706,CHEMBL2023706,,0.0,http://www.openphacts.org/units/Nanomolar,1639315.0,>,1.0,1.0,>,IC50,nM,1001890.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1001.89,CHEMBL613497
5300,980341.0,[],CHEMBL655544,Inhibition of wild type HIV-1-IIIB strain replication in CEM-SS cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(C)cnc(O)c2[N+](=O)[O-])c1,CHEMBL1128194,J Med Chem,1995.0,CHEMBL356674,CHEMBL356674,6.92,0.0,http://www.openphacts.org/units/Nanomolar,276265.0,=,1.0,1.0,=,IC50,nM,120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,120.0,CHEMBL378
5301,6336419.0,[],CHEMBL1821125,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by measuring HBsAg and HBeAg production after 9 days by EIA,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(NC(C)=O)cc1,CHEMBL1817553,Bioorg Med Chem,2011.0,CHEMBL1819245,CHEMBL1819245,5.04,0.0,http://www.openphacts.org/units/Nanomolar,1451647.0,=,1.0,1.0,=,IC50,nM,9060.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,9.06,CHEMBL613497
5302,19262018.0,[],CHEMBL4404422,Antiviral activity against enfuvirtide-resistant HIV1 9491 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.33,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,470.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.47,CHEMBL378
5303,24868584.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5152415,Antiviral activity against HBV infected in human HepG2-hNTCP cells assessed as reduction in HBsAg level preincubated for 2 hrs followed by viral infection for 16 hrs further compound washout and measured after 12 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2,CHEMBL5150016,J Med Chem,2022.0,CHEMBL408,CHEMBL408,5.00,0.0,http://www.openphacts.org/units/Nanomolar,3886065.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.0,CHEMBL613497
5304,2432641.0,[],CHEMBL1027472,Antiviral activity against HIV1 3B infected in human HOG.R5 assessed as inhibition of viral replication by microtiter assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(CC[C@H](O)C(=C)C)[C@H]1CC[C@]2(C)[C@@H]1CC[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,CHEMBL1159344,J Nat Prod,2003.0,CHEMBL491343,CHEMBL491343,5.21,0.0,http://www.openphacts.org/units/Nanomolar,735814.0,=,1.0,1.0,=,IC50,nM,6100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.1,CHEMBL378
5305,8027834.0,[],CHEMBL1948542,Antiviral activity against HIV1 NF-462 expressing wild-type Vpr infected in human 293T cells containing 1 ng of viral p24 antigen after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O[C@]12COc3ccccc3[C@H]1c1ccccc1C2,CHEMBL1944615,Bioorg Med Chem Lett,2012.0,CHEMBL1945223,CHEMBL1945223,,0.0,,1574223.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5306,19288705.0,[],CHEMBL4410537,Antiviral activity against wild type HIV-1 3B infected in human MT4 cells,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)[C@H](C)NP(=O)(OC[C@@H]1C=C[C@H](n2cc(C)c(=O)[nH]c2=O)O1)Oc1ccc(C(F)(F)F)cc1,CHEMBL4406893,Bioorg Med Chem Lett,2019.0,CHEMBL4585169,CHEMBL4585169,7.43,0.0,http://www.openphacts.org/units/Nanomolar,3220825.0,=,1.0,1.0,=,IC50,nM,37.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.037,CHEMBL378
5307,18183411.0,[],CHEMBL4040187,Antiviral activity against CXCR4-tropic HIV-1 NL4-3 infected in human PHA-stimulated PBMC assessed as inhibition of viral replication by measuring reduction in p24 antigen production preincubated with cells for 30 mins followed by viral infection measured on day 10 post infection in presence of IL-2 by ELISA,F,BAO_0000190,BAO_0000019,assay format,CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)Oc1ccccc1,CHEMBL4038313,J Med Chem,2017.0,CHEMBL2107825,CHEMBL2107825,9.00,0.0,http://www.openphacts.org/units/Nanomolar,3016406.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
5308,15166103.0,[],CHEMBL3404734,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBeAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(/C=C/C(=O)Oc2ccc(C(C)=O)cc2)c1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402769,CHEMBL3402769,,0.0,http://www.openphacts.org/units/Nanomolar,2284123.0,>,1.0,1.0,>,IC50,nM,2782200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2782.2,CHEMBL613497
5309,1401888.0,[],CHEMBL835252,In vitro inhibitory concentration against HIV K101E and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)Nc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL128569,CHEMBL128569,,0.0,http://www.openphacts.org/units/Nanomolar,360373.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5310,2930165.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COCCSCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL567837,CHEMBL567837,8.80,0.0,http://www.openphacts.org/units/Nanomolar,852983.0,=,1.0,1.0,=,IC50,nM,1.58,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.58,CHEMBL378
5311,12627456.0,[],CHEMBL2317015,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(N/N=C/c1ccccc1O)c1cnccn1,CHEMBL2311445,Bioorg Med Chem,2013.0,CHEMBL569410,CHEMBL569410,,0.0,http://www.openphacts.org/units/Nanomolar,1841360.0,>,1.0,1.0,>,IC50,nM,40000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,40.0,CHEMBL378
5312,10938597.0,[],CHEMBL2051599,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cccc(/C=C/C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(OC(=O)/C=C/c3cccc(OC)c3)C(C)=O)C2)c1,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046592,CHEMBL2046592,,0.0,http://www.openphacts.org/units/Nanomolar,1651476.0,>,1.0,1.0,>,IC50,nM,1367030.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1367.03,CHEMBL613497
5313,10938611.0,[],CHEMBL2051599,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C=C/C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(O)C(C)=O)C2)cc1,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046559,CHEMBL2046559,,0.0,http://www.openphacts.org/units/Nanomolar,1651442.0,=,1.0,1.0,=,IC50,nM,568510.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,568.51,CHEMBL613497
5314,637803.0,[],CHEMBL696966,Concentration required for reduction of plaque against influenza B,F,BAO_0000190,BAO_0000218,organism-based format,CCCN(CCC)C(=O)[C@@H]1OC(C(=O)O)=C[C@H](N)[C@H]1NC(=O)CC,CHEMBL1134218,Bioorg Med Chem Lett,2001.0,CHEMBL346767,CHEMBL346767,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,313076.0,=,1.0,1.0,=,IC50,ug.mL-1,3.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,3.0,CHEMBL613129
5315,1143590.0,[],CHEMBL818227,Cytotoxicity was determined in the vero cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(O)c2ncn([C@H]3CS[C@H](CO)O3)c2n1,CHEMBL1126808,J Med Chem,1993.0,CHEMBL61093,CHEMBL61093,,0.0,http://www.openphacts.org/units/Nanomolar,100973.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5316,1402309.0,[],CHEMBL834774,In vitro inhibitory concentration against HIV Y188L mutant strain; not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(Cc2ccccc2)Cc2ccccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL366811,CHEMBL366811,,0.0,http://www.openphacts.org/units/Nanomolar,360421.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5317,1194680.0,[],CHEMBL880061,Inhibitory activity against LAI strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1[N+](=O)[O-],CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL70514,CHEMBL70514,7.75,0.0,http://www.openphacts.org/units/Nanomolar,127439.0,=,1.0,1.0,=,IC50,nM,18.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.018,CHEMBL378
5318,6299471.0,[],CHEMBL1811268,Antiviral activity against HIV1 3B infected in human MAGI-CCR5 cells assessed as inhibition of viral replication after 48 hrs by beta-galactosidase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1806431,Bioorg Med Chem,2011.0,CHEMBL57,CHEMBL57,7.05,0.0,http://www.openphacts.org/units/Nanomolar,1443679.0,=,1.0,1.0,=,IC50,nM,90.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.09,CHEMBL378
5319,18239569.0,[],CHEMBL4052029,Antiviral activity against darunavir-resistant HIV1 derived from 51 passages harboring protease L10I/I15V/K20R/L24I/V32I/L33F/M36I/M46L/I54M/L63P/K70Q/V82I/I84V/L89M mutant infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2nc(NC3CC3)sc2c1,CHEMBL4049446,J Med Chem,2017.0,CHEMBL4059839,CHEMBL4059839,6.32,0.0,http://www.openphacts.org/units/Nanomolar,3026804.0,=,1.0,1.0,=,IC50,nM,480.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,480.0,CHEMBL378
5320,2681559.0,[],CHEMBL1064013,Antiviral activity against HIV1 Q23.71 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCNC(C)=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL508943,CHEMBL508943,6.35,0.0,http://www.openphacts.org/units/Nanomolar,823861.0,=,1.0,1.0,=,IC50,nM,450.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.45,CHEMBL378
5321,22933239.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)/C=C/c4ccc(OCc5cccc([N+](=O)[O-])c5)c(OC)c4)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4756003,CHEMBL4756003,6.12,0.0,http://www.openphacts.org/units/Nanomolar,3560844.0,=,1.0,1.0,=,IC50,nM,758.58,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.12,CHEMBL378
5322,2601911.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CSC(c2c(Cl)cccc2Cl)N1c1cccnc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL51254,CHEMBL51254,4.02,0.0,http://www.openphacts.org/units/Nanomolar,807115.0,=,1.0,1.0,=,IC50,nM,95100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,95.1,CHEMBL378
5323,12135668.0,[],CHEMBL2187933,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as p24 antigen level after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(CCCC(=O)O)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2176886,J Med Chem,2012.0,CHEMBL2177448,CHEMBL2177448,7.96,0.0,http://www.openphacts.org/units/Nanomolar,1750144.0,=,1.0,1.0,=,IC50,nM,11.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.011,CHEMBL378
5324,2091727.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(OC)cc2)CCCNCCCN(S(=O)(=O)c2ccc(OC)cc2)C1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL202658,CHEMBL202658,,0.0,http://www.openphacts.org/units/Nanomolar,700559.0,=,1.0,1.0,=,IC50,nM,158489319246111.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,5.2,CHEMBL378
5325,2930207.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cnc(C)n3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL577276,CHEMBL577276,7.80,0.0,http://www.openphacts.org/units/Nanomolar,852963.0,=,1.0,1.0,=,IC50,nM,15.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,15.8,CHEMBL378
5326,12651414.0,[],CHEMBL2327724,Antiviral activity against 0.001 MOI wild type Human immunodeficiency virus 1 NL4-3 infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCCC(=O)N[C@@H](CCC(N)=O)C(=O)OC)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL2324144,CHEMBL2324144,7.00,0.0,http://www.openphacts.org/units/Nanomolar,1850170.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
5327,594093.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(O)nc(Cc3c(Cl)cccc3Cl)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL74003,CHEMBL74003,5.67,0.0,http://www.openphacts.org/units/Nanomolar,126933.0,=,1.0,1.0,=,IC50,nM,2120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.12,CHEMBL378
5328,2594531.0,[],CHEMBL958175,Antiviral activity against X4-tropic HIV1 3B assessed as inhibition of viral attachment,F,BAO_0000190,BAO_0000218,organism-based format,C1=C(CS/C(=N\C2CCCCCC2)NC2CCCCCC2)N2CCN=C2S1,CHEMBL1151747,J Med Chem,2008.0,CHEMBL508054,CHEMBL508054,7.30,0.0,http://www.openphacts.org/units/Nanomolar,726868.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,50.0,CHEMBL378
5329,1402170.0,[],CHEMBL837462,In vitro inhibitory concentration against HIV E138K mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCOCCN(C)c1c(Cc2cccc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL174536,CHEMBL174536,,0.0,http://www.openphacts.org/units/Nanomolar,360385.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5330,20677931.0,[],CHEMBL4622140,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in cytoplasmic HBV-DNA replication incubated for 8 days by real-time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Cn2nc(-c3cc(Cl)c(NCCO)nc3F)c3ccccc3c2=O)cc1,CHEMBL4619801,J Med Chem,2020.0,CHEMBL4641708,CHEMBL4641708,7.55,0.0,http://www.openphacts.org/units/Nanomolar,3482221.0,=,1.0,1.0,=,IC50,nM,28.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.028,CHEMBL613497
5331,1201122.0,[],CHEMBL710533,Inhibitory activity against 181C strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL309975,CHEMBL309975,7.21,0.0,http://www.openphacts.org/units/Nanomolar,127461.0,=,1.0,1.0,=,IC50,nM,61.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.061,CHEMBL378
5332,5199470.0,[],CHEMBL1670944,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,[N-]=[N+]=NCCc1c(Cl)nc2ccc(Cl)cc2c1-c1ccccc1Cl,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668637,CHEMBL1668637,,0.0,http://www.openphacts.org/units/Nanomolar,1328421.0,>,1.0,1.0,>,IC50,nM,2513200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2513.2,CHEMBL613497
5333,1213165.0,[],CHEMBL880061,Inhibitory activity against LAI strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL308954,CHEMBL308954,8.85,0.0,http://www.openphacts.org/units/Nanomolar,127449.0,=,1.0,1.0,=,IC50,nM,1.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0014,CHEMBL378
5334,2244483.0,[],CHEMBL1002205,Antiviral activity against wild type HIV1 in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL223228,CHEMBL223228,9.40,0.0,http://www.openphacts.org/units/Nanomolar,798658.0,=,1.0,1.0,=,IC50,nM,0.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.4,CHEMBL378
5335,6216896.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2cc(S(C)(=O)=O)ccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784399,CHEMBL1784399,5.13,0.0,http://www.openphacts.org/units/Nanomolar,1429337.0,=,1.0,1.0,=,IC50,nM,7413.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.13,CHEMBL378
5336,18342087.0,[],CHEMBL4139012,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(-c2cc(NC(=O)c3ccc(Cl)cc3O)c[nH]c2=O)c1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL4165996,CHEMBL4165996,4.65,0.0,http://www.openphacts.org/units/Nanomolar,3045865.0,=,1.0,1.0,=,IC50,nM,22420.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,22.42,CHEMBL613497
5337,1954150.0,[],CHEMBL891425,Antiviral activity against HIV1 RT 188L mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(Sc2ccccc2)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL233453,CHEMBL233453,6.10,0.0,http://www.openphacts.org/units/Nanomolar,647181.0,=,1.0,1.0,=,IC50,nM,794.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,794.0,CHEMBL378
5338,2099776.0,[],CHEMBL949220,Antiviral activity against HIV1 BaL by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(Cl)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL270571,CHEMBL270571,7.80,0.0,http://www.openphacts.org/units/Nanomolar,699414.0,=,1.0,1.0,=,IC50,nM,16.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.016,CHEMBL378
5339,16422825.0,[],CHEMBL3751454,Antiviral activity against recombinant HIV-1 NL4-3 expressing HIV-1 JR-CSF envelope infected in U87.CD4.CCR5 cells assessed as inhibition of Env mediated cell entry by HIV-1 single round infection assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)NCC3CN(C(=O)c4ccccc4)C3)c12,CHEMBL3745657,Bioorg Med Chem Lett,2016.0,CHEMBL3747576,CHEMBL3747576,5.60,0.0,http://www.openphacts.org/units/Nanomolar,2740453.0,=,1.0,1.0,=,IC50,nM,2500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.5,CHEMBL378
5340,164830.0,[],CHEMBL756132,Compound was tested for the inhibition of LPS-induced TNF-alpha production in human peripheral blood mononuclear cells (PBMC),F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)CCC(C(=O)O)N1C(=O)c2ccccc2C1=S,CHEMBL1146001,J Med Chem,2003.0,CHEMBL146928,CHEMBL146928,,0.0,http://www.openphacts.org/units/Nanomolar,291255.0,>,1.0,1.0,>,IC50,nM,30000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,30.0,CHEMBL378
5341,2649341.0,[],CHEMBL1024326,"Antiviral activity against HIV1 expressed in 293T cells assessed as protection against viral M33 envelope infection in human U87 cells coexpressing CD4, CCR5 receptors after 72 hrs by luciferase reporter gene pseudoviral assay",F,BAO_0000190,BAO_0000218,organism-based format,CC1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1ccc(-c2ccn(C)n2)cc1,CHEMBL1158460,J Med Chem,2009.0,CHEMBL550217,CHEMBL550217,5.75,0.0,http://www.openphacts.org/units/Nanomolar,816090.0,=,1.0,1.0,=,IC50,nM,1800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1800.0,CHEMBL378
5342,162425.0,[],CHEMBL756132,Compound was tested for the inhibition of LPS-induced TNF-alpha production in human peripheral blood mononuclear cells (PBMC),F,BAO_0000190,BAO_0000218,organism-based format,O=C1NC(=S)CCC1N1C(=O)c2ccccc2C1=S,CHEMBL1146001,J Med Chem,2003.0,CHEMBL149057,CHEMBL149057,4.96,0.0,http://www.openphacts.org/units/Nanomolar,291265.0,=,1.0,1.0,=,IC50,nM,11000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,11.0,CHEMBL378
5343,2930414.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3cnc(C)c3/C=N/O)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL575040,CHEMBL575040,8.20,0.0,http://www.openphacts.org/units/Nanomolar,848228.0,=,1.0,1.0,=,IC50,nM,6.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.3,CHEMBL378
5344,1036641.0,[],CHEMBL713934,Concentration required to inhibit the viral (HIV-1 IIIB strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CCC1N=C(S)N(Nc2cccc(C)c2)C1c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39135,CHEMBL39135,4.93,0.0,http://www.openphacts.org/units/Nanomolar,62324.0,=,1.0,1.0,=,IC50,nM,11640.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,11.64,CHEMBL378
5345,16626948.0,[],CHEMBL3821894,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 48 hrs by SYBR Green based RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,O=[N+]([O-])c1ccccc1S(=O)(=O)Oc1cc(-c2ccccn2)[nH]n1,CHEMBL3817822,Medchemcomm,2016.0,CHEMBL3818406,CHEMBL3818406,5.04,0.0,http://www.openphacts.org/units/Nanomolar,2783930.0,=,1.0,1.0,=,IC50,nM,9190.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,9.19,CHEMBL613497
5346,5230926.0,[],CHEMBL1677600,Antiviral activity against Human immunodeficiency virus 1 3B infected in human H9 cells infected with 50 uL of virus stock assessed as expression of p24 antigen after 6 days postinfection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL129,CHEMBL129,,0.0,http://www.openphacts.org/units/Nanomolar,1332124.0,>,1.0,1.0,>,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
5347,2414501.0,[],CHEMBL954254,Antiviral activity against HIV1 with reverse transcriptase Y188L mutation in human CEM cells assessed as protection against virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1153955,J Med Chem,2009.0,CHEMBL57,CHEMBL57,,0.0,http://www.openphacts.org/units/Nanomolar,809634.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10000.0,CHEMBL378
5348,18202861.0,[],CHEMBL4043728,Antiviral activity against wild type HIV-1 NL4-3 infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2ccc(C(F)(F)F)nc2)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4090840,CHEMBL4090840,6.07,0.0,http://www.openphacts.org/units/Nanomolar,3019992.0,=,1.0,1.0,=,IC50,nM,860.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.86,CHEMBL378
5349,2649334.0,[],CHEMBL1024326,"Antiviral activity against HIV1 expressed in 293T cells assessed as protection against viral M33 envelope infection in human U87 cells coexpressing CD4, CCR5 receptors after 72 hrs by luciferase reporter gene pseudoviral assay",F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1ccc(-c2ccncc2)cc1,CHEMBL1158460,J Med Chem,2009.0,CHEMBL549874,CHEMBL549874,5.60,0.0,http://www.openphacts.org/units/Nanomolar,815928.0,=,1.0,1.0,=,IC50,nM,2500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2500.0,CHEMBL378
5350,14596904.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2cccc(C(N)=O)c2)n(COCCO)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL330759,CHEMBL330759,5.46,0.0,http://www.openphacts.org/units/Nanomolar,2082746.0,=,1.0,1.0,=,IC50,nM,3510.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.51,CHEMBL378
5351,18808331.0,[],CHEMBL4275448,Antiviral activity against Zika virus SMGC infected in BHK cells assessed as inhibition of virus induced cytopathic effect after 8 days by CellTiter-Glo luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)NCCCN(C[C@H]2O[C@@H](n3cnc4c(NCc5cccc(Cl)c5)ncnc43)[C@H](O)[C@@H]2O)C(C)C)cc1,CHEMBL4270631,Eur J Med Chem,2018.0,CHEMBL4292671,CHEMBL4292671,5.24,0.0,http://www.openphacts.org/units/Nanomolar,3125045.0,=,1.0,1.0,=,IC50,nM,5800.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,5.8,CHEMBL4296612
5352,23153200.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4810870,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 production treated at 48 hrs post-infection and measured on day 4 post-viral infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1=C[C@H]2[C@@]3(O)[C@H](C)[C@@H](OC(=O)CCc4ccccc4)[C@]4(OC(=O)CCc5ccccc5)[C@H]([C@@H]3C=C(CO)C[C@]2(O)C1=O)C4(C)C,CHEMBL4808236,Bioorg Med Chem Lett,2021.0,CHEMBL4861116,CHEMBL4861116,9.31,0.0,http://www.openphacts.org/units/Nanomolar,3599008.0,=,1.0,1.0,=,IC50,nM,0.49,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.49,CHEMBL378
5353,2464792.0,[],CHEMBL963691,Antiviral activity against HBV assessed as inhibition of viral e-antigen production by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1cc2c(CN(C)C)c(O)c(OC)cc2nc1CSc1ccccc1OC,CHEMBL1157455,Bioorg Med Chem,2008.0,CHEMBL488474,CHEMBL488474,4.69,0.0,http://www.openphacts.org/units/Nanomolar,720483.0,=,1.0,1.0,=,IC50,nM,20500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,20.5,CHEMBL613497
5354,18382579.0,[],CHEMBL4146252,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 6 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL4145455,Eur J Med Chem,2018.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/Nanomolar,3051086.0,<,1.0,1.0,<,IC50,nM,100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.1,CHEMBL613497
5355,13933276.0,[],CHEMBL3124242,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV e antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O,CHEMBL3120134,Eur J Med Chem,2014.0,CHEMBL41092,CHEMBL41092,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1969500.0,=,1.0,1.0,=,IC50,ug.mL-1,300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,300.0,CHEMBL613497
5356,3008330.0,[],CHEMBL1037279,Antiviral activity against Human immunodeficiency virus 1 NL4-3 infected HeLaP4 cells after 5 days by beta-galactosidase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(Oc1ccnc2ccccc12)C(=O)N1CCN(C(=O)c2ccccc2)C[C@H]1C,CHEMBL1155317,Bioorg Med Chem Lett,2009.0,CHEMBL571641,CHEMBL571641,,0.0,,861789.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5357,3014820.0,[],CHEMBL1050519,Antiviral activity against multidrug-resistant HIV1 isolate MM infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,CHEMBL1156053,J Med Chem,2009.0,CHEMBL115,CHEMBL115,,0.0,http://www.openphacts.org/units/Nanomolar,862677.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
5358,19288672.0,[],CHEMBL4410545,Antiviral activity against HIV-1 3IIB infected in thymidine kinase deficient human C8166 cells,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)[C@H](C)NP(=O)(OC[C@@H]1C=C[C@H](n2cc(C)c(=O)[nH]c2=O)O1)Oc1cccc(C(F)(F)F)c1,CHEMBL4406893,Bioorg Med Chem Lett,2019.0,CHEMBL4546368,CHEMBL4546368,,0.0,,3220826.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5359,2517077.0,[],CHEMBL975243,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(Cc2ccc(Br)cc2)nc(SCc2ccc(OC)cc2)[nH]c1=O,CHEMBL1138559,Eur J Med Chem,2009.0,CHEMBL474401,CHEMBL474401,,0.0,http://www.openphacts.org/units/Nanomolar,733103.0,>,1.0,1.0,>,IC50,nM,281000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,281.0,CHEMBL378
5360,12463715.0,[],CHEMBL3057688,Antiviral activity against wild type Human immunodeficiency virus 1,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)C(Cc1c(Cl)cccc1Cl)/N=C(\S)Nc1ccc(C#N)cc1,CHEMBL3046335,Med Chem Res,2009.0,CHEMBL306909,CHEMBL306909,,0.0,http://www.openphacts.org/units/Nanomolar,1805844.0,=,1.0,1.0,=,IC50,nM,3899419.87,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,2.409,CHEMBL378
5361,12627602.0,[],CHEMBL2317015,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1NS(=O)(=O)c1ccc(N/N=C(\C)c2ccccc2Br)c([N+](=O)[O-])c1,CHEMBL2311445,Bioorg Med Chem,2013.0,CHEMBL2311890,CHEMBL2311890,4.92,0.0,http://www.openphacts.org/units/Nanomolar,1841388.0,=,1.0,1.0,=,IC50,nM,12000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.0,CHEMBL378
5362,22845272.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '49.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '49.0'}]",CHEMBL4721686,Antiviral activity against Laboratory adapted HIV-1 LA1 infected in human PBMC cells assessed as reduction in viral transmission to TZM-bl cells pretreated for 1 hr before viral transmission and further incubated for 48 hrs by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c12,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL3301620,CHEMBL3301620,7.00,0.0,http://www.openphacts.org/units/Nanomolar,3547082.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
5363,2091738.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(C2CCCC2)CCCN(S(=O)(=O)c2ccc(C)cc2)C1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL270963,CHEMBL270963,,0.0,http://www.openphacts.org/units/Nanomolar,700548.0,=,1.0,1.0,=,IC50,nM,154881661891248.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,5.19,CHEMBL378
5364,2947347.0,[],CHEMBL1038497,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1)[C@@H](OC(=O)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1)C(C)(C)OC(=O)c1cc([N+](=O)[O-])ccc1[N+](=O)[O-])C1=C2C[C@H](OC(=O)c3cc([N+](=O)[O-])cc([N+](=O)[O-])c3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL584793,CHEMBL584793,,0.0,http://www.openphacts.org/units/Nanomolar,850754.0,>,1.0,1.0,>,IC50,nM,990000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.99,CHEMBL613497
5365,3603848.0,[],CHEMBL1291738,Antiviral activity against Hepatitis B virus infected in HepG2.2.15 assessed as inhibition of HBV replication at <506.3 +/- 3.2 uM by quantitative Southern blot hybridization analysis,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)Cc2nc3c(Cn4ccnc4)c(O)ccc3n2C)cc1,CHEMBL1287795,Bioorg Med Chem Lett,2010.0,CHEMBL1288204,CHEMBL1288204,,0.0,,973225.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
5366,14658822.0,[],CHEMBL3266157,Antagonist activity at recombinant human EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)c3ccc(C)c(C)c3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262893,CHEMBL3262893,7.36,0.0,http://www.openphacts.org/units/Nanomolar,2101735.0,=,1.0,1.0,=,IC50,nM,43.65,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,pIC50,,UO_0000065,7.36,CHEMBL3259470
5367,3084021.0,[],CHEMBL1072584,Antiviral activity against HIV1 infected in human JC53-BL cells after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)nc(C)c1C(=O)N1C[C@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@H]2C1,CHEMBL1153211,Bioorg Med Chem Lett,2010.0,CHEMBL593042,CHEMBL593042,8.40,0.0,http://www.openphacts.org/units/Nanomolar,872815.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.0,CHEMBL378
5368,2199479.0,[],CHEMBL952475,Antiviral activity against HBV in adriamycin-resistant wild type HepW10 cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1156464,Proc Natl Acad Sci U S A,2007.0,CHEMBL141,CHEMBL141,7.00,0.0,http://www.openphacts.org/units/Nanomolar,791643.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.1,CHEMBL613497
5369,2413633.0,[],CHEMBL987708,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/C=C/C(=O)O[C@@H](C[C@@H](C)C1=C2C[C@H](OC(=O)/C=C/C=C/C)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)[C@@H](OC(=O)/C=C/C=C/C)C(C)(C)O,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL443940,CHEMBL443940,,0.0,http://www.openphacts.org/units/Nanomolar,810682.0,>,1.0,1.0,>,IC50,nM,900000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.9,CHEMBL613497
5370,2649357.0,[],CHEMBL1024326,"Antiviral activity against HIV1 expressed in 293T cells assessed as protection against viral M33 envelope infection in human U87 cells coexpressing CD4, CCR5 receptors after 72 hrs by luciferase reporter gene pseudoviral assay",F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(C(=O)C(=O)N2CCN(C(=O)c3ccccc3)C[C@H]2C)ccc1-c1cc(C)no1,CHEMBL1158460,J Med Chem,2009.0,CHEMBL559568,CHEMBL559568,6.08,0.0,http://www.openphacts.org/units/Nanomolar,816427.0,=,1.0,1.0,=,IC50,nM,830.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,830.0,CHEMBL378
5371,1438154.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cccnc1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL185622,CHEMBL185622,8.00,0.0,http://www.openphacts.org/units/Nanomolar,371555.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
5372,1233284.0,[],CHEMBL878997,Inhibition of Hepatitis C RNA dependent RNA polymerase Nonstructural protein 5B activity.,B,BAO_0000190,BAO_0000357,single protein format,O=C(O)[C@H](Cc1ccccc1)N(Cc1cccc(Br)c1)C(=O)c1ccc(F)cc1F,CHEMBL1136248,Bioorg Med Chem Lett,2003.0,CHEMBL323191,CHEMBL323191,4.37,0.0,http://www.openphacts.org/units/Nanomolar,213340.0,=,1.0,1.0,=,IC50,nM,43000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,43.0,CHEMBL4620
5373,6218343.0,[],CHEMBL1785353,Antiviral activity against Human immunodeficiency virus 1 Bal-PBL,F,BAO_0000190,BAO_0000218,organism-based format,CNS(=O)(=O)c1cc(C(=O)N2CCC(CCN3C4CCC3CC(n3c(C)nc5ccccc53)C4)(c3cccc(F)c3)CC2)c(Cl)cc1F,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784521,CHEMBL1784521,8.46,0.0,http://www.openphacts.org/units/Nanomolar,1429460.0,=,1.0,1.0,=,IC50,nM,3.467,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,8.46,CHEMBL378
5374,18323323.0,[],CHEMBL4134874,Antiviral activity against VSV-G pseudotyped HIV1 infected in human SupT1 cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL4130477,J Nat Prod,2017.0,CHEMBL141,CHEMBL141,7.00,0.0,http://www.openphacts.org/units/Nanomolar,3042118.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
5375,10961159.0,[],CHEMBL2061267,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M10 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CNC=C1C(=O)Nc2ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)cc21,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057460,CHEMBL2057460,7.48,0.0,http://www.openphacts.org/units/Nanomolar,1655122.0,=,1.0,1.0,=,IC50,nM,33.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,33.0,CHEMBL378
5376,10961115.0,[],CHEMBL2061265,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M8 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL1163,CHEMBL1163,6.12,0.0,http://www.openphacts.org/units/Nanomolar,1655449.0,=,1.0,1.0,=,IC50,nM,750.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,750.0,CHEMBL378
5377,1402219.0,[],CHEMBL837466,In vitro inhibitory concentration against HIV K101E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177744,CHEMBL177744,,0.0,http://www.openphacts.org/units/Nanomolar,360400.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5378,3221780.0,[],CHEMBL1102829,Antiviral activity against HIV1 carrying reverse transcriptase K103N mutant infected human MT4 cells by phenoscreen assay in the presence of 40 percent normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,CS(=O)(=O)c1ccc(NC(=O)CSC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,CHEMBL1153798,Bioorg Med Chem Lett,2009.0,CHEMBL1078944,CHEMBL1078944,5.70,0.0,http://www.openphacts.org/units/Nanomolar,898067.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,0.002,CHEMBL378
5379,1228112.0,[],CHEMBL652107,Inhibitory concentration required to inhibit HIV-induced cytopathicity in CEM-4 cells by 50% based in the MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N(CC)CCCCCCCCCCC(=O)NC(CCC(=O)[O-])C(=O)O.[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL1627024,CHEMBL1206362,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221520.0,=,1.0,1.0,=,IC50,ug.mL-1,25.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,25.0,CHEMBL378
5380,2203573.0,[],CHEMBL987023,Antiviral activity against HIV1 3B in human MT4 cells assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCNC(=S)Nc1ccc(-c2n[nH]c(=S)n2CCCCCC)cc1,CHEMBL1149790,Eur J Med Chem,2008.0,CHEMBL493410,CHEMBL493410,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,765392.0,>,1.0,1.0,>,IC50,ug.mL-1,1.71,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,1.71,CHEMBL378
5381,2929664.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(Cn3cnc(C#N)c3C#N)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL583428,CHEMBL583428,6.00,0.0,http://www.openphacts.org/units/Nanomolar,852934.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
5382,7843560.0,[],CHEMBL1913152,Antiviral activity against HIV1 Ba-L infected in human HOS cells assessed as reduction of viral replication after 4 days by Steady-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(NS(C)(=O)=O)cc2)ccc1CN1CCC(N(C(=O)Nc2cc(C(N)=O)c(F)cc2F)c2cccc(F)c2)CC1,CHEMBL1909524,Bioorg Med Chem Lett,2011.0,CHEMBL1909863,CHEMBL1909863,8.70,0.0,http://www.openphacts.org/units/Nanomolar,1541992.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
5383,12680758.0,[],CHEMBL2342599,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)Nc3ccccc3)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333692,CHEMBL2333692,4.80,0.0,http://www.openphacts.org/units/Nanomolar,1867768.0,=,1.0,1.0,=,IC50,nM,15980.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,15.98,CHEMBL613497
5384,19261838.0,[],CHEMBL4404361,Antiviral activity against HIV1 subtypeA QF495.23M.ENV.A3,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.15,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,710.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.71,CHEMBL378
5385,18173478.0,[],CHEMBL4038383,Antiviral activity against VSV pseudotyped HIV1 infected in SupT1 cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1cc(O)c2c(=O)c3c(C)cc(O)cc3oc2c1,CHEMBL4038266,J Nat Prod,2017.0,CHEMBL4081067,CHEMBL4081067,4.10,0.0,http://www.openphacts.org/units/Nanomolar,3015257.0,=,1.0,1.0,=,IC50,nM,79400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,79.4,CHEMBL378
5386,2462091.0,[],CHEMBL964561,Antiviral activity against hepatitis B virus infected Hep G2.2.15 cells assessed as inhibition of HBsAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,O=c1cc(-c2ccccc2)c2cc(Cl)ccc2[nH]1,CHEMBL1157443,Bioorg Med Chem Lett,2008.0,CHEMBL452292,CHEMBL452292,,0.0,http://www.openphacts.org/units/Nanomolar,720746.0,=,1.0,1.0,=,IC50,nM,485000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.485,CHEMBL613497
5387,413227.0,[],CHEMBL756140,Inhibition of human peripheral blood mononuclear cell (PBMC)donor A proliferation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCC(=O)CC(=O)N[C@H]1CCOC1=O,CHEMBL1145979,J Med Chem,2003.0,CHEMBL8463,CHEMBL8463,4.52,0.0,http://www.openphacts.org/units/Nanomolar,4336.0,=,1.0,1.0,=,IC50,nM,30000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,30.0,CHEMBL378
5388,1830890.0,[],CHEMBL918634,Antiviral activity against wild type HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,C=CCSc1nc(C(C#N)c2cccc3ccccc23)c(CC)c(=O)[nH]1,CHEMBL1144474,J Med Chem,2007.0,CHEMBL375081,CHEMBL375081,6.24,0.0,http://www.openphacts.org/units/Nanomolar,629301.0,=,1.0,1.0,=,IC50,nM,580.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.58,CHEMBL378
5389,5250564.0,[],CHEMBL1687034,Antiviral activity against HIV1 G3-G infected in human PBMC assessed as reduction of p24 antigen production after 7 days,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2c(c1)nc(Nc1cccc(C(F)(F)F)c1)c1nc(NC3CC3)ncc12,CHEMBL1681725,Bioorg Med Chem Lett,2011.0,CHEMBL1682297,CHEMBL1682297,7.00,0.0,http://www.openphacts.org/units/Nanomolar,1333376.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
5390,18320123.0,[],CHEMBL4134181,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA level incubated for 3 days followed by medium replacement measured after 3 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C2C[C@@H](NS(C)(=O)=O)CN2C(c2nccs2)=N[C@H]1c1ccc(F)cc1Cl,CHEMBL4130455,ACS Med Chem Lett,2017.0,CHEMBL4167446,CHEMBL4167446,4.16,0.0,http://www.openphacts.org/units/Nanomolar,3041718.0,=,1.0,1.0,=,IC50,nM,70000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,70.0,CHEMBL613497
5391,15571659.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,CC(C)c1ccc(CN2CCN(C(=O)/C=C/c3ccc(Br)cc3)CC2)cc1,CHEMBL1201862,,,CHEMBL3561719,CHEMBL3561719,8.23,0.0,http://www.openphacts.org/units/Nanomolar,2477125.0,=,7.0,1.0,=,IC50,nM,5.92,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.00592,CHEMBL3259470
5392,2432636.0,[],CHEMBL1027472,Antiviral activity against HIV1 3B infected in human HOG.R5 assessed as inhibition of viral replication by microtiter assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,CHEMBL1159344,J Nat Prod,2003.0,CHEMBL169,CHEMBL169,4.83,0.0,http://www.openphacts.org/units/Nanomolar,735819.0,=,1.0,1.0,=,IC50,nM,14700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,14.7,CHEMBL378
5393,1219734.0,[],CHEMBL710537,Inhibitory activity against 188L strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nccc(Nc3c(Cl)cc(Cl)cc3Cl)n2)cc1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72713,CHEMBL72713,7.00,0.0,http://www.openphacts.org/units/Nanomolar,127462.0,=,1.0,1.0,=,IC50,nM,99.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.099,CHEMBL378
5394,14714276.0,[],CHEMBL3293255,Antiviral activity against HIV1 harboring reverse transcriptase K103N/Y181C mutant infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(c1ccc(C#N)cc1)c1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL3288564,CHEMBL3288564,,0.0,http://www.openphacts.org/units/Nanomolar,2116122.0,>,1.0,1.0,>,IC50,nM,189130.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,189.13,CHEMBL378
5395,15602743.0,[],CHEMBL3578657,Inhibition of ASCT2-mediated [3H]glutamine uptake in HEK293 cells after 15 mins by Live-cell glutamine uptake assay,B,BAO_0000190,BAO_0000219,cell-based format,N[C@@H](CCC(=O)Nc1ccccc1CN1CCOCC1)C(=O)O,CHEMBL3576761,Bioorg Med Chem Lett,2015.0,CHEMBL3576929,CHEMBL3576929,3.51,1.0,http://www.openphacts.org/units/Nanomolar,2479426.0,=,1.0,1.0,=,IC50,nM,312000.0,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,uM,UO_0000065,312.0,CHEMBL3562162
5396,2413724.0,[],CHEMBL987710,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)OCC(=O)O[C@@H](C[C@@H](C)[C@]12CC[C@@]3(C)[C@@]1(C[C@H](OC(=O)COC(C)=O)[C@H]1[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@@]13C)O2)[C@@H](OC(=O)COC(C)=O)C(C)(C)O,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL498852,CHEMBL498852,,0.0,http://www.openphacts.org/units/Nanomolar,810804.0,>,1.0,1.0,>,IC50,nM,250000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.25,CHEMBL613497
5397,1051212.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CCC1N=C(S)N(Nc2cccc(Cl)c2)C1c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39825,CHEMBL39825,,0.0,http://www.openphacts.org/units/Nanomolar,62364.0,>,1.0,1.0,>,IC50,nM,38960.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,38.96,CHEMBL378
5398,16626950.0,[],CHEMBL3821894,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 48 hrs by SYBR Green based RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)Oc2cc(-c3ccccn3)[nH]n2)cc1,CHEMBL3817822,Medchemcomm,2016.0,CHEMBL3819428,CHEMBL3819428,4.65,0.0,http://www.openphacts.org/units/Nanomolar,2783933.0,=,1.0,1.0,=,IC50,nM,22170.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,22.17,CHEMBL613497
5399,2244585.0,[],CHEMBL1002204,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase K103N/P225H mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL57,CHEMBL57,,0.0,http://www.openphacts.org/units/Nanomolar,798657.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2000.0,CHEMBL378
5400,1834520.0,[],CHEMBL909291,Antiviral activity against wild type HIV1 in CBMCs,F,BAO_0000190,BAO_0000218,organism-based format,CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1,CHEMBL1142192,Antimicrob Agents Chemother,2007.0,CHEMBL222559,CHEMBL222559,7.04,0.0,http://www.openphacts.org/units/Nanomolar,625902.0,=,1.0,1.0,=,IC50,nM,92.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.092,CHEMBL378
5401,23153206.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4810870,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 production treated at 48 hrs post-infection and measured on day 4 post-viral infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)OCC1=C[C@H]2[C@@H]3C(C)(C)[C@]3(OC(=O)CCC)[C@H](OC(=O)/C=C/c3ccc(OC(C)=O)c(OC)c3)[C@@H](C)[C@]2(O)[C@@H]2C=C(C)C(=O)[C@@]2(O)C1,CHEMBL4808236,Bioorg Med Chem Lett,2021.0,CHEMBL4851659,CHEMBL4851659,,0.0,http://www.openphacts.org/units/Nanomolar,3599016.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10000.0,CHEMBL378
5402,833283.0,[],CHEMBL701249,"Inhibitory concentration was evaluated against human respiratory syncytial virus,(HRSV) strain A2.",F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)cc1Nc1nc(Nc2ccc(-c3ccc(Nc4nc(Nc5cc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)ccc5C)nc(Nc5cc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)ccc5C)n4)cc3S(=O)(=O)O)c(S(=O)(=O)O)c2)nc(Nc2cc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)ccc2C)n1,CHEMBL1131306,J Med Chem,1998.0,CHEMBL1160589,CHEMBL1160589,,0.0,http://www.openphacts.org/units/Nanomolar,164087.0,>,1.0,1.0,>,IC50,nM,25000.0,CHEMBL613127,Human respiratory syncytial virus,Human respiratory syncytial virus,11250,IC50,uM,UO_0000065,25.0,CHEMBL613127
5403,1402128.0,[],CHEMBL833792,In vitro inhibitory concentration against HIV-1 Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCCCO)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL367745,CHEMBL367745,5.80,0.0,http://www.openphacts.org/units/Nanomolar,360369.0,=,1.0,1.0,=,IC50,nM,1585.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.585,CHEMBL378
5404,286232.0,[],CHEMBL706841,Antiviral activity by observing cytopathic effect induced by HIV-1 strain IIIB in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)[C@@H](NC1CCCCC1)C(=O)N[C@H](C(=O)NCc1ccccc1)C(C)C,CHEMBL1127464,J Med Chem,1994.0,CHEMBL105617,CHEMBL105617,6.03,0.0,http://www.openphacts.org/units/Nanomolar,195828.0,=,1.0,1.0,=,IC50,nM,940.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,940.0,CHEMBL378
5405,1487011.0,[],CHEMBL833976,Inhibitory concentration against wild type human immunodeficiency virus type 1 was determined by recombinant virus assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(O)nc2ccc(F)cc2c1OCC1CCC1,CHEMBL1138845,J Med Chem,2004.0,CHEMBL359990,CHEMBL359990,6.21,0.0,http://www.openphacts.org/units/Nanomolar,384122.0,=,1.0,1.0,=,IC50,nM,610.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,610.0,CHEMBL378
5406,10961110.0,[],CHEMBL2061265,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M8 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COCCNC=C1C(=O)Nc2ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)cc21,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058055,CHEMBL2058055,7.16,0.0,http://www.openphacts.org/units/Nanomolar,1655881.0,=,1.0,1.0,=,IC50,nM,70.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,70.0,CHEMBL378
5407,22845276.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '49.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '49.0'}]",CHEMBL4721686,Antiviral activity against Laboratory adapted HIV-1 LA1 infected in human PBMC cells assessed as reduction in viral transmission to TZM-bl cells pretreated for 1 hr before viral transmission and further incubated for 48 hrs by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4747551,CHEMBL4747551,6.14,0.0,http://www.openphacts.org/units/Nanomolar,3547084.0,=,1.0,1.0,=,IC50,nM,730.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.73,CHEMBL378
5408,501707.0,[],CHEMBL683866,The compound was tested for inhibition against HIV-1 from CEM-SS cell lines,F,BAO_0000190,BAO_0000218,organism-based format,CCC1(c2cccc(OC)c2)Oc2ccccc2-n2cccc2C1=O,CHEMBL1132456,J Med Chem,1999.0,CHEMBL140665,CHEMBL140665,6.70,0.0,http://www.openphacts.org/units/Nanomolar,268402.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.2,CHEMBL378
5409,3084560.0,[],CHEMBL1065277,Antiviral activity against HIV1 fTOI primary isolate assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)C(=O)NC2CC(C)(C)NC(C)(C)C2)cc1,CHEMBL1153139,Bioorg Med Chem Lett,2010.0,CHEMBL610204,CHEMBL610204,4.80,0.0,http://www.openphacts.org/units/Nanomolar,873929.0,=,1.0,1.0,=,IC50,nM,16000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,16.0,CHEMBL378
5410,950075.0,[],CHEMBL683812,Antiviral activity against Human immunodeficiency virus 1 (HIV-1) up to 100 uM concentration; inactive,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@@H]2C[C@H](CO)N(N=O)C2)c(=O)[nH]c1=O,CHEMBL1124550,J Med Chem,1989.0,CHEMBL2374366,CHEMBL2374366,,0.0,http://www.openphacts.org/units/Nanomolar,82344.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5411,15679666.0,[],CHEMBL3607182,Antiviral activity against Measles virus infected in African green monkey CV1 cells after 3 days by neutral red dye-based plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(F)cc2c1ncn2[C@@H]1C=C(CO)[C@@H](O)[C@H]1O,CHEMBL3603790,Bioorg Med Chem,2015.0,CHEMBL3604363,CHEMBL3604363,5.07,0.0,http://www.openphacts.org/units/Nanomolar,2494266.0,=,1.0,1.0,=,IC50,nM,8500.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,8.5,CHEMBL613738
5412,615367.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)c1nc(Cc2c(Cl)cccc2Cl)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL421492,CHEMBL421492,4.87,0.0,http://www.openphacts.org/units/Nanomolar,126905.0,=,1.0,1.0,=,IC50,nM,13400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,13.4,CHEMBL378
5413,14658837.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)c3ccc(Br)cc3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262886,CHEMBL3262886,7.04,0.0,http://www.openphacts.org/units/Nanomolar,2101728.0,=,1.0,1.0,=,IC50,nM,92.0,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,IC50,nM,UO_0000065,92.0,CHEMBL3259471
5414,1438299.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)/C=C/c1cccc(C(=O)c2c(CC)c(C)nc(O)c2N(C)C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL183249,CHEMBL183249,6.82,0.0,http://www.openphacts.org/units/Nanomolar,371580.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.15,CHEMBL378
5415,18044726.0,[],CHEMBL4010426,"Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 AC10.0, clone 29",F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.30,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.5,CHEMBL378
5416,917689.0,[],CHEMBL728516,Anti-HIV activity against HIV-1 IIIB chronically infected Molt-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC1COc2c(N3CCN(c4ccccn4)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,CHEMBL1131862,Bioorg Med Chem Lett,1999.0,CHEMBL104078,CHEMBL104078,5.43,0.0,http://www.openphacts.org/units/Nanomolar,194335.0,=,1.0,1.0,=,IC50,nM,3700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.7,CHEMBL378
5417,624211.0,[],CHEMBL712246,Inhibitory activity against LAI strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)cc(Cl)c1Oc1nc(N)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL73044,CHEMBL73044,8.68,0.0,http://www.openphacts.org/units/Nanomolar,126914.0,=,1.0,1.0,=,IC50,nM,2.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0021,CHEMBL378
5418,14999562.0,[],CHEMBL3366533,Antiviral activity against HIV1 harboring reverse transcriptase Y188L mutant infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CNc2nc(-c3ccccc3F)c(Cc3ccccc3)s2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3330435,CHEMBL3330435,,0.0,http://www.openphacts.org/units/Nanomolar,2246872.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
5419,15064921.0,[],CHEMBL3366183,Antiviral activity against wild type HIV1 infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CNc2nc(-c3ccccc3Cl)c(Cc3ccccc3)s2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3330438,CHEMBL3330438,7.34,0.0,http://www.openphacts.org/units/Nanomolar,2248824.0,=,1.0,1.0,=,IC50,nM,46.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.046,CHEMBL378
5420,7924553.0,[],CHEMBL1921362,Antiviral activity against Human immunodeficiency virus 1 Ba-L in human PBL cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(NS(C)(=O)=O)cc2F)ccc1CN1CCC(N(C(=O)Nc2ccc(C(N)=O)nc2)c2cccc(F)c2)CC1,CHEMBL1914281,Bioorg Med Chem Lett,2011.0,CHEMBL1914526,CHEMBL1914526,9.30,0.0,http://www.openphacts.org/units/Nanomolar,1556601.0,=,1.0,1.0,=,IC50,nM,0.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.5,CHEMBL378
5421,7967189.0,[],CHEMBL1930242,Antiviral activity against R5 tropic Human immunodeficiency virus 1 BAL infected in human PBMC cells assessed as reduction in viral replication by p24 detection based ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(N(Cc2cccnc2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1,CHEMBL1926604,Bioorg Med Chem Lett,2011.0,CHEMBL1926897,CHEMBL1926897,7.53,0.0,http://www.openphacts.org/units/Nanomolar,1563514.0,=,1.0,1.0,=,IC50,nM,29.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,29.6,CHEMBL378
5422,3383633.0,[],CHEMBL1211563,Antiviral activity against HIV1 NL-BAL infected in CCR5-expressing human JC53-BL cells assessed as inhibition of viral replication after 16 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(N[C@@H](CCN1C[C@@H]2CN(C(=O)c3ccc(C(F)F)cn3)C[C@@H]2C1)c1cccc(F)c1)C1CCCC1,CHEMBL1208790,Bioorg Med Chem Lett,2010.0,CHEMBL1209672,CHEMBL1209672,8.30,0.0,http://www.openphacts.org/units/Nanomolar,927427.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.0,CHEMBL378
5423,606615.0,[],CHEMBL710373,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(Cc3c(Cl)cccc3Cl)nc(NO)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL71683,CHEMBL71683,6.97,0.0,http://www.openphacts.org/units/Nanomolar,126901.0,=,1.0,1.0,=,IC50,nM,107.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.107,CHEMBL378
5424,14658829.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(OCC(=O)N2CCN(C(=O)Cc3ccccc3)CC2)cc1C,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262878,CHEMBL3262878,5.36,0.0,http://www.openphacts.org/units/Nanomolar,2101720.0,=,1.0,1.0,=,IC50,nM,4341.0,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,IC50,nM,UO_0000065,4341.0,CHEMBL3259471
5425,2244558.0,[],CHEMBL1002217,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase K101E mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(C(F)(F)F)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL275658,CHEMBL275658,8.51,0.0,http://www.openphacts.org/units/Nanomolar,798655.0,=,1.0,1.0,=,IC50,nM,3.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.1,CHEMBL378
5426,2413726.0,[],CHEMBL987710,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@H](OC(=O)COCC)[C@H](C[C@@H](C)[C@]12CC[C@@]3(C)[C@@]1(C[C@H](OC(=O)COCC)[C@H]1[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@@]13C)O2)OC(=O)COCC,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL498829,CHEMBL498829,,0.0,http://www.openphacts.org/units/Nanomolar,810806.0,>,1.0,1.0,>,IC50,nM,1800000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.8,CHEMBL613497
5427,3596605.0,[],CHEMBL1292013,Antiviral activity against HIV1 BaL in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,Cn1cc(Cl)c(C(=O)N2CCC(CCN3CCC(N(C(=O)NCc4ccc(C#N)cc4)c4cccc(F)c4)CC3)(c3cccc(F)c3)CC2)n1,CHEMBL1287766,Bioorg Med Chem Lett,2010.0,CHEMBL1288681,CHEMBL1288681,7.77,0.0,http://www.openphacts.org/units/Nanomolar,973791.0,=,1.0,1.0,=,IC50,nM,17.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,17.0,CHEMBL378
5428,2681615.0,[],CHEMBL1064019,Antiviral activity against HIV1 NL4-3 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL525076,CHEMBL525076,5.72,0.0,http://www.openphacts.org/units/Nanomolar,823863.0,=,1.0,1.0,=,IC50,nM,1910.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.91,CHEMBL378
5429,1671943.0,[],CHEMBL865135,Antiviral activity against HIV1 V106A mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(C(F)(F)F)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL275658,CHEMBL275658,7.98,0.0,http://www.openphacts.org/units/Nanomolar,411926.0,=,1.0,1.0,=,IC50,nM,10.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.5,CHEMBL378
5430,1437838.0,[],CHEMBL834620,Inhibitory activity against HIV-1 mutant strain 188L; ND = not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCNC(=O)Nc1cccc(C(=O)c2c(CC)c(C)nc(O)c2N(C)C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL425531,CHEMBL425531,,0.0,http://www.openphacts.org/units/Nanomolar,371467.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5431,16626915.0,[],CHEMBL3821892,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg secretion by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1cc(-c2ccccn2)[nH][nH]1,CHEMBL3817822,Medchemcomm,2016.0,CHEMBL3818876,CHEMBL3818876,,0.0,http://www.openphacts.org/units/Nanomolar,2783926.0,=,1.0,1.0,=,IC50,nM,1368310.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1368.31,CHEMBL613497
5432,5189383.0,[],CHEMBL1659267,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 6 days by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/c1cccc(F)c1)OCCc1c(-c2ccccc2Cl)c2cc(Cl)ccc2[nH]c1=O,CHEMBL1649405,Eur J Med Chem,2011.0,CHEMBL1652522,CHEMBL1652522,,0.0,http://www.openphacts.org/units/Nanomolar,1326897.0,=,1.0,1.0,=,IC50,nM,110000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.11,CHEMBL613497
5433,2212960.0,[],CHEMBL989684,Antiviral activity against HBV assessed as inhibition of viral e-antigen secretion in HepG2.2.15 cells by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(c1OC)C(=O)N1CCc3cc4c(cc3[C@@H]1C2)OCO4,CHEMBL1150244,J Nat Prod,2008.0,CHEMBL468974,CHEMBL468974,,0.0,http://www.openphacts.org/units/Nanomolar,767837.0,>,1.0,1.0,>,IC50,nM,3400000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,3.4,CHEMBL613497
5434,3267367.0,[],CHEMBL1109941,Antiviral activity against HIV1 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,C=CCCN1Cc2cccc3[nH]c(=O)n(c23)C[C@@H]1C,CHEMBL1157041,Eur J Med Chem,2010.0,CHEMBL1099293,CHEMBL1099293,4.30,0.0,http://www.openphacts.org/units/Nanomolar,906525.0,=,1.0,1.0,=,IC50,nM,50118.72,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.3,CHEMBL378
5435,22480469.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '120.0'}]",CHEMBL4687212,Antiviral activity against HIV-1 NL4-3 infected in human TZM-bl cells infected with supernatants from virus-infected human H9 cells treated with compound for 72 hrs assessed as reduction in luciferase expression measured after 48 hrs by luciferase reporter gene assay based BiCycle assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCc1cn(-c2ccc(NC(=O)Nc3cc(OC4CCCC4)ccc3C)cc2)nn1,CHEMBL4680261,Eur J Med Chem,2020.0,CHEMBL4743218,CHEMBL4743218,6.70,0.0,http://www.openphacts.org/units/Nanomolar,3523699.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.2,CHEMBL378
5436,14653344.0,[],CHEMBL3266817,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)COCC(=O)O)[C@H](OC(=O)COCC(=O)O)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL3262992,CHEMBL3262992,,0.0,http://www.openphacts.org/units/Nanomolar,2101875.0,>,1.0,1.0,>,IC50,nM,1933000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1933.0,CHEMBL613497
5437,1141833.0,[],CHEMBL697278,Compound was tested for binding of HIV-1 to CEM-ss cells; NI = No inhibition,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)C(=S)S,CHEMBL1130070,J Med Chem,1997.0,CHEMBL961,CHEMBL961,,0.0,http://www.openphacts.org/units/Nanomolar,103198.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,I50,uM,UO_0000065,,CHEMBL378
5438,10911778.0,[],CHEMBL2038371,Antiviral activity against NNRTI-resistant HIV1 clade B A-17 clinical isolate infected in PHA-P-stimulated human PBMC assessed as reverse transcriptase activity incubated for 6 hrs followed by incubated in drug-free medium for 6 days by multiround infection assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)CC[C@H](NC(=O)CCC(=O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3F)C(=O)OC[C@@H]3O[C@H](n4ccc(N)nc4=O)CS3)O2)c(=O)[nH]c1=O,CHEMBL2034836,J Med Chem,2012.0,CHEMBL2035198,CHEMBL2035198,7.89,0.0,http://www.openphacts.org/units/Nanomolar,1644927.0,=,1.0,1.0,=,IC50,nM,12.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,12.9,CHEMBL378
5439,19099179.0,[],CHEMBL4368145,Antiviral activity against wild type HIV1 3B infected in human MT2 cells after 3 days by BrightGlo luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)Nc1[nH]c2ccc(Br)cc2c1C(C)(O)C(F)(F)F,CHEMBL4364320,Eur J Med Chem,2019.0,CHEMBL4435051,CHEMBL4435051,8.52,0.0,http://www.openphacts.org/units/Nanomolar,3186194.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
5440,907731.0,[],CHEMBL650153,Compound was tested for anti-retroviral activity against moloney murine sarcoma virus (MSV) in murine C3H/3T3 embryo fibroblast cell culture,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Cn1nnc2nc(N)nc(O)c21)OCP(=O)(O)O,CHEMBL1129435,J Med Chem,1996.0,CHEMBL335422,CHEMBL335422,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,251934.0,>,1.0,1.0,>,IC50,ug.mL-1,40.0,CHEMBL613501,Moloney murine sarcoma virus,Moloney murine sarcoma virus,11809,IC50,ug ml-1,UO_0000274,40.0,CHEMBL613501
5441,24788561.0,[],CHEMBL5131664,Antiviral activity against protease resistant HIV-1 mutant in monocyte,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,CHEMBL5131375,J Med Chem,2022.0,CHEMBL14762,CHEMBL14762,9.44,0.0,http://www.openphacts.org/units/Nanomolar,3869388.0,=,1.0,1.0,=,IC50,nM,0.36,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.36,CHEMBL378
5442,24830933.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c2ccc(N3CCCCC3)cc2oc2c(Cl)cccc12,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5207806,CHEMBL5207806,6.01,0.0,http://www.openphacts.org/units/Nanomolar,3878106.0,=,1.0,1.0,=,IC50,nM,980.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.98,CHEMBL613497
5443,8027847.0,[],CHEMBL1948452,Antiviral activity against HIV1 NL432 infected in human TZM-Bl cells assessed as inhibition of viral replication after 2 days by luciferase reporter gene analysis,F,BAO_0000190,BAO_0000218,organism-based format,Oc1cc2c(cc1O)[C@@H]1c3cccc(O)c3OC[C@]1(O)C2,CHEMBL1944615,Bioorg Med Chem Lett,2012.0,CHEMBL1944933,CHEMBL1944933,,0.0,,1573824.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5444,19261933.0,[],CHEMBL4404392,"Antiviral activity against HIV1 subtypeC ZM197M.PB7, SVPC6",F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.57,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,270.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.27,CHEMBL378
5445,24851920.0,[],CHEMBL5147988,Antiviral activity against HIV-1 JR-CSF assessed as inhibition of viral growth,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncn(-c2ncc(F)c3c(C(=O)C(=O)N4CC5CN(C(=O)c6ccccc6)CC5C4)c[nH]c23)n1,CHEMBL5143686,J Med Chem,2022.0,CHEMBL5181540,CHEMBL5181540,9.10,0.0,http://www.openphacts.org/units/Nanomolar,3882297.0,=,1.0,1.0,=,IC50,nM,0.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0008,CHEMBL378
5446,1173062.0,[],CHEMBL679241,Concentration required to reduce vaccinia virus-inducted cytopathicity by 50% (E6SM cells),F,BAO_0000190,BAO_0000218,organism-based format,O=C([O-])CC(SCCCOC[C@H]1O[C@@](COCCCSC(CC(=O)[O-])C(=O)[O-])(O[C@H]2O[C@H](COCCCSC(CC(=O)[O-])C(=O)[O-])[C@@H](OCCCSC(CC(=O)[O-])C(=O)[O-])[C@H](OCCCSC(CC(=O)[O-])C(=O)[O-])[C@H]2OCCCSC(CC(=O)[O-])C(=O)[O-])[C@@H](OCCCSC(CC(=O)[O-])C(=O)[O-])[C@@H]1OCCCSC(CC(=O)[O-])C(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],CHEMBL1130336,J Med Chem,1997.0,CHEMBL3142950,CHEMBL3306061,,0.0,http://www.openphacts.org/units/Nanomolar,225163.0,>,1.0,1.0,>,IC50,nM,181000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,181.0,CHEMBL613493
5447,1471575.0,[],CHEMBL834620,Inhibitory activity against HIV-1 mutant strain 188L; ND = not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1ccc(Cl)cc1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL186723,CHEMBL186723,,0.0,http://www.openphacts.org/units/Nanomolar,380929.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5448,10862000.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCc6ccc(OC(F)(F)F)cc6)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022389,CHEMBL2022389,,0.0,http://www.openphacts.org/units/Nanomolar,1637639.0,>,1.0,1.0,>,IC50,nM,1132840.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1132.84,CHEMBL613497
5449,1402519.0,[],CHEMBL834487,In vitro inhibitory concentration value against HIV K103N and Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL57,CHEMBL57,4.00,0.0,http://www.openphacts.org/units/Nanomolar,360370.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5450,3084546.0,[],CHEMBL1065278,Antiviral activity against HIV1 KYAG primary isolate assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC(C)(C)N1,CHEMBL1153139,Bioorg Med Chem Lett,2010.0,CHEMBL254781,CHEMBL254781,,0.0,http://www.openphacts.org/units/Nanomolar,873907.0,>,1.0,1.0,>,IC50,nM,30000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,30.0,CHEMBL378
5451,10961187.0,[],CHEMBL2061268,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M3 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCC(C)(C)C)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058323,CHEMBL2058323,8.10,0.0,http://www.openphacts.org/units/Nanomolar,1656263.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.0,CHEMBL378
5452,19261850.0,[],CHEMBL4404365,Antiviral activity against HIV1 subtypeA/D QA790.204I.ENV.E2,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4459495,CHEMBL4459495,6.44,0.0,http://www.openphacts.org/units/Nanomolar,3216284.0,=,1.0,1.0,=,IC50,nM,360.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.36,CHEMBL378
5453,5199550.0,[],CHEMBL1670948,Antiviral activity against HBV infected in human HepG 2.215 cells assessed as inhibition of DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,OCCc1c(OCc2c(Cl)cccc2Cl)nc2ccc(Cl)cc2c1-c1ccccc1Cl,CHEMBL1667864,Bioorg Med Chem,2011.0,CHEMBL1668642,CHEMBL1668642,4.75,0.0,http://www.openphacts.org/units/Nanomolar,1328426.0,=,1.0,1.0,=,IC50,nM,17700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,17.7,CHEMBL613497
5454,2099836.0,[],CHEMBL949222,Antiviral activity against HIV1 RU570 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL272748,CHEMBL272748,8.10,0.0,http://www.openphacts.org/units/Nanomolar,699397.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
5455,1498132.0,[],CHEMBL833971,Concentration required to inhibit 50% viral production of human immunodeficiency virus type 1 (HIV-1-IIIB),F,BAO_0000190,BAO_0000218,organism-based format,CC(C)c1nc(COC(N)=O)n(Cc2ccncc2)c1Sc1cc(Cl)cc(Cl)c1,CHEMBL1143567,J Med Chem,2005.0,CHEMBL435128,CHEMBL435128,8.51,0.0,http://www.openphacts.org/units/Nanomolar,388287.0,=,1.0,1.0,=,IC50,nM,3.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0031,CHEMBL378
5456,3383649.0,[],CHEMBL1211563,Antiviral activity against HIV1 NL-BAL infected in CCR5-expressing human JC53-BL cells assessed as inhibition of viral replication after 16 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1ccc(C(=O)N2C[C@H]3CN(CC[C@H](NC(=O)C4CCCC4)c4ccccc4)C[C@H]3C2)cc1,CHEMBL1208790,Bioorg Med Chem Lett,2010.0,CHEMBL1209371,CHEMBL1209371,,0.0,http://www.openphacts.org/units/Nanomolar,927085.0,<,1.0,1.0,<,IC50,nM,1.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.2,CHEMBL378
5457,12680709.0,[],CHEMBL2342598,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)NCc3ccccc3F)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333688,CHEMBL2333688,,0.0,http://www.openphacts.org/units/Nanomolar,1867764.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
5458,15606431.0,[],CHEMBL3579362,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBV DNA replication by real-time fluorescence quantitative PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C=C/C(=O)O/N=C/c2cccs2)cc1OC,CHEMBL3576819,Eur J Med Chem,2015.0,CHEMBL3577787,CHEMBL3577787,,0.0,,2480526.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
5459,19472249.0,[],CHEMBL4478788,Antiviral activity against wild type HIV1 NL4-3 assessed as inhibition of viral infection in human TZM-bl cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CS(=O)(=O)Nc1ccc(NC(=O)Nc2sc(-c3ccc(Cl)c(Cl)c3)cc2C(=O)O)cc1,CHEMBL4477221,J Med Chem,2016.0,CHEMBL4524634,CHEMBL4524634,5.30,0.0,http://www.openphacts.org/units/Nanomolar,3256036.0,=,1.0,1.0,=,IC50,nM,5000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.0,CHEMBL378
5460,18754882.0,[],CHEMBL4265061,Antiviral activity against HIV1 cYTA48P infected in PM1/CCR5 cells by single round assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1CCN(C(=O)c2cc3ccc(Cl)cc3[nH]2)CC1,CHEMBL4261625,Bioorg Med Chem,2018.0,CHEMBL4281798,CHEMBL4281798,,0.0,http://www.openphacts.org/units/Nanomolar,3116228.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5461,2930468.0,[],CHEMBL1056903,Antiviral activity against HIV1 HXB2 harboring 227L and 106A mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL57,CHEMBL57,6.79,0.0,http://www.openphacts.org/units/Nanomolar,848288.0,=,1.0,1.0,=,IC50,nM,163.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,163.0,CHEMBL378
5462,23153197.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4810870,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 production treated at 48 hrs post-infection and measured on day 4 post-viral infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C/C=C(/C)C(=O)O[C@@]12[C@H](O)[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@H]34)[C@@H]1C2(C)C,CHEMBL4808236,Bioorg Med Chem Lett,2021.0,CHEMBL4850876,CHEMBL4850876,,0.0,http://www.openphacts.org/units/Nanomolar,3599005.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10000.0,CHEMBL378
5463,3383666.0,[],CHEMBL1211563,Antiviral activity against HIV1 NL-BAL infected in CCR5-expressing human JC53-BL cells assessed as inhibition of viral replication after 16 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)nc(C)c1C(=O)N1C[C@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@H]2C1,CHEMBL1208790,Bioorg Med Chem Lett,2010.0,CHEMBL1095827,CHEMBL1095827,9.15,0.0,http://www.openphacts.org/units/Nanomolar,926852.0,=,1.0,1.0,=,IC50,nM,0.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.7,CHEMBL378
5464,14999594.0,[],CHEMBL3364773,Antiviral activity against HIV1 harboring reverse transcriptase K103N/V108I double mutant infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CNc2nc(-c3ccccc3Cl)c(Cc3ccccc3)s2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3330438,CHEMBL3330438,6.09,0.0,http://www.openphacts.org/units/Nanomolar,2248824.0,=,1.0,1.0,=,IC50,nM,820.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.82,CHEMBL378
5465,15748660.0,[],CHEMBL3630970,Antiviral activity against HIV1 3B assessed as inhibition of viral attachment to human MAGI cells,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(C[C@@H]1CN(C(=O)c2ccco2)CCN1)[C@H]1CCCc2cccnc21,CHEMBL3627700,Bioorg Med Chem Lett,2015.0,CHEMBL3627798,CHEMBL3627798,6.82,0.0,http://www.openphacts.org/units/Nanomolar,2506626.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.15,CHEMBL378
5466,2165099.0,[],CHEMBL921434,Antiviral activity against HIV1 with RT K101E/G190A mutation in human MT4 cells in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ccccc34)ccc2Cl)c1,CHEMBL1145601,Bioorg Med Chem Lett,2008.0,CHEMBL402823,CHEMBL402823,7.68,0.0,http://www.openphacts.org/units/Nanomolar,711002.0,=,1.0,1.0,=,IC50,nM,21.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,21.0,CHEMBL378
5467,2462114.0,[],CHEMBL965355,Antiviral activity against hepatitis B virus infected Hep G2.2.15 cells assessed as inhibition of HBeAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1157443,Bioorg Med Chem Lett,2008.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/Nanomolar,721013.0,=,1.0,1.0,=,IC50,nM,25900000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,25.9,CHEMBL613497
5468,8057965.0,[],CHEMBL1960698,Antiinfluenza activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)OCCCCCN1CCN(c2ccccc2)CC1)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL1955749,Bioorg Med Chem Lett,2012.0,CHEMBL1956409,CHEMBL1956409,,0.0,http://www.openphacts.org/units/Nanomolar,1580697.0,>,1.0,1.0,>,IC50,nM,25800.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,25.8,CHEMBL613129
5469,902574.0,[],CHEMBL685389,Inhibition of HIV replication in H9 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@@]45O[C@@H]4C(=O)C(S(C)(=O)=O)C[C@]5(C)[C@H]3CC[C@]12C,CHEMBL1128512,J Med Chem,1995.0,CHEMBL3137919,CHEMBL3137919,6.52,0.0,http://www.openphacts.org/units/Nanomolar,204888.0,=,1.0,1.0,=,IC50,nM,300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.3,CHEMBL378
5470,18342104.0,[],CHEMBL4139012,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)Nc2c[nH]c(=O)c(-c3ccc(OC)c(F)c3)c2)c(O)c1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL4168566,CHEMBL4168566,4.50,0.0,http://www.openphacts.org/units/Nanomolar,3045882.0,=,1.0,1.0,=,IC50,nM,31560.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,31.56,CHEMBL613497
5471,1401613.0,[],CHEMBL834488,In vitro inhibitory concentration against HIV L100I and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL366692,CHEMBL366692,7.40,0.0,http://www.openphacts.org/units/Nanomolar,360329.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
5472,1438121.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(CC#N)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL434518,CHEMBL434518,6.00,0.0,http://www.openphacts.org/units/Nanomolar,371616.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
5473,1222248.0,[],CHEMBL710530,Inhibitory activity against 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Nc1nc(Nc2ccc(C#N)cc2)ncc1Cl,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL312764,CHEMBL312764,9.05,0.0,http://www.openphacts.org/units/Nanomolar,127444.0,=,1.0,1.0,=,IC50,nM,0.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0009,CHEMBL378
5474,24830932.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CCCN1c1ccc2c(=O)c3cccc(F)c3oc2c1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5209182,CHEMBL5209182,6.08,0.0,http://www.openphacts.org/units/Nanomolar,3878105.0,=,1.0,1.0,=,IC50,nM,830.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.83,CHEMBL613497
5475,1244727.0,[],CHEMBL711623,Concentration required to inhibit HIV-1 induced cytopathicity in MT-4 cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N(CC)CCCCCCCCCCC(=O)[O-].[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL324258,CHEMBL1206912,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221543.0,>,1.0,1.0,>,IC50,ug.mL-1,16.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,16.0,CHEMBL378
5476,3084555.0,[],CHEMBL1065277,Antiviral activity against HIV1 fTOI primary isolate assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(NC(=O)C(=O)Nc2ccc(F)cc2)CC(C)(C)N1,CHEMBL1153139,Bioorg Med Chem Lett,2010.0,CHEMBL595942,CHEMBL595942,,0.0,,873917.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5477,16626918.0,[],CHEMBL3821892,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg secretion by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,O=[N+]([O-])c1ccccc1S(=O)(=O)Oc1cc(-c2ccccn2)[nH]n1,CHEMBL3817822,Medchemcomm,2016.0,CHEMBL3818406,CHEMBL3818406,4.92,0.0,http://www.openphacts.org/units/Nanomolar,2783930.0,=,1.0,1.0,=,IC50,nM,12020.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,12.02,CHEMBL613497
5478,12542803.0,[],CHEMBL3076900,Antiviral activity against Human immunodeficiency virus 1 IIIB infected MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2nc(Nn3c(-c4ccc([N+](=O)[O-])cc4)nnc3-c3cccnc3)sc2c1,CHEMBL3046062,Med Chem Res,2013.0,CHEMBL2282274,CHEMBL2282274,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824484.0,>,1.0,1.0,>,IC50,ug.mL-1,64.43,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,64.43,CHEMBL378
5479,1671927.0,[],CHEMBL870624,Antiviral activity against HIV1 K103N mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ncc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL198398,CHEMBL198398,8.30,0.0,http://www.openphacts.org/units/Nanomolar,411919.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.0,CHEMBL378
5480,1439780.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(NC(C)=O)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL359490,CHEMBL359490,6.92,0.0,http://www.openphacts.org/units/Nanomolar,371457.0,=,1.0,1.0,=,IC50,nM,120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.12,CHEMBL378
5481,2292362.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(C)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL55187,CHEMBL55187,4.30,0.0,http://www.openphacts.org/units/Nanomolar,812443.0,=,1.0,1.0,=,IC50,nM,50003.45,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.301,CHEMBL378
5482,2614776.0,[],CHEMBL1014293,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1[S+]([O-])c1cccc(N)c1C#N,CHEMBL1152795,Bioorg Med Chem,2009.0,CHEMBL293331,CHEMBL293331,,0.0,http://www.openphacts.org/units/Nanomolar,731469.0,=,1.0,1.0,=,IC50,nM,4797334.49,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,2.319,CHEMBL378
5483,7943059.0,[],CHEMBL1921170,Antiviral activity against R5 tropic HIV1 YTA infected in human TZM-bl cells assessed as beta-galactosidase activity preincubated for 15 mins before infection measured after 2 days by single-round assay using luminometry,F,BAO_0000190,BAO_0000218,organism-based format,NC(=S)N1CCC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC1,CHEMBL1914307,Bioorg Med Chem,2011.0,CHEMBL1917741,CHEMBL1917741,5.26,0.0,http://www.openphacts.org/units/Nanomolar,1560416.0,=,1.0,1.0,=,IC50,nM,5500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.5,CHEMBL378
5484,10860653.0,[],CHEMBL2020780,Antiviral against R5 tropic HIV1 Bal infected in human CEMx174 5.25M7 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCC(C(=O)N(CCCN2CCC(CNC(=O)c3ccsc3)CC2)c2ccc(C)c(Cl)c2)CC1,CHEMBL2016501,Bioorg Med Chem Lett,2012.0,CHEMBL2017364,CHEMBL2017364,7.06,0.0,http://www.openphacts.org/units/Nanomolar,1634920.0,=,1.0,1.0,=,IC50,nM,87.48,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,87.48,CHEMBL378
5485,3238684.0,[],CHEMBL1116129,Antiviral activity against Human immunodeficiency virus 1 NL4.3 infected human CEM cells expressing GFP measured up to 8 days postinfection by p24 antigen capture ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1156233,Bioorg Med Chem,2010.0,CHEMBL129,CHEMBL129,5.98,0.0,http://www.openphacts.org/units/Nanomolar,904796.0,=,1.0,1.0,=,IC50,nM,1040.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.04,CHEMBL378
5486,23274452.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](OC(=O)CC[C@@H](C)[C@@H]4CC[C@H]5[C@@H]6[C@@H](O)C[C@@H]7C[C@H](O)CC[C@]7(C)[C@H]6CC[C@@]54C)C[C@]4(C)C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4856640,CHEMBL4856640,5.73,0.0,http://www.openphacts.org/units/Nanomolar,3621252.0,=,1.0,1.0,=,IC50,nM,1878.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,1878.0,CHEMBL613497
5487,341453.0,[],CHEMBL697276,In vitro inhibition of HIV-1 plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCCCOCC[N+](C)(C)CC(O)CO.[I-],CHEMBL1125666,J Med Chem,1991.0,CHEMBL280747,CHEMBL1183116,6.70,0.0,http://www.openphacts.org/units/Nanomolar,43724.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.2,CHEMBL378
5488,15158577.0,[],CHEMBL3398830,Inhibition of HBV HBsAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCC(=O)OCc1cccc2c1CCOC2=O,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397173,CHEMBL3397173,,0.0,http://www.openphacts.org/units/Nanomolar,2278972.0,>,1.0,1.0,>,IC50,nM,3450000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,3.45,CHEMBL613497
5489,13475614.0,[],CHEMBL2439262,Antiviral activity against Human immunodeficiency virus 1 clade E isolate ID12 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc(Sc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2434978,CHEMBL2434978,8.40,0.0,http://www.openphacts.org/units/Nanomolar,1924232.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.0,CHEMBL378
5490,10866473.0,[],CHEMBL2025518,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCC(C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(O)C(C)=O)C2)CC1,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2024035,CHEMBL2024035,4.26,0.0,http://www.openphacts.org/units/Nanomolar,1639757.0,=,1.0,1.0,=,IC50,nM,54840.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,54.84,CHEMBL613497
5491,6200549.0,[],CHEMBL1781474,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication after 4 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CCN(CCc1c[nH]c2ccccc12)Cc1ccco1,CHEMBL1777761,Bioorg Med Chem,2011.0,CHEMBL1779180,CHEMBL1779180,5.28,0.0,http://www.openphacts.org/units/Nanomolar,1425136.0,=,1.0,1.0,=,IC50,nM,5300.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,5.3,CHEMBL613497
5492,19472241.0,[],CHEMBL4478790,Antiviral activity against NNRTI resistant HIV1 harboring reverse transcriptase V106I/Y181C/G190A/H221Y mutant assessed as inhibition of viral infection in human TZM-bl cells after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(NS(=O)(=O)c2ccccc2)cc1)Nc1sc(-c2ccc(Cl)c(Cl)c2)cc1C(=O)O,CHEMBL4477221,J Med Chem,2016.0,CHEMBL4523060,CHEMBL4523060,,0.0,http://www.openphacts.org/units/Nanomolar,3256037.0,>,1.0,1.0,>,IC50,nM,1500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.5,CHEMBL378
5493,24831035.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142776,Antiviral activity against HBV infected in human HepG2 cells assessed as reduction in HBeAg secretion incubated for 5 days by counter screen assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)[C@H]1CCN(c2ccc3c(=O)c4cccc(Cl)c4oc3c2)C1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5202800,CHEMBL5202800,,0.0,http://www.openphacts.org/units/Nanomolar,3878147.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
5494,2601724.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(NC2CC2)cc(OCCOCP(=O)(O)O)n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL59520,CHEMBL59520,9.48,0.0,http://www.openphacts.org/units/Nanomolar,807558.0,=,1.0,1.0,=,IC50,nM,0.3289,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.000328947,CHEMBL378
5495,508776.0,[],CHEMBL757967,Inhibition of cell growth against HIV-1 infected PBM (Human peripheral blood mononuclear) cells,F,BAO_0000190,BAO_0000218,organism-based format,O=c1[nH]c(=O)n([C@H]2CS[C@@H](CO)O2)cc1F,CHEMBL1126792,J Med Chem,1993.0,CHEMBL88360,CHEMBL88360,,0.0,http://www.openphacts.org/units/Nanomolar,161288.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5496,3104086.0,[],CHEMBL1070323,Antiviral activity against human influenza B virus B/TW/710/05 in MDCK cells assessed as reduction of virus-induced cytopathic,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)oc2c1ccc1oc(C(=O)c3cccs3)c(-c3ccccc3)c12,CHEMBL1156875,J Med Chem,2010.0,CHEMBL602496,CHEMBL602496,7.05,0.0,http://www.openphacts.org/units/Nanomolar,886613.0,=,1.0,1.0,=,IC50,nM,90.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,0.09,CHEMBL613129
5497,18528870.0,[],CHEMBL4194999,Antiviral activity against HIV1 virions derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)N(c1cc(OC)c(OC)c(OC)c1)C(=O)CC2,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4217210,CHEMBL4217210,,0.0,http://www.openphacts.org/units/Nanomolar,3076513.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
5498,3399341.0,[],CHEMBL1219621,Antiviral activity against R5 tropic HIV1 HXB2 infected in human TZM-bl cells assessed as inhibition of virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)CC,CHEMBL1212937,J Med Chem,2010.0,CHEMBL1215926,CHEMBL1215926,4.34,0.0,http://www.openphacts.org/units/Nanomolar,933727.0,=,1.0,1.0,=,IC50,nM,46000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,46.0,CHEMBL378
5499,10860656.0,[],CHEMBL2020780,Antiviral against R5 tropic HIV1 Bal infected in human CEMx174 5.25M7 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCC(C(=O)N(CCCN2CCC(Oc3ccccc3)CC2)c2ccc(C)c(Cl)c2)CC1,CHEMBL2016501,Bioorg Med Chem Lett,2012.0,CHEMBL2017367,CHEMBL2017367,7.28,0.0,http://www.openphacts.org/units/Nanomolar,1634923.0,=,1.0,1.0,=,IC50,nM,52.27,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,52.27,CHEMBL378
5500,820758.0,[],CHEMBL683814,Inhibitory activity against NNI-resistant HIV-1 strain A17 with Y181C mutation,F,BAO_0000190,BAO_0000218,organism-based format,Fc1ccccc1CC/N=C(\S)Nc1ccc(Br)cn1,CHEMBL1133139,Bioorg Med Chem Lett,2000.0,CHEMBL295585,CHEMBL295585,6.70,0.0,http://www.openphacts.org/units/Nanomolar,111927.0,=,1.0,1.0,=,IC50,nM,200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.2,CHEMBL378
5501,24830975.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)[C@H]1CCN(c2ccc3c(=O)c4c(Cl)ccc(Cl)c4oc3c2)C1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5170791,CHEMBL5170791,6.19,0.0,http://www.openphacts.org/units/Nanomolar,3878148.0,=,1.0,1.0,=,IC50,nM,650.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.65,CHEMBL613497
5502,2602121.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL106247,CHEMBL106247,8.00,0.0,http://www.openphacts.org/units/Nanomolar,807035.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
5503,8051467.0,[],CHEMBL1959807,Antiviral activity against HIV1 LAL infected in human MT2 cells by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2C[C@@H]3[C@@H](OC(=O)N(C)C)CO[C@@H]3C2)cc1,CHEMBL1955842,Bioorg Med Chem Lett,2012.0,CHEMBL1958486,CHEMBL1958486,8.33,0.0,http://www.openphacts.org/units/Nanomolar,1583262.0,=,1.0,1.0,=,IC50,nM,4.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.7,CHEMBL378
5504,12687134.0,[],CHEMBL2344305,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral e antigen production,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)O[C@H]1C[C@@H]2C(=CC[C@@H]3[C@@]2(C)C(=O)C[C@]2(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](OC(C)=O)C[C@@]32C)C(C)(C)[C@@H]1OC(=O)CC,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332401,CHEMBL2332401,,0.0,http://www.openphacts.org/units/Nanomolar,1866095.0,>,1.0,1.0,>,IC50,nM,649900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,649.9,CHEMBL613497
5505,3239334.0,[],CHEMBL1106187,Inhibition of AP-1 expressed in HEK293 cells assessed as PMA-stimulated transcriptional activation treated 24 hrs before PMA challenge measured after 20 to 24 hrs by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(-n2c(-c3cc(-c4ccc(S(C)(=O)=O)cc4)c(N4CCOCC4)s3)nc3ccccc3c2=O)cc1,CHEMBL1156197,Bioorg Med Chem,2010.0,CHEMBL1089477,CHEMBL1089477,,0.0,,903885.0,,1.0,0.0,,IC50,,,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,,,,CHEMBL4977
5506,2601999.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(Cl)c2ncn([C@@H]3O[C@H](CO)C=C3F)c2n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL472870,CHEMBL472870,5.37,0.0,http://www.openphacts.org/units/Nanomolar,807484.0,=,1.0,1.0,=,IC50,nM,4300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.3,CHEMBL378
5507,532466.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1Sc1ccccc1,CHEMBL1134494,J Med Chem,2001.0,CHEMBL52068,CHEMBL52068,4.84,0.0,http://www.openphacts.org/units/Nanomolar,94213.0,=,1.0,1.0,=,IC50,nM,14600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,14.6,CHEMBL378
5508,2413715.0,[],CHEMBL987710,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@H](OC(=O)CC(C)C)[C@H](C[C@@H](C)C1=C2C[C@H](OC(=O)CC(C)C)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)OC(=O)CC(C)C,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL503482,CHEMBL503482,,0.0,http://www.openphacts.org/units/Nanomolar,810795.0,>,1.0,1.0,>,IC50,nM,1200000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.2,CHEMBL613497
5509,12651350.0,[],CHEMBL2327721,Antiviral activity against 0.001 MOI bevirimat-resistant Human immunodeficiency virus 1 NL4-3 harboring gag V370 deletion mutant infected in human MT4 cells assessed as inhibition of viral replication measured 4 days post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL2321690,J Med Chem,2013.0,CHEMBL404519,CHEMBL404519,,0.0,http://www.openphacts.org/units/Nanomolar,1850178.0,>,1.0,1.0,>,IC50,nM,6800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.8,CHEMBL378
5510,812988.0,[],CHEMBL697279,Anti-HIV-1 activity against syncytial plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCCC(=O)NCC(COP(=O)([O-])OC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)C[C@@H]1N=[N+]=[N-])OCC.[Na+],CHEMBL1125670,J Med Chem,1991.0,CHEMBL3350978,CHEMBL3558648,4.52,0.0,http://www.openphacts.org/units/Nanomolar,47352.0,=,1.0,1.0,=,IC50,nM,30000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,mM,UO_0000065,0.03,CHEMBL378
5511,1421942.0,[],CHEMBL834672,Inhibitory activity against human immunodeficiency virus type 1,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(Sc2cc(C)cc(C)c2)n(COCc2cccs2)c(=O)[nH]c1=O,CHEMBL1144258,Bioorg Med Chem Lett,2005.0,CHEMBL367214,CHEMBL367214,,0.0,http://www.openphacts.org/units/Nanomolar,364788.0,<,1.0,1.0,<,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
5512,1031666.0,[],CHEMBL713936,Concentration required to inhibit the viral (HIV-1 NNRTI resistant strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(S)n(Nc2cccc(Cl)c2)c1-c1cccc(Br)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL37967,CHEMBL37967,5.52,0.0,http://www.openphacts.org/units/Nanomolar,62314.0,=,1.0,1.0,=,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.0,CHEMBL378
5513,2432643.0,[],CHEMBL1027472,Antiviral activity against HIV1 3B infected in human HOG.R5 assessed as inhibition of viral replication by microtiter assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC[C@]2(CO)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL1159344,J Nat Prod,2003.0,CHEMBL400074,CHEMBL400074,4.34,0.0,http://www.openphacts.org/units/Nanomolar,735820.0,=,1.0,1.0,=,IC50,nM,45200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,45.2,CHEMBL378
5514,2601654.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc2ccc(/C=C/c3ccc(O)cc3)nc2c1O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL418613,CHEMBL418613,4.02,0.0,http://www.openphacts.org/units/Nanomolar,807392.0,=,1.0,1.0,=,IC50,nM,95000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,95.0,CHEMBL378
5515,1176256.0,[],CHEMBL818227,Cytotoxicity was determined in the vero cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,CNc1ncnc2c1ncn2[C@H]1CS[C@H](CO)O1,CHEMBL1126808,J Med Chem,1993.0,CHEMBL58457,CHEMBL58457,,0.0,http://www.openphacts.org/units/Nanomolar,100961.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5516,3084000.0,[],CHEMBL1072584,Antiviral activity against HIV1 infected in human JC53-BL cells after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)N1C[C@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@H]2C1,CHEMBL1153211,Bioorg Med Chem Lett,2010.0,CHEMBL593520,CHEMBL593520,7.41,0.0,http://www.openphacts.org/units/Nanomolar,872808.0,=,1.0,1.0,=,IC50,nM,39.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,39.0,CHEMBL378
5517,24823610.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '144.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '6.0'}]",CHEMBL5140688,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in intracellular core HBV DNA level incubated for 6 days by qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCCC1COc3ccccc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5180911,CHEMBL5180911,8.92,0.0,http://www.openphacts.org/units/Nanomolar,3876709.0,=,1.0,1.0,=,IC50,nM,1.2,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0012,CHEMBL613497
5518,19271300.0,[],CHEMBL4406716,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as reduction in p24 Gag protein production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL4402610,J Med Chem,2020.0,CHEMBL1323,CHEMBL1323,8.38,0.0,http://www.openphacts.org/units/Nanomolar,3217926.0,=,1.0,1.0,=,IC50,nM,4.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.2,CHEMBL378
5519,879173.0,[],CHEMBL683811,Antiviral activity against HIV-1 using antiinfectivity assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc(CO[C@H]2C(=O)Nc3ccc(Cl)cc3[C@@]2(C#CC2CC2)C(F)(F)F)cc1,CHEMBL1134695,Bioorg Med Chem Lett,2001.0,CHEMBL57216,CHEMBL57216,7.68,0.0,http://www.openphacts.org/units/Nanomolar,100522.0,=,1.0,1.0,=,IC50,nM,21.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,21.0,CHEMBL378
5520,12091413.0,[],CHEMBL2168515,Antiviral activity against R5 tropic HIV1 Ba-L infected human PBMC assessed as inhibition of viral replication by p-24 antigen specific ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COCCONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1,CHEMBL2163215,ACS Med Chem Lett,2012.0,CHEMBL2164211,CHEMBL2164211,7.67,0.0,http://www.openphacts.org/units/Nanomolar,1736634.0,=,1.0,1.0,=,IC50,nM,21.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,21.3,CHEMBL378
5521,2149858.0,[],CHEMBL935682,Antiviral activity against HIV1 098-T1249 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL427801,CHEMBL427801,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708029.0,=,1.0,1.0,=,IC50,ug.mL-1,0.151,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.151,CHEMBL378
5522,2413701.0,[],CHEMBL987710,Antiviral activity against HBV assessed as inhibition of viral early antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)c1ccccc1I)[C@@H](OC(=O)c1ccccc1I)C(C)(C)O)C1=C2C[C@H](OC(=O)c3ccccc3I)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1153983,Bioorg Med Chem Lett,2009.0,CHEMBL504682,CHEMBL504682,,0.0,http://www.openphacts.org/units/Nanomolar,810689.0,>,1.0,1.0,>,IC50,nM,1500000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.5,CHEMBL613497
5523,10938626.0,[],CHEMBL2051599,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1cccc(/C=C/C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(O)C(C)=O)C2)c1,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046566,CHEMBL2046566,,0.0,http://www.openphacts.org/units/Nanomolar,1651449.0,=,1.0,1.0,=,IC50,nM,140570.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,140.57,CHEMBL613497
5524,2345705.0,[],CHEMBL953829,Antiviral activity against HIV1 NL4.3 in human MT4 cells,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21,CHEMBL1150800,Antimicrob Agents Chemother,2007.0,CHEMBL518924,CHEMBL518924,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,793938.0,=,1.0,1.0,=,IC50,ug.mL-1,0.0023,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ng/ml,UO_0000274,2.3,CHEMBL378
5525,3083973.0,[],CHEMBL1072584,Antiviral activity against HIV1 infected in human JC53-BL cells after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)N1C[C@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@H]2C1,CHEMBL1153211,Bioorg Med Chem Lett,2010.0,CHEMBL594914,CHEMBL594914,,0.0,,872645.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5526,2009857.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccnc2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)c12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL337301,CHEMBL337301,8.10,0.0,http://www.openphacts.org/units/Nanomolar,668056.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.0,CHEMBL378
5527,1470584.0,[],CHEMBL832526,Inhibitory activity against HIV-1 double mutants strain 103N and 181C,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL57,CHEMBL57,7.40,0.0,http://www.openphacts.org/units/Nanomolar,380791.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
5528,23153208.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4810870,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 production treated at 48 hrs post-infection and measured on day 4 post-viral infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCC(=O)O[C@@]12[C@H](OC(=O)/C=C/c3ccc(O)c(OC)c3)[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@H]34)[C@@H]1C2(C)C,CHEMBL4808236,Bioorg Med Chem Lett,2021.0,CHEMBL4870378,CHEMBL4870378,7.06,0.0,http://www.openphacts.org/units/Nanomolar,3599018.0,=,1.0,1.0,=,IC50,nM,87.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,87.2,CHEMBL378
5529,2681603.0,[],CHEMBL1051714,Antiviral activity against HIV1 ZM197M.PB7 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)N[C@@H](CC(C)C)[C@H](O)CC(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL137752,CHEMBL137752,7.05,0.0,http://www.openphacts.org/units/Nanomolar,823862.0,=,1.0,1.0,=,IC50,nM,90.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.09,CHEMBL378
5530,1064953.0,[],CHEMBL713935,Concentration required to inhibit the viral (HIV-1 NL4.3 strain) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1cccc(C2C(C)N=C(S)N2Nc2cccc(Cl)c2)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL38391,CHEMBL38391,,0.0,http://www.openphacts.org/units/Nanomolar,62355.0,>,1.0,1.0,>,IC50,nM,67360.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,67.36,CHEMBL378
5531,24788568.0,[],CHEMBL5131671,Antiviral activity against HBV infected in human HepG2-hNTCP cells,F,BAO_0000190,BAO_0000218,organism-based format,Fc1ccc(N2CCCCC2)c(NC(=S)c2ccncc2)c1,CHEMBL5131375,J Med Chem,2022.0,CHEMBL5169987,CHEMBL5169987,6.48,0.0,http://www.openphacts.org/units/Nanomolar,3869385.0,=,1.0,1.0,=,IC50,nM,330.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.33,CHEMBL613497
5532,15159553.0,[],CHEMBL3398834,Inhibition of HBV DNA replication in HepG2(2.2.15) cells exposed to fresh medium supplemented with compound every other day for additional 5 days by real-time PCR-fluorescent probing method,F,BAO_0000190,BAO_0000218,organism-based format,O=C1OCCc2c(/C=C\c3ccccc3)cccc21,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397169,CHEMBL3397169,4.10,0.0,http://www.openphacts.org/units/Nanomolar,2278967.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.08,CHEMBL613497
5533,1006087.0,[],CHEMBL714338,"Antiviral activity against HIV-1, IIIB, in MT-4 Cells",F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)[C@@H](NCc1ccc(OCCO)cc1)C(=O)NC1c2ccccc2C[C@H]1O,CHEMBL1129316,J Med Chem,1996.0,CHEMBL64441,CHEMBL64441,5.40,0.0,http://www.openphacts.org/units/Nanomolar,111244.0,=,1.0,1.0,=,IC50,nM,4000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4000.0,CHEMBL378
5534,1038828.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC1N=CN(Nc2cccc(Cl)c2)C1c1cccc(C(=O)O)c1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL40011,CHEMBL40011,,0.0,http://www.openphacts.org/units/Nanomolar,62311.0,>,1.0,1.0,>,IC50,nM,160570.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,160.57,CHEMBL613499
5535,10961209.0,[],CHEMBL2061270,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M5 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(C)=C1C(=O)Nc2ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)cc21,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057466,CHEMBL2057466,7.75,0.0,http://www.openphacts.org/units/Nanomolar,1655128.0,=,1.0,1.0,=,IC50,nM,18.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,18.0,CHEMBL378
5536,15158538.0,[],CHEMBL3398830,Inhibition of HBV HBsAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,O=C1OCCc2c(/C=N\O)cccc21,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397166,CHEMBL3397166,,0.0,http://www.openphacts.org/units/Nanomolar,2278964.0,>,1.0,1.0,>,IC50,nM,4000000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,4.0,CHEMBL613497
5537,18775488.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(c(OC)c1)-c1cc(=O)c(C(=O)O)cn1C(C)C2,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4290970,CHEMBL4290970,5.34,0.0,http://www.openphacts.org/units/Nanomolar,3119646.0,=,1.0,1.0,=,IC50,nM,4560.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,4.56,CHEMBL613497
5538,10911775.0,[],CHEMBL2038372,Antiviral activity against multidrug-resistant HIV1 clade B 4775-5 clinical isolate infected in PHA-P-stimulated human PBMC assessed as reverse transcriptase activity incubated for 6 hrs followed by incubated in drug-free medium for 6 days by multiround infection assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL2034836,J Med Chem,2012.0,CHEMBL129,CHEMBL129,5.62,0.0,http://www.openphacts.org/units/Nanomolar,1644914.0,=,1.0,1.0,=,IC50,nM,2425.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2425.0,CHEMBL378
5539,18044498.0,[],CHEMBL4010365,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of p24 antigen production pretreated with virus for 30 mins followed by 4 days incubation with cells by sandwich ELISA based multicycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(C(CCN)NC(=O)c2ccc(-c3ccc(F)c(Cl)c3)[nH]2)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4080427,CHEMBL4080427,5.11,0.0,http://www.openphacts.org/units/Nanomolar,2990193.0,=,1.0,1.0,=,IC50,nM,7800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.8,CHEMBL378
5540,12680705.0,[],CHEMBL2342598,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)NCCc3ccccc3F)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333289,CHEMBL2333289,,0.0,http://www.openphacts.org/units/Nanomolar,1867252.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
5541,2464774.0,[],CHEMBL963689,Antiviral activity against HBV assessed as inhibition of viral surface-antigen production by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1cc2c(CN3CCOCC3)c(O)c(OC)cc2nc1CSc1ccc(F)c(F)c1,CHEMBL1157455,Bioorg Med Chem,2008.0,CHEMBL488643,CHEMBL488643,5.24,0.0,http://www.openphacts.org/units/Nanomolar,720572.0,=,1.0,1.0,=,IC50,nM,5800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,5.8,CHEMBL613497
5542,1402188.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369599,CHEMBL369599,7.80,0.0,http://www.openphacts.org/units/Nanomolar,360395.0,=,1.0,1.0,=,IC50,nM,16.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.016,CHEMBL378
5543,12542796.0,[],CHEMBL3076900,Antiviral activity against Human immunodeficiency virus 1 IIIB infected MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Fc1ccc2nc(Nn3c(-c4ccc(Cl)cc4)nnc3-c3cccnc3)sc2c1,CHEMBL3046062,Med Chem Res,2013.0,CHEMBL2282281,CHEMBL2282281,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824491.0,>,1.0,1.0,>,IC50,ug.mL-1,92.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,92.9,CHEMBL378
5544,3194836.0,[],CHEMBL1102708,Antiviral activity against CCR5-tropic recombinant HIV1 NLBal virus infected in JC53-BL cells assessed as inhibition of viral replication after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3cccc(F)c3)C[C@@H]2C1,CHEMBL1154938,Bioorg Med Chem Lett,2010.0,CHEMBL1081486,CHEMBL1081486,6.68,0.0,http://www.openphacts.org/units/Nanomolar,892624.0,=,1.0,1.0,=,IC50,nM,210.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,210.0,CHEMBL378
5545,10938639.0,[],CHEMBL2051599,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccc(C=O)cc4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046555,CHEMBL2046555,4.72,0.0,http://www.openphacts.org/units/Nanomolar,1651438.0,=,1.0,1.0,=,IC50,nM,19190.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,19.19,CHEMBL613497
5546,1470131.0,[],CHEMBL832524,Inhibitory activity against HIV-1 double mutants strain 100I and 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(Br)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188223,CHEMBL188223,7.16,0.0,http://www.openphacts.org/units/Nanomolar,380674.0,=,1.0,1.0,=,IC50,nM,70.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.07,CHEMBL378
5547,672202.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)Nc2ccccc2SSc2ccccc2NS(=O)(=O)c2ccc(C)cc2)cc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL330941,CHEMBL330941,,0.0,,228675.0,=,1.0,0.0,=,IC50,,5.05,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,5.05,CHEMBL378
5548,2321201.0,[],CHEMBL1004248,Antiviral activity against HIV1 3B in human H9 cells after 4 days by p24 antigen ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC6(CC(=O)O)CCCC6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL1150942,J Nat Prod,1998.0,CHEMBL323157,CHEMBL323157,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,787875.0,=,1.0,1.0,=,IC50,ug.mL-1,4.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,4.7,CHEMBL378
5549,10861994.0,[],CHEMBL2024923,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)OCc6cc(C(F)(F)F)cc(C(F)(F)F)c6)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,CHEMBL2021793,Bioorg Med Chem Lett,2012.0,CHEMBL2022386,CHEMBL2022386,,0.0,http://www.openphacts.org/units/Nanomolar,1637636.0,>,1.0,1.0,>,IC50,nM,1702450.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1702.45,CHEMBL613497
5550,2212959.0,[],CHEMBL989684,Antiviral activity against HBV assessed as inhibition of viral e-antigen secretion in HepG2.2.15 cells by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1150244,J Nat Prod,2008.0,CHEMBL141,CHEMBL141,,0.0,http://www.openphacts.org/units/Nanomolar,767838.0,=,1.0,1.0,=,IC50,nM,25900000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,25.9,CHEMBL613497
5551,693359.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,N=C(N)Nc1ccccc1SSc1ccccc1N=C(N)N,CHEMBL1129635,J Med Chem,1996.0,CHEMBL332116,CHEMBL332116,,0.0,,228541.0,=,1.0,0.0,=,IC50,,38.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,38.4,CHEMBL378
5552,15158617.0,[],CHEMBL3398832,Inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,O=C1OCCc2c(CO)cccc21,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397162,CHEMBL3397162,,0.0,http://www.openphacts.org/units/Nanomolar,2278960.0,=,1.0,1.0,=,IC50,nM,1460000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.46,CHEMBL613497
5553,3467379.0,[],CHEMBL1250743,Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 6 hrs by p24 antigen based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)oc2c3c(ccc12)[S+]([O-])[C@@H](C)C(OC(=O)C12CCC(C)(C(=O)O1)C2(C)C)C3OC(=O)C12CCC(C)(C(=O)O1)C2(C)C,CHEMBL1250555,Bioorg Med Chem,2010.0,CHEMBL1253537,CHEMBL1253537,4.42,0.0,http://www.openphacts.org/units/Nanomolar,955462.0,=,1.0,1.0,=,IC50,nM,38200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,38.2,CHEMBL378
5554,15210773.0,[],CHEMBL3421426,Antiviral activity against Human immunodeficiency virus 1 3b infected in human MT4 cells assessed as inhibition of virus replication after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL3414423,J Nat Prod,2014.0,CHEMBL57,CHEMBL57,8.00,0.0,http://www.openphacts.org/units/Nanomolar,2289953.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
5555,23314837.0,[],CHEMBL4845002,"Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid probe from human TIM-3 IgV domain (residues 22 to 130) expressed in Escherichia coli BL21 (DE3) by FPA competition assay",B,BAO_0000190,BAO_0000019,assay format,Cc1nc2c3cc(-c4ccncc4C)c(Cl)cc3[nH]c(=O)n2n1,CHEMBL4842382,J Med Chem,2021.0,CHEMBL4863477,CHEMBL4863477,4.28,0.0,http://www.openphacts.org/units/Nanomolar,3628757.0,=,1.0,1.0,=,IC50,nM,53000.0,CHEMBL4630879,Homo sapiens,Hepatitis A virus cellular receptor 2,9606,IC50,uM,UO_0000065,53.0,CHEMBL4630879
5556,16431830.0,[],CHEMBL3748184,Inhibition of human FER using poly[Glu:Tyr] (4:1) as substrate,B,BAO_0000190,BAO_0000357,single protein format,Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21,CHEMBL3745707,Bioorg Med Chem,2016.0,CHEMBL3745885,CHEMBL3745885,,0.0,http://www.openphacts.org/units/Nanomolar,2741358.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL3982,Homo sapiens,Tyrosine-protein kinase FER,9606,IC50,uM,UO_0000065,10.0,CHEMBL3982
5557,1954162.0,[],CHEMBL891427,Antiviral activity against HIV1 RT 100I/103N mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(SC)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL233452,CHEMBL233452,7.20,0.0,http://www.openphacts.org/units/Nanomolar,647179.0,=,1.0,1.0,=,IC50,nM,63.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,63.1,CHEMBL378
5558,10865194.0,[],CHEMBL2025516,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as suppression of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)c4cnccn4)CC3=CC[C@]12O,CHEMBL2021791,Bioorg Med Chem,2012.0,CHEMBL2023673,CHEMBL2023673,4.02,0.0,http://www.openphacts.org/units/Nanomolar,1639237.0,=,1.0,1.0,=,IC50,nM,95520.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,95.52,CHEMBL613497
5559,15158580.0,[],CHEMBL3398830,Inhibition of HBV HBsAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,O=C1OCCc2c(COC(=O)C3CCCCC3)cccc21,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397176,CHEMBL3397176,,0.0,http://www.openphacts.org/units/Nanomolar,2278975.0,>,1.0,1.0,>,IC50,nM,1840000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.84,CHEMBL613497
5560,15666369.0,[],CHEMBL3602699,Antiviral activity against HIV-1 SF162 pseudovirus infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL3600303,J Med Chem,2015.0,CHEMBL428607,CHEMBL428607,7.90,0.0,http://www.openphacts.org/units/Nanomolar,2492328.0,=,1.0,1.0,=,IC50,nM,12.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,12.5,CHEMBL378
5561,3603772.0,[],CHEMBL1291722,Antiviral activity against Hepatitis B virus infected in HepG2.2.15 assessed as inhibition of HBsAg production at <163.9 +/- 4.4 uM by EIA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(SCc2nc3c(Cn4ccnc4C)c(O)ccc3n2C)cc1,CHEMBL1287795,Bioorg Med Chem Lett,2010.0,CHEMBL1288111,CHEMBL1288111,,0.0,,973126.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
5562,18585125.0,[],CHEMBL4223280,Antiviral activity against Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBeAg secretion after 3 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CCC(=O)OC(C)(C)[C@@H]5CC[C@]43C)[C@H]12,CHEMBL4219203,Bioorg Med Chem Lett,2018.0,CHEMBL596403,CHEMBL596403,,0.0,http://www.openphacts.org/units/Nanomolar,3086245.0,=,1.0,1.0,=,IC50,nM,176500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,176.5,CHEMBL613497
5563,10996095.0,[],CHEMBL2072873,Antiviral activity against VSV-G pseudotyped HIV1 lentiviral particles infected in human HeLa cells incubated for 48 hrs by spectrofluorometry,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,CHEMBL2069294,Bioorg Med Chem,2012.0,CHEMBL254316,CHEMBL254316,8.00,0.0,http://www.openphacts.org/units/Nanomolar,1663496.0,=,1.0,1.0,=,IC50,nM,10.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.01,CHEMBL378
5564,1486657.0,[],CHEMBL833976,Inhibitory concentration against wild type human immunodeficiency virus type 1 was determined by recombinant virus assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCc1c(O)nc2ccc(F)cc2c1OC#CC1CC1,CHEMBL1138845,J Med Chem,2004.0,CHEMBL188706,CHEMBL188706,7.18,0.0,http://www.openphacts.org/units/Nanomolar,384073.0,=,1.0,1.0,=,IC50,nM,66.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,66.0,CHEMBL378
5565,2362900.0,[],CHEMBL1026417,"Antiviral activity against multidrug-resistant HIV1 with protease L10I, V11I, T12E, I15V, L19I, R41K, M46L, L63P, A71T, V82A, L90M mutation in phytohemagglutininin-activated PBMC assessed as inhibition of p24G protein production",F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,CHEMBL1140100,J Med Chem,2008.0,CHEMBL115,CHEMBL115,6.54,0.0,http://www.openphacts.org/units/Nanomolar,747152.0,=,1.0,1.0,=,IC50,nM,290.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,290.0,CHEMBL378
5566,2516348.0,[],CHEMBL975243,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(Cc2ccc(-c3ccccc3)cc2)nc(SCc2ccc(OC)cc2)[nH]c1=O,CHEMBL1138559,Eur J Med Chem,2009.0,CHEMBL475241,CHEMBL475241,,0.0,http://www.openphacts.org/units/Nanomolar,733104.0,>,1.0,1.0,>,IC50,nM,194000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,194.0,CHEMBL378
5567,1402233.0,[],CHEMBL835178,In vitro inhibitory concentration against HIV-1 Y181C mutant strain; not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCNC(=S)Nc1c(Cc2cccc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL178043,CHEMBL178043,,0.0,http://www.openphacts.org/units/Nanomolar,360408.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5568,2930368.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOCc1c(C)[nH]c(=O)c(I)c1Sc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL565703,CHEMBL565703,8.70,0.0,http://www.openphacts.org/units/Nanomolar,852919.0,=,1.0,1.0,=,IC50,nM,1.99,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.99,CHEMBL378
5569,1401967.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C(C)COC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177709,CHEMBL177709,8.22,0.0,http://www.openphacts.org/units/Nanomolar,360424.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
5570,2929559.0,[],CHEMBL1056894,Antiviral activity against HIV1 HXB2 harboring 106A mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3cnnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL584409,CHEMBL584409,9.30,0.0,http://www.openphacts.org/units/Nanomolar,848312.0,=,1.0,1.0,=,IC50,nM,0.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.5,CHEMBL378
5571,12687184.0,[],CHEMBL2344307,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral surface antigen production,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=O)O[C@H]1C[C@@H]2C(=CC[C@@H]3[C@@]2(C)C(=O)C[C@]2(C)[C@@H]([C@@](C)(O)C(=O)CCC(C)(C)OC(C)=O)[C@H](O)C[C@@]32C)C(C)(C)[C@@H]1O,CHEMBL2331335,Bioorg Med Chem Lett,2013.0,CHEMBL2332395,CHEMBL2332395,4.81,0.0,http://www.openphacts.org/units/Nanomolar,1866089.0,=,1.0,1.0,=,IC50,nM,15600.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,15.6,CHEMBL613497
5572,14714272.0,[],CHEMBL3293255,Antiviral activity against HIV1 harboring reverse transcriptase K103N/Y181C mutant infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nccc(C(NO)c3ccc(C#N)cc3)n2)cc1,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL3288561,CHEMBL3288561,,0.0,http://www.openphacts.org/units/Nanomolar,2116118.0,>,1.0,1.0,>,IC50,nM,218730.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,218.73,CHEMBL378
5573,220793.0,[],CHEMBL731743,Antiretroviral activity in the XC-plaque assay using Moloney leukemia virus (MoLV) as a model for human immunodeficiency virus (HIV).,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ncnc2c1ncn2[C@@H]1O/C(=C(/F)Cl)[C@@H](O)[C@H]1O,CHEMBL1125244,J Med Chem,1991.0,CHEMBL2368687,CHEMBL2368687,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,311005.0,=,1.0,1.0,=,IC50,ug.mL-1,0.1,CHEMBL613500,Moloney murine leukemia virus,Moloney murine leukemia virus,11801,IC50,ug ml-1,UO_0000274,0.1,CHEMBL613500
5574,18044420.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(C(NC(=O)c2ccc(-c3ccc(Cl)cc3)[nH]2)C2CCCCN2)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4096918,CHEMBL4096918,5.66,0.0,http://www.openphacts.org/units/Nanomolar,2990237.0,=,1.0,1.0,=,IC50,nM,2200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.2,CHEMBL378
5575,2462106.0,[],CHEMBL964561,Antiviral activity against hepatitis B virus infected Hep G2.2.15 cells assessed as inhibition of HBsAg secretion,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CN=C(c2ccccc2F)c2cc(Cl)ccc2N1,CHEMBL1157443,Bioorg Med Chem Lett,2008.0,CHEMBL974,CHEMBL974,,0.0,http://www.openphacts.org/units/Nanomolar,720836.0,=,1.0,1.0,=,IC50,nM,294000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,0.294,CHEMBL613497
5576,2321217.0,[],CHEMBL1004248,Antiviral activity against HIV1 3B in human H9 cells after 4 days by p24 antigen ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(CO)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL1150942,J Nat Prod,1998.0,CHEMBL498636,CHEMBL498636,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,787818.0,=,1.0,1.0,=,IC50,ug.mL-1,25.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,25.0,CHEMBL378
5577,19281781.0,[],CHEMBL4409378,Antiviral activity against HIV1 NARI-DR infected in human TZM-bl cells incubated for 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL4406854,Eur J Med Chem,2019.0,CHEMBL57,CHEMBL57,,0.0,http://www.openphacts.org/units/Nanomolar,3219946.0,=,1.0,1.0,=,IC50,nM,232300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,232.3,CHEMBL378
5578,3104752.0,[],CHEMBL1074496,Antiviral activity against HIV1 LAI in human MT2 cells after 7 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(CO)ccc1CNC(=O)[C@H]1N(C(=O)[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CO[C@H]3OCC[C@H]32)CSC1(C)C,CHEMBL1159037,Bioorg Med Chem Lett,2010.0,CHEMBL601052,CHEMBL601052,6.64,0.0,http://www.openphacts.org/units/Nanomolar,883171.0,=,1.0,1.0,=,IC50,nM,230.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.23,CHEMBL378
5579,2196136.0,[],CHEMBL990231,Antiviral activity against Simian immunodeficiency virus,F,BAO_0000190,BAO_0000218,organism-based format,CN1C(=O)[C@@H](c2cc(Cl)c(O)c(Cl)c2)NC(=O)[C@@H]2NC(=O)[C@@H](c3cc(Cl)c(O)c(Cl)c3)NC(=O)[C@H](NC(=O)C(=O)c3cc(Cl)c(O)c(Cl)c3)Cc3c[nH]c4cc(ccc34)-c3cc2cc(c3O)Oc2ccc(cc2)C[C@H]1C(=O)N[C@@H](C(=O)O)c1ccc(O)cc1,CHEMBL1155718,J Nat Prod,2001.0,CHEMBL506605,CHEMBL506605,7.00,0.0,http://www.openphacts.org/units/Nanomolar,717351.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,0.1,CHEMBL613499
5580,1755807.0,[],CHEMBL864208,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(SCC(=O)Nc2ccccc2Cl)n1-c1ccccc1,CHEMBL1146046,Bioorg Med Chem Lett,2006.0,CHEMBL379598,CHEMBL379598,,0.0,http://www.openphacts.org/units/Nanomolar,545180.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
5581,2601943.0,[],CHEMBL1034012,Antiviral activity against influenza virus,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)/C(O)=C/C(=O)c1ccccc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL456227,CHEMBL456227,,0.0,http://www.openphacts.org/units/Nanomolar,806772.0,=,1.0,1.0,=,IC50,nM,500000.0,CHEMBL613128,unidentified influenza virus,unidentified influenza virus,11309,IC50,uM,UO_0000065,500.0,CHEMBL613128
5582,24823553.0,[],CHEMBL5140686,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in HBsAg level in cellular supernatant by luminescence based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3ccc(Br)cc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5206176,CHEMBL5206176,7.61,0.0,http://www.openphacts.org/units/Nanomolar,3876727.0,=,1.0,1.0,=,IC50,nM,24.5,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0245,CHEMBL613497
5583,2527502.0,[],CHEMBL1003777,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 5 days by MTS method,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,CHEMBL1138484,J Med Chem,2009.0,CHEMBL491521,CHEMBL491521,5.92,0.0,http://www.openphacts.org/units/Nanomolar,735626.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1200.0,CHEMBL378
5584,11014430.0,[],CHEMBL2089834,Antiviral activity against HIV1 in human TZM-bl cells assessed as viral infectivity by luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@]3(C)COC(c4ccc(O)cc4O)O[C@@H]3CC[C@@]2(C)[C@@H]1C/C=C1/C(=O)OC[C@H]1O,CHEMBL2086289,Eur J Med Chem,2012.0,CHEMBL2088489,CHEMBL2088489,5.96,0.0,http://www.openphacts.org/units/Nanomolar,1675625.0,=,1.0,1.0,=,IC50,nM,1096.48,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,5.96,CHEMBL378
5585,1034160.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(S)n(Nc2cccc(Cl)c2)c1-c1ccc(Cl)cc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL290021,CHEMBL290021,5.11,0.0,http://www.openphacts.org/units/Nanomolar,62368.0,=,1.0,1.0,=,IC50,nM,7710.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,7.71,CHEMBL613499
5586,702918.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(CSSCC(=O)c1ccccc1)c1ccccc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL333106,CHEMBL333106,,0.0,,228590.0,=,1.0,0.0,=,IC50,,11.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,11.3,CHEMBL378
5587,2601807.0,[],CHEMBL1034017,Antiviral activity against Vaccinia virus,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nn([C@H]2C[C@H](O)[C@@H](CO)S2)c(=O)nc1O,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL186389,CHEMBL186389,5.66,0.0,http://www.openphacts.org/units/Nanomolar,806761.0,=,1.0,1.0,=,IC50,nM,2200.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,2.2,CHEMBL613493
5588,625361.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Cc3ccc(Cl)cc3Cl)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL72343,CHEMBL72343,6.10,0.0,http://www.openphacts.org/units/Nanomolar,126945.0,=,1.0,1.0,=,IC50,nM,791.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.791,CHEMBL378
5589,1870796.0,[],CHEMBL904573,Antiviral activity against HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCOCn1c(C(=O)c2cccc3ccccc23)c(CC)c(=O)[nH]c1=O,CHEMBL1142880,Eur J Med Chem,2007.0,CHEMBL229049,CHEMBL229049,6.55,0.0,http://www.openphacts.org/units/Nanomolar,636396.0,=,1.0,1.0,=,IC50,nM,280.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.28,CHEMBL378
5590,10938622.0,[],CHEMBL2051599,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral e antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Oc1ccc(/C=C/C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(O)C(C)=O)C2)cc1,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046567,CHEMBL2046567,,0.0,http://www.openphacts.org/units/Nanomolar,1651450.0,=,1.0,1.0,=,IC50,nM,230830.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,230.83,CHEMBL613497
5591,13941196.0,[],CHEMBL3129261,Inhibition of FER (unknown origin) using Km levels of ATP,B,BAO_0000190,BAO_0000357,single protein format,Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1,CHEMBL3124869,J Med Chem,2014.0,CHEMBL3128069,CHEMBL3128069,8.70,0.0,http://www.openphacts.org/units/Nanomolar,1974217.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL3982,Homo sapiens,Tyrosine-protein kinase FER,9606,IC50,nM,UO_0000065,2.0,CHEMBL3982
5592,6268209.0,[],CHEMBL1803184,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CO)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@@H]5CCCN5C(=O)[C@H]([C@@H](C)CC)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc5ccc(O)cc5)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H]5CCCN5C1=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N4)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC3=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N2,CHEMBL1799917,J Nat Prod,2010.0,CHEMBL525248,CHEMBL525248,6.30,0.0,http://www.openphacts.org/units/Nanomolar,1440220.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.5,CHEMBL378
5593,8043646.0,[],CHEMBL1953039,Antiviral activity against HIV1 3B infected human TZM-bl cells assessed as inhibition of viral replication by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@@H](CO)C(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/N[C@@H](CO)C(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+],CHEMBL1949531,Bioorg Med Chem Lett,2012.0,CHEMBL1952323,CHEMBL1962941,5.54,0.0,http://www.openphacts.org/units/Nanomolar,1579966.0,=,1.0,1.0,=,IC50,nM,2880.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.88,CHEMBL378
5594,2292396.0,[],CHEMBL1016319,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc([S+]([O-])c2cccc(N)c2C#N)cc1,CHEMBL1137741,Eur J Med Chem,2009.0,CHEMBL300934,CHEMBL300934,,0.0,http://www.openphacts.org/units/Nanomolar,813408.0,=,1.0,1.0,=,IC50,nM,48977881.94,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,1.31,CHEMBL378
5595,18202499.0,[],CHEMBL4043712,Antiviral activity against HIV1 LAI infected in human MT2 cells assessed as reduction in p24 Gag protein production incubated for 6 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cccc(C(=O)N(C)Cc3coc(C)n3)c2)cc1,CHEMBL4043088,Bioorg Med Chem,2017.0,CHEMBL4069842,CHEMBL4069842,7.64,0.0,http://www.openphacts.org/units/Nanomolar,3019923.0,=,1.0,1.0,=,IC50,nM,23.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,23.0,CHEMBL378
5596,12203996.0,[],CHEMBL2211838,Antiviral activity against HIV-1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C2C3Cc4cc(OC)c(OC)cc4C3=NN2C(N)=O)cc1,CHEMBL2203270,Bioorg Med Chem Lett,2012.0,CHEMBL1910219,CHEMBL1910219,,0.0,http://www.openphacts.org/units/Nanomolar,1758533.0,>,1.0,1.0,>,IC50,nM,150350.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,150.35,CHEMBL378
5597,18168879.0,[],CHEMBL4037080,Antiviral activity against HIV1 3B infected in human H9 cells after 4 days by ELISA,F,BAO_0000190,BAO_0000219,cell-based format,CC(=O)O[C@@H]1[C@H](OC(=O)CC(C)C)c2c(ccc3ccc(=O)oc23)OC1(C)C,CHEMBL4033775,J Med Chem,2018.0,CHEMBL68956,CHEMBL68956,5.58,0.0,http://www.openphacts.org/units/Nanomolar,3014222.0,=,1.0,1.0,=,IC50,nM,2600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.6,CHEMBL378
5598,149895.0,[],CHEMBL683693,Tested in vitro against human immunodeficiency virus (HIV) infected CEM cells using XTT assay (LAV-BRU strain),F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H](Cn1cnc2c(O)nc(N)nc21)OCP(=O)(O)O,CHEMBL1126801,J Med Chem,1993.0,CHEMBL91794,CHEMBL91794,4.92,0.0,http://www.openphacts.org/units/Nanomolar,169348.0,=,1.0,1.0,=,IC50,nM,12000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.0,CHEMBL378
5599,13967491.0,[],CHEMBL3135326,Antiviral activity against wild type HIV1 VSVG infected in 293ET cells assessed as inhibition of viral replication by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)OC(=O)c1sc(Cl)cc1S(=O)(=O)N1c2cc(Cl)ccc2NC(=O)C1C,CHEMBL3132804,Medchemcomm,2014.0,CHEMBL3133049,CHEMBL3133049,5.26,0.0,http://www.openphacts.org/units/Nanomolar,1974720.0,=,1.0,1.0,=,IC50,nM,5550.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.55,CHEMBL378
5600,15165599.0,[],CHEMBL3404732,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBsAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(OC(=O)c2ccco2)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402780,CHEMBL3402780,,0.0,http://www.openphacts.org/units/Nanomolar,2284134.0,=,1.0,1.0,=,IC50,nM,1831000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1831.0,CHEMBL613497
5601,2602116.0,[],CHEMBL1034012,Antiviral activity against influenza virus,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL1229,CHEMBL1229,4.35,0.0,http://www.openphacts.org/units/Nanomolar,806784.0,=,1.0,1.0,=,IC50,nM,45000.0,CHEMBL613128,unidentified influenza virus,unidentified influenza virus,11309,IC50,uM,UO_0000065,45.0,CHEMBL613128
5602,289960.0,[],CHEMBL706841,Antiviral activity by observing cytopathic effect induced by HIV-1 strain IIIB in de novo infected MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)[C@@H](NCc1cccc2ccccc12)C(=O)N[C@H](C(=O)NCc1ccccc1)C(C)C,CHEMBL1127464,J Med Chem,1994.0,CHEMBL102431,CHEMBL102431,,0.0,http://www.openphacts.org/units/Nanomolar,195827.0,>,1.0,1.0,>,IC50,nM,3000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3000.0,CHEMBL378
5603,3292034.0,[],CHEMBL1108227,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1C(=O)N1C[C@H]2CN(CC[C@H](NC(=O)c3ccccc3)c3ccccc3)C[C@H]2C1,CHEMBL1157775,Bioorg Med Chem Lett,2010.0,CHEMBL1096766,CHEMBL1096766,6.91,0.0,http://www.openphacts.org/units/Nanomolar,910714.0,=,1.0,1.0,=,IC50,nM,124.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,124.0,CHEMBL378
5604,18775527.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCC1Cc2cc(OCc3ccccc3)c(OC)cc2-c2cc(=O)c(C(=O)NCCO)cn21,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4286903,CHEMBL4286903,4.37,0.0,http://www.openphacts.org/units/Nanomolar,3119685.0,=,1.0,1.0,=,IC50,nM,43000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,43.0,CHEMBL613497
5605,2244563.0,[],CHEMBL1003071,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase P225H mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL203420,CHEMBL203420,9.70,0.0,http://www.openphacts.org/units/Nanomolar,798654.0,=,1.0,1.0,=,IC50,nM,0.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.2,CHEMBL378
5606,23274463.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4CC(O)(C5(O)CC[C@@]6(C)[C@H](C[C@H](O)[C@@H]7[C@@H]6CC[C@]6(C)[C@@H]([C@H](C)CCC(=O)NCCS(=O)(=O)O)CC[C@@H]76)C5)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4846260,CHEMBL4846260,,0.0,http://www.openphacts.org/units/Nanomolar,3621263.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,10000.0,CHEMBL613497
5607,613879.0,[],CHEMBL710381,Inhibitory activity against 103N strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Sc2ncnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL431572,CHEMBL431572,8.52,0.0,http://www.openphacts.org/units/Nanomolar,126917.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
5608,454506.0,[],CHEMBL683690,Inhibitory effect upon disintegration catalyzed by the (50-212) deletion mutant,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc1,CHEMBL1133718,J Med Chem,2000.0,CHEMBL39883,CHEMBL39883,4.92,0.0,http://www.openphacts.org/units/Nanomolar,61383.0,=,1.0,1.0,=,IC50,nM,12000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.0,CHEMBL378
5609,1124560.0,[],CHEMBL698085,Inhibitory activity against HIV-1 mutant strain K103N/Y181C,F,BAO_0000190,BAO_0000218,organism-based format,CCN1c2ncc(CSc3ccncc3)cc2C(=O)Nc2c(C)cc(Cl)nc21,CHEMBL1137947,Bioorg Med Chem Lett,2004.0,CHEMBL162118,CHEMBL162118,7.10,0.0,http://www.openphacts.org/units/Nanomolar,321332.0,=,1.0,1.0,=,IC50,nM,80.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,80.0,CHEMBL378
5610,5163181.0,[],CHEMBL1666138,Antiviral activity against HIV1 HXB2 infected in HEK293 cells assessed as inhibition of viral replication after 2 days,F,BAO_0000190,BAO_0000218,organism-based format,CCCN(CCC)CCCCN(C)Cc1ccc(CN(Cc2ncc[nH]2)Cc2nccn2C)cc1.O=C(O)C(O)C(O)C(=O)O,CHEMBL1649540,Antimicrob Agents Chemother,2009.0,CHEMBL2062277,CHEMBL1242211,9.22,0.0,http://www.openphacts.org/units/Nanomolar,1327042.0,=,1.0,1.0,=,IC50,nM,0.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.6,CHEMBL378
5611,2681573.0,[],CHEMBL1062326,Antiviral activity against HIV1 REJO4541.67 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCNC(C)=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL508943,CHEMBL508943,6.07,0.0,http://www.openphacts.org/units/Nanomolar,823861.0,=,1.0,1.0,=,IC50,nM,850.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.85,CHEMBL378
5612,10961188.0,[],CHEMBL2061268,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M3 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCCC(C)(C)C)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058322,CHEMBL2058322,7.72,0.0,http://www.openphacts.org/units/Nanomolar,1656262.0,=,1.0,1.0,=,IC50,nM,19.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.0,CHEMBL378
5613,24788547.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '25.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '25.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '73.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '73.0'}]",CHEMBL5131650,Antiviral activity against ZIKV- FSS13025 infected in 1 hr pretreated African green monkey Vero E6 cells measured after 24 to 72 hrs,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,CHEMBL5131375,J Med Chem,2022.0,CHEMBL14762,CHEMBL14762,7.62,0.0,http://www.openphacts.org/units/Nanomolar,3869388.0,=,1.0,1.0,=,IC50,nM,24.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,nM,UO_0000065,24.0,CHEMBL4296612
5614,1243029.0,[],CHEMBL816327,DNA relaxation activity tested by the inhibition of the type 1B topoisomerase of molluscum contagiosum virus (MCV); ND=Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC2(CC(C)(C)c3cc(C=O)c(O)cc32)c2cc(O)c(C=O)cc21,CHEMBL1133186,J Med Chem,2000.0,CHEMBL417029,CHEMBL417029,,0.0,http://www.openphacts.org/units/Nanomolar,108752.0,,1.0,0.0,,IC50,nM,,CHEMBL613121,Molluscum contagiosum virus,Molluscum contagiosum virus,10279,IC50,uM,UO_0000065,,CHEMBL613121
5615,18044783.0,[],CHEMBL4010392,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 p9021_14.B2.4571,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.51,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,310.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.31,CHEMBL378
5616,1402488.0,[],CHEMBL837466,In vitro inhibitory concentration against HIV K101E mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177666,CHEMBL177666,8.22,0.0,http://www.openphacts.org/units/Nanomolar,360358.0,=,1.0,1.0,=,IC50,nM,6.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.006,CHEMBL378
5617,18528932.0,[],CHEMBL4195005,Antiviral activity against HIV1 virions containing reverse transcriptase E138K/M184V mutant derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)N(c1cc(OC)c(OC)c(OC)c1)C(C)CC2,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4209863,CHEMBL4209863,5.07,0.0,http://www.openphacts.org/units/Nanomolar,3076510.0,=,1.0,1.0,=,IC50,nM,8530.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.53,CHEMBL378
5618,18530778.0,[],CHEMBL4195355,Antiviral activity against HIV-1 LAI infected in human MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,COC[C@@H]1C[C@@H]2[C@H]3[C@H](CO[C@H]3O1)C[C@@H]2OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN(CC(C)C)S(=O)(=O)c1ccc(OC)cc1,CHEMBL4190391,J Med Chem,2018.0,CHEMBL4214741,CHEMBL4214741,6.61,0.0,http://www.openphacts.org/units/Nanomolar,3076688.0,=,1.0,1.0,=,IC50,nM,248.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,248.0,CHEMBL378
5619,1402178.0,[],CHEMBL834487,In vitro inhibitory concentration value against HIV K103N and Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CC#N)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL180008,CHEMBL180008,,0.0,http://www.openphacts.org/units/Nanomolar,360390.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5620,634423.0,[],CHEMBL713945,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,Sc1nc2cc(Cl)cc3c2n1CCN1CCCC31,CHEMBL1128252,J Med Chem,1995.0,CHEMBL165204,CHEMBL165204,,0.0,http://www.openphacts.org/units/Nanomolar,326383.0,>,1.0,1.0,>,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.0,CHEMBL378
5621,23317003.0,[],CHEMBL4845562,Antiviral activity against Influenza B virus (B/Sichuan/531/2018(Victoria)) infected in cells assessed as reduction in infected cells,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC[C@]2(C(=O)NCCCCCc3cn(CC(CO)(Cn4cc(CCCCCNC(=O)[C@]56CCC(C)(C)C[C@H]5C5=CC[C@@H]7[C@@]8(C)CC[C@H](O)C(C)(C)[C@@H]8CC[C@@]7(C)[C@]5(C)CC6)nn4)Cn4cc(CCCCCNC(=O)[C@]56CCC(C)(C)C[C@H]5C5=CC[C@@H]7[C@@]8(C)CC[C@H](O)C(C)(C)[C@@H]8CC[C@@]7(C)[C@]5(C)CC6)nn4)nn3)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL4842395,ACS Med Chem Lett,2021.0,CHEMBL4866899,CHEMBL4866899,,0.0,http://www.openphacts.org/units/Nanomolar,3629101.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,100.0,CHEMBL613129
5622,1751223.0,[],CHEMBL854522,Antiviral activity against Measles virus variant in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Cc1ccccc1)Nc1cc([N+](=O)[O-])ccc1C(=O)OCc1ccccc1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL215625,CHEMBL215625,4.12,0.0,http://www.openphacts.org/units/Nanomolar,532807.0,=,1.0,1.0,=,IC50,nM,75000.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,75.0,CHEMBL613738
5623,702920.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,N/N=C(/S)SS/C(S)=N\N,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120073,CHEMBL120073,,0.0,,228579.0,=,1.0,0.0,=,IC50,,24.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,24.3,CHEMBL378
5624,2368190.0,[],CHEMBL1031556,Antiviral activity against HIV1 infected in human 293T cells assessed as inhibition of pseudovirus infection,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CCn2cc(NC(=O)CCc3ccoc3)cn2)cc1OC,CHEMBL1140132,J Med Chem,2008.0,CHEMBL495132,CHEMBL495132,,0.0,http://www.openphacts.org/units/Nanomolar,746236.0,>,1.0,1.0,>,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
5625,18585134.0,[],CHEMBL4223279,Antiviral activity against Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBsAg secretion after 3 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,CHEMBL4219203,Bioorg Med Chem Lett,2018.0,CHEMBL168,CHEMBL168,,0.0,http://www.openphacts.org/units/Nanomolar,3086252.0,=,1.0,1.0,=,IC50,nM,1364500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1364.5,CHEMBL613497
5626,19261722.0,[],CHEMBL4404352,Antiviral activity against HIV1 HXB2 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cn2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4570868,CHEMBL4570868,5.92,0.0,http://www.openphacts.org/units/Nanomolar,3216257.0,=,1.0,1.0,=,IC50,nM,1200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.2,CHEMBL378
5627,12680729.0,[],CHEMBL2342599,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C/c1coc2cc(O)ccc2c1=O)NCc1ccc(F)cc1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333298,CHEMBL2333298,,0.0,http://www.openphacts.org/units/Nanomolar,1867261.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
5628,86457.0,[],CHEMBL809002,The compound was tested in vitro for the inhibitory concentration against influenza B/Mem/89 sialidase from whole virus by fetuin assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc(C(=O)O)cc1[N+](=O)[O-],CHEMBL1128587,J Med Chem,1995.0,CHEMBL111082,CHEMBL111082,,0.0,http://www.openphacts.org/units/Nanomolar,206094.0,=,1.0,1.0,=,IC50,nM,5000000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,mM,UO_0000065,5.0,CHEMBL613129
5629,3014839.0,[],CHEMBL1050517,Antiviral activity against multidrug-resistant HIV1 isolate G infected in PHA-stimulated human PBMC assessed as inhibition of p24 gap protein production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL1156053,J Med Chem,2009.0,CHEMBL1323,CHEMBL1323,7.64,0.0,http://www.openphacts.org/units/Nanomolar,862439.0,=,1.0,1.0,=,IC50,nM,23.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.023,CHEMBL378
5630,19271301.0,[],CHEMBL4406716,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as reduction in p24 Gag protein production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1C[C@H]2CO[C@H]3OC1C[C@@H]23)S(=O)(=O)c1ccc2nc(NC(C)C)oc2c1,CHEMBL4402610,J Med Chem,2020.0,CHEMBL4568050,CHEMBL4568050,7.42,0.0,http://www.openphacts.org/units/Nanomolar,3217925.0,=,1.0,1.0,=,IC50,nM,38.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,38.0,CHEMBL378
5631,1401633.0,[],CHEMBL833792,In vitro inhibitory concentration against HIV-1 Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1[nH]c(=O)c(N(C)C)c(Cc2cc(C)cc(C)c2)c1C,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175823,CHEMBL175823,6.60,0.0,http://www.openphacts.org/units/Nanomolar,360335.0,=,1.0,1.0,=,IC50,nM,251.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.251,CHEMBL378
5632,598063.0,[],CHEMBL712878,Concentration required for 50% protection of MT-4 cells against the cytopathic effect of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCN1Cc2c(Br)ccc3nc(O)n(c23)C[C@@H]1C,CHEMBL1128253,J Med Chem,1995.0,CHEMBL58952,CHEMBL58952,7.33,0.0,http://www.openphacts.org/units/Nanomolar,327797.0,=,1.0,1.0,=,IC50,nM,47.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0473,CHEMBL378
5633,8057919.0,[],CHEMBL1960698,Antiinfluenza activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)OCCCCn1cncn1)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL1955749,Bioorg Med Chem Lett,2012.0,CHEMBL1956541,CHEMBL1956541,4.11,0.0,http://www.openphacts.org/units/Nanomolar,1580871.0,=,1.0,1.0,=,IC50,nM,77500.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,77.5,CHEMBL613129
5634,1220994.0,[],CHEMBL710530,Inhibitory activity against 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)cc(Cc3c(Cl)cccc3Cl)n2)cc1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL74239,CHEMBL74239,7.92,0.0,http://www.openphacts.org/units/Nanomolar,127470.0,=,1.0,1.0,=,IC50,nM,12.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.012,CHEMBL378
5635,14581369.0,[],CHEMBL3243478,Antiviral activity against HIV-1 pseudotyped virus expressing HIV-1 isolate D envelope QD435.100M.ENV.E1 assessed as reduction of luciferase production after 3 days by single-cycle neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]1CSCc2ccc(cc2)-c2ccc(cc2)CSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC1=O,CHEMBL3232893,Bioorg Med Chem Lett,2014.0,CHEMBL3233156,CHEMBL3233156,4.81,0.0,http://www.openphacts.org/units/Nanomolar,2081351.0,=,1.0,1.0,=,IC50,nM,15400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,15.4,CHEMBL378
5636,10961817.0,[],CHEMBL2061272,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M7 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)CCN2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2057724,CHEMBL2057724,8.12,0.0,http://www.openphacts.org/units/Nanomolar,1655447.0,=,1.0,1.0,=,IC50,nM,7.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,7.5,CHEMBL378
5637,24830915.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc2c(=O)c3ccccc3oc2c1)c1ccccc1F,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5185486,CHEMBL5185486,5.39,0.0,http://www.openphacts.org/units/Nanomolar,3878088.0,=,1.0,1.0,=,IC50,nM,4030.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,4.03,CHEMBL613497
5638,22480474.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '120.0'}]",CHEMBL4687212,Antiviral activity against HIV-1 NL4-3 infected in human TZM-bl cells infected with supernatants from virus-infected human H9 cells treated with compound for 72 hrs assessed as reduction in luciferase expression measured after 48 hrs by luciferase reporter gene assay based BiCycle assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCc1cn(-c2ccc(NC(=O)Nc3cccc4cnccc34)cc2)nn1,CHEMBL4680261,Eur J Med Chem,2020.0,CHEMBL4744776,CHEMBL4744776,5.66,0.0,http://www.openphacts.org/units/Nanomolar,3523690.0,=,1.0,1.0,=,IC50,nM,2200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.2,CHEMBL378
5639,1036645.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CCC1N=C(S)N(Nc2cccc(C)c2)C1c1ccccc1,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39135,CHEMBL39135,,0.0,http://www.openphacts.org/units/Nanomolar,62324.0,>,1.0,1.0,>,IC50,nM,53550.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,53.55,CHEMBL613499
5640,1470139.0,[],CHEMBL833074,Inhibitory activity against HIV-1 mutant strain 100I,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(Br)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188223,CHEMBL188223,7.70,0.0,http://www.openphacts.org/units/Nanomolar,380674.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.02,CHEMBL378
5641,1870794.0,[],CHEMBL904573,Antiviral activity against HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C(=O)c2cccc3ccccc23)n(COCc2ccccc2)c(=O)[nH]c1=O,CHEMBL1142880,Eur J Med Chem,2007.0,CHEMBL426358,CHEMBL426358,6.82,0.0,http://www.openphacts.org/units/Nanomolar,636398.0,=,1.0,1.0,=,IC50,nM,150.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.15,CHEMBL378
5642,550354.0,[],CHEMBL710864,Antiviral activity against HIV-1 infected human MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,CCCCNc1cccc(S(=O)(=O)c2cc(C)cc(C)c2)c1C#N,CHEMBL1134494,J Med Chem,2001.0,CHEMBL54111,CHEMBL54111,,0.0,http://www.openphacts.org/units/Nanomolar,94218.0,>,1.0,1.0,>,IC50,nM,12000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.0,CHEMBL378
5643,23274448.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4835865,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion incubated for 24 hrs followed replacement with fresh medium and measured at day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](CCCOC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL4834431,J Med Chem,2021.0,CHEMBL4865060,CHEMBL4865060,5.57,0.0,http://www.openphacts.org/units/Nanomolar,3621248.0,=,1.0,1.0,=,IC50,nM,2700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,nM,UO_0000065,2700.0,CHEMBL613497
5644,599380.0,[],CHEMBL712878,Concentration required for 50% protection of MT-4 cells against the cytopathic effect of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CCC(=CCN1Cc2cc(C(C)(C)C)cc3nc(O)n(c23)C[C@@H]1C)CC,CHEMBL1128253,J Med Chem,1995.0,CHEMBL168117,CHEMBL168117,6.50,0.0,http://www.openphacts.org/units/Nanomolar,327819.0,=,1.0,1.0,=,IC50,nM,314.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.3142,CHEMBL378
5645,263350.0,[],CHEMBL883644,Compound was evaluated for the inhibition of SIV induced syncytia formation,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)C1CCCN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)OC,CHEMBL1125316,J Med Chem,1992.0,CHEMBL3349494,CHEMBL3349494,5.10,0.0,http://www.openphacts.org/units/Nanomolar,238400.0,=,1.0,1.0,=,IC50,nM,8000.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,8.0,CHEMBL613499
5646,12683868.0,[],CHEMBL2339980,Antiviral activity against Hepatitis B virus transfected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 6 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC1CN2CC(C)O[Si](CCCNC(=O)CCC(=O)OCCOCn3cnc4c(=O)[nH]c(N)nc43)(O1)O[C@@H](C)C2,CHEMBL2331251,Bioorg Med Chem Lett,2013.0,CHEMBL2333795,CHEMBL2333795,4.05,0.0,http://www.openphacts.org/units/Nanomolar,1867888.0,=,1.0,1.0,=,IC50,nM,89800.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,89.8,CHEMBL613497
5647,5126320.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,CN1c2ccc(Cl)cc2N(c2ccccc2)C(=O)c2cn(C)nc21,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642316,CHEMBL1642316,6.16,0.0,http://www.openphacts.org/units/Nanomolar,1317606.0,=,1.0,1.0,=,IC50,nM,700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.7,CHEMBL378
5648,5188245.0,[],CHEMBL1664702,Antiviral activity against HIV1 LAI infected in human MT2 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CCO[C@H]3OCC[C@H]32)cc1,CHEMBL1649426,J Med Chem,2011.0,CHEMBL1651153,CHEMBL1651153,9.30,0.0,http://www.openphacts.org/units/Nanomolar,1324304.0,=,1.0,1.0,=,IC50,nM,0.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0005,CHEMBL378
5649,18044485.0,[],CHEMBL4010365,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of p24 antigen production pretreated with virus for 30 mins followed by 4 days incubation with cells by sandwich ELISA based multicycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,CNCC(NC(=O)c1ccc(-c2ccc(Cl)cc2)[nH]1)c1nc(C)c(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4072286,CHEMBL4072286,5.51,0.0,http://www.openphacts.org/units/Nanomolar,2990180.0,=,1.0,1.0,=,IC50,nM,3100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.1,CHEMBL378
5650,5229819.0,[],CHEMBL1677716,Antiviral activity against Human immunodeficiency virus 1 3B infected in human H9 cells infected with 12.5 uL of virus stock assessed as expression of p24 antigen after 6 days postinfection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,<,1.0,1.0,<,IC50,nM,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1,CHEMBL378
5651,1402146.0,[],CHEMBL837471,In vitro inhibitory concentration against HIV Y188L mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCOC)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177275,CHEMBL177275,6.40,0.0,http://www.openphacts.org/units/Nanomolar,360374.0,=,1.0,1.0,=,IC50,nM,398.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.398,CHEMBL378
5652,3114764.0,[],CHEMBL1073712,Antiviral activity against HIV1 NL4-3 infected in GFP expressing human CEM cells assessed as inhibition of viral infection measured after 9 days postinfection by microfluorometry,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1157554,Bioorg Med Chem,2010.0,CHEMBL129,CHEMBL129,5.98,0.0,http://www.openphacts.org/units/Nanomolar,887200.0,=,1.0,1.0,=,IC50,nM,1050.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.05,CHEMBL378
5653,553943.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,O=c1c2ccccc2sn1-c1ccc(S(=O)(=O)c2ccc(NS(=O)(=O)Cc3ccccc3[N+](=O)[O-])cc2)cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL169673,CHEMBL169673,4.22,0.0,http://www.openphacts.org/units/Nanomolar,334029.0,=,1.0,1.0,=,IC50,nM,59500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,59.5,CHEMBL378
5654,5294578.0,[],CHEMBL1696680,Antiviral activity against HIV-1 3B infected in human PBMC assessed as inhibition of viral replication by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1687706,Antimicrob Agents Chemother,2008.0,CHEMBL129,CHEMBL129,7.22,0.0,http://www.openphacts.org/units/Nanomolar,1337220.0,=,1.0,1.0,=,IC50,nM,60.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.06,CHEMBL378
5655,576947.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc(S(=O)(=O)c2ccc(NC(=O)c3ccccc3C(=O)CCCC[n+]3ccccc3)cc2)cc1.[Br-],CHEMBL1132203,J Med Chem,1999.0,CHEMBL169847,CHEMBL1181409,,0.0,http://www.openphacts.org/units/Nanomolar,334022.0,>,1.0,1.0,>,IC50,nM,613000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,613.0,CHEMBL378
5656,15027131.0,[],CHEMBL3367171,Inhibition of AP-1-mediated transcriptional activation in human Jurkat cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)c1cnc(-c2ccccc2)nc1NN1C(=O)C=C(C)C1=O,CHEMBL3352097,J Med Chem,2014.0,CHEMBL42952,CHEMBL42952,7.00,0.0,http://www.openphacts.org/units/Nanomolar,2265193.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.1,CHEMBL4977
5657,19243741.0,[],CHEMBL4400278,Antiviral activity against Zika virus infected in human A549 cells assessed as reduction in viral titer incubated for 48 hrs by plaque assay,F,BAO_0000190,BAO_0000218,organism-based format,C=CCNc1nc(NC(=O)Nc2ccc(Cl)cc2)ns1,CHEMBL4396960,Bioorg Med Chem Lett,2019.0,CHEMBL4475511,CHEMBL4475511,10.07,0.0,http://www.openphacts.org/units/Nanomolar,3212368.0,=,1.0,1.0,=,IC50,nM,0.0851,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,pM,UO_0000065,85.1,CHEMBL4296612
5658,1058651.0,[],CHEMBL713938,Concentration required to inhibit the viral (SIV mac251) cytopathic effect by 50% in MT-4 cells.,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C1N=C(S)N(Nc2cccc(Cl)c2)C1C,CHEMBL1144865,J Med Chem,2003.0,CHEMBL39105,CHEMBL39105,,0.0,http://www.openphacts.org/units/Nanomolar,62357.0,>,1.0,1.0,>,IC50,nM,48800.0,CHEMBL613499,Simian immunodeficiency virus,Simian immunodeficiency virus,11723,IC50,uM,UO_0000065,48.8,CHEMBL613499
5659,7969196.0,[],CHEMBL1930947,"Antiviral activity against LacZ-containing HIV1 in COS7 cells expressing HXB2 Env, R8.91, and pTY-EFnLacZ assessed as reduction of viral vector infection into human HeLa cells expressing CD4 after 2 days using 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside staining",F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2c3c4cc(OC)c(OS(=O)(=O)[O-])cc4oc(=O)c3n3ccc4cc(OS(=O)(=O)[O-])c(OC)cc4c23)cc1OS(=O)(=O)[O-].[Na+].[Na+].[Na+],CHEMBL1926605,Bioorg Med Chem,2011.0,CHEMBL1928868,CHEMBL1962477,4.68,0.0,http://www.openphacts.org/units/Nanomolar,1565984.0,=,1.0,1.0,=,IC50,nM,20700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.7,CHEMBL378
5660,3013893.0,[],CHEMBL1045234,Antiviral activity against HIV1 3B infected human HOS cells expressing human CXCR4 and CD4 assessed as inhibition of viral infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(c2cccc3nc(CN(CC4CC4)[C@H]4CCCc5cccnc54)cn23)CC1,CHEMBL1156094,Bioorg Med Chem Lett,2009.0,CHEMBL571202,CHEMBL571202,8.40,0.0,http://www.openphacts.org/units/Nanomolar,860805.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.004,CHEMBL378
5661,3084558.0,[],CHEMBL1065275,Antiviral activity against HIV1 3B laboratory isolate assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(NC(=O)C(=O)NC2CC(C)(C)NC(C)(C)C2)cc1,CHEMBL1153139,Bioorg Med Chem Lett,2010.0,CHEMBL610204,CHEMBL610204,4.64,0.0,http://www.openphacts.org/units/Nanomolar,873929.0,=,1.0,1.0,=,IC50,nM,23000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,23.0,CHEMBL378
5662,189420.0,[],CHEMBL815090,Inhibition of HIV-1 (ADA) entry into U-87 (human glioblastoma) cells.,F,BAO_0000190,BAO_0000218,organism-based format,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)cncc3Br)CC2)CC1,CHEMBL1136595,Bioorg Med Chem Lett,2003.0,CHEMBL349008,CHEMBL349008,8.98,0.0,http://www.openphacts.org/units/Nanomolar,317575.0,=,1.0,1.0,=,IC50,nM,1.04,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.04,CHEMBL378
5663,14658826.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,O=C(COc1ccc2ccccc2c1)N1CCN(C(=O)Cc2ccccc2)CC1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262876,CHEMBL3262876,6.37,0.0,http://www.openphacts.org/units/Nanomolar,2101717.0,=,1.0,1.0,=,IC50,nM,423.0,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,IC50,nM,UO_0000065,423.0,CHEMBL3259471
5664,19173460.0,[],CHEMBL4385476,Antiviral activity against CXCR4 tropic HIV1 3B infected in human MAGI-CCR5/CXCR4 cells measured after 2 to 6 days by beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,NCCCCCN(C[C@H]1Cc2ccccc2CN1)[C@H]1CCCc2cccnc21,CHEMBL4382290,ACS Med Chem Lett,2019.0,CHEMBL4456899,CHEMBL4456899,6.77,0.0,http://www.openphacts.org/units/Nanomolar,3199994.0,=,1.0,1.0,=,IC50,nM,170.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.17,CHEMBL378
5665,2929534.0,[],CHEMBL1056896,Antiviral activity against HIV1 HXB2 harboring 179E mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL366692,CHEMBL366692,8.60,0.0,http://www.openphacts.org/units/Nanomolar,848229.0,=,1.0,1.0,=,IC50,nM,2.51,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.51,CHEMBL378
5666,1672793.0,[],CHEMBL863515,Antiviral activity against HIV1 3B in MT4 cells,F,BAO_0000190,BAO_0000218,organism-based format,CNS(=O)(=O)c1ccc(NC(=O)COc2ccc(Cl)cc2C(=O)c2cc(F)cc(C(F)(F)F)c2)c(C)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL199539,CHEMBL199539,8.10,0.0,http://www.openphacts.org/units/Nanomolar,411946.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,8.0,CHEMBL378
5667,1470583.0,[],CHEMBL832525,Inhibitory activity against HIV-1 double mutants strain 101E and 103N,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL57,CHEMBL57,6.30,0.0,http://www.openphacts.org/units/Nanomolar,380791.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.5,CHEMBL378
5668,6152258.0,[],CHEMBL1763053,Antiviral activity against Human immunodeficiency virus 1 BAL infected in human PBMC assessed as inhibition of viral replication by p24 antigen specific ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C(F)(F)F)c2)c2ccc(C(F)(F)F)cc2)CC1,CHEMBL1759996,Bioorg Med Chem Lett,2011.0,CHEMBL1762322,CHEMBL1762322,7.52,0.0,http://www.openphacts.org/units/Nanomolar,1414773.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.03,CHEMBL378
5669,943242.0,[],CHEMBL716463,Inhibitory concentration required to reduce virus Plaque formation (measles),F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(F)nc2c1ncn2[C@@H]1C=C(CO)[C@@H](O)[C@H]1O,CHEMBL1129081,J Med Chem,1996.0,CHEMBL443288,CHEMBL443288,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,240301.0,=,1.0,1.0,=,IC50,ug.mL-1,0.03,CHEMBL613738,Measles virus,Measles virus,11234,IC50,ug ml-1,UO_0000274,0.03,CHEMBL613738
5670,16449875.0,[],CHEMBL3757559,Inhibition of ASCT2-mediated glutamine transport in human HEK293 cells using [3H]-glutamine after 15 mins by scintillation counting,B,BAO_0000190,BAO_0000219,cell-based format,N[C@@H](CCN(Cc1ccccc1OCc1ccc(Cl)cc1)Cc1ccccc1OCc1ccc(Cl)cc1)C(=O)O,CHEMBL3751750,Bioorg Med Chem Lett,2016.0,CHEMBL3754369,CHEMBL3754369,4.47,0.0,http://www.openphacts.org/units/Nanomolar,2744501.0,=,1.0,1.0,=,IC50,nM,33700.0,CHEMBL3562162,Homo sapiens,Neutral amino acid transporter B(0),9606,IC50,uM,UO_0000065,33.7,CHEMBL3562162
5671,3003261.0,[],CHEMBL1045518,Antiviral activity against HIV1 Ba-L infected in HOS cells assessed as inhibition of viral infection,F,BAO_0000190,BAO_0000218,organism-based format,CNS(=O)(=O)c1cc(C(=O)N[C@H]2CC[C@@H](CN3[C@@H]4CC[C@H]3C[C@@H](n3c(C)nc5ccccc53)C4)CC2)c(Cl)cc1F,CHEMBL1155363,Bioorg Med Chem Lett,2009.0,CHEMBL571521,CHEMBL571521,,0.0,http://www.openphacts.org/units/Nanomolar,857694.0,>,1.0,1.0,>,IC50,nM,20000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,20.0,CHEMBL378
5672,3019585.0,[],CHEMBL1040990,Antiviral activity against Human immunodeficiency virus 1 NL4-3 assessed as inhibition of viral entry in HeLaP4 cells after 5 days by beta galactosidase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(=O)c1cc(OC)c(O[C@@H](C)C(=O)N2CCN(C(=O)c3ccccc3)C[C@H]2C)cn1,CHEMBL1155287,Bioorg Med Chem Lett,2009.0,CHEMBL568903,CHEMBL568903,8.70,0.0,http://www.openphacts.org/units/Nanomolar,857248.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
5673,15666349.0,[],CHEMBL3602744,Antiviral activity against ENF-resistant HIV1 NL4-3 harboring gp41 N-terminal heptad repeat V38M mutant infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,CHEMBL3600303,J Med Chem,2015.0,CHEMBL428607,CHEMBL428607,8.74,0.0,http://www.openphacts.org/units/Nanomolar,2492328.0,=,1.0,1.0,=,IC50,nM,1.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.8,CHEMBL378
5674,10938659.0,[],CHEMBL2051598,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccccc4C)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046552,CHEMBL2046552,4.09,0.0,http://www.openphacts.org/units/Nanomolar,1651435.0,=,1.0,1.0,=,IC50,nM,81060.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,81.06,CHEMBL613497
5675,1437979.0,[],CHEMBL834618,Inhibitory activity against HIV-1 mutant strain 103N; ND = Not determined,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(-c2ccco2)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL182477,CHEMBL182477,,0.0,http://www.openphacts.org/units/Nanomolar,371591.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5676,2244549.0,[],CHEMBL1002214,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase V106M mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL203420,CHEMBL203420,9.40,0.0,http://www.openphacts.org/units/Nanomolar,798654.0,=,1.0,1.0,=,IC50,nM,0.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.4,CHEMBL378
5677,23153214.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4810870,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 production treated at 48 hrs post-infection and measured on day 4 post-viral infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL4808236,Bioorg Med Chem Lett,2021.0,CHEMBL129,CHEMBL129,7.77,0.0,http://www.openphacts.org/units/Nanomolar,3599025.0,=,1.0,1.0,=,IC50,nM,16.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,16.9,CHEMBL378
5678,19407954.0,[],CHEMBL4426963,Antiviral activity against wild type HIV1 NL4-3 infected in human MT4 cells by p24 assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](CC23CC4CC(CC(C4)C2)C3)NC(=O)O[C@H]2CO[C@H]3OCC[C@H]32)cc1,CHEMBL4425138,J Med Chem,2016.0,CHEMBL4516606,CHEMBL4516606,7.82,0.0,http://www.openphacts.org/units/Nanomolar,3243721.0,=,1.0,1.0,=,IC50,nM,15.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.015,CHEMBL378
5679,3008362.0,[],CHEMBL1037279,Antiviral activity against Human immunodeficiency virus 1 NL4-3 infected HeLaP4 cells after 5 days by beta-galactosidase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CNC(=O)c1cc(OC)c(O[C@@H](C)C(=O)N2CCN(c3n[nH]c4ccccc34)C[C@H]2C)cn1,CHEMBL1155317,Bioorg Med Chem Lett,2009.0,CHEMBL571612,CHEMBL571612,6.01,0.0,http://www.openphacts.org/units/Nanomolar,861755.0,=,1.0,1.0,=,IC50,nM,979.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,979.0,CHEMBL378
5680,24777542.0,[],CHEMBL5128766,Antiviral activity against HIV-1 89.6 infected in human TZM-bl cells assessed as reduction in viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@H](NC(=O)CCCCCCCNC(=O)[C@]12CC[C@@H](C)[C@H](C)[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)[C@H](O)CC(=O)O,CHEMBL5126557,Bioorg Med Chem Lett,2022.0,CHEMBL5201771,CHEMBL5201771,5.96,0.0,http://www.openphacts.org/units/Nanomolar,3867173.0,=,1.0,1.0,=,IC50,nM,1100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.1,CHEMBL378
5681,2272900.0,[],CHEMBL956847,Antiviral activity against HIV1 Bal in human HOS cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1[C@H]1C[C@H]2CC[C@@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)SC(C)C)CC1,CHEMBL1153314,Bioorg Med Chem Lett,2009.0,CHEMBL443730,CHEMBL443730,6.99,0.0,http://www.openphacts.org/units/Nanomolar,755459.0,=,1.0,1.0,=,IC50,nM,101.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.1014,CHEMBL378
5682,7967273.0,[],CHEMBL1930242,Antiviral activity against R5 tropic Human immunodeficiency virus 1 BAL infected in human PBMC cells assessed as reduction in viral replication by p24 detection based ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ccnc3Cl)CC2)cc1,CHEMBL1926604,Bioorg Med Chem Lett,2011.0,CHEMBL1926891,CHEMBL1926891,7.65,0.0,http://www.openphacts.org/units/Nanomolar,1563508.0,=,1.0,1.0,=,IC50,nM,22.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,22.3,CHEMBL378
5683,15720843.0,[],CHEMBL3618898,Antiviral activity against HBV infected in human HepG2 cells expressing hNTCP-C4 assessed as viral envelope surface protein secretion treated for 16 hrs followed by compound washout measured after 12 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCC(C)CC(C)C(=O)OC1(C)C(=O)c2c(cc(O)c3c2C[C@@H](O)C[C@H]3C)C(C)(O)C1=O,CHEMBL3616413,Bioorg Med Chem Lett,2015.0,CHEMBL3617544,CHEMBL3617544,4.98,0.0,http://www.openphacts.org/units/Nanomolar,2502040.0,=,1.0,1.0,=,IC50,nM,10500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.5,CHEMBL613497
5684,1672757.0,[],CHEMBL870624,Antiviral activity against HIV1 K103N mutant using HeLa MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(F)c1,CHEMBL1147746,J Med Chem,2006.0,CHEMBL201084,CHEMBL201084,7.42,0.0,http://www.openphacts.org/units/Nanomolar,411938.0,=,1.0,1.0,=,IC50,nM,38.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,38.0,CHEMBL378
5685,23306095.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL4843120,Antiviral activity against Zika virus H/PF/2013 infected in pre-seeded Huh-7 cells assessed as inhibition of viral replication incubated for 72 hrs by immunodetection based plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1,CHEMBL4842338,Eur J Med Chem,2021.0,CHEMBL1259059,CHEMBL1259059,5.70,0.0,http://www.openphacts.org/units/Nanomolar,3627096.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,2.0,CHEMBL4296612
5686,1186905.0,[],CHEMBL710372,Inhibitory activity against 100I strain and 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Oc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL305803,CHEMBL305803,5.09,0.0,http://www.openphacts.org/units/Nanomolar,127464.0,=,1.0,1.0,=,IC50,nM,8200.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.2,CHEMBL378
5687,17602992.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@@H]1CN(S(=O)(=O)c2ccc(Br)cc2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1,CHEMBL3639049,,2013.0,CHEMBL3644927,CHEMBL3644927,6.30,0.0,http://www.openphacts.org/units/Nanomolar,2518047.0,=,37.0,1.0,=,IC50,nM,500.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,500.0,CHEMBL4620
5688,3399340.0,[],CHEMBL1219621,Antiviral activity against R5 tropic HIV1 HXB2 infected in human TZM-bl cells assessed as inhibition of virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C,CHEMBL1212937,J Med Chem,2010.0,CHEMBL1212971,CHEMBL1212971,4.31,0.0,http://www.openphacts.org/units/Nanomolar,933732.0,=,1.0,1.0,=,IC50,nM,48800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,48.8,CHEMBL378
5689,18202576.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2ccc(O)cc2)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4091347,CHEMBL4091347,7.40,0.0,http://www.openphacts.org/units/Nanomolar,3019960.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
5690,1751288.0,[],CHEMBL854522,Antiviral activity against Measles virus variant in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Cc1ccccc1)Nc1cccc([N+](=O)[O-])c1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL213884,CHEMBL213884,,0.0,,532784.0,,1.0,0.0,,IC50,,,CHEMBL613738,Measles virus,Measles virus,11234,IC50,,,,CHEMBL613738
5691,176180.0,[],CHEMBL683822,Compound was tested for antiviral activity against HIV-1 sensitive to AZT,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(Cn2c(Br)nc3cc(Cl)c(Cl)cc32)c1,CHEMBL1131326,J Med Chem,1998.0,CHEMBL282937,CHEMBL282937,5.06,0.0,http://www.openphacts.org/units/Nanomolar,30685.0,=,1.0,1.0,=,IC50,nM,8700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,8.7,CHEMBL378
5692,2244489.0,[],CHEMBL1002211,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase G190A mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL223228,CHEMBL223228,8.23,0.0,http://www.openphacts.org/units/Nanomolar,798658.0,=,1.0,1.0,=,IC50,nM,5.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.9,CHEMBL378
5693,890621.0,[],CHEMBL710366,Inhibitory activity tested against the HIV-1 in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)NCC(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1129508,J Med Chem,1996.0,CHEMBL584984,CHEMBL584984,6.81,0.0,http://www.openphacts.org/units/Nanomolar,9087.0,=,1.0,1.0,=,IC50,nM,156.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,156.0,CHEMBL378
5694,19033606.0,[],CHEMBL4350058,Antiviral activity against HIV1 HXB2 pseudovirus infected in human TZM-bl cells assessed as inhibition of viral infection incubated for 20 mins prior to infection and measured after 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL4346738,Bioorg Med Chem,2019.0,CHEMBL223228,CHEMBL223228,9.05,0.0,http://www.openphacts.org/units/Nanomolar,3175422.0,=,1.0,1.0,=,IC50,nM,0.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.9,CHEMBL378
5695,11017269.0,[],CHEMBL2090658,Antiviral activity against HIV1 94US3393IN clade B clinical isolate infected in PHA-stimulated human PBMC assessed as inhibition of viral replication incubated for 6 hrs followed by compound-wash out measured after 6 days by liquid scintillation counting,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCC(=O)OC[C@@H]1O[C@H](n2ccc(N)nc2=O)CS1,CHEMBL2086298,J Med Chem,2012.0,CHEMBL2087753,CHEMBL2087753,8.38,0.0,http://www.openphacts.org/units/Nanomolar,1674773.0,=,1.0,1.0,=,IC50,nM,4.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.2,CHEMBL378
5696,20677925.0,[],CHEMBL4622140,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in cytoplasmic HBV-DNA replication incubated for 8 days by real-time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1ccc(-c2nn(Cc3ccc(C#N)cc3)c(=O)c3ccccc23)c(F)n1,CHEMBL4619801,J Med Chem,2020.0,CHEMBL4645215,CHEMBL4645215,5.68,0.0,http://www.openphacts.org/units/Nanomolar,3482215.0,=,1.0,1.0,=,IC50,nM,2110.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,2.11,CHEMBL613497
5697,14714246.0,[],CHEMBL3293254,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nccc(C(NO)c3ccc(C#N)cc3)n2)cc1,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL3288561,CHEMBL3288561,5.10,0.0,http://www.openphacts.org/units/Nanomolar,2116118.0,=,1.0,1.0,=,IC50,nM,7900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.9,CHEMBL378
5698,5229792.0,[],CHEMBL1676873,Antiviral activity against Human immunodeficiency virus 1 3B expressing nef protein infecting in CEM-SS cells assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,7.40,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
5699,19285284.0,[],CHEMBL4409788,Antiviral activity against oseltamivir resistant Yamagata lineage of Influenza B virus (B/Massachusetts/2/2012) BX-51B infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect measured after 45 hrs by CellTiter-Glo luminescence assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1.O=P(O)(O)O,CHEMBL4406875,Bioorg Med Chem,2019.0,CHEMBL1200340,CHEMBL1229,,0.0,http://www.openphacts.org/units/Nanomolar,3220504.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,100.0,CHEMBL613129
5700,13861110.0,[],CHEMBL3101351,Antiviral activity against HIV1 NL4.3 infected in human TZM-bl cells expressing CXCR4-tropic incubated for 1 hr prior to infection measured after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCC1C(C)=CCc2c1ccc(O)c2O,CHEMBL3098125,Bioorg Med Chem Lett,2014.0,CHEMBL3099065,CHEMBL3099065,5.34,0.0,http://www.openphacts.org/units/Nanomolar,1956068.0,=,1.0,1.0,=,IC50,nM,4600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.6,CHEMBL378
5701,3453353.0,[],CHEMBL1247792,Antiviral activity against HIV1 isolate 05-121771 assessed as inhibition of viral replication after 7 days by scintillation counting,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCN(c2cccc3nc(CN(C)[C@H]4CCCc5cccnc54)c(CO)n23)CC1,CHEMBL1240366,Antimicrob Agents Chemother,2010.0,CHEMBL1242210,CHEMBL1242210,9.00,0.0,http://www.openphacts.org/units/Nanomolar,953332.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
5702,2099737.0,[],CHEMBL949218,Antiviral activity against HIV1 JRCSF by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(ncn2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL403457,CHEMBL403457,,0.0,http://www.openphacts.org/units/Nanomolar,699407.0,>,1.0,1.0,>,IC50,nM,10000000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10000.0,CHEMBL378
5703,1403538.0,[],CHEMBL834757,Inhibitory concentration against 181C mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccccc1Oc1nc(Nc2ccc(Cl)cc2)c(=O)n(C)c1C,CHEMBL1145199,J Med Chem,2005.0,CHEMBL368765,CHEMBL368765,,0.0,http://www.openphacts.org/units/Nanomolar,360689.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
5704,13940315.0,[],CHEMBL3131385,Antiviral activity against Influenza B virus jifang/13/97 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity after 40 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)NCc1cn(Cc2cccc(Cl)c2)nn1)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL3124823,Eur J Med Chem,2014.0,CHEMBL3126778,CHEMBL3126778,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1972631.0,=,1.0,1.0,=,IC50,ug.mL-1,7.41,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,ug ml-1,UO_0000274,7.41,CHEMBL613129
5705,640040.0,[],CHEMBL683819,Anti-HIV activity in cell culture assay expressed as IC50 values.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1O)c1cc(O)c(O)c(O)c1,CHEMBL1126373,Bioorg Med Chem Lett,1992.0,CHEMBL39744,CHEMBL39744,4.10,0.0,http://www.openphacts.org/units/Nanomolar,60617.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,80.0,CHEMBL378
5706,13476907.0,[],CHEMBL2439256,Antiviral activity against Human immunodeficiency virus 1 clade B isolate CI#19 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435856,CHEMBL2435856,,0.0,,1924231.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5707,1401624.0,[],CHEMBL837462,In vitro inhibitory concentration against HIV E138K mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1C(=O)c1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL366692,CHEMBL366692,8.30,0.0,http://www.openphacts.org/units/Nanomolar,360329.0,=,1.0,1.0,=,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.005,CHEMBL378
5708,2601773.0,[],CHEMBL1034013,Antiviral activity against Moloney sarcoma virus,F,BAO_0000190,BAO_0000218,organism-based format,Nc1cc(SCCOCP(=O)(O)O)nc(N)n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL57548,CHEMBL57548,6.22,0.0,http://www.openphacts.org/units/Nanomolar,807918.0,=,1.0,1.0,=,IC50,nM,607.0,CHEMBL613501,Moloney murine sarcoma virus,Moloney murine sarcoma virus,11809,IC50,10'-1microM,UO_0000065,6.07,CHEMBL613501
5709,1218711.0,[],CHEMBL645946,Concentration required to inhibit activator protein-1(AP-1) mediated transcriptional activation in human Jurkat T-cells,B,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(C(F)(F)F)ncc1C(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1,CHEMBL1133475,J Med Chem,2000.0,CHEMBL131007,CHEMBL131007,,0.0,http://www.openphacts.org/units/Nanomolar,247715.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,10.0,CHEMBL4977
5710,1750605.0,[],CHEMBL866135,Antiviral activity against multi drug-resistant HIV1 B variant in human PHA-PBMC cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,CHEMBL1146019,J Med Chem,2006.0,CHEMBL163,CHEMBL163,,0.0,http://www.openphacts.org/units/Nanomolar,539999.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
5711,6152260.0,[],CHEMBL1763053,Antiviral activity against Human immunodeficiency virus 1 BAL infected in human PBMC assessed as inhibition of viral replication by p24 antigen specific ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccc(C(F)(F)F)cc2)c2ccc(C(F)(F)F)cc2)CC1,CHEMBL1759996,Bioorg Med Chem Lett,2011.0,CHEMBL1762323,CHEMBL1762323,,0.0,http://www.openphacts.org/units/Nanomolar,1414774.0,>,1.0,1.0,>,IC50,nM,1230.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.23,CHEMBL378
5712,22933293.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)/C=C/c4ccc(O)c(OC)c4)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4762130,CHEMBL4762130,7.75,0.0,http://www.openphacts.org/units/Nanomolar,3560854.0,=,1.0,1.0,=,IC50,nM,18.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.018000000000000002,CHEMBL378
5713,18239549.0,[],CHEMBL4052026,Antiviral activity against wild type HIV1 NL4-3 infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,CHEMBL4049446,J Med Chem,2017.0,CHEMBL729,CHEMBL729,7.70,0.0,http://www.openphacts.org/units/Nanomolar,3026806.0,=,1.0,1.0,=,IC50,nM,20.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,20.0,CHEMBL378
5714,1403528.0,[],CHEMBL834756,Inhibitory concentration against 103N mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)c(Sc2cn(C)c(=O)c(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL175152,CHEMBL175152,6.20,0.0,http://www.openphacts.org/units/Nanomolar,360671.0,=,1.0,1.0,=,IC50,nM,631.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.631,CHEMBL378
5715,7924549.0,[],CHEMBL1921362,Antiviral activity against Human immunodeficiency virus 1 Ba-L in human PBL cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(NC(=O)N(c2cccc(F)c2)C2CCN(Cc3ccc(Oc4ccc(NS(C)(=O)=O)cc4)nc3C)CC2)cnc1C(N)=O,CHEMBL1914281,Bioorg Med Chem Lett,2011.0,CHEMBL1914524,CHEMBL1914524,8.28,0.0,http://www.openphacts.org/units/Nanomolar,1556599.0,=,1.0,1.0,=,IC50,nM,5.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.3,CHEMBL378
5716,18342086.0,[],CHEMBL4139012,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 8 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)Nc2c[nH]c(=O)c(-c3cccc(C)c3)c2)c(O)c1,CHEMBL4138083,Eur J Med Chem,2017.0,CHEMBL4173928,CHEMBL4173928,4.35,0.0,http://www.openphacts.org/units/Nanomolar,3045864.0,=,1.0,1.0,=,IC50,nM,44610.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,44.61,CHEMBL613497
5717,1402307.0,[],CHEMBL837467,In vitro inhibitory concentration against HIV K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(Cc2ccccc2)Cc2ccccc2)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL366811,CHEMBL366811,4.30,0.0,http://www.openphacts.org/units/Nanomolar,360421.0,=,1.0,1.0,=,IC50,nM,50120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.12,CHEMBL378
5718,10937566.0,[],CHEMBL2051603,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as inhibition of viral DNA replication by PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)/C=C/c4ccccc4)CC3=CC[C@]12O,CHEMBL2046311,Eur J Med Chem,2012.0,CHEMBL2046551,CHEMBL2046551,5.23,0.0,http://www.openphacts.org/units/Nanomolar,1651434.0,=,1.0,1.0,=,IC50,nM,5910.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,5.91,CHEMBL613497
5719,3199203.0,[],CHEMBL1104121,Antiviral activity against HIV1 Ba-L infected in PBMCs assessed as reverse transcriptase activity after 7 days by MTS assay,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)CCNC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@H](Cc1ccc(O)cc1)NC[C@@H](N)Cc1ccc(O)cc1,CHEMBL1153724,Bioorg Med Chem Lett,2009.0,CHEMBL1075828,CHEMBL1075828,4.96,0.0,http://www.openphacts.org/units/Nanomolar,889151.0,=,1.0,1.0,=,IC50,nM,11000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,11.0,CHEMBL378
5720,12642494.0,[],CHEMBL2317525,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCCN2C(=O)c3c(O)c(=O)c(C(=O)NCc4ccc(F)cc4)cn3CC12,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314690,CHEMBL2314690,8.42,0.0,http://www.openphacts.org/units/Nanomolar,1844822.0,=,1.0,1.0,=,IC50,nM,3.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.8,CHEMBL378
5721,629352.0,[],CHEMBL710374,Inhibitory activity against 100I strain of HIV-I in MT-4 cell was determined.,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(Cc3c(Cl)cccc3Cl)nc(N=[N+]=[N-])n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL71298,CHEMBL71298,,0.0,http://www.openphacts.org/units/Nanomolar,126938.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5722,1221281.0,[],CHEMBL645946,Concentration required to inhibit activator protein-1(AP-1) mediated transcriptional activation in human Jurkat T-cells,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ncc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c(C(F)(F)F)n1,CHEMBL1133475,J Med Chem,2000.0,CHEMBL441830,CHEMBL441830,,0.0,http://www.openphacts.org/units/Nanomolar,247721.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,10.0,CHEMBL4977
5723,1150042.0,[],CHEMBL757806,Cytotoxicity against human peripheral blood mononuclear (PBM) cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,O=c1ccn([C@@H]2CS[C@H](CO)O2)c(=O)[nH]1,CHEMBL1126808,J Med Chem,1993.0,CHEMBL300569,CHEMBL300569,,0.0,http://www.openphacts.org/units/Nanomolar,100999.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5724,2665974.0,[],CHEMBL1061338,Inhibition of TPA-induced AP1 transfected in HEK293 cells assessed as inhibition of beta-lactamase reporter activity treated 1 hr before TPA stimulation measured after 18 hrs by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,CC(=O)O[C@H]1C(=O)O[C@@H]2C[C@H]3C(C)=CC(=O)[C@@H](O)[C@]3(C)[C@H]3[C@]4(O)OC[C@]32[C@@H]1[C@@H](C)[C@H]4O,CHEMBL1152334,J Nat Prod,2009.0,CHEMBL519243,CHEMBL519243,,0.0,,818227.0,,1.0,0.0,,IC50,,,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,,,,CHEMBL4977
5725,1401995.0,[],CHEMBL834487,In vitro inhibitory concentration value against HIV K103N and Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCSC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL178936,CHEMBL178936,,0.0,http://www.openphacts.org/units/Nanomolar,360356.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5726,1402396.0,[],CHEMBL837535,In vitro inhibitory concentration against HIV LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)CCOC)c1C(=O)c1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL369697,CHEMBL369697,9.00,0.0,http://www.openphacts.org/units/Nanomolar,360426.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
5727,12051180.0,[],CHEMBL2156563,Antiviral activity against CXCR4-tropic HIV1 NL4-3 infected in HEK293T cells assessed as inhibition of viral replication after 4 days by beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(c(-c3cc(O)c4c(O)c5oc6c(C(=O)O)cc(C)cc6c(=O)c5c(O)c4c3OC)c1)CC(C)OC2=O,CHEMBL2151018,J Nat Prod,2012.0,CHEMBL2152440,CHEMBL2152440,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1731136.0,=,1.0,1.0,=,IC50,ug.mL-1,21.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,21.0,CHEMBL378
5728,5217244.0,[],CHEMBL1678148,Antiviral activity against HIV-1 isolate RF infected in human CEM-SS cells assessed as inhibition of virus induced cytopathic effect by XTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1NC(=O)c1c(NC(=O)Cc2ccccc2)sc2c1CCCCC2,CHEMBL1671700,Antimicrob Agents Chemother,2010.0,CHEMBL1673225,CHEMBL1673225,4.27,0.0,http://www.openphacts.org/units/Nanomolar,1332203.0,=,1.0,1.0,=,IC50,nM,54000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,54.0,CHEMBL378
5729,3358079.0,[],CHEMBL1175710,Antiviral activity against HIV1 expressing reverse transcriptase K103N/Y181C double mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)n1,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1169811,CHEMBL1169811,7.70,0.0,http://www.openphacts.org/units/Nanomolar,922946.0,=,1.0,1.0,=,IC50,nM,20.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,20.2,CHEMBL378
5730,1402122.0,[],CHEMBL834488,In vitro inhibitory concentration against HIV L100I and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCCCO)c1Cc1cccc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL367745,CHEMBL367745,,0.0,http://www.openphacts.org/units/Nanomolar,360369.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5731,332362.0,[],CHEMBL653803,In vitro inhibition of CEM-SS cell growth by 50 %,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCOCC(C[n+]1ccccc1)OCC.[Br-],CHEMBL1125666,J Med Chem,1991.0,CHEMBL282790,CHEMBL1183160,5.96,0.0,http://www.openphacts.org/units/Nanomolar,43746.0,=,1.0,1.0,=,IC50,nM,1100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.1,CHEMBL378
5732,15200460.0,[],CHEMBL3413997,Antiviral activity against X4 tropic HIV-1 clone pNL4-3 infected in H9 cells assessed as reduction in p24 antigen after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,N#C/C(=C\c1ccc(C(=O)O)cc1)c1nc2ccccc2[nH]1,CHEMBL3407469,Eur J Med Chem,2015.0,CHEMBL3410116,CHEMBL3410116,,0.0,http://www.openphacts.org/units/Nanomolar,2288845.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
5733,2930210.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CN(C)Cc3ccco3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL573021,CHEMBL573021,7.80,0.0,http://www.openphacts.org/units/Nanomolar,848284.0,=,1.0,1.0,=,IC50,nM,15.84,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,15.84,CHEMBL378
5734,3603845.0,[],CHEMBL1291735,Antiviral activity against Hepatitis B virus infected in HepG2.2.15 assessed as inhibition of HBV replication at <757.8 +/- 4.3 uM by quantitative Southern blot hybridization analysis,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc([S+]([O-])Cc2nc3c(Cn4ccnc4)c(O)ccc3n2C)cc1,CHEMBL1287795,Bioorg Med Chem Lett,2010.0,CHEMBL1288173,CHEMBL1288173,,0.0,,973192.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
5735,16556890.0,[],CHEMBL3795205,Antiviral activity against CXCR4 using HIV-1 NL4.3 infected in human MT4 cells assessed as reduction of viral replication preincubated for 15 mins with cells followed by viral infection measured after 4 days by MTS/PES method,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(C(=O)c2ccc(N)cc2)CCCN(Cc2ccccc2)CCCN(S(=O)(=O)c2ccc(C)cc2)C1.Cl,CHEMBL3792300,J Med Chem,2016.0,CHEMBL3794526,CHEMBL3794649,,0.0,http://www.openphacts.org/units/Nanomolar,2770920.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
5736,863180.0,[],CHEMBL713546,Compound potency to achieve protection of MT-4 cells from HIV-1 cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(NC(=S)NC(=N)Cc2ccc(Cl)cc2Cl)cc1,CHEMBL1134808,Bioorg Med Chem Lett,2001.0,CHEMBL69893,CHEMBL69893,8.15,0.0,http://www.openphacts.org/units/Nanomolar,126230.0,=,1.0,1.0,=,IC50,nM,7.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.007,CHEMBL378
5737,591864.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)Nc1ccc(S(=O)(=O)c2ccc(NC(=O)c3ccccc3SSc3ccccc3C(=O)Nc3ccc(S(=O)(=O)c4ccc(NC(C)=O)cc4)cc3)cc2)cc1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL170951,CHEMBL170951,,0.0,http://www.openphacts.org/units/Nanomolar,334009.0,=,1.0,1.0,=,IC50,nM,160000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,160.0,CHEMBL378
5738,15568201.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(F)cc1)N1CCN(S(=O)(=O)C2=Cc3ccccc3CC2)CC1,CHEMBL1201862,,,CHEMBL3560117,CHEMBL3560117,8.94,0.0,http://www.openphacts.org/units/Nanomolar,2474456.0,=,7.0,1.0,=,IC50,nM,1.15,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.00115,CHEMBL3259470
5739,12680736.0,[],CHEMBL2342599,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)NCCc3ccc(F)cc3)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333291,CHEMBL2333291,4.83,0.0,http://www.openphacts.org/units/Nanomolar,1867254.0,=,1.0,1.0,=,IC50,nM,14660.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,14.66,CHEMBL613497
5740,3509178.0,[],CHEMBL1261042,Antiviral activity against HIV1 harboring reverse transcriptase V106A mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL223228,CHEMBL223228,8.24,0.0,http://www.openphacts.org/units/Nanomolar,963716.0,=,1.0,1.0,=,IC50,nM,5.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.7,CHEMBL378
5741,3077005.0,[],CHEMBL1067297,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,O=C1CCCC2=C1C(c1ccc(F)cc1Cl)N=C(c1nccs1)N2,CHEMBL1153099,Bioorg Med Chem Lett,2010.0,CHEMBL594559,CHEMBL594559,5.06,0.0,http://www.openphacts.org/units/Nanomolar,877001.0,=,1.0,1.0,=,IC50,nM,8750.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,8.75,CHEMBL613497
5742,1081581.0,[],CHEMBL709777,Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1.,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)CN1Cc2cccc3[nH]c(=O)n(c23)C[C@@H]1C,CHEMBL1125252,J Med Chem,1991.0,CHEMBL1095239,CHEMBL1095239,4.72,0.0,http://www.openphacts.org/units/Nanomolar,322356.0,=,1.0,1.0,=,IC50,nM,19000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,19.0,CHEMBL378
5743,15158570.0,[],CHEMBL3398830,Inhibition of HBV HBsAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method,F,BAO_0000190,BAO_0000218,organism-based format,O=C1OCCc2c1cccc2C1OCCO1,CHEMBL3396983,Bioorg Med Chem Lett,2015.0,CHEMBL3397167,CHEMBL3397167,,0.0,http://www.openphacts.org/units/Nanomolar,2278965.0,>,1.0,1.0,>,IC50,nM,2580000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,2.58,CHEMBL613497
5744,340061.0,[],CHEMBL756133,Inhibition of concanavalin A (con A)-induced proliferation of human peripheral blood mononuclear cells.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1)c1ccc(Cl)cc1,CHEMBL1133605,J Med Chem,2000.0,CHEMBL100350,CHEMBL100350,6.35,0.0,http://www.openphacts.org/units/Nanomolar,188090.0,=,1.0,1.0,=,IC50,nM,445.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,445.0,CHEMBL378
5745,24830967.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Cl)c2oc3cc(N4CCC(C(=O)O)C4)ccc3c(=O)c12,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5180255,CHEMBL5180255,5.95,0.0,http://www.openphacts.org/units/Nanomolar,3878140.0,=,1.0,1.0,=,IC50,nM,1120.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.12,CHEMBL613497
5746,19139098.0,[],CHEMBL4376259,Antiviral activity against Influenza B virus infected in MDCK cells assessed as inhibition in virus-induced cytopathic effect incubated for 40 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)OC)[C@@H]1CC[C@H](C)[C@H]2C(=C(C)C(=O)[C@H]2NC(C)=O)C1,CHEMBL4373726,Bioorg Med Chem Lett,2019.0,CHEMBL4483331,CHEMBL4483331,,0.0,http://www.openphacts.org/units/Nanomolar,3194251.0,=,1.0,1.0,=,IC50,nM,522400.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,522.4,CHEMBL613129
5747,1954102.0,[],CHEMBL890376,Antiviral activity against HIV1 LAI assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(Br)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL234077,CHEMBL234077,8.70,0.0,http://www.openphacts.org/units/Nanomolar,647172.0,=,1.0,1.0,=,IC50,nM,1.99,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.99,CHEMBL378
5748,17720717.0,[],CHEMBL3889300,"Cellular Firefly Luciferase Assay (AP-1): Curcumin is a known inhibitor of the AP-1 activation cascade. Therefore, modification of the structure of curcumin could lead to analogs with enhanced activity. The library consisting of three series of curcumin analogs were used to examine the role of the enone functionality in aryl systems where the spacer is 7-carbons (as in curcumin), 5-carbons or 3-carbons in length. In addition, the importance of aryl ring substituents was assessed. The AP-1 activities of curcumin and analogs were determined by a cellular firefly luciferase assay. This assay utilized a commercially available cell line (Panomics 293-luc cellular assay) developed for screening inhibitors of AP-1. This cell line is stably transfected with a luciferase reporter controlled by an AP-1 dependent promoter. The cell is stimulated with phorbol ester which activates AP-1. AP-1 then binds to one of three promoter regions on the cells DNA leading to the production of a luciferase enzyme. Luciferin is added to the cell lysates and the luciferase enzyme catalyzes a cleavage of luciferin leading to the emission of light.",B,BAO_0000190,BAO_0000019,assay format,COc1ccc(OC)c(/C=C/C(=O)/C=C/c2cc(OC)ccc2OC)c1,CHEMBL3886177,,2015.0,CHEMBL557311,CHEMBL557311,5.85,0.0,http://www.openphacts.org/units/Nanomolar,2849111.0,=,37.0,1.0,=,IC50,nM,1400.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,nM,UO_0000065,1400.0,CHEMBL4977
5749,18890509.0,[],CHEMBL4314138,Antiviral activity against HIV-1 NL4-3 infected in human CEM-GFP cells assessed as suppression of viral replication by measuring reduction in p24 level measured at 72 hrs post-infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2cc(CC(=O)Nc3cccc(C)c3)no2)cc1,CHEMBL4311980,Eur J Med Chem,2019.0,CHEMBL4563578,CHEMBL4563578,6.55,0.0,http://www.openphacts.org/units/Nanomolar,3151803.0,=,1.0,1.0,=,IC50,nM,284.18,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,284.18,CHEMBL378
5750,3083991.0,[],CHEMBL1072584,Antiviral activity against HIV1 infected in human JC53-BL cells after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)N1C[C@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)CO)C3)C[C@H]2C1,CHEMBL1153211,Bioorg Med Chem Lett,2010.0,CHEMBL604680,CHEMBL604680,6.89,0.0,http://www.openphacts.org/units/Nanomolar,872781.0,=,1.0,1.0,=,IC50,nM,130.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,130.0,CHEMBL378
5751,1402252.0,[],CHEMBL837467,In vitro inhibitory concentration against HIV K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(CC)CC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175534,CHEMBL175534,6.40,0.0,http://www.openphacts.org/units/Nanomolar,360399.0,=,1.0,1.0,=,IC50,nM,398.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.398,CHEMBL378
5752,19175392.0,[],CHEMBL4385901,Antiviral activity against Zika virus harboring subgenomic GFP replicon infected in African green monkey Vero cells assessed as reduction in viral infection preincubated for 30 mins followed by viral infection and measured after 72 hrs,F,BAO_0000190,BAO_0000218,organism-based format,c1csc(CNCc2cc(CNCc3cccs3)cc(-c3cc(CNCc4cccs4)cc(CNCc4cccs4)c3)c2)c1,CHEMBL4385601,J Med Chem,2019.0,CHEMBL4592586,CHEMBL4592586,5.88,0.0,http://www.openphacts.org/units/Nanomolar,3200394.0,=,1.0,1.0,=,IC50,nM,1310.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,1.31,CHEMBL4296612
5753,7843571.0,[],CHEMBL1913153,Antiviral activity against HIV1 Ba-L infected in human PBL cells assessed as reduction of viral replication after 4 days by Steady-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(S(C)(=O)=O)cc2)ccc1CN1CCC(N2C(=O)N(c3cc(C(N)=O)c(F)cc3F)C[C@H]2c2ccccc2)CC1,CHEMBL1909524,Bioorg Med Chem Lett,2011.0,CHEMBL1909867,CHEMBL1909867,9.00,0.0,http://www.openphacts.org/units/Nanomolar,1541996.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.0,CHEMBL378
5754,575629.0,[],CHEMBL655294,Antiviral activity against HIV-1 infected CEM-SS cells was determined in XTT cytoprotection assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3SSc3ccccc3C(=O)Nc3ccc(S(=O)(=O)Nc4cc(C)on4)cc3)cc2)no1,CHEMBL1132203,J Med Chem,1999.0,CHEMBL168225,CHEMBL168225,4.56,0.0,http://www.openphacts.org/units/Nanomolar,333989.0,=,1.0,1.0,=,IC50,nM,27600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,27.6,CHEMBL378
5755,18509587.0,[],CHEMBL4191605,Antiviral activity against HIV1 isolate 89.6 infected in PHA-stimulated human PBMC assessed as reduction in p24 level after 7 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(O[C@@H]3O[C@H](C)[C@@H](O)[C@H](O)[C@H]3O)c3c(c(-c4ccc5c(c4)OCO5)c2cc1OC)C(=O)OC3,CHEMBL4190218,J Nat Prod,2017.0,CHEMBL458904,CHEMBL458904,7.50,0.0,http://www.openphacts.org/units/Nanomolar,3073111.0,=,1.0,1.0,=,IC50,nM,32.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,32.0,CHEMBL378
5756,1401952.0,[],CHEMBL837464,In vitro inhibitory concentration against HIV G190A mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCCNc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL175925,CHEMBL175925,,0.0,http://www.openphacts.org/units/Nanomolar,360394.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5757,24830945.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)C1CCCN(c2ccc3c(=O)c4cccc(Cl)c4oc3c2)C1,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5206934,CHEMBL5206934,5.42,0.0,http://www.openphacts.org/units/Nanomolar,3878118.0,=,1.0,1.0,=,IC50,nM,3820.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,3.82,CHEMBL613497
5758,18683316.0,[],CHEMBL4237101,Antiviral activity against CCR5-dependent HIV1 Ba-L infected in human PM1 cells assessed as reduction in virus infection measured after 5 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1,CHEMBL4229569,J Med Chem,2018.0,CHEMBL4244935,CHEMBL4244935,8.21,0.0,http://www.openphacts.org/units/Nanomolar,3103078.0,=,1.0,1.0,=,IC50,nM,6.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.2,CHEMBL378
5759,2244570.0,[],CHEMBL1003073,Antiviral activity against NNRTI-resistant HIV1 with reverse transcriptase Y188C mutant in HeLa cells by MAGI assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,CHEMBL1156569,J Med Chem,2008.0,CHEMBL57,CHEMBL57,6.10,0.0,http://www.openphacts.org/units/Nanomolar,798657.0,=,1.0,1.0,=,IC50,nM,801.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,801.0,CHEMBL378
5760,3083967.0,[],CHEMBL1072584,Antiviral activity against HIV1 infected in human JC53-BL cells after 3 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)N1C[C@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@H]2C1,CHEMBL1153211,Bioorg Med Chem Lett,2010.0,CHEMBL596519,CHEMBL596519,6.46,0.0,http://www.openphacts.org/units/Nanomolar,872509.0,=,1.0,1.0,=,IC50,nM,351.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,351.0,CHEMBL378
5761,2371519.0,[],CHEMBL1035735,Antiviral activity against wild type HIV1 in presence of 40% normal human serum,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ncccc34)ccc2Cl)c1,CHEMBL1140177,J Med Chem,2008.0,CHEMBL491019,CHEMBL491019,8.82,0.0,http://www.openphacts.org/units/Nanomolar,773465.0,=,1.0,1.0,=,IC50,nM,1.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.5,CHEMBL378
5762,23306087.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL4843118,Antiviral activity against Zika virus H/PF/2013 infected in pre-seeded Huh-7 cells assessed as inhibition of viral replication incubated for 72 hrs by immunodetection based secondary yield reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,Fc1cccc(/N=N/c2nc(NCCOc3ccccc3)nc3[nH]cnc23)c1,CHEMBL4842338,Eur J Med Chem,2021.0,CHEMBL4873306,CHEMBL4873306,5.55,0.0,http://www.openphacts.org/units/Nanomolar,3627103.0,=,1.0,1.0,=,IC50,nM,2800.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,2.8,CHEMBL4296612
5763,5132876.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2nc(O)c(CN(Cc3ccco3)C(=O)c3ccccc3)cc2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1550421,CHEMBL1550421,,0.0,http://www.openphacts.org/units/Nanomolar,1321056.0,>,1.0,1.0,>,IC50,nM,25700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,25.7,CHEMBL378
5764,18940388.0,[],CHEMBL4328847,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(S(=O)(=O)n2ccc3ccc(-c4ccc5ccn(Cc6cccc(C(=O)O)c6)c5c4)cc32)cc1,CHEMBL4325884,Eur J Med Chem,2019.0,CHEMBL4445474,CHEMBL4445474,6.10,0.0,http://www.openphacts.org/units/Nanomolar,3159823.0,=,1.0,1.0,=,IC50,nM,800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.8,CHEMBL378
5765,12680754.0,[],CHEMBL2342599,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2c(=O)c(/C=C/C(=O)Nc3cc(C)ccc3C)coc2c1,CHEMBL2331205,Eur J Med Chem,2013.0,CHEMBL2333696,CHEMBL2333696,,0.0,http://www.openphacts.org/units/Nanomolar,1867772.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,100.0,CHEMBL613497
5766,2178183.0,[],CHEMBL1019290,Antiviral activity against HIV1 HTLV-3B in human H9 cells after 3 days by p24 antigen capture assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(c(OC)c1O)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,CHEMBL1158954,J Nat Prod,1991.0,CHEMBL1080,CHEMBL1080,6.58,0.0,http://www.openphacts.org/units/Nanomolar,740162.0,=,1.0,1.0,=,IC50,nM,260.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.26,CHEMBL378
5767,2099803.0,[],CHEMBL949221,Antiviral activity against HIV1 97-ZA-003 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(nc(C(C)C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2ccccc2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL257274,CHEMBL257274,6.92,0.0,http://www.openphacts.org/units/Nanomolar,699409.0,=,1.0,1.0,=,IC50,nM,121.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.121,CHEMBL378
5768,18528856.0,[],CHEMBL4194999,Antiviral activity against HIV1 virions derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc([C@H]2c3cc(OC)c(OC)cc3C[C@H](C)[C@@H]2C)cc1OC,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4203607,CHEMBL4203607,6.07,0.0,http://www.openphacts.org/units/Nanomolar,3076499.0,=,1.0,1.0,=,IC50,nM,860.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.86,CHEMBL378
5769,15166141.0,[],CHEMBL3404736,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as decrease in viral DNA replication treated for 7 days by real time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(OC(=O)/C=C/c2ccccc2)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL1578081,CHEMBL1578081,,0.0,http://www.openphacts.org/units/Nanomolar,2284122.0,>,1.0,1.0,>,IC50,nM,718700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,718.7,CHEMBL613497
5770,14596893.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCOCCOCn1c(Sc2ccccc2)c(C)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL142593,CHEMBL142593,5.35,0.0,http://www.openphacts.org/units/Nanomolar,2082735.0,=,1.0,1.0,=,IC50,nM,4460.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.46,CHEMBL378
5771,3008334.0,[],CHEMBL1037279,Antiviral activity against Human immunodeficiency virus 1 NL4-3 infected HeLaP4 cells after 5 days by beta-galactosidase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(Oc1cccc2c(=O)[nH]ccc12)C(=O)N1CCN(C(=O)c2ccccc2)C[C@H]1C,CHEMBL1155317,Bioorg Med Chem Lett,2009.0,CHEMBL584337,CHEMBL584337,5.98,0.0,http://www.openphacts.org/units/Nanomolar,861812.0,=,1.0,1.0,=,IC50,nM,1050.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1050.0,CHEMBL378
5772,2009858.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2ncccc12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL442078,CHEMBL442078,7.52,0.0,http://www.openphacts.org/units/Nanomolar,668055.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,30.0,CHEMBL378
5773,3008350.0,[],CHEMBL1037279,Antiviral activity against Human immunodeficiency virus 1 NL4-3 infected HeLaP4 cells after 5 days by beta-galactosidase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CNc1nccc2c(O[C@@H](C)C(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)cccc12,CHEMBL1155317,Bioorg Med Chem Lett,2009.0,CHEMBL569457,CHEMBL569457,,0.0,,861815.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5774,167429.0,[],CHEMBL844410,Inhibition of 50% of the integrase-mediated catalysis of the Y-oligo substrate with 95% confidence interval,F,BAO_0000190,BAO_0000218,organism-based format,O=C(/C=C\c1ccc(O)c(O)c1)NC(COC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,CHEMBL1135546,J Med Chem,2002.0,CHEMBL122180,CHEMBL122180,6.92,0.0,http://www.openphacts.org/units/Nanomolar,231562.0,=,1.0,1.0,=,IC50,nM,120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.12,CHEMBL378
5775,3104729.0,[],CHEMBL1065872,Antiviral activity against multi drug-resistant HIV1 isolate of subtype MM in PHA-stimulated human PBMC assessed as inhibition of p24 antigen production,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,CHEMBL1159037,Bioorg Med Chem Lett,2010.0,CHEMBL1163,CHEMBL1163,7.40,0.0,http://www.openphacts.org/units/Nanomolar,883254.0,=,1.0,1.0,=,IC50,nM,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.04,CHEMBL378
5776,6304750.0,[],CHEMBL1815967,Antiviral activity against R5 tropic multidrug-resistant HIV1 MM infected PBMC assessed as inhibition of viral p24 antigen expression,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCC3)cc1.[Cl-],CHEMBL1811891,Bioorg Med Chem,2011.0,CHEMBL41275,CHEMBL1178786,7.85,0.0,http://www.openphacts.org/units/Nanomolar,1447830.0,=,1.0,1.0,=,IC50,nM,14.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,14.0,CHEMBL378
5777,6216945.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(OC(C)C)c2)CCN(C(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784503,CHEMBL1784503,6.07,0.0,http://www.openphacts.org/units/Nanomolar,1429442.0,=,1.0,1.0,=,IC50,nM,851.14,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.07,CHEMBL378
5778,18044760.0,[],CHEMBL4010411,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype D QA013.70I.ENV.H1,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.34,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,460.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.46,CHEMBL378
5779,18775507.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1cc2c(cc1OC)CC(CC)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4286406,CHEMBL4286406,7.62,0.0,http://www.openphacts.org/units/Nanomolar,3119665.0,=,1.0,1.0,=,IC50,nM,24.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.024,CHEMBL613497
5780,3509171.0,[],CHEMBL1261042,Antiviral activity against HIV1 harboring reverse transcriptase V106A mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cnc(NC2CCN(c3cccc(C(N)=O)c3)CC2)nc1Oc1c(C)cc(C#N)cc1C,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1257665,CHEMBL1257665,9.22,0.0,http://www.openphacts.org/units/Nanomolar,962573.0,=,1.0,1.0,=,IC50,nM,0.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.6,CHEMBL378
5781,3008328.0,[],CHEMBL1037279,Antiviral activity against Human immunodeficiency virus 1 NL4-3 infected HeLaP4 cells after 5 days by beta-galactosidase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(Oc1cccc2ncccc12)C(=O)N1CCN(C(=O)c2ccccc2)C[C@H]1C,CHEMBL1155317,Bioorg Med Chem Lett,2009.0,CHEMBL569615,CHEMBL569615,6.57,0.0,http://www.openphacts.org/units/Nanomolar,861777.0,=,1.0,1.0,=,IC50,nM,271.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,271.0,CHEMBL378
5782,14596828.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(Sc2cc(Cl)cc(Cl)c2)n(COCCO)c(=O)[nH]c1=O,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL116501,CHEMBL116501,5.23,0.0,http://www.openphacts.org/units/Nanomolar,2082348.0,=,1.0,1.0,=,IC50,nM,5890.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.89,CHEMBL378
5783,16394333.0,[],CHEMBL3744526,Inhibition of HBV DNA replication in HepG2.2.15 cells,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C1=C(C)NC(c2ncc(F)cc2F)=N[C@H]1c1ccc(F)cc1Cl,CHEMBL3739304,Medchemcomm,2015.0,CHEMBL605300,CHEMBL605300,7.30,0.0,http://www.openphacts.org/units/Nanomolar,2738854.0,=,1.0,1.0,=,IC50,nM,50.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.05,CHEMBL613497
5784,14714283.0,[],CHEMBL3293255,Antiviral activity against HIV1 harboring reverse transcriptase K103N/Y181C mutant infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCNC(c1ccc(/C=C/C#N)cc1)c1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL3288571,CHEMBL3288571,,0.0,http://www.openphacts.org/units/Nanomolar,2116129.0,>,1.0,1.0,>,IC50,nM,37324.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,37.324,CHEMBL378
5785,22845264.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '49.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '49.0'}]",CHEMBL4721684,Antiviral activity against clinical isolate HIV-1 93RW018 infected in human PBMC cells assessed as reduction in viral transmission to TZM-bl cells pretreated for 1 hr before viral transmission and further incubated for 48 hrs by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4547005,CHEMBL4547005,5.62,0.0,http://www.openphacts.org/units/Nanomolar,3547094.0,=,1.0,1.0,=,IC50,nM,2400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.4,CHEMBL378
5786,15666374.0,[],CHEMBL3602697,Antiviral activity against wild type HIV1 NL4-3 infected in human TZM-bl cells assessed as inhibition of viral replication after 2 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)O,CHEMBL3600303,J Med Chem,2015.0,CHEMBL3600954,CHEMBL3600954,7.76,0.0,http://www.openphacts.org/units/Nanomolar,2492335.0,=,1.0,1.0,=,IC50,nM,17.37,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,17.37,CHEMBL378
5787,6216904.0,[],CHEMBL1788062,Antiviral activity against Human immunodeficiency virus 1 Bal-HOS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)C2(C(=O)O)CCC2)CC1,CHEMBL1781974,J Med Chem,2011.0,CHEMBL1784407,CHEMBL1784407,7.77,0.0,http://www.openphacts.org/units/Nanomolar,1429345.0,=,1.0,1.0,=,IC50,nM,16.98,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,7.77,CHEMBL378
5788,19004631.0,[],CHEMBL4344048,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells measured on day 3 post-infection by Nano-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@]12O[C@@]3(/C=C\C=C/CCCCC)O[C@@H]1[C@@H]1[C@@H]4O[C@]4(CO)[C@@H](O)[C@]4(O)C(=O)C(C)=C[C@H]4[C@@]1(O3)[C@H](C)[C@H]2OC(C)=O,CHEMBL4342444,J Nat Prod,2020.0,CHEMBL4450270,CHEMBL4450270,,0.0,http://www.openphacts.org/units/Nanomolar,3171222.0,<,1.0,1.0,<,IC50,nM,0.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.9,CHEMBL378
5789,3397934.0,[],CHEMBL1217303,Antiviral activity against HIV1 3B infected in human MAGI cells after 40 to 48 hrs assessed as inhibition of viral life cycle,F,BAO_0000190,BAO_0000218,organism-based format,O=C1C(c2ccc(O)c(OS(=O)(=O)O)c2)=c2c(c3c(n2CCc2ccc(O)cc2)=C(c2ccc(O)c(OS(=O)(=O)O)c2)C(=O)c2cc(O)c(OS(=O)(=O)O)cc2-3)-c2cc(O)c(O)cc21,CHEMBL1212851,Bioorg Med Chem,2010.0,CHEMBL1214284,CHEMBL1214284,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,931716.0,=,1.0,1.0,=,IC50,ug.mL-1,4.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,4.4,CHEMBL378
5790,22449741.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.5', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.5'}]",CHEMBL4680705,Antiviral activity against HIV1 JRFL infected in dog Cf2Th/CD4-CCR5 cells assessed as inhibition of viral entry incubated for 30 mins prior to infection and measured after 48 hrs post infection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CNCc1ccc2c(c1)[C@H](NC(=O)C(=O)Nc1ccc(Cl)c(F)c1)[C@@H](CNC(=N)N)C2.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL4680075,ACS Med Chem Lett,2016.0,CHEMBL4755140,CHEMBL4802887,4.43,0.0,http://www.openphacts.org/units/Nanomolar,3518671.0,=,1.0,1.0,=,IC50,nM,37300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,37.3,CHEMBL378
5791,1954090.0,[],CHEMBL890376,Antiviral activity against HIV1 LAI assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(C(C)C)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL397934,CHEMBL397934,7.70,0.0,http://www.openphacts.org/units/Nanomolar,647184.0,=,1.0,1.0,=,IC50,nM,19.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.9,CHEMBL378
5792,317929.0,[],CHEMBL653791,Inhibition of HIV-1 mediated cytotoxicity in CEM (human leukemia) cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)O[C@H](CCC(C)C)[C@@H](C)[C@H]1CCC2C3C[C@H](OS(=O)(=O)[O-])C4C[C@@H](OS(=O)(=O)[O-])CC[C@]4(C)C3=CC[C@@]21C.[Na+].[Na+],CHEMBL1127706,J Med Chem,1994.0,CHEMBL436059,CHEMBL1207747,,0.0,http://www.openphacts.org/units/Nanomolar,327182.0,>,1.0,1.0,>,IC50,nM,150000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,150.0,CHEMBL378
5793,5132850.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2[nH]c(=O)c(CN(Cc3cccs3)C(=O)c3ccccc3)cc2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645070,CHEMBL1645070,,0.0,http://www.openphacts.org/units/Nanomolar,1321059.0,>,1.0,1.0,>,IC50,nM,12900.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,12.9,CHEMBL378
5794,18320109.0,[],CHEMBL4134181,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA level incubated for 3 days followed by medium replacement measured after 3 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)C1=C2CCCN2C(c2nccs2)=NC1c1nccs1,CHEMBL4130455,ACS Med Chem Lett,2017.0,CHEMBL4172873,CHEMBL4172873,,0.0,http://www.openphacts.org/units/Nanomolar,3041704.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.0,CHEMBL613497
5795,609111.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)cc(C)c1Oc1nc(N)nc(Nc2ccc(C#N)cc2)n1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL302791,CHEMBL302791,7.38,0.0,http://www.openphacts.org/units/Nanomolar,126912.0,=,1.0,1.0,=,IC50,nM,42.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.042,CHEMBL378
5796,1750607.0,[],CHEMBL866135,Antiviral activity against multi drug-resistant HIV1 B variant in human PHA-PBMC cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,CHEMBL1146019,J Med Chem,2006.0,CHEMBL584,CHEMBL584,,0.0,http://www.openphacts.org/units/Nanomolar,540001.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
5797,5293940.0,[],CHEMBL1697614,Antiviral activity against HIV-1 ADA infected in PHA-stimulated human PBMC cells assessed as viral p24 core protein level after 7 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C,CHEMBL1687698,ACS Med Chem Lett,2010.0,CHEMBL1688243,CHEMBL1688243,9.44,0.0,http://www.openphacts.org/units/Nanomolar,1336884.0,=,1.0,1.0,=,IC50,nM,0.36,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.36,CHEMBL378
5798,14658859.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)N2CCN(C(=O)c3ccc(Br)cc3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262886,CHEMBL3262886,7.10,0.0,http://www.openphacts.org/units/Nanomolar,2101728.0,=,1.0,1.0,=,IC50,nM,79.43,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,pIC50,,UO_0000065,7.1,CHEMBL3259471
5799,2149702.0,[],CHEMBL926964,Antiviral activity against HIV1 LAI in MT2 cells,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1C[C@@H]2CCO[C@@H]2C1)S(=O)(=O)c1ccc(CO)cc1,CHEMBL1147040,J Biol Chem,2007.0,CHEMBL254349,CHEMBL254349,8.85,0.0,http://www.openphacts.org/units/Nanomolar,707765.0,=,1.0,1.0,=,IC50,nM,1.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0014,CHEMBL378
5800,2464791.0,[],CHEMBL963691,Antiviral activity against HBV assessed as inhibition of viral e-antigen production by enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1cc2c(CN3CCOCC3)c(O)c(OC)cc2nc1CSc1ccc(F)c(F)c1,CHEMBL1157455,Bioorg Med Chem,2008.0,CHEMBL488643,CHEMBL488643,4.96,0.0,http://www.openphacts.org/units/Nanomolar,720572.0,=,1.0,1.0,=,IC50,nM,10900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,10.9,CHEMBL613497
5801,3498076.0,[],CHEMBL1259505,Antiviral activity against HIV1 MTA infected in human PM1 cells expressing CCR5 assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C(=O)N1CCC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC1,CHEMBL1255517,Bioorg Med Chem Lett,2010.0,CHEMBL1258729,CHEMBL1258729,,0.0,,963752.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5802,602237.0,[],CHEMBL691384,Inhibitory concentration for cytopathicity of HIV-1 (HTLV-IIIB) in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cc(C(O)(c2ccc(O)c(C(=O)O)c2)c2ccc(O)c(C(=O)O)c2)ccc1O,CHEMBL1125737,J Med Chem,1991.0,CHEMBL440154,CHEMBL440154,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,217787.0,>,1.0,1.0,>,IC50,ug.mL-1,100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,100.0,CHEMBL378
5803,1219732.0,[],CHEMBL710530,Inhibitory activity against 103N strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nccc(Nc3c(Cl)cc(Cl)cc3Cl)n2)cc1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72713,CHEMBL72713,8.52,0.0,http://www.openphacts.org/units/Nanomolar,127462.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
5804,1401946.0,[],CHEMBL837468,In vitro inhibitory concentration against HIV L100I mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCCNc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,CHEMBL1145200,J Med Chem,2005.0,CHEMBL424972,CHEMBL424972,,0.0,http://www.openphacts.org/units/Nanomolar,360389.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5805,14999554.0,[],CHEMBL3366531,Antiviral activity against HIV1 harboring reverse transcriptase L1001/K103N double mutant infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(CNc2nc(-c3ccccc3Cl)c(Cc3ccccc3)s2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3330438,CHEMBL3330438,5.29,0.0,http://www.openphacts.org/units/Nanomolar,2248824.0,=,1.0,1.0,=,IC50,nM,5110.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.11,CHEMBL378
5806,10961212.0,[],CHEMBL2061270,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M5 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNC1CCC1)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058325,CHEMBL2058325,7.48,0.0,http://www.openphacts.org/units/Nanomolar,1656265.0,=,1.0,1.0,=,IC50,nM,33.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,33.0,CHEMBL378
5807,125129.0,[],CHEMBL692689,Inhibition of HCV NS5B polymerase,B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(S(=O)(=O)Nc2cc(-c3ccccc3)sc2C(=O)O)c(C)cc1Cl,CHEMBL1148275,Bioorg Med Chem Lett,2004.0,CHEMBL165038,CHEMBL165038,5.27,0.0,http://www.openphacts.org/units/Nanomolar,326853.0,=,1.0,1.0,=,IC50,nM,5400.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,5.4,CHEMBL4620
5808,18812954.0,[],CHEMBL4276408,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL4270667,J Med Chem,2018.0,CHEMBL116,CHEMBL116,6.37,0.0,http://www.openphacts.org/units/Nanomolar,3125925.0,=,1.0,1.0,=,IC50,nM,431.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,431.0,CHEMBL378
5809,24868601.0,[],CHEMBL5152424,Antiviral activity against HBV infected HepG2 cells assessed as reduction in HBsAg level,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(C(=O)NCC(=O)N/N=C/c2ccccc2OCc2ccccc2Cl)cc1,CHEMBL5150016,J Med Chem,2022.0,CHEMBL4563053,CHEMBL4563053,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,3886077.0,=,1.0,1.0,=,IC50,ug.mL-1,0.00395,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ng/ml,UO_0000274,3.95,CHEMBL613497
5810,13475414.0,[],CHEMBL2439741,Antiviral activity against Human immunodeficiency virus 1 R5 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435891,CHEMBL2435891,6.46,0.0,http://www.openphacts.org/units/Nanomolar,1924267.0,=,1.0,1.0,=,IC50,nM,347.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,347.9,CHEMBL378
5811,13475457.0,[],CHEMBL2439745,Antiviral activity against Human immunodeficiency virus 1 clade A isolate UG273 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc(Sc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2434978,CHEMBL2434978,7.11,0.0,http://www.openphacts.org/units/Nanomolar,1924232.0,=,1.0,1.0,=,IC50,nM,78.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,78.0,CHEMBL378
5812,2947374.0,[],CHEMBL1038495,Antiviral activity against HBV assessed as inhibition of viral surface antigen secretion,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](C[C@H](OC(=O)c1ccccc1)[C@@H](OC(=O)c1ccccc1)C(C)(C)OC(=O)c1ccccc1)C1=C2C[C@H](OC(=O)c3ccccc3)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,CHEMBL1154649,Bioorg Med Chem Lett,2009.0,CHEMBL584379,CHEMBL584379,,0.0,http://www.openphacts.org/units/Nanomolar,850751.0,>,1.0,1.0,>,IC50,nM,1400000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,mM,UO_0000065,1.4,CHEMBL613497
5813,2635008.0,[],CHEMBL1000603,Antiviral activity against HIV1 LAI in human MT2 cells by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc(S(=O)(=O)N(C[C@H]2CCC(=O)N2)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2C[C@@H]3CCO[C@@H]3C2)cc1,CHEMBL1136990,J Med Chem,2009.0,CHEMBL453255,CHEMBL453255,9.22,0.0,http://www.openphacts.org/units/Nanomolar,785238.0,=,1.0,1.0,=,IC50,nM,0.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.6,CHEMBL378
5814,3276414.0,[],CHEMBL1104905,Antiviral activity against HBV infected in HepG2(2.2.15) cells assessed as inhibition of viral surface antigen secretion after 8 days by radio immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,CHEMBL1157863,Eur J Med Chem,2010.0,CHEMBL141,CHEMBL141,,0.0,,912591.0,,1.0,0.0,,IC50,,,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,,,,CHEMBL613497
5815,22898319.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731094,Antiviral activity against HIV1 DRVR P51 infected in human MT4 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL1323,CHEMBL1323,,0.0,http://www.openphacts.org/units/Nanomolar,3554418.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
5816,14714295.0,[],CHEMBL3293255,Antiviral activity against HIV1 harboring reverse transcriptase K103N/Y181C mutant infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,CHEMBL3286160,Eur J Med Chem,2014.0,CHEMBL223228,CHEMBL223228,6.80,0.0,http://www.openphacts.org/units/Nanomolar,2116142.0,=,1.0,1.0,=,IC50,nM,160.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.16,CHEMBL378
5817,18775495.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CCOc1cc2c(cc1OC)-c1cc(=O)c(C(=O)O)cn1C(CC)C2,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4280179,CHEMBL4280179,7.37,0.0,http://www.openphacts.org/units/Nanomolar,3119653.0,=,1.0,1.0,=,IC50,nM,43.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.043,CHEMBL613497
5818,18044680.0,[],CHEMBL4010433,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype A Q259env.w6,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.44,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,360.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.36,CHEMBL378
5819,14658828.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,O=C(COc1ccc(Br)cc1)N1CCN(C(=O)Cc2ccccc2)CC1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262877,CHEMBL3262877,7.00,0.0,http://www.openphacts.org/units/Nanomolar,2101719.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,IC50,nM,UO_0000065,100.0,CHEMBL3259471
5820,307539.0,[],CHEMBL653791,Inhibition of HIV-1 mediated cytotoxicity in CEM (human leukemia) cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CCC[C@@H](COS(=O)(=O)[O-])[C@H]1CC[C@H]2[C@@H]3CCC4[C@H](O)[C@H](OS(=O)(=O)[O-])CC[C@]4(C)[C@H]3[C@@H](O)[C@@H](O)[C@]12C.[Na+].[Na+],CHEMBL1127706,J Med Chem,1994.0,CHEMBL3138297,CHEMBL3138475,,0.0,http://www.openphacts.org/units/Nanomolar,327190.0,>,1.0,1.0,>,IC50,nM,152000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,152.0,CHEMBL378
5821,15166168.0,[],CHEMBL3404736,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as decrease in viral DNA replication treated for 7 days by real time PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(O[C@@H]2O[C@H](COC(=O)c3cccs3)[C@@H](O)[C@H](O)[C@H]2O)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402793,CHEMBL3402793,4.50,0.0,http://www.openphacts.org/units/Nanomolar,2284149.0,=,1.0,1.0,=,IC50,nM,31400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,31.4,CHEMBL613497
5822,18509594.0,[],CHEMBL4191606,Antiviral activity against NRTI-resistant HIV1 isolate 1617-1 infected in PHA-stimulated human PBMC assessed as reduction in p24 level after 7 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL4190218,J Nat Prod,2017.0,CHEMBL129,CHEMBL129,5.46,0.0,http://www.openphacts.org/units/Nanomolar,3073113.0,=,1.0,1.0,=,IC50,nM,3508.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3508.0,CHEMBL378
5823,18849448.0,[],CHEMBL4305534,Inhibition of recombinant N-terminal His-tagged human FER (SH2 domain to C-terminal) expressed in Escherichia coli assessed as decrease in FL-Peptide22 substrate phosphorylation incubated for 90 mins,B,BAO_0000190,BAO_0000019,assay format,Cc1cccc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)c(C#N)c3cn[nH]c(=O)c23)c1,CHEMBL4304751,ACS Med Chem Lett,2019.0,CHEMBL4461851,CHEMBL4461851,9.31,0.0,http://www.openphacts.org/units/Nanomolar,3145974.0,=,1.0,1.0,=,IC50,nM,0.49,CHEMBL3982,Homo sapiens,Tyrosine-protein kinase FER,9606,IC50,nM,UO_0000065,0.49,CHEMBL3982
5824,22845201.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL4721666,Antiviral activity against pseudovirus HIV-1 HXB-2 subtype C harboring pseudotyped Env ZM53M.PB12 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)c(F)c2)[nH]1)c1nc(CO)cs1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4533529,CHEMBL4533529,6.77,0.0,http://www.openphacts.org/units/Nanomolar,3547069.0,=,1.0,1.0,=,IC50,nM,170.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.17,CHEMBL378
5825,10961101.0,[],CHEMBL2061265,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M8 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2c(c1)C(=CNCC1CCCCC1)C(=O)N2,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL2058321,CHEMBL2058321,7.57,0.0,http://www.openphacts.org/units/Nanomolar,1656261.0,=,1.0,1.0,=,IC50,nM,27.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,27.0,CHEMBL378
5826,1502776.0,[],CHEMBL834971,Inhibitory concentration against hepatitis C virus NS3 protease (IC50 spans 2.5 log units),B,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H](C(=O)N[C@H](C(=O)C1C[C@H](O)C[C@H]1C(=O)CC1(C(=O)O)CC1)C(C)C)C1CCCCC1,CHEMBL1143583,J Med Chem,2005.0,CHEMBL370975,CHEMBL370975,,0.0,http://www.openphacts.org/units/Nanomolar,389089.0,<,1.0,1.0,>,IC50,nM,1000000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,Log 1/IC50,,UO_0000065,3.0,CHEMBL4620
5827,1402027.0,[],CHEMBL834488,In vitro inhibitory concentration against HIV L100I and K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCCCCO)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL176107,CHEMBL176107,,0.0,http://www.openphacts.org/units/Nanomolar,360364.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5828,15606363.0,[],CHEMBL3579358,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C=C/C(=O)O/N=C/c2cccs2)cc1OC,CHEMBL3576819,Eur J Med Chem,2015.0,CHEMBL3577787,CHEMBL3577787,,0.0,http://www.openphacts.org/units/Nanomolar,2480526.0,=,1.0,1.0,=,IC50,nM,228670.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,228.67,CHEMBL613497
5829,1470560.0,[],CHEMBL826114,Inhibitory activity against HIV-1 mutant strain 138K,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL338047,CHEMBL338047,,0.0,http://www.openphacts.org/units/Nanomolar,380766.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5830,5294485.0,[],CHEMBL1697288,"Antiviral activity against LPV, APV, ATV, IDV, NFV, RTV, SQV-resistant HIV-1 52-52 infected in human PBMC assessed as inhibition of viral replication by ELISA",F,BAO_0000190,BAO_0000218,organism-based format,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(CC)[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,CHEMBL1687706,Antimicrob Agents Chemother,2008.0,CHEMBL1651956,CHEMBL1651956,5.51,0.0,http://www.openphacts.org/units/Nanomolar,1337219.0,=,1.0,1.0,=,IC50,nM,3120.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.12,CHEMBL378
5831,625366.0,[],CHEMBL710531,Inhibitory activity against 181C strain of HIV-I in MT-4 cell was determined,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nc(N)nc(Cc3c(Cl)cc(Cl)cc3Cl)n2)cc1,CHEMBL1133922,Bioorg Med Chem Lett,2001.0,CHEMBL71684,CHEMBL71684,8.21,0.0,http://www.openphacts.org/units/Nanomolar,126947.0,=,1.0,1.0,=,IC50,nM,6.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0062,CHEMBL378
5832,1258339.0,[],CHEMBL683624,In vitro integration activity provided by preintegration complexes isolated from HIV-infected cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(cc1O)C1(CC2(C)C)CC(C)(C)c2cc(C)c(O)cc21,CHEMBL1133186,J Med Chem,2000.0,CHEMBL62609,CHEMBL62609,4.10,0.0,http://www.openphacts.org/units/Nanomolar,108741.0,=,1.0,1.0,=,IC50,nM,80000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,80.0,CHEMBL378
5833,18469012.0,[],CHEMBL4182244,Antiviral activity against HIV-1 3B infected in human TZM-bl cells treated for 2 hrs followed by compound washout measured after 2 days by luciferase reporter assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@@H](Cc1c[nH]c4ccccc14)C(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/N[C@@H](Cc1c[nH]c3ccccc13)C(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+],CHEMBL4177704,Bioorg Med Chem Lett,2018.0,CHEMBL1949746,CHEMBL1963094,5.04,0.0,http://www.openphacts.org/units/Nanomolar,3065412.0,=,1.0,1.0,=,IC50,nM,9060.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,umol/L,UO_0000065,9.06,CHEMBL378
5834,12108667.0,[],CHEMBL2173498,Antiviral activity against HIV1 harboring reverse transcriptase Y188L mutant,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1Br,CHEMBL2169791,J Med Chem,2012.0,CHEMBL439757,CHEMBL439757,8.23,0.0,http://www.openphacts.org/units/Nanomolar,1740559.0,=,1.0,1.0,=,IC50,nM,5.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.9,CHEMBL378
5835,1751359.0,[],CHEMBL854522,Antiviral activity against Measles virus variant in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccc2oc(Cc3ccccc3)nc2c1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL214087,CHEMBL214087,,0.0,http://www.openphacts.org/units/Nanomolar,532783.0,>,1.0,1.0,>,IC50,nM,150000.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,150.0,CHEMBL613738
5836,13861061.0,[],CHEMBL3101351,Antiviral activity against HIV1 NL4.3 infected in human TZM-bl cells expressing CXCR4-tropic incubated for 1 hr prior to infection measured after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)=CCCC1=CCc2ccc(O)c(O)c2C1,CHEMBL3098125,Bioorg Med Chem Lett,2014.0,CHEMBL3099064,CHEMBL3099064,4.91,0.0,http://www.openphacts.org/units/Nanomolar,1956067.0,=,1.0,1.0,=,IC50,nM,12302.69,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,4.91,CHEMBL378
5837,19261842.0,[],CHEMBL4404362,Antiviral activity against HIV1 subtypeA BG505-T332N,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.91,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,124.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.124,CHEMBL378
5838,18775468.0,[],CHEMBL4269007,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in HBsAg secretion after 10 mins by chemiluminescence immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)-c1cc(=O)c(C(=O)O)cn1C(C)C2,CHEMBL4265974,J Med Chem,2018.0,CHEMBL4283241,CHEMBL4283241,6.30,0.0,http://www.openphacts.org/units/Nanomolar,3119626.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.5,CHEMBL613497
5839,2930231.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Oc2c(CO)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL565712,CHEMBL565712,6.80,0.0,http://www.openphacts.org/units/Nanomolar,852941.0,=,1.0,1.0,=,IC50,nM,158.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,158.0,CHEMBL378
5840,14596846.0,[],CHEMBL3243451,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection from cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Sc2c(C)c(=O)[nH]c(=O)n2COCCO)cc1,CHEMBL3232777,Eur J Med Chem,2014.0,CHEMBL16686,CHEMBL16686,5.44,0.0,http://www.openphacts.org/units/Nanomolar,2082366.0,=,1.0,1.0,=,IC50,nM,3660.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.66,CHEMBL378
5841,24731867.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5115940,Antiviral activity against ZIKV-SMGC-1 infected in human BHK cells incubated for 7 days by CellTiter 96 luminescent cell viability assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)CCn1nnnc1Sc1c(Cl)cc(C(=O)c2ccc(C(F)(F)F)cc2O)n1-c1c(C(=O)c2ccc(C(F)(F)F)cc2O)[nH]c(Cl)c1Cl,CHEMBL5113415,Eur J Med Chem,2022.0,CHEMBL5177070,CHEMBL5177070,5.77,0.0,http://www.openphacts.org/units/Nanomolar,3857943.0,=,1.0,1.0,=,IC50,nM,1690.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,1.69,CHEMBL4296612
5842,2516311.0,[],CHEMBL975243,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(Cc2cccc(Br)c2)nc(SCc2ccc(OC)cc2)[nH]c1=O,CHEMBL1138559,Eur J Med Chem,2009.0,CHEMBL474588,CHEMBL474588,6.55,0.0,http://www.openphacts.org/units/Nanomolar,733101.0,=,1.0,1.0,=,IC50,nM,280.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.28,CHEMBL378
5843,24823621.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '144.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '6.0'}]",CHEMBL5140688,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as reduction in intracellular core HBV DNA level incubated for 6 days by qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OCC1COc3cc(F)ccc3O1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc1-2,CHEMBL5137052,Eur J Med Chem,2022.0,CHEMBL5205341,CHEMBL5205341,7.81,0.0,http://www.openphacts.org/units/Nanomolar,3876719.0,=,1.0,1.0,=,IC50,nM,15.5,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.0155,CHEMBL613497
5844,42381.0,[],CHEMBL695518,Antiviral activity against P236L strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL593,CHEMBL593,5.80,0.0,http://www.openphacts.org/units/Nanomolar,20822.0,=,1.0,1.0,=,IC50,nM,1600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1600.0,CHEMBL378
5845,24868600.0,[],CHEMBL5152424,Antiviral activity against HBV infected HepG2 cells assessed as reduction in HBsAg level,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)OC(=O)N1CCN(CC(=O)NCc2cccc(CNS(=O)(=O)c3ccc(C(F)(F)F)cc3)c2)CC1,CHEMBL5150016,J Med Chem,2022.0,CHEMBL5189020,CHEMBL5189020,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,3886076.0,=,1.0,1.0,=,IC50,ug.mL-1,0.00324,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ng/ml,UO_0000274,3.24,CHEMBL613497
5846,10981182.0,[],CHEMBL2065764,Antiviral activity against Human immunodeficiency virus 1 infected in human 293T cells assessed as inhibition of viral replication after 48 hrs by luminescence analysis,F,BAO_0000190,BAO_0000218,organism-based format,CCN(CC)CC.O=C(O)c1[nH]c2ccc(Cl)cc2c1C1(c2ccccc2)CC1,CHEMBL2062389,ACS Med Chem Lett,2012.0,CHEMBL2063261,CHEMBL2079248,4.54,0.0,http://www.openphacts.org/units/Nanomolar,1659041.0,=,1.0,1.0,=,IC50,nM,28500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,28.5,CHEMBL378
5847,42379.0,[],CHEMBL695509,Antiviral activity against G190A strain of HIV-1,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,CHEMBL1148482,J Med Chem,2004.0,CHEMBL593,CHEMBL593,7.46,0.0,http://www.openphacts.org/units/Nanomolar,20822.0,=,1.0,1.0,=,IC50,nM,35.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,35.0,CHEMBL378
5848,1234156.0,[],CHEMBL824446,Concentration required to inhibit Sindbis induced cytopathicity in Vero cells by 50%,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCSCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N(CC)CCCCCCCCCCC(=O)NC(CCC(=O)[O-])C(=O)O.[Na+],CHEMBL1130289,J Med Chem,1997.0,CHEMBL1627028,CHEMBL1206127,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,221530.0,>,1.0,1.0,>,IC50,ug.mL-1,10.0,CHEMBL613725,Sindbis virus,Sindbis virus,11034,IC50,ug ml-1,UO_0000274,10.0,CHEMBL613725
5849,1438425.0,[],CHEMBL834620,Inhibitory activity against HIV-1 mutant strain 188L; ND = not determined,F,BAO_0000190,BAO_0000218,organism-based format,CC/C=C/c1cccc(C(=O)c2c(CC)c(C)nc(O)c2N(C)C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL185445,CHEMBL185445,,0.0,http://www.openphacts.org/units/Nanomolar,371598.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5850,15568232.0,[],CHEMBL3561999,PubChem BioAssay. SAR confirmation of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assa.   (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,O=C(/C=C/c1ccc(F)cc1)N1CCN(S(=O)(=O)c2ccc(F)cc2)CC1,CHEMBL1201862,,,CHEMBL3560941,CHEMBL3560941,7.73,0.0,http://www.openphacts.org/units/Nanomolar,2475799.0,=,7.0,1.0,=,IC50,nM,18.5,CHEMBL3259470,Homo sapiens,G-protein coupled receptor 183,9606,IC50,uM,UO_0000065,0.0185,CHEMBL3259470
5851,15156716.0,[],CHEMBL3399640,Decrease in hepatitis B viral surface antigen HBsAg secretion in human HepG2(2.2.15) cells at 0.75 to 3 uM after 72 hrs by EIA analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(C)=O)c(OS(=O)(=O)c2ccc(F)cc2)c1,CHEMBL3397002,Eur J Med Chem,2015.0,CHEMBL3397408,CHEMBL3397408,5.30,0.0,http://www.openphacts.org/units/Nanomolar,2279255.0,=,1.0,1.0,=,IC50,nM,5050.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,5.05,CHEMBL613497
5852,22806661.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@@H](Sc3ccc(CN4CCN(C)CC4)cc3)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4793793,CHEMBL4793793,5.81,0.0,http://www.openphacts.org/units/Nanomolar,3541897.0,=,1.0,1.0,=,IC50,nM,1541.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.541,CHEMBL613497
5853,3292028.0,[],CHEMBL1108227,Antiviral activity against HIV1 NL4-3 infected in human JC53-BL cells assessed as luciferase activity after 3 days post infection,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(F)cc(C)c1C(=O)N1C[C@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@H]2C1,CHEMBL1157775,Bioorg Med Chem Lett,2010.0,CHEMBL1097815,CHEMBL1097815,8.52,0.0,http://www.openphacts.org/units/Nanomolar,910860.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,3.0,CHEMBL378
5854,16498291.0,[],CHEMBL3777089,Antiviral activity against HIV1 dual CXCR4/CCR5-tropic strain 89.6 infected in human 293T cells after 48 hrs by neutralization assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)c1ccc(-c2csc(N3N=C(c4ccccc4)/C(=N/Nc4ccc5c(S(=O)(=O)O)cc(S(=O)(=O)O)cc5c4)C3=O)n2)cc1,CHEMBL3774382,Bioorg Med Chem,2016.0,CHEMBL3775330,CHEMBL3775330,5.42,0.0,http://www.openphacts.org/units/Nanomolar,2762412.0,=,1.0,1.0,=,IC50,nM,3800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.8,CHEMBL378
5855,1147606.0,[],CHEMBL818227,Cytotoxicity was determined in the vero cells infected with HIV-I,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(Cl)c2ncn([C@H]3CS[C@H](CO)O3)c2n1,CHEMBL1126808,J Med Chem,1993.0,CHEMBL294695,CHEMBL294695,,0.0,http://www.openphacts.org/units/Nanomolar,100975.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5856,10860668.0,[],CHEMBL2020780,Antiviral against R5 tropic HIV1 Bal infected in human CEMx174 5.25M7 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(C(F)(F)F)cc3)CC2)c2ccc(C)c(Cl)c2)CC1,CHEMBL2016501,Bioorg Med Chem Lett,2012.0,CHEMBL2017378,CHEMBL2017378,8.73,0.0,http://www.openphacts.org/units/Nanomolar,1634935.0,=,1.0,1.0,=,IC50,nM,1.85,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1.85,CHEMBL378
5857,22752437.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '216.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '9.0'}]",CHEMBL4700093,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15.7 assessed as reduction in HBV DNA level incubated for 9 days media replaced every 3 days once with test compound by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,C=C1[C@@H](n2cc(Cl)c3c(N)ncnc32)[C@H](O)[C@H](O)[C@@]1(C)CO,CHEMBL4699415,RSC Med Chem,2020.0,CHEMBL4793004,CHEMBL4793004,4.64,0.0,http://www.openphacts.org/units/Nanomolar,3531379.0,=,1.0,1.0,=,IC50,nM,22900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,22.9,CHEMBL613497
5858,5247011.0,[],CHEMBL1687411,Antiviral activity against HIV1 Ba-L infected in human PBL cells assessed as reverse transcriptase activity after 7 days,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2nc(C)n([C@H]3C[C@H]4CC[C@@H](C3)N4CCC(CNS(=O)(=O)c3ccccc3)c3ccccc3)c2C1,CHEMBL1681652,Bioorg Med Chem Lett,2011.0,CHEMBL3084347,CHEMBL3084347,9.00,0.0,http://www.openphacts.org/units/Nanomolar,1333574.0,=,1.0,1.0,=,IC50,nM,1.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.001,CHEMBL378
5859,19243750.0,[],CHEMBL4400278,Antiviral activity against Zika virus infected in human A549 cells assessed as reduction in viral titer incubated for 48 hrs by plaque assay,F,BAO_0000190,BAO_0000218,organism-based format,C#CCSc1nsc(NC(=S)Nc2ccc(Br)cc2)n1,CHEMBL4396960,Bioorg Med Chem Lett,2019.0,CHEMBL4573163,CHEMBL4573163,6.15,0.0,http://www.openphacts.org/units/Nanomolar,3212377.0,=,1.0,1.0,=,IC50,nM,706.3,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,nM,UO_0000065,706.3,CHEMBL4296612
5860,2601803.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Nc1nc(O)c2ncn([C@H]3C=C(F)[C@H](CO)O3)c2n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL472673,CHEMBL472673,4.00,0.0,http://www.openphacts.org/units/Nanomolar,808129.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5861,1401641.0,[],CHEMBL837467,In vitro inhibitory concentration against HIV K103N mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Cc2c(CC(C)C)c(C)[nH]c(=O)c2N(C)C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177978,CHEMBL177978,7.20,0.0,http://www.openphacts.org/units/Nanomolar,360341.0,=,1.0,1.0,=,IC50,nM,63.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.063,CHEMBL378
5862,1403547.0,[],CHEMBL834756,Inhibitory concentration against 103N mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Oc2nc(Nc3ccc(Cl)cc3)c(=O)n(C)c2C)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL178054,CHEMBL178054,5.40,0.0,http://www.openphacts.org/units/Nanomolar,360703.0,=,1.0,1.0,=,IC50,nM,3981.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.981,CHEMBL378
5863,18202859.0,[],CHEMBL4043728,Antiviral activity against wild type HIV-1 NL4-3 infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(C#N)cc3)cs2)C(c2ccc(Br)nc2)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4101094,CHEMBL4101094,6.30,0.0,http://www.openphacts.org/units/Nanomolar,3019987.0,=,1.0,1.0,=,IC50,nM,500.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.5,CHEMBL378
5864,5132823.0,[],CHEMBL1646260,Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc2[nH]c(=O)c(CN(Cc3ccc(Cl)cc3)C(=O)c3cn4cccc(C)c4n3)cc2c1,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645063,CHEMBL1645063,5.03,0.0,http://www.openphacts.org/units/Nanomolar,1321051.0,=,1.0,1.0,=,IC50,nM,9270.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,9.27,CHEMBL378
5865,309418.0,[],CHEMBL697276,In vitro inhibition of HIV-1 plaque formation,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCCCC(=O)NCC(COP(=O)([O-])OCC[N+](C)(C)C)OCC,CHEMBL1125666,J Med Chem,1991.0,CHEMBL416753,CHEMBL416753,6.80,0.0,http://www.openphacts.org/units/Nanomolar,43735.0,=,1.0,1.0,=,IC50,nM,160.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.16,CHEMBL378
5866,13464671.0,[],CHEMBL2432161,Antiviral activity against HIV-1 infected in human MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1c(N)cccc1S(=O)(=O)c1cc(Cl)ccc1Cl,CHEMBL2429824,Med Chem Res,2013.0,CHEMBL301055,CHEMBL301055,6.52,0.0,http://www.openphacts.org/units/Nanomolar,1920721.0,=,1.0,1.0,=,IC50,nM,302.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,pIC50,,UO_0000065,6.52,CHEMBL378
5867,12627470.0,[],CHEMBL2317015,Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,C/C(=N\N1CCN(Cc2ccccc2Cl)CC1)c1ccc([N+](=O)[O-])cc1,CHEMBL2311445,Bioorg Med Chem,2013.0,CHEMBL2311906,CHEMBL2311906,,0.0,http://www.openphacts.org/units/Nanomolar,1841404.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5868,12529836.0,[],CHEMBL3078221,Antiviral activity against HIV1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(-[n+]2noc([O-])c2CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,CHEMBL3044741,Med Chem Res,2013.0,CHEMBL2282168,CHEMBL2282168,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824327.0,>,1.0,1.0,>,IC50,ug.mL-1,31.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,31.7,CHEMBL378
5869,2362920.0,[],CHEMBL1026417,"Antiviral activity against multidrug-resistant HIV1 with protease L10I, V11I, T12E, I15V, L19I, R41K, M46L, L63P, A71T, V82A, L90M mutation in phytohemagglutininin-activated PBMC assessed as inhibition of p24G protein production",F,BAO_0000190,BAO_0000218,organism-based format,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,CHEMBL1140100,J Med Chem,2008.0,CHEMBL163,CHEMBL163,,0.0,http://www.openphacts.org/units/Nanomolar,747153.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
5870,2149846.0,[],CHEMBL935682,Antiviral activity against HIV1 098-T1249 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL266465,CHEMBL266465,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708041.0,=,1.0,1.0,=,IC50,ug.mL-1,0.046,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.046,CHEMBL378
5871,18202569.0,[],CHEMBL4043720,Antiviral activity against HIV-1 Bal infected in human MAGI-CCR5 cells assessed as reduction in viral infection after 48 hrs by fluorescence based beta-galactosidase reporter gene assay,F,BAO_0000190,BAO_0000219,cell-based format,CC1=C(c2nc(-c3ccc(F)cc3)cs2)C(c2cccc(O)c2)NC(=O)N1,CHEMBL4043090,Bioorg Med Chem,2017.0,CHEMBL4064351,CHEMBL4064351,5.42,0.0,http://www.openphacts.org/units/Nanomolar,3019953.0,=,1.0,1.0,=,IC50,nM,3800.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.8,CHEMBL378
5872,10961207.0,[],CHEMBL2061269,Antiviral activity against Human immunodeficiency virus 1 HXB2 expressing protease M4 mutant infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,CHEMBL2057112,Bioorg Med Chem Lett,2012.0,CHEMBL1163,CHEMBL1163,6.22,0.0,http://www.openphacts.org/units/Nanomolar,1655449.0,=,1.0,1.0,=,IC50,nM,600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,600.0,CHEMBL378
5873,327904.0,[],CHEMBL653791,Inhibition of HIV-1 mediated cytotoxicity in CEM (human leukemia) cells.,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C1(CC[C@@H](C)[C@H]2CC[C@@]3(C)C4C[C@H](OS(=O)(=O)[O-])C5C[C@H](OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])C[C@]5(C)C4=CC[C@]23C)CC1C.[Na+].[Na+].[Na+],CHEMBL1127706,J Med Chem,1994.0,CHEMBL351513,CHEMBL1207126,,0.0,http://www.openphacts.org/units/Nanomolar,327169.0,>,1.0,1.0,>,IC50,nM,128000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,128.0,CHEMBL378
5874,19262048.0,[],CHEMBL4404437,Antiviral activity against multiple-PI-resistant HIV1 11804 infected in human TZM-bl cells preincubated for 30 min followed by viral infection and measured after 3 days by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4447583,CHEMBL4447583,6.58,0.0,http://www.openphacts.org/units/Nanomolar,3216259.0,=,1.0,1.0,=,IC50,nM,260.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.26,CHEMBL378
5875,11017277.0,[],CHEMBL2090660,Antiviral activity against NNTRI-resistant HIV1 A-17 clade B clinical isolate infected in PHA-stimulated human PBMC assessed as inhibition of viral replication incubated for 6 hrs followed by compound-wash out measured after 6 days by liquid scintillation counting,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCC(=O)OC[C@@H]1O[C@H](n2ccc(N)nc2=O)CS1,CHEMBL2086298,J Med Chem,2012.0,CHEMBL2087753,CHEMBL2087753,8.55,0.0,http://www.openphacts.org/units/Nanomolar,1674773.0,=,1.0,1.0,=,IC50,nM,2.8,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.8,CHEMBL378
5876,10911769.0,[],CHEMBL2038370,Antiviral activity against wild type HIV1 clade C 98USMSC5016 clinical isolate infected in PHA-P-stimulated human PBMC assessed as reverse transcriptase activity incubated for 6 hrs followed by incubated in drug-free medium for 6 days by multiround infection assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](F)[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL2034836,J Med Chem,2012.0,CHEMBL105318,CHEMBL105318,8.70,0.0,http://www.openphacts.org/units/Nanomolar,1644913.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.0,CHEMBL378
5877,5222679.0,[],CHEMBL1675428,Antiviral activity against HIV1 harboring reverse transcriptase M184V mutant infected in human HeLa P4/R5 cells assessed as inhibition of viral replication,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1671666,Antimicrob Agents Chemother,2009.0,CHEMBL129,CHEMBL129,6.75,0.0,http://www.openphacts.org/units/Nanomolar,1332027.0,=,1.0,1.0,=,IC50,nM,180.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.18,CHEMBL378
5878,16556888.0,[],CHEMBL3795205,Antiviral activity against CXCR4 using HIV-1 NL4.3 infected in human MT4 cells assessed as reduction of viral replication preincubated for 15 mins with cells followed by viral infection measured after 4 days by MTS/PES method,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(C(=O)c2ccc([N+](=O)[O-])cc2)CCCN(Cc2ccccc2)CCCN(S(=O)(=O)c2ccc(C)cc2)C1.Cl,CHEMBL3792300,J Med Chem,2016.0,CHEMBL3793982,CHEMBL3794647,,0.0,http://www.openphacts.org/units/Nanomolar,2770918.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
5879,3229741.0,[],CHEMBL1113200,Antiviral activity against recombinant HIV1 virus infected in human JC53BL cells after 3 days,F,BAO_0000190,BAO_0000218,organism-based format,CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ccnc3C)CC1)CC2,CHEMBL1154224,Bioorg Med Chem Lett,2009.0,CHEMBL1078936,CHEMBL1078936,8.40,0.0,http://www.openphacts.org/units/Nanomolar,898385.0,=,1.0,1.0,=,IC50,nM,4.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,4.0,CHEMBL378
5880,22898287.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4731089,Antiviral activity against HIV1 NL4-3 infected in human MT4 cells incubated for 7 days by fully automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,CHEMBL4725443,ACS Med Chem Lett,2020.0,CHEMBL729,CHEMBL729,7.57,0.0,http://www.openphacts.org/units/Nanomolar,3554416.0,=,1.0,1.0,=,IC50,nM,27.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,27.0,CHEMBL378
5881,16580173.0,[],CHEMBL3800939,Antiviral activity against HIV1 BAL infected in human TZM-bl cells assessed as inhibition of viral infection,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(Br)cc1/C=C/C(=O)c1c(O)cccc1OCc1ccccc1,CHEMBL3797057,Bioorg Med Chem,2016.0,CHEMBL2386680,CHEMBL2386680,5.33,0.0,http://www.openphacts.org/units/Nanomolar,2774360.0,=,1.0,1.0,=,IC50,nM,4700.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.7,CHEMBL378
5882,2602147.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,NC1C=CN(/C=C2/CC2(F)CO)C(=O)N1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL464972,CHEMBL464972,4.00,0.0,http://www.openphacts.org/units/Nanomolar,807309.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5883,14653342.0,[],CHEMBL3266817,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of hepatitis B surface antigen secretion by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CC[C@@H]2[C@](C)(COC(=O)c3cccnc3)[C@H](OC(=O)c3cccnc3)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,CHEMBL3259753,Bioorg Med Chem Lett,2014.0,CHEMBL2403199,CHEMBL2403199,,0.0,http://www.openphacts.org/units/Nanomolar,2101870.0,>,1.0,1.0,>,IC50,nM,1919000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1919.0,CHEMBL613497
5884,18202487.0,[],CHEMBL4043712,Antiviral activity against HIV1 LAI infected in human MT2 cells assessed as reduction in p24 Gag protein production incubated for 6 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cccc(C(=O)N3CSC[C@@H]3c3nc(C)cs3)c2)cc1,CHEMBL4043088,Bioorg Med Chem,2017.0,CHEMBL4091454,CHEMBL4091454,7.50,0.0,http://www.openphacts.org/units/Nanomolar,3019935.0,=,1.0,1.0,=,IC50,nM,32.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,32.0,CHEMBL378
5885,22806639.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@@H](Sc3cc(OC)cc(OC)c3)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4763468,CHEMBL4763468,6.93,0.0,http://www.openphacts.org/units/Nanomolar,3541919.0,=,1.0,1.0,=,IC50,nM,117.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.11699999999999999,CHEMBL613497
5886,2681574.0,[],CHEMBL1051710,Antiviral activity against HIV1 WITO4160.33 infected in human TZM-b1 cells assessed as inhibition of viral infection after 2 days postinfection by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCNC(C)=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1152462,Antimicrob Agents Chemother,2008.0,CHEMBL508943,CHEMBL508943,6.85,0.0,http://www.openphacts.org/units/Nanomolar,823861.0,=,1.0,1.0,=,IC50,nM,140.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.14,CHEMBL378
5887,2321213.0,[],CHEMBL1004248,Antiviral activity against HIV1 3B in human H9 cells after 4 days by p24 antigen ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC(=O)[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@]1(C)O,CHEMBL1150942,J Nat Prod,1998.0,CHEMBL461703,CHEMBL461703,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,787840.0,=,1.0,1.0,=,IC50,ug.mL-1,40.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,40.0,CHEMBL378
5888,2930377.0,[],CHEMBL1056887,Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)CC1CN(Cc2c(C)[nH]c(=O)c(I)c2Sc2cc(C)cc(C)c2)CCO1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL573720,CHEMBL573720,8.60,0.0,http://www.openphacts.org/units/Nanomolar,848369.0,=,1.0,1.0,=,IC50,nM,2.51,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,2.51,CHEMBL378
5889,6335945.0,[],CHEMBL1820049,Antiviral activity against wild type Human immunodeficiency virus 1 ERS104pre infected in PHA-stimulated human PBMC assessed as inhibition of p24 Gag protein production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL1817554,J Med Chem,2011.0,CHEMBL1323,CHEMBL1323,8.43,0.0,http://www.openphacts.org/units/Nanomolar,1451590.0,=,1.0,1.0,=,IC50,nM,3.7,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0037,CHEMBL378
5890,5126324.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,CN1c2ccc(Cl)cc2N(c2ccccc2)C(=O)c2cn(Cc3ccc(CN4CCOCC4)cc3)nc21,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642530,CHEMBL1642530,6.00,0.0,http://www.openphacts.org/units/Nanomolar,1317840.0,=,1.0,1.0,=,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.0,CHEMBL378
5891,1751342.0,[],CHEMBL854523,Antiviral activity against wild type Measles virus Edmonston in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Cc1ccccc1)Nc1cccc(O)c1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL211693,CHEMBL211693,4.60,0.0,http://www.openphacts.org/units/Nanomolar,532788.0,=,1.0,1.0,=,IC50,nM,25000.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,25.0,CHEMBL613738
5892,1402055.0,[],CHEMBL837462,In vitro inhibitory concentration against HIV E138K mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(NC(C)=O)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL129144,CHEMBL129144,,0.0,http://www.openphacts.org/units/Nanomolar,360368.0,=,1.0,0.0,=,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5893,18044734.0,[],CHEMBL4010430,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 pCAAN5342 clone A2,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.22,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,600.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.6,CHEMBL378
5894,2149818.0,[],CHEMBL935680,Antiviral activity against HIV1 098 isolate infected in human PBMCs by reverse transcriptase assay,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O,CHEMBL1147044,Proc Natl Acad Sci U S A,2007.0,CHEMBL440443,CHEMBL440443,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,708031.0,=,1.0,1.0,=,IC50,ug.mL-1,0.021,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,0.021,CHEMBL378
5895,6335927.0,[],CHEMBL1820053,"Antiviral activity against multidrug-resistant Human immunodeficiency virus 1 MDR/TM harboring protease L10I, K14R, R41K, M46L, I54V, L63P, A71V, V82A, L90M, I93L mutation infected in PHA-stimulated human PBMC assessed as inhibition of p24 Gag protein production",F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2C[C@@H]3[C@@H](O)CO[C@@H]3C2)cc1,CHEMBL1817554,J Med Chem,2011.0,CHEMBL1817686,CHEMBL1817686,8.51,0.0,http://www.openphacts.org/units/Nanomolar,1451706.0,=,1.0,1.0,=,IC50,nM,3.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.0031,CHEMBL378
5896,1439775.0,[],CHEMBL833931,Inhibitory activity against wild type HIV-1 LAI cell line,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1cccc(N(CC)CC)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL362586,CHEMBL362586,5.70,0.0,http://www.openphacts.org/units/Nanomolar,371452.0,=,1.0,1.0,=,IC50,nM,1990.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.99,CHEMBL378
5897,678757.0,[],CHEMBL697213,Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.,F,BAO_0000190,BAO_0000218,organism-based format,Oc1ccccc1/C=N\c1ccccc1SSc1ccccc1/N=C\c1ccccc1O,CHEMBL1129635,J Med Chem,1996.0,CHEMBL333202,CHEMBL333202,,0.0,,228634.0,=,1.0,0.0,=,IC50,,8.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,8.1,CHEMBL378
5898,12642490.0,[],CHEMBL2317525,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1CCCCN2C(=O)c3c(O)c(=O)c(C(=O)NCc4ccc(F)cc4)cn3CC12,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314674,CHEMBL2314674,8.19,0.0,http://www.openphacts.org/units/Nanomolar,1844806.0,=,1.0,1.0,=,IC50,nM,6.4,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.4,CHEMBL378
5899,2930185.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,COC1CCCN(Cc2c(C)[nH]c(=O)c(I)c2Oc2cc(C)cc(C)c2)C1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL578764,CHEMBL578764,8.20,0.0,http://www.openphacts.org/units/Nanomolar,852785.0,=,1.0,1.0,=,IC50,nM,6.3,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.3,CHEMBL378
5900,2929737.0,[],CHEMBL1056890,Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(CSCCc3cnccn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL574840,CHEMBL574840,7.50,0.0,http://www.openphacts.org/units/Nanomolar,848257.0,=,1.0,1.0,=,IC50,nM,31.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,31.6,CHEMBL378
5901,5126314.0,[],CHEMBL1646095,Antiviral activity against HIV1 assessed as inhibition of capsid assembly,F,BAO_0000190,BAO_0000218,organism-based format,COCCN/C=C1\C(=O)N(C)c2ccc(C(F)(F)F)cc2N(c2ccccc2)C1=O,CHEMBL1641406,Bioorg Med Chem Lett,2011.0,CHEMBL1642310,CHEMBL1642310,6.05,0.0,http://www.openphacts.org/units/Nanomolar,1317600.0,=,1.0,1.0,=,IC50,nM,890.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.89,CHEMBL378
5902,2099802.0,[],CHEMBL949221,Antiviral activity against HIV1 97-ZA-003 by viral entry assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CCCN(C(=O)Nc2ccc(C)cc2)c2cccc(F)c2)C1,CHEMBL1143192,Bioorg Med Chem Lett,2008.0,CHEMBL403954,CHEMBL403954,7.77,0.0,http://www.openphacts.org/units/Nanomolar,699410.0,=,1.0,1.0,=,IC50,nM,17.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.017,CHEMBL378
5903,15066686.0,[],CHEMBL3390094,Antiviral activity against HIV1 infected in HEK293T cells by p24 ELISA based phenotypic assay,F,BAO_0000190,BAO_0000218,organism-based format,NNC(=O)c1[nH]c2ccc(Cl)cc2c1C1(c2ccccc2)CC1,CHEMBL3352750,Bioorg Med Chem Lett,2014.0,CHEMBL3325514,CHEMBL3325514,5.36,0.0,http://www.openphacts.org/units/Nanomolar,2270410.0,=,1.0,1.0,=,IC50,nM,4400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,4.4,CHEMBL378
5904,18320079.0,[],CHEMBL4134181,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA level incubated for 3 days followed by medium replacement measured after 3 days by RT-PCR method,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)C1=C(C)NC(c2ncc(F)cc2F)=N[C@H]1c1ccc(F)cc1Cl,CHEMBL4130455,ACS Med Chem Lett,2017.0,CHEMBL605300,CHEMBL605300,7.12,0.0,http://www.openphacts.org/units/Nanomolar,3041674.0,=,1.0,1.0,=,IC50,nM,75.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.075,CHEMBL613497
5905,15200457.0,[],CHEMBL3413997,Antiviral activity against X4 tropic HIV-1 clone pNL4-3 infected in H9 cells assessed as reduction in p24 antigen after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CCCN(CCC)c1ccc(/C=C(\C#N)c2nc3ccccc3[nH]2)cc1,CHEMBL3407469,Eur J Med Chem,2015.0,CHEMBL3410118,CHEMBL3410118,5.96,0.0,http://www.openphacts.org/units/Nanomolar,2288848.0,=,1.0,1.0,=,IC50,nM,1090.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.09,CHEMBL378
5906,281747.0,[],CHEMBL756812,The compound was tested in vitro for inhibition of PIC (preintegrated complexes) from HIV-1 infected cells; Not Determined,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2c3c4cc(OC)c(O)cc4oc(=O)c3n3ccc4c(OC)c(OC)c(OC)cc4c23)cc1O,CHEMBL1132222,J Med Chem,1999.0,CHEMBL301410,CHEMBL301410,,0.0,http://www.openphacts.org/units/Nanomolar,96585.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5907,12203994.0,[],CHEMBL2211838,Antiviral activity against HIV-1 3B infected in MT4 cells assessed as inhibition of virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)C1=NN(C(N)=S)C(c3ccccc3Cl)C1C2,CHEMBL2203270,Bioorg Med Chem Lett,2012.0,CHEMBL1824326,CHEMBL1824326,,0.0,http://www.openphacts.org/units/Nanomolar,1758535.0,>,1.0,1.0,>,IC50,nM,6870.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,6.87,CHEMBL378
5908,1401678.0,[],CHEMBL833792,In vitro inhibitory concentration against HIV-1 Y181C mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cccc(C(=O)c2c(C)c(C)nc(O)c2N(C)C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL176207,CHEMBL176207,5.70,0.0,http://www.openphacts.org/units/Nanomolar,360265.0,=,1.0,1.0,=,IC50,nM,2000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.0,CHEMBL378
5909,3074423.0,[],CHEMBL1069925,Antiviral activity against HIV1 Ba-L(R5) infected in human PBMC by p24 antigen capture assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,CHEMBL1153238,Bioorg Med Chem Lett,2010.0,CHEMBL584,CHEMBL584,7.92,0.0,http://www.openphacts.org/units/Nanomolar,874053.0,=,1.0,1.0,=,IC50,nM,12.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,12.0,CHEMBL378
5910,691055.0,[],CHEMBL683678,Tested for cytoprotection against production of HIV-1 p24.,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1ccc(SSc2ccc(C(=O)O)cc2)cc1,CHEMBL1129635,J Med Chem,1996.0,CHEMBL120846,CHEMBL120846,,0.0,http://www.openphacts.org/units/Nanomolar,228646.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5911,16662893.0,[],CHEMBL3832828,AntiDengue activity HCI DV4/A549 IC50 (uM),F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1ccc(F)cc1NS(=O)(=O)c1cccc(-c2cnn(Cc3ccccc3)c2)c1,CHEMBL3832761,,,CHEMBL3637931,CHEMBL3637931,,0.0,http://www.openphacts.org/units/Nanomolar,2790167.0,>,34.0,1.0,>,IC50,nM,50000.0,CHEMBL613757,Dengue virus,Dengue virus,12637,IC50,uM,UO_0000065,50.0,CHEMBL613757
5912,2091742.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCCN(C(C)C)CCCN(S(=O)(=O)c2ccc(C)cc2)C1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL270525,CHEMBL270525,,0.0,http://www.openphacts.org/units/Nanomolar,700544.0,=,1.0,1.0,=,IC50,nM,95499258602143.69,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,4.98,CHEMBL378
5913,19407960.0,[],CHEMBL4426964,Antiviral activity against multi-drug resistant HIV1B harboring protease L10I/L33I/M36I/M46I/F53L/K55R/I62V/L63P/A71V/G73S/V82A/L90M/I93L mutant infected in human MT4 cells by p24 assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CHEMBL4425138,J Med Chem,2016.0,CHEMBL1323,CHEMBL1323,7.37,0.0,http://www.openphacts.org/units/Nanomolar,3243729.0,=,1.0,1.0,=,IC50,nM,43.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.043,CHEMBL378
5914,22983730.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '144.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '6.0'}]",CHEMBL4773497,Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of DNA replication supplemented with fresh medium containing compound every 2 days for 6 days by RT-PCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccccc1CSc1nc2ccc(OCCN(C)C)cc2c(=O)n1Cc1ccco1,CHEMBL4765418,Eur J Med Chem,2020.0,CHEMBL4778569,CHEMBL4778569,6.14,0.0,http://www.openphacts.org/units/Nanomolar,3569408.0,=,1.0,1.0,=,IC50,nM,720.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.72,CHEMBL613497
5915,2009854.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(C(=O)N1CCN(C(=O)c2ccccc2)CC1)c1c[nH]c2c(-n3ccnn3)ncc(F)c12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL236995,CHEMBL236995,,0.0,http://www.openphacts.org/units/Nanomolar,668059.0,<,1.0,1.0,<,IC50,nM,5.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.0,CHEMBL378
5916,8057969.0,[],CHEMBL1960698,Antiinfluenza activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C(=O)OCCCCCCCCN1CCN(C)CC1)[C@@H]1CC[C@H](C)[C@@H]2CC(=O)C(C)=C2C1,CHEMBL1955749,Bioorg Med Chem Lett,2012.0,CHEMBL1956537,CHEMBL1956537,,0.0,http://www.openphacts.org/units/Nanomolar,1580867.0,>,1.0,1.0,>,IC50,nM,26900.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,uM,UO_0000065,26.9,CHEMBL613129
5917,2602168.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(Cn2nnnc2/C(O)=C/C(=O)c2c[nH]c3ccccc23)cc1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL472878,CHEMBL472878,4.00,0.0,http://www.openphacts.org/units/Nanomolar,808046.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5918,1421803.0,[],CHEMBL824926,Inhibitory activity against human immunodeficiency virus type 1 (inactive>0.1),F,BAO_0000190,BAO_0000218,organism-based format,Cc1c(SC2CCCCC2)n(COCN)c(=O)[nH]c1=O,CHEMBL1144258,Bioorg Med Chem Lett,2005.0,CHEMBL181714,CHEMBL181714,,0.0,http://www.openphacts.org/units/Nanomolar,364829.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5919,13857147.0,[],CHEMBL3097947,Antiviral activity against enfuvirtide-resistant HIV-1 NL4-3 harboring gp41 (36G)N42T/N43K mutation infected in human MT2 cells assessed as inhibition of p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COC(=O)c1ccc(CN2C(=O)/C(=C/c3cc(C)n(-c4ccc(O)c(C(=O)O)c4)c3C)SC2=S)cc1,CHEMBL3091377,Bioorg Med Chem,2013.0,CHEMBL3092872,CHEMBL3092872,5.64,0.0,http://www.openphacts.org/units/Nanomolar,1952754.0,=,1.0,1.0,=,IC50,nM,2300.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,2.3,CHEMBL378
5920,1211889.0,[],CHEMBL710537,Inhibitory activity against 188L strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(Br)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL309456,CHEMBL309456,7.10,0.0,http://www.openphacts.org/units/Nanomolar,127435.0,=,1.0,1.0,=,IC50,nM,79.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.079,CHEMBL378
5921,15668304.0,[],CHEMBL3603050,Antiviral activity against HIV-1 HXB2 assessed as inhibition of viral infection in human TZM-bl cells after 18 hrs by steady-glo luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCCCCCCC(O)C(CO)NCNC(=O)[C@@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC,CHEMBL3600350,Medchemcomm,2014.0,CHEMBL3601730,CHEMBL3601730,6.54,0.0,http://www.openphacts.org/units/Nanomolar,2493293.0,=,1.0,1.0,=,IC50,nM,287.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,287.0,CHEMBL378
5922,2997337.0,[],CHEMBL1046975,Antiviral activity against HBV infected in human HepG2(2.2.15) cells assessed as inhibition of HBeAg level after 9 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(C(=O)c2ccc(=O)n(-c3ccc(Cl)cc3)c2)c(O)c1,CHEMBL1156796,J Med Chem,2010.0,CHEMBL576454,CHEMBL576454,5.80,0.0,http://www.openphacts.org/units/Nanomolar,856567.0,=,1.0,1.0,=,IC50,nM,1600.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1.6,CHEMBL613497
5923,1219731.0,[],CHEMBL710376,Inhibitory activity against 100I strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1ccc(Nc2nccc(Nc3c(Cl)cc(Cl)cc3Cl)n2)cc1,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72713,CHEMBL72713,7.85,0.0,http://www.openphacts.org/units/Nanomolar,127462.0,=,1.0,1.0,=,IC50,nM,14.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.014,CHEMBL378
5924,1471865.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1C(=O)c1ccc(OC)c(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL186129,CHEMBL186129,4.00,0.0,http://www.openphacts.org/units/Nanomolar,380838.0,=,1.0,1.0,=,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5925,15166111.0,[],CHEMBL3404734,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBeAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC(=O)c1ccc(OC(=O)c2ccccc2)cc1,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402777,CHEMBL3402777,,0.0,http://www.openphacts.org/units/Nanomolar,2284131.0,>,1.0,1.0,>,IC50,nM,3349700.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,3349.7,CHEMBL613497
5926,1740546.0,[],CHEMBL854478,Inhibition of HBV DNA replication,F,BAO_0000190,BAO_0000218,organism-based format,O=C1c2ccccc2C(=O)N1CCc1nc2cc(F)c(F)cc2n1S(=O)(=O)c1ccc(C(F)(F)F)cc1,CHEMBL1138932,J Med Chem,2006.0,CHEMBL378876,CHEMBL378876,5.50,0.0,http://www.openphacts.org/units/Nanomolar,520768.0,=,1.0,1.0,=,IC50,nM,3200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,3.2,CHEMBL613497
5927,10995191.0,[],CHEMBL2072873,Antiviral activity against VSV-G pseudotyped HIV1 lentiviral particles infected in human HeLa cells incubated for 48 hrs by spectrofluorometry,F,BAO_0000190,BAO_0000218,organism-based format,OCc1cccc(Nc2ccnc3cc(Cl)ccc23)c1,CHEMBL2069294,Bioorg Med Chem,2012.0,CHEMBL2071265,CHEMBL2071265,,0.0,,1663487.0,,1.0,0.0,,IC50,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,,,,CHEMBL378
5928,22933269.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)/C=C/c4ccc5c(c4)OCO5)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL3937852,CHEMBL3937852,7.72,0.0,http://www.openphacts.org/units/Nanomolar,3560830.0,=,1.0,1.0,=,IC50,nM,19.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.019,CHEMBL378
5929,19281747.0,[],CHEMBL4409363,Antiviral activity against HIV1 92/BR/018 infected in human TZM-bl cells incubated for 48 hrs by bright Glo-luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(-n2ncc3c(=O)[nH]c(C)cc32)c1,CHEMBL4406854,Eur J Med Chem,2019.0,CHEMBL4546070,CHEMBL4546070,5.13,0.0,http://www.openphacts.org/units/Nanomolar,3219931.0,=,1.0,1.0,=,IC50,nM,7420.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,7.42,CHEMBL378
5930,15165590.0,[],CHEMBL3404732,Antiviral activity against hepatitis B viral in human HepG2.2.15 cells assessed as surface antigen HBsAg secretion after 72 hrs by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(/C=C/C(=O)Oc2ccc(C(C)=O)cc2)cc1OC,CHEMBL3400016,Bioorg Med Chem Lett,2015.0,CHEMBL3402771,CHEMBL3402771,,0.0,http://www.openphacts.org/units/Nanomolar,2284125.0,=,1.0,1.0,=,IC50,nM,1037900.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,1037.9,CHEMBL613497
5931,2929526.0,[],CHEMBL1056897,Antiviral activity against HIV1 HXB2 harboring 190A mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3cnnn3)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL584409,CHEMBL584409,9.05,0.0,http://www.openphacts.org/units/Nanomolar,848312.0,=,1.0,1.0,=,IC50,nM,0.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,0.9,CHEMBL378
5932,482670.0,[],CHEMBL683684,In vitro inhibition of recombinant HIV-1 IIIB mutant Y181C,F,BAO_0000190,BAO_0000218,organism-based format,CCN(c1nc(F)ccc1NC(C)(C)C)C1CCN(C(=O)c2cc3cc(NC(=O)N4CCN(C)CC4)ccc3[nH]2)CC1,CHEMBL1129647,J Med Chem,1996.0,CHEMBL331912,CHEMBL331912,6.10,0.0,http://www.openphacts.org/units/Nanomolar,236810.0,=,1.0,1.0,=,IC50,nM,790.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.79,CHEMBL378
5933,7843569.0,[],CHEMBL1913153,Antiviral activity against HIV1 Ba-L infected in human PBL cells assessed as reduction of viral replication after 4 days by Steady-Glo luciferase assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(S(C)(=O)=O)cc2)ccc1CN1CCC(N2C(=O)N(c3cc(C(N)=O)c(F)cc3F)C[C@@H]2c2ccccc2)CC1,CHEMBL1909524,Bioorg Med Chem Lett,2011.0,CHEMBL1909868,CHEMBL1909868,6.54,0.0,http://www.openphacts.org/units/Nanomolar,1541997.0,=,1.0,1.0,=,IC50,nM,289.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,289.0,CHEMBL378
5934,18585143.0,[],CHEMBL4223279,Antiviral activity against Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBsAg secretion after 3 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Nc1ccn([C@H]2CS[C@@H](CO)O2)c(=O)n1,CHEMBL4219203,Bioorg Med Chem Lett,2018.0,CHEMBL18314,CHEMBL18314,,0.0,http://www.openphacts.org/units/Nanomolar,3086259.0,=,1.0,1.0,=,IC50,nM,917400.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,917.4,CHEMBL613497
5935,2929489.0,[],CHEMBL1056900,Antiviral activity against HIV1 HXB2 harboring 100I and K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL233664,CHEMBL233664,7.70,0.0,http://www.openphacts.org/units/Nanomolar,848384.0,=,1.0,1.0,=,IC50,nM,19.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.9,CHEMBL378
5936,1954170.0,[],CHEMBL891426,Antiviral activity against HIV1 RT 100I mutant assessed as inhibition of viral-induced cytopathicity in MT4 cells by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(I)c1Oc1cc(C)cc(C)c1,CHEMBL1146329,Bioorg Med Chem Lett,2007.0,CHEMBL233664,CHEMBL233664,8.20,0.0,http://www.openphacts.org/units/Nanomolar,647185.0,=,1.0,1.0,=,IC50,nM,6.31,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.31,CHEMBL378
5937,2930216.0,[],CHEMBL1056889,Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(Sc2c(Cn3nc(CC#N)nc3C)c(C)[nH]c(=O)c2I)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL575047,CHEMBL575047,7.60,0.0,http://www.openphacts.org/units/Nanomolar,848382.0,=,1.0,1.0,=,IC50,nM,25.11,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,25.11,CHEMBL378
5938,3084556.0,[],CHEMBL1065278,Antiviral activity against HIV1 KYAG primary isolate assessed as inhibition of virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(NC(=O)C(=O)Nc2ccc(F)cc2)CC(C)(C)N1,CHEMBL1153139,Bioorg Med Chem Lett,2010.0,CHEMBL595942,CHEMBL595942,,0.0,http://www.openphacts.org/units/Nanomolar,873917.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,100.0,CHEMBL378
5939,1401983.0,[],CHEMBL837462,In vitro inhibitory concentration against HIV E138K mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C(C)COC)c1Cc1cc(C)cc(C)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL177709,CHEMBL177709,7.77,0.0,http://www.openphacts.org/units/Nanomolar,360424.0,=,1.0,1.0,=,IC50,nM,17.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.017,CHEMBL378
5940,1402508.0,[],CHEMBL837468,In vitro inhibitory concentration against HIV L100I mutant strain,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)CCOC)c1Cc1cccc(/C=C/C#N)c1,CHEMBL1145200,J Med Chem,2005.0,CHEMBL426046,CHEMBL426046,8.10,0.0,http://www.openphacts.org/units/Nanomolar,360366.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
5941,1471417.0,[],CHEMBL833076,Inhibitory activity against HIV-1 mutant strain 103N,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)nc(O)c(N(C)C)c1Cc1cccc(C(F)(F)F)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL188995,CHEMBL188995,6.41,0.0,http://www.openphacts.org/units/Nanomolar,380836.0,=,1.0,1.0,=,IC50,nM,390.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.39,CHEMBL378
5942,5229808.0,[],CHEMBL1677602,Antiviral activity against of Human immunodeficiency virus 1 3B infected in AA5 cells infected with 0.78 uL of virus stock assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL1671682,Antimicrob Agents Chemother,2010.0,CHEMBL331237,CHEMBL331237,,0.0,http://www.openphacts.org/units/Nanomolar,1332123.0,<,1.0,1.0,<,IC50,nM,170.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.17,CHEMBL378
5943,3509129.0,[],CHEMBL1261037,Antiviral activity against wild type HIV1 infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect by replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3Cl)CC2)ncc1Br,CHEMBL1255200,Bioorg Med Chem Lett,2010.0,CHEMBL1171403,CHEMBL1171403,8.21,0.0,http://www.openphacts.org/units/Nanomolar,963717.0,=,1.0,1.0,=,IC50,nM,6.1,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,6.1,CHEMBL378
5944,1403342.0,[],CHEMBL837591,Inhibitory concentration against wild-type HIV-1 LAI Virus was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Oc2nc(Nc3ccc(C#N)cc3)c(=O)n(C)c2C)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL176383,CHEMBL176383,8.52,0.0,http://www.openphacts.org/units/Nanomolar,360753.0,=,1.0,1.0,=,IC50,nM,3.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.003,CHEMBL378
5945,2569053.0,[],CHEMBL972599,Antiviral activity against wild type HIV1 3B in human P4/R5 cells assessed as beta-galactosidase activity by single-cycle viral replication assay in presence of 10% FBS,F,BAO_0000190,BAO_0000218,organism-based format,CCN1C[C@H](C)n2c(c(O)c3c(=O)n(Cc4ccc(F)c(Cl)c4)ncc32)C1=O,CHEMBL1156547,Bioorg Med Chem Lett,2008.0,CHEMBL458717,CHEMBL458717,7.72,0.0,http://www.openphacts.org/units/Nanomolar,798718.0,=,1.0,1.0,=,IC50,nM,19.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,19.0,CHEMBL378
5946,15027162.0,[],CHEMBL3367171,Inhibition of AP-1-mediated transcriptional activation in human Jurkat cells by luciferase reporter gene assay,B,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cnc(F)nc1C(F)(F)F,CHEMBL3352097,J Med Chem,2014.0,CHEMBL131006,CHEMBL131006,7.00,0.0,http://www.openphacts.org/units/Nanomolar,2265156.0,=,1.0,1.0,=,IC50,nM,100.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,uM,UO_0000065,0.1,CHEMBL4977
5947,19159729.0,[],CHEMBL4382833,Inhibition of recombinant GST/His-tagged human FER catalytic domain expressed in baculovirus expression system by Z-LYTE assay,B,BAO_0000190,BAO_0000019,assay format,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C,CHEMBL4382192,Eur J Med Chem,2017.0,CHEMBL4473365,CHEMBL4473365,8.70,0.0,http://www.openphacts.org/units/Nanomolar,3197524.0,=,1.0,1.0,=,IC50,nM,2.0,CHEMBL3982,Homo sapiens,Tyrosine-protein kinase FER,9606,IC50,nM,UO_0000065,2.0,CHEMBL3982
5948,2030618.0,[],CHEMBL886374,Inhibition of cJun translocation in IL-1-beta-stimulated A549 cells,B,BAO_0000190,BAO_0000219,cell-based format,CNC(=O)CN1CCC[C@@H](Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)C1,CHEMBL1139954,Bioorg Med Chem Lett,2007.0,CHEMBL392615,CHEMBL392615,5.55,0.0,http://www.openphacts.org/units/Nanomolar,674110.0,=,1.0,1.0,=,IC50,nM,2807.0,CHEMBL4977,Homo sapiens,Proto-oncogene c-JUN,9606,IC50,nM,UO_0000065,2807.0,CHEMBL4977
5949,15200444.0,[],CHEMBL3413997,Antiviral activity against X4 tropic HIV-1 clone pNL4-3 infected in H9 cells assessed as reduction in p24 antigen after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(/C=C(\C#N)c2nc3ccccc3[nH]2)cc(OC)c1OC,CHEMBL3407469,Eur J Med Chem,2015.0,CHEMBL1933875,CHEMBL1933875,,0.0,http://www.openphacts.org/units/Nanomolar,2288861.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,50.0,CHEMBL378
5950,5139125.0,[],CHEMBL1648257,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication by semi-quantitative EIA,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)OC(=O)N1C[C@@H](O)[C@@H](O)[C@H](O)[C@H]1n1cnc2c(N)ncnc21,CHEMBL1641452,Bioorg Med Chem,2011.0,CHEMBL1645541,CHEMBL1645541,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321610.0,=,1.0,1.0,=,IC50,ug.mL-1,247.42,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,ug ml-1,UO_0000274,247.42,CHEMBL613497
5951,12642506.0,[],CHEMBL2317525,Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)C(=O)CN1CCn2cc(C(=O)NCc3ccc(F)cc3)c(=O)c(O)c2C1=O,CHEMBL2311388,J Med Chem,2013.0,CHEMBL2314678,CHEMBL2314678,7.58,0.0,http://www.openphacts.org/units/Nanomolar,1844810.0,=,1.0,1.0,=,IC50,nM,26.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,26.0,CHEMBL378
5952,18044746.0,[],CHEMBL4010404,Antiviral activity against ENV pseudotyped CCR5-tropic HIV1 subtype C ZM53M.PB12,F,BAO_0000190,BAO_0000019,assay format,NCC(NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4083672,CHEMBL4083672,6.19,0.0,http://www.openphacts.org/units/Nanomolar,2990215.0,=,1.0,1.0,=,IC50,nM,640.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.64,CHEMBL378
5953,821428.0,[],CHEMBL772932,Inhibition of Hepatitis C virus NS3 protease in vitro.,B,BAO_0000190,BAO_0000357,single protein format,CC(C)COC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(F)F)C(=O)NCCc1ccc(C(=O)O)cc1Cl)C(C)C,CHEMBL1147550,Bioorg Med Chem Lett,2004.0,CHEMBL68035,CHEMBL68035,5.62,0.0,http://www.openphacts.org/units/Nanomolar,119345.0,=,1.0,1.0,=,IC50,nM,2400.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,2.4,CHEMBL4620
5954,2091763.0,[],CHEMBL950071,Inhibition of HIV1 replication,F,BAO_0000190,BAO_0000218,organism-based format,N#Cc1cccc(S(=O)(=O)c2cccc(N)c2C#N)c1,CHEMBL1143212,Bioorg Med Chem,2008.0,CHEMBL299271,CHEMBL299271,,0.0,http://www.openphacts.org/units/Nanomolar,700523.0,=,1.0,1.0,=,IC50,nM,416869383470.34,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,Log IC50,,UO_0000065,2.62,CHEMBL378
5955,23228459.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '36.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '36.0'}]",CHEMBL4826198,Antiviral activity against Human hepatitis B virus in Huh-7 cells assessed as reduction in intracellular viral DNA level incubated for 36 hrs by qPCR analysis,F,BAO_0000190,BAO_0000218,organism-based format,COc1ncccc1C(=O)NCCNc1cc(Nc2ccc(F)cc2)nc([S+](C)[O-])n1,CHEMBL4825668,J Med Chem,2021.0,CHEMBL4858511,CHEMBL4858511,6.68,0.0,http://www.openphacts.org/units/Nanomolar,3613077.0,=,1.0,1.0,=,IC50,nM,210.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.21,CHEMBL613497
5956,6335899.0,[],CHEMBL1820048,Antiviral activity against Human immunodeficiency virus 1 LAI infected in human MT2 cells assessed as inhibition of p24 Gag protein production,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL1817554,J Med Chem,2011.0,CHEMBL116,CHEMBL116,7.52,0.0,http://www.openphacts.org/units/Nanomolar,1451587.0,=,1.0,1.0,=,IC50,nM,30.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.03,CHEMBL378
5957,24830971.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5142775,Antiviral activity against HBV infected in human HepDES19 cells assessed as reduction in HBV cccDNA production by measuring inhibition of HBeAg secretion incubated for 5 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(Cl)c2oc3cc(N4CCC(C(=O)O)C4)ccc3c(=O)c12,CHEMBL5137099,J Med Chem,2022.0,CHEMBL5206403,CHEMBL5206403,,0.0,http://www.openphacts.org/units/Nanomolar,3878144.0,>,1.0,1.0,>,IC50,nM,50000.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,50.0,CHEMBL613497
5958,19175390.0,[],CHEMBL4385901,Antiviral activity against Zika virus harboring subgenomic GFP replicon infected in African green monkey Vero cells assessed as reduction in viral infection preincubated for 30 mins followed by viral infection and measured after 72 hrs,F,BAO_0000190,BAO_0000218,organism-based format,c1c[nH]c(CNCc2cc(CNCc3ccc[nH]3)cc(-c3cc(CNCc4ccc[nH]4)cc(CNCc4ccc[nH]4)c3)c2)c1,CHEMBL4385601,J Med Chem,2019.0,CHEMBL4588298,CHEMBL4588298,6.44,0.0,http://www.openphacts.org/units/Nanomolar,3200392.0,=,1.0,1.0,=,IC50,nM,360.0,CHEMBL4296612,Zika virus,Zika virus,64320,IC50,uM,UO_0000065,0.36,CHEMBL4296612
5959,2929687.0,[],CHEMBL1056891,Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1154778,J Med Chem,2009.0,CHEMBL338047,CHEMBL338047,6.60,0.0,http://www.openphacts.org/units/Nanomolar,848385.0,=,1.0,1.0,=,IC50,nM,251.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,251.0,CHEMBL378
5960,13475569.0,[],CHEMBL2439259,Antiviral activity against Human immunodeficiency virus 1 clade B isolate SF162 infected in PHA-stimulated human PBMC after 10 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1,CHEMBL2434870,J Med Chem,2013.0,CHEMBL2435853,CHEMBL2435853,7.97,0.0,http://www.openphacts.org/units/Nanomolar,1924228.0,=,1.0,1.0,=,IC50,nM,10.6,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,10.6,CHEMBL378
5961,22806652.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '28.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '28.0'}]",CHEMBL4712709,Antiviral activity against HBV infected in human HepG2-NTCP cells assessed as reduction in HBeAg secretion cells inoculated with virus for 4 hrs at room temperature and 37 degree C for 24 hrs followed inoculum changed with PMM medium for every 2 days until day 5 post infection by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,CC[C@@H]1NC(=O)[C@H]([C@@H]2O[C@@H](Sc3cccc(OCc4ccccc4)c3)C[C@H]2C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,CHEMBL4706643,J Med Chem,2021.0,CHEMBL4781848,CHEMBL4781848,6.96,0.0,http://www.openphacts.org/units/Nanomolar,3541906.0,=,1.0,1.0,=,IC50,nM,110.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,0.11,CHEMBL613497
5962,252855.0,[],CHEMBL690480,In vitro antiviral activity against NNRTI-resistant DLVR-MF (P236L) HIV-1 variant,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](Sc1nc(N)cc(Cl)n1)c1cc2ccoc2cn1,CHEMBL1131332,J Med Chem,1998.0,CHEMBL280541,CHEMBL280541,8.10,0.0,http://www.openphacts.org/units/Nanomolar,41262.0,=,1.0,1.0,=,IC50,nM,8.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.008,CHEMBL378
5963,18044360.0,[],CHEMBL4010364,Antiviral activity against X4 tropic HIV1 HXB2 infected in human TZM-bl cells pretreated with virus for 30 mins followed by 3 days incubation with cells by luciferase reporter gene based single cycle infection assay,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(C(CN)NC(=O)c2ccc(-c3ccc(F)c(F)c3)[nH]2)sc1CO,CHEMBL4007461,J Med Chem,2017.0,CHEMBL4072066,CHEMBL4072066,5.47,0.0,http://www.openphacts.org/units/Nanomolar,2990177.0,=,1.0,1.0,=,IC50,nM,3400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,3.4,CHEMBL378
5964,1422385.0,[],CHEMBL837251,Antiviral activity in an in vitro HIV replication assay; ND means not determined,F,BAO_0000190,BAO_0000218,organism-based format,CN(C[C@@](C)(CCN1CCC2NCCC2C1)c1ccccc1)S(=O)(=O)c1ccccc1,CHEMBL1141903,Bioorg Med Chem Lett,2005.0,CHEMBL362637,CHEMBL362637,,0.0,http://www.openphacts.org/units/Nanomolar,365559.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,,CHEMBL378
5965,2203537.0,[],CHEMBL987023,Antiviral activity against HIV1 3B in human MT4 cells assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CCn1c(COc2ccc(NC(=S)Nc3ccccc3)cc2)n[nH]c1=S,CHEMBL1149790,Eur J Med Chem,2008.0,CHEMBL493580,CHEMBL493580,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,765661.0,>,1.0,1.0,>,IC50,ug.mL-1,27.2,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,ug ml-1,UO_0000274,27.2,CHEMBL378
5966,1470565.0,[],CHEMBL833080,Inhibitory activity against HIV-1 mutant strain 188L,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,CHEMBL1138799,J Med Chem,2004.0,CHEMBL338047,CHEMBL338047,6.60,0.0,http://www.openphacts.org/units/Nanomolar,380766.0,=,1.0,1.0,=,IC50,nM,250.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.25,CHEMBL378
5967,2009790.0,[],CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(C(=O)N1CCN(C(=O)c2ccccc2)CC1)c1c[nH]c2ncccc12,CHEMBL1138356,J Med Chem,2007.0,CHEMBL393719,CHEMBL393719,6.28,0.0,http://www.openphacts.org/units/Nanomolar,668054.0,=,1.0,1.0,=,IC50,nM,520.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,520.0,CHEMBL378
5968,2097983.0,[],CHEMBL931656,Antiviral activity against influenza B virus expressed in dog MDCK cells assessed as reduction of virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,CHEMBL1143112,Bioorg Med Chem Lett,2008.0,CHEMBL1643,CHEMBL1643,,0.0,http://www.openphacts.org/units/MicrogramPerMilliliter,697889.0,=,1.0,1.0,=,IC50,ug.mL-1,4270.0,CHEMBL613129,Influenza B virus,Influenza B virus,11520,IC50,mg/ml,UO_0000274,4.27,CHEMBL613129
5969,5132797.0,[],CHEMBL1646715,Antiviral activity against protease-resistant HIV1 isolate 93BR020 infected in human PBMC assessed as inhibition of viral p24 antigen production after 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(=O)n2c3ccccc3n(C[C@@H](O)N3CCN(C(c4ccccc4)c4ccccc4)CC3)c2c1C#N,CHEMBL1641440,Bioorg Med Chem,2011.0,CHEMBL1645090,CHEMBL1645090,5.30,0.0,http://www.openphacts.org/units/Nanomolar,1321079.0,=,1.0,1.0,=,IC50,nM,5000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,5.0,CHEMBL378
5970,1199859.0,[],CHEMBL710537,Inhibitory activity against 188L strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(C)cc(C#N)cc1C,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL308004,CHEMBL308004,7.80,0.0,http://www.openphacts.org/units/Nanomolar,127441.0,=,1.0,1.0,=,IC50,nM,16.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.016,CHEMBL378
5971,2414498.0,[],CHEMBL954254,Antiviral activity against HIV1 with reverse transcriptase Y188L mutation in human CEM cells assessed as protection against virus-induced cytopathicity,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCC(N)=O)[nH]c3ccc(Cl)cc23)c1,CHEMBL1153955,J Med Chem,2009.0,CHEMBL469985,CHEMBL469985,,0.0,http://www.openphacts.org/units/Nanomolar,810559.0,>=,1.0,1.0,>=,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
5972,15064909.0,[],CHEMBL3366183,Antiviral activity against wild type HIV1 infected in HEK293T cells transfected with plasmid VSV-G/pNL4-3.luc.R-E- assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc(-c2nc(NCc3cccc([N+](=O)[O-])c3)sc2Cc2ccccc2)cc1,CHEMBL3351628,Eur J Med Chem,2014.0,CHEMBL3330426,CHEMBL3330426,5.83,0.0,http://www.openphacts.org/units/Nanomolar,2246863.0,=,1.0,1.0,=,IC50,nM,1470.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.47,CHEMBL378
5973,2464766.0,[],CHEMBL964490,Antiviral activity against HBV assessed as inhibition of viral DNA replication by Southern blot,F,BAO_0000190,BAO_0000218,organism-based format,CCOC(=O)c1cc2c(CN3CCCCC3)c(O)c(OC)cc2nc1CSc1ccccc1,CHEMBL1157455,Bioorg Med Chem,2008.0,CHEMBL488472,CHEMBL488472,4.34,0.0,http://www.openphacts.org/units/Nanomolar,720481.0,=,1.0,1.0,=,IC50,nM,45200.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,45.2,CHEMBL613497
5974,816043.0,[],CHEMBL683815,Inhibitory activity against NNI-resistant HIV-1 strain A17 with Y181C mutation; ND is not determined.,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H](/N=C(\S)Nc1ccc(Br)cn1)c1ccccc1,CHEMBL1133139,Bioorg Med Chem Lett,2000.0,CHEMBL65242,CHEMBL65242,,0.0,http://www.openphacts.org/units/Nanomolar,111937.0,,1.0,0.0,,IC50,nM,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,,CHEMBL378
5975,22933308.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '4.0'}]",CHEMBL4739043,Antiviral activity against HIV-1 NL4-3 infected in human MT4 cells assessed as reduction in p24 gag protein incubated for 4 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCN(C(=O)CCc4ccc5c(c4)OCO5)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL4732243,Eur J Med Chem,2021.0,CHEMBL4740647,CHEMBL4740647,7.66,0.0,http://www.openphacts.org/units/Nanomolar,3560869.0,=,1.0,1.0,=,IC50,nM,22.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.022000000000000002,CHEMBL378
5976,800504.0,[],CHEMBL772932,Inhibition of Hepatitis C virus NS3 protease in vitro.,B,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc(F)c(CCNC(=O)[C@H](CC(F)F)NC(=O)[C@@H]2C[C@@H](c3ccccc3)CN2C(=O)[C@@H](O)c2ccccc2)c(F)c1,CHEMBL1147550,Bioorg Med Chem Lett,2004.0,CHEMBL303953,CHEMBL303953,,0.0,http://www.openphacts.org/units/Nanomolar,119337.0,>,1.0,1.0,>,IC50,nM,100000.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,uM,UO_0000065,100.0,CHEMBL4620
5977,2703498.0,[],CHEMBL1051806,Antiviral activity against wild type HIV1 by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(CSc1nnnn1-c1cccc2ccccc12)Nc1ccccc1[N+](=O)[O-],CHEMBL1153517,Bioorg Med Chem,2009.0,CHEMBL207900,CHEMBL207900,8.02,0.0,http://www.openphacts.org/units/Nanomolar,828898.0,=,1.0,1.0,=,IC50,nM,9.5,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,9.5,CHEMBL378
5978,1210460.0,[],CHEMBL710380,Inhibitory activity against 103N strain and 181C strain of HIV-I in MT-4 cells,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1Cl,CHEMBL1133923,Bioorg Med Chem Lett,2001.0,CHEMBL72205,CHEMBL72205,7.42,0.0,http://www.openphacts.org/units/Nanomolar,127443.0,=,1.0,1.0,=,IC50,nM,38.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.038,CHEMBL378
5979,17602981.0,[],CHEMBL3705251,"Inhibition Assay: Briefly, 2-10 nM of purified NS3 protease domains were pre-incubated at 37 C. for 10 minutes with 20 M isogenic NS4A peptide cofactors (Sigma, St. Louis, Mo.), in 40% glycerol buffer with 50 mM HEPES pH 7.5 and 10 mM DTT. Compounds were diluted serially 1:3 in DMSO, incubated with the enzyme/cofactor mixture for 10 minutes and reactions were started by the addition of 2 M RET S1 substrate (final concentration). Fluorescence increase was measured continuously over one hour using a Victor3 V fluorescence plate reader (Perkin Elmer, Waltham, Mass.).",B,BAO_0000190,BAO_0000357,single protein format,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CN(c2ccc(-c3cccc(F)c3)cc2)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,CHEMBL3639049,,2013.0,CHEMBL3644916,CHEMBL3644916,7.09,0.0,http://www.openphacts.org/units/Nanomolar,2518036.0,=,37.0,1.0,=,IC50,nM,82.0,CHEMBL4620,Hepatitis C virus genotype 1a (isolate 1) (HCV),Hepatitis C virus polyprotein,11104,IC50,nM,UO_0000065,82.0,CHEMBL4620
5980,19262008.0,[],CHEMBL4404417,Antiviral activity against HIV1 subtypeA mother ML274.W0M.ENV.B1,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1ncc(CO)s1,CHEMBL4402563,J Med Chem,2020.0,CHEMBL4547005,CHEMBL4547005,6.18,0.0,http://www.openphacts.org/units/Nanomolar,3216251.0,=,1.0,1.0,=,IC50,nM,660.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.66,CHEMBL378
5981,14658863.0,[],CHEMBL3266158,Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay,F,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1ccc(C(=O)N2CCN(C(=O)/C=C/c3ccc(OC)cc3)CC2)cc1,CHEMBL3259772,J Med Chem,2014.0,CHEMBL3262890,CHEMBL3262890,7.74,0.0,http://www.openphacts.org/units/Nanomolar,2101732.0,=,1.0,1.0,=,IC50,nM,18.2,CHEMBL3259471,Mus musculus,G-protein coupled receptor 183,10090,pIC50,,UO_0000065,7.74,CHEMBL3259471
5982,3467386.0,[],CHEMBL1250743,Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 6 hrs by p24 antigen based assay,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,CHEMBL1250555,Bioorg Med Chem,2010.0,CHEMBL129,CHEMBL129,,0.0,http://www.openphacts.org/units/Nanomolar,955469.0,=,1.0,1.0,=,IC50,nM,500000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,500.0,CHEMBL378
5983,3358052.0,[],CHEMBL1175764,Antiviral activity against HIV1 expressing reverse transcriptase K103N/L100I double mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3Cl)CC2)ncc1Br,CHEMBL1177791,Bioorg Med Chem Lett,2010.0,CHEMBL1170005,CHEMBL1170005,8.23,0.0,http://www.openphacts.org/units/Nanomolar,922327.0,=,1.0,1.0,=,IC50,nM,5.9,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,5.9,CHEMBL378
5984,482668.0,[],CHEMBL871947,In vitro inhibition of recombinant HIV-1 IIIB mutant WT,F,BAO_0000190,BAO_0000218,organism-based format,CCN(c1nc(F)ccc1NC(C)(C)C)C1CCN(C(=O)c2cc3cc(NC(=O)N4CCN(C)CC4)ccc3[nH]2)CC1,CHEMBL1129647,J Med Chem,1996.0,CHEMBL331912,CHEMBL331912,6.68,0.0,http://www.openphacts.org/units/Nanomolar,236810.0,=,1.0,1.0,=,IC50,nM,210.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.21,CHEMBL378
5985,18528902.0,[],CHEMBL4195001,Antiviral activity against HIV1 virions containing reverse transcriptase K103N mutant derived from HIV/VSG-G or HIV/HA virions infected 293T cells using human A549 cells as target cells assessed as inhibition of viral replication using compound pre-mixed virions followed by incubation with target cells for 24 hrs by luciferase reporter gene assay based defective HIV1 pseudoviral assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc2c(cc1OC)N(c1cc(OC)c(OC)c(OC)c1)C(C)CC2,CHEMBL4190384,Bioorg Med Chem Lett,2018.0,CHEMBL4209863,CHEMBL4209863,5.85,0.0,http://www.openphacts.org/units/Nanomolar,3076510.0,=,1.0,1.0,=,IC50,nM,1400.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,1.4,CHEMBL378
5986,12717564.0,[],CHEMBL2350960,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion after 12 days by ELISA,F,BAO_0000190,BAO_0000218,organism-based format,COc1cc(C2c3cc(O)c(OC)cc3C[C@@H](CO)[C@@H]2CO[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)ccc1O,CHEMBL2346656,Bioorg Med Chem Lett,2013.0,CHEMBL2346750,CHEMBL2346750,5.16,0.0,http://www.openphacts.org/units/Nanomolar,1874418.0,=,1.0,1.0,=,IC50,nM,6980.0,CHEMBL613497,Hepatitis B virus,Hepatitis B virus,10407,IC50,uM,UO_0000065,6.98,CHEMBL613497
5987,1403414.0,[],CHEMBL834758,Inhibitory concentration against 188L mutant was determined,F,BAO_0000190,BAO_0000218,organism-based format,Cc1ccc(Oc2nc(Nc3ccc(C#N)cc3)c(=O)n(C)c2C)c(C)c1,CHEMBL1145199,J Med Chem,2005.0,CHEMBL176383,CHEMBL176383,6.80,0.0,http://www.openphacts.org/units/Nanomolar,360753.0,=,1.0,1.0,=,IC50,nM,158.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.158,CHEMBL378
5988,3498061.0,[],CHEMBL1259504,Antiviral activity against HIV1 isolate 89.6 infected in human PM1 cells expressing CCR5 assessed as protection against virus-induced cytopathogenicity by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC(C)(C)N1,CHEMBL1255517,Bioorg Med Chem Lett,2010.0,CHEMBL254781,CHEMBL254781,5.00,0.0,http://www.openphacts.org/units/Nanomolar,963494.0,=,1.0,1.0,=,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
5989,2371453.0,[],CHEMBL1024879,Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1=NN(c2cccc(C(=O)O)c2)C(=O)/C1=C\c1ccc(-c2cccc(Cl)c2C)o1,CHEMBL1140145,J Med Chem,2008.0,CHEMBL492294,CHEMBL492294,4.85,0.0,http://www.openphacts.org/units/Nanomolar,746179.0,=,1.0,1.0,=,IC50,nM,14000.0,CHEMBL613493,Vaccinia virus,Vaccinia virus,10245,IC50,uM,UO_0000065,14.0,CHEMBL613493
5990,2927898.0,[],CHEMBL1044799,Antiviral activity against HIV1 NL4-3 infected in human TZM-b1 cells assessed as reduction in luciferase activity after 2 days by luciferase reporter gene assay,F,BAO_0000190,BAO_0000218,organism-based format,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCC(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL1154770,J Med Chem,2009.0,CHEMBL137174,CHEMBL137174,6.08,0.0,http://www.openphacts.org/units/Nanomolar,852843.0,=,1.0,1.0,=,IC50,nM,840.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.84,CHEMBL378
5991,22845273.0,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '49.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '49.0'}]",CHEMBL4721686,Antiviral activity against Laboratory adapted HIV-1 LA1 infected in human PBMC cells assessed as reduction in viral transmission to TZM-bl cells pretreated for 1 hr before viral transmission and further incubated for 48 hrs by luciferase based assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)c(F)c2)[nH]1)c1nc(CO)cs1,CHEMBL4715822,Eur J Med Chem,2018.0,CHEMBL4533529,CHEMBL4533529,6.58,0.0,http://www.openphacts.org/units/Nanomolar,3547069.0,=,1.0,1.0,=,IC50,nM,260.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.26,CHEMBL378
5992,18754866.0,[],CHEMBL4265061,Antiviral activity against HIV1 cYTA48P infected in PM1/CCR5 cells by single round assay,F,BAO_0000190,BAO_0000218,organism-based format,CC1(C)CC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC(C)(C)N1,CHEMBL4261625,Bioorg Med Chem,2018.0,CHEMBL254781,CHEMBL254781,6.20,0.0,http://www.openphacts.org/units/Nanomolar,3116212.0,=,1.0,1.0,=,IC50,nM,630.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.63,CHEMBL378
5993,2530523.0,[],CHEMBL1011336,Antiviral activity against Rift Valley fever virus infected in african green monkey Vero cells after 6 days by plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C1N[C@@H]2C(=C[C@H](O)[C@@H](O)[C@H]2O)c2cc3c(c(O)c21)OCO3,CHEMBL1150051,J Nat Prod,1992.0,CHEMBL98745,CHEMBL98745,,0.0,,790620.0,,1.0,0.0,,IC50,,,CHEMBL613130,Rift Valley fever virus,Rift Valley fever virus,11588,IC50,,,,CHEMBL613130
5994,159960.0,[],CHEMBL844410,Inhibition of 50% of the integrase-mediated catalysis of the Y-oligo substrate with 95% confidence interval,F,BAO_0000190,BAO_0000218,organism-based format,CC(CCC(=O)O)C1CC[C@H]2[C@@H]3CCC4C[C@H](OC(=O)/C=C/c5ccc(O)c(O)c5)CC[C@]4(C)[C@H]3C[C@H](OC(=O)/C=C/c3ccc(O)c(O)c3)[C@]12C.CC(CCC(=O)O)C1CC[C@H]2[C@@H]3[C@H](OC(=O)/C=C/c4ccc(O)c(O)c4)CC4C[C@H](OC(=O)/C=C/c5ccc(O)c(O)c5)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,CHEMBL1135546,J Med Chem,2002.0,CHEMBL3138127,CHEMBL3138127,,0.0,http://www.openphacts.org/units/Nanomolar,231558.0,>,1.0,1.0,>,IC50,nM,10000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,10.0,CHEMBL378
5995,1870797.0,[],CHEMBL904573,Antiviral activity against HIV1 3B in MT4 cells after 4 days by MTT method,F,BAO_0000190,BAO_0000218,organism-based format,CCc1c(C(=O)c2cccc3ccccc23)n(CC2CC=CC2)c(=O)[nH]c1=O,CHEMBL1142880,Eur J Med Chem,2007.0,CHEMBL229048,CHEMBL229048,6.66,0.0,http://www.openphacts.org/units/Nanomolar,636395.0,=,1.0,1.0,=,IC50,nM,220.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.22,CHEMBL378
5996,1751338.0,[],CHEMBL854523,Antiviral activity against wild type Measles virus Edmonston in Vero-CD150w cells by cytopathicity assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(Cc1ccccc1)Nc1cccc([N+](=O)[O-])c1,CHEMBL1145335,J Med Chem,2006.0,CHEMBL213884,CHEMBL213884,5.07,0.0,http://www.openphacts.org/units/Nanomolar,532784.0,=,1.0,1.0,=,IC50,nM,8500.0,CHEMBL613738,Measles virus,Measles virus,11234,IC50,uM,UO_0000065,8.5,CHEMBL613738
5997,2601825.0,[],CHEMBL1033994,Antiviral activity against HIV1,F,BAO_0000190,BAO_0000218,organism-based format,Cc1cc(/C=C/C#N)ccc1Oc1ccnc(Nc2ccc(C#N)cc2)n1,CHEMBL1136837,Bioorg Med Chem,2009.0,CHEMBL475087,CHEMBL475087,9.20,0.0,http://www.openphacts.org/units/Nanomolar,807844.0,=,1.0,1.0,=,IC50,nM,0.63,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,0.00063,CHEMBL378
5998,18812959.0,[],CHEMBL4276413,Antiviral activity against darunavir-resistant HIV1 at passage 30 infected in human MT4 cells assessed as reduction in p24 Gag protein production after 7 days by automated chemiluminescent enzyme immunoassay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL4270667,J Med Chem,2018.0,CHEMBL116,CHEMBL116,,0.0,http://www.openphacts.org/units/Nanomolar,3125925.0,>,1.0,1.0,>,IC50,nM,1000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,nM,UO_0000065,1000.0,CHEMBL378
5999,1497529.0,[],CHEMBL874206,Inhibitory concentration that required to Induced a 50% decrease in PBMC+PHA (healthy human's peripheral blood cells) cells survival ,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)(C)c1ccc(C(C)(C)C)c(C(=O)CC(SCC(=O)O)C(=O)O)c1,CHEMBL1141166,J Med Chem,2005.0,CHEMBL372501,CHEMBL372501,4.43,0.0,http://www.openphacts.org/units/Nanomolar,386651.0,=,1.0,1.0,=,IC50,nM,37100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676,IC50,uM,UO_0000065,37.1,CHEMBL378
